nctid,title,Study_Designs,Other_IDs,Locations,URL
NCT04372602,Duvelisib to Combat COVID-19,"Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",202007009,"Missouri Baptist Medical Center, Saint Louis, Missouri, United States|Washington University School of Medicine, Saint Louis, Missouri, United States",https://ClinicalTrials.gov/show/NCT04372602
NCT04902157,Relationship Between CT- Value With Prognosis in COVID-19 Patients,Observational Model: Cohort|Time Perspective: Prospective,SBMU.34.675,"SBMU, Tehran, Iran, Islamic Republic of|Nooshin Dalili, Tehran, Iran, Islamic Republic of",https://ClinicalTrials.gov/show/NCT04902157
NCT04364698,Observational Cohort of COVID-19 Patients at Raymond-Poincare,Observational Model: Cohort|Time Perspective: Prospective,20SBS-COVID-RPC,"Department of Infectiology, Raymond Poincaré Hospital, APHP, Garches, France",https://ClinicalTrials.gov/show/NCT04364698
NCT04482621,Decitabine for Coronavirus (COVID-19) Pneumonia- Acute Respiratory Distress Syndrome (ARDS) Treatment: DART Trial,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",IRB00247544,"Johns Hopkins University, Baltimore, Maryland, United States",https://ClinicalTrials.gov/show/NCT04482621
NCT04459637,COVID-19 Surveillance Based on Smart Wearable Device,Observational Model: Cohort|Time Perspective: Prospective,2020055-0615,"Peking University First Hospital, Beijing, Beijing, China",https://ClinicalTrials.gov/show/NCT04459637
NCT04425538,A Phase 2 Trial of Infliximab in Coronavirus Disease 2019 (COVID-19).,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,STUDY00000564,"Tufts Medical Center, Boston, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT04425538
NCT04547257,Safety & Performance Evaluation of Seraph 100 in Treatment of Pts With COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,CP022,"Carla Kikken-Jussen, Vaals, Limburg, Netherlands",https://ClinicalTrials.gov/show/NCT04547257
NCT04454307,Safety and Efficacy of Tramadol in COVID-19 Egyptian Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment",TRAM/COVID19,NA,https://ClinicalTrials.gov/show/NCT04454307
NCT04452435,Safety and Efficacy of C21 in Subjects With COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",VP-C21-006|2020-001502-38,"Department of Medicine, Civil Hospital and B J Medical College, Ahmadabad, Gujarat, India|Infectious Disease, Metas Adventist Hospital, Surat, Gujarat, India|Clinical Research Department, Basement, Unity Trauma Centre and ICU (Unity Hospital, Surat, Gujarat, India|First Floor Clinical Research Department Rhythm Heart Institute, Vadodara, Gujarat, India|Internal Medicine S.L. Raheja Hospital, Mumbai, Maharashtra, India|Department of Medicine, Government Medical College and Hospital, Nagpur, Maharashtra, India|Neuro Critical Care, Grant Medical Foundation Ruby Hall Clinic, Pune, Maharashtra, India|Department of Medicine, Noble Hospitals Pvt. Ltd, Pune, Maharashtra, India|Respiratory Medicine, University College Hospital, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04452435
NCT04333550,Application of Desferal to Treat COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",1398.1224,"Regenerative Medicine Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran, Kermanshah, Iran, Islamic Republic of",https://ClinicalTrials.gov/show/NCT04333550
NCT04432987,Dornase Alpha for the Treatment of COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,8820,"Acıbadem Altunizade Hospital, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04432987
NCT04537559,Impact of COVID-19 Outbreak on Non-COVID-19 Patients,Observational Model: Cohort|Time Perspective: Retrospective,2020-01017,"Geneva University Hospital, Geneva, Canton De Genève, Switzerland",https://ClinicalTrials.gov/show/NCT04537559
NCT04628143,A Study Evaluating the Efficacy and Safety of CKD-314 in Hospitalized Adult Patients Diagnosed With COVID-19 Pneumonia,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,A108_01CVD2013,NA,https://ClinicalTrials.gov/show/NCT04628143
NCT04336904,Clinical Study To Evaluate The Performance And Safety Of Favipiravir in COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment",HS216C17-PHASE III,"Asst Fatebenefratelli Sacco, Milano, Italy",https://ClinicalTrials.gov/show/NCT04336904
NCT04568031,Study of AZD1222 for the Prevention of COVID-19 in Japan,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",D8111C00002,"Research Site, Fukuoka-shi, Japan|Research Site, Hachioji-shi, Japan|Research Site, Minato-ku, Japan|Research Site, Sumida-ku, Japan|Research Site, Toshima-ku, Japan",https://ClinicalTrials.gov/show/NCT04568031
NCT04869228,"A Phase 3 Randomized, Double-Blind Placebo Controlled, Multi-regional Trial to Evaluate the Efficacy and Safety of GT0918 for the Treatment of Mild to Moderate COVID-19 Male Patients","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",GT0918-MR-3001,NA,https://ClinicalTrials.gov/show/NCT04869228
NCT04445272,Clinical Trial to Evaluate the Effectiveness and Safety of Tocilizumab for Treating Patients With COVID-19 Pneumonia,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,BREATH-19 (FSG011-20),"Hospital Universitario de Cabueñes, Gijón, Asturias, Spain|Hospital Universitari de Bellvitge, L'Hospitalet De Llobregat, Barcelona, Spain|Hospital Sant Joan de Déu de Manresa, Manresa, Barcelona, Spain|Hospital de Mataró, Mataró, Barcelona, Spain|Hospital Universitario de Galdakao, Galdakao, Bizkaia, Spain|Hospital Universitario Marqués Valdecilla, Santander, Cantabria, Spain|Hospital Público General del Tomelloso, Tomelloso, Ciudad Real, Spain|Hospital Jerez de la Frontera, Jerez De La Frontera, Cádiz, Spain|Hospital Universitari Son Espases, Palma De Mallorca, Islas Baleares, Spain|Hospital Universitario Fundación Alcorcón, Alcorcón, Madrid, Spain|Hospital Universitario de Fuenlabrada, Fuenlabrada, Madrid, Spain|Hospital Universitario de Getafe, Getafe, Madrid, Spain|Hospital Rey Juan Carlos, Móstoles, Madrid, Spain|Hospital Universitario Rey Juan Carlos, Móstoles, Madrid, Spain|Hospital Universitario Infanta Sofía, San Sebastián De Los Reyes, Madrid, Spain|Complejo Hospitalario de Navarra, Pamplona, Navarra, Spain|Hospital Nuestra Señora del Prado, Talavera De La Reina, Toledo, Spain|Complejo Hospitalario Universitario de Albacete, Albacete, Spain|Hospital Infanta Cristina, Badajoz, Spain|Hospital Clínic i Provincial Barcelona, Barcelona, Spain|Hospital de la Santa Creu i Sant Pau, Barcelona, Spain|Hospital Universitario de Burgos, Burgos, Spain|Hospital Universitario Dr. Josep Trueta, Gerona, Spain|Hospital Universitario Clínico San Cecilio, Granada, Spain|Hospital Universitario Virgen de las Nieves, Granada, Spain|Hospital General Universitario Gregorio Marañón, Madrid, Spain|Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain|Hospital Universitario HM Sanchinarro, Madrid, Spain|Hospital Universitario Infanta Leonor, Madrid, Spain|Hospital Universitario Ramón y Cajal, Madrid, Spain|Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain|Hospital Regional Universitario de Málaga, Málaga, Spain|Complexo Hospitalario Universitario de Ourense, Orense, Spain|Hospital Universitario Salamanca, Salamanca, Spain|Hospital Universitario Virgen de la Macarena, Sevilla, Spain|Hospital Universitario Virgen del Rocío, Sevilla, Spain|Hospital Virgen de la Salud, Toledo, Spain|Hospital Clinico Universitario de Valencia, Valencia, Spain|Hospital Universitari i Poliectenic La Fe, Valencia, Spain|Hospital Universitario Dr. Peset, Valencia, Spain|Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain|Hospital Universitario Miguel Servet, Zaragoza, Spain",https://ClinicalTrials.gov/show/NCT04445272
NCT04354831,A Study Evaluating the Efficacy and Safety of High-Titer Anti-SARS-CoV-2 Plasma in Hospitalized Patients With COVID-19 Infection,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,PRO00037712,"Froedtert Hospital, Milwaukee, Wisconsin, United States",https://ClinicalTrials.gov/show/NCT04354831
NCT04582266,PK and Safety of Remdesivir for Treatment of COVID-19 in Pregnant and Non-Pregnant Women in the US,Observational Model: Cohort|Time Perspective: Prospective,IMPAACT 2032|DAIDS Study ID 38746,"USC/Los Angeles County Medical Center NICHD CRS (5048), Los Angeles, California, United States|David Geffen School of Medicine at UCLA (CRS 5112), Los Angeles, California, United States|University California, San Diego (CRS 4601), San Diego, California, United States|Childrens Hospital (U. Colorado, Denver) NICHD CRS (5052), Denver, Colorado, United States|University of Florida (5051), Jacksonville, Florida, United States|Univ of Miami Pediatric/Perinatal HIV/AIDS (4201), Miami, Florida, United States|Emory University School of Medicine (CRS 5030), Atlanta, Georgia, United States|Ann & Robert H Lurie Children's Hospital of Chicago (4001), Chicago, Illinois, United States|Rush University Cook County Hospital NICHD CRS (5083), Chicago, Illinois, United States|Johns Hopkins University NICHD CRS (5092), Baltimore, Maryland, United States|Boston Medical Center Ped. HIV Program NICHD CRS (5011), Boston, Massachusetts, United States|Bronx-Lebanon Hospital Center (CRS 5114), Bronx, New York, United States|Jacobi Med. Ctr. Bronx NICHD CRS (5013), Bronx, New York, United States|Stony Brook University Medical Center (CRS 5040), Stony Brook, New York, United States|St. Jude Childrens Research Hosp, Memphis (6501), Memphis, Tennessee, United States|Texas Children's Hospital (Site 5128), Houston, Texas, United States|University of Puerto Rico Pediatric HIV/AIDS CRS (6601), San Juan, Puerto Rico",https://ClinicalTrials.gov/show/NCT04582266
NCT04351802,CORonavirus (COVID-19) Diagnostic Lung UltraSound Study,Observational Model: Cohort|Time Perspective: Prospective,282661,"Derriford Hospital, Plymouth, Devon, United Kingdom",https://ClinicalTrials.gov/show/NCT04351802
NCT04359095,Effectiveness and Safety of Medical Treatment for SARS-CoV-2 (COVID-19) in Colombia,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,76968,"Clinica santa Maria del lago, Bogota, DC, Colombia|Hospital Universitario de Neiva, Neiva, Huila, Colombia|Clínica Reina Sofía, Bogotá, Colombia|Fundacion Cardio Infantil, Bogotá, Colombia|Hospital Universitario San Ignacio, Bogotá, Colombia|Clinica Universitaria Colombia, Bogotá, Colombia|Hospital Universitario Nacional de Colombia, Bogotá, Colombia",https://ClinicalTrials.gov/show/NCT04359095
NCT04540393,AZD1222 Vaccine for the Prevention of COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,D8111C00001,"Research Site, Moscow, Russian Federation|Research Site, Moscow, Russian Federation|Research Site, Saint Petersburg, Russian Federation|Research Site, Saint-Petersburg, Russian Federation|Research Site, St. Petersburg, Russian Federation",https://ClinicalTrials.gov/show/NCT04540393
NCT04723394,Phase III Study of AZD7442 for Treatment of COVID-19 in Outpatient Adults,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",D8851C00001,"Research Site, Jasper, Alabama, United States|Research Site, Tempe, Arizona, United States|Research Site, Tucson, Arizona, United States|Research Site, Conway, Arkansas, United States|Research Site, Huntington Beach, California, United States|Research Site, Long Beach, California, United States|Research Site, Northridge, California, United States|Research Site, Pomona, California, United States|Research Site, Rolling Hills Estates, California, United States|Research Site, Cutler Bay, Florida, United States|Research Site, Miami, Florida, United States|Research Site, Miami, Florida, United States|Research Site, Pompano Beach, Florida, United States|Research Site, Conyers, Georgia, United States|Research Site, Chicago, Illinois, United States|Research Site, Lexington, Kentucky, United States|Research Site, Lake Charles, Louisiana, United States|Research Site, Saint Louis, Missouri, United States|Research Site, La Vista, Nebraska, United States|Research Site, North Las Vegas, Nevada, United States|Research Site, Secaucus, New Jersey, United States|Research Site, New York, New York, United States|Research Site, Charlotte, North Carolina, United States|Research Site, Charlotte, North Carolina, United States|Research Site, Charlotte, North Carolina, United States|Research Site, Salisbury, North Carolina, United States|Research Site, Statesville, North Carolina, United States|Research Site, Fargo, North Dakota, United States|Research Site, Columbus, Ohio, United States|Research Site, West Columbia, South Carolina, United States|Research Site, Knoxville, Tennessee, United States|Research Site, Dallas, Texas, United States|Research Site, Houston, Texas, United States|Research Site, Houston, Texas, United States|Research Site, Houston, Texas, United States|Research Site, Houston, Texas, United States|Research Site, Houston, Texas, United States|Research Site, Humble, Texas, United States|Research Site, Buenos Aires, Argentina|Research Site, Buenos Aires, Argentina|Research Site, Ciudad de Buenos Aires, Argentina|Research Site, Munro, Argentina|Research Site, Blumenau, Brazil|Research Site, Botucatu, Brazil|Research Site, Maringa, Brazil|Research Site, Porto Alegre, Brazil|Research Site, Porto Alegre, Brazil|Research Site, Ribeirão Preto, Brazil|Research Site, Sao Bernardo do Campo, Brazil|Research Site, Sao Paulo, Brazil|Research Site, Sorocaba, Brazil|Research Site, São Paulo, Brazil|Research Site, São Paulo, Brazil|Research Site, Plovdiv, Bulgaria|Research Site, Sofia, Bulgaria|Research Site, Sofia, Bulgaria|Research Site, Vratsa, Bulgaria|Research Site, Bilina, Czechia|Research Site, Hradec Kralove, Czechia|Research Site, Kolin, Czechia|Research Site, Ostrava, Czechia|Research Site, Svitavy, Czechia|Research Site, Berlin - Friedrichshain, Germany|Research Site, Berlin, Germany|Research Site, Berlin, Germany|Research Site, Frankfurt/Main, Germany|Research Site, Frankfurt, Germany|Research Site, Hamburg, Germany|Research Site, Hannover, Germany|Research Site, Koblenz, Germany|Research Site, Köln, Germany|Research Site, Mainz, Germany|Research Site, München-Pasing, Germany|Research Site, München, Germany|Research Site, Budapest, Hungary|Research Site, Budapest, Hungary|Research Site, Debrecen, Hungary|Research Site, Gyöngyös, Hungary|Research Site, Nyíregyháza, Hungary|Research Site, Tatabánya, Hungary|Research Site, Bologna, Italy|Research Site, Guastalla, Italy|Research Site, Milano, Italy|Research Site, Milano, Italy|Research Site, Napoli, Italy|Research Site, Piacenza, Italy|Research Site, Pisa, Italy|Research Site, Roma, Italy|Research Site, Chiba-shi, Japan|Research Site, Hachioji-shi, Japan|Research Site, Iruma-Gun, Japan|Research Site, Kobe-shi, Japan|Research Site, Kyoto-shi, Japan|Research Site, Maebashi-shi, Japan|Research Site, Narita-shi, Japan|Research Site, Sendai-shi, Japan|Research Site, Shinagawa-ku, Japan|Research Site, Shinagawa-ku, Japan|Research Site, Shinjuku-ku, Japan|Research Site, Tsukuba-shi, Japan|Research Site, Aguascalientes, Mexico|Research Site, Chihuahua, Mexico|Research Site, Cuauhtemoc, Mexico|Research Site, Cuautitlan Izcalli, Mexico|Research Site, Ecatepec de Morelos, Mexico|Research Site, Guadalajara, Mexico|Research Site, Guadalajara, Mexico|Research Site, Mazatlán, Mexico|Research Site, Monterrey, Mexico|Research Site, Mérida, Mexico|Research Site, Tlalpan, Mexico|Research Site, Tlalpan, Mexico|Research Site, Chancay, Peru|Research Site, Lima, Peru|Research Site, Lima, Peru|Research Site, Lima, Peru|Research Site, Elbląg, Poland|Research Site, Poznań, Poland|Research Site, Rzeszów, Poland|Research Site, Skierniewice, Poland|Research Site, Strzelce Opolskie, Poland|Research Site, Wołomin, Poland|Research Site, Wrocław, Poland|Research Site, Łódź, Poland|Research Site, Moscow, Russian Federation|Research Site, Murmansk, Russian Federation|Research Site, Saint-Petersburg, Russian Federation|Research Site, Saint-Petersburg, Russian Federation|Research Site, Saint-Petersburg, Russian Federation|Research Site, Saint-Petersburg, Russian Federation|Research Site, Saint-Petersburg, Russian Federation|Research Site, Cabra, Spain|Research Site, Centelles (Barcelona), Spain|Research Site, Girona, Spain|Research Site, Madrid, Spain|Research Site, Málaga, Spain|Research Site, Dnipro, Ukraine|Research Site, Ivano-Frankivsk, Ukraine|Research Site, Kharkiv Region, Ukraine|Research Site, Kherson, Ukraine|Research Site, Kyiv, Ukraine|Research Site, Lutsk, Ukraine|Research Site, Zaporizhia, Ukraine|Research Site, Zhytomyr, Ukraine|Research Site, Blackpool, United Kingdom|Research Site, Bracknell, United Kingdom|Research Site, Bristol, United Kingdom|Research Site, Cambridge, United Kingdom|Research Site, Connor Downs, United Kingdom|Research Site, Highgate, United Kingdom|Research Site, Leicester, United Kingdom|Research Site, Preston, United Kingdom|Research Site, Rochdale, United Kingdom",https://ClinicalTrials.gov/show/NCT04723394
NCT04345445,Study to Evaluate the Efficacy and Safety of Tocilizumab Versus Corticosteroids in Hospitalised COVID-19 Patients With High Risk of Progression,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,TVCS-COVID19,"University Malaya Medical Centre, Kuala Lumpur, Malaysia",https://ClinicalTrials.gov/show/NCT04345445
NCT04883138,Recombinant Hyperimmune Polyclonal Antibody (GIGA-2050) in COVID-19 Patients,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,GG-GIGA-2050-001,"Icahn School of Medicine at Mount Sinai, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04883138
NCT04508712,Long-term Outcomes in Patients With COVID-19,Observational Model: Case-Only|Time Perspective: Prospective,COVID-19 Prognosis,"Renji Hospital, Shanghai Jiaotong University School of Medicine, Pudong, Shanghai, China",https://ClinicalTrials.gov/show/NCT04508712
NCT04361422,Isotretinoin in Treatment of COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,9469305c,NA,https://ClinicalTrials.gov/show/NCT04361422
NCT04460547,Worldwide Trends on COVID-19 Research After the Declaration of COVID-19 Pandemic,Observational Model: Cohort|Time Perspective: Retrospective,COAHS,NA,https://ClinicalTrials.gov/show/NCT04460547
NCT04355741,"Gut Microbiota, ""Spark and Flame"" of COVID-19 Disease",Observational Model: Case-Only|Time Perspective: Cross-Sectional,COVID19_Microbiota,"Hospital CUF Infante Santo, S.A., Lisbon, Portugal|Hospital de São Francisco Xavier, Lisbon, Portugal|Centro Hospitalar Universitário São João, Oporto, Portugal",https://ClinicalTrials.gov/show/NCT04355741
NCT04388683,Inhaled Nitric Oxide for Preventing Progression in COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,STUDY00000554,"Tufts Medical Center, Boston, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT04388683
NCT04625972,"Phase III Double-blind, Placebo-controlled Study of AZD7442 for Post- Exposure Prophylaxis of COVID-19 in Adults","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention",D8850C00003,"Research Site, Guntersville, Alabama, United States|Research Site, Tempe, Arizona, United States|Research Site, Little Rock, Arkansas, United States|Research Site, Bakersfield, California, United States|Research Site, Corona, California, United States|Research Site, Garden Grove, California, United States|Research Site, Huntington Beach, California, United States|Research Site, Huntington Park, California, United States|Research Site, Modesto, California, United States|Research Site, Coral Springs, Florida, United States|Research Site, Miami Lakes, Florida, United States|Research Site, Miami Lakes, Florida, United States|Research Site, Miami, Florida, United States|Research Site, Miami, Florida, United States|Research Site, Miami, Florida, United States|Research Site, Miami, Florida, United States|Research Site, Miami, Florida, United States|Research Site, Miami, Florida, United States|Research Site, Mount Dora, Florida, United States|Research Site, North Miami, Florida, United States|Research Site, Pembroke Pines, Florida, United States|Research Site, Pompano Beach, Florida, United States|Research Site, Tampa, Florida, United States|Research Site, West Palm Beach, Florida, United States|Research Site, Atlanta, Georgia, United States|Research Site, Buford, Georgia, United States|Research Site, Conyers, Georgia, United States|Research Site, Chicago, Illinois, United States|Research Site, Chicago, Illinois, United States|Research Site, Hazel Crest, Illinois, United States|Research Site, Noblesville, Indiana, United States|Research Site, West Des Moines, Iowa, United States|Research Site, Wichita, Kansas, United States|Research Site, Owensboro, Kentucky, United States|Research Site, Bethesda, Maryland, United States|Research Site, High Point, North Carolina, United States|Research Site, Wilmington, North Carolina, United States|Research Site, Orangeburg, South Carolina, United States|Research Site, Dallas, Texas, United States|Research Site, El Paso, Texas, United States|Research Site, Friendswood, Texas, United States|Research Site, Gonzales, Texas, United States|Research Site, Harlingen, Texas, United States|Research Site, Houston, Texas, United States|Research Site, San Antonio, Texas, United States|Research Site, Riverton, Utah, United States|Research Site, Alexandria, Virginia, United States|Research Site, Norfolk, Virginia, United States|Research Site, Portsmouth, Virginia, United States|Research Site, Richmond, Virginia, United States|Research Site, Tacoma, Washington, United States|Research Site, Bournemouth, United Kingdom|Research Site, Hayle, United Kingdom|Research Site, London, United Kingdom|Research Site, London, United Kingdom|Research Site, London, United Kingdom|Research Site, Manchester, United Kingdom|Research Site, Southampton, United Kingdom",https://ClinicalTrials.gov/show/NCT04625972
NCT04377763,Developement and Evaluation of Serological Assays for COVID-19,Observational Model: Cohort|Time Perspective: Retrospective,20MWI-SEROCOV,"Laboratory of microbiology of hospital hygiene, Ambroise Paré Hospital, APHP, Boulogne-Billancourt, France",https://ClinicalTrials.gov/show/NCT04377763
NCT04578158,Trial to Study the Adjuvant Benefits of Quercetin Phytosome in Patients With COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,LUMHS/REC/894,"Liaquat University Hospital, Jāmshoro, Sindh, Pakistan",https://ClinicalTrials.gov/show/NCT04578158
NCT04421534,Utility of Lactoferrin as an Adjunct Therapeutic Agent for COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,CUKA-001,NA,https://ClinicalTrials.gov/show/NCT04421534
NCT04501796,A Trial of NT-I7 in COVID-19 (SPESELPIS),"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",NIT-116 (SPESELPIS),"Nih/Niaid, Bethesda, Maryland, United States|University of Nebraska Medical Center, Omaha, Nebraska, United States",https://ClinicalTrials.gov/show/NCT04501796
NCT04428801,Autologous Adipose-derived Stem Cells (AdMSCs) for COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment",CTX0020-003,NA,https://ClinicalTrials.gov/show/NCT04428801
NCT04628039,"Chronic Lung Disease and COVID-19: Understanding Severity, Recovery and Rehabilitation Needs",Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,F3666-R|1I01RX003666-01,"VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle, Washington, United States",https://ClinicalTrials.gov/show/NCT04628039
NCT04932941,MP1032 Treatment in Patients With Moderate to Severe COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",MP1032-CT05|2021-000344-21,NA,https://ClinicalTrials.gov/show/NCT04932941
NCT04466644,COVID-19: A Prevalence Study of Two ART Centres After the Pandemic Lockdown in the USA (COVID-19 Free Clinics),Observational Model: Other|Time Perspective: Prospective,IGX2-COV-JC-20-04|20201490,"Boston IVF Fertility Clinic, Boston, Massachusetts, United States|Utah Fertility Clinic, Pleasant Grove, Utah, United States",https://ClinicalTrials.gov/show/NCT04466644
NCT04431908,Validation of a Rapid Quantitative Test for Loss of Smell in COVID-19 Subjects,Observational Model: Cohort|Time Perspective: Prospective,2000028259,"Yale New Haven Hospital, New Haven, Connecticut, United States",https://ClinicalTrials.gov/show/NCT04431908
NCT04343183,Hyperbaric Oxygen Therapy (HBOT) as a Treatment for COVID-19 (COVID-19) Infection,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,STUDY00001051,"Ochsner Medical Center, New Orleans, Louisiana, United States",https://ClinicalTrials.gov/show/NCT04343183
NCT04347915,The Phase 2 Study to Evaluate the Safety and Efficacy of Clevudine in Patients With Moderate COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,BK-CLV-201,"Korea University Guro Hospital, Seoul, Korea, Republic of",https://ClinicalTrials.gov/show/NCT04347915
NCT04625725,"Phase III Double-blind, Placebo-controlled Study of AZD7442 for Pre-exposure Prophylaxis of COVID-19 in Adult.","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention",D8850C00002,"Research Site, Birmingham, Alabama, United States|Research Site, Tempe, Arizona, United States|Research Site, Little Rock, Arkansas, United States|Research Site, Cerritos, California, United States|Research Site, Fountain Valley, California, United States|Research Site, Fresno, California, United States|Research Site, Garden Grove, California, United States|Research Site, Huntington Beach, California, United States|Research Site, Lancaster, California, United States|Research Site, Modesto, California, United States|Research Site, Victorville, California, United States|Research Site, Hartford, Connecticut, United States|Research Site, Middlebury, Connecticut, United States|Research Site, Clearwater, Florida, United States|Research Site, Coral Springs, Florida, United States|Research Site, Hollywood, Florida, United States|Research Site, Lauderdale Lakes, Florida, United States|Research Site, Miami, Florida, United States|Research Site, Miami, Florida, United States|Research Site, Miami, Florida, United States|Research Site, Ormond Beach, Florida, United States|Research Site, Wesley Chapel, Florida, United States|Research Site, West Palm Beach, Florida, United States|Research Site, Atlanta, Georgia, United States|Research Site, Columbus, Georgia, United States|Research Site, Conyers, Georgia, United States|Research Site, Chicago, Illinois, United States|Research Site, Hazel Crest, Illinois, United States|Research Site, Quincy, Illinois, United States|Research Site, Evansville, Indiana, United States|Research Site, Noblesville, Indiana, United States|Research Site, Wichita, Kansas, United States|Research Site, Wichita, Kansas, United States|Research Site, Minneapolis, Minnesota, United States|Research Site, Saint Louis, Missouri, United States|Research Site, Omaha, Nebraska, United States|Research Site, Las Vegas, Nevada, United States|Research Site, Las Vegas, Nevada, United States|Research Site, Albuquerque, New Mexico, United States|Research Site, Bronx, New York, United States|Research Site, Jamaica, New York, United States|Research Site, Ridgewood, New York, United States|Research Site, Greensboro, North Carolina, United States|Research Site, Columbus, Ohio, United States|Research Site, Oklahoma City, Oklahoma, United States|Research Site, Summerville, South Carolina, United States|Research Site, Rapid City, South Dakota, United States|Research Site, Austin, Texas, United States|Research Site, Conroe, Texas, United States|Research Site, El Paso, Texas, United States|Research Site, El Paso, Texas, United States|Research Site, Houston, Texas, United States|Research Site, San Antonio, Texas, United States|Research Site, Sugar Land, Texas, United States|Research Site, Layton, Utah, United States|Research Site, Alexandria, Virginia, United States|Research Site, Chesapeake, Virginia, United States|Research Site, Alken, Belgium|Research Site, Bruxelles, Belgium|Research Site, Gozée, Belgium|Research Site, Namur, Belgium|Research Site, Wetteren, Belgium|Research Site, Clermont-Ferrand cedex, France|Research Site, Dijon cedex, France|Research Site, La Roche S/ Yon Cedex 9, France|Research Site, Lille, France|Research Site, Limoges cedex, France|Research Site, Nantes Cedex 1, France|Research Site, Paris cedex 10, France|Research Site, Paris cedex 14, France|Research Site, Saint Etienne Cedex 2, France|Research Site, Tours cedex 9, France|Research Site, Barcelona, Spain|Research Site, Madrid, Spain|Research Site, Madrid, Spain|Research Site, Marbella (Málaga), Spain|Research Site, Pozuelo de Alarcón, Spain|Research Site, Enfield, United Kingdom|Research Site, Hayle, United Kingdom|Research Site, London, United Kingdom|Research Site, Manchester, United Kingdom|Research Site, Preston, United Kingdom|Research Site, Rochdale, United Kingdom|Research Site, Southampton, United Kingdom|Research Site, Torpoint, United Kingdom|Research Site, Wakefield, United Kingdom",https://ClinicalTrials.gov/show/NCT04625725
NCT04333407,Preventing Cardiac Complication of COVID-19 Disease With Early Acute Coronary Syndrome Therapy: A Randomised Controlled Trial.,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,20HH5868,"Charing Cross Hospital, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04333407
NCT04331509,COVID-19 Symptom Tracker,Observational Model: Cohort|Time Perspective: Prospective,COVID-19 Symptom tracker,"Massachusetts General Hospital, Boston, Massachusetts, United States|King's College London, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04331509
NCT04470622,Aprepitant Injectable Emulsion in Patients With COVID-19 (GUARDS-1),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",HTX-019-202,"Helen Keller Hospital, Sheffield, Alabama, United States|University of California, Irvine Medical Center, Orange, California, United States|Yale University School of Medicine, New Haven, Connecticut, United States|Stony Brook University Hospital, Stony Brook, New York, United States|Memorial Hermann - Memorial City Medical Center, Houston, Texas, United States|Ponce Medical School Foundation, Ponce, Puerto Rico",https://ClinicalTrials.gov/show/NCT04470622
NCT04610554,Lung Diffusing Capacity for Nitric Oxide and Carbon Monoxide Early After Mild-to-severe COVID-19,Observational Model: Cohort|Time Perspective: Cross-Sectional,SARS-CoV-2_DLNO,"IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy",https://ClinicalTrials.gov/show/NCT04610554
NCT04523090,Catalysing the Containment of COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",C3-RCT,"The Aurum Institute, Tembisa, Gauteng, South Africa|University of KwaZulu-Natal, Durban, KwaZulu-Natal, South Africa|Perinatal HIV Research Unit, Klerksdorp, North West, South Africa|University of Cape Town, Cape Town, Western Cape, South Africa",https://ClinicalTrials.gov/show/NCT04523090
NCT04452669,VentaProst in Subjects With COVID-19 Requiring Mechanical Ventilation,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",APC-VPCOV-CLN-001,"Ohio State University, Columbus, Ohio, United States",https://ClinicalTrials.gov/show/NCT04452669
NCT04406389,Anticoagulation in Critically Ill Patients With COVID-19 (The IMPACT Trial),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,20-04021936,"Weill Cornell Medicine, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04406389
NCT04889040,Study to Evaluate the Effects of RO7496998 (AT-527) in Non-Hospitalized Adult and Adolescent Participants With Mild or Moderate COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",CV43043|2020-005759-18,"Centro de Diagnóstico Dr. Enrique Rossi, Ciudad Autonoma Buenos Aires, Argentina|Instituto Medico Rio Cuarto, Cordoba, Argentina|Sanatorio Allende, Cordoba, Argentina|Clínica Olivos, Florida, Argentina|Instituto Medico Platense, La Plata, Argentina|Instituto Ave Pulmo, Mar Del Plata, Argentina|Clínica Independencia, Munro, Argentina|Hospital Interzonal General de Agudos Eva Perón, Parque San Martín, Argentina|Instituto Medico de la Fundacion Estudios Clinicos, Rosario, Argentina|Clinica Mayo de U.M.C.B. S.R.L, San Miguel de Tucumán, Argentina|Sanatorio Medico de Diagnostico Y Tratamiento, Santa Fe, Argentina|Centro de Investigación Clínica - Clínica Viedma, Viedma, Argentina|Maison Médicale La Brèche, Châtelineau, Belgium|Private Practice Dr Jean Benoit Martinot, Erpent, Belgium|Medif, Gozée, Belgium|L2 Ip Instituto de Pesquisas Clinicas Ltda ME; Centro Medico Hospitalar, Brasilia, DF, Brazil|Chronos Pesquisa Clinica, Taguatinga, DF, Brazil|Hospital Vera Cruz, Belo Horizonte, MG, Brazil|Hospital das Clinicas - UFMG, Belo Horizonte, MG, Brazil|Hospital Agamenon Magalhães, Recife, PE, Brazil|Hospital Nossa Senhora das Graças, Curitiba, PR, Brazil|Hospital Erasto Gaertner, Curitiba, PR, Brazil|Instituto D'Or de Pesquisa e Ensino, Rio de Janeiro, RJ, Brazil|Instituto Méderi de Pesquisa e Saúde, Passo Fundo, RS, Brazil|Santa Casa de Porto Alegre, Porto Alegre, RS, Brazil|Hospital Dia do Pulmão, Blumenau, SC, Brazil|Clínica SUPERA, Chapeco, SC, Brazil|Hospital E Maternidade Celso Pierro PUCCAMP, Campinas, SP, Brazil|Hospital Das Clinicas da Faculdade de Medicina de Ribeirão Preto - USP, Ribeirão Preto, SP, Brazil|CEMEC - Centro Multidisciplinar de Estudos Clínicos, Sao Bernardo Do Campo, SP, Brazil|Fundacao Faculdade Regional de Medicina de Sao Jose Do Rio Preto Hospital de Base - PPDS, Sao Jose Do Rio Preto, SP, Brazil|CPQuali Pesquisa Clínica Sao Paulo, Sao Paulo, SP, Brazil|Grupo NotreDame Intermedica, Sao Paulo, SP, Brazil|Institute of Infectious Diseases Emilio Ribas, Sao Paulo, SP, Brazil|Conjunto Hospitalar do Mandaqui, Sao Paulo, SP, Brazil|Instituto do Coração - HCFMUSP, Sao Paulo, SP, Brazil|Multiprofile Hospital for Active Treatment Puls AD PPDS, Blagoevgrad, Bulgaria|Multiprofile Hospital for Active Treatment - Dobrich AD, Dobrich, Bulgaria|MHAT Stamen Iliev AD; Pharmacy, Montana, Bulgaria|Multiprofile Hospital for Active Treatment Plovdiv, Plovdiv, Bulgaria|Specialized Hospital for Active Treatment of Pneumophthisiatric Diseases Dr. D. Gramatikov - Ruse, Ruse, Bulgaria|Multiprofile Hospital for Active Treatment - Samokov EOOD, Samokov, Bulgaria|Multiprofile Hospital For Active Treatment Sliven То Military Hospital Sofia; Pharmacy, Sliven, Bulgaria|Clinica Vespucio (CV), La Florida, Chile|Centro de Estudios Clinicos E Investigaciones Medicas, Peñalolen, Chile|Hospital Clinico de la Pontificia universidad Catolica de Chile, Santiago, Chile|Fundacion Hospital Universidad del Norte, Barranquilla, Colombia|Centro de Atencion y Diagnostico de Enfermedades Infecciosas CDI S.A., Bucaramanga, Colombia|Fundacion Centro de Investigacion Clinica CIC, Cali, Colombia|Fundacion Oftalmologica de Santander Foscal, Floridablanca, Colombia|Instituto Neumológico del Oriente, Floridablanca, Colombia|Caja de Compensación Familiar de Caldas, Manizales, Colombia|Asociación IPS Médicos Internistas de Caldas, Manizales, Colombia|Clinica Cardiovascular Santa Maria, Medellin, Colombia|Fundacion Hospitalaria San Vicente de Paul, Medellín, Colombia|Healthy Medical Center SAS, Zipaquirá, Colombia|Corporacion GIHEMA SA, San José, Costa Rica|General county hospital Pozega, Pozega, Croatia|University Hospital Centre Split, Split, Croatia|General Hospital Dr Josip Bencevic, Vinkovci, Croatia|Opca bolnica Zadar, Zadar, Croatia|University Hospital for Infection Diseases ""Dr. Fran Mihaljevic"" - PPDS, Zagreb, Croatia|Aalborg Universitetshospital, Aalborg, Denmark|Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark|Sjællands Universitetshospital, Roskilde, Roskilde, Denmark|Centre Hospitalier Victor Dupouy, Argenteuil, France|Hôpital Saint Joseph, Marseille, France|Hopital Tenon, Paris, France|Centre Hospitalier Saint Quentin, Saint Quentin, France|zibp Zentrum für Infektiologie Berlin Prenzlauer Berg GmbH, Berlin, Germany|Klinikum Chemnitz gGmbH, Chemnitz, Germany|Städtisches Klinikum Dessau, Dessau-Roßlau, Germany|IKF Pneumologie, Frankfurt am Main, Germany|Universitätsklinikum Frankfurt, Frankfurt, Germany|Universitätsklinikum Freiburg, Freiburg, Germany|Praxis am Ebertplatz, Köln, Germany|IKF Pneumologie Mainz, Mainz, Germany|Evangelismos General Hospital of Athens, Athens, Greece|Alexandra Hospital, Athens, Greece|Orszagos Koranyi Pulmonologiai Intezet, Budapest, Hungary|Szent Janos Korhaz es Eszak-budai Egyesitett Korhazak, Budapest, Hungary|Debreceni Egyetem Klinikai Kozpont, Debrecen, Hungary|Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Klinikai Kozpont, Szeged, Hungary|Fejer Megyei Szent Gyorgy Egyetemi Oktato Korhaz, Székesfehérvár, Hungary|Mentaház Magánorvosi Központ Kft., Székesfehérvár, Hungary|MGM's Medical College & Hospital, Aurangabad, Maharashtra, India|ASST di Lecco - Presidio Ospedaliero A. Manzoni di Lecco, Lecco, Lombardia, Italy|Ospedale San Raffaele S.r.l., Milano, Lombardia, Italy|ASST Fatebenefratelli Sacco - Ospedale Luigi Sacco, Milano, Lombardia, Italy|Asst Grande Ospedale Metropolitano Niguarda, Milano, Lombardia, Italy|Comprensorio Amedeo Di Savoia Birago Di Vische, Torino, Piemonte, Italy|Ospedali Riuniti Azienda Ospedaliero Universitaria, Foggia, Puglia, Italy|Azienda Ospedaliero Universitaria Pisana, Pisa, Toscana, Italy|Funabashi Central Hospital, Funabashi-Shi, Japan|Higashiosaka city Medical Center, Higashiosaka-Shi, Japan|Rinku General Medical Center, Izumisano, Japan|Sagamihara Kyodo Hospital, Kanagawa, Japan|Misyuku hospital, Meguro-Ku, Japan|Nagoya City East Medical Center, Nagoya-Shi Chikusa-Ku, Japan|Fujita Health University Banbuntane Hotokukai Hospital, Nagoya-shi, Japan|Tokyo Metropolitan Police Hospital, Nakano-Ku, Japan|IUHW Narita Hospital, Narita, Japan|Houjin Syadan Kouhoukai Takagi Hospital, Okawa-Shi, Japan|Okayama City Hospital, Okayama, Japan|Ome Municipal General Hospital, Ome-Shi, Japan|Osaka City General Hospital, Osaka, Japan|National Hospital Organization Kinki-Chuo Chest Medical Center, Sakai-shi, Japan|Tokyo Shinagawa Hospital Medical Corporation Association Tokyokyojuno-kai, Shinagawa, Japan|St. Luke's International Hospital, Tokyo, Japan|Edogawa Medicare Hospital, Tokyo, Japan|Center Hospital of the National Center for Global Health and Medicine, Tokyo, Japan|JCHO Tokyo Shinjuku Medical Center, Tokyo, Japan|Tokyo Medical University Hachioji Medical Center, Tokyo, Japan|National Hospital Organization Kasumigaura Medical Center, Tsuchiurat, Japan|Mie Prefectural Medical Centre, Yokkaichi, Japan|CIMAB SA de CV, Torreón, Coahuila, Mexico|Hospital Civil Fray Antonio Alcalde, Guadalajara, Jalisco, Mexico|Panamerican Clinical Research S.A de C.V., Guadalajara, Jalisco, Mexico|Clinstile S.A de C.V., Mexico City, Mexico CITY (federal District), Mexico|PanAmerican Clinical Research, Querétaro, Queréaro, Queretaro, Mexico|Kohler and Milstein Research, García Gineres, Yucatan, Mexico|Hospital General de Culiacan, Culiacan, Mexico|Instituto Jalisciense de Investigacion Clinica S.A. de C.V., Guadalajara, Mexico|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico, Mexico|CEPREP; Hospital Universitario, Monterrey, Mexico|Asociacion Civil Impacta Salud y Educacion, Barranco, Peru|Hospital Alberto Sabogal Sologuren ESSALUD, Callao, Peru|Hospital Chancay y Servicios Basicos de Salud, Huaral, Peru|Clinica Providencia (Inverconsult Sociedad Anonima), Lima, Peru|Clinica Internacional Sede Lima, LIma, Peru|Krakowskie Centrum Medyczne, Kraków, Poland|ID Clinic, Myslowice, Poland|Centrum Medyczne CMP, Piaseczno, Poland|Centrum Badan Klinicznych Piotr Napora Lekarze Spolka Partnerska, Wrocław, Poland|Unidade Local de Saúde do Alto Minho, Arcos de Valdevez, Portugal|Hospital Senhora da Oliveira - Guimaraes, E.P.E, Guimarães, Portugal|Centro Hospitalar de Leiria (CHL), Leiria, Portugal|Unidade Local de Saude de Matosinhos SA, Matosinhos, Portugal|Prof. Dr. Matei Bals Institute of Infectious Diseases, Bucuresti, Romania|Dr. Victor Babes Clinical Hospital For Tropical and Infectious Diseases, Bucuresti, Romania|County Hospital Caracal, Caracal, Romania|Clinical Hospital For Infectious Diseases; Infectious Diseases, Constanţa, Romania|Spitalul Clinic de Boli Infectioase ""Sfanta Parascheva"" Iasi, Iasi, Romania|Sibiu Emergency Clinical County Hospital, Sibiu, Romania|Dr. Victor Babes Clinical Hospital of Pneumophthisiology and Infectious Diseases, Timişoara, Romania|Dorozhnaya Clinical Hospital n.a. Semashko at Lublino Station OAO Rzhd, Moscow, Moskovskaja Oblast, Russian Federation|Moscow Scientific Research Institute of Epidemiology, Moscow, Moskovskaja Oblast, Russian Federation|MEDSI Clinical Hospital on Pyatnitsky Highway; Department of antitumor drug therapy, Moscow, Moskovskaja Oblast, Russian Federation|Central Clinical Hospital of the General Management, Moskva, Moskovskaja Oblast, Russian Federation|St Petersburg City Outpatient Clinic #109, Saint Petersburg, Sankt Petersburg, Russian Federation|SPb GBUZ City Outpatient Clinic #106, Saint Petersburg, Sankt Petersburg, Russian Federation|City Hospital #40 of Kurortniy Administrative District, St. Petersburg, Sankt Petersburg, Russian Federation|Influenza Research Institute, St. Petersburg, Sankt Petersburg, Russian Federation|Medical Military Academy n.a S.M.Kirov, St.Petersburg, Russian Federation|Health Centre 'Dr. Dragisa Misovic' Cacak, Cacak, Serbia|Poliklinika Kragujmedic, Kragujevac, Serbia|Clinical Center Nis, NIS, Serbia|Clinical Centre of Vojvodina, Nova Sad, Serbia|Health Center Uzice, Užice, Serbia|Health Center Valjevo, Valjevo, Serbia|Dr JM Engelbrecht Trial site, Cape Town, South Africa|TASK Eden, George, South Africa|Chris Hani Baragwanath Hospital, Johannesburg, South Africa|Langeberg Clinical Trials, Kraaifontein, South Africa|FCRN Clinical Trial Centre (Pty) Ldt, Rust Ter Vaal, South Africa|Clinical Projects Research, Worcester, South Africa|Radiodiagnostic CETIR - Clinica del Pilar, Esplugues de Llobregat, Barcelona, Spain|Hospital Universitario Son Espases, Palma de Mallorca, Islas Baleares, Spain|Hospital Quiron de Madrid; Servicio de Oncologia, Pozuelo de Alarcon, Madrid, Spain|Hospital Costa del Sol, Marbella, Malaga, Spain|Centro de Salud Quart de Poblet, Manises, Valencia, Spain|Hospital Universitario Cruces, Barakaldo, Vizcaya, Spain|IDIAPJGol_Fundacion Instituto Universitario Investigacion AP Salud Jordi Gol i Gurina, Barcelona, Spain|Hospital Universitario La Paz - PPDS, Barcelona, Spain|Hospital Universitario Infanta Leonor, Madrid, Spain|Hospital Universitario Infanta Leonor, Madrid, Spain|Centro de Salud Las Aguilas, Madrid, Spain|Hospital Universitario Virgen de La Arrixaca, Murcia, Spain|Hôpital Universitaire de Genève (HUG), Genève, Switzerland|Universitätsspital Zürich, Zürich, Switzerland|Gazi Universitesi Tip Fakultesi, Ankara, Turkey|Hacettepe University Medical Faculty, Ankara, Turkey|Hacettepe University Medical Faculty, Ankara, Turkey|Koc University Medical Faculty Hospital, Istanbul, Turkey|Ege University Medical Faculty, Izmir, Turkey|Karadeniz Technical University Faculty of Medicine, Trabzon, Turkey|Ankara University Medical Faculty - PPDS, Çankaya, Turkey|Ankara University Medical Faculty - PPDS, Çankaya, Turkey|Istanbul University Cerrahpasa Medical Faculty Hospital; Tesvikiye Caddesi No:20, Şi̇şli̇, Turkey|Municipal Non-profit enterprise Central City Clinical Hospital of Ivano-Frankivsk City Council, Ivano-Frankivsk, Katerynoslav Governorate, Ukraine|Municipal Non-profit Enterprise ""City Clinical Hospital #13"" of Kharkiv City Council, Kharkiv, Kharkiv Governorate, Ukraine|Public Non-Profit Enterprise ""City Outpatient Clinic #9"" of Kharkiv City Council, Kharkiv, Kharkiv Governorate, Ukraine|CNPE City Clinical Hospital #6 of DCC, Dnipro, Kholm Governorate, Ukraine|Municipal Non-profit Enterprise ""City Clinical Hospital # 4"" of Dnipro City Council, Dnipro, KIEV Governorate, Ukraine|CNPE Ivano-Frankivsk Regional Centre of Phthisiology and Pulmonology of IFRC, Ivano Frankivsk, KIEV Governorate, Ukraine|Private Enterprise Private Manufacture Company ""Acinus"", diagnostic and treatment center, Kirovograd, KIEV Governorate, Ukraine|Medical Center LLC ""Harmony of Health"", Kyiv, KIEV Governorate, Ukraine|CNE Kyiv City Clinical Hospital#1 of Exec. Body, Kyiv, KIEV Governorate, Ukraine|Medical Center of LLC Preventclinic, Kyiv, KIEV Governorate, Ukraine|Kyiv Railway Clinical Hospital No2 of Branch Health Center of the JSC Ukrainian Rail, Kyiv, KIEV Governorate, Ukraine|Polyclinic of Center of Medical Service and Rehabilitation of State JSHC Artem, Kyiv, KIEV Governorate, Ukraine|Communal Non-Commercial Enterprise Vinnytsia City Clinical Hospital 1, Vinnytsya, Podolia Governorate, Ukraine|Communal Non-Profit Enterprise City Hospital #7 of Zaporizhzhia City Council, Zaporizhzhia, Tavria Okruha, Ukraine|Chelsea & Westminster Hospital, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04889040
NCT04742569,Wearable Diagnostic for Detection of COVID-19 Infection,Observational Model: Cohort|Time Perspective: Prospective,1294415,"ClinOne, Inc, Greenwood Village, Colorado, United States",https://ClinicalTrials.gov/show/NCT04742569
NCT04291053,The Efficacy and Safety of Huai er in the Adjuvant Treatment of COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,TJ-IRB20200205,NA,https://ClinicalTrials.gov/show/NCT04291053
NCT04342637,COVID-19 Endoscopy Survey,Observational Model: Cohort|Time Perspective: Prospective,WES-2,"Kings County Hospital Center, Brooklyn, NY, USA, Albertson, New York, United States|Faculty of Medicine, Zagazig University, Zagazig, Sharkia, Egypt|Al-Azhar Univerisity, Cairo, Egypt|Ahvaz Imam hospital, Ahvaz, Iran, Islamic Republic of",https://ClinicalTrials.gov/show/NCT04342637
NCT04854928,Study to Evaluate a Single Dose of LTX-109 in Subjects With COVID-19 (Coronavirus Disease 2019) Infection.,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",C21-109-09,"ClinSmart Sweden AB, Uppsala, Sweden",https://ClinicalTrials.gov/show/NCT04854928
NCT04412486,COVID-19 Convalescent Plasma (CCP) Transfusion,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2020-0137,"University of Mississippi Medical Center, Jackson, Mississippi, United States",https://ClinicalTrials.gov/show/NCT04412486
NCT04842435,Clinical Study in the Treatment of Patients With Moderate Course of COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",IGK-P-II/III-00-003/2020,"15. Municipal Autonomous Institution ""Central City Clinical Hospital No. 24"", Ekaterinburg, Russian Federation|9. State Autonomous Healthcare Institution ""Professor A. F. Agafonov Republican Clinical Infectious Hospital"", Kazan, Russian Federation|13. State Budgetary Healthcare Institution ""Specialized Clinical Infectious Diseases Hospital"" of the Ministry of Health of the Krasnodar Territory, Krasnodar, Russian Federation|6. State Budgetary Healthcare Institution ""Scientific and Research Institute Professor S. V. Ochapovskiy Territorial Clinical Hospital"" of the Ministry of Health of the Krasnodar Territory, Krasnodar, Russian Federation|1. State Budgetary Institution of Healthcare of Moscow ""City Clinical Hospital No. 40 of the Moscow Department of Health"", Moscow, Russian Federation|14. State Budgetary Institution of Healthcare of Moscow ""Infectious Clinical Hospital No. 2"" of the Moscow Department of Health, Moscow, Russian Federation|16. State Budgetary Institution of Healthcare of Moscow ""Infectious Clinical Hospital No. 1"" of the Moscow Department of Health, Moscow, Russian Federation|18. State Budgetary Institution of Healthcare of Moscow ""City Clinical Hospital No. 52 of the Moscow Department of Health"", Moscow, Russian Federation|19. State Budgetary Institution of Healthcare of Moscow ""City Clinical Hospital of V.P. Demikhova of the Moscow Department of Health"", Moscow, Russian Federation|20. State Budgetary Institution of Healthcare of Moscow ""Scientific and Research Institute of N.V. Sklifosovskiy of the Moscow Department of Health"", Moscow, Russian Federation|21. State Budgetary Institution of Healthcare of Moscow ""City Clinical Hospital No. 4 of the Moscow Department of Health"", Moscow, Russian Federation|3. State Budgetary Healthcare Institution of Moscow ""City Clinical Hospital No. 24 of the Moscow Department of Health"", Moscow, Russian Federation|7. Federal State Budgetary Institution ""Central Clinical Hospital with an Outpatient Facility"" of the Administrative Directorate of the President of the Russian Federation, Moscow, Russian Federation|4. Federal State Budgetary Educational Institution of Higher Education ""Orenburg State Medical University"" of the Ministry of Health of the Russian Federation, Orenburg, Russian Federation|10. Federal State Budgetary Educational Institution of Higher Education ""Academician I. P. Pavlov Ryazan State Medical University"" of the Ministry of Health of the Russian Federation, Ryazan', Russian Federation|5. Saint Petersburg State Budgetary Healthcare Institution ""City Hospital No. 40 of the Kurortny Region"", Saint Petersburg, Russian Federation|12. Federal State Budgetary Educational Institution of Higher Education ""Samara State Medical University"" of the Ministry of Health of the Russian Federation, Samara, Russian Federation|11. Regional State Budgetary Healthcare Institution ""Clinical Hospital No. 1"", Smolensk, Russian Federation|17. Federal State Budgetary Educational Institution of Higher Education ""Bashkiria State Medical University"" of the Ministry of Health of the Russian Federation, Ufa, Russian Federation|8. State Budgetary Healthcare Institution of the Yaroslavl Region ""Yaroslavl Regional Clinical Hospital of War Veterans - International Center for Problems of the Elderly ""Zdorovoye Dolgoletiye"", Yaroslavl, Russian Federation|2. State Budgetary Institution of Healthcare of the Moscow Region ""Zhukovskiy City Clinical Hospital"", Zhukovskiy, Russian Federation",https://ClinicalTrials.gov/show/NCT04842435
NCT04780672,Clinical Study in the Treatment of Patients With COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",MNCV-III/2-2020,"Yaroslavl Regional Clinical Hospital for War Veterans - The International Center for the Elderly ""Healthy Longevity"", Yaroslavl, Russian Federation",https://ClinicalTrials.gov/show/NCT04780672
NCT04336462,Hydrogen-Oxygen Generator With Nebulizer in the Improvement of Symptoms in Patients Infected With COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",JT202002LZ,"First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China",https://ClinicalTrials.gov/show/NCT04336462
NCT04552366,A Clinical Trial of a Recombinant Adenovirus 5 Vectored COVID-19 Vaccine (Ad5-nCoV) With Two Doses in Healthy Adults,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,AMMS85-2004,"Zhongnan Hospital, Wuhan, Hubei, China",https://ClinicalTrials.gov/show/NCT04552366
NCT04747769,COVID-19. CT-Scan Modeling in COVID19 Sequelae,Observational Model: Case-Only|Time Perspective: Retrospective,APHP210006,"Hôpital Avicenne APHP, Bobigny, France",https://ClinicalTrials.gov/show/NCT04747769
NCT04534673,Pegylated Interferon Lambda for Treatment of COVID-19 Infection,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,0129-20-SOR|SCRC200006,"Soroka UMC, Be'er Sheva, Israel",https://ClinicalTrials.gov/show/NCT04534673
NCT04393038,ABX464 in Treating Inflammation and Preventing Acute Respiratory Failure in Patients With COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",ABX464-401,"Centre hospitalier Saint Pierre, Brussels, Belgium|Hôpital Erasme, Brussels, Belgium|UZ Gent, Gent, Belgium|Fundacao de Medicina Tropical Doutor Heitor Vieira Dourado - Instituto de Pesquisa Clínica Carlos Borborema, Manaus, Amazonas, Brazil|Centro Oncológico de Roraima - CECOR - NAP, Boa Vista, Roraima, Brazil|Hospital das Clinicas da FMUSP, São Paulo, Sao Paulo, Brazil|Instituto Nacional de Infectologia Evandro Chagas - FIOCRUZ Rio de Janeiro, Rio De Janeiro, Brazil|Conjunto Hospitalar do Mandaqui, Sao Paulo, Brazil|Hôpital Nord, Amiens, France|Centre Hospitalier Départemental de Vendée, La Roche-sur-Yon, France|Centre Hospitalier Universitaire de Nice, Nice, France|Hôpital Saint-Antoine, Paris, France|Universitätsmedizin Mannheim Ruprecht-Karls-Universität Heid, Mannheim, Baden-Württemberg, Germany|Universitätsklinikum Bonn, Bonn, Nordrhein-Westfalen, Germany|Asklepios Klinik St. Georg, Hamburg, Germany|Asklepios Klinik Altona, Hamburg, Germany|Fondazione IRCCS Cà Granda - Ospedale Maggiore Policlinico - Infectious Diseases, Milano, Lombardia, Italy|Ospedale San Paolo, Milano, Lombardia, Italy|Ospedale Luigi Sacco, AO-PU, Milano, Lombardia, Italy|Ospedale di Vittorio Veneto - Medecina generale, Vittorio Veneto, Treviso, Italy|Ospedale A. Manzonidi Lecco - ASST Lecco, Lecco, Italy|Ospedale Niguarda, Milano, Italy|Consultorio médico, Mérida, Yucatan, Mexico|Centro de Prevención y Rehabilitación de Enfermedades Pulmon, Nuevo León, Mexico|Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain|H.G.U. Alicante, Alicante, Spain|Hospital del Mar, Barcelona, Spain|Hospital de La Princesa, Madrid, Spain|Hospital Universitario Infanta Leonor, Madrid, Spain|Royal Free Hospital, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04393038
NCT04770467,"A Safety and Efficacy Study of Human Monoclonal Antibodies, BRII-196 and BRII-198 for the Treatment of Patients With COVID-19",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,BRII-196-198-002,"Investigative Site 1, Hong Kong, China",https://ClinicalTrials.gov/show/NCT04770467
NCT04404179,Setting up a COVID-19 Care Facility at a Prison in Pakistan,Observational Model: Case-Only|Time Perspective: Prospective,CovJ,"Camp Jail / COVID-19 CARE FACILITY/ SIMS, Lahore, Pakistan",https://ClinicalTrials.gov/show/NCT04404179
NCT04490174,Serological Surveillance for COVID-19 in Central North Carolina,Observational Model: Cohort|Time Perspective: Prospective,200143|20-E-0143,"NIEHS Clinical Research Unit (CRU), Research Triangle Park, North Carolina, United States",https://ClinicalTrials.gov/show/NCT04490174
NCT04757857,COVID-19 Antithrombotic Rivaroxaban Evaluation,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,36066320.5.1001.0070,"Clínica Senhor do Bonfim, Feira de Santana, Bahia, Brazil|Hospital Maternidade São Vicente de Paulo, Barbalha, Ceará, Brazil|Hospital de Base do Distrito Federal, Brasília, Distrito Federal, Brazil|Hospital de Campanha Covid-19 Goiânia/Sesgo, Goiânia, Goias, Brazil|Hospital Estadual de Urgências de Trindade/SESGO, Trindade, Goias, Brazil|Núcleo de Pesquisa Clínica do Hospital Vera Cruz, Belo Horizonte, Minas Gerais, Brazil|Hospital São Lucas, Belo Horizonte, Minas Gerais, Brazil|Santa Casa de Misericórdia de Passos, Passos, Minas Gerais, Brazil|Hospital Universitário Regional de Maringá, Maringá, Paraná, Brazil|Beneficencia Nipo Brasileira Da Amazonia, Belém, Para, Brazil|Hospital Adventista de Belém, Belém, Para, Brazil|Associação Dr. Bartholomeu Tacchini, Bento Gonçalves, Rio Grande Do Sul, Brazil|Hospital São Vicente de Paulo, Passo Fundo, Rio Grande Do Sul, Brazil|Hospital das Clínicas de Porto Alegre, Porto Alegre, Rio Grande Do Sul, Brazil|Hospital Universitario de Santa Maria, Santa Maria, Rio Grande Do Sul, Brazil|Clínica Procárdio Ltda, Blumenau, Santa Catarina, Brazil|H&W Cardiologia LTDA, Joinville, Santa Catarina, Brazil|Irmandade santa Casa de Araras, Araras, São Paulo, Brazil|Alphacor Cardiologia Clínica e Diagnóstica LTDA, Barueri, São Paulo, Brazil|Maestri e Kormann Consultoria Medico-Cientifica LTDA - EPP, Blumenau, São Paulo, Brazil|Hospital Regional do Litoral Norte - Instituto Sócrates Guanaes, Caraguatatuba, São Paulo, Brazil|Hospital Santos Dumont Litoral Norte, Caraguatatuba, São Paulo, Brazil|Hospital de Corderiopolis, Cordeiropolis, São Paulo, Brazil|Hospital Regional Jorge Rossman - Instituto Sócrates Guanaes, Itanhaém, São Paulo, Brazil|Hospital Carlos Fernando Malzoni, Matão, São Paulo, Brazil|Hospital Moinhos de Vento, Porto Alegre, São Paulo, Brazil|Hospital Regional de Registro - Instituto Sócrates Guanaes, Registro, São Paulo, Brazil|Hospital Unimed Ribeirão Preto, Ribeirão Preto, São Paulo, Brazil|Kaiser Clinica e Hospital Dia, São José do Rio Preto, São Paulo, Brazil|Braile Hospital Dia Ltda, São José Do Rio Preto, São Paulo, Brazil|Hospital Policlin, São José Dos Campos, São Paulo, Brazil|Hospital Regional de São José dos Campos - Instituto Sócrates Guanaes, São José Dos Campos, São Paulo, Brazil|Santa Casa de Misericórdia de Votuporanga, Votuporanga, São Paulo, Brazil|International Research Center - Hospital Alemão Oswaldo Cruz, São Paulo, Brazil|Hospital Leforte Liberdade, São Paulo, Brazil|Incor - Instituto do Coração do Hospital das Clínicas da FMUSP, São Paulo, Brazil",https://ClinicalTrials.gov/show/NCT04757857
NCT04474483,Safety and Efficacy of Melatonin in Outpatients Infected With COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",UBMELCOVID19,"University at Buffalo, Buffalo, New York, United States",https://ClinicalTrials.gov/show/NCT04474483
NCT04928430,Efficacy and Safety of XAV-19 for the Treatment of Moderate-to-severe COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",XT-2002|2020-005979-12,"Multiprofile Hospital for Active Treatment "" St. Ekaterina"" - Dimitrovgrad - EOOD, COVID Departement, Dimitrovgrad, Bulgaria|University Multiprofile Hospital for Active Treatment - Plovdiv - AD, COVID Departement, Plovdiv, Bulgaria|Complex Oncological Center - Ruse Ltd, COVID Departement, Ruse, Bulgaria|Specialized Hospital for Active Treatment for Pneumophtisiatrics Diseases Dr. Dimitar Gramatikov - Ruse - EOOD, Departement of Pneumology, Ruse, Bulgaria|5th Multiprofile hospital for Active Treatment - Sofia - EAD, Departement of Pneumology and Phtisiatric, Sofia, Bulgaria|Evangelismos General Hospital of Athens, Critical Care Departement, Athens, Greece|""Sotiria"" General Hospital of Chest Diseases of Athens, 3rd Department of Medicine of University of Athens, Athens, Greece|University Hospital of Heraklion, Department of Internal Medicine & Infectious Diseases Unit, Heraklion, Greece|AHEPA University General Hospital of Thessaloniki, Infectious Diseases Division of 1st Internal Medicine Department, Thessaloniki, Greece|""Hippokration"" General Hospital of Thessaloniki, 3rd Department of Pediatrics, Thessaloniki, Greece|Leon Daniello Clinical Hospital of Pneumoftiziology, Cluj-napoca, Romania|Hospital for Infectious Diseases and Pneumology ""Victor Babeş"" Craiova, Craiova, Romania|Military Field Hospital ROL-2, Otopeni, Romania|Pius Brinzeu County Emergency Clinical Hospital Timisoara, Timisoara, Romania|Ramón y Cajal University Hospital, Madrid, Spain|Puerta del Hierro University Hospital, Majadahonda, Spain|Bağcılar Medipol Mega Universite Hastanesi, Bağcılar, Turkey|Istanbul University Cerrahpasa-Cerrahpasa Medical Faculty, Fatih, Turkey",https://ClinicalTrials.gov/show/NCT04928430
NCT04716426,APT™ T3X on the COVID-19 Contamination Rate,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",4.485.847,"Santa Casa de Misericórdia de Porto Alegre, Porto Alegre, Rio Grande Do Sul, Brazil",https://ClinicalTrials.gov/show/NCT04716426
NCT04342689,The Role of Resistant Starch in COVID-19 Infection,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",2000027887,"Yale University, New Haven, Connecticut, United States|University of Michigan, Ann Arbor, Michigan, United States",https://ClinicalTrials.gov/show/NCT04342689
NCT04389658,Contagiousness and Immunogenicity Status of COVID-19 in Asymptomatic Population (COVID-19 CONDITION),Observational Model: Other|Time Perspective: Retrospective,IGX1-COV-XS-20-01,"Igenomix, Paterna, Valencia, Spain",https://ClinicalTrials.gov/show/NCT04389658
NCT04479358,Low-dose Tocilizumab Versus Standard of Care in Hospitalized Patients With COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,IRB20-1179,"University of Chicago Medicine, Chicago, Illinois, United States",https://ClinicalTrials.gov/show/NCT04479358
NCT04853069,Oestrogen Treatment for COVID-19 Symptoms,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,MRC-05-099,"Hamad Medical Corporation, Doha, Qatar",https://ClinicalTrials.gov/show/NCT04853069
NCT04363346,Study of FT516 for the Treatment of COVID-19 in Hospitalized Patients With Hypoxia,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,IDIM-2020-28708|2020LS083,"University of Minnesota, Minneapolis, Minnesota, United States",https://ClinicalTrials.gov/show/NCT04363346
NCT04369820,C5a Receptor Expression - COVID-19 (C5-COV),Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,2020-14|IDRCB,"Assistance Publique Hôpitaux de Marseille, Marseille, France",https://ClinicalTrials.gov/show/NCT04369820
NCT04401423,TXA127 for the Treatment of Severe COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",AAAT0535,"Columbia University Irving Medical Center, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04401423
NCT04470557,Relation Between Lab Finding and COVID-19 Severity,Observational Model: Other|Time Perspective: Cross-Sectional,RLCS,NA,https://ClinicalTrials.gov/show/NCT04470557
NCT04666116,Changes in Viral Load in COVID-19 After Probiotics,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,HdeSagunto,"Hospital de Sagunto, Sagunto, Valencia, Spain|Hospital de Sagunto, Valencia, Spain",https://ClinicalTrials.gov/show/NCT04666116
NCT04514302,Safety and Efficacy of Anti-SARS-CoV-2 Equine Antibody Fragments (INOSARS) for Hospitalized Patients With COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",INOSARS-CoV-2 TecSalud,"Hospital San José, Monterrey, Nuevo Leon, Mexico",https://ClinicalTrials.gov/show/NCT04514302
NCT04558372,Genosvid Diagnostic Test for Early Detection of COVID-19,"Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Diagnostic",1.6/2020,"RS Bhayangkara Tk I R.Said Soekanto, Jakarta, Indonesia|Saiful Anwar, Malang, Indonesia|Dr Sardjito Hospital, Yogyakarta, Indonesia|Bambanglipuro Hospital, Yogyakarta, Indonesia|Bhayangkara Tk III Polda DIY, Yogyakarta, Indonesia|RS Akademik UGM, Yogyakarta, Indonesia|RSPAU Hardjolukito, Yogyakarta, Indonesia|RST Tk III Dr Soetarto, Yogyakarta, Indonesia",https://ClinicalTrials.gov/show/NCT04558372
NCT04392141,Colchicine Plus Phenolic Monoterpenes to Treat COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",1399.062,"Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran, Kermanshah, Iran, Islamic Republic of",https://ClinicalTrials.gov/show/NCT04392141
NCT04418284,Online Learning of Veterinary Anatomy During COVID-19 Pandemic,Observational Model: Other|Time Perspective: Cross-Sectional,2-2020,"South Valley University, Qinā, Egypt",https://ClinicalTrials.gov/show/NCT04418284
NCT04449718,Vitamin D Supplementation in Patients With COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",30959620.4.0000.0068,"Clinical Hospital of the School of Medicine, University of Sao Paulo, Sao Paulo, Brazil",https://ClinicalTrials.gov/show/NCT04449718
NCT04587323,VEGF and sFlt-1 Levels in the Pathogenesis and Severity of COVID-19 Disease,Observational Model: Cohort|Time Perspective: Prospective,IRB-300005378,"University of Alabama at Birmingham, Birmingham, Alabama, United States",https://ClinicalTrials.gov/show/NCT04587323
NCT04324489,DAS181 for Severe COVID-19: Compassionate Use,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,DAS181-SARS-CoV-2,"Renmin Hospital of Wuhan University, Wuhan, Hubei, China",https://ClinicalTrials.gov/show/NCT04324489
NCT04889313,Post COVID-19 Neurologic Symptoms : a Somatic Spectrum Disorder ? (SOMATiC),Observational Model: Other|Time Perspective: Prospective,CHSD_NEURO_01,"Centre Hospitalier de Saint-Denis, Saint-denis, Ile De France, France",https://ClinicalTrials.gov/show/NCT04889313
NCT04370262,Multi-site Adaptive Trials for COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",20-0268,"Southside Hospital, Bay Shore, New York, United States|North Shore University Hospital, Manhasset, New York, United States|Northern Westchester Hospital, Mount Kisco, New York, United States|Lenox Hill Hospital, New York, New York, United States|Long Island Jewish Medical Center, Queens, New York, United States",https://ClinicalTrials.gov/show/NCT04370262
NCT04347993,"A Prospective ""Universal"" Observational Database for COVID-19",Observational Model: Case-Only|Time Perspective: Prospective,Pro2020-0342,"Hackensack Meridian Health - John Theurer Cancer Center, Hackensack, New Jersey, United States",https://ClinicalTrials.gov/show/NCT04347993
NCT04978233,The Opal - COVID-19 Study,Observational Model: Other|Time Perspective: Prospective,2021-6763,"Research Institute of the McGill University Health Centre, Montréal, Quebec, Canada",https://ClinicalTrials.gov/show/NCT04978233
NCT04472572,Expanded Access to Convalescent Plasma for Treatment of COVID-19,NA,Pro2020-0663,"Hackensack University Medical Center, Hackensack, New Jersey, United States",https://ClinicalTrials.gov/show/NCT04472572
NCT04549831,Genetic Bases of COVID-19 Clinical Variability,Observational Model: Case-Control|Time Perspective: Prospective,16917,"University of Siena, Siena, Italy",https://ClinicalTrials.gov/show/NCT04549831
NCT04497324,PERUCONPLASMA: Evaluating the Use of Convalescent Plasma as Management of COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,PER-016-20|20997,"Hospital Cayetano Heredia, Lima, Peru|Hospital Nacional Hipolito Unanue, Lima, Peru",https://ClinicalTrials.gov/show/NCT04497324
NCT04386759,COVID-19 Infection in Healthcare Workers,Observational Model: Cohort|Time Perspective: Other,APHP200483,"Assistance Publique Hôpitaux de Paris - CHU Henri Mondor, Créteil, France",https://ClinicalTrials.gov/show/NCT04386759
NCT04590586,Study of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalized Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",COV-01,"Pinnacle Research Group LLC, Anniston, Alabama, United States|Good Samaritan Hospital, Bakersfield, California, United States|Sharp Chula Vista Medical Center, Chula Vista, California, United States|El Centro Regional Medical Center, El Centro, California, United States|University of California Irvine Medical Center, Orange, California, United States|Riverside Community Hospital, Riverside, California, United States|National Institute of Clinical Research, S. El Monte, California, United States|University of California Davis Health System, Sacramento, California, United States|UF Health Shands Hospital, Gainesville, Florida, United States|Memorial Hospital Jacksonville, Jacksonville, Florida, United States|Grady Health System, Atlanta, Georgia, United States|Great Lakes Clinical Trials, Chicago, Illinois, United States|The University of Iowa, Iowa City, Iowa, United States|Harper University Hospital, Detroit, Michigan, United States|Sinai Grace Hospital, Detroit, Michigan, United States|Detroit Receiving Hospital, Royal Oak, Michigan, United States|University of Tennessee Health Sciences Center, Memphis, Tennessee, United States|Medical City Ft. Worth, Fort Worth, Texas, United States|University of Texas Health Science Center at Houston, Houston, Texas, United States|Texoma Medical Center, Sherman, Texas, United States|MultiCare Health System Institute for Research and Innovation, Tacoma, Washington, United States|Hospital San Juan de Dios, Ramos Mejia, Buenos Aires, Argentina|Hospital General de Agudos Dr. J. M. Ramos Mejia, Ciudad Autonoma Buenos Aires, Argentina|Hospital General de Agudos Dr. Ignacio Pirovano, Ciudad Autonoma Buenos Aires, Argentina|Clinica Adventista Belgrano, Ciudad Autonoma Buenos Aires, Argentina|Hospital Italiano de Rosario, Rosario, Argentina|Chronos Pesquisa Clinica, Brasília, Distrito Federal, Brazil|HC-UFG - Hospital das Clínicas da Universidade Federal de Goiás, Goiânia, Goiás, Brazil|Santa Casa de Misericórdia de Belo Horizonte, Belo Horizonte, Minas Gerais, Brazil|Hospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande Do Sul, Brazil|UNESP - Faculdade de Medicina da Universidade Estadual Paulista - Campus Botucatu, Botucatu, Sao Paulo, Brazil|Praxis Pesquisa Médica, Santo André, Sao Paulo, Brazil|Hospital Base Osorno, Osorno, Chile|Hospital General de Tijuana, Tijuana, Baja California Norte, Mexico|Hospital Civil de Guadalajara Dr. Juan I. Menchaca, Guadalajara, Jalisco, Mexico|Universidad Autonoma de Nuevo Leon, Hospital Universitario Dr. Jose Eleuterio Gonzalez, Monterrey, Nuevo León, Mexico|Hospital Civil de Culiacan, Culiacán, Sinaloa, Mexico|TSBIH ""Krasnoyarsk Interdistrict Clinical Hospital of Emergency Medical Care n.a. N.S. Karpovich, Krasnoyarsk, Russian Federation|SBIH of Moscow ""Infectious Clinical Hospital # 1 of Department of Healthcare of Moscow"", Moscow, Russian Federation|SPb SBIH ""Alexandrovskaya City Hospital"", Saint Petersburg, Russian Federation|St-George Hospital, Saint Petersburg, Russian Federation|SPb SBIH ""Nikolaevskaya Hospital"", Saint Petersburg, Russian Federation|SPb SBIH ""City Pokrovskaya Hospital"", Saint Petersburg, Russian Federation|SPb SBIH ""City Hospital # 40 of Kurortnyi region"", Sestroretsk, Russian Federation|Nelson Mandela Academic Clinical Research Unit (NeMACRU), Mthatha, Eastern Cape, South Africa|Johese Clinical Research: Unitas, Centurion, Gauteng, South Africa|MERC SiReN, Johannesburg, Gauteng, South Africa|Drs Sarvan and Moodley, Durban, KwaZulu-Natal, South Africa|Tread Research, Cape Town, Western Cape, South Africa|Tiervlei Trial Centre, Cape Town, Western Cape, South Africa|2 Military Hospital Internal Medicine, Cape Town, Western Cape, South Africa|Dr JM Engelbrecht Trial Site, Somerset West, Western Cape, South Africa|Clinical Projects Research SA (PTY) LTD, Worcester, Western Cape, South Africa|Communal Noncommercial Profit ""Clinical City Hospital 16 of Dnipro Regional Council"", Dnipro, Ukraine|CNE of Kharkov RC Reg Cl Infectious Hospital, Kharkiv, Ukraine|Communal Non-Commercial Medical Enterprise ""O.T.Bohayevskyi Kremenchuk City Hospital #1"", Kremenchuk, Ukraine|City Clinical infectious Hospital, Odesa, Ukraine|Municipal Non-Profit Enterprise Central City Hospital Of Rivne City Council, Rivne, Ukraine|CCH #1 Vinnytsia M.I.Pyrogov NMU Ch of Infectious Diseases, Vinnytsia, Ukraine",https://ClinicalTrials.gov/show/NCT04590586
NCT04420468,Descriptive and Retrospective Analysis of Acute Myocarditis Associated With Pandemic COVID-19 in Children,Observational Model: Cohort|Time Perspective: Retrospective,APHP200632,"Hôpital Bicêtre, Le Kremlin-Bicêtre, France|Hôpital Armand Trousseau, Paris, France|Hôpital Necker-Enfants Malades, Paris, France|Hôpital Robert Debré, Paris, France",https://ClinicalTrials.gov/show/NCT04420468
NCT04323228,Anti-inflammatory/Antioxidant Oral Nutrition Supplementation in COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Supportive Care",ONS_COVID-19,"Prince Mohamed BinAbdulaziz Hospital, Riyadh, Saudi Arabia",https://ClinicalTrials.gov/show/NCT04323228
NCT04834752,Effect of H2 Receptor Antagonist and Proton Pump Inhibitor on the Positivity Rates and Clinical Outcomes of COVID-19,Observational Model: Cohort|Time Perspective: Retrospective,2102-004-1192,"Seoul National University Hospital, Seoul, Korea, Republic of",https://ClinicalTrials.gov/show/NCT04834752
NCT04708236,A Study of ORTD-1 in Patients Hospitalized With COVID-19 Related Pneumonia,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",ORTD1-COV-001,"UC Irvine Medical Center, Orange, California, United States",https://ClinicalTrials.gov/show/NCT04708236
NCT04376788,Exchange Transfusion Versus Plasma From Convalescent Patients With Methylene Blue in Patients With COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,FMASU P22/2020,"Ain Shams University, Cairo, Egypt",https://ClinicalTrials.gov/show/NCT04376788
NCT04960202,A Study of PF-07321332/Ritonavir in Nonhospitalized High Risk Adult Participants With COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",C4671005|2021-002895-38,NA,https://ClinicalTrials.gov/show/NCT04960202
NCT04366882,Minimal Invasive Autopsies to Investigate Changes in Deceased COVID-19 Patients,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,JessaH_COVID-19_MIA,"Jessa Hospital, Hasselt, Belgium",https://ClinicalTrials.gov/show/NCT04366882
NCT04664010,Efficacy and Safety of High-dose Vitamin C Combined With Chinese Medicine Against Coronavirus Pneumonia (COVID-19),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,XianInternationalMCH_HXJ,"Xi'an International Medical Center Hospital, Xi'an, Shaanxi, China",https://ClinicalTrials.gov/show/NCT04664010
NCT04335123,Study of Open Label Losartan in COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,STUDY00145514,"University of Kansas Medical Center, Kansas City, Kansas, United States",https://ClinicalTrials.gov/show/NCT04335123
NCT04474496,Impact of COVID-19 on Marshallese Communities in the U.S.,Observational Model: Other|Time Perspective: Cross-Sectional,261131,"University of Arkansas for Medical Sciences Northwest, Fayetteville, Arkansas, United States",https://ClinicalTrials.gov/show/NCT04474496
NCT04360356,Ivermectin and Nitazoxanide Combination Therapy for COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",IVR/NTZ,NA,https://ClinicalTrials.gov/show/NCT04360356
NCT04733833,A Study to Evaluate the Efficacy and Safety of VB-201 in Patients With COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,VB-201-019,"Chaim Sheba Medical Center, Ramat Gan, Israel",https://ClinicalTrials.gov/show/NCT04733833
NCT04434248,An Adaptive Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19,Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,COVID-FPR-01,"Republican Clinical Hospital, Makhachkala, Russian Federation|""K+31"" Clinic, Moscow, Russian Federation|""Khaven"" Llc, Moscow, Russian Federation|Central Clinical Hospital with Polyclinic, Moscow, Russian Federation|Central Research Institute of Epidemiology, Moscow, Russian Federation|City Clinical Hospital n.a. O.M. Filatov, Moscow, Russian Federation|City Clinical Hospital named after S.S. Yudin, Moscow, Russian Federation|City Clinical Hospital No. 24, Moscow, Russian Federation|City Clinical Hospital No. 51, Moscow, Russian Federation|First Moscow State Medical University n.a. I.M. Sechenov, Moscow, Russian Federation|Moscow State University n.a. M. V. Lomonosov, Moscow, Russian Federation|National Medical and Surgical Center named after N.I. Pirogov, Moscow, Russian Federation|City Hospital № 33 of the Leninsky region of Nizhny Novgorod, Nizhny Novgorod, Russian Federation|Infectious clinical hospital No.2 of Nizhny Novgorod, Nizhny Novgorod, Russian Federation|Ryazan State Medical University named after I.P. Pavlov, Ryazan, Russian Federation|Military Medical Academy named after S.M. Kirova, Saint Petersburg, Russian Federation|Saratov State Medical University named after V.I. Razumovsky, Saratov, Russian Federation|Clinical hospital No.1, Smolensk, Russian Federation|Regional Clinic Hospital, Tver, Russian Federation|Bashkir State Medical University, Ufa, Russian Federation|Yakutsk City Clinical Hospital, Yakutsk, Russian Federation|Yaroslavl Regional Clinical Hospital for War Veterans, Yaroslavl, Russian Federation",https://ClinicalTrials.gov/show/NCT04434248
NCT04619706,Ultramicronized Palmitoylethanolamide (PEA) Treatment in Hospitalized Participants With COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",FSD201-03,"Miami, Florida, Miami, Florida, United States|Palms of Pasadena Hospital, Saint Petersburg, Florida, Saint Petersburg, Florida, United States|Theia Clinical Research, St. Petersburg, Florida, Saint Petersburg, Florida, United States|Idaho Falls, Idaho, Idaho Falls, Idaho, United States|Winfield, Illinois, Winfield, Illinois, United States|Butte, Montana, Butte, Montana, United States|Tulsa, Oklahoma, Tulsa, Oklahoma, United States|Kingsport, Tennessee, Kingsport, Tennessee, United States|Amarillo, Texas, Amarillo, Texas, United States|Mesquite, Texas, Mesquite, Texas, United States|Mesquite, Texas, Mesquite, Texas, United States",https://ClinicalTrials.gov/show/NCT04619706
NCT04350593,Dapagliflozin in Respiratory Failure in Patients With COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",D1690C00081|ESR-20-20653,"Heart Group of the Eastern Shore, Fairhope, Alabama, United States|Baptist Hospital of Miami, Miami, Florida, United States|NorthShore University HealthSystem, Evanston, Illinois, United States|Loyola University, Maywood, Illinois, United States|Ascension - St. Vincent, Indianapolis, Indiana, United States|Lahey Health, Burlington, Massachusetts, United States|McLaren Health Care, Auburn Hills, Michigan, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|Saint Luke's Mid America Heart Institute, Kansas City, Missouri, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|Jacobi Medical Center, Bronx, New York, United States|SUNY Downstate Medical Center, Brooklyn, New York, United States|Maimonides Medical Center, Brooklyn, New York, United States|St. Francis Hospital, Roslyn, New York, United States|University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States|Wake Forest Baptist Health, Winston-Salem, North Carolina, United States|Lancaster General Hospital, Lancaster, Pennsylvania, United States|Rhode Island Hospital, Providence, Rhode Island, United States|Clinical Trials Network of Tennessee, Memphis, Tennessee, United States|DHR Health Institute for Research and Development, Edinburg, Texas, United States|Baylor College of Medicine, Houston, Texas, United States|Sentara Healthcare, Norfolk, Virginia, United States|Clínica de Especialidades Villa María, Villa María, Province Of Córdoba, Argentina|Fundación Favaloro, Buenos Aires, Argentina|Hospital Español, Buenos Aires, Argentina|Hospital Fernández, Buenos Aires, Argentina|Hospital Pirovano, Buenos Aires, Argentina|Hospital Santojanni, Buenos Aires, Argentina|Sanatorio Anchorena, Buenos Aires, Argentina|Sanatorio Güemes, Buenos Aires, Argentina|Clínica Vélez Sarsfield, Córdoba, Argentina|Hospital San Roque, Córdoba, Argentina|Sanatorio Privado Duarte Quiros de Clinica Colombo S.A., Córdoba, Argentina|Centro de Pesquisa Dr. Marco Mota, Maceió, Alagoas, Brazil|Hospital EMEC e Hospital da Cidade, Feira de Santana, Bahia, Brazil|Hospital e Clínica São Roque, Ipiaú, Bahia, Brazil|Hospital Regional Deputado Luis Eduardo Magalhães, Porto Seguro, Bahia, Brazil|Hospital Cárdio Pulmonar, Salvador, Bahia, Brazil|Hospital Maternidade São Vicente de Paulo, Barbalha, Ceará, Brazil|Unimed de Fortaleza, Fortaleza, Ceará, Brazil|Hospital de Messejana Dr Carlos Alberto Studart Gomes, Fortaleza, Ceará, Brazil|Hospital Coração do Brasil, Brasília, Distrito Federal, Brazil|Hospital Estadual Jayme dos Santos Neves, Serra, Espírito Santo, Brazil|Liga de Hipertensão Arterial, Goiania, Goias, Brazil|Santa Casa de Misericórdia de Passos, Passos, Minas Gerais, Brazil|Hospital São Domingos - Unimed Uberaba, Uberaba, Minas Gerais, Brazil|PROCAPE, Recife, Pernambuco, Brazil|Hospital Giselda Trigueiro, Natal, Rio Grande Do Norte, Brazil|Associação Dr. Bartholomeu Tacchini, Bento Gonçalves, Rio Grande Do Sul, Brazil|Hospital São Vicente de Paulo, Passo Fundo, Rio Grande Do Sul, Brazil|Irmandade da Santa Casa de Misericórdia de Porto Alegre, Porto Alegre, Rio Grande Do Sul, Brazil|Hospital Mãe de Deus, Porto Alegre, Rio Grande Do Sul, Brazil|Hospital São José - Criciúma, Criciuma, Santa Catarina, Brazil|IPEMI- Instituto de Pesquisas Médicas de Itajaí, Itajai, Santa Catarina, Brazil|Hospital Municipal São José, Joinville, Santa Catarina, Brazil|Hospital Regional Hans Dieter Schmidt, Joinville, Santa Catarina, Brazil|Centro de Pesquisa Clínica do Coração, Aracaju, Sergipe, Brazil|Faculdade de Medicina de Botucatu, UNESP, Botucatu, São Paulo, Brazil|Instituto de Pesquisa Clínica de Campinas, Campinas, São Paulo, Brazil|Unimed Ribeirao Preto, Ribeirão Preto, São Paulo, Brazil|Fundação do ABC (Hospital Estadual Mário Covas), Santo André, São Paulo, Brazil|Centro Integrado de Pesquisas, São José do Rio Preto, São Paulo, Brazil|Santa Casa de Votuporanga, Votuporanga, São Paulo, Brazil|Fundação Pio XII, Barretos, Brazil|Hospital Naval Marcílio Dias, Rio de Janeiro, Brazil|Hospital Moriah, São Paulo, Brazil|Hospital Santa Paula, São Paulo, Brazil|InCor - Instituto do Coração do Hospital das Clínicas FMUSP, São Paulo, Brazil|Halton Healthcare Services, Oakville, Ontario, Canada|Lakeridge Health, Oshawa, Ontario, Canada|CIMS Hospital Pvt. Ltd, Sola, Ahmedabad, India|MIOT International Hospitals, Manapakkam, Chennai-89, India|All India Institute of Medical Science, New Delhi, Delhi, India|Sanjivani Super Speciality Hospital Pvt Ltd, Ahmedabad, Gujarat, India|Lokmanya Tilak General Hospital, Mumbai, Maharashtra, India|Max Smart Super Speciality Hospital, Saket, New Delhi, India|Max Super Speciality Hospital (A unit of Devki Devi Foundation), Saket, New Delhi, India|Dayanand Medical College & Hospital, Ludhiāna, Punjab, India|Hospital del Prado, Acapulco, Mexico|Icaro Investigaciones en Medicina, Chihuahua, Mexico|HG de Cuernavaca Dr. Jose G Parres, Cuernavaca, Mexico|JM Research, Cuernavaca, Mexico|Instituto de Investigaciones Aplicadas a la Neurosciencias, Durango, Mexico|Antiguo Hospital Civil de Guadalajara ""Fray Antonio Alcade"", Guadalajara, Mexico|Hospital San Javier, Guadalajara, Mexico|Invesclinic MX, Guanajuato, Mexico|CIMEZAP, Jalisco, Mexico|Hospital Medica Sur, Mexico City, Mexico|Hospital Clinica Nova, Monterrey, Mexico|Hospital San Jose TEC Salud, Monterrey, Mexico|ECI Estudios Clinicos Internacionales, Puebla, Mexico|Hospital SMIQ, Queretaro, Mexico|Investigacion Medica Sonora, Sonora, Mexico|Sanatorio Santa Cruz de Toluca, Toluca, Mexico|Addenbrooke's Hospital, Cambridge, Cb2 0qq, United Kingdom",https://ClinicalTrials.gov/show/NCT04350593
NCT04372979,Efficacy of Convalescent Plasma Therapy in the Early Care of COVID-19 Patients.,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",2020-A01166-33,"HIA Percy, Clamart, France|HIA Laveran, Marseille, France|HIA Bégin, Saint-Mandé, France|HIA Sainte Anne, Toulon, France",https://ClinicalTrials.gov/show/NCT04372979
NCT04456413,Convalescent Plasma as Treatment for Subjects With Early COVID-19 Infection,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,Pro2020-0542,"Hackensack University Medical Center, Hackensack, New Jersey, United States",https://ClinicalTrials.gov/show/NCT04456413
NCT04464395,Study of CPI-006 as Immunotherapy for Hospitalized COVID-19 Patients,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,CPI-006-002,"El Centro Regional Medical Center, El Centro, California, United States|Icahn School of Medicine at Mount Sinai, New York, New York, United States|Temple University Hospital, Philadelphia, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04464395
NCT04467151,"Administration of Anti-SARS-CoV-2 Convalescent Plasma in Hospitalized, Non-ICU Patients With COVID-19","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",HS-20-00516,NA,https://ClinicalTrials.gov/show/NCT04467151
NCT04343755,Convalescent Plasma as Treatment for Hospitalized Subjects With COVID-19 Infection,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,Pro2020-0375,"Hackensack University Medical Center, Hackensack, New Jersey, United States",https://ClinicalTrials.gov/show/NCT04343755
NCT04784754,Dose-Ranging Study to Assess the Safety and Efficacy of Melatonin in Outpatients Infected With COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",UBMELCOVID19-P|UL1TR001412,"University at Buffalo, Buffalo, New York, United States",https://ClinicalTrials.gov/show/NCT04784754
NCT04321421,Hyperimmune Plasma for Critical Patients With COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,IRCCSSanMatteoH,"Catherine Klersy, Pavia, PV, Italy|Ospedale Asst Carlo Poma Mantova, Mantova, Italy",https://ClinicalTrials.gov/show/NCT04321421
NCT04685603,Dendritic Cell Vaccine to Prevent COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention",CL-COV-P02-ID|U1111-1263-0568,"Rumah Sakit Umum Pusat Dr. Kariadi, Semarang, Jawa Tengah, Indonesia",https://ClinicalTrials.gov/show/NCT04685603
NCT04880109,A Phase 2 Study of APX-115 in Hospitalized Patients With Confirmed Mild to Moderate COVID-19.,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",A01-115-03,NA,https://ClinicalTrials.gov/show/NCT04880109
NCT04784897,A Study to Evaluate the Efficacy and Safety of Brilacidin in Hospitalized Participants With COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",IPI-BRIc-201,"IPI Investigator Site, Winfield, Illinois, United States|IPI Investigator Site, Toledo, Ohio, United States|IPI Investigator Site, Barnaul, Russian Federation|IPI Investigator Site, Moscow, Russian Federation|IPI Investigator Site, Moscow, Russian Federation|IPI Investigator Site, Moscow, Russian Federation|IPI Investigator Site, Moscow, Russian Federation|IPI Investigator Site, Nizniy Novgorod, Russian Federation|IPI Investigator Site, Pushkin, Russian Federation|IPI Investigator Site, Saint Petersburg, Russian Federation|IPI Investigator Site, Saint Petersburg, Russian Federation|IPI Investigator Site, Saint Petersburg, Russian Federation",https://ClinicalTrials.gov/show/NCT04784897
NCT04425629,"Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for the Treatment of Ambulatory Adult and Pediatric Patients With COVID-19","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",R10933-10987-COV-2067|2020-003690-21,"Regeneron Study Site, Mesa, Arizona, United States|Regeneron Study Site, Tucson, Arizona, United States|Regeneron Study Site, Tucson, Arizona, United States|Regeneron Study Site, Canoga Park, California, United States|Regeneron Study Site, La Mesa, California, United States|Regeneron Study Site, La Palma, California, United States|Regeneron Study Site 1, Long Beach, California, United States|Regeneron Study Site 2, Long Beach, California, United States|Regeneron Study Site 3, Long Beach, California, United States|Regeneron Study Site, Los Angeles, California, United States|Regeneron Study Site, Montclair, California, United States|Regeneron Study Site, Rolling Hills Estates, California, United States|Regeneron Study Site, Sacramento, California, United States|Regeneron Study Site, San Francisco, California, United States|Regeneron Study Site, Santa Monica, California, United States|Regeneron Study Site, Stanford, California, United States|Regeneron Study Site, Aurora, Colorado, United States|Regeneron Study Site, Colorado Springs, Colorado, United States|Regeneron Study Site, Washington, District of Columbia, United States|Regeneron Study Site, Boca Raton, Florida, United States|Regeneron Study Site, DeLand, Florida, United States|Regeneron Study Site, Fort Pierce, Florida, United States|Regeneron Study Site, Hialeah, Florida, United States|Regeneron Study Site, Loxahatchee Groves, Florida, United States|Regeneron Study Site, Maitland, Florida, United States|Regeneron Study Site, Miami, Florida, United States|Regeneron Study Site, Miami, Florida, United States|Regeneron Study Site, Miami, Florida, United States|Regeneron Study Site, Miami, Florida, United States|Regeneron Study Site, Miami, Florida, United States|Regeneron Study Site, Miami, Florida, United States|Regeneron Study Site, Saint Petersburg, Florida, United States|Regeneron Study Site, Sarasota, Florida, United States|Regeneron Study Site, Tampa, Florida, United States|Regeneron Study Site, West Palm Beach, Florida, United States|Regeneron Study Site, Winter Haven, Florida, United States|Regeneron Study Site, Winter Park, Florida, United States|Regeneron Study Site, Atlanta, Georgia, United States|Regeneron Study Site, Atlanta, Georgia, United States|Regeneron Study Site, Augusta, Georgia, United States|Regeneron Study Site, Columbus, Georgia, United States|Regeneron Study Site, Marietta, Georgia, United States|Regeneron Study Site, Chicago, Illinois, United States|Regeneron Study Site 1, Downers Grove, Illinois, United States|Regeneron Study Site 2, Downers Grove, Illinois, United States|Regeneron Study Site, Downers Grove, Illinois, United States|Regeneron Study Site, Ames, Iowa, United States|Regeneron Study Site, Iowa City, Iowa, United States|Regeneron Study Site, Lake Charles, Louisiana, United States|Regeneron Study Site, Marrero, Louisiana, United States|Regeneron Study Site, New Orleans, Louisiana, United States|Regeneron Study Site, Shreveport, Louisiana, United States|Regeneron Study Site, Baltimore, Maryland, United States|Regeneron Study Site, Royal Oak, Michigan, United States|Regeneron Study Site, Jackson, Mississippi, United States|Regeneron Study Site, Las Vegas, Nevada, United States|Regeneron Study Site, Ridgewood, New Jersey, United States|Regeneron Study Site, Teaneck, New Jersey, United States|Regeneron Study Site, Santa Fe, New Mexico, United States|Regeneron Study Site, Bronx, New York, United States|Regeneron Study Site, Bronx, New York, United States|Regeneron Study Site, Jamaica, New York, United States|Regeneron Study Site, New York, New York, United States|Regeneron Study Site, New York, New York, United States|Regeneron Study Site, New York, New York, United States|Regeneron Study Site, New York, New York, United States|Regeneron Study Site, New York, New York, United States|Regeneron Study Site, New York, New York, United States|Regeneron Study Site, Charlotte, North Carolina, United States|Regeneron Study Site, Durham, North Carolina, United States|Regeneron Study Site, Wilmington, North Carolina, United States|Regeneron Study Site, Columbus, Ohio, United States|Regeneron Study Site, Dayton, Ohio, United States|Regeneron Study Site, Dayton, Ohio, United States|Regeneron Study Site, Philadelphia, Pennsylvania, United States|Regeneron Study Site, Providence, Rhode Island, United States|Regeneron Study Site, Charleston, South Carolina, United States|Regeneron Study Site, Clinton, South Carolina, United States|Regeneron Study Site, Sioux Falls, South Dakota, United States|Regeneron Study Site 2, Memphis, Tennessee, United States|Regeneron Study Site, Memphis, Tennessee, United States|Regeneron Study Site, Amarillo, Texas, United States|Regeneron Study Site, Corpus Christi, Texas, United States|Regeneron Study Site, Dallas, Texas, United States|Regeneron Study Site, Dallas, Texas, United States|Regeneron Study Site, Houston, Texas, United States|Regeneron Study Site, Houston, Texas, United States|Regeneron Study Site, Houston, Texas, United States|Regeneron Study Site, Houston, Texas, United States|Regeneron Study Site, Houston, Texas, United States|Regeneron Study Site, Houston, Texas, United States|Regeneron Study Site, Pearland, Texas, United States|Regeneron Study Site, Red Oak, Texas, United States|Regeneron Study Site, San Antonio, Texas, United States|Regeneron Study Site, San Antonio, Texas, United States|Regeneron Study Site, San Antonio, Texas, United States|Regeneron Study Site, Tyler, Texas, United States|Regeneron Study Site, Falls Church, Virginia, United States|Regeneron Study Site, Everett, Washington, United States|Regeneron Study Site, Seattle, Washington, United States|Regeneron Study Site, Seattle, Washington, United States|Regeneron Study Site, Madison, Wisconsin, United States|Regeneron Study Site, Las Condes, Santiago De Chile, Chile|Regeneron Study Site, Guadalajara, Jalisco, Mexico|Regeneron Study Site, Guadalajara, Jalisco, Mexico|Regeneron Study Site, Zapopan, Jalisco, Mexico|Regeneron Study Site, Monterrey, Nuevo Leon, Mexico|Regeneron Study Site, Monterrey, Nuevo León, Mexico|Regeneron Study Site, Merida, Yucatan, Mexico|Regeneron Study Site, Chihuahua, Mexico|Regeneron Study Site, Ciudad de Mexico, Mexico|Regeneron Study Site, Durango, Mexico|Regeneron Study Site, Mérida, Mexico|Regeneron Study Site, Veracruz, Mexico|Regeneron Study Site, Bucuresti, Romania",https://ClinicalTrials.gov/show/NCT04425629
NCT04880694,A Study to Evaluate the Safety and Effect of STC3141 Continuous Infusion in Subjects With Severe Corona Virus Disease 2019（COVID-19）Pneumonia,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,GPHIP-0202|2021-000399-12,"Onze-Lieve-Vrouwziekenhuis Aalst, VZW, Aalst, Belgium|Universitair Ziekenhuis Brussel, Brussel, Belgium|Jan Yperman Ziekenhuis vzw, Ieper, Belgium|CHU Liège, Liège, Belgium",https://ClinicalTrials.gov/show/NCT04880694
NCT04810117,Monitoring the IgG/IgM Antibodies in COVID-19 Patients,Observational Model: Cohort|Time Perspective: Prospective,15032021-1,"University of Sargodha, Sub campus Bhakkar, Bhakkar, Punjab, Pakistan|University of Sargodha, Sargodha, Punjab, Pakistan",https://ClinicalTrials.gov/show/NCT04810117
NCT04527133,An Open Non-comparative Study of the Efficacy and Safety of Aprotinin in Patients Hospitalized With COVID-19,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,COVID-APR-01,"Regional State Budgetary Healthcare Institution ""Clinical Hospital №1"", Smolensk, Russian Federation",https://ClinicalTrials.gov/show/NCT04527133
NCT04659187,CORONA Germany- Clinical Outcome and Risk in Hospitalized COVID-19 Patients - An Epidemiological Study From Germany,Observational Model: Cohort|Time Perspective: Prospective,#3871,"Asklepios Fachkliniken München-Gauting, Gauting, Bavaria, Germany|Asklepios Klinik St. Georg, Hamburg, Germany|Asklepios Klinik Wandsbek, Hamburg, Germany|Asklepios Klinik Barmbek, Hamburg, Germany|Asklepios Kliniken GmbH & Co. KGaA, Hamburg, Germany|Asklepios Klinik Nord, Hamburg, Germany|Asklepios Westklinikum Hamburg, Hamburg, Germany|Asklepios Klinik Altona, Hamburg, Germany",https://ClinicalTrials.gov/show/NCT04659187
NCT04928495,Clinical Trial With N-acetylcysteine and Bromhexine for COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",AVANTI-C19,"Núcleo de Biomedicina - NUBIMED, Fortaleza, Ceará, Brazil",https://ClinicalTrials.gov/show/NCT04928495
NCT04544605,Special Chinese Medicine Out-patient Programme for Discharged COVID-19 Patients,Observational Model: Case-Only|Time Perspective: Other,HA Covid-19,"School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, Hong Kong, China",https://ClinicalTrials.gov/show/NCT04544605
NCT04668235,Study on Safety and Clinical Efficacy of AZVUDINE in COVID-19 Patients (SARS-CoV-2 Infected),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",FNC IGZ-1,"Santa Casa de Misericórdia de Campos, Campos Dos Goytacazes, RJ, Brazil",https://ClinicalTrials.gov/show/NCT04668235
NCT04646109,Ivermectin for Severe COVID-19 Management,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,IVMC_03,"Afyonkarahisar Health Science University, Afyonkarahisar, Turkey|Gulhane Faculty of Medicine, University of Health Sciences, Ankara, Turkey|Yıldırım Beyazıt University, Ankara City Hospital, Ankara, Turkey|Haydarpasa Sultan Abdulhamid Han Training and Research Hospital, İstanbul, Turkey",https://ClinicalTrials.gov/show/NCT04646109
NCT04445233,COVID-19 Household Transmission Study,Observational Model: Cohort|Time Perspective: Prospective,20-0982|550KR242023,"University of North Carolina Health Care, Chapel Hill, North Carolina, United States",https://ClinicalTrials.gov/show/NCT04445233
NCT04329611,ALBERTA HOPE COVID-19 for the Prevention of Severe COVID19 Disease,"Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",ABCOV-01 version 1.5,"University of Calgary/Foothills Medical Centre, Calgary, Alberta, Canada|University of Alberta, Edmonton, Alberta, Canada",https://ClinicalTrials.gov/show/NCT04329611
NCT04621071,Efficacy of Probiotics in Reducing Duration and Symptoms of COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",2021-3700,"CIUSSS de L'Estrie-CHUS Hospital, Sherbrooke, Quebec, Canada",https://ClinicalTrials.gov/show/NCT04621071
NCT04325633,Efficacy of Addition of Naproxen in the Treatment of Critically Ill Patients Hospitalized for COVID-19 Infection,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,APHP200387,"Réanimation médico-chirurgicale, Avicenne Hospital, Bobigny, France|Urgences, Avicenne Hospital, Bobigny, France",https://ClinicalTrials.gov/show/NCT04325633
NCT04387929,Detection of Anti-COVID-19 Antibody Levels in an Hospital Population,Observational Model: Cohort|Time Perspective: Prospective,1374 IgG COVID-19 HUMANITAS,"Humanitas Rozzano/San Pio X, Rozzano, Lombardia, Italy",https://ClinicalTrials.gov/show/NCT04387929
NCT04808882,ANTIcoagulation in Severe COVID-19 Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,APHP201624|2020-A03531-38,"Henri Mondor Hospital, Créteil, France",https://ClinicalTrials.gov/show/NCT04808882
NCT04682912,Blood Types in Children With COVID-19,Observational Model: Cohort|Time Perspective: Retrospective,MersinTRH,"Mersin City Training & Research Hospital, Mersi̇n, Turkey",https://ClinicalTrials.gov/show/NCT04682912
NCT04546841,Safety and Immunogenicity Trial of Multi-peptide Vaccination to Prevent COVID-19 Infection in Adults,Allocation: N/A|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,P-pVAC-SARS-CoV-2,"University Hospital Tuebingen, Tuebingen, Baden-Wuerttemberg, Germany",https://ClinicalTrials.gov/show/NCT04546841
NCT04306497,TCM Differentiation and Treatment Protocol of COVID-19,Observational Model: Cohort|Time Perspective: Other,JSZYJ202001,"Huai'an fourth people's Hospital, Huaian, Jiangsu, China",https://ClinicalTrials.gov/show/NCT04306497
NCT04415086,Treatment of Patients With COVID-19 With Convalescent Plasma,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,COOP-COVID-19-MCTIC,"University of Sao Paulo - General Hospital, São Paulo, SP, Brazil",https://ClinicalTrials.gov/show/NCT04415086
NCT04321993,Treatment of Moderate to Severe Coronavirus Disease (COVID-19) in Hospitalized Patients,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,SAIL-004,"Nova Scotia Health Authority, Halifax, Nova Scotia, Canada",https://ClinicalTrials.gov/show/NCT04321993
NCT04808284,Neuromodulation in COVID-19 Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",PRJ2007,"D'Or Institute for Research and Education (IDOR), Rio de Janeiro, RJ, Brazil",https://ClinicalTrials.gov/show/NCT04808284
NCT04364022,Efficacy of Pragmatic Same-day COVID-19 Ring Prophylaxis for Adult Individuals Exposed to SARS-CoV-2 in Switzerland,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,CCER 2020-00864,"Instituto Nacional de Infectiologia Evandro Chagas, Fiocruz, Rio De Janeiro, Brazil|Universitätsspital Basel and SwissTPH, Basel, Switzerland|Hôpitaux Universitaires de Genève, Geneva, Switzerland|Ospedale Regionale di Lugano, Lugano, Switzerland",https://ClinicalTrials.gov/show/NCT04364022
NCT04619628,"Safety and Immunogenicity of COVI-VAC, a Live Attenuated Vaccine Against COVID-19","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",CDX-CoV-001,"hVIVO, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04619628
NCT04351659,Novel Adoptive Cellular Therapy With SARS-CoV-2 Specific T Cells in Patients With Severe COVID-19,Observational Model: Cohort|Time Perspective: Prospective,COVID-T 1.0,"National University Hospital, Singapore, Singapore|Singapore General Hospital, Singapore, Singapore",https://ClinicalTrials.gov/show/NCT04351659
NCT04382066,Proof of Concept Study to Evaluate the Safety Profile of Plitidepsin in Patients With COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,APL-D-002-20|2020-001993-31,"Hospital Universitario Hm Montepríncipe, Boadilla Del Monte, Madrid, Spain|Hospital Germans Trias i Pujol, Badalona, Spain|Hospital Clínic de Barcelona, Barcelona, Spain|Hospital de la Santa Creu i Sant Pau, Barcelona, Spain|Hospital Ciudad Real, Ciudad Real, Spain|Hospital Universitario de Getafe, Getafe, Spain|Hospital Universitario de Guadalajara, Guadalajara, Spain|Hospital Universitari Arnau de Vilanova, Lleida, Spain|Hospital La Princesa, Madrid, Spain|Hospital Gregorio Marañón, Madrid, Spain|Hospital Ramón Y Cajal, Madrid, Spain|Hospital Clínico San Carlos, Madrid, Spain|Hosptial Quironsalud Madrid, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04382066
NCT04550338,Antiviral Effects of TXA as a Preventative Treatment Following COVID-19 Exposure,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",TXA.COVID.3,NA,https://ClinicalTrials.gov/show/NCT04550338
NCT04323332,Traditional Chinese Medicine for Severe COVID-19,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2020XLA015-1,"Hao Li, Beijing, Beijing, China",https://ClinicalTrials.gov/show/NCT04323332
NCT04869592,A Clinical Trial to Evaluate the Recombinant SARS-CoV-2 Vaccine (CHO Cell) for COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention",2021-YM-006-02,"Ning ling Center for Disease Control and Prevention, Shang Qiu, He Nan, China",https://ClinicalTrials.gov/show/NCT04869592
NCT04412252,Safety and Efficacy of Tofacitinib in Hospitalized Participants With COVID-19 Pneumonia Who Are Receiving Standard of Care Therapy,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",A3921377,"Hartford Hospital (HH), Hartford, Connecticut, United States|University of Iowa Hospitals & Clinics Investigational Drug Services, Iowa City, Iowa, United States|University of Iowa, Iowa City, Iowa, United States|LSUHSC-Shreveport, Shreveport, Louisiana, United States|Ochsner LSU Health Shreveport Academic Medical Center, Shreveport, Louisiana, United States|University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States",https://ClinicalTrials.gov/show/NCT04412252
NCT04715295,Safety and Efficacy of Doxycycline and Rivaroxaban in COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,CNO0032020,"Yaounde Central Hospital, Yaounde, Centre, Cameroon",https://ClinicalTrials.gov/show/NCT04715295
NCT04352348,Cohort of Patients Infected With SARS-CoV2 (COVID-19) or Suspected of Being,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science,APHP200382|2020-A00754-35,"GH Pitié-Salpêtrière / Service d'Accueil des Urgences, Paris, Ile-de-France, France",https://ClinicalTrials.gov/show/NCT04352348
NCT04390178,Convalescent Plasma as Treatment for Acute Coronavirus Disease (COVID-19),Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,CP1,"Danderyd Hospital, Danderyd, Sweden",https://ClinicalTrials.gov/show/NCT04390178
NCT04528368,Convalescent Plasma for Treating Patients With COVID-19 Pneumonia Without Indication of Ventilatory Support,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,34651120.8.0000.5249,"D'Or Institute for Research and Education, Rio de Janeiro, Brazil",https://ClinicalTrials.gov/show/NCT04528368
NCT04405102,COVID-19 Ozanimod Intervention Study,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2021-3474,"Hôpital de la Cité-de-la-Santé (CISSS de Laval), Laval, Quebec, Canada|Institut universitaire de cardiologie et de pneumologie de Québec - Université Laval, Québec, Canada",https://ClinicalTrials.gov/show/NCT04405102
NCT04339660,Clinical Research of Human Mesenchymal Stem Cells in the Treatment of COVID-19 Pneumonia,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Treatment",Pr20200402,"Puren Hospital Affiliated to Wuhan University of Science and Technology, Wuhan, Hubei, China",https://ClinicalTrials.gov/show/NCT04339660
NCT04465695,Dual Therapy With Interferon Beta-1b and Clofazimine for COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,UW 20-463,"The University of Hong Kong, Queen Mary Hospital, Hong Kong, Hong Kong, China",https://ClinicalTrials.gov/show/NCT04465695
NCT04527081,Study of COVID-19 DNA Vaccine (AG0302-COVID19),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,AG0302-COVID19-JN-01,"Osaka University Hospital, Osaka, Japan",https://ClinicalTrials.gov/show/NCT04527081
NCT04454372,Clinical Characteristics and Outcomes of 187 Critically Ill Patients With Coronavirus Disease 2019 (COVID-19),Observational Model: Cohort|Time Perspective: Retrospective,covid-19 ICU,NA,https://ClinicalTrials.gov/show/NCT04454372
NCT04463472,Study of COVID-19 DNA Vaccine (AG0301-COVID19),Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,AG0301-COVID19-JN-01,"Osaka City University Hospital, Osaka, Japan",https://ClinicalTrials.gov/show/NCT04463472
NCT04333420,"Randomized, Controlled Study of IFX-1 in Patients With Severe COVID-19 Pneumonia","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",IFX-1-P2.9,"Inflarx Site, Yvoir, Belgium|Inflarx Site, Campinas, Brazil|University Porto Alegre, Porto Alegre, Brazil|Inflarx Site, São José, Brazil|Inflarx Site, Nantes, France|University Nice, Nice, France|Inflarx Site, Paris, France|University Paris 1, Paris, France|University Paris 2, Paris, France|University Paris 3, Paris, France|University Suresnes, Suresnes, France|Inflarx Site, Aachen, Germany|University Aachen, Aachen, Germany|University Augsburg, Augsburg, Germany|University Berlin- Charite, Berlin, Germany|University Dresden, Dresden, Germany|University Greifswald, Greifswald, Germany|Inflarx Site, Hannover, Germany|Inflarx Site, Jena, Germany|University of Chiuhuahua, Chihuahua, Mexico|University Simon Campos, Mérida, Mexico|Inflarx Site, Amsterdam, Netherlands|Inflarx, Amsterdam, Netherlands|Inflarx Site, Enschede, Netherlands|Inflarx Site, Maastricht, Netherlands|Inflarx Site, Callao, Peru|University of Peru, Lima, Peru|Inflarx Site, Barnaul, Russian Federation|University Ryazan, Ryazan', Russian Federation|University of Somerset West, Somerset West, South Africa",https://ClinicalTrials.gov/show/NCT04333420
NCT04444310,Antibody Responses in Contacts of COVID-19 Patients,Observational Model: Cohort|Time Perspective: Prospective,Assiut13,"AssiutU, Assiut, Egypt",https://ClinicalTrials.gov/show/NCT04444310
NCT04724395,Disability Following Hospitalization in People of Working-age Surviving SARS-CoV-2 Infection - COVID-19,Observational Model: Cohort|Time Perspective: Prospective,P200601|2020-A02552-37,"Cochin Hospital, Paris, France",https://ClinicalTrials.gov/show/NCT04724395
NCT04887142,Predictors of Disease Severity in COVID-19 Patients,Observational Model: Case-Control|Time Perspective: Prospective,01/20-405,"Spitali Amerikan, Tirana, Albania|General Hospital ""Prim. dr. Abdulah Nakaš"", Sarajevo, Bosnia and Herzegovina|KBC Rijeka, University of Rijeka, Rijeka, Croatia|University of Montenegro, Faculty of Medicine, Podgorica, Montenegro|Faculty of Medical Sciences, University Clinical Center Kragujevac, Kragujevac, Srbija, Serbia",https://ClinicalTrials.gov/show/NCT04887142
NCT04813562,Immunogenicity and Safety of Recombinant COVID-19 Vaccine (CHO Cells),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention",JSVCT097,"Jiangsu Provincial Center for Diseases Control and Prevention, Nanjing, Jiangsu, China",https://ClinicalTrials.gov/show/NCT04813562
NCT04375202,Colchicine in COVID-19: a Pilot Study,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2020-001475-33,"Associazione Italiana Pneumologi Ospedalieri, Milan, Italy|Società Italiana di Reumatologia, Milan, Italy",https://ClinicalTrials.gov/show/NCT04375202
NCT04765475,Protecting Native Families From COVID-19,Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Single (Investigator)|Primary Purpose: Prevention,IRB00014147,"Johns Hopkins Center for American Indian Health Whiteriver Office, Whiteriver, Arizona, United States",https://ClinicalTrials.gov/show/NCT04765475
NCT04287686,Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,GIRH-APN01,"GCP Office of The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China",https://ClinicalTrials.gov/show/NCT04287686
NCT04354857,Qualitative and Quantitative Evaluation of Anosmia Over Time in Clinically Symptomatic Patients Tested for COVID-19 Infection,Observational Model: Cohort|Time Perspective: Prospective,IRB: 20.04.09,"CHU de Nimes, Nîmes, France",https://ClinicalTrials.gov/show/NCT04354857
NCT04382092,Co-infection Management in COVID-19 Critically Ill,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,2019/14MAR/124,"Cliniques Universitaires Saint-Luc, Brussels, Belgium",https://ClinicalTrials.gov/show/NCT04382092
NCT04824391,"Efficacy, Immunogenicity and Safety of Inactivated ERUCOV-VAC Compared With Placebo in COVID-19","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention",IDEAL00620-EU02-PK537-3,"Erciyes University, Kayseri, Turkey",https://ClinicalTrials.gov/show/NCT04824391
NCT04464408,Favipiravir Therapy in Adults With Mild COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",RC 20/220/R,"Prince Mohammed Bin Abdul Aziz Hospital - Al Madinah, Al Madinah, Saudi Arabia|King Fahad Hospital - Madinah, Al Madīnah, Saudi Arabia|Primary Health Care-Safiyah, Al Madīnah, Saudi Arabia|King Abdullah Medical City - Makkah, Mecca, Saudi Arabia|King Abdulaziz Medical City - Riyadh, Riyadh, Saudi Arabia|Primary Health Care-Al Mansoura, Riyadh, Saudi Arabia|Primary Health Care-Al Urijah, Riyadh, Saudi Arabia",https://ClinicalTrials.gov/show/NCT04464408
NCT04361916,Home Care for Patients With COVID-19: Active Monitoring in Two Italian Health Units (Casale Monferrato and Torino),Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,Mon-Covid,"Asl Alessandria, Casale Monferrato, Alessandria, Italy",https://ClinicalTrials.gov/show/NCT04361916
NCT04375046,Recombinant Bacterial ACE2 Receptors -Like Enzyme of B38-CAP Could be Promising Treatment for COVID-19 Infection- and Its Inflammatory Complications Better Than Recombinant Human ACE2,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,proposed by Mahmoud kazazzaz,NA,https://ClinicalTrials.gov/show/NCT04375046
NCT04385108,Predictive Immune Biomarkers for COVID-19 Pathogenesis,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science,RC31/20/0162,"Purpan University Hospital, Toulouse, France",https://ClinicalTrials.gov/show/NCT04385108
NCT04910191,Collecting Respiratory Sound Samples From Corona Patients to Extend the Diagnostic Capability of VOQX Electronic Stethoscope to Diagnose COVID-19 Patients,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Screening,VOQX,"Barzilai Medical Center, Ashkelon, Israel|Hille Yaffe Medical Center, Hadera, Israel|Shamir Medical Center (Assaf Harofah), Zrifin, Israel",https://ClinicalTrials.gov/show/NCT04910191
NCT04370808,VITACOV: Vitamin D Polymorphisms and Severity of COVID-19 Infection,Observational Model: Case-Only|Time Perspective: Prospective,VITACOV,"Cardiovascular Center at Universidade de Lisboa, Lisbon, Lisboa, Portugal|Centro Hospitalar Universitário Lisboa Norte, Lisbon, Lisboa, Portugal|Centro Hospitalar de São João, Oporto, Portugal",https://ClinicalTrials.gov/show/NCT04370808
NCT04352582,COVID-19 and Vaccination Attitudes,Observational Model: Other|Time Perspective: Prospective,VACAT,"Survey, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04352582
NCT04344145,Exhaustion and Needs in Frontline COVID-19 Healthcare Workers: Cross-sectional Study in a Belgian Population,Observational Model: Case-Control|Time Perspective: Cross-Sectional,PSY-ENCOVID19,"Hôpital de Warquignies, Boussu, Hainaut, Belgium|Hôpital de Jolimont, Haine-Saint-Paul, Hainaut, Belgium|Hôpital de Lobbes, Lobbes, Hainaut, Belgium|Hôpital de Mons, Mons, Hainaut, Belgium|Erasme Hospital CUB, Brussels, Belgium",https://ClinicalTrials.gov/show/NCT04344145
NCT04343768,"An Investigation Into Beneficial Effects of Interferon Beta 1a, Compared to Interferon Beta 1b And The Base Therapeutic Regiment in Moderate to Severe COVID-19: A Randomized Clinical Trial",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,Different Interferons in COVID,"Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences and Health Services, Tehran, Iran, Islamic Republic of",https://ClinicalTrials.gov/show/NCT04343768
NCT04495101,Study to Evaluate the Safety and Efficacy of Prolastin in Hospitalized Subjects With COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,GC2005|2020-001953-36,"Hospital Universitario de Burgos, Burgos, Castilla León, Spain|Hospital Universitari Germans Trias i Pujol, Badalona, Spain|Hospital Clínic de Barcelona, Barcelona, Spain|Hospital Universitario Valle de Hebrón, Barcelona, Spain|Hospital Clínico San Carlos, Madrid, Spain|Hospital General Gregorio Marañón, Madrid, Spain|Hospital Universitario Infanta Leonor, Madrid, Spain|Hospital Universitario Príncipe de Asturias, Madrid, Spain|Hospital Universitario Ramón y Cajal, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04495101
NCT04355338,Assessment of Incidence of SARS-CoV-2 Infection and COVID-19 in Brazil (AVISA),Observational Model: Cohort|Time Perspective: Prospective,COV-01-IB,"Universidade Federal do Ceará, Fortaleza, CE, Brazil|Universidade de Brasília, Brasilia, DF, Brazil|Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil|Hospital Universitário Júlio Müller da Universidade Federal de Mato Grosso, Cuiabá, Mount, Brazil|Universidade Federal de Roraima - UFRR, Boa Vista, Roraima, Brazil|Centro de Pesquisas em Medicina Tropical de Rondônia (CEPEM), Porto Velho, RO, Brazil|Universidade Federal de Sergipe, Laranjeiras, SE, Brazil|Hospital Estadual de Serrana, Serrana, SP, Brazil|Faculdade Santa Marcelina, São Paulo, SP, Brazil|Faculdade de Medicina de São José do Rio Preto - FAMERP, São José Do Rio Preto, São Paulo, Brazil|Instituto de Infectologia Evandro Chagas - Fiocruz, Rio De Janeiro, Brazil",https://ClinicalTrials.gov/show/NCT04355338
NCT04832061,Respiratory Supports and COVID-19 Mortality,Observational Model: Cohort|Time Perspective: Retrospective,2000028070,"Yale University School of Medicine, New Haven, Connecticut, United States",https://ClinicalTrials.gov/show/NCT04832061
NCT04381052,Study for the Use of the IL-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",AAAT0142,"Columbia University Medical Center / New York Presbyerian Hospital, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04381052
NCT04952727,Study on Sequential Immunization of Inactivated COVID-19 Vaccine and Recombinant COVID-19 Vaccine (Ad5 Vector),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",JSVCT117,"Jiangsu Provincial Center for Diseases Control and Prevention, Nanjing, Jiangsu, China",https://ClinicalTrials.gov/show/NCT04952727
NCT04410354,Study of Merimepodib in Combination With Remdesivir in Adult Patients With Advanced COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",VC-02-01,"Mayo Clinic in Arizona, Phoenix, Arizona, United States|Holy Cross Hospital, Fort Lauderdale, Florida, United States|Mayo Clinic in Florida, Jacksonville, Florida, United States|Mayo Clinic, Rochester, Minnesota, United States|Atlantic Health System / Morristown Medical Center, Morristown, New Jersey, United States|Atlantic Health System / Overlook Medical Center, Summit, New Jersey, United States|St. David's South Austin Medical Center, Austin, Texas, United States|St. David's Medical Center, Austin, Texas, United States|HCA Houston Healthcare Medical Center, Houston, Texas, United States|HCA Houston Healthcare Mainland, Texas City, Texas, United States",https://ClinicalTrials.gov/show/NCT04410354
NCT04354389,DAS181 for STOP COVID-19,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",DAS181-2-08|2020-003192-17,"Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milano, Italy|A.O.U Policlinico Di Modena, Modena, Italy",https://ClinicalTrials.gov/show/NCT04354389
NCT04480632,Therapeutic Plasmapheresis in Critically Ill Adult Patients With COVID-19 Confirmed Diagnosis,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,CEI-2020-01200,"Hospital Internacional de Colombia, Piedecuesta, Santander, Colombia",https://ClinicalTrials.gov/show/NCT04480632
NCT04344015,COVID-19 Plasma Collection,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,20D.346,"Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04344015
NCT04655625,Phase II / III Study of COVID-19 DNA Vaccine (AG0302-COVID19),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",AG0302-COVID19-JN-02,"UHW Narita Hospital, Narita, Chiba, Japan|Medical Corporation Heishinkai OCROM Clinic, Suita, Osaka, Japan|Medical Corporation Tsurukamekai Shinjuku Tsurukame C linic, Shibuya-ku, Tokyo, Japan|Medical Corporation Heishinkai ToCROM Clinic, Shinjuku-ku, Tokyo, Japan|Medical Corporation Shinanokai Shinanozaka Clinic, Shinjuku-ku, Tokyo, Japan|Sekino Clinical Pharmacology Clinic, Toshima-ku, Tokyo, Japan|NISHI-UMEDA Clinic for Asian Medical Collaboration, Osaka, Japan|Medical Corporation Heishinkai OPHAC Hospital, Osaka, Japan",https://ClinicalTrials.gov/show/NCT04655625
NCT04718467,Phase IIb Clinical Trial of Recombinant Novel Coronavirus Pneumonia (COVID-19) Vaccine (Sf9 Cells),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention",JSVCT107,"Jiangsu Provincial Center for Diseases Control and Prevention, Nanjing, Jiangsu, China",https://ClinicalTrials.gov/show/NCT04718467
NCT04681053,Inhaled Ivermectin and COVID-19,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,R.20.11.1090.R1,"Mansoura Faculty of Medicine, Mansoura, Dakahlyia, Egypt",https://ClinicalTrials.gov/show/NCT04681053
NCT04324996,A Phase I/II Study of Universal Off-the-shelf NKG2D-ACE2 CAR-NK Cells for Therapy of COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",ChongqingPublicHMC,"Chongqing Public Health Medical Center, Chongqing, China",https://ClinicalTrials.gov/show/NCT04324996
NCT04640402,A Phase Ⅱ Clinical Trial of Recombinant Corona Virus Disease-19 (COVID-19) Vaccine (Sf9 Cells),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention",JSVCT099,"Jiangsu Provincial Center for Diseases Control and Prevention, Nanjing, Jiangsu, China",https://ClinicalTrials.gov/show/NCT04640402
NCT04732858,"Educational Interventions for Surgeons During COVID-19 Pandemic: Cross-sectional, E-survey",Observational Model: Ecologic or Community|Time Perspective: Cross-Sectional,APHP201297,"Assistance Publique Hôpitaux de Paris - GHU AP-HP Hôpitaux Universitaires Henri-Mondor, Créteil, France",https://ClinicalTrials.gov/show/NCT04732858
NCT04433013,A Randomized Controlled Trial Assessing the Efficacy of Lianhua Qingwen as an Adjuvant Treatment in Patients With Mild Symptoms of COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Treatment",IRB-2020-05-029,NA,https://ClinicalTrials.gov/show/NCT04433013
NCT04426695,"Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for Hospitalized Adult Patients With COVID-19","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",R10933-10987-COV-2066|2020-002537-15,"Regeneron Study Site, Birmingham, Alabama, United States|Regeneron Study Site, Chandler, Arizona, United States|Regeneron Study Site, Phoenix, Arizona, United States|Regeneron Study Site 1, Tucson, Arizona, United States|Regeneron Study Site, Long Beach, California, United States|Regeneron Study Site, Mission Hills, California, United States|Regeneron Study Site, Sacramento, California, United States|Regeneron Study Site, Santa Monica, California, United States|Regeneron Study Site, Stanford, California, United States|Regeneron Study Site, Aurora, Colorado, United States|Regeneron Study Site, Boca Raton, Florida, United States|Regeneron Study Site, Fort Pierce, Florida, United States|Regeneron Study Site, Gainesville, Florida, United States|Regeneron Study Site, Orlando, Florida, United States|Regeneron Study Site, Pensacola, Florida, United States|Regeneron Study Site, Sarasota, Florida, United States|Regeneron Study Site, Tampa, Florida, United States|Regeneron Study Site, Atlanta, Georgia, United States|Regeneron Study Site, Atlanta, Georgia, United States|Regeneron Study Site, Augusta, Georgia, United States|Regeneron Study Site, Marietta, Georgia, United States|Regeneron Study Site, Chicago, Illinois, United States|Regeneron Study Site, Chicago, Illinois, United States|Regeneron Study Site, Glenview, Illinois, United States|Regeneron Study Site, Urbana, Illinois, United States|Regeneron Study Site, Indianapolis, Indiana, United States|Regeneron Study Site, Iowa City, Iowa, United States|Regeneron Study Site, Louisville, Kentucky, United States|Regeneron Study Site, Louisville, Kentucky, United States|Regeneron Study Site, New Orleans, Louisiana, United States|Regeneron Study Site, New Orleans, Louisiana, United States|Regeneron Study Site, Baltimore, Maryland, United States|Regeneron Study Site, Boston, Massachusetts, United States|Regeneron Study Site, Boston, Massachusetts, United States|Regeneron Study Site, Boston, Massachusetts, United States|Regeneron Study Site, Grand Rapids, Michigan, United States|Regeneron Study Site, Royal Oak, Michigan, United States|Regeneron Study Site, Rochester, Minnesota, United States|Regeneron Study Site, Chesterfield, Missouri, United States|Regeneron Study Site, Saint Louis, Missouri, United States|Regeneron Study Site, Omaha, Nebraska, United States|Regeneron Study Site, Las Vegas, Nevada, United States|Regeneron Study Site, Englewood, New Jersey, United States|Regeneron Study Site, Hackensack, New Jersey, United States|Regeneron Study Site, Morristown, New Jersey, United States|Regeneron Study Site, Neptune, New Jersey, United States|Regeneron Study Site, Pennington, New Jersey, United States|Regeneron Study Site, Summit, New Jersey, United States|Regeneron Study Site, Teaneck, New Jersey, United States|Regeneron Study Site, Albuquerque, New Mexico, United States|Regeneron Study Site, Bronx, New York, United States|Regeneron Study Site, Bronx, New York, United States|Regeneron Study Site, Brooklyn, New York, United States|Regeneron Study Site, Buffalo, New York, United States|Regeneron Study Site 1, Buffalo, New York, United States|Regeneron Study Site 2, Buffalo, New York, United States|Regeneron Study Site, Jamaica, New York, United States|Regeneron Study Site, New York, New York, United States|Regeneron Study Site, New York, New York, United States|Regeneron Study Site, New York, New York, United States|Regeneron Study Site, New York, New York, United States|Regeneron Study Site, New York, New York, United States|Regeneron Study Site, New York, New York, United States|Regeneron Study Site, Rochester, New York, United States|Regeneron Study Site, Syracuse, New York, United States|Regeneron Study Site, West Islip, New York, United States|Regeneron Study Site, White Plains, New York, United States|Regeneron Study Site, Chapel Hill, North Carolina, United States|Regeneron Study Site, Concord, North Carolina, United States|Regeneron Study Site, Greensboro, North Carolina, United States|Regeneron Study Site, Columbus, Ohio, United States|Regeneron Study Site, Columbus, Ohio, United States|Regeneron Study Site, Dayton, Ohio, United States|Regeneron Study Site, Portland, Oregon, United States|Regeneron Study Site, Portland, Oregon, United States|Regeneron Study Site, Philadelphia, Pennsylvania, United States|Regeneron Study Site, Providence, Rhode Island, United States|Regeneron Study Site, Providence, Rhode Island, United States|Regeneron Study Site, Sioux Falls, South Dakota, United States|Regeneron Study Site 1, Amarillo, Texas, United States|Regeneron Study Site 2, Amarillo, Texas, United States|Regeneron Study Site, Dallas, Texas, United States|Regeneron Study Site, Dallas, Texas, United States|Regeneron Study Site, Dallas, Texas, United States|Regeneron Study Site, Houston, Texas, United States|Regeneron Study Site, Houston, Texas, United States|Regeneron Study Site, Lubbock, Texas, United States|Regeneron Study Site, Sugar Land, Texas, United States|Regeneron Study Site, Tyler, Texas, United States|Regeneron Study Site, Murray, Utah, United States|Regeneron Study Site, Salt Lake City, Utah, United States|Regeneron Study Site, Richmond, Virginia, United States|Regeneron Study Site, Everett, Washington, United States|Regeneron Study Site 1, Seattle, Washington, United States|Regeneron Study Site, Madison, Wisconsin, United States|Regeneron Study Site, Salvador, Bahia, Brazil|Regeneron Study Site, Fortaleza, Ceara, Brazil|Regeneron Study Site, Curitiba, Paraná, Brazil|Regeneron Study Site, Porto Alegre, Rio Grande Do Sul, Brazil|Regeneron Study Site, Passo Fundo, RS, Brazil|Regeneron Study Site, Chapeco, Santa Catarina, Brazil|Regeneron Study Site, Criciuma, Santa Catarina, Brazil|Regeneron Study Site, Botucatu, Sao Paolo, Brazil|Regeneron Study Site, Campinas, Sao Paolo, Brazil|Regeneron Study Site, São Paulo, Brazil|Regeneron Study Site, São Paulo, Brazil|Regeneron Study Site, São Paulo, Brazil|Regeneron Study Site 1, Las Condes, Santiago De Chile, Chile|Regeneron Study Site 2, Las Condes, Santiago De Chile, Chile|Regeneron Study Site, Vitacura, Santiago De Chile, Chile|Regeneron Study Site, Santiago de Chile, Chile|Regeneron Study Site, Guadalajara, Jalisco, Mexico|Regeneron Study Site, Monterrey, Nuevo Leon, Mexico|Regeneron Study Site, Culiacan, Mexico|Regeneron Study Site, Monterrey, Mexico|Regeneron Study Site 1, Mérida, Mexico|Regeneron Study Site 2, Mérida, Mexico|Regeneron Study Site, Veracruz, Mexico|Regeneron Study Site, Zapopan, Mexico|Regeneron Study Site, Chisinau, Moldova, Republic of|Regeneron Study Site, Bucuresti, Romania",https://ClinicalTrials.gov/show/NCT04426695
NCT04391712,Photobiomodulation Laser Therapy for COVID-19 Positive Patients With Pulmonary Disease,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2020.01,"Lowell General Hospital, Lowell, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT04391712
NCT04595773,"COVID-19, Chronic Adaptation and Response to Exercise (COVID-CARE)",Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,10000102|000102-CC,"National Institutes of Health Clinical Center, Bethesda, Maryland, United States",https://ClinicalTrials.gov/show/NCT04595773
NCT04932850,Study to Evaluate the Safety and Concentrations of Monoclonal Antibody Against Virus That Causes COVID-19 Disease.,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",A0001A|2020-005469-15,"Inmi 'L.Spallanzani' - Irccs, Roma, Lazio, Italy|Crc - Verona, Verona, Veneto, Italy",https://ClinicalTrials.gov/show/NCT04932850
NCT04973449,"Phase II/III Study of AZD2816, for the Prevention of COVID-19 in Adults","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",D7220C00001,"Research Site, Brasilia, Brazil|Research Site, Curitiba, Brazil|Research Site, Natal, Brazil|Research Site, Natal, Brazil|Research Site, Porto Alegre, Brazil|Research Site, Salvador, Brazil|Research Site, São Paulo, Brazil|Research Site, Birmingham, United Kingdom|Research Site, Bournemouth, United Kingdom|Research Site, Bristol, United Kingdom|Research Site, Bristol, United Kingdom|Research Site, Dundee, United Kingdom|Research Site, Edinburgh, United Kingdom|Research Site, Hull, United Kingdom|Research Site, London, United Kingdom|Research Site, London, United Kingdom|Research Site, London, United Kingdom|Research Site, London, United Kingdom|Research Site, Manchester, United Kingdom|Research Site, Newcastle-upon-Tyne, United Kingdom|Research Site, Nottingham, United Kingdom|Research Site, Oxford, United Kingdom|Research Site, Plymouth, United Kingdom|Research Site, Sheffield, United Kingdom|Research Site, Truro, United Kingdom",https://ClinicalTrials.gov/show/NCT04973449
NCT04432298,"Study of the Efficacy and Safety of Intravenous Pamrevlumab, in Hospitalized Participants With Acute COVID-19 Disease","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",FGCL-3019-098,"Research Center, Detroit, Michigan, United States|Research Center, Greensboro, North Carolina, United States|Research Center, Philadelphia, Pennsylvania, United States|Research Center, Philadelphia, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04432298
NCT04504032,A Trial to Evaluate Safety and Efficacy of Rivaroxaban (COVID-19),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",Gates MRI - COD-01-T01-01,"Woodland Research Northwest LLC - ERG - PPDS, Rogers, Arkansas, United States|Science 37, Inc, Los Angeles, California, United States|Allergy and Asthma Medical Group and Research Center - CRN - PPDS, San Diego, California, United States|Invesclinic, LLC, Fort Lauderdale, Florida, United States|Advanced Pulmonary Research Institute, Loxahatchee Groves, Florida, United States|LCC Medical Research - Miami - BTC - PPDS, Miami, Florida, United States|Adult Medicine of Lake County, Mount Dora, Florida, United States|Providea Health Partners LLC, Evergreen Park, Illinois, United States|Clinical Research Institute, Inc - CRN - PPDS, Minneapolis, Minnesota, United States|Encompass Care, North Las Vegas, Nevada, United States|Riverside Medical Group - Circuit- PPDS, Secaucus, New Jersey, United States|NYC Health + Hospitals/Lincoln, Bronx, New York, United States|Elmhurst Hospital Center, Elmhurst, New York, United States|Harlem Hospital Center, New York, New York, United States|Premier Family Physicians - Austin - Hunt - PPDS, Austin, Texas, United States|Village Health Partners - Plano - Hunt - PPDS, Plano, Texas, United States|South Texas Allergy and Asthma Medical Professionals, San Antonio, Texas, United States|Boundary House Medical Centre, Sale, Cheshire, United Kingdom|St Mary's Hospital - PPDS, London, City Of London, United Kingdom|Royal Free Hospital, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04504032
NCT04564287,An Observational Study of Neurologic Function After COVID-19 Infection,Observational Model: Cohort|Time Perspective: Prospective,10000094|000094-N,"National Institutes of Health Clinical Center, Bethesda, Maryland, United States",https://ClinicalTrials.gov/show/NCT04564287
NCT04443270,Chloroquine Phosphate Prophylactic Use in Health Personnel Exposed to COVID-19 Patients,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention,1,"Centro Médico Nacional ""20 de Noviembre"", Mexico City, Benito Juárez, Mexico",https://ClinicalTrials.gov/show/NCT04443270
NCT04385043,Hyperimmune Plasma in Patients With COVID-19 Severe Infection,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,Covid-19 convalescent plasma,"Azienda Ospedaliera Policlinico Mater Domini, Catanzaro, Italy|Azienda Ospedaliera Pugliese Ciaccio Catanzaro, Catanzaro, Italy|Azienda Ospedaliera Annunziata, Cosenza, Italy|Azienda Sanitaria Provinciale, Crotone, Italy|Azienda Ospedaliera Bianchi Melacrino Morelli, Reggio Calabria, Italy|Azienda Sanitaria Provinciale, Vibo Valentia, Italy",https://ClinicalTrials.gov/show/NCT04385043
NCT04873414,Convalescent Plasma as Adjunct Therapy for COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,COVID-CT002,"Aceh Tamiang Hospital, Aceh Tamiang, Aceh, Indonesia|Sanglah Central Hospital, Denpasar, Bali, Indonesia|Udayana University Hospital, Denpasar, Bali, Indonesia|Dr. Soeradji Tirtonegoro Hospital, Klaten, Central Java, Indonesia|Dr. Wongsonegoro Regency Hospital, Semarang, Central Java, Indonesia|Pasar Minggu Hospital, Jakarta, DKI, Indonesia|Dr. Haryoto Regency Hospital, Lumajang, East Java, Indonesia|Waluyo Jati Kraksaan Regency Hospital, Probolinggo, East Java, Indonesia|Sidoarjo Regency Hospital, Sidoarjo, East Java, Indonesia|Dr Ramelan Navy Hospital, Surabaya, East Java, Indonesia|Dr. Soetomo Hospital, Surabaya, East Java, Indonesia|Emergency Hospital for COVID-19 - Wisma Atlet Kemayoran, Jakarta Pusat, Jakarta, Indonesia|Prof. Dr. R.D. Kandou Hospital, Manado, North Sulawesi, Indonesia|Dr. Tadjuddin Chalid Hospital, Makassar, Souh Sulawesi, Indonesia|Dr. Wahidin Sudirohusodo Central Hospital, Makassar, South Sulawesi, Indonesia|Hasanuddin University Hospital, Makassar, South Sulawesi, Indonesia|Dadi Hospital, Makassar, South Sulawesi, Indonesia|Dr. Mohammad Hoesin Central Hospital, Palembang, South Sumatra, Indonesia|Dr. Hasan Sadikin Central Hospital, Bandung, West Java, Indonesia|RSD Gunung Jati, Cirebon, West Java, Indonesia|Gatot Soebroto Central Army Hospital, Jakarta Pusat, Indonesia|dr. Cipto Mangunkusumo National Central General Hospital, Jakarta, Indonesia|YARSI Hospital, Jakarta, Indonesia|Dr. Suyoto Pusrehab Kemenhan Hospital, Jakarta, Indonesia|Persahabatan Central hospital, Jakarta, Indonesia|Fatmawati Central Hospital, Jakarta, Indonesia|Prof. Dr. Sulianti Saroso Infectious Disease Hospital, Jakarta, Indonesia|University Of Indonesia Hospital (RSUI), Jakarta, Indonesia",https://ClinicalTrials.gov/show/NCT04873414
NCT04432324,Study to Evaluate the Safety and Efficacy of High Dose IVIG in Hospitalized Participants With Coronavirus Disease (COVID-19),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,GC2004|2020-001696-32,"Hospital Universitario Infanta Sofía, San Sebastián De Los Reyes, Madrid, Spain|Hospital Germans Trias i Pujol, Badalona, Spain|Hospital Del Mar, Barcelona, Spain|Hospital Universitari Vall d'Hebron, Barcelona, Spain|Hospital Universitari de Bellvitge, Barcelona, Spain|Hospital de la Santa Creu i Sant Pau, Barcelona, Spain|Hospital Universitario de Getafe, Getafe, Spain|Hospital Arnau de Vilanova, Lleida, Spain|Hospital General Universitario Gregorio Marañón, Madrid, Spain|Hospital Clinico San Carlos, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04432324
NCT04384497,Convalescent Plasma for Treatment of COVID-19: An Exploratory Dose Identifying Study,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,CP2,"Danderyd Hospital, Danderyd, Stockholm, Sweden|Karolinska University Hospital, Stockholm, Sweden",https://ClinicalTrials.gov/show/NCT04384497
NCT04359615,Favipiravir in Hospitalized COVID-19 Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",Favipiravir in COVID-19,"Shahid Modarres Hospital, Shahid Beheshti University of Medical Sciences and Health Services, Tehran, Iran, Islamic Republic of",https://ClinicalTrials.gov/show/NCT04359615
NCT04542694,Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,FAV052020,"State Clinical Hospital №50, Moscow, Russian Federation|Regional Clinic Hospital of Ryazan, Ryazan', Russian Federation|City Hospital N40 of Kurortny District, Saint Petersburg, Russian Federation|Medical institute Ogarev Mordovia State university, Saransk, Russian Federation|Smolensk clinical hospital №1, Smolensk, Russian Federation",https://ClinicalTrials.gov/show/NCT04542694
NCT04397822,COVID-19 : Study of INFLAmmasome and PLAtelets Functions,Observational Model: Cohort|Time Perspective: Prospective,RC31/20/0142,"CHU Toulouse, Toulouse, France",https://ClinicalTrials.gov/show/NCT04397822
NCT04492475,Adaptive COVID-19 Treatment Trial 3 (ACTT-3),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",20-0006 ACTT-3,"University of Alabama at Birmingham School of Medicine - Infectious Disease, Birmingham, Alabama, United States|UCSF Fresno Center for Medical Education and Research - Clinical Research Center, Fresno, California, United States|University of California San Diego Health - Jacobs Medical Center, La Jolla, California, United States|University of California Los Angeles Medical Center - Westwood Clinic, Los Angeles, California, United States|University of California Irvine Medical Center - Infectious Disease, Orange, California, United States|VA Palo Alto Health Care System - Infectious Diseases, Palo Alto, California, United States|Stanford University - Stanford Hospital and Clinics - Pediatrics - Infectious Diseases, Palo Alto, California, United States|University of California Davis Medical Center - Internal Medicine - Infectious Disease, Sacramento, California, United States|Naval Medical Center San Diego - Infectious Disease Clinic, San Diego, California, United States|University of California San Francisco - Zuckerberg San Francisco General Hospital - Division of HIV, ID, and Global Medicine, San Francisco, California, United States|Cedars Sinai Medical Center, West Hollywood, California, United States|Eastern Colorado Health Care System, Aurora, Colorado, United States|Denver Health Division of Hospital Medicine - Main Campus, Denver, Colorado, United States|University of Florida Health - Shands Hospital - Division of Infectious Diseases and Global Medicine, Gainesville, Florida, United States|University of Florida Health - Jacksonville - Department of Emergency Medicine, Jacksonville, Florida, United States|University of Miami Miller School of Medicine - Infectious Diseases, Miami, Florida, United States|Emory Vaccine Center - The Hope Clinic, Decatur, Georgia, United States|Atlanta VA Medical Center - Infectious Diseases Clinic, Decatur, Georgia, United States|Tripler Army Medical Center (TAMC), Honolulu, Hawaii, United States|Northwestern Hospital - Infectious Disease, Chicago, Illinois, United States|University of Illinois at Chicago Division of Infectious Diseases, Chicago, Illinois, United States|University of Iowa Hospitals & Clinics - Department of Internal Medicine, Iowa City, Iowa, United States|Ochsner Medical Center - Kenner - Department of Infectious Diseases, Kenner, Louisiana, United States|Southeast Louisiana Veterans Health Care System - Section of Infectious Diseases, New Orleans, Louisiana, United States|University of Maryland School of Medicine - Center for Vaccine Development - Baltimore, Baltimore, Maryland, United States|Johns Hopkins Hospital - Medicine - Infectious Diseases, Baltimore, Maryland, United States|Walter Reed National Military Medical Center, Bethesda, Maryland, United States|National Institutes of Health - Clinical Center, National Institute of Allergy and Infectious Diseases Laboratory Of Immunoregulation, Clinical Research Section, Bethesda, Maryland, United States|Massachusetts General Hospital - Infectious Diseases, Boston, Massachusetts, United States|University of Massachusetts Medical School - Infectious Diseases and Immunology, Worcester, Massachusetts, United States|University of Minnesota Medical Center, Fairview - Infectious Diseases and International Medicine, Minneapolis, Minnesota, United States|Saint Louis University - Center for Vaccine Development, Saint Louis, Missouri, United States|University of Nebraska Medical Center - Infectious Diseases, Omaha, Nebraska, United States|University of New Mexico Clinical and Translational Science Center, Albuquerque, New Mexico, United States|Montefiore Medical Center - Infectious Diseases, Bronx, New York, United States|New York University School of Medicine - Langone Medical Center - Microbiology - Parasitology, New York, New York, United States|University of Rochester Medical Center - Vaccine Research Unit, Rochester, New York, United States|Duke Human Vaccine Institute - Duke Vaccine and Trials Unit, Durham, North Carolina, United States|Womack Army Medical Center - Pulmonary and Respiratory Services, Fort Bragg, North Carolina, United States|Kaiser Permanente Northwest - Center for Health Research, Portland, Oregon, United States|Penn State Health Milton S. Hershey Medical Center - Division of Infectious Diseases, Hershey, Pennsylvania, United States|Hospital of the University of Pennsylvania - Infectious Diseases, Philadelphia, Pennsylvania, United States|Baylor Scott & White Health - Baylor University Medical Center - North Texas Infectious Disease Consultants, Dallas, Texas, United States|University of Texas Southwestern Medical Center - Internal Medicine - Infectious Diseases, Dallas, Texas, United States|Brooke Army Medical Center, Fort Sam Houston, Texas, United States|University of Texas Medical Branch - Division of Infectious Disease, Galveston, Texas, United States|Baylor College of Medicine - Molecular Virology and Microbiology, Houston, Texas, United States|Methodist Hospital - Houston, Houston, Texas, United States|University of Texas Health Science Center at San Antonio - Infectious Diseases, San Antonio, Texas, United States|University of Utah - Infectious Diseases, Salt Lake City, Utah, United States|University of Virginia - Acute Care Surgery, Charlottesville, Virginia, United States|Naval Medical Center Portsmouth - Infectious Disease Division, Portsmouth, Virginia, United States|EvergreenHealth Infectious Disease Service, Kirkland, Washington, United States|Providence Sacred Heart Medical Center, Spokane, Washington, United States|Madigan Army Medical Center - Infectious Disease Clinic, Tacoma, Washington, United States|National Center for Global Health and Medicine Hospital - Disease Control and Prevention Center, Tokyo, Japan|Seoul National University Bundang Hospital - Division of Infectious Diseases, Seongnam, Gyeonggi-do, Korea, Republic of|Seoul National University Hospital, Seoul, Jongno-gu, Korea, Republic of|Instituto Nacional de Enfermedades Respiratorias (INER) - Ismael Cosío Villegas, Mexico City, Mexico|Instituto Nacional de Ciencias Medicas y Nutrición Salvador Zubirán - Departamento de Infectologia, Mexico City, Mexico|National University Health System - Division of Infectious Diseases, Singapore, Singapore|National Centre for Infectious Diseases (NCID), Singapore, Singapore|Changi General Hospital - Clinical Trials and Research Unit (CTRU), Singapore, Singapore|Ng Teng Fong General Hospital - Infectious Disease Service, Singapore, Singapore",https://ClinicalTrials.gov/show/NCT04492475
NCT04901676,Leronlimab in Moderatelly Ill Patients With COVID-19 Pneumonia,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",ARO_21_018_001,"Hospital Israelita Albert Einstein, Sao Paulo, Brazil",https://ClinicalTrials.gov/show/NCT04901676
NCT04582344,Clinical Trial For SARS-CoV-2 Vaccine (COVID-19),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention",9026-ASI,"T.R. Ministry of Health Ankara City Hospital, Infectious Diseases and Clinical Microbiology Clinic, Ankara, Turkey Region, Turkey|T.R. Ministry of Health Ankara Provincial Health Directorate Ankara Training and Research Hospital, Infectious Diseases, Ankara, Turkey Region, Turkey|Ankara University Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Ankara, Turkey Region, Turkey|Çukurova University Faculty of Medicine, Department of Infectious Diseases, Adana, Turkey|Hacettepe University Faculty of Medicine Department of Infections Diseases and Clinical Microbiology, Ankara, Turkey|T.C Ministry of Health Ankara Provincial Health Directorate Health Sciences University Ankara Atatürk Chest Diseases and Thoracic Surgery Training and Research Hospital, Ankara, Turkey|Akdeniz University Faculty of Medicine, Department of Infectious Diseases, Antalya, Turkey|Bursa Uludağ University Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Bursa, Turkey|Dicle University Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Diyarbakır, Turkey|Gaziantep University Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Gaziantep, Turkey|Acıbadem Atakent Hospital, Infectious Diseases and Clinical Microbiology, Istanbul, Turkey|Cerrahpaşa Faculty of Medicine, Department of Internal Medicine - Department of Infectious Diseases and Clinical Microbiology, Istanbul, Turkey|Istanbul Medipol University Faculty of Medicine, Department of Internal Medicine, Istanbul, Turkey|Istanbul University Istanbul Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Istanbul, Turkey|T.R. Ministry of Health Istanbul Provincial Health Directorate Marmara Univesity Istanbul Pendik Education and Research Hospital, Istanbul, Turkey|T.R. Ministry of Health Istanbul Provincial Health Directorate Prof. Dr. Cemil Taşçıoğlu City Hospital, Infectious Diseases Clinic, Istanbul, Turkey|T.R. Ministry of Health Istanbul Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital, Istanbul, Turkey|University of Health Sciences İstanbul Ümraniye Training and Research Hospital, Istanbul, Turkey|Ege University Faculty of Medicine Hospital, Department of Infectious Diseasesaculty of Medicine Hospital, Department of Infectious Diseases, İzmir, Turkey|Republic Of Turkey Ministry Of Health Izmir Provincial Health Directorate Health Sciences University Dr Suat Seren Chest Diseases And Chest Surgery Training And Research Hospital, İzmir, Turkey|T.R. Ministry of Health İzmir Provincial Health Directorate İzmir Health Sciences University Tepecik Training and Research Hospital, Infectious Diseases, İzmir, Turkey|T.R. Ministry of Health Kayseri City Training and Research Hospital, Infectious Diseases and Clinical Microbiology Department, Kayseri, Turkey|Kocaeli University Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Kocaeli, Turkey|Malatya İnönü University Faculty of Medicine, Department of Infectious Diseases, Malatya, Turkey|Karadeniz Technical University Medical Faculty Hospital, Department of Infectious Diseases and Clinical Microbiology, Trabzon, Turkey",https://ClinicalTrials.gov/show/NCT04582344
NCT04359316,Azithromycin in Hospitalized COVID-19 Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",Azithromycin in COVID-19,"Shahid Modarres Hospital, Shahid Beheshti University of Medical Sciences and Health Services, Tehran, Iran, Islamic Republic of",https://ClinicalTrials.gov/show/NCT04359316
NCT04547140,Study to Evaluate the Safety and Efficacy of Liquid Alpha1-Proteinase Inhibitor (Human) in Hospitalized Participants With Coronavirus Disease (COVID-19),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",GC2006,"Birmingham VA, Birmingham, Alabama, United States|St. Joseph's Hospital, Phoenix, Arizona, United States|Sparrow Hospital, Lansing, Michigan, United States|Hannibal Clinic, Hannibal, Missouri, United States|Kansas City VA, Kansas City, Missouri, United States|CHI Health Center, Omaha, Nebraska, United States|Columbia University Medical Center, New York, New York, United States|Temple University Hospital, Philadelphia, Pennsylvania, United States|Memphis VA, Memphis, Tennessee, United States|University of Utah, Salt Lake City, Utah, United States|MultiCare Tacoma General Hospital, Tacoma, Washington, United States|AngioCor Blumenau, Blumenau, Santa Catarina, Brazil|Hospital Sao Jose, Criciúma, Santa Catarina, Brazil|Hospital das Clinicas da Faculdade de Medicina de Botucatu, Botucatu, São Paulo, Brazil|Hospital Dia do Pulmão, Blumenau, Brazil|Hospital Alemao Oswaldo Cruz, São Paulo, Brazil|Hospital Padre Hurtado, Santiago, Chile|Hospital Carlos Van Buren, Valparaíso, Chile",https://ClinicalTrials.gov/show/NCT04547140
NCT04401579,Adaptive COVID-19 Treatment Trial 2 (ACTT-2),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",20-0006 ACTT-2,"University of Alabama at Birmingham School of Medicine - Infectious Disease, Birmingham, Alabama, United States|University of California San Diego Health - Jacobs Medical Center, La Jolla, California, United States|University of California Los Angeles Medical Center - Westwood Clinic, Los Angeles, California, United States|University of California Irvine Medical Center - Infectious Disease, Orange, California, United States|VA Palo Alto Health Care System - Infectious Diseases, Palo Alto, California, United States|Stanford University - Stanford Hospital and Clinics - Pediatrics - Infectious Diseases, Palo Alto, California, United States|University of California Davis Medical Center - Internal Medicine - Infectious Disease, Sacramento, California, United States|Naval Medical Center San Diego - Infectious Disease Clinic, San Diego, California, United States|University of California San Francisco - Zuckerberg San Francisco General Hospital - Division of Human Immunodeficiency Virus, Infectious Disease, and Global Medicine, San Francisco, California, United States|Cedars Sinai Medical Center, West Hollywood, California, United States|Eastern Colorado Health Care System, Aurora, Colorado, United States|Denver Health Division of Hospital Medicine - Main Campus, Denver, Colorado, United States|Georgetown University Medical Center - Division of Infectious Diseases, Washington, District of Columbia, United States|University of Florida Health - Shands Hospital - Division of Infectious Diseases and Global Medicine, Gainesville, Florida, United States|University of Miami Miller School of Medicine - Infectious Diseases, Miami, Florida, United States|Emory Vaccine Center - The Hope Clinic, Decatur, Georgia, United States|Atlanta VA Medical Center - Infectious Diseases Clinic, Decatur, Georgia, United States|Northwestern Hospital - Infectious Disease, Chicago, Illinois, United States|University of Illinois at Chicago College of Medicine - Division of Infectious Diseases, Chicago, Illinois, United States|Indiana University School of Medicine - Infectious Diseases, Indianapolis, Indiana, United States|Ochsner Medical Center - Kenner - Department of Infectious Diseases, Kenner, Louisiana, United States|Southeast Louisiana Veterans Health Care System (SLVHCS) - Section of Infectious Diseases, New Orleans, Louisiana, United States|University of Maryland School of Medicine - Center for Vaccine Development - Baltimore, Baltimore, Maryland, United States|Johns Hopkins Hospital - Medicine - Infectious Diseases, Baltimore, Maryland, United States|Walter Reed National Military Medical Center, Bethesda, Maryland, United States|National Institutes of Health - Clinical Center, National Institute of Allergy and Infectious Diseases Laboratory Of Immunoregulation, Clinical Research Section, Bethesda, Maryland, United States|Massachusetts General Hospital - Infectious Diseases, Boston, Massachusetts, United States|University of Massachusetts Medical School - Infectious Diseases and Immunology, Worcester, Massachusetts, United States|University of Minnesota Medical Center, Fairview - Infectious Diseases and International Medicine, Minneapolis, Minnesota, United States|Saint Louis University - Center for Vaccine Development, Saint Louis, Missouri, United States|University of Nebraska Medical Center - Infectious Diseases, Omaha, Nebraska, United States|University of New Mexico Clinical and Translational Science Center, Albuquerque, New Mexico, United States|Montefiore Medical Center - Infectious Diseases, Bronx, New York, United States|New York University School of Medicine - Langone Medical Center - Microbiology - Parasitology, New York, New York, United States|University of Rochester Medical Center - Vaccine Research Unit, Rochester, New York, United States|Duke Human Vaccine Institute - Duke Vaccine and Trials Unit, Durham, North Carolina, United States|Womack Army Medical Center - Pulmonary and Respiratory Services, Fort Bragg, North Carolina, United States|Kaiser Permanente Northwest - Center for Health Research, Portland, Oregon, United States|Penn State Health Milton S. Hershey Medical Center - Division of Infectious Diseases, Hershey, Pennsylvania, United States|University of Pennsylvania Perelman School of Medicine - Penn Institute for Immunology, Philadelphia, Pennsylvania, United States|Vanderbilt University Medical Center - Infectious Diseases, Nashville, Tennessee, United States|Baylor Scott & White Health - Baylor University Medical Center - North Texas Infectious Disease Consultants, Dallas, Texas, United States|University of Texas Southwestern Medical Center - Internal Medicine - Infectious Diseases, Dallas, Texas, United States|Brooke Army Medical Center, Fort Sam Houston, Texas, United States|University of Texas Medical Branch - Division of Infectious Disease, Galveston, Texas, United States|Baylor College of Medicine - Molecular Virology and Microbiology, Houston, Texas, United States|University of Texas Health Science Center at San Antonio - Infectious Diseases, San Antonio, Texas, United States|University of Utah - Infectious Diseases, Salt Lake City, Utah, United States|University of Virginia - Acute Care Surgery, Charlottesville, Virginia, United States|Naval Medical Center Portsmouth - Infectious Disease Division, Portsmouth, Virginia, United States|EvergreenHealth Infectious Disease Service, Kirkland, Washington, United States|Providence Sacred Heart Medical Center, Spokane, Washington, United States|Madigan Army Medical Center - Infectious Disease Clinic, Tacoma, Washington, United States|University of Copenhagen - Centre of Excellence for Health, Immunity and Infections (CHIP) - Department of Infectious Diseases, Copenhagen, Denmark|National Center for Global Health and Medicine Hospital - Disease Control and Prevention Center, Tokyo, Japan|Seoul National University Bundang Hospital - Division of Infectious Diseases, Bundang-gu Seongnam-si, Korea, Republic of|Seoul National University Hospital, Seoul, Korea, Republic of|Instituto Nacional de Ciencias Medicas y Nutrición Salvador Zubirán - Departamento de Infectologia, Mexico City, Mexico|Instituto Nacional de Enfermedades Respiratorias (INER) - Ismael Cosío Villegas, Mexico City, Mexico|National University Health System - Division of Infectious Diseases, Singapore, Singapore|National Centre for Infectious Diseases (NCID), Singapore, Singapore|Changi General Hospital - Clinical Trials and Research Unit (CTRU), Singapore, Singapore|Ng Teng Fong General Hospital - Infectious Disease Service, Singapore, Singapore|Hospital Clinic Barcelona, Servicio de Salud Internacional, Barcelona, Cataluña, Spain|Hospital Germans Trias i Pujol - Servei Malalties Infeccioses, Barcelona, Cataluña, Spain|Hospital Clinico San Carlos - Enfermedades Infecciosas, Madrid, Spain|Royal Sussex County Hospital - Department of Intensive Care Medicine, Brighton, United Kingdom|Saint Thomas' Hospital - Directorate of Infection, City Of London, United Kingdom|St. James's University Hospital - Infectious Diseases, Leeds, United Kingdom|Royal Victoria Infirmary - Department of Infectious Diseases, Newcastle Upon Tyne, United Kingdom|John Radcliffe Hospital, Oxford, United Kingdom",https://ClinicalTrials.gov/show/NCT04401579
NCT04280705,Adaptive COVID-19 Treatment Trial (ACTT),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",20-0006,"University of Alabama at Birmingham School of Medicine - Infectious Disease, Birmingham, Alabama, United States|University of California San Diego Health - Jacobs Medical Center, La Jolla, California, United States|University of California Los Angeles Medical Center - Westwood Clinic, Los Angeles, California, United States|University of California Irvine Medical Center - Infectious Disease, Orange, California, United States|VA Palo Alto Health Care System - Infectious Diseases, Palo Alto, California, United States|Stanford University - Stanford Hospital and Clinics - Pediatrics - Infectious Diseases, Palo Alto, California, United States|University of California Davis Medical Center - Internal Medicine - Infectious Disease, Sacramento, California, United States|Naval Medical Center San Diego - Infectious Disease Clinic, San Diego, California, United States|University of California San Francisco - Zuckerberg San Francisco General Hospital - Division of Human Immunodeficiency Virus, Infectious Disease, and Global Medicine, San Francisco, California, United States|Cedars Sinai Medical Center, West Hollywood, California, United States|Denver Health Division of Hospital Medicine - Main Campus, Denver, Colorado, United States|Emory Vaccine Center - The Hope Clinic, Decatur, Georgia, United States|Northwestern Hospital - Infectious Disease, Chicago, Illinois, United States|University of Illinois at Chicago College of Medicine - Division of Infectious Diseases, Chicago, Illinois, United States|Southeast Louisiana Veterans Health Care System (SLVHCS) - Section of Infectious Diseases, New Orleans, Louisiana, United States|University of Maryland School of Medicine - Center for Vaccine Development - Baltimore, Annapolis, Maryland, United States|Johns Hopkins Hospital - Medicine - Infectious Diseases, Baltimore, Maryland, United States|Walter Reed National Military Medical Center, Bethesda, Maryland, United States|National Institutes of Health - Clinical Center, National Institute of Allergy and Infectious Diseases Laboratory Of Immunoregulation, Clinical Research Section, Bethesda, Maryland, United States|Massachusetts General Hospital - Infectious Diseases, Boston, Massachusetts, United States|University of Massachusetts Medical School - Infectious Diseases and Immunology, Worcester, Massachusetts, United States|University of Minnesota Medical Center, Fairview - Infectious Diseases and International Medicine, Minneapolis, Minnesota, United States|Saint Louis University - Center for Vaccine Development, Saint Louis, Missouri, United States|University of Nebraska Medical Center - Infectious Diseases, Omaha, Nebraska, United States|Montefiore Medical Center - Infectious Diseases, Bronx, New York, United States|New York University School of Medicine - Langone Medical Center - Microbiology - Parasitology, New York, New York, United States|University of Rochester Medical Center - Vaccine Research Unit, Rochester, New York, United States|Duke Human Vaccine Institute - Duke Vaccine and Trials Unit, Durham, North Carolina, United States|Penn State Health Milton S. Hershey Medical Center - Division of Infectious Diseases, Hershey, Pennsylvania, United States|Hospital of the University of Pennsylvania - Infectious Diseases, Philadelphia, Pennsylvania, United States|Vanderbilt University Medical Center - Infectious Diseases, Nashville, Tennessee, United States|Brooke Army Medical Center, Fort Sam Houston, Texas, United States|University of Texas Medical Branch - Division of Infectious Disease, Galveston, Texas, United States|Baylor College of Medicine - Molecular Virology and Microbiology, Houston, Texas, United States|University of Texas Health Science Center at San Antonio - Infectious Diseases, San Antonio, Texas, United States|University of Virginia - Acute Care Surgery, Charlottesville, Virginia, United States|Naval Medical Center Portsmouth - Infectious Disease Division, Portsmouth, Virginia, United States|EvergreenHealth Infectious Disease Service, Kirkland, Washington, United States|The University of Washington - Virology Research Clinic, Seattle, Washington, United States|Providence Sacred Heart Medical Center, Spokane, Washington, United States|Madigan Army Medical Center - Infectious Disease Clinic, Tacoma, Washington, United States|University of Copenhagen - Centre of Excellence for Health, Immunity and Infections (CHIP) - Department of Infectious Diseases, Copenhagen, Denmark|Universitatsklinikum Bonn, Medizinische Klinik I - Bereich Infektiologie/HIV der Medizinischen Klinik, Bonn, Nordrhein-Westfalen, Germany|Universitatsklinikum Koeln Klinik I fur Innere Medizin Klinisches Studienzentrum fur Infektiologie I, Cologne, Germany|Universitätsklinikum Frankfurt -Medizinische Klinik II - Infektiologie, Frankfurt, Germany|AHEPA University Hospital - 1st Department of Internal Medicine, Thessaloniki, Central Macedonia, Greece|Medical School of Athens University - Evangelismos Hospital - Department of Critical Care and Pulmonary Services, Athens, Greece|National Center for Global Health and Medicine Hospital - Disease Control and Prevention Center, Tokyo, Japan|Seoul National University Bundang Hospital - Division of Infectious Diseases, Bundang-gu Seongnam-si, Gyeonggi-do, Korea, Republic of|Seoul National University Hospital, Seoul, Jongno-gu, Korea, Republic of|Instituto Nacional de Ciencias Medicas y Nutrición Salvador Zubirán - Departamento de Infectologia, Mexico City, Mexico|Instituto Nacional de Enfermedades Respiratorias (INER) - Ismael Cosío Villegas, Mexico City, Mexico|National Centre for Infectious Diseases (NCID), Singapore, Singapore|Hospital Clinic Barcelona, Servicio de Salud Internacional, Barcelona, Cataluña, Spain|Hospital Germans Trias i Pujol - Servei Malalties Infeccioses, Barcelona, Cataluña, Spain|Royal Sussex County Hospital - Department of Intensive Care Medicine, East Sussex, Brighton, United Kingdom|Saint Thomas' Hospital - Directorate of Infection, London, London, City Of, United Kingdom|Royal Victoria Infirmary - Department of Infectious Diseases, Level 6, Ward 19, Newcastle Upon Tyne, United Kingdom|St. James's University Hospital - Infectious Diseases, Leeds, West Yorkshire, United Kingdom|John Radcliffe Hospital, Headington, Oxford, United Kingdom",https://ClinicalTrials.gov/show/NCT04280705
NCT04894435,Mix and Match of the Second COVID-19 Vaccine Dose for Safety and Immunogenicity,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Prevention",CT24,"Northern Alberta Clinical Trial Trials and Research Centre, U of Alberta, Edmonton, Alberta, Canada|BC Children's Hospital Research Institute, Vancouver, British Columbia, Canada|Children's Hospital Research Institute of Manitoba, Winnipeg, Manitoba, Canada|Canadian Center for Vaccinology, Halifax, Nova Scotia, Canada|Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada|CHU de Québec, Université Laval, Québec, Canada",https://ClinicalTrials.gov/show/NCT04894435
NCT04348071,Safety and Efficacy of Ruxolitinib for COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,20-0869,NA,https://ClinicalTrials.gov/show/NCT04348071
NCT04583969,ACTIV-5 / Big Effect Trial (BET-B) for the Treatment of COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",20-0013B,"University of Alabama at Birmingham School of Medicine - Infectious Disease, Birmingham, Alabama, United States|St Joseph's Hospital and Medical Center, Phoenix, Arizona, United States|Mayo Clinic, Phoenix - Infectious Diseases, Phoenix, Arizona, United States|The University of Arizona - Banner University Medical Center Tucson Campus - Tucson, Tucson, Arizona, United States|University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States|Kern Medical Center, Bakersfield, California, United States|UCSF Fresno Center for Medical Education and Research - Clinical Research Center, Fresno, California, United States|University of California San Diego Health - Jacobs Medical Center, La Jolla, California, United States|University of California, San Diego, La Jolla, California, United States|University of Southern California - Infectious Diseases, Los Angeles, California, United States|University of California Los Angeles Medical Center - Westwood Clinic, Los Angeles, California, United States|Hoag Hospital Newport Beach, Newport Beach, California, United States|Stanford University - Stanford Hospital and Clinics - Pediatrics - Infectious Diseases, Stanford, California, United States|Penrose Hospital - Emergency Medicine, Colorado Springs, Colorado, United States|St. Francis Medical Center, Colorado Springs, Colorado, United States|St. Anthony Hospital, Lakewood, Colorado, United States|St. Anthony Hospital North Health Campus, Westminster, Colorado, United States|Nuvance Health Danbury Hospital - Infectious Disease, Danbury, Connecticut, United States|Yale School of Medicine - The Anlyan Center for Medical Research & Education - Immunobiology, New Haven, Connecticut, United States|Nuvance Health - Norwalk Hospital - Asthma Pulmonary and Critical Care Medicine, Norwalk, Connecticut, United States|MedStar Washington Hospital Center - Infectious Diseases, Washington, District of Columbia, United States|University of Florida Health - Pulmonary - Internal Medicine and Medical Specialties Clinic, Gainesville, Florida, United States|University of Florida Health - Shands Hospital - Division of Infectious Diseases and Global Medicine, Gainesville, Florida, United States|Mayo Clinic Florida, Jacksonville, Florida, United States|Advent Health Orlando - Critical Care, Orlando, Florida, United States|Grady Memorial Hospital, Atlanta, Georgia, United States|Emory Vaccine Center - The Hope Clinic, Decatur, Georgia, United States|Cook County Health and Hospitals System - Ruth M Rothstein CORE Center, Chicago, Illinois, United States|Rush University Medical Center, Chicago, Illinois, United States|Great Lakes Clinical Trials, Chicago, Illinois, United States|Carle Foundation Hospital, Urbana, Illinois, United States|Northwestern Medicine - Central DuPage Hospital - Infectious Disease, Winfield, Illinois, United States|Norton Healthcare, Louisville, Kentucky, United States|University of Louisville - Division of Infectious Diseases, Louisville, Kentucky, United States|Pikeville Medical Center - Department of Infectious Disease, Pikeville, Kentucky, United States|Louisiana State University Health Shreveport - Infectious Diseases, Shreveport, Louisiana, United States|Brigham and Women's Hospital - Infectious Diseases, Boston, Massachusetts, United States|Boston Medical Center - Center for Infectious Diseases - Shapiro Center, Boston, Massachusetts, United States|William Beaumont Hospital - Royal Oak Campus - Infectious Disease, Royal Oak, Michigan, United States|Hennepin Healthcare Research Institute, Minneapolis, Minnesota, United States|Mayo Clinic, Rochester - Infectious Diseases, Rochester, Minnesota, United States|University of Nebraska Medical Center - Infectious Diseases, Omaha, Nebraska, United States|Englewood Hospital, Englewood, New Jersey, United States|Virtua Health - Virtua Voorhees Hospital - Pulmonology, Voorhees, New Jersey, United States|Jacobi Medical Center, Bronx, New York, United States|Montefiore Medical Center - Infectious Diseases, Bronx, New York, United States|The State University of New York - University at Buffalo - Department of Medicine, Buffalo, New York, United States|Mount Sinai School of Medicine - Medicine - Infectious Diseases, New York, New York, United States|Nuvance Health - Vassar Brothers Medical Center, Poughkeepsie, New York, United States|Stony Brook Medicine - Stony Brook University Hospita, Stony Brook, New York, United States|Atrium Health ID Consultants & Infusion Care Specialists, Charlotte, North Carolina, United States|East Carolina University Brody School of Medicine - Adult Specialty Care, Greenville, North Carolina, United States|Wake Forest Baptist Health - Infectious Diseases, Winston-Salem, North Carolina, United States|University of Toledo Medical Center - Ruppert Clinic, Toledo, Ohio, United States|St. Charles Health System - St. Charles Bend Hospital, Bend, Oregon, United States|Doylestown Hospital, Doylestown, Pennsylvania, United States|Penn State Health Milton S. Hershey Medical Center - Division of Infectious Diseases, Hershey, Pennsylvania, United States|Kent County Memorial Hospital, Warwick, Rhode Island, United States|Monument Health - Clinical Research, Rapid City, South Dakota, United States|Hendrick Health - Hendrick Medical Center, Abilene, Texas, United States|Texas Tech University Health Science Center, Amarillo, Texas, United States|Baptist Hospitals of Southeast Texas Site, Beaumont, Texas, United States|Baylor Scott & White Health - Baylor University Medical Center - North Texas Infectious Disease Consultants, Dallas, Texas, United States|Methodist Hospital - Houston, Houston, Texas, United States|University of Texas Health Science Center at San Antonio - Infectious Diseases, San Antonio, Texas, United States|University of Texas Health Science Center San Antonio - Pediatrics - Immunology & Infectious Disease, San Antonio, Texas, United States|University of Texas Health Science Center at Tyler, Tyler, Texas, United States|University of Utah - Infectious Diseases, Salt Lake City, Utah, United States|Marshall Health - Marshall University Medical Center - Internal Medicine, Huntington, West Virginia, United States|West Virginia University - Infectious Diseases Clinic, Morgantown, West Virginia, United States|Seoul National University Bundang Hospital - Division of Infectious Diseases, Bundang-gu Seongnam-si, Gyeonggi-do, Korea, Republic of|Seoul National University Hospital, Seoul, Jongno-gu, Korea, Republic of",https://ClinicalTrials.gov/show/NCT04583969
NCT04340232,Safety and Efficacy of Baricitinib for COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,20-0738,"University of Colorado, Denver, Aurora, Colorado, United States",https://ClinicalTrials.gov/show/NCT04340232
NCT04428008,Thymosin Alpha 1 to Prevent COVID-19 Infection in Renal Dialysis Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,ACW-1221958-1,"Clinical Research Consultants, Kansas City, Kansas, United States",https://ClinicalTrials.gov/show/NCT04428008
NCT04852835,COVID-19 Vaccine Response,Observational Model: Case-Only|Time Perspective: Other,8223,"Service de Virologie - Hôpital Civil, Strasbourg, France",https://ClinicalTrials.gov/show/NCT04852835
NCT04828772,A Study of Anticoagulation Treatment Patterns and Outcomes of Participants Hospitalized With Coronavirus Disease 2019 (COVID-19) in Japan,Observational Model: Cohort|Time Perspective: Retrospective,CV185-801,"Medical Data Vision, Tokyo, Japan",https://ClinicalTrials.gov/show/NCT04828772
NCT04382781,Immunosupressive Treatment in COVID-19 Patients,Observational Model: Cohort|Time Perspective: Retrospective,FIS-INM-2020-03,"Hospital Virgen Macarena, Sevilla, Spain",https://ClinicalTrials.gov/show/NCT04382781
NCT04511819,Losmapimod Safety and Efficacy in COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",FIS-001-2020,"University of California Irvine - Irvine Medical Center, Irvine, California, United States|University of Miami, Miami, Florida, United States|University of South Florida, Tampa, Florida, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Memorial Hermann Hospital South West, Houston, Texas, United States|University of Texas Health Science Center at Houston, Houston, Texas, United States|United Medical Memorial Hospital, Houston, Texas, United States|Hospital Universitario Cassiano Antonio de Moraes-HUCAM/Hospital das Clinicas, Vitória, ES, Brazil|Santa Casa de Misericordia de Belo Horizonte, Belo Horizonte, MG, Brazil|Irmandade de Santa Casa de Misericordia de Porto Alegre, Porto Alegre, SC, Brazil|Hospital Santa Paula, San Paolo, SP, Brazil|Hospital Civil Fray Antonio Alcalde, Guadalajara, Jalisco, Mexico|Nuevo Hospital Civil de Guadalajara, Guadalajara, JC, Mexico|JM Research Cuernavaca, Cuernavaca, Morelos, Mexico|Centro para el Desarrollo de la Medicina y de Asistencia Médica Especializada, S.C., Culiacán, Sinaloa, Mexico|Hospital Nacional Carlos Alberto Seguín Escobedo - EsSalud Arequipa, Arequipa, AR, Peru",https://ClinicalTrials.gov/show/NCT04511819
NCT04547127,A Study to Evaluate Safety and Efficacy of Convalescent Methylene Blue Treated (MBT) Plasma From Donors Recovered From Coronavirus Disease 2019 (COVID-19),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,GC2003|2020-001299-14,"Hospital General Universitario de Alicante, Alicante, Spain|Hospital Universitari Vall d'Hebron, Barcelona, Spain|Hospital Universitari de Girona Doctor Josep Trueta, Girona, Spain|Hospital Universitari de Bellvitge, L'Hospitalet De Llobregat, Spain|Hospital Universitari Arnau de Vilanova, Lleida, Spain|Fundación Jimenez Diaz, Madrid, Spain|Hospital Clínico San Carlos, Madrid, Spain|Hospital Universitario La Paz, Madrid, Spain|Hospital Universitario La Princesa, Madrid, Spain|Complejo Hospitalario Universitario de Canarias, Santa Cruz De Tenerife, Spain|Hospital Clínico Universitario de Santiago -CHUS, Santiago, Spain|Hospital Universitari Joan XXIII, Tarragona, Spain",https://ClinicalTrials.gov/show/NCT04547127
NCT04802018,Clinical Decision Support System Based on Non-invasive Tele-monitoring of COVID-19 Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Supportive Care",CASVE-NM-21-508,"Faculty of Medicine of Valladolid, Valladolid, Spain",https://ClinicalTrials.gov/show/NCT04802018
NCT04532931,COVID-19 Treatment in South Africa,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,SP-PA-COV-202,"Ezintsha, Wits Reproductive Health & HIV Institute University of the Witwatersrand, Johannesburg, South Africa",https://ClinicalTrials.gov/show/NCT04532931
NCT04444115,Loneliness During Strict and Lifted Social Distancing Protocols Against the COVID-19 Pandemic,Observational Model: Ecologic or Community|Time Perspective: Prospective,802810-1,NA,https://ClinicalTrials.gov/show/NCT04444115
NCT04449588,Efficacy and Safety Study of BDB-001 in Severe COVID-19 With ALI/ARDS,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,STS-BDB001-04,"Asgar Ali Hospital, Dhaka, Bangladesh|Bangladesh Specialized Hospital, Dhaka, Bangladesh|Southwest Hospital Chongqing, Chongqing, Chongqing, China|Noble Hospital Pvt Ltd, Nagpur, India|Government Medical College and Hospital, Pune, India|RSUP Persahabatan(Persahabatan General Hospital), East Jakarta, Jakarta, Indonesia|RSUD Pasar Minggu(Pasar Minggu General Hospital), South Jakarta, Jakarta, Indonesia|RSUD Cengkareng(Cengkareng General Hospital), West Jakrata, Jakrata, Indonesia|Hospital Universitario 12 De Octubre, Madrid, Spain|Hospital Universitario Clínico San Carlos, Madrid, Spain|Hospital Universitario de la Princesa, Madrid, Spain|Hospital Universitario Fundación Díaz, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04449588
NCT04691947,Safety and Immunogenicity of Two Different Strengths of the Inactivated COVID-19 Vaccine ERUCOV-VAC,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention",IDEAL00420-EU01-PK537-1,"Erciyes University Hakan Çetinsaya Iyi Klinik Uygulama ve Arastirma Merkezi, IKUM (Center for GCP), Kayseri, Turkey",https://ClinicalTrials.gov/show/NCT04691947
NCT04640168,Adaptive COVID-19 Treatment Trial 4 (ACTT-4),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",20-0006 ACTT-4,"University of Alabama at Birmingham School of Medicine - Infectious Disease, Birmingham, Alabama, United States|UCSF Fresno Center for Medical Education and Research - Clinical Research Center, Fresno, California, United States|University of California San Diego Health - Jacobs Medical Center, La Jolla, California, United States|University of California Los Angeles Medical Center - Westwood Clinic, Los Angeles, California, United States|University of California Irvine Medical Center - Infectious Disease, Orange, California, United States|VA Palo Alto Health Care System - Infectious Diseases, Palo Alto, California, United States|University of California Davis Medical Center - Internal Medicine - Infectious Disease, Sacramento, California, United States|Kaiser Permanente San Diego Medical Center, San Diego, California, United States|Naval Medical Center San Diego - Infectious Disease Clinic, San Diego, California, United States|University of California San Francisco - Zuckerberg San Francisco General Hospital - Division of Human Immunodeficiency Virus, Infectious Disease, and Global Medicine, San Francisco, California, United States|Stanford University - Stanford Hospital and Clinics - Pediatrics - Infectious Diseases, Stanford, California, United States|Cedars Sinai Medical Center, West Hollywood, California, United States|VA Eastern Colorado Health Care System, Aurora, Colorado, United States|Denver Health Division of Hospital Medicine - Main Campus, Denver, Colorado, United States|Georgetown University Medical Center - Division of Infectious Diseases, Washington, District of Columbia, United States|University of Florida Health - Shands Hospital - Division of Infectious Diseases and Global Medicine, Gainesville, Florida, United States|University of Florida Health - Jacksonville - Department of Emergency Medicine, Jacksonville, Florida, United States|University of Miami Miller School of Medicine - Infectious Diseases, Miami, Florida, United States|Emory Vaccine Center - The Hope Clinic, Decatur, Georgia, United States|Atlanta VA Medical Center - Infectious Diseases Clinic, Decatur, Georgia, United States|Tripler Army Medical Center, Honolulu, Hawaii, United States|Northwestern Hospital - Infectious Disease, Chicago, Illinois, United States|University of Illinois at Chicago College of Medicine - Division of Infectious Diseases, Chicago, Illinois, United States|University of Iowa Hospitals & Clinics - Department of Internal Medicine, Iowa City, Iowa, United States|Tulane University - Section of Pulmonary Diseases, Critical Care, and Environmental Medicine, New Orleans, Louisiana, United States|University of Maryland School of Medicine - Center for Vaccine Development - Baltimore, Baltimore, Maryland, United States|Johns Hopkins Hospital - Medicine - Infectious Diseases, Baltimore, Maryland, United States|Walter Reed National Military Medical Center, Bethesda, Maryland, United States|National Institutes of Health - Clinical Center, National Institute of Allergy and Infectious Diseases Laboratory Of Immunoregulation, Clinical Research Section, Bethesda, Maryland, United States|Massachusetts General Hospital - Infectious Diseases, Boston, Massachusetts, United States|University of Massachusetts Medical School - Infectious Diseases and Immunology, Worcester, Massachusetts, United States|University of Michigan - Infectious Disease Clinic at Taubman Center, Ann Arbor, Michigan, United States|University of Minnesota Medical Center, Fairview - Infectious Diseases and International Medicine, Minneapolis, Minnesota, United States|Saint Louis University - Center for Vaccine Development, Saint Louis, Missouri, United States|University of Nebraska Medical Center - Infectious Diseases, Omaha, Nebraska, United States|CHI Health Creighton University Medical Center - Bergan Mercy - Pulmonary Medicine, Omaha, Nebraska, United States|Atlantic Health System - Morristown Medical Center, Morristown, New Jersey, United States|University of New Mexico Clinical and Translational Science Center, Albuquerque, New Mexico, United States|Montefiore Medical Center - Infectious Diseases, Bronx, New York, United States|New York University School of Medicine - Langone Medical Center - Microbiology - Parasitology, New York, New York, United States|University of Rochester Medical Center - Vaccine Research Unit, Rochester, New York, United States|Duke Human Vaccine Institute - Duke Vaccine and Trials Unit, Durham, North Carolina, United States|Womack Army Medical Center - Pulmonary and Respiratory Services, Fort Bragg, North Carolina, United States|University of Oklahoma Health Science Center - Surgery, Oklahoma City, Oklahoma, United States|Kaiser Permanente Northwest - Center for Health Research, Portland, Oregon, United States|Penn State Health Milton S. Hershey Medical Center - Division of Infectious Diseases, Hershey, Pennsylvania, United States|Hospital of the University of Pennsylvania - Infectious Diseases, Philadelphia, Pennsylvania, United States|University of Pittsburgh - Medicine - Infectious Diseases, Pittsburgh, Pennsylvania, United States|Baylor Scott & White Health - Baylor University Medical Center - North Texas Infectious Disease Consultants, Dallas, Texas, United States|University of Texas Southwestern Medical Center - Internal Medicine - Infectious Diseases, Dallas, Texas, United States|Brooke Army Medical Center, Fort Sam Houston, Texas, United States|University of Texas Medical Branch - Division of Infectious Disease, Galveston, Texas, United States|Methodist Hospital - Houston, Houston, Texas, United States|Baylor College of Medicine - Molecular Virology and Microbiology, Houston, Texas, United States|University of Texas Health Science Center at San Antonio - Infectious Diseases, San Antonio, Texas, United States|University of Utah - Infectious Diseases, Salt Lake City, Utah, United States|University of Virginia - Acute Care Surgery, Charlottesville, Virginia, United States|Naval Medical Center Portsmouth - Infectious Disease Division, Portsmouth, Virginia, United States|EvergreenHealth Infectious Disease Service, Kirkland, Washington, United States|Providence Sacred Heart Medical Center, Spokane, Washington, United States|Madigan Army Medical Center - Infectious Disease Clinic, Tacoma, Washington, United States|Tokyo Medical and Dental University - Medical Hospital - Department of Respiratory Medicine, Tokyo, Japan|National Center for Global Health and Medicine Hospital - Disease Control and Prevention Center, Tokyo, Japan|Seoul National University Bundang Hospital - Division of Infectious Diseases, Bundang-gu Seongnam-si, Gyeonggi-do, Korea, Republic of|Seoul National University Hospital, Seoul, Jongno-gu, Korea, Republic of|Instituto Nacional de Ciencias Medicas y Nutrición Salvador Zubirán - Departamento de Infectologia, Mexico City, Mexico|Instituto Nacional de Enfermedades Respiratorias (INER) - Ismael Cosío Villegas, Mexico City, Mexico|National University Health System - Division of Infectious Diseases, Singapore, Singapore|National University Health System - Alexandra Hospital - Division of Infectious Diseases, Singapore, Singapore|National Centre for Infectious Diseases, Singapore, Singapore|Changi General Hospital - Clinical Trials and Research Unit (CTRU), Singapore, Singapore|Ng Teng Fong General Hospital - Infectious Disease Service, Singapore, Singapore",https://ClinicalTrials.gov/show/NCT04640168
NCT04536298,Vitamin D and COVID-19 Trial,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",2020P002815,"Brigham and Women's Hospital, Boston, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT04536298
NCT04364828,NGS Diagnostic in COVID-19 Hosts - Genetic Cause Relating to the Course of Disease Progression,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,COVID-19 NGS,"University Hospital Tübingen, Tübingen, Germany",https://ClinicalTrials.gov/show/NCT04364828
NCT04935476,Dapsone Coronavirus SARS-CoV-2 Trial (DAP-CORONA) COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",PDC01,"Arizona Pulmonary and Medical Specialists, Phoenix, Arizona, United States|The Lundquist Institute At Harbor-UCLA Medical Center, Torrance, California, United States|Florida Lung Specialists, Kissimmee, Florida, United States|University of Miami-Miller School of Medicine, Miami, Florida, United States|Temple University Hospital, Philadelphia, Pennsylvania, United States|University of Pittsburgh UPMC, Pittsburgh, Pennsylvania, United States|Inspiration Research Limited, Toronto, Ontario, Canada|McGill University Health Centre, Montreal, Quebec, Canada",https://ClinicalTrials.gov/show/NCT04935476
NCT04364815,The University of the Philippines Hydroxychloroquine PEP Against COVID-19 Trial,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Prevention",RGAO-2020-0339,"Philippine General Hospital - University of the Philippines Manila, Manila, Philippines",https://ClinicalTrials.gov/show/NCT04364815
NCT04355793,Expanded Access Program of Ruxolitinib for the Emergency Treatment of Cytokine Storm From COVID-19 Infection,NA,INCB 18424-MA-COVID-19-301,NA,https://ClinicalTrials.gov/show/NCT04355793
NCT04329832,Hydroxychloroquine vs. Azithromycin for Hospitalized Patients With Suspected or Confirmed COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,1051355,"Intermountain Medical Center, Murray, Utah, United States|University of Utah, Salt Lake City, Utah, United States",https://ClinicalTrials.gov/show/NCT04329832
NCT04459520,Effect of Availability of COVID-19 Testing on Choice to Isolate and Socially Distance,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Screening,IRB#20-000980,"UCLA Health Department of Medicine, Quality Office, Los Angeles, California, United States",https://ClinicalTrials.gov/show/NCT04459520
NCT04534595,Data Collection on the Model Schools Pediatric Health Initiative at 5 SBHC Sites: COVID-19 Questionnaire,Observational Model: Case-Only|Time Perspective: Prospective,19-060,"Unity Health Toronto, Toronto, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04534595
NCT04388410,Safety and Efficacy of Convalescent Plasma Transfusion for Patients With COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",3380,"Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Tlalpan, Mexico",https://ClinicalTrials.gov/show/NCT04388410
NCT04358536,Classification of COVID-19 Infection in Posteroanterior Chest X-rays,Observational Model: Cohort|Time Perspective: Retrospective,4202002,"Dascena, Oakland, California, United States",https://ClinicalTrials.gov/show/NCT04358536
NCT04252118,Mesenchymal Stem Cell Treatment for Pneumonia Patients Infected With COVID-19,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2020003D,"Beijing 302 Military Hospital of China, Beijing, China",https://ClinicalTrials.gov/show/NCT04252118
NCT04647604,Resolving Inflammatory Storm in COVID-19 Patients by Omega-3 Polyunsaturated Fatty Acids -,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,2020-002293-28,"Karolinska Universitetssjuhuset, Stockholm, Sweden|Södersjukhuset, Stockholm, Sweden",https://ClinicalTrials.gov/show/NCT04647604
NCT04497948,Acalabrutinib Study With Best Supportive Care in Participants Hospitalized With COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,D822FC00005,"Research Site, Baltimore, Maryland, United States|Research Site, Rochester, Minnesota, United States|Research Site, Chapel Hill, North Carolina, United States|Research Site, Philadelphia, Pennsylvania, United States|Research Site, Porto Alegre, Brazil|Research Site, Ribeirão Preto, Brazil|Research Site, Sao Paulo, Brazil|Research Site, Sao Paulo, Brazil",https://ClinicalTrials.gov/show/NCT04497948
NCT04358835,Keto-diet for Intubated Critical Care COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,IRB00247383,NA,https://ClinicalTrials.gov/show/NCT04358835
NCT04524507,COVID-19 Antibody Plasma Research Study in Hospitalized Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",20-1544,"University of North Carolina Health Care, Chapel Hill, North Carolina, United States",https://ClinicalTrials.gov/show/NCT04524507
NCT04361942,Treatment of Severe COVID-19 Pneumonia With Allogeneic Mesenchymal Stromal Cells (COVID_MSV),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",TerCel_007|2020-001682-36,"Hospital Universitario Rio Hortega, Valladolid, Spain",https://ClinicalTrials.gov/show/NCT04361942
NCT04362865,Investigation of the B- and T-cell Repertoire and Immune Response in Patients With Acute and Resolved COVID-19 Infection,Observational Model: Cohort|Time Perspective: Prospective,200103|20-C-0103,"Medstar Washington Hospital Center, Washington, District of Columbia, United States|Medstar Franklin Square Medical Center, Baltimore, Maryland, United States|National Institutes of Health Clinical Center, Bethesda, Maryland, United States|Medstar Montgomery Medical Center, Olney, Maryland, United States",https://ClinicalTrials.gov/show/NCT04362865
NCT04497298,Clinical Trial to Evaluate the Safety and Immunogenicity of the COVID-19 Vaccine,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",2020-016|2020-002973-89,"SGS Life Sciences, Clinical Pharmacology Unit, Antwerp, Belgium|CIC Cochin - Pasteur, Paris, France",https://ClinicalTrials.gov/show/NCT04497298
NCT04348396,Clinical and Biological Predictors of COVID-19 Disease in Older Patients,Observational Model: Case-Only|Time Perspective: Prospective,INRCA_01_2020,"IRCCS INRCA Hospital, Ancona, Italy|IRCCS INRCA Hospital, Casatenovo, Italy|IRCCS INRCA Hospital, Fermo, Italy",https://ClinicalTrials.gov/show/NCT04348396
NCT04516746,"Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",D8110C00001,"Research Site, Phoenix, Arizona, United States|Research Site, Scottsdale, Arizona, United States|Research Site, Little Rock, Arkansas, United States|Research Site, Berkeley, California, United States|Research Site, El Centro, California, United States|Research Site, Los Angeles, California, United States|Research Site, Los Angeles, California, United States|Research Site, San Diego, California, United States|Research Site, San Diego, California, United States|Research Site, San Francisco, California, United States|Research Site, San Francisco, California, United States|Research Site, Torrance, California, United States|Research Site, Denver, Colorado, United States|Research Site, Danbury, Connecticut, United States|Research Site, Atlantis, Florida, United States|Research Site, Coral Gables, Florida, United States|Research Site, Miami Lakes, Florida, United States|Research Site, Orlando, Florida, United States|Research Site, Stockbridge, Georgia, United States|Research Site, Honolulu, Hawaii, United States|Research Site, Meridian, Idaho, United States|Research Site, Chicago, Illinois, United States|Research Site, Indianapolis, Indiana, United States|Research Site, Ankeny, Iowa, United States|Research Site, Fairway, Kansas, United States|Research Site, Kansas City, Kansas, United States|Research Site, Wichita, Kansas, United States|Research Site, Wichita, Kansas, United States|Research Site, Lexington, Kentucky, United States|Research Site, Lake Charles, Louisiana, United States|Research Site, Monroe, Louisiana, United States|Research Site, Baltimore, Maryland, United States|Research Site, Baltimore, Maryland, United States|Research Site, Bethesda, Maryland, United States|Research Site, Boston, Massachusetts, United States|Research Site, Boston, Massachusetts, United States|Research Site, Ann Arbor, Michigan, United States|Research Site, Royal Oak, Michigan, United States|Research Site, Bloomington, Minnesota, United States|Research Site, Gulfport, Mississippi, United States|Research Site, Butte, Montana, United States|Research Site, Henderson, Nevada, United States|Research Site, Portsmouth, New Hampshire, United States|Research Site, Berlin, New Jersey, United States|Research Site, Albuquerque, New Mexico, United States|Research Site, Bronx, New York, United States|Research Site, Brooklyn, New York, United States|Research Site, Mineola, New York, United States|Research Site, New York, New York, United States|Research Site, New York, New York, United States|Research Site, New York, New York, United States|Research Site, Rochester, New York, United States|Research Site, Rochester, New York, United States|Research Site, Valhalla, New York, United States|Research Site, Durham, North Carolina, United States|Research Site, Fargo, North Dakota, United States|Research Site, Cincinnati, Ohio, United States|Research Site, Columbus, Ohio, United States|Research Site, Columbus, Ohio, United States|Research Site, Yukon, Oklahoma, United States|Research Site, Portland, Oregon, United States|Research Site, Pittsburgh, Pennsylvania, United States|Research Site, Warwick, Rhode Island, United States|Research Site, Charleston, South Carolina, United States|Research Site, Charleston, South Carolina, United States|Research Site, Spartanburg, South Carolina, United States|Research Site, Knoxville, Tennessee, United States|Research Site, Nashville, Tennessee, United States|Research Site, Austin, Texas, United States|Research Site, Dallas, Texas, United States|Research Site, Houston, Texas, United States|Research Site, McAllen, Texas, United States|Research Site, San Antonio, Texas, United States|Research Site, San Antonio, Texas, United States|Research Site, The Woodlands, Texas, United States|Research Site, West Jordan, Utah, United States|Research Site, Burlington, Vermont, United States|Research Site, Fort Belvoir, Virginia, United States|Research Site, Richmond, Virginia, United States|Research Site, Seattle, Washington, United States|Research Site, Seattle, Washington, United States|Research Site, South Charleston, West Virginia, United States|Research Site, Madison, Wisconsin, United States|Research Site, Caba, Argentina|Research Site, Ciudad Autónoma de Bs. As., Argentina|Research Site, Ciudad Autónoma de Buenos Aire, Argentina|Research Site, Quillota, Chile|Research Site, Region Metropolitana, Chile|Research Site, Santiago, Chile|Research Site, Santiago, Chile|Research Site, Barranquilla, Colombia|Research Site, Bogota, Colombia|Research Site, Floridablanca, Colombia|Research Site, Manizales, Colombia|Research Site, Medellin, Colombia|Research Site, Callao, Peru|Research Site, Cercado De Lima, Peru|Research Site, Cercardo De Lima, Peru|Research Site, Lima, Peru|Research Site, Lima, Peru|Research Site, Lima, Peru|Research Site, Lima, Peru|Research Site, Lima, Peru|Research Site, Lima, Peru|Research Site, Lima, Peru",https://ClinicalTrials.gov/show/NCT04516746
NCT04701515,Cardiovascular Manifestations of COVID-19,Observational Model: Cohort|Time Perspective: Other,030.CVS.2020.D,"Methodist Dallas Medical Center, Dallas, Texas, United States",https://ClinicalTrials.gov/show/NCT04701515
NCT04411147,A Longitudinal Study of COVID-19 Sequelae and Immunity,Observational Model: Cohort|Time Perspective: Prospective,200123|20-I-0123,"National Institutes of Health Clinical Center, Bethesda, Maryland, United States",https://ClinicalTrials.gov/show/NCT04411147
NCT04475107,The Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",SP-PA-COV-201,"Korea University Ansan Hospital, Ansan, Korea, Republic of|Chungnam national University Hospital, Daejeon, Korea, Republic of|Inha University Hospital, Incheon, Korea, Republic of|Gangnam Severance Hospital, Seoul, Korea, Republic of|Hallym University Kangnam Sacred Heart Hospital, Seoul, Korea, Republic of|Korea University Guro Hospital, Seoul, Korea, Republic of|Kyungpook National University Hospital, Seoul, Korea, Republic of|National Medical Center, Seoul, Korea, Republic of|Sahmyook Medical Center, Seoul, Korea, Republic of|Seoul Medical Center, Seoul, Korea, Republic of|Severance Hospital, Seoul, Korea, Republic of|The Catholic University of Korea, Eunpyeong St. Marys' Hospital, Seoul, Korea, Republic of|Ajou University Hospital, Suwon, Korea, Republic of",https://ClinicalTrials.gov/show/NCT04475107
NCT04406324,COVID-19: Respiratory and Sleep Follow-up,Observational Model: Cohort|Time Perspective: Prospective,38RC20.157,"Hôpital Avicenne, Bobigny, France|Centre Hospitalier Henri Mondor, APHP, Créteil, France|CHU Grenoble Alpes, Grenoble, France|CHRU Nancy, Nancy, France",https://ClinicalTrials.gov/show/NCT04406324
NCT04449731,Changes in Dietary Behaviours During the COVID-19 Outbreak Confinement in the Adult Population (COVIDiet_Int),Observational Model: Ecologic or Community|Time Perspective: Cross-Sectional,1526/CEIH/2020,"Universidad de Granada, Granada, Spain",https://ClinicalTrials.gov/show/NCT04449731
NCT04832919,A Nurse-Community Health Worker-Family Partnership Model: Addressing Uptake of COVID-19 Testing and Control Measures,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention,3P30DA011041-23S1,NA,https://ClinicalTrials.gov/show/NCT04832919
NCT04330586,A Trial of Ciclesonide in Adults With Mild-to-moderate COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,KUMC-COVID-19,"Korea University Guro Hospital, Seoul, Korea, Republic of",https://ClinicalTrials.gov/show/NCT04330586
NCT04641988,Cardiac Biomarkers and Mortality in Critically Ill Patients With SARS-CoV-2 (COVID-19),Observational Model: Cohort|Time Perspective: Retrospective,RECHMPL20_0625,"Uhmontpellier, Montpellier, France",https://ClinicalTrials.gov/show/NCT04641988
NCT04359953,"Efficacy of Hydroxychloroquine, Telmisartan and Azithromycin on the Survival of Hospitalized Elderly Patients With COVID-19",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,7747,"CHU de Strasbourg, Strasbourg, France",https://ClinicalTrials.gov/show/NCT04359953
NCT04331171,Epidemiological Observation From a Smartphone Self-monitoring Application for Suspected COVID-19 Patients' Triage,Observational Model: Cohort|Time Perspective: Prospective,WP-2020-02,"All French Emergency services, Le Mans, France",https://ClinicalTrials.gov/show/NCT04331171
NCT04603924,Study of Niclosamide in Moderate and Severe Hospitalized Coronavirus-19 (COVID-19) Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",ANA001-001,"Helen Keller Hospital, Sheffield, Alabama, United States|Baptist Health Research Institute, Jacksonville, Florida, United States|AdventHealth Tampa, Tampa, Florida, United States|University of Missouri Health Care, Columbia, Missouri, United States|Therapeutic Concepts, PA, Houston, Texas, United States|Memorial Hermann Memorial City Medical Center, Houston, Texas, United States|Memorial Hermann Southeast Hospital, Houston, Texas, United States",https://ClinicalTrials.gov/show/NCT04603924
NCT04355936,Telmisartan for Treatment of COVID-19 Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2020-001,"Hospital de Clínicas 'José de San Martín', Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Ciudad De Buenos Aires, Argentina|Hospital Español de Buenos Aires, Ciudad Autonoma de Buenos Aires, Argentina",https://ClinicalTrials.gov/show/NCT04355936
NCT04668170,Predictive Immune Biomarkers of COVID-19 Pathogenesis to Influence Therapeutic Management,Observational Model: Cohort|Time Perspective: Retrospective,RC31/20/0187,"University Hospital Bordeaux, Bordeau, France|University Hospital Toulouse, Toulouse, France",https://ClinicalTrials.gov/show/NCT04668170
NCT04397328,COVID-19 PEP- High-risk Individuals in Long-term and Specialized Care - Canada,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",9881,NA,https://ClinicalTrials.gov/show/NCT04397328
NCT04341168,"Clinical and Immunological Characterisation of COVID-19 in Children, Adolescents and Adults",Observational Model: Cohort|Time Perspective: Prospective,KICC19,"University Hospital Cologne, Cologne, NRW, Germany",https://ClinicalTrials.gov/show/NCT04341168
NCT04583956,ACTIV-5 / Big Effect Trial (BET-A) for the Treatment of COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",20-0013A,"St Joseph's Hospital and Medical Center, Phoenix, Arizona, United States|Mayo Clinic, Phoenix - Infectious Diseases, Phoenix, Arizona, United States|The University of Arizona - Banner University Medical Center Tucson Campus - Tucson, Tucson, Arizona, United States|University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States|Kern Medical Center, Bakersfield, California, United States|UCSF Fresno Center for Medical Education and Research - Clinical Research Center, Fresno, California, United States|Hoag Hospital Newport Beach, Newport Beach, California, United States|Stanford University - Stanford Hospital and Clinics - Pediatrics - Infectious Diseases, Stanford, California, United States|Penrose Hospital - Emergency Medicine, Colorado Springs, Colorado, United States|St. Francis Medical Center, Colorado Springs, Colorado, United States|St. Anthony Hospital, Lakewood, Colorado, United States|St. Anthony Hospital North Health Campus, Westminster, Colorado, United States|Nuvance Health Danbury Hospital - Infectious Disease, Danbury, Connecticut, United States|Yale School of Medicine - The Anlyan Center for Medical Research & Education - Immunobiology, New Haven, Connecticut, United States|Nuvance Health - Norwalk Hospital - Asthma Pulmonary and Critical Care Medicine, Norwalk, Connecticut, United States|MedStar Washington Hospital Center - Infectious Diseases, Washington, District of Columbia, United States|University of Florida Health - Shands Hospital - Division of Infectious Diseases and Global Medicine, Gainesville, Florida, United States|Advent Health Orlando - Critical Care, Orlando, Florida, United States|Grady Memorial Hospital, Atlanta, Georgia, United States|Emory Vaccine Center - The Hope Clinic, Decatur, Georgia, United States|Cook County Health and Hospitals System - Ruth M Rothstein CORE Center, Chicago, Illinois, United States|Rush University Medical Center, Chicago, Illinois, United States|Great Lakes Clinical Trials, Chicago, Illinois, United States|Carle Foundation Hospital, Urbana, Illinois, United States|Northwestern Medicine - Central DuPage Hospital - Infectious Disease, Winfield, Illinois, United States|Norton Healthcare, Louisville, Kentucky, United States|University of Louisville - Division of Infectious Diseases, Louisville, Kentucky, United States|Pikeville Medical Center - Department of Infectious Disease, Pikeville, Kentucky, United States|Tulane University - Section of Pulmonary Diseases, Critical Care, and Environmental Medicine, New Orleans, Louisiana, United States|Louisiana State University Health Shreveport - Infectious Diseases, Shreveport, Louisiana, United States|TidalHealth - Peninsula Regional - Pulmonary and Critical Care, Salisbury, Maryland, United States|Brigham and Women's Hospital - Infectious Diseases, Boston, Massachusetts, United States|Boston Medical Center - Center for Infectious Diseases - Shapiro Center, Boston, Massachusetts, United States|Hennepin Healthcare Research Institute, Minneapolis, Minnesota, United States|Englewood Hospital, Englewood, New Jersey, United States|Virtua Health - Virtua Voorhees Hospital - Pulmonology, Voorhees, New Jersey, United States|Jacobi Medical Center, Bronx, New York, United States|The State University of New York - University at Buffalo - Department of Medicine, Buffalo, New York, United States|Mount Sinai School of Medicine - Medicine - Infectious Diseases, New York, New York, United States|Nuvance Health - Vassar Brothers Medical Center, Poughkeepsie, New York, United States|Stony Brook Medicine - Stony Brook University Hospita, Stony Brook, New York, United States|East Carolina University Brody School of Medicine - Adult Specialty Care, Greenville, North Carolina, United States|Wake Forest Baptist Health - Infectious Diseases, Winston-Salem, North Carolina, United States|University of Toledo Medical Center - Ruppert Clinic, Toledo, Ohio, United States|St. Charles Health System - St. Charles Bend Hospital, Bend, Oregon, United States|Geisinger Medical Center-Department of Pulmonary and Critical Care Medicine, Danville, Pennsylvania, United States|Doylestown Hospital, Doylestown, Pennsylvania, United States|Kent County Memorial Hospital, Warwick, Rhode Island, United States|Monument Health - Clinical Research, Rapid City, South Dakota, United States|Hendrick Health - Hendrick Medical Center, Abilene, Texas, United States|Texas Tech University Health Science Center, Amarillo, Texas, United States|Baptist Hospitals of Southeast Texas Site, Beaumont, Texas, United States|Methodist Hospital - Houston, Houston, Texas, United States|University of Texas Health Science Center at Tyler, Tyler, Texas, United States|West Virginia University - Infectious Diseases Clinic, Morgantown, West Virginia, United States",https://ClinicalTrials.gov/show/NCT04583956
NCT04901689,Leronlimab in Critically Ill Patients With Coronavirus Disease 2019 (COVID-19) With Need for Mechanical Ventilation or Extracorporeal Membrane Oxygenation,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",ARO_21_018_002,"Hospital Israelita Albert Einstein, Sao Paulo, Brazil",https://ClinicalTrials.gov/show/NCT04901689
NCT04696562,"The Effect of Deep Breathing Exercise on Dyspnea, Anxiety and Quality of Life in Patients Treated for COVID-19",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,OCengiz,NA,https://ClinicalTrials.gov/show/NCT04696562
NCT04466670,Hemostasis in COVID-19: an Adaptive Clinical Trial,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",33788820.9.0000.0068,"Vanderson Rocha, Sao Paulo, Brazil",https://ClinicalTrials.gov/show/NCT04466670
NCT04603794,Efficacy of Mouthwash in Reducing Salivary Carriage of COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention",2020H0346,"The Ohio State University Wexner Medical Center, Columbus, Ohio, United States",https://ClinicalTrials.gov/show/NCT04603794
NCT04568499,"Presenting Nutrition Characteristics, Comorbidities and Outcomes of COVID-19 in African Humanitarian Settings",Observational Model: Cohort|Time Perspective: Prospective,13736,"Goma General Hospital, Goma, Congo, The Democratic Republic of the|Bukavu General Hospital, Kinshasa, Congo, The Democratic Republic of the|Dr John Garang Infectious Diseases Unit, Juba, South Sudan",https://ClinicalTrials.gov/show/NCT04568499
NCT04380688,Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19.,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,D822FC00003,"Research Site, Anniston, Alabama, United States|Research Site, Escondido, California, United States|Research Site, Fullerton, California, United States|Research Site, Glendale, California, United States|Research Site, Newport Beach, California, United States|Research Site, Washington, District of Columbia, United States|Research Site, Fort Lauderdale, Florida, United States|Research Site, Jacksonville, Florida, United States|Research Site, Jacksonville, Florida, United States|Research Site, Loxahatchee Groves, Florida, United States|Research Site, Peoria, Illinois, United States|Research Site, Fort Wayne, Indiana, United States|Research Site, Louisville, Kentucky, United States|Research Site, Annapolis, Maryland, United States|Research Site, Baltimore, Maryland, United States|Research Site, Bethesda, Maryland, United States|Research Site, Bethesda, Maryland, United States|Research Site, Silver Spring, Maryland, United States|Research Site, Hackensack, New Jersey, United States|Research Site, Albany, New York, United States|Research Site, Bronx, New York, United States|Research Site, Buffalo, New York, United States|Research Site, New York, New York, United States|Research Site, New York, New York, United States|Research Site, Philadelphia, Pennsylvania, United States|Research Site, Nashville, Tennessee, United States|Research Site, Houston, Texas, United States|Research Site, Houston, Texas, United States|Research Site, Tyler, Texas, United States|Research Site, Richmond, Virginia, United States|Research Site, Renton, Washington, United States",https://ClinicalTrials.gov/show/NCT04380688
NCT04350684,Umifenovir in Hospitalized COVID-19 Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",Umifenovir in COVID-19,"Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences and Health Services, Tehran, Iran, Islamic Republic of",https://ClinicalTrials.gov/show/NCT04350684
NCT04381884,Ivermectin Effect on SARS-CoV-2 Replication in Patients With COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,IVM-AR-1,"Hospital de Cuenca Alta, Cañuelas, Buenos Aires, Argentina|Centro de Educación Médica e Investigaciones Clínicas ""Norberto Quirno"" CEMIC, Buenos Aires, Ciudad De Buenos Aires, Argentina|Hospital de Infecciosas Francisco Javier Muñiz, Ciudad Autonoma de Buenos Aires, Argentina",https://ClinicalTrials.gov/show/NCT04381884
NCT04346199,Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19.,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,D822FC00001,"Research Site, Ciudad de Buenos Aires, Argentina|Research Site, Ciudad de Buenos Aires, Argentina|Research Site, Monte Grande, Argentina|Research Site, Ramos Mejía, Argentina|Research Site, Botucatu, Brazil|Research Site, Florianópolis, Brazil|Research Site, Porto Alegre, Brazil|Research Site, Porto Alegre, Brazil|Research Site, Ribeirão Preto, Brazil|Research Site, Salvador, Brazil|Research Site, Sao Bernardo do Campo, Brazil|Research Site, Sao Paulo, Brazil|Research Site, Sao Paulo, Brazil|Research Site, São Paulo, Brazil|Research Site, Curico, Chile|Research Site, Santiago, Chile|Research Site, Talca, Chile|Research Site, Villejuif Cedex, France|Research Site, Frankfurt, Germany|Research Site, Gauting, Germany|Research Site, Hamburg, Germany|Research Site, Köln, Germany|Research Site, Bangalore, India|Research Site, New Delhi, India|Research Site, Milano, Italy|Research Site, Roma, Italy|Research Site, Shinjuku-ku, Japan|Research Site, D.F, Mexico|Research Site, Monterrey, Mexico|Research Site, México, Mexico|Research Site, Lima, Peru|Research Site, Lima, Peru|Research Site, Lima, Peru|Research Site, Moscow, Russian Federation|Research Site, Moscow, Russian Federation|Research Site, Moscow, Russian Federation|Research Site, Moscow, Russian Federation|Research Site, Murmansk, Russian Federation|Research Site, Cape Town, South Africa|Research Site, George, South Africa|Research Site, Johannesburg, South Africa|Research Site, Johannesburg, South Africa|Research Site, Pretoria, South Africa|Research Site, Ankara, Turkey|Research Site, Bakirkoy, Turkey|Research Site, Istanbul, Turkey|Research Site, Istanbul, Turkey|Research Site, Umraniye, Turkey",https://ClinicalTrials.gov/show/NCT04346199
NCT04934111,"Safety and Immunogenicity of LNP-nCOV saRNA-02 Vaccine Against SARS-CoV-2, the Causative Agent of COVID-19",Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,COVAC Uganda,"MRC/UVRI & LSHTM Uganda Research Unit, Entebbe, Uganda",https://ClinicalTrials.gov/show/NCT04934111
NCT04771013,Safety and Efficacy of Thymic Peptides in the Treatment of Hospitalized COVID-19 Patients in Honduras,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,AEC-01-2021|COM-2020-01,"Hospital de Santa Bárbara Integrado, Santa Bárbara, Honduras",https://ClinicalTrials.gov/show/NCT04771013
NCT04521309,SARS-CoV-2 Antibodies Based IVIG Therapy for COVID-19 Patients,Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,biotech001,"Dow University of Health Sciences, Karachi, Sindh, Pakistan",https://ClinicalTrials.gov/show/NCT04521309
NCT04365257,Prazosin to Prevent COVID-19 (PREVENT-COVID Trial),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,IRB00246659|COV2001,"Johns Hopkins Hospital, Baltimore, Maryland, United States",https://ClinicalTrials.gov/show/NCT04365257
NCT04390594,Efficacy and Safety Evaluation of Treatment Regimens in Adult COVID-19 Patients in Senegal,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2020-002,"Infectious and Tropical Diseases Department, Fann Hospital, Dakar, Senegal|Diamniadio Children Hospital, Diamniadio, Senegal|Dalal Jamm Hospital, Guédiawaye, Senegal",https://ClinicalTrials.gov/show/NCT04390594
NCT04581135,Study to Investigate Long-term Pulmonary and Extrapulmonary Effects of COVID-19,Observational Model: Cohort|Time Perspective: Prospective,2020-00799,"St. Claraspital AG - Department of Pulmonary Medicine, Basel, Switzerland|Universtiy Hospital Bern (Inselspital), Department of Pulmonary Medicine - Lead Center, Bern, Switzerland|University and Hospital of Fribourg, Fribourg, Switzerland|Hôpitaux Universitaires de Genève - Service de Pneumologie, Genève, Switzerland|CHUV - Service de Pneumologie, Lausanne, Switzerland|Clinica Moncucco, Lugano, Switzerland|Hôpital du Valais - Service de Pneumologie, Sion, Switzerland|Kantonspital St. Gallen - Klinik für Pneumologie und Schlafmedizin Lungenzentrum, St. Gallen, Switzerland|Universitätsspital Zürich - Klinik für Pneumologie, Zürich, Switzerland",https://ClinicalTrials.gov/show/NCT04581135
NCT04361318,Hydroxychloroquine and Nitazoxanide Combination Therapy for COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment",HCQ/NTZ,NA,https://ClinicalTrials.gov/show/NCT04361318
NCT04374695,"Renin-Angiotensin-Aldosterone System Inhibitors, Hypertension, and COVID-19",Observational Model: Case-Control|Time Perspective: Retrospective,P20/11_COVHYP,NA,https://ClinicalTrials.gov/show/NCT04374695
NCT04452942,Cytokine and Eicosanoid Mediators in Coronavirus Disease 2019 (COVID-19),Observational Model: Cohort|Time Perspective: Prospective,EC1153-2-01,"Stony Brook University Hospital, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04452942
NCT04317092,Tocilizumab in COVID-19 Pneumonia (TOCIVID-19),Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,TOCIVID-19|2020-001110-38,"Azienda Ospedaliera ""SS. Antonio e Biagio e C. Arrigo"" (Dipartimento Internistico SSD Reumatologia), Alessandria, Italy|Ospedale di Busto Arsizio ASST Valle Olona (U.O.C. Malattie Infettive), Busto Arsizio, Italy|A.O.U. Policlinico V. Emanuele (U.O. di Malattie infettive, U.O. di Anestesia e Rianimazione, U.O. di Medicina d'Urgenza), Catania, Italy|AOE Cannizzaro di Catania (U.O. di Malattie Infettive, U.O. di Anestesia e Rianimazione, U.O., Catania, Italy|Ospedale Annunziata Azienda Ospedaliera di Cosenza (U.O.C. Malattie Infettive), Cosenza, Italy|ASST OVEST MILANESE presidi Legnano - Magenta, Magenta, Italy|Azienda Ospedaliero-Universitaria di Modena, Modena, Italy|A.O.U. di Modena (Dipartimento Chirurgie Generali e Specialità Chirurgiche - Struttura Complessa di Anestesia e Rianimazione I), Modena, Italy|A.O.U. di Modena (Dipartimento Chirurgie Generali e Specialità Chirurgiche - Struttura Complessa di Anestesia e Rianimazione II), Modena, Italy|A.O.U. di Modena (Dipartimento Medicine Specialistiche - Struttura Complessa Malattie Infettive), Modena, Italy|Dipartimento Medicine Specialistiche - Struttura Complessa Malattie dell'Apparato Respiratorio, Modena, Italy|A.O.R.N. Ospedale dei Colli Monaldi-Cotugno-CTO (U.O.C. Oncologia), Naples, Italy|National Cancer Institute, Naples, Italy|A.O.R.N. Ospedale dei Colli Monaldi-Cotugno-CTO (U.O.C. Anestesia Rianimazione e terapia intensiva), Naples, Italy|A.O.R.N. Ospedale dei Colli Monaldi-Cotugno-CTO (U.O.C. Malattie Infettive ad indirizzo respiratorio), Naples, Italy|A.O. Ospedali Riuniti Marche Nord - Presidio Ospedaliero San Salvatore di Pesaro (UOC Pronto Soccorso e Medicina d'Urgenza), Pesaro, Italy|Denominazione: UOC di Medicina e Chirurgia d'Accettazione e d'Urgenza dell'Ospedale Santa Maria delle Grazie di Pozzuoli, Pozzuoli, Italy|Ospedale Santa Maria delle Croci, AUSL della Romagna (U.O. Anestesia e Rianimazione), Ravenna, Italy|Grande Ospedale Metropolitano, Reggio Calabria, Reggio Calabria, Italy|Ospedale Infermi, AUSL della Romagna (U.O. Malattie Infettive), Rimini, Italy|Policlinico Gemelli (U.O.C. Dipartimento Scienze di Laboratorio e Infettivologiche), Rome, Italy|ASST Sette Laghi (Dipartimento di Medicina Interna), Varese, Italy|ASST Sette Laghi (Dipartimento Emergenze ed Urgenze), Varese, Italy|ASST Sette Laghi (U.O.C. Anestesia e Rianimazione Neurochirurgica e Generale), Varese, Italy|ASST Sette Laghi (U.O.C. Malattie Infettive e Tropicali), Varese, Italy|A.O.U. Integrata di Verona (Dip. Malattie Infettive), Verona, Italy|Ospedale Magalini (U.O. Malattie Infettive), Villafranca Di Verona, Italy",https://ClinicalTrials.gov/show/NCT04317092
NCT04418505,Vielight RX Plus for the Treatment of COVID-19 Respiratory Symptoms,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,VL-2020-02,"Progressive Medical Research, Port Orange, Florida, United States|Dr. Michael Zahavi, Oshawa, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04418505
NCT04367792,Cardiac Injury in COVID-19: a Pathology Study,Observational Model: Case-Control|Time Perspective: Retrospective,56/20,"ASST Ospedale Papa Giovanni XXIII, Bergamo, Italy",https://ClinicalTrials.gov/show/NCT04367792
NCT04345523,Convalescent Plasma Therapy vs. SOC for the Treatment of COVID-19 in Hospitalized Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,ConPlas-19,"Hospital Clínico Universitario Lozano Blesa, Zaragoza, Aragón, Spain|Hospital Universitario Mútua Terrassa, Terrassa, Barcelona, Spain|Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, Madrid, Spain|Hospital General de Albacete, Albacete, Spain|Hospital del Mar, Barcelona, Spain|Hospital General Universitario de Ciudad Real, Ciudad Real, Spain|Hospital Universitario Donostia, Donostia, Spain|Hospital Doctor Josep Trueta, Girona, Spain|Hospital Doctor Negrín, Las Palmas, Spain|Complejo Asistencial Universitario de León, León, Spain|Hospital Universitario Arnau de Vilanova, Lleida, Spain|Hospital San Pedro, Logroño, Spain|Hospital Universitario La Princesa, Madrid, Spain|Hospital General Universitario Gregorio Marañón, Madrid, Spain|Hospital Universitario Ramón y Cajal, Madrid, Spain|Hospital Clínico San Carlos, Madrid, Spain|Hospital Universitario 12 de Octubre, Madrid, Spain|Hospital Universitario HM Sanchinarro, Madrid, Spain|Hospital Sant Joan de Deu de Manresa. Fundación Althaia, Manresa, Spain|Hospital Universitario de Asturias, Oviedo, Spain|Hospital Universitario Son Espases, Palma De Mallorca, Spain|Clínica Universidad de Navarra (CUN). Sedes Pamplona y Madrid, Pamplona, Spain|Complejo Hospitalario de Navarra, Pamplona, Spain|Hospital Universitario de Salamanca, Salamanca, Spain|Hospital Universitario Marqués de Valdecilla, Santander, Spain|Complejo Hospitalario de Toledo, Toledo, Spain|Hospital General Universitario de Valencia, Valencia, Spain|Hospital Clínico Universitario de Valladolid, Valladolid, Spain|Hospital Universitario Miguel Servet, Zaragoza, Spain",https://ClinicalTrials.gov/show/NCT04345523
NCT04961333,Internet-based Multidisciplinary Rehabilitation for Longterm COVID-19 Syndrome,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,Danderyd University Hospital,"St Göran Hospital, Stockholm, Sweden",https://ClinicalTrials.gov/show/NCT04961333
NCT04841759,The Effects of a Multi-factorial Rehabilitation Program for Healthcare Workers Suffering From Post-COVID-19 Fatigue Syndrome,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Supportive Care,1181/2021,"Medical University of Vienna, Vienna, Austria",https://ClinicalTrials.gov/show/NCT04841759
NCT04350671,Interferon Beta 1a in Hospitalized COVID-19 Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",Interferon Beta 1a in COVID-19,"Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences and Health Services, Tehran, Iran, Islamic Republic of",https://ClinicalTrials.gov/show/NCT04350671
NCT04527198,Brainstem Dysfunction in COVID-19 Critically Ill Patients: a Prospective Observational Study,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,APHP200644|2020-A01559-30,"Hôpital Cochin, Paris, France|HEGP, Paris, France",https://ClinicalTrials.gov/show/NCT04527198
NCT04466540,Randomized Placebo-controlled Trial of Hydroxychloroquine in Outpatient Cases With Coronavirus Disease 2019 (COVID-19),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",30415320.8.1001.0070,"Centro de Pesquisas Clínicas Dr. Marco Mota HCOR, Maceió, Alagoas, Brazil|Hospital e Clínica São Roque, Ipiaú, Bahia, Brazil|Clínica Otorhinus, Salvador, Bahia, Brazil|Hospital da Bahia, Salvador, Bahia, Brazil|Hospital Santa Izabel, Salvador, Bahia, Brazil|Instituto Cárdio Pulmonar da Bahia, Salvador, Bahia, Brazil|Hospital SAMUR, Vitória Da Conquista, Bahia, Brazil|Hospital Maternidade São Vicente de Paulo, Barbalha, Ceará, Brazil|Hospital Unimed Cariri, Juazeiro Do Norte, Ceará, Brazil|Unimed Sul Capixaba, Cachoeiro De Itapemirim, Espírito Santo, Brazil|Hospital das Clínicas Universidade Federal de Goiás, Goiânia, Goiás, Brazil|Santa Casa de Misericórdia de Passos, Passos, Minas Agerais, Brazil|Hospital Júlia Kubitschek, Belo Horizonte, Minas Gerais, Brazil|Instituto da Pequenas Missionárias de Maria Imaculada - Hospital Madre Teresa, Belo Horizonte, Minas Gerais, Brazil|Casa de Caridade de Carangola, Carangola, Minas Gerais, Brazil|Hospital Maternidade e Pronto Socorro Santa Lucia, Poços De Caldas, Minas Gerais, Brazil|Hospital da Unimed, São João Del Rei, Minas Gerais, Brazil|Santa Casa de Misericórdia de São João Del Rei, São João Del Rei, Minas Gerais, Brazil|Hospital de Clínicas da Universidade Federal do Triangulo Mineiro, Uberaba, Minas Gerais, Brazil|Hospital de Clínicas da Universidade Federal de Uberlândia, Uberlândia, Minas Gerais, Brazil|Hospital do Rocio, Campo Largo, Paraná, Brazil|Clínica Clinilive, Maringá, Paraná, Brazil|Hospital Universitário Regional de Maringá, Maringá, Paraná, Brazil|PROCAPE, Recife, Pernambuco, Brazil|Real Hospital Português de Beneficência em Pernambuco, Recife, Pernambuco, Brazil|SECRETARIA MUNICIPAL DE SAÚDE DE SAIRÉ (Unidade Mista Olília Mendonça Souto Maior), Sairé, Pernambuco, Brazil|Complexo Hospitalar de Niterói, Niterói, Rio De Janeiro, Brazil|Hospital Unimed Volta Redonda, Volta Redonda, Rio De Janeiro, Brazil|Associação Dr. Bartholomeu Tacchini, Bento Gonçalves, Rio Grande Do Sul, Brazil|Hospital São Vicente de Paulo, Passo Fundo, Rio Grande Do Sul, Brazil|Hospital Moinhos de Vento, Porto Alegre, Rio Grande Do Sul, Brazil|Santa Casa de Misericórdia de Porto Alegre (ISCMPA), Porto Alegre, Rio Grande Do Sul, Brazil|Universidade Federal de Santa Maria, Santa Maria, Rio Grande Do Sul, Brazil|CEPEM Centro de Pesquisa de Medicina Tropical de Rondônia, Porto Velho, Rondônia, Brazil|Irmandade de Misericórdia Do Hospital Da Santa Casa de Monte Alto, Monte alto, Salto Alto, Brazil|Maestri e Kormann Consultoria Medico Cientifica, Blumenau, Santa Catarina, Brazil|Imigrantes Hospital e Maternidade, Brusque, Santa Catarina, Brazil|Hospital São José, Criciúma, Santa Catarina, Brazil|Hospital Regional Hans Dieter Schmidt, Joinville, Santa Catarina, Brazil|Santa Casa de Araras, Araras, São Paulo, Brazil|Hospital de Amor, Barretos, São Paulo, Brazil|Santa Casa de Misericórdia de Barretos, Barretos, São Paulo, Brazil|Alphacor Cardiologia Clinica E Diagnóstica LTDA, Barueri, São Paulo, Brazil|Faculdade de Medicina de Botucatu, UNESP, Botucatu, São Paulo, Brazil|Hospital Regional do Litoral Norte, Caraguatatuba, São Paulo, Brazil|Hospital de Cordeirópolis, Cordeirópolis, São Paulo, Brazil|Centro de Combate ao Coronavírus de Itapevi, Itapevi, São Paulo, Brazil|Dux Medicina, Jundiaí, São Paulo, Brazil|Hospital Carlos Fenando Malzoni, Matão, São Paulo, Brazil|Centro de Atendimento Para O Enfrentamento A Covid-19 Da Prefeitura Municipal de Monte Altoprefeitura de Monte Alto, Monte alto, São Paulo, Brazil|Faculdade de Medicina de Ribeirão Preto, Ribeirão Preto, São Paulo, Brazil|Unimed Ribeirão Preto, Ribeirão Preto, São Paulo, Brazil|Hospital Casa de Saúde de Santos, Santos, São Paulo, Brazil|Kaiser Clínica e Hospital Dia, São José Do Rio Preto, São Paulo, Brazil|Hospital Policlin, São José Dos Campos, São Paulo, Brazil|Hospital Regional de São José dos Campos, São José Dos Campos, São Paulo, Brazil|Santa Casa de Misericórdia de Votuporanga, Votuporanga, São Paulo, Brazil|ESF Dr. João Paccola Primo, Lençois Paulista, Brazil|Cardioclinica da Ilha do Governador, Rio De Janeiro, Brazil|International Research Center - Hospital Alemão Oswaldo Cruz, São Paulo, Brazil|Hospital do Coração, São Paulo, Brazil|Hospital Israelita Albert Einstein, São Paulo, Brazil|Hospital Leforte, São Paulo, Brazil|Hospital Moriah, São Paulo, Brazil|Hospital Samaritano, São Paulo, Brazil|Hospital Santa Paula, São Paulo, Brazil|Hospital São Camilo Pompéia, São Paulo, Brazil|Hospital São Paulo - UNIFESP, São Paulo, Brazil|Hospital Sírio-Libanês, São Paulo, Brazil",https://ClinicalTrials.gov/show/NCT04466540
NCT04481620,"Development and Validation of a Prediction Model for the Transition From Mild to Moderate Form of COVID-19, Using Data From Chest CT",Observational Model: Cohort|Time Perspective: Retrospective,CHUBX 2020/23,"CHU Bordeaux, Bordeaux, France|Clinique Bordeaux Nord, Bordeaux, France|Clinique Saint Augustin, Bordeaux, France|CHU de Grenoble Alpes, Grenoble, France|Hôpital Arnaud-de-Villeneuve CHU de Montpellier, Montpellier, France|Hôpitaux de Brabois CHU de Nancy, Nancy, France|Hôpital de la Milétrie CHU de Poitiers, Poitiers, France",https://ClinicalTrials.gov/show/NCT04481620
NCT04474067,COVID-19 - Cytokine Storm,Observational Model: Case-Control|Time Perspective: Prospective,DM002,"Hadassah Medical Center, Jerusalem, Israel",https://ClinicalTrials.gov/show/NCT04474067
NCT04347850,A Cohort of Patients With Possible or Confirmed SARS-CoV-2 (COVID-19),Observational Model: Cohort|Time Perspective: Prospective,RECHMPL20_0185,"Uh Montpellier, Montpellier, France",https://ClinicalTrials.gov/show/NCT04347850
NCT04348656,CONvalescent Plasma for Hospitalized Adults With COVID-19 Respiratory Illness (CONCOR-1),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,CONCOR-1,"Brooklyn Hospital, Brooklyn, New York, United States|Lower Manhattan Hospital, New York, New York, United States|Weill Cornell Medical Center, New York, New York, United States|Hospital Universitário Antônio Pedro (HUAP), Niterói, Brazil|Hemario, Rio De Janeiro, Brazil|Peter Lougheed Center, Calgary, Alberta, Canada|Foothills Medical Centre, Calgary, Alberta, Canada|Rockyview General Hospital, Calgary, Alberta, Canada|University of Alberta - Royal Alexandra Hospital, Edmonton, Alberta, Canada|University of Alberta Hospital, Edmonton, Alberta, Canada|Sturgeon Community Hospital, St. Albert, Alberta, Canada|Fraser Health Authority - Abbotsford Regional Hospital and Cancer Centre, Abbotsford, British Columbia, Canada|Vancouver General Hospital, Vancouver, British Columbia, Canada|St. Paul's Hospital, Vancouver, British Columbia, Canada|Royal Jubilee Hospital, Victoria, British Columbia, Canada|Victoria General Hospital, Victoria, British Columbia, Canada|St. Boniface General Hospital, Winnipeg, Manitoba, Canada|Health Sciences Centre Winnipeg, Winnipeg, Manitoba, Canada|Grace General Hospital, Winnipeg, Manitoba, Canada|Vitalité Health Network - Acadie-Bathurst, Bathurst, New Brunswick, Canada|Vitalité Health Network - Restigouche, Campbellton, New Brunswick, Canada|Vitalité Health Network- Northwest, Edmundston, New Brunswick, Canada|Dr. Georges-L.-Dumont University Hospital Centre, Moncton, New Brunswick, Canada|Lakeridge Health Ajax Pickering, Ajax, Ontario, Canada|Hamilton General Hospital, Hamilton, Ontario, Canada|Juravinski Hospital, Hamilton, Ontario, Canada|St. Joseph's Healthcare, Hamilton, Ontario, Canada|Grand River Hospital, Kitchener, Ontario, Canada|St. Mary's Hospital, Kitchener, Ontario, Canada|London Health Sciences Centre - University Hospital, London, Ontario, Canada|Victoria Hospital, London, Ontario, Canada|Markham Stouffville Hospital, Markham, Ontario, Canada|Trillium Health Partners - Mississauga Hospital, Mississauga, Ontario, Canada|Trillium Health Partners - Credit Valley, Mississauga, Ontario, Canada|North York General Hospital, North York, Ontario, Canada|Lakeridge Health Oshawa, Oshawa, Ontario, Canada|Ottawa Hospital - General Campus, Ottawa, Ontario, Canada|Ottawa Hospital - Civic Campus, Ottawa, Ontario, Canada|Queensway Carleton Hospital, Ottawa, Ontario, Canada|Bluewater Health, Sarnia, Ontario, Canada|Scarborough Health Network, Centenary Hospital, Scarborough, Ontario, Canada|Scarborough Health Network, General Hospital, Scarborough, Ontario, Canada|Scarborough Health Network, Birchmount Hospital, Scarborough, Ontario, Canada|Niagara Health System - St. Catherines, St. Catherines, Ontario, Canada|Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada|Unity Health St. Michael's Hospital, Toronto, Ontario, Canada|Sinai Health System, Toronto, Ontario, Canada|Toronto General Hospital, Toronto, Ontario, Canada|Toronto Western Hospital, Toronto, Ontario, Canada|Unity Health, St. Joseph's Health Care Centre, Toronto, Ontario, Canada|Windsor Regional Hospital - Metropolitan Campus, Windsor, Ontario, Canada|Windsor Regional Hospital - Ouellette Campus, Windsor, Ontario, Canada|L'Hopital Chicoutimi, Chicoutimi, Quebec, Canada|Hôpital de la Cité-de-la-Santé, Laval, Quebec, Canada|Hôpital Charles-Le Moyne, Longueuil, Quebec, Canada|Hotel Dieu Hospital of Lévis, Lévis, Quebec, Canada|Hôpital Maisonneuve-Rosemont, Montréal, Quebec, Canada|Centre hospitalier de l'Université de Montréal, Montréal, Quebec, Canada|Montréal General Hospital, Montréal, Quebec, Canada|Centre hospitalier universitaire Sainte-Justine, Montréal, Quebec, Canada|Jewish General Hospital, Montréal, Quebec, Canada|McGill University Health Centre, Montréal, Quebec, Canada|Hôpital du Sacré-Coeur de Montreal, Montréal, Quebec, Canada|Centre Hospitalier Universitaire (CHU) de Québec - Université Laval, Quebec City, Quebec, Canada|Institut Universitaire de cardiologie et pneumologie de Québec, Quebec City, Quebec, Canada|Centre hospitalier régional de St-Jérôme, Saint-Jérôme, Quebec, Canada|Centre Hospitalier Universitaire de Sherbrooke (CHUS) - Hôpital Hôtel-Dieu, Sherbrooke, Quebec, Canada|Centre Hospitalier Universitaire de Sherbrooke (CHUS) - Hôpital Fleurimont, Sherbrooke, Quebec, Canada|Centre hospitalier affilié universitaire régional de Trois-Rivières, Trois-Rivières, Quebec, Canada|Regina General Hospital, Regina, Saskatchewan, Canada|Pasqua Hospital, Regina, Saskatchewan, Canada|St. Paul's Hospital, Saskatoon, Saskatchewan, Canada|Royal University Hospital, Saskatoon, Saskatchewan, Canada",https://ClinicalTrials.gov/show/NCT04348656
NCT04366739,Repurposing of Chlorpromazine in Covid-19 Treatment,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,D20-P016,"Centre Hospitalier Sainte-Anne, Paris, France",https://ClinicalTrials.gov/show/NCT04366739
NCT04482023,Emotional Support and Stress Management in Patients Diagnosed With COVID-19,Observational Model: Case-Only|Time Perspective: Cross-Sectional,2020663,"Montserrat Montaña, Sabadell, Barcelona, Spain",https://ClinicalTrials.gov/show/NCT04482023
NCT04350073,Longitudinal Energy Expenditure and Metabolic Effects in Patients With COVID-19 (LEEP-COVID),Observational Model: Cohort|Time Perspective: Prospective,Pro00105221,"Duke University Medial Center, Durham, North Carolina, United States",https://ClinicalTrials.gov/show/NCT04350073
NCT04362943,Clinical-epidemiological Characterization of COVID-19 Disease in Hospitalized Older Adults,Observational Model: Other|Time Perspective: Retrospective,PAS-BAR-2020-04,"Complejo Hospitalario Universitario de Albacete, Albacete, Spain",https://ClinicalTrials.gov/show/NCT04362943
NCT04399356,Niclosamide for Mild to Moderate COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",STUDY00000605,"Tufts Medical Center, Boston, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT04399356
NCT04828161,"A Dose Finding, Efficacy and Safety Study of Ensovibep (MP0420) in Ambulatory Adult Patients With Symptomatic COVID-19","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",MP0420-CP302|2021-000890-10,"Jasper Summit Research, LLC, Jasper, Alabama, United States|Cognitive Clinical Trials, LLC, Phoenix, Arizona, United States|Benchmark SoCal, Colton, California, United States|Positron Research International, Fremont, California, United States|Gastrointestinal and Liver Consultants, Irvine, California, United States|Collaborative Neuroscience Network, LLC, Long Beach, California, United States|Abbracci Med Spa, Torrance, California, United States|Future Innovative Treatments, Colorado Springs, Colorado, United States|Clinical Research Investments, LLC, DeLand, Florida, United States|Panax Clinical Research, LLC, Miami Lakes, Florida, United States|Goji Group - Research Trials Group, Miami Lakes, Florida, United States|Suncoast Research Group, LLC, Miami, Florida, United States|Integral Medicine Group, Miami, Florida, United States|Life Spring Research Foundation, Miami, Florida, United States|University Community Hospital Inc, Tampa, Florida, United States|Palm Beach Research Center, West Palm Beach, Florida, United States|Gwinnett Research Institute, Buford, Georgia, United States|IACT Health, Columbus, Georgia, United States|Great Lakes Clinical Trials, Chicago, Illinois, United States|Centennial Medical Group, PC, Laurel, Maryland, United States|Jefferson City Medical Group, Jefferson City, Missouri, United States|Monroe Biomedical Research, Monroe, North Carolina, United States|Wilmington Health, Wilmington, North Carolina, United States|Clinical Research of Rock Hill, Rock Hill, South Carolina, United States|VitaLink Research Union, Union, South Carolina, United States|Fairway Medical Clinical, Houston, Texas, United States|BioPharma Clinc site, Houston, Texas, United States|Zion Urgent Care Clinic, Katy, Texas, United States|BioPharma Family Practice Center McAllen, McAllen, Texas, United States|Epic Medical Research, Red Oak, Texas, United States|Semmelweis Egyetem, Budapest, Hungary|Debreceni Egyetem, Debrecen, Hungary|Bugat Pal Korhaz, Gyöngyös, Hungary|Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Klinikai Kozpont, Szeged, Hungary|Universitair Medisch Centrum Utrecht, Utrecht, Netherlands|Medicome Sp. z o.o., Oświęcim, Poland|Centrum Medyczne Medyk, Rzeszów, Poland|ETG Skierniewice, Skierniewice, Poland|ETG Lodz, Łódź, Poland|Sandton Medical Research Centre, Johannesburg, Gauteng, South Africa|Clinresco Centres (Pty) Ltd, Kempton Park, Gauteng, South Africa|DJW Research, Krugersdorp, Gauteng, South Africa|Jongaie Research, Pretoria, Gauteng, South Africa|Enhancing Care Foundation, Durban, KwaZulu-Natal, South Africa|Dr JM Engelbrecht Trial Site, Somerset West, Western Cape, South Africa",https://ClinicalTrials.gov/show/NCT04828161
NCT04870164,"Safety, Tolerability and PK of Ensovibep (MP0420 - a New Candidate With Potential for Treatment of COVID-19)","Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Other",MP0420-CP101|2020-004365-39,"HMR, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04870164
NCT04407494,Diagnostic Value of Patient - Reported and Clinically Verified Olfactory Disorders (COVID-19),Observational Model: Cohort|Time Perspective: Prospective,RECHMPL20_0176,"Uhmontpellier, Montpellier, France",https://ClinicalTrials.gov/show/NCT04407494
NCT04757792,Back to the Traditional: Anti-COX Drugs Can Improve the Outcome of COVID-19 Patients Admitted to ICU,Observational Model: Case-Only|Time Perspective: Retrospective,RC1-2-2021,"Faculty of Medicine, Banhā, Qalubia, Egypt",https://ClinicalTrials.gov/show/NCT04757792
NCT04456153,Atovaquone for Treatment of COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",STU-2020-0707,"University of Texas Medical Center, Dallas, Texas, United States",https://ClinicalTrials.gov/show/NCT04456153
NCT04376853,CoronaWatch - Early Detection of Cardiovascular Risks in COVID-19 Via SmartWatch,Observational Model: Cohort|Time Perspective: Prospective,CoronaWatch,"Department III of Internal Medicine, University Hospital Heidelberg, Heidelberg, Baden-Württemberg, Germany",https://ClinicalTrials.gov/show/NCT04376853
NCT04394884,Pathogenesis of BTK-mediated Hyper-Inflammatory Responses in COVID-19 (RESPOND),Observational Model: Cohort|Time Perspective: Prospective,200114|20-I-0114,"Johns Hopkins Hospital, Baltimore, Maryland, United States|Walter Reed National Medical Center, Bethesda, Maryland, United States|National Institutes of Health Clinical Center, Bethesda, Maryland, United States",https://ClinicalTrials.gov/show/NCT04394884
NCT04468087,Antiviral Agents Against COVID-19 Infection,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",REVOLUTIOn,"Hospital do Coracao, Sao Paulo, SP, Brazil",https://ClinicalTrials.gov/show/NCT04468087
NCT04416048,Effect of Anticoagulation Therapy on Clinical Outcomes in COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,COVID-PREVENT|2020-002282-33,"Kardiologie und Angiologie I Universitätsherzzentrum Freiburg, Freiburg, Baden-Württemberg, Germany|Friedrichshafen Hospital Clinic for cardiology, angiology, pneumology and internal intensive care medicine, Friedrichshafen, Baden-Württemberg, Germany|Clinic for Gastroenterology, Infectology and Poisoning Universitäsklinikum Heidelberg, Heidelberg, Baden-Württemberg, Germany|Medical Clinic and Polyclinic I. L. Ludwigs-Maximilians-University Clinic, Munich, Munich, Bayern, Germany|Immanuel Klinikum Bernau Herzzentrum Brandenburg ( Immanuel Clinic Bernau Heart Center Brandenburg), Bernau, Brandenburg, Germany|Internal Medicine and Cardiology Klinik Henningsdorf. Oberhavel Kliniken, Hennigsdorf, Brandenburg, Germany|Clinic for Cardiology, Angiology und Nephrology Universitätsklinikum Frankfurt, Goethe-Universität, Frankfurt am Main, Hessen, Germany|Clinic for Cardiology and Intensive Care - Klinikum Bielefeld, Bielefeld, Nordrhein-Westfalen, Germany|Westdeutsches Herz- und Gefäßzentrum Essen (West German Heart and Vascular Center Essen), Essen, Nordrhein-Westfalen, Germany|Medical Clinic I. Marien Hospital, Universitätsklinikum der Ruhr Universität Bochum, Herne, Herne, Nordrhein-Westfalen, Germany|Pneumology, Allergology, Sleep-and Respiratory Medicine Clinic Helios Universitätsklinikum Wupperthal, Wuppertal, Nordrhein-Westfalen, Germany|Katholisches Klinikum Koblenz-Montabaur (Catholic Hospital Koblenz-Montabaur), Koblenz, Rheinland-Pfalz, Germany|Center for Cardiology, University Medicine Mainz, Mainz, Rheinland-Pfalz, Germany|Universitätsklinikum Halle (Saale) (University Hospital Halle (Saale)), Halle, Sachsen-Anhalt, Germany|Medical Clinic I. Universitätsklinikum Carl Gustav Carus, Dresden, Dresden, Sachsen, Germany|Medical Clinic II, University Clinic Schleswig-Holstein - Campus Lübeck, Lübeck, Schleswig-Holstein, Germany|Department of Pneumology and Infectology Charité University Medicine Berlin, Campus Mitte, Berlin, Germany|Department of Cardiology Charité University Medicine Berlin, Campus Benjamin Franklin, Berlin, Germany|Internal Medicine/Cardiology department Unfallkrankenhaus Berlin, Berlin, Germany|Pulmonary Clinic Berlin-Buch (Lungenklinik Berlin-Buch), Berlin, Germany|Department of Cardiology Charité University Medicine Berlin, Campus Virchow, Berlin, Germany|Internal Medicine, Cardiology and Intensive Care Clinic Vivantes Humboldt Klinikum, Berlin, Berlin, Germany|Berlin Vivantes Hospital Spandau Clinic for internal medicine, cardiology and conservative intensive care medicine, Berlin, Germany|Internal Medicine Deparment Hospital Waldfriede, Berlin, Berlin, Germany",https://ClinicalTrials.gov/show/NCT04416048
NCT04354714,Ruxolitinib to Combat COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,04-13-20-DiPersio,NA,https://ClinicalTrials.gov/show/NCT04354714
NCT04328285,Chemoprophylaxis of SARS-CoV-2 Infection (COVID-19) in Exposed Healthcare Workers,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",20PH061|2020-001188-96,"CHU d'Angers, Angers, France|CHU de Bordeaux, Bordeaux, France|CHU de Clermont-Ferrand, Clermont-ferrand, France|CHU de Montpellier, Montpellier, France|CHU de Nancy, Nancy, France|CHU de Nantes, Nantes, France|CHU de Rennes, Rennes, France|CHU de Rouen, Rouen, France|CHU de Saint-Etienne, Saint-Étienne, France",https://ClinicalTrials.gov/show/NCT04328285
NCT04441385,Study to Evaluate the Efficacy and Safety of Maraviroc in SARS-CoV-2 Infection (COVID-19).,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,MARACOVID|2020-002011-21,"Hospital Clínic, Barcelona, Spain|Hospital Universitario Infanta Leonor, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04441385
NCT04866082,Corticosteroids in Severe COVID-19 (ASAP-ESICM Study),Observational Model: Other|Time Perspective: Prospective,ESICM survey 2021,"Brno University Hospital, Brno, South Moravian Region, Czechia",https://ClinicalTrials.gov/show/NCT04866082
NCT04681079,Comparison of Viral Particle Dispersion Following Administration of an MDI or Nebulizer in Subjects With COVID-19,Observational Model: Other|Time Perspective: Other,192,"Theravance Biopharma Investigational Site, Kansas City, Kansas, United States",https://ClinicalTrials.gov/show/NCT04681079
NCT04636333,Phase I Trial of a Recombinant COVID-19 Vaccine (CHO Cell),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention",JSVCT096,"Jiangsu Provincial Center for Diseases Control and Prevention, Nanjing, Jiangsu, China",https://ClinicalTrials.gov/show/NCT04636333
NCT04389359,PROphylaxis for paTiEnts at Risk of COVID-19 infecTion,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,A095590,NA,https://ClinicalTrials.gov/show/NCT04389359
NCT04367896,COVID-19 OUTBREAK AND SOLID ORGAN TRANSPLANTATION (SOT) : AN INTERNATIONAL WEB-BASED SURVEY,Observational Model: Other|Time Perspective: Prospective,Covid-19_V1,"Fondazione Policlinico Universitario ""Agostino Gemelli"", Rome, Italy",https://ClinicalTrials.gov/show/NCT04367896
NCT04616976,COVID-19 With Convalescent Plasma,Observational Model: Case-Control|Time Perspective: Retrospective,COVID-19 convalescent plasma,"Zhongda Hospital, Southeast University, Nanjing, Jiangsu, China",https://ClinicalTrials.gov/show/NCT04616976
NCT04435184,Crizanlizumab for Treating COVID-19 Vasculopathy,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",IRB00249874,"Johns Hopkins Hospital, Baltimore, Maryland, United States",https://ClinicalTrials.gov/show/NCT04435184
NCT04352933,PROLIFIC ChemoprophylaxisTrial (COVID-19),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",PROLIFIC2020 (A095583),"Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom",https://ClinicalTrials.gov/show/NCT04352933
NCT04915001,An Investigation on the Role of Emergency Departments in Combatting Against COVID-19 in Zhejiang Province,Observational Model: Other|Time Perspective: Other,2020-292,"Second Affiliated Hospital, Zhejiang University School of Medicine & Institute of Emergency Medicine, Zhejiang University, Hangzhou, Zhejiang, China",https://ClinicalTrials.gov/show/NCT04915001
NCT04315298,Evaluation of the Efficacy and Safety of Sarilumab in Hospitalized Patients With COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",6R88-COV-2040,"Regeneron Study Site, Los Angeles, California, United States|Regeneron Study Site, Sacramento, California, United States|Regeneron Study Site, Santa Monica, California, United States|Regeneron Study Site, Aurora, Colorado, United States|Regeneron Study Site, Denver, Colorado, United States|Regeneron Study Site, New Haven, Connecticut, United States|Regeneron Study Site, Washington, District of Columbia, United States|Regeneron Study Site, Gainesville, Florida, United States|Regeneron Study Site, Orlando, Florida, United States|Regeneron Study Site, Tampa, Florida, United States|Regeneron Study Site, Atlanta, Georgia, United States|Regeneron Study Site, Decatur, Georgia, United States|Regeneron Study Site, Marietta, Georgia, United States|Regeneron Study Site, Chicago, Illinois, United States|Regeneron Study Site, Chicago, Illinois, United States|Regeneron Study Site, New Orleans, Louisiana, United States|Regeneron Study Site, Boston, Massachusetts, United States|Regeneron Study Site, Boston, Massachusetts, United States|Regeneron Study Site, Boston, Massachusetts, United States|Regeneron Study Site, Ann Arbor, Michigan, United States|Regeneron Study Site, Rochester, Minnesota, United States|Regeneron Study Site, Edison, New Jersey, United States|Regeneron Study Site, Hackensack, New Jersey, United States|Regeneron Study Site, Livingston, New Jersey, United States|Regeneron Study Site, Morristown, New Jersey, United States|Regeneron Study Site, Neptune, New Jersey, United States|Regeneron Study Site, Newark, New Jersey, United States|Regeneron Study Site, Teaneck, New Jersey, United States|Regeneron Study Site, Bronx, New York, United States|Regeneron Study Site 1, Bronx, New York, United States|Regeneron Study Site 2, Bronx, New York, United States|Regeneron Study Site, Bronx, New York, United States|Regeneron Study Site, Brooklyn, New York, United States|Regeneron Study Site, Buffalo, New York, United States|Regeneron Study Site, Elmhurst, New York, United States|Regeneron Study Site 1, Manhasset, New York, United States|Regeneron Study Site 2, Manhasset, New York, United States|Regeneron Study Site, New York, New York, United States|Regeneron Study Site, New York, New York, United States|Regeneron Study Site 1, New York, New York, United States|Regeneron Study Site 2, New York, New York, United States|Regeneron Study Site, New York, New York, United States|Regeneron Study Site, New York, New York, United States|Regeneron Study Site, New York, New York, United States|Regeneron Study Site, New York, New York, United States|Regeneron Study Site, New York, New York, United States|Regeneron Study Site, Stony Brook, New York, United States|Regeneron Study Site, Valhalla, New York, United States|Regeneron Study Site, Tulsa, Oklahoma, United States|Regeneron Study Site, Portland, Oregon, United States|Regeneron Study Site, Portland, Oregon, United States|Regeneron Study Site, Danville, Pennsylvania, United States|Regeneron Study Site, Philadelphia, Pennsylvania, United States|Regeneron Study Site, Scranton, Pennsylvania, United States|Regeneron Study Site, Wilkes-Barre, Pennsylvania, United States|Regeneron Study Site, Dallas, Texas, United States|Regeneron Study Site, Dallas, Texas, United States|Regeneron Study Site, Murray, Utah, United States|Regeneron Study Site, Falls Church, Virginia, United States|Regeneron Study Site, Richmond, Virginia, United States|Regeneron Study Site, Everett, Washington, United States|Regeneron Study Site, Renton, Washington, United States",https://ClinicalTrials.gov/show/NCT04315298
NCT04379466,Effector and Regulatory T Cell Receptor Repertoire Analyses in Patients Affected by COVID-19,Observational Model: Cohort|Time Perspective: Prospective,APHP200544|2020-A01245-34,"Hôpital Pitie Salpétrère, Paris, France",https://ClinicalTrials.gov/show/NCT04379466
NCT04920942,Ivermectin Treatment Efficacy in Covid-19 High Risk Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Treatment,I-TECH21,"Sultanah Aminah Hospital, Johor Bahru, Johor, Malaysia|Sultanah Bahiyah Hospital, Alor Setar, Kadah, Malaysia|Sultan Abdul Halim Hospital, Sungai Petani, Kedah, Malaysia|Hospital Raja Permaisuri Bainun, Ipoh, Ipoh, Perak, Malaysia|Taiping Hospital, Taiping, Perak, Malaysia|Tuanku Fauziah Hospital, Kangar, Perlis, Malaysia|Pulau Pinang Hospital, George Town, Pulau Pinang, Malaysia|Lahad Datu Hospital, Tawau, Sabah, Malaysia|Sarawak General Hospital, Kuching, Sarawak, Malaysia|Sungai Buloh Hospital, Shah Alam, Selangor, Malaysia|Kuala Lumpur Hospital, Kuala Lumpur, Malaysia|Melaka Hospital, Melaka, Malaysia",https://ClinicalTrials.gov/show/NCT04920942
NCT04898088,A Proof of Concept Study for the DNA Repair Driven by the Mesenchymal Stem Cells in Critical COVID-19 Patients,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,8860/9193,"Istinye University, Istanbul, Turkey|SBÜ Dr. Sadi Konuk Eğitim ve Araştırma Hastanesi, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04898088
NCT04525443,Endothelial Function and COVID-19,Observational Model: Case-Control|Time Perspective: Prospective,20/451,"Mayo Clinic, Rochester, Minnesota, United States|Hospital Clínico San Carlos, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04525443
NCT04475991,Safety and Efficacy of Maraviroc and/or Favipiravir With Standard Therapy in Severe COVID-19 Adults,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,DI/20/407/04/38,"Hospital General de México ""Dr. Eduardo Liceaga"", Mexico City, Cdmx, Mexico",https://ClinicalTrials.gov/show/NCT04475991
NCT04425252,Safety and Anti-coronavirus Response of Suppression of Host Nucleotide Synthesis in Patients With COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,CCB-CRISIS-01,"Hartford Hospital, Hartford, Connecticut, United States|Baptist Medical Center, Jacksonville, Florida, United States|University of South Florida/Tampa General, Tampa, Florida, United States|University of New Mexico, Albuquerque, New Mexico, United States|Temple University, Philadelphia, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04425252
NCT04844541,Prophylaxis and Treatment of COVID-19,Observational Model: Cohort|Time Perspective: Prospective,PC02,"Johns Hopkins University, Baltimore, Maryland, United States|Duke Global Health Institute, Durham, North Carolina, United States",https://ClinicalTrials.gov/show/NCT04844541
NCT04896762,Extrapulmonary Presentations of COVID-19 Patients,Observational Model: Cohort|Time Perspective: Prospective,Soh-Med-21-04-25,"Sohag University, Sohag, Egypt",https://ClinicalTrials.gov/show/NCT04896762
NCT04377620,Assessment of Efficacy and Safety of Ruxolitinib in Participants With COVID-19-Associated ARDS Who Require Mechanical Ventilation (RUXCOVID-DEVENT),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",INCB 18424-369,"Honor Health Research Institute, Scottsdale, Arizona, United States|Sharp Memorial Hospital, San Diego, California, United States|Georgetown University Hospital, Washington, District of Columbia, United States|Teradan Clinical Trials, Brandon, Florida, United States|University of Florida, Gainesville, Florida, United States|Tampa General Hospital, Tampa, Florida, United States|University of South Florida, Tampa, Florida, United States|Northshore University Health System, Chicago, Illinois, United States|Loyola University Medical Center, Maywood, Illinois, United States|Indiana University Simon Cancer Center, Indianapolis, Indiana, United States|Indiana University Health Central Indiana Cancer Centers, Indianapolis, Indiana, United States|East Jefferson General Hospital, Metairie, Louisiana, United States|Johns Hopkins University, Baltimore, Maryland, United States|Boston Medical Center, Boston, Massachusetts, United States|Lahey Hospital & Medical Center, Burlington, Massachusetts, United States|University of Massachusetts Medical School, Worcester, Massachusetts, United States|Healthpartners Cancer Care Center - Regions Hospital, Saint Paul, Minnesota, United States|Mercy Research, Springfield, Missouri, United States|Hackensack University Medical Center, Hackensack, New Jersey, United States|Rutgers Njms Clinical Research Unit, Newark, New Jersey, United States|Holy Name Medical Center, Teaneck, New Jersey, United States|University of Rochester Medical Center, Rochester, New York, United States|Duke University Medical Center, Durham, North Carolina, United States|East Carolina University, Greenville, North Carolina, United States|University of Cincinnati, Cincinnati, Ohio, United States|Kettering Cancer Care, Dayton, Ohio, United States|Jefferson University Hospitals, Philadelphia, Pennsylvania, United States|Temple University, Philadelphia, Pennsylvania, United States|West Penn Hospital, Pittsburgh, Pennsylvania, United States|Allegheny Health Network, Wexford, Pennsylvania, United States|St David'S Medical Center, Austin, Texas, United States|University of Texas Health Science Center At Houston - McGovern Medical School, Houston, Texas, United States|University of Texas Health Science Cente, San Antonio, Texas, United States|Wenatchee Valley Hospital and Clinics, Wenatchee, Washington, United States|Aurora Research Institute, Milwaukee, Wisconsin, United States|Sbih City Hospital 15, Saint Petersburg, Russian Federation",https://ClinicalTrials.gov/show/NCT04377620
NCT04641195,Vitamin D and Zinc Supplementation for Improving Treatment Outcomes Among COVID-19 Patients in India,"Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",VR3- 172649,"Saifee Hospital, Mumbai, Maharashtra, India|King Edward Memorial (KEM) Hospital, Pune, Maharashtra, India",https://ClinicalTrials.gov/show/NCT04641195
NCT04275947,The COVID-19 Mobile Health Study (CMHS),Observational Model: Cohort|Time Perspective: Prospective,CAALC-008-CMHS,"Renmin Hospital of Wuhan University, Wuhan, Hubei, China",https://ClinicalTrials.gov/show/NCT04275947
NCT04709172,Pilot Study of Cefditoren Pivoxil in COVID-19 Patients With Mild to Moderate Pneumonia,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,MPS-ME1207/401,"HU Henares, Coslada, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04709172
NCT04501783,Study of Efficacy and Safety of TL-FVP-t vs. SOC in Patients With Mild to Moderate COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,TL-FVP-t-01,"Medical center LLC ""Neuroprofi"", Korolev, Russian Federation|Federal budgetary institution of science ""Central Research Institute of Epidemiology"" of Russian Federal Supervision Service for Consumer Rights Protection and People's Welfare, Moscow, Russian Federation|Medical centers JSC ""Medsi Group of Companies"", Moscow, Russian Federation|State budgetary institution of health care of the city of Moscow ""City Clinical Hospital №57 of the Moscow City Healthcare Department"", Moscow, Russian Federation|State budgetary institution of health care of the city of Moscow ""City Clinical Hospital №67 n.a. LA Vorokhobova of the Moscow City Healthcare Department"", Moscow, Russian Federation|State budgetary institution of health care of the city of Moscow ""Infectious Diseases Clinical Hospital №1 of the Moscow City Healthcare Department"", Moscow, Russian Federation|Medical center LLC ""Medical Center Eco-safety"", Saint Petersburg, Russian Federation|St. Petersburg State Budgetary Healthcare Institution ""City Hospital No. 40 of the Kurortny District"", Saint Petersburg, Russian Federation|Budgetary healthcare institution of the Voronezh region ""Voronezh Regional Clinical Hospital No. 1"", Voronezh, Russian Federation|State Budgetary Healthcare Institution of the Moscow Region ""Zhukovskaya City Clinical Hospital""., Zhukovskiy, Russian Federation",https://ClinicalTrials.gov/show/NCT04501783
NCT04416256,COVID-19 Pandemic and Worldwide Organ Procurement,Observational Model: Cohort|Time Perspective: Prospective,COVID/W.W.,"Paris Transplant Group, Paris, France",https://ClinicalTrials.gov/show/NCT04416256
NCT04385940,Vitamin D and COVID-19 Management,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",Pro00100606,"University of Alberta, Edmonton, Alberta, Canada",https://ClinicalTrials.gov/show/NCT04385940
NCT04394442,Hydroxychloroquine in COVID-19 Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,SNH1352020,"SNH, Mecca, Saudi Arabia",https://ClinicalTrials.gov/show/NCT04394442
NCT04535869,Efficacy and Safety of Direct Anti HCV Drugs in the Treatment of SARS-COV-2 (COVID-19),Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,MS.20.08.1214,"Mansoura Faculty of Medicine, Mansoura, Dakahlyia, Egypt",https://ClinicalTrials.gov/show/NCT04535869
NCT04814914,"An Observational Clinical Study to Evaluate COVID-19 Symptoms in ""Long Hauler"" Patients Who Participated in K031-120 or K032-120",Observational Model: Cohort|Time Perspective: Prospective,K034-120,"HealthStar Research, LLC, Hot Springs, Arkansas, United States|Quad Clinical Research, Chicago, Illinois, United States",https://ClinicalTrials.gov/show/NCT04814914
NCT04477889,Methodist Health System COVID-19 Patient Registry,Observational Model: Other|Time Perspective: Prospective,024.CRI.2020.A,"Clinical Research Institute Methodist Health System, Dallas, Texas, United States",https://ClinicalTrials.gov/show/NCT04477889
NCT04330638,Treatment of COVID-19 Patients With Anti-interleukin Drugs,Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,COV-AID,"AZ Sint-Jan Brugge, Brugge, Belgium|University Hospital Saint-Pierre, Brussels, Belgium|Erasmus University Hospital, Brussels, Belgium|University Hospital Saint-Luc, Brussels, Belgium|University Hospital Antwerp, Edegem, Belgium|Ziekenhuis Oost-Limurg, Genk, Belgium|AZ Sint-Lucas, Gent, Belgium|University Hospital Ghent, Gent, Belgium|Jessa ZH, Hasselt, Belgium|University Hospital Brussels, Jette, Belgium|CHU Tivoli, La Louvière, Belgium|CHR de la Citadelle, Liège, Belgium|University Hospital Liège, Liège, Belgium|Cliniques Saint-Pierre Ottignies, Ottignies-Louvain-la-Neuve, Belgium|AZ Delta, Roeselare, Belgium",https://ClinicalTrials.gov/show/NCT04330638
NCT04368065,COVID-19 Active Research Experience (CARE),Observational Model: Cohort|Time Perspective: Prospective,IQVIA_COVIDREGISTRY_2020,"IQVIA, Cambridge, Massachusetts, United States|IQVIA, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04368065
NCT04337996,Dynamic Evaluation of COVID-19 Diagnostic Tests,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,RIPH_2020_6,"CH Tourcoing, Tourcoing, France",https://ClinicalTrials.gov/show/NCT04337996
NCT04838080,Safety and Immunogenicity of the Inactivated Koçak-19 Inaktif Adjuvanlı COVID-19 Vaccine Compared to Placebo,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention",ALP-2020-FZ-01-PK-537-2,"Yeditepe AR-GE ve Analiz Merkezi İyi Klinik Uygulamaları Merkezi (Center for GCP), Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04838080
NCT04473053,Rapid Experimental Medicine for COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,AC20063,"NHS Lothian, Edinburgh, United Kingdom",https://ClinicalTrials.gov/show/NCT04473053
NCT04537338,Evaluation of the Immune Response to SARS-CoV-2 Among Patients With Covid-19 in Costa Rica,Observational Model: Case-Control|Time Perspective: Other,R020-SABI-00261,NA,https://ClinicalTrials.gov/show/NCT04537338
NCT04363372,A Study for Efficacy and Safety of Live Biotherapeutic MRx4DP0004 to Treat COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",MRx-4DP0004-II-001,"University Hospitals Plymouth NHS Trust, Plymouth, United Kingdom",https://ClinicalTrials.gov/show/NCT04363372
NCT04422509,Lanadelumab for Treatment of COVID-19 Disease,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,UMCN-AKF20.04,"Amsterdam UMC, Amsterdam, Netherlands|Rijnstate hospital, Arnhem, Netherlands|Radboudumc, Nijmegen, Netherlands|UMC Utrecht, Utrecht, Netherlands",https://ClinicalTrials.gov/show/NCT04422509
NCT04359797,COVID-19 Patient Positioning Pragmatic Trial,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Supportive Care,200727,"NorthShore University HealthSystem, Highland Park, Illinois, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States",https://ClinicalTrials.gov/show/NCT04359797
NCT04513470,Allocetra-OTS in COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,DM003,"Hadassah Medical Center, Jerusalem, Israel",https://ClinicalTrials.gov/show/NCT04513470
NCT04389567,Famotidine Outpatient COVID-19 Treatment Study,Observational Model: Case-Only|Time Perspective: Retrospective,1605914-1,"Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, United States",https://ClinicalTrials.gov/show/NCT04389567
NCT04361214,Leflunomide in Mild COVID-19 Patients,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,IRB20-0622,"University of Chicago, Chicago, Illinois, United States",https://ClinicalTrials.gov/show/NCT04361214
NCT04413045,"Novel COVID-19, A National Analysis",Observational Model: Other|Time Perspective: Retrospective,Novel COVID-19 Prevalence,"Assiut University Hospitals, Assiut, Egypt",https://ClinicalTrials.gov/show/NCT04413045
NCT04337762,Beat COVID-19 - Observational Trial,Observational Model: Case-Control|Time Perspective: Prospective,20200835,"Beat COIVD, LLC, Chicago, Illinois, United States",https://ClinicalTrials.gov/show/NCT04337762
NCT04493294,Low Dose Whole Lung Radiotherapy for Older Patients With COVID-19 Pneumonitis,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,IGRG01,NA,https://ClinicalTrials.gov/show/NCT04493294
NCT04977960,Efficacy of Canrenone as add-on Treatment in Moderate to Severe ARDS in COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,MINECRAFT,NA,https://ClinicalTrials.gov/show/NCT04977960
NCT04954118,A Different Use of The Aerosol Box in COVID-19 Patients; Internal Jugular Vein Cannulation,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Care Provider)|Primary Purpose: Prevention,2020-287,"Bakirkoy Dr. Sadi Konuk Research and Training Hospital, Istanbul, Bakirkoy, Turkey",https://ClinicalTrials.gov/show/NCT04954118
NCT04369742,Treating COVID-19 With Hydroxychloroquine (TEACH),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment",20-00463,"State University of New York (SUNY) Downstate Medical Center, Brooklyn, New York, United States|NYU Langone Health, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04369742
NCT04833101,Study on Sequential Immunization of Recombinant COVID-19 Vaccine (Ad5 Vector) and RBD-based Protein Subunit Vaccine,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",JSVCT115,"Jiangsu Provincial Center for Diseases Control and Prevention, Nanjing, Jiangsu, China",https://ClinicalTrials.gov/show/NCT04833101
NCT04604184,ACTION ON COVID-19: A Study to Test Whether BI 764198 Helps Lung Health of People Hospitalised With COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",1434-0009|2020-003211-96,"University of California Irvine, Orange, California, United States|Rapides Regional Medical Center, Alexandria, Louisiana, United States|St. Elizabeth's Medical Center, Boston, Massachusetts, United States|Newton-Wellesley Hospital, Newton, Massachusetts, United States|Mercy Health St. Vincent Medical Center, Toledo, Ohio, United States|Providence Regional Medical Center, Everett, Washington, United States|MultiCare Tacoma General Hospital, Tacoma, Washington, United States|Hospital Luxemburgo, Belo Horizonte, Brazil|IPECC - Instituto de Pesquisa Clínica de Campinas, Campinas, Brazil|Hospital Sao Jose, Criciuma, Brazil|Hospital Ernesto Dornelles, Porto Alegre, Brazil|Hospital Regional Hans Dieter Schmidt, Santa Catarina, Brazil|Hospital de Base - Fac Med de Sao Jose do Rio Preto, Sao Jose do Rio Preto, Brazil|Hospital Padre Alberto Hurtado, Santiago, Chile|Hospital Carlos Van Buren, Valparaiso, Chile|Hospital Cardiologica Aguascalientes, Aguascalientes, Mexico|Hospital General de Culiacán ""Dr. Bernardo J. Gastellum"", Culiacán, Mexico|Hospital Universitario Dr Jose Eleuterio Gonzalez, Monterrey, Mexico|Hospital Auxilio Mutuo, Hato Rey, Puerto Rico|Hospital Municipal de San Juan, Rio Piedras, Puerto Rico|Hospital A Coruña, A Coruña, Spain|Hospital General Universitario de Alicante, Alicante, Spain|Hospital Universitario Infanta Leonor, Madrid, Spain|Hospital Clínico San Carlos, Madrid, Spain|Hospital Universitario 12 de Octubre, Madrid, Spain|Hospital Son Espases, Palma de Mallorca, Spain",https://ClinicalTrials.gov/show/NCT04604184
NCT04368234,Duke COVID-19 Shared Data and Specimen Repository,Observational Model: Cohort|Time Perspective: Prospective,Pro00105316,"Duke University Medical Center, Durham, North Carolina, United States",https://ClinicalTrials.gov/show/NCT04368234
NCT04348942,"A COVID-19 Symptom, Exposure and Immune Response Registry",Observational Model: Cohort|Time Perspective: Prospective,OBVIO-OBV-001,"ObvioHealth, Orlando, Florida, United States",https://ClinicalTrials.gov/show/NCT04348942
NCT04343690,COPING With COVID-19( CWC-19),Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,Pro00105319,"Duke University, Durham, North Carolina, United States",https://ClinicalTrials.gov/show/NCT04343690
NCT04485429,Efficacy Assessment of Methylprednisolone and Heparin in Patients With COVID-19 Pneumonia,Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,3.12E+16,"D'Or Institute for Research and Education, Rio de Janeiro, Brazil",https://ClinicalTrials.gov/show/NCT04485429
NCT04667247,Mushroom-based Product for COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",200633-1a,"University of California, Los Angeles, Los Angeles, California, United States|University of California, San Diego, San Diego, California, United States",https://ClinicalTrials.gov/show/NCT04667247
NCT04387214,COVID-19 Pandemic and Academic Performance of Veterinary Students,Observational Model: Other|Time Perspective: Cross-Sectional,1-2020,"South Valley University, Qinā, Egypt",https://ClinicalTrials.gov/show/NCT04387214
NCT04487964,Complementary Intervention for COVID-19,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,0925-0586,"Faculty of Medicine, Assiut University, Assiut, Egypt",https://ClinicalTrials.gov/show/NCT04487964
NCT04452474,Study of the Efficacy and Safety of a Single Administration of Olokizumab vs. Placebo in Addition to Standard Treatment in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19).,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",CL04041080,"George Washington University Medical Center, Washington, District of Columbia, United States|Center For Haptitis C/ Atlanta Medical Center, Atlanta, Georgia, United States|PMG Research of DuPage Medical Group, Downers Grove, Illinois, United States|Northwest Indiana Center for Clinical Research, Portage, Indiana, United States|Baystate Infectious Diseases Clinical Research, Springfield, Massachusetts, United States|PMG Research, Inc., Winston-Salem, North Carolina, United States",https://ClinicalTrials.gov/show/NCT04452474
NCT04465604,Hypertonic Saline for COVID-19 Symptoms,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,RAC # 2201072|H-01-R-007,"King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia",https://ClinicalTrials.gov/show/NCT04465604
NCT04952519,Efficacy of Amantadine Treatment in COVID-19 Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",00980.045|2021-000981-13,"Oddział Chorób Płuc i Niewydolności Oddychania z Pododdziałem NWM i Pododdziałem Zaburzeń Oddychania w Czasie Snu, Kujawsko - Pomorskie Centrum Pulmonologii w Bydgoszczy, Bydgoszcz, Poland|Oddział Pneumonologii Górnośląskie Centrum Medyczne im. prof. Leszka Gieca Śląskiego Uniwersytetu Medycznego w Katowicach, Katowice, Poland",https://ClinicalTrials.gov/show/NCT04952519
NCT04408066,COVID-19: A POC Test Under Research & Evaluation,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,S-CLIN-PROT-00028,"Barts Health NHS Trust, London, United Kingdom|Homerton University Hospital NHS Foundation Trust, London, United Kingdom|University College London Hospitals NHS Foundation Trust, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04408066
NCT04365725,"Multicenter, Retrospective Study of the Effects of Remdesivir in the Treatment of Severe Covid-19 Infections",Observational Model: Cohort|Time Perspective: Retrospective,APHP200522,"Hôpital Cochin, Paris, France",https://ClinicalTrials.gov/show/NCT04365725
NCT04836052,Omega-3 Oil Use in COVID-19 Patients in Qatar,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,MRC-04-20-1120,"Hamad Medical Corporation, Doha, DC, Qatar",https://ClinicalTrials.gov/show/NCT04836052
NCT04380519,Study of the Efficacy and Safety of a Single Administration of Olokizumab and RPH-104 With Standard Therapy in Patients With Severe Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",CL04041078,"Federal State Budget Institution ""National Medical Surgery Center named after N.I. Pirogov"" of Ministry of Health of Russian Federation, Moscow, Russian Federation|State Budget Healthcare Institution ""City Clinical Hospital № 15 named after O.M. Filatov"" of Moscow City Healthcare Department, Moscow, Russian Federation|Federal State Budgetary Institution ""Federal Center for Cerebrovascular Pathology and Stroke"" of the Ministry of Health of the Russian Federation, Moscow, Russian Federation|Federal State Autonomous Education Insitution of High Education the First Moscow State Medical University named after I.M. Sechenov of Ministry of Healthcare of Russian Federation (Sechenov University), Moscow, Russian Federation|Federal State Budget Institution ""National Medicine Research Center on Cardiology"" By Ministry of Healthcare of Russian Federation, Moscow, Russian Federation|State Budget Institution of Healthcare ""City Clinical Hospital #52"", Moscow City Healthcare Department, Moscow, Russian Federation|Moscow State Budget Institution of Healthcare ""Scientific Research Institute of Emergency Medicine named after N.V. Sklifosovsky of Moscow Department of Healthcare"", Moscow, Russian Federation|State Budget Healthcare Institution ""City Clinical Hospital #40"", Moscow City Healthcare Department, ""Communarca"" Division, Moscow, Russian Federation|АО ""State Company ""Medsi"" based on Clinical Hospital №1"", Moscow, Russian Federation|Saint Petersburg State Budget Institution of Healthcare ""Clinical infectious diseases hospital named after S.P. Botkin"", Saint Petersburg, Russian Federation|Saint-Petersburg State Budget Institution of Healthcare ""City Hospital №40"", Saint Petersburg, Russian Federation",https://ClinicalTrials.gov/show/NCT04380519
NCT04326920,Sargramostim in Patients With Acute Hypoxic Respiratory Failure Due to COVID-19 (SARPAC),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,SARPAC,"AZ Sint Jan Brugge, Brugge, Belgium|University Hospital Ghent, Gent, Belgium|UZ Brussel, Jette, Belgium|AZ Delta Roeselare, Roeselare, Belgium",https://ClinicalTrials.gov/show/NCT04326920
NCT04498273,COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",ACTIV4-Outpatient,"University of Southern California, Los Angeles, California, United States|Stanford University School of Medicine, Palo Alto, California, United States|Zuckerberg San Francisco General, San Francisco, California, United States|Olive View-UCLA Medical Center, Sylmar, California, United States|Pine Ridge Family Medicine, Colorado Springs, Colorado, United States|Life Tree Health, Inc., Washington, District of Columbia, United States|Midland Florida Clinical Research Center, LLC, DeLand, Florida, United States|University of Florida at Gainesville, Gainesville, Florida, United States|Vital Pharma Research, Hialeah, Florida, United States|Advanced Research for Health Improvement, LLC, Immokalee, Florida, United States|University of Floridia at Jacksonville, Jacksonville, Florida, United States|Lakeland Regional, Lakeland, Florida, United States|Total Research Group LLC, Miami, Florida, United States|Jackson Memorial, Miami, Florida, United States|Well Pharma Medical Research, Miami, Florida, United States|Innovation Clinical Trials, Palmetto Bay, Florida, United States|Bond Community Health Center, Tallahassee, Florida, United States|Tallahassee Memorial, Tallahassee, Florida, United States|USF Tampa General Hospital, Tampa, Florida, United States|Alliance Clinical Research, Tampa, Florida, United States|Hawaii Pacific Health, Honolulu, Hawaii, United States|Fox Valley Clinical Research Center, LLC, Aurora, Illinois, United States|UIC - Mile Square, Chicago, Illinois, United States|Jesse Brown VA, Chicago, Illinois, United States|University of Illinois at Chicago, Chicago, Illinois, United States|Olivo Wellness Medical Center, Chicago, Illinois, United States|University of Chicago, Chicago, Illinois, United States|OSF Saint Francis Medical Center, Peoria, Illinois, United States|Ascension Via Christi, Wichita, Kansas, United States|University Medical Center New Orleans, New Orleans, Louisiana, United States|Jadestone Clinical Research, LLC, Gaithersburg, Maryland, United States|Brigham & Women's Hospital, Boston, Massachusetts, United States|GFC of Southeastern Michigan, Detroit, Michigan, United States|SRI International, Plymouth, Michigan, United States|Metro Health-University of Michigan Health, Wyoming, Michigan, United States|Raritan Bay Primary Care and Cardiology Associates, Matawan, New Jersey, United States|G&S Medical Associates, LLC, Paterson, New Jersey, United States|University of New Mexico, Albuquerque, New Mexico, United States|Montefiore Medical Center, Bronx, New York, United States|Strong Memorial, Rochester, New York, United States|Spinal Pain and Rehab Medicine, Yonkers, New York, United States|Duke, Durham, North Carolina, United States|Peters Medical Research, High Point, North Carolina, United States|The Heart and Medical Center, Durant, Oklahoma, United States|Ascension St. John Clinical Research Institute, Tulsa, Oklahoma, United States|UPMC Passavant Cranberry, Cranberry, Pennsylvania, United States|UPMC McKeesport, McKeesport, Pennsylvania, United States|UPMC East, Monroeville, Pennsylvania, United States|UPMC Magee, Pittsburgh, Pennsylvania, United States|UPMC Presby, Pittsburgh, Pennsylvania, United States|UPMC Mercy, Pittsburgh, Pennsylvania, United States|Preferred Primary Care Physicians, Pittsburgh, Pennsylvania, United States|UPMC Shadyside, Pittsburgh, Pennsylvania, United States|UPMC Passavant McCandless, Pittsburgh, Pennsylvania, United States|Preferred Primary Care Physicians, Inc, Pittsburgh, Pennsylvania, United States|Preferred Primary Care Physicians, Pittsburgh, Pennsylvania, United States|Preferred Primary Care Physicians, Uniontown, Pennsylvania, United States|Pharma Tex Research, Amarillo, Texas, United States|Ascension Seton Medical Center, Austin, Texas, United States|Baptist Beaumont, Beaumont, Texas, United States|McGoven Medical School - UT- Houston, Houston, Texas, United States|Diversifield Medical Practices, Houston, Texas, United States|Next Level Urgent Care, Houston, Texas, United States|Mesquite Regional Internal Medicine, Mesquite, Texas, United States|University of Texas at Tyler, Tyler, Texas, United States|University of Texas at Rio Grande Valley, Weslaco, Texas, United States|Intermountain Healthcare, Murray, Utah, United States|Community Care of Clay, Clay, West Virginia, United States|University Healthcare Physicians, Harpers Ferry, West Virginia, United States|Community Care of Weston, Weston, West Virginia, United States|Gundersen Health System, La Crosse, Wisconsin, United States",https://ClinicalTrials.gov/show/NCT04498273
NCT04790994,COVID-19 Prevalence in UNIVI Geriatric Institutions: Epidemiological Study of Immunological Status With Rapid Serological Tests,Observational Model: Cohort|Time Perspective: Prospective,2020-A01838-31,"CentreMédicalPorteVerte, Versailles, France",https://ClinicalTrials.gov/show/NCT04790994
NCT04369300,Anxiety And Depression During COVID-19 IN INDIA,Observational Model: Other|Time Perspective: Cross-Sectional,Covid-19/MHC/PSYCH/20-10,"Max Super Speciality hospital, New Delhi, Delhi, India",https://ClinicalTrials.gov/show/NCT04369300
NCT04351646,Diagnostics of COVID-19/DARTS (Development and Assessment of Rapid Testing for SARS-CoV-2 Outbreak),Observational Model: Cohort|Time Perspective: Prospective,2020.0075,"St. Georges Hospital Foundation Trust, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04351646
NCT04332081,Hyperbaric Oxygen for COVID-19 Patients,Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,20-00399,"NYU Winthrop Hospital, Mineola, New York, United States",https://ClinicalTrials.gov/show/NCT04332081
NCT04492865,MSCT Chest in Suspected COVID-19 Patients,Observational Model: Cohort|Time Perspective: Prospective,CTCOV,"Assiut university, Assiut, Egypt",https://ClinicalTrials.gov/show/NCT04492865
NCT04848584,Pfizer-BioNTech COVID-19 BNT162b2 Vaccine Effectiveness Study - Kaiser Permanente Southern California,Observational Model: Case-Control|Time Perspective: Retrospective,C4591014,NA,https://ClinicalTrials.gov/show/NCT04848584
NCT04333355,Safety in Convalescent Plasma Transfusion to COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,PC-TecSalud Fase I,"Hospital San José, Monterrey, Nuevo Leon, Mexico",https://ClinicalTrials.gov/show/NCT04333355
NCT04377477,COVID-19 Pneumonitis Low Dose Lung Radiotherapy (COLOR-19),Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,NP 4097,"Radiation Oncology Department, ASST SpedaliCivili, Brescia, Brescia, Italy",https://ClinicalTrials.gov/show/NCT04377477
NCT04304313,A Pilot Study of Sildenafil in COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,GST-G1,"Department and Institute of Infectious Disease, Wuhan, Hubei, China",https://ClinicalTrials.gov/show/NCT04304313
NCT04365699,Cardiovascular Effects of COVID-19,Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,20-00416,"NYU Langone Health, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04365699
NCT04477642,Abatacept for Patients With COVID-19 and Respiratory Distress,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2020-P-00XXX,"Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Boston Children's Hospital, Boston, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT04477642
NCT04382755,Zilucoplan® in Improving Oxygenation and Short- and Long-term Outcome of COVID-19 Patients With Acute Hypoxic Respiratory Failure,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,ZILU-COV,"OLVZ Aalst, Aalst, Belgium|AZ Sint Jan Brugge, Brugge, Belgium|Erasmus University Hospital, Brussels, Belgium|AZ Sint-Lucas, Gent, Belgium|University Hospital Ghent, Gent, Belgium|Jan Yperman Ziekenhuis Ieper, Ieper, Belgium|University Hospital Liège, Liège, Belgium|AZ Delta, Roeselare, Belgium|AZ Vesalius, Tongeren, Belgium",https://ClinicalTrials.gov/show/NCT04382755
NCT04372368,Convalescent Plasma for the Treatment of Patients With COVID-19,NA,20-0990,"Children's Hospital Colorado, Aurora, Colorado, United States|University of Colorado Hospital, Aurora, Colorado, United States|UCHealth Memorial Hospital North, Colorado Springs, Colorado, United States|Denver Health Medical Center, Denver, Colorado, United States|UCHealth Poudre Valley Hospital, Fort Collins, Colorado, United States|UCHealth Highlands Ranch Hospital, Highlands Ranch, Colorado, United States",https://ClinicalTrials.gov/show/NCT04372368
NCT04422379,COVID-19 and Liver Injury in Patients With or Without Underlying Liver Disease: A Multi-centre Retrospective-prospective Observational Study,Observational Model: Cohort|Time Perspective: Other,COVID 19/LI/2020,"Max Super Speciality Hospital, Saket (A Unit Of Devki Devi Foundation), New Delhi, Dlelhi, India",https://ClinicalTrials.gov/show/NCT04422379
NCT04644341,Tele-monitoring of COVID-19 Survivors for Long-Term Impacts,Observational Model: Case-Only|Time Perspective: Retrospective,B2020:114 (HS24395),"University of Manitoba, Winnipeg, Manitoba, Canada",https://ClinicalTrials.gov/show/NCT04644341
NCT04691921,Current Pharmacological Practices in Severe COVID-19,Observational Model: Cohort|Time Perspective: Cross-Sectional,NMCSH,"Reliance Hospital, Mumbai, Mumbai, Mahrastra, India",https://ClinicalTrials.gov/show/NCT04691921
NCT04400890,"Randomized Proof-of-Concept Trial to Evaluate the Safety and Explore the Effectiveness of Resveratrol, a Plant Polyphenol, for COVID-19","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",McCreary2020,"Mt Carmel HealthSystems, Columbus, Ohio, United States",https://ClinicalTrials.gov/show/NCT04400890
NCT04395664,Arrhythmias in Patients With COVID-19,Observational Model: Cohort|Time Perspective: Prospective,H-20021500,"Department of Cardiology, Herlev & Gentofte Hospital, Copenhagen, Hellerup, Denmark",https://ClinicalTrials.gov/show/NCT04395664
NCT04569188,Convalescent Plasma in COVID-19 Elderly Patients,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,Asstmantova,"Transfusion Service, Mantova, Italy",https://ClinicalTrials.gov/show/NCT04569188
NCT04363034,Arkansas Expanded Access COVID-19 Convalescent Plasma Treatment Program,NA,260944,NA,https://ClinicalTrials.gov/show/NCT04363034
NCT04353154,The RAPID COVID-19 TRIAGE Algorithm,Observational Model: Cohort|Time Perspective: Prospective,20200228-01H,"University of Ottawa Heart Institute, Ottawa, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04353154
NCT04405908,SCB-2019 as COVID-19 Vaccine,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",CLO-SCB-2019-001,"Linear Clinical Research Ltd, Nedlands, Western Australia, Australia",https://ClinicalTrials.gov/show/NCT04405908
NCT04351243,A Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19 (BREATHE),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",KIN-1901-2001,"Banner University Medical Center, Phoenix, Arizona, United States|HonorHealth John C. Lincoln Medical Center, Phoenix, Arizona, United States|HonorHealth Scottsdale Osborn Medical Center, Scottsdale, Arizona, United States|HonorHealth, Scottsdale, Arizona, United States|HonorHealth Scottsdale Shea Medical Center, Scottsdale, Arizona, United States|Banner University Medical Center, Tucson, Arizona, United States|UCLA Ronald Reagan Medical Center, Los Angeles, California, United States|University of Florida, Gainesville, Florida, United States|Miami Cancer institute, Miami, Florida, United States|Piedmont Healthcare, Atlanta, Georgia, United States|Emory University School of Medicine, Atlanta, Georgia, United States|NorthShore University HealthSystem, Evanston, Illinois, United States|East Jefferson General Hospital, Metairie, Louisiana, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States|Beaumont Hospital - Royal Oak, Royal Oak, Michigan, United States|Jamaica Hospital Medical Center, Jamaica, New York, United States|Mount Sinai Beth Israel, New York, New York, United States|Mount Sinai West, New York, New York, United States|Icahn School of Medicine at Mount Sinai, New York, New York, United States|University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States|Temple University Hospital, Philadelphia, Pennsylvania, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|Baylor Jack & Jane Hamilton Heart and Vascular Hospital, Dallas, Texas, United States|Baylor University Medical Center, Dallas, Texas, United States|Baylor Scott & White All Saints Medical Center, Fort Worth, Texas, United States|Memorial Hermann Hospital Affiliated with University of Texas Health Science Center at Houston, McGovern Medical School, Houston, Texas, United States|Baylor Scott & White Medical Center, Irving, Texas, United States|Baylor Scott & White Medical Center, Plano, Texas, United States|Baylor Scott & White Medical Center, Temple, Texas, United States|Inova Fairfax Medical Campus, Falls Church, Virginia, United States",https://ClinicalTrials.gov/show/NCT04351243
NCT04344587,Awake Prone Position for Early Hypoxemia in COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,H-40070,"Long Beach Medical Center - MemorialCare, Long Beach, California, United States|Alvarado Hospital, San Diego, California, United States|St. Joseph's Hospital National Jewish Health, Denver, Colorado, United States|MedStar Georgetown University Hospital, Washington, District of Columbia, United States|Piedmont Atlanta, Atlanta, Georgia, United States|University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States|University of Kansas Medical Center, Kansas City, Kansas, United States|Boston Medical Center, Boston, Massachusetts, United States|University of Michigan, Ann Arbor, Michigan, United States|Creighton University, Omaha, Nebraska, United States|Michael E. DeBakey Veteran Affairs Medical Center, Houston, Texas, United States|VCU Medical Center, Richmond, Virginia, United States|Hospital Universitario La Paz, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04344587
NCT04436484,Immune Biomarkers of Outcome From COVID-19,Observational Model: Cohort|Time Perspective: Prospective,20/HEP/381,"University Hospitals Plymouth NHS Trust, Plymouth, Devon, United Kingdom",https://ClinicalTrials.gov/show/NCT04436484
NCT04492943,To Observe Whether Isoflurane Can Treat COVID-19 Patients,Observational Model: Cohort|Time Perspective: Retrospective,2020P001048,"Massachusetts General Hospital, Boston, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT04492943
NCT04382586,Covid-19 Infection and Pulmonary Distress Treatment With Zanubrutinib in Hospitalized Participants,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",BGB-3111-219,"Honor Health, Scottsdale, Arizona, United States|St. Jude Medical Center, Fullerton, California, United States|Olive View - UCLA Medical Center, Sylmar, California, United States|MedStar Heath Research Institute/ MedStar Washington Hospital Center, Washington, District of Columbia, United States|Augusta University, Augusta, Georgia, United States|John D. Archbold Memorial Hospital, Thomasville, Georgia, United States|Loyola University Medical Center, Maywood, Illinois, United States|SIU School of Medicine, Springfield, Illinois, United States|University of Iowa, Iowa City, Iowa, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Brigham And Women's Hospital, Boston, Massachusetts, United States|Morristown Medical Center, Morristown, New Jersey, United States|Rutgers University Hospital, Newark, New Jersey, United States|Atlantic Health System, Inc. / Chilton Medical Center, Pompton Plains, New Jersey, United States|Overlook Medical Center, Summit, New Jersey, United States|Therapeutic Concepts, Houston, Texas, United States|Covenant Health System, Lubbock, Texas, United States|Medical College of Wisconsin, Milwaukee, Wisconsin, United States",https://ClinicalTrials.gov/show/NCT04382586
NCT04353284,Camostat Mesylate in COVID-19 Outpatients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",2000027971,"Yale University, New Haven, Connecticut, United States",https://ClinicalTrials.gov/show/NCT04353284
NCT04337541,Reduction in COVID-19 Infection Using Surgical Facial Masks Outside the Healthcare System,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,2020/4/2,"Rigshospitalet, Copenhagen, Denmark",https://ClinicalTrials.gov/show/NCT04337541
NCT04441996,Therapeutic Plasma Exchange for COVID-19-associated Hyperviscosity,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,STUDY00000949,"Emory Saint Joseph's Hospital, Atlanta, Georgia, United States|Emory University Hospital Midtown, Atlanta, Georgia, United States|Emory University Hospital, Atlanta, Georgia, United States",https://ClinicalTrials.gov/show/NCT04441996
NCT04766294,Macrophage Activation Markers in COVID-19 Patients,Observational Model: Other|Time Perspective: Cross-Sectional,Soh-Med-21-02-20,"Faculty of medicine - sohag university, Sohag, Egypt",https://ClinicalTrials.gov/show/NCT04766294
NCT04389710,Convalescent Plasma for the Treatment of COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,20D.379,"Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04389710
NCT04974164,Effectiveness of COVID-19 Vaccine for Prevention of COVID-19 in the Dominican Republic,Observational Model: Case-Control|Time Perspective: Prospective,CoronaVacTND,"Moscoso Puello Hospital, Bella Vista, Distrito Nacional, Dominican Republic|Felix Maria Goico Hospital, Villa Francisca, Distrito Nacional, Dominican Republic|Gral Esp Ntra Sra dela Alt, Higuamo, La Altagracia, Dominican Republic|Hospital IMG, Higuey, La Altagracia, Dominican Republic|Centro Médico Bournigal, San Felipe de Puerto Plata, Puerto Plata, Dominican Republic|Ricardo Limardo, Sosúa, Puerto Plata, Dominican Republic|JoséM.Cabral V Báez, Puñal, Santiago, Dominican Republic|Clinica Unión Medica del Norte, Santiago de los Caballeros, Santiago, Dominican Republic|Fuerza AéreaDr Ramón Lara, Los Alcarrizos, Santo Domingo, Dominican Republic|Marcelino Vélez Santana, San Antonio de Guerra, Santo Domingo, Dominican Republic",https://ClinicalTrials.gov/show/NCT04974164
NCT04338347,CAP-1002 in Severe COVID-19 Disease,NA,CAP-1002-COVID-19,"Cedars-Sinai Medical Center, Los Angeles, California, United States",https://ClinicalTrials.gov/show/NCT04338347
NCT04527497,Clinical Course and Treatment of COVID-19 Inpatients in Hospital,Observational Model: Cohort|Time Perspective: Prospective,WI_20-1294,"Institut für Pneumologie an der Universität zu Köln / Wissenschaftliches Institut Bethanien für Pneumologie e.V., Solingen, Nordrhein-Westfalen, Germany",https://ClinicalTrials.gov/show/NCT04527497
NCT04398303,ACT-20 in Patients With Severe COVID-19 Pneumonia,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",AHS 20-03,NA,https://ClinicalTrials.gov/show/NCT04398303
NCT04418544,Vocal Feature Analysis Algorithm for COVID-19 Detection,Observational Model: Cohort|Time Perspective: Cross-Sectional,002 Soniphi,"Soniphi, Sebastopol, California, United States",https://ClinicalTrials.gov/show/NCT04418544
NCT04750317,Efficacy and Safety of Tofacitinib in Patients With COVID-19 Pneumonia,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,107892,"Sechenov First Moscow State Medical University (Sechenov University) - University Clinical Hospital, Moscow, Russian Federation",https://ClinicalTrials.gov/show/NCT04750317
NCT04400812,Attitude and Perception Towards COVID-19 Pandemic,Observational Model: Other|Time Perspective: Cross-Sectional,ZU#IRB#6138-17-5-2020,"Zagazig University, Zagazig, Sharkia, Egypt",https://ClinicalTrials.gov/show/NCT04400812
NCT04528641,GRAd-COV2 Vaccine Against COVID-19,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,RT-CoV-2,"INMI Spallanzani, Rome, Italy|Centro Ricerche Cliniche, Verona, Italy",https://ClinicalTrials.gov/show/NCT04528641
NCT04370223,Ozone Auto-hemotherapy for COVID-19 Pneumonia,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,COVID-19 Networking group,"Hospital Universitari Dr Josep Trueta, Girona, Spain|Clinica Nuestra Señora del Rosario, Ibiza, Spain|Hospital Quirón Rey Juan Carlos I, Madrid, Spain|Hospital Universitario 12 de Octubre, Madrid, Spain|Hospital Universitario Infanta Leonor, Madrid, Spain|Hospital Universitario Príncipe de Asturias de Alcalá de Henares, Madrid, Spain|Fundació Althaia de Manresa, Manresa, Spain|Hospital Vithas Valencia Consuelo, Valencia, Spain|Hospital Clínico Universitario de Valladolid, Valladolid, Spain|Clinica Claro, Vigo, Spain",https://ClinicalTrials.gov/show/NCT04370223
NCT04723589,Restoration of Endothelial Integrity in Patients With COVID-19 (RELIC),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,IRB-300005853,NA,https://ClinicalTrials.gov/show/NCT04723589
NCT04404062,Serological and PCR Testing for COVID-19,Observational Model: Cohort|Time Perspective: Prospective,C20010,"Richmond Pharmacology Ltd. 1a Newcomen St, London Bridge, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04404062
NCT04379440,Geriatric Population COVID-19 Observational Study (GEROCOVIDobs),Observational Model: Cohort|Time Perspective: Other,GC01-Obs,"RSA La Quiete, Castiglione Cosentino, Calabria, Italy|ASP Catanzaro, Catanzaro Lido, Calabria, Italy|AOU Ferrara, Ferrara, Emilia Romagna, Italy|Policlinico Campus Bio-Medico, Rome, Roma, Italy|AOU Careggi, Firenze, Toscana, Italy|AOU Pisana Geriatria, Pisa, Toscana, Italy|Ospedale di Comunita' ULSS 6 Euganea- COVID Center, Camposampiero, Veneto, Italy",https://ClinicalTrials.gov/show/NCT04379440
NCT04380402,Atorvastatin as Adjunctive Therapy in COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,MountAuburn,"Mount Auburn Hospital, Cambridge, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT04380402
NCT04377035,The Role of Ultrasound in COVID-19,Observational Model: Cohort|Time Perspective: Prospective,H-20021500,"Cardiovascular Non-Invasive Imaging Research Laboratory, department of Cardiology, Herlev & Gentofte Hospital, Hellerup, Denmark",https://ClinicalTrials.gov/show/NCT04377035
NCT04348422,Evaluating the Immune Response for COVID-19,Observational Model: Cohort|Time Perspective: Prospective,105-20-ASF,"Assaf-Harofeh Medical Center, Ramla, Israel",https://ClinicalTrials.gov/show/NCT04348422
NCT04407533,Dietary Intake and Eating Habits During the COVID-19 Pandemic,Observational Model: Ecologic or Community|Time Perspective: Prospective,20-04-064,"McGill University - School of Human Nutrition, Montréal, Quebec, Canada",https://ClinicalTrials.gov/show/NCT04407533
NCT04462757,SCIL-1Ra in COVID-19 Feasibility & PK/PD,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,282110|2020-001636-95,"Manchester Univesity NHS Foundation Trust, Manchester, United Kingdom|Salford Royal NHS Foundation Tust, Salford, United Kingdom",https://ClinicalTrials.gov/show/NCT04462757
NCT04359277,A Randomized Trial of Anticoagulation Strategies in COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,s20-00479,"NYU Langone Health, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04359277
NCT04354805,Administration of Chlorpromazine as a Treatment for COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,Medical,"Cairo University, Cairo, Egypt",https://ClinicalTrials.gov/show/NCT04354805
NCT04351763,Amiodarone or Verapamil in COVID-19 Hospitalized Patients With Symptoms,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,NCU-COVID19,"Nicolaus Copernicus University, Bydgoszcz, Poland",https://ClinicalTrials.gov/show/NCT04351763
NCT04467047,Safety and Feasibility of Allogenic MSC in the Treatment of COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,20200148,NA,https://ClinicalTrials.gov/show/NCT04467047
NCT04742725,A Study to Evaluate the Efficacy and Safety of Prothione™ Capsules for Mild to Moderate Coronavirus Disease 2019 (COVID-19),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",TAL-PRO-001,"Rinda Ubuzima, Kigali, Rwanda",https://ClinicalTrials.gov/show/NCT04742725
NCT04476927,Detection of COVID-19 Subjects Using DiaNose Exhalation Test,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,CORON01,NA,https://ClinicalTrials.gov/show/NCT04476927
NCT04340544,Hydroxychloroquine for the Treatment of Mild COVID-19 Disease,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",COMIHY,"Institute for Tropical Medicine, Tübingen, Germany",https://ClinicalTrials.gov/show/NCT04340544
NCT04458298,A Study to Evaluate OP-101 (Dendrimer N-acetyl-cysteine) in Severe Coronavirus Disease 2019 (COVID-19) Patients,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",OP-101-004,"Research Site, Loma Linda, California, United States|Research site, Fort Lauderdale, Florida, United States|Research Site, Atlanta, Georgia, United States|Research site, Baltimore, Maryland, United States|Research Site, Sioux Falls, South Dakota, United States|Research Site, Houston, Texas, United States",https://ClinicalTrials.gov/show/NCT04458298
NCT04953325,Immunogenicity and Safety of an Inactivated COVID-19 Vaccine,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,PRO-nCOV-MA4004-SD,"Rushan City Center for Disease Control and Prevention, Weihai, Shandong, China",https://ClinicalTrials.gov/show/NCT04953325
NCT04446377,A Study of LAM-002A for the Prevention of Progression of COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",LAM-002A-CVD-CLN01,"Yale University, New Haven, Connecticut, United States",https://ClinicalTrials.gov/show/NCT04446377
NCT04384900,Accelerated Prone Position Ventilation of Patients With COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,H-20027361,"Nordsjællands Hospital, Hillerød, Region Hovedstanden, Denmark",https://ClinicalTrials.gov/show/NCT04384900
NCT04415151,Tofacitinib for Treatment of Moderate COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",2000027848,"Yale New Haven Health System, New Haven, Connecticut, United States",https://ClinicalTrials.gov/show/NCT04415151
NCT04356690,Etoposide in Patients With COVID-19 Infection,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,H-40102,"Boston Medical Center, Boston, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT04356690
NCT04369807,Mapping Organ Health Following COVID-19 Disease Due to SARS-CoV-2 Infection,Observational Model: Cohort|Time Perspective: Prospective,20/SC/0185,"Mayo Clinic Healthcare, London, United Kingdom|Gemini, Oxford, United Kingdom",https://ClinicalTrials.gov/show/NCT04369807
NCT04375124,Treatment of Angiotensin Peptide (1-7) for COVID-19,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,KSSEAH--0059,"Kanuni Sultan Suleyman Training and Research Hospital, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04375124
NCT04381351,Noncoding RNAs in COVID-19 and COVID-19 Related Kidney Dysfunction,Observational Model: Cohort|Time Perspective: Prospective,1,"Klinik für Anästhesiologie, Düsseldorf, Germany",https://ClinicalTrials.gov/show/NCT04381351
NCT04509999,Bicalutamide to Block TMPRSS2 in Males With COVID-19 Infection,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",IRB202001669-A|OCR38162,NA,https://ClinicalTrials.gov/show/NCT04509999
NCT04377789,Effect of Quercetin on Prophylaxis and Treatment of COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,KSSEAH--0058,"Kanuni Sultan Suleyman Training and Research Hospital, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04377789
NCT04412785,Cyclosporine in Patients With Moderate COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,842998,"University of Pennsylvania, Philadelphia, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04412785
NCT04459819,Respiratory Physiotherapy in Severe COVID-19 Patients,Observational Model: Case-Only|Time Perspective: Retrospective,FTR-COVID,"Department of Pathophysiology and Transplantation, University of Milan Internal Medicine Department, Respiratory Unit and Cystic Fibrosis Adult Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy",https://ClinicalTrials.gov/show/NCT04459819
NCT04731116,Cannabidiol Treatment for Severe and Critical Coronavirus (COVID-19) Pulmonary Infection,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,0245-20-RMC,"Rabin Medical Center, Petach Tikva, Israel",https://ClinicalTrials.gov/show/NCT04731116
NCT04472013,"Systematic Assessment of SARS-CoV-2 Neurotropic Capacity in Modestly and Critically Ill Patients, and Patients Who Died From COVID-19",Observational Model: Cohort|Time Perspective: Prospective,2020-01503; ch20Hutter,"Neurosurgery, University Hospital Basel, Basel, Switzerland",https://ClinicalTrials.gov/show/NCT04472013
NCT04836065,ESICM UNITE COVID-19 Project (UNITE-COVID),Observational Model: Cohort|Time Perspective: Prospective,ESICMUNITE2020,"Ghent University Hospital, Ghent, Belgium",https://ClinicalTrials.gov/show/NCT04836065
NCT04443725,Efficacy and Safety of Anti HCV Drugs in the Treatment of COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,CUKA-003,NA,https://ClinicalTrials.gov/show/NCT04443725
NCT04649827,A Clinical Trial for Hospitalized Patients With COVID-19 in Ceará: ResCOVID Study,Observational Model: Case-Only|Time Perspective: Other,3.948.100,"Hospital Leonardo Da Vinci, Fortaleza, Ceara, Brazil",https://ClinicalTrials.gov/show/NCT04649827
NCT04542850,"Pilot Study to Evaluate the Safety, Tolerability, and Efficacy of 5-ALA-Phosphate + SFC in Subjects With COVID-19",Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,68 / 02-Aug-2020,"Bahrain Defense Force Royal Medical Services, Military Hospital, Manama, Bahrain|Salmaniya Medical Complex, Manama, Bahrain",https://ClinicalTrials.gov/show/NCT04542850
NCT04858633,Hydroxychloroquine (HCQ) as Post Exposure Prophylaxis (PEP) for Prevention of COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention",INT/IEC/2021/SPL456,"Post Graduate Institute of Medical Education and Research, Chandigarh, India",https://ClinicalTrials.gov/show/NCT04858633
NCT04383002,High Dose Inhaled Nitric Oxide for COVID-19 (ICU Patients),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,20-5449,"University Health Network, Toronto General Hospital, Toronto, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04383002
NCT04904692,Virological and Immunological Monitoring in Patients (Suspected of/Confirmed With) COVID-19,Observational Model: Cohort|Time Perspective: Prospective,BC-07492,"AZ Jan Palfijn, Gent, Oost-Vlaanderen, Belgium|AZ Maria Middelares, Gent, Oost-Vlaanderen, Belgium|UZ Gent, Gent, Oost-Vlaanderen, Belgium",https://ClinicalTrials.gov/show/NCT04904692
NCT04575610,IRAK4 Inhibition in Treatment of COVID-19 With ARDS (I-RAMIC),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",2000028042,"Yale New Haven Hospital, New Haven, Connecticut, United States",https://ClinicalTrials.gov/show/NCT04575610
NCT04376398,Survey: COVID-19 Patients Managed in the Operating Theatre of Belgian Hospitals,Observational Model: Case-Only|Time Perspective: Prospective,COVID-ANESTHESIO,"Cliniques Universitaires Saint Luc, Brussels, Belgium",https://ClinicalTrials.gov/show/NCT04376398
NCT04667780,Study to Investigate the Treatment Effect of Colchicine in Patients With COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,ATH/IRB/Colchicine/25.11.2020,"Ayub Teaching Hospital, Abbottabad, Khyber Pakhtunkhwa, Pakistan",https://ClinicalTrials.gov/show/NCT04667780
NCT04453891,Hexoskin Feasibility Study With COVID-19 Patients,Observational Model: Cohort|Time Perspective: Prospective,Hexoskin COVID-19 Study,NA,https://ClinicalTrials.gov/show/NCT04453891
NCT04941131,The Role of Chlorhexidine in Minimizing the Viral Load Among COVID-19 Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,1485,"King Abdulaziz University , Faculty of Dentistry, Jeddah, Saudi Arabia",https://ClinicalTrials.gov/show/NCT04941131
NCT04483635,PRevention of COVID-19 With Oral Vitamin D Supplemental Therapy in Essential healthCare Teams,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",MP-21-2021-3044,"CHUM, Montreal, Quebec, Canada|CHU Sainte-Justine (CHUSJ), Montreal, Quebec, Canada",https://ClinicalTrials.gov/show/NCT04483635
NCT04753242,Psychosocial Care During the COVID-19 Pandemic in Acute Hospitals,Observational Model: Cohort|Time Perspective: Cross-Sectional,Req-2020-00861; th21Schaefert,"Medical University of Graz, University Hospital Graz, Graz, Steiermark, Austria|Ghent University Hospital, Department of Psychiatry, Ghent, Belgium|University of Montreal, Department of Psychosomatic Medicine, Montreal, Canada|TorontoSinai Health, University of Toronto, Department of Psychiatry, Toronto, Canada|Oulu University Hospital and University of Oulu, Oulu, Finland|Université de Paris, Service de Psychiatrie de l'adulte, Paris, France|Nuremberg Hospital, Department of Psychosomatic Medicine and Psychotherapy, Nürnberg, Bayern, Germany|University Hospital Cologne, Department of Psychosomatics and Psychotherapy, Köln, Nordrhein-Westfalen, Germany|Aristotle University Thessaloniki, Thessaloniki, Greece|University of Medical Sciences, Department of Psychiatry, Tehran, Iran, Islamic Republic of|University College Dublin, Dublin, Ireland|Bologna University, Bologna, Italy|University of Modena & Reggio Emilia, Modena, Italy|Oslo University Hospital, Oslo, Norway|Wroclaw Medical University, Wroclaw, Poland|Hospital de Santa Maria, Lisboa, Portugal|Universidade Católica Portuguesa Lisboa, Lisboa, Portugal|Barcelona University, Barcelona, Spain|University Hospital Basel, Department of Psychosomatic Medicine, Basel, Basel-City, Switzerland|University of Basel, Department of Psychiatry (UPK), Basel, Switzerland|University of Exeter, Exeter, United Kingdom|University of York, York, United Kingdom",https://ClinicalTrials.gov/show/NCT04753242
NCT04695678,Epidemiological Multicohort Study of Latent COVID-19 Infections,Observational Model: Cohort|Time Perspective: Prospective,WI-2020179,"Institut für Pneumologie an der Universität zu Köln / Wissenschaftliches Institut Bethanien für Pneumologie e.V., Solingen, Nordrhein-Westfalen, Germany",https://ClinicalTrials.gov/show/NCT04695678
NCT04327674,The Use of Focused Lung Ultrasound in Patients Suspected of COVID-19,Observational Model: Cohort|Time Perspective: Prospective,COVID-FLUS,"Lungemedicinsk Forskningsafdeling. Aarhus University Hospital, Aarhus, Denmark|Regionshospitalet Horsens., Horsens, Denmark",https://ClinicalTrials.gov/show/NCT04327674
NCT04918875,Oxygen Requirements and Use in Patients With COVID-19 in LMICs,Observational Model: Cohort|Time Perspective: Prospective,CERC.0040,NA,https://ClinicalTrials.gov/show/NCT04918875
NCT04521088,Epidemiological Analysis of Ambulant Patients in a COVID-19 Outpatient Clinic,Observational Model: Cohort|Time Perspective: Prospective,WI-1252,"Institut für Pneumologie an der Universität zu Köln / Wissenschaftliches Institut Bethanien für Pneumologie e.V., Solingen, Nordrhein-Westfalen, Germany",https://ClinicalTrials.gov/show/NCT04521088
NCT04573764,Acute Effects of Oral Ketone Ester on Cardiac Function in Patients With COVID-19,"Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",H-20021500,"Bispebjerg Hospital, Copenhagen, Please Select, Denmark",https://ClinicalTrials.gov/show/NCT04573764
NCT04361981,Influence of COVID-19 Infection in Thromboembolic Venous Disease: National Cohort Study,Observational Model: Cohort|Time Perspective: Prospective,RIV-R3,"Red de Investigacion Vascular (SEACV), Madrid, Spain",https://ClinicalTrials.gov/show/NCT04361981
NCT04424797,Prone Positioning on Admission for Hospitalized COVID-19 Pneumonia Protocol,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,20-6034,"UCHealth Poudre Valley Hospital, Fort Collins, Colorado, United States|UCHealth Greeley Hospital, Greeley, Colorado, United States|UCHealth Medical Center of the Rockies, Loveland, Colorado, United States",https://ClinicalTrials.gov/show/NCT04424797
NCT04451889,Probe-based Confocal Laser Endomicroscopy in Critically Ill COVID-19 Patients,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,COVID-pCLE,"Federal Research Clinical Center FMBA Russia, Moscow, Russian Federation",https://ClinicalTrials.gov/show/NCT04451889
NCT04366050,Ramipril for the Treatment of COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",RAMIC Trial,"University of California, San Diego, La Jolla, California, United States",https://ClinicalTrials.gov/show/NCT04366050
NCT04922827,Infliximab in the Treatment of Patients With Severe COVID-19 Disease,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,ZKSJ0137_INFLIXCOVID|2021-002098-25,"Jena University Hospital, Jena, Germany",https://ClinicalTrials.gov/show/NCT04922827
NCT04561193,Investigation of Subsequent and Co-infections Associated With SARS-CoV-2 (COVID-19),Observational Model: Cohort|Time Perspective: Retrospective,033.PHA.2020.A,"Methodist Dallas Medical Center, Dallas, Texas, United States",https://ClinicalTrials.gov/show/NCT04561193
NCT04591717,COVID-19 Vaccination Using a 2nd Generation (E1/E2B/E3-Deleted) Adenoviral-COVID-19 in Normal Healthy Volunteers,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,QUILT-COVID-19-hAd5-Vaccine,"Chan Soon - Shiong Institute for Medicine, El Segundo, California, United States|Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States",https://ClinicalTrials.gov/show/NCT04591717
NCT04861298,Study to Investigate the Clinical Benefits of Dietary Supplement Quercetin for Managing Early COVID-19 Symptoms at Home,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,192/RC/KEMU,"King Edward Medical University Teaching Hospital, Lahore, Punjab, Pakistan",https://ClinicalTrials.gov/show/NCT04861298
NCT04435041,Remote-by-Default Care in the COVID-19 Pandemic,Observational Model: Other|Time Perspective: Other,283196,"University of Oxford, Oxford, United Kingdom",https://ClinicalTrials.gov/show/NCT04435041
NCT04374903,Hydroxychloroquine in Combination With Azithromycin or Sirolimus for Treating COVID-19 Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,20 KHCC 74,"King Hussein Cancer Center, Amman, Jordan",https://ClinicalTrials.gov/show/NCT04374903
NCT04964024,SaRS-Cov-2 Antibodies Following Exposure to Coronavirus Disease 2019 (COVID-19) and/or Vaccination in Nursing Homes,Observational Model: Cohort|Time Perspective: Retrospective,EHPAD-COVID-19,NA,https://ClinicalTrials.gov/show/NCT04964024
NCT04884490,The Role of High Dose Co-trimoxazole in Severe Covid-19 Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",BSMMU/2021/4098(A),"Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh",https://ClinicalTrials.gov/show/NCT04884490
NCT04444271,Mesenchymal Stem Cell Infusion for COVID-19 Infection,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,NIBMT-MSc-COVID-2020,"NIBMT, Rawalpindi, Punjab, Pakistan",https://ClinicalTrials.gov/show/NCT04444271
NCT04341675,Sirolimus Treatment in Hospitalized Patients With COVID-19 Pneumonia,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",2020-0337,"Loyola University Medical Center, Chicago, Illinois, United States|University of Cincinnati, Cincinnati, Ohio, United States",https://ClinicalTrials.gov/show/NCT04341675
NCT04604327,Comparison of Two Different Doses of Bemiparin in COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,BEMICOP,"Hospital Rey Juan Carlos, Móstoles, Madrid, Spain|Clinica Universidad de Navarra, Pamplona, Navarra, Spain|Hospital Clinic, Barcelona, Spain|Hospital Sant Pau, Barcelona, Spain|Hospital Universitario Bellvitge, L'Hospitalet De Llobregat, Spain|Fundación Jiménez Díaz, Madrid, Spain|Hospital Clínico San carlos, Madrid, Spain|Hospital Universitario La Paz, Madrid, Spain|Complejo Hospitalario de Navarra, Pamplona, Spain|Hospital Universitario de Salamanca, Salamanca, Spain|Complejo Hospitalario de Toledo, Toledo, Spain|Hospital Universitario Río Hortega, Valladolid, Spain",https://ClinicalTrials.gov/show/NCT04604327
NCT04890509,A Study of Bemcentinib for the Treatment of COVID-19 in Hospitalised Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,BGBC020,"Nirmal Hospital Private Limited, Surat, Gujarat, India|Kasturba Medical College, Mangalore, Karnataka, India|JSS Hospital, Mysuru, Karnataka, India|Chopda Medicare & Research Centre Pvt. Ltd (CMARC) - Magnum Heart Institute, Nashik, Maharashtra, India|Sahyadri Specialty Hospital, Pune, Maharastra, India|Krishna Institute of Medical Sciences (KIMS Hospitals), Secunderabad, Telangana, India|Maulana Azad Medical College, New Delhi, India",https://ClinicalTrials.gov/show/NCT04890509
NCT04665752,Ocular Findings and Viral Persistence in Ocular Fluids in COVID-19 Survivors,Observational Model: Cohort|Time Perspective: Prospective,10000078|000078-EI,"National Institutes of Health Clinical Center, Bethesda, Maryland, United States",https://ClinicalTrials.gov/show/NCT04665752
NCT04451174,Early Use of Corticosteroids in Non-critical Patients With COVID-19 Pneumonia,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,2092,"Hospital Santiago Oriente, Santiago, Peñalolen, Chile",https://ClinicalTrials.gov/show/NCT04451174
NCT04329923,The PATCH Trial (Prevention And Treatment of COVID-19 With Hydroxychloroquine),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",842838,"University of Pennsylvania, Philadelphia, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04329923
NCT04394416,Trial of Imatinib for Hospitalized Adults With COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2038GCCC,"University of Maryland Medical Center, Baltimore, Maryland, United States",https://ClinicalTrials.gov/show/NCT04394416
NCT04397757,COVID-19 Convalescent Plasma for the Treatment of Hospitalized Patients With Pneumonia Caused by SARS-CoV-2.,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,843003 (PennCCP-02),"Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04397757
NCT04313322,Treatment of COVID-19 Patients Using Wharton's Jelly-Mesenchymal Stem Cells,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,COVID-19,"Stem Cells Arabia, Amman, Jordan",https://ClinicalTrials.gov/show/NCT04313322
NCT04421404,Effects of COVID-19 Convalescent Plasma (CCP) on Coronavirus-associated Complications in Hospitalized Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",20-30794,"San Francisco General Hospital, San Francisco, California, United States|UCSF Medical Center at Mount Zion, San Francisco, California, United States|University of California, San Francisco Medical Center (Parnassus Campus), San Francisco, California, United States",https://ClinicalTrials.gov/show/NCT04421404
NCT04852289,A Clinical Observational Study of SARS-CoV-2 Specific CD8 T-Cell Responses to COVID-19 Vaccines in Humans,Observational Model: Cohort|Time Perspective: Prospective,10000383|000383-AG,"National Institute of Aging, Clinical Research Unit, Baltimore, Maryland, United States|NIH/NIA/Biomedical Research Center at Johns Hopkins Bayview campus, Baltimore, Maryland, United States",https://ClinicalTrials.gov/show/NCT04852289
NCT04666441,COVID-19 Study Assessing the Virologic Efficacy of REGN10933+REGN10987 Across Different Dose Regimens in Adult Outpatients With SARS-CoV-2 Infection,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",R10933-10987-COV-20145,"Regeneron Study Site, Mesa, Arizona, United States|Regeneron Study Site, Tucson, Arizona, United States|Regeneron Study Site, Canoga Park, California, United States|Regeneron Study Site, Long Beach, California, United States|Regeneron Study Site, Los Angeles, California, United States|Regeneron Study Site, Rolling Hills Estates, California, United States|Regeneron Study Site, San Francisco, California, United States|Regeneron Study Site, Santa Monica, California, United States|Regeneron Study Site, Stanford, California, United States|Regeneron Study Site, Colorado Springs, Colorado, United States|Regeneron Study Site, Washington, District of Columbia, United States|Regeneron Study Site, DeLand, Florida, United States|Regeneron Study Site, Fort Pierce, Florida, United States|Regeneron Study Site, Hialeah, Florida, United States|Regeneron Study Site, Hialeah, Florida, United States|Regeneron Study Site, Maitland, Florida, United States|Regeneron Study Site, Miami, Florida, United States|Regeneron Study Site, Miami, Florida, United States|Regeneron Study Site, Saint Petersburg, Florida, United States|Regeneron Study Site, Tampa, Florida, United States|Regeneron Study Site, West Palm Beach, Florida, United States|Regeneron Study Site, Winter Haven, Florida, United States|Regeneron Study Site, Winter Park, Florida, United States|Regeneron Study Site, Atlanta, Georgia, United States|Regeneron Study Site, Columbus, Georgia, United States|Regeneron Study Site, Downers Grove, Illinois, United States|Regeneron Study Site, Ames, Iowa, United States|Regeneron Study Site, Iowa City, Iowa, United States|Regeneron Study Site, Lake Charles, Louisiana, United States|Regeneron Study Site, Marrero, Louisiana, United States|Regeneron Study Site, Shreveport, Louisiana, United States|Regeneron Study Site, Baltimore, Maryland, United States|Regeneron Study Site, Las Vegas, Nevada, United States|Regeneron Study Site, Teaneck, New Jersey, United States|Regeneron Study Site, Bronx, New York, United States|Regeneron Study Site, New York, New York, United States|Regeneron Study Site, Charlotte, North Carolina, United States|Regeneron Study Site, Durham, North Carolina, United States|Regeneron Study Site, Wilmington, North Carolina, United States|Regeneron Study Site, Columbus, Ohio, United States|Regeneron Study Site, Dayton, Ohio, United States|Regeneron Study Site, Dayton, Ohio, United States|Regeneron Study Site, Philadelphia, Pennsylvania, United States|Regeneron Study Site, Charleston, South Carolina, United States|Regeneron Study Site, Clinton, South Carolina, United States|Regeneron Study Site, Amarillo, Texas, United States|Regeneron Study Site, Corpus Christi, Texas, United States|Regeneron Study Site, Houston, Texas, United States|Regeneron Study Site, Houston, Texas, United States|Regeneron Study Site, Houston, Texas, United States|Regeneron Study Site, Houston, Texas, United States|Regeneron Study Site, Pearland, Texas, United States|Regeneron Study Site, Red Oak, Texas, United States|Regeneron Study Site, San Antonio, Texas, United States|Regeneron Study Site, Splendora, Texas, United States|Regeneron Study Site, Tyler, Texas, United States|Regeneron Study Site, Falls Church, Virginia, United States",https://ClinicalTrials.gov/show/NCT04666441
NCT04361643,Low-dose Lenalidomide for Non-severe COVID-19 Treatment Trial,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",COVID19-EC01,"Hospital Universitario de Getafe, Getafe, Spain",https://ClinicalTrials.gov/show/NCT04361643
NCT04801017,A Study to Evaluate the Safety and Efficacy of OT-101+Artemisinin in Hospitalized COVID-19 Subjects,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",C002 2020 01,"Praxis Pesquisa Medica S / S Ltda, Jardim, Brazil",https://ClinicalTrials.gov/show/NCT04801017
NCT04455243,Inflammatory Regulation Effect of NAC on COVID-19 Treatment,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",E-20-4934,NA,https://ClinicalTrials.gov/show/NCT04455243
NCT04318418,"ACE Inhibitors, Angiotensin II Type-I Receptor Blockers and Severity of COVID-19",Observational Model: Cohort|Time Perspective: Retrospective,DEP_012020,"IRCCS Neuromed, Department of Epidemiology and Prevention, Pozzilli, Italy",https://ClinicalTrials.gov/show/NCT04318418
NCT04463602,Desidustat in the Management of COVID-19 Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,DESI.20.004,"Avant Sante Site 1, Monterrey, Mexico",https://ClinicalTrials.gov/show/NCT04463602
NCT04285801,Critically Ill Patients With COVID-19 in Hong Kong: a Multicentre Observational Cohort Study,Observational Model: Case-Only|Time Perspective: Retrospective,2020.059,"Pamela Youde Nethersole Eastern Hospital, Hong Kong, Hong Kong|Prince of Wales Hospital, Hong Kong, Hong Kong|Princess Margaret Hospital, Hong Kong, Hong Kong",https://ClinicalTrials.gov/show/NCT04285801
NCT04679584,COVIDOM: Longterm Morbidity of SARS-CoV-2 Infection and COVID-19 Disease - Consequences for Health Status and Quality of Life,Observational Model: Cohort|Time Perspective: Prospective,COVIDOM-Protokoll_V01F_2020-10|DRKS00023742,"University Hospital Wuerzburg, Würzburg, Bavaria, Germany|University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Schleswig-Holstein, Germany|University Hospital Charité Berlin, Berlin, Germany",https://ClinicalTrials.gov/show/NCT04679584
NCT04333628,Chloroquine for Mild Symptomatic and Asymptomatic COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,EMC 0045-20,"Haemek Medical Center, Afula, Israel",https://ClinicalTrials.gov/show/NCT04333628
NCT04480424,Study to Evaluate the Safety and Efficacy of High Dose Intravenous Immune Globulin (IVIG) Plus Standard Medical Treatment (SMT) Versus SMT Alone in Participants in Intensive Care Unit (ICU) With Coronavirus Disease (COVID-19),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,GC2007,"Chandler Regional Medical Center, Chandler, Arizona, United States|Southern California Research Center, Coronado, California, United States|University of Illinois at Chicago, Chicago, Illinois, United States|Via Christi Research, Wichita, Kansas, United States|University of Louisville, Louisville, Kentucky, United States|Louisiana State University Health Sciences Center, Shreveport, Louisiana, United States|McLaren Flint, Flint, Michigan, United States|McLaren Health Care-Macomb, Mount Clemens, Michigan, United States|McLaren Health Care Oakland, Pontiac, Michigan, United States|CHI Health, Omaha, Nebraska, United States|Columbia University Medical Center, New York, New York, United States|Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States|Summa Health, Akron, Ohio, United States|Temple University Hospital, Philadelphia, Pennsylvania, United States|Allegheny Health Network Research Institute, Pittsburgh, Pennsylvania, United States|CHRISTUS Health, Tyler, Texas, United States|MultiCare Deaconess Hospital, Spokane, Washington, United States|MultiCare Tacoma General Hospital, Tacoma, Washington, United States",https://ClinicalTrials.gov/show/NCT04480424
NCT04330599,Longitudinal Population-based Observational Study of COVID-19 in the UK Population,Observational Model: Cohort|Time Perspective: Prospective,COVIDENCE UK,"Queen Mary University of London, London, County (optional), United Kingdom",https://ClinicalTrials.gov/show/NCT04330599
NCT04412772,Trial of Tocilizumab for Treatment of Severe COVID-19: ARCHITECTS,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",RA-2020-019,"Queen's Medical Center, Honolulu, Hawaii, United States",https://ClinicalTrials.gov/show/NCT04412772
NCT04493307,The Evaluation of Hemostasis in Hospitalized COVID-19 Patients,Observational Model: Other|Time Perspective: Prospective,1602903,"Sinai Center for Thrombosis Research, Baltimore, Maryland, United States",https://ClinicalTrials.gov/show/NCT04493307
NCT04365738,Pulmonary Rehabilitation in Post-Acute Period of COVID-19 Infection,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Treatment,PR COVID-19,"Istanbul Bilgi University, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04365738
NCT04372628,Trial of Early Therapies During Non-hospitalized Outpatient Window for COVID-19,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",200827,"University of Colorado School of Medicine, Aurora, Colorado, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|Oregon Health & Science University, Portland, Oregon, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|University of Wisconsin, Madison, Wisconsin, United States",https://ClinicalTrials.gov/show/NCT04372628
NCT04354597,Hydroxychloroquine and Azithromycin as Prophylaxis for Healthcare Workers Dealing With COVID19 Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,20 KHCC 67,"King Hussein Cancer Center, Amman, Jordan",https://ClinicalTrials.gov/show/NCT04354597
NCT04429763,Safety and Efficacy of Mesenchymal Stem Cells in the Management of Severe COVID-19 Pneumonia,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",202001,NA,https://ClinicalTrials.gov/show/NCT04429763
NCT04706143,Immunologic Responses to Single and Double Doses of COVID-19 Vaccines in Egyptians,Observational Model: Cohort|Time Perspective: Prospective,AssiutU21,NA,https://ClinicalTrials.gov/show/NCT04706143
NCT04427865,Utility of Lactoferrin as a Preventive Agent for Healthcare Workers Exposed to COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,CUKA-002,NA,https://ClinicalTrials.gov/show/NCT04427865
NCT04541979,Aerosoliserat DNase for Treatment of Respiratory Failure in Severe COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,NETSC-19,"Lund ED, Lund, Sweden",https://ClinicalTrials.gov/show/NCT04541979
NCT04341389,A Phase II Clinical Trial to Evaluate the Recombinant Vaccine for COVID-19 (Adenovirus Vector),"Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention",JSVCT089,"Hubei Provincial Center for Disease Control and Prevention, Wuhan, Hubei, China",https://ClinicalTrials.gov/show/NCT04341389
NCT04514627,Neuromodulation With Percutaneous Electrical Nerve Field Stimulation for Adults With COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",1600899,"Olive View-UCLA Medical Center, Sylmar, California, United States",https://ClinicalTrials.gov/show/NCT04514627
NCT04805671,Evaluation of ADG20 for the Treatment of Mild or Moderate COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",ADG20-TRMT-001,NA,https://ClinicalTrials.gov/show/NCT04805671
NCT04421027,A Study of Baricitinib (LY3009104) in Participants With COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",17830|I4V-MC-KHAA|2020-001517-21,"Dignity Health Mercy Gilbert Medical Center, Gilbert, Arizona, United States|Valleywise Health, Phoenix, Arizona, United States|St Joseph's Hospital and Medical Center, Phoenix, Arizona, United States|Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States|Sharp Memorial Hospital, San Diego, California, United States|San Francisco VA Medical Center, San Francisco, California, United States|Torrance Memorial Medical Center, Torrance, California, United States|Holy Cross Hospital Inc., Fort Lauderdale, Florida, United States|Westchester General Hospital, Miami, Florida, United States|Grady Health System, Atlanta, Georgia, United States|Atlanta VA Medical Center, Decatur, Georgia, United States|Great Lakes Clinical Trials, Chicago, Illinois, United States|Parkview Regional Medical Center, Fort Wayne, Indiana, United States|Community Hospital South, Indianapolis, Indiana, United States|Franciscan St. Francis Health, Indianapolis, Indiana, United States|South Shore Hospital, Weymouth, Massachusetts, United States|Henry Ford Hospital, Detroit, Michigan, United States|Renown Regional Med. Center, Reno, Nevada, United States|SUNY Downstate, Brooklyn, New York, United States|East Carolina University, Greenville, North Carolina, United States|OSU Med Intl Med Houston Ctr, Tulsa, Oklahoma, United States|Oregon Health and Science University, Portland, Oregon, United States|Temple Univ School of Med, Philadelphia, Pennsylvania, United States|Swedish Medical Center, Seattle, Washington, United States|MultiCare Good Samaritan Hospital, Tacoma, Washington, United States|Sanatorio Sagrado Corazón, Ciudad de Buenos Aires, AR, Argentina|ClÃ-nica Zabala, Ciudad de Buenos Aires, AR, Argentina|Hospital Z.G.A.D ""Evita Pueblo"", Berazategui, Buenos Aires, Argentina|Sanatorio de la Trinidad Mitre, Caba, Buenos Aires, Argentina|Fundacion Sanatorio Guemes, Caba, Buenos Aires, Argentina|Casa Hospital San Juan de Dios, Ramos Mejía, Buenos Aires, Argentina|Hospital Interzonal General de Agudos ""Eva Peron"", San Martin, Buenos Aires, Argentina|Clinica Adventista Belgrano, Caba, Ciudad Autónoma De Buenos Aire, Argentina|Clinica Central S.A., Villa Regina, Rio Negro, Argentina|Clinica Viedma, Viedma, Río Negro, Argentina|Hospital San Roque, Cordoba, Argentina|Hospital Felício Rocho, Belo Horizonte, Minas Gerais, Brazil|Centro Hospitalar de Reabilitacao Ana Carolina Moura Xavier, Curitiba, Parana, Brazil|CEPETI Centro de Ensino e Pesquisa em Terapia Intensiva, Curitiba, Paraná, Brazil|CPCLIN, Natal, Rio Grande Do Norte, Brazil|Hospital de Clinicas de Porto Alegre, Porto Alegre, RS, Brazil|Hospital Carlos Fernando Malzoni Matao, Matao, Sao Paulo, Brazil|Pesquisare, Santo Andre, Sao Paulo, Brazil|Praxis Pesquisa Medica, Santo André, Sao Paulo, Brazil|Faculdade de Medicina do ABC, Santo Andre, SP, Brazil|Upeclin - Unidade de Pesquisa Clínica da Faculdade de Medicina de Botucatu - UNESP, Botucatu, São Paulo, Brazil|IPECC - Instituto de Pesquisa Clinica de Campinas, Campinas, São Paulo, Brazil|Hospital PUC-CAMPINAS, Campinas, São Paulo, Brazil|CECIP - Centro de Estudos do Interior Paulista, Jaú, São Paulo, Brazil|CEMEC - Centro Multidisciplinar de Estudos Clinicos EPP Ltda, São Bernardo do Campo, São Paulo, Brazil|Real e Benemerita Associação Portuguesa de Beneficiencia, São Paulo, Brazil|Hospital Alemão Oswaldo Cruz, São Paulo, Brazil|Universidade Federal de São Paulo - Escola Paulista de Medicina, São Paulo, Brazil|Hospital Santa Paula, São Paulo, Brazil|Casa de Saude Santa Marcelina - Centro de Pesquisa Clinica, São Paulo, Brazil|Universitätsklinikum Erlangen, Erlangen, Bayern, Germany|Klinikum Rechts der Isar der TU München, München, Bayern, Germany|Universitätsklinikum Schleswig-Holstein, Kiel, Schleswig-Holstein, Germany|Klinikum Chemnitz gGmbH, Chemnitz, Germany|Sir Ganga Ram Hospital, New Delhi, Delhi, India|Unity Hospital, Surat, Gujarat, India|Medanta-The Medicity, Gurgaon, Haryana, India|Government Medical College (GMC) Aurangabad, Aurangabad, Maharashtra, India|Government Medical College, Nagpur, Maharashtra, India|Ruby Hall Clinic and Grant Medical Foundation, Pune, Maharashtra, India|Medica Superspecialty Hospital, Kolkata, West Bengal, India|Aakash Healthcare Super Speciality Hospital, New Delhi, India|INMI Lazzaro Spallanzani, Roma, Rome, Italy|Ospedale Niguarda Ca Granda, Milano, Italy|Nuovo Ospedale di Prato S. Stefano, Prato, Italy|Yokohama Municipal Citizen's Hospital, Yokohama, Kanagawa, Japan|Edogawa Medicare Hospital, Edogawa-ku, Tokyo, Japan|Tokyo Medical University Hachioji Medical Center, Hachioji, Tokyo, Japan|Korea University Ansan Hospital, Ansan-si, Gyeonggi-do, Korea, Republic of|Ajou University Hospital, Suwon, Gyeonggi-do, Korea, Republic of|Seoul National University Boramae Medical Center, Seoul, Seoul, Korea, Korea, Republic of|Seoul Medical Center, Seoul, Korea, Republic of|Instituto Nacional de Cardiologia Ignacio Chavez, Mexico, DF, Mexico|Instituto Nacional de Enfermedades Respiratorias, Mexico, DF, Mexico|Instituto Nacional de Cancerologia, Mexico City, FD, Mexico|Hospital General Agustín O'Horán, Yucatan, Merida, Mexico|ITESM Campus Monterrey, Monterrey, Nuevo Leon, Mexico|Hospital Universitario ""Dr. Jose Eleuterio Gonzalez"", Monterrey, Nuevo León, Mexico|Instituto Nacional de Ciencias Medicas y Nutrici Salva Zubir, Federal District, Mexico|Advanced Clinical Research, LLC, Bayamon, Puerto Rico|City Clinical Hospital #15 named after O.M. Filatov, Moscow, Russian Federation|First Moscow State Medical University n.a. Sechenov, Moscow, Russian Federation|Saint-Petersburg City Pokrovskaya Hospital, Saint-Petersburg, Russian Federation|Hospital Txagorritxu, Vitoria, Alava, Spain|Hospital Universitario Quironsalud Madrid, Pozuelo de Alarcon, Madrid, Spain|Hospital Universitario Infanta Leonor-INTERNAL MED, Madrid, Spain|Hospital Clinico San Carlos, Madrid, Spain|Hospital Clínico Universitario de Valencia, Valencia, Spain|The Royal Cornwall Hospital, Truro, Cornwall, United Kingdom|Barnet Hospital, Barnet, Herts, United Kingdom|St. George's University Hospitals NHS Foundation Trust, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04421027
NCT04304053,Treatment of COVID-19 Cases and Chemoprophylaxis of Contacts as Prevention,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,HCQ4COV19|2020-001031-27,"Departament de Salut, Barcelona, Spain",https://ClinicalTrials.gov/show/NCT04304053
NCT04380792,Prevalence of DVT or PE in Patients Infected With COVID-19 Admitted to Hospital,Observational Model: Other|Time Perspective: Retrospective,SCREENING042020,"Manuel Monreal, Badalona, Barcelona, Spain",https://ClinicalTrials.gov/show/NCT04380792
NCT04376879,Predicting the Need for Intubation in Hospitalised COVID-19 Patients (PRED ICU COVID19),Observational Model: Cohort|Time Perspective: Prospective,2020-A01076-33,"Louis Mourier hospital (AP-HP), Colombes, France|Brabois Hospital (CHRU de Nancy), Vandœuvre-lès-Nancy, France",https://ClinicalTrials.gov/show/NCT04376879
NCT04361500,Registry of COVID-19 Patients Treated With the Seraph 100 Microbind Affinity Blood Filter,Observational Model: Case-Only|Time Perspective: Prospective,COSA-8998,"Academic Teaching Hospital Brunswick, Brunswick, Lower Saxony, Germany|Hannover Medical School, Hannover, Germany",https://ClinicalTrials.gov/show/NCT04361500
NCT04355143,Colchicine to Reduce Cardiac Injury in COVID-19 (COLHEART-19),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,20-000685,"UCLA Ronald Reagan Medical Center, Los Angeles, California, United States|UCLA Santa Monica Hospital, Santa Monica, California, United States",https://ClinicalTrials.gov/show/NCT04355143
NCT04484545,Prognostic Factors in Patients Admitted to an Urban Teaching Hospital With COVID-19 Infection,Observational Model: Cohort|Time Perspective: Retrospective,IRAS 282807,"Glasgow Royal Infirmary, Glasgow, United Kingdom",https://ClinicalTrials.gov/show/NCT04484545
NCT04751604,Improvement of the Nutritional Status Regarding Nicotinamide (Vitamin B3) and the Disease Course of COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Other",A 107/20,"University Hospital Schleswig-Holstein, Kiel, Schleswig-Holstein, Germany",https://ClinicalTrials.gov/show/NCT04751604
NCT04586153,Study to Assess the Effect of Meplazumab on COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",MPZ-II-02,NA,https://ClinicalTrials.gov/show/NCT04586153
NCT04362085,Coagulopathy of COVID-19: A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,RAPID COVID-COAG,"St. Michael's Hospital, Toronto, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04362085
NCT04351620,High-dose Hydroxychloroquine for the Treatment of Ambulatory Patients With Mild COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,IRB20-0572,"University of Chicago, Chicago, Illinois, United States",https://ClinicalTrials.gov/show/NCT04351620
NCT04372004,Comparison of the Efficacy of Rapid Tests to Identify COVID-19 Infection (CATCh COVID-19),Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,TCAI_CATCH COVID-19,"Texas Cardiac Arrhythmia Institute, Austin, Texas, United States",https://ClinicalTrials.gov/show/NCT04372004
NCT04319315,Social Media Effect on Knowledge Dissemination During COVID-19 Virus Outbreak,Observational Model: Other|Time Perspective: Prospective,AssiutU-3-2020,"Assiut University Hospitals, Assiut, Egypt",https://ClinicalTrials.gov/show/NCT04319315
NCT04360278,Plasma Collection From Convalescent and/or Immunized Donors for the Treatment of COVID-19,Observational Model: Cohort|Time Perspective: Prospective,200092|20-CC-0092,"National Institutes of Health Clinical Center, Bethesda, Maryland, United States",https://ClinicalTrials.gov/show/NCT04360278
NCT04433026,"BNP, Serum Troponin and D-dimer as Risk Factors in Patients With COVID-19",Observational Model: Case-Only|Time Perspective: Retrospective,Cardiac markers in COVID-19,NA,https://ClinicalTrials.gov/show/NCT04433026
NCT04363216,Pharmacologic Ascorbic Acid as an Activator of Lymphocyte Signaling for COVID-19 Treatment,Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,JT#15681,NA,https://ClinicalTrials.gov/show/NCT04363216
NCT04583592,Camostat Efficacy vs. Placebo for Outpatient Treatment of COVID-19 (CAMELOT),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",NI03-CV19-001,"Palmtree Clinical Research, Inc. (Site 125), Palm Springs, California, United States|Synergy Healthcare, LLC (Site 124), Bradenton, Florida, United States|Clinical Research of Brandon, LLC (Site 123), Brandon, Florida, United States|Reliable Clinical Research, LLC (Site 100), Hialeah, Florida, United States|A+ Research (Site 112), Miami, Florida, United States|NextPhase Research Alliance at CANO HEALTH (Site 107), Miami, Florida, United States|Ezy Medical Research (Site 106), Miami, Florida, United States|Eminat LLC (Site 117), Plantation, Florida, United States|Invictus Clinical Research Group, LLC (Site 101), Pompano Beach, Florida, United States|Visionaries Clinical Research, LLC (Site 121), Atlanta, Georgia, United States|Family Care Research (Site 114), Boise, Idaho, United States|Cedar Crosse Research Center (Site 122), Chicago, Illinois, United States|Massachusetts General Hospital (Site 110), Boston, Massachusetts, United States|Oakland Medical Research Center (Site 108), Troy, Michigan, United States|Cary Research Group (Site 111), Cary, North Carolina, United States|Onsite Solutions (Site 118), Charlotte, North Carolina, United States|STAT Research (Site 109), Springboro, Ohio, United States|Toledo Institute of Clinical Research, Inc.(Site 105), Toledo, Ohio, United States|Advanced Medical Trials (Site 104), Georgetown, Texas, United States|Next Innovative Clinical Research (Site 115), Houston, Texas, United States|Rio Grand Valley Clinical Research Institute (Site 120), Pharr, Texas, United States",https://ClinicalTrials.gov/show/NCT04583592
NCT04403386,"Prospective Natural History Study of Smoking, Immune Cell Profiles, Epigenetics and COVID-19",Observational Model: Cohort|Time Perspective: Prospective,200108|20-E-0108,"NIEHS Clinical Research Unit (CRU), Research Triangle Park, North Carolina, United States",https://ClinicalTrials.gov/show/NCT04403386
NCT04839965,Study of Intravenous Ampion in Adult COVID-19 Patients Requiring Supplemental Oxygen,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",AP-017,"Ampio Pharmaceuticals, Englewood, Colorado, United States",https://ClinicalTrials.gov/show/NCT04839965
NCT04334382,Hydroxychloroquine vs. Azithromycin for Outpatients in Utah With COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,1051360,"Intermountain Medical Center, Murray, Utah, United States|University of Utah, Salt Lake City, Utah, United States",https://ClinicalTrials.gov/show/NCT04334382
NCT04424849,Thorax Computed Tomography Severity Score and Outcome in COVID-19 Patients,Observational Model: Cohort|Time Perspective: Retrospective,2020/5/4,"Tepecik Training and Research Hospital, Izmir, Izmir, Konak, Turkey",https://ClinicalTrials.gov/show/NCT04424849
NCT04552951,Effect of Vitamin D on Morbidity and Mortality of the COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment",2020-019-PF-CAANJ,"Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain",https://ClinicalTrials.gov/show/NCT04552951
NCT04438057,Evaluating the Efficacy of Convalescent Plasma in Symptomatic Outpatients Infected With COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,MIDC-CCP,"Metro Infectious Disease Consultants, Burr Ridge, Illinois, United States",https://ClinicalTrials.gov/show/NCT04438057
NCT04494724,Clazakizumab vs. Placebo - COVID-19 Infection,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",Pro00025969,"Houston Methodist Hospital, Houston, Texas, United States",https://ClinicalTrials.gov/show/NCT04494724
NCT04367662,Study of the Vascular Compartment and Hypercoagulability During Coronavirus Infection COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,2020/0104/OB,"Rouen University Hospital, Rouen, France",https://ClinicalTrials.gov/show/NCT04367662
NCT04747158,COVID-19 Convalescent Plasma Therapy,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,PINV20-388,"Facultad de Ciencias Médicas - Universidad Nacional de Asunción, Asunción, Paraguay",https://ClinicalTrials.gov/show/NCT04747158
NCT04473118,Assessment of Mental Health in Healthcare Workers Exposed to COVID-19 Patients,Observational Model: Cohort|Time Perspective: Prospective,MRC-05-017,"Hamad Medical Corporation, Doha, Qatar",https://ClinicalTrials.gov/show/NCT04473118
NCT04690387,"Dendritic Cell Vaccine, AV-COVID-19, to Prevent COVID-19 Infection",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,CL-COV-P01-ID,"Rumah Sakit Umum Pusat Dr. Kariadi, Semarang, Jawa Tengah, Indonesia",https://ClinicalTrials.gov/show/NCT04690387
NCT04583761,Tobacco and Nicotine Consumption and the Risk of Acquisition of Coronavirus Disease 2019 (COVID-19),Observational Model: Cohort|Time Perspective: Prospective,APHP200663,"Hotel-Dieu Hospital, Paris, France",https://ClinicalTrials.gov/show/NCT04583761
NCT04463420,Safety and Efficacy of PHR 160 Spray on the Outcomes of Patients With COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",IR.BMSU.REC.1399.176,"Mohammad Sadegh Bagheri Baghdasht, Tehran, Iran, Islamic Republic of",https://ClinicalTrials.gov/show/NCT04463420
NCT04410159,Povidone-Iodine Vs Essential Oil Vs Tap Water Gargling For COVID-19 Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,USIMalaysia,"Universiti Kebangsaan Malaysia Medical Centre, Bandar Tun Razak, Wilayah Persekutuan Kuala Lumpur, Malaysia",https://ClinicalTrials.gov/show/NCT04410159
NCT04357990,Viruxal Oral and Nasal Spray for Treating the Symptoms of COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",KS-0470,"National Hospital of Iceland (Landspítali), Reykjavík, Iceland",https://ClinicalTrials.gov/show/NCT04357990
NCT04676971,Efficacy and Safety of hzVSF-v13 in Patients With COVID-19 Pneumonia,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",hzVSF_v13-0006,"UOC Pneumologia, Bergamo, Italy|Dipartimento di Medicina Interna, Milano, Italy|Federal Siberian Scientific and Clinical Center of the Federal Medical and Biological Agency, Krasnoyarsk, Russian Federation|Central City Hospital of Novoshakhtinsk, Novoshakhtinsk, Russian Federation|Regional Clinical Hospital, Saratov, Russian Federation|Federal State Budgetary Educational Institution of Higher Education, Ufa, Russian Federation",https://ClinicalTrials.gov/show/NCT04676971
NCT04621149,An Outpatient Study Investigating Non-prescription Treatments for COVID-19,"Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",Profact-01,"AZ Good Health Center, Tempe, Arizona, United States",https://ClinicalTrials.gov/show/NCT04621149
NCT04393311,Ulinastatin for the Treatment of COVID-19 in Hospitalized Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",56639,"Stanford University, Stanford, California, United States",https://ClinicalTrials.gov/show/NCT04393311
NCT04368013,"Host-pathogen Interactions, Immune Response, and Clinical Prognosis at COVID-19 - the CoVUm Trial",Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Screening,CoVUm,"Incectious Diseases Clinic, Umeå, Västerbotten, Sweden",https://ClinicalTrials.gov/show/NCT04368013
NCT04933799,IRAK 4 Inhibitor (PF-06650833) in Hospitalized Patients With COVID-19 Pneumonia and Exuberant Inflammation.,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",PNA-COV,"Bronx-Lebanon Hospital Center Health Care System, Bronx, New York, United States",https://ClinicalTrials.gov/show/NCT04933799
NCT04392414,Hyperimmune Convalescent Plasma in Moderate and Severe COVID-19 Disease,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,CovPlas-Covid19,"Federal Research Clinical Center of Federal Medical & Biological Agency, Moscow, Russian Federation",https://ClinicalTrials.gov/show/NCT04392414
NCT04442191,Convalescent Plasma as a Possible Treatment for COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",2020-0441,"University of Illinois at Chicago, Chicago, Illinois, United States",https://ClinicalTrials.gov/show/NCT04442191
NCT04500132,To Evaluate Safety and Efficacy of EC-18 in COVID-19 Infection to Pneumonia,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",EC-18-C201,"Chungbuk National University Hospital, Cheongju-si, Korea, Republic of",https://ClinicalTrials.gov/show/NCT04500132
NCT04358211,Expanded Access to Convalescent Plasma to Treat and Prevent Pulmonary Complications Associated With COVID-19,NA,2020-595,"Tulane Medical Center, New Orleans, Louisiana, United States",https://ClinicalTrials.gov/show/NCT04358211
NCT04362189,Efficacy and Safety Study of Allogeneic HB-adMSCs for the Treatment of COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",HBCOV03,"River Oaks Hospital and Clinics, Houston, Texas, United States|United Memorial Medical Center, Houston, Texas, United States",https://ClinicalTrials.gov/show/NCT04362189
NCT04924894,Determinants of Obtaining Covid Vaccination Among Health Care Workers,Observational Model: Case-Crossover|Time Perspective: Cross-Sectional,Attitude towards COVID vaccine,NA,https://ClinicalTrials.gov/show/NCT04924894
NCT04483908,COVID-19 in Baselland: Investigation and Validation of Serological Diagnostic Assays and Epidemiological Study of Sars-CoV-2 Specific Antibody Responses,Observational Model: Cohort|Time Perspective: Prospective,BASEC Project-ID 2020-00816,"Department of Health, Economics and Health Directorate Canton Basel-Land, Liestal, Switzerland",https://ClinicalTrials.gov/show/NCT04483908
NCT04927442,Natural History Study of COVID-19 Using Digital Wearables,Observational Model: Cohort|Time Perspective: Prospective,10000315|000315-MD,"National Institute on Minority Health and Health Disparities (NIMHD), Bethesda, Maryland, United States",https://ClinicalTrials.gov/show/NCT04927442
NCT04583982,ImmuneSense™ COVID-19 Study,Observational Model: Cohort|Time Perspective: Prospective,PRO-00781,"Adaptive Biotechnologies Clinical Investigational Site, Secaucus, New Jersey, United States",https://ClinicalTrials.gov/show/NCT04583982
NCT04932824,Long-term Follow-up to the Phase 1 Study of Adjuvanted SARS-CoV-2 (SCB 2019) Vaccine for COVID-19.,Allocation: Non-Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,CLO-SCB-2019-002,"Linear Clinical Research, Nedlands, Territory Western Australia, Australia",https://ClinicalTrials.gov/show/NCT04932824
NCT04335136,Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",APN01-01-COVID19,"Medizinische Universität Innsbruck, Innsbruck, Austria|Kaiser Franz Josef Spital, 4. Medizinische Abteilung mit Infektions- und Tropenmedizin, Wien, Austria|Medizinische Universität Wien, Wien, Austria|The National University Hospital, Rigshospitalet, Copenhagen, Denmark|Herlev Gentofte Hospital, Herlev, Denmark|Nordsjællands Hospital, Hillerød, Denmark|Hvidovre Hospital, Hvidovre, Denmark|Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany|Klinikum rechts der Isar, Technische Universität München, München, Germany|Regional State Budgetary Educational Institution ""Clinical Hospital № 5, Barnaul"", Barnaul, Russian Federation|State Healthcare Institution ""State Clinical Hspital № 15 named after O.M. Filatov"", Moscow, Russian Federation|Moscow State Budgetary Healthcare Institution ""City Clinical Hospital №52 of Health Department of Moscow"", Moscow, Russian Federation|Moscow State Budgetary Healthcare Institution ""N.V. Sklifosovsky Research Institute for Emergency Medicine of Health Department of Moscow"", Moscow, Russian Federation|Saint Petersburg SBHI City Hospital 38 named after N A Semashko, Pushkin, Russian Federation|Federal State Budgetary Educational Institution of Higher Education ""Ryazan State Medical University named after I.P. Pavlov"" HD RF, Ryazan, Russian Federation|Alexandrovskaya Hospital, Saint-Petersburg, Russian Federation|Saint-Petersburg State Budget Healthcare Institution City Hospital 15, Saint-Petersburg, Russian Federation|Federal State Budgetary Educational Institution of Higher Education "" Saratov State Medical University named after V.I. Razumovsky"" HD RF, Saratov, Russian Federation|Regional State Budgetary Healthcare Institution ""Clinical Hospital №1"", Smolensk, Russian Federation|State budgetary institution of Healthcare of Tver region ""Regional clinical hospital"", Tver, Russian Federation|Yaroslavl Regional Clinical Hospital for Military Veterans - International Centre for Gerontological Problems ""Healthy Ageing"", Yaroslavl, Russian Federation|Cambridge University Hospitals NHS Trust/University of Cambridge, Cambridge, United Kingdom",https://ClinicalTrials.gov/show/NCT04335136
NCT04370236,INB03 for the Treatment of Pulmonary Complications From COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",INB03-COVID-19_01,"NEA Baptist, Jonesboro, Arkansas, United States|St. Bernard's, Jonesboro, Arkansas, United States|Jewish Hospital, Louisville, Kentucky, United States|Mississippi Baptist, Kosciusko, Mississippi, United States|Baptist Memorial Hospital-DeSoto, Southard, Missouri, United States|Richmond University Medical Center, Staten Island, New York, United States|Baptist Clinical Research Institute, Memphis, Tennessee, United States|Memorial Hermann, Houston, Texas, United States|Memorial Hermann Southeast, Houston, Texas, United States",https://ClinicalTrials.gov/show/NCT04370236
NCT04821934,Tele-rehabilitation Program After Hospitalization for COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Health Services Research,ICS Maugeri 2514 CE,"S Maugeri IRCCS, U.O. Emergenza Coronavirus di Lumezzane, Brescia, Italy|ICS Maugeri IRCCS, U.O. Emergenza Coronavirus di Tradate, Varese, Italy",https://ClinicalTrials.gov/show/NCT04821934
NCT04391127,Hydroxychloroquine and Ivermectin for the Treatment of COVID-19 Infection,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment",2020-A-09,"Jose Manuel Arreola Guerra, Aguascalientes, Mexico",https://ClinicalTrials.gov/show/NCT04391127
NCT04389645,Interferon Gamma Induced Protein 10 (IP-10) in a Clinical Decision Support Protocol in COVID-19 Patients,NA,MM-5000-BV,"Rabin Medical Center, Petach Tikva, Israel",https://ClinicalTrials.gov/show/NCT04389645
NCT04331366,Bidirectional Oxygenation Valve in the Management of Pulmonary Complications of COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,STUDY00000381,"Emory University Hospital, Atlanta, Georgia, United States|Emory St. Joseph's Hospital, Atlanta, Georgia, United States",https://ClinicalTrials.gov/show/NCT04331366
NCT04358549,Study of the Use of Favipiravir in Hospitalized Subjects With COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,FAVI-COV-US201,"HonorHealth, Scottsdale, Arizona, United States|University of Miami Miller School of Medicine, Miami, Florida, United States|Boston Medical Center, Boston, Massachusetts, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|UMass Memorial Health Care, Worcester, Massachusetts, United States|Atlantic Health System / Morristown Medical Center, Morristown, New Jersey, United States|Houston Methodist Hospital, Houston, Texas, United States",https://ClinicalTrials.gov/show/NCT04358549
NCT04457726,Part Two of Novel Adoptive Cellular Therapy With SARS-CoV-2 Specific T Cells in Patients With Severe COVID-19,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,COVID-T 2.0,"Changi General Hospital, Singapore, Singapore|KK Women's and Children's Hospital, Singapore, Singapore|National University Hospital, Singapore, Singapore|Sengkang General Hospital, Singapore, Singapore|Singapore General Hospital, Singapore, Singapore",https://ClinicalTrials.gov/show/NCT04457726
NCT04473131,Immune Profiling of COVID19-patients Admitted to ICU,Observational Model: Cohort|Time Perspective: Prospective,MRC-05-007,"Hamad Medical Corporation, Doha, Qatar",https://ClinicalTrials.gov/show/NCT04473131
NCT04330690,Treatments for COVID-19: Canadian Arm of the SOLIDARITY Trial,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2114,"Peter Lougheed Centre, Calgary, Alberta, Canada|Foothills Medical Centre, Calgary, Alberta, Canada|Rockyview General Hospital, Calgary, Alberta, Canada|South Health Campus, Calgary, Alberta, Canada|Royal Alexandra Hospital, Edmonton, Alberta, Canada|Misericordia Community Hospital, Edmonton, Alberta, Canada|University of Alberta Hopsital, Edmonton, Alberta, Canada|Grey Nuns Community Hospital, Edmonton, Alberta, Canada|Interior Health Royal Inland Hospital, Kamloops, British Columbia, Canada|Lions Gate Hospital, North Vancouver, British Columbia, Canada|Richmond Hospital, Richmond, British Columbia, Canada|Vancouver General Hospital, Vancouver Coastal Health, Univeristy of British Columbia, Vancouver, British Columbia, Canada|St Paul's Hospital, Vancouver, British Columbia, Canada|Island Health - Royal Jubilee Hospital, Victoria, British Columbia, Canada|Island Health - Victoria General Hospital, Victoria, British Columbia, Canada|Island Health - Nanaimo Regional General Hospital, Victoria, British Columbia, Canada|St. Boniface Hospital, Winnipeg, Manitoba, Canada|Health Sciences Centre, Winnipeg, Manitoba, Canada|Grace General Hospital, Winnipeg, Manitoba, Canada|Eastern Regional Health Authority, Saint John's, Newfoundland and Labrador, Canada|Nova Scotia Health Authority, Halifax, Nova Scotia, Canada|Royal Victoria Regional Health Centre, Barrie, Ontario, Canada|William Osler Health System - Brampton Civic Hospital, Brampton, Ontario, Canada|William Osler Health System - Etobicoke General Hospital, Etobicoke, Ontario, Canada|St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada|Grand River Hospital, Kitchener, Ontario, Canada|St. Mary's General Hospital, Kitchener, Ontario, Canada|St.Joseph's Health Care, London, Ontario, Canada|University Hospital, London, Ontario, Canada|Victoria Hospital, London, Ontario, Canada|Markham Stouffville Hospital, Markham, Ontario, Canada|Trillium Health Partners -Mississauga Site, Mississauga, Ontario, Canada|Trillium Health Partners-Credit Valley Hospital, Mississauga, Ontario, Canada|The Ottawa Hospital - General Campus, Ottawa, Ontario, Canada|Hôpital Montfort, Ottawa, Ontario, Canada|The Ottawa Hospital - Civic Campus, Ottawa, Ontario, Canada|Queensway Carleton Hospital, Ottawa, Ontario, Canada|Niagara Health, Saint Catharines, Ontario, Canada|Scarborough Health Network - Centenary Hospital, Scarborough, Ontario, Canada|Scarborough Health Network - General Hospital, Scarborough, Ontario, Canada|Scarborough Health Network - Birchmount Hospital, Scarborough, Ontario, Canada|Thunder Bay Regional Health Sciences Centre, Thunder Bay, Ontario, Canada|North York General Hospital, Toronto, Ontario, Canada|Humber River Hospital, Toronto, Ontario, Canada|Michael Garron Hospital, Toronto, Ontario, Canada|Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada|St. Michael's Hospital, Toronto, Ontario, Canada|Mount Sinai Hospital, Toronto, Ontario, Canada|Toronto Western Hospital, Toronto, Ontario, Canada|Unity Health Toronto - St. Joseph's Health Centre, Toronto, Ontario, Canada|CISSS de la Montérégie Centre, Greenfield Park, Quebec, Canada|Centre Hospitalier de l'Université de Montréal (CHUM), Montréal, Quebec, Canada|McGill University Health Centre-Glen Site Royal Victoria Hospital, Montréal, Quebec, Canada|CHU de Québec - Université Laval, Québec, Quebec, Canada|Institut Universitaire de Cardiologie et de Pneumologie de Québec- Université Laval, Québec, Quebec, Canada|Centre Intégré Universitaire de Santé et de Services Sociaux de l'Estrie - Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Quebec, Canada|Royal University Hospital, Saskatoon, Saskatchewan, Canada",https://ClinicalTrials.gov/show/NCT04330690
NCT04977934,"Clinical, Molecular and Functional Biomarkers for PROgnosis, Pathomechanisms and Treatment Strategies of COVID-19",Observational Model: Cohort|Time Perspective: Prospective,PROVID-PROGRESS,"Kepler Universitätsklinikukm GmbH, Med Campus III, Linz, Austria|Charité - Universitätsmedizin Berlin, Medizinische Klinik m. S. Infektiologie und Pneumologie, Berlin, Germany|Universitätsklinikum Halle (Saale), Universitätsklinik und Poliklinik für Innere Medizin III, Halle (Saale), Germany|Klinik St. Georg gGmbH; Klinik für Infektiologie, Tropenmedizin, Nephrologie und Rheumatologie, Leipzig, Germany|Universitätsklinikum Leipzig, Medizinische Klinik II - Bereich Pneumologie, Leipzig, Germany",https://ClinicalTrials.gov/show/NCT04977934
NCT04347954,PVP-I Nasal Sprays and SARS-CoV-2 Nasopharyngeal Titers (for COVID-19),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",IRB-56134,"Stanford Health Care, Stanford, California, United States",https://ClinicalTrials.gov/show/NCT04347954
NCT04359511,Efficacy and Safety of Corticosteroids in Oxygen-dependent Patients With COVID-19 Pneumonia,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,CORTI-COVID-19-HUGO|DR200136,NA,https://ClinicalTrials.gov/show/NCT04359511
NCT04679350,Efficacy and Safety of hzVSFv13 in Patients With COVID-19 Pneumonia,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",IM_hzVSF_v13-0004,"Yeungnam University Medical Center, Daegu, Korea, Republic of|Keimyung University Dongsan Hospital, Daegu, Korea, Republic of|Chungnam National University Hospital, Daejeon, Korea, Republic of",https://ClinicalTrials.gov/show/NCT04679350
NCT04317040,CD24Fc as a Non-antiviral Immunomodulator in COVID-19 Treatment (MK-7110-007),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",7110-007|20200674|CD24Fc-007|MK-7110-007,"Baptist Health Research Institute, Jacksonville, Florida, United States|Anne Anundel Medical Center, Annapolis, Maryland, United States|Institute of Human Virology, University of Maryland Baltimore, Baltimore, Maryland, United States|Shady Grove Medical Center, Rockville, Maryland, United States|White Oak Medical Center, Silver Spring, Maryland, United States|Cooper University Hospital, Camden, New Jersey, United States|Atlantic Health System, Morristown, New Jersey, United States|University Hospitals of Cleveland, Cleveland, Ohio, United States|The Ohio State University Medical Center, Columbus, Ohio, United States|University of Texas at Houston, Houston, Texas, United States",https://ClinicalTrials.gov/show/NCT04317040
NCT04756830,A Study to Assess the Safety and Immunogenicity of the Coronavac Vaccine Against COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,IDOR_VAC_01,"Hospital Gloria D'Or - Hospitais Integrados da Gavea S/A, Rio De Janeiro, Brazil|D'Or Institute for Research and Education, Rio De Janeiro, Brazil",https://ClinicalTrials.gov/show/NCT04756830
NCT04456452,Study of Ampion for the Treatment of Adult COVID-19 Patients Requiring Oxygen Supplementation,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,AP-016,"Research Site, Colorado Springs, Colorado, United States",https://ClinicalTrials.gov/show/NCT04456452
NCT04396106,Safety and Efficacy of AT-527 in Subjects With Moderate Coronavirus Disease (COVID-19),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",AT-03A-001,"Atea Study Site, Scottsdale, Arizona, United States|Atea Study Site, Davis, California, United States|Atea Study Site, Los Angeles, California, United States|Atea Study Site, Washington, District of Columbia, United States|Atea Study Site, Orlando, Florida, United States|Atea Study Site, Atlanta, Georgia, United States|Atea Study Site, Chicago, Illinois, United States|Atea Study Site, Chicago, Illinois, United States|Atea Study Site, Boston, Massachusetts, United States|Atea Study Site, Butte, Montana, United States|Atea Study Site, Charlotte, North Carolina, United States|Atea Study Site, Cincinnati, Ohio, United States|Atea Study Site, Columbus, Ohio, United States|Atea Study Site, Charleston, South Carolina, United States|Atea Study Site, Columbia, South Carolina, United States|Atea Study Site, Brussels, Belgium|Atea Study Site, Mechelen, Belgium|Atea Study Site, Belo Horizonte, Brazil|Atea Study Site, Brasília, Brazil|Atea Study Site, Campo Largo, Brazil|Atea Study Site, Porto Alegre, Brazil|Atea Study Site, São Paulo, Brazil|Atea Study Site, Chisinau, Moldova, Republic of|Atea Study Site, Bucharest, Romania|Atea Study Site, Bloemfontein, South Africa|Atea Study Site, Cape Town, South Africa|Atea Study Site, Centurion, South Africa|Atea Study Site, George, South Africa|Atea Study Site, Worcester, South Africa|Atea Study Site, Brovary, Ukraine|Atea Study Site, Kyiv, Ukraine",https://ClinicalTrials.gov/show/NCT04396106
NCT04331795,"Tocilizumab to Prevent Clinical Decompensation in Hospitalized, Non-critically Ill Patients With COVID-19 Pneumonitis",Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,IRB20-0515,"University of Chicago Medicine, Chicago, Illinois, United States",https://ClinicalTrials.gov/show/NCT04331795
NCT04549337,Feasibility and Safety of High-intensity Exercise Training in Patients Surviving COVID-19,"Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Prevention",H-20033733|75068,"Rigshospitalet, Copenhagen, Denmark",https://ClinicalTrials.gov/show/NCT04549337
NCT04308317,Tetrandrine Tablets Used in the Treatment of COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,TT-NPC,"Tetrandrine Tablets, Jinhua, Zhejiang, China",https://ClinicalTrials.gov/show/NCT04308317
NCT04333225,Hydroxychloroquine in the Prevention of COVID-19 Infection in Healthcare Workers,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,020-132,"Baylor University Medical Center, Dallas, Texas, United States",https://ClinicalTrials.gov/show/NCT04333225
NCT04822701,A Study to Test BI 767551 in People With Mild to Moderate Symptoms of COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",1487-0001|2020-005588-29,"Ocean Blue Medical Research Center, Inc., Miami Springs, Florida, United States|Pharmatex Research, Amarillo, Texas, United States|Advanced Surgeons and Physicians Network, Houston, Texas, United States|Crossroads Clinical Research, Victoria, Texas, United States|RespiSom, Erpent, Belgium|emovis GmbH, Berlin, Germany|Universitätsklinikum Köln (AöR), Köln, Germany|Erasmus Medisch Centrum, Rotterdam, Netherlands|HPP Hospital de Cascais Dr José Almeida, Alcabideche, Portugal|Hospital da Luz Setúbal, Setúbal, Portugal|Hospital da Arrábida, Vila Nova de Gaia, Portugal|Hospital Clínic de Barcelona, Barcelona, Spain|Hospital Universitario Infanta Leonor, Madrid, Spain|Hospital Quirónsalud Madrid, Pozuelo de Alarcón, Spain",https://ClinicalTrials.gov/show/NCT04822701
NCT04492254,Early Prophylactic Low-molecular-weight Heparin (LMWH) in Symptomatic COVID-19 Positive Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,TRI-08892|2020-003125-39,"Harry Gibbs, National Co-ordinating Investigator, The Alfred Hospital, Melbourne, Australia|Dr Frank Cools, National Co-ordinating Investigator, AZ Klina, Brasschaat, Belgium|Prof. Barry Jacobson, National Coordinating Investigator, University of the Witwatersrand, Johannesburg, South Africa",https://ClinicalTrials.gov/show/NCT04492254
NCT04776044,Clinical Trial to Evaluate the Safety and Efficacy of ATR-002 in Adult Hospitalized Patients With COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",ATR-002-202,"Atriva study site 49006, Augsburg, Germany|Atriva study site 49001, Berlin, Germany|Atriva study site 49011, Dresden, Germany|Atriva study site 49003, Frankfurt, Germany|Atriva study site 49008, Frankfurt, Germany|Atriva study site 49009, Freiburg, Germany|Atriva study site 49007, Halle, Germany|Atriva study site 49004, Münster, Germany|Atriva study site 49012, Rostock, Germany|Atriva study site 91002, Ahmedabad, India|Atriva study site 91001, Alīgarh, India|Atriva study site 91008, Mumbai, India|Atriva study site 91003, New Delhi, India|Atriva study site 91006, Pune, India|Atriva study site 91004, Raipur, India|Atriva study site 31001, Eindhoven, Netherlands|Atriva study site 31002, Tilburg, Netherlands|Atriva study site 27005, Benoni, South Africa|Atriva study site 27002, Cape Town, South Africa|Atriva study site 27003, George, South Africa|Atriva study site 27006, KwaZulu, South Africa|Atriva study site 27007, Mayville, South Africa|Atriva study site 34001, Barcelona, Spain|Atriva study site 34011, Lleida, Spain|Atriva study site 34002, Madrid, Spain|Atriva study site 34005, Madrid, Spain|Atriva study site 34008, Madrid, Spain|Atriva study site 34010, Pontevedra, Spain|Atriva study site 34004, Valencia, Spain",https://ClinicalTrials.gov/show/NCT04776044
NCT04351724,Austrian CoronaVirus Adaptive Clinical Trial (COVID-19),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,ACOVACT,"Medical University of Innsbruck, Innsbruck, Tirol, Austria|Medical University of Graz, Graz, Austria|Kepler University Hospital, Linz, Austria|Medical University of Vienna, Vienna, Austria|Wilhelminenspital, Vienna, Austria|SMZ Süd Kaiser Franz Josef Spital, Vienna, Austria|KH Hietzing, Vienna, Austria|SMZ Baumgartner Höhe Otto Wagner Spital, Vienna, Austria|SMZ Ost Donauspital, Vienna, Austria",https://ClinicalTrials.gov/show/NCT04351724
NCT04332094,Clinical Trial of the Use of Tocilizumab for Treatment of SARS-CoV-2 Infection (COVID-19),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,IIBSP-COV-2020-23,"Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain|Hospital General Universitario de Alicante, Alicante, Valencia, Spain|Hospital General Universitario de Elche, Elche, Valencia, Spain|Hospital de la Santa Creu i Sant Pau, Barcelona, Spain|Hospital del Mar, Barcelona, Spain|Hospital Sant Joan Despí, Barcelona, Spain|Hospital Clinico San Carlos, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04332094
NCT04487886,Duvelisib Ameliorates Manifestations of Pneumonia in Established Novel Coronavirus Infection (COVID-19),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment",STUDY00000701,"Emory Saint Joseph's Hospital, Atlanta, Georgia, United States|Emory University Hospital Midtown, Atlanta, Georgia, United States|Emory University Hospital, Atlanta, Georgia, United States",https://ClinicalTrials.gov/show/NCT04487886
NCT04344444,Treatment in Patients With Suspected or Confirmed COVID-19 With Early Moderate or Severe Disease,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,COVID 2020-001,"University Medical Center New Orleans, New Orleans, Louisiana, United States",https://ClinicalTrials.gov/show/NCT04344444
NCT04452617,Safety of Short-term Hydroxychloroquine Plus Azithromycin Treatment in Critically Ill Patients With Severe COVID-19,Observational Model: Cohort|Time Perspective: Retrospective,REA-03-2020,"Institut Mutualiste Montsouris, Paris, France",https://ClinicalTrials.gov/show/NCT04452617
NCT04745611,Neurological and Neuropsychological Sequelae of COVID-19 Infection,Observational Model: Case-Only|Time Perspective: Prospective,NL75102.068.20,"Maastricht University, Maastricht, Limburg, Netherlands|Amsterdam Universitair Medische Centra, Amsterdam, Netherlands|Universitair Medische Centra Utrecht, Utrecht, Netherlands",https://ClinicalTrials.gov/show/NCT04745611
NCT04429867,Hydroxychloroquine Use in Hospitalized Patients With COVID-19: Impact on Progression to Severe or Critical Disease,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",1604885,"Wellstar Kennestone Hospital, Marietta, Georgia, United States",https://ClinicalTrials.gov/show/NCT04429867
NCT04773067,"A Study to Evaluate UB-612 COVID-19 Vaccine in Adolescent, Younger and Elderly Adult Volunteers","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention",V-205,"Changhua Christian Hospital, Changhua, Taiwan|Chang-Geng Medical Foundation Kaoshiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan|Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Taiwan|Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan|Far Eastern Memorial Hospital, New Taipei City, Taiwan|China Medical University Hospital, Taichung, Taiwan|Taichung Veterans General Hospital, Taichung, Taiwan|National Cheng Kung University Hospital, Tainan, Taiwan|Taipei Medical University Hospital, Taipei, Taiwan|Taipei Veterans General Hospital, Taipei, Taiwan|Tri-Service General Hospital, Taipei, Taiwan|Chang-Geng Medical Foundation Linkou Chang-Geng Memorial Hospital, Taoyuan, Taiwan",https://ClinicalTrials.gov/show/NCT04773067
NCT04359264,Direct Income SupporT and Advice Negating Spread of Epidemic COVID-19: a Randomized Controlled Trial,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Prevention",20-081,"Municipality of Assiginack Family Health Team, Assiginack, Ontario, Canada|St Michael's Hospital Academic Family Health Team, Toronto, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04359264
NCT04344080,Effect of CytoSorb Adsorber on Hemodynamic and Immunological Parameters in Critical Ill Patients With COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,CYTOCOV-19|U1111-1250-2078|DRKS00021199,"University Medical Center Hamburg-Eppendorf, Hamburg, Germany",https://ClinicalTrials.gov/show/NCT04344080
NCT04425772,A Clinical Trial for Azvudine in the Treatment of Novel Coronavirus Pneumonia (COVID-19）,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",FNC-Hope4,NA,https://ClinicalTrials.gov/show/NCT04425772
NCT04377659,Tocilizumab for Prevention of Respiratory Failure in Patients With Severe COVID-19 Infection,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,20-185,"Memorial Sloan Kettering Cancer Center, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04377659
NCT04601077,The Evaluation of Nitric Oxide Generating Lozenges on Outcome in Newly Diagnosed COVID-19 Patient of African Americans,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",IND150758 Pilot,"American Institute of Therapeutics, Lake Bluff, Illinois, United States",https://ClinicalTrials.gov/show/NCT04601077
NCT04341506,Non-contact ECG Sensor System for COVID19,Observational Model: Cohort|Time Perspective: Prospective,20-0407,"Northwestern Medicine, Chicago, Illinois, United States",https://ClinicalTrials.gov/show/NCT04341506
NCT04352465,Efficacy and Safety of MTX-loaded Nanoparticles to Treat Severe COVID-19 Patients,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,LDE-MTX_COVID19,"Prevent Senior Private Operadora de Saúde LTDA., São Paulo, Brazil",https://ClinicalTrials.gov/show/NCT04352465
NCT04380779,Prevalence of Severe Bleeding in COVID-19 Patients Treated With Higher Than Recommended Thromboprophylaxis Doses,Observational Model: Other|Time Perspective: Retrospective,BLEEDING042020,"Manuel Monreal, Badalona, Barcelona, Spain",https://ClinicalTrials.gov/show/NCT04380779
NCT04474457,Efficacy and Safety of Favipiravir in the Treatment of COVID-19 Patients Over 15 Years of Age,Observational Model: Cohort|Time Perspective: Prospective,COVID-19-PMS-FAV,"Hacettepe University, School of Medicine, Ankara, Turkey",https://ClinicalTrials.gov/show/NCT04474457
NCT04348448,"Observational Study, Use of Canakinumab Administered Subcutaneously in the Treatment COVID-19 Pneumonia",Observational Model: Cohort|Time Perspective: Prospective,CANASCOV,NA,https://ClinicalTrials.gov/show/NCT04348448
NCT04486313,Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Mild or Moderate COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",RM08-3008,"Invesclinic US LLC, Fort Lauderdale, Florida, United States|RH Medical Urgent Care, Bronx, New York, United States",https://ClinicalTrials.gov/show/NCT04486313
NCT04637828,A Study to Compare the Efficacy of GNS561 Versus Standard of Care in Patients With SARS-CoV-2 (COVID-19) Infection,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,GNS561-CL-I-Q-0291,"Genoscience Pharma, Marseille, France",https://ClinicalTrials.gov/show/NCT04637828
NCT04634409,A Study of Immune System Proteins in Participants With Mild to Moderate COVID-19 Illness,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",18160|J2X-MC-PYAH,"University of Alabama at Birmingham, Birmingham, Alabama, United States|The Institute for Liver Health, Mesa, Arizona, United States|Perseverance Research Center, Scottsdale, Arizona, United States|CRI of Arizona, LLC, Sun City West, Arizona, United States|Fiel Family and Sports Medicine PC, Tempe, Arizona, United States|The Institute for Liver Health, Tucson, Arizona, United States|KLR Business Group, Inc. dba Arkansas Clinical Research, Little Rock, Arkansas, United States|Applied Rsch Ctr - Arkansas Inc., Little Rock, Arkansas, United States|Smart Cures Clin Research, Anaheim, California, United States|Hope Clinical Research, Canoga Park, California, United States|VCT-Covina, Covina, California, United States|Neighborhood Healthcare, Escondido, California, United States|Chemidox Clinical Trials, Lancaster, California, United States|Ark Clinical Research, Long Beach, California, United States|Long Beach Clinical Trials LLC, Long Beach, California, United States|Cedars Sinai Medical Center, Los Angeles, California, United States|Central Valley Research, LLC, Modesto, California, United States|Inland Empire Liver Foundation, Rialto, California, United States|Sutter Institute For Medical Research, Sacramento, California, United States|Wolverine Clinical Trials, LLC, Santa Ana, California, United States|St. Joe Heritage HC-Santa Rosa, Santa Rosa, California, United States|Stanford University Hospital, Stanford, California, United States|Mazur, Statner, Dutta, Nathan, Thousand Oaks, California, United States|South Bay Clinical Research Institute, Torrance, California, United States|Infect Disease Doctors Med Grp, Walnut Creek, California, United States|Allianz Research Institute, Westminster, California, United States|Future Innovative Treatments LLC, Colorado Springs, Colorado, United States|Georgetown Univ Sch of Med, Washington, District of Columbia, United States|Synergy Healthcare LLC, Bradenton, Florida, United States|Holy Cross Hospital Inc., Fort Lauderdale, Florida, United States|I R & Health Center, Inc., Hialeah, Florida, United States|Encore Medical Research, Hollywood, Florida, United States|Elixia CRC, Hollywood, Florida, United States|Lakeland Regional Medical Center, Lakeland, Florida, United States|Panax Clinical Research, Miami Lakes, Florida, United States|Hope Clinical Trials, Inc., Miami, Florida, United States|Miami Cancer Institute at Baptist Health, Inc., Miami, Florida, United States|Bio-Medical Research, LLC, Miami, Florida, United States|Clinical Site Partners, LLC d/b/a CSP Miami, Miami, Florida, United States|Testing Matters Lab, Sunrise, Florida, United States|Advent Health Tampa, Tampa, Florida, United States|Triple O Research Inst, West Palm Beach, Florida, United States|Encore Medical Research - Weston, Weston, Florida, United States|Clinical Site Partners, LLC DBA CSP Orlando, Winter Park, Florida, United States|Gwinnett Research Inst, Buford, Georgia, United States|Paramount Rch Sol - College Pk, College Park, Georgia, United States|IACT Health - VHC, Columbus, Georgia, United States|Central Georgia Infectious Disease, Macon, Georgia, United States|Rophe Adult and Pediatric Medicine, Union City, Georgia, United States|Rocky Mountain Clinical Research, Idaho Falls, Idaho, United States|Ann & Robert H Lurie Children's Hospital of Chicago, Chicago, Illinois, United States|Great Lakes Clinical Trials, Chicago, Illinois, United States|Franciscan Health Hammond, Dyer, Indiana, United States|Qualmedica Research Evansville, Evansville, Indiana, United States|Franciscan St. Francis Health, Indianapolis, Indiana, United States|St.Vincent - Indy, Indianapolis, Indiana, United States|Qualmedica Research, LLC, Owensboro, Kentucky, United States|Tandem Clinical Research,LLC, Marrero, Louisiana, United States|Imperial Health Urgent Care Center - Moss Bluff, Moss Bluff, Louisiana, United States|Nola Research Works, LLC, New Orleans, Louisiana, United States|University of Maryland Medical Center, Baltimore, Maryland, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|U of MA Mem Med Ctr, Worcester, Massachusetts, United States|University of Michigan, Ann Arbor, Michigan, United States|Great Lakes Research Group, Inc., Bay City, Michigan, United States|Revive Research Institute, Farmington Hills, Michigan, United States|Revival Research Institute, Sterling Heights, Michigan, United States|Sky Clinical Prime and Health Wellness Clinic, Fayette, Mississippi, United States|Olive Branch Family Medical Center, Olive Branch, Mississippi, United States|Sky Clin Resch - Quinn HC, Ridgeland, Mississippi, United States|Bio-Kinetic Clinical Applications, LLC, Springfield, Missouri, United States|Quality Clinical Research, Omaha, Nebraska, United States|Excel Clinical Research, Las Vegas, Nevada, United States|Las Vegas Medical Research, Las Vegas, Nevada, United States|SVG Clinical, Las Vegas, Nevada, United States|Holy Name Medical Center, Teaneck, New Jersey, United States|Prime Global Research, LLC, Bronx, New York, United States|Onsite Clinical Solutions, LLC, Charlotte, North Carolina, United States|East Carolina University, Greenville, North Carolina, United States|Monroe Biomed Research, Monroe, North Carolina, United States|Carteret Medical Group, Morehead City, North Carolina, United States|PMG Research of Wilmington, Wilmington, North Carolina, United States|Valley Medical Primary Care, Centerville, Ohio, United States|Hometown UC and Rch- Cincy, Cincinnati, Ohio, United States|Aventiv Research Inc, Columbus, Ohio, United States|Urgent Care Specialists, LLC, Columbus, Ohio, United States|Remington-Davis, Inc, Columbus, Ohio, United States|Urgent Care Specialists, LLC, Dayton, Ohio, United States|META Medical Research Institute, Dayton, Ohio, United States|Ascension St. John Tulsa OK, Tulsa, Oklahoma, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States|Jefferson Hosp for Neurosci, Philadelphia, Pennsylvania, United States|Temple University Hospital, Philadelphia, Pennsylvania, United States|VITALINK - Anderson, Anderson, South Carolina, United States|Carolina Medical Research - Clinton, Clinton, South Carolina, United States|VITALINK - Gaffney, Gaffney, South Carolina, United States|Carolina Medical Research - Greenville, Greenville, South Carolina, United States|VITALINK - Greenville, Greenville, South Carolina, United States|VITALINK - Spartanburg, Spartanburg, South Carolina, United States|VITALINK - Union, Union, South Carolina, United States|Univ Diab & Endo Consult, Chattanooga, Tennessee, United States|New Phase Research and Development, Knoxville, Tennessee, United States|Gadolin Research, LLC, Beaumont, Texas, United States|Conroe Willis Medical Research, Conroe, Texas, United States|Crossroads Clinical Research, Corpus Christi, Texas, United States|B S & W Med Center, Dallas, Texas, United States|Baylor - Fort Worth, Fort Worth, Texas, United States|North Texas Clinical Trials, LLC, Fort Worth, Texas, United States|Houston Methodist Research Ins, Houston, Texas, United States|Next Level Urgent Care, Houston, Texas, United States|Accurate Clinical Management, LLC., Houston, Texas, United States|1960 Family Practice, PA, Houston, Texas, United States|B S & W Med Center, Irving, Texas, United States|Zion Urgent Care Clinic, Katy, Texas, United States|BioPharma Family Practice Center McAllen, McAllen, Texas, United States|BRCR Medical Center, Inc, McAllen, Texas, United States|North Hills Medical Research, North Richland Hills, Texas, United States|Bay Area Infectious Diseases Associates, Pasadena, Texas, United States|Epic Medical Research, Red Oak, Texas, United States|Baylor - Round Rock, Round Rock, Texas, United States|Sun Research Institute, San Antonio, Texas, United States|Consano Clinical Research, LLC, Shavano Park, Texas, United States|APD Clinical Research, Splendora, Texas, United States|Crossroads Clin Rch-Victoria, Victoria, Texas, United States|CLS Research Ctr, PLLC, Webster, Texas, United States|CARE ID, Annandale, Virginia, United States|Evergreen Health Research, Kirkland, Washington, United States|Sanatorio Sagrado Corazón, Ciudad de Buenos Aires, AR, Argentina|Clínica Zabala, Ciudad de Buenos Aires, AR, Argentina|Sanatorio de la Trinidad Mitre, Caba, Buenos Aires, Argentina|Clínica Privada Independencia, Munro, Buenos Aires, Argentina|Go Centro Medico San Nicolás, San Nicolás, Buenos Aires, Argentina|Instituto de Investigaciones Clinicas Zarate, Zarate, Buenos Aires, Argentina|Instituto Médico Rio Cuarto, Rio Cuarto, Cordoba, Argentina|Clinica Central S.A., Villa Regina, Rio Negro, Argentina|Centro de Investigaciones Clínicas - Clínica Viedma, Viedma, RN, Argentina|INECO Neurociencias Oroño, Rosario, Santa Fe, Argentina|Hospital San Roque, Cordoba, Argentina|Advanced Clinical Research, LLC, Bayamon, Puerto Rico|Dorado Medical Complex Inc, Dorado, Puerto Rico|GCM Medical Group, PSC - Hato Rey Site, San Juan, Puerto Rico",https://ClinicalTrials.gov/show/NCT04634409
NCT04891302,The Proof of Concept Phase 2 Study to Evaluate the Safety and Efficacy of Clevudine in Patients With Mild and Moderate COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",BK-CLV-203,"Chungnam National University Hospital, Daejeon, Korea, Republic of|Ajou University Hospital, Gyeonggi-do, Korea, Republic of|Korea University Ansan Hospital, Gyeonggi-do, Korea, Republic of|Myongji Hospital, Gyeonggi-do, Korea, Republic of|Gachon University Gil Medical Center, Incheon, Korea, Republic of|Incheon Medical Center, Incheon, Korea, Republic of|Inha University Hospital, Incheon, Korea, Republic of|Kangnam Sacred Heart Hospital, Seoul, Korea, Republic of|Korea University Anam Hospital, Seoul, Korea, Republic of|Korea University Guro Hospital, Seoul, Korea, Republic of|Seoul Medical Center, Seoul, Korea, Republic of",https://ClinicalTrials.gov/show/NCT04891302
NCT04666012,Safety and Immunogenicity Study of AdCLD-CoV19: A COVID-19 Preventive Vaccine in Healthy Volunteers,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,AdCLD-CoV19-001,"Korea University Ansan Hospital, Ansan, Province, Korea, Republic of|The Catholic University of Korea, ST. Vincent's Hospital, Suwon, Province, Korea, Republic of|Hallym University Kangnam Sacred Heart Hospital, Seoul, State, Korea, Republic of|The Catholic University of Korea, Seoul ST. Mary's Hospital, Seoul, State, Korea, Republic of|Korea University Guro Hospital, Seoul, Korea, Republic of",https://ClinicalTrials.gov/show/NCT04666012
NCT04432961,Natural Language Processing (NLP) Analysis of Free Text Notes to Investigate Coronavirus (COVID-19),Observational Model: Case-Only|Time Perspective: Retrospective,A095625,"Cambridge University NHS Foundation Trust, Cambridge, United Kingdom",https://ClinicalTrials.gov/show/NCT04432961
NCT04941703,"""CHANGE COVID-19 Severity""","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",210598,"Vanderbilt University Medical Center, Nashville, Tennessee, United States",https://ClinicalTrials.gov/show/NCT04941703
NCT04391920,Registry of CytoSorb Therapy in COVID-19 ICU Patients,Observational Model: Cohort|Time Perspective: Other,2020-001|FDA EUA,"Medical Center of Aurora, Aurora, Colorado, United States|University of Chicago Medicine, Chicago, Illinois, United States|Franciscan Health Indianapolis, Indianapolis, Indiana, United States|Baptist Memorial Hospital, Southaven, Mississippi, United States|New York University Medical Center, New York, New York, United States|West Virginia University, Morgantown, West Virginia, United States|Medical College of Wisconsin, Milwaukee, Wisconsin, United States",https://ClinicalTrials.gov/show/NCT04391920
NCT04701658,A Real World Study of Bamlanivimab in Participants With Mild-to-moderate Coronavirus Disease 2019 (COVID-19),Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,18216|J2X-MC-PYAJ,"Presbyterian Medical Center, Albuquerque, New Mexico, United States",https://ClinicalTrials.gov/show/NCT04701658
NCT04953234,"Effect of Tumor Treating Fields (TTFields, 150 kHz) Concomitant With Best Standard of Care for the Treatment of Hospitalized COVID-19 Patients and Continued Treatment Following Discharge",Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,EF-37,"Hadassah Medical Center, Jerusalem, Israel",https://ClinicalTrials.gov/show/NCT04953234
NCT04427566,Low Dose Whole Lung Radiation Therapy for Patients With COVID-19 and Respiratory Compromise,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,VENTED,"Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center, Columbus, Ohio, United States",https://ClinicalTrials.gov/show/NCT04427566
NCT04405843,Efficacy of Ivermectin in Adult Patients With Early Stages of COVID-19 (EPIC Trial),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",ScDi823|IVE-PA,"Centro de Estudios en Infectología Pediátrica, Cali, Valle, Colombia",https://ClinicalTrials.gov/show/NCT04405843
NCT04679415,Efficacy and Safety of hzVSF-v13 in Moderate to Severe Patients With COVID-19 Pneumonia,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",hzVSF_v13-0007,"Rumah Sakit Pusat Pertamina (include RSPP Extension Simprug), Jakarta, Daerah Khusus Ibukota Jakarta, Indonesia|Rumah Sakit Pasar Minggu, Jakarta, Daerah Khusus Ibukota Jakarta, Indonesia|Rumah Sakit Umum Persahabatan, Jakarta, Daerah Khusus Ibukota Jakarta, Indonesia",https://ClinicalTrials.gov/show/NCT04679415
NCT04432766,A Phase 1/2 Study to Assess Safety and Efficacy of BAT2020 in Hospitalized COVID-19 Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",BAT-2020-001-CR,"Snake River Research, Idaho Falls, Idaho, United States",https://ClinicalTrials.gov/show/NCT04432766
NCT04365634,A Single-center Retrospective Study to Find Prediction Factors Related to Mortality of COVID-19 Patients.,Observational Model: Case-Control|Time Perspective: Retrospective,TJ20200202,"Tongji Hospital, Wuhan, Hubei, China",https://ClinicalTrials.gov/show/NCT04365634
NCT04429711,Ivermectin vs. Placebo for the Treatment of Patients With Mild to Moderate COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",SHEBA-20-7156-ES-CTIL,"Sheba Medical Center, Ramat-Gan, Israel",https://ClinicalTrials.gov/show/NCT04429711
NCT04307693,Comparison of Lopinavir/Ritonavir or Hydroxychloroquine in Patients With Mild Coronavirus Disease (COVID-19),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,S2020-0472-0001,"Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of",https://ClinicalTrials.gov/show/NCT04307693
NCT04709835,Study to Evaluate the Effects of AT-527 in Non-Hospitalized Adult Patients With Mild or Moderate COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",WV43042,"Multiprofile Hospital for Active Treatment Puls AD PPDS, Blagoevgrad, Bulgaria|Multiprofile Hospital For Active Treatment Dr. Tota Venkova JSC, Gabrovo, Bulgaria|MHAT Dr. Atanas Dafovski AD, Kardzhali, Bulgaria|Multiprofile Hospital for Active Treatment - Prof. Dr. Paraskev Stoyanov AD, Lovech, Bulgaria|Medical center Medconsult Pleven OOD, Pleven, Bulgaria|University Multiprofile Hospital for Active Treatment Sveta Marina Pleven OOD, Pleven, Bulgaria|Multiprofile Hospital for Active Treatment Plovdiv, Plovdiv, Bulgaria|MHAT ""Sv. Ivan Rilski"" - Razgrad AD; Department of pnemology and phthisiatry, Razgrad, Bulgaria|Specialized Hospital for Active Treatment of Pneumophthisiatric Diseases Dr. D. Gramatikov - Ruse, Ruse, Bulgaria|Multiprofile Hospital for Active Treatment - Samokov EOOD, Samokov, Bulgaria|Diagnostic and Consulting Center Aleksandrovska EOOD, Sofia, Bulgaria|Diagnostic Consultative CTR XX Sofia EOOD, Sofia, Bulgaria|Multiprofile Hospital for Active Treatment (MHAT) - Targovishte, Targovishte, Bulgaria|Vancouver Infectious Diseases Centre, Vancouver, British Columbia, Canada|Hamilton Medical Research Group, Hamilton, Ontario, Canada|Evangelismos General Hospital of Athens, Athens, Greece|Sotiria General Hospital of Athens; 3rd Department of Internal Medicine, Athens, Greece|National and Kapodistrian University of Athens, Athens, Greece|University General Hospital of Ioannina, Ioannina, Greece|General State Hospital of Nikaia St Panteleimon, Nikaia Attikis, Greece|Connolly Hospital, Dublin, Ireland|Private Practice of Dr Liga Kozlovska, Balvi, Latvia|RSU Ambulance, Riga, Latvia|Outpatient Clinic Alma, Rīga, Latvia|Outpatient Clinic Adoria, Rīga, Latvia|The Family Physician's Practice of Dr. Maija Kozlovska, Salaspils, Latvia|M & M Centrs, Ādaži, Latvia|UAB Inmedica, Kaunas, Lithuania|JSC Saules Family Health Center, Kaunas, Lithuania|Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania|Krakowskie Centrum Medyczne Sp. z o.o., Krakow, Poland|Centrum Medyczne Pulawska SP. z o.o., Piaseczno, Poland|Centralny Szpital Klinicznty MSWiA w Warszawie, Warszawa, Poland|Centrum Badań Klinicznych, Wrocław, Poland|Hospital El Pilar - Grupo Quirónsalud, Esplugues de Llobregat, Barcelona, Spain|Hospital Universitario Son Espases, Palma de Mallorca, Islas Baleares, Spain|Hospital Costa del Sol, Marbella, Malaga, Spain|Hospital Universitario La Paz - PPDS, Barcelona, Spain|Hospital Universitario Infanta Leonor, Madrid, Spain|Chapel Street Medical Centre, Ashton-under-Lyne, United Kingdom|Tower Family Healthcare - Moorgate Primary Care Ce, Bury, United Kingdom|CPS Research, Glasgow, United Kingdom|Chelsea and Westminster NHS Trust, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04709835
NCT04344236,Gargling and Nasal Rinses to Reduce Oro- and Nasopharyngeal Viral Load in Patients With COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,s20-00444,"NYU Langone Health, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04344236
NCT04385849,Study of the Safety of Therapeutic Treatment With an Immunomodulatory Agent (N-803) in Adults With COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",QUILT-COVID-19,"St. Francis, Lynwood, California, United States",https://ClinicalTrials.gov/show/NCT04385849
NCT04355507,Computed Tomography for COVID-19 Diagnosis,Observational Model: Cohort|Time Perspective: Retrospective,APHP200434,"Cochin Hospital, Paris, France",https://ClinicalTrials.gov/show/NCT04355507
NCT04536090,Study of Isoquercetin (IQC-950AN) Plus Standard of Care Versus Standard of Care Only for the Treatment of COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,IRCM-IQC-001,NA,https://ClinicalTrials.gov/show/NCT04536090
NCT04732949,Study to Assess Efficacy and Safety of Inhaled Interferon-β Therapy for COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",SG018|2020-004743-83,"Professional Health Care of Pi, Saint Petersburg, Florida, United States|Icahn School of Medicine at Mo, New York, New York, United States|PharmaTex Research, LLC, Amarillo, Texas, United States|AZ Groeninge, Kortrijk, West-Vlaanderen, Belgium|Centre Hospitalier Universitai, Bruxelles, Belgium|CHR de la Citadelle - Site Cit, Liège, Belgium|CHU de Liège - Domaine Univers, Liège, Belgium|Clinica de la Mujer, Bogotá, Cundinamarca, Colombia|CHU De Nantes - Infectious Dis, Nantes, Loire-Atlantique, France|CHU de Grenoble - Hôpital Albe, La Tronche, France|CHU Saint Antoine - Infectious, Paris, France|Hôpital Européen Georges-Pompi, Paris, France|Hopital Bichat - Infectious Di, Paris, France|King George Hospital, Visakhapatnam, Andhra Pradesh, India|Bangalore Medical College and Research Institute, Bangalore, Karnataka, India|Vishwa Raj Hospital, Pune, Maharashtra, India|Post Graduate Institute of Medical Education & Research, Chandigarh, Punjab, India|Saveetha Medical College & Hospital, Chennai, India|Assuta Ashdod University Hospi, Ashdod, HaDarom, Israel|Rambam Health Care Campus, Haifa, Israel|Ziv Medical Center, Safed, Israel|The Chaim Sheba Medical Center, Tel Hashomer, Israel|Sourasky Tel Aviv Medical Cent, Tel-Aviv, Israel|Assaf Harofeh Medical Center, Zerifin, Israel|Azienda Socio Sanitaria Territ, Monza, Lombardia, Italy|Azienda Ospedaliera Nazionale, Alessandria, Italy|PO A.Manzoni di Lecco, ASST Le, Lecco, Italy|Ospedale Luigi Sacco, AO-PU, Milano, Italy|Azienda Ospedaliera Ospedale N, Milano, Italy|IRCCS Policlinico San Matteo, Pavia, Italy|Gelre Ziekenhuis Zutphen, Zutphen, Gelderland, Netherlands|Isala Klinieken, Zwolle, Overijssel, Netherlands|C.H. de Vila Nova de Gaia/Espi, Vila Nova de Gaia, Porto, Portugal|Hospital de Braga, Braga, Portugal|Hospital da Senhora de Oliveir, Guimarães, Portugal|Centro Hospitalar de Entre Dou, Rodrigues, Portugal|Clinical Center Nis, Nis, Nišavski Okrug, Serbia|Clinical Center of Vojvodina, Novi Sad, Vojvodina, Serbia|Clinical Center Kragujevac, Cl, Kragujevac, Serbia|The Institute for Pulmonary Di, Sremska Kamenica, Serbia|CHU A Coruña, Madrid, A Coruña, Spain|Hospital Universitario Son Esp, Palma De Mallorca, Baleares, Spain|Hospital Universitario de Puer, Puerto Real, Cádiz, Spain|Hospital Santa Creu i Sant Pau, Barcelona, Spain|Hospital Universitario Infanta, Madrid, Spain|Hospital Universitario Ramón y, Madrid, Spain|H.Clinico San Carlos, Madrid, Spain|Wexham Park Hospital, Slough, Bracknell Forest, United Kingdom|Hull Royal Infirmary, Hull, North Humberside, East Riding Of Yorkshire, United Kingdom|Newcastle University - Institute of Cellular Medicine (ICM), Newcastle, England, United Kingdom|Southampton General Hospital, Southampton, Hampshire, United Kingdom|Churchill Hospital, Headington, Oxfordshire, United Kingdom|Frimley Park Hospital, Frimley, Surrey, United Kingdom|Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom|The Royal Bournemouth & Christ, Bournemouth, United Kingdom|University Hospital of North D, Durham, United Kingdom|Glasgow Royal Infirmary, Glasgow, United Kingdom|Glenfield Hospital, Leicester, United Kingdom|University Hospital Lewisham, London, United Kingdom|Guy's Hospital, London, United Kingdom|North Manchester General Hospi, Manchester, United Kingdom|The James Cook University Hosp, Middlesbrough, United Kingdom|Nottingham University Hospital, Nottingham, United Kingdom|Plymouth Hospitals NHS Trust, Plymouth, United Kingdom|Morriston Hospital Swansea NHS, Swansea, United Kingdom",https://ClinicalTrials.gov/show/NCT04732949
NCT04363814,Clinical Impact of BACTEK-R in Subject With Mild Pneumonia Due to COVID-19 Infection,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,MV130-SLG-35,"Hospital Metropolitano Santiago, Santiago De Los Caballeros, Dominican Republic",https://ClinicalTrials.gov/show/NCT04363814
NCT04345692,A Randomized Controlled Clinical Trial: Hydroxychloroquine for the Treatment of COVID-19 in Hospitalized Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,RA-2020-018,"Queen's Medical Center, Honolulu, Hawaii, United States",https://ClinicalTrials.gov/show/NCT04345692
NCT04445935,Anticoagulation in Patients Suffering From COVID-19 Disease The ANTI-CO Trial,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Supportive Care",MRC-05-082,"Hamad Medical Corporation, Doha, Qatar",https://ClinicalTrials.gov/show/NCT04445935
NCT04397562,A Clinical Trial of the Efficacy and Safety of Levilimab (BCD-089) in Patients With Severe COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",BCD-089-4,"State Budgetary Healthcare Institution Kaluga region ""Kaluga Regional Clinical Hospital"", Kaluga, Russian Federation|State Budget Institution of the Republic of Dagestan ""Republican Clinical Hospital"", Machačkala, Russian Federation|A.N. Bakulev National Medical Research Center of Cardiovascular Surgery, Moscow, Russian Federation|City Clinical Hospital No. 40 of the Department of Health of the city of Moscow, Moscow, Russian Federation|City Clinical Hospital No.52, Moscow, Russian Federation|City Clinical Hospital № 15 named. O.M. Filatov, Moscow, Russian Federation|City Clinical Hospital №1 named after N.I. Pirogov, Moscow City Health Department, Moscow, Russian Federation|Federal State Budgetary Institution ""Central Clinical Hospital with Clinic"", Office of the President of the Russian Federation, Moscow, Russian Federation|I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russian Federation|Pirogov Russian National Research Medical University, Moscow, Russian Federation|Railway clinical hospital named after N.A. Semashko, Moscow, Russian Federation|Almazov National Medical Research Centre, Saint Petersburg, Russian Federation|Clinical Infectious Disease Hospital named after S.P. Botkin, Saint Petersburg, Russian Federation|North-western State Medical University named after I.I.Mechnikov, Saint Petersburg, Russian Federation|Federal State Budgetary Educational Institution of Higher Education ""Bashkir State Medical University"" of the Ministry of Healthcare of the Russian Federation, Ufa, Russian Federation|Federal State Budgetary Educational Institution of Higher Education ""North Ossetian State Medical Academy"" of the Ministry of Health of the Russian Federation (FSBEI HE SOGMA of the Ministry of Health of Russia), Vladikavkaz, Russian Federation",https://ClinicalTrials.gov/show/NCT04397562
NCT04400461,Short-term Physical Function Outcomes in Severe COVID-19 Patients Admitted to ICU for Invasive Mechanical Ventilation,Observational Model: Cohort|Time Perspective: Cross-Sectional,165/20,"Medical ICU. Hospital Universitario Ramón y Cajal, Madrid, Spain|Surgical ICU. Hospital Universitario Ramón y Cajal, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04400461
NCT04364763,A Study to Evaluate the Effect of RBT-9 on Progression of COVID-19 in High-Risk Individuals (The PREVENT Study),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,REN-005,"New Smyrna Beach, FL, New Smyrna Beach, Florida, United States|Berkley, MI, Berkley, Michigan, United States|El Paso, TX, El Paso, Texas, United States|Fort Worth, TX, Fort Worth, Texas, United States|Houston, Houston, Texas, United States",https://ClinicalTrials.gov/show/NCT04364763
NCT04433910,A Clinical Trial of Convalescent Plasma Compared to Best Supportive Care for Treatment of Patients With Severe COVID-19,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,CAPSID2020-DRK-BSD|2020-001310-38,"University Hospital Ulm, Ulm, Baden-Württmberg, Germany|University Hopsital Frankfurt, Frankfurt, Hessia, Germany|Saarland University Hospital, Homburg, Saarland, Germany|University Hospital Berlin, Charite, Berlin, Germany|Universitiy Hospital Dresden, Dresden, Germany|University Düsseldorf, Düsseldorf, Germany|University Hospital Freiburg, Freiburg, Germany|University Hospital Gießen, Gießen, Germany|University Hopsital Greifswald, Greifswald, Germany|Städtisches Klinikum Karslruhe, Karlsruhe, Germany|Universtity Hospital Schleswig-Holstein, Kiel, Germany|Universtity Hospital Schleswig-Holstein, Lübeck, Germany|University Hospital Mannheim, Mannheim, Germany|University Hospital Marburg, Marburg, Germany|Klinikum Stuttgart, Stuttgart, Germany|University Hospital Tübingen, Tübingen, Germany",https://ClinicalTrials.gov/show/NCT04433910
NCT04397718,Hormonal Intervention for the Treatment in Veterans With COVID-19 Requiring Hospitalization,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",COVID19-8900-15,"Phoenix VA Health Care System, Phoenix, AZ, Phoenix, Arizona, United States|Central Arkansas VHS John L. McClellan Memorial Veterans Hospital, Little Rock, AR, Little Rock, Arkansas, United States|VA Long Beach Healthcare System, Long Beach, CA, Long Beach, California, United States|VA Greater Los Angeles Healthcare System, West Los Angeles, CA, Los Angeles, California, United States|Miami VA Healthcare System, Miami, FL, Miami, Florida, United States|St. Louis VA Medical Center John Cochran Division, St. Louis, MO, Saint Louis, Missouri, United States|Brooklyn Campus of the VA NY Harbor Healthcare System, Brooklyn, NY, Brooklyn, New York, United States|Manhattan Campus of the VA NY Harbor Healthcare System, New York, NY, New York, New York, United States|Philadelphia MultiService Center, Philadelphia, PA, Philadelphia, Pennsylvania, United States|Ralph H. Johnson VA Medical Center, Charleston, SC, Charleston, South Carolina, United States|Memphis VA Medical Center, Memphis, TN, Memphis, Tennessee, United States|VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX, Dallas, Texas, United States|Michael E. DeBakey VA Medical Center, Houston, TX, Houston, Texas, United States|VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle, Washington, United States",https://ClinicalTrials.gov/show/NCT04397718
NCT04411628,A Study of LY3819253 (LY-CoV555) in Participants Hospitalized for COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Basic Science",17823|J2W-MC-PYAA,"Cedars Sinai Medical Center, Los Angeles, California, United States|Veterans Affairs Medical Center San Diego, San Diego, California, United States|Emory University, Atlanta, Georgia, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|University of Massachusetts Medical Center, Worcester, Massachusetts, United States|University of Michigan, Ann Arbor, Michigan, United States|Quality Clinical Research, Inc., Omaha, Nebraska, United States|Alexandria Center for Life - NYC/ NYCEDC, New York, New York, United States|University of North Carolina, Chapel Hill, North Carolina, United States|Unified Research Enterprise Brody School of Medicine at ECU, Greenville, North Carolina, United States|Temple Univ School of Med, Philadelphia, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04411628
NCT04362332,"Chloroquine, Hydroxychloroquine or Only Supportive Care in Patients AdmItted With Moderate to Severe COVID-19",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,NL73529.041.20 versie 3,"UMCU, Utrecht, Netherlands",https://ClinicalTrials.gov/show/NCT04362332
NCT04386252,Phase I-II Trial of Dendritic Cell Vaccine to Prevent COVID-19 in Adults,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,CL-COV-P01-US,NA,https://ClinicalTrials.gov/show/NCT04386252
NCT04331899,Single-Blind Study of a Single Dose of Peginterferon Lambda-1a Compared With Placebo in Outpatients With Mild COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,55619,"Stanford University School of Medicine, Stanford, California, United States",https://ClinicalTrials.gov/show/NCT04331899
NCT04399317,Flow Controlled Ventilation in ARDS Associated With COVID-19,"Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment",MRC-05-018,"Hamad Medical Corporation, Doha, Qatar",https://ClinicalTrials.gov/show/NCT04399317
NCT04323631,Hydroxychloroquine for the Treatment of Patients With Mild to Moderate COVID-19 to Prevent Progression to Severe Infection or Death,Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,0154-20-RMB,NA,https://ClinicalTrials.gov/show/NCT04323631
NCT04434131,Treatment With Investigational Convalescent Plasma and Measure Antibody Levels in Patients Hospitalized With COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,20-227,"University of New Mexico Health Sciences Center, Albuquerque, New Mexico, United States",https://ClinicalTrials.gov/show/NCT04434131
NCT04598334,Cytokine Storm Among Bangladeshi Patients With COVID-19,Observational Model: Cohort|Time Perspective: Prospective,PR-20084,"Icddr,B, Dhaka, Bangladesh",https://ClinicalTrials.gov/show/NCT04598334
NCT04848610,The Factors That Affect the Infection of COVID-19,Observational Model: Other|Time Perspective: Cross-Sectional,Covid-19 Infection,"Istanbul University-Cerrahpasa Florence Nightingale Nursing Faculty, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04848610
NCT04623021,A Study Evaluating the Efficacy and Safety of CKD-314 (Nafabelltan) in Hospitalized Adult Patients Diagnosed With COVID-19 Pneumonia,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,A108_02CVD2014,"A108_02CVD2014 Site# 9, Barnaul, Russian Federation|A108_02CVD2014 Site# 26, Krasnoyarsk, Russian Federation|A108_02CVD2014 Site# 5, Moscow, Russian Federation|A108_02CVD2014 Site# 8, Moscow, Russian Federation|A108_02CVD2014 Site# 31, Ryazan, Russian Federation|A108_02CVD2014 Site# 25, St. Petersburg, Russian Federation|A108_02CVD2014 Site# 29, St. Petersburg, Russian Federation|A108_02CVD2014 Site# 30, St. Petersburg, Russian Federation|A108_02CVD2014 Site# 3, St. Petersburg, Russian Federation|A108_02CVD2014 Site# 4, St. Petersburg, Russian Federation|A108_02CVD2014 site#1, Ufa, Russian Federation",https://ClinicalTrials.gov/show/NCT04623021
NCT04427501,A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Participants With Mild to Moderate COVID-19 Illness,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",17947|J2W-MC-PYAB,"University of Alabama at Birmingham, Birmingham, Alabama, United States|Arizona Clin Trials-Mesa, Mesa, Arizona, United States|Perseverance Research Center, Scottsdale, Arizona, United States|CRI of Arizona, LLC, Sun City West, Arizona, United States|Fiel Family and Sports Medicine PC, Tempe, Arizona, United States|Orange Grove Banner Clinic, Tucson, Arizona, United States|Arizona Clin Trials-Tucson, Tucson, Arizona, United States|Arkansas Children's, Little Rock, Arkansas, United States|KLR Business Group, Inc. dba Arkansas Clinical Research, Little Rock, Arkansas, United States|Applied Rsch Ctr - Arkansas Inc., Little Rock, Arkansas, United States|Smart Cures Clin Research, Anaheim, California, United States|Hope Clinical Research, Canoga Park, California, United States|VCT-Covina, Covina, California, United States|AMCR Institute, Escondido, California, United States|Chemidox Clinical Trials, Lancaster, California, United States|Ark Clinical Research, Long Beach, California, United States|Long Beach Clinical Trials LLC, Long Beach, California, United States|Cedars Sinai Medical Center, Los Angeles, California, United States|UCLA Mattel Children's Hospital, Los Angeles, California, United States|Central Valley Research, LLC, Modesto, California, United States|Catalina Research Institute, LLC, Montclair, California, United States|Inland Empire Liver Foundation, Rialto, California, United States|Sutter Institute For Medical Research, Sacramento, California, United States|Zion Medical Center, San Diego, California, United States|Kaiser Permanente - SD Med Ctr, San Diego, California, United States|Wolverine Clinical Trials, LLC, Santa Ana, California, United States|St. Joe Heritage HC-Santa Rosa, Santa Rosa, California, United States|Stanford University Hospital, Stanford, California, United States|Mazur, Statner, Dutta, Nathan, Thousand Oaks, California, United States|South Bay Clinical Research Institute, Torrance, California, United States|Infect Disease Doctors Med Grp, Walnut Creek, California, United States|Allianz Research Institute, Westminster, California, United States|Future Innovative Treatments LLC, Colorado Springs, Colorado, United States|Nemours Childrens Clinic - Delaware Valley of The Nemours Foundation, Wilmington, Delaware, United States|Georgetown Univ Sch of Med, Washington, District of Columbia, United States|Synergy Healthcare LLC, Bradenton, Florida, United States|Holy Cross Hospital Inc., Fort Lauderdale, Florida, United States|I R & Health Center, Inc., Hialeah, Florida, United States|Encore Medical Research, Hollywood, Florida, United States|Elixia CRC, Hollywood, Florida, United States|University of Florida Jacksonville, Jacksonville, Florida, United States|Lakeland Regional Medical Center, Lakeland, Florida, United States|Panax Clinical Research, Miami Lakes, Florida, United States|Hope Clinical Trials, Inc., Miami, Florida, United States|Miami Cancer Institute at Baptist Health, Inc., Miami, Florida, United States|Bio-Medical Research, LLC, Miami, Florida, United States|Clinical Site Partners, LLC d/b/a CSP Miami, Miami, Florida, United States|GCPR, Saint Petersburg, Florida, United States|Testing Matters Lab, Sunrise, Florida, United States|Advent Health Tampa, Tampa, Florida, United States|Triple O Research Inst, West Palm Beach, Florida, United States|Encore Medical Research - Weston, Weston, Florida, United States|Clinical Site Partners, LLC DBA CSP Orlando, Winter Park, Florida, United States|Gwinnett Research Inst, Buford, Georgia, United States|Paramount Rch Sol - College Pk, College Park, Georgia, United States|IACT Health - VHC, Columbus, Georgia, United States|Central Georgia Infectious Disease, Macon, Georgia, United States|Rophe Adult and Pediatric Medicine, Union City, Georgia, United States|Rocky Mountain Clinical Research, Idaho Falls, Idaho, United States|Ann & Robert H Lurie Children's Hospital of Chicago, Chicago, Illinois, United States|Northwestern University, Chicago, Illinois, United States|J H. Stroger Hosp of Cook Co, Chicago, Illinois, United States|University of Chi Med Center, Chicago, Illinois, United States|Great Lakes Clinical Trials, Chicago, Illinois, United States|Franciscan Health Hammond, Dyer, Indiana, United States|Qualmedica Research Evansville, Evansville, Indiana, United States|Community Hospital South, Indianapolis, Indiana, United States|Franciscan St. Francis Health, Indianapolis, Indiana, United States|St.Vincent - Indy, Indianapolis, Indiana, United States|University of Louisville, Louisville, Kentucky, United States|Qualmedica Research, LLC, Owensboro, Kentucky, United States|Tandem Clinical Research,LLC, Marrero, Louisiana, United States|Imperial Health Urgent Care Center - Moss Bluff, Moss Bluff, Louisiana, United States|Nola Research Works, LLC, New Orleans, Louisiana, United States|University of Maryland Medical Center, Baltimore, Maryland, United States|Institute for Advanced Clinical Trials for Children, Rockville, Maryland, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|U of MA Mem Med Ctr, Worcester, Massachusetts, United States|University of Michigan Health Systems, Ann Arbor, Michigan, United States|Great Lakes Research Group, Inc., Bay City, Michigan, United States|Childrens Hospital of Michigan, Detroit, Michigan, United States|Henry Ford Hospital, Detroit, Michigan, United States|Revive Research Institute, Farmington Hills, Michigan, United States|Revival Research Institute, Sterling Heights, Michigan, United States|Sky Clinical Prime and Health Wellness Clinic, Fayette, Mississippi, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|Olive Branch Family Medical Center, Olive Branch, Mississippi, United States|Sky Clin Resch - Quinn HC, Ridgeland, Mississippi, United States|Bio-Kinetic Clinical Applications, LLC, Springfield, Missouri, United States|Childrens Endocrine Clinic, Omaha, Nebraska, United States|Quality Clinical Research, Omaha, Nebraska, United States|Excel Clinical Research, Las Vegas, Nevada, United States|Las Vegas Medical Research, Las Vegas, Nevada, United States|SG Clinical Research - PC, Las Vegas, Nevada, United States|Robert Wood Johnson University Medical School, New Brunswick, New Jersey, United States|Holy Name Medical Center, Teaneck, New Jersey, United States|Care Access Research - Bronx, Bronx, New York, United States|Icahn Sch of Med at Mt. Sinai, New York, New York, United States|University of North Carolina, Chapel Hill, North Carolina, United States|OnSite Clinical Solutions, Charlotte, North Carolina, United States|East Carolina University, Greenville, North Carolina, United States|Monroe Biomed Research, Monroe, North Carolina, United States|Carteret Medical Group, Morehead City, North Carolina, United States|Carolina Research Center, Inc., Shelby, North Carolina, United States|PMG Research of Wilmington, Wilmington, North Carolina, United States|Valley Medical Primary Care, Centerville, Ohio, United States|Hometown UC and Rch- Cincy, Cincinnati, Ohio, United States|Cleveland Clinic Foundation, Cleveland, Ohio, United States|OH State Univ College of Med, Columbus, Ohio, United States|Aventiv Research Inc, Columbus, Ohio, United States|Urgent Care Specialists, LLC, Columbus, Ohio, United States|Remington-Davis, Inc, Columbus, Ohio, United States|Urgent Care Specialists, LLC, Dayton, Ohio, United States|META Medical Research Institute, Dayton, Ohio, United States|Ascension St. John Tulsa OK, Tulsa, Oklahoma, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States|Jefferson Hosp for Neurosci, Philadelphia, Pennsylvania, United States|Temple University Hospital, Philadelphia, Pennsylvania, United States|Hasbro Children's Hospital, Providence, Rhode Island, United States|VITALINK - Anderson, Anderson, South Carolina, United States|Carolina Medical Research - Clinton, Clinton, South Carolina, United States|VITALINK - Gaffney, Gaffney, South Carolina, United States|Carolina Medical Research - Greenville, Greenville, South Carolina, United States|VITALINK - Greenville, Greenville, South Carolina, United States|VITALINK - Spartanburg, Spartanburg, South Carolina, United States|VITALINK - Union, Union, South Carolina, United States|Univ Diab & Endo Consult, Chattanooga, Tennessee, United States|New Phase Research and Development, Knoxville, Tennessee, United States|St Jude Childrens Research Hospital, Memphis, Tennessee, United States|Gadolin Research, LLC, Beaumont, Texas, United States|Conroe Willis Medical Research, Conroe, Texas, United States|Driscoll Children's Hospital, Corpus Christi, Texas, United States|Crossroads Clinical Research, Corpus Christi, Texas, United States|B S & W Med Center, Dallas, Texas, United States|Baylor - Fort Worth, Fort Worth, Texas, United States|North Texas Clinical Trials, LLC, Fort Worth, Texas, United States|Houston Methodist Research Ins, Houston, Texas, United States|Next Level Urgent Care, Houston, Texas, United States|Centex-Houston, Houston, Texas, United States|Accurate Clinical Management, LLC., Houston, Texas, United States|BioPharma Clinc Site, Houston, Texas, United States|Centex-Wesfield, Houston, Texas, United States|B S & W Med Center, Irving, Texas, United States|Zion Urgent Care Clinic, Katy, Texas, United States|BioPharma Family Practice Center McAllen, McAllen, Texas, United States|BRCR Medical Center, Inc, McAllen, Texas, United States|North Hills Medical Research, North Richland Hills, Texas, United States|Bay Area Infectious Diseases Associates, Pasadena, Texas, United States|Epic Medical Research, Red Oak, Texas, United States|Baylor - Round Rock, Round Rock, Texas, United States|Sun Research Institute, San Antonio, Texas, United States|Consano Clinical Research, LLC, Shavano Park, Texas, United States|APD Clinical Research, Splendora, Texas, United States|Baylor Scott and White Medical Center, Temple, Texas, United States|Crossroads Clin Rch-Victoria, Victoria, Texas, United States|CLS Research Ctr, PLLC, Webster, Texas, United States|CARE ID, Annandale, Virginia, United States|Virginia Commonwealth University, Richmond, Virginia, United States|Evergreen Health Research, Kirkland, Washington, United States|West Virginia University Hospital, Morgantown, West Virginia, United States|Advanced Clinical Research, LLC, Bayamon, Puerto Rico|Dorado Medical Complex Inc, Dorado, Puerto Rico|GCM Medical Group, PSC - Hato Rey Site, San Juan, Puerto Rico",https://ClinicalTrials.gov/show/NCT04427501
NCT04331834,Pre-Exposure Prophylaxis With Hydroxychloroquine for High-Risk Healthcare Workers During the COVID-19 Pandemic,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",PrEP_COVID,"ISGlobal, Barcelona, Spain",https://ClinicalTrials.gov/show/NCT04331834
NCT04780321,JS016 (Anti-SARS-CoV-2 Monoclonal Antibody)With Mild and Moderate COVID-19 or SARS-CoV-2 Asymptomatic Infection Subects,Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,JS016-002-Ib/II,"Beijing Ditan Hospital affiliated to Capital Medical University, Beijing, China|Huashan Hospital affiliated to Fudan University, Shanghai, China",https://ClinicalTrials.gov/show/NCT04780321
NCT04371926,Prophylactic Benefit of Hydroxychloroquine in COVID-19 Cases With Mild to Moderate Symptoms and in Healthcare Workers With High Exposure Risk,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Prevention,TCAI_PREVENT,NA,https://ClinicalTrials.gov/show/NCT04371926
NCT04443803,Characterizing the Perioperative Epidemiology of SARS-CoV-2 (COVID-19) Spread for Quality Improvement of Perioperative Infection Control Program,Observational Model: Case-Only|Time Perspective: Prospective,202005391,"University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States",https://ClinicalTrials.gov/show/NCT04443803
NCT04845971,Efficacy and Safety of Oral Immunotherapy With GcMAF in Hospitalized Patients With COVID-19 Pneumonia,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,COral-MAF1 Trial - Version 1.0,"Ospedale del Mare Hospital, Naples, Italy",https://ClinicalTrials.gov/show/NCT04845971
NCT04757298,COVID-19 Treatment Cascade Optimization Study,Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,UIUC-NJCRI 102497-18274-267805|3R01MD010629-04S2,"North Jersey Community Research Initiative, Newark, New Jersey, United States",https://ClinicalTrials.gov/show/NCT04757298
NCT04914013,Fugal Infection in COVID-19 Patients,Observational Model: Case-Only|Time Perspective: Prospective,Fungi in COVID-19,NA,https://ClinicalTrials.gov/show/NCT04914013
NCT04465474,"Coronavirus Disease 2019 (COVID-19) During Pregnancy: Prevalence of Seroconversion, Effect on Maternal and Perinatal Outcomes and Risk of Vertical Transmission (COVID-MAP)",Observational Model: Other|Time Perspective: Other,COVID-MAP,"Peking University First Hospital, Beijing, Beijing, China|Kwong Wah Hospital, Hong Kong, Hong Kong|Pamela Youde Nethersole Eastern Hospital, Hong Kong, Hong Kong|Princess Margaret Hospital, Hong Kong, Hong Kong|Queen Elizabeth Hospital, Hong Kong, Hong Kong|Queen Mary Hospital, Hong Kong, Hong Kong|The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, Hong Kong|Tuen Mun Hospital, Hong Kong, Hong Kong|United Christian Hospital, Hong Kong, Hong Kong|Hospital Universitario de Torrejón, Torrejón De Ardoz, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04465474
NCT04569851,Clinical Characteristics and Prognostic Factors of Patients With COVID-19 (Coronavirus Disease 2019),Observational Model: Other|Time Perspective: Retrospective,BigCoviData,"Hospital Universitario de Guadalajara, Guadalajara, Spain|Hospital Universitario La Princesa, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04569851
NCT04313023,The Use PUL-042 to Reduce the Infection Rate and Progression to COVID-19 in Adults Exposed to SARS-CoV-2,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",PUL-042-501,"University of California Irvine, Orange, California, United States|Premier Urgent Care of California, San Bernardino, California, United States|Clinical Research of South Florida Alliance for Multispecialty Research, Coral Gables, Florida, United States|Invesclinic US LLC, Fort Lauderdale, Florida, United States|Luminous Cinical Research- South Florida Urgent Care, Miami, Florida, United States|Entrust Clinical Research, Miami, Florida, United States|DBC Research, Tamarac, Florida, United States|Affinity Clinical Research, LLC, Tampa, Florida, United States|Clinical Research Atlanta, Stockbridge, Georgia, United States|Willis-Knighton Physcian Network, Bossier City, Louisiana, United States|Ascension St John, Bartlesville, Oklahoma, United States|Ascension St. John, Tulsa, Oklahoma, United States|Invesclinic US LLC, Edinburg, Texas, United States|MD Anderson Cancer Center, Houston, Texas, United States|Next Level Urgent Care, Houston, Texas, United States",https://ClinicalTrials.gov/show/NCT04313023
NCT04336254,Safety and Efficacy Study of Allogeneic Human Dental Pulp Mesenchymal Stem Cells to Treat Severe COVID-19 Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",2020K-G005|hDPSC-CoVID-2019-02-2020,"Renmin Hospital of Wuhan University (East Campus), Wuhan, Hubei, China",https://ClinicalTrials.gov/show/NCT04336254
NCT04488081,I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,I-SPY-COVID,"University of Alabama at Birmingham, Birmingham, Alabama, United States|UC Davis Medical Center, Davis, California, United States|Long Beach Memorial Medical Center, Long Beach, California, United States|University of Southern California, Los Angeles, California, United States|Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States|University of California San Francisco (UCSF), San Francisco, California, United States|University of Colorado, Aurora, Colorado, United States|Yale Cancer Center, New Haven, Connecticut, United States|Georgetown University, Washington, District of Columbia, United States|Emory University, Atlanta, Georgia, United States|Northwestern University, Chicago, Illinois, United States|University of Iowa, Iowa City, Iowa, United States|Kalispell Regional Medical Center, Kalispell, Montana, United States|Montefiore Medical Center, Bronx, New York, United States|Columbia University Medical Center, New York, New York, United States|Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina, United States|University of Pennsylvania (U Penn), Philadelphia, Pennsylvania, United States|Main Line Health - Lankenau Medical Center, Wynnewood, Pennsylvania, United States|Sanford Health, Sioux Falls, South Dakota, United States",https://ClinicalTrials.gov/show/NCT04488081
NCT04292899,Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Severe Coronavirus Disease (COVID-19),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,GS-US-540-5773|2020-000841-15|ISRCTN15874265,"Kaiser Permanente Los Angeles Medical Center, 3340 E. La Palma Avenue, Anaheim, California, United States|Alta Bates Summit Medical Center, Berkeley, California, United States|Mills-Peninsula Medical Center, Burlingame, California, United States|Eden Medical Center, Castro Valley, California, United States|Kaiser Permanente Los Angeles Medical Center, 9333 Imperial Highway, Downey, California, United States|Kaiser Permanente Los Angeles Medical Center, 9961 Sierra Ave, Fontana, California, United States|St Joseph Hospital Eureka, Fortuna, California, United States|Kaiser Permanente Los Angeles Medical Center, 25825 S. Vermont Ave., Harbor City, California, United States|Kaiser Permanente Los Angeles Medical Center, Los Angeles, California, United States|Kaiser Permanente Los Angeles Medical Center, 6041 Cadillac Ave., Los Angeles, California, United States|Kaiser Permanente Los Angeles Medical Center, 5601 De Soto Avenue, Los Angeles, California, United States|Mission Hospital Regional Medical Center, Mission Viejo, California, United States|Kaiser Permanente Los Angeles Medical Center, 27300 Iris Avenue, Moreno Valley, California, United States|El Camino Hospital, Mountain View, California, United States|Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States|Kaiser Permanente Oakland Medical Center, Oakland, California, United States|Kaiser Permanente Los Angeles Medical Center, 2295 S. Vineyard Avenue, Ontario, California, United States|The Center for Cancer Prevention and Treatment at St. Joseph Hospital of Orange, Orange, California, United States|Kaiser Permanente Los Angeles Medical Center, 13651 Willard Street, Panorama City, California, United States|Kaiser Permanente Los Angeles Medical Center, 10800 Magnolia Avenue, Riverside, California, United States|Sutter Medical Center Sacramento, One Medical Plaza, Roseville, California, United States|Sutter Medical Center Sacramento, Sacramento, California, United States|Kaiser Permanente Los Angeles Medical Center, 4647 Zion Avenue, San Diego, California, United States|Kaiser Permanente Los Angeles Medical Center, 9455 Clairemont Mesa Blvd, San Diego, California, United States|Kaiser Permanente Oakland Medical Center, 1200 El Camino Real, San Francisco, California, United States|California Pacific Medical Center-Infectious Disease Associates Medical Group, San Francisco, California, United States|Kaiser Permanente Oakland Medical Center, 2425 Geary Blvd, San Francisco, California, United States|Kaiser Permanente Oakland Medical Center, 250 Hospital Parkway, Suite 850, San Jose, California, United States|Kaiser Permanente Oakland Medical Center, 2500 Merced St, San Leandro, California, United States|Kaiser Permanente Oakland Medical Center, 700 Lawrence Expressway, Santa Clara, California, United States|Providence St. Johns Medical Center, Santa Monica, California, United States|Sutter Santa Rosa Regional Hospital, Santa Rosa, California, United States|Stanford Hospital, Stanford, California, United States|University of Colorado Denver, University of Colorado Hospital, Aurora, Colorado, United States|SCL Health St. Joseph Hospital, 1375 East 19th Ave, Denver, Colorado, United States|SCL Health St. Joseph Hospital, Denver, Colorado, United States|Rose Medical Center, Denver, Colorado, United States|SCL Health St. Joseph Hospital, 200 Exempla Circle., Lafayette, Colorado, United States|Yale-New Haven Hospital, New Haven, Connecticut, United States|Kaiser Permanente Hawaii Moanalua Medical Center, Honolulu, Hawaii, United States|John H. Stroger Jr. Hospital of Cook County, Chicago, Illinois, United States|Rush University Medical Center, Chicago, Illinois, United States|University of Chicago, Chicago, Illinois, United States|IU Health Methodist Hospital, Indianapolis, Indiana, United States|University of Iowa Hospitals & Clinics, Iowa City, Iowa, United States|Tulane University, New Orleans, Louisiana, United States|Maine Medical Center, Portland, Maine, United States|Holy Cross Hospital, Silver Spring, Maryland, United States|Tufts Medical Center, Boston, Massachusetts, United States|Brigham & Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|The University of Michigan Hospitals and Health Systems, Ann Arbor, Michigan, United States|Henry Ford Health System, Detroit, Michigan, United States|Hennepin Healthcare, Minneapolis, Minnesota, United States|Mayo Clinic, Rochester, Minnesota, United States|Providence St Patrick Hospital and International Heart Institute of MT Foundation, Missoula, Montana, United States|Darmouth-Hitchhock Medical Center, Lebanon, New Hampshire, United States|Hackensack University Medical Center, Hackensack, New Jersey, United States|Robert Wood Johnson University Hospital Somerset, Hillsborough, New Jersey, United States|Robert Wood Johnson University Hospital Somerset, 1 RWJ Place, New Brunswick, New Jersey, United States|Robert Wood Johnson University Hospital Somerset, 201 Lyons Avenue, Newark, New Jersey, United States|St. Joseph's University Medical Center, Paterson, New Jersey, United States|Jacobi Medical Center, Bronx, New York, United States|James J. Peters Veterans Administration Medical Center, Bronx, New York, United States|Jamaica Hospital Medical Center, Jamaica, New York, United States|Danbury Hospital, Lagrangeville, New York, United States|North Shore University Hospital, Manhasset, New York, United States|North Shore University Hospital, 270-05 76th Ave, New Hyde Park, New York, United States|Icahn School of Medicine at Mount Sinai, 350 East 17th Street, New York, New York, United States|Icahn School of Medicine at Mount Sinai, 1000 10th Avenue, New York, New York, United States|Icahn School of Medicine at Mount Sinai, 440 West 114th St., New York, New York, United States|Icahn School of Medicine at Mount Sinai, New York, New York, United States|Columbia University Medical Center-New York Presbyterian Hospital, New York, New York, United States|New York Presbyterian Hospital/Weill Cornell Medical Center, New York, New York, United States|Duke University Medical Center, Durham, North Carolina, United States|University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States|Kaiser Sunnyside Medical Center, 2875 NW Stucki Ave, Hillsboro, Oregon, United States|Providence Portland Medical Center, Portland, Oregon, United States|Providence St. Vincent Medical Center, Portland, Oregon, United States|Kaiser Sunnyside Medical Center, Portland, Oregon, United States|Hospital of the University of Pennsylvania, 51 N. 31st Street, Philadelphia, Pennsylvania, United States|Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States|Temple University Hospital, Philadelphia, Pennsylvania, United States|The Miriam Hospital, Providence, Rhode Island, United States|Prisma Health Richland Hospital, Columbia, South Carolina, United States|Prisma Health Richland Hospital, 701 Grove Road, Greenville, South Carolina, United States|The Liver Institute of Methodist Dallas Medical Center, Dallas, Texas, United States|UT Southwestern Medical Center Amelia Court, HIV Research Clinic, Dallas, Texas, United States|Baylor University Medical Center, Dallas, Texas, United States|UT Southwestern Medical Center Amelia Court, HIV Research Clinic, 5201 Harry Hines Blvd., Dallas, Texas, United States|UT Southwestern Medical Center Amelia Court, HIV Research Clinic, 6201 Harry Hines Blvd, Dallas, Texas, United States|Baylor University Medical Center, 1400 8th Ave, Fort Worth, Texas, United States|Houston Methodist Hospital, Houston, Texas, United States|Baylor University Medical Center, 2401 S. 31st St., Temple, Texas, United States|University of Utah Health, Salt Lake City, Utah, United States|Virginia Hospital Center, Arlington, Virginia, United States|Inova Fairfax Medical Campus, Falls Church, Virginia, United States|VCU Health Medical Center, Richmond, Virginia, United States|Providence Regional Medical Center Everett, Everett, Washington, United States|Kadlec Regional Medical Center, Kennewick, Washington, United States|Providence St. Peter Hospital, Olympia, Washington, United States|Virginia Mason Medical Center, Seattle, Washington, United States|Swedish Center for Comprehensive Care, Seattle, Washington, United States|MultiCare Deaconess Hospital, Spokane, Washington, United States|MultiCare Tacoma General Hospital, Tacoma, Washington, United States|St Joseph Medical Center, Tacoma, Washington, United States|The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China|CHU Pellegrin, Bordeaux, France|CHU de Montpellier-Hopital Gui de Chauliac, Montpelier Cedex 5, France|CHU de Nantes-Hotel Dieu, Nantes, France|Hopital Saint-Louis, Paris, France|Hopital Saint Antoine, Paris, France|Charite Universitatsmedizin Berlin, Campus Virchow-Klinikum, Medizinische Klinik Infektiologie Pneumologie, Berlin, Germany|Universitatsklinikum Dusseldorf, Klinik fur Gastroenterologie, Hepatologie und Infektiologie, Düsseldorf, Germany|Universitatsklinikum Hamburg-Eppendorf, Hamburg, Germany|Universitätsklinikum Schleswig-Holstein Campus Kiel, Kiel, Germany|Klinikum St. Georg gGmbH Klinik fur Infektiologie, Tropenmedizin, Nephrologie und Rheumatologie, Leipzig, Germany|Klinikum rechts der Isar der TU Munchen, Klinik und Poliklinik Innere Medizin 2, Munich, Germany|Klinik für Hämatologie, Onkologie, Immunologie, München, Germany|Robert-Bosch-Krankenhaus (RBK), Klinik Schillerhohe (KSH) und Dr. Margarete Fischer-Bosch-Institut fur klinische Pharmakologie (IKP), Stuttgart, Germany|Prince of Wales Hospital, Hong Kong, Hong Kong|Princess Margaret Hospital, Hong Kong, Hong Kong|Queen Mary Hospital, Hong Kong, Hong Kong|UOC Malattie Infettive, ASST Papa Giovanni XXIII, Bergamo, Italy|ASST degli Spedali Civili di Brescia, Brescia, Italy|ASST di Cremona - Azienda Socio Sanitaria Territor, Cremona, Italy|UOC Malattie Infettive, IRCCS Ospedale San Raffaele, Milano, Italy|Dipartimento di Malattie Infettive, Malattie Infettive I- Malattie Infettive III, AssT Fatebenefratelli Sacco Ospedale Luigi Sacco, Milano, Italy|UO Malattie Infettive, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy|UOC Medicina Di Laboratorio, Azienda Ospedaliera di Padova, Padova PD, Italy|Azienda Ospedaliero Universitaria di Parma, Parma, Italy|UOC Malattie Infettive I, Fondazione IRCCS Policlinio San Matteo, Pavia, Italy|Ospedale Guglielmo da Saliceto AUSL di Piacenza, Piacenza, Italy|UOC Malattie Infettive ad Alta Intensita di Cure, Istituto Nazionale Malattie Infettive Lazzaro Spallanzani I.R.C.C.S., Roma, Italy|Clinica Universitaria Malattie Infettive, Ospedale Amedeo di Savoia, Torino, Italy|Yokohama Municipal Citizen's Hospital, Kanagawa, Japan|Nagoya City East Medical Center, Nagoya, Japan|Tokyo Metropolitan Bokutoh Hospital, Tokyo, Japan|Kyungpook National University Hospital, Daegu, Korea, Republic of|Seoul Medical Center, Seoul, Korea, Republic of|National Medical Center, Seoul, Korea, Republic of|Amsterdam University Medical Centre - Location AMC, Amsterdam, Netherlands|Leiden University Medical Center, Leiden, Netherlands|Erasmus Medical Centre, Rotterdam, Netherlands|National University Hospital, Singapore, Singapore|Singapore General Hospital, Singapore, Singapore|National Centre for Infectious Diseases, Tan Tock Seng Hospital, Singapore, Singapore|Hospital Principe de Asturias, Alcalá De Henares, Madrid, Spain|Complejo Hospitalario Universitario A Coruña, A Coruña, Spain|Hospital Universitari Vall d'Hebron, Barcelona, Spain|Hospital Universitari de Bellvitge, Barcelona, Spain|Hospital Clinic de Barcelona, Barcelona, Spain|Hospital Universitario Cruces, Bizkaia, Spain|Hospital Universitario Ramón y Cajal, Madrid, Spain|Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain|Hospital Universitario 12 de Octubre, Madrid, Spain|Hospital Universitario La Paz, Madrid, Spain|Hospital Regional Universitario de Málaga, Málaga, Spain|Hospital Universitario Virgen del Rocio, Sevilla, Spain|Sahlgrenska University Hospital, Ostra, Gothenburg, Sweden|SUS (Skanes University Hospital), Malmo, Sweden|Karolinska University Hospital, Stockholm, Sweden|Hopitaux Universitaires de Genève, Genève 14, Switzerland|Ospedale Regionale di Locarno La Carità, Lugano, Switzerland|Universitätsspital Zürich, Zürich, Switzerland|Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan|China Medical University Hospital, Taichung, Taiwan|National Taiwan University Hospital, Taipei City, Taiwan|Imperial College Healthcare NHS Trust, London, Greater London, United Kingdom|Royal Infirmary of Edinburgh, Edinburgh, United Kingdom|Queen Elizabeth University Hospital, Glasgow, United Kingdom|Hull University Teaching Hospitals NHS Trust, Hull, United Kingdom|Royal Lancaster Hospital, Lancaster, United Kingdom|Liverpool University Hospital, Liverpool, United Kingdom|Northwick Park Hospital, London, United Kingdom|Royal Free London NHS Foundation Trust, London, United Kingdom|King's College Hospital NHS Trust, London, United Kingdom|University College London, London, United Kingdom|Manchester University NHS Foundation Trust, Manchester, United Kingdom|Manchester University NHS Foundation Trust, Manchester, United Kingdom|Pennine Acute Hospitals NHS Trust, Manchester, United Kingdom|Derriford Hospital, Plymouth, United Kingdom|Sheffield Teaching Hospitals, Sheffield, United Kingdom",https://ClinicalTrials.gov/show/NCT04292899
NCT04501952,Study to Evaluate the Efficacy and Safety of Remdesivir (GS-5734™) Treatment of Coronavirus Disease 2019 (COVID-19) in an Outpatient Setting,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",GS-US-540-9012|2020-003510-12,"Arizona Liver Health, Chandler, Arizona, United States|Arizona Clinical Trials, Tucson, Arizona, United States|St Joseph Hospital Eureka, Eureka, California, United States|St. Joseph Heritage Healthcare, Fullerton, California, United States|Elevated Health, Huntington Beach, California, United States|Ruane Clinical Research Group, Los Angeles, California, United States|LA Universal Center, INC., Los Angeles, California, United States|Mills Clinical Research, Los Angeles, California, United States|Kaiser Permanente Northern California, Oakland, California, United States|FOMAT Medical Research, Oxnard, California, United States|UC Davis Health, Sacramento, California, United States|Kaiser Permanente Northern California, 6600 Bruceville Road, Sacramento, California, United States|Kaiser Permanente Northern California, 2025 Morse Ave, Sacramento, California, United States|Kaiser Permanente Northern California, 1200 El Camino Real, San Francisco, California, United States|Kaiser Permanente Northern California, 2425 Geary Blvd, San Francisco, California, United States|UCSF Medical Center, San Francisco, California, United States|Kaiser Permanente Northern California, 250 Hospital Parkway, Suite 850, San Jose, California, United States|Kaiser Permanente Northern California, 2500 Merced St, San Leandro, California, United States|St. Joseph Heritage Healthcare, Santa Rosa, California, United States|Premiere Medical Center of Burbank, Inc, Toluca Lake, California, United States|Kaiser Permanente Northern California, 975 Sereno Drive, Vallejo, California, United States|New Hope Research Development DBA HCD, Whittier, California, United States|Centura Health Porter Place, Denver, Colorado, United States|Nuvance Health, Danbury, Connecticut, United States|RecioMed Clinical Research Network, Boynton Beach, Florida, United States|Midland Florida Clinical Research Center, LLC, DeLand, Florida, United States|Invesclinic, Fort Lauderdale, Florida, United States|Lawnwood Regional Medical Center, Fort Pierce, Florida, United States|Evolution Clinical Trials, Hialeah Gardens, Florida, United States|Encore Medical Research, Hollywood, Florida, United States|Advanced Pulmonary Research Institute, Loxahatchee Groves, Florida, United States|L&C Professional Medical Research Institute, Miami, Florida, United States|Laguna Clinical Research Associates, Miami, Florida, United States|CTMD Research, Inc, Palm Springs, Florida, United States|IMIC Inc, Palmetto Bay, Florida, United States|Luminous Clinical Research - South Florida Urgent Care, Pembroke Pines, Florida, United States|St. Josephs Comprehensive Research Institute, Tampa, Florida, United States|AIDS Research and Treatment Center of the Treasure Coast, Vero Beach, Florida, United States|Triple O Research Institute PA, West Palm Beach, Florida, United States|Agile Clinical Research Trials, Atlanta, Georgia, United States|Mercer University School of Medicine, Macon, Georgia, United States|Infectious Disease Associates of Kansas City, P.C.Infectious Disease Associates of Kansas City, P.C., Burr Ridge, Illinois, United States|Metro Infectious Disease Consultants, Burr Ridge, Illinois, United States|NorthStar Medical Center, Chicago, Illinois, United States|NorthShore University Healthsystem, Evanston, Illinois, United States|Tulane University, New Orleans, Louisiana, United States|Holy Cross Hospital, Inc., Baltimore, Maryland, United States|University of Maryland Baltimore, Baltimore, Maryland, United States|Tufts Medical Center, Boston, Massachusetts, United States|South Shore Hospital, South Weymouth, Massachusetts, United States|VA Boston Healthcare System, West Roxbury, Massachusetts, United States|Be Well Medical Center, Berkley, Michigan, United States|Onyx Research Institute, Flint, Michigan, United States|Memorial Hospital of Gulfport, Gulfport, Mississippi, United States|Metro Infectious Disease Consultants, Kansas City, Missouri, United States|Quality Clinical Research Inc., Omaha, Nebraska, United States|AB Clinical Trials, Las Vegas, Nevada, United States|AXCES Research Group, Santa Fe, New Mexico, United States|New York Presbyterian Hospital, Flushing, New York, United States|Northwell Health, New Hyde Park, New York, United States|Atrium Health Carolinas Medical Center, Charlotte, North Carolina, United States|East Carolina University, Greenville, North Carolina, United States|Rosedale Infectious Diseases, Huntersville, North Carolina, United States|Christ Hospital, Cincinnati, Ohio, United States|Cherokee Nation WW Hastings Hospital, Tahlequah, Oklahoma, United States|Providence St. Vincent Medical Center, Portland, Oregon, United States|Temple University, Philadelphia, Pennsylvania, United States|Avera Research Institute, Sioux Falls, South Dakota, United States|University of Tennessee Health Science Center, Knoxville, Tennessee, United States|Central Texas Clinical Research, Austin, Texas, United States|UT Physicians, Bellaire, Texas, United States|Baylor University Medical Center, 700 Scott and White Dr., College Station, Texas, United States|Baylor University Medical Center, Dallas, Texas, United States|UT Southwestern Medical Center, Dallas, Texas, United States|Care United Research, LLC, Forney, Texas, United States|VIP Trials, Harlingen, Texas, United States|University of Texas, Houston, Texas, United States|The Crofoot Research Center, Inc, Houston, Texas, United States|Baylor University Medical Center, 1901 North McArthur Blvd, Irving, Texas, United States|Laguna Clinical Research Associates, Laredo, Texas, United States|Diagnostic Clinic of Longview - Center for Clinical Research, Longview, Texas, United States|STAAMP Research, San Antonio, Texas, United States|Sugar Lakes Family Practice, Sugar Land, Texas, United States|Baylor University Medical Center, 2201 MacArthur Dr., Suite 100, Waco, Texas, United States|ClinPoint Trials, Waxahachie, Texas, United States|Intermountain Healthcare, Murray, Utah, United States|Virginia Commonwealth University, Richmond, Virginia, United States|Providence Regional Medical Center Everett, Everett, Washington, United States|Sound Medical Research, Port Orchard, Washington, United States|Fred Hutchinson Cancer Research Center, Seattle, Washington, United States|Providence Medical Research Center, Spokane, Washington, United States|Wisconsin Corporation for Biomedical Research, Milwaukee, Wisconsin, United States|Aalborg University Hospital, Aalborg, Denmark|Aarhus University Hospital, Aarhus N, Denmark|Rigshospitalet, Copenhagen, Denmark|Hvidovre Hospital, Hvidovre, Denmark|Odense University Hospital, Odense, Denmark|Hospital Senhora da Oliveira, Guimaraes, Portugal|Hospital Universitari Germans Trias i Pujol, Badalona, Spain|Hospital Clinic, Barcelona, Spain|Hospital Universitario Infanta Leonor, Madrid, Spain|Bradford Teaching Hospitals NHS Foundation Trust, Bradford, United Kingdom|University College Hospital, London, United Kingdom|St Mary's Hospital, London, United Kingdom|Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, United Kingdom",https://ClinicalTrials.gov/show/NCT04501952
NCT04456595,Clinical Trial of Efficacy and Safety of Sinovac's Adsorbed COVID-19 (Inactivated) Vaccine in Healthcare Professionals,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",COV-02-IB,"Universidade de Brasília, Brasilia, DF, Brazil|Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil|Hospital Universitário Júlio Müller, Cuiabá, Mount, Brazil|Hospital Universitário Maria Aparecida Pedrossian, Campo Grande, MS, Brazil|Hospital das Clínicas da Universidade Federal do Paraná, Curitiba, PR, Brazil|Hospital Escola da Universidade Federal de Pelotas, Pelotas, RS, Brazil|Hospital São Lucas da Pontificia Universidade Catolica do Rio Grande do Sul, Porto Alegre, RS, Brazil|Hospital de Amor - Fundação Pio XII, Barretos, SP, Brazil|Hospital das Clínicas da UNICAMP, Campinas, SP, Brazil|Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo, Ribeirao Preto, SP, Brazil|Instituto de Infectologia Emílio Ribas, Sao Paulo, SP, Brazil|Centro de Pesquisas Clínicas do Instituto Central do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, SP, Brazil|Instituto Israelita de Ensino e Pesquisa Albert Einstein, Sao Paulo, SP, Brazil|Universidade Municipal de São Caetano do Sul, São Caetano do Sul, SP, Brazil|Faculdade de Medicina de São José do Rio Preto - FAMERP, São José Do Rio Preto, São Paulo, Brazil|Instituto de Infectologia Evandro Chagas - Fiocruz, Rio De Janeiro, Brazil",https://ClinicalTrials.gov/show/NCT04456595
NCT04466280,"Efficacy and Safety of Mucoadhesive Sustained Release, Mucodentol, in Comparison With Hydroxychloroquine to Prevent COVID-19","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Prevention",IR.BMSU.REC.1399.086,"Mohammad Sadegh Bagheri Baghdasht, Tehran, Iran, Islamic Republic of",https://ClinicalTrials.gov/show/NCT04466280
NCT04481633,Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,RC31/20/0186|2020-A01906-33,"Limoges university Hospital, Limoges, France|Montpellier University Hospital, Montpellier, France|Pitié Salpêtrière Hospital - Hépatologie, Paris, France|Pitié Salpêtrière Hospital - Médecine interne, Paris, France|Haut-Lévêque Hospital - Gastro-entérologie, Pessac, France|Haut-Lévêque Hospital - Médecine interne, Pessac, France|Joseph Ducuing Hospital - Médecine interne, Toulouse, France|Toulouse university Hospital - Larrey Dermatologie, Toulouse, France|Toulouse University Hospital - Rhumatologie, Toulouse, France|Toulouse University Hospital, Toulouse, France|University Hospital of Toulouse - Rangueil Médecine interne, Toulouse, France|University hospital Toulouse - Purpan Médecine interne, Toulouse, France",https://ClinicalTrials.gov/show/NCT04481633
NCT04385264,#StayHome: Early Hydroxychloroquine to Reduce Secondary Hospitalisation and Household Transmission in COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",Unisante,"Unisanté, Lausanne, Vaud, Switzerland",https://ClinicalTrials.gov/show/NCT04385264
NCT04312997,The Use of PUL-042 Inhalation Solution to Reduce the Severity of COVID-19 in Adults Positive for SARS-CoV-2 Infection,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",PUL-042-502,"University of California Irvine, Orange, California, United States|Premeir Urgent Care of California, San Bernardino, California, United States|Clinical Research of South Florida Alliance for Multispecialty Research, Coral Gables, Florida, United States|Invesclinic US LLC, Fort Lauderdale, Florida, United States|DBC Research Corp., Tamarac, Florida, United States|Affinity Clinical Research, LLC, Tampa, Florida, United States|St. Elizabeth Healthcare, Edgewood, Kentucky, United States|Ascension St. John, Bartlesville, Oklahoma, United States|Ascension St. John, Tulsa, Oklahoma, United States|MD Anderson Cancer Center, Houston, Texas, United States|Next Level Urgent Care, Houston, Texas, United States",https://ClinicalTrials.gov/show/NCT04312997
NCT04370782,Hydroxychloroquine and Zinc With Either Azithromycin or Doxycycline for Treatment of COVID-19 in Outpatient Setting,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,20-21,"St Francis Hospital, Roslyn, New York, United States",https://ClinicalTrials.gov/show/NCT04370782
NCT04334980,"Evaluating the Safety, Tolerability and Immunogenicity of bacTRL-Spike Vaccine for Prevention of COVID-19",Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,bacTRL-Spike-1,"Nucleus Network Pty Ltd (Trading as Centre for Clinical Studies), Melbourne, Victoria, Australia",https://ClinicalTrials.gov/show/NCT04334980
NCT04374279,Trial to Promote Recovery From COVID-19 With Endocrine Therapy,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,COV2003|IRB00249425,"Johns Hopkins Hospital, Baltimore, Maryland, United States",https://ClinicalTrials.gov/show/NCT04374279
NCT04539262,"Study in Participants With Early Stage Coronavirus Disease 2019 (COVID-19) to Evaluate the Safety, Efficacy, and Pharmacokinetics of Remdesivir Administered by Inhalation","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",GS-US-553-9020,"The Institute for Liver Health, Mesa, Arizona, United States|The Institute for Liver Health, Tucson, Arizona, United States|Franco Felizarta, MD, Bakersfield, California, United States|Aurora FDRC Inc., Costa Mesa, California, United States|Elevated Health, Huntington Beach, California, United States|Cedars-Sinai Medical Center, Los Angeles, California, United States|Western Clinical Research, Placentia, California, United States|UC Davis Health/Medical Center, Sacramento, California, United States|Bradenton Research Center, Inc., Bradenton, Florida, United States|Integrity Clinical Research, LLC, Doral, Florida, United States|Holy Cross Hospital, Fort Lauderdale, Florida, United States|Evolution Clinical Trials, Inc., Hialeah Gardens, Florida, United States|Research in Miami, Inc., Hialeah, Florida, United States|Optimus U Corporation, Miami, Florida, United States|L & C Professional Medical Research Institute, Miami, Florida, United States|Westchester Research Center at Westchester General Hospital, Miami, Florida, United States|MedBio Trials, Miami, Florida, United States|Nuovida Research Center, Corp, Miami, Florida, United States|IMIC Inc, Palmetto Bay, Florida, United States|Triple O Research Institute, PA, West Palm Beach, Florida, United States|Family Care Research, Boise, Idaho, United States|CTU Covid Research Center, New Orleans, Louisiana, United States|STAT Research, Vandalia, Ohio, United States|Inquest Clinical Research, Baytown, Texas, United States|DFW Clinical Research, Dallas, Texas, United States|Baylor Research Institute, Dallas, Texas, United States|PCP for Life-Tidwell, Houston, Texas, United States|Providence Regional Medical Center Everett, Everett, Washington, United States",https://ClinicalTrials.gov/show/NCT04539262
NCT04377711,A Study of the Safety and Efficacy of Ciclesonide in the Treatment of Non-hospitalized COVID-19 Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",ALV-020-001,"University of Buffalo, Buffalo, New York, United States",https://ClinicalTrials.gov/show/NCT04377711
NCT04348409,Efficacy and Safety of Nitazoxanide for the Treatment of Hospitalized Patients With Moderate COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",NITFQM0320OR,"Hospital Vera Cruz, Campinas, São Paulo, Brazil|Centro de Genomas, São Paulo, Brazil|Hospital Emílio Ribas, São Paulo, Brazil",https://ClinicalTrials.gov/show/NCT04348409
NCT04576312,Study to Assess the Safety of Ascending Doses of UNI911 INHALATION in Healthy Volunteers in Preparation for Evaluation in Adults With COVID-19,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Other",UNI911-101,"DanTrials, Copenhagen, Denmark",https://ClinicalTrials.gov/show/NCT04576312
NCT04649840,Estimation of Dynamics of Humoral and Cellular Immunity in COVID-19 Patients,Observational Model: Other|Time Perspective: Prospective,IBCE_COVID19_Immunity,"Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus, Minsk, Belarus",https://ClinicalTrials.gov/show/NCT04649840
NCT04672395,A Controlled Phase 2/3 Study of Adjuvanted Recombinant SARS-CoV-2 Trimeric S-protein Vaccine (SCB-2019) for the Prevention of COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",CLO-SCB-2019-003,"Anima, Alken, Belgium|Universitair Ziekenhuis Gent, Gent, Belgium|Private Practice RESPISOM Namur, Namur, Belgium|Instituto D'OR de Pesquisa e Ensino, Rio de Janeiro, Rio Do Janeiro, Brazil|Instituto Atena de Pesquisa Clinica, Natal, Rio Grande Do Norte, Brazil|CPCLIN - Centro de Pesquisas Clínicas de Natal, Natal, Rio Grande Do Norte, Brazil|Hospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande Do Sul, Brazil|Hospital da Universidade Federal de Santa Maria CEP/UFSM, Santa Maria, Rio Grande Do Sul, Brazil|Centro de Atención e investigación Médica S.A.S, CAIMED S.A.S - sede Bogotá D.C., Bogotá, Cundinamarca, Colombia|Centro de Atención e investigación Médica S.A.S, CAIMED S.A.S - sede Acacías, Acacías, Colombia|Clínica de la Costa Ltda., Barranquilla, Colombia|Centro de Estudios en Infectología Pediátrica S.A.S. - CEIP S.A.S., Cali, Colombia|Centro de Atención e investigación Médica S.A.S, CAIMED S.A.S - sede Aguazul, Casanare, Colombia|Centro de Atención e investigación Médica S.A.S, CAIMED S.A.S - sede Yopal, Yopal, Colombia|Centro Sanitario de Santo Domingo (Satellite Site), Santo Domingo, Dominican Republic|Hospital Universitario Maternidad Nuestra Senora de la Altagracia., Santo Domingo, Dominican Republic|Klinikum Würzburg Mitte gGmbH - Standort Juliusspital, Wuerzburg, Bayern, Germany|IKF Pneumologie GmbH & Co. KG, Frankfurt am Main, Hessen, Germany|IKF Pneumologie Mainz, Mainz, Rheinland Pfalz, Germany|Berliner Centrum f. Reise- und Tropenmedizin (BCRT), Berlin, Germany|Institute of Medicine, Maharajgunj, Kathmandu, Nepal|Dhulikhel Hospital, Dhulikhel, Nepal|Cevaxin David, David, Doleguita, Panama|Cevaxin 24 de diciembre, Ciudad de Panamá, Panama|Cevaxin Panama Clinic, Ciudad de Panamá, Panama|CEVAXIN Chorrera, Panama, Panama|Instituto de Investigaciones Cientificas y Servicios de Alta Tecnologia INDICASAT, Panama, Panama|Cevaxin Av Mexico, Panamá, Panama|De La Salle Medical and Health Sciences Institute, Dasmariñas, Cavite, Philippines|Las Pinas Doctors Hospital, Las Piñas, Philippines|Tropical Disease Foundation, Makati, Philippines|Manila Doctors Hospital, Manila, Philippines|University of the Philippines Manila - College of Public Health, Manila, Philippines|Asian Hospital and Medical Center, Muntinlupa, Philippines|UERM Memorial Medical Center, Quezon City, Philippines|University of the East Ramon Magsaysay Memorial Medical Center, Quezon City, Philippines|FEU-NRMF Medical Center, Quezon City, Philippines|St. Luke's Medical Center, Taguig, Philippines|KO-MED Centra Kliniczne Lublin II, Lublin, Poland|KO-MED Centra Kliniczne Pulawy, Puławy, Poland|Centrum Medyczne Medyk, Rzeszów, Poland|Centrum Medyczne Pratia Poznan, Skórzewo, Poland|KO-MED Centra Kliniczne Staszow, Staszów, Poland|ETG Warszawa, Warszawa, Poland|Wits Clinical Research, Johannesburg, Gauteng, South Africa|DJW Research, Krugersdorp, Gauteng, South Africa|Soweto Clinical Trials Centre, Soweto, Gauteng, South Africa|Dr JM Engelbrecht Trial Site, Somerset West, Western Cape, South Africa",https://ClinicalTrials.gov/show/NCT04672395
NCT04418375,Establishment of a Biological Collection During COVID-19 Serological Screening in APHP Professionals (COVID-HOP),Observational Model: Cohort|Time Perspective: Prospective,APHP200609|2020-A01364-35,"HEGP, Paris, France",https://ClinicalTrials.gov/show/NCT04418375
NCT04353518,Clinical Trial to Evaluate Mycobacterium w in Preventing COVID-19 in Subjects at Risk of Getting Infected With COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",CRSC20005,"All India Institute of Medical Sciences, Bhopal, Bhopal, Madhya Pradesh, India|Post Graduate Institute of Medical Education and Research, Chandigarh, India|All lndia Institute of Medical Science, Delhi, Delhi, India",https://ClinicalTrials.gov/show/NCT04353518
NCT04852705,"A Study to Evaluate the Efficacy, Safety and Immunogenicity of SARS-CoV-2 Vaccine (Vero Cells), Inactivated in Healthy Adults Aged 18 Years and Older (COVID-19)","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention",2021L001,NA,https://ClinicalTrials.gov/show/NCT04852705
NCT04981405,"COVID-19 Vaccine Effectiveness in St. Petersburg, Russia",Observational Model: Case-Control|Time Perspective: Retrospective,CDRU-003,"Mikhail Cherkashin, Saint Petersburg, Saint-Petersburg, Russian Federation|Oksana Stanevich, Saint Petersburg, Russian Federation",https://ClinicalTrials.gov/show/NCT04981405
NCT04780035,"Study of the Tolerability, Safety, Immunogenicity and Preventive Efficacy of the EpiVacCorona Vaccine for the Prevention of COVID-19","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention",COV/pept-03/20,"State Budgetary Healthcare Institution of the Moscow region - Krasnogorsk City Hospital # 1 (short name: SBHI MR KCH # 1), Krasnogorsk, Moscow Region, Russian Federation|Federal State Autonomous Educational Institution of Higher Education - Immanuel Kant Baltic University (short name: FSAEIHE- I. Kant Baltic Federal University), Kaliningrad, Russian Federation|State Autonomous Healthcare Institution - Clinical City Hospital # 7 of Kazan (short name: SAHI CCH # 7), Kazan, Russian Federation|Federal State Budgetary Institution - N.I. Pirogov National Medical and Surgical Center, Ministry of Health of the Russian Federation (short name: FSBI - N.I. Pirogov NMSC, Ministry of Health of the Russian Federation), Moscow, Russian Federation|Federal State Budgetary Research Institution - Academician B.V. Petrovsky Russian Research Center for Surgery (short name: FSBRI - Academician B.V. Petrovsky RRCS), Moscow, Russian Federation|Research Center: Federal State Budgetary Institution - Central Clinical Hospital with Polyclinic, Administrative Office of the President of the Russian Federation (short name: FSBI Central Clinical Hospital with Polyclinic), Moscow, Russian Federation|State Budgetary Healthcare Institution of the Moscow region - M.F. Vladimirsky Moscow Regional Research Clinical Institute (short name: M.F. Vladimirsky SBHI MRRCI), Moscow, Russian Federation|State Budgetary Educational Institution of Higher Professional Education - Tyumen State Medical University, Ministry of Health of the Russian Federation (short name: SBEIHPE - Tyumen State Medical University, Ministry of Health of Russian Federation), Tyumen, Russian Federation",https://ClinicalTrials.gov/show/NCT04780035
NCT04745351,Study to Evaluate the Efficacy and Safety of Remdesivir in Participants With Severely Reduced Kidney Function Who Are Hospitalized for Coronavirus Disease 2019 (COVID-19),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",GS-US-540-5912|2020-005416-22,"St. Vincent's Health System, Birmingham, Alabama, United States|Pulmonary Associates of Mobile, P.C., Mobile, Alabama, United States|St. Joseph Hospital Eureka, Eureka, California, United States|Hoag Memorial Hospital Presbyterian, 16200 Sand Canyon Ave, Irvine, California, United States|Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States|Sutter Medical Center Sacramento, Sacramento, California, United States|San Francisco VA Medical Center, San Francisco, California, United States|Stanford Hospital and Clinics, Stanford, California, United States|Torrance Memorial Medical Center, Torrance, California, United States|Mayo Clinic Florida, Jacksonville, Florida, United States|Genesis Clinical Research, Tampa, Florida, United States|Northwestern University Comprehensive Transplant Center, Chicago, Illinois, United States|University of Chicago, Chicago, Illinois, United States|Great Lakes Clinical Trials, Chicago, Illinois, United States|Northwestern Medicine Central DuPage Hospital, Winfield, Illinois, United States|Rapides Regional Medical Center, Alexandria, Louisiana, United States|Tulane Medical Center, 2000 Canal St., New Orleans, Louisiana, United States|Tulane Medical Center, New Orleans, Louisiana, United States|Maine Medical Center, Portland, Maine, United States|Wake Forest University Health Sciences, Bethesda, Maryland, United States|Holy Cross Hospital, 19801 Observation Dr, Germantown, Maryland, United States|Holy Cross Hospital, Silver Spring, Maryland, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Mayo Clinic Hospital, Rochester, Minnesota, United States|Renown Regional Medical Center, Reno, Nevada, United States|Lincoln Medical Center, Bronx, New York, United States|Jacobi Medical Center, Bronx, New York, United States|Montefiore Medical Center, Bronx, New York, United States|New York - Presbyterian Hospital/Weill Cornell Medical Center, New York, New York, United States|PMG Infectious Disease Consultants (administrative), Portland, Oregon, United States|Temple University Hospital, Philadelphia, Pennsylvania, United States|Houston Methodist Hospital, Houston, Texas, United States|Memorial Hermann Hospital at TMC, Houston, Texas, United States|VCU Health Medical Center, Richmond, Virginia, United States|Providence Regional Medical Center Everett, Everett, Washington, United States|Swedish Medical Center, Seattle, Washington, United States|MultiCare Health System - Pulmonary and Critical Care Center, Spokane, Washington, United States|Providence Health Care, Spokane, Washington, United States|Providence Health Care, 5633 N Lidgerwood, Spokane, Washington, United States|MultiCare Good Samaritan Hospital, Tacoma, Washington, United States|Hospital Garcia de Orta, Almada, Portugal|Centro Hospitalar Cova da Beira EPE, Covilhã, Portugal|Hospital Senhora da Oliveira, Guimaraes, Portugal|Hospital da Luz, Lisboa, Portugal|Centro Hospitalar Lisboa Ocidental, Lisbon, Portugal|Centro Hospitalar do Porto - Hospital de Santo Antonio, Odivelas, Portugal|Centro Hospitalar de Vila Nova de Gaia, Vila Nova de Gaia, Portugal|Hospital Universitario Germans Trias I Pujol, Badalona, Spain|Hospital del Mar, Barcelona, Spain|Hospital Universitari de Bellvitge, Barcelona, Spain|Hospital Clinic de Barcelona, Barcelona, Spain|Hospital General Universitario de Elche, Elche, Spain|Hospital General Universitario Gregorio Maranon, Madrid, Spain|Hospital Universitario 12 de Octubre, Madrid, Spain|Hospital General Universitario de Valencia, Valencia, Spain|Hospital Universitari i Politecnic La Fe, Valencia, Spain|Barts Health NHS Trust, The Royal London Hospital, London, United Kingdom|Kings College Hospital, London, United Kingdom|Imperial College Healthcare NHS Trust, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04745351
NCT04379479,Clinical Effect of Dialyzable Leukocyte Extract in Suspected or Confirmed Cases of COVID-19 (FUTURE-T),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",IC-20-001|SH-001-2020,"Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Mexico City, Mexico",https://ClinicalTrials.gov/show/NCT04379479
NCT04360551,Pilot Clinical Trial of the Safety and Efficacy of Telmisartan for the Mitigation of Pulmonary and Cardiac Complications in COVID-19 Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",H051,"University of Hawaii - Manoa, John A Burns School of Medicine UH Clinics at Kakaako, Honolulu, Hawaii, United States",https://ClinicalTrials.gov/show/NCT04360551
NCT04484597,Predictors of COVID-19 Infection and Disease Progression,Observational Model: Case-Control|Time Perspective: Cross-Sectional,Prof. Refat Sadeq,"Prof. Refat Sadeq, Port Said, Egypt",https://ClinicalTrials.gov/show/NCT04484597
NCT04343989,A Randomized Placebo-controlled Safety and Dose-finding Study for the Use of the IL-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",20-00392,"New York University School of Medicine, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04343989
NCT04460183,A Study to Assess Efficacy and Safety of RESP301 Plus Standard of Care (SOC) Compared to SOC Alone in Hospitalized Participants With COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,RESP301-002,"Bradford Teaching Hospitals NHS Foundation Trust, Bradford, United Kingdom|Imperial College Healthcare NHS Trust, St. Mary's Hospital, London, United Kingdom|Pennine Acute Hospitals Trust (Nroth Manchester General Hospital), Manchester, United Kingdom|Royal Preston Hospital, Preston, United Kingdom",https://ClinicalTrials.gov/show/NCT04460183
NCT04348435,"A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Allogeneic Mesenchymal Stem Cell Therapy (HB-adMSCs) to Provide Protection Against COVID-19","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",HBCOV02,"Hope Biosciences Stem Cell Research Foundation, Sugar Land, Texas, United States",https://ClinicalTrials.gov/show/NCT04348435
NCT04329572,Efficacy and Safety of Hydroxychloroquine and Azithromycin for the Treatment of Hospitalized Patients With Moderate to Severe COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,HIAPRE0320OR,"Prevent Senior Private Operadora de Saúde LTDA., São Paulo, Brazil",https://ClinicalTrials.gov/show/NCT04329572
NCT04421625,Patients and Health Staff of Cancer Centres During the Covid-19 Pandemic,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Screening,ICO-2020-16,"Institut de Cancerologie de l'Ouest, Angers, France|Centre Jean Perrin, Clermont-Ferrand, France|Institut de Cancérologie de Lorraine, Vandoeuvre les nancy, France",https://ClinicalTrials.gov/show/NCT04421625
NCT04832932,The COVID-19 Back-to-Normal Study,Observational Model: Other|Time Perspective: Prospective,20210103MEBO,"MEBO Research, Inc, Miami, Florida, United States|Kahite, Vonore, Tennessee, United States|Mary Washington Hospital Research, Fredericksburg, Virginia, United States|MEBO Research Africa, Kilifi, Kenya|Mebo Research (Uk), London, England, United Kingdom",https://ClinicalTrials.gov/show/NCT04832932
NCT04707534,Dexamethasone for COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,12927,"University of Oklahoma Medical Center, Oklahoma City, Oklahoma, United States",https://ClinicalTrials.gov/show/NCT04707534
NCT04292730,Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,GS-US-540-5774|2020-000842-32|ISRCTN85762140,"Kaiser Permanente Los Angeles Medical Center, 3340 E. La Palma Avenue, Anaheim, California, United States|Alta Bates Summit Medical Center, Berkeley, California, United States|Mills-Peninsula Medical Center, Burlingame, California, United States|Eden Medical Center, Castro Valley, California, United States|Kaiser Permanente Los Angeles Medical Center, 9333 Imperial Highway, Downey, California, United States|Kaiser Permanente Los Angeles Medical Center, 9961 Sierra Ave, Fontana, California, United States|St Joseph Hospital Eureka, Fortuna, California, United States|Kaiser Permanente Los Angeles Medical Center, 25825 S. Vermont Ave., Harbor City, California, United States|Kaiser Permanente Los Angeles Medical Center, Los Angeles, California, United States|Kaiser Permanente Los Angeles Medical Center, 6041 Cadillac Ave., Los Angeles, California, United States|Kaiser Permanente Los Angeles Medical Center, 5601 De Soto Avenue, Los Angeles, California, United States|Mission Hospital Regional Medical Center, Mission Viejo, California, United States|Kaiser Permanente Los Angeles Medical Center,27300 Iris Avenue, Moreno Valley, California, United States|El Camino Hospital, Mountain View, California, United States|Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States|Kaiser Permanente Oakland Medical Center, Oakland, California, United States|Kaiser Permanente Los Angeles Medical Center, 2295 S. Vineyard Avenue, Ontario, California, United States|The Center for Cancer Prevention and Treatment at St. Joseph Hospital of Orange, Orange, California, United States|Kaiser Permanente Los Angeles Medical Center,13651 Willard Street, Panorama City, California, United States|Kaiser Permanente Los Angeles Medical Center, 10800 Magnolia Avenue, Riverside, California, United States|Sutter Medical Center Sacramento, One Medical Plaza, Roseville, California, United States|Sutter Medical Center Sacramento, Sacramento, California, United States|Kaiser Permanente Los Angeles Medical Center, 4647 Zion Avenue, San Diego, California, United States|Kaiser Permanente Los Angeles Medical Center, 9455 Clairemont Mesa Blvd, San Diego, California, United States|Kaiser Permanente Oakland Medical Center, 1200 El Camino Real, San Francisco, California, United States|California Pacific Medical Center-Infectious Disease Associates Medical Group, San Francisco, California, United States|Kaiser Permanente Oakland Medical Center, 2425 Geary Blvd, San Francisco, California, United States|Kaiser Permanente Oakland Medical Center, 250 Hospital Parkway, Suite 850, San Jose, California, United States|Kaiser Permanente Oakland Medical Center, 2500 Merced St, San Leandro, California, United States|Kaiser Permanente Oakland Medical Center, 700 Lawrence Expressway, Santa Clara, California, United States|Providence St. Johns Medical Center, Santa Monica, California, United States|Sutter Santa Rosa Regional Hospital, Santa Rosa, California, United States|Stanford Hospital, Stanford, California, United States|University of Colorado Denver, University of Colorado Hospital, Aurora, Colorado, United States|SCL Health St. Joseph Hospital, 1375 East 19th Ave, Denver, Colorado, United States|SCL Health St. Joseph Hospital, Denver, Colorado, United States|Rose Medical Center, Denver, Colorado, United States|SCL Health St. Joseph Hospital, 200 Exempla Circle., Lafayette, Colorado, United States|Yale University, New Haven, Connecticut, United States|Kaiser Permanente Hawaii Moanalua Medical Center, Honolulu, Hawaii, United States|Cook County General Hospital, Chicago, Illinois, United States|Rush University Medical Center, Chicago, Illinois, United States|University of Chicago, Chicago, Illinois, United States|IU Health Methodist Hospital, Indianapolis, Indiana, United States|University of Iowa Hospitals & Clinics, Iowa City, Iowa, United States|Tulane University, New Orleans, Louisiana, United States|Maine Medical Center, Portland, Maine, United States|Holy Cross Hospital, Silver Spring, Maryland, United States|Tufts Medical Center, Boston, Massachusetts, United States|Brigham & Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States|Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|The University of Michigan Hospitals and Health Systems, Ann Arbor, Michigan, United States|Henry Ford Health System, Detroit, Michigan, United States|Hennepin Healthcare, Minneapolis, Minnesota, United States|Mayo Clinic, Rochester, Minnesota, United States|Providence St Patrick Hospital and International Heart Institute of MT Foundation, Missoula, Montana, United States|Darmouth-Hitchhock Medical Center, Lebanon, New Hampshire, United States|Hackensack Medical Center, Hackensack, New Jersey, United States|Robert Wood Johnson University Hospital Somerset, Hillsborough, New Jersey, United States|Robert Wood Johnson University Hospital Somerset, 1 RWJ Place, New Brunswick, New Jersey, United States|Robert Wood Johnson University Hospital Somerset, 201 Lyons Avenue, Newark, New Jersey, United States|St. Joseph's University Medical Center, Paterson, New Jersey, United States|Jacobi Medical Center, Bronx, New York, United States|James J. Peters Veterans Administration Medical Center, Bronx, New York, United States|Jamaica Hospital Medical Center, Jamaica, New York, United States|Danbury Hospital, Lagrangeville, New York, United States|North Shore University Hospital, Manhasset, New York, United States|North Shore University Hospital, 270-05 76th Ave, New Hyde Park, New York, United States|Icahn School of Medicine at Mount Sinai, 350 East 17th Street, New York, New York, United States|Icahn School of Medicine at Mount Sinai, 1000 10th Avenue, New York, New York, United States|Icahn School of Medicine at Mount Sinai, 440 West 114th St., New York, New York, United States|Icahn School of Medicine at Mount Sinai, New York, New York, United States|Columbia University Irving Medical Center, New York, New York, United States|Weill Cornell Medical College/NYU Presbyterian Hospital, New York, New York, United States|Duke University Medical Center, Durham, North Carolina, United States|University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States|Kaiser Sunnyside Medical Center, 2875 NW Stucki Ave, Hillsboro, Oregon, United States|Providence Portland Medical Center, Portland, Oregon, United States|Providence St. Vincent Medical Center, Portland, Oregon, United States|Kaiser Sunnyside Medical Center, Portland, Oregon, United States|Hospital of the University of Pennsylvania, 51 N. 31st Street, Philadelphia, Pennsylvania, United States|Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States|Temple University Hospital, Philadelphia, Pennsylvania, United States|The Miriam Hospital, Providence, Rhode Island, United States|Prisma Health Richland Hospital, Columbia, South Carolina, United States|Prisma Health Richland Hospital, 701 Grove Road, Greenville, South Carolina, United States|The Liver Institute of Methodist Dallas Medical Center, Dallas, Texas, United States|UT Southwestern Medical Center Amelia Court, HIV Research Clinic, Dallas, Texas, United States|Baylor University Medical Center, Dallas, Texas, United States|UT Southwestern Medical Center Amelia Court, HIV Research Clinic, 5201 Harry Hines Blvd., Dallas, Texas, United States|UT Southwestern Medical Center Amelia Court, HIV Research Clinic, 6201 Harry Hines Blvd, Dallas, Texas, United States|Baylor University Medical Center, 1400 8th Ave, Fort Worth, Texas, United States|Houston Methodist Hospital, Houston, Texas, United States|Baylor University Medical Center, 2401 S. 31st St., Temple, Texas, United States|University of Utah Health, Salt Lake City, Utah, United States|Virginia Hospital Center, Arlington, Virginia, United States|Inova Fairfax Hospital, Falls Church, Virginia, United States|VCU Health Medical Center, Richmond, Virginia, United States|Providence Medical Research Center, Everett, Washington, United States|Kadlec Regional Medical Center, Kennewick, Washington, United States|Providence St. Peter Hospital, Olympia, Washington, United States|Virginia Mason Medical Center, Seattle, Washington, United States|Swedish Center for Comprehensive Care, Seattle, Washington, United States|MultiCare Deaconess Hospital, Spokane, Washington, United States|MultiCare Tacoma General Hospital, Tacoma, Washington, United States|St Joseph Medical Center, Tacoma, Washington, United States|The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China|CHU Pellegrin, Bordeaux, France|CHU de Montpellier-Hopital Gui de Chauliac, Montpelier Cedex 5, France|CHU de Nantes-Hotel Dieu, Nantes, France|Hopital Saint-Louis, Paris, France|Hopital Saint Antoine, Paris, France|Charite Universitatsmedizin Berlin, Campus Virchow-Klinikum, Medizinische Klinik Infektiologie Pneumologie, Berlin, Germany|Universitatsklinikum Dusseldorf, Klinik fur Gastroenterologie, Hepatologie und Infektiologie, Düsseldorf, Germany|Universitatsklinikum Hamburg-Eppendorf, Hamburg, Germany|Universitätsklinikum Schleswig-Holstein Campus Kiel, Kiel, Germany|Klinikum St. Georg gGmbH Klinik fur Infektiologie, Tropenmedizin, Nephrologie und Rheumatologie, Leipzig, Germany|Klinikum rechts der Isar der TU Munchen, Klinik und Poliklinik Innere Medizin 2, Munich, Germany|Klinik für Hämatologie, Onkologie, Immunologie, München, Germany|Robert-Bosch-Krankenhaus (RBK), Klinik Schillerhohe (KSH) und Dr. Margarete Fischer-Bosch-Institut fur klinische Pharmakologie (IKP), Stuttgart, Germany|Prince of Wales Hospital, Hong Kong, Hong Kong|Princess Margaret Hospital, Hong Kong, Hong Kong|Queen Mary Hospital, Hong Kong, Hong Kong|UOC Malattie Infettive, ASST Papa Giovanni XXIII, Bergamo, Italy|ASST degli Spedali Civili di Brescia, Brescia, Italy|ASST di Cremona - Azienda Socio Sanitaria Territor, Cremona, Italy|UOC Malattie Infettive, IRCCS Ospedale San Raffaele, Milano, Italy|ASST Fatebenefratelli Sacco, Milano, Italy|UO Malattie Infettive, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy|UOC Malattie Infettive e Tropicali, Azienda Ospedaliera di Padova, Padova PD, Italy|Azienda Ospedaliero Universitaria di Parma, Parma, Italy|Malattie Infettive I, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy|Ospedale Guglielmo da Saliceto AUSL di Piacenza, Piacenza, Italy|UOC Malattie Infettive ad Alta Intensita di Cure, Istituto Nazionale Malattie Infettive Lazzaro Spallanzani I.R.C.C.S., Roma, Italy|Clinica Universitaria Malattie Infettive, Ospedale Amedeo di Savoia, Torino, Italy|Yokohama Municipal Citizen's Hospital, Kanagawa, Japan|Nagoya City East Medical Center, Nagoya, Japan|Tokyo Metropolitan Bokutoh Hospital, Tokyo, Japan|Kyungpook National University Hospital, Daegu, Korea, Republic of|Seoul Medical Center, Seoul, Korea, Republic of|National Medical Center, Seoul, Korea, Republic of|Amsterdam University Medical Centre - Location AMC, Amsterdam, Netherlands|Leiden University Medical Center, Leiden, Netherlands|Erasmus Medical Centre, Rotterdam, Netherlands|National University Hospital, Singapore, Singapore|Singapore General Hospital, Singapore, Singapore|National Centre for Infectious Diseases, Tan Tock Seng Hospital, Singapore, Singapore|Hospital Principe de Asturias, Alcalá De Henares, Madrid, Spain|Complejo Hospitalario Universitario A Coruña, A Coruña, Spain|Hospital Universitario Vall d'Hebron, Barcelona, Spain|Hospital Universitari de Bellvitge, Barcelona, Spain|Hospital Clinic de Barcelona, Barcelona, Spain|Hospital Universitario Cruces, Bizkaia, Spain|Hospital Universitario Ramón y Cajal, Madrid, Spain|Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain|Hospital Universitario 12 de Octubre, Madrid, Spain|Hospital Universitario La Paz, Madrid, Spain|Hospital Regional Universitario de Málaga, Málaga, Spain|Hospital Universitario Virgen del Rocio, Sevilla, Spain|Hospital Universitari i Politecnic La Fe, Valencia, Spain|Sahlgrenska University Hospital, Ostra, Gothenburg, Sweden|SUS (Skanes University Hospital), Malmo, Sweden|Karolinska University Hospital, Stockholm, Sweden|Hopitaux Universitaires de Genève, Genève 14, Switzerland|Ospedale Regionale di Locarno La Carità, Lugano, Switzerland|Universitätsspital Zürich, Zürich, Switzerland|Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan|China Medical University Hospital, Taichung, Taiwan|National Taiwan University Hospital, Taipei City, Taiwan|Imperial College NHS Trust, London, Greater London, United Kingdom|NHS Lothian, Royal lnfirmary of Edinburgh, Edinburgh, United Kingdom|Queen Elizabeth University Hospital, Glasgow, United Kingdom|Hull University Teaching Hospitals NHS Trust, Hull, United Kingdom|Royal Lancaster Hospital, Lancaster, United Kingdom|Liverpool University Hospital, Liverpool, United Kingdom|Northwick Park Hospital, London, United Kingdom|Royal Free London NHS Foundation Trust, London, United Kingdom|King's College Hospital NHS Trust, London, United Kingdom|University College London, London, United Kingdom|Manchester University NHS Foundation Trust, Manchester, United Kingdom|Manchester University NHS Foundation Trust, Manchester, United Kingdom|Pennine Acute Hospitals NHS Trust, Manchester, United Kingdom|Derriford Hospital, Plymouth, United Kingdom|Sheffield Teaching Hospitals, Sheffield, United Kingdom",https://ClinicalTrials.gov/show/NCT04292730
NCT04431453,"Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of Remdesivir (GS-5734™) in Participants From Birth to < 18 Years of Age With Coronavirus Disease 2019 (COVID-19)",Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,GS-US-540-5823|2020-001803-17,"Children's Hospital of Alabama, Birmingham, Alabama, United States|Children's Hospital Los Angeles, Los Angeles, California, United States|Ronald Reagan University of California, Los Angeles Medical Center, Los Angeles, California, United States|Valley Children's Hospital, Madera, California, United States|Rady Children's Hospital San Diego, San Diego, California, United States|Tampa General Hospital (Inpatient Visits), Tampa, Florida, United States|Ann & Robert H. Lurie Children's Hospital, Chicago, Illinois, United States|Norton Children's Hospital, Louisville, Kentucky, United States|Tulane University School of Medicine, New Orleans, Louisiana, United States|Johns Hopkins Children's Center, Baltimore, Maryland, United States|Boston Children's Hospital, Boston, Massachusetts, United States|UMass Memorial Medical Center - University Campus, Worcester, Massachusetts, United States|Children's Hospital of Michigan, Detroit, Michigan, United States|Spectrum Health/Helen De Vos Children's Hospital, Grand Rapids, Michigan, United States|Children's Minnesota, Minneapolis, Minnesota, United States|Children's Hospital & Medical Center, Omaha, Nebraska, United States|NYC Health + Hospitals/Jacobi Medical Center, Bronx, New York, United States|Montefiore Medical Center, Bronx, New York, United States|Northwell Health-Cohen Children's Medical Center, New Hyde Park, New York, United States|Carolinas Medical Center-Levine Children's Hospital, Charlotte, North Carolina, United States|Lehigh Valley Hospital/Lehigh Valley Health Network (LVH/LVHN), Allentown, Pennsylvania, United States|St. Christopher's Hospital for Children, Philadelphia, Pennsylvania, United States|Children's Medical Center, Dallas, Texas, United States|Texas Children's Hospital, Houston, Texas, United States|Azienda Ospedaliero Universitaria Meyer, Florence, Italy|University Hospital of Padova, Clinic of Pediatric Hematology-Oncology, Padova, Italy|University Hospital of Parma, Parma, Italy|Hospital Universitari Vall D'Hebron, Barcelona, Spain|Hospital Sant Joan de Déu, Esplugues de llobregat, Spain|Hospital General Universitario Gregorio Maranon, Madrid, Spain|Hospital Universitario 12 de Octubre, Madrid, Spain|Hospital Universitario La Paz, Madrid, Spain|Hospital Clínico Universitario de Santiago, Santiago de Compostela, Spain|University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom|Alder Hey Children's NHS Foundation Trust, Liverpool, United Kingdom|Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom|King's College NHS Foundation Trust, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04431453
NCT04568018,Surfactant-BL in Adult Acute Respiratory Distress Syndrome Due to COVID-19,Observational Model: Cohort|Time Perspective: Prospective,Sur/ARDS-2020,"FSAEI of Higher Education I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation",https://ClinicalTrials.gov/show/NCT04568018
NCT04345510,Testing for COVID-19 Infection in Asymptomatic Persons,Observational Model: Cohort|Time Perspective: Prospective,COVID-19-1.0-DKFZ,"German Cancer Research Center, Heidelberg, Baden-Württemberg, Germany",https://ClinicalTrials.gov/show/NCT04345510
NCT04632043,Early Versus Delayed Intubation of Patients With COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"32635, 13-10-2020","Evangelismos Hospital, Athens, Attiki, Greece",https://ClinicalTrials.gov/show/NCT04632043
NCT04542967,Study on the Safety and Efficacy of Convalescent Plasma in Patients With Severe COVID-19 Disease,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",047/2020,"Hospital Central Militar, Mexico City, Mexico",https://ClinicalTrials.gov/show/NCT04542967
NCT04931238,"Tolerability,Safety of JS016 in SARS-CoV-2 (COVID-19)",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,Peking JS016,"Li Weng, Beijing, Beijing, China|Shi Jiazhuang People's Hospital, Shijia Zhuang, He Bei, China|The First Affliated Hospital of Harbin Medical University, Harbin, Hei Longjiang, China|Suihua first hospital, Suihua, Hei Longjiang, China",https://ClinicalTrials.gov/show/NCT04931238
NCT04473170,Study Evaluating the Safety and Efficacy of Autologous Non-Hematopoietic Peripheral Blood Stem Cells in COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,CT.001.1.0.SENTAD-COVID,"Abu Dhabi Stem Cells Center, Abu Dhabi, United Arab Emirates",https://ClinicalTrials.gov/show/NCT04473170
NCT04428021,Standard or Convalescent Plasma in Patients With Recent Onset of COVID-19 Respiratory Failure,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Treatment",CS3/33,"AO Città della salute e della scienza di Torino, Torino, Italy",https://ClinicalTrials.gov/show/NCT04428021
NCT04463264,Efficacy and Safety Study of Nitazoxanide (NTX) in the Treatment of Patients With SARS-CoV-2 Virus Infection (COVID-19),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,NTZ-COVID ARG1,"Hospital Universitario Austral, Presidente Derqui, Buenos Aires, Argentina, Argentina",https://ClinicalTrials.gov/show/NCT04463264
NCT04448119,Control of COVID-19 Outbreaks in Long Term Care,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",CONTROL-COVID-Favipiravir-1,"Mount Sinai Hospital, Toronto, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04448119
NCT04582903,Send-In Sample Collection for Comprehensive Analyses of Innate and Adaptive Immune Responses During Acute COVID-19 and Convalescence,Observational Model: Cohort|Time Perspective: Prospective,10000044|000044-I,"Niaid/Lcim, Rockville, Maryland, United States",https://ClinicalTrials.gov/show/NCT04582903
NCT04482699,RAPA-501-Allo Therapy of COVID-19-ARDS,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",RAPA-501-ALLO-COVID-19,"Hackensack University Medical Center, Hackensack, New Jersey, United States",https://ClinicalTrials.gov/show/NCT04482699
NCT04363866,Assessing Hydroxychloroquine in Patients With SARS-CoV-2 (COVID-19),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",STUDY00021303,"Oregon Health and Science University, Portland, Oregon, United States",https://ClinicalTrials.gov/show/NCT04363866
NCT04343976,Pegylated Interferon Lambda Treatment for COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,2020P001083,"Massachusetts General Hospital, Boston, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT04343976
NCT04751734,Impact of Maternal COVID-19 Vaccines on Breast Milk,Observational Model: Case-Control|Time Perspective: Prospective,IATA-CSIC,"Fundacion Investigacion Sanitaria INCLIVA, Valencia, Spain|Hospital Universitario y Politecnico la Fe, Valencia, Spain",https://ClinicalTrials.gov/show/NCT04751734
NCT04887623,Dynamics of Markers of Infection and Inflammation in Hospitalized Coronavirus Disease 2019 (COVID-19) Patients,Observational Model: Cohort|Time Perspective: Prospective,UHHK042021,"University Hospital Hradec Kralove, Hradec Kralove, Czechia",https://ClinicalTrials.gov/show/NCT04887623
NCT04395391,Home Usability Study of the SARS-CoV-2 (COVID-19) Test,Observational Model: Cohort|Time Perspective: Prospective,20-Jun,"Exact Sciences, Madison, Wisconsin, United States",https://ClinicalTrials.gov/show/NCT04395391
NCT04362124,Performance Evaluation of BCG Vaccination in Healthcare Personnel to Reduce the Severity of COVID-19 Infection.,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Supportive Care",PEC03_2020,"Program for Research and Control in Tropical Diseases - PECET, Medellín, Antioquia, Colombia",https://ClinicalTrials.gov/show/NCT04362124
NCT04883164,Immunity After COVID-19 Vaccination,Observational Model: Case-Control|Time Perspective: Prospective,Pro00053511,"Plexision, Pittsburgh, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04883164
NCT04359992,Study of Hemostasis in Case of Severe COVID-19,Observational Model: Cohort|Time Perspective: Prospective,7774,NA,https://ClinicalTrials.gov/show/NCT04359992
NCT04426084,Cardiovascular Risk Factors and Severe COVID-19. A Nationwide Registry-based Case-Control Study,Observational Model: Case-Control|Time Perspective: Other,4,"Södersjukhuset, Stockholm, Sweden",https://ClinicalTrials.gov/show/NCT04426084
NCT04382625,Hydroxychloroquine in SARS-CoV-2 (COVID-19) Pneumonia Trial,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,18244,"Kootenai Health, Coeur d'Alene, Idaho, United States",https://ClinicalTrials.gov/show/NCT04382625
NCT04689477,Non-invasive Characterization of Systemic Microvascular Reactivity by Near-infrared Diffuse Optical Spectroscopy in COVID-19 Patients,Observational Model: Cohort|Time Perspective: Prospective,2020/579,"Hospital de Clinicas da UNICAMP, Campinas, Sao Paulo, Brazil|Hospital General de México, México, Mexico|Institut d'Investigació i Innovació Parc Taulí, Sabadell, Barcelona, Spain|Hospital Clínic i Provincial de Barcelona, Barcelona, Spain|Hospital Parc Salut Mar, Barcelona, Spain|Hospital Vall d'Hebron, Barcelona, Spain",https://ClinicalTrials.gov/show/NCT04689477
NCT04933994,Comparison of COVID-19 and H1N1 Influenza Pneumonia,Observational Model: Cohort|Time Perspective: Other,2021-0187,NA,https://ClinicalTrials.gov/show/NCT04933994
NCT04312464,Myocardial Damage in COVID-19,Observational Model: Case-Control|Time Perspective: Retrospective,MD-COVID-19,"Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China",https://ClinicalTrials.gov/show/NCT04312464
NCT04661462,Health After Covid-19 in Tyrol,Observational Model: Other|Time Perspective: Cross-Sectional,20200928-2379,"Medizinische Universität Innsbruck, Innsbruck, Tyrol, Austria",https://ClinicalTrials.gov/show/NCT04661462
NCT04371965,"Povidone Iodine Mouthwash, Gargle, and Nasal Spray to Reduce Naso- Pharyngeal Viral Load in Patients With COVID-19",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,KILLER,"University Hospital of Poitiers, Poitiers, France",https://ClinicalTrials.gov/show/NCT04371965
NCT04346615,Safety and Efficacy Trial of Zavegepant* Intranasal for Hospitalized Patients With COVID-19 Requiring Supplemental Oxygen,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",BHV3500-203,"Georgetown University Medical Center, Washington, District of Columbia, United States|Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States|Roper Hospital, Charleston, South Carolina, United States",https://ClinicalTrials.gov/show/NCT04346615
NCT04926428,In Situ Thrombolysis With tPA and Inflow Perfusion Analysis in Patient With Severe Covid-19 Infection,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,DI-222-2020,"Hospital General de Mexico Dr Eduardo Liceaga, Mexico City, Mexico",https://ClinicalTrials.gov/show/NCT04926428
NCT04686773,"Study in Adults to Determine the Safety and Immunogenicity of AZD1222, a Non-replicating ChAdOx1 Vector Vaccine, Given in Combination With rAd26-S, Recombinant Adenovirus Type 26 Component of Gam-COVID-Vac Vaccine, for the Prevention of COVID-19.",Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,AZD1222 - rAd26-S,"Baki Saglamic Merkezi, Baku, Azerbaijan",https://ClinicalTrials.gov/show/NCT04686773
NCT04381962,A Multicentre Open-label Two-arm Randomised Superiority Clinical Trial of Azithromycin Versus Usual Care In Ambulatory COVID19 (ATOMIC2),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,ATOMIC2|2020-001740-26|282892|20/HRA/2105,"Horton General Hospital, Banbury, Oxfordshire, United Kingdom|John Radcliffe Hospital, Oxford, Oxfordshire, United Kingdom|Ninewells Hospital, Dundee, Scotland, United Kingdom|Birmingham City Hospital, Birmingham, United Kingdom|Sandwell General Hospital, West Bromwich, United Kingdom",https://ClinicalTrials.gov/show/NCT04381962
NCT04959786,MANS-NRIZ Trial for COVID-19 Treatment : Extension Study,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,mu-med-2020-26,"Mansoura University Hospital, Mansoura, Select A State Or Province, Egypt",https://ClinicalTrials.gov/show/NCT04959786
NCT04830033,ENO Breathe vs Usual Care in COVID-19 Recovery,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment",SHIELD COVID - ENO sub-study 2,"National Heart and Lung Institute, Imperial College London, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04830033
NCT04508777,COVID SAFE: COVID-19 Screening Assessment for Exposure,Observational Model: Cohort|Time Perspective: Prospective,843565-OBS,"Penn Medicine, Philadelphia, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04508777
NCT04794998,A Simple Approach to Treat COVID-19 Patients at Home.,Observational Model: Cohort|Time Perspective: Retrospective,COVER,"Clinical Reserach Center for Rare Diseases ""Aldo e Cele Daccò"", Ranica, BG, Italy",https://ClinicalTrials.gov/show/NCT04794998
NCT04394117,Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY Disease,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,11052020,"Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia|Royal prince Alfred Virtual Hospital, Camperdown, New South Wales, Australia|Canterbury Hospital, Campsie, New South Wales, Australia|The Sutherland Hospital, Caringbah, New South Wales, Australia|Concord Hospital, Concord, New South Wales, Australia|St George Hospital, Kogarah, New South Wales, Australia|Liverpool Hospital, Liverpool, New South Wales, Australia|John Hunter Hospital, New Lambton Heights, New South Wales, Australia|Prince of Wales Hospital, Randwick, New South Wales, Australia|Royal North Shore Hospital, St Leonards, New South Wales, Australia|Westmead Hospital, Westmead, New South Wales, Australia|Wollongong Hospital, Wollongong, New South Wales, Australia|Northern Health, Epping, Victoria, Australia|Austin Health, Heidelberg, Victoria, Australia|Alfred Health, Melbourne, Victoria, Australia|Western Health, St Albans, Victoria, Australia|Lok Nayak Jai Prakash, Delhi, India|Christian Hospital, Nabarangpur, India|All India Institute of Medical Science, Raipur, India",https://ClinicalTrials.gov/show/NCT04394117
NCT04353596,Stopping ACE-inhibitors in COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,EudraCT 2020-001206-35,"Medical University Innsbruck, University Hospital of Internal Medicine III, Innsbruck, Tyrol, Austria|Medical University of Graz, Graz, Austria|Landeskrankenhaus Hall, Hall In Tirol, Austria|Medical University Innsbruck, Intensive Care and Emergency Medicine Department, Innsbruck, Austria|Medical University Innsbruck, University Hospital of Internal Medicine II, Innsbruck, Austria|Medical University Innsbruck, University Hospital of Internal Medicine IV, Innsbruck, Austria|Medical University Innsbruck, University Hospital of Internal Medicine I, Innsbruck, Austria|Medical University Innsbruck, University Hospital of Internal Medicine V, Innsbruck, Austria|Klinikum Klagenfurt, Klagenfurt, Austria|Bezirkskrankenhaus Kufstein, Kufstein, Austria|Klinikum Lienz, Lienz, Austria|Bezirkskrankenhaus St. Johann, Sankt Johann In Tirol, Austria|Bezirkskrankenhaus Schwaz, Schwaz, Austria|Krankenhaus St. Vinzenz Zams, Zams, Austria|LMU Klinikum, Medizinische Klinik I, Munich, Bavaria, Germany|University Hospital Aachen, Aachen, Germany|University Hospital Augsburg, Augsburg, Germany|Asklepios Stadtklinik Bad Tölz, Bad Tölz, Germany|Klinikum Dachau, Dachau, Germany|University Hospital Erlangen, Erlangen, Germany|University Hospital Essen, Essen, Germany|University of Freiburg, Freiburg, Germany|Klinikum Memmingen, Memmingen, Germany|LMU Klinikum, Medizinische Klinik III, Munich, Germany|LMU Klinikum, Medizinische Klinik II, Munich, Germany|LMU Klinikum, Medizinische Klinik IV, Munich, Germany|München Klinik Bogenhausen und Schwabing, Munich, Germany|Rotkreuzklinikum Munich, Munich, Germany|Krankenhaus Mühldorf, Mühldorf, Germany|Klinikum Rosenheim, Rosenheim, Germany|Krankenhaus Weiden, Weiden, Germany",https://ClinicalTrials.gov/show/NCT04353596
NCT04779359,Role of Lymphocyte Subsets and Laboratory Measurements in COVID-19 Disease,Observational Model: Cohort|Time Perspective: Cross-Sectional,COVID-19 Disease,NA,https://ClinicalTrials.gov/show/NCT04779359
NCT04904471,A Global Phase III Clinical Trial of Recombinant COVID- 19 Vaccine (Sf9 Cells),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention",JSVCT109,"Jiangsu Provincial Center for Diseases Control and Prevention, Nanjing, Jiangsu, China",https://ClinicalTrials.gov/show/NCT04904471
NCT04648410,Corticosteroids in Severe COVID-19(ASAP-C Study),Observational Model: Other|Time Perspective: Prospective,ASAP-C study,"University Hospital Brno, Brno, Czechia",https://ClinicalTrials.gov/show/NCT04648410
NCT04593940,Immune Modulators for Treating COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",Pro00106301,"Banner University Medical Center, Phoenix, Arizona, United States|University of Arkansas Medical Sciences, Little Rock, Arkansas, United States|Scripps Clinical Medical Group, La Jolla, California, United States|UCLA - Ronald Reagan Medical Center, Los Angeles, California, United States|Riverside University, Moreno Valley, California, United States|UC Irvine Medical Center, Orange, California, United States|Stanford University Medical Center, Palo Alto, California, United States|UCLA Medical Center- Santa Monica, Santa Monica, California, United States|Medstar Washington Hospital Center, Washington, District of Columbia, United States|University of Florida-Jacksonville, Jacksonville, Florida, United States|University of Illinois at Chicago, Chicago, Illinois, United States|Northwestern University, Chicago, Illinois, United States|Loyola University Medical Center, Maywood, Illinois, United States|University of Iowa, Iowa City, Iowa, United States|University of Kansas, Kansas City, Kansas, United States|University of Kentucky, Lexington, Kentucky, United States|Tulane School of Medicine, New Orleans, Louisiana, United States|University Medical Center New Orleans, New Orleans, Louisiana, United States|Ochsner Medical Center, New Orleans, Louisiana, United States|Anne Arundel Medical Center, Annapolis, Maryland, United States|Johns Hopkins Medical Center, Baltimore, Maryland, United States|Tufts Medical Center, Boston, Massachusetts, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States|Boston Medical Center, Boston, Massachusetts, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|U Mass Memorial Medical Center, Worcester, Massachusetts, United States|U Mass University Medical Center, Worcester, Massachusetts, United States|MidMichigan Medical Center- Gratiot, Alma, Michigan, United States|MidMichigan Medical Center - Midland, Midland, Michigan, United States|Mayo Clinic, Rochester, Minnesota, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|University of Missouri Health Care, Columbia, Missouri, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|Trinitas Hospital, Elizabeth, New Jersey, United States|Hackensack University Medical Center, Hackensack, New Jersey, United States|Rutgers New Jersey Medical School, New Brunswick, New Jersey, United States|NYU Brooklyn, Brooklyn, New York, United States|University at Buffalo, Buffalo, New York, United States|Flushing Hospital Medical Center, Flushing, New York, United States|Jamaica Hospital Medical Center, Jamaica, New York, United States|NYU Long Island, Long Island City, New York, United States|New York University Langone Medical Center, New York, New York, United States|Harlem Hospital Center, New York, New York, United States|Weill Cornell Medicine, New York, New York, United States|St Lawrence Health System, Potsdam, New York, United States|University of Rochester Medical Center-Strong Memorial Hospital, Rochester, New York, United States|University of North Carolina - Chapel Hill, Chapel Hill, North Carolina, United States|Duke University, Durham, North Carolina, United States|Wake Forest University, Winston-Salem, North Carolina, United States|Mercy Saint Vincent Medical Center, Toledo, Ohio, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States|Oregon Health and Science University, Portland, Oregon, United States|Temple University Hospital, Philadelphia, Pennsylvania, United States|Reading Hospital Study, Wyomissing, Pennsylvania, United States|Avera McKennan Hospital, Sioux Falls, South Dakota, United States|University of Tennessee Medical Center, Knoxville, Tennessee, United States|Methodist Health System Clinical Research Institute, Dallas, Texas, United States|University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States|Trinity Mother Frances Hospital, Tyler, Texas, United States|University of Utah, Salt Lake City, Utah, United States|Virginia Commonwealth University Medical Center, Richmond, Virginia, United States|University of Washington Medical Center, Seattle, Washington, United States|Providence Medical Research Center, Spokane, Washington, United States|West Virginia University, Morgantown, West Virginia, United States|Gundersen Health System, La Crosse, Wisconsin, United States|Instituto Medico Platense, La Plata, Buenos Aires, Argentina|Clinica Central S.A., Villa Regina, Rio Negro, Argentina|Hospital Ramos Mejia, Buenos Aires, Argentina|Hospital Rawson, Cordoba, Argentina|Sanatorio Allende, Córdoba, Argentina|Sanatorio Britanico, Rosario, Argentina|Sanatorio Diagnóstico/ Instituto del Buen Aire, Santa Fe, Argentina|Hospital Felício Rocho, Belo Horizonte, MG, Brazil|Instituto DOR de Ensino e Pesquisa Hospital Glória D'Or, Rio De Janeiro, Rio De Janeiro / RJ, Brazil|Hospital Ernesto Dornelles, Porto Alegre, Rio Grande D Sul /RS, Brazil|Hospital de Clinicas de Porto Alegre HCPA, Porto Alegre, Rio Grande Do Sul / RS, Brazil|Santa Casa de Misericordia de Porto Alegre, Porto Alegre, Rio Grande Do Sul/RS, Brazil|Hospital e Maternidade Celso Pierro - PUC Campinas, Campinas, São Paulo/SP, Brazil|Hospital Central FAP, Lima, Lima/Lima, Peru|Hospital Regional Lambayeque, Chiclayo, Peru|Hospitala Nacional Hipólito Unánue, Lima, Peru|Hospital Nacional Aezobispo Loayza, Lima, Peru|Hospital de Chancay y Servicios Basicos de Salud, Lima, Peru|Clínica Belén SANNA, Piura, Peru",https://ClinicalTrials.gov/show/NCT04593940
NCT04871633,Effectiveness of Remedesvir in COVID-19 Patients Presenting at Mayo Hospital Lahore,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,483/RC/KEMU,"Mayo Hospital, Lahore, Punjab, Pakistan",https://ClinicalTrials.gov/show/NCT04871633
NCT04491292,Assessment of the Psychosocial Impact of the COVID-19 Pandemic on the MD Anderson Cancer Center Workforce,Observational Model: Cohort|Time Perspective: Cross-Sectional,2020-0428|NCI-2020-04259,"M D Anderson Cancer Center, Houston, Texas, United States",https://ClinicalTrials.gov/show/NCT04491292
NCT04799834,Genotype and Susceptibility to COVID-19,Observational Model: Cohort|Time Perspective: Other,ORIGIN,"Centro di Ricerche Cliniche per le Malattie Rare ""Aldo e Cele Daccò"", Ranica, BG, Italy",https://ClinicalTrials.gov/show/NCT04799834
NCT04979221,Effect of Cyproheptadine on Ventilatory Support-free Days in Critically Ill Patients With COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2021-0157,NA,https://ClinicalTrials.gov/show/NCT04979221
NCT04900454,Allogeneic Natural Killer (NK) Cell Therapy in Subjects Hospitalized for COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,DVX201-COV-01|RG1121470,NA,https://ClinicalTrials.gov/show/NCT04900454
NCT04657419,Fatigue and Sleep in Patients With COVID-19,Observational Model: Cohort|Time Perspective: Prospective,CHUBX 2020/52,"CHU de Bordeaux, Bordeaux, France",https://ClinicalTrials.gov/show/NCT04657419
NCT04905875,Prone Positioning for Invasively Ventilated Patients With COVID-19 Registry,Observational Model: Cohort|Time Perspective: Other,22/21,"Silvia De Rosa, Vicenza, Italy",https://ClinicalTrials.gov/show/NCT04905875
NCT04482647,Breathing Techniques and Meditation for Health Care Workers During COVID-19 Pandemic,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,2020-0483|NCI-2020-04931,"M D Anderson Cancer Center, Houston, Texas, United States",https://ClinicalTrials.gov/show/NCT04482647
NCT04798066,Intermediate Size Expanded Access Protocol Evaluating HB-adMSC's for the Treatment of Post-COVID-19 Syndrome,NA,HBPCOV01,"Hope Biosciences Stem Cell Research Foundation, Sugar Land, Texas, United States",https://ClinicalTrials.gov/show/NCT04798066
NCT04537117,"Knowledge, Attitudes and Clinical Practices of Pediatric Dentists Regarding Covid-19",Observational Model: Other|Time Perspective: Cross-Sectional,pedodontists during Covid-19,"Fayoum University, Fayoum, Egypt",https://ClinicalTrials.gov/show/NCT04537117
NCT04762186,Adoptive SARS-CoV-2 Specific T Cell Transfer in Patients at Risk for Severe COVID-19,Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,Uni-Koeln-4480,"Department I for Internal Medicine University Hospital of Cologne, Cologne, NRW, Germany",https://ClinicalTrials.gov/show/NCT04762186
NCT04444531,Ozone Therapy and Coronavirus Disease of 2019 (COVID-19) Pneumonia,Observational Model: Cohort|Time Perspective: Prospective,COVID Networking group,"Policlinic Ibiza Hospital, Ibiza, Spain",https://ClinicalTrials.gov/show/NCT04444531
NCT04845048,Active Pharmacovigilance Study of Adsorbed COVID-19 (Inactivated) Vaccine,Observational Model: Cohort|Time Perspective: Prospective,CFV-01-IB,"Centro de Saúde Escola da Faculdade de Medicina de Botucatu - Unesp., Botucatu, São Paulo, Brazil|Centro de Saúde Escola da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo (HCFMRP-USP) Dr. Joel Domingos Machado., Ribeirão Preto, São Paulo, Brazil|Centro de Referência de Imunobiológicos Especiais. Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (CRIEHCFMUSP), São Paulo, Brazil",https://ClinicalTrials.gov/show/NCT04845048
NCT04918901,Comparative Analysis of Clinical Parameters and Radiographic Changes of Severe COVID-19,Observational Model: Case-Only|Time Perspective: Other,xp2020-355,"Neuroscience care unit, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China",https://ClinicalTrials.gov/show/NCT04918901
NCT04347070,Implementation of Physiotherapy on COVID-19 Patients in ICU,Observational Model: Cohort|Time Perspective: Retrospective,RECHMPL20_0175,"Uhmontpellier, Montpellier, France",https://ClinicalTrials.gov/show/NCT04347070
NCT04534790,Anti-inflammatory Effect of Low-Dose Whole-Lung Radiation for COVID-19 Pneumonia,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment",PI-2020-2858,"Social Secure Mexican Institute, Leon, Guanajuato, Mexico",https://ClinicalTrials.gov/show/NCT04534790
NCT04951336,RCT of Mushroom Based Natural Product to Enhance Immune Response to COVID-19 Vaccination,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Supportive Care",200633-1c,"University of California, San Diego, San Diego, California, United States",https://ClinicalTrials.gov/show/NCT04951336
NCT04344171,CovidDB: The Covid-19 Inpatient Database,Observational Model: Cohort|Time Perspective: Prospective,CovidDB,"RoMed - Klinikum Bad Aibling, Bad Aibling, Germany|DONAUISAR Klinikum Deggendorf, Deggendorf, Germany|DONAUISAR Klinikum Dingolfing, Dingolfing, Germany|RoMed - Klinikum Prien am Chiemsee, Prien, Germany|RoMed - Klinikum Rosenheim, Rosenheim, Germany|Universitätsklinikum Ulm, Ulm, Germany|RoMed - Klinikum Wasserburg Am Inn, Wasserburg Am Inn, Germany|Klinikum Altmühlfranken, Weißenburg, Germany|Timiş County Emergency Clinical Hospital, Timisoara, Romania",https://ClinicalTrials.gov/show/NCT04344171
NCT04568655,The Noninvasive Ventilation to COVID-19 Patients,Observational Model: Cohort|Time Perspective: Retrospective,FAHGuangzhouYLS03,"The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China",https://ClinicalTrials.gov/show/NCT04568655
NCT04701905,The Offer of Neurosurgery Care in the Grand Est of France During the Health Crisis Linked to Covid-19,Observational Model: Case-Only|Time Perspective: Retrospective,7780,"Department of Neurosurgery - Strasbourg University Hospitals, Strasbourg, France",https://ClinicalTrials.gov/show/NCT04701905
NCT04718480,Fluvoxamine Administration in Moderate SARS-CoV-2 (COVID-19) Infected Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",SD-COVID19-01|2020-002299-11,"Dél-pesti Centrumkórház, Budapest, Hungary|Semmelweis Egyetem Pulmonológiai Klinika, Budapest, Hungary|Országos Korányi Pulmonológiai Intézet, Budapest, Hungary|Debreceni Egyetem Kenézy Gyula Kórház Infektológia, Debrecen, Hungary",https://ClinicalTrials.gov/show/NCT04718480
NCT04408209,Convalescent Plasma for the Treatment of Patients With Severe COVID-19 Infection,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,245-14-4-20,"""Evangelismos"" General Hospital, Athens, Attiki, Greece|""Agios Savas"" Oncology Hospital, Athens, Attiki, Greece|""Alexandra"" General Hospital, Athens, Attiki, Greece|""Sotiria"" General Hospital, Athens, Attiki, Greece|Attikon"" University General Hospital, Athens, Chaidari, Greece|University General Hospital of Patras, Patra, Rio, Greece",https://ClinicalTrials.gov/show/NCT04408209
NCT04347369,A Retrospective Study of Neural Network Model to Dynamically Quantificate the Severity in COVID-19 Disease,Observational Model: Case-Only|Time Perspective: Retrospective,XQonc-015,"Xinqiao Hospital of Chongqing, Chongqing, China",https://ClinicalTrials.gov/show/NCT04347369
NCT04530435,PEP Flute-selfcare in COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention,0211-00023B,"Research Unit for Dietary Studies at the Parker Institute, Bispebjerg and Frederiksberg Hospitals, Frederiksberg, Denmark",https://ClinicalTrials.gov/show/NCT04530435
NCT04859517,Evaluation of ADG20 for the Prevention of COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",ADG20-PREV-001,"Adagio Investigative Site, Birmingham, Alabama, United States|Adagio Investigative Site, Tucson, Arizona, United States|Adagio Investigative Site, Fayetteville, Arkansas, United States|Adagio Investigative Site, North Little Rock, Arkansas, United States|Adagio Investigative Site, Banning, California, United States|Adagio Investigative Site, Chula Vista, California, United States|Adagio Investigative Site, Fullerton, California, United States|Adagio Investigative Site, Long Beach, California, United States|Adagio Investigative Site, Los Angeles, California, United States|Adagio Investigative Site, Modesto, California, United States|Adagio Investigative Site, San Diego, California, United States|Adagio Investigative Site, Stamford, Connecticut, United States|Adagio Investigative Site, Edgewater, Florida, United States|Adagio Investigative Site, Miami, Florida, United States|Adagio Investigative Site, Miami, Florida, United States|Adagio Investigative Site, Miami, Florida, United States|Adagio Investigative Site, Mount Dora, Florida, United States|Adagio Investigative Site, Ormond Beach, Florida, United States|Adagio Investigative Site, The Villages, Florida, United States|Adagio Investigative Site, West Palm Beach, Florida, United States|Adagio Investigative Site, Hinesville, Georgia, United States|Adagio Investigative Site, Oak Brook, Illinois, United States|Adagio Investigative Site, Owensboro, Kentucky, United States|Adagio Investigative Site, Marrero, Louisiana, United States|Adagio Investigative Site, Rockville, Maryland, United States|Adagio Investigative Site, Burlington, Massachusetts, United States|Adagio Investigative Site, Grosse Pointe Woods, Michigan, United States|Adagio Investigative Site, Albuquerque, New Mexico, United States|Adagio Investigative Site, Garden City, New York, United States|Adagio Investigative Site, Beachwood, Ohio, United States|Adagio Investigative Site, Cincinnati, Ohio, United States|Adagio Investigative Site, Dresden, Ohio, United States|Adagio Investigative Site, Middleburg Heights, Ohio, United States|Adagio Investigative Site, Yukon, Oklahoma, United States|Adagio Investigative Site, Medford, Oregon, United States|Adagio Investigative Site, West Columbia, South Carolina, United States|Adagio Investigative Site, Jackson, Tennessee, United States|Adagio Investigative Site, Milan, Tennessee, United States|Adagio Investigative Site, Beaumont, Texas, United States|Adagio Investigative Site, College Station, Texas, United States|Adagio Investigative Site, Corpus Christi, Texas, United States|Adagio Investigative Site, Dickinson, Texas, United States|Adagio Investigative Site, Houston, Texas, United States|Adagio Investigative Site, Hurst, Texas, United States|Adagio Investigative Site, Sugar Land, Texas, United States|Adagio Investigative Site, West Jordan, Utah, United States|Adagio Investigative Site, Richmond, Virginia, United States|Adagio Investigative Site, Chisinau, Moldova, Republic of",https://ClinicalTrials.gov/show/NCT04859517
NCT04472494,Study of Abatacept in the Treatment of Hospitalized COVID-19 Participants With Respiratory Compromise,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",IM101-873|U1111-1250-4217,"Norton Infectious Disease Institute, Louisville, Kentucky, United States|Local Institution, Boston, Massachusetts, United States|Local Institution, Boston, Massachusetts, United States|Atlantic Health System, Morristown, New Jersey, United States|Local Institution, New Brunswick, New Jersey, United States|Local Institution, Dallas, Texas, United States|Local Institution, Guaynabo, Puerto Rico|Local Institution, Monterrey Ponce, Puerto Rico|Local Institution, San Juan, Puerto Rico",https://ClinicalTrials.gov/show/NCT04472494
NCT04521010,Staff Absenteeism and Delivery of Healthcare Services During the COVID-19 Pandemic,Observational Model: Other|Time Perspective: Retrospective,3/2020/Reh,"Department of Rehabilitation and Physiotherapy Rehabilitation,, Poznań, Poland",https://ClinicalTrials.gov/show/NCT04521010
NCT04381858,Convalescent Plasma vs Human Immunoglobulin to Treat COVID-19 Pneumonia,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment",2020-A-10,"Centenario Hospital Miguel Hidalgo, Aguascalientes, Mexico",https://ClinicalTrials.gov/show/NCT04381858
NCT04427098,Enoxaparin in COVID-19 Moderate to Severe Hospitalized Patients,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2020-001308-40,"Policlinico S. Orsola Malpighi Dipartimento Malattie Infettive, Bologna, Emilia Romagna, Italy|Azienda Ospedaliero-Universitaria di Parma Anestesia e Rianimazione Dipartimento di Medicina e Chirurgia, Parma, Emilia Romagna, Italy|I.R.C.C.S. ""Casa Sollievo della Sofferenza"", San Giovanni Rotondo (FG) UOVD Emostasi e trombosi- Poliambulatorio Giovanni Paolo II Viale Padre Pio n.7 San Giovanni Rotondo (FG), San Giovanni Rotondo, Foggia, Italy|Fondazione Poliambulanza Chirurgia Vascolare, Brescia, Italy|Piazzale Spedali Civili, 1, 25123 Brescia BS Medicina Interna UniBS 2° Medicina ASST Spedali Civili, Brescia, Italy|Azienda Ospedaliero-Universitaria ""Policlinico - V. Emanuele"", Catania Anestesia e Rianimazione UO Malattie Infettive, Catania, Italy|ASST Cremona Unità Operativa di Chirurgia Vascolare Dipartimento di Medicina di Laboratorio e di Radiologia- Centro Emostasi e Trombosi, Cremona, Italy|Ospedale Morgagni Pierantoni U.O.C. Malattie Infettive, Forlì, Italy|Ospedale Carlo Poma di Mantova MALATTIE INFETTIVE Padiglione 37 Str. Lago Paiolo, 10, 46100 Mantova, Mantova, Italy|AZIENDA OSPEDALIERA Regionale S CARLO POTENZA Struttura Complessa Interaziendale ""Malattie Infettive"", Matera, Italy|Ospedale San Raffaele Unità Funzionale dell'Unità Operativa di Malattie Infettive Osp. San Raffaele, Milano, Italy|Ospedale Amedeo di Savoia Torino Università di Torino Malattie Infettive, Torino, Italy|Azienda Ospedaliera Universitaria Integrata Verona UOC Malattie Infettive e Tropicali, Verona, Italy",https://ClinicalTrials.gov/show/NCT04427098
NCT04402892,COVID-19: SARS-CoV-2 Specific Memory B and T-CD4+ Cells,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science,APHP200551,NA,https://ClinicalTrials.gov/show/NCT04402892
NCT04461925,Treatment of Coronavirus COVID-19 Pneumonia (Pathogen SARS-CoV-2) With Cryopreserved Allogeneic P_MMSCs and UC-MMSCs,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,#4/24.04.2020,"Institute of Cell Therapy, Kyiv, Ukraine",https://ClinicalTrials.gov/show/NCT04461925
NCT04346355,Efficacy of Early Administration of Tocilizumab in COVID-19 Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,RCT-TCZ-COVID-19|2020-001386-37,"Ospedale di Guastalla, Guastalla, RE, Italy|Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Reggio Emilia, RE, Italy|Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo, Alessandria, Italy|Policlinico Sant'Orsola Malpighi, Bologna, Italy|ASST Cremona, Cremona, Italy|Azienda Ospedaliera S. Croce e Carle, Cuneo, Italy|Azienda Ospedaliero Universitaria Ferrara, Ferrara, Italy|Azienda Ospedaliero Universitaria Careggi, Firenze, Italy|Ospedale Evangelico Internazionale di Genova, Genova, Italy|Azienda Sociosanitaria ASL 1 ,Imperia, Imperia, Italy|Azienda Sociosanitaria ASL 5 La Spezia, La Spezia, Italy|ASST Mantova - Ospedale Carlo Poma, Mantova, Italy|IRCCS Istituto Auxologico Italiano Milano, Milano, Italy|Azienda Ospedaliero-Universitaria ""Maggiore della Carità"" di Novara, Novara, Italy|Ospedali Riuniti Padova Sud - ULSS 6 Euganea, Padova, Italy|Azienda Ospedaliero-Universitaria Parma, Parma, Italy|Azienda Unità Sanitaria Locale di Piacenza, Piacenza, Italy|Azienda Ospedaliera Universitaria Pisana, Pisa, Italy|AO Ordine Mauriziano di Torino, Torino, Italy|ASST Bergamo Ovest -Treviglio, Treviglio, Italy|AULSS 2 Marca Trevigiana, Treviso, Italy|AULSS2 Marca Trevigiana - Ospedale Vittorio Veneto, Treviso, Italy|AULSS 3 Serenissima Ospedale ""Dell'Angelo"", Venezia, Italy|Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy|IRCCS Sacro Cuore Don Calabria, Verona, Italy",https://ClinicalTrials.gov/show/NCT04346355
NCT04389411,The COvid-19 Symptom MOntelukast Trial,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",443807,NA,https://ClinicalTrials.gov/show/NCT04389411
NCT04305106,Bevacizumab in Severe or Critically Severe Patients With COVID-19 Pneumonia-RCT,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Treatment",QLEmer,"Qilu Hospital of Shandong University, Jinan, Shandong, China",https://ClinicalTrials.gov/show/NCT04305106
NCT04315987,NestaCell® Mesenchymal Stem Cell to Treat Patients With Severe COVID-19 Pneumonia,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",HOPE,"Hospital Vera Cruz, Campinas, São Paulo, Brazil|Hospital de Barueri, São Paulo, Brazil|IncCOR, São Paulo, Brazil|UNIFESP, São Paulo, Brazil",https://ClinicalTrials.gov/show/NCT04315987
NCT04942405,"Efficacy, Immunogenicity, and Safety of the Inactivated COVID-19 Vaccine (TURKOVAC) Versus the CoronaVac Vaccine","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention",TURKOVAC,"Hacettepe University Faculty of Medicine Department of Infections Diseases and Clinical Microbiology, Ankara, Turkey",https://ClinicalTrials.gov/show/NCT04942405
NCT04371822,Efficacy of Sunlight Activated Synthetic Porphyrin in COVID-19 Infected Patients,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,Proposed by Mahmoud Elkazz,"Kafr El-sheikh University, Cairo, Kafr El-sheikh, Egypt",https://ClinicalTrials.gov/show/NCT04371822
NCT04460105,Lanadelumab in Participants Hospitalized With COVID-19 Pneumonia,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",TAK-743-1002,NA,https://ClinicalTrials.gov/show/NCT04460105
NCT04357535,Prognosis of Coronavirus Disease 2019 (COVID-19) Patients Receiving Receiving Antihypertensives,Observational Model: Cohort|Time Perspective: Prospective,2210061,"King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia",https://ClinicalTrials.gov/show/NCT04357535
NCT04538586,"Influence of the COVId-19 Pandemic on STRESS, and Screening Procedures (COVISTRESS Screening)",Observational Model: Cohort|Time Perspective: Cross-Sectional,2020 COVISTRESS Screening,"Univeristy Hospital, Clermont-Ferrand, Clermont-Ferrand, France",https://ClinicalTrials.gov/show/NCT04538586
NCT04723524,Jinhua Qinggan Granules in the Treatment of COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment",CRO-003-TCM- JHQG -2020,"Center for Bioequivalence Studies and Clinical Research (CBSCR), ICCBS, university of Karachi, Karachi, Pakistan",https://ClinicalTrials.gov/show/NCT04723524
NCT04713176,Efficacy and Safety of DWJ1248 With Remdesivir in Severe COVID-19 Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",DW_DWJ1248302,"National Medical Center, Seoul, Korea, Republic of",https://ClinicalTrials.gov/show/NCT04713176
NCT04541485,"To Evaluate Safety, Tolerability and Pharmacodynamics of DWRX2003 Against COVID-19 (in Philippines)","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",DW_DWJ1516101_Phillipphines,NA,https://ClinicalTrials.gov/show/NCT04541485
NCT04445415,Diagnostic Value of New COVID-19 Antibodies Testing Among Laboratory Healthcare Workers,Observational Model: Case-Only|Time Perspective: Retrospective,COVID-19 antibodies testing,NA,https://ClinicalTrials.gov/show/NCT04445415
NCT04572360,Cardiorespiratory Exercise & Chinese Medicine for Rehabilitation of Discharged Coronavirus Disease (COVID-19) Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",HKCOVID19Rehab,"Linda Zhong, Kowloon Tong, Kowloon, Hong Kong",https://ClinicalTrials.gov/show/NCT04572360
NCT04376593,PET/CT Imaging in COVID-19 Patients,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,1592298,"University of California Davis, Sacramento, California, United States",https://ClinicalTrials.gov/show/NCT04376593
NCT04978051,Investigating the Efficacy and Safety ICATIBANT For The Treatment of Patients With SARS-CoV-2 (COVID-19) Infection,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,HUB-MdI-ICAT·COVID-201,"Hospital Universitari de Bellvitge, L'Hospitalet De Llobregat, Catalonia, Spain",https://ClinicalTrials.gov/show/NCT04978051
NCT04417335,Reducing COVID-19 Related Hospital Admission in Elderly by BCG Vaccination,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Prevention,NL73430.091.20|2020-001591-15,"Radboud University, Nijmegen, Gelderland, Netherlands|UMC Utrecht, Utrecht, Netherlands",https://ClinicalTrials.gov/show/NCT04417335
NCT04374838,Effect of COVID-19 Pandemic on Pediatric Cancer Care,Observational Model: Cohort|Time Perspective: Cross-Sectional,COVID-19 and Pediatric Cancer,"South Egypt Cancer Institute, Assiut University, Assiut, Egypt",https://ClinicalTrials.gov/show/NCT04374838
NCT04244591,Glucocorticoid Therapy for COVID-19 Critically Ill Patients With Severe Acute Respiratory Failure,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,Glucocorticoid COVID-19,"Medical ICU,Peking Union Medical College Hospital, Beijing, Beijing, China",https://ClinicalTrials.gov/show/NCT04244591
NCT04713878,Mesenchymal Stem Cells Therapy in Patients With COVID-19 Pneumonia,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2020.05.20,"University of Health Sciences, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04713878
NCT04345679,Anti COVID-19 Convalescent Plasma Therapy,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,AntiCOVID19ORT,"Semmelweis University's Department of Pulmonology, Budapest, Hungary",https://ClinicalTrials.gov/show/NCT04345679
NCT04784559,Trial to Determine the Efficacy/Safety of Plitidepsin vs Control in Patients With Moderate COVID-19 Infection,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,APL-D-003-20|2020-005951-19,"Instituto Medico Platense S.A., La Plata, Buenos Aires, Argentina|Clinica Privada Monte Grande S.A, Monte Grande, Buenos Aires, Argentina|Clinica Central S.A., Villa Regina, Rio Negro, Argentina|Sanatorio Parque - Rosario, Rosario, Santa Fe, Argentina|Hospital General Agudos Ignacio, Buenos Aires, Argentina|Hospital Francisco Muñiz, Ciudad autónoma de Buenos Aires, Argentina|Hospital Rawson, Cordoba, Argentina|Hospital São Rafael, Salvador, BA, Brazil|Hospital Felicio Rocho, Belo Horizonte, MG, Brazil|CePCLIN - Centro de Estudos e Pesquisas em Moléstias Infecciosas Ltda, Natal, RN, Brazil|Hospital Moinhos de Vento (HMV), Porto Alegre, RS, Brazil|Hospital Dia Do Pulmão, Blumenau, SC, Brazil|Hospital São José, Criciuma, SC, Brazil|CEMEC - Centro Multidisciplinar de Estudos Clínicos, São Bernardo Do Campo, Brazil|University Multiprofile Hospital for Active Treatment Sveta Ekaterina EAD, Dimitrovgrad, Bulgaria|Specialized Hospital for Active Treatment of Pneumo-Phthisiatric Diseases - Haskovo, Haskovo, Bulgaria|MHAT ""Dr. Nikola Vasiliev"" AD, Kyustendil, Bulgaria|Military Medical Academy - MBAL Pleven, Pleven, Bulgaria|""Specialised Hospital for Active Treatment for Pneumophthisiatric Diseases Dr. Dimitar Gramatikov - Ruse"" Ltd Department of Pneumology and Phthisiatry, Ruse, Bulgaria|SHATPPD Dr. Dimitar Gramatikov, Ruse Ltd., Ruse, Bulgaria|University First MHAT ""St.Yoan Krastitel""-Sofia EAD, Sofia, Bulgaria|University Multiprofile Hospital for Active Treatment ACIBADEM CITY CLINIC TOKUDA HOSPIAL, Sofia, Bulgaria|""MHAT ""Sveta Anna"""" - Sofia AD, Sofia, Bulgaria|CliniSalud del Sur S.A.S - Centro de Investigación, Envigado, Antioquia, Colombia|Organización Clinica Bonnadona Prevenir S.A.S, Barranquilla, Atlantico, Colombia|Clínica de la Costa Ltda., Barranquilla, Atlántico, Colombia|Sociedad de Cirugía de Bogotá; Hospital de San José, Bogotá, Bogotá D.C., Colombia|Hospital Universitario MEDERI, Bogotá, Bogotá D.C., Colombia|Caja de Compensacion Familiar de Caldas, Manizales, Caldas, Colombia|Centre Hospitalier Universitaire (CHU) Dijon Bourgogne - Hopital Francois Mitterand, Dijon, France|Nouvel Hôpital Civil Service des maladies infectieuses, Strasbourg, France|Centre Hospitalier Regional et Universitaire de Tours (CHRU Tours) - Hopital Bretonneau, Tours, France|Democritus University Hospital University General Hospital of Alexandroupolis, Alexandroupoli, Greece|Evangelismos Hospital General Hospital of Athens Evangelismos, Intensive Care Unit, Athens, Greece|Sotiria Hospital General Hospital of Chest Diseases of Athens ""Sotiria"" 3rd Department of Internal Medicine of University of Athens, Athens, Greece|Alexandra Hospital, Athens, Greece|Attikon Hospital, Chaïdári, Greece|Tzaneio Hospital General Hospital of Piraeus Tzaneio, Piraeus, Greece|AHEPA Hospital University General Hospital AHEPA, Thessaloníki, Greece|Hospital Cardiologica Aguascalientes, Aguascalientes, Ags, Mexico|Hospital Médica Sur, Mexico City, Cdmx, Mexico|Sanatorio Palmore, A.C., Chihuahua, CHH, Mexico|Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, DIF, Mexico|Centro de Investigación Clínica Chapultepec, Morelia, Michoacan, Mexico|Universidad Autonoma de Nuevo Leon - Hospital Universitario ""Dr. Jose Eleuterio Gonzalez"", Monterrey, NL, Mexico|Hospital Alberto Sabogal Sologuren, Bellavista, Lima, Peru|Hospital de Chancay, Chancay, Lima, Peru|Hospital Nacional Hipolito Unanue (HNHU), El Agustino, Lima, Peru|Spitalul Clinic De Boli Infectioase Cluj-Napoca, Sectia HIV/SIDA, Cluj-Napoca, Cluj, Romania|Spitalul Clinic de Boli Infectioase Constanta, Constanţa, Tomis, Romania|Institutul National De Boli Infectioase ""Prof. Dr. Matei Bals"", Bucharest, Romania|Spitalul Clinic de Boli Infectioase si Tropicale Dr. Victor Babes - Bucharest, Bucharest, Romania|Institutul National De Boli Infectioase ""Prof. Dr. Matei Bals"", Bucharest, Romania|Spitalul Clinic De Boli Infectioase ""Sfanta Parascheva"" IASI, Sectia Boli Infectioase III, Iaşi, Romania|Spitalul Judetean de Urgenta 'Sf. Ioan cel Nou' Suceava, Sectia de Boli Infectioase, Suceava, Romania|Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain|Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain|Hospital Universitario HM Montepríncipe, Boadilla Del Monte, Madrid, Spain|Hospital Universitario de Getafe, Getafe, Madrid, Spain|Hospital Universitario de Móstoles, Móstoles, Madrid, Spain|Hospital Quirónsalud Madrid, Pozuelo De Alarcón, Madrid, Spain|HM Torrelodones, Torrelodones, Madrid, Spain|Hospital Costa Del Sol, Marbella, Málaga, Spain|Hospital Álvaro Cunqueiro, Vigo, Pontevedra, Spain|Hospital Universitario de Cruces, Barakaldo, Vizcaya, Spain|Hospital General Universitario de Alicante, Alicante, Spain|Hospital Clinico San Cecilio, Granada, Spain|Hospital Universitario de Guadalajara, Guadalajara, Spain|Hospital Universitari Arnau de Vilanova de Lleida, Lleida, Spain|H.U. La Princesa, Madrid, Spain|Hospital Gregorio Marañón, Madrid, Spain|Hospital Infanta Leonor, Madrid, Spain|Hospital Universitario Ramón y Cajal, Madrid, Spain|Fundacion Jimenez Diaz, Madrid, Spain|Hospital Clínico San Carlos, Madrid, Spain|Hospital 12 Octubre, Madrid, Spain|H. HM Sanchinarro, Madrid, Spain|Hospital de Emergencias Enfermera Isabel Zendal, Madrid, Spain|Hospital Universitario de Salamanca, Salamanca, Spain|Instituto de Investigación Sanitaria Valdecilla (IDIVAL), Santander, Spain|Hospital Universitario Virgen del Rocío, Sevilla, Spain|Ege University Medical School, Department of Infectious Diseases and Clinical Microbiology, Bornova, İzmir, Turkey|T.C. Saglik Bakanligi Tepecik Egitim ve Arastirma Hastanesi - Enfeksiyon Hastaliklari ve Klinik Mikrobiyoloji Klinigi, Konak, Izmir, Turkey|Kocaeli Universitesi - Kocaeli Universitesi Tip Fakultesi - Kocaeli Universitesi Arastirma ve Uygulama Hastanesi, İzmit, Kocaeli, Turkey|Hacettepe University, School of Medicine, Ankara, Turkey|Ankara City Hospital, Ankara, Turkey",https://ClinicalTrials.gov/show/NCT04784559
NCT04320615,A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 Pneumonia,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",WA42380|2020-001154-22,"University of California San Diego, La Jolla, California, United States|eStudySite, La Mesa, California, United States|David Geffen School of Medicine UCLA, Los Angeles, California, United States|Stanford University, Stanford, California, United States|Denver Health Medical Center, Denver, Colorado, United States|University of Miami Miller School of Medicine, Miami, Florida, United States|Rush University Medical Center, Chicago, Illinois, United States|University of Chicago, Chicago, Illinois, United States|Ochsner Clinic Foundation, Baton Rouge, Louisiana, United States|Baystate Health System, Springfield, Massachusetts, United States|Mayo Clinic - PPDS, Rochester, Minnesota, United States|Hackensack University Medical Center, Hackensack, New Jersey, United States|Robert Wood Johnson University Hospital/Rutgers, New Brunswick, New Jersey, United States|James J Peters Veterans Administration Medical Center - NAVREF, Bronx, New York, United States|Duke University Medical Center, Durham, North Carolina, United States|Cleveland Clinic Foundation; Pulmonary, Allergy & Critical Care Medicine, Cleveland, Ohio, United States|Thomas Jefferson University, Philadelphia, Pennsylvania, United States|Baylor St. Luke's Medical Center, Houston, Texas, United States|Ben Taub General Hospital - HCHD, Houston, Texas, United States|Intermountain Medical Group, Saint George, Utah, United States|Intermountain LDS Hospital, Salt Lake City, Utah, United States|Evergreen Health Infectious Disease, Kirkland, Washington, United States|Swedish Hospital Medical Center, Seattle, Washington, United States|Hamilton General Hospital; Pharmacy, Hamilton, Ontario, Canada|St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada|University Health Network, Toronto, Ontario, Canada|Clinical Research Institute of Montreal, Montreal, Quebec, Canada|Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark|Hvidovre Hospital, Hvidovre, Denmark|Odense Universitetshospital, Odense C, Denmark|Sjællands Universitetshospital, Roskilde, Roskilde, Denmark|Centre Hospitalier Departemental de Vendee, La Roche Sur Yon, France|Centre Hospitalier et Universitaire de Limoges, Limoges, France|Hôpital de La Croix Rousse, Lyon, France|Hotel Dieu - Nantes, Nantes, France|Hopital de la Pitie Salpetriere, Paris, France|HOPITAL COCHIN university hospital, Paris, France|CHRU de Tours, Pharmacie, Tours, France|Universitatsklinikum Dusseldorf, Dusseldorf, Germany|Medizinische Hochschule Hannover, Hannover, Germany|Universitätsklinikum Köln; Innere Medizin I; Onkologie, Hämatologie, Köln, Germany|LMU Klinikum der Universitat Munchen, Munchen, Germany|Azienda Ospedaliera San Gerardo di Monza, Monza MI, Lombardia, Italy|Fondazione IRCCS Policlinico San Matteo di Pavia; S.S. Fisiopatologia Respiratoria, Pavia, Lombardia, Italy|Amphia Ziekenhuis, Breda, Netherlands|St. Antonius Ziekenhuis Nieuwegein, Nieuwegein, Netherlands|Erasmus MC, Rotterdam, Netherlands|Universitair Medisch Centrum Utrecht, Utrecht, Netherlands|Hospital Universitario de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain|Hospital Universitari Vall d'Hebron, Barcelona, Spain|Hospital Clinic de Barcelona, Barcelona, Spain|Hospital Universitario La Paz, Madrid, Spain|Hospital Universitario Ramon y Cajal, Madrid, Spain|Hospital General Universitario Gregorio Maranon, Madrid, Spain|Hospital Universitario HM Sanchinarro-CIOCC, Madrid, Spain|Greater Glasgow and Clyde Health Board, Glasgow, United Kingdom|Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom|University College Hospital, London, United Kingdom|Royal Free Hospital, London, United Kingdom|St George's Clinical Research Facility, London, United Kingdom|Imperial College London, London, United Kingdom|North Manchester General Hospital, Manchester, United Kingdom",https://ClinicalTrials.gov/show/NCT04320615
NCT04455815,A Trial Looking at the Use of Camostat to Reduce Progression of Symptoms of Coronavirus (COVID-19) in People Who Have Tested Positive.,Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,CRUKD/20/002|2020-002110-41,"Chawton Park Surgery, Alton, United Kingdom|The University of Edinburgh, Edinburgh, United Kingdom|Church Avenue Medical Group, Harrogate, United Kingdom|Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom|Trafalgar Medical Practice, Portsmouth, United Kingdom|Preston Lantern Centre, Preston, United Kingdom|Clarence Medical Centre, Rhyl, United Kingdom|Velindre Cancer Centre, Wales, United Kingdom|Eynsham Medical Centre, Witney, United Kingdom",https://ClinicalTrials.gov/show/NCT04455815
NCT04810689,"Pilot Trial of XFBD, a TCM, in Persons With COVID-19","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Other",HS-20-00632,"University of Southern California, Los Angeles, California, United States",https://ClinicalTrials.gov/show/NCT04810689
NCT04407130,Efficacy and Safety of Ivermectin and Doxycycline in Combination or IVE Alone in Patients With COVID-19 Infection.,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",PR-20039,"Icddr,B, Dhaka, Bangladesh",https://ClinicalTrials.gov/show/NCT04407130
NCT04372186,A Study to Evaluate the Efficacy and Safety of Tocilizumab in Hospitalized Participants With COVID-19 Pneumonia,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",ML42528,"Banner - University Medical Center Phoenix; In-Patient Pharmacy, Phoenix, Arizona, United States|Univ of AZ Coll of Med, Tucson, Arizona, United States|El Centro Regional Medical Center, El Centro, California, United States|eStudySite, La Mesa, California, United States|Highland Hospital Oakland, Oakland, California, United States|St. Joseph'S Hospital, Orange, California, United States|San Leandro Hospital; Inpatient Pharmacy, San Leandro, California, United States|Larkin Community Hospital Palm Springs Campus (Hialeah), Hialeah, Florida, United States|Miami Veterans Administration Healthcare System - NAVREF, Miami, Florida, United States|University of Miami Pulmonary, Miami, Florida, United States|Larkin Community Hospital, South Miami, Florida, United States|St. Lukes Boise Medical Center, Boise, Idaho, United States|Ochsner Clinic, New Orleans, Louisiana, United States|Holy Cross Germantown Hospital, Germantown, Maryland, United States|Holy Cross Hospital, Silver Spring, Maryland, United States|Henry Ford Health System, Detroit, Michigan, United States|St. Joseph'S Regional Medical Center, Paterson, New Jersey, United States|San Juan Oncology Associates, Farmington, New Mexico, United States|St. Barnabas Hospital, Bronx, New York, United States|SUNY Downstate Medical Center., Brooklyn, New York, United States|Elmhurst Hospital Center, Elmhurst, New York, United States|Flushing Hospital, Flushing, New York, United States|Jamaica Hospital Medical Center, Jamaica, New York, United States|Harlem Hospital, New York, New York, United States|Canton-Potsdam Hospital, Potsdam, New York, United States|Novant Health Presbyterian Medical Center (Presbyterian Hospital), Charlotte, North Carolina, United States|Cape Fear Valley Medical Center, Fayetteville, North Carolina, United States|Temple University Hospital, Philadelphia, Pennsylvania, United States|Valley Baptist Medical Center, Harlingen, Texas, United States|Michael E Debakey VA Medical Center, Houston, Texas, United States|McAllen Medical Center, McAllen, Texas, United States|Sentara Medical Group, Virginia Beach, Virginia, United States|Hospital E Maternidade Celso Pierro PUCCAMP, Campinas, SP, Brazil|Centro Multidisciplinar de Estudos Clínicos CEMEC FMABC, Sao Bernardo Do Campo, SP, Brazil|BR Trials - Pesquisa Clínica, Sao Paulo, SP, Brazil|Aga Khan University Hospital, Nairobi, Kenya|Organismo Publico Descentralizado Hospital Juarez de Mexico, Ciudad De México, Mexico|Hospital General de Culiacan, Culiacan, Mexico|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico, Mexico|Hospital Militar Central, Jesus Maria, Peru|Hospital Nacional Sergio E. Bernales, Lima, Peru|Hospital Nacional Arzobispo Loayza; Oncology, Lima, Peru|Hospital Nacional Cayetano Heredia, Lima, Peru|Hospital Nacional Hipolito; Unanue, Lima, Peru|Hospital Maria Auxiliadora, Lima, Peru|Hospital Nacional Dos de Mayo, Lima, Peru|University of the Free State, Bloemfontein, South Africa|George Provincial Hospital, George, South Africa|Peermed Clinical Trial Centre, Kempton Park, South Africa|Mzansi Ethical Research Centre, Middelburg, South Africa|Milpark Hospital, Parktown West, South Africa",https://ClinicalTrials.gov/show/NCT04372186
NCT04377464,COVID-19 - Quality of Life After Infection,Observational Model: Cohort|Time Perspective: Prospective,NTEC-2020-0227,NA,https://ClinicalTrials.gov/show/NCT04377464
NCT04903327,Study of Intravenous COVI-MSC for Treatment of COVID-19-Induced Acute Respiratory Distress,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",MSC-COV-201BR,NA,https://ClinicalTrials.gov/show/NCT04903327
NCT04916886,A Clinical Trial of Immunobridging and Lot-to-lot Consistency of COVID-19 Vaccine (Ad5-nCoV) in Different Age Groups.,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Other",JSVCT118,"Funing Center for Disease Control and Prevention, Yancheng, Jiangsu, China",https://ClinicalTrials.gov/show/NCT04916886
NCT04969172,"A Phase II Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Exosomes Overexpressing CD24 to Prevent Clinical Deterioration in Patients With Moderate or Severe COVID-19 Infection","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",0206-21-TLV,"Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel",https://ClinicalTrials.gov/show/NCT04969172
NCT04373889,COVID-19 Among Healthcare Workers in Belgian Hospitals,Observational Model: Cohort|Time Perspective: Prospective,Sciensano,"Sciensano, Brussels, Belgium",https://ClinicalTrials.gov/show/NCT04373889
NCT04336956,Covid-19 Pediatric Observatory,Observational Model: Cohort|Time Perspective: Other,PANDOR,"Chu Felix Guyon, Saint Denis, La Réunion, France|Ch St Esprit, Agen, France|Ch General Aix En Provence -, Aix-en-Provence, France|CHU Angers, Angers, France|CH d'ANGOULEME, Angoulème, France|Pringy - Ch D'Annecy, Annecy, France|CH Argenteuil, Argenteuil, France|Ch Armentieres, Armentières, France|CH Arpajon, Arpajon, France|Ch Auxerre, Auxerre, France|CH GENERAL Henri Duffaut, Avignon, France|CHU de BESANCON, Besançon, France|Hopital Femme Enfant, Caen, France|Ch de Pontoise, Cergy-Pontoise, France|Ch W. Morey, Chalon-sur-Saône, France|CH de CHAMBERY, Chambéry, France|Ch Hotel Dieu, Chartres, France|CHU Estaing, Clermont-Ferrand, France|Hopital Louis Pasteur, Colmar, France|Hopital Louis Mourrier, Colombes, France|CH Sud Francilien, Corbeil-Essonnes, France|Centre Hospitalier intercommunal de Creteil, Creteil, France|Ch de Dax, Dax, France|Hopital D'Enfants Chu Dijon, Dijon, France|CH Louviers Val de Reuil, Elbeuf, France|CH Gonesse, Gonesse, France|CH d'HYERES, Hyères, France|Ch de Marne La Vallee, Jossigny, France|Chru de Grenoble, La Tronche, France|CHGénéral du HAVRE, Le Havre, France|Hopital Jeanne de Flandre, Lille, France|Hopital Roger Salengro - Lille, Lille, France|Hopital Saint Vincent de Paul, Lille, France|Ch de Longjumeau, Longjumeau, France|Lorient - Ch de Bretagne Sud, Lorient, France|Hopital Femme Mere Enfant-Bron, Lyon, France|Hopital de Mantes, Mantes-la-Jolie, France|Hopital Nord Enfants, Marseille, France|Hopital de Meaux, Meaux, France|Ch de Melun, Meulin, France|CH de Montargis, Montargis, France|CH de MONTBRISON, Montbrison, France|Hopital Arnaud de Villeneuve, Montpellier, France|CHRU de Nancy, Nancy, France|Nantes - Hopital Mere Enfant, Nantes, France|Ch de Neuilly Sur Seine, Neuilly-sur-Seine, France|Hopital Lenval, Nice, France|CHU Nimes Caremeau, Nîmes, France|Chr Orleans, Orléans, France|Assistance Publique Hôpitaux de Paris, Paris, France|Hopital St Jean Roussillon, Perpignan, France|POISSY - CH de POISSY, Poissy, France|QUIMPER - CH de Cornouaille, Quimper, France|RANG du FLIERS - C.H.A.M., RANG du FLIERS, France|Hopital Américain CHU REIMS, Reims, France|CH RODEZ, Rodez, France|CH de ROMANS, Romans-sur-Isère, France|Chu Rouen, Rouen, France|Hopital Charles-Nicolle, Rouen, France|Chu St Etienne, Saint Etienne, France|Ch de Saint Denis, Saint-Denis, France|Ch de Saint Malo, Saint-Malo, France|Ch Du Pays Du Mont Blanc, Sallanches, France|Chg Salon de Provence, Salon de Provence, France|CH Hautepierre, Strasbourg, France|CH Tarbes, Tarbes, France|CH Bel Air, Thionville, France|Hopital Sainte Musse, Toulon, France|CHU Toulouse-hôpital des Enfants, Toulouse, France|Hôpital Gatien De Clocheville, Tours, France|CH de TROYES, Troyes, France|Hôpital Nord Franche-Comté, Trévenans, France|Ch Bretagne Atlantique, Vannes, France|Ch Le Chesnay, Versailles, France|Hopital de Villeneuve Saint Georges, Villeneuve-Saint-Georges, France|CH Jean Monnet, Épinal, France",https://ClinicalTrials.gov/show/NCT04336956
NCT04386616,A Study to Evaluate the Safety and Efficacy of MSTT1041A (Astegolimab) or UTTR1147A in Patients With Severe COVID-19 Pneumonia,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",GA42469|2020-002713-17,"University of Arkansas For Medical Sciences, Little Rock, Arkansas, United States|eStudySite - Chula Vista - PPDS, Chula Vista, California, United States|eStudySite, La Mesa, California, United States|Alta Bates Summit Medical Center, Oakland, California, United States|Torrance Memorial Medical Center, Torrance, California, United States|Denver Health Medical Center, Denver, Colorado, United States|Bay Pines VA Medical Center - NAVREF, Bay Pines, Florida, United States|Larkin Community Hospital Palm Springs Campus (Hialeah), Hialeah, Florida, United States|Larkin Community Hospital, South Miami, Florida, United States|Northside Hospital; Peachtree Dunwoody Medical Center, Atlanta, Georgia, United States|WellStar Research Institute, Marietta, Georgia, United States|University Of Iowa Hospitals And Clinics, Coralville, Iowa, United States|DM Clinical Research - Alexandria Cardiology Clinic - ERN - PPDS, Alexandria, Louisiana, United States|MedPharmics, Metairie, Louisiana, United States|Southeast Louisiana Veterans Health Care System - NAVREF, New Orleans, Louisiana, United States|Henry Ford Health System, Detroit, Michigan, United States|St. Joseph'S Regional Medical Center, Paterson, New Jersey, United States|San Juan Oncology Associates, Farmington, New Mexico, United States|Albany Medical Center, Albany, New York, United States|Lincoln Medical Mental Health Center, Bronx, New York, United States|Jacobi Medical Center; Lewis M. Fraad Department of Pediatrics, Bronx, New York, United States|Staten Island University Hospital; Department of Pharmacy, Staten Island, New York, United States|Cape Fear Valley Health System, Fayetteville, North Carolina, United States|Mercy St. Vincent Medical Center, Toledo, Ohio, United States|Providence Portland Medical Center; Investigational Drug Services/Regional Research, Portland, Oregon, United States|Lehigh Valley Health Network, Allentown, Pennsylvania, United States|Temple Uni Medical Center; Pulmonary & Critical Care Medicine, Philadelphia, Pennsylvania, United States|Parkland Health & Hospital System, Dallas, Texas, United States|University of Texas Southwestern Medical Center, Dallas, Texas, United States|Virginia Commonwealth University, Richmond, Virginia, United States|Virginia Mason Medical Center, Seattle, Washington, United States|MultiCare Institute for Research and Innovation; Clinic/Outpatient Facility, Tacoma, Washington, United States|Instituto de Pesquisa Clinica Evandro Chagas FIOCRUZ, Rio de Janeiro, RJ, Brazil|Centro De Estudos Pesquisas em Molestias Infecciosas - CPCLIN, Natal, RN, Brazil|Santa Casa de Porto Alegre, Porto Alegre, RS, Brazil|Hospital E Maternidade Celso Pierro PUCCAMP, Campinas, SP, Brazil|Hospital de Base Da Faculdade de Medicina de Sao Jose Do Rio Preto, Sao Jose Do Rio Preto, SP, Brazil|Hospital Alemao Oswaldo Cruz, Sao Paulo, SP, Brazil|Instituto do Coração - HCFMUSP, Sao Paulo, SP, Brazil|Nuevo Hospital Civil de Guadalajara Dr. Juan I. Menchaca, Guadalajara, Jalisco, Mexico|Hospital Universitario Dr. Jose Eleuterio Gonzalez, Monterrey, Nuevo LEON, Mexico|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico, Mexico|Instituto Nacional De Enfermedades Respiratorias INER National Institute of Respiratory Diseases, Mexico, Mexico|Hospital General de Tijuana, Tijuana, Mexico|Hospital Universitario de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain|Hospital Mutua de Terrassa, Terrassa, Barcelona, Spain|Hospital Universitario A Coruña, Coruna, LA Coruña, Spain|Hospital San Pedro, Logroño, LA Rioja, Spain|Hospital Costa del Sol; Servicio de Oncologia, Marbella, Malaga, Spain|Hospital del Mar, Barcelona, Spain|Hospital General Universitario de Guadalajara, Guadalajara, Spain|Hospital General Universitario Gregorio Maranon, Madrid, Spain|Complejo Asistencial Universitario de Salamanca - H. Clinico, Salamanca, Spain|Hospital Clinico Universitario Valladolid, Valladolid, Spain",https://ClinicalTrials.gov/show/NCT04386616
NCT04359602,COVID-19 Recovered Volunteer Research Participant Pool Registry,Observational Model: Case-Only|Time Perspective: Prospective,20-000625,"Ronald Reagan UCLA Medical Center, Los Angeles, California, United States",https://ClinicalTrials.gov/show/NCT04359602
NCT04885517,"Breathing Effort in Covid-19 Pneumonia: Effects of Positive Pressure, Inspired Oxygen Fraction and Decubitus",Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Other,2782,"A.O.U. San Luigi Gonzaga Di Orbassano, Orbassano, Italy/Turin, Italy",https://ClinicalTrials.gov/show/NCT04885517
NCT04542421,Lung Ultrasound Implementation in the Management of Patients Hospitalized With COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,20-0781,"University of Colorado, Denver, Colorado, United States",https://ClinicalTrials.gov/show/NCT04542421
NCT04905836,Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Treatment of COVID-19 Acute Respiratory Distress,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",MSC-COV-202,NA,https://ClinicalTrials.gov/show/NCT04905836
NCT04363736,A Study to Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 Pneumonia,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,CA42481,"Mayo Clinic - Arizona, Phoenix, Arizona, United States|St. Jude Medical Center, Fullerton, California, United States|LAC + USC Medical Center, Los Angeles, California, United States|USC Keck Medical Center of USC, Los Angeles, California, United States|Norwalk Hospital, Norwalk, Connecticut, United States|Medstar Georgetown University Hospital, Washington, District of Columbia, United States|Mayo Clinic, Jacksonville, Florida, United States|Advocate Christ Medical Center, Oak Lawn, Illinois, United States|Advocate Lutheran General Hospital, Park Ridge, Illinois, United States|MedPharmics, Metairie, Louisiana, United States|University of Maryland, Baltimore, Maryland, United States|Renown Institute for Heart & Vascular Health, Reno, Nevada, United States|St Joseph's Regional Medical Center, Wayne, New Jersey, United States|SUNY Downstate Medical Center., Brooklyn, New York, United States|Jamaica Hospital Medical Center, Jamaica, New York, United States|Vassar Brothers Medical Center, Poughkeepsie, New York, United States|Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States|University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States|Mercy St. Vincent Medical Center, Toledo, Ohio, United States|Lehigh Valley Health Network, Allentown, Pennsylvania, United States|Temple University Hospital, Philadelphia, Pennsylvania, United States|Allegheny Health Network (Pittsburg PA), Pittsburgh, Pennsylvania, United States|Medical University of South Carolina, Charleston, South Carolina, United States|Houston Methodist Hospital, Houston, Texas, United States|Michael E. DeBakey VA Medical Center, Houston, Texas, United States|Houston Methodist Sugar Land Hospital, Sugar Land, Texas, United States",https://ClinicalTrials.gov/show/NCT04363736
NCT04974190,"A Randomized, Double Blind, Placebo-controlled Study to Evaluate the Efficacy of Lavandula Angustifolia Containing Nasal Spray Medical Device in Preventing Deterioration of COVID-19 in Symptomatic Patients","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",0037-21-COM1,NA,https://ClinicalTrials.gov/show/NCT04974190
NCT04534478,Oral Prednisone Regimens to Optimize the Therapeutic Strategy in Patients With Organizing Pneumonia Post-COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2020-003651-15,NA,https://ClinicalTrials.gov/show/NCT04534478
NCT04390503,Convalescent Plasma for Early Treatment of COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment",AAAT0052,"National Institute of Infectious Diseases Evandro Chagas (INI), Rio de Janeiro, Brazil",https://ClinicalTrials.gov/show/NCT04390503
NCT04970719,Baricitinib in Hospitalized Covid-19 Patients With Diabetes Mellitus,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,BADAS-ERC/EC/21/00311,"Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh|BIRDEM General Hospital, Dhaka, Bangladesh|Mugda Medical College and Hospital, Dhaka, Bangladesh|Bangladesh Specialized Hospital, Dhaka, Bangladesh|Central Police Hospital, Dhaka, Bangladesh|SQUARE Hospitals Limited, Dhaka, Bangladesh|Khulna Medical College Hospital, Khulna, Bangladesh|Rajshahi Medical College & Hospital, Rajshahi, Bangladesh",https://ClinicalTrials.gov/show/NCT04970719
NCT04822402,COVID-19 Among Pregnant Women in Assiut,Observational Model: Case-Only|Time Perspective: Cross-Sectional,COVID-19 among Pregnant Women,NA,https://ClinicalTrials.gov/show/NCT04822402
NCT04417257,Study of LAU-7b for the Treatment of COVID-19 Disease in Adults,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",LAU-20-01,"Chandler Regional Medical Center / Mercy Gilbert Medical Center, Chandler, Arizona, United States|Baptist Medical Center Beaches, Jacksonville Beach, Florida, United States|St Lukes Hospital, Boise, Idaho, United States|University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States|Anne Arundel Medical Center, 2001 Medical Parkway, Belcher Pavillion, Annapolis, Maryland, United States|Wayne State University, Harper University Hospital and Detroit Receiving Hospital, Detroit, Michigan, United States|Henry Ford Health System, Detroit, Michigan, United States|Houston Methodist Hospital, Houston, Texas, United States|Centre d'études cliniques CIUSS SLJ, Hôpital Chicoutimi, Chicoutimi, Quebec, Canada|CIUSSSS de l'Est-de-l'Ile-de-Montréal, Hôpital Maisonneuve-Rosemont, Montréal, Quebec, Canada|Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada|Jewish General Hospital, Montréal, Quebec, Canada|McGill University Health Centre, Montréal, Quebec, Canada|CISSS Des Laurentides, Saint-Jérôme, Quebec, Canada",https://ClinicalTrials.gov/show/NCT04417257
NCT04712344,Assessment of Efficacy and Safety of Therapy With COVID-19 Convalescent Plasma in Subjects With Severe COVID-19 (IPCO),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,UKER-COV2-01,"University Hospital Erlangen, Erlangen, Germany",https://ClinicalTrials.gov/show/NCT04712344
NCT04315896,Hydroxychloroquine Treatment for Severe COVID-19 Pulmonary Infection (HYDRA Trial),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",HidroxycloroquinaCOVID19,"Instituto Nacional de Enfermedades Respiratorias, ""Ismael Cosío Villegas"", Mexico, City, Mexico",https://ClinicalTrials.gov/show/NCT04315896
NCT04951310,COVID-19 Vaccinations With a Sweepstakes,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,849044,"University of Pennsylvania, Philadelphia, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04951310
NCT04404244,Extraordinary Measures for Egyptian Children With Hemato-Oncological Disorders During COVID-19 Pandemic,Observational Model: Case-Only|Time Perspective: Prospective,FMASU P25a/ 2020,"Faculty of Medicine Ain Shams University Research Institute- Clinical Research Center, Cairo, Non-US, Egypt",https://ClinicalTrials.gov/show/NCT04404244
NCT04646031,Expanded Access to T89 for Treatment Use in Intermediate-size Patients Population With COVID-19,NA,T89-ROUSA-01,"MultiCare Health System, Tacoma, Washington, United States",https://ClinicalTrials.gov/show/NCT04646031
NCT04738175,Study to Evaluate the Safety and Efficacy of a Single Dose of STI-2020 (COVI-AMG™) to Treat COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",AMG-COV-201-BR,NA,https://ClinicalTrials.gov/show/NCT04738175
NCT04329650,Efficacy and Safety of Siltuximab vs. Corticosteroids in Hospitalized Patients With COVID-19 Pneumonia,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,SILCOR-COVID-19,"Hospital Germans Trias i Pujol, Badalona, Spain|Hospital Clínic de Barcelona, Barcelona, Spain|Hospital Universitario de Salamanca, Salamanca, Spain|Hospital Universitari Mútua de Terrassa, Terrassa, Spain",https://ClinicalTrials.gov/show/NCT04329650
NCT04273529,The Efficacy and Safety of Thalidomide in the Adjuvant Treatment of Moderate New Coronavirus (COVID-19) Pneumonia,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",20200214-COVID-19-M-T,NA,https://ClinicalTrials.gov/show/NCT04273529
NCT04273581,The Efficacy and Safety of Thalidomide Combined With Low-dose Hormones in the Treatment of Severe COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",20200214-COVID-19-S-T,NA,https://ClinicalTrials.gov/show/NCT04273581
NCT04409262,A Study to Evaluate the Efficacy and Safety of Remdesivir Plus Tocilizumab Compared With Remdesivir Plus Placebo in Hospitalized Participants With Severe COVID-19 Pneumonia,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",WA42511|2020-002275-34,"Valleywise Health Medical Center, Phoenix, Arizona, United States|eStudySite - Chula Vista - PPDS, Chula Vista, California, United States|Hoag Hospital Irvine, Irvine, California, United States|Providence St. John's Health Center, Santa Monica, California, United States|Yale University School of Medicine; HIV Clinical Trials Program, New Haven, Connecticut, United States|Medstar Georgetown University Hospital, Washington, District of Columbia, United States|Holy Cross Hospital Inc, Fort Lauderdale, Florida, United States|Larkin Community Hospital Palm Springs Campus (Hialeah), Hialeah, Florida, United States|University of Miami Miller School of Medicine; Clinical Reseach Building, Miami, Florida, United States|Larkin Community Hospital, South Miami, Florida, United States|St Luke's Health System; Rheumatology Research, Boise, Idaho, United States|Advocate Christ Medical Center, Oak Lawn, Illinois, United States|Ochsner Clinic Foundation, New Orleans, Louisiana, United States|Louisiana State University Health Sciences Center/Ochsner, Shreveport, Louisiana, United States|University of Maryland, Baltimore, Maryland, United States|Boston Medical Center, Boston, Massachusetts, United States|Baystate Medical Center, Springfield, Massachusetts, United States|Henry Ford Medical Center, Novi, Michigan, United States|Saint Elizabeth Regional Medical Center, Lincoln, Nebraska, United States|St. Michael'S Medical Center, Newark, New Jersey, United States|San Juan Oncology Associates, Farmington, New Mexico, United States|Wyckoff Heights Medical Center, Staten Island, New York, United States|Novant Health Clinical Research, Charlotte, North Carolina, United States|OhioHealth Research Institute, Columbus, Ohio, United States|Providence Saint Vincent's Medical Center, Portland, Oregon, United States|Lehigh Valley Hospital, Allentown, Pennsylvania, United States|Thomas Jefferson University, Philadelphia, Pennsylvania, United States|Medical University of South Carolina, Charleston, South Carolina, United States|Prisma Health-Midlands, Columbia, South Carolina, United States|The Liver Institute at Methodist Dallas, Arlington, Texas, United States|Baylor Scott and White Medical Center - College Station, College Station, Texas, United States|Baylor University Medical Center, Dallas, Texas, United States|Baylor St. Luke's Medical Center, Houston, Texas, United States|Ben Taub General Hospital - HCHD, Houston, Texas, United States|Houston Methodist Hospital, Houston, Texas, United States|Baylor Scott & White Medical Center - Irving, Irving, Texas, United States|Baylor Scott & White Hospital - Plano, Plano, Texas, United States|Baylor Scott & White Health, Temple, Texas, United States|Intermountain LDS Hospital, Salt Lake City, Utah, United States|The Providence Regional Medical Center Everett, Everett, Washington, United States|West Virginia University Hospital, Morgantown, West Virginia, United States|Santa Casa de Misericordia de Belo Horizonte, Belo Horizonte, MG, Brazil|Hospital Nossa Senhora das Graças; Setor de Pesquisa em Neurologia, Curitiba, PR, Brazil|Instituto de Pesquisa Clinica Evandro Chagas - IPEC FIOCRUZ, Rio de Janeiro, RJ, Brazil|Faculdade de Medicina do ABC - FMABC, Santo Andre, SP, Brazil|CEMEC - Centro Multidisciplinar de Estudos Clínicos, Sao Bernardo Do Campo, SP, Brazil|Hospital de Base de Sao Jose do Rio Preto, Sao Jose do Rio Preto, SP, Brazil|Instituto de Infectologia Emilio Ribas, Sao Paulo, SP, Brazil|Instituto do Coração - HCFMUSP, Sao Paulo, SP, Brazil|Medsi Clinic, Moscow, Adygeja, Russian Federation|Clinical Infectious Diseases Hospital #1; Chair of Infectious Disease and Epidemiology, Moskva, Moskovskaja Oblast, Russian Federation|City Clinical Hospital #15, Moscow, Russian Federation|City Clinical Hospital # 52, Moscow, Russian Federation|Pokrovsky City Hosptial, St Petersburg, Russian Federation|Hospital Universitario de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain|Hospital Universitario Principe de Asturias; Medicina Interna - Servicio de Enfermedades Infecciosas, Alcala de Henares, Madrid, Spain|Hospital Universitario HM Torrelodones, Torrelodones, Madrid, Spain|Hospital Universitario Vall d'Hebron - PPDS, Barcelona, Spain|Hospital Clinic de Barcelona, Barcelona, Spain|Hospital General Universitario de Guadalajara, Guadalajara, Spain|Hospital Universitario Fundacion Jimenez Diaz., Madrid, Spain|Hospital Universitario 12 de Octubre, Madrid, Spain|Hospital Universitario de Salamanca, Salamanca, Spain",https://ClinicalTrials.gov/show/NCT04409262
NCT04331470,Evaluation of Efficacy of Levamisole and Formoterol+Budesonide in Treatment of COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment",97548,"Vali-Asr Hospital, Fasa, Fars, Iran, Islamic Republic of",https://ClinicalTrials.gov/show/NCT04331470
NCT04771351,Study to Evaluate a Single Dose of STI-2020 (COVI-AMG™) in Hospitalized Adults With COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",AMG-COV-202,"Teradan Clinical Trials, Brandon, Florida, United States",https://ClinicalTrials.gov/show/NCT04771351
NCT04661527,Sarilumab Treatment In cytoKinE Storm Caused by Infection With COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,STRIKESARS-COV|2020-001255-40,"Clínica Universidad de Navarra, Universidad de Navarra, Pamplona, Navarra, Spain|Hospital Universitario Infanta Leonor, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04661527
NCT04959760,BinaxNow COVID-19 IgG Rapid Test Device and Antibody Self Test,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,CLDG-0511,"Rush University Medical Center, Chicago, Illinois, United States|Duke University Health System, Durham, North Carolina, United States|Urgent Care Clinical Trials, Powdersville, South Carolina, United States|Urgent Care Clinical Trials at Complete Health Partners, Nashville, Tennessee, United States|Urgent Care Clinical Trials, Dallas, Texas, United States",https://ClinicalTrials.gov/show/NCT04959760
NCT04914364,Balance in COVID-19,Observational Model: Cohort|Time Perspective: Prospective,Pro00108353,"Duke University Health System, Durham, North Carolina, United States",https://ClinicalTrials.gov/show/NCT04914364
NCT04906694,Study to Evaluate a Single Intranasal Dose of STI-2099 (COVI-DROPS™) in Outpatient Adults With COVID-19 (US),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",DRP-COV-201US,NA,https://ClinicalTrials.gov/show/NCT04906694
NCT04986176,HC-1119 Adjuvant Treatment for Hospitalized COVID-19 Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",HC-1119-DRUG-SARS-001,NA,https://ClinicalTrials.gov/show/NCT04986176
NCT04411680,Study of Sargramostim in Patients With COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,PTX-001-002,"St. Jude Medical Center, Fullerton, California, United States|St. Joseph Hospital of Orange, Orange, California, United States|California Pacific Medical Center - Van Ness Campus, San Francisco, California, United States|TidalHealth Peninsula Regional, Inc, Salisbury, Maryland, United States|University of Missouri Health Care, Columbia, Missouri, United States|Great Plains Health, North Platte, Nebraska, United States|Richmond University Medical Center, Staten Island, New York, United States|Brody School of Medicine at East Carolina University, Greenville, North Carolina, United States|University of Toledo Medical Center, Toledo, Ohio, United States|Memorial Hermann Hospital Affiliated with the University of Texas Health Science Center at Houston, McGovern Medical School, Houston, Texas, United States|University of Utah Health, Salt Lake City, Utah, United States",https://ClinicalTrials.gov/show/NCT04411680
NCT04937582,Cognitive and Psychological Disorders After Severe COVID-19 Infection,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,2021-A00447-34,NA,https://ClinicalTrials.gov/show/NCT04937582
NCT04734860,Study to Evaluate a Single Dose of STI-2020 (COVI-AMG™) in Adults With Mild COVID-19 Symptoms,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",AMG-COV-201,"Collaborative NeuroScience Research, LLC, Garden Grove, California, United States|Synergy Healthcare LLC, Bradenton, Florida, United States|Med-Care Research, Miami, Florida, United States|ETNA Medical Center, Tamarac, Florida, United States",https://ClinicalTrials.gov/show/NCT04734860
NCT04374032,Clinical Trial to Evaluate the Efficacy and Safety of an Immunomodulatory Therapy for the Treatment of Patients With Moderate to Severe COVID-19 Infection,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,EN-COVCS-01,"Clinical Center University of Sarajevo, Sarajevo, Sarajevo Canton, Bosnia and Herzegovina|University Clinical Centre of the Republic of Srpska, Banja Luka, Bosnia and Herzegovina|University Clinical Hospital Mostar, Mostar, Bosnia and Herzegovina|Hospital Travnik, Travnik, Bosnia and Herzegovina|Cantonal Hospital Zenica, Zenica, Bosnia and Herzegovina",https://ClinicalTrials.gov/show/NCT04374032
NCT04560881,"Clinical Trial to Evaluate the Efficacy, Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (COVID-19)","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention",BIBP2020003AR,"Fundación Huésped, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina|Vacunar Liniers, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina|Vacunar Cañitas, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina|Vacunar Coghlan, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina",https://ClinicalTrials.gov/show/NCT04560881
NCT04355884,Opportunistic Screening for Asymptomatic Left Ventricular Dysfunction in Coronavirus Disease 2019 (COVID19) Survivors,Observational Model: Cohort|Time Perspective: Prospective,COVID_LVD_SCREEN,"The University of Hong Kong, Queen Mary Hospital, Hong Kong, Hong Kong",https://ClinicalTrials.gov/show/NCT04355884
NCT04691609,Assiut University Registry for ACS Patients During COVID-19 Pandemic,Observational Model: Cohort|Time Perspective: Cross-Sectional,ACS in COVID-19 era,"Samah ObiedAllah Fouad, Assiut, Resident, Egypt",https://ClinicalTrials.gov/show/NCT04691609
NCT04747821,An Effectiveness Study of the Sinovac's Adsorbed COVID-19 (Inactivated) Vaccine,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,COV-04-IB,"Hospital Estadual de Serrana, Serrana, SP, Brazil",https://ClinicalTrials.gov/show/NCT04747821
NCT04900428,Study to Evaluate a Single Intranasal Dose of STI-2099 (COVI-DROPS™) in Outpatient Adults With COVID-19 (UK),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",DRP-COV-201UK,NA,https://ClinicalTrials.gov/show/NCT04900428
NCT04368000,Prone Positioning in Awake Patients With COVID-19 Requiring Hospitalization,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,IRB_00132123,"University of Utah Health Sciences Center, Salt Lake City, Utah, United States",https://ClinicalTrials.gov/show/NCT04368000
NCT04358809,"Clinical Trial of Mycobacterium w in COVID-19 Positive Patients, Hospitalized But Not Critically Ill","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",CRSC20006,"All India Institute of Medical Science, Raipur, Raipur, Chhattisgarh, India|All India Institute of Medical Sciences, Bhopal, Bhopal, India|Post Graduate Institute of Medical Education and Research, Chandigarh, India|All India Institute of Medical Sciences, Delhi, Delhi, India",https://ClinicalTrials.gov/show/NCT04358809
NCT04325061,Efficacy of Dexamethasone Treatment for Patients With ARDS Caused by COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2020-001278-31,"ICU, Hospital Universitari Mutua Terrassa, Terrassa, Barcelona, Spain|Hospital Universitario Dr. Negrin, Las Palmas de Gran Canaria, Las Palmas, Spain|Department of Anesthesia, Hospital Universitario de Cruces, Barakaldo, Vizcaya, Spain|Intensive Care Unit, Hospital Universitario de Cruces, Barakaldo, Vizcaya, Spain|AVI, Hospital Clinic, Barcelona, Spain|Cardiac ICU, Hospital Clinic, Barcelona, Spain|Department of Anesthesia, Hospital Clinic, Barcelona, Spain|Hepatic ICU, Hospital Clínic, Barcelona, Spain|UVIR, Hospital Clinic, Barcelona, Spain|Intensive Care Unit, Hospital General de Ciudad Real, Ciudad Real, Spain|Department of Anesthesia, Hospital Universitario La Princesa, Madrid, Spain|Intensive Care Unit, Hospital Universitario La Princesa, Madrid, Spain|Intensive Care Unit, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain|Department of Anesthesia, Hospital Universitario La Paz, Madrid, Spain|Intensive Care Unit, Hospital Universitario La Paz, Madrid, Spain|Department of Anesthesia, Hospital Universitario Virgen de Arrixaca, Murcia, Spain|Intensive Care Unit, Hospital Universitario Virgen de la Arrixaca, Murcia, Spain|Department of Anesthesia, Hospital Unversitario Montecelo, Pontevedra, Spain|Anesthesia, Hospital General Universitario de Valencia, Valencia, Spain|Department of Anesthesia, Hospital Clinico Universitario, Valencia, Spain|Intensive Care Unit, Hospital Clinico Universitario, Valencia, Spain|Department of Anesthesia, Hospital Clínico Universitario, Valladolid, Spain|Anesthesia, Hospital Universitario Río Hortega, Valladolid, Spain|Intensive Care Unit, Hospital Universitario Río Hortega, Valladolid, Spain",https://ClinicalTrials.gov/show/NCT04325061
NCT04567173,Convalescent Plasma as Adjunctive Therapy for Hospitalized Patients With COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,PHRR200824-002868,"UP Philippine General Hospital, Manila, Philippines",https://ClinicalTrials.gov/show/NCT04567173
NCT04528667,Study of the Safety and Efficacy of STI-5656 (Abivertinib Maleate) in Subjects Hospitalized Due to COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",BTK-COV-202BR,"Hospital e Maternidade Christovão da Gama, Santo André, SP, Brazil",https://ClinicalTrials.gov/show/NCT04528667
NCT04658121,SARS-CoV-2/COVID-19 Prevalence Study,Observational Model: Ecologic or Community|Time Perspective: Cross-Sectional,CoVPN 5002,"Children's Hospital Colorado CRS, Aurora, Colorado, United States|U of Miami, IDRU at Jackson Memorial Hospital CRS, Miami, Florida, United States|The Ponce de Leon Center CRS, Atlanta, Georgia, United States|UIC Project Wish CRS, Chicago, Illinois, United States|New Orleans Adolescent Trials Unit CRS, New Orleans, Louisiana, United States|John's Hopkins CRS, Baltimore, Maryland, United States|New Jersey Medical School CRS, Newark, New Jersey, United States|Harlem Prevention, New York, New York, United States|Bronx Prevention Center, New York, New York, United States|Chapel Hill CRS, Chapel Hill, North Carolina, United States|Cincinnati CRS, Cincinnati, Ohio, United States|Penn Prevention CRS, Philadelphia, Pennsylvania, United States|University of Pittsburgh, Pittsburgh, Pennsylvania, United States|Baylor College of Medicine, Houston, Texas, United States|St. Louis University VTEU-CAIMED-PHSU, Ponce, Puerto Rico",https://ClinicalTrials.gov/show/NCT04658121
NCT04816084,SERUR: COVID-19 Serological Survey of Staff From the University Reims-Champagne Ardennes,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Screening,2020-004-SERUR,"Université de Reims Champagne-Ardenne, Reims, France",https://ClinicalTrials.gov/show/NCT04816084
NCT04643691,Losartan and Spironolactone Treatment for ICU Patients With COVID-19 Suffering From ARDS,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2020-24|2020-001766-11,"Assistance Publique Hôpitaux de Marseille, Marseille, France",https://ClinicalTrials.gov/show/NCT04643691
NCT04313127,Phase I Clinical Trial of a COVID-19 Vaccine in 18-60 Healthy Adults,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,JSVCT088,"Hubei Provincial Center for Disease Control and Prevention, Wuhan, Hubei, China",https://ClinicalTrials.gov/show/NCT04313127
NCT04344925,Non Invasive Positive Pressure Ventilation to Minimize Aerosolization for COVID 19,Observational Model: Cohort|Time Perspective: Prospective,137654,"London Health Science Centre, London, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04344925
NCT04589117,Expressive Writing for COVID-19 Resilience for Parents,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,Pro00105586,"Duke Integrative Medicine, Durham, North Carolina, United States",https://ClinicalTrials.gov/show/NCT04589117
NCT04428268,Chloroquine + Losartan Compared to Chloroquine Alone for the Treatment of COVID-19 Pneumonia,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment",IF20-00003,"Hospital Universitario José E. Gonzalez, Monterrey, Nuevo Leon, Mexico",https://ClinicalTrials.gov/show/NCT04428268
NCT04487210,A Study to Evaluate the Safety and Immunogenicity of MVC-COV1901 Against COVID-19,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,CT-COV-11,"National Taiwan University Hospital, Taipei, Taiwan",https://ClinicalTrials.gov/show/NCT04487210
NCT04483622,Immunoglobulin G Antibody Immune Response Profile Following Infection With SARS-CoV-2 in COVID-19 Egyptian Patients,Observational Model: Case-Only|Time Perspective: Prospective,IBR#S20-133,"Sohag University Hospital, Sohag, Egypt",https://ClinicalTrials.gov/show/NCT04483622
NCT04460690,"Rapid, Onsite COVID-19 Detection",Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,2020-0855|A536300|SMPH/PATHOL-LAB MED/ANAT PATH|Protocol Version 8/30/2020|5P51OD011106-59,"University of Wisconsin, Madison, Wisconsin, United States",https://ClinicalTrials.gov/show/NCT04460690
NCT04328441,Reducing Health Care Workers Absenteeism in Covid-19 Pandemic Through BCG Vaccine,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",NL73249.041.20,"Jeroen Bosch ziekenhuis, Den Bosch, Brabant, Netherlands|Canisius Wilhelmina Ziekenhuis, Nijmegen, Gelderland, Netherlands|Radboud UMC, Nijmegen, Gelderland, Netherlands|Sint Maartenskliniek, Nijmegen, Gelderland, Netherlands|Noordwest Ziekenhuisgroep locatie Alkmaar, Alkmaar, Noord Holland, Netherlands|Hagaziekenhuis, Den Haag, Zuid-Holland, Netherlands|Leiden University Medical Center, Leiden, Zuid-Holland, Netherlands|Erasmus Medical Center, Rotterdam, Zuid-Holland, Netherlands|University Medical Center Utrecht, Utrecht, Netherlands",https://ClinicalTrials.gov/show/NCT04328441
NCT04498325,"Evaluating the Effect of NT-I7, a Long Acting Interleukin-7, to Increase Lymphocyte Counts and Enhance Immune Clearance of SARS-CoV-2 (COVID-19)","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",202009065,"Saint Louis University Hospital, Saint Louis, Missouri, United States",https://ClinicalTrials.gov/show/NCT04498325
NCT04930874,Cerebral Autoregulation and COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,CA-COVID 196/10-6-2021,NA,https://ClinicalTrials.gov/show/NCT04930874
NCT04584697,"Study to Evaluate the Safety, Pharmacokinetics and Efficacy of STI-2020 (COVI-AMG™) in Outpatients With COVID-19","Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",AMG-COV-102,NA,https://ClinicalTrials.gov/show/NCT04584697
NCT04577534,COVID-19: Salvage TOcilizumab as a Rescue Measure,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,EudraCT 2020-002039-31|2020-002039-31|T124/2020|KLnro 36/2020|dnro 68/06.00.01/2020,"Turku University Hospital, Turku, Finland",https://ClinicalTrials.gov/show/NCT04577534
NCT04854772,Mind Body Intervention for COVID-19 Long Haul Syndrome,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2021P-000336,"Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT04854772
NCT04615208,Screening for COVID-19,Observational Model: Cohort|Time Perspective: Prospective,B2020:070 (HS24165),"University of Manitoba, Winnipeg, Manitoba, Canada",https://ClinicalTrials.gov/show/NCT04615208
NCT04941183,"Phase 1 Study to Assess Safety, Tolerability, PD, PK, Immunogenicity of IV NTR-441 Solution in Healthy Volunteers and COVID-19 Patients","Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",NTR441-1001,"Medical University of Vienna, Department of Infectiology and Tropical Medicine, Vienna, Austria|Medical University Vienna, Department of Clinical Pharmacology, Vienna, Austria",https://ClinicalTrials.gov/show/NCT04941183
NCT04476888,Convalescent Plasma Treatment in COVID-19,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,CON000000000880,"Aga Khan University Hospital, Karachi, Sind, Pakistan",https://ClinicalTrials.gov/show/NCT04476888
NCT04342221,Hydroxychloroquine for COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",COV-HCQ|2020-001224-33,"Zollernalb Klinikum Balingen, Balingen, Germany|Klinikum Darmstadt, Darmstadt, Germany|Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany|Johannes Wesling Klinikum Minden, Minden, Germany|Klinikum am Steinenberg, Reutlingen, Germany|RoMed Klinikum Rosenheim, Rosenheim, Germany|Robert-Bosch-Krankenhaus, Stuttgart, Germany|Institute for Tropical Medicine, Tübingen, Germany",https://ClinicalTrials.gov/show/NCT04342221
NCT04376996,Slovenian National COVID-19 Prevalence Study,Observational Model: Cohort|Time Perspective: Prospective,ULMF2020-COVID-19,"University of Ljubljana, Ljubljana, Slovenia",https://ClinicalTrials.gov/show/NCT04376996
NCT04386109,Neonatal Complications of Coronavirus Disease (COVID-19),Observational Model: Cohort|Time Perspective: Prospective,14905,"Imperial College, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04386109
NCT04933981,Benefit of Expanded Surveillance of Nursing Homes During the COVID-19 Pandemic,Observational Model: Case-Control|Time Perspective: Prospective,3S fuer Koeln,"University Hospital Cologne, Cologne, NRW, Germany",https://ClinicalTrials.gov/show/NCT04933981
NCT04624997,Coagulopathy and Vasculopathy Assessment as a Predictor of the Severity of SARS-CoV-2 / COVID-19 Infection,Observational Model: Cohort|Time Perspective: Prospective,APHP200521|2020-A01048-31,"Hôpital Cochin, Paris, France|Hôpital Européen Georges Pompidou, Paris, France",https://ClinicalTrials.gov/show/NCT04624997
NCT04425460,"A Multi-center,Randomized,Double-blind,Placebo-controlled,Phase 3 Study Evaluating Favipiravir in Treatment of COVID19","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",HS216C17(MRCT),"The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Shangcheng District, China|Peking University First Hospital, Beijing, Xicheng District, China|Department of Internal Medicine Pneumology and infectious diseases Neukölln Clinic, Berlin, Germany|Medical clinic and polyclinic IV Hospital of the University of Munich, München, Germany|Infectious Diseases Hospital Cluj-Napoca, Cluj-Napoca, Cluj, Romania|National Institute of Infectious Diseases ""Prof.Dr.Matei Bals"", Bucharest, Ilfov, Romania|""Dr.Victor Babes"" Infectious Diseases and Pneumoftiziology Clinical Hospital Timisoara, Timisoara, Timis, Romania|""Dr.Victor Babes"" Infectious Diseases and Pneumoftiziology Clinical Hospital Timisoara, Timişoara, Timis, Romania|Dr.Victor Babes Infectious Diseases and Pneumoftiziology Clinical Hospital Timisoara, Timişoara, Timis, Romania|Emergency County Hospital ""Pius Brinzeu""Timisoara, Timişoara, Timis, Romania",https://ClinicalTrials.gov/show/NCT04425460
NCT04367805,COVID-19 Infection in Patients With Hepatocellular Carcinoma,Observational Model: Case-Only|Time Perspective: Prospective,PI2020_843_0042,"CHU Amiens, Amiens, France",https://ClinicalTrials.gov/show/NCT04367805
NCT04907877,Bifido- and Lactobacilli in Symptomatic Adult COVID-19 Outpatients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",MS-Resp-CoV-2-A0003,NA,https://ClinicalTrials.gov/show/NCT04907877
NCT04539626,Estrogen Therapy in Non-severe COVID-19 Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,3,"CMN ""20 de Noviembre"", Mexico City, Benito Juárez, Mexico",https://ClinicalTrials.gov/show/NCT04539626
NCT04445285,Phase 2 Trial Using rhDNase to Reduce Mortality in COVID-19 Patients With Respiratory Failure,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",USAH 1002 000,"University of South Alabama, Mobile, Alabama, United States",https://ClinicalTrials.gov/show/NCT04445285
NCT04449380,Clinical Study for the Treatment With Interferon-ß-1a (IFNß-1a) of COVID-19 Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,INTERCOP,"IRCCS Ospedale San Raffaele, Milano, Italy",https://ClinicalTrials.gov/show/NCT04449380
NCT04803227,Safety and Tolerability of Emricasan in Symptomatic Outpatients Diagnosed With Mild-COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",EMR-COV-PR001,"SUNY Downstate Health Sciences University, Brooklyn, New York, United States",https://ClinicalTrials.gov/show/NCT04803227
NCT04371744,QT-Logs : Artificial Intelligence for QT Interval Analysis of ECG From Smartwatches in Patient Receiving Treatment for Covid-19,Observational Model: Cohort|Time Perspective: Prospective,CIL 2020-52,"Assistance Publique Hôpitaux de Marseille, Marseille, France",https://ClinicalTrials.gov/show/NCT04371744
NCT04736732,The IRCM POST-COVID-19 (IPCO) Clinic,Observational Model: Cohort|Time Perspective: Prospective,2021-1092,"Montreal Clinical Research Institute, Montréal, Quebec, Canada",https://ClinicalTrials.gov/show/NCT04736732
NCT04750369,Enhanced Triage for COVID-19,Observational Model: Case-Control|Time Perspective: Prospective,20-5225,"University Health Network, Toronto, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04750369
NCT04355533,Immunity Against SARS-CoV2 in Children and Their Parents / COVID-19,Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,APHP200467|2020-A00999-30,"Hôpital necker Enfants-Malades, ¨Paris, France",https://ClinicalTrials.gov/show/NCT04355533
NCT04368728,"Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention",C4591001|2020-002641-42,"North Alabama Research Center, LLC, Athens, Alabama, United States|Birmingham Clinical Research Unit, Birmingham, Alabama, United States|Medical Affiliated Research Center, Huntsville, Alabama, United States|Optimal Research, LLC, Huntsville, Alabama, United States|Alliance for Multispecialty Research, LLC, Mobile, Alabama, United States|Chinle Comprehensive Health Care Facility, Chinle, Arizona, United States|Johns Hopkins Center for American Indian Health, Chinle, Arizona, United States|The Pain Center of Arizona, Phoenix, Arizona, United States|HOPE Research Institute, Phoenix, Arizona, United States|Alliance for Multispecialty Research, LLC, Tempe, Arizona, United States|Whiteriver Indian Hospital, Whiteriver, Arizona, United States|Anaheim Clinical Trials, LLC, Anaheim, California, United States|Collaborative Neuroscience Research, LLC, Long Beach, California, United States|Long Beach Clinical Trials Services Inc., Long Beach, California, United States|Kaiser Permanente Los Angeles Medical Center, Los Angeles, California, United States|National Research Institute, Los Angeles, California, United States|Providence Clinical Research, North Hollywood, California, United States|Paradigm Clinical Research Center, Redding, California, United States|Kaiser Permanente Sacramento, Sacramento, California, United States|UC Davis Medical Center, Sacramento, California, United States|California Research Foundation, San Diego, California, United States|Kaiser Permanente Santa Clara, Santa Clara, California, United States|Bayview Research Group, Valley Village, California, United States|Diablo Clinical Research, Inc., Walnut Creek, California, United States|Lynn Institute of Denver, Aurora, Colorado, United States|Clinical Research Consulting, LLC, Milford, Connecticut, United States|Yale Center for Clinical Investigations (CSRU), New Haven, Connecticut, United States|Alliance for Multispecialty Research, LLC-Miami, Coral Gables, Florida, United States|Clinical Research of South Florida, Coral Gables, Florida, United States|DeLand Clinical Research Unit, DeLand, Florida, United States|Fleming Island Center for Clinical Research, Fleming Island, Florida, United States|Indago Research & Health Center, Inc, Hialeah, Florida, United States|Research Centers of America, Hollywood, Florida, United States|Jacksonville Center for Clinical Research, Jacksonville, Florida, United States|Clinical Neuroscience Solutions, Inc., Jacksonville, Florida, United States|Acevedo Clinical Research Associates, Miami, Florida, United States|Clinical Neuroscience Solutions, Inc. dba CNS Healthcare, Orlando, Florida, United States|Atlanta Center for Medical Research, Atlanta, Georgia, United States|IACT Health, Columbus, Georgia, United States|Meridian Clinical Research, LLC, Savannah, Georgia, United States|Clinical Research Atlanta, Stockbridge, Georgia, United States|East-West Medical Research Institute, Honolulu, Hawaii, United States|Solaris Clinical Research, Meridian, Idaho, United States|Optimal Research, LLC, Peoria, Illinois, United States|University of Iowa Hospitals & Clinics Investigational Drug Servces, Iowa City, Iowa, United States|University of Iowa Hospitals & Clinics, Iowa City, Iowa, United States|Meridian Clinical Research, LLC, Sioux City, Iowa, United States|Alliance for Multispecialty Research, LLC, Newton, Kansas, United States|Alliance for Multispecialty Research, LLC, Wichita, Kansas, United States|Kentucky Pediatric/ Adult Research, Bardstown, Kentucky, United States|Benchmark Research, Metairie, Louisiana, United States|Ochsner Clinic Foundation, New Orleans, Louisiana, United States|LSUHSC-Shreveport Clinical Trials Office, Shreveport, Louisiana, United States|LSUHSC-Shreveport, Shreveport, Louisiana, United States|Pharmaron CPC, Inc., Baltimore, Maryland, United States|University of Maryland, Center for Vaccine Development and Global Health, Baltimore, Maryland, United States|Center for Immunization Research Inpatient Unit, Baltimore, Maryland, United States|Boston Medical Center, Boston, Massachusetts, United States|UMass Memorial Medical Center - University Campus, Worcester, Massachusetts, United States|Michigan Center for Medical Research, Farmington Hills, Michigan, United States|MedPharmics, Limited Liability Company, Gulfport, Mississippi, United States|MedPharmics, LLC, Gulfport, Mississippi, United States|Clinical Research Professionals, Chesterfield, Missouri, United States|Sundance Clinical Research, LLC, Saint Louis, Missouri, United States|Methodist Physicians Clinic / CCT Research, Fremont, Nebraska, United States|Meridian Clinical Research, LLC, Norfolk, Nebraska, United States|Quality Clinical Research, Inc., Omaha, Nebraska, United States|Meridian Clinical Research, LLC, Omaha, Nebraska, United States|Wake Research-Clinical Research Center of Nevada, LLC, Las Vegas, Nevada, United States|Amici Clinical Research, Raritan, New Jersey, United States|South Jersey Infectious Disease, Somers Point, New Jersey, United States|Johns Hopkins Center for American Indian Health, Gallup, New Mexico, United States|Johns Hopkins Center for American Indian Health, Shiprock, New Mexico, United States|Meridian Clinical Research, LLC, Binghamton, New York, United States|Meridian Clinical Research LLC, Endwell, New York, United States|NYU Langone Health, New York, New York, United States|Icahn School of Medicine at Mount Sinai, New York, New York, United States|Rochester Clinical Research, Inc., Rochester, New York, United States|Rochester Regional Health/Rochester General Hospital, Rochester, New York, United States|SUNY Upstate Medical University, Syracuse, New York, United States|SUNY Upstate Medical University, Syracuse, New York, United States|PMG Research of Raleigh, LLC d/b/a PMG Research of Cary, Cary, North Carolina, United States|PMG Research of Charlotte LLC, Charlotte, North Carolina, United States|Clinical Research Pickett Road, Durham, North Carolina, United States|Accessioning Unit and Repository, Durham, North Carolina, United States|Duke University Medicine Circle- Duke Early Phase Clinical Research Unit, Durham, North Carolina, United States|PharmQuest, Greensboro, North Carolina, United States|PMG Research of Hickory, LLC, Hickory, North Carolina, United States|PMG Research of Raleigh, LLC, Raleigh, North Carolina, United States|M3 Wake Research, Inc., Raleigh, North Carolina, United States|PMG Research of Salisbury, LLC, Salisbury, North Carolina, United States|PMG Research of Wilmington, LLC, Wilmington, North Carolina, United States|PMG Research of Winston-Salem, LLC, Winston-Salem, North Carolina, United States|Lillestol Research Llc, Fargo, North Dakota, United States|Sterling Research Group, Ltd., Cincinnati, Ohio, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|Sterling Research Group, Ltd., Cincinnati, Ohio, United States|University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States|VA Northeast Ohio Healthcare System, Cleveland, Ohio, United States|Velocity Clinical Research, Inc., Cleveland, Ohio, United States|Aventiv Research Inc., Columbus, Ohio, United States|Dayton Clinical Research, Dayton, Ohio, United States|PriMED Clinical Research, Dayton, Ohio, United States|Senders Pediatrics, South Euclid, Ohio, United States|Lynn Institute of Norman, Norman, Oklahoma, United States|Kaiser Permanente Northwest-Center for Health Research, Portland, Oregon, United States|Lehigh Valley Health Network/Network Office of Research and Innovation, Allentown, Pennsylvania, United States|Velocity Clinical Research, Providence, Warwick, Rhode Island, United States|Main Street Physician's Care, Little River, South Carolina, United States|Main Street Physician's Care, Loris, South Carolina, United States|Holston Medical Group, Bristol, Tennessee, United States|Holston Medical Group, Kingsport, Tennessee, United States|Alliance for Multispecialty Research, LLC, Knoxville, Tennessee, United States|Alliance for Multispecialty Research, LLC, Knoxville, Tennessee, United States|Clinical Neuroscience Solutions, Inc., Memphis, Tennessee, United States|Clinical Research Associates, Inc., Nashville, Tennessee, United States|Trinity Clinical Research, Tullahoma, Tennessee, United States|Benchmark Research, Austin, Texas, United States|ARC Clinical Research at Wilson Parke, Austin, Texas, United States|Tekton Research, Inc., Austin, Texas, United States|North Texas Infectious Diseases Consultants, P.A., Dallas, Texas, United States|Ventavia Research Group, LLC, Fort Worth, Texas, United States|Benchmark Research, Fort Worth, Texas, United States|Texas Health Resources, Fort Worth, Texas, United States|University of Texas Medical Branch, Galveston, Texas, United States|Ventavia Research Group, LLC, Houston, Texas, United States|Texas Center for Drug Development, Inc., Houston, Texas, United States|Ventavia Research Group, LLC, Keller, Texas, United States|SMS Clinical Research, LLC, Mesquite, Texas, United States|LinQ Research, LLC, Pearland, Texas, United States|Benchmark Research., San Angelo, Texas, United States|Clinical Trials of Texas, Inc., San Antonio, Texas, United States|Diagnostics Research Group, San Antonio, Texas, United States|Martin Diagnostic Clinic, Tomball, Texas, United States|J. Lewis Research, Inc. / Foothill Family Clinic, Salt Lake City, Utah, United States|J. Lewis Research, Inc. / Foothill Family Clinic South, Salt Lake City, Utah, United States|Clinical Alliance for Research & Education - Infectious Diseases, LLC (CARE-ID), Annandale, Virginia, United States|Virginia Research Center LLC, Midlothian, Virginia, United States|Benaroya Research Institute at Virginia Mason, Seattle, Washington, United States|Wenatchee Valley Hospital, Wenatchee, Washington, United States|Hospital Militar Central Cirujano Mayor Dr. Cosme Argerich, Caba, Argentina|Hospital Santo Antonio/ Associacao Obras Sociais Irma Dulce, Salvador, Bahia, Brazil|CEPIC - Centro Paulista de Investigacao Clinica e Servicos Medicos Ltda (Casa Branca), Sao Paulo, Brazil|CRS Clinical Research Services Berlin GmbH, Berlin, Germany|Medizentrum Essen Borbeck, Essen, Germany|IKF Pneumologie GmbH & Co KG, Frankfurt am Main, Germany|Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany|CRS Clinical Research Services Mannheim GmbH, Mannheim, Germany|Studienzentrum Brinkum Dr. Lars Pohlmeier und Torsten Drescher, Stuhr, Germany|Newtown Clinical Research Centre, Johannesburg, Gauteng, South Africa|Jongaie Research, Pretoria, Gauteng, South Africa|Limpopo Clinical Research Initiative, Thabazimbi, Limpopo, South Africa|Tiervlei Trial Centre, Basement Level, Karl Bremer Hospital, Cape Town, Western CAPE, South Africa|Ankara Universitesi Tip Fakultesi, Ibni Sina Hastanesi, Ankara, Turkey|Hacettepe Universitesi Tip Fakultesi, Ankara, Turkey|Istanbul Yedikule Gogus Hastaliklari ve Gogus Cerrahisi Egitim Arastirma Hastanesi, Istanbul, Turkey|Istanbul Universitesi Istanbul Tip Fakultesi, Istanbul, Turkey|Istanbul Universitesi-Cerrahpasa, Cerrahpasa Tip Fakultesi, Istanbul, Turkey|Medipol Mega Universite Hastanesi, Istanbul, Turkey|Acibadem Atakent Hastanesi, Istanbul, Turkey|Kocaeli Universitesi Tip Fakultesi, Kocaeli, Turkey|Sakarya Universitesi Egitim ve Arastirma Hastanesi, Sakarya, Turkey",https://ClinicalTrials.gov/show/NCT04368728
NCT04475471,WORLD HEART FEDERATION (WHF) COVID-19 and Cardiovascular Disease Survey,Observational Model: Cohort|Time Perspective: Prospective,RA1413,"Hospital de Clinicas of the University, Buenos Aires, Argentina|Hospital de Clinicas of the University, Buenos Aires, Argentina|Hospital de Clinicas of the University, Buenos Aires, Argentina|Hospital de Clinicas of the University, Buenos Aires, Argentina|Hospital de Clinicas of the University, Buenos Aires, Argentina|Sanatorio Güemes Hospital, Buenos Aires, Argentina|University Clinical Center Republic of Srpska, Srpska, Bosnia and Herzegovina|Komfo Anokye Teaching Hospital, Kumasi, Ghana|Kumasi South Regional Hospital, Kumasi, Ghana|Dayanand medical college hospital, Ludhiyana, Punjab, India|Amin Hospital, Isfahan, Iran, Islamic Republic of|Amin Hospital, Isfahan, Iran, Islamic Republic of|Khorshid Hospital, Isfahan, Iran, Islamic Republic of|Fedail Hospital, Khartoum, Sudan",https://ClinicalTrials.gov/show/NCT04475471
NCT04335201,Defibrotide in COVID-19 Pneumonia,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,DEFI-VID19,"Ospedale San Raffaele, Milano, Lombardia, Italy",https://ClinicalTrials.gov/show/NCT04335201
NCT04368390,Neuroradiolological Analysis of COVID-19 Patients,Observational Model: Case-Only|Time Perspective: Other,7759,"Service d'Imagerie 2 - Neuroradiologie, Strasbourg, France",https://ClinicalTrials.gov/show/NCT04368390
NCT04949412,Assessment of Vitamin D Level in COVID-19,Observational Model: Cohort|Time Perspective: Prospective,Soh-Med-21-06-30,"Mona Mohammed Abdelrahman, Sohag, Egypt",https://ClinicalTrials.gov/show/NCT04949412
NCT04401241,How Routine Biomarkers and Blood Leucocytes Count Can Assist Diagnosis of COVID-19 in Emergency Department,Observational Model: Other|Time Perspective: Retrospective,6月20日,"Centre Hospitalier Princesse Grace, Monaco, MON, Monaco",https://ClinicalTrials.gov/show/NCT04401241
NCT04589104,Expressive Writing for COVID-19 Resilience,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,Pro00105575,"Duke Integrative Medicine, Durham, North Carolina, United States",https://ClinicalTrials.gov/show/NCT04589104
NCT04350476,COVID-19 Remote Monitoring,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Screening,GCO 20-0932,NA,https://ClinicalTrials.gov/show/NCT04350476
NCT04531748,Selective Estrogen Modulation and Melatonin in Early COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",20-842,NA,https://ClinicalTrials.gov/show/NCT04531748
NCT04663737,"Evaluating Safety, Pharmacokinetics and Clinical Benefit of Silmitasertib (CX-4945) in Subjects With Moderate COVID-19",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,CX4945 AV01-IIT,"Center for Advanced Research and Education, Gainesville, Georgia, United States",https://ClinicalTrials.gov/show/NCT04663737
NCT04932954,Immunohematology in COVID-19 Patients: A Hospital-based Retrospective Cohort Study,Observational Model: Other|Time Perspective: Retrospective,TJ-IRB20210603,"Tongji Hospital, Wuhan, Hubei, China",https://ClinicalTrials.gov/show/NCT04932954
NCT04354870,COVID-19 PrEP HCW HCQ Study,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,s20-00390,"NYU Langone Health, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04354870
NCT04824469,"The Effects of Web-Based Training for Covid-19 Patients on Symptom Management, Medication Compliance and Quality of Life","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Supportive Care",EkisehirOsmangaziU,NA,https://ClinicalTrials.gov/show/NCT04824469
NCT04527562,Colchicine in Moderate Symptomatic COVID-19 Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",U1111-1255-3541,"Dhaka Medical College Hospital, Dhaka-1000, Bangladesh",https://ClinicalTrials.gov/show/NCT04527562
NCT04382729,Neuromuscular Electrical Stimulation in Patients With COVID19 Associated Pneumonia,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Supportive Care,ESC270320,"San Luigi Gonzaga Hospital, Orbassano, TO, Italy",https://ClinicalTrials.gov/show/NCT04382729
NCT04414098,Ruxolitinib in the Treatment of Covid-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,CZabala,NA,https://ClinicalTrials.gov/show/NCT04414098
NCT04803370,Efficacy of Reinforcing Standard Therapy in COVID-19 Patients With Repeated Transfusion of Convalescent Plasma,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,CO-PLASMA-2020,"University Hospital Son Llatzer, Palma De Mallorca, Islas De Balears, Spain",https://ClinicalTrials.gov/show/NCT04803370
NCT04422626,Data Analysis of the Cytokine Adsorption Treatment on Coronavirus Disease-19 (COVID-19) Patients With Respiratory Failure,Observational Model: Cohort|Time Perspective: Prospective,20802-5/2020/EÜIG,NA,https://ClinicalTrials.gov/show/NCT04422626
NCT04346056,Retrospective Study on Severe Respiratory Illness to Access the Presence of COVID-19,Observational Model: Cohort|Time Perspective: Retrospective,FMASU P17a/ 2020,"Faculty of Medicine Ain Shams University, Cairo, Non-US, Egypt|Faculty of Medicine Ain Shams University Research Institute- Clinical Research Center, Cairo, Non-US, Egypt",https://ClinicalTrials.gov/show/NCT04346056
NCT04463433,Psychological Intervention for Parent-child Relationship and Couple Relationship Under COVID-19 in China,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention",bnulxy,"Beijing Normal University, Beijing, Beijing, China",https://ClinicalTrials.gov/show/NCT04463433
NCT04466657,Antioxidant Therapy for COVID-19 Study,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Supportive Care,GSHSOD-COVID2020,"Abia State Isolation Centre, Amachara, Umuahia, Abia State, Nigeria|Benue State University Teaching Hospital, Makurdi, Benue State, Nigeria|Brigadier Abba Kyari Memorial Hospital, Borno, Borno State, Nigeria|University of Maiduguri Teaching Hospital, Maiduguri, Borno State, Nigeria|University of Calabar Teaching Hospital, Calabar, Cross River, Nigeria|Federal Medical Centre Idi-Aba, Abeokuta, Ogun State, Nigeria|Olabisi Onabanjo University Teaching Hospital, Sagamu, Ogun State, Nigeria|Infectious Disease Hospital, Amanawa, Sokoto State, Nigeria|Murtala Muhammad Speciaist Hospital, Sokoto, Sokoto State, Nigeria|Occupational Therapy Center, Sokoto, Sokoto State, Nigeria|Usmanu Danfodiyo University Teaching Hospital, Sokoto, Sokoto State, Nigeria",https://ClinicalTrials.gov/show/NCT04466657
NCT04849637,Virgin Coconut Oil as Adjunctive Therapy for Hospitalized COVID-19 Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,UPMREB 2020-306-01,"Philippine General Hospital, Manila, Metro Manila, Philippines",https://ClinicalTrials.gov/show/NCT04849637
NCT04510623,Host Response Mediators in Coronavirus (COVID-19) Infection,Observational Model: Cohort|Time Perspective: Other,H20-00600,"University of Calgary - Foothills, Calgary, Alberta, Canada|Stollery Children's Hospital, Edmonton, Alberta, Canada|University of Alberta, Edmonton, Alberta, Canada|Surrey Memorial Hospital, Surrey, British Columbia, Canada|St Pauls Hospital, Vancouver, British Columbia, Canada|Vancouver General Hospital, Vancouver, British Columbia, Canada|William Osler Health System, Brampton, Ontario, Canada|Queens University, Kingston, Ontario, Canada|Humber River Hospital, North York, Ontario, Canada|Mount Sinai Hospital, Toronto, Ontario, Canada|St Michael's Hospital, Toronto, Ontario, Canada|Sunnybrook Hospital, Toronto, Ontario, Canada|Jewish General Hospital, Montréal, Quebec, Canada|McGill University Health Center, Montréal, Quebec, Canada|Université de Sherbrooke, Sherbrooke, Quebec, Canada",https://ClinicalTrials.gov/show/NCT04510623
NCT04425889,COVID-19 Antibodies Among Healthcare Workers,Observational Model: Cohort|Time Perspective: Cross-Sectional,IF20-00008,"Hospital Universitario José E. Gonzalez, Monterrey, Nuevo Leon, Mexico",https://ClinicalTrials.gov/show/NCT04425889
NCT04461340,Efficacy and Safety of Sirolimus in COVID-19 Infection,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,sirolimus in COVID 19,"Faculty of Medicine, Alexandria university, Egypt, Alexandria, Egypt",https://ClinicalTrials.gov/show/NCT04461340
NCT04964154,Building Resiliency and Vital Equity (BRAVE) Project: Understanding Native Americans' Perceptions/Beliefs About COVID-19 Testing and Vaccination Study,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Screening,1201571,"Lumbee Tribe Tribal Housing Complex, Pembroke, North Carolina, United States",https://ClinicalTrials.gov/show/NCT04964154
NCT04540406,NBT-NM108 as an Early Treatment for Suspected or Confirmed Symptomatic COVID-19 Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,NBTNM10810012020,"University of South Florida Morsani College of Medicine, Tampa, Florida, United States",https://ClinicalTrials.gov/show/NCT04540406
NCT04366960,Comparison of Two Doses of Enoxaparin for Thromboprophylaxis in Hospitalized COVID-19 Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2020-001708-41,"Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda, Milano, Italy",https://ClinicalTrials.gov/show/NCT04366960
NCT04459325,Tigerase® Efficacy and Safety as Part of Complex Therapy in Patients With COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,DRN-ALI-III|#216 eff date 27.05.2020,"City Clinical Hospital #15, Moscow, Russian Federation|I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russian Federation|City Clinical Hospital #51, Moscow, Russian Federation|City Clinical Hospital #52, Moscow, Russian Federation|N.V. Sklifosovsky Scientific Research Institute of First Aid, Moscow, Russian Federation|Siberian State Medical University (SibMed), Moscow, Russian Federation",https://ClinicalTrials.gov/show/NCT04459325
NCT04644198,Convalescent Plasma Transfusion in Severe COVID-19 Patients in Jamaica,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"ECP/195,19/20","University of the West Indies, Kingston, Jamaica",https://ClinicalTrials.gov/show/NCT04644198
NCT04413838,Efficiency and Security of NIVOLUMAB Therapy in Obese Individuals With COVID-19(COrona VIrus Disease) Infection,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,69HCL20_0478,"Hôpital Lyon Sud Service Endocrinologie, Diabète et Nutrition, Pierre-Bénite, France",https://ClinicalTrials.gov/show/NCT04413838
NCT04947943,Geriatric Care for Older People Hospitalised for COVID-19,Observational Model: Cohort|Time Perspective: Retrospective,RECHMPL21_0372,"Uhmontpellier, Montpellier, France",https://ClinicalTrials.gov/show/NCT04947943
NCT04586413,Post Acute COVID-19 Quality of Life (PAC-19QoL) Tool Development and Patient Registry (PAC-19QoLReg),Observational Model: Cohort|Time Perspective: Prospective,Med_Asst 33,"Medialis, Oxford, United Kingdom",https://ClinicalTrials.gov/show/NCT04586413
NCT04639440,Impact of Adipose Tissue in COVID-19,Observational Model: Case-Control|Time Perspective: Prospective,APHP200983|2020-A02403-36,"Hôpital de la Pitié Salpêtrière, Paris, France",https://ClinicalTrials.gov/show/NCT04639440
NCT04836351,Rehabilitation for Patients With Persistent Symptoms Post COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,WesternNorwayUAS,"Helse i Hardanger, Øystese, Kvam Herad, Norway",https://ClinicalTrials.gov/show/NCT04836351
NCT04343248,Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Post-Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses in Elderly Residents of Long-Term Care Facilities (LTCF),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention",RM08-3006,"The Chappel Group Research, Kissimmee, Florida, United States|Clinical Trial Specialists, Inc., Acworth, Georgia, United States|Centex Studies, Inc., Lake Charles, Louisiana, United States|Centex Studies, Inc., Houston, Texas, United States",https://ClinicalTrials.gov/show/NCT04343248
NCT04649879,Convalescent Plasma for Treatment of COVID-19: An Open Randomised Controlled Trial,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,CP3,"Department of Infectious Disease, Falu Hospital, Falun, Dalarn, Sweden|Department of Geriatrics, Karolinska University Hospital, Stockholm, Sweden|Danderyd Hospital, Stockholm, Sweden",https://ClinicalTrials.gov/show/NCT04649879
NCT04393558,Wearable Sensor to Monitor COVID-19 Like Signs and Symptoms,Observational Model: Cohort|Time Perspective: Prospective,STU00212522,"Shirley Ryan AbilityLab, Chicago, Illinois, United States",https://ClinicalTrials.gov/show/NCT04393558
NCT04821674,Study of DS-5670a (COVID-19 Vaccine) in Japanese Healthy Adults and Elderly Subjects,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention",DS5670-A-J101|jRCT2071200110,"SOUSEIKAI Hakata Clinic, Hakata, Fukuoka, Japan",https://ClinicalTrials.gov/show/NCT04821674
NCT04389554,D-dimer Levels in Pregnant With COVID-19,Observational Model: Case-Control|Time Perspective: Prospective,MTalmac,"Kanuni Sultan Suleyman Training and Research Hospital, Istanbul, Turgut Ozal, Turkey",https://ClinicalTrials.gov/show/NCT04389554
NCT04381312,Direct and Indirect Impact of COVID-19 In Older Populations,Observational Model: Cohort|Time Perspective: Prospective,38RC20.118|2020-A00846-33,"Chu Grenoble Alpes, Grenoble Cedex 9, Grenoble, France",https://ClinicalTrials.gov/show/NCT04381312
NCT04339608,Max COVID19- Study,Observational Model: Cohort|Time Perspective: Prospective,Covid-19/MHC/2020,"Max Super Speciality Hospital, A Unit of Devki Devi Foundation, New Delhi, Delhi, India",https://ClinicalTrials.gov/show/NCT04339608
NCT04878042,COVID-19 Infection Control Using H2O2 Mouth Wash and Nasal Spray,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment",20121617,"AIAS di Afragola, Napoli, Italy|Clinica Nuova ITOR, Roma, Italy",https://ClinicalTrials.gov/show/NCT04878042
NCT04572412,Low Dose Lung Radiotherapy to Treat COVID-19 Pneumonia,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,285167,"Lancashire Teaching Hospitals NHS, Preston, United Kingdom",https://ClinicalTrials.gov/show/NCT04572412
NCT04359680,Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Pre- and Post Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses (VRI) in Healthcare Workers and Others at Increased Risk of SARS-CoV-2 Infection,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention",RM08-3007,"HealthStar Research LLC, Hot Springs, Arkansas, United States|So Cal Clinical Research, Huntington Beach, California, United States|Long Beach Clinical Trials, LLC, Long Beach, California, United States|Meris Clinical Research, Brandon, Florida, United States|Invesclinica US LLC, Fort Lauderdale, Florida, United States|The Chappel Group Research, Kissimmee, Florida, United States|New Horizon Research Center, Miami, Florida, United States|Clinical Neuroscience Solutions, Inc., Orlando, Florida, United States|DMI Research, Pinellas Park, Florida, United States|Tampa General Hospital, Tampa, Florida, United States|Chicago Clinical Research Institute, Inc., Chicago, Illinois, United States|Chicago Medical Research Institute, Inc., Chicago, Illinois, United States|Quad Clinical Research, Chicago, Illinois, United States|Chicago Medical Research, LLC, Hazel Crest, Illinois, United States|Centex Studies, Inc., Lake Charles, Louisiana, United States|Vida Clinical Studies, Dearborn, Michigan, United States|Beacom Family Health Connection, Fremont, Nebraska, United States|North Jersey Community Research Initiative, Newark, New Jersey, United States|RH Medical Urgent Care Professional PLLC, Bronx, New York, United States|Integrative Clinical Trials LLC, Brooklyn, New York, United States|The New York Center for Travel and Tropical Medicine, New York, New York, United States|Centex Studies, Inc., Houston, Texas, United States|SMS Clinical Research LLC, Mesquite, Texas, United States|LinQ Research LLC, Pearland, Texas, United States|Rio Grande Valley Clinical Research Institute, Pharr, Texas, United States|BFHC Research, San Antonio, Texas, United States",https://ClinicalTrials.gov/show/NCT04359680
NCT04981379,Clinical Trial For Early SARS-CoV-2 (COVID-19) Treatment,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",COVID-19-FAV-HQ,"Ankara City Hospital, Ankara, Turkey|Başakşehir Çam ve Sakura City Hospital, Istanbul, Turkey|Istanbul Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Istanbul, Turkey|Istanbul University Istanbul Medicine Faculty, Istanbul, Turkey|Kartal Dr. Lütfi Kırdar City Hospital, Istanbul, Turkey|Sancaktepe Şehit Prof. Dr. İlhan Varank Training and Research Hospital, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04981379
NCT04456036,Rehabilitation Needs and Functional Recovery in Covid-19 Acute and Post-acute Care,Observational Model: Cohort|Time Perspective: Prospective,NeuroRehabAN_Covid_2020,"Neurorehabilitation Clinic, University Hospital Ospedali Riuniti di Ancona, Ancona, Italy",https://ClinicalTrials.gov/show/NCT04456036
NCT04558307,Feasibility of Rapid COVID-19 Testing in Disadvantaged Populations,Observational Model: Ecologic or Community|Time Perspective: Prospective,20-004046,"Mayo Clinic, Rochester, Minnesota, United States",https://ClinicalTrials.gov/show/NCT04558307
NCT04356560,COVID-19 Surveillance of Patients and Healthcare Workers in a Hospital Department,Observational Model: Cohort|Time Perspective: Prospective,DT P-2020-353,"Rigshospitalet University Hospital of Copenhagen, Copenhagen, Denmark",https://ClinicalTrials.gov/show/NCT04356560
NCT04625036,NO-mediated Vascular Function in Covid-19 Patient,Observational Model: Case-Only|Time Perspective: Cross-Sectional,ICS Maugeri 2437 CE,"ICS Maugeri IRCCS, U.O. Emergenza Coronavirus di Lumezzane, Lumezzane, Brescia, Italy",https://ClinicalTrials.gov/show/NCT04625036
NCT04329559,COVID-19 in Patients With Pre-existing Cirrhosis (COVID-Cirrhosis-CHESS2002): A Multicentre Observational Study,Observational Model: Cohort|Time Perspective: Cross-Sectional,CHESS2002,"Dalian Sixth People's Hospital, Dalian, China|Minda Hospital Affiliated to Hubei University for Nationalities, Enshi, China|The Central Hospital of Enshi Tujia And Miao Autonomous Prefecture, Enshi, China|The First Hospital of Lanzhou University, Lanzhou, China|The Central Hospital of Lishui City, Lishui, China|Guangxi Zhuang Autonomous Region, Nanning, China|The Sixth Peoples Hospital of Shenyang, Shenyang, China|Shenzhen Third People's Hospital, Shenzhen, China|Suizhou Hospital, Hubei University of Medicine, Suizhou, China|Tianjin Second People's Hospital, Tianjin, China|Ankang Central Hospital, Wuhan, China|Renmin Hospital of Wuhan University, Wuhan, China|Wuhan Union Hospital, Wuhan, China|Xingtai People's Hospital, Xingtai, China|The Affiliated Third Hospital of Jiangsu University, Zhenjiang, China",https://ClinicalTrials.gov/show/NCT04329559
NCT04854486,Impact of GSE and Xylitol (Xlear) on COVID-19 Symptoms and Time to PCR Negativisation in COVID-19 Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",LCH-2-112020,"Larkin Community Hospital Palm Springs Campus, Miami, Florida, United States|Larkin Community Hospital, Miami, Florida, United States",https://ClinicalTrials.gov/show/NCT04854486
NCT04716907,Thymic Function in Patients With COVID-19,Observational Model: Case-Control|Time Perspective: Prospective,20-Jun,"CMC Ambroise Paré, Neuilly-sur-Seine, France",https://ClinicalTrials.gov/show/NCT04716907
NCT04473690,KBP-201 COVID-19 Vaccine Trial in Healthy Volunteers,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",KBP-201,"Velocity Clinical Research, Meridian, Idaho, United States|PMG Research of Winston-Salem, Winston-Salem, North Carolina, United States|PanAmerican Clinical Research, Brownsville, Texas, United States|ICON, San Antonio, Texas, United States|DM Clinical Research, Tomball, Texas, United States|LMC Manna Research, Burlington, Burlington/Ontario, Canada|LMC Manna Research, Montréal, Point Claire, Quebec, Canada",https://ClinicalTrials.gov/show/NCT04473690
NCT04382651,Study of Efficacy and Safety of MAS825 in Patients With COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",CMAS825F12201,"Novartis Investigative Site, Chula Vista, California, United States|Novartis Investigative Site, Glendale, California, United States|Novartis Investigative Site, Irvine, California, United States|Novartis Investigative Site, La Mesa, California, United States|Novartis Investigative Site, Santa Monica, California, United States|Novartis Investigative Site, Torrance, California, United States|Novartis Investigative Site, Denver, Colorado, United States|Novartis Investigative Site, Washington, District of Columbia, United States|Novartis Investigative Site, Idaho Falls, Idaho, United States|Novartis Investigative Site, Alexandria, Louisiana, United States|Novartis Investigative Site, Baton Rouge, Louisiana, United States|Novartis Investigative Site, Lafayette, Louisiana, United States|Novartis Investigative Site, Boston, Massachusetts, United States|Novartis Investigative Site, Boston, Massachusetts, United States|Novartis Investigative Site, Brooklyn, New York, United States|Novartis Investigative Site, Asheville, North Carolina, United States|Novartis Investigative Site, Columbus, Ohio, United States|Novartis Investigative Site, Bend, Oregon, United States|Novartis Investigative Site, Philadelphia, Pennsylvania, United States|Novartis Investigative Site, Houston, Texas, United States|Novartis Investigative Site, Mesquite, Texas, United States",https://ClinicalTrials.gov/show/NCT04382651
NCT04375761,COVID-19: Human Epidemiology and Response to SARS-CoV-2,Observational Model: Family-Based|Time Perspective: Prospective,DAIT-COVID-19-001,"Children's Hospital Colorado: Inner City Asthma Consortium (ICAC) Site, Aurora, Colorado, United States|Children's Hospital Colorado: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages (OMEGA) Site, Aurora, Colorado, United States|Children's National Medical Center: Inner City Asthma Consortium (ICAC) Site, Washington, District of Columbia, United States|Ann & Robert H. Lurie Children's Hospital of Chicago: Food Allergy Outcomes Related to White and African American Racial Differences (FORWARD) and Improving Technology-Assisted Recording of Asthma Control in Children (iTRACC) Site, Chicago, Illinois, United States|Massachusetts General Hospital:Childhood Microbiome (CHIME) and Wheezing Index (WIND) Site, Boston, Massachusetts, United States|Boston Children's Hospital: School Inner-City Asthma Study (SICAS-2), Environmental Assessment of Sleep in Youth (EASY), Severe Asthma Research Program (SARP) and Preventing Asthma in High Risk Kids (PARK) Site, Boston, Massachusetts, United States|Boston Medical Center: Inner City Asthma Consortium (ICAC) Site, Boston, Massachusetts, United States|Henry Ford Health System: Childhood Allergy Study (CAS) Site, Detroit, Michigan, United States|Henry Ford Health System: Inner City Asthma Consortium (ICAC) Site, Detroit, Michigan, United States|Henry Ford Health System: Microbes, Asthma, Allergy and Pets (MAAP) and Wayne County Health, Environment, Allergy, and Asthma Longitudinal Study (WHEALS) Site, Detroit, Michigan, United States|St. Louis Children's Hospital: Inner City Asthma Consortium (ICAC) Site, Saint Louis, Missouri, United States|Columbia University Medical Center: Inner City Asthma Consortium (ICAC) Site, New York, New York, United States|Cincinnati Children's Hospital Medical Center: Greater Cincinnati Pediatric Clinic Repository (GCPCR) and Mechanisms of Progression of Atopic Dermatitis to Asthma in Children (MPAACH) Site, Cincinnati, Ohio, United States|Cincinnati Children's Hospital Medical Center: Inner City Asthma Consortium (ICAC) Site, Cincinnati, Ohio, United States|Cincinnati Children's Hospital Medical Center: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages (OMEGA) Site, Cincinnati, Ohio, United States|Cincinnati Children's Hospital Medical Center:Cincinnati Childhood Allergy & Air Pollution Study (CCAAPS) Site, Cincinnati, Ohio, United States|Vanderbilt University Medical Center: Infant Susceptibility to Pulmonary Infections and Asthma Following RSV Exposure Study (INSPIRE) Site, Nashville, Tennessee, United States|University of Texas Southwestern Medical Center: Inner City Asthma Consortium (ICAC) Site, Dallas, Texas, United States|University of Wisconsin Hospital and Clinics: Childhood Origins of Asthma (COAST) Site, Madison, Wisconsin, United States|University of Wisconsin Hospital and Clinics: Wisconsin Infant Study Cohort (WISC) Site, Madison, Wisconsin, United States",https://ClinicalTrials.gov/show/NCT04375761
NCT04385017,Role of Inflammasomes in COVID-19 Disease,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,20-PP-07,"Ch Cannes, Réanimation, Cannes, Alpes Maritimes, France|CHU de nice, Nice, Alpes-Maritimes, France",https://ClinicalTrials.gov/show/NCT04385017
NCT04455347,Cardiac and Thoracic Imaging in Pediatric Patients With Evidence of Systemic Inflammation COVID19 Linked,Observational Model: Cohort|Time Perspective: Prospective,HJ-20-CARDOVID,"Hôpital Necker, Paris, France",https://ClinicalTrials.gov/show/NCT04455347
NCT04703777,Relationship Between Social Status and Use of Healthcare Services During the Confinement Period Linked to the COVID-19 Epidemic,Observational Model: Case-Only|Time Perspective: Retrospective,7814,"Adult Emergency Department - Strasbourg University Hospitals, Strasbourg, France",https://ClinicalTrials.gov/show/NCT04703777
NCT04575571,MAVIPAN: My Life and the COVID-19 Pandemic,Observational Model: Cohort|Time Perspective: Prospective,To be assigned,"VITAM-Research Center in Sustainable Health, Québec, Canada",https://ClinicalTrials.gov/show/NCT04575571
NCT04647734,The Protective Potential of Exercise Training on the Cardiopulmonary Morbidity After COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Health Services Research,H-20033733 v.2,"Rigshospitalet, Copenhagen, Denmark",https://ClinicalTrials.gov/show/NCT04647734
NCT04280588,Fingolimod in COVID-19,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"MRCTA, ECFAH of FMU [2020]027","Wan-Jin Chen, Fuzhou, China",https://ClinicalTrials.gov/show/NCT04280588
NCT04318301,Hypertension in Patients Hospitalized With COVID-19,Observational Model: Case-Control|Time Perspective: Retrospective,HT-COVID19,"Hankou Hospital, Hankou, Hubei, China",https://ClinicalTrials.gov/show/NCT04318301
NCT04701944,Clinical Study of Pregnant Women With COVID-19,Observational Model: Case-Only|Time Perspective: Retrospective,7794,"Department of Gynecology-Obstetrics and Fertility - Strasbourg University Hospitals, Strasbourg, France",https://ClinicalTrials.gov/show/NCT04701944
NCT04668469,Efficacy and Safety of Ivermectin for Treatment and Prophylaxis of COVID-19 Pandemic,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",Re96.2020,"Benha Faculty of Medicine, Benha University, Banhā, Qaluopia, Egypt",https://ClinicalTrials.gov/show/NCT04668469
NCT04530474,Outpatient Use of Ivermectin in COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Treatment",1285242,"Temple University Hospital, Philadelphia, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04530474
NCT04657484,Comparison of Two Corticosteroid Regimens for Post COVID-19 Diffuse Lung Disease,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,INT/IEC/2020/SPL-1528,"Postgraduate Institute of Medical Education and Research, Chandigarh, India",https://ClinicalTrials.gov/show/NCT04657484
NCT04768179,Safety & Efficacy of Low Dose Aspirin / Ivermectin Combination Therapy for Treatment of Covid-19 Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,IVCOM PROTOCOL VERSION 03,NA,https://ClinicalTrials.gov/show/NCT04768179
NCT04712279,The (HD)IVACOV Trial (The High-Dose IVermectin Against COVID-19 Trial),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",CORPO-DRUG-SARSCoV2-001,NA,https://ClinicalTrials.gov/show/NCT04712279
NCT04754113,Effect of Prone Position onV/Q Matching in Non-intubated Patients With COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,COVID-19 PPV,"Ling Liu, Nanjing, Jiangsu, China",https://ClinicalTrials.gov/show/NCT04754113
NCT04930861,Study of Codivir in Patients With COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,20-01-ZM,"Hospital Vera Cruz S A (Campinas-SP), Campinas, State Of São Paulo, Brazil",https://ClinicalTrials.gov/show/NCT04930861
NCT04497610,SARS-CoV-2 (COVID-19) Detection Using the Breath Analizer TeraSystem,Observational Model: Cohort|Time Perspective: Prospective,Tera-CR-1,"Instituto Costarricense de Investigaciones Clínicas, San José, Costa Rica",https://ClinicalTrials.gov/show/NCT04497610
NCT04706390,Comparison of the Immune Response to Natural COVID-19 Infection and Vaccination,Observational Model: Cohort|Time Perspective: Prospective,COVID-19vacc-1,"University of Bergen, Bergen, Norway",https://ClinicalTrials.gov/show/NCT04706390
NCT04377815,Finding Out if COVID-19 Infection Can be pREdicted by ChAnges in Smell and/or Taste,Observational Model: Cohort|Time Perspective: Other,132311|20/HRA/1879,"University College London Hospital, London, United Kingdom|GP Practices, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04377815
NCT04676867,Effect of Dalcetrapib in Patients With Confirmed Mild to Moderate COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",DAL-401,"Institut de Cardiologie de Montréal, Montréal, Quebec, Canada",https://ClinicalTrials.gov/show/NCT04676867
NCT04374084,Moxibustion Plus Cupping in Convalescent Patients With COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,2020YFC0845000,"Hubei Province Hospital, Wuhan, Hubei, China",https://ClinicalTrials.gov/show/NCT04374084
NCT04605887,Angiotensin 1-7 as a Therapy in the Treatment of COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",0328-20-RMB|MOH_2020-11-02_009463,"Rambam Medical Center, Haifa, Israel",https://ClinicalTrials.gov/show/NCT04605887
NCT04726865,COVID-19 Pandemic and Medical Students,Observational Model: Other|Time Perspective: Cross-Sectional,Jordan Universities,"Al-Husban University Naser, Amman, Jordan",https://ClinicalTrials.gov/show/NCT04726865
NCT04436471,"An Open Study of the Safety, Tolerability and Immunogenicity of the Drug ""Gam-COVID-Vac"" Vaccine Against COVID-19",Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,02-Gam-COVID-Vac-2020,"Main military clinical hospital named after academician N. N. Burdenko, Moscow, Russian Federation",https://ClinicalTrials.gov/show/NCT04436471
NCT04912011,Mineralocorticoid Receptor Antagonist and Pulmonary Fibrosis in COVID-19.,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Treatment",0012/100/2020,"Pomeranian Medical University, Szczecin, Poland",https://ClinicalTrials.gov/show/NCT04912011
NCT04426344,Core Warming of COVID-19 Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,202005150,"Barnes-Jewish Hospital, Saint Louis, Missouri, United States",https://ClinicalTrials.gov/show/NCT04426344
NCT04600141,Clinical Efficacy of Heparin and Tocilizumab in Patients With Severe COVID-19 Infection,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,5057/20/086,"Fundação São Francisco Xavier, Ipatinga, Minas Gerais, Brazil|UNIMED Varginha, Varginha, Minas Gerais, Brazil|Universidade Federal de Sergipe, Aracaju, Sergipe, Brazil",https://ClinicalTrials.gov/show/NCT04600141
NCT04410107,"Lung Function, Exercise Capacity and Health-Related Quality of Life After Severe COVID-19",Observational Model: Cohort|Time Perspective: Prospective,2020-0169,"Universidade de Passo Fundo, Passo Fundo, Rio Grande Do Sul, Brazil|Hospital Moinhos de Vento, Porto Alegre, Rio Grande Do Sul, Brazil|Hospital de Clínicas de Porto Alegre/Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande Do Sul, Brazil|Univesidade de Ciências da Saúde de Porto Alegre, Porto Alegre, Rio Grande Do Sul, Brazil|Hospital Nossa Senhora da Conceição, Porto Alegre, Rio Grande Do Sul, Brazil",https://ClinicalTrials.gov/show/NCT04410107
NCT04475601,Enzalutamide Treatment in COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,COVIDENZA,"Anders Bjartell, Malmö, Skåne, Sweden|Ryhovs Hospital, Jönköping, Småland, Sweden",https://ClinicalTrials.gov/show/NCT04475601
NCT04486482,A Clinical Study to Assess the Physiologic Effects of KB109 in Patients With COVID-19 on Gut Microbiota Structure and Function,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,K032-120,"Cullman Clinical Trials, Cullman, Alabama, United States|American Institute of Research, Los Angeles, California, United States|Rancho Cucamonga Clinical Research, Rancho Cucamonga, California, United States|Next Phase Research Alliance, Boca Raton, Florida, United States|Advanced Pharma CR, LLC, Miami, Florida, United States|Hope Clinical Trials, Miami, Florida, United States|Kendall South Medical Center, Inc., Miami, Florida, United States|Quad Clinical Research, Chicago, Illinois, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Inquest Research, Baytown, Texas, United States|Olympus Family Medicine, Salt Lake City, Utah, United States|South Ogden Family Medicine Center, South Ogden, Utah, United States",https://ClinicalTrials.gov/show/NCT04486482
NCT04356534,Convalescent Plasma Trial in COVID -19 Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,BDF/R&REC/2020-423,"Royal College of Surgeons in Ireland - Bahrain, Manama, Bahrain",https://ClinicalTrials.gov/show/NCT04356534
NCT04673162,Evaluation of the Efficacy of High Doses of Methylprednisolone in SARS-CoV2 ( COVID-19) Pneumonia Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",RCT-MP-COVID-19,"SOC Pneumologia, SOC Malattie Infettive, SOC Reumatologia, Az USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy",https://ClinicalTrials.gov/show/NCT04673162
NCT04581031,COntinuous Signs Monitoring In Covid-19 Patients,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,CFTSp187,"The Christie NHS Foundation Trust, Manchester, United Kingdom|Manchester University NHS Foundation Trust, Manchester, United Kingdom",https://ClinicalTrials.gov/show/NCT04581031
NCT04627519,Effectiveness and Safety of Rhea Health Tone® as add-on Therapy for COVID-19 in Hospitalized Adults in Indonesia,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,Pharm-202010.01,"Rumah Sakit Darurat Penanganan Covid-19 Wisma Atlet Kemayoran (RSDCWA), Jakarta, DKI Jakarta, Indonesia|Dr. Hasan Sadikin Central General Hospital, Bandung, West Java, Indonesia",https://ClinicalTrials.gov/show/NCT04627519
NCT04459286,The Nitazoxanide Plus Atazanavir for COVID-19 Study,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,NACOVID,"Olabisi Onabanjo University Teaching Hospital, Sagamu, Ogun State, Nigeria|Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Osun State, Nigeria|State Specialist Hospital Asubiaro, Osogbo, Osun State, Nigeria|Infectious Disease Hospital, Olodo, Ibadan, Oyo State, Nigeria",https://ClinicalTrials.gov/show/NCT04459286
NCT04756869,Monitoring Health Care Workers at Risk for COVID-19 Using Wearable Sensors and Smartphone Technology,Observational Model: Cohort|Time Perspective: Prospective,HUM00180076,"Michigan Medicine, Ann Arbor, Michigan, United States",https://ClinicalTrials.gov/show/NCT04756869
NCT04622891,Clarithromycin Versus Azithromycin in Treatment of Mild COVID-19 Infection,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment",SVU-MED-CHT019-420860,"south-Vally University faculty of medicine, Qena, Egypt",https://ClinicalTrials.gov/show/NCT04622891
NCT04420182,COVID-19 Virtual Care at Home,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,CTO 3210,"St. Mary's General Hospital, Kitchener, Ontario, Canada|London Health Sciences Centre, London, Ontario, Canada|Ottawa Heart Research Institute, Ottawa, Ontario, Canada|Niagara Health, St. Catharines, Ontario, Canada|St. Joseph's Health Centre, Toronto, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04420182
NCT04490811,Seroprevalence and Immunoprotection Against COVID-19 in Parisian Children,Observational Model: Cohort|Time Perspective: Retrospective,HNeckerNM,"Necker Hospital, Paris, France",https://ClinicalTrials.gov/show/NCT04490811
NCT04303299,Fight COVID-19 Trial,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,TH-DMS-COVID19 study,"Assistant Professor Subsai Kongsaengdao, Bangkok, Thailand",https://ClinicalTrials.gov/show/NCT04303299
NCT04513158,Convalescent Plasma in the Early Treatment of High-Risk Patients With SARS-CoV-2 (COVID-19) Infection,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,20-N0124,"Norton Hospital, Louisville, Kentucky, United States|Norton Women's and Children's Hospital, Louisville, Kentucky, United States|Norton Audubon Hospital, Louisville, Kentucky, United States|Norton Brownsboro Hospital, Louisville, Kentucky, United States",https://ClinicalTrials.gov/show/NCT04513158
NCT04370821,"COVID-19 CHAMPS Study of Healthcare, First Responder and Service Workers",Observational Model: Cohort|Time Perspective: Prospective,IRB FY2020-215,"Villanova University, Villanova, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04370821
NCT04854824,A Simple Approach to Prevent Hospitalization for COVID-19 Patients,Observational Model: Cohort|Time Perspective: Retrospective,COVER 2,NA,https://ClinicalTrials.gov/show/NCT04854824
NCT04355871,Characteristics and Outcomes of Hospitalized Patients With COVID-19 in Spain,Observational Model: Cohort|Time Perspective: Retrospective,COVID-19/SEIMC-FSG,"Comp. Hosp. Univ. A Coruña, A Coruña, Spain|H. Quiron A Coruña, A Coruña, Spain|H. de Alcaniz, Alcañiz, Spain|H. Gral Univ. de Alicante, Alicante, Spain|H. Univ. San Juan de Alicante, Alicante, Spain|H. Univ. de la Ribera, Alzira, Spain|H. Santos Reyes, Aranda De Duero, Spain|H. Dr. Jose Molina Orosa, Arrecife, Spain|Consorcio Sanitari Integral (CAIDM), Barcelona, Spain|H. Clinic, Barcelona, Spain|H. del Mar, Barcelona, Spain|H. Parc Sanitari Sant Joan de Deu, Barcelona, Spain|H. Santa Creu y Sant Pau, Barcelona, Spain|H. Univ. de Bellvitge, Barcelona, Spain|H. Vall d'Hebron, Barcelona, Spain|Hospital CIMA-Sanitas, Barcelona, Spain|SCIAS H. de Barcelona, Barcelona, Spain|H. Clinica de Benidorm, Benidorm, Spain|H. de Cruces, Bilbao, Spain|H. San Eloy_Barakaldo, Bilbao, Spain|H. Univ. de Basurto, Bilbao, Spain|H. Urduliz-Alfredo Espinosa, Bilbao, Spain|H. Gral de La Palma, Breña Alta, Spain|H. de Puerto Real, Cadiz, Spain|H. de Calahorra, Calahorra, Spain|H. Sant Jaume de Calella, Calella, Spain|H. Univ Santa Lucia, Cartagena, Spain|H. Univ de Henares, Coslada, Spain|Hospital Marina Salud de Dénia, Denia, Spain|Hospital Don Benito-Villanueva de la Serena, Don Benito, Spain|H. Gral Univ. de Elche, Elche, Spain|H. Univ. del Vinalopo, Elche, Spain|Comp. Hospt. Univ. de Ferrol, Ferrol, Spain|H. Francesc de Borja, Gandia, Spain|H. de Figueres, Gerona, Spain|H. Comarcal de Blanes, Girona, Spain|H. Josep Trueta, Girona, Spain|H. Clinico San Cecilio, Granada, Spain|Hospital HLA Inmaculada, Granada, Spain|H. de Guadalajara, Guadalajara, Spain|H. de Guadarrama, Guadarrama, Spain|H. Juan Ramón Jiménez, Huelva, Spain|H. Riotinto, Huelva, Spain|H. Can Misses, Ibiza, Spain|H. Universitario de Jaén, Jaén, Spain|H. Univ. de Jerez de la Frontera, Jerez De La Frontera, Spain|H. Univ Insular de Gran Canaria, Las Palmas De Gran Canaria, Spain|H. Universitario de Gran Canaria Dr. Negrin, Las Palmas De Gran Canaria, Spain|H. Univ. Severo Ochoa, Leganés, Spain|H. San Pedro, Logroño, Spain|H. Univ. Menez Rafael Mendez, Lorca, Spain|H. Lucus Augusti, Lugo, Spain|H. 12 de Octubre, Madrid, Spain|H. Clinica Univ. de Navarra_ Campus Madrid, Madrid, Spain|H. Clinico San Carlos, Madrid, Spain|H. Fundacion Jiménez Díaz, Madrid, Spain|H. Gral de la Defensa Gomez Ulla, Madrid, Spain|H. HLA Univ. Moncloa, Madrid, Spain|H. HM Sanchinarro, Madrid, Spain|H. Puerta de Hierro, Madrid, Spain|H. Univ HM Madrid, Madrid, Spain|H. Univ Principe de Asturias, Madrid, Spain|H. Univ. de Alcorcón, Madrid, Spain|H. Univ. de Getafe, Madrid, Spain|H. Univ. de Móstoles, Madrid, Spain|H. Univ. Gregorio Marañon, Madrid, Spain|H. Univ. HM Monteprincipe, Madrid, Spain|H. UNiv. HM Puerta del Sur, Madrid, Spain|H. Univ. Infanta Leonor, Madrid, Spain|H. Univ. La Paz, Madrid, Spain|H. Univ. La Princesa, Madrid, Spain|H. Univ. Ramón y Cajal, Madrid, Spain|H. Univ. Rey Juan Carlos, Madrid, Spain|H. Costa del Sol, Marbella, Spain|H. de Mataro, Mataró, Spain|H. de Melilla, Melilla, Spain|H. de Mendaro, Mendaro, Spain|Hospital Alto Deba, Mondragón, Spain|H. Virgen de la Arrixaca, Murcia, Spain|H. Marbella Internacional, Málaga, Spain|H. Virgen de la Victoria, Málaga, Spain|H. Vega Baja, Orihuela, Spain|H. Univ. Central de Asturias, Oviedo, Spain|H. de Palamos, Palamós, Spain|H. Son Espases, Palma De Mallorca, Spain|H. Son Llatzer, Palma De Mallorca, Spain|H. Clinica Univ. Navarra, Pamplona, Spain|H. Virgen del Puerto, Plasencia, Spain|H. El Bierzo, Ponferrada, Spain|H. Do Salnes, Pontevedra, Spain|H. UNiv. Los Arcos del Mar Menor, Pozo Aledo, Spain|H. Santa Barbara, Puertollano, Spain|H. Parc Tauli, Sabadell, Spain|Complejo Asist. Univ. de Salamanca, Salamanca, Spain|H. Infanta Sofia, San Sebastián De Los Reyes, Spain|H. de Donostia, San Sebastián, Spain|H. de l'Esperit Sant, Santa Coloma De Gramenet, Spain|H. Univ. Marques de Valdecilla, Santander, Spain|H. Clinico Univ. Santiago de Compostela, Santiago De Compostela, Spain|H. Univ de Valme, Sevilla, Spain|H. Univ. Virgen del Rocio, Sevilla, Spain|H. Univ. Virgen Macarena, Sevilla, Spain|H. Virgen Macarena, Sevilla, Spain|H. Univ Joan XXIII, Tarragona, Spain|H. U. de Canarias, Tenerife, Spain|H. Univ. Nuestra Sra. de la Candelaria, Tenerife, Spain|H. Mutua de Terrasa, Terrassa, Spain|Complejo Hospitalario Virgen de la Salud, Toledo, Spain|H. Univ. HM Torrelodones, Torrelodones, Spain|H. Quiron Salud Torrevieja, Torrevieja, Spain|H. Virgen de la Cinta, Tortosa, Spain|H. Reina Sofia de Tudela, Tudela, Spain|H. Arnau de Vilanova-Lliria, Valencia, Spain|H. Clinico Univ. de Valencia, Valencia, Spain|H. de Sagunto, Valencia, Spain|H. Univ. y Polit. La Fe, Valencia, Spain|H. Clin. Univ. de Valladolid, Valladolid, Spain|H. Rio Hortega, Valladolid, Spain|H. Alvaro Cunqueiro, Vigo, Spain|H. de Viladecans, Viladecans, Spain|H. de la Marina Baixa, Villajoyosa, Spain|Hospital de la Plana, Villareal, Spain|H. Univ de Alava, Vitoria, Spain|H. Virgen de la Concha, Zamora, Spain|H. Lozano Blesa, Zaragoza, Spain|H. Miguel Servet, Zaragoza, Spain|H. Ntra. Sra. de Gracia, Zaragoza, Spain|Complejo Asistencial de Avila, Ávila, Spain",https://ClinicalTrials.gov/show/NCT04355871
NCT04794985,Post-COVID-Health Study: Multidimensional Health Status of COVID-19 Survivors One Year After a SARS-CoV-2 Infection,Observational Model: Case-Only|Time Perspective: Prospective,NL76949.068.21,NA,https://ClinicalTrials.gov/show/NCT04794985
NCT04888793,Immune Response to Anti COVID-19 Vaccine in Immunocompromised Patients: a Cohort Study,Observational Model: Cohort|Time Perspective: Prospective,210405014,"Red de Salud UC Christus, Santiago, Chile",https://ClinicalTrials.gov/show/NCT04888793
NCT04273646,Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Severe COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,202001,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China",https://ClinicalTrials.gov/show/NCT04273646
NCT04962906,Study to Evaluate the Immunogenicity and Safety of Heterologous SARS-CoV-2 Vaccine Schemes,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Health Services Research,5143,"Ministerio de Salud de la Ciudad Autónoma de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina",https://ClinicalTrials.gov/show/NCT04962906
NCT04911790,Safety of an Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Adults,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,PRO-nCOV-MA4002,"Yongping Center for Diseases Control and Prevention, Dali, Yunnan, China",https://ClinicalTrials.gov/show/NCT04911790
NCT04816643,"Study to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy Children <12 Years of Age",Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,C4591007|2020-005442-42,"University of Alabama at Birmingham - School of Medicine, Birmingham, Alabama, United States|Kaiser Permanente Oakland, Oakland, California, United States|Clinical & Translational Research Unit (CTRU) & Spectrum BioBank, Stanford University, Palo Alto, California, United States|Center for Clinical Trials, LLC, Paramount, California, United States|Center for Clinical Trials, Paramount, California, United States|Peninsula Research Associates, Rolling Hills Estates, California, United States|Kaiser Permanente Sacramento, Sacramento, California, United States|Kaiser Permanente Santa Clara, Santa Clara, California, United States|Bayview Research Group, LLC, Valley Village, California, United States|Children's Hospital Colorado, Aurora, Colorado, United States|Yale Center for Clinical Investigation, New Haven, Connecticut, United States|Children's National Medical Center, Washington, District of Columbia, United States|Acevedo Clinical Research Associates, Miami, Florida, United States|Clinical Neuroscience Solutions, Orlando, Florida, United States|Emory Children's Center Illness POD, Atlanta, Georgia, United States|Emory University Investigational Drug Service, Atlanta, Georgia, United States|Emory University School of Medicine, Atlanta, Georgia, United States|Atlanta Center for Medical Research, Atlanta, Georgia, United States|Meridian Clinical Research, LLC, Macon, Georgia, United States|Clinical Research Prime, Idaho Falls, Idaho, United States|Solaris Clinical Research, Meridian, Idaho, United States|University of Kansas Medical Center - CTSU, Fairway, Kansas, United States|Alliance for Multispecialty Research, LLC, Newton, Kansas, United States|Alliance for Multispecialty Research, LLC, Wichita, Kansas, United States|Kentucky Pediatric/ Adult Research, Bardstown, Kentucky, United States|Novak Center for Children's Health, Louisville, Kentucky, United States|Ochsner Clinic Foundation, New Orleans, Louisiana, United States|LSUHSC-Shreveport Clinical Trials Office, Shreveport, Louisiana, United States|Center for Immunization Research Inpatient Unit, Baltimore, Maryland, United States|Boston Medical Center Investigational Pharmacy, Boston, Massachusetts, United States|Boston Medical Center, Boston, Massachusetts, United States|Clinical Research Professionals, Chesterfield, Missouri, United States|Children's Mercy Hospital, Kansas City, Missouri, United States|Meridian Clinical Research, LLC, Hastings, Nebraska, United States|Children's Hospital & Medical Center, Omaha, Nebraska, United States|Children's Physician's Clinic, Spring Valley, Omaha, Nebraska, United States|Rutgers University, New Brunswick, New Jersey, United States|Meridian Clinical Research, LLC, Binghamton, New York, United States|Advanced Specialty Care, Commack, New York, United States|Clinical Research Center, East Setauket, New York, United States|Rochester Clinical Research, Inc., Rochester, New York, United States|University of Rochester Medical Center, Rochester, New York, United States|Stony Brook University, Stony Brook, New York, United States|SUNY Upstate Medical University, Syracuse, New York, United States|Clinical Research Pickett Road, Durham, North Carolina, United States|Duke Vaccine and Trials Unit, Durham, North Carolina, United States|Accessioning Unit and Repository, Durham, North Carolina, United States|Duke Investigational Drug Service Pharmacy, Durham, North Carolina, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|Cincinnati Childrens Hospital Medical Center, Cincinnati, Ohio, United States|Cincinnati Childrens Hospital Medical Center, Cincinnati, Ohio, United States|Aventiv Research Inc., Columbus, Ohio, United States|PriMed Clinical Research, Dayton, Ohio, United States|Senders Pediatrics, South Euclid, Ohio, United States|Allegheny Health and Wellness Pavilion, Erie, Pennsylvania, United States|Velocity Clinical Research-Providence, Warwick, Rhode Island, United States|Palmetto Pediatrics, PA, North Charleston, South Carolina, United States|St. Jude Children's Research Hospital, Memphis, Tennessee, United States|Clinical Research Associates Inc, Nashville, Tennessee, United States|ARC Clinical Research at Wilson Parke, Austin, Texas, United States|Driscoll Children's Hospital, Corpus Christi, Texas, United States|University of Texas Medical Branch-Sealy Institute for Vaccine Sciences Clinical Trials Program, Galveston, Texas, United States|Ventavia Research Group, LLC, Houston, Texas, United States|Texas Children's Hospital - Clinical Research Center, Houston, Texas, United States|West Houston Clinical Research Service, Houston, Texas, United States|J. Lewis Research, Inc. / Foothill Family Clinic, Salt Lake City, Utah, United States|J. Lewis Research, Inc. / Foothill Family Clinic South, Salt Lake City, Utah, United States|Pediatric Associates of Charlottesville, PLC (Private Pediatric Practice), Charlottesville, Virginia, United States|Pediatric Research of Charlottesville, LLC (Regulatory Only), Charlottesville, Virginia, United States|Pediatric Research of Charlottesville, LLC, Charlottesville, Virginia, United States|Virginia Research Center, Midlothian, Virginia, United States|Seattle Children's Hospital, Seattle, Washington, United States|Tampere Vaccine Research Clinic, Tampere, Pirkanmaa, Finland|Tampere university/ Oulu vaccine research clinic, Oulu, Pohjois-pohjanmaa, Finland|Helsinki East Vaccine Research Clinic, Helsinki, Uusimaa, Finland|Tampere University Vaccine Research Turku, Turku, Varsinais-suomi, Finland|Espoo Vaccine Research Clinic, Espoo, Finland|Helsinki South Vaccine Research Clinic, Helsinki, Finland|MeVac, Meilahti Vaccine Research Center, Helsinki, Finland|Jarvenpaa Vaccine Research Clinic, Jarvenpaa, Finland|Kokkola Vaccine Research Clinic, Kokkola, Finland|Pori Vaccine Research Clinic, Pori, Finland|Seinäjoki Vaccine Research Center, Seinäjoki, Finland|IN VIVO, Bydgoszcz, Poland|Centrum Badan Klinicznych JCI, Krakow, Poland|O?rodek Bada? Klinicznych Appletreeclinics, Lodz, Poland|GRAVITA Diagnostyka i Leczenie nieplodnosci, Lodz, Poland|Rodzinne Centrum Medyczne LUBMED, Lubon, Poland|Niepubliczny Zaklad Lecznictwa Ambulatoryjnego MICHALKOWICE, Siemianowice Slaskie, Poland|Nasz Lekarz Osrodek Badan Klinicznych, Torun, Poland|Provita 001, Warszawa, Poland|Hospital Clínico Universitario Santiago de Compostela, Santiago de Compostela, A Coruna, Spain|EAP Centelles, Centelles, Barcelona, Spain|Hospital Sant Joan de Deu, Esplugues De Llobregrat, Barcelona, Spain|Hospital Universitari General de Catalunya, Sant Cugat del Valles, Barcelona, Spain|Hospital Universitario HM Monteprincipe, Boadilla del Monte, Madrid, Spain|Hospital de Antequera, Antequera, Malaga, Spain|Grupo Pediátrico Uncibay, Malaga, Málaga, Spain|Hospital Universitario 12 de Octubre, Madrid, Spain|Hospital HM Puerta del Sur, Mostoles, Spain|Instituto Hispalense de Pediatria, Sevilla, Spain",https://ClinicalTrials.gov/show/NCT04816643
NCT04332107,Azithromycin for COVID-19 Treatment in Outpatients Nationwide,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",20-30504,"University of California San Francisco, San Francisco, California, United States",https://ClinicalTrials.gov/show/NCT04332107
NCT04895683,Using Text Messages to Improve COVID-19 Vaccination Uptake,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention,21SM6815,NA,https://ClinicalTrials.gov/show/NCT04895683
NCT04590365,Carrageenan Nasal Spray for COVID-19 Prophylaxis,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",283187,"Joint Clinical Research Facility, Swansea, United Kingdom",https://ClinicalTrials.gov/show/NCT04590365
NCT04545047,Observational Study of Convalescent Plasma for Treatment of Veterans With COVID-19,Observational Model: Other|Time Perspective: Prospective,2030,"VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA, Boston, Massachusetts, United States|VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle, Washington, United States",https://ClinicalTrials.gov/show/NCT04545047
NCT04614012,Hyperimmune Plasma for Patients With COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,IMMUNO-COVID19,"Anna Falanga, Bergamo, Italy",https://ClinicalTrials.gov/show/NCT04614012
NCT04728919,Nasal and Pulmonary Nitric Oxide Output in COVID-19 Infection,Observational Model: Case-Control|Time Perspective: Prospective,R200090,"Tampere University Hospital, Tampere, Finland",https://ClinicalTrials.gov/show/NCT04728919
NCT04623671,Intravenous Infusion of CAP-1002 in Patients With COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",CAP-1002-COVID-19-02,"Cedars-Sinai Medical Center, Los Angeles, California, United States|University of California Davis, Sacramento, California, United States|Henry Ford Health System, Detroit, Michigan, United States|PharmaTex Research, LLC, Amarillo, Texas, United States",https://ClinicalTrials.gov/show/NCT04623671
NCT04448743,Role of Microparticles in Covid-19 Infection,Observational Model: Cohort|Time Perspective: Prospective,7829,NA,https://ClinicalTrials.gov/show/NCT04448743
NCT04345991,"Efficacy of Convalescent Plasma to Treat COVID-19 Patients, a Nested Trial in the CORIMUNO-19 Cohort",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,APHP200375-10|2020-001246-18,"SMIT, Saint Antoine hospital, Paris, France",https://ClinicalTrials.gov/show/NCT04345991
NCT04429724,Health Professional Exposure Assessment to Covid-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,RIPH_2020_8,"CH Roubaix, Roubaix, France|CH Tourcoing, Tourcoing, France|CH Wasquehal, Wasquehal, France|CH Wattrelos, Wattrelos, France",https://ClinicalTrials.gov/show/NCT04429724
NCT04978207,A Faithful Response to COVID-19 Project,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,IRB #2038603 KC,"Rhema Church, Independence, Missouri, United States|Boone Tabernacle, Kansas City, Missouri, United States|Centennial United Methodist Church, Kansas City, Missouri, United States|Kansas City Health Department, Kansas City, Missouri, United States|University of Missouri-Kansas City, Kansas City, Missouri, United States|Sunlight Missionary Baptist Church, Kansas City, Missouri, United States|Apostolic Church of God, Kansas City, Missouri, United States|Jameson Memorial Temple, Kansas City, Missouri, United States|Kingdom Word Ministries, Kansas City, Missouri, United States|Memorial Church International, Kansas City, Missouri, United States",https://ClinicalTrials.gov/show/NCT04978207
NCT04337359,Ruxolitinib Managed Access Program (MAP) for Patients Diagnosed With Severe/Very Severe COVID-19 Illness,NA,CINC424A2001M,NA,https://ClinicalTrials.gov/show/NCT04337359
NCT04983537,Study to Evaluate the Immunogenicity and Safety of Heterologous SARS-CoV-2 Vaccine Schemes in an Elderly Population,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Health Services Research,5143_2,"Hospital Ramos Mejía, Ciudad Autonoma de Buenos Aire, CBA, Argentina|Ministerio de Salud de la Ciudad Autónoma de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina",https://ClinicalTrials.gov/show/NCT04983537
NCT04423978,Implications of Covid-19 on the Lifestyle Changes,Observational Model: Ecologic or Community|Time Perspective: Cross-Sectional,ICOLS_CovidStyle,"Elisa Mazzini, Reggio Emilia, Italy",https://ClinicalTrials.gov/show/NCT04423978
NCT04766931,The Safety and Efficacy of FB2001 in Healthy Subjects and Patients With COVID-19 Infection,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",FB2001-102,"Frontage Clinical Services, Inc., Secaucus, New Jersey, United States",https://ClinicalTrials.gov/show/NCT04766931
NCT04359459,Nasal Epithelial Genetic and Single Cell RNA COVID-19 Study,Observational Model: Cohort|Time Perspective: Prospective,CIPOLLINI,NA,https://ClinicalTrials.gov/show/NCT04359459
NCT04444596,Conjunctival Swab vs Nasopharyngeal Swab in Patients With COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,1104/2020,"Medical University Innsbruck, Innsbruck, Tirol, Austria",https://ClinicalTrials.gov/show/NCT04444596
NCT04438239,Rehabilitation Needs After COVID-19 Hospital Treatment,Observational Model: Other|Time Perspective: Prospective,428/2020/OSS/AUSLRE,"Azienda USL-IRCCS S.Maria Nuova Hospital, Reggio Emilia, Italy",https://ClinicalTrials.gov/show/NCT04438239
NCT04414124,A Clinical Study to Assess the Natural History of COVID-19 and Effects of KB109 and Supportive Self-care in Outpatients With Mild-to-moderate COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,K031-120,"Healthstar Research, Hot Springs, Arkansas, United States|Axon Clinical Research, Riverside, California, United States|Medical Center for Clinical Research, San Diego, California, United States|Vista Health Research, Miami, Florida, United States|Bio-Medical Research, Miami, Florida, United States|Mount Vernon Clinical Research, Atlanta, Georgia, United States|Centex Studies, Inc. - Lake Charles, Lake Charles, Louisiana, United States|University of Massachusetts Medical School, Worcester, Massachusetts, United States|Wake Research - Clinical Research Center of Nevada, LLC, Las Vegas, Nevada, United States|Carolina Institute For Clinical Research, Fayetteville, North Carolina, United States|M3 Wake Research, Inc, Raleigh, North Carolina, United States|TruCare Internal Medicine and Infectious Diseases, DuBois, Pennsylvania, United States|ClinSearch LLC, Chattanooga, Tennessee, United States|Global Medical Research, DeSoto, Texas, United States|Centex Studies, Houston, Texas, United States|Infectious Diseases Associates of Central Virginia, Lynchburg, Virginia, United States",https://ClinicalTrials.gov/show/NCT04414124
NCT04798027,Study of mRNA Vaccine Formulation Against COVID-19 in Healthy Adults 18 Years of Age and Older,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",VAW00001|U1111-1251-5486,"Investigational Site Number 8400003, Rolling Hills Estates, California, United States|Investigational Site Number 8400002, Hollywood, Florida, United States|Investigational Site Number 8400006, Miami, Florida, United States|Investigational Site Number 8400017, Iowa City, Iowa, United States|Investigational Site Number 8400007, Kansas City, Missouri, United States|Investigational Site Number 8400001, Rochester, New York, United States|Investigational Site Number 8400010, Philadelphia, Pennsylvania, United States|Investigational Site Number 8400004, North Charleston, South Carolina, United States|Investigational Site Number 8400009, Houston, Texas, United States|Investigational Site Number 8400005, Salt Lake City, Utah, United States|Investigational Site Number 3400002, Municipio Del Distrito Central, Honduras|Investigational Site Number 3400001, San Pedro Sula, Honduras",https://ClinicalTrials.gov/show/NCT04798027
NCT04962308,Clinical Trial of Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Healthy Adults,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,PRO-nCOV-4003,"Beijing Centers for Diseases Control and Prevention, Beijing, China",https://ClinicalTrials.gov/show/NCT04962308
NCT04649515,"Efficacy and Safety of TY027, a Treatment for COVID-19, in Humans","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",SCT-301,"Singapore General Hospital, Singapore, Singapore",https://ClinicalTrials.gov/show/NCT04649515
NCT04500418,Charité Trial of Cenicriviroc (CVC) Treatment for COVID-19 Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",CVC for COVID-19|2020-001493-29,"Medical Department of Hepatology and Gastroenterology, Charité University Medicine, Campus Virchow Klinikum (CVK) and Campus Charité Mitte (CCM), Berlin, Germany",https://ClinicalTrials.gov/show/NCT04500418
NCT04730323,TOCILIZUMAB - An Option for Patients With COVID-19 Associated Cytokine Release Syndrome; A Single Center Experience,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,IRB# FMH-05-2020-IRB-75,"Fatima Memorial Hospital College of Medicine & Dentistry, Lahore, Punjab, Pakistan",https://ClinicalTrials.gov/show/NCT04730323
NCT04790786,"UPMC OPTIMISE-C19 Trial, a COVID-19 Study",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,STUDY21020179,"UPMC, Pittsburgh, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04790786
NCT04511650,"A Study to Evaluate the Safety and Efficacy of Razuprotafib, a Novel Tie 2 Activator, in Hospitalized Subjects With Moderate to Severe Coronavirus Disease 2019 (COVID-19)","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",AKB-9778-CI-6001,"University of Southern California, Los Angeles, California, United States|University of California- Irvine Medical Center, Orange, California, United States|MedStar Georgetown University Hospital, Washington, District of Columbia, United States|Snake River Research, Idaho Falls, Idaho, United States|University of Minnesota, Minneapolis, Minnesota, United States|University of Cincinnati, Cincinnati, Ohio, United States|Rhode Island Hospital, Providence, Rhode Island, United States",https://ClinicalTrials.gov/show/NCT04511650
NCT04909892,"Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells to Treat Post COVID-19 ""Long Haul"" Pulmonary Compromise",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,MSC-PLH-201,NA,https://ClinicalTrials.gov/show/NCT04909892
NCT04978246,Cognitive Functions After COVID-19,Observational Model: Case-Control|Time Perspective: Prospective,Medipol Mega3,"İstanbul Medipol Üniversitesi, Beykoz, İstanbul, Turkey",https://ClinicalTrials.gov/show/NCT04978246
NCT04463862,COVID - AirPollution,Observational Model: Cohort|Time Perspective: Other,7922,"Unité de neurologie-gériatrie, Hôpital Erasme, Cliniques Universitaires de Bruxelles, Bruxelles, Belgium|Unité de soins palliatifs gériatriques, Centre Hospitalier Départemental de Bischwiller, Bischwiller, France|Service de Gériatrie, Centre Hospitalier Départemental de Vendée, La Roche Sur Yon, France|Service de médecine aigüe gériatrique, Hôpital Nord Laennec, Hôpitaux Universitaires de Nantes, Nantes, France|Service de Gériatrie, Hôpitaux Bichat et Bretonnaux, Assistance Publique des Hôpitaux de Paris, Paris, France|Service de Médecine Interne et Gériatrie, Hôpitaux Universitaires de Reims, Reims, France|Service de Gériatrie, Hôpital de la Robertsau, Hôpitaux Universitaires de Strasbourg, Strasbourg, France|Service de médecine gériatrique, Hôpitaux Universitaires de Tours, Tours, France",https://ClinicalTrials.gov/show/NCT04463862
NCT04785898,Diagnostic Performance of the ID Now™ COVID-19 Screening Test Versus Simplexa™ COVID-19 Direct Assay,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,COVID-IDNow,"Groupe Hospitalier Paris Saint-Joseph, Paris, Ile De France, France",https://ClinicalTrials.gov/show/NCT04785898
NCT04896957,Perceptions and Representations of Vaccination Against COVID-19,Observational Model: Cohort|Time Perspective: Prospective,PERCECOVAC,"CHI Villeneuve-Saint-Georges, Villeneuve-Saint-Georges, France",https://ClinicalTrials.gov/show/NCT04896957
NCT04805840,Sensitivity of Frequent SARS-CoV-2 (COVID-19) Rapid Antigen Testing Regimen,Observational Model: Ecologic or Community|Time Perspective: Prospective,AAAT5233,"Columbia University Medical Center, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04805840
NCT04874792,Clinical Characteristics of Deceased With COVID-19,Observational Model: Case-Only|Time Perspective: Retrospective,ERC-DMC-ECC/2020/142,"Dhaka Medical College Hospital, Dhaka, Bangladesh",https://ClinicalTrials.gov/show/NCT04874792
NCT04813328,The Effect of Helminth Infection Plus COVID-19 Infection on the Immune Response and Intestinal Microorganisms,Observational Model: Ecologic or Community|Time Perspective: Cross-Sectional,SARS-CoV-2/helminth,NA,https://ClinicalTrials.gov/show/NCT04813328
NCT04328493,The Vietnam Chloroquine Treatment on COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,COVID,"National Hospital for Tropical Diseases, Hanoi, Vietnam|Can Gio COVID Hospital, Ho Chi Minh City, Vietnam|Cho Ray Hospital, Ho Chi Minh City, Vietnam|Cu Chi COVID Hospital, Ho Chi Minh City, Vietnam|Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam",https://ClinicalTrials.gov/show/NCT04328493
NCT04401202,Nigella Sativa in COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,266-20,"King Abdulaziz University Hospital, Jeddah, Saudi Arabia",https://ClinicalTrials.gov/show/NCT04401202
NCT04639466,"A Synthetic MVA-based SARS-CoV-2 Vaccine, COH04S1, for the Prevention of COVID-19","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",20447,"City of Hope Medical Center, Duarte, California, United States",https://ClinicalTrials.gov/show/NCT04639466
NCT04487119,Hematology and Clinical Picture in Pediatric COVID-19 Infection,Observational Model: Cohort|Time Perspective: Retrospective,RC 6-7-2020,"Benha Faculty of Medicine, Banhā, Qalubia, Egypt",https://ClinicalTrials.gov/show/NCT04487119
NCT04894227,Lot-to-lot Consistency of an Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Healthy Adults,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention",PRO-nCOV-4001,"Jingliang Wu, Huai'an, Jiangsu, China",https://ClinicalTrials.gov/show/NCT04894227
NCT04420741,Infusion of Prostacyclin (Iloprost) vs Placebo for 72-hours in COVID-19 Patients With Respiratory Failure,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",COMBAT-COVID-19|2020-001296-33,"Dept. of Anaesthesia and Intensive Care, Bispebjerg Hospital, Copenhagen, Denmark|Dept. of Intensive Care, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark|Dept. of Intensive Care, Copenhagen University Hospital Herlev, Herlev, Denmark|Dept. of Anaesthesia and Intensive Care, Nordsjaelands Hospital, Hillerød, Denmark|Dept. of Anaesthesia and Intensive Care, Hvidovre Hospital, Hvidovre, Denmark",https://ClinicalTrials.gov/show/NCT04420741
NCT04634370,Fase I Clinical Trial on NK Cells for COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,20200210,"Hospital de Clinicas de Porto Alegre, Porto Alegre, RS, Brazil",https://ClinicalTrials.gov/show/NCT04634370
NCT04468256,The Heart Hive COVID-19 Study,Observational Model: Case-Control|Time Perspective: Prospective,20IC6036,"Imperial College London, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04468256
NCT04508972,The VOICE-COVID-19,Observational Model: Cohort|Time Perspective: Prospective,2020-6583,"Muhc-Rimuhc, Montreal, Quebec, Canada",https://ClinicalTrials.gov/show/NCT04508972
NCT04883203,The Effect of Vitamin D Supplementation on COVID-19 Recovery,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,VITD COVIDMonastir,"Asma Sriha Belguit, Monastir, Tunisia",https://ClinicalTrials.gov/show/NCT04883203
NCT04354428,Treatment for COVID-19 in High-Risk Adult Outpatients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",STUDY00009878|INV-017062,"Ruth M. Rothstein CORE Center - Cook County Health, Chicago, Illinois, United States|Tulane University, New Orleans, Louisiana, United States|Boston University, Boston, Massachusetts, United States|SUNY Upstate Medical University, Syracuse, New York, United States|University of Washington Coordinating Center, Seattle, Washington, United States|UW Virology Research Clinic, Seattle, Washington, United States",https://ClinicalTrials.gov/show/NCT04354428
NCT04522089,A Study to Evaluate the Safety and Immunogenicity of COVID-19 (AdimrSC-2f) Vaccine,Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,ADPCT20011X,"National Taiwan University Hospital, Taipei, Taiwan",https://ClinicalTrials.gov/show/NCT04522089
NCT04551547,Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention",PRO-nCOV-1003,"Zanhuang county Center for Disease Control and Prevention, Shijiazhuang, Hebei, China",https://ClinicalTrials.gov/show/NCT04551547
NCT04334044,Treatment of SARS Caused by COVID-19 With Ruxolitinib,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,HAL 345/2020,"Grupo Cooperativo de Hemopatías Malignas, Huixquilucan, Estado De México, Mexico",https://ClinicalTrials.gov/show/NCT04334044
NCT04331600,Chloroquine as Antiviral Treatment in Coronavirus Infection 2020,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,WROCLAW CORONA STUDY 2020,"Uniwersytecki Szpital Kliniczny, Wrocław, Ul. Borowska 213, Poland|Wielospecjalistyczny Szpital Miejski, Poznań, Ul. Szwajcarska 3, Poland",https://ClinicalTrials.gov/show/NCT04331600
NCT04382794,Sitagliptin Treatment in Diabetic COVID-19 Positive Patients,Observational Model: Case-Control|Time Perspective: Retrospective,5/2020,"ASST FBF-Sacco P.O. Sacco, Milan, MI, Italy|Papa Giovanni XXIII Hospital, Bergamo, Italy|Ospedale dell'Angelo, Venezia-Mestre, Mestre, Italy|Humanitas Hospital, Milan, Italy|University of Pavia, Pavia, Italy|IRCCS Policlinico S. Matteo, Pavia, Italy",https://ClinicalTrials.gov/show/NCT04382794
NCT04713553,"A Phase 3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of Multiple Production Lots and Dose Levels of BNT162b2 RNA-Based COVID-19 Vaccines Against COVID-19 in Healthy Participants","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention",C4591017,"Kaiser Permanente Oakland, Oakland, California, United States|Clinical Research Consulting, Milford, Connecticut, United States|Indago Research & Health Center, Inc, Hialeah, Florida, United States|Research Centers of America, Hollywood, Florida, United States|Clinical Neuroscience Solutions, Orlando, Florida, United States|Clinical Research Atlanta, Stockbridge, Georgia, United States|East-West Medical Research Institute, Honolulu, Hawaii, United States|Solaris Clinical Research, Meridian, Idaho, United States|Kentucky Pediatric/Adult Research, Bardstown, Kentucky, United States|Amici Clinical Research LLC, Raritan, New Jersey, United States|PMG Research of Wilmington, LLC, Wilmington, North Carolina, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|Texas Center for Drug Development, Inc., Houston, Texas, United States|Clinical Trials of Texas, Inc., San Antonio, Texas, United States|Martin Diagnostic Clinic, Tomball, Texas, United States|J. Lewis Research, Inc. / Foothill Family Clinic South, Salt Lake City, Utah, United States",https://ClinicalTrials.gov/show/NCT04713553
NCT04877509,Micronutrient Status Involved in Immunity in Elderly Patients With COVID-19,Observational Model: Cohort|Time Perspective: Other,69HCL20_0730 A067,"Chls Cbap, Pierre-Bénite, France",https://ClinicalTrials.gov/show/NCT04877509
NCT04510233,Ivermectin Nasal Spray for COVID19 Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,IvrInh,NA,https://ClinicalTrials.gov/show/NCT04510233
NCT04894474,A Study to Test Whether BI 767551 Can Prevent COVID-19 in People Who Have Been Exposed to SARS-CoV-2,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",1487-0003|2021-000408-39,NA,https://ClinicalTrials.gov/show/NCT04894474
NCT04659239,"The Efficacy, Safety and Immunogenicity Study of Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",20200404,"CEMEC Pesquisa Clinica, São Bernardo do Campo, São Paulo, Brazil|Hospital Sungai Buloh, Sungai Buloh, Selangor, Malaysia",https://ClinicalTrials.gov/show/NCT04659239
NCT04437706,Network-Targeted Strategies for Efficient Community SARS-CoV-2 (COVID-19) Sampling,Observational Model: Ecologic or Community|Time Perspective: Prospective,Pro00105430,"Duke University Medical Center, Durham, North Carolina, United States",https://ClinicalTrials.gov/show/NCT04437706
NCT04912804,Perceived Health After Hospitalization for COVID-19,Observational Model: Cohort|Time Perspective: Prospective,DEVILLIERS AOIc 2020,"Chu Dijon Bourogne, Dijon, France",https://ClinicalTrials.gov/show/NCT04912804
NCT04810728,Efficacy of Psidii Guava's Extract For COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment",PSIDII0520_COV19,"Faculty of Medicine, Baiturrahmah University, Padang, West Sumatera, Indonesia",https://ClinicalTrials.gov/show/NCT04810728
NCT04646603,MRG-001 as an Immunoregulatory and Regenerative Therapy for COVID-19 Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",MRG2020,"ICON Early Phase Services, San Antonio, Texas, United States",https://ClinicalTrials.gov/show/NCT04646603
NCT04427345,Predictive Factors COVID-19 Patients,Observational Model: Cohort|Time Perspective: Retrospective,MI-COVID,"ASST Monza-Ospedale San Gerardo, Monza, Italy",https://ClinicalTrials.gov/show/NCT04427345
NCT04403828,Impact of COVID-19 on Personal Protection Among Dentist in Egypt,Observational Model: Cohort|Time Perspective: Cross-Sectional,PPE in COVID-19,"Faculty of Dentistry, Fayoum, Egypt",https://ClinicalTrials.gov/show/NCT04403828
NCT04412538,Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",20200401,"West China Second University Hospital, Sichuan University / West China women's and children's Hospital, Chengdu, Sichuan, China",https://ClinicalTrials.gov/show/NCT04412538
NCT04447131,Effect of COVID-19 on Platelet Aggregation,Observational Model: Case-Control|Time Perspective: Prospective,SDC 5089/20/118,"Instituto do Coracao (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil",https://ClinicalTrials.gov/show/NCT04447131
NCT04910334,Long-term Cognitive and Functional Status After COVID-19 Treatment at Danish ICUs,Observational Model: Cohort|Time Perspective: Prospective,REG-135-2020,"Department of Anaesthesiology, Køge, Denmark",https://ClinicalTrials.gov/show/NCT04910334
NCT04512118,CT Abnormalities Evocative of Lung Infection Are Associated With Lower 18F-FDG Uptake in Confirmed COVID-19 Patients,Observational Model: Case-Only|Time Perspective: Retrospective,2020PI153,"CHRU of Nancy, Vandœuvre-lès-Nancy, Grand Est, France",https://ClinicalTrials.gov/show/NCT04512118
NCT04273321,Efficacy and Safety of Corticosteroids in COVID-19,Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,Methylprednisolone in COVID-19,"Hubei province hospital of integrated Chinese & Western Medicine, Wuhan, Hubei, China|Yichang first people's Hospital, Yichang, Hubei, China|Beijing YouAn Hospital, Beijing, China|Renmin Hospital of Wuhan University, Wuhan, China|Tianyou Hospital Affiliated to Wuhan University of science and technology, Wuhan, China|Union Hospital Affiliated to Tongji Medical College of Huazhong University of science and technology, Wuhan, China|the first peopel hospital of Xiangyang, Xiangyang, China",https://ClinicalTrials.gov/show/NCT04273321
NCT04659941,Use of BCG Vaccine as a Preventive Measure for COVID-19 in Health Care Workers,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Prevention",31942220.8.1001.5257,"Universidade Federal do Rio de Janeiro, Rio De Janeiro, RJ, Brazil",https://ClinicalTrials.gov/show/NCT04659941
NCT04718285,Investigation the Effect of Montelukast in COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,MON786.168.1,"Bahcesehir University, School of Medicine, Department of Biophysics,, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04718285
NCT04904783,Low-Dose Radiation Therapy to Lungs in Moderate COVID-19 Pneumonitis: A Case-Control Pilot Study,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,MGIMS/IEC/RADTHP/215/2021,"Mahatma Gandhi Institute of Medical Sciences,, Sevagram, Maharashtra, India|Mahatma Gandhi Institute of Medical Sciences, Sevagram, Maharashtra, India",https://ClinicalTrials.gov/show/NCT04904783
NCT04365127,Progesterone for the Treatment of COVID-19 in Hospitalized Men,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,STUDY00000611,"Cedars Sinai Medical Center, Los Angeles, California, United States",https://ClinicalTrials.gov/show/NCT04365127
NCT04854759,The Use of Amantadine in the Prevention of Progression and Treatment of COVID-19 Symptoms,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",LUB-COV-2021-01,"Regionalny Szpital Specjalistyczny im. dr Władysława Biegańskiego Oddział Neurologii i Neuroimmunologii Klinicznej, Grudziądz, Poland|Oddział Obserwacyjno-Zakaźny SPSz Woj. Im. Jana Bożego Lublin, Lublin, Poland|Samodzielny Publiczny Szpital Kliniczny Nr 4 w Lublinie, Lublin, Poland|Oddział Hematologii MSWiA w Poznaniu, Poznań, Poland|Klinika Chorób Wewnętrznych Nefrologii i Endokrynologii Klinicznego Szpitala Wojewódzkiego nr 2 im. Św. Jadwigi Królowej, Rzeszów, Poland|Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu Medycznego Szpital Kliniczny Dzieciątka Jezus, Warszawa, Poland|Centralny Szpital Kliniczny Ministerstwa Spraw Wewnętrznych i Administracji w Warszawie, Warszawa, Poland|Oddział Kardiologiczny Samodzielny Publiczny Zespół Zakładów Opieki Zdrowotnej w Wyszkowie, Wyszków, Poland",https://ClinicalTrials.gov/show/NCT04854759
NCT04458519,Efficacy of Intranasal Probiotic Treatment to Reduce Severity of Symptoms in COVID19 Infection,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Care Provider, Outcomes Assessor)|Primary Purpose: Treatment",PROBCO|249512,"Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, Quebec, Canada",https://ClinicalTrials.gov/show/NCT04458519
NCT04435808,Efficacy of Hydroxychloroquine Prophylaxis for Health Care Workers at High Risk for COVID-19,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,20-206,"University of New Mexico Health Sciences Center, Albuquerque, New Mexico, United States",https://ClinicalTrials.gov/show/NCT04435808
NCT04470609,Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19 in People Aged ⩾60 Years,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",20200402,"West China Second University Hospital, Sichuan University / West China women's and children's Hospital, Chengdu, Sichuan, China",https://ClinicalTrials.gov/show/NCT04470609
NCT04709328,To Evaluate SCTA01 Treatment of High-risk Outpatients With COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",SCTA01-A301,NA,https://ClinicalTrials.gov/show/NCT04709328
NCT04972864,Effects of Respiratory Muscle Training in Patients With Post COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",203,"Gazi University, Çankaya, Ankara, Turkey",https://ClinicalTrials.gov/show/NCT04972864
NCT04610138,Study of ZnAg Liquid Solution to Treat COVID-19 Symptomatic Participants,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",CNMZnAg.202,NA,https://ClinicalTrials.gov/show/NCT04610138
NCT04758273,A Safety and Immunogenicity Study of Inactivated SARS-CoV-2 Vaccine (Vero Cells) in Healthy Population Aged 18 Years and Above(COVID-19),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",2020L001-1A,"Jiangsu Provincial Center for Diseases Control and Prevention, Nanjing, Jiangsu, China",https://ClinicalTrials.gov/show/NCT04758273
NCT04383574,Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of SARS-CoV-2 Infection(COVID-19),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention",PRO-nCOV-1002,"Renqiu City Center for Disease Control and Prevention, Renqiu, Hebei, China",https://ClinicalTrials.gov/show/NCT04383574
NCT04338074,TXA and Corona Virus 2019 (COVID19) in Outpatients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",TXACOVID1,"University of Alabama at Birmingham, Birmingham, Alabama, United States",https://ClinicalTrials.gov/show/NCT04338074
NCT04656691,At-Home Infusion Using Bamlanivimab in Participants With Mild to Moderate COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2020-0081_,"QueryLab, Minnetonka, Minnesota, United States",https://ClinicalTrials.gov/show/NCT04656691
NCT04352608,Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",PRO-nCOV-1001,"Suining County Center for Disease Control and Prevention, Xuzhou, Jiangsu, China",https://ClinicalTrials.gov/show/NCT04352608
NCT04860908,COVID 19 ANTOBODIES IN PREGNANT WOMEN AND THEIR CONNECTION TO BETA CELL FUNCTION IN THE FETUS,Observational Model: Cohort|Time Perspective: Prospective,MaayneiHMC,"Maayanei Hayeshua Medical Center, Bnei Brak, Merkaz, Israel",https://ClinicalTrials.gov/show/NCT04860908
NCT04371432,Genetics of COVID-19 Susceptibility and Manifestations,Observational Model: Case-Control|Time Perspective: Prospective,200090|20-HG-0090,"National Institutes of Health Clinical Center, Bethesda, Maryland, United States",https://ClinicalTrials.gov/show/NCT04371432
NCT04372017,Hydroxychloroquine as Post-Exposure Prophylaxis Against COVID-19 Infection,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention",PEPCOH,"Sanford Health, Sioux Falls, South Dakota, United States",https://ClinicalTrials.gov/show/NCT04372017
NCT04449965,Povidone-Iodine Rinses in the Management of COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",Betadine COVID-19,NA,https://ClinicalTrials.gov/show/NCT04449965
NCT04545060,VIR-7831 for the Early Treatment of COVID-19 in Outpatients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",VIR-7831-5001|GSK Study 214367,"Investigative Site, Anniston, Alabama, United States|Investigative Site, Cullman, Alabama, United States|Investigative Site, Mesa, Arizona, United States|Investigative Site, Tucson, Arizona, United States|Investigative Site, Los Angeles, California, United States|Investigative Site, Los Angeles, California, United States|Investigative Site, Northridge, California, United States|Investigative Site, Oxnard, California, United States|Investigative Site, Rolling Hills Estates, California, United States|Investigative Site, Sacramento, California, United States|Investigative Site, Doral, Florida, United States|Investigative Site, Gainesville, Florida, United States|Investigative Site, Hialeah, Florida, United States|Investigative Site, Miami, Florida, United States|Investigative Site, Miami, Florida, United States|Investigative Site, Miami, Florida, United States|Investigative Site, Miami, Florida, United States|Investigative Site, Miami, Florida, United States|Investigative Site, Miramar, Florida, United States|Investigative Site, North Miami, Florida, United States|Investigative Site, Palmetto Bay, Florida, United States|Investigative Site, Pembroke Pines, Florida, United States|Investigative Site, Pompano Beach, Florida, United States|Investigative Site, Tampa, Florida, United States|Investigative Site, Tampa, Florida, United States|Investigative Site, Atlanta, Georgia, United States|Investigative Site, Atlanta, Georgia, United States|Investigative Site, Decatur, Georgia, United States|Investigative Site, Stockbridge, Georgia, United States|Investigative Site, Idaho Falls, Idaho, United States|Investigative Site, Mishawaka, Indiana, United States|Investigative Site, Lake Charles, Louisiana, United States|Investigative Site, Marrero, Louisiana, United States|Investigative Site, Baltimore, Maryland, United States|Investigative Site, Caro, Michigan, United States|Investigative Site, Hazelwood, Missouri, United States|Investigative Site, Las Vegas, Nevada, United States|Investigative Site, Las Vegas, Nevada, United States|Investigative Site, Santa Fe, New Mexico, United States|Investigative Site, Bronx, New York, United States|Investigative Site, Asheboro, North Carolina, United States|Investigative Site, Charlotte, North Carolina, United States|Investigative Site, Columbus, Ohio, United States|Investigative Site, Smithfield, Pennsylvania, United States|Investigative Site, Chattanooga, Tennessee, United States|Investigative Site, Austin, Texas, United States|Investigative Site, Baytown, Texas, United States|Investigative Site, Beaumont, Texas, United States|Investigative Site, Denton, Texas, United States|Investigative Site, El Paso, Texas, United States|Investigative Site, Forney, Texas, United States|Investigative Site, Houston, Texas, United States|Investigative Site, Houston, Texas, United States|Investigative Site, Houston, Texas, United States|Investigative Site, Houston, Texas, United States|Investigative Site, Humble, Texas, United States|Investigative Site, Laredo, Texas, United States|Investigative Site, McAllen, Texas, United States|Investigative Site, Mesquite, Texas, United States|Investigative Site, Sugar Land, Texas, United States|Investigative Site, Kirkland, Washington, United States|Investigative Site, Seattle, Washington, United States|Investigative Site, Vienna, Austria|Investigative Site, Vienna, Austria|Investigative Site, Belo Horizonte, Minas Gerais, Brazil|Investigative Site, Maringá, Parana, Brazil|Investigative Site, Natal, Rio Grande Do Norte, Brazil|Investigative Site, Passo Fundo, Rio Grande Do Sul, Brazil|Investigative Site, Porto Alegre, Rio Grande Do Sul, Brazil|Investigative Site, Porto Alegre, Rio Grande Do Sul, Brazil|Investigative Site, Chapecó, Santa Catarina, Brazil|Investigative Site, Santo André, Sao Paulo, Brazil|Investigative Site, Vila Assuncao, Sao Paulo, Brazil|Investigative Site, Campinas, São Paulo, Brazil|Investigative Site, Sarnia, Ontario, Canada|Investigative Site, Toronto, Ontario, Canada|Investigative Site, Québec, Quebec, Canada|Investigative Site, Bellavista, Callao, Peru|Investigative Site, El Agustino, Lima, Peru|Investigative Site, Huaral, Lima, Peru|Investigative Site, San Isidro, Lima, Peru|Investigative Site, Bella Vista, Peru|Investigative Site, Lima, Peru|Investigative Site, Terrassa, Barcelona, Spain|Investigative Site, Albacete, Spain|Investigative Site, Centelles, Spain|Investigative Site, Girona, Spain|Investigative Site, Granada, Spain|Investigative Site, Granada, Spain|Investigative Site, Vigo, Spain|Investigative Site, Belfast, United Kingdom",https://ClinicalTrials.gov/show/NCT04545060
NCT04913675,Intramuscular VIR-7831 (Sotrovimab) for Mild/Moderate COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,VIR-7831-5008,"Investigative Site, Anniston, Alabama, United States|Investigative Site, Mesa, Arizona, United States|Investigative Site, Tucson, Arizona, United States|Investigative Site, Long Beach, California, United States|Investigative Site, Los Angeles, California, United States|Investigative Site, Rolling Hills Estates, California, United States|Investigative Site, Bradenton, Florida, United States|Investigative Site, Cutler Bay, Florida, United States|Investigative Site, Doral, Florida, United States|Investigative Site, Doral, Florida, United States|Investigative Site, Gainesville, Florida, United States|Investigative Site, Hialeah Gardens, Florida, United States|Investigative Site, Hialeah, Florida, United States|Investigative Site, Hialeah, Florida, United States|Investigative Site, Hialeah, Florida, United States|Investigative Site, Miami Lakes, Florida, United States|Investigative Site, Miami, Florida, United States|Investigative Site, Miami, Florida, United States|Investigative Site, Miami, Florida, United States|Investigative Site, Miami, Florida, United States|Investigative Site, Miami, Florida, United States|Investigative Site, Miami, Florida, United States|Investigative Site, Miami, Florida, United States|Investigative Site, Miami, Florida, United States|Investigative Site, Miami, Florida, United States|Investigative Site, Miami, Florida, United States|Investigative Site, Miami, Florida, United States|Investigative Site, Miami, Florida, United States|Investigative Site, Miami, Florida, United States|Investigative Site, Miami, Florida, United States|Investigative Site, Miami, Florida, United States|Investigative Site, North Miami Beach, Florida, United States|Investigative Site, North Miami Beach, Florida, United States|Investigative Site, Ormond Beach, Florida, United States|Investigative Site, Palmetto Bay, Florida, United States|Investigative Sites, Pembroke Pines, Florida, United States|Investigative Site, Pompano Beach, Florida, United States|Investigative Site, Pompano Beach, Florida, United States|Investigative Site, Tampa, Florida, United States|Investigative Site, Tampa, Florida, United States|Investigative Site, West Palm Beach, Florida, United States|Investigative Site, Atlanta, Georgia, United States|Investigative Site, Idaho Falls, Idaho, United States|Investigative Site, Chicago, Illinois, United States|Investigative Site, Mishawaka, Indiana, United States|Investigative Site, Baltimore, Maryland, United States|Investigative Site, Sterling Heights, Michigan, United States|Investigative Site, Las Vegas, Nevada, United States|Investigative Site, Bronx, New York, United States|Investigative Site, Charlotte, North Carolina, United States|Investigative Site, High Point, North Carolina, United States|Investigative Site, Mount Airy, North Carolina, United States|Investigative Site, Columbus, Ohio, United States|Investigative Site, Smithfield, Pennsylvania, United States|Investigative Site, Baytown, Texas, United States|Investigative Site, Forney, Texas, United States|Investigative Site, Houston, Texas, United States|Investigative Site, Houston, Texas, United States|Investigative Site, Houston, Texas, United States|Investigative Site, Houston, Texas, United States|Investigative Site, Houston, Texas, United States|Investigative Site, Laredo, Texas, United States|Investigative Site, McAllen, Texas, United States|Investigative Site, McAllen, Texas, United States|Investigative Site, Mesquite, Texas, United States|Investigative Site, Pharr, Texas, United States|Investigative Site, Kirkland, Washington, United States|Investigative Site, Seattle, Washington, United States|Investigative Site, Rosario, Santa Fe, Argentina|Investigative Site, Wien, Vienna, Austria|Investigative Site, Québec, Quebec, Canada|Investigative Site, Strasbourg, Bas-Rhin, France|Investigative Site, Marseille, Bouches-du-RhÃ´ne, France|Investigative Site, Raipur, Chhattisgarh, India|Investigative Site, Baroda, Gujarat, India|Investigative Site, Rājkot, Gujarat, India|Investigative Site, Sūrat, Gujarat, India|Investigative Site, Vadodara, Gujarat, India|Investigative Site, Gurgaon, Haryana, India|Investigative Site, Bangalore, Karnataka, India|Investigative Site, Mumbai, Maharashtra, India|Investigative Site, Mumbai, Maharashtra, India|Investigative Site, Nagpur, Maharashtra, India|Investigative Site, Nashik, Maharashtra, India|Investigative Site, Pune, Maharashtra, India|Investigative Site, Pune, Maharashtra, India|Investigative Site, Pune, Maharashtra, India|Investigative Site, Lucknow, Pradesh, India|Investigative Site, Ludhiāna, Punjab, India|Investigative Site, Milano, Lombardia, Italy|Investigative Site, Milan, Lombardia, Italy|Investigative Site, Milan, Lombardia, Italy|Investigative Site, Torino, Piemonte, Italy|Investigative Site, Bellavista, Callao, Peru",https://ClinicalTrials.gov/show/NCT04913675
NCT04413955,Registry of Seraph®-100 Microbind® Affinity Blood Filter for COVID-19 Under EUA,Observational Model: Cohort|Time Perspective: Prospective,001-Seraph®-100 for SARS-CoV-2,"AdventHealth Orlando, Orlando, Florida, United States",https://ClinicalTrials.gov/show/NCT04413955
NCT04750720,Study of the Kinetics of COVID-19 Antibodies for 24 Months in Patients With Confirmed SARS-CoV-2 Infection,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science,CHRO-2020-12,"Centre Hospitalier Régional d'Orléans, France, Orléans, France",https://ClinicalTrials.gov/show/NCT04750720
NCT04756323,A Study to Evaluate Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccine (Vero Cells) in Healthy Population Aged 18 Years and Above(COVID-19),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",2020L001-1B,"Jiangsu Provincial Center for Diseases Control and Prevention, Nanjing, Jiangsu, China",https://ClinicalTrials.gov/show/NCT04756323
NCT04379154,Analysis of Volatile Organic Compounds by Electronic Noses in Hospitalised Patients for an Infection by SARS-COV-2 (COVID-19),Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,2020_0060,"Hôpital Foch, Suresnes, France",https://ClinicalTrials.gov/show/NCT04379154
NCT04504240,Role of Famotidine in the Clinical Improvement of COVID-19 Patients.,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,10000753/980,"Chattogram General Hospital, Chittagong, Bangladesh|M. Abdur Rahim Medical College Hospital, Dinājpur, Bangladesh",https://ClinicalTrials.gov/show/NCT04504240
NCT04392245,Proctologic Practice and Covid-19,Observational Model: Other|Time Perspective: Prospective,1,"Gallo Gallo, Catanzaro, Italy",https://ClinicalTrials.gov/show/NCT04392245
NCT04368884,Assess the Seroconversion Status of Health Care Workers Suspected or Confirmed Cases of COVID-19 Patients,Observational Model: Cohort|Time Perspective: Prospective,Covid-19/MHC-2/2020,"Max Super Speciality Hospital, A Unit of Devki Devi Foundation, New Delhi, Delhi, India",https://ClinicalTrials.gov/show/NCT04368884
NCT04555096,A Trial of GC4419 in Patients With Critical Illness Due to COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",COV-4419-201,"University of Iowa, Iowa City, Iowa, United States|Saint Louis University, Saint Louis, Missouri, United States|Mercy Research, Saint Louis, Missouri, United States",https://ClinicalTrials.gov/show/NCT04555096
NCT04642014,Application of Convalescent Plasma in the Treatment of SARS CoV-2 Disease (COVID-19) With Evaluation of Therapy Effectiveness,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2020.ABM.COVID19.0005,"Wroclaw Medical University, Wroclaw, Dolnośląskie, Poland",https://ClinicalTrials.gov/show/NCT04642014
NCT04470583,Evaluating Clinical Parameters of COVID-19 in Pregnancy,Observational Model: Cohort|Time Perspective: Retrospective,C&W20/034|283995,"Chelsea and Westminster Hospital NHS Foundation Trust, London, United Kingdom|Chelsea and Westminster Hospital, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04470583
NCT04469179,"Safety, Tolerability, and Pharmacokinetics of SAB-185 in Ambulatory Participants With COVID-19","Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",SAB-185-102,"Quantum Clinical Trials, Miami Beach, Florida, United States|University of Nebraska Medical Center, Omaha, Nebraska, United States|Sanford Health, Sioux Falls, South Dakota, United States",https://ClinicalTrials.gov/show/NCT04469179
NCT04344457,"Evaluate the Efficacy and Safety of Oral Hydroxychloroquine, Indomethacin and Zithromax in Subjects With Mild Symptoms of COVID-19",Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,HIZ-PRC-COVID-19,"Perseverance Research Center, Scottsdale, Arizona, United States|Covidcraz 19, Llc, New Orleans, Louisiana, United States",https://ClinicalTrials.gov/show/NCT04344457
NCT04346017,Evaluation of Interleukine 6 (and Other Cytokines and Inflammatory Markers) in COVID-19 Patients With a Systemic Inflammatory Response Syndrome,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science,CHUB-IL6-COVID-19,"CHU Brugmann, Brussels, Belgium",https://ClinicalTrials.gov/show/NCT04346017
NCT04963790,Enabling Family Physicians to Reduce Vaccine Hesitancy and Increase Covid-19 Vaccine Uptake,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,20-21-09-027,"Eastern Ontario Health Unit, Cornwall, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04963790
NCT04876417,tDCS for Post COVID-19 Fatigue,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",202009381,"Department of Health and Human Physiology, Iowa City, Iowa, United States",https://ClinicalTrials.gov/show/NCT04876417
NCT04799691,Comparison of 2 Ventilatory Support Strategies During Coronavirus Disease 2019 (Covid-19) Pneumonia,Observational Model: Case-Control|Time Perspective: Retrospective,2021-CHITS-004,"Hôpital Sainte Musse, Toulon, Var, France",https://ClinicalTrials.gov/show/NCT04799691
NCT04363203,VA Remote and Equitable Access to COVID-19 Healthcare Delivery (VA-REACH TRIAL),"Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",20-30517,"San Francisco VA, San Francisco, California, United States",https://ClinicalTrials.gov/show/NCT04363203
NCT04537949,A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,BNT162-04|2020-003267-26|U1111-1254-4840,"Contract Research Organization, Berlin, Germany|Contract Research Organization, Mannheim, Germany",https://ClinicalTrials.gov/show/NCT04537949
NCT04670328,Role of Hematological Parameters in the Stratification of COVID-19 Disease Severity,Observational Model: Case-Only|Time Perspective: Retrospective,FMHCMD,"FMH college of medicine and dentistry, Lahore, Punjab, Pakistan",https://ClinicalTrials.gov/show/NCT04670328
NCT04343781,National Survey of Symptoms of People Aged 70 and Overs Diagnosed With COVID-19,Observational Model: Cohort|Time Perspective: Cross-Sectional,ar20-0031v1,"Angers University Hospital, Angers, France",https://ClinicalTrials.gov/show/NCT04343781
NCT04343742,Determination of the Effectiveness of Oral Chlorine Dioxide in the Treatment of COVID 19,Observational Model: Case-Only|Time Perspective: Prospective,Genesis AKCOVID- FG-1,"Hospital Fhsj, Bogota, Cundinamarca, Colombia|San Carlos Hospital, Bogota, Cundinamarca, Colombia",https://ClinicalTrials.gov/show/NCT04343742
NCT04478019,SHIELD Study: Using Naso-oropharyngeal Antiseptic Decolonization to Reduce COVID-19 Viral Shedding,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,2020-0540|A534265|SMPH/MEDICINE/INFECT DIS|Protocol Version 6/1/2020,"University of Wisconsin-Madison, Madison, Wisconsin, United States",https://ClinicalTrials.gov/show/NCT04478019
NCT04401475,"A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of EB05 + SOC vs. Placebo + SOC in Adult Hospitalized Patients With COVID-19","Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",EB05-04-2020,"UCSF Fresno, Fresno, California, United States|St. Jude Medical Center/ Providence, Fullerton, California, United States|St. Joseph Hospital, Orange - Providence, Orange, California, United States|University of Miami Hospital, Coral Gables, Florida, United States|Augusta University Medical Center, Augusta, Georgia, United States|Methodist Medical Center IL, Peoria, Illinois, United States|Norton Hospital, Louisville, Kentucky, United States|Norton Brownsboro Hospital, Louisville, Kentucky, United States|Baystate Medical Center, Springfield, Massachusetts, United States|Henry Ford Hospital, Detroit, Michigan, United States|Providence Regional Medical Center - Everett, Everett, Washington, United States|UW Medicine Valley Medical Center, Renton, Washington, United States|West Virginia University Medicine Heart & Vascular Institute, Morgantown, West Virginia, United States|Royal Alexandra Hospital, Edmonton, Alberta, Canada|Misericordia Community Hospital, Edmonton, Alberta, Canada|University of Alberta Hospital, Edmonton, Alberta, Canada|Grey Nuns Community Hospital, Edmonton, Alberta, Canada|Vancouver General Hospital, Vancouver, British Columbia, Canada|University Hospital - LHSC, London, Ontario, Canada|Victoria Hospital - LHSC, London, Ontario, Canada|North York General Hospital, Toronto, Ontario, Canada|Toronto General Hospital, Toronto, Ontario, Canada|Hôpital Maisonneuve Rosemont, Montréal, Quebec, Canada|Hôpital Régional de Rimouski, Rimouski, Quebec, Canada|Clinica de las Americas, Medellín, Antioquia, Colombia|IPS de Universidad de Antioquia, Medellín, Antioquia, Colombia|FOSCAL, Bucaramanga, Santander, Colombia|Fund.Cardiovascular de Colombia-FCV, Bucaramanga, Santander, Colombia",https://ClinicalTrials.gov/show/NCT04401475
NCT04596085,"Study to Evaluate Efficacy and Safety of ""VIRACIDE"" IN THE MANAGEMENT OF CORONA VIRUS DISEASE 2019 (COVID-19)","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Supportive Care",NS-VC-CT01-20,"Department of General medicine/ clinical research. Government medical college and Government general hospital, Srikakulam, Andhra Pradesh, India|Gunjkar Multispeciality Hospital, Pune, Maharashtra, India",https://ClinicalTrials.gov/show/NCT04596085
NCT04705844,Study of Adalimumab or Placebo in Patients With Mild to Moderate COVID-19 (COMBAAT),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",A21-070,NA,https://ClinicalTrials.gov/show/NCT04705844
NCT04768257,Physical Activity Post COVID-19,Observational Model: Cohort|Time Perspective: Prospective,CEID/HU/2020/51,NA,https://ClinicalTrials.gov/show/NCT04768257
NCT04252664,A Trial of Remdesivir in Adults With Mild and Moderate COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",CAP-China remdesivir 1,"Jin Yin-tan hospital, Wuhan, Hubei, China",https://ClinicalTrials.gov/show/NCT04252664
NCT04909996,Study on the Performance and Safety of Sentinox in COVID-19 Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,STX-2021,"Ospedale Policlinico San Martino IRCCS, Genova, Italy",https://ClinicalTrials.gov/show/NCT04909996
NCT04345536,Prospective Quality Register of Patients With Confirmed Covid-19 at Oslo University Hospital,Observational Model: Cohort|Time Perspective: Prospective,CovidRegOUH,"Oslo University Hospital, Oslo, Norway",https://ClinicalTrials.gov/show/NCT04345536
NCT04342182,Convalescent Plasma as Therapy for Covid-19 Severe SARS-CoV-2 Disease (CONCOVID Study),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,NL73489.078.20,"Erasmus Medical Center, Rotterdam, Zuid-Holland, Netherlands|NoordWest Ziekenhuisgroep, Alkmaar, Netherlands|Onze Lieve Vrouwen Gasthuis, Amsterdam, Netherlands|Rijnstate Ziekenhuis, Arnhem, Netherlands|Reinier de Graaf Gasthuis, Delft, Netherlands|Haaglanden Medisch Centrum, Den Haag, Netherlands|Catharina Ziekenhuis, Eindhoven, Netherlands|Medisch Spectrum Twente, Enschede, Netherlands|Groene Hart Ziekenhuis, Gouda, Netherlands|Martini Hospital, Groningen, Netherlands|Spaarna Gasthuis, Haarlem, Netherlands|Alrijne Ziekenhuis, Leiderdorp, Netherlands|Sint Antonius Ziekenhuis, Nieuwegein, Netherlands|Canisius-Wilhelmina Hospital, Nijmegen, Netherlands|Maasstad Ziekenhuis, Rotterdam, Netherlands|ZorgSaam Hospital, Terneuzen, Netherlands|Bernhoven Hospital, Uden, Netherlands|VieCuri, Venlo, Netherlands",https://ClinicalTrials.gov/show/NCT04342182
NCT04535674,Asunercept in Patients With Severe COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,APG101_CD_017|2020-001887-27,"Republican Clinical Infectious Hospital n.a. professor A.F. Agafonov, Kazan, Russian Federation|Scientific Research lnstitute fоr Соmрlех lssues of Cardiovascular Diseases, Kemerovo, Russian Federation|Federal State Budgetary Educational Institution of Higher Education ""Kuban State Medical University"" of the Ministry of Health of the Russian Federation, Krasnodar, Russian Federation|State Budgetary Healthcare Institution ""Scientific Research Institute - Regional clinical hospital No. 1 n.a. professor S.V. Ochapovsky"" of the Ministry of Healthcare of Krasnodar Krai, Krasnodar, Russian Federation|Kursk Regional Clinical Hospital, Kursk, Russian Federation|State Budgetary Institution of Health of the Nizhny Novgorod Region ""Infectious Clinical Hospital No. 2 of Nizhny Novgorod"", Nizhny Novgorod, Russian Federation|Ryazan State Medical University n.a. academician I.P. Pavlov, Ryazan, Russian Federation|Saint Petersburg state budgetary healthcare institution ""City hospital of Saint George the great Martyr"", Saint Petersburg, Russian Federation|Hospital de la Santa Creu i Sant Pau, Barcelona, Spain|Hospital Universitario Infanta Leonor, Madrid, Spain|Hospital Universitario La Paz, Madrid, Spain|Hospital Universitario Ramón y Cajal, Madrid, Spain|Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, Spain|Hospital Universitario Infanta Sofia, San Sebastián De Los Reyes, Spain|Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain",https://ClinicalTrials.gov/show/NCT04535674
NCT04894721,Prophylaxis for COVID-19: Ivermectin in Close Contacts of COVID-19 Cases (IVERNEX-TUC),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention",5077/410 CH 2020,"SI.PRO.SA, Ministerio de Salud Pública, Tucumán, Argentina",https://ClinicalTrials.gov/show/NCT04894721
NCT04443881,Clinical Trial of the Use of Anakinra in Cytokine Storm Syndrome Secondary to Covid-19 (ANA-COVID-GEAS),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,ANA-COVID-GEAS,"Hospital Universitario Miguel Servet, Zaragoza, Aragón, Spain|Hospital Universitario de Cabueñes, Gijón, Asturias, Spain|Hospital Clinic, Barcelona, Cataluña, Spain|Hospital Universitario Vall d´Hebron, Barcelona, Cataluña, Spain|Complexo Hospitalario Universitario de Santiago, Santiago De Compostela, Galicia, Spain|Hospital Universitario Son Espases, Palma De Mallorca, Mallorca, Spain|Complejo Hospitalario de Navarra, Pamplona, Navarra, Spain|Hospital Universitario La Paz, Madrid, Spain|Hospital Universitario Ramon y Cajal, Madrid, Spain|Hospital Universitario y Politecnico La Fe, Valencia, Spain|Complejo Hospitalario Universitario de Vigo, Vigo, Spain|Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain",https://ClinicalTrials.gov/show/NCT04443881
NCT04612972,"Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) to Prevent COVID-19 in Healthy Adult Population In Peru Healthy Adult Population In Peru","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",UPeruanaCH,"Av. Honorio Delgado 430, Urb. Ingeniería, San Martin De Porres, Lima, Peru",https://ClinicalTrials.gov/show/NCT04612972
NCT04405492,"Evaluation of Rapid Diagnostic Solutions, Serological and Molecular Tests for COVID-19",Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,APHP200556,NA,https://ClinicalTrials.gov/show/NCT04405492
NCT04852861,COVID-19: Safety and Immunogenicity of a Reduced Dose of the BioNTech/Pfizer BNT162b2 Vaccine,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Diagnostic",DemiVac2021|2021-002088-23,"Mensura EDPB, Antwerp, Belgium",https://ClinicalTrials.gov/show/NCT04852861
NCT04363489,The CEDiD Study (COVID-19 Early Diagnosis in Doctors and Healthcare Workers),Observational Model: Cohort|Time Perspective: Prospective,CEDiD Study,"Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04363489
NCT04347174,A Clinical Trial of Mycobacterium w in Critically Ill COVID 19 Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",CRSC20004,"All India Institute of Medical Science, Raipur, Raipur, Chhattisgarh, India|All India Institute of Medical Sciences, Bhopal, Bhopal, Madhya Pradesh, India|Postgraduate Institute of Medical Education and Research, Chandigarh, India|All lndia Institute of Medical Science, Delhi, Delhi, India",https://ClinicalTrials.gov/show/NCT04347174
NCT04644120,Study to Assess Adverse Events and How Intravenous (IV) ABBV-47D11 and IV ABBV-2B04 Given Alone and in Combination Moves Through the Body of Adult Participants With Coronavirus Disease 2019 (COVID-19),"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",M20-404|2020-005203-39,"Glendale Adventist Medical Center /ID# 225188, Glendale, California, United States|Beautiful Minds Clinical Research Center /ID# 228708, Cutler Bay, Florida, United States|University of Miami /ID# 225038, Miami, Florida, United States|AdventHealth Orlando /ID# 225965, Orlando, Florida, United States|Triple O Research Institute /ID# 228612, West Palm Beach, Florida, United States|University of Illinois Hospital and Health Sciences System /ID# 224323, Chicago, Illinois, United States|Pikeville Medical Center /ID# 224539, Pikeville, Kentucky, United States|Saint Peter's University Hospital /ID# 225183, New Brunswick, New Jersey, United States|Saint Michael's Medical Center /ID# 225258, Newark, New Jersey, United States|The Christ Hospital /ID# 224541, Cincinnati, Ohio, United States|Prisma Health Upstate /ID# 224556, Greenville, South Carolina, United States|Gadolin Research, LLC /ID# 229394, Beaumont, Texas, United States|Budai Irgalmasrendi Korhaz /ID# 226015, Budapest, Hungary|Semmelweis Egyetem /ID# 226016, Budapest, Hungary|Hadassah Medical Center /ID# 225827, Jerusalem, Yerushalayim, Israel|Sheba Medical Center /ID# 225857, Tel Hashomer, Ramat Gan, Israel|Universitair Medisch Centrum Utrecht /ID# 225919, Utrecht, Netherlands|San Juan Bautista School of Medicine /ID# 225963, Caguas, Puerto Rico|Manati Medical Center /ID# 225936, Manati, Puerto Rico",https://ClinicalTrials.gov/show/NCT04644120
NCT04904549,Study of Monovalent and Bivalent Recombinant Protein Vaccines Against COVID-19 in Adults 18 Years of Age and Older,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",VAT00008|U1111-1264-3238,"Investigational Site Number 8400004, Birmingham, Alabama, United States|Investigational Site Number 8400019, Huntsville, Alabama, United States|Investigational Site Number 8400021, Rolling Hills Estates, California, United States|Investigational Site Number 8400013, Centennial, Colorado, United States|Investigational Site Number 8400002, Melbourne, Florida, United States|Investigational Site Number 8400020, Orlando, Florida, United States|Investigational Site Number 8400017, Pinellas Park, Florida, United States|Investigational Site Number 8400005, Atlanta, Georgia, United States|Investigational Site Number 8400024, Decatur, Georgia, United States|Investigational Site Number 8400012, Chicago, Illinois, United States|Investigational Site Number 8400026, Chicago, Illinois, United States|Investigational Site Number 8400008, Evansville, Indiana, United States|Investigational Site Number 8400006, Saint Louis, Missouri, United States|Investigational Site Number 8400018, Henderson, Nevada, United States|Investigational Site Number 8400023, Rochester, New York, United States|Investigational Site Number 8400009, Akron, Ohio, United States|Investigational Site Number 8400010, Cincinnati, Ohio, United States|Investigational Site Number 8400011, Columbus, Ohio, United States|Investigational Site Number 8400007, Anderson, South Carolina, United States|Investigational Site Number 8400022, Mount Pleasant, South Carolina, United States|Investigational Site Number 8400025, Rapid City, South Dakota, United States|Investigational Site Number 8400003, Austin, Texas, United States|Investigational Site Number 8400014, Dallas, Texas, United States|Investigational Site Number 8400015, San Antonio, Texas, United States|Investigational Site Number 8400016, Murray, Utah, United States|Investigational Site Number 1700002, Barranquilla, Colombia|Investigational Site Number 1700005, Cali, Colombia|Investigational Site Number 1700006, Chía, Colombia|Investigational Site Number 1700004, Floridablanca, Colombia|Investigational Site Number 1700003, Soledad, Colombia|Investigational Site Number 3400001, Municipio Del Distrito Central, Honduras|Investigational Site Number 3400002, San Pedro Sula, Honduras|Investigational Site Number 3920005, Chiyoda-Ku, Japan|Investigational Site Number 3920004, Haramachi,Shinjuku-Ku, Japan|Investigational Site Number 3920003, Kouenji Minami,Suginami-Ku, Japan|Investigational Site Number 3920001, Kyobashi Chuo-Ku, Japan|Investigational Site Number 3920002, Ohta-Ku, Japan",https://ClinicalTrials.gov/show/NCT04904549
NCT04720612,COVID-19 Immunologic Antiviral Therapy With Omalizumab,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",CIAO (2021-7500),"Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada",https://ClinicalTrials.gov/show/NCT04720612
NCT04409522,Evaluation of Therapeutic Effects of Melatonin by Inhibition of NLRP3 Inflammasome in COVID19 Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment",IR.BMSU.REC.1399.039,"Mohammad Sadegh Bagheri Baghdasht, Tehran, Iran, Islamic Republic of",https://ClinicalTrials.gov/show/NCT04409522
NCT04360980,The Effects of Standard Protocol With or Without Colchicine in Covid-19 Infection,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",SBMU.IR.REC.165423,"SBMU, Tehran, Iran, Islamic Republic of|Nooshin Dalili, Tehran, Iran, Islamic Republic of",https://ClinicalTrials.gov/show/NCT04360980
NCT04611256,Mesenchymal Stem Cells in Patients Diagnosed With COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,060I.2020,"Hospital Regional Lic Adolfo Lopez Mateos, Mexico City, Ciudad De Mexico CDMX (Mexico City), Mexico",https://ClinicalTrials.gov/show/NCT04611256
NCT03891420,"A Study to Evaluate the Safety, Pharmacokinetics and Antiviral Effects of Galidesivir in Yellow Fever or COVID-19","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",BCX4430-108|272201300017C-18-0-1|DMID18-0022,"Hospital de Clinicas da Universidade Federal do Parana, Curitiba, Parana, Brazil|Hospital Sao Vicente de Paulo-PPDS, Passo Fundo, Rio Grande Do Sul, Brazil|Hospital Sao Lucas da Pucrs, Porto Alegre, Rio Grande Do Sul, Brazil|Foundation Regional Faculty of Medicine of São José do Rio Preto, São José Do Rio Preto, SP, Brazil|Clinical Research Unit and Department of Infectious and Parasitic Diseases Hospital das Clínicas, School of Medicine, USP, São Paulo, SP, Brazil",https://ClinicalTrials.gov/show/NCT03891420
NCT04331106,Survey of the Anxiety Associated With the COVID-19 Pandemic,Observational Model: Cohort|Time Perspective: Prospective,EA1/071/20,"Charité-Universitätsmedizin Berlin - Department of Psychiatry and Psychotherapy, Berlin, Germany",https://ClinicalTrials.gov/show/NCT04331106
NCT04519424,CSL324 in COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",CSL324_COVID-19,NA,https://ClinicalTrials.gov/show/NCT04519424
NCT04363060,Azithromycin+Amoxicillin/Clavulanate vs Amoxicillin/Clavulanate in COVID19 Patients With Pneumonia in Non-intensive Unit,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,RC20_0168,"Chu Angers, Angers, France|CHD Vendée, La Roche-sur-Yon, France|CHU Poitiers, Poitiers, France",https://ClinicalTrials.gov/show/NCT04363060
NCT04694651,Potential Acceptance of COVID-19 Vaccines in Healthcare Workers in Egypt,Observational Model: Cohort|Time Perspective: Prospective,AssiutU18,"AssiutU, Assiut, Egypt|Aliae AR Mohamed-Hussein, Assiut, Egypt",https://ClinicalTrials.gov/show/NCT04694651
NCT04336774,CAPTION AI to Minimize Risk of COVID Exposure,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,pro00105212,"Duke Health, Durham, North Carolina, United States|Duke University Medical Center, Durham, North Carolina, United States",https://ClinicalTrials.gov/show/NCT04336774
NCT04492904,Singapore COVID-19 Chemosensory Tracking (SCCT) Study,Observational Model: Case-Control|Time Perspective: Other,2020/00810,"Clinical Nutrition Research Centre, Singapore, Singapore, Singapore",https://ClinicalTrials.gov/show/NCT04492904
NCT04393246,mulTi-Arm Therapeutic Study in Pre-ICu Patients Admitted With Covid-19 - Experimental Drugs and Mechanisms,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,TACTIC-E,"Cambridge University Hospitals NHS Foundation Trust, Cambridge, Cambridgeshire, United Kingdom",https://ClinicalTrials.gov/show/NCT04393246
NCT04426253,"Identification of Genetic Factors Determining Disease Course in the New Type of Coronavirus Infection, COVID-19",Observational Model: Case-Only|Time Perspective: Prospective,COVID19_HUNGEN_001,"University of Pécs 1st Department of Internal Medicine Intensive Care Unit, Pécs, Hungary|University of Pécs First Department of Internal Medicine, Pécs, Hungary|University of Pécs Infection Department of the Coronavirus Center, Pécs, Hungary|University of Pécs Institute of Laboratory Medicine, Pécs, Hungary|University of Pécs Szentágotahi Research Centre, Pécs, Hungary|University of Pécs Szentágothai Research Centre Genomics and Bioinformatics Core Facility, Pécs, Hungary|University of Szeged Szentágothai Research Centre Virology Research Group, Pécs, Hungary|University of Szeged Department of Anaesthesiology And Inthensive Therapy, Szeged, Hungary|University of Szeged Department of Dermatology and Allergology, Szeged, Hungary|University of Szeged Department of Medical Biology, Szeged, Hungary|University of Szeged Department of Paediatrics, Szeged, Hungary|University of Szeged First Department of Medicine, Szeged, Hungary|University of Szeged Institute of Clinical Microbiology, Szeged, Hungary|University of Szeged Institute of Medical Microbiology and Immunobiology, Szeged, Hungary",https://ClinicalTrials.gov/show/NCT04426253
NCT04516512,Assessment of SARS-CoV-2 Seroprevalence in Detention,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Screening,APHP200667,NA,https://ClinicalTrials.gov/show/NCT04516512
NCT04688372,Hospital COVID-19 Surge and Associated Mortality Risk,Observational Model: Cohort|Time Perspective: Retrospective,BD022386,"National Institutes of Health Clinical Center (primary center conducting large database study), Bethesda, Maryland, United States",https://ClinicalTrials.gov/show/NCT04688372
NCT04811456,MultiOrgan Inflammatory Syndromes COVID-19 Related Study,Observational Model: Case-Only|Time Perspective: Cross-Sectional,MOIS-CoR,"Medical University of Warsaw Children's Hospital, Warsaw, Poland|Wroclaw Medical University, Wrocław, Poland",https://ClinicalTrials.gov/show/NCT04811456
NCT04649658,Pronation in COVID-19 Patients Undergoing Non Invasive Respiratory Support,Observational Model: Cohort|Time Perspective: Retrospective,UModenaReggio10,"Azienda Ospedaliero Universitaria Policlinico di Modena, Modena, Italy",https://ClinicalTrials.gov/show/NCT04649658
NCT04694716,Determination of Serum Trace Element and Physical Activity Levels in COVID-19,Observational Model: Cohort|Time Perspective: Prospective,2020-12-141,"Kadirhan Ozdemir, İzmir, Turkey",https://ClinicalTrials.gov/show/NCT04694716
NCT04403581,"Egyptian Doctors Stresses, Knowledge and Attitude During COVID-19 Pandemic",Observational Model: Cohort|Time Perspective: Cross-Sectional,Egyptian doctors in COVID-19,NA,https://ClinicalTrials.gov/show/NCT04403581
NCT04470531,Role of Co-trimoxazole in Severe COVID-19 Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,BSMMU/2020/6969,"Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh",https://ClinicalTrials.gov/show/NCT04470531
NCT04365816,NutriCovid30 : Nutritional Evaluation for Covid-19 Infection at D30,Observational Model: Cohort|Time Perspective: Prospective,2020-A01120-39,"Marie-France VAILLANT, Grenoble, France",https://ClinicalTrials.gov/show/NCT04365816
NCT04828564,Efficacy and Safety of Favipiravir and Ribavirin Formulation for Treatment of COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,MON775.159.4,"Ankara University, School of Medicine, Ankara, Cebeci, Turkey|Ankara City Hospital, Ankara, Turkey|Koc University Hospital, Istanbul, Turkey|Umraniye Training and Research Hospital, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04828564
NCT04979195,Acute Kidney Injury Among COVID-19 Positive Patients,Observational Model: Case-Control|Time Perspective: Prospective,2020/1467,"Osama Gheith, Kuwait, AZ, Kuwait|Osama Gheith, Kuwait, Rf, Kuwait",https://ClinicalTrials.gov/show/NCT04979195
NCT04573153,Metabolic Cofactor Supplementation and Hydroxychloroquine Combination in Covid-19 Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,COVID-19-MCS,"University of Health Sciences Istanbul Ümraniye Training and Research Hospital, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04573153
NCT04379271,"A Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 as Addition to Investigator's Choice of Standard of Care Therapy, in Patients With Coronavirus Disease 19 (COVID-19)","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",P2-IMU-838-COV,"Military Medical Academy, Clinic of Infectious Diseases, Sofia, Bulgaria|UMHATEM N.I.Pirogov, Clinic of internal diseases, Sofia, Bulgaria|University Hospital Frankfurt, Infectious Diseases, Frankfurt, Germany|Clinic of the Hannover Medical School, Pneumology Clinic, Hannover, Germany",https://ClinicalTrials.gov/show/NCT04379271
NCT04785144,Safety and Immunogenicity Study of a SARS-CoV-2 (COVID-19) Variant Vaccine (mRNA-1273.351) in Naïve and Previously Vaccinated Adults,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,21-0002,"Emory Vaccine Center - The Hope Clinic, Decatur, Georgia, United States|Cincinnati Children's Hospital Medical Center - Infectious Diseases, Cincinnati, Ohio, United States|Vanderbilt University - Pediatric - Vanderbilt Vaccine Research Center, Nashville, Tennessee, United States|Kaiser Permanente Washington Health Research Institute - Vaccines and Infectious Diseases, Seattle, Washington, United States",https://ClinicalTrials.gov/show/NCT04785144
NCT04486001,Study of Intravenous Administration of Allogeneic Adipose Stem Cells for COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,PSC-CP-004,"Fresno Community Hospital, Fresno, California, United States",https://ClinicalTrials.gov/show/NCT04486001
NCT04380532,Tableted COVID-19 Therapeutic Vaccine,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,Imm24,"Immunitor Inc, Vancouver, BC - British Columbia, Canada|Aldar Bourinbayar, Ulaanbaatar, BZD, 3-khoroo, Mongolia",https://ClinicalTrials.gov/show/NCT04380532
NCT04364802,COVID-19: Povidone-Iodine Intranasal Prophylaxis in Front-line Healthcare Personnel and Inpatients,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,58748,"University of Kentucky, Lexington, Kentucky, United States",https://ClinicalTrials.gov/show/NCT04364802
NCT04610502,Efficacy and Safety of Two Hyperimmune Equine Anti Sars-CoV-2 Serum in COVID-19 Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",R020-SABI-00259,"Centro Especializado de Atención COVID19 (CEACO), San José, Costa Rica|Hospital Dr. Rafael Ángel Calderón Guardia, San José, Costa Rica|Hospital México, San José, Costa Rica|Hospital San Juan de Dios, San José, Costa Rica",https://ClinicalTrials.gov/show/NCT04610502
NCT04393805,Heparins for Thromboprophylaxis in COVID-19 Patients: HETHICO Study in Veneto,Observational Model: Cohort|Time Perspective: Retrospective,HETHICO,"Giuseppe Camporese, Padova, Italy",https://ClinicalTrials.gov/show/NCT04393805
NCT04346628,Oral Favipiravir Compared to Placebo in Subjects With Mild COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",56032,"Stanford University, Stanford, California, United States",https://ClinicalTrials.gov/show/NCT04346628
NCT04374513,Community Pharmacists Behaviour During Covid-19,Observational Model: Other|Time Perspective: Prospective,Pharmacists and covid-19,"Damanhour university, Beheira, Damanhour, Egypt|Damanhour universty, Alexandria, Egypt",https://ClinicalTrials.gov/show/NCT04374513
NCT04283461,Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for Prophylaxis of SARS-CoV-2 Infection (COVID-19),Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,20-0003|5UM1AI148684-02,"Emory Vaccine Center - The Hope Clinic, Decatur, Georgia, United States|National Institutes of Health - Clinical Center - Vaccine Research Center Clinical Trials Program, Bethesda, Maryland, United States|Kaiser Permanente Washington Health Research Institute - Vaccines and Infectious Diseases, Seattle, Washington, United States",https://ClinicalTrials.gov/show/NCT04283461
NCT04928456,Augmentation of Immune Response to COVID-19 mRNA Vaccination Through OMT With Lymphatic Pumps,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Care Provider, Investigator)|Primary Purpose: Prevention",FB21/IRB026,"Western University of Health Sciences, Pomona, California, United States",https://ClinicalTrials.gov/show/NCT04928456
NCT04858425,Safety and Efficacy of Niclosamide in Patients With COVID-19 With Gastrointestinal Infection,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",AZ-NICL-COV-1,"Physicians Research Group II, LLC, Tempe, Arizona, United States|Synergy Healthcare, Bradenton, Florida, United States|Midland Florida Clinical Research Center, LLC, DeLand, Florida, United States|Lakes Research -ClinEdge - PPDS, Miami Lakes, Florida, United States|LCC Medical Reserach Institute, LLC, Miami, Florida, United States|P & S Research, LLC, Miami, Florida, United States|Snake River Research, PLLC, Idaho Falls, Idaho, United States|SMS Clinical Research LLC, Mesquite, Texas, United States|Tranquil Research, Webster, Texas, United States",https://ClinicalTrials.gov/show/NCT04858425
NCT04706039,Rapid Diagnosis of COVID-19 by Chemical Analysis of Exhaled Air,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,69HCL20_1148,"Centre de prélèvement COVID-19 HCL et Métropole de Lyon, Lyon, France",https://ClinicalTrials.gov/show/NCT04706039
NCT04460170,COVID-19 Follow up Intensive Care Studies,Observational Model: Cohort|Time Perspective: Prospective,COFICS201800422,"University Medical Center Groningen, Groningen, Netherlands",https://ClinicalTrials.gov/show/NCT04460170
NCT04521296,Efficacy and Safety of DWJ1248 in Patients With Mild to Moderate COVID-19 Compared to the Placebo,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",DW_DWJ1248201,NA,https://ClinicalTrials.gov/show/NCT04521296
NCT04349241,Efficacy and Safety of Favipiravir in Management of COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,FMASU P14 / 2020,"Faculty of Medicine Ain Shams University Research Institute- Clinical Research Center, Cairo, Non-US, Egypt",https://ClinicalTrials.gov/show/NCT04349241
NCT04816669,"Study to Evaluate the Safety, Tolerability, and Immunogenicity of Multiple Formulations of BNT162b2 Against COVID-19 in Healthy Adults","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention",C4591020,"Anaheim Clinical Trials, LLC, Anaheim, California, United States|Diablo Clinical Research, Inc., Walnut Creek, California, United States|Indago Research & Health Center, Inc, Hialeah, Florida, United States|Research Centers of America ( Hollywood ), Hollywood, Florida, United States|Clinical Neuroscience Solutions, Inc. dba CNS Healthcare, Jacksonville, Florida, United States|Clinical Neuroscience Solutions, Orlando, Florida, United States|Clinical Research Atlanta, Stockbridge, Georgia, United States|East-West Medical Research Institute, Honolulu, Hawaii, United States|Solaris Clinical Research, Meridian, Idaho, United States|Kentucky Pediatric/ Adult Research, Bardstown, Kentucky, United States|Meridian Clinical Research, LLC, Omaha, Nebraska, United States|Amici Clinical Research LLC, Raritan, New Jersey, United States|PMG Research of Wilmington, LLC, Wilmington, North Carolina, United States|Aventiv Research Inc, Columbus, Ohio, United States|Benchmark Research, Austin, Texas, United States|University of Texas Medical Branch, Galveston, Texas, United States|Texas Center For Drug Development, Inc., Houston, Texas, United States|DM Clinical Research (Administrative and Storage Office only), Tomball, Texas, United States|Martin Diagnostic Clinic, Tomball, Texas, United States|J. Lewis Research, Inc. / Foothill Family Clinic, Salt Lake City, Utah, United States|J. Lewis Research, Inc. / Foothill Family Clinic South, Salt Lake City, Utah, United States",https://ClinicalTrials.gov/show/NCT04816669
NCT04896853,Treatment of Respiratory Complications Associated With COVID-19 Infection Using ProTrans®,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,PRO TRANS 19+|2020-002078-29,"Department of Cardiology, Respiratory medicine and Physiology, Örebro University Hospital, Örebro, Sweden",https://ClinicalTrials.gov/show/NCT04896853
NCT04779424,Prevalence and Incidence of Antibodies Against SARS-CoV-2 Among Primary Healthcare Providers in Belgium (COVID-19),Observational Model: Cohort|Time Perspective: Prospective,OZ8478,"Niels Adriaenssens, Wilrijk, Antwerp, Belgium",https://ClinicalTrials.gov/show/NCT04779424
NCT04371510,Blood Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Chronic Haemodialysis Patients,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,20-PP-08,"CHU de nice, Nice, Alpes-Maritimes, France",https://ClinicalTrials.gov/show/NCT04371510
NCT04358068,Evaluating the Efficacy of Hydroxychloroquine and Azithromycin to Prevent Hospitalization or Death in Persons With COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",ACTG A5395|38720,"Alabama CRS, Birmingham, Alabama, United States|UCSD Antiviral Research Center CRS, San Diego, California, United States|Harbor-UCLA CRS, Torrance, California, United States|Whitman-Walker Health CRS, Washington, District of Columbia, United States|Northwestern University CRS, Chicago, Illinois, United States|Rush University CRS, Chicago, Illinois, United States|Greensboro CRS, Greensboro, North Carolina, United States|Cincinnati Clinical Research Site, Cincinnati, Ohio, United States|University of Pittsburgh CRS, Pittsburgh, Pennsylvania, United States|Trinity Health and Wellness Center CRS, Dallas, Texas, United States|University of Washington AIDS CRS, Seattle, Washington, United States",https://ClinicalTrials.gov/show/NCT04358068
NCT04568135,A Survey Study to Assess the Impact of the COVID-19 Pandemic on Participants With Pre-Existing Mental Health Diagnosis,Observational Model: Other|Time Perspective: Prospective,SCR-SUR-001,NA,https://ClinicalTrials.gov/show/NCT04568135
NCT04446065,Previfenon® as Chemoprophylaxis of COVID-19 in Health Workers,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",MEL109042020,NA,https://ClinicalTrials.gov/show/NCT04446065
NCT04680949,suPAR-Guided Anakinra Treatment for Management of Severe Respiratory Failure by COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",SAVE-MORE,"2nd Department of Internal Medicine, University General Hospital of Alexandroupolis, Alexandroupolis, Greece|10th Department of Pulmonary Medicine, SOTIRIA General Hospital of Chest Diseases of Athens, Athens, Greece|1st Department of Internal Medicine, AMALIA FLEMING Prefecture General Hospital of Melissia, Athens, Greece|1st Department of Internal Medicine, General Hospital of Athens KORGIALENIO-BENAKIO E.E.S., Athens, Greece|1st Department of Internal Medicine, General Hospital of Eleusis THRIASIO, Athens, Greece|1st Department of Internal Medicine, General Hospital of Nea Ionia CONSTANTOPOULIO-PATISION, Athens, Greece|1st Department of Internal Medicine, General Hospital of Voula ASKLEPIEIO, Athens, Greece|1st University Department of Internal Medicine, General Hospital of Athens LAIKO, Athens, Greece|1st University Department of Pulmonary Medicine, SOTIRIA General Hospital of Chest Diseases of Athens, Athens, Greece|2nd Department of Internal Medicine, General Hospital of Eleusis THRIASIO, Athens, Greece|2nd Department of Pulmonary Medicine, SOTIRIA General Hospital of Chest Diseases of Athens, Athens, Greece|2nd University Department of Internal Medicine, IPPOKRATEION General Hospital of Athens, Athens, Greece|3rd Department of Internal Medicine, General Hospital of Athens KORGIALENEIO-BENAKEIO E.E.S., Athens, Greece|3rd University Department of Internal Medicine, General Hospital of Chest Diseases of Athens SOTIRIA, Athens, Greece|4th Department of Internal Medicine, ATTIKON University General Hospital, Athens, Greece|4th Department of Pulmonary Medicine, SOTIRIA General Hospital of Chest Diseases of Athens, Athens, Greece|5th Department of Pulmonary Medicine, SOTIRIA General Hospital of Chest Diseases of Athens, Athens, Greece|COVID-19 Department, General Hospital of Attica SISMANOGLEIO-AMALIA FLEMING, Athens, Greece|Department of Clinical Therapeutics, ALEXANDRA General Hospital of Athens, Athens, Greece|Department of COVID-19, Evangelismos General Hospital, Athens, Greece|Department of Internal Medicine, General Hospital of Athens Elpis, Athens, Greece|• 1st Department of Internal Medicine, General Hospital of Athens G. GENNIMATAS, Athens, Greece|• Department of Internal Medicine, General Hospital of Chest Diseases of Athens SOTIRIA, Athens, Greece|Department of Pulmonary Medicine, General Hospital of Kerkyra, Corfu, Greece|1st Department of Internal Medicine, General University Hospital of Ioannina, Ioánnina, Greece|Department of Internal Medicine, University General Hospital of Larissa,, Larissa, Greece|Department of Internal Medicine, University General Hospital of Patras PANAGIA I VOITHIA, Patra, Greece|2nd Department of Internal Medicine, General Hospital of Piraeus TZANEIO, Piraeus, Greece|1st Department of Internal Medicine, AHEPA University General Hospital of Thessaloniki, Thessaloníki, Greece|1st Department of Internal Medicine, PAPAGEORGIOU General Hospital of Thessaloniki, Thessaloníki, Greece|2nd Department of Propedeutic Medicine, Ippokrateion University General Hospital of Thessaloniki, Thessaloníki, Greece|3rd University Department of Internal Medicine, PAPAGEORGIOU General Hospital of Thessaloniki, Thessaloníki, Greece|Dipartimento di Medicina Dipartimento di Malattie Infettive, ASST Spedali civili, Brescia, Italy|Unità Operativa Clinica Malattie Infettive, Ospedale Policlinico San Martino, Genova, Italy|Dipartimento di Medicina Interna, Istituto Clinico Humanitas, Milano, Italy|Medicina Interna, Reumatologia, Immunologia, IRCCS San Raffaele, Milano, Italy|Dipartimento di Malattie Infettive e Tropicali e Microbiologia, IRCCS Ospedale Sacro Cuore Don Calabria, Negrar, Italy|Dipartimento di Malattie Infettive ad alta Intensità di cura ed altamente contagiose, IRCCS Lazzaro Spallanzani, Roma, Italy|Dipartimento Scienze di laboratorio e infettivologiche, Policlinico Universitario Agostino Gemelli, Roma, Italy|Dipartimento di Malattie infettive e tropicali-Università dell'Insubria, ASST dei Sette Laghi, Varese, Italy",https://ClinicalTrials.gov/show/NCT04680949
NCT04363541,Local Thermotherapy for Patients With Mild-to-moderate COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,U1111-1250-7416,"Hospital Dr. Ángel Leaño, Guadalajara, Jalisco, Mexico|Hospital Regional de Alta Especialidad ""Dr. Juan Graham Casasus"", Villahermosa, Tabasco, Mexico|Unidad Temporal Movil COVID-19 Autódromo Hermanos Rodríguez IMSS, Mexico City, Mexico",https://ClinicalTrials.gov/show/NCT04363541
NCT04664023,"Description of Immunologic, Enzymatic and Metabolic Biomarkers Associated to the Severity of COVID-19 (SARS-CoV-2) and Its Resolution",Observational Model: Cohort|Time Perspective: Prospective,BIOMARK-COVID,"C.H.U.de Poitiers, Poitiers, France",https://ClinicalTrials.gov/show/NCT04664023
NCT04779879,"Safety, Tolerability and Pharmacokinetics of Second Generation VIR-7831 Material in Non-hospitalized Participants With Mild to Moderate COVID-19",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,VIR-7831-5006|GSK Study 216912,"Investigative Site, Anniston, Alabama, United States|Investigative Site, Bakersfield, California, United States|Investigative Site, Northridge, California, United States|Investigative Site, Sacramento, California, United States|Investigative Site, Stratford, Connecticut, United States|Investigative Site, Fort Pierce, Florida, United States|Investigative Site, Gainesville, Florida, United States|Investigative Site, Hialeah, Florida, United States|Investigative Site, Miami, Florida, United States|Investigative Site, Miami, Florida, United States|Investigative Site, Miami, Florida, United States|Investigative Site, Miami, Florida, United States|Investigative Site, Orlando, Florida, United States|Investigative Site, Pembroke Pines, Florida, United States|Investigative Site, Tampa, Florida, United States|Investigative Site, Columbus, Georgia, United States|Investigative Site, Winfield, Illinois, United States|Investigative Site, Annapolis, Maryland, United States|Investigative Site, Rockville, Maryland, United States|Investigative Site, Bronx, New York, United States|Investigative Site, Smithfield, Pennsylvania, United States|Investigative Site, Houston, Texas, United States|Investigative Site, Houston, Texas, United States|Investigative Site, Sarnia, Ontario, Canada|Investigative Site, Toronto, Ontario, Canada|Investigative Site, Milano, Italy|Investigative Site, Milano, Italy|Investigative Site, Roma, Italy|Investigative Site, Verona, Italy|Investigative Site, Daejeon, Korea, Republic of|Investigative Site, Gwangju, Korea, Republic of|Investigative Site, Gwangju, Korea, Republic of|Investigative Site, Alicante, Spain|Investigative Site, Barcelona, Spain|Investigative Site, Centelles, Spain|Investigative Site, Granada, Spain|Investigative Site, La Roca Del Vallès, Spain|Investigative Site, Madrid, Spain|Investigative Site, Madrid, Spain|Investigative Site, Pozuelo De Alarcón, Spain|Investigative Site, Vigo, Spain",https://ClinicalTrials.gov/show/NCT04779879
NCT04333472,Piclidenoson for Treatment of COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",CF101-241COVID-19,"Hadassah Medical Center, Jerusalem, Israel|Shaare Zedek Medical Center, Jerusalem, Israel",https://ClinicalTrials.gov/show/NCT04333472
NCT04471051,An Observational Cohort Trial of Outcomes and Antibody Responses Following Treatment With COVID19 Convalescent Plasma in Hospitalized COVID-19 Patients,Observational Model: Cohort|Time Perspective: Prospective,20-0986,"Children's Hospital Colorado, Aurora, Colorado, United States|University of Colorado Hospital, Aurora, Colorado, United States|UCHealth Memorial Hospital North, Colorado Springs, Colorado, United States|Denver Health Medical Center, Denver, Colorado, United States|UCHealth Poudre Valley Hospital, Fort Collins, Colorado, United States|UCHealth Highlands Ranch Hospital, Highlands Ranch, Colorado, United States",https://ClinicalTrials.gov/show/NCT04471051
NCT04559100,Long-term Characterization of Patients With Severe/Critical Infection by COVID-19 Virus,Observational Model: Other|Time Perspective: Prospective,1631 COVID-LFT,"Fundacion Valle del Lili, Cali, Valle Del Cauca, Colombia",https://ClinicalTrials.gov/show/NCT04559100
NCT04423003,Endoscopic Interventions in Patients With COVID-19,Observational Model: Cohort|Time Perspective: Prospective,242/2020BO2,"University Hospital of Tuebingen, Tuebingen, Germany",https://ClinicalTrials.gov/show/NCT04423003
NCT04394208,Silymarin in COVID-19 Pneumonia,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment",CairoU COVID-19 Study Group,"Cairo University, Giza, Cairo, Egypt",https://ClinicalTrials.gov/show/NCT04394208
NCT04412668,Study to Evaluate the Safety and Efficacy of ATYR1923 In Patients With Severe Pneumonia Related to COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",ATYR1923-C-003,"University of Alabama at Birmingham, Birmingham, Alabama, United States|aTyr Investigative Site, Washington, District of Columbia, United States|University of Miami, Miami, Florida, United States|University of Iowa, Iowa City, Iowa, United States|Anne Arundel Medical Center, Annapolis, Maryland, United States|aTyr Investigative Site, Vineland, New Jersey, United States|aTyr Investigative Site, Toledo, Ohio, United States|Inova Fairfax Medical Campus, Falls Church, Virginia, United States|Alliance Medical Service, Cardio Pulmonary Research, Guaynabo, Puerto Rico|Manati Medical Center, Manatí, Puerto Rico",https://ClinicalTrials.gov/show/NCT04412668
NCT04323345,Efficacy of Natural Honey Treatment in Patients With Novel Coronavirus,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Treatment,MUST23032020,"Mahmoud Tantawy, Cairo, Egypt",https://ClinicalTrials.gov/show/NCT04323345
NCT04384250,Genetic Basis of COVID-19 Infection,Observational Model: Case-Only|Time Perspective: Prospective,RP:20.05.70,"Mansoura University, Mansoura, Dakahlyia, Egypt",https://ClinicalTrials.gov/show/NCT04384250
NCT04477655,Prone Positioning in Non-intubated Patients With COVID-19 Associated Acute Respiratory Failure,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,048/20,"Hospital Civil Fray Antonio Alcalde, Guadalajara, Jalisco, Mexico|Hospital General de Occidente, Guadalajara, Jalisco, Mexico",https://ClinicalTrials.gov/show/NCT04477655
NCT04956445,Collection of SARS CoV-2 (COVID-19) Virus Secretions and Serum for Countermeasure Development,Observational Model: Cohort|Time Perspective: Prospective,2020-396,"Tulane University Medical Center, New Orleans, Louisiana, United States|University Medical Center New Orleans, New Orleans, Louisiana, United States",https://ClinicalTrials.gov/show/NCT04956445
NCT04718506,Rehabilitation for Post-COVID-19 Syndrome Through a Supervised Exercise Intervention,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment",3036/2020,"Faculty of Sport Sciences, Murcia, San Javier, Spain",https://ClinicalTrials.gov/show/NCT04718506
NCT04669015,Phase 3 Inhaled Novaferon Study in Hospitalized Patients With Moderate to Severe COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",JH-COR-003,"Casa De Saude, Campinas, Brazil|Hospital Base Osorno, Osorno, Chile|Hospital Sotero del Rio, Santiago, Chile|Fundacion Cardiovascular de Colombia - Instituto del Carazon Floridablanco, Floridablanca, Santander, Colombia",https://ClinicalTrials.gov/show/NCT04669015
NCT04651374,COVID-19 And Geko Evaluation: The CAGE Study,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,ISS-COV-002,"London Health Sciences Centre, London, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04651374
NCT04330521,Impact of the Coronavirus (COVID-19) on Patients With Cancer,Observational Model: Cohort|Time Perspective: Retrospective,55596,"Stanford University School of Medicine, Stanford, California, United States",https://ClinicalTrials.gov/show/NCT04330521
NCT04366180,Evaluation of the Probiotic Lactobacillus Coryniformis K8 on COVID-19 Prevention in Healthcare Workers,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",P054,"Raquel Rodriguez Blanque, Granada, Spain",https://ClinicalTrials.gov/show/NCT04366180
NCT04863638,"A Immuno-bridging and Immunization Schedules Study of COVID-19 Vaccine (Vero Cell), Inactivated",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,BIBP2020004CN,"Yanjin County Center for Disease Control and Prevention, Xinxiang, Henan, China",https://ClinicalTrials.gov/show/NCT04863638
NCT04679428,Immunological Characteristics of COVID-19 Patients,Observational Model: Case-Only|Time Perspective: Prospective,Golnik_Covid-19,"University Clinic of Respiratory and Allergic Diseases Golnik, Golnik, Slovenia",https://ClinicalTrials.gov/show/NCT04679428
NCT04548908,Prevalence Of COVID-19 Among Health-workers in a French General Hospital,Observational Model: Cohort|Time Perspective: Prospective,POCAH-COVID19,"Centre Hospitalier Sud Essonne, Etampes, France",https://ClinicalTrials.gov/show/NCT04548908
NCT04347889,Preventing COVID-19 in Healthcare Workers With HCQ: A RCT,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention,IRB2020-00222,NA,https://ClinicalTrials.gov/show/NCT04347889
NCT04476706,Canakinumab MAP in COVID-19 Pneumonia With CRS,NA,CACZ885D2001M,NA,https://ClinicalTrials.gov/show/NCT04476706
NCT04844580,A Clinical Study Evaluating Inhaled Aviptadil on COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",K-AY001-HOPE,"Başkent University School of Medicine, Ankara, Turkey|Hacettepe University School of Medicine, Ankara, Turkey|Health Sciences University Yedikule Training and Research Hospital, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04844580
NCT04678739,Efficacy and Safety of Remdesivir and Tociluzumab for the Management of Severe COVID-19: A Randomized Controlled Trial,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,M.A.R.M.C.D./2020/1985,"Chattogram General Hospital, Chittagong, Bangladesh|Cox's Bazar 250 Bed District Sadar Hospital, Cox's Bazar, Bangladesh|M. Abdur Rahim Medical College Hospital, Dinajpur, Bangladesh|M. Abdur Rahim Medical College Hospital, Dinajpur, Bangladesh",https://ClinicalTrials.gov/show/NCT04678739
NCT04830735,Dasatinib for the Treatment of Moderate and Severe COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",0S-20-5|NCI-2020-04367|P30CA014089,"USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States",https://ClinicalTrials.gov/show/NCT04830735
NCT04712357,Clinical Experimentation With Tenofovir Disoproxyl Fumarate and Emtricitabine for COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",CAAE: 34182620.0.0000.5045,"Núcleo de Biomedicina - NUBIMED, Fortaleza, Ceará, Brazil",https://ClinicalTrials.gov/show/NCT04712357
NCT04867161,Superinfection and Hyperinflammatory Phenotype in COVID-19 (Coronavirus Disease 2019) Pneumonia Patients,Observational Model: Cohort|Time Perspective: Prospective,146/20,"University Hospital Brno, Brno, Czechia",https://ClinicalTrials.gov/show/NCT04867161
NCT04424446,Saliva as Source of Detection for SARS-CoV-2,Observational Model: Case-Only|Time Perspective: Cross-Sectional,200128|20-CC-0128,"Washington Hospital Center, Washington, District of Columbia, United States|National Institutes of Health Clinical Center, Bethesda, Maryland, United States",https://ClinicalTrials.gov/show/NCT04424446
NCT04779775,Best Practices in Perinatal Mental Health During COVID-19,Observational Model: Other|Time Perspective: Cross-Sectional,RISEUP-PPD-DEVOTION- COVID-19,NA,https://ClinicalTrials.gov/show/NCT04779775
NCT04750330,Mitochondrial DNA and Nuclear SNPs to Predict Severity of COVID-19 Infection,Observational Model: Case-Control|Time Perspective: Retrospective,COVIDmtDNA1.0,"Centre Hospitalier Universitaire de Liège, Liège, Wallonie, Belgium|Regional Chest Diseases Hospital of Athens <Sotiria>, Athens, Greece|University of Florence, Firenze, Italy",https://ClinicalTrials.gov/show/NCT04750330
NCT04437875,"An Open Study of the Safety, Tolerability and Immunogenicity of ""Gam-COVID-Vac Lyo"" Vaccine Against COVID-19",Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,03-Gam-COVID-Vac Lyo-2020,"Sechenov First Moscow State Medical University, Moscow, Russian Federation",https://ClinicalTrials.gov/show/NCT04437875
NCT04922788,"Study to Evaluate the Safety, Immunogenicity, and Efficacy of Nanocovax Vaccine Against COVID-19","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",NNG27,"Military Medical Academy, Hanoi, Vietnam",https://ClinicalTrials.gov/show/NCT04922788
NCT04386044,Investigating the Role of Vitamin D in the Morbidity of COVID-19 Patients,Observational Model: Other|Time Perspective: Other,TGH1234,"Tameside Hospital NHS Foundation Trust, Ashton-under-Lyne, Greater Manchester, United Kingdom",https://ClinicalTrials.gov/show/NCT04386044
NCT04404361,PRE-VENT Study in Hospitalized Patients With Severe COVID-19 With or Without Cancer,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",PAC319,"St. Jude Hospital Yorba Linda dba St. Joseph Heritage Healthcare, Orange, California, United States|Ascension St. Vincent's Riverside Hospital, Jacksonville, Florida, United States|Grady Memorial Hospital, Atlanta, Georgia, United States|St. Vincent Medical Group, Inc, Indianapolis, Indiana, United States|St. Agnes Healthcare, Baltimore, Maryland, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States|University of Michigan, Ann Arbor, Michigan, United States|Ascension St. John Hospital, Detroit, Michigan, United States|Ascension Providence Hospital - Novi Campus, Novi, Michigan, United States|Providence Cancer Institute, Southfield, Michigan, United States|Atlantic Melanoma Center, Morristown, New Jersey, United States|Overlook Medical Center, Morristown, New Jersey, United States|Chilton Medical Center, Pompton Plains, New Jersey, United States|Mount Sinai Medical Center, New York, New York, United States|The Carl and Edyth Lindner Center for Research and Education at The Christ Hospital, Cincinnati, Ohio, United States|St. John Medical Center, Tulsa, Oklahoma, United States|Albert Einstein Medical Center, Philadelphia, Pennsylvania, United States|Rhode Island Hospital, Providence, Rhode Island, United States|The Miriam Hospital, Providence, Rhode Island, United States|Ascension St. Francis Hospital, Milwaukee, Wisconsin, United States|Ascension All Saints, Racine, Wisconsin, United States",https://ClinicalTrials.gov/show/NCT04404361
NCT04802083,COVID-19 Soliris Expanded Access Protocol,NA,ECU-COV-402,NA,https://ClinicalTrials.gov/show/NCT04802083
NCT04411433,Efficacy and Safety of Hydroxychloroquine and Favipiravir in the Treatment of Mild to Moderate COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,COVID-19-FAV,"Hacettepe University, School of Medicine, Ankara, Turkey",https://ClinicalTrials.gov/show/NCT04411433
NCT04402866,TD-0903 for ALI Associated With COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",0188|2020-001807-18,"Theravance Biopharma Investigational Site, Duarte, California, United States|Theravance Biopharma Investigational Site, Denver, Colorado, United States|Theravance Biopharma Investigational Site, Sebring, Florida, United States|Theravance Biopharma Investigational Site, Boston, Massachusetts, United States|Theravance Biopharma Investigational Site, Fall River, Massachusetts, United States|Theravance Biopharma Investigational Site, Kalispell, Montana, United States|Theravance Biopharma Investigational Site, Glens Falls, New York, United States|Theravance Biopharma, Hyde Park, New York, United States|Theravance Biopharma Investigational Site, Columbus, Ohio, United States|Theravance Biopharma Investigational Site, Allentown, Pennsylvania, United States|Theravance Biopharma Investigational Site, Bethlehem, Pennsylvania, United States|Theravance Biopharma Investigational Site, Wenatchee, Washington, United States|Theravance Biopharma Investigational Site, Bela Vista, Brazil|Theravance Biopharma Investigational Site, Botucatu, Brazil|Theravance Biopharma Investigational Site, Caxias Do Sul, Brazil|Theravance Biopharma Investigational Site, São José Do Rio Preto, Brazil|Theravance Biopharma Investigational Site, Helsinki, Finland|Theravance Biopharma Investigational Site, Turku, Finland|Theravance Biopharma Investigational Site, Chisinau, Moldova, Republic of|Theravance Biopharma Investigational Site, Bucharest, Romania|Theravance Biopharma Investigational Site, Brovary, Ukraine|Theravance Biopharma Investigational Site, Kyiv, Ukraine|Theravance Biopharma Investigational Site, Kyiv, Ukraine|Theravance Biopharma Investigational Site, Manchester, United Kingdom",https://ClinicalTrials.gov/show/NCT04402866
NCT04625257,"COVID-19 in Baselland: Validation of Simple and Accurate Tests for COVID-19 Detection, Monitoring and Tracing (ACCURATE-BL-COVID-19)",Observational Model: Cohort|Time Perspective: Prospective,2020-01112; ch20Savic2,"Cantonal Office of Public Health, Economics and Health Directorate, Canton Basel-Landschaft, Liestal, Switzerland",https://ClinicalTrials.gov/show/NCT04625257
NCT04530422,Efficacy of Sofosbuvir Plus Ledipasvir in Egyptian Patients With COVID-19 Compared to Standard Treatment,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,14,"Almaza Military Fever Hospital, Cairo, Egypt",https://ClinicalTrials.gov/show/NCT04530422
NCT04420299,Clinical Trial on the Efficacy and Safety of Bemiparin in Patients Hospitalized Because of COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,BEMICOVID-19|2020-001548-24,"Hospital Universitario HM Montepríncipe, Boadilla Del Monte, Madrid, Spain|Hospital Universitario HM Puerta del Sur, Móstoles, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04420299
NCT04471766,Locally Produced Cloth Face Mask and COVID-19 Like Illness Prevention,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention,BHP MASK01,"Bandim Health Project, Bissau, Bissau Codex, Guinea-Bissau",https://ClinicalTrials.gov/show/NCT04471766
NCT04389944,Amotosalen-Ultraviolet A Pathogen-Inactivated Convalescent Plasma in Addition to Best Supportive Care and Antiviral Therapy on Clinical Deterioration in Adults Presenting With Moderate to Severe COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,Req-2020-00508; me20khanna2,"Blutspendezentrum SRK beider Basel, University Hospital Basel, Basel, Switzerland",https://ClinicalTrials.gov/show/NCT04389944
NCT04625296,Behaviour and Experience of Communities Healthcare Professionals Facing the SARS CoV-2 (COVID-19) Epidemic,Observational Model: Cohort|Time Perspective: Prospective,AP-HP 200512,"URC/CIC Paris Centre, Paris, France",https://ClinicalTrials.gov/show/NCT04625296
NCT04604678,Pilot Study Into the Use of Metformin and LDN for Patients With COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,ALRx003,"AgelessRx, Ann Arbor, Michigan, United States",https://ClinicalTrials.gov/show/NCT04604678
NCT04489446,Sildenafil in COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",UNAB-003,"Hospital Naval Almirante Nef, Viña Del Mar, Valparaiso, Chile",https://ClinicalTrials.gov/show/NCT04489446
NCT04400448,Acceptance of Telemedicine During the COVID-19 Pandemic,Observational Model: Ecologic or Community|Time Perspective: Prospective,TELECOVID,NA,https://ClinicalTrials.gov/show/NCT04400448
NCT04497987,A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Preventing SARS-CoV-2 Infection and COVID-19 in Nursing Home Residents and Staff,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention",18063|J2X-MC-PYAD|CoVPN #3501,"Unv of AL Sch of Med Div of Infectious Diseases, Birmingham, Alabama, United States|Care Access Research, Phoenix, Arizona, United States|Allergy and Asthma Clin of NW Ark, Bentonville, Arkansas, United States|Care Access Research LLC, Huntington Beach, California, United States|Alta Bates SMC, Oakland, California, United States|University of Colorado-Anschultz Medical Campus, Aurora, Colorado, United States|NIAID, Miami, Florida, United States|NIAID, Decatur, Georgia, United States|Belmont Village Lincoln Park, Lincoln Park, Illinois, United States|Family Medicine, Indianapolis, Indiana, United States|University of Louisville, Louisville, Kentucky, United States|Care Access Rch Lake Charles, Lake Charles, Louisiana, United States|Tulane University School of Medicine, New Orleans, Louisiana, United States|NIAID - National Institute of Allergy & Infectious Diseases, Bethesda, Maryland, United States|Care Access, Boston, Massachusetts, United States|St. Paul IDA-CARe, Saint Paul, Minnesota, United States|Care Access, Jackson, Mississippi, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|Children's Hospital & Medical Center, Omaha, Nebraska, United States|Care Access Research - Bronx, Bronx, New York, United States|NIAD, Chapel Hill, North Carolina, United States|Valley Medical Primary Care, Centerville, Ohio, United States|Univ of Cin College of Med, Cincinnati, Ohio, United States|OSU Med Intl Med Houston Ctr, Tulsa, Oklahoma, United States|Donahoe Manor, Bedford, Pennsylvania, United States|Belmont Village, West Univ, Houston, Texas, United States|Burke Internal Medicine and Research, Burke, Virginia, United States",https://ClinicalTrials.gov/show/NCT04497987
NCT04480593,The Use of Brazilian Green Propolis Extract (EPP-AF) in Patients Affected by COVID-19.,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,31099320.6.0000.0048,"Hospital Sao Rafael, Salvador, BA, Brazil",https://ClinicalTrials.gov/show/NCT04480593
NCT04557046,Performance Evaluation of LumiraDx COVID-19 (SARS-CoV-2) Ag Test,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,S-CLIN-PROT-00032,"Children's Pediatric Associates of Altamonte Springs, Altamonte Springs, Florida, United States|Chappel Group, Kissimmee, Florida, United States|Good Samaritan Minute Clinic, Georgia Tech, Atlanta, Georgia, United States|Gvozden Pediatrics, Millersville, Maryland, United States|Ardmore Family Practice, Winston-Salem, North Carolina, United States|Physicians Quality Care of Jackson, Jackson, Tennessee, United States|Village Health Partners, Plano, Texas, United States",https://ClinicalTrials.gov/show/NCT04557046
NCT04569877,GM-CSF Inhalation to Prevent ARDS in COVID-19 Pneumonia,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",KKS-279|2020-001654-21,"Universitätsklinikum Carl Gustav Carus Dresden, Dresden, Germany|Universitätsklinikum Essen, Essen, Germany|Krankenhaus Nordwest GmbH, Frankfurt am Main, Germany|Universitätsklinikum Frankfurt, Frankfurt am Main, Germany|Universitätsklinikum Giessen und Marburg GmbH, Standort Giessen, Gießen, Germany|Medizinische Hochschule Hannover, Hannover, Germany|Universitätsklinikum Heidelberg, Heidelberg, Germany|Lungenfachklinik Immenhausen, Immenhausen, Germany|Sana Klinikum Offenbach, Offenbach am Main, Germany",https://ClinicalTrials.gov/show/NCT04569877
NCT04367402,"COST (COvid STudio) ACTION: Study for the Evaluation of Specific Antibodies Anti Covid-19 Linked to Covid-19 Infection, Symptoms and Genetic Expression of ACE2 Polymorphisms in Patients (COST ACTION)",Observational Model: Case-Control|Time Perspective: Retrospective,2020/ST/057,"AO San Paolo, Milan, IT, Italy",https://ClinicalTrials.gov/show/NCT04367402
NCT04336332,Randomized Comparison of Combination Azithromycin and Hydroxychloroquine vs. Hydroxychloroquine Alone for the Treatment of Confirmed COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,002011|Pro2020000712,"Saint Barnabas Medical Center, Livingston, New Jersey, United States|Robert Wood Johnson University Hopsital, New Brunswick, New Jersey, United States|Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States|The University Hospital, Newark, New Jersey, United States",https://ClinicalTrials.gov/show/NCT04336332
NCT04383444,Surveillance of Individuals Following SARS-CoV-2 Infection,Observational Model: Cohort|Time Perspective: Prospective,200117|20-I-0117,"National Institutes of Health Clinical Center, Bethesda, Maryland, United States",https://ClinicalTrials.gov/show/NCT04383444
NCT04490837,Rapid Diagnostic Test for COVID-19 Based on Antibody Detection (YCOVID),Observational Model: Case-Control|Time Perspective: Prospective,2020/587,"Parc Tauli University Hospital, Sabadell, Barcelona, Spain",https://ClinicalTrials.gov/show/NCT04490837
NCT04806880,Study Evaluating the Olfactory Recovery of Anosmia Post COVID-19 by Olfactory Rehabilitation Assisted by Web-application,Observational Model: Cohort|Time Perspective: Prospective,WP-2020-06,"ILC, Le Mans, France",https://ClinicalTrials.gov/show/NCT04806880
NCT04353401,WGS Analysis of COVID-19 Positive Patients,Observational Model: Cohort|Time Perspective: Prospective,VP-01-01,"Vanda Investigational Site, Cleveland, Ohio, United States",https://ClinicalTrials.gov/show/NCT04353401
NCT04360876,Targeted Steroids for ARDS Due to COVID-19 Pneumonia: A Pilot Randomized Clinical Trial,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment",20-0811,NA,https://ClinicalTrials.gov/show/NCT04360876
NCT04427332,Smell and Taste Disorders in COVID-19 Patients,Observational Model: Cohort|Time Perspective: Prospective,COVID-19 ORL,"ASST Monza-Ospedale San Gerardo, Monza, Italy",https://ClinicalTrials.gov/show/NCT04427332
NCT04729140,An Outpatient Clinical Trial Using Ivermectin and Doxycycline in COVID-19 Positive Patients at High Risk to Prevent COVID-19 Related Hospitalization,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",COVIVER-OUT PLUS,"MAX HEALTH, Subsero Health 2055 Wood Street, Suite 100, Sarasota, Florida, United States",https://ClinicalTrials.gov/show/NCT04729140
NCT04473352,COVID-19 Detection Tests in Different Body Fluids,Observational Model: Other|Time Perspective: Prospective,COVID Fluids,NA,https://ClinicalTrials.gov/show/NCT04473352
NCT04549376,Virucidal Effect of Povidone Iodine on COVID-19 In-Vivo,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,PiRCC-1131-2020,"Dhaka Medical College, Dhaka, Bangladesh",https://ClinicalTrials.gov/show/NCT04549376
NCT04780698,DCI COVID-19 Surveillance Project,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Screening,27042,"Dialysis Clinic, Inc., Philadelphia, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04780698
NCT04644146,Genetic Predisposition to Severe Forms of COVID-19 (SARS-CoV2 Infection),Observational Model: Case-Control|Time Perspective: Retrospective,69HCL20_1072,"University Hospital LYON (Hospices Civils de LYON), Lyon, France",https://ClinicalTrials.gov/show/NCT04644146
NCT04392089,Effects of Cardiovascular and Pulmonary Optimization on Cerebral Oxygenation in COVID-19 Patients With Severe ARDS,Observational Model: Cohort|Time Perspective: Prospective,H-20027818,"Hvidovre Hospital, Copenhagen, Denmark",https://ClinicalTrials.gov/show/NCT04392089
NCT04659122,A Clinical Safety Study on AT-100 in Treating Adults With Severe COVID-19 Infection,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,AT-100/002,NA,https://ClinicalTrials.gov/show/NCT04659122
NCT04523181,Double-blind Study to Evaluate the Safety and Efficacy of Antroquinonol in Mild-Moderate COVID-19 Hospitalized Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",GHCovid-2-001,"Franciscan Health Michigan City, Michigan City, Indiana, United States|Ascension.Via Christi Research, Wichita, Kansas, United States|Adventist Healthcare Shady Grove Medical Center, Rockville, Maryland, United States|South Jersey Infectious Disease, Somers Point, New Jersey, United States|Duke University Southeastern Health, Lumberton, North Carolina, United States|Centro Gallego, Buenos Aires, Capital Federal, Argentina|Clinica de los Virreyes, Buenos Aires, Capital Federal, Argentina|Sanatorio Privado Mayo SA, Cordoba, Ciudad De Cordoba, Argentina|Hospital Rawson, Cordoba, Cuidad De Cordoba, Argentina|Clinica Viedma SA, Viedma, Pcia De Rio Negro, Argentina|Clínica Internacional S.A. - Sede Lima, Lima Cercado, Lima, Peru|Unidad de Investigacion, Hospital Nacional IV Alberto Sabogal Sologuren-Essalud, Red Assitencial Sabogal, Callao, Peru|Hospital de Chancay, Chancay, Peru|Asociación Civil Selva Amazónica, Iquitos, Peru|Hospital III Daniel Alcides Carrion - EsSalud, Tacna, Peru",https://ClinicalTrials.gov/show/NCT04523181
NCT04825301,Prognostic Prediction of COVID-19 Clinical Course Through the Development of Machine Learning Based Algorithms,Observational Model: Cohort|Time Perspective: Prospective,prot. N. 28958,"University of L'Aquila, L'Aquila, Italy",https://ClinicalTrials.gov/show/NCT04825301
NCT04357444,Low Dose of IL-2 In Acute Respiratory DistrEss Syndrome Related to COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",APHP200406|2020-001571-32,"Service Anesthésie Réanimation - Groupe Hospitalier Pitié-Salpêtrière, Paris, France",https://ClinicalTrials.gov/show/NCT04357444
NCT04978259,SOLIDARITY Finland Long COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,SOL21,"University of Helsinki, Helsinki, Finland",https://ClinicalTrials.gov/show/NCT04978259
NCT04710771,Effect of Prone Positioning in Patients With COVID-19,Observational Model: Cohort|Time Perspective: Prospective,138,"DHQ Hospital, Faisalabad, Punjab, Pakistan",https://ClinicalTrials.gov/show/NCT04710771
NCT04838834,Monitoring Serologic Response to Severe Acute Respiratory Syndrome-2 (SARS-COV-2)/COVID-19 in Children,Observational Model: Cohort|Time Perspective: Prospective,20-073,"Connecticut Children's Medical Center, Hartford, Connecticut, United States",https://ClinicalTrials.gov/show/NCT04838834
NCT04642196,COVID-19 in Home Healthcare,Observational Model: Cohort|Time Perspective: Retrospective,Home healthcare 2020,"Dept of anesthesia, Linköping, Sweden",https://ClinicalTrials.gov/show/NCT04642196
NCT04591600,Effectiveness of Ivermectin and Doxycycline on COVID-19 Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,IVM-DOX,"Akarkh Healt hdirectorate, Baghdad, Iraq",https://ClinicalTrials.gov/show/NCT04591600
NCT04659473,Spanish Survey on Third Wave of COVID-19,Observational Model: Ecologic or Community|Time Perspective: Cross-Sectional,CovidSal01/2020,"Universidad de Salamanca, Salamanca, Spain",https://ClinicalTrials.gov/show/NCT04659473
NCT04767087,Honey and Nigella Sativa in COVID-19 Prophylaxis,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",SZMC/IRB/Internal/273/2021,"Shaikh Zayed Post-Graduate Medical Institute, Lahore, MA, Pakistan",https://ClinicalTrials.gov/show/NCT04767087
NCT04900441,Tele-assessment in Individuals With COVID-19,Observational Model: Other|Time Perspective: Cross-Sectional,GYGokmen,"Bandırma Onyedi Eylül University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation, Balıkesir, Turkey",https://ClinicalTrials.gov/show/NCT04900441
NCT04529499,Clinical Trial Evaluating the Efficacy and Safety of Favipiravir in Moderate to Severe COVID-19 Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",CVD-04-CD-001,"Jaber Al-Ahmad Al-Sabah Hospital (South Surra), Kuwait City, Kuwait|Mishref Field Hospital (Mishref), Kuwait City, Kuwait",https://ClinicalTrials.gov/show/NCT04529499
NCT04900961,CISCO-21 Prevent and Treat Long COVID-19.,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,GN20CA537,NA,https://ClinicalTrials.gov/show/NCT04900961
NCT04380727,Almitrine and COVID-19 Related Hypoxemia,Observational Model: Case-Control|Time Perspective: Prospective,2020PI080_2,"Centre Hospitalier Universitaire NANCY, Vandoeuvre-les-Nancy, France",https://ClinicalTrials.gov/show/NCT04380727
NCT04682093,Risk Stratification of Patients With Suspected COVID-19 Presenting to the ED,Observational Model: Cohort|Time Perspective: Retrospective,123456,"EUSEM RN Country lead, Zagreb, Croatia|EUSEM RN Country lead, Hämeenlinna, Finland|EUSEM RN Country lead, Tours, France|EUSEM RN Country lead, Athens, Greece|EUSEM RN Country lead, Forlì, Italy",https://ClinicalTrials.gov/show/NCT04682093
NCT04452812,Statistical and Epidemiological Study Based on the Use of Convalescent Plasma for the Management of Patients With COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment",HUS-001/2020,"Hospital Universitario ""Dr. Gonzalo Valdés Valdés"", Saltillo, Coahuila, Mexico",https://ClinicalTrials.gov/show/NCT04452812
NCT04402840,Stellate Ganglion Block (SGB) for COVID-19 Acute Respiratory Distress Syndrome (ARDS),Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2004963113,"West Virginia University Rockefeller Neuroscience Institute, Morgantown, West Virginia, United States",https://ClinicalTrials.gov/show/NCT04402840
NCT04588480,"Study to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy Japanese Adults","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention",C4591005,"SOUSEIKAI Sumida Hospital, Sumida-ku, Tokyo, Japan|SOUSEIKAI PS Clinic, Fukuoka, Japan",https://ClinicalTrials.gov/show/NCT04588480
NCT04664049,The Outcomes of NRICM101 on SARS-COV-2 (COVID-19) Infection,Observational Model: Case-Only|Time Perspective: Prospective,NRICM101,"National Research Institute of Chinese Medicine, Ministry of Health and Welfare, Taipei, Taiwan",https://ClinicalTrials.gov/show/NCT04664049
NCT04360122,Levamisole and Isoprinosine in Immune-prophylaxis of Egyptian Healthcare Workers Facing COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,FMASU P20a/ 2020,"Faculty of Medicine Ain Shams University Research Institute- Clinical Research Center, Cairo, Non-US, Egypt",https://ClinicalTrials.gov/show/NCT04360122
NCT04341116,Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Subjects With Severe Coronavirus Disease 2019 (COVID-19),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",TJ003234COV201,"Olive View-UCLA Medical Center, Sylmar, California, United States|Georgetown University Hospital, Washington, District of Columbia, United States|The GW Medical Faculty Associates, Washington, District of Columbia, United States|University of Miami, Miami, Florida, United States|OSF Healthcare Saint Francis Medical Center, Peoria, Illinois, United States|Indiana University Health, Indianapolis, Indiana, United States|Medpharmics, LLC, Metairie, Louisiana, United States|Ochsner Medical Center, New Orleans, Louisiana, United States|University of Maryland Medical Center, Baltimore, Maryland, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States|Henry Ford Health System, Detroit, Michigan, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|University Medical Center of Southern Nevada, Las Vegas, Nevada, United States|UNM Hospitals, Albuquerque, New Mexico, United States|Houston Methodist Hospital, Houston, Texas, United States",https://ClinicalTrials.gov/show/NCT04341116
NCT04868864,The Ontario Multi-Regional Hospital COVID-19 Registry (COREG)- Recovery Trajectory Sub-study,Observational Model: Cohort|Time Perspective: Prospective,13161,"Juravinski Hospital, Hamilton, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04868864
NCT04871165,"Analysis of Immunogenicity, Safety and Efficacy of COVID-19 Vaccines in Immunosuppressed Individuals",Observational Model: Cohort|Time Perspective: Prospective,OH-VACC-IMMUN,"Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania",https://ClinicalTrials.gov/show/NCT04871165
NCT04434157,Association of the Neutrophil/Lymphocyte Ratio With Clinical Complications and Mortality in COVID-19 Patients,Observational Model: Cohort|Time Perspective: Cross-Sectional,NR-09-2020,"Hospital Regional de Alta Especialidad de Ixtapaluca, Ixtapaluca, State Of Mexico, Mexico",https://ClinicalTrials.gov/show/NCT04434157
NCT04432103,Treatment of Severe and Critical COVID-19 Pneumonia With Convalescent Plasma,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,ABC-20-14,"Centro Medico Abc, Mexico City, Mexico",https://ClinicalTrials.gov/show/NCT04432103
NCT04705597,"Study to Evaluate the Safety, Tolerability, and Efficacy of BGE-175 in Hospitalized Adults With Coronavirus Disease 2019 (COVID-19) That Are Not in Respiratory Failure","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",BGE-175-201,"Banner Health, Mesa, Arizona, United States|Velocity Clinical Research, Chula Vista, Chula Vista, California, United States|UCI Center for Clinical Research, Orange, California, United States|Sharp Memorial Hospital, San Diego, California, United States|Stamford Hospital, Stamford, Connecticut, United States|Baptist Health, Lexington, Lexington, Kentucky, United States|University of Maryland Medical System, Baltimore, Maryland, United States|Clinica Adventista Belgrano (CAB), Buenos Aires, Ciudad Autónoma De Buenos Aires, Argentina|Hospital Universitário Cassiano Antônio de Moraes, Vitória, Espiritu Santo, Brazil|Hospital Felicio Rocho (HFR), Belo Horizonte, Minas Gerais, Brazil|Centro de Pesquisa Hospital Ana Nery Santa Cruz do Sul, Santa Cruz Do Sul, Rio Grande Do Sol, Brazil|Clínica Supera Oncologia, Chapecó, Santa Catarina, Brazil|Unidade de Pesquisa Clinica da Fundação Pio XII - Hospital de Amor de Barretos, Barretos, Sao Paulo, Brazil|Hospital das Clínicas da Faculdade de Medicina de Botucatu UNESP (HC-FMB/UNESP), Botucatu, Sao Paulo, Brazil|Pontificia Universidade Catolica de Campinas (PUC-CAMP) - Hospital e Maternidade Celso Pierro (HMCP) - Centro de Pesquisa São Lucas, Campinas, Sao Paulo, Brazil|Clinica de Alergia Martti Antila, Sorocaba, Sao Paulo, Brazil|Conjunto Hospitalar de Mandaqui, São Paulo, Sao Paulo, Brazil|Fundação Faculdade Regional de Medicina de São José do Rio Preto, São José do Rio Preto, São Paulo, Brazil|Instituto Nacional de Infectologia Evandro Chagas / Fundação Oswaldo Cruz (FIOCRUZ), Rio De Janeiro, Brazil",https://ClinicalTrials.gov/show/NCT04705597
NCT04583306,The Salivary Raman COVID-19 Fingerprint,Observational Model: Case-Control|Time Perspective: Prospective,FDG_SalivaCOVID01,", IRCCS Fondazione Don Carlo Gnocchi, Centro Spalenza, Rovato, BS, Italy|IRCCS Fondazione Don Carlo Gnocchi, Santa Maria Nascente Hospital (Milano), Milano, MI, Italy",https://ClinicalTrials.gov/show/NCT04583306
NCT04625218,Hydroxychloroquine for the Treatment of SARS-CoV2 (COVID 19) : Pharmacokinetic Study,Observational Model: Other|Time Perspective: Prospective,RC31/20/0155|2020-A01094-35,"University Hospital of Toulouse, Toulouse, France",https://ClinicalTrials.gov/show/NCT04625218
NCT04513184,Randomized Clinical Trial of Intranasal Dexamethasone as an Adjuvant in Patients With COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment",DI/20/407/04/36,"Hospital General de Mexico Dr. Eduardo Liceaga, Mexico City, Cdmx, Mexico|Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Cdmx, Mexico|El Instituto Nacional de Neurologia Y Neurocirugia Manuel Velasco Suarez, Mexico City, Cdmx, Mexico",https://ClinicalTrials.gov/show/NCT04513184
NCT04710381,IMUNOR® Preparation in the Prevention of COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,FNO-IMUNOR-2020,"University Hospital Ostrava, Ostrava, Moravian-Silesian Region, Czechia",https://ClinicalTrials.gov/show/NCT04710381
NCT04885361,"To Evaluate the Safety, and Immunogenicity of Vaccine Candidate Against COVID-19, in Healthy Adults",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,OSE-13E-C102,"Center for Vaccinology (CEVAC),, Gent, Belgium",https://ClinicalTrials.gov/show/NCT04885361
NCT04359667,Serum IL-6 and Soluble IL-6 Receptor in Severe COVID-19 Pneumonia Treated With Tocilizumab,Observational Model: Case-Only|Time Perspective: Prospective,UHID-04,"University Hospital for Infectious Diseases ""Dr Fran Mihaljevic"", Zagreb, Croatia",https://ClinicalTrials.gov/show/NCT04359667
NCT04485130,DISulfiram for COvid-19 (DISCO) Trial,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",DSF151837,"University of California San Francisco, Fresno, Fresno, California, United States|San Francisco General Hospital, San Francisco, California, United States",https://ClinicalTrials.gov/show/NCT04485130
NCT04629222,Tracheobronchitis in Respiratory Involvement on the Lung SPECT/CT Images of COVID-19 Patients,Observational Model: Case-Control|Time Perspective: Retrospective,2020PI154,"CHRU of Nancy, Vandœuvre-lès-Nancy, France",https://ClinicalTrials.gov/show/NCT04629222
NCT04935450,Pulmonary Inflammation in COVID-19 ARDS,Observational Model: Cohort|Time Perspective: Prospective,398-20,"Hospital Universitario Ramon y Cajal, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04935450
NCT04408456,Efficacy of Hydroxychloroquine (HCQ) as Post Exposure Prophylaxis (PEP) for Prevention of COVID-19,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,IEC-04/2020-1624,"Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India|Post Graduate Institute of Medical Education and Research, Chandigarh, India",https://ClinicalTrials.gov/show/NCT04408456
NCT04838821,Efficacy and Safety of Three Different Doses of an Anti SARS-CoV-2 Hyperimmune Equine Serum in COVID-19 Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",R020-SABI-00268,"Centro Especializado de Atención COVID19 (CEACO), San José, Costa Rica|Hospital Dr. Rafael Ángel Calderón Guardia, San José, Costa Rica|Hospital México, San José, Costa Rica|Hospital San Juan de Dios, San José, Costa Rica",https://ClinicalTrials.gov/show/NCT04838821
NCT04527575,"Study of the Safety, Reactogenicity and Immunogenicity of ""EpiVacCorona"" Vaccine for the Prevention of COVID-19","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention",COV/pept-01/20,"Federal State Budgetary Institution of Healthcare ""Medical and Sanitary Unit No. 163 of the Federal Medical and Biological Agency"" (FGBUZ MSCH-163, FMBA of Russia), Koltsovo, Novosibirsk Region, Russian Federation",https://ClinicalTrials.gov/show/NCT04527575
NCT04505709,"Clinical, Immunological, Genomic, Virological and Bioethical Actors of COVID-19",Observational Model: Cohort|Time Perspective: Prospective,STOP-Coronavirus|COV20/00181,"Fundacion Jimenez Diaz, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04505709
NCT04350931,Application of BCG Vaccine for Immune-prophylaxis Among Egyptian Healthcare Workers During the Pandemic of COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Prevention,FMASU P19a/ 2020,"Faculty of Medicine Ain Shams University Research Institute- Clinical Research Center, Cairo, Non-US, Egypt",https://ClinicalTrials.gov/show/NCT04350931
NCT04567953,COVID-19 Tests With Saliva Specimens,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Screening,PLRD202001,"Paradigm Laboratories, Tucson, Arizona, United States",https://ClinicalTrials.gov/show/NCT04567953
NCT04820803,Assessment of the Impact of Oral Intervention With Cetylpyridinium Chloride to Decrease SARS-CoV-2 Viral Load in Patients With COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention",CPC01,"Seminario Health Center and Lozano Blesa University Clinical Hospital, Zaragoza, Spain",https://ClinicalTrials.gov/show/NCT04820803
NCT04939428,Study of MK-4482 for Prevention of Coronavirus Disease 2019 (COVID-19) in Adults (MK-4482-013),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",4482-013|2021-000904-39|MK-4482-013,NA,https://ClinicalTrials.gov/show/NCT04939428
NCT04346043,To Access the Egyptian COVID-19 Whole Genome by NGS and Compare to the International Worldwide Database,Observational Model: Case-Only|Time Perspective: Other,FMASU P16a/ 2020,"Faculty of Medicine Ain Shams University Research Institute- Clinical Research Center, Cairo, Non-US, Egypt",https://ClinicalTrials.gov/show/NCT04346043
NCT04889209,Delayed Heterologous SARS-CoV-2 Vaccine Dosing (Boost) After Receipt of EUA Vaccines,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,21-0012|5UM1AI148684-02,"Emory Vaccine Center - The Hope Clinic, Decatur, Georgia, United States|University of Maryland Baltimore - Institute of Human Virology, Baltimore, Maryland, United States|New York University School of Medicine - Langone Medical Center - Microbiology - Parasitology, New York, New York, United States|University of Rochester Medical Center - Vaccine Research Unit, Rochester, New York, United States|Cincinnati Children's Hospital Medical Center - Infectious Diseases, Cincinnati, Ohio, United States|University of Pittsburgh - Medicine - Infectious Diseases, Pittsburgh, Pennsylvania, United States|University of Texas Medical Branch - Division of Infectious Disease, Galveston, Texas, United States|Baylor College of Medicine - Molecular Virology and Microbiology, Houston, Texas, United States|The University of Texas Medical Branch - Sealy Center for Vaccine Development (SCVD), League City, Texas, United States|Kaiser Permanente Washington Health Research Institute - Vaccines and Infectious Diseases, Seattle, Washington, United States|The University of Washington - Virology Research Clinic, Seattle, Washington, United States",https://ClinicalTrials.gov/show/NCT04889209
NCT04682041,Evaluating the Impact of EnteraGam In People With COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,PICNIC Study,"Hospital del Mar, Barcelona, Spain",https://ClinicalTrials.gov/show/NCT04682041
NCT04896918,Tobacco Use and the Risk of COVID-19,Observational Model: Cohort|Time Perspective: Retrospective,4-1457/2021,NA,https://ClinicalTrials.gov/show/NCT04896918
NCT04896788,Monitoring of the Post-vaccination Immune Response to COVID-19 Among Hospital Staff,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,RBHP 2021 HENQUELL,"Clermont-Ferrand University Hospital, Clermont-Ferrand, Aura, France",https://ClinicalTrials.gov/show/NCT04896788
NCT04575584,Efficacy and Safety of Molnupiravir (MK-4482) in Hospitalized Adult Participants With COVID-19 (MK-4482-001),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",4482-001|2020-003367-26|MK-4482-001|PHRR201210-003189|jRCT2031200404,"Kaiser Foundation Hospital - South Bay ( Site 1832), Harbor City, California, United States|Cedars-Sinai Medical Center ( Site 1822), Los Angeles, California, United States|University of California Davis Health ( Site 1809), Sacramento, California, United States|University Of Florida ( Site 1810), Gainesville, Florida, United States|Wellstar Kennestone Hospital ( Site 1801), Marietta, Georgia, United States|Loretto Hospital ( Site 1838), Chicago, Illinois, United States|LSU-HSC Shreveport ( Site 1824), Shreveport, Louisiana, United States|Henry Ford Health System ( Site 1821), Detroit, Michigan, United States|University of Mississippi Medical Center ( Site 1846), Jackson, Mississippi, United States|University of Nebraska Medical Center ( Site 1835), Omaha, Nebraska, United States|University of New Mexico, Health Sciences Center ( Site 1806), Albuquerque, New Mexico, United States|Carolinas Medical Center ( Site 1850), Charlotte, North Carolina, United States|ECU Adult Specialty Care ( Site 1865), Greenville, North Carolina, United States|Sanford Health ( Site 1851), Fargo, North Dakota, United States|Temple University ( Site 1836), Philadelphia, Pennsylvania, United States|CHRISTUS Institute for Innovation & Advanced Clinical Care ( Site 1864), Corpus Christi, Texas, United States|Houston Methodist Hospital ( Site 1863), Houston, Texas, United States|Swedish Medical Center ( Site 1812), Edmonds, Washington, United States|Valley Medical Center ( Site 1815), Renton, Washington, United States|Swedish Medical Center ( Site 1861), Seattle, Washington, United States|Chronos Pesquisa Clínica ( Site 0105), Brasilia, Distrito Federal, Brazil|Santa Casa de Misericordia de Belo Horizonte ( Site 0100), Belo Horizonte, Minas Gerais, Brazil|Hospital de Clinicas da Universidade Federal do Parana ( Site 0104), Curitiba, Parana, Brazil|Hospital Tacchini ( Site 0107), Bento Goncalves, Rio Grande Do Sul, Brazil|FUNFARME Hospital de Base Centro Integrado de Pesquisa ( Site 0101), Sao Jose do Rio Preto, Sao Paulo, Brazil|University Health Network - Toronto General Hospital ( Site 0201), Toronto, Ontario, Canada|Hospital Clinico Fusat ( Site 0300), Rancagua, Libertador General Bernardo O Higgins, Chile|Clinica Universidad de los Andes ( Site 0301), Santiago, Region M. De Santiago, Chile|Hospital Sotero del Rio [Santiago, Chile] ( Site 0304), Santiago, Region M. De Santiago, Chile|Complejo Hospitalario San Jose ( Site 0306), Santiago, Region M. De Santiago, Chile|Servicio de Salud Sur Hospital Lucio Cordova ( Site 0305), Santiago, Region M. De Santiago, Chile|Hospital Pablo Tobon Uribe ( Site 0404), Medellin, Antioquia, Colombia|Clinica de la Costa Ltda. ( Site 0402), Barranquilla, Atlantico, Colombia|Oncomedica S.A. ( Site 0406), Monteria, Cordoba, Colombia|Hospital Universitario San Ignacio ( Site 0401), Bogota, Distrito Capital De Bogota, Colombia|Fundacion Cardiovascular de Colombia ( Site 0403), Bucaramanca, Santander, Colombia|Fundacion Valle del Lili ( Site 0400), Cali, Valle Del Cauca, Colombia|Groupe Hospitalier Pellegrin ( Site 0511), Bordeaux, Gironde, France|Pitie Salpetriere University Hospital-Infectious Disease - Tropical Diseases ( Site 0504), Paris, Ile-de-France, France|C.H.U. de Toulouse. Hopital de Purpan ( Site 0501), Toulouse, Midi-Pyrenees, France|Centre Hospitalier de Tourcoing ( Site 0502), Tourcoing, Nord, France|CHU Hopital Saint Antoine ( Site 0505), Paris, France|Hopital Bichat - Claude Bernard ( Site 0503), Paris, France|Rambam Medical Center ( Site 2102), Haifa, Israel|Hadassah Medical Center. Ein Kerem ( Site 2103), Jerusalem, Israel|Chaim Sheba Medical Center ( Site 2100), Ramat Gan, Israel|ASST Fatebenefratelli-Ospedale Sacco ( Site 0601), Milano, Italy|Chungnam National University Hospital ( Site 2202), Daejeon, Taejon-Kwangyokshi, Korea, Republic of|Inha University Hospital ( Site 2204), Incheon, Korea, Republic of|The Catholic University of Korea Eunpyeong St Mary s Hospital ( Site 2205), Seoul, Korea, Republic of|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran ( Site 0802), Ciudad de mexico, Distrito Federal, Mexico|Hospital Regional de Alta Especialidad del Bajio ( Site 0807), Leon, Guanajuato, Mexico|Hospital Civil de Guadalajara Fray Antonio Alcalde ( Site 0800), Guadalajara, Jalisco, Mexico|Hospital Universitario Dr. Jose Eleuterio Gonzalez ( Site 0803), Monterrey, Nuevo Leon, Mexico|University of the Philippines-Philippine General Hospital ( Site 0900), Manila, National Capital Region, Philippines|Lung Center of the Philippines ( Site 0902), Quezon City, National Capital Region, Philippines|Wojewodzki Szpital Specjalistyczny im. dr. Wladyslawa Bieganskiego ( Site 1001), Lodz-Baluty, Lodzkie, Poland|Samodzielny Publiczny Szpital Kliniczny Nr 1 w Lublinie ( Site 1004), Lublin, Lubelskie, Poland|Centrum Medyczne Pratia, Mazowiecki Szpital Specjalistyczny, Oddział Obserwacyjno - Zakaźny ( Site 1, Ostroleka, Mazowieckie, Poland|Centrum Medyczne w Lancucie Sp.zo.o. ( Site 1000), Lancut, Podkarpackie, Poland|Krasnogorsk City Hospital Number 1 ( Site 1119), Krasnogorsk, Moskovskaya Oblast, Russian Federation|City Clinical Hospital #40 ( Site 1109), Moscow, Moskva, Russian Federation|FSBI Central Hospital with Policlinics ( Site 1105), Moscow, Moskva, Russian Federation|Moscow Clinical Hospital #52 ( Site 1103), Moscow, Moskva, Russian Federation|City Hospital #40 ( Site 1113), Saint Petersburg, Sankt-Peterburg, Russian Federation|City Pokrovskaya hospital ( Site 1116), Saint-Petersburg, Sankt-Peterburg, Russian Federation|City Clinical Hospital #1 ( Site 1112), Smolensk, Smolenskaya Oblast, Russian Federation|Republican Clinical Infectious Hospital n.a. A.F. Agafonov ( Site 1100), Kazan, Tatarstan, Respublika, Russian Federation|IATROS International ( Site 1202), Bloemfontein, Free State, South Africa|Wits Baragwanath Clinical Trial Site ( Site 1204), Soweto, Gauteng, South Africa|TREAD Research ( Site 1201), Cape Town, Western Cape, South Africa|Clinical Projects Research Centre ( Site 1205), Worcester, Western Cape, South Africa|Hospital Universitari Vall d Hebron ( Site 1305), Barcelona, Cataluna, Spain|Hospital Clinic ( Site 1304), Barcelona, Spain|Hospital Universitari Germans Trias i Pujol ( Site 1303), Barcelona, Spain|Hospital Universitario Gregorio Maranon ( Site 1302), Madrid, Spain|Hospital Universitario Ramon y Cajal ( Site 1301), Madrid, Spain|Hospital Universitario La Paz ( Site 1300), Madrid, Spain|Ivano-Frankivsk Regional Clinical Infectious Diseases Hospital ( Site 1605), Ivano-Frankivsk, Ivano-Frankivska Oblast, Ukraine|CNE Central city clinical hospital of Ivano-Frankivsk city council ( Site 1604), Ivano-Frankivsk, Ivano-Frankivska Oblast, Ukraine|MNE Ivano-Frankivsk Regional Phthisiology-Pulmonology Center ( Site 1603), Ivano-Frankivsk, Ivano-Frankivska Oblast, Ukraine|CNPE of Kharkiv RC Regional Clinical Infectious Diseases Hospital ( Site 1606), Kharkiv, Kharkivska Oblast, Ukraine|Сommunal non-com. Institution Oleksandrivska clinical hospital Kyiv ( Site 1600), Kyiv, Kyivska Oblast, Ukraine|Odesa City Clinical Infectious Hospital ( Site 1611), Odesa, Odeska Oblast, Ukraine|Communal Non-Commercial Enterprise Central City Hospital ( Site 1615), Rivne, Rivnenska Oblast, Ukraine|Volyn Regional Clinical Hospital ( Site 1613), Lutsk, Volynska Oblast, Ukraine|Royal Free London NHS Foundation Trust ( Site 1700), London, London, City Of, United Kingdom|King's College Hospital ( Site 1705), London, London, City Of, United Kingdom|North Manchester General Hospital ( Site 1701), Manchester, United Kingdom",https://ClinicalTrials.gov/show/NCT04575584
NCT04427267,Assessment of Thermal Condition of Health Workers Who Use Personal Protective Equipment From Biological Hazards During Their Work With COVID-19 Patients,Observational Model: Case-Control|Time Perspective: Prospective,PPE-02,"Federal State Budgetary Scientific Institution Izmerov Research Institute of Occupational Health, Moscow, Russian Federation",https://ClinicalTrials.gov/show/NCT04427267
NCT04476823,European Pathology Laboratories and COVID-19,Observational Model: Ecologic or Community|Time Perspective: Cross-Sectional,20labocovid01,"CHU de Nice, Nice, France",https://ClinicalTrials.gov/show/NCT04476823
NCT04834856,"Viral Clearance, PK and Tolerability of Ensovibep in COVID-19 Patients",Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,MP0420-CP204|2021-000365-33,"Centre for Human Drug Research, Leiden, Netherlands",https://ClinicalTrials.gov/show/NCT04834856
NCT04373044,"Baricitinib, Placebo and Antiviral Therapy for the Treatment of Patients With Moderate and Severe COVID-19","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",0S-20-3|NCI-2020-02685|P30CA014089,"Los Angeles County-USC Medical Center, Los Angeles, California, United States|USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States",https://ClinicalTrials.gov/show/NCT04373044
NCT04513990,Novel Point-of-Care Diagnostic Test for SARS-CoV-2 (COVID-19),Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,2020-0318|NCI-2020-03470,"Lyndon Baines Johnson General Hospital, Houston, Texas, United States|M D Anderson Cancer Center, Houston, Texas, United States",https://ClinicalTrials.gov/show/NCT04513990
NCT04516759,AZD1656 in Diabetic Patients Hospitalised With Suspected or Confirmed COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",SGS.1656.201|2020-002211-21,"Masarykova Univerzita - Fakultni Nemocnice U SV Anny V Brne (308), Brno, Czechia|Nemocnice Hořovice (309), Hořovice, Czechia|Oblastni Nemocnice Kolín (306), Kolín, Czechia|Klaudianova Nemonice (302), Mladá Boleslav, Czechia|Fakultni Nemocnice V Motole (303), Prague, Czechia|Thomayerova Nemonice (310), Prague, Czechia|Nemocnice Třebíč (305), Třebíč, Czechia|Colentina Clinical Hospital (204), Bucharest, Romania|Spitalul Clinic de Boli Infectioase Cluj-Napoca (203), Cluj-Napoca, Romania|Spitalul Clinic de Pneumoftiziologie ""Leon Daniello"" Cluj-Napoca (202), Cluj-Napoca, Romania|Spitalul Clinic de Boli Infectioase Constanţa (207), Constanţa, Romania|Spitalul Clinic de Boli Infectioase si Pneumoftiziologie Dr Victor Babes Craiova (206), Craiova, Romania|Spitalul Judetean de Urgenta Deva (208), Deva, Romania|Spitalul Clinic de Boli Infectioase ""Sfanta Parascheva"" Iaşi (205), Iaşi, Romania|Spitalul Clinic de Boli Infectioase si Pneumoftiziologie Dr Victor Babes Timişoara (201), Timişoara, Romania|Barnsley Hospital NHS Foundation Trust (105), Barnsley, United Kingdom|Bolton NHS Foundation Trust (122), Bolton, United Kingdom|Bradford Teaching Hospitals NHS Foundation Trust (103), Bradford, United Kingdom|North Bristol NHS Trust (116), Bristol, United Kingdom|County Durham and Darlington NHS Foundation Trust (121), Darlington, United Kingdom|The Dudley Group NHS Foundation Trust (107), Dudley, United Kingdom|Medway NHS Foundation Trust (108), Gillingham, United Kingdom|Hull & East Yorkshire NHS Trust (102), Hull, United Kingdom|Barts Health NHS Trust (101 and 111), London, United Kingdom|Royal Free London NHS Foundation Trust (119), London, United Kingdom|St George's University Hospitals NHS Foundation Trust (114), London, United Kingdom|Penine Acute Hospitals NHS Trust (106), Salford, United Kingdom|Sheffield Hospitals NHS Foundation Trust (104), Sheffield, United Kingdom|Somerset NHS Foundation Trust (109), Taunton, United Kingdom|Walsall Healthcare NHS Trust (113), Walsall, United Kingdom",https://ClinicalTrials.gov/show/NCT04516759
NCT04584671,Lung Structure-Function In Survivors of Mild and Severe COVID-19 Infection,Observational Model: Cohort|Time Perspective: Prospective,ROB0050,"Department of Medicine (Respirology), McMaster University, Hamilton, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04584671
NCT04575597,Efficacy and Safety of Molnupiravir (MK-4482) in Non-Hospitalized Adult Participants With COVID-19 (MK-4482-002),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",4482-002|2020-003368-24|MK-4482-002|PHRR201209-003186|jRCT2031210148,"Phoenix Medical Group ( Site 1822), Peoria, Arizona, United States|Ruane Clinical Research Group, Inc. ( Site 2406), Los Angeles, California, United States|Men's Health Foundation ( Site 1820), Los Angeles, California, United States|Carbon Health Technologies Inc ( Site 2505), North Hollywood, California, United States|UC Davis Medical Center ( Site 1833), Sacramento, California, United States|Emerson Clinical Research Institute ( Site 1828), Washington, District of Columbia, United States|JEM Research Institute ( Site 2508), Atlantis, Florida, United States|Midway Immunology and Research Center ( Site 1837), Fort Pierce, Florida, United States|Indago Research & Health Center, Inc ( Site 1809), Hialeah, Florida, United States|Advanced Research For Health Improvement LLC ( Site 1816), Immokalee, Florida, United States|Advanced Medical Research, LLC ( Site 1864), Miami, Florida, United States|Advanced Research For Health Improvement LLC ( Site 1813), Naples, Florida, United States|Bliss Healthcare Services ( Site 1847), Orlando, Florida, United States|Javara Inc. ( Site 1869), Albany, Georgia, United States|IACT Health ( Site 1818), Columbus, Georgia, United States|Javara Inc. ( Site 1868), Fayetteville, Georgia, United States|Loretto Hospital ( Site 1886), Chicago, Illinois, United States|Jadestone Clinical Research, LLC ( Site 2502), Rockville, Maryland, United States|Michigan Center of Medical Research ( Site 2500), Farmington Hills, Michigan, United States|University of Nebraska Medical Center ( Site 2414), Omaha, Nebraska, United States|Amici Clinical Research LLC ( Site 2507), Raritan, New Jersey, United States|University of New Mexico, Health Sciences Center ( Site 1819), Albuquerque, New Mexico, United States|AXCES Research Group ( Site 2418), Santa Fe, New Mexico, United States|Saint Hope Foundation, Inc. ( Site 1830), Bellaire, Texas, United States|The Crofoot Research Center, Inc. ( Site 1812), Houston, Texas, United States|Javara Inc. ( Site 1866), Sugar Land, Texas, United States|Clinical Research Partners, LLC. ( Site 2503), Richmond, Virginia, United States|Swedish Medical Center First Hill ( Site 1807), Seattle, Washington, United States|Fred Hutchinson Cancer Center ( Site 1829), Seattle, Washington, United States|Multicare Health System ( Site 1811), Spokane, Washington, United States|Multicare Health System ( Site 1814), University Place, Washington, United States|Medical College Of Wisconsin ( Site 2510), Milwaukee, Wisconsin, United States|Chronos Pesquisa Clínica ( Site 0155), Brasilia, Distrito Federal, Brazil|Santa Casa de Misericordia de Belo Horizonte ( Site 0150), Belo Horizonte, Minas Gerais, Brazil|Hospital de Clinicas da Universidade Federal do Parana ( Site 0154), Curitiba, Parana, Brazil|Hospital Tacchini ( Site 0157), Bento Goncalves, Rio Grande Do Sul, Brazil|FUNFARME Hospital de Base Centro Integrado de Pesquisa ( Site 0151), Sao Jose do Rio Preto, Sao Paulo, Brazil|Instituto de Infectologia Emilio Ribas ( Site 0153), Sao Paulo, Brazil|Centro de Pesquisa Clinica II - ICHC - FMUSP ( Site 0152), Sao Paulo, Brazil|Hamilton Medical Research Group ( Site 0207), Hamilton, Ontario, Canada|University Health Network - Toronto General Hospital ( Site 0201), Toronto, Ontario, Canada|Centre Hospitalier de l Universite de Montreal - CHUM ( Site 0200), Montreal, Quebec, Canada|McGill University Health Centre ( Site 0204), Montreal, Quebec, Canada|Servicios Medicos Urumed ( Site 0307), Rancagua, Lbtdr Gen Bernardo O Higgins, Chile|Clinical Research Chile SpA ( Site 0308), Valdivia, Los Rios, Chile|Clinica Universidad de los Andes ( Site 0302), Santiago, Region M. De Santiago, Chile|Fundacion Arturo Lopez Perez ( Site 0305), Santiago, Region M. De Santiago, Chile|Espacio EME ( Site 0304), Santiago, Region M. De Santiago, Chile|Clinica Bicentenario Spa ( Site 0306), Santiago, Region M. De Santiago, Chile|Hospital Pablo Tobon Uribe ( Site 0405), Medellin, Antioquia, Colombia|Clinica de la Costa Ltda. ( Site 0403), Barranquilla, Atlantico, Colombia|Oncomedica S.A. ( Site 0407), Monteria, Cordoba, Colombia|Caja de Compensación Familiar CAFAM. Sede Centro de Atención en Salud CAFAM Floresta ( Site 0406), Bogota, Cundinamarca, Colombia|Centro de Atencion e Investigacion Medica CAIMED ( Site 0413), Bogota, Cundinamarca, Colombia|Fundacion Santa Fe de Bogota ( Site 0412), Bogota, Distrito Capital De Bogota, Colombia|Fundacion Cardiovascular de Colombia ( Site 0402), Bucaramanca, Santander, Colombia|Fundacion Valle del Lili ( Site 0401), Cali, Valle Del Cauca, Colombia|Centro Medico Imbanaco de Cali S.A ( Site 0415), Cali, Valle Del Cauca, Colombia|Hopital Saint Joseph ( Site 0513), Marseille, Bouches-du-Rhone, France|Groupe Hospitalier Pellegrin ( Site 0511), Bordeaux, Gironde, France|C.H.U. de Toulouse Hopital Purpan ( Site 0501), Toulouse, Midi-Pyrenees, France|Centre Hospitalier de Tourcoing ( Site 0502), Tourcoing, Nord, France|CHU Hopital Saint Antoine ( Site 0505), Paris, France|Pitie Salpetriere University Hospital-Infectious Disease - Tropical Diseases ( Site 0504), Paris, France|Hopital Bichat Claude Bernard ( Site 0503), Paris, France|Universitaetsklinikum Frankfurt ( Site 2302), Frankfurt a main, Hessen, Germany|Universitaetsklinikum Essen ( Site 2305), Essen, Nordrhein-Westfalen, Germany|ZIBP-Zentrum fur Infektiologie Berlin Prenzlauer Berg GmbH ( Site 2301), Berlin, Germany|ICH Study Center GmbH & Co.KG ( Site 2306), Hamburg, Germany|Hadassah Medical Center. Ein Kerem ( Site 2100), Jerusalem, Israel|Fondazione IRCCS Ca' Granda-Ospedale Maggiore Policlinico ( Site 0606), Milano, Lombardia, Italy|Policlinico S. Orsola-Malpighi ( Site 0604), Bologna, Italy|IRCCS Ospedale Policlinico San Martino ( Site 0603), Genova, Italy|Ospedale San Raffaele ( Site 0605), Milano, Italy|ASST Fatebenefratelli-Ospedale Sacco ( Site 0601), Milano, Italy|AOU Policlinico Paolo Giaccone ( Site 0609), Palermo, Italy|Ospedale Amedeo di Savoia, Malattie Infettive ( Site 0602), Torino, Italy|Azienda Sanitaria Universitaria Friuli Centrale -ASU FC ( Site 0607), Udine, Italy|Chiba Aoba Municipal Hospital ( Site 0702), Chiba, Japan|Den-en-chofu family clinic ( Site 0701), Tokyo, Japan|Center Hospital of the National Center for Global Health and Medicine ( Site 0700), Tokyo, Japan|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran ( Site 0802), Ciudad de mexico, Distrito Federal, Mexico|Hospital Regional de Alta Especialidad del Bajio ( Site 0807), Leon, Guanajuato, Mexico|Hospital Civil de Guadalajara Fray Antonio Alcalde ( Site 0800), Guadalajara, Jalisco, Mexico|Hospital Universitario Dr. Jose Eleuterio Gonzalez ( Site 0803), Monterrey, Nuevo Leon, Mexico|Köhler & Milstein Research S.A. de C.V. ( Site 0809), Merida, Yucatan, Mexico|Arké SMO S.A de C.V ( Site 0808), Veracruz, Mexico|Lung Center of the Philippines ( Site 0902), Quezon City, National Capital Region, Philippines|Krakowskie Centrum Medyczne Sp. z o.o ( Site 1008), Krakow, Malopolskie, Poland|Central Scientific Research Institute of Epidemiology ( Site 1104), Moscow, Moskva, Russian Federation|Open Joint Stock Company Clinical and Diagnostic Center Euromedservice ( Site 1122), Moscow, Moskva, Russian Federation|Hadassah Medical LTD ( Site 1124), Moscow, Moskva, Russian Federation|Central Clinical Hospital with Polyclinic ( Site 1105), Moscow, Moskva, Russian Federation|City Hospital No.33 of Leninsky ( Site 1127), Nizhny Novgorod, Nizhegorodskaya Oblast, Russian Federation|SPb SBHI City outpatient clinic 112 ( Site 1128), Saint Petersburg, Sankt-Peterburg, Russian Federation|Medical Research Institute LLC ( Site 1116), Saint Petersburg, Sankt-Peterburg, Russian Federation|Smorodintsev Research Institute of Influenza ( Site 1129), Saint Petersburg, Sankt-Peterburg, Russian Federation|SPb SBHI City outpatient clinic 4 ( Site 1131), Saint Petersburg, Sankt-Peterburg, Russian Federation|Strategic Medical System LLC ( Site 1114), Saint-Petersburg, Sankt-Peterburg, Russian Federation|St.Petersburg Outpatient Clinic No. 109 ( Site 1119), Saint-Petersburg, Sankt-Peterburg, Russian Federation|Limited liability company ""Scientific research center Eco-safety"" ( Site 1117), Saint-Petersburg, Sankt-Peterburg, Russian Federation|City Polyclinic N44 ( Site 1130), St.Petersburg, Sankt-Peterburg, Russian Federation|Smolensk State Medical University ( Site 1110), Smolensk, Smolenskaya Oblast, Russian Federation|Republican Clinical Infectious Hospital n.a. A.F. Agafonov ( Site 1100), Kazan, Tatarstan, Respublika, Russian Federation|IATROS International ( Site 1212), Bloemfontein, Free State, South Africa|Right To Care Research - Esizayo ( Site 1229), Johannesburg, Gauteng, South Africa|Mzansi Ethical Research Centre ( Site 1225), Mpumalanga, Gauteng, South Africa|Jongaie Research ( Site 1223), Pretoria-West, Gauteng, South Africa|Wits Baragwanath Clinical Trial Site ( Site 1214), Soweto, Gauteng, South Africa|Enhancing Care Foundation-DICRS ( Site 1216), Durban, Kwazulu-Natal, South Africa|Limpopo Clinical Research Initiative ( Site 1227), Thabazimbi, Limpopo, South Africa|TREAD Research ( Site 1211), Cape Town, Western Cape, South Africa|Desmond Tutu HIV Foundation Clinical Trial Unit ( Site 1219), Cape Town, Western Cape, South Africa|Be Part Yoluntu Centre ( Site 1218), Paarl, Western Cape, South Africa|Paarl Research Centre ( Site 1228), Paarl, Western Cape, South Africa|Clinical Projects Research Centre ( Site 1215), Worcester, Western Cape, South Africa|CAP Centelles ( Site 1308), Centelles, Barcelona, Spain|Hospital General Universitario Gregorio Maranon ( Site 1302), Madrid, Madrid, Comunidad De, Spain|CAP Sardenya - Barcelona ( Site 1307), Barcelona, Spain|Hospital Clinic ( Site 1304), Barcelona, Spain|Hospital Universitari Germans Trias i Pujol ( Site 1303), Barcelona, Spain|Hospital Universitario Infanta Leonor ( Site 1310), Madrid, Spain|Hospital Universitario Ramon y Cajal ( Site 1301), Madrid, Spain|Hospital Universitario La Paz ( Site 1300), Madrid, Spain|Karolinska Universitetssjukhuset Solna ( Site 1400), Stockholm, Stockholms Lan, Sweden|ClinSmart Sweden AB.Uppsala ( Site 1402), Uppsala, Uppsala Lan, Sweden|Sahlgrenska Universitetssjukhuset Ostra ( Site 1401), Goteborg, Vastra Gotalands Lan, Sweden|National Taiwan University Hospital ( Site 3100), Taipei, Taiwan|Taoyuan General Hospital ( Site 3101), Taoyuan, Taiwan|Ivano-Frankivsk Regional Clinical Infectious Diseases Hospital ( Site 1605), Ivano-Frankivsk, Ivano-Frankivska Oblast, Ukraine|CNE Central city clinical hospital of Ivano-Frankivsk city council ( Site 1604), Ivano-Frankivsk, Ivano-Frankivska Oblast, Ukraine|MNE Ivano-Frankivsk Regional Phthisiology-Pulmonology Center ( Site 1603), Ivano-Frankivsk, Ivano-Frankivska Oblast, Ukraine|Non profit municipal enterprise City hospital student of Kharkiv city council ( Site 1621), Kharkiv, Kharkivska Oblast, Ukraine|LLC ""Adonis plus"" ( Site 1619), Kyiv, Kyivska Oblast, Ukraine|Kyiv railway clinical hospital 2 of Branch Health center ( Site 1602), Kyiv, Kyivska Oblast, Ukraine|ARTEM. State Holding Company ( Site 1618), Kyiv, Kyivska Oblast, Ukraine|Municipal Noncommercial Enterprise Lviv 4th City Clinical Hospital ( Site 1622), Lviv, Lvivska Oblast, Ukraine|The Adam Practice ( Site 1708), Poole, Dorset, United Kingdom|Accellacare South London Quality Research Centre ( Site 1709), Orpington, Kent, United Kingdom|Layton Medical Centre ( Site 1705), Blackpool, Lancashire, United Kingdom|Royal Free London NHS Foundation Trust ( Site 1700), London, London, City Of, United Kingdom|King's College Hospital ( Site 1707), London, London, City Of, United Kingdom|Newcastle upon Tyne Hospitals NHS Foundation Trust ( Site 1704), Newcastle upon Tyne, United Kingdom",https://ClinicalTrials.gov/show/NCT04575597
NCT04342897,A Study of LY3127804 in Participants With COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",17824|I7W-MC-UDAA,"Banner Univ Med Ctr Phoenix, Phoenix, Arizona, United States|Banner Univ Med Ctr Tucson, Tucson, Arizona, United States|National Jewish Medical and Research Center, Denver, Colorado, United States|Nuvance Danbury Hospital, Danbury, Connecticut, United States|NorthShore University HealthSystem, Evanston, Illinois, United States|Parkview Research Center, Fort Wayne, Indiana, United States|Franciscan St. Francis Health, Indianapolis, Indiana, United States|Ochsner Clinic Foundation, New Orleans, Louisiana, United States|Lahey Hospital and Medical Center, Burlington, Massachusetts, United States|Henry Ford Hospital Detroit, Detroit, Michigan, United States|Allina Hospital Network, Minneapolis, Minnesota, United States|State University of New York Hospital, Syracuse, New York, United States|East Carolina University, Greenville, North Carolina, United States",https://ClinicalTrials.gov/show/NCT04342897
NCT04844515,The ESPERES Prospective Cohort of Healthcare Workers in France: Study on COVID-19 Vaccine and the COVID-19 Pandemic (ESPERES_COVID19),Observational Model: Cohort|Time Perspective: Prospective,APHP210173.1,"Pitié-Salpêtrière - Charles Foix, AP-HP, Paris, France",https://ClinicalTrials.gov/show/NCT04844515
NCT04347876,Outcome of COVID-19 Cases Based on Tuberculin Test: Can Previous BCG Alter the Prognosis?,Observational Model: Case-Control|Time Perspective: Prospective,AssiutU12,"AssiutU, Assiut, Egypt",https://ClinicalTrials.gov/show/NCT04347876
NCT04701606,The Safety and Efficacy of Pyronaridine-artesunate (Pyramax® or Artecom®)in COVID-19 Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",SP-PA-COV-203,"Lung Center of the Philippines, Quezon City, Quezon Avenue, Quezon City, 1100 Philippines, Philippines|Philippine General Hospital, Manila, Taft Ave, Ermita, Manila, 1000 Metro, Philippines",https://ClinicalTrials.gov/show/NCT04701606
NCT04497779,Analysis of Coronavirus Disease 19 (COVID-19) Convalescent Plasma,Observational Model: Cohort|Time Perspective: Prospective,20204|NCI-2020-04000|P30CA033572|TGen,"City of Hope Medical Center, Duarte, California, United States",https://ClinicalTrials.gov/show/NCT04497779
NCT04969250,Vaccination for Recovered Inpatients With COVID-19 (VATICO),Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,016 / VATICO,NA,https://ClinicalTrials.gov/show/NCT04969250
NCT04895007,Comparative Evaluation of Covid-19 Vaccines Response,Observational Model: Case-Crossover|Time Perspective: Prospective,2021-04-30T1,"Karamanoglu Mehmetbey University, Karaman, Turkey|Selcuk University, Konya, Turkey|Tekirdag Namık Kemal University, Faculty of Medicine, Tekirdağ, Turkey|Karadeniz Technic University, Faculty of Medicine, Trabzon, Turkey",https://ClinicalTrials.gov/show/NCT04895007
NCT04753346,Comparison of Cardiopulmonary Fitness Level With Normal Values After COVID-19,Observational Model: Other|Time Perspective: Cross-Sectional,I11-670-20,"Ankara University, Faculty of Medicine, Physical Medicine and Rehabilitation Department, Ankara, Turkey",https://ClinicalTrials.gov/show/NCT04753346
NCT04483960,Australasian COVID-19 Trial (ASCOT) ADAptive Platform Trial,Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,ERM 62646-A,"Calvary Public Bruce Hospital, Bruce, Australian Capital Territory, Australia|The Canberra Hospital, Canberra, Australian Capital Territory, Australia|Armidale Hospital, Armidale, New South Wales, Australia|Bankstown-Lidcombe Hospital, Bankstown, New South Wales, Australia|Blacktown Hospital, Blacktown, New South Wales, Australia|Campbelltown Hospital, Campbelltown, New South Wales, Australia|Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia|Canterbury Hospital, Campsie, New South Wales, Australia|The Sutherland Hospital, Caringbah, New South Wales, Australia|Coffs Harbour Health Campus, Coffs Harbour, New South Wales, Australia|Concord Repatriation General Hospital, Concord, New South Wales, Australia|St Vincent's Hospital Sydney, Darlinghurst, New South Wales, Australia|Northern Beaches Hospital, Frenchs Forest, New South Wales, Australia|Griffith Base Hospital, Griffith, New South Wales, Australia|Nepean Hospital, Kingswood, New South Wales, Australia|St George Hospital, Kogarah, New South Wales, Australia|Lismore Base Hospital, Lismore, New South Wales, Australia|Liverpool Hospital, Liverpool, New South Wales, Australia|John Hunter Hospital, New Lambton Heights, New South Wales, Australia|Orange Health Service, Orange, New South Wales, Australia|Port Macquarie Base Hospital, Port Macquarie, New South Wales, Australia|Prince of Wales Hospital, Randwick, New South Wales, Australia|Royal North Shore Hospital, St Leonards, New South Wales, Australia|The Tweed Hospital, Tweed Heads, New South Wales, Australia|Wagga Wagga Base Hospital, Wagga Wagga, New South Wales, Australia|Calvary Mater Newcastle, Waratah, New South Wales, Australia|Westmead Hospital, Westmead, New South Wales, Australia|Wollongong Hospital, Wollongong, New South Wales, Australia|Royal Darwin Hospital, Tiwi, Northern Territory, Australia|Sunshine Coast University Hospital, Birtinya, Queensland, Australia|Caboolture Hospital, Caboolture, Queensland, Australia|Cairns Hospital, Cairns, Queensland, Australia|The Prince Charles Hospital, Chermside, Queensland, Australia|Royal Brisbane and Women's Hospital, Herston, Queensland, Australia|Mackay Base Hospital, Mackay, Queensland, Australia|Logan Hospital, Meadowbrook, Queensland, Australia|Redcliffe Hospital, Redcliffe, Queensland, Australia|Mater, South Brisbane, Queensland, Australia|Gold Coast University Hospital, Southport, Queensland, Australia|Townsville University Hospital, Townsville, Queensland, Australia|Princess Alexandra Hospital, Woolloongabba, Queensland, Australia|Royal Adelaide Hospital, Adelaide, South Australia, Australia|Flinders Medical Centre, Bedford Park, South Australia, Australia|Lyell McEwin Hospital, Elizabeth Vale, South Australia, Australia|Royal Hobart Hospital, Hobart, Tasmania, Australia|Launceston General Hospital, Launceston, Tasmania, Australia|Ballarat Health Services, Ballarat Central, Victoria, Australia|St John of God Ballarat Hospital, Ballarat, Victoria, Australia|Bendigo Health, Bendigo, Victoria, Australia|Eastern Health (Box Hill Hospital), Box Hill, Victoria, Australia|Monash Health, Clayton, Victoria, Australia|Northern Health, Epping, Victoria, Australia|St. Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia|Frankston Hospital - Penninsula Health, Frankston, Victoria, Australia|Peninsula Private Hospital, Frankston, Victoria, Australia|Barwon Health - University Hospital Geelong, Geelong, Victoria, Australia|Austin Health, Heidelberg, Victoria, Australia|Cabrini Health, Malvern, Victoria, Australia|Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia|Alfred Hospital, Melbourne, Victoria, Australia|Royal Melbourne Hospital, Parkville, Victoria, Australia|Epworth Richmond, Richmond, Victoria, Australia|Goulburn Valley Health, Shepparton, Victoria, Australia|Western Health, St Albans, Victoria, Australia|Latrobe Regional Hospital, Traralgon, Victoria, Australia|West Gippsland Hospital, Warragul, Victoria, Australia|Albury Wodonga Health, Wodonga, Victoria, Australia|Rockingham General Hospital, Cooloongup, Western Australia, Australia|Joondalup Health Campus, Joondalup, Western Australia, Australia|Armadale Health Service, Mount Nasura, Western Australia, Australia|Fiona Stanley Hospita, Murdoch, Western Australia, Australia|Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia|Royal Perth Hospital, Perth, Western Australia, Australia|St John of God Subiaco Hospital, Subiaco, Western Australia, Australia|Knox Private Hospital, Wantirna, Australia",https://ClinicalTrials.gov/show/NCT04483960
NCT04871867,Cardiac and Lung Assessment of Professional Soccer Players Following COVID-19 Disease,Observational Model: Cohort|Time Perspective: Prospective,americanHparis,"American Hospital of Paris, Neuilly-sur-Seine, France",https://ClinicalTrials.gov/show/NCT04871867
NCT04787211,"A Phase 2 Study of Human Monoclonal Antibodies, BRII-196 and BRII-198",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,BRII-196-198-004,"Beijing Ditan Hospital Capital Medical University, Beijing, Beijing, China|Guangzhou Eighth Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China|The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China|The Third People's Hospital of Shenzhen, Shenzhen, Guangdong, China",https://ClinicalTrials.gov/show/NCT04787211
NCT04847583,"A Phase 2 Study to Evaluate Biomarker Change, Efficacy, Pharmacokinetics, Safety and Tolerability of Telacebec (Q203) in Covid-19 Patients",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,Q203-COVID-P2-ZA001,"Chris Hani Baragwanath Academic Hospital, Soweto, Gauteng, South Africa|KwaPhila Health Solutions, Durban, Kwa-Zula Natal, South Africa|TASK Eden, George, Western Cape, South Africa",https://ClinicalTrials.gov/show/NCT04847583
NCT04878328,Leveraging CHWs to Improve COVID-19 Testing and Mitigation Among CJIs Accessing a Corrections-focused CBO,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Screening,2021-12976,"Montefiore Medical Center, Bronx, New York, United States|Fortune Society, Long Island City, New York, United States",https://ClinicalTrials.gov/show/NCT04878328
NCT04333732,CROWN CORONATION: COVID-19 Research Outcomes Worldwide Network for CORONAvirus prevenTION,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention",202004099|INV-017499,"Washington University School of Medicine, Saint Louis, Missouri, United States|University of Ghana Medical Centre, Accra, Greater Accra Region, Ghana|Groote Schuur/J52, Desmond Tutu Health Foundation, Mowbray, Cape Town, South Africa|Masiphumelele, Desmond Tutu Health Foundation, Sunnydale, Cape Town, South Africa|JOSHA Research, Bloemfontein, Free State, South Africa|Wits RHI, University of the Witwatersrand, Hillbrow, Johannesburg,Gauteng, South Africa|Clinical HIV Research Unit (CHRU), Auckland Park, Johannesburg, South Africa|Perinatal HIV Research Unit (PHRU), Diepkloof, Johannesburg, South Africa|Setshaba Research Centre, Soshanguve, Tshwane, South Africa|Groote Schuur Hospital, Cape Town, Western Cape, South Africa|FAMCRU (Family Clinical Research with Ubuntu), Cape Town, South Africa|Chatsworth, HIV Prevention Research Unit, South African Medical Research Council, Chatsworth, South Africa|Isipingo, HIV Prevention Research Unit, South African Medical Research Council, Durban, South Africa|Aurum Institute Tembisa, Tembisa, South Africa|University College London, London, United Kingdom|Levy Mwanawasa University Teaching Hospital, Lusaka, Zambia|Centre for Infectious Disease Research in Zambia [CIDRZ], Lusaka, Zambia",https://ClinicalTrials.gov/show/NCT04333732
NCT04866303,Protecting Our Community: COVID-19 Testing,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Diagnostic",3P20GM104417-07S1,"Salish Kootenai College, Pablo, Montana, United States|Fred Hutchinson Cancer Research Center, Seattle, Washington, United States",https://ClinicalTrials.gov/show/NCT04866303
NCT04916639,Seawater Nasal Wash to Relieve COVID-19 Nasal Symptoms and Reduce SARS-CoV-2 Viral Load.,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,SeaCare,NA,https://ClinicalTrials.gov/show/NCT04916639
NCT04351152,Phase 3 Study to Evaluate Efficacy and Safety of Lenzilumab in Patients With COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",HGEN003-06,"Mayo Clinic, Phoenix, Arizona, United States|University of California, Irvine, Irvine, California, United States|University of Southern California (USC) Medical Center, Los Angeles, California, United States|USC - Los Angeles County Medical Center, Los Angeles, California, United States|MedStar Washington Hospital Center, Washington, District of Columbia, United States|Mayo Clinic, Jacksonville, Florida, United States|AdventHealth Orlando, Orlando, Florida, United States|Emory University, Atlanta, Georgia, United States|St. Elizabeth Healthcare, Edgewood, Kentucky, United States|Hennepin County Medical Center, Minneapolis, Minnesota, United States|Mayo Clinic, Rochester, Minnesota, United States|Dartmouth-Hitchcock, Lebanon, New Hampshire, United States|Saint Barnabas Medical Center, Livingston, New Jersey, United States|Mercy Medical Center, Rockville Centre, New York, United States|Atrium Health, Charlotte, North Carolina, United States|St. David's Healthcare, Austin, Texas, United States|St. David's North Austin Medical Center, Austin, Texas, United States|Texas Health, Dallas, Texas, United States|Hospital Vera Cruz, Belo Horizonte, Minas Gerais, Brazil|CPCLIN - Centro de Pesquisas Clínicas de Natal, Natal, Rio Grande Do Norte, Brazil|Hospital São Lucas - PUCRS, Porto Alegre, Rio Grande Do Sul, Brazil|Sociedade Literaria e Caritativa Santo Agostinho, Criciúma, Santa Catarina, Brazil|Hospital Dia do Pulmão, Blumenau, São Paulo, Brazil|Hospital Guilherme Alvaro, Santos, São Paulo, Brazil|Clinica de Alergia Martti Antila S/S LTDA, Sorocaba, São Paulo, Brazil|CEMEC - Centro Multidisciplinar de Estudos Clínicos LTDA-EPP, São Bernardo do Campo, São Paulo, Brazil|Escola Paulista de Medicina (UNIFESP), São Paulo, Brazil|Hospital Heliópolis, São Paulo, Brazil|Hospital São Luiz do Jabaquara/IDOR, São Paulo, Brazil",https://ClinicalTrials.gov/show/NCT04351152
NCT04356417,Long-term Use of Drugs That Could Prevent the Risk of Serious COVID-19 Infections or Make it Worse,Observational Model: Cohort|Time Perspective: Other,APHP200412,"Assistance Publique Hôpitaux de Paris - CHU Henri Mondor, Créteil, France",https://ClinicalTrials.gov/show/NCT04356417
NCT04498247,"A Study to Assess Safety, Tolerability, and Immunogenicity of V591 (COVID-19 Vaccine) in Healthy Participants (V591-001)","Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",V591-001|2020-003493-46,"Research Centers of America, LLC ( Site 0014), Hollywood, Florida, United States|Alliance for Multispecialty Research, LLC ( Site 0013), Wichita, Kansas, United States|Central Kentucky Research Associates, Inc. ( Site 0011), Lexington, Kentucky, United States|The Center for Pharmaceutical Research PC ( Site 0012), Kansas City, Missouri, United States|SCRI-CCCIT GesmbH ( Site 0006), Salzburg, Austria|Medizinische Universitaet Wien ( Site 0007), Wien, Austria|Universitair Ziekenhuis Gent ( Site 0003), Gent, Oost-Vlaanderen, Belgium|SGS Life Science Services ( Site 0001), Antwerpen, Belgium|ATC - Clinical Pharmacology Unit ( Site 0002), Liege, Belgium",https://ClinicalTrials.gov/show/NCT04498247
NCT04608383,Laparoscopy and COVID-19 Contamination,Observational Model: Case-Only|Time Perspective: Prospective,APHP200611,"AP-HP, Bicêtre Hospital, Anesthesia Department, Le Kremlin Bicêtre, France|AP-HP, Bicêtre Hospital, Gynecology department, Le Kremlin Bicêtre, France|AP-HP, Bicêtre Hospital, Department of Digestive and Oncological Surgery, Le Kremlin-Bicêtre, France|AP-HP, Bicêtre Hospital, Urology Department, Le Kremlin-Bicêtre, France",https://ClinicalTrials.gov/show/NCT04608383
NCT04412265,Frailty in Elderly Patients With COVID-19,Observational Model: Case-Only|Time Perspective: Retrospective,FRA-COVID,"Dipartimento di Geriatria, Fondazione Poliambulanza, Brescia, Italy|Dipartimento di Medicina e Riabilitazione, Istituto Clinico Ospedale S. Anna, Brescia, Italy|UO Malattie Infettive, Spedali Civili, Brescia, Italy|UOC Medicina I a indirizzo Geriatrico, Spedali Civili, Montichiari, Italy|ASST Monza-Ospedale San Gerardo, Monza, Italy|SCDU Geriatria, AOU Città della Salute e della Scienza - Presidio Molinette, Torino, Italy",https://ClinicalTrials.gov/show/NCT04412265
NCT04279197,Treatment of Pulmonary Fibrosis Due to COVID-19 With Fuzheng Huayu,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",Fzhy-ncp-2,"Shuguang Hospital, Shanghai, Shanghai, China",https://ClinicalTrials.gov/show/NCT04279197
NCT04937543,Efficacy of Inhaled Therapies in the Treatment of Acute Symptoms Associated With COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,TRIV001,"Hospital das Clínicas da Faculdade de Medicina de Botucatu, Botucatu, São Paulo, Brazil",https://ClinicalTrials.gov/show/NCT04937543
NCT04329507,Non-invasive Detection of Pneumonia in Context of Covid-19 Using Gas Chromatography - Ion Mobility Spectrometry (GC-IMS),Observational Model: Cohort|Time Perspective: Prospective,282014,"NHS Lothian, Edinburgh, United Kingdom",https://ClinicalTrials.gov/show/NCT04329507
NCT04795414,Safety and Immunogenicity of an Inactivated Vaccine Against COVID-19 in Medical Workers,Observational Model: Cohort|Time Perspective: Prospective,RJHKY2021-12,"Ruijin Hospital affiliated to Shanghai JiaoTong University School of Medicine, Shanghai, Shanghai, China",https://ClinicalTrials.gov/show/NCT04795414
NCT04350736,"First in Human SAD and MAD Study of Inhaled TD-0903, a Potential Treatment for ALI Associated With COVID-19","Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",0183|2020-000577-24,"Theravance Biopharma Investigational Site, Manchester, United Kingdom",https://ClinicalTrials.gov/show/NCT04350736
NCT04591210,The COVID-RASi Trial (COVID-19),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,CTO-3212,"Centro de Pesquisa Clinicas Dr Marco Mota, Maceio, Alagoas, Brazil|Santa Casa de Itabuna, Itabuna, Bahia, Brazil|Hospital Felicio Rocho, Belo Horizonte, MG, Brazil|Centro de Pesquisa Clinica da Unimed Campo Grande, Campo Grande, MG, Brazil|Clinica de Campo Grande, Campo Grande, MG, Brazil|Hospital Agamenom Magalhaes, Recife, PE, Brazil|Pronto Socorro Cardiologico de Pernambuco Recife, Recife, PE, Brazil|Instituto Atena de Pesquisa Clinica, Natal, RN, Brazil|Hospital Universitar Canoas, Canoas, RS, Brazil|Hospital Sao Vicente de Paulo, Passo Fundo, RS, Brazil|Instituto de Pesquisa Clinica de Campinas, Campinas, SP, Brazil|Hospital Bela Vista, Consolacao, SP, Brazil|Instituto Prevent Senior, Sao Paulo, SP, Brazil|Instituto de Coracao, São Paulo, SP, Brazil|Instituto Goiano de Oncologia e Hematologia, Goiânia, Brazil|Alberta Health Services, Edmonton, Alberta, Canada|University of Ottawa Heart Institute, Ottawa, Ontario, Canada|Hospital General 1, IMSS, Ciudad de Mexico, Mexico|Hospital General de zona 27- IMSS, Ciudad de Mexico, Mexico",https://ClinicalTrials.gov/show/NCT04591210
NCT04609839,FOLLOW-UP OF PATIENTS WITH COVID-19.,Observational Model: Case-Only|Time Perspective: Prospective,TeleRea'nCo|7883,"Hopitaux Universitaires de Strasbourg, Strasbourg, France",https://ClinicalTrials.gov/show/NCT04609839
NCT04848467,"COVID-19: A Trial Studying the SARS-CoV-2 mRNA Vaccine CVnCoV to Learn About the Immune Response, the Safety, and the Degree of Typical Vaccination Reactions When CVnCoV is Given at the Same Time as a Flu Vaccine Compared to When the Vaccines Are Separately Given in Adults 60 Years of Age and Older","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",21819,"Instituto de Investigaciones Clinicas de Quilmes, Quilmes, Buenos Aires, Argentina|Fundación Cenit para la Investigación en Neurociencias, Caba, Ciudad Auton. De Buenos Aires, Argentina|Sanatorio Parque S.A., Rosario, Santa Fe, Argentina|Centro de Atencion e Investigation Medica S.A.S. - CAIMED CH, Cundinamarca, Distrito Capital De Bogotá, Colombia|Centro de Investigacion Medico Asistencial S.A.S - CIMEDICAL, Barranquilla, Colombia|Centros de Estudios en Infectologia Pediatrica S.A.S. CEIP, Calì, Colombia|Istituto de Investigacion Nutricional, Lima-12, Lima, Peru|Clinica Medica San Martin EIRL - Inv. Metabolicas-Cardiolog, Ica, Peru|Clinica Renal y Oncologica - Centro para Ensayos Clinicos, Lima, Peru",https://ClinicalTrials.gov/show/NCT04848467
NCT04382235,Non-invasive Ventilatory Support of Patients Affected by COVID-19,Observational Model: Cohort|Time Perspective: Prospective,WARd-COVID,"Policlinico San Marco - Ospedale Zingonia, Bergamo, BG, Italy|ASST Papa Giovanni XXIII - Bergamo, Bergamo, Italy|Azienda Ospedaliera - Universitaria di Bologna, Policlinico S. Orsola Malpighi, Bologna, Italy|ASST Spedali Civili - Brescia, Brescia, Italy|ASST Valle Olona - Ospedale di Busto Arsizio, Busto Arsizio, Italy|ASST Lariana - Ospedale Sant'Anna, Como, Italy|ASST Crema - Ospedale Maggiore di Crema, Crema, Italy|ASST Cremona - Ospedale di Cremona, Cremona, Italy|Istituto Clinico Humanitas Gavazzeni, Cremona, Italy|ASST Garda - Presidio di Desenzano del Garda, Desenzano Del Garda, Italy|ASST Monza - Desio, Desio, Italy|ASST Spedali Civili -Ospedale di Gardone Val Trompia, Gardone Val Trompia, Italy|ASST Lecco - Ospedale ""A. Manzoni"", Lecco, Italy|ASST Ovest milanese - Ospedale di Legnano, Legnano, Italy|ASST Lodi - Ospedale Maggiore di Lodi, Lodi, Italy|ASST OVEST Milanese - Ospedale di Magenta, Magenta, Italy|ASST Garda - Ospedale di Manerbio, Manerbio, Italy|ASST Mantova - Ospedale Carlo Poma, Mantova, Italy|ASST Melegnano e della Martesana - Presidio di Melzo-Gorgonzola, Melzo, Italy|ASST Fatebenefratelli - Presidi Fatebenefratelli & M. Melloni, Milano, Italy|ASST Fatebenefratelli - Sacco, Milano, Italy|ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy|Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milano, Italy|Ospedale San Giuseppe, Milano, Italy|ASST Spedali Civili -Presidio Ospedaliero di Montichiari, Montichiari, Italy|ASST Monza - Ospedale San Gerardo, Monza, Italy|Fondazione IRCCS Policlinico San Matteo - Pavia, Pavia, Italy|Policlinico San Pietro, Ponte San Pietro, Italy|Istituto Clinico Humanitas Rozzano, Rozzano, Italy|ASST Valle Olona - Ospedale di Saronno, Saronno, Italy|ASST Bergamo OVEST - Ospedale ""Treviglio-Caravaggio"" di Treviglio, Treviglio, Italy|Ospedale di Circolo e Fondazione Macchi - Varese, Varese, Italy|ASST Vimercate - Ospedale di Vimercate, Vimercate, Italy|ASST Melegnano e della Martesana - Ospedale di Vizzolo Predabissi, Vizzolo Predabissi, Italy",https://ClinicalTrials.gov/show/NCT04382235
NCT04348214,Screening & Risk Assessment of Healthcare Workers & Infection Control in University & COVID-19 Quarantine Hospitals,Observational Model: Cohort|Time Perspective: Prospective,FMASU P18a/ 2020,"Faculty of Medicine Ain Shams University Research Institute- Clinical Research Center, Cairo, Non-US, Egypt",https://ClinicalTrials.gov/show/NCT04348214
NCT04527458,Case Fatalities in Hospitalised COVID-19 Patients in the UK,Observational Model: Cohort|Time Perspective: Prospective,ISARIC_COVID_CF,"University of Edinburgh, Edinburgh, United Kingdom",https://ClinicalTrials.gov/show/NCT04527458
NCT04526054,Morphological Abnormalities of the Olfactory Bulb on MRI and Olfactometry in Anosmic Versus Normosmic COVID-19 Patients,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,2020_0057,"Hopital Foch, Suresnes, Ile-de-France, France|Hopital Raymond Poincare, Garches, France",https://ClinicalTrials.gov/show/NCT04526054
NCT04649320,Perception of the COVID-19 Pandemic in Patients With Haematological or Solid Neoplasias,Observational Model: Cohort|Time Perspective: Other,1264/2020,"Medical University of Innsbruck, Innsbruck, Tyrol, Austria",https://ClinicalTrials.gov/show/NCT04649320
NCT04632537,BCG Vaccination to Prevent COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention",USUHS.2020-062,NA,https://ClinicalTrials.gov/show/NCT04632537
NCT04609969,Diagnostic Performance Evaluation of a Novel SARS-CoV-2 (COVID-19) Antigen Detection Test,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,CHRO-2020-18,"Centre Hospitalier Régional d'Orléans, France, Orléans, France",https://ClinicalTrials.gov/show/NCT04609969
NCT04894617,Amantadine for COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",02032021|2021-001177-22,NA,https://ClinicalTrials.gov/show/NCT04894617
NCT04569292,COVID-19 Infection in Cancer Pantients,Observational Model: Case-Only|Time Perspective: Other,COICA_PAG_01,"Oncology Unit, Hospital Andrea Tortora, Pagani, Salerno, Italy",https://ClinicalTrials.gov/show/NCT04569292
NCT04365231,Hydroxychloroquine Azithromycin COVID-19 Pregnancy Trial,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,HASCOPT2020,NA,https://ClinicalTrials.gov/show/NCT04365231
NCT04797975,Off-the-shelf NK Cells (KDS-1000) as Immunotherapy for COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",KNK-COV-001,NA,https://ClinicalTrials.gov/show/NCT04797975
NCT04558463,The Effectivity and Safety of Favipiravir Compared to Oseltamivir as Adjuvant Therapy for COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,20-04-0455,"Cipto Mangunkusumo National Referral Hospital, Jakarta, DKI Jakarta, Indonesia",https://ClinicalTrials.gov/show/NCT04558463
NCT04911868,Surgical Management During the Era of COVID-19,Observational Model: Other|Time Perspective: Retrospective,2020-5014-11563.,"Aga Khan University, Karachi, Sindh, Pakistan",https://ClinicalTrials.gov/show/NCT04911868
NCT04912284,Africa COVID-19 Vaccine Hesitancy,Observational Model: Ecologic or Community|Time Perspective: Cross-Sectional,2021-10550-BO-ff,"Henri Gautier Ouedragogo, Ouagadougou, Burkina Faso|Alpha Mahmoud Barry, Conakry, Guinea|Seydou Doumbia, Bamako, Mali|Sylvain Faye, Dakar, Senegal|Abdul Mbawah, Freetown, Sierra Leone",https://ClinicalTrials.gov/show/NCT04912284
NCT04508985,The McGill RAAS-COVID-19 Trial,Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,MP-37-2021-6614,NA,https://ClinicalTrials.gov/show/NCT04508985
NCT04455308,COVID-19 and Chilblains,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,35RC20_8888_ECCES,"CHU Angers, Angers, France|CHRU Brest, Brest, France|CHU Nantes, Nantes, France|CHU Rennes, Rennes, France|CHRU Tours, Tours, France",https://ClinicalTrials.gov/show/NCT04455308
NCT04953247,Use of Compromised Lung Volume in Monitoring Usage of Steroid Therapy on Severe COVID-19,Observational Model: Cohort|Time Perspective: Retrospective,CLVMUST,"Zhongshan hospital, Fudan university, Shanghai, China",https://ClinicalTrials.gov/show/NCT04953247
NCT04570449,Fluoxetine to Reduce Hospitalization From COVID-19 Infection (FloR COVID-19),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",15598,"Milton S. Hershey Medical Center Clinical Research Center, Hershey, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04570449
NCT04456049,Randomized Open Label Phase II Study to Evaluate the Efficacy of Enzalutamide in High Risk Male Outpatients With COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,COVID_ENZA,"Oncology Institute of Southern Switzerland (IOSI), Bellinzona, Switzerland",https://ClinicalTrials.gov/show/NCT04456049
NCT04568096,Combination of Chemopreventive Agents (All- Trans Retinoic Acid and Tamoxifen) as Potential Treatment for the Lung Complication of COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,COVID-2019,NA,https://ClinicalTrials.gov/show/NCT04568096
NCT04351529,Austrian COVID-19 Registry,Observational Model: Other|Time Perspective: Other,AGMT_COVID-19,"LKH Feldkirch: Innere Medizin II/ Interne E (Hämatologie und Onkologie), Feldkirch, Austria|Kepler Universitätsklinikum Linz, Med. Campus III., Klinik für Lungenheilkunde / Pneumologie, Linz, Austria|IIIrd Medical Department, Private Medical University Hospital Salzburg, Salzburg, Austria|KH Zams: Innere Medizin Internistische Onkologie und Hämatologie, Zams, Austria",https://ClinicalTrials.gov/show/NCT04351529
NCT04482634,Tele-rehabilitation Versus Home Exercise Program in COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,2020.219.IRB1.069,"Koc University School of Medicine, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04482634
NCT04374526,Early transfusIon of Convalescent Plasma in Elderly COVID-19 Patients. to Prevent Disease Progression.,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,3205,"Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, RM, Italy|Ospedale SS Annunziata, Chieti, Italy|Istituto Nazionale Malattie Infettive Lazzaro Spallanzani, Rome, Italy",https://ClinicalTrials.gov/show/NCT04374526
NCT04796402,A Study to Assess if a Medicine Called Bamlanivimab is Safe and Effective in Reducing Hospitalization Due to COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,FHREB 2021-023,"Fraser Health Authority, Fraser Health Region, British Columbia, Canada",https://ClinicalTrials.gov/show/NCT04796402
NCT04657497,A Study of FOY-305 in Patients With SARS-Cov-2 Infection (COVID-19),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",FOY-305-01,"Aichi Clinical Site 1, Tokoname, Aichi, Japan|Chiba Clinical Site 1, Narita, Chiba, Japan|Fukuoka Clinical Site 1, Okawa, Fukuoka, Japan|Ibaraki Clinical Site 1, Tsuchiura, Ibaraki, Japan|Ishikawa Clinical Site 1, Kanazawa, Ishikawa, Japan|Kanagawa Clinical Site 3, Kawasaki, Kanagawa, Japan|Kanagawa Clinical Site 1, Yokohama, Kanagawa, Japan|Kanagawa Clinical Site 2, Yokosuka, Kanagawa, Japan|Mie Clinical Site 1, Yokkaichi, Mie, Japan|Niigata Clinical Site 1, Nagaoka, Niigata, Japan|Osaka Clinical Site 2, Daito, Osaka, Japan|Saitama Clinical Site 3, Kawagoe, Saitama, Japan|Saitama Clinical Site 1, Kuki, Saitama, Japan|Saitama Clinical Site 2, Kumagaya, Saitama, Japan|Tokyo Clinical Site 5, Bunkyo-ku, Tokyo, Japan|Tokyo Clinical Site 9, Bunkyo-ku, Tokyo, Japan|Tokyo Clinical Site1, Hachioji, Tokyo, Japan|Tokyo Clinical Site 7, Itabashi-ku, Tokyo, Japan|Tokyo Clinical Site 3, Meguro-ku, Tokyo, Japan|Tokyo Clinical Site 4, Shinagawa-ku, Tokyo, Japan|Tokyo Clinical Site 8, Sibuya-ku, Tokyo, Japan|Tokyo Clinical Site2, Sibuya-ku, Tokyo, Japan|Tokyo Clinical Site 6, Tachikawa, Tokyo, Japan|Okayama Clinical Site 1, Okayama, Japan|Osaka Clinical Site 1, Osaka, Japan",https://ClinicalTrials.gov/show/NCT04657497
NCT04713163,COVID-19 Vaccine Induced Immunity,Observational Model: Cohort|Time Perspective: Prospective,B2021:008,NA,https://ClinicalTrials.gov/show/NCT04713163
NCT04576728,Efficacy and Safety of Trimodulin in Subjects With Severe COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",998,"Investigational site # 5503, Porto Alegre, Brazil|Investigational site # 5502, Santo André, Brazil|Investigational site # 5505, Santo André, Brazil|Investigational site # 5501, São Paulo, Brazil|Investigational site # 3304, Paris, France|Investigational Site # 3301, Paris, France|Investigational site # 3305, Saint-Étienne, France|Investigational site # 0707, Kemerovo, Russian Federation|Investigational site # 0709, Krasnoyarsk, Russian Federation|Investigational site # 0702, Moscow, Russian Federation|Investigational site # 0706, Moscow, Russian Federation|Investigational site # 0711, Moscow, Russian Federation|Investigational Site # 0704, Moscow, Russian Federation|Investigational site # 0708, Moscow, Russian Federation|Investigational site # 0701, Saint Petersburg, Russian Federation|Investigational Site # 3401, Barcelona, Spain|Investigational Site # 3402, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04576728
NCT04912700,The Impact of Vaccination on Severity of Illness in COVID-19,Observational Model: Cohort|Time Perspective: Retrospective,2021-118,"Beaumont Hospital - Royal Oak, Royal Oak, Michigan, United States",https://ClinicalTrials.gov/show/NCT04912700
NCT04869579,"Selenium as a Potential Treatment for Moderately-ill, Severely-ill, and Critically-ill COVID-19 Patients.","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",2020-190,"CHRISTUS Good Shepherd Medical Center, Longview, Texas, United States",https://ClinicalTrials.gov/show/NCT04869579
NCT04878809,"Rapid Screening Circuit of COVID 19 in Schools, Pilot Study",Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,ESCORAT,"John Talabot, Barcelona, Spain|Escola l'Horitzó, Barcelona, Spain",https://ClinicalTrials.gov/show/NCT04878809
NCT04389476,The Impact and Coping Strategy of COVID-19 Among Taiwan Society and Medical and Nursing Institutes,Observational Model: Case-Only|Time Perspective: Prospective,KSPH-2020-03,NA,https://ClinicalTrials.gov/show/NCT04389476
NCT04420988,Investigational COVID-19 Convalescent Plasma Infusion for Severely or Life-threateningly Ill COVID-19 Patients,NA,"Pro2020000746, Pro2020000911","Rutgers New Jersey Medical School, Newark, New Jersey, United States|University Hospital, Newark, New Jersey, United States",https://ClinicalTrials.gov/show/NCT04420988
NCT04555109,Convalescent Plasma for COVID-19 Research Donor Study,Observational Model: Cohort|Time Perspective: Prospective,1000070462,"The Hospital for Sick Children, Toronto, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04555109
NCT04794374,Effects of Telerehabilitation After Discharge in COVID-19 Survivors,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,KA-20085,"Hacettepe University, Ankara, Turkey",https://ClinicalTrials.gov/show/NCT04794374
NCT04937569,Ivermectin Versus Standard Treatment in Mild COVID-19,Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,AssiutU-Ivercom,"Aliae AR Mohamed-Hussein, Assiut, Egypt",https://ClinicalTrials.gov/show/NCT04937569
NCT04681950,Assessment of Self-Collected Sample Compared to Clinician Collected Sample in COVID-19 and Influenza Program,Observational Model: Case-Only|Time Perspective: Other,47586,"Biocerna LLC, Fulton, Maryland, United States",https://ClinicalTrials.gov/show/NCT04681950
NCT04424940,COVID-19 Lessons Learned: the Outcome of TOMEKA® Project is to Teach,Observational Model: Cohort|Time Perspective: Prospective,UKinshasa|Tshima Guyguy Kabundi,"Cliniques Universitaires de Kinshasa, Kinshasa, Congo, The Democratic Republic of the",https://ClinicalTrials.gov/show/NCT04424940
NCT04338932,COVID-19 and Deep Venous Thrombosis,Observational Model: Cohort|Time Perspective: Retrospective,JessaH_COVID19_DVT,"Jessa hospital, Hasselt, Belgium",https://ClinicalTrials.gov/show/NCT04338932
NCT04432805,Descriptive and Evaluation Study of the Use of Pulmonary Ultrasound in the Initial Management of Pregnant Women in the Context of COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,2020-30|2020-A01303-36,"Assistance Publique Hôpitaux de Marseille, Marseille, France",https://ClinicalTrials.gov/show/NCT04432805
NCT04668625,"Risk of Infection of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), COVID-19, in a Massive Musical Show With Transmission Prevention Measures",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,PRIMACOV,"Germans Trias i Pujol Hospital, Badalona, Barcelona, Spain",https://ClinicalTrials.gov/show/NCT04668625
NCT04518735,Evolution of COVID-19 in Anticoagulated or Antiaggregated Patients (CORONA Study),Observational Model: Case-Control|Time Perspective: Retrospective,IIBSP-COV-2020-24,"Hospital de la Santa Creu i Sant Pau, Barcelona, Catalonia, Spain",https://ClinicalTrials.gov/show/NCT04518735
NCT04739410,Effectiveness of Ivermectin in SARS-CoV-2/COVID-19 Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,IRB#FMH-07-2020-IRB-766-M,"Aijaz Zeeshan Khan Chachar, Lahore, Punjab, Pakistan",https://ClinicalTrials.gov/show/NCT04739410
NCT04425837,Effectiveness and Safety of Convalescent Plasma in Patients With High-risk COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,PLASMA COVID-19,"Fundación Santa Fe de Bogotá, Bogotá, Cundinamarca, Colombia",https://ClinicalTrials.gov/show/NCT04425837
NCT04358939,Prone Position in Patients on High-flow Nasal Oxygen Therapy for COVID-19 (HIGH-PRONE-COVID-19),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,HIGH-PRONE-COVID-19|2020-A01121-38|DR200125,"Intensive Care Unit, University Hospital, Aix, Aix-en-Provence, France|Medical Intensive Care Unit, University Hospital, Amiens, Amiens, France|Intensive Care Unit, Hospital, Argenteuil, Argenteuil, France|Intensive Care Unit, Hospital,, Blois, France|Medical Intensive Care Unit, University Hospital, Brest, Brest, France|Medical Intensive Care Unit, Hospital, Béthune, Béthune, France|Medical Intensive Care Unit, University Hospital, Caen, Caen, France|Intensive Care Unit, Louis Mourier-APHP, Colombes, France|Intensive Care Unit, Hospital, Dax, Dax, France|Medical Intensive Care Unit, University Hospital, Dijon, Dijon, France|Medical Intensive Care Unit, University Hospital, Grenoble, Grenoble, France|Intensive Care Unit, Hospital, La Roche-sur-Yon, La Roche-sur-Yon, France|Intensive Care Unit, Hospital, Le Mans, Le Mans, France|Intensive Care Unit, University Hospital, Lille, Lille, France|Medical Intensive Care Unit, University Hospital, Nantes, Nantes, France|Medical Intensive Care Unit, University Hospital, Nice, NIce, France|Medical Intensive Care Unit, Hospital, Orléans, Orléans, France|Medical Intensive Care Unit, Tenon-APHP, Paris, France|Medical Intensive Care Unit, University Hospital, Poitiers, Poitiers, France|Medical Intensive Care Unit, University Hospital, Tours, Tours, France|Surgical Intensive Care Unit, University Hospital, Tours, Tours, France|Intensive Care Unit, Hospital, Valence, Valence, France|Medical Intensive Care Unit, University Hospital, Nancy, Vandœuvre-lès-Nancy, France|Intensive Care Unit, Hospital, Vannes, Vannes, France",https://ClinicalTrials.gov/show/NCT04358939
NCT04789460,Relationship Between Potential Predictors and Mortality in COVID-19 Patients ın Turkey,Observational Model: Cohort|Time Perspective: Retrospective,TURKEYPROMOD,"SBU Sultan Abdulhamid Han, Istanbul, Asia, Turkey",https://ClinicalTrials.gov/show/NCT04789460
NCT04648709,Evaluation and Longitudinal Follow-up of Biomarkers Predictive of Severe Forms of COVID-19,Observational Model: Cohort|Time Perspective: Prospective,20CH207|2020-A02943-36,"CHU Saint-Etienne, Saint-Étienne, France",https://ClinicalTrials.gov/show/NCT04648709
NCT04438980,Glucocorticoids in COVID-19 (CORTIVID),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",CORTIVID,"Hospital Sant Joan Despí Moisès Broggi, Sant Joan Despí, Barcelona, Spain|Complejo Hospitalario de Navarra, Pamplona, Navarra, Spain",https://ClinicalTrials.gov/show/NCT04438980
NCT04533347,Tafenoquine in Patients With Mild to Moderate COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",TQ 2020_06,"Clinical Trial Network, Houston, Texas, United States",https://ClinicalTrials.gov/show/NCT04533347
NCT04371406,Efficacy of Azithromycin-associated Hydroxychloroquine Therapy Given in General Practice in Early-stage Disease in COVID-19 Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,APHP200447|2020-001702-35,NA,https://ClinicalTrials.gov/show/NCT04371406
NCT04412226,Effect of Using Barrier Devices for Intubation in COVID-19 Patients,Observational Model: Other|Time Perspective: Prospective,2020/56,"Kocaeli Derince Training and Research Hospital, Kocaeli, Izmit, Turkey",https://ClinicalTrials.gov/show/NCT04412226
NCT04346147,Clinical Trial to Evaluate Efficacy of 3 Types of Treatment in Patients With Pneumonia by COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,24032020,"Hospital Universitario de Fuenlabrada, Fuenlabrada, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04346147
NCT04843761,ACTIV-3b: Therapeutics for Severely Ill Inpatients With COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",015 / ACTIV-3b,"Banner University Medical Center Tucson (Site 206-004), 1501 N. Campbell Avenue, Tucson, Arizona, United States|Community Regional Medical Center (UCSF Fresno) (Site 203-005), 2823 Fresno Street, Fresno, California, United States|VA Loma Linda Healthcare System (Site 074-017), 11201 Benton Street, Loma Linda, California, United States|Ronald Reagan UCLA Medical Center (Site 203-002), 757 Westwood Plaza, Los Angeles, California, United States|Mount Zion Hospital, UCSF Medical Center (Site 203-007), 1600 Divisadero St., San Francisco, California, United States|Moffitt-Long Hospital, UCSF Medical Center (Site 203-001), 505 Parnassus Ave., San Francisco, California, United States|University of Colorado Hospital (Site 204-001), 12605 E. 16th Avenue, Aurora, Colorado, United States|Denver Health Medical Center (Site 204-004), 780 Delaware Street, Pavilion B, Denver, Colorado, United States|MedStar Health Research Institute (Site 009-021), 110 Irving St., NW., Washington, District of Columbia, United States|Washington DC VA Medical Center (Site 009-004), 50 Irving Street, NW., Washington, District of Columbia, United States|Emory University (Site 301-008), Bldg. A, Suite 2236, 1365 Clifton Rd., NE., Atlanta, Georgia, United States|Edward Hines VA Hospital (Site 074-012), 5000 S. 5th Ave., Hines, Illinois, United States|Baystate Medical Center (Site 201-001), Critical Care Research, 759 Chestnut Street, Springfield, Massachusetts, United States|Montefiore Medical Center - Weiler campus (Site 206-003), 1825 Eastchester Road, Bronx, New York, United States|Montefiore Medical Center - Moses campus (Site 206-001), 111 E. 210th Street, Bronx, New York, United States|Mount Sinai Medical Center (Site 301-012), Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, New York, United States|Columbia University Irving Medical Center (Site 301-027), 177 Fort Washington Ave., New York, New York, United States|Duke University Hospital (Site 301-006), 2301 Erwin Road, Durham, North Carolina, United States|Wake Forest Baptist Health (Site 210-001), Medical Center Blvd, Winston-Salem, North Carolina, United States|University of Cincinnati Medical Center (Site 207-003), 234 Goodman Street, ML 0740, Cincinnati, Ohio, United States|Cleveland Clinic Fairview Hosptial (Site 207-005), 18101 Lorain Ave., Cleveland, Ohio, United States|Cleveland Clinic Foundation (Site 207-001), 9500 Euclid Ave., Cleveland, Ohio, United States|Cleveland Clinic Marymount Campus (Site 207-006), 12300 McCracken Road, Garfield Heights, Ohio, United States|Cleveland Clinic Hillcrest Hospital (Site 207-007), 6780 Mayfield Road, Mayfield Heights, Ohio, United States|Oregon Health & Science University (Site 208-003), 3181 SW Sam Jackson Park Rd., Portland, Oregon, United States|Medical University of South Carolina Research Nexus Clinic (Site 210-002), 96 Jonathan Lucas St., CSB 214, Charleston, South Carolina, United States|Vanderbilt University Medical Center (Site 212-001), 1301 Medical Center Dr., Nashville, Tennessee, United States|University of Texas Health Science Center (Site 203-006), 7000 Fannin St., Houston, Texas, United States|Intermountain Medical Center (Site 211-001), 5121 South Cottonwood Street, Murray, Utah, United States|University of Utah Health (Site 211-002), 419 Wakara Way, Ste. 207, Salt Lake City, Utah, United States|University of Virginia Health System, University Hospital (Site 210-003), 1215 Lee St., Charlottesville, Virginia, United States|Harborview Medical Center (Site 208-001), 325 9th Ave., Seattle, Washington, United States",https://ClinicalTrials.gov/show/NCT04843761
NCT04652518,LYT-100 in Post-acute COVID-19 Respiratory Disease,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",LYT-100-2020-02,"University of Alabama at Birmingham, Birmingham, Alabama, United States|North Alabama Medical Center, Florence, Alabama, United States|University of Southern California - Keck School of Medicine, Los Angeles, California, United States|Broward Research Center, Aventura, Florida, United States|Central Florida Pulmonary Group, Orlando, Florida, United States|Tampa General Hospital, Tampa, Florida, United States|Southeastern Research Center, Winston-Salem, North Carolina, United States|University of Pittsburg Medical Center, Pittsburgh, Pennsylvania, United States|Site Coordinator, Austin, Texas, United States|Frostwood Family Medicine, Houston, Texas, United States|The University of Texas Health Sciences Center at San Antonio, San Antonio, Texas, United States|PMSI Republican Clinical Hospital ""T. Mosneaga"", Chisinau, Moldova, Republic of|University of the Philippines Manila - Philippine General Hospital (PGH), Manila, Philippines|Quirino Memorial Medical Center (QMMC), Quezon City, Philippines|Institutul de Pneumoftiziologie ""Marius Nasta"" (""Marius Nasta"" Pneumoftiziology Institute), Bucharest, Romania|National Institute for Infectious Diseases ""Prof. Dr. Matei Balş"" (Arensia Eploratory Medicine), Bucharest, Romania|Spitalul Clinic De Pneumoftiziologie ""Leon Daniello"" Cluj-Napoca, Cluj-Napoca, Romania|Spitalul Clinic de Boli Infectioase si Pneumoftiziologie Dr. Victor Babes Craiova, Craiova, Romania|Spitalul Clinic de Boli Infectioase si Pneumoftiziologie Dr. Victor Babes - Timisoara, Timişoara, Romania|Medical Center of Limited Liability Company ""Harmoniya krasy"", Kiev, Ukraine|Guy's and St Thomas' NHS Foundation Trust - St Thomas' Hospital, London, United Kingdom|St George's University Hospitals NHS Foundation Trust - St George's Hospital, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04652518
NCT04354701,COVID-19 and Cancer Consortium Registry,Observational Model: Case-Only|Time Perspective: Prospective,VICC MD 2032,"Vanderbilt University Medical Center, Nashville, Tennessee, United States",https://ClinicalTrials.gov/show/NCT04354701
NCT04627467,Prevention With Chloroquine in Health Personnel Exposed to Infection With Coronavirus Disease 2019 (COVID-19) (TS-COVID),Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,FVL-1567,"Fundacion Valle del Lili, Cali, Valle Del Cauca, Colombia",https://ClinicalTrials.gov/show/NCT04627467
NCT04707742,Antiseptic Mouth Rinses to Reduce Salivary Viral Load in COVID-19 Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",Interventional,"Alejandro Mira, Valencia, Spain",https://ClinicalTrials.gov/show/NCT04707742
NCT04397523,Efficacy and Safety of COVID-19 Convalescent Plasma,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,ITM05/2020MKD,"Institute for Transfusion Medicine of RNM, Skopje, North Macedonia",https://ClinicalTrials.gov/show/NCT04397523
NCT04697927,A Study of Risk Factors for the COVID-19 Virus Infection,Observational Model: Cohort|Time Perspective: Prospective,20-418,"Memoral Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States|Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States|Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States|Memorial Sloan Kettering Commack, Commack, New York, United States|Memorial Sloan Kettering Westchester, Harrison, New York, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|Memorial Sloan Kettering Nassau, Rockville Centre, New York, United States",https://ClinicalTrials.gov/show/NCT04697927
NCT04510207,"A Study to Evaluate The Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) in Healthy Population Aged 18 Years Old and Above","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",CNBG2020003SQ,"Bahrain International Exhibition & Convention Centre Affiliated to Salymynia Medical Complex S, Sanabis, Bahrain|Katameya Medical Center, Cairo, Egypt|Vacsera health Care facilities , MoH, Cairo, Egypt|Prince Hamza Hospital, Amman, Jordan|Sheikh Khalifa Medical City, SEHA, Abu Dhabi, United Arab Emirates|Al Qarain Primary Health Care Centre-MOHAP, Sharjah, United Arab Emirates",https://ClinicalTrials.gov/show/NCT04510207
NCT04407195,COVID-19 and Mental Health,Observational Model: Cohort|Time Perspective: Prospective,2020/5/22,"Northeastern University, Boston, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT04407195
NCT04439084,COVID-19 in Patients With Chronic Liver Diseases,Observational Model: Cohort|Time Perspective: Prospective,55819,"University of Arizona,, Phoenix, Arizona, United States|Mayo Clinic, Scottsdale, Arizona, United States|UCSF Fresno, Fresno, California, United States|University of Southern California, Los Angeles, California, United States|Stanford University, Stanford, California, United States|Georgetown University, Washington, District of Columbia, United States|VA Medical Center, Washington, District of Columbia, United States|University of Miami, Miami, Florida, United States|Rush University Medical Center, Chicago, Illinois, United States|The University of Kansas Medical Center, Kansas City, Kansas, United States|Oschner Medical Center, Baton Rouge, Louisiana, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|University of Michigan, Ann Arbor, Michigan, United States|Hennepin County Medical Center (HCMC), Minneapolis, Minnesota, United States|University of Minnesota, Minneapolis, Minnesota, United States|Mount Sinai School of Medicine, New York, New York, United States|Weill Cornell Medicine, New York, New York, United States|Duke University, Durham, North Carolina, United States|University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States|University of Pennsylvania, Philadelphia, Pennsylvania, United States|University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04439084
NCT04539275,COVID-19 (VA CURES-1),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",COVID19-8900-22,"Birmingham VA Medical Center, Birmingham, AL, Birmingham, Alabama, United States|Phoenix VA Health Care System, Phoenix, AZ, Phoenix, Arizona, United States|Rocky Mountain Regional VA Medical Center, Aurora, CO, Aurora, Colorado, United States|North Florida/South Georgia Veterans Health System, Gainesville, FL, Gainesville, Florida, United States|Orlando VA Medical Center, Orlando, FL, Orlando, Florida, United States|James A. Haley Veterans' Hospital, Tampa, FL, Tampa, Florida, United States|Atlanta VA Medical and Rehab Center, Decatur, GA, Decatur, Georgia, United States|Edward Hines Jr. VA Hospital, Hines, IL, Hines, Illinois, United States|VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor, Michigan, United States|John D. Dingell VA Medical Center, Detroit, MI, Detroit, Michigan, United States|VA Southern Nevada Healthcare System, North Las Vegas, NV, North Las Vegas, Nevada, United States|James J. Peters VA Medical Center, Bronx, NY, Bronx, New York, United States|Durham VA Medical Center, Durham, NC, Durham, North Carolina, United States|Louis Stokes VA Medical Center, Cleveland, OH, Cleveland, Ohio, United States|Oklahoma City VA Medical Center, Oklahoma City, OK, Oklahoma City, Oklahoma, United States|VA Portland Health Care System, Portland, OR, Portland, Oregon, United States|Ralph H. Johnson VA Medical Center, Charleston, SC, Charleston, South Carolina, United States|VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX, Dallas, Texas, United States|Michael E. DeBakey VA Medical Center, Houston, TX, Houston, Texas, United States|South Texas Health Care System, San Antonio, TX, San Antonio, Texas, United States|VA Salt Lake City Health Care System, Salt Lake City, UT, Salt Lake City, Utah, United States|Hunter Holmes McGuire VA Medical Center, Richmond, VA, Richmond, Virginia, United States|William S. Middleton Memorial Veterans Hospital, Madison, WI, Madison, Wisconsin, United States|VA Caribbean Healthcare System, San Juan, PR, San Juan, Puerto Rico",https://ClinicalTrials.gov/show/NCT04539275
NCT04726111,COVID-19 and Pregnancy: Placental and Immunological Impacts,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,2020_0170,"Hopital Foch, Suresnes, France",https://ClinicalTrials.gov/show/NCT04726111
NCT04379336,BCG Vaccination for Healthcare Workers in COVID-19 Pandemic,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",TASK-008 BCG-CORONA,"TASK Foundation, Cape Town, Western Cape, South Africa",https://ClinicalTrials.gov/show/NCT04379336
NCT04405271,TAF/FTC for Pre-exposure Prophylaxis of COVID-19 in Healthcare Workers (CoviPrep Study),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",5616,"Sociedad Argentina de Infectología, A. J. Carranza 974, Ciudad Autonoma de Buenos Aires, Capital Federal, Argentina",https://ClinicalTrials.gov/show/NCT04405271
NCT04891172,Anti COVID 19 Intravenous Immunoglobulin (C-IVIG) Therapy for Severe COVID-19 Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,C-IVIG-02,"Dow University of Health Sciences, Karachi, Sindh, Pakistan",https://ClinicalTrials.gov/show/NCT04891172
NCT04772833,"Spanish Study to Analyze the Histopathological, Ultrastructural and Microbiological Findings Obtained in Autopsies of Patients Who Died Due to COVID-19",Observational Model: Cohort|Time Perspective: Prospective,NECROVID,"Marqués de Valdecilla University Hospital, Santander, Cantabria, Spain|Puerta de Hierro University Hospital, Majadahonda, Madrid, Spain|Navarra University Hospital, Pamplona, Navarra, Spain|Barcelona Clinic University Hospital, Barcelona, Spain|Reina Sofía University Hospital, Córdoba, Spain|Ramón y Cajal University Hospital, Madrid, Spain|Fundación Jiménez Díaz University Hospital, Madrid, Spain|12 de Octubre University Hospital, Madrid, Spain|Virgen del Rocío University Hospital, Sevilla, Spain|Araba University Hospital, Vitoria, Álava, Spain",https://ClinicalTrials.gov/show/NCT04772833
NCT04872699,Prevalence of COVID-19 in a French Dependent Care Facility for the Elderly and in a French Long-term Care Unit: Observational Study,Observational Model: Cohort|Time Perspective: Prospective,SPEED-COVID19,"Centre Hospitalier Sud Essonne, Étampes, Essonne, France",https://ClinicalTrials.gov/show/NCT04872699
NCT04705116,COVID-19 Vaccines International Pregnancy Exposure Registry,Observational Model: Cohort|Time Perspective: Prospective,PR004,"Pregistry, Los Angeles, California, United States",https://ClinicalTrials.gov/show/NCT04705116
NCT04795583,Corticosteroids for COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",1,"Clinica de la Mujer, Bogotá, Colombia|ABC Medical Center, Mexico City, Mexico",https://ClinicalTrials.gov/show/NCT04795583
NCT04967729,COVID-19 and Lung Ultrasound Utility,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,2021-2711-6322-3,"Rocket Doctor Inc., Toronto, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04967729
NCT04775563,COVID-19 Vaccine Hesitancy Among Rheumatic Diseases Patients,Observational Model: Other|Time Perspective: Cross-Sectional,IRE-3639,"Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico",https://ClinicalTrials.gov/show/NCT04775563
NCT04531501,COVID-19 Saliva Test Research Study,Observational Model: Cohort|Time Perspective: Cross-Sectional,283560,"Gloucestershire Royal Hospital, Gloucester, United Kingdom|Salford Royal NHS Foundation Trust, Salford, United Kingdom",https://ClinicalTrials.gov/show/NCT04531501
NCT04568811,The Phase I Clinical Trial of Booster Vaccination of Adenovirus Type-5 Vectored COVID-19 Vaccine,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,JSVCT100,"A rehabilitation centre in Wuhan, Wuhan, Hubei, China",https://ClinicalTrials.gov/show/NCT04568811
NCT04724720,Famotidine vs Placebo for the Treatment of Non-Hospitalized Adults With COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",20-1155,"Northwell Health, Lake Success, New York, United States",https://ClinicalTrials.gov/show/NCT04724720
NCT04647682,Physical Activity Program Implementation in Hospitalized Positive Covid-19 Older Adults,Observational Model: Case-Only|Time Perspective: Prospective,RC31/20/0145,"University Hospital Toulouse, Toulouse, France",https://ClinicalTrials.gov/show/NCT04647682
NCT04427254,Study of the Sars-Cov2 Neuroinvasiveness - COVID19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,PBN_2020_16,"Fondation A de Rothschild, Paris, France",https://ClinicalTrials.gov/show/NCT04427254
NCT04359121,COVID-19 and the Developement of Phobic Fears of Disease,Observational Model: Cohort|Time Perspective: Prospective,32-354 ex 19/20,"Medical University of Graz, Graz, Styria, Austria",https://ClinicalTrials.gov/show/NCT04359121
NCT04542434,Niclosamide in COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",FW-COV-003,NA,https://ClinicalTrials.gov/show/NCT04542434
NCT04346368,Bone Marrow-Derived Mesenchymal Stem Cell Treatment for Severe Patients With Coronavirus Disease 2019 (COVID-19),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,SC-2020-01,"Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China",https://ClinicalTrials.gov/show/NCT04346368
NCT04487951,N-terminal Pro B-type Natriuretic Peptide and Vitamin D Levels as Prognostic Markers in COVID-19 Pneumonia,Observational Model: Case-Control|Time Perspective: Cross-Sectional,2020/7/1,"Kasr Alainy Cairo University, Cairo, Giza, Egypt",https://ClinicalTrials.gov/show/NCT04487951
NCT04924660,Novel Experimental COVID-19 Therapies Affecting Host Response,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",210982,"Vanderbilt University Medical Center, Nashville, Tennessee, United States",https://ClinicalTrials.gov/show/NCT04924660
NCT04813718,Post COVID-19 Syndrome and the Gut-lung Axis,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Other",PostCov,"Medical University Graz, Graz, Austria",https://ClinicalTrials.gov/show/NCT04813718
NCT04830774,Natural History of COVID-19-Related Atrial Fibrillation,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Screening,TCAI-unCOVer1,"Kansas City Heart Rhythm Institute, Overland Park, Kansas City, Kansas, United States|Montefiore Medical Center, New York, New York, United States|Texas Cardiac Arrhythmia Institute, Austin, Texas, United States|Vrije Universiteit Brussel, Brussel, Belgium|Department of Cardiovascular/Respiratory Diseases, Nephrology, Anesthesiology, and Geriatric Sciences, Policlinico Umberto I, Sapienza University of Rome, Rome, Lazio, Italy|Cardiology Unit, ASST-Fatebenefratelli Sacco, Luigi Sacco University Hospital, Milan, Italy, Milan, Lombardia, Italy|Università Politecnica delle Marche, Ancona, Italy|Ospedale San Donato, Arezzo, Italy|Ospedale di Cagliari, Cagliari, Italy|Maria Cecilia Hospital, Cotignola, Italy|Presidio Ospedaliero Lecce, Lecce, Italy|Ospedale San Raffaele, Milan, Italy|Policlinico Milano, Milan, Italy|Universita' Vanvitelli, Napoli, Italy|ARNAS Ospedale Civico, Palermo, Italy|Policlinico San Matteo, Pavia, Italy|Università di Pisa, Pisa, Italy|Ospedale Sant'Andrea, Roma, Italy|Policlinico Gemelli, Roma, Italy|Policlinico Tor Vergata, Roma, Italy|Ospedale San Bortolo, Vicenza, Italy|Cardiology University Hospital, Zürich, Switzerland|Arrhythmia and Electrophysiology Unit, Department of Cardiology, Hacettepe University School of Medicine, Ankara, Turkey",https://ClinicalTrials.gov/show/NCT04830774
NCT04653857,Cardiac Assessment After Covid-19 Disease in Elite Altheltic Population,Observational Model: Case-Only|Time Perspective: Retrospective,RECHMPL20_0648,"Uhmontpellier, Montpellier, France",https://ClinicalTrials.gov/show/NCT04653857
NCT04746183,AGILE (Early Phase Platform Trial for COVID-19),"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",UoL001542,"Desmond Tutu Health Foundation, Cape Town, South Africa|Ezintsha, Johannesburg, South Africa|Liverpool University Hospitals NHS Foundation Trust, Liverpool, United Kingdom|University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom",https://ClinicalTrials.gov/show/NCT04746183
NCT04453553,CICERO- A Care Home Study of COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,285524,"Queen Mary University London, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04453553
NCT04678830,COVID-19 Long-Haulers Study,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",CD15_COVID-19,"Arthritis & Rheumatic Disease Specialties, Aventura, Florida, United States|Center for Advanced Research & Education (CARE), Gainesville, Georgia, United States",https://ClinicalTrials.gov/show/NCT04678830
NCT04867174,COVID-19 Vaccination Take-Up,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,27165,"Contra Costa Health Plan, Martinez, California, United States",https://ClinicalTrials.gov/show/NCT04867174
NCT04715919,Long Term Outcomes of Coronavirus Disease-19 (COVID-19),Observational Model: Cohort|Time Perspective: Prospective,195/ADF14,"1University of Health Sciences Turkey, Dr Suat Seren Chest Diseases and Chest Surgery Training and Research Hospital, Intensive Care Unit, İzmir, Turkey",https://ClinicalTrials.gov/show/NCT04715919
NCT04758286,Anesthetic & Surgical Protocol for Emergency Surgeries During the Era of COVID-19,Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,RC2-2-2021,"Faculty of Medicine, Banhā, Qalubia, Egypt",https://ClinicalTrials.gov/show/NCT04758286
NCT04907890,Long Term Outcomes in COVID-19 Patients Recruited in the CORIST Project,Observational Model: Case-Control|Time Perspective: Retrospective,DEP_012021,"IRCCS Neuromed, Department of Epidemiology and Prevention, Pozzilli, Italy",https://ClinicalTrials.gov/show/NCT04907890
NCT04838093,COVID-19 Testing in Patients With Vascular Disorders,Observational Model: Cohort|Time Perspective: Prospective,2049/2020,"Medical University of Vienna, Vienna, Austria",https://ClinicalTrials.gov/show/NCT04838093
NCT04409925,DISmantling COvid iNduced Neutrophil ExtraCellular Traps (DISCONNECT-1),Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,DISCONNECT-1,"Hamilton General Hospital, Hamilton Health Sciences, Hamilton, Ontario, Canada|McGill University Health Centre, Montreal, Quebec, Canada",https://ClinicalTrials.gov/show/NCT04409925
NCT04682132,Polk COVID-19 and Flu Response,Observational Model: Cohort|Time Perspective: Prospective,1784,"Polk County Fire Rescue, Bartow, Florida, United States",https://ClinicalTrials.gov/show/NCT04682132
NCT04747366,"Analysis of the Pathophysiology and Pathology of Coronavirus Disease 2019 (COVID-19), Including Chronic Morbidity",Observational Model: Cohort|Time Perspective: Prospective,NAPKON-HAP,"University Medical Center Freiburg Department of Internal Medicine II Department of Infectiology, Freiburg, Baden-Württemberg, Germany|University Hospital Heidelberg Clinic for Gastroenterology, Infections, Poisoning, Heidelberg, Baden-Württemberg, Germany|Clinic of the University of Munich Medical Clinic and Polyclinic III, Munich, Bayern, Germany|University Hospital Frankfurt Medical Clinic II Department of infectiology, Frankfurt, Hessen, Germany|University Hospital Giessen (+Marburg) Medical Clinic II Pneumology and internal intensive care medicine Infectiology, Gastroenterology, Nephrology, Gießen, Hessen, Germany|Hanover Medical School Clinic for Pneumology, Hannover, Niedersachsen, Germany|University Hospital Cologne Internal Medicine I and Hematology and Oncology, Infectiology, additional qualification in Emergency Medicine, Cologne, Nordrhein-Westfalen, Germany|University Medical Center Schleswig-Holstein (Campus Kiel): Internal medicine, gastroenterology, pneumology, allergology, sleep medicine, emergency medicine, intensive care, Kiel, Schleswig-Holstein, Germany|University Medical Center Schleswig-Holstein (Campus Lübeck): Internal medicine, gastroenterology, pneumology, allergology, sleep medicine, emergency medicine, intensive care, Lübeck, Schleswig-Holstein, Germany|University Hospital Jena Department of Internal Medicine IV, Jena, Thüringen, Germany|Charité University Hospital Berlin Medical Clinic Infectiology and Pneumology CCM/CVK, Berlin, Germany",https://ClinicalTrials.gov/show/NCT04747366
NCT04427358,RT-PCR SARS-CoV-2 at 1 Month of COVID-19 Infection in the Geriatric Population,Observational Model: Case-Only|Time Perspective: Other,7838,"Service SSR Gériatrique, Strasbourg, France",https://ClinicalTrials.gov/show/NCT04427358
NCT04366830,"Intermediate-size Expanded Access Program (EAP), Mesenchymal Stromal Cells (MSC) for Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19 Infection",NA,MSB-MSC-ARDS001,"Mount Sinai Hospital, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04366830
NCT04373161,Home Pulse Oximeter Use in Patients With COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,2020032301,"Swedish Hospital, Chicago, Illinois, United States",https://ClinicalTrials.gov/show/NCT04373161
NCT04599998,Long-term Follow-up Findings of Inpatients for COVID-19 Pneumonia,Observational Model: Cohort|Time Perspective: Prospective,2020.188.IRB1.056,"Koç University Hospital, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04599998
NCT04386850,Oral 25-hydroxyvitamin D3 and COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",IRCT2020-0401046909N2|IRCT20200401046909N1,"Tehran University of Medical Sciences, Tehran, Iran, Islamic Republic of",https://ClinicalTrials.gov/show/NCT04386850
NCT04345315,"Correlative Study on Cancer Patients and Healthcare Professionals Exposed to Infection by Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-Cov-2), COVID-19 Causative Agent.",Observational Model: Cohort|Time Perspective: Other,IRSTB113,"UO Microbiologia,Centro Servizi Pievesestina, AUSL Romagna, Cesena, FC, Italy|Irst Irccs, Meldola, FC, Italy",https://ClinicalTrials.gov/show/NCT04345315
NCT04470414,COVID-19 IgG Antibodies in the Serum of Recovered Patients,Observational Model: Cohort|Time Perspective: Prospective,Cov-PH2020,"Faculty of medicine- Assiut university, Assiut, Egypt",https://ClinicalTrials.gov/show/NCT04470414
NCT04357808,Efficacy of Subcutaneous Sarilumab in Hospitalised Patients With Moderate-severe COVID-19 Infection (SARCOVID),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,SARCOVID|2020-001634-36,"Hospital Universitario de la Princesa, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04357808
NCT04499391,COVID-19 Project ECHO in Nursing Homes,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,PCORI Nursing Homes,"Penn State College of Medicine, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04499391
NCT04678193,COVID-19 Risk Assessment for Hospitalization Outcomes and Epidemiology Efficacy,Observational Model: Cohort|Time Perspective: Other,CORAVT 001,"Multiple Locations, Phoenix, Arizona, United States|Multiple Locations, Bangalore, India|Multiple Locations, Stockholm, Sweden",https://ClinicalTrials.gov/show/NCT04678193
NCT04839107,Institutional Registry on Outpatient and Hospitalized COVID-19 Infected Patients,Observational Model: Cohort|Time Perspective: Other,5604,"Hospital Italiano, Caba, Ciudad Autónoma De Buenos Aires, Argentina",https://ClinicalTrials.gov/show/NCT04839107
NCT04395170,Convalescent Plasma (PC) and Human Intravenous Anti-COVID-19 Immunoglobulin (IV Anti COVID-19 IgG) in Patients Hospitalized for COVID-19.,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,LFCOLCOVID-19-001,"LifeFactors Zona Franca SAS, Medellín, Antioquia, Colombia",https://ClinicalTrials.gov/show/NCT04395170
NCT04930757,Involvement of Polymorphonuclear Neutrophils and Platelets in Severe Form of COVID-19,Observational Model: Cohort|Time Perspective: Prospective,APHP210061,"Intensive care department, Hôpital Saint Antoine, Paris, France",https://ClinicalTrials.gov/show/NCT04930757
NCT04645498,COVID-19 and Hereditary Metabolic Diseases,Observational Model: Cohort|Time Perspective: Prospective,2020_52|2020-A02886-33,NA,https://ClinicalTrials.gov/show/NCT04645498
NCT04829552,Prophylactic Versus Therapeutic Dose Anticoagulation In COVID-19 Infection at the Time of Admission To Critical Care Units,Observational Model: Cohort|Time Perspective: Retrospective,2020-219,"Beaumont Health System (BHS), Royal Oak, Michigan, United States",https://ClinicalTrials.gov/show/NCT04829552
NCT04733729,Covid-19 in Hematological Malignancies,Observational Model: Cohort|Time Perspective: Cross-Sectional,EHA-IDWG,"ASST-Spedali Civili, Brescia, Italy|AOU Policlinico Federico II, Napoli, Italy|Fondazione Policlinico A. Gemelli IRCCS, Rome, Italy|Istituto Nazionale Tumori Regina Elena IFO, Rome, Italy|Osp. di Circolo-Fondazione Macchi, Varese, Italy|AOUI Verona, Verona, Italy",https://ClinicalTrials.gov/show/NCT04733729
NCT04783025,A Blended Gaming COVID-19 Training System (BGCTS) With WHO Guidelines for Staff in Residential Care Homes,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Health Services Research,HSEARS20200903007,"The Hong Kong Polytechnic University, Hong Kong, Hong Kong",https://ClinicalTrials.gov/show/NCT04783025
NCT04842305,Mucosal Immunity in Terms of SARS-CoV-2 Antibodies in Saliva After COVID-19 Infection and Vaccination,Observational Model: Cohort|Time Perspective: Cross-Sectional,P-2021-224,NA,https://ClinicalTrials.gov/show/NCT04842305
NCT04778020,International COVID-19 Clinical Evaluation Registry -2 (HOPE-2),Observational Model: Cohort|Time Perspective: Prospective,21/128-E,NA,https://ClinicalTrials.gov/show/NCT04778020
NCT04374591,The Role of Sodium Bicarbonate as Adjuvant Treatment of Computed Tomography Identified COVID-19 Pneumonia,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,Sodium Bicarbonate COVID-19,"Gomhoria Street, Mansoura, Outside U.S./Canada, Egypt",https://ClinicalTrials.gov/show/NCT04374591
NCT04355715,Combination of Chest Scanography and Nasal Viral Detection Test to Detect COVID-19 Positive Patients Before Surgical Intervention in a University Hospital During Coronavirus Pandemia,Observational Model: Cohort|Time Perspective: Prospective,RECHMPL20_0223,"Uh Montpellier, Montpellier, France",https://ClinicalTrials.gov/show/NCT04355715
NCT04359212,Increased Risk of VTE and Higher Hypercoagulability in Patients Recovered in ICU and in Medical Ward for COVID-19,Observational Model: Cohort|Time Perspective: Prospective,VTE-COVID,"Giuseppe Camporese, Padova, Italy",https://ClinicalTrials.gov/show/NCT04359212
NCT04847479,COVID-19 Close Contact Self-Testing Study,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,3R01HL151292-01S1-2|3R01HL151292-01S1,"Public Health Management Corporation, Philadelphia, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04847479
NCT04974203,Saliva-based COVID-19 DNA Aptamer Test,Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Diagnostic,2021.03.3.0102,"Udayana University Hospital, Badung, Bali, Indonesia",https://ClinicalTrials.gov/show/NCT04974203
NCT04894409,Evaluation of Silver Nanoparticles for the Prevention of COVID-19,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Other,CONBIOETICA-02-CEI-001-20170,"Tijuana General Hospital, Tijuana, Baja California, Mexico",https://ClinicalTrials.gov/show/NCT04894409
NCT04809480,COVID-19 and Acute Invasive Fungal Rhinosinusitis,Observational Model: Cohort|Time Perspective: Retrospective,20- 11- 002,NA,https://ClinicalTrials.gov/show/NCT04809480
NCT04522817,CLBS119 for Repair of COVID-19 Induced Pulmonary Damage,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,CLBS119-P01,"NYU Langone Health, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04522817
NCT04349592,Hydroxychloroquine With or Without Azithromycin for Virologic Cure of COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",MRC-05-001,"Hamad Medical Corporation, Doha, Qatar",https://ClinicalTrials.gov/show/NCT04349592
NCT04422574,COVID 19 Serology in Pulmonologists,Observational Model: Ecologic or Community|Time Perspective: Cross-Sectional,RECHMPL20_0343,"Uh Montpellier, Montpellier, France",https://ClinicalTrials.gov/show/NCT04422574
NCT04865029,Estradiol and Progesterone in Hospitalized COVID-19 Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",2020-939,"Tulane University Medical Center, New Orleans, Louisiana, United States",https://ClinicalTrials.gov/show/NCT04865029
NCT04592354,Anhydrous Enol-Oxaloacetate (AEO) on Improving Fatigue in Post-COVID-19 Survivors,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",TB-AEO-2020 Post Covid Fatigue,"Energy Medicine research Institute, Boulder, Colorado, United States",https://ClinicalTrials.gov/show/NCT04592354
NCT04558385,Seroconversion in COVID-19 Recovered Population,Observational Model: Case-Only|Time Perspective: Retrospective,LGH006,"Lahore General Hospital, Lahore, Punjab, Pakistan",https://ClinicalTrials.gov/show/NCT04558385
NCT04913129,The Burden of COVID-19 Survivorship,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,21-002693,"Mayo Clinic in Florida, Jacksonville, Florida, United States",https://ClinicalTrials.gov/show/NCT04913129
NCT04537585,"COVID-19: Collecting Measurements of Renin-angiotensin-system Markers, Such as Angiotensin-2 and Angiotensin 1-7",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,TOMEKA,"Cliniques Universitaires de Kinshasa, Kinshasa, Congo, The Democratic Republic of the",https://ClinicalTrials.gov/show/NCT04537585
NCT04347980,Dexamethasone Treatment for Severe Acute Respiratory Distress Syndrome Induced by COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,2037815010,"Reanimation adulte. Hopital Marie Lannelongue, Le Plessis-Robinson, France",https://ClinicalTrials.gov/show/NCT04347980
NCT04339816,Azithromycin Added to Hydrochloroquine in Patients Admitted to Intensive Care With COVID-19: Randomised Controlled Trial,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Treatment",AZIQUINE-ICU-25032020|2020-001456-18,"František Duška, Praha, Česká Republika, Czechia",https://ClinicalTrials.gov/show/NCT04339816
NCT04286503,The Clinical Study of Carrimycin on Treatment Patients With COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,BeijingYouan Hospital,NA,https://ClinicalTrials.gov/show/NCT04286503
NCT04654416,Clinical Outcome of Patients With COVID-19 Pneumonia Treated With Corticosteroids and Colchicine,Observational Model: Case-Crossover|Time Perspective: Cross-Sectional,04-2020,"Clínica Medellín - Grupo Quirónsalud, Medellín, Antioquia, Colombia",https://ClinicalTrials.gov/show/NCT04654416
NCT04870723,#SafeHandsSafeHearts: An eHealth Intervention for COVID-19 Prevention and Support,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,39769,"Women's Health in Women's Hands, Toronto, Ontario, Canada|Humsafar Trust, Mumbai, Maharashtra, India|Institute of HIV Research and Innovation, Bangkok, Thailand",https://ClinicalTrials.gov/show/NCT04870723
NCT04565067,Identification and Characterization of SARS-CoV-2 Specific CD8 T Cells in Humans,Observational Model: Cohort|Time Perspective: Prospective,10000140|000140-AG,"National Institute of Aging, Clinical Research Unit, Baltimore, Maryland, United States",https://ClinicalTrials.gov/show/NCT04565067
NCT04410939,COVID-19 PCR Test Results in Asymptomatic Pregnants,Observational Model: Case-Crossover|Time Perspective: Retrospective,Gpolat1,"Istanbul Medipol University, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04410939
NCT04954287,Phase 1 Study of Intranasal PIV5-vectored COVID-19 Vaccine Expressing SARS-CoV-2 Spike Protein in Healthy Adults,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,CVXGA1-001,"Kentucky Pediatric/ Adult Research, Bardstown, Kentucky, United States|University of Rochester Medical Center, Rochester, New York, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States",https://ClinicalTrials.gov/show/NCT04954287
NCT04632732,Apelin; ACE2 and Biomarkers of Alveolar-capillary Permeability in SARS-cov-2 (COVID-19).,Observational Model: Cohort|Time Perspective: Prospective,2021-3862-APEL-COVID,"Sherbrooke University, Sherbrooke, Quebec, Canada",https://ClinicalTrials.gov/show/NCT04632732
NCT04348240,Transmissibility and Viral Load of SARS-CoV-2 in Oral Secretions,Observational Model: Cohort|Time Perspective: Prospective,200094|20-D-0094,"National Institutes of Health Clinical Center, Bethesda, Maryland, United States",https://ClinicalTrials.gov/show/NCT04348240
NCT04760730,Safety and Immunogenicity Study in Adults of AZD1222 and rAd26-S Administered as Heterologous Prime Boost Regimen for the Prevention of Coronavirus Disease 2019 (COVID-19),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Prevention,CV03872091,NA,https://ClinicalTrials.gov/show/NCT04760730
NCT04575532,Detection of COVID-19 Decompensation,Observational Model: Cohort|Time Perspective: Prospective,CTP-004|75N91020C00040,"Rush University Medical Center, Chicago, Illinois, United States|University of Illinois Hospital and Health Sciences System, Chicago, Illinois, United States|NorthShore University HealthSystem, Evanston, Illinois, United States|University of Texas Health, Houston, Texas, United States",https://ClinicalTrials.gov/show/NCT04575532
NCT04288102,Treatment With Human Umbilical Cord-derived Mesenchymal Stem Cells for Severe Corona Virus Disease 2019 (COVID-19),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",2020-013-D,"General Hospital of Central Theater Command, Wuhan, Hubei, China|Maternal and Child Hospital of Hubei Province, Wuhan, Hubei, China|Wuhan Huoshenshan Hospital, Wuhan, Hubei, China",https://ClinicalTrials.gov/show/NCT04288102
NCT04702945,Canadian COVID-19 Emergency Department Registry,Observational Model: Cohort|Time Perspective: Other,H20-01015,"Foothills Medical Centre, Calgary, Alberta, Canada|Peter Lougheed Centre, Calgary, Alberta, Canada|Rockyview General Hospital, Calgary, Alberta, Canada|South Health Campus, Calgary, Alberta, Canada|Northeast Community Health Centre, Edmonton, Alberta, Canada|Royal Alexandra Hospital, Edmonton, Alberta, Canada|University of Alberta Hospital, Edmonton, Alberta, Canada|Abbotsford Regional Hospital, Abbotsford, British Columbia, Canada|Royal Inland Hospital, Kamloops, British Columbia, Canada|Kelowna General Hospital, Kelowna, British Columbia, Canada|Royal Columbian Hospital, New Westminster, British Columbia, Canada|Lions Gate Hospital, North Vancouver, British Columbia, Canada|Eagle Ridge Hospital, Port Moody, British Columbia, Canada|Surrey Memorial Hospital, Surrey, British Columbia, Canada|Mount Saint Joseph Hospital, Vancouver, British Columbia, Canada|St. Paul's Hospital, Vancouver, British Columbia, Canada|Vancouver General Hospital, Vancouver, British Columbia, Canada|Saint John Regional Hospital, Saint John, New Brunswick, Canada|Dartmouth General Hospital, Dartmouth, Nova Scotia, Canada|Halifax Infirmary, Halifax, Nova Scotia, Canada|Cobequid Community Health Centre, Lower Sackville, Nova Scotia, Canada|Hants Community Hospital, Windsor, Nova Scotia, Canada|Hamilton General Hospital, Hamilton, Ontario, Canada|Juravinski Hospital, Hamilton, Ontario, Canada|Hotel Dieu Hospital, Kingston, Ontario, Canada|Kingston General Hospital, Kingston, Ontario, Canada|London Health Sciences Centre (University Hospital), London, Ontario, Canada|London Health Sciences Centre (Victoria Hospital), London, Ontario, Canada|The Ottawa Hospital - Civic Campus, Ottawa, Ontario, Canada|The Ottawa Hospital - General Campus, Ottawa, Ontario, Canada|Health Science North, Sudbury, Ontario, Canada|North York General Hospital, Toronto, Ontario, Canada|Sunnybrook Hospital, Toronto, Ontario, Canada|Toronto Western Hospital, Toronto, Ontario, Canada|Hôtel-Dieu de Lévis, Lévis, Quebec, Canada|Hôpital du Sacré-Coeur, Montréal, Quebec, Canada|Jewish General Hospital, Montréal, Quebec, Canada|Montréal General Hospital (MUHC), Montréal, Quebec, Canada|Royal Victoria Hospital (MUHC), Montréal, Quebec, Canada|Centre Hospitalier de l'Université Laval (CHU de Québec), Québec, Quebec, Canada|Hôpital de l'Enfant-Jésus (CHU de Québec), Québec, Quebec, Canada|Hôpital du Saint-Sacrement (CHU de Québec), Québec, Quebec, Canada|Hôpital Saint-François d'Assise (CHU de Québec), Québec, Quebec, Canada|Hôtel-Dieu de Québec (CHU de Québec), Québec, Quebec, Canada|Institut universitaire de cardiologie et de pneumologie de Québec, Québec, Quebec, Canada|Pasqua Hospital, Regina, Saskatchewan, Canada|Regina General Hospital, Regina, Saskatchewan, Canada|Royal University, Saskatoon, Saskatchewan, Canada|Saskatoon City Hospital, Saskatoon, Saskatchewan, Canada|St Paul's Hospital, Saskatoon, Saskatchewan, Canada",https://ClinicalTrials.gov/show/NCT04702945
NCT04351581,Effects of Discontinuing Renin-angiotensin System Inhibitors in Patients With and Without COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,H-20026484|2020-001544-26,"Department of Medicine, Gentofte Hospital, University of Copenhagen, Hellerup, Capital Region Of Denmark, Denmark|Department of Medicine, Herlev Hospital, University of Copenhagen, Herlev, Capital Region Of Denmark, Denmark",https://ClinicalTrials.gov/show/NCT04351581
NCT04784546,"Evaluation of Muscle Strength, Functional Independence, Myalgia, Fatigue and Dyspnea in COVID-19 Infection",Observational Model: Cohort|Time Perspective: Prospective,Gazi University PMR INF,"Gazi University Faculty of Medicine, Physical Medicine and Rehabilitation Department, Ankara, Turkey",https://ClinicalTrials.gov/show/NCT04784546
NCT04334005,Vitamin D on Prevention and Treatment of COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment",COVITD-19,"Universidad de Granada, Granada, Andalucia, Spain|Medicine Faculty, Granada, Spain",https://ClinicalTrials.gov/show/NCT04334005
NCT04459676,Study to Assess Efficacy and Safety Relative to Standard of Care in Patients With COVID-19 Pneumonia,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",ANG3777-ALI-201,"Hospital Vera Cruz - NUPEC Nucleo de Pesquisa Clínica, Belo Horizonte, Minas Gerais, Brazil|Santa Casa de Misericórdia de Porto Alegre, Porto Alegre, Rio Grande Do Sul, Brazil|Pontifícia Universidade Catolica de Campinas, Campinas, Sao Paulo, Brazil|UPCLIN - Faculdade de Medicina da UNESP Campus de Botucatu, Botucatu, Brazil|Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo (HCFMRP), Ribeirão Preto, Brazil|Hospital Vila Nova Star, Sao Paulo, Brazil|Irmandade da Santa Casa de Misericórdia de São, Sao Paulo, Brazil|Hospital Alemao Oswaldo Cruz, São Paulo, Brazil|Hospital Heliópolis-SP, São Paulo, Brazil|Santa Casa de Misericordia de Sao Paulo, São Paulo, Brazil",https://ClinicalTrials.gov/show/NCT04459676
NCT04332913,Efficacy and Safety of Tocilizumab in the Treatment of SARS-Cov-2 Related Pneumonia,Observational Model: Cohort|Time Perspective: Prospective,0064468/20,"Ospedale San Salvatore, L'Aquila, Italy",https://ClinicalTrials.gov/show/NCT04332913
NCT04939532,SCALE-UP Utah: Community-Academic Partnership to Address COVID-19 Testing Among Utah Community Health Centers,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Screening,00136001|3UL1TR002538-03S2,"Huntsman Cancer Institute/ University of Utah, Salt Lake City, Utah, United States",https://ClinicalTrials.gov/show/NCT04939532
NCT04795557,Efficacy of Adaptogens in Patients With Long COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",SHIRD-2021-01|Nr2-2021/86,NA,https://ClinicalTrials.gov/show/NCT04795557
NCT04926779,"Open Label, Single-Center Study Utilizing BIOZEK COVID-19 Antigen Rapid Test",Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,Biozek-ARTC-US/002/4-12-2021,"Quality Research and Invention LLC, Southampton, New York, United States",https://ClinicalTrials.gov/show/NCT04926779
NCT04323878,Early CPAP in COVID-19 Patients With Respiratory Failure. A Prospective Cohort Study.,Observational Model: Cohort|Time Perspective: Retrospective,EC-COVID-PCS-Fenice,"Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy",https://ClinicalTrials.gov/show/NCT04323878
NCT04310228,Favipiravir Combined With Tocilizumab in the Treatment of Corona Virus Disease 2019,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2020YFC0844100,"Guiqiang Wang, Beijing, Beijing, China|Peking University First Hospital, Beijing, Beijing, China|Ezhou Central Hospital, Wuhan, Hubei, China|Huoshenshan Hospital of Wuhan, Wuhan, Hubei, China|Jinyintan Hospital of Wuhan, Wuhan, Hubei, China|Wuhan Pulmonary Hospital, Wuhan, Hubei, China",https://ClinicalTrials.gov/show/NCT04310228
NCT04437693,Post Exposure Prophylaxis in Healthcare Workers Exposed to COVID-19 Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Prevention,MRC-02-20-442,NA,https://ClinicalTrials.gov/show/NCT04437693
NCT04501978,ACTIV-3: Therapeutics for Inpatients With COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",014 / ACTIV-3,"Banner University Medical Center Tucson (Site 206-004), 1625 N. Campbell Avenue, Tucson, Arizona, United States|Southern Arizona VA Health Care System (Site 074-009), 3601 S. 6th Ave., Tucson, Arizona, United States|Velocity Chula Vista (Site 080-034), 752 Medical Center Ct., Ste. 304, Chula Vista, California, United States|Community Regional Medical Center (Site 203-005), 2823 Fresno Street, Fresno, California, United States|Velocity San Diego (Site 080-035), 5565 Grossmont Center Drive, Building 2, Suite 1, La Mesa, California, United States|VA Loma Linda Healthcare System (Site 074-017), 11201 Benton Street, Loma Linda, California, United States|VA Long Beach Healthcare System (Site 074-026), 5901 East 7th Street (09/151-M2), Long Beach, California, United States|Keck Hospital of USC (Site 301-020), 1500 San Pablo Street, Los Angeles, California, United States|Cedars-Sinai Medical Center (Site 208-002), 8700 Beverly Blvd., Los Angeles, California, United States|Ronald Reagan UCLA Medical Center (Site 203-002), 757 Westwood Plaza, Los Angeles, California, United States|VA Northern California Health Care System - Sacramento VAMC (Site 074-023), 10535 Hospital Way, Mather, California, United States|Hoag Memorial Hospital Presbyterian (Site 080-026), One Hoag Drive, Newport Beach, California, United States|Mount Zion Hospital, UCSF Medical Center (Site 203-007), 1600 Divisadero St., San Francisco, California, United States|San Francisco VA Healthcare System (Site 074-002), 4150 Clement St., San Francisco, California, United States|Moffitt-Long Hospital, UCSF Medical Center (Site 203-001), 505 Parnassus Ave., San Francisco, California, United States|Stanford University Hospital & Clinics (Site 203-003), 300 Pasteur Dr., Stanford, California, United States|Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center (Site 066-002), 1124 W. Carson Street, Torrance, California, United States|University of Colorado Hospital (Site 204-001), 12605 E. 16th Avenue, Aurora, Colorado, United States|Denver Public Health (Site 017-004), 605 Bannock St., MC2600 (Infectious Disease Clinic), Denver, Colorado, United States|National Jewish Health (Site 204-003), 1400 Jackson Street, Denver, Colorado, United States|West Haven VA Medical Center (Site 025-007), 950 Campbell Avenue, West Haven, Connecticut, United States|MedStar Georgetown University Hospital (Site 067-001), 3800 Reservoir Road NW, Washington, District of Columbia, United States|MedStar Health Research Institute (Site 009-021), MedStar Washington Hospital Center, 110 Irving St., NW., Washington, District of Columbia, United States|VA Medical Center (Site 009-004), 50 Irving Street NW, Washington, District of Columbia, United States|Bay Pines VA Healthcare System (Site 074-004), 10000 Bay Pines Blvd., Bldg. 100, Room 5B-104, Bay Pines, Florida, United States|Baycare Health System (Site 301-025), Morton Plant Hospital, 300 Pinellas Street, Clearwater, Florida, United States|North Florida/South Georgia Veterans Health System (Site 074-011), 1601 SW. Archer Road, Gainesville, Florida, United States|Memorial Healthcare System (Site 648-002), Memorial Regional Hospital, 3501 Johnson Street, Hollywood, Florida, United States|Miami VA Healthcare System (Site 074-003), 1201 NW 16 Street, Miami, Florida, United States|Hillsborough County Health Department, University of South Florida (Site 032-001), Tampa, Florida, United States|The Emory Clinic (Site 301-008), Bldg. A, Suite 2236, 1365 Clifton Rd., NE, Atlanta, Georgia, United States|Lutheran Medical Group (Site 301-010), 7916 W. Jefferson Boulevard, Fort Wayne, Indiana, United States|Cotton O'Neil Clinical Research Center (Site 080-030), Stormont Vail Health, 1500 SW 10th Avenue, Topeka, Kansas, United States|University of Kentucky Hospital (Site 210-004), 1000 South Limestone St., Lexington, Kentucky, United States|Ochsner Clinic Foundation (Site 301-015), 1514 Jefferson Highway, New Orleans, Louisiana, United States|University of Maryland Medical Center (Site 301-019), 22 South Greene Street, Baltimore, Maryland, United States|Massachusetts General Hospital (Site 202-002), 55 Fruit Street, Boston, Massachusetts, United States|Baystate Medical Center (Site 201-001), 759 Chestnut Street, Springfield, Massachusetts, United States|University of Michigan (Site 205-001), 1500 East Medical Center Drive, Ann Arbor, Michigan, United States|Henry Ford Health System, Henry Ford Hospital (Site 014-001), 2799 W. Grand Blvd., Detroit, Michigan, United States|Allina Health System, dba Abbott Northwestern Hospital (Site 301-026), 800 East 28th Street, Minneapolis, Minnesota, United States|Hennepin Healthcare (Site 027-001), 701 Park Avenue, Minneapolis, Minnesota, United States|Minneapolis VA Health Care System (Site 105-001), 1 Veterans Drive, Bldg 70, Minneapolis, Minnesota, United States|M Health Fairview University of Minnesota Medical Center (Site 112-001), 500 Harvard St. SE., Minneapolis, Minnesota, United States|University of Mississippi Medical Center (Site 202-005), 2500 North State Street, Jackson, Mississippi, United States|VA St. Louis Healthcare System (Site 074-027), 915 North Grand Blvd., Rm. C201, Saint Louis, Missouri, United States|Dartmouth-Hitchcock Medical Center/Mary Hitchcock Memorial Hospital (Site 301-024), One Medical Center Drive, Lebanon, New Hampshire, United States|Cooper University Hospital (Site 019-001), One Cooper Plaza, Camden, New Jersey, United States|Lincoln Medical Center (New York Health and Hospitals/Lincoln) (Site 003-016), 234 E. 149th Street, Bronx, New York, United States|Montefiore Medical Center Weiler Hospital (Site 206-003), 1825 Eastchester Road, Bronx, New York, United States|Montefiore Medical Center Moses Hospital (Site 206-001), 111 E. 210th Street, Bronx, New York, United States|SUNY Downstate Medical Center (Site 033-001), 450 Clarkson Ave., Brooklyn, New York, United States|Maimonides Medical Center (Site 033-002), 4802 10th Avenue, Brooklyn, New York, United States|Duke University Hospital (Site 301-006), 2301 Erwin Road, Durham, North Carolina, United States|Wake Forest University Health Sciences (Site 210-001), Medical Center Blvd, Winston-Salem, North Carolina, United States|University of Cincinnati Medical Center (Site 207-003), 234 Goodman Ave., Cincinnati, Ohio, United States|Cleveland Clinic Fairview Hospital (Site 207-005), 18101 Lorain Avenue, Cleveland, Ohio, United States|Cleveland Clinic Foundation (Site 207-001), 9500 Euclid Avenue, Cleveland, Ohio, United States|Cleveland Clinic Marymount Hospital (Site 207-006), 12300 McCraken Road, Garfield Heights, Ohio, United States|Oregon Health & Science University (Site 208-003), 3181 SW Sam Jackson Park Rd., Portland, Oregon, United States|UPMC Magee-Womens Hospital (Site 209-003), 300 Halket Street, Pittsburgh, Pennsylvania, United States|UPMC Presbyterian Hospital (Site 209-001), 200 Lothrop Street, Pittsburgh, Pennsylvania, United States|UPMC Shadyside Hospital (Site 209-005), 5230 Centre Avenue, Pittsburgh, Pennsylvania, United States|Rhode Island Hospital (Site 080-036), 593 Eddy Street, Providence, Rhode Island, United States|The Miriam Hospital (Site 080-039), 164 Summit Ave., Providence, Rhode Island, United States|VA Providence Healthcare System (Site 074-025), 830 Chalkstone Ave., Providence, Rhode Island, United States|Medical University of South Carolina (Site 210-002), 171 Ashley Avenue, Charleston, South Carolina, United States|VA Tennessee Valley Healthcare System (TVHS) Nashville Campus (Site 074-022), 1310 24th Avenue South, Nashville, Tennessee, United States|Vanderbilt University Medical Center (Site 212-001), 1211 Medical Center Drive, Nashville, Tennessee, United States|Hendrick Medical Center (Site 080-014), 1900 Pine Street, Abilene, Texas, United States|CHRISTUS Spohn Shoreline Hospital (Site 080-001), 600 Elizabeth Street, Corpus Christi, Texas, United States|Parkland Health and Hospital Systems (Site 084-002), 5200 Harry Hines Blvd, Dallas, Texas, United States|UT Southwestern Medical Center (Site 084-001), 1936 Amelia Court, 2nd Floor, Dallas, Texas, United States|Baylor, Scott and White Health (Site 301-003), Baylor University Medical Center, 3500 Gaston Ave., Dallas, Texas, United States|Memorial Hermann Hospital (Site 203-006), 6411 Fannin Street, Houston, Texas, United States|Michael E. DeBakey Veterans Affairs Medical Center (MEDV AMC) (Site 074-006), 2002 Holcombe Blvd., Houston, Texas, United States|Texas Heart Institute (Site 301-017), 6770 Bertner, MC4-266, Houston, Texas, United States|CHRISTUS Good Shepherd Medical Center (Site 080-031), 700 E. Marshall Ave., Longview, Texas, United States|Intermountain Medical Center (Site 211-001), 5121 South Cottonwood Street, Murray, Utah, United States|University of Utah Health (Site 211-002), 419 Wakara Way, Suite 207, Salt Lake City, Utah, United States|LDS Hospital (Site 211-004), 8th Ave. C Street, Salt Lake City, Utah, United States|University of Virginia Health Systems (Site 301-021), 1215 Lee Street, Charlottesville, Virginia, United States|Virginia Commonwealth University Health System (Site 210-005), 1250 East Marshall Street, Richmond, Virginia, United States|Salem VA Medical Center (Site 074-014), 1970 Roanoke Blvd., Salem, Virginia, United States|Harborview Medical Center (Site 208-001), 325 9th Avenue, Seattle, Washington, United States|Swedish Medical Center (Site 208-005), 747 Broadway, Seattle, Washington, United States|University of Washington Medical Center - Montlake (Site 208-006), 1959 NE Pacific Street, Seattle, Washington, United States|WVU Medicine (Site 301-023), One Medical Center Drive, Morgantown, West Virginia, United States|Aalborg University Hospital (Site 625-005), Hobrovej 18, Aalborg, Denmark|Department of Infectious Diseases (Site 625-002), Aarhus University Hospital, Skejby, Palle Juul-Hensens Boulevard 99, Aarhus N, Denmark|Righospitalet (Site 625-006), Blegdamsvej 9,, Copenhagen Ø, Denmark|Bispebjerg Hospital (Site 625-013), Bispebjerg Bakke 23, Copenhagen, Denmark|Herlev Hospital (Site 625-012), Medicinsk Afdeling, Herlev Ringvej 75, Herlev, Denmark|Nordsjællands Hospital (Site 625-009), Dyrehavevej 29, Hillerød, Denmark|Hvidovre Hospital (Site 625-001), Department of Infectious Diseases, Kettegård allé 30, Hvidovre, Denmark|Medicinsk Afdeling (Site 625-011), Kolding Sygehus, Sygehusvej 24, Kolding, Denmark|Odense Universitetshospital (Site 625-004), Infektionsmedicinsk Forskningsenhed,J.B. Winsløwsgade 4, Odense, Denmark|Zealand University Hospital, Roskilde (Site 625-010), Sygehusvej 10, Roskilde, Denmark|Democritus University of Thrace (Site 635-021), University General Hospital of Alexandroupolis, Dragana, Alexandroupolis, Evros, Greece|Evangelismos COVID-19 Unit, (Site 635-020), 1st Dept. of Pulmonary and Critical Care Medicine, Evangelismos General Hospital, Dept., Ipsilantou 45-47, Athens, Greece|1st Respiratory Medicine Dept., Athens University Medical School (Site 635-015), Athens Hospital for Diseases of the Chest ""Sotiria Hospital"", 152 Mesogeion Ave., Athens, Greece|3rd Dept. of Medicine, Medical School, NKUA (Site 635-022), Sotiria General Hospital, 152 Mesogeion Ave., Athens, Greece|Attikon University General Hospital (Site 635-009), 4th Dept. of Internal Medicine, Medical School, National and Kapodistrian University of Athens, 1 Rimini St., Haidari, Athens, Greece|Chennai Antiviral Research and Treatment Clinical Research Site (Site 612-402), VHS-IDMC, Voluntary Health Services, Rajiv Gandhi Salai, Taramani, Chennai, Tamil Nadu, India|Medical Centre, Voluntary Health Services (Site 612-402), Rajiv Gandhi Salai, Taramani, Chennai, Tamil Nadu, India|Institute of Human Virology Nigeria (IHVN) (Site 612-601), Plot 252, Herbert Macaulay Way, Central Business District, Abuja, Nigeria|Wojewódzki Szpital Zakazny (Site 625-302), Wolska 37, Warsaw, Poland|Tan Tock Seng Hospital (Site 612-201), National Centre for Infectious Diseases (NCID), 11 Jalan Tan Tock Seng, Singapore, Singapore|Germans Trias i Pujol Hospital (Site 626-003), Unidad de enfermedades infecciosas, Carretera de Canyet s/n, Badalona, Barcelona, Spain|Hospital Universitari Arnau de Vilanova (Site 626-035), Av. Alcalde Rovira Roure 80, Lleida, Leida, Spain|Hospital Del Mar (Site 626-025), Paseo Maritimo 25-29, Barcelona, Spain|Hospital Universitari Vall d'Hebron (Site 626-033), Passeig de la Vall d'Hebron 119-129, Barcelona, Spain|Hospital Clínic de Barcelona (Site 626-004), Carrer de Villaroel 170, Barcelona, Spain|Hospital Universitario de Bellvitge (Site 626-034), Carrer de la Feixa Llarga, s/n, Barcelona, Spain|Hospital General Universitario Gregorio Marañón (Site 626-001), Dr. Esquerdo, 46, Madrid, Spain|Hospital Clínico San Carlos (Site 626-017), Enfermedades infecciosas, C/Martin Lagos CN, Madrid, Spain|UCICEC (Clinical Trial Unit) Hospital Universitario La Paz (Site 626-012), Paseo de la Castellana 261, 2a planta Hospital Maternal, Madrid, Spain|University Hospital Zurich (Site 621-201), Department of Infectious Diseases and Hospital Epidemiology, Raemistrasse 100, Zürich, Zurich, Switzerland|MRC/UVRI and LSHTM Uganda Research Unit (Site 634-601), Entebbe Regional Referral Hospital, Entebbe, Uganda|Gulu Regional Referral Hospital (Site 634-603), Laroo Division, PO Box 160, Gulu, Uganda|Makerere University Lung Institute (Site 634-604), New Mulago Hospital Complex, Mulago Hill, Kampala, Uganda|St. Francis Hospital, Nsambya (Site 634-607), Nsambya Road Nsambya Hill, P.O. Box 7146, Kampala, Uganda|Lira Regional Referral Hospital (Site 634-605), Lira, Uganda|MRC/UVRI and LSHTM Uganda Research Unit (Site 634-606), Masaka Regional Referral Hospital, Plot 6 Circle Road, PO Box 556, Masaka, Uganda|Royal Victoria Infirmary (Site 634-007), Queen Victoria Road, Newcastle Upon Tyne, Northumbria, United Kingdom|Royal Free Hospital (Site 634-006), Dept. of Infectious Diseases / HIV Medicine, Pond Street, Hampstead, London, United Kingdom|Guy's and St. Thomas' NHS Foundation Trust (Site 634-011), London, United Kingdom",https://ClinicalTrials.gov/show/NCT04501978
NCT04581863,COVID-19 Watch + COVID-19 Pulse,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,844043,"Perelman Center for Advanced Medicine, Philadelphia, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04581863
NCT04613310,PCR and Rapid Diagnostic Test on Saliva and Nasopharyngeal Swabs for the Detection of SARS-CoV-2 (COVID-19),Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,2020-02269,"Unisanté, Lausanne, Vaud, Switzerland",https://ClinicalTrials.gov/show/NCT04613310
NCT04939519,SCALE-UP Utah: Community-Academic Partnership to Address COVID-19 Vaccination Rates Among Utah Community Health Centers,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Screening,00136001_2|3UL1TR002538-03S2,"Huntsman Cancer Institute/ University of Utah, Salt Lake City, Utah, United States",https://ClinicalTrials.gov/show/NCT04939519
NCT04811391,COVID-19 Vaccine Effectiveness in Albanian Health Workers,Observational Model: Cohort|Time Perspective: Prospective,COV-VE-0001,"Durres Regional Hospital, Durrës, Albania|Fier Regional Hospital, Fier, Albania|Tirana University Hospital "" Mother Theresa"", Tirana, Albania",https://ClinicalTrials.gov/show/NCT04811391
NCT04689711,Prognostic Models for COVID-19 Care,Observational Model: Cohort|Time Perspective: Prospective,PCORI-ME-1606-35555,"Tufts Medical Center, Boston, Massachusetts, United States|Northwell Health (The Feinstein Institutes for Medical Research), Manhasset, New York, United States",https://ClinicalTrials.gov/show/NCT04689711
NCT04343339,Evolution of Psychoactive Substances Consumption in Connection With COVID-19 Containment,Observational Model: Cohort|Time Perspective: Prospective,RECHMPL20_0195,"Uhmontpellier, Montpellier, France",https://ClinicalTrials.gov/show/NCT04343339
NCT04470258,Elmo Respiratory Support Project - COVID-19,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Device Feasibility,4.104.233,"Hospital Leonardo Da Vinci, Fortaleza, Brazil",https://ClinicalTrials.gov/show/NCT04470258
NCT04868448,COVID-19 Vaccine Effectiveness Among Health Workers in Georgia,Observational Model: Cohort|Time Perspective: Prospective,CERC.0097B,"The Batumi Republican Clinical Hospital, Batumi, Ajara, Georgia|The Bokeria Tbilisi Referral Hospital, Tbilisi, Georgia|Academician N. Kipshidze Central University Clinic, Tbilisi, Georgia|The Bochorishvili Clinic, Tbilisi, Georgia|The Infectious Diseases and AIDS Center, Tbilisi, Georgia|The Caucasus Medical Centre, Tbilisi, Georgia",https://ClinicalTrials.gov/show/NCT04868448
NCT04437121,Dietary and Lifestyle Habits During the Pandemic of COVID-19 in Greece,Observational Model: Case-Crossover|Time Perspective: Cross-Sectional,COV-EAT,"Department of Nutrition-Dietetics, Tríkala, Thessaly, Greece",https://ClinicalTrials.gov/show/NCT04437121
NCT04353206,Convalescent Plasma in ICU Patients With COVID-19-induced Respiratory Failure,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,Acute Care CP Consortium Trial,"8700 Beverly Blvd., Los Angeles, California, United States|Johns Hopkins University, Baltimore, Maryland, United States",https://ClinicalTrials.gov/show/NCT04353206
NCT04508023,"A Study of Rivaroxaban to Reduce the Risk of Major Venous and Arterial Thrombotic Events, Hospitalization and Death in Medically Ill Outpatients With Acute, Symptomatic Coronavirus Disease 2019 (COVID-19) Infection","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",CR108849|39039039DVT3004,"University of Arizona, Tucson, Arizona, United States|Southern California Permanente Medical Group, Los Angeles, California, United States|Kaiser Permanente Northern California, Oakland, California, United States|University of Colorado Denver, Aurora, Colorado, United States|Florida Hospital Orlando, Orlando, Florida, United States|Emory University, Atlanta, Georgia, United States|Morehouse School of Medicine, Atlanta, Georgia, United States|Atlanta VA Medical Center, Decatur, Georgia, United States|Northshore Universite Healthsystem, Evanston, Illinois, United States|Meritus Center for Clinical Research, Hagerstown, Maryland, United States|Brigham & Women's Hospital, Boston, Massachusetts, United States|Henry Ford Hospital, Detroit, Michigan, United States|Mayo Clinic, Rochester, Minnesota, United States|Lenox Hill Hospital -Northwell Health, New York, New York, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|Texas Health Physicians Group, Fort Worth, Texas, United States|Franciscan Research Center, Tacoma, Washington, United States",https://ClinicalTrials.gov/show/NCT04508023
NCT04797858,COVID-19 Self-Testing Through Rapid Network Distribution,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Health Services Research",3R01HL151292-01S1,"Public Health Management Corporation, Philadelphia, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04797858
NCT04716465,Dysautonomia in Patients Post COVID-19 Infection,Observational Model: Cohort|Time Perspective: Prospective,DYSCO,"Universitair Ziekenhuis Brussel, Jette, Brussel, Belgium",https://ClinicalTrials.gov/show/NCT04716465
NCT04559035,Nasal Irrigation to Reduce COVID-19 Morbidity,Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,1603291,"Augusta University, Augusta, Georgia, United States",https://ClinicalTrials.gov/show/NCT04559035
NCT04962347,Real World Study of COVID-19 in a Flyover Region,Observational Model: Cohort|Time Perspective: Retrospective,2021-112,"Tulane University Medical Center, New Orleans, Louisiana, United States",https://ClinicalTrials.gov/show/NCT04962347
NCT04649333,COVID-19 and Sports - an Online Survey on the Impact of the Pandemic and Possible Preventive Measures,Observational Model: Cohort|Time Perspective: Cross-Sectional,20200609,"Medical University Innsbruck, Innsbruck, Tyrol, Austria",https://ClinicalTrials.gov/show/NCT04649333
NCT04659759,"COVID-19 Pregnancy Related Immunological, Clinical and Epidemiological Factors and Perinatal Outcomes",Observational Model: Cohort|Time Perspective: Prospective,20F.1043,"Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04659759
NCT04368845,Telerehabilitation in Patients With COVID-19 After Hospitalization. The ATHLOS Study,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,1,"Clinical exercise Physiology and rehabilitation research laboratory, Lamia, Greece",https://ClinicalTrials.gov/show/NCT04368845
NCT04686734,Long-term Effects of COVID-19 in Adolescents,Observational Model: Cohort|Time Perspective: Prospective,LoTECA,"Vegard Bratholm Wyller, Oslo, Norway",https://ClinicalTrials.gov/show/NCT04686734
NCT04606069,Treat COVID-19 Patients With Regadenoson,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",HP-00091372,"University of Maryland Medical Center, Baltimore, Maryland, United States",https://ClinicalTrials.gov/show/NCT04606069
NCT04831866,COVID-19 Surveillance and Exposure Testing in School Communities,Observational Model: Other|Time Perspective: Prospective,Pro00108049,"Durham Charter Schools, Durham, North Carolina, United States|Iredell-Statesville Schools, Statesville, North Carolina, United States",https://ClinicalTrials.gov/show/NCT04831866
NCT04456439,"Intermediate-size Expanded Access Program (EAP), Mesenchymal Stromal Cells (MSC) for Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With Coronavirus Disease (COVID-19)",NA,MSB-MSC-MISC001,NA,https://ClinicalTrials.gov/show/NCT04456439
NCT04832867,Pulmonary Rehabilitation in COVID-19 Patients,Observational Model: Cohort|Time Perspective: Retrospective,Pulmonary rehabilitation,"Bakirkor Dr. Sadi Konuk Research and Training hospital, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04832867
NCT04684433,Surgery in the Time of COVID-19 Pandemic,Observational Model: Cohort|Time Perspective: Retrospective,CHUB-Farid,"St Pierre, Brussels, Belgium|CHU Brugmann, Brussels, Belgium|Erasme, Brussels, Belgium|UZ Brussel, Brussel, Belgium",https://ClinicalTrials.gov/show/NCT04684433
NCT04575038,CRISIS2: A Phase 2 Study of the Safety and Antiviral Activity of Brequinar in Non-hospitalized Pts With COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",CCB-CRISIS-02,"Central Alabama Research, Homewood, Alabama, United States|Ark Clinical Research, Long Beach, California, United States|Doral Medical Research, Doral, Florida, United States|South Jersey Infectious Disease, Somers Point, New Jersey, United States|Monroe Biomedical Research, Monroe, North Carolina, United States|Wilmington Health, Wilmington, North Carolina, United States|Remington-Davis, Inc., Columbus, Ohio, United States|Toledo Institute of Clinical Research, Toledo, Ohio, United States|VitaLink - Gaffney, Gaffney, South Carolina, United States|Self Regional Healthcare Research Center - Self Medical Group, Greenwood, South Carolina, United States|VitaLink Research, Spartanburg, South Carolina, United States|Clinical Trials Center of Middle Tennessee, Franklin, Tennessee, United States|Centex Studies, Inc. - McAllen, McAllen, Texas, United States|Synexus Clinical Research US, Inc. - Olympus Family Medicine, Salt Lake City, Utah, United States",https://ClinicalTrials.gov/show/NCT04575038
NCT04773665,"Safety, Tolerability, and Immunogenicity of the COVID-19 Vaccine Candidate (VBI-2902a)","Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",VBI-2902a-CT01,"Canadian Center for Vaccinology, Halifax, Nova Scotia, Canada|Ottawa Hospital, Ottawa, Ontario, Canada|LMC Manna - Bayview CPU, Toronto, Ontario, Canada|Manna Toronto, Toronto, Ontario, Canada|Manna Montreal, Montreal, Quebec, Canada|Manna Research Quebec, Quebec City, Quebec, Canada",https://ClinicalTrials.gov/show/NCT04773665
NCT04509752,Dysphagia Management During COVID-19 Pandemic,Observational Model: Cohort|Time Perspective: Prospective,Dysphagia during COVID-19,"Hacetttepe University, Ankara, Turkey",https://ClinicalTrials.gov/show/NCT04509752
NCT04715243,"Comparison of High Flow Nasal Cannula (HFNC), Face-mask Non-Invasive Ventilation (NIV) & Helmet NIV in COVID-19 ARDS Patients",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,SQU-EC/206/2020,"Sultan Qaboos University Hospital, Muscat, Oman",https://ClinicalTrials.gov/show/NCT04715243
NCT04377750,The Use of Tocilizumab in the Management of Patients Who Have Severe COVID-19 With Suspected Pulmonary Hyperinflammation,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,0224-20-HMO-CTIL,"Hadassah Medical Orginisation, Jerusalem, Please Select:, Israel|Barzilai Medical Center, Ashkelon, Israel|Wolfson Medical Center, H̱olon, Israel|Sheba Medical Center, Ramat Gan, Israel",https://ClinicalTrials.gov/show/NCT04377750
NCT04828538,"Vitamin D, Omega-3, and Combination Vitamins B, C and Zinc Supplementation for the Treatment and Prevention of COVID-19","Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Other",NUTROVID,"Hospital de Soledad, San Luis Potosí, SLP, Mexico",https://ClinicalTrials.gov/show/NCT04828538
NCT04358081,Hydroxychloroquine Monotherapy and in Combination With Azithromycin in Patients With Moderate and Severe COVID-19 Disease,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",CJWT629A12301,"Novartis Investigative Site, Fullerton, California, United States|Novartis Investigative Site, Los Angeles, California, United States|Novartis Investigative Site, Chicago, Illinois, United States|Novartis Investigative Site, Baton Rouge, Louisiana, United States|Novartis Investigative Site, Baltimore, Maryland, United States|Novartis Investigative Site, Chapel Hill, North Carolina, United States|Novartis Investigative Site, Seattle, Washington, United States",https://ClinicalTrials.gov/show/NCT04358081
NCT04751617,Pulmonary Rehabilitation of Patients With a History of COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,Rehabilitation after COVID-19,"University of Rzeszów / Podkarpackie Center for Lung Diseases in Rzeszów, Rzeszów, Poland",https://ClinicalTrials.gov/show/NCT04751617
NCT04939415,Chinese Herbal Formula for COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",200633-1b,"University of California, Los Angeles, Los Angeles, California, United States|University of California, San Diego, San Diego, California, United States",https://ClinicalTrials.gov/show/NCT04939415
NCT04885530,ACTIV-6: COVID-19 Study of Repurposed Medications,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment",Pro00107921|3U24TR001608-05W1,"Emory Healthcare, Atlanta, Georgia, United States|Duke Clinical Research Institute, Durham, North Carolina, United States|Duke University Medical Center, Durham, North Carolina, United States|Wake Forest Baptist Health, Winston-Salem, North Carolina, United States",https://ClinicalTrials.gov/show/NCT04885530
NCT04799873,Alpha-1-Antitrypsin-Deficiency in COVID-19,Observational Model: Cohort|Time Perspective: Prospective,CORSAAR-AAT-001,"Saarland University, Homburg, Saarland, Germany",https://ClinicalTrials.gov/show/NCT04799873
NCT04386694,Photobiomodulation Therapy Combined With Static Magnetic Field in Patients With COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",3.985.226,"Hospital Tacchini, Bento Gonçalves, RS, Brazil",https://ClinicalTrials.gov/show/NCT04386694
NCT04789356,Effectiveness of the Adsorbed Vaccine COVID-19 (Coronavac) Among Education and Public Safety Workers With Risk Factors for Severity,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,CAAE: 44076721.5.0000.0005,"Escola Normal Superior - Universidade do Estado do Amazonas, Manaus, Amazonas, Brazil",https://ClinicalTrials.gov/show/NCT04789356
NCT04451291,Study of Decidual Stromal Cells to Treat COVID-19 Respiratory Failure,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,U-DEPLOY: DSC-COVID-19|20-5527,"Brampton Civic Hospital, Brampton, Ontario, Canada|Etobicoke General Hospital, Etobicoke, Ontario, Canada|Toronto General Hospital, Toronto, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04451291
NCT04771598,Breathing Exercise After COVID-19 Pneumonia,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,123458,NA,https://ClinicalTrials.gov/show/NCT04771598
NCT04478539,Extracorporeal Blood Purification as a Treatment Modality for COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,EBPZ.357,"Zan Mitrev Clinic, Skopje, North Macedonia",https://ClinicalTrials.gov/show/NCT04478539
NCT04460703,"COVID-19 Vaccine Messaging, Part 1",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,2000027983,"Yale University, New Haven, Connecticut, United States",https://ClinicalTrials.gov/show/NCT04460703
NCT04578509,Evaluation of a Screening Program for SARS-CoV-2 Infection in the General Population Based on the Use of New Detection Approaches or for Diagnostic Orientation on Saliva,Observational Model: Cohort|Time Perspective: Prospective,APHP200960|2020-A02431-38,"SARS-CoV-2 screening device of Assistance Publique des Hôpitaux de Paris (AP-HP), Paris, France",https://ClinicalTrials.gov/show/NCT04578509
NCT04817319,Risk of Contamination by COVID-19 During Oral Care With Aerosolization,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,APHP200933,NA,https://ClinicalTrials.gov/show/NCT04817319
NCT04347512,EVALUATION OF THE EFFICACY OF THE HYDROXYCHLOROQUINE-AZITHROMYCIN COMBINATION IN THE IN THE PREVENTION OF COVID-19 RELATED SDRA,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,7783,NA,https://ClinicalTrials.gov/show/NCT04347512
NCT04460274,Forecast Number of Covid-19 Cases Worldwide,Observational Model: Cohort|Time Perspective: Retrospective,TurkishMOHITH-TimeSeries,"Republic of Turkey, Health Sciences University, Izmir Bozyaka Education and Training Hospital, İzmir, Turkey",https://ClinicalTrials.gov/show/NCT04460274
NCT04859881,Risk Factors for Barotrauma in COVID-19,Observational Model: Case-Control|Time Perspective: Retrospective,HGAM01,"Hospital General Ajusco Medio, Mexico city, Mexico",https://ClinicalTrials.gov/show/NCT04859881
NCT04824495,Evaluation of Inflammatory Cytokines During COVID-19,Observational Model: Cohort|Time Perspective: Prospective,"Version 1.1, 31.12.2021","Medical University of Vienna, Vienna, Austria",https://ClinicalTrials.gov/show/NCT04824495
NCT04841707,Total-Body Parametric 18F-FDG PET of COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science,1697954,"University of California, Davis, Sacramento, California, United States",https://ClinicalTrials.gov/show/NCT04841707
NCT04514003,The Corona and COVID-19 Study in Telemark and Agder,Observational Model: Case-Control|Time Perspective: Prospective,COVITA,"Telemark Hospital, Skien, Vestfold And Telemark, Norway",https://ClinicalTrials.gov/show/NCT04514003
NCT04512079,FREEDOM COVID-19 Anticoagulation Strategy,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,GCO 20-2115,"Icahn School of Medicine at Mount Sinai, New York, New York, United States|Instituto do Coração - INCOR, São Paulo, Brazil|Instituto Prevent Senior - IPS, São Paulo, Brazil|Clínica de la Costa, Barranquilla, Colombia|Clínica Shaio, Bogotá, Colombia|Fundación Cardioinfantil, Bogotá, Colombia|Fundacion Oftalmológica de Santander - Foscal, Bucaramanga, Colombia|Centro Médico Imbanaco, Cali, Colombia|CardioVid, Medellín, Colombia|Eternal Heart Care Centre and Research Ins Pvt Ltd., Jaipur, India|Jaipur National University, Jaipur, India|Sawai Mann Singh Hospital, Jaipur, India|Jaslok Hospital & Research Center, Mumbai, India|Saifee Hospital, Mumbai, India|Sengupta Hospital & Research Institute, Nagpur, India|D Y Patil University School of Medicine & D Y Patil Hospital, Navi Mumbai, India|Hospital Cardiológica Aguascalientes, Aguascalientes, Mexico|Centro Médico Nacional 20 de Noviembre, Mexico City, Mexico|Christus Muguerza Hospital Alta Especialidad, Monterrey, Mexico|Centro de Estudios Clinicos de Querétaro S.C., Santiago de Querétaro, Mexico|Centro Medico Hospital del Prado, Tijuana, Mexico",https://ClinicalTrials.gov/show/NCT04512079
NCT04669925,COVID-19 Impact on the Lombardy Region's Emergency System,Observational Model: Cohort|Time Perspective: Retrospective,Tsunami,"Ospedale Papa Giovanni XXIII, Bergamo, Italy|Presidio Ospedaliero di Lodi, Lodi, Italy|Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy|Ospedale San Carlo Borromeo, Milan, Italy",https://ClinicalTrials.gov/show/NCT04669925
NCT04353323,COVID 19-Caregivers IGg Seroconversion,Observational Model: Cohort|Time Perspective: Prospective,87RI20_0016/CoSigS,"CHU de Limoges, Limoges, France",https://ClinicalTrials.gov/show/NCT04353323
NCT04657263,Impact of the COVID-19 Pandemic on Vaccination,Observational Model: Cohort|Time Perspective: Prospective,RECHMPL20_0655,"Uhmontpellier, Montpellier, France",https://ClinicalTrials.gov/show/NCT04657263
NCT04895189,Yale COVID-19 Recovery Study,Observational Model: Cohort|Time Perspective: Prospective,2000030423,"Yale New Haven Hospital, New Haven, Connecticut, United States",https://ClinicalTrials.gov/show/NCT04895189
NCT04537650,Swallowing Impairment After COVID-19 Infection,Observational Model: Cohort|Time Perspective: Prospective,CAPCR 20-5477|3R01DC011020-08S1,"University of Florida, Gainesville, Florida, United States|McMaster University, Hamilton, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04537650
NCT04497402,Sex-Informed Data in the COVID-19 Pandemic.,Observational Model: Cohort|Time Perspective: Prospective,SAPIENZAGENDERCOVID,"Sapienza University of Rome - Policlinico Umberto I Roma, Rome, Italy",https://ClinicalTrials.gov/show/NCT04497402
NCT04388813,Predictors of Severe COVID-19 Outcomes,Observational Model: Cohort|Time Perspective: Prospective,102293,"The University of Arizona, Tucson, Arizona, United States|Cedars-Sinai Medical Center, Los Angeles, California, United States|University of Illinois at Chicago, Chicago, Illinois, United States|Rush University Medical Center, Chicago, Illinois, United States|Weill Cornell Medical College, New York, New York, United States|University of Texas Southwestern Medical Center, Dallas, Texas, United States|Baylor College of Medicine, Houston, Texas, United States|Inova Health Care Services, Falls Church, Virginia, United States",https://ClinicalTrials.gov/show/NCT04388813
NCT04799652,Are Surgeons Ready to Get the COVID-19 Vaccine?,Observational Model: Cohort|Time Perspective: Prospective,CHUB-Farid-vaccination,"CHU Brugmann, Brussels, Belgium",https://ClinicalTrials.gov/show/NCT04799652
NCT04979091,Sex Hormone Dysregulations Are Associated With Critical Illness in COVID-19 Patients,Observational Model: Cohort|Time Perspective: Retrospective,HAM-SEX-C19,"University Medical Center, Hamburg, Germany",https://ClinicalTrials.gov/show/NCT04979091
NCT04390074,COVID-19 in the Swedish ICU-cohort: Risk Factors of Critical Care Admission and Intensive Care Mortality,Observational Model: Case-Control|Time Perspective: Other,UTN: U1111-1251-8195,"Björn Ahlström, Falun, Sweden",https://ClinicalTrials.gov/show/NCT04390074
NCT04788459,"Safety and Immunogenicity of COVID-eVax, a Candidate Plasmid DNA Vaccine for COVID-19, in Healthy Adult Volunteers",Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,COV-1/2-01|2020-003734-20,"San Gerardo Hospital, Monza, Italy|Istituto Nazionale Tumori, IRCCS, Fondazione G. Pascale, Naples, Italy|INMI Lazzaro Spallanzani, Rome, Italy",https://ClinicalTrials.gov/show/NCT04788459
NCT04650087,COVID-19 Thrombosis Prevention Trials: Post-hospital Thromboprophylaxis,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",Pro00107078,"Valleywise Health Medical Center, Phoenix, Arizona, United States|Central Arkansas Veterans Health Care System, Little Rock, Arkansas, United States|University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States|National Institute of Clinical Research, Inc. Healthcare System 2000, Garden Grove, California, United States|Emanate Health (Reddy Medical Center), Pomona, California, United States|New Ananda Medical and Urgent Care, Inc., S. El Monte, California, United States|UCSF at Zuckerberg San Francisco General Hospital, San Francisco, California, United States|Torrance Medical Center, Torrance, California, United States|Penrose Hospital, Colorado Springs, Colorado, United States|St. Francis Medical Center, Colorado Springs, Colorado, United States|Centura Health Porter Adventist Hospital, Denver, Colorado, United States|Saint Anthony Hospital, Lakewood, Colorado, United States|St. Anthony North Health Campus, Westminster, Colorado, United States|Baycare Hospital, Clearwater, Florida, United States|Florida Heart Center, Fort Pierce, Florida, United States|University of Florida, Gainesville, Florida, United States|Tallahassee Memorial HealthCare, Tallahassee, Florida, United States|Triple O Research Institute, P.A., West Palm Beach, Florida, United States|BayCare Hospital- Winter Haven, Winter Haven, Florida, United States|Medical College of Georgia/Augusta University, Augusta, Georgia, United States|Savannah Health Services, LLC DBA Memorial Health University Medical Center, Savannah, Georgia, United States|Snake River Research, PLLC, Idaho Falls, Idaho, United States|University of Illinois at Chicago, Chicago, Illinois, United States|OSF Little Company of Mary, Evergreen Park, Illinois, United States|Loyola University Medical Center, Maywood, Illinois, United States|Indiana University Health Bloomington Hospital, Bloomington, Indiana, United States|Indiana University Health Methodist Hospital, Indianapolis, Indiana, United States|Reid Physician Associates, Richmond, Indiana, United States|University Medical Center New Orleans, New Orleans, Louisiana, United States|Ochsner Clinic Foundation-Baton Rouge, New Orleans, Louisiana, United States|Ochsner Clinic Foundation, New Orleans, Louisiana, United States|Willis-Knighton Physician Network/Tri-State Medical Clinic, Shreveport, Louisiana, United States|Maine Medical Center/Maine Medical Partners Adult Hospital Medicine, Portland, Maine, United States|Pen Bay Medical Center, Rockport, Maine, United States|Anne Arundel Medical Center, Annapolis, Maryland, United States|Lifebridge (Sinai Hospital of Baltimore), Baltimore, Maryland, United States|Lahey Hospital and Medical Center, Burlington, Massachusetts, United States|Baystate Medical center, Springfield, Massachusetts, United States|Bay Regional Medical Center d/b/a/ McLaren Bay Region, Bay City, Michigan, United States|Henry Ford Hospital, Detroit, Michigan, United States|Western Michigan University, Kalamazoo, Michigan, United States|MidMichigan Medical Center, Midland, Michigan, United States|McLaren Macomb, Mount Clemens, Michigan, United States|Truman Medical Center, Kansas City, Missouri, United States|Barnes-Jewish Hospital, Saint Louis, Missouri, United States|Mercury Street Medical Group, Butte, Montana, United States|Renown Health, Reno, Nevada, United States|AtlantiCare Regional Medical Center, Atlantic City, New Jersey, United States|Capital Health System, Inc., Trenton, New Jersey, United States|Christus St. Vincent Regional Medical Center, Santa Fe, New Mexico, United States|Montefiore Medical Center, Bronx, New York, United States|Buffalo General Medical Center, Buffalo, New York, United States|Jamaica Hospital Medical Center, Jamaica, New York, United States|New York University Langone Health, New York, New York, United States|Stony Brook University Hospital, Stony Brook, New York, United States|University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States|Duke Medical Center, Durham, North Carolina, United States|East Carolina University/Vidant Health, Greenville, North Carolina, United States|Wake Med Hospital, Raleigh, North Carolina, United States|Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States|Ohio State University, Columbus, Ohio, United States|Kettering Medical Center, Kettering, Ohio, United States|Oregon Health and Science University, Portland, Oregon, United States|University of Pittsburgh, Pittsburgh, Pennsylvania, United States|Tower Health Medical Group, West Reading, Pennsylvania, United States|Rhode Island Hospital, Providence, Rhode Island, United States|The Miriam Hospital, Providence, Rhode Island, United States|Monument Health Clinical Research, Rapid City, South Dakota, United States|Christus St. Elizabeth Hospital, Beaumont, Texas, United States|Baylor Scott and White Medical Center- College Station, College Station, Texas, United States|UTHouston, Houston, Texas, United States|Baylor Scott and White-Round Rock, Round Rock, Texas, United States|Baylor Scott and White-Temple, Temple, Texas, United States|The Woodlands Center For Respiratory & Sleep Research, The Woodlands, Texas, United States|MultiCare Institute for Research & Innovation, Puyallup, Washington, United States|UW Medicine Valley Medical Center, Renton, Washington, United States|CAMC Clinical Trials Center, Charleston, West Virginia, United States|West Virginia University Hospital, Morgantown, West Virginia, United States|Blood Center of Wisconsin, Milwaukee, Wisconsin, United States",https://ClinicalTrials.gov/show/NCT04650087
NCT04487691,Nebulized PL for Post-COVID-19 Syndrome,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment",RGX2020-RCT01,"Centeno-Schultz Clinic, Broomfield, Colorado, United States",https://ClinicalTrials.gov/show/NCT04487691
NCT04422678,The Safety & Efficacy of Imatinib for the Treatment of SARS-COV-2 Induced Pneumonia,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,Alex CCM 2020/5,NA,https://ClinicalTrials.gov/show/NCT04422678
NCT04366765,COVID-19 Survival - The COVIVA Study,Observational Model: Case-Control|Time Perspective: Prospective,UHospital Switz,"University Hospital Basel, Basel, Switzerland",https://ClinicalTrials.gov/show/NCT04366765
NCT04794387,The Lymphoma and Leukemia Society COVID-19 Registry,Observational Model: Cohort|Time Perspective: Prospective,LLSC19-001,"Lymphoma and Leukemia Society, Rye Brook, New York, United States",https://ClinicalTrials.gov/show/NCT04794387
NCT04746521,Cellular-Mediated Immunity in COVID-19,Observational Model: Other|Time Perspective: Cross-Sectional,L. Vanvitelli,"U.O.C. Division of Clinical Immunology, Immunohematology, Transfusion Medicine and Transplant Immunology, Regional Reference Laboratory of Transplant Immunology, Department of Internal and Specialty Medicine, A.O.U., UniversityofCampania ""Luigi Vanvitelli, Napoli, Italy",https://ClinicalTrials.gov/show/NCT04746521
NCT04473248,Spartan COVID-19 System: Evaluation of Clinical Sample Collection,Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: Single (Participant)|Primary Purpose: Diagnostic,VNV-00552,"Humber River Hospital, North York, Ontario, Canada|The Univeristy of Ottawa Heart Institute, Ottawa, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04473248
NCT04473365,Rapid Diagnostic Profiling of SARS-CoV-2 (COVID-19),Observational Model: Cohort|Time Perspective: Prospective,RIA2020EF-2905,"Mekelle University College of Health Sciences, Mekelle, Ethiopia",https://ClinicalTrials.gov/show/NCT04473365
NCT04842448,Safety and Efficacy of Hyperbaric Oxygen Therapy for Long COVID Syndrome,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment",HOT-LoCO|2021-000764-30|K 2021-1592|4-621/2021,"Karolinska University Hospital, Stockholm, Sweden",https://ClinicalTrials.gov/show/NCT04842448
NCT04801524,Text-based Reminders to Promote COVID-19 Vaccinations,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Health Services Research",IRB#21-000268 (2),"UCLA Health Department of Medicine, Quality Office, Westwood, California, United States",https://ClinicalTrials.gov/show/NCT04801524
NCT04412382,Covid-19: Possible Role of Neutrophil Extracellular Traps,Observational Model: Case-Control|Time Perspective: Prospective,NETS IN COVID-19,"Univeristy of Verona, Verona, Italy",https://ClinicalTrials.gov/show/NCT04412382
NCT04813497,Monitoring of COVID-19 Seroprevalence Among GHdC Staff Members,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,SARS-COV-2-SERO_FU-2021_GHdC,"Grand Hôpital de Charleroi, Charleroi, Hainaut, Belgium",https://ClinicalTrials.gov/show/NCT04813497
NCT04544891,TREM-1 Pathway Activation in COVID-19,Observational Model: Cohort|Time Perspective: Prospective,2020PI120,"CHRU Limoges, Limoges, France|Central hospital, Nancy, France",https://ClinicalTrials.gov/show/NCT04544891
NCT04853901,Remdesivir Efficacy In Management Of COVID-19 Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,FMASU P56a/ 2020,"Faculty of Medicine Ain Shams University Research Institute- Clinical Research Center, Cairo, Non-US, Egypt",https://ClinicalTrials.gov/show/NCT04853901
NCT04353180,Assessment the Activity Value of Isotretinoin (13- Cis-Retinoic Acid ) in the Treatment of COVID-19 ( Isotretinoin in Treatment of COVID-19) (Randomized),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,Proposed by Mahmoud Elkazzaz,"Faculty of Medicine, Kafr El-sheikh University, Cairo, Kafr El-sheikh, Egypt|Faculty of Medicine, Kafr El-sheikh University, Cairo, Egypt",https://ClinicalTrials.gov/show/NCT04353180
NCT04516486,Coronavirus Studied by Metagenomics in ARDS COVID-19 Patients,Observational Model: Cohort|Time Perspective: Retrospective,APHP200418,"CHU Henri Mondor, Créteil, France",https://ClinicalTrials.gov/show/NCT04516486
NCT04918849,WhatsApp in India During the COVID-19 Pandemic,Observational Model: Cohort|Time Perspective: Cross-Sectional,2020-CERC-001C,"Yale-NUS College, Singapore, Singapore",https://ClinicalTrials.gov/show/NCT04918849
NCT04355767,Convalescent Plasma in Outpatients With COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment",C3PO|1OT2HL156812-01,"Chandler Regional Medical Center, Chandler, Arizona, United States|Valleywise Health Medical Center, Phoenix, Arizona, United States|UCSD Health La Jolla, La Jolla, California, United States|Loma Linda University Medical Center, Loma Linda, California, United States|Ronald Reagan UCLA Medical Center, Los Angeles, California, United States|Cedars-Sinai Medical Center, Los Angeles, California, United States|UC Davis Medical Center, Sacramento, California, United States|Stanford University, Stanford, California, United States|Harbor-UCLA Medical Center, Torrance, California, United States|University of Colorado Hospital, Aurora, Colorado, United States|UF Health Shands Hospital, Gainesville, Florida, United States|Jackson Memorial Hospital, Miami, Florida, United States|Grady Memorial Hospital, Atlanta, Georgia, United States|Rush University Medical Center, Chicago, Illinois, United States|University of Illinois Hospital, Chicago, Illinois, United States|University of Chicago Medical Center, Chicago, Illinois, United States|University of Iowa Hospitals & Clinics, Iowa City, Iowa, United States|University of Louisville Hospital, Louisville, Kentucky, United States|Maine Medical Center, Portland, Maine, United States|Tufts Medical Center, Boston, Massachusetts, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Newton-Wellesley Hospital, Newton, Massachusetts, United States|Baystate Medical Center, Springfield, Massachusetts, United States|University of Michigan University Hospital, Ann Arbor, Michigan, United States|Detroit Receiving Hospital, Detroit, Michigan, United States|Harper University Hospital, Detroit, Michigan, United States|Henry Ford Hospital, Detroit, Michigan, United States|Sinai-Grace Hospital, Detroit, Michigan, United States|Spectrum Health Hospitals Butterworth Hospital, Grand Rapids, Michigan, United States|William Beaumont Hospital, Royal Oak, Michigan, United States|William Beaumont Hospital-Troy, Troy, Michigan, United States|HealthPartners Methodist Hospital, Saint Louis Park, Minnesota, United States|Regions Hospital, Saint Paul, Minnesota, United States|Barnes Jewish Hospital, Saint Louis, Missouri, United States|Cooper University Hospital, Camden, New Jersey, United States|Robert Wood Johnson University Hospital, New Brunswick, New Jersey, United States|University of New Mexico Hospital, Albuquerque, New Mexico, United States|SUNY Downstate Medical Center, Brooklyn, New York, United States|Duke University Hospital, Durham, North Carolina, United States|Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States|University of Cincinnati Medical Center, Cincinnati, Ohio, United States|OSU Wexner Medical Center, Columbus, Ohio, United States|Mercy St. Vincent Medical Center, Toledo, Ohio, United States|Oregon Health & Science University Hospital, Portland, Oregon, United States|Geisinger Medical Center, Danville, Pennsylvania, United States|Temple University Hospital, Philadelphia, Pennsylvania, United States|Einstein Medical Center, Philadelphia, Pennsylvania, United States|UPMC Presbyterian Hospital, Pittsburgh, Pennsylvania, United States|William P. Clements Jr. University Hospital, Dallas, Texas, United States|Ben Taub General Hospital, Houston, Texas, United States|Memorial Hermann Texas Medical Center, Houston, Texas, United States|University of Utah Healthcare, Salt Lake City, Utah, United States|Froedtert Hospital, Milwaukee, Wisconsin, United States",https://ClinicalTrials.gov/show/NCT04355767
NCT04395768,International ALLIANCE Study of Therapies to Prevent Progression of COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment",Alliance-COVID19,"National Institute of Integrative Medicine, Melbourne, Victoria, Australia",https://ClinicalTrials.gov/show/NCT04395768
NCT04380376,Low-doses Melphalan Inhalation in Patients With COVID-19 (CoronavIrus Disease 2019) Pneumonia,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,PSRI05-20,"Kirill Zykov, Moscow, Russian Federation|Clinical hospital, Moscow, Russian Federation",https://ClinicalTrials.gov/show/NCT04380376
NCT04412291,"A Study in Patients With COVID-19 and Respiratory Distress Not Requiring Mechanical Ventilation, to Compare Standard-of-care With Anakinra and Tocilizumab Treatment The Immunomodulation-CoV Assessment (ImmCoVA) Study",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2020-001748-24,"Karolinska University Hospital, Huddinge, Stockholm, Sweden",https://ClinicalTrials.gov/show/NCT04412291
NCT04958161,Reconditioning Exercise for COVID-19 Patients Experiencing Residual sYmptoms,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,IRB00075690,"Wake Forest University, Winston-Salem, North Carolina, United States",https://ClinicalTrials.gov/show/NCT04958161
NCT04817332,STOP-COVID19: Superiority Trial Of Protease Inhibition in COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",01.01.20|2020-001643-13|281986,"NHS Grampian, Aberdeen, United Kingdom|Royal United Hospitals Bath NHS Foundation Trust, Bath, United Kingdom|University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom|Cardiff & Vale University Health Board, Cardiff, United Kingdom|NHS Tayside, Dundee, United Kingdom|NHS Fife, Dunfermline, United Kingdom|Frimley Health NHS Foundation Trust, Frimley, United Kingdom|Princess Alexandra Hospital NHS Trust, Harlow, United Kingdom|NHS Highland, Inverness, United Kingdom|NHS Forth Valley, Larbert, United Kingdom|University Hospitals of Leicester NHS Trust, Leicester, United Kingdom|Liverpool University Hospitals NHS Foundation Trust, Liverpool, United Kingdom|Portsmouth Hospitals NHS Trust, Portsmouth, United Kingdom|Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom|University Hospitals North Midlands NHS Trust, Stoke-on-Trent, United Kingdom|NHS Lanarkshire, Wishaw, United Kingdom",https://ClinicalTrials.gov/show/NCT04817332
NCT04615429,Clinical Trial to Assess the Efficacy of MSC in Patients With ARDS Due to COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",COVID-AT|2020-002193-27,"Hospital Universitario Puerta de Hierro-Majadahonda, Majadahonda, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04615429
NCT04344431,Management by Hyperbaric Oxygen Therapy of Patients With Hypoxaemic Pneumonia With SARS-CoV-2 (COVID-19),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,2020PPRC03,"Hôpital d'Instruction des Armées Laveran, Marseille, France|Centre Hospitalier Intercommunal de Toulon - La Seyne-sur-Mer, Toulon, France|Hôpital d'Instruction des Armées Sainte-Anne, Toulon, France",https://ClinicalTrials.gov/show/NCT04344431
NCT04529460,Healthy Volunteer COVID-19 Antibody Testing Study,Observational Model: Cohort|Time Perspective: Prospective,134035,NA,https://ClinicalTrials.gov/show/NCT04529460
NCT04721236,Early Use of Hyperimmune Plasma in COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,100490/2020,"Catherine Klersy, Pavia, Italy",https://ClinicalTrials.gov/show/NCT04721236
NCT04647695,IFN-beta 1b and Remdesivir for COVID19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,UW 20-535,"Queen Mary Hospital, Hong Kong, Hong Kong",https://ClinicalTrials.gov/show/NCT04647695
NCT04917523,Immuno-bridging Study of Inactivated SARS-CoV-2 Vaccine in Healthy Population Aged 3-17 vs Aged 18 Years Old and Above,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,CNBG2021001,"Sheikh Khalifa Medical City, SEHA, Abu Dhabi, United Arab Emirates",https://ClinicalTrials.gov/show/NCT04917523
NCT04800965,Text-based Interventions to Promote COVID-19 Vaccinations,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Health Services Research",IRB#21-000268 (1),"UCLA Health Department of Medicine, Quality Office, Westwood, California, United States",https://ClinicalTrials.gov/show/NCT04800965
NCT04803409,UNITE Study (UCSD-SW) for COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,201611,"University of California San Diego, San Diego, California, United States",https://ClinicalTrials.gov/show/NCT04803409
NCT04623047,Using Smart Watches to Detect and Monitor COVID-19,Observational Model: Other|Time Perspective: Prospective,PRO00106404,"Duke University, Durham, North Carolina, United States",https://ClinicalTrials.gov/show/NCT04623047
NCT04870333,PROphylaxis for paTiEnts at Risk of COVID-19 infecTion -V,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention",CCTU0307|2020-004144-28,"Cambridge University Hospitals NHS Foundation Trust, Cambridge, Cambridshire, United Kingdom",https://ClinicalTrials.gov/show/NCT04870333
NCT04723563,Nebulized Heparin for the Treatment of COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",FHHep2121,"Frederick Health Hospital, Frederick, Maryland, United States",https://ClinicalTrials.gov/show/NCT04723563
NCT04516954,Convalescent Plasma for COVID-19 Patients,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,ISC.20.11.1,"Vinmec Research Institute of Stem cell and Gene Technology, Hanoi, Vietnam",https://ClinicalTrials.gov/show/NCT04516954
NCT04404426,CACOLAC : Citrulline Administration in the Hospital Patient in Intensive Care for COVID-19 Acute Respiratory Distress Syndrome,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",35RC20_9815_CACOLAC|CPP 1288 HPS1|2020-A01189-30,"Rennes University Hospital, Rennes, Britanny, France",https://ClinicalTrials.gov/show/NCT04404426
NCT04821973,Respiratory Tele Monitoring COVID 19 (TMR COVID-19),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,2020-35|2020-A01627-32,"Assistance Publique Hôpitaux de Marseille, Marseille, France",https://ClinicalTrials.gov/show/NCT04821973
NCT04822012,Anti COVID-19 Antibodies in Follicular Fluid and Spermatic Fluid,Observational Model: Cohort|Time Perspective: Prospective,0053-21-HMO,"Meir Medical Center, Kfar Saba, Israel",https://ClinicalTrials.gov/show/NCT04822012
NCT04364984,"ARB, ACEi, DRi in COVID-19",Observational Model: Cohort|Time Perspective: Prospective,COVID20,"Medical Practice Prof D.Ivanov, Kiev, Please Select, Ukraine|Medical Practice Prof D.Ivanov, Kiev, Please Select, Ukraine",https://ClinicalTrials.gov/show/NCT04364984
NCT04600895,The Prevent Severe COVID-19 (PRESECO) Study,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",ATI0220,"Cahaba Research, Inc., Pelham, Alabama, United States|Absolute Clinical Research, Phoenix, Arizona, United States|B.G Clinical Research Center, LLC, Little Rock, Arkansas, United States|Xera Med Research, Boca Raton, Florida, United States|Synergy Healthcare, Bradenton, Florida, United States|Best Quality Research,Inc., Hialeah, Florida, United States|Elixia Clinical Research Collaborative, Hollywood, Florida, United States|Homestead Associates In Research, Miami, Florida, United States|Verus Clinical Research Corporation, Miami, Florida, United States|Quality Professional HealthCare, Miami, Florida, United States|Continental Clinical Research, LLC, Miami, Florida, United States|Global Life Research Network, Llc, Miami, Florida, United States|Sanitas Research, LLC, Miami, Florida, United States|US Associates in Research, LLC, Miami, Florida, United States|Biore'Search Institute Llc, Pembroke Pines, Florida, United States|Luminous Clinical Research - South Florida Urgent Care, Pembroke Pines, Florida, United States|Alliance Clinical Research of Tampa, Tampa, Florida, United States|University of Massachusettts Medical School, Worcester, Massachusetts, United States|Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States|Frontier Clinical Research, LLC, Scottdale, Pennsylvania, United States|Frontier Clinical Research, LLC, Smithfield, Pennsylvania, United States|New Phase Research & Development, Knoxville, Tennessee, United States|Clinical Trial Network, Houston, Texas, United States|Frontier Clinical Research, Kingwood, West Virginia, United States",https://ClinicalTrials.gov/show/NCT04600895
NCT04341688,A Clinical Trial of Gargling Agents in Reducing Intraoral Viral Load Among COVID-19 Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Supportive Care",2020-Sur-ERC-4926,NA,https://ClinicalTrials.gov/show/NCT04341688
NCT04553055,Antibiotic Misuse During COVID-19 Pandemic,Observational Model: Ecologic or Community|Time Perspective: Cross-Sectional,AA86,"BeniSuefU, Cairo, BeniSuef, Egypt",https://ClinicalTrials.gov/show/NCT04553055
NCT04981314,Echinacea Drug for Covid-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",2021-000850-24,"Hospital de Barbastro, Barbastro, Spain|Hospital do Barbanza, Ribeira, Spain|Hospital Clínico Universitario de Santiago, Santiago De Compostela, Spain|Hospital Clínico Universitario Miguel Blesa, Zaragoza, Spain",https://ClinicalTrials.gov/show/NCT04981314
NCT04818320,Favipiravir in High-risk COVID-19 Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,Favirpiravir-A1,"Penang General Hospital, George Town, Pulau Pinang, Malaysia",https://ClinicalTrials.gov/show/NCT04818320
NCT04459312,National Covid-19 Surveillance Physicians,Observational Model: Cohort|Time Perspective: Prospective,2020_2,"University Hospital Duesseldorf, Dept. of Anesthesiology, Duesseldorf, Germany",https://ClinicalTrials.gov/show/NCT04459312
NCT04542408,Hamburg Edoxaban for Anticoagulation in COVID-19 Study,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment",HERO-19,"Universitätsklinikum Düsseldorf, Düsseldorf, Germany|Universitätsklinikum Freiburg, Freiburg, Germany|Marienkrankenhaus, Hamburg, Germany|Universitärsklinikum Hamburg-Eppendorf, Hamburg, Germany|Medizinische Hochschule Hannover, Hanover, Germany|Krankenhaus Köln-Merheim, Köln, Germany|TU München Klinikum rechts der Isar, München, Germany|Universitätsklinikum Münster, Münster, Germany",https://ClinicalTrials.gov/show/NCT04542408
NCT04924816,Awake Prone Position in Patients With COVID-19,Observational Model: Cohort|Time Perspective: Prospective,ISECENSA,"Luciano M Chicayban, Campos Dos Goytacazes, RJ, Brazil",https://ClinicalTrials.gov/show/NCT04924816
NCT04655716,Urine Alkalinisation to Prevent AKI in COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,283852,NA,https://ClinicalTrials.gov/show/NCT04655716
NCT04547660,Convalescent Plasma for Severe COVID-19 Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,2020-0158,"Hospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande Do Sul, Brazil",https://ClinicalTrials.gov/show/NCT04547660
NCT04353674,Modulation of Hyperinflammation in COVID-19,Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,115785,"University Hospital, London, Ontario, Canada|Victoria Hospital - Critical Care Trauma Centre, London, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04353674
NCT04816786,COVID-19 Patients Admitted to the ICU,Observational Model: Cohort|Time Perspective: Retrospective,1591/2020,"Mubarak al Kabeer hospital, Kuwait, Outside U.S./Canada, Kuwait",https://ClinicalTrials.gov/show/NCT04816786
NCT04602442,Safety and Efficiency of Method of Exosome Inhalation in COVID-19 Associated Pneumonia,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Other",COVID-19 EXO Extended,"Medical Centre Dinasty, Samara, Russian Federation",https://ClinicalTrials.gov/show/NCT04602442
NCT04662086,COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Master Protocol,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",COPPS-Master Protocol,"ValleyCare Medical Center, Pleasanton, California, United States|Stanford University, Stanford, California, United States",https://ClinicalTrials.gov/show/NCT04662086
NCT04649944,Serological Profile of Children and Young Adolescents With at Least One COVID-19 Diagnosed Family Member,Observational Model: Other|Time Perspective: Prospective,GMT_CD_CT_LG_EB_10_2020,"UOC Maxillofacial Surgery and Odontology, University of Milan, Milan, Lombardy, Italy",https://ClinicalTrials.gov/show/NCT04649944
NCT04582331,Improving Real-time COVID-19 Monitoring Through Smartphone Voice Analysis,Observational Model: Case-Control|Time Perspective: Prospective,SH2020.COV01,"UC San Diego Medical Center, San Diego, California, United States|Brigham & Woman's Hospital, Boston, Massachusetts, United States|Montefiore Medical Center, New York, New York, United States|Deenanath Mangeshkar Hospital & Research Centre, Pune, India",https://ClinicalTrials.gov/show/NCT04582331
NCT04954222,Recovery of Respiratory System in COVID-19 Patients,Observational Model: Cohort|Time Perspective: Prospective,21-001028,"Mayo Clinic in Arizona, Scottsdale, Arizona, United States|Mayo Clinic in Rochester, Rochester, Minnesota, United States",https://ClinicalTrials.gov/show/NCT04954222
NCT04716972,Evaluating the Impact of COVID-19 (Coronavirus) on Research in Care Homes,Observational Model: Cohort|Time Perspective: Prospective,2021COV114,NA,https://ClinicalTrials.gov/show/NCT04716972
NCT04634318,Organization of Pulmonary Rehabilitation of Post-COVID-19 Patient With Sequelae (REHABCOVID),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,2020-CHITS-06|2020-A02838-31,"Hôpital Renée Sabran, Hyères, Var, France|HIA Sainte Anne, Toulon, Var, France",https://ClinicalTrials.gov/show/NCT04634318
NCT04420390,Low Dose Radiotherapy for COVID-19 Pneumonitis,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,LOWRAD-Cov19,"Servicio de Oncología Radioterápica. Hospital Clínico San Carlos, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04420390
NCT04386564,Kidney Injury Severity and COVID-19,Observational Model: Cohort|Time Perspective: Prospective,Sechenov-COVID19_AKI,"Sechenov University., Moscow, Russian Federation",https://ClinicalTrials.gov/show/NCT04386564
NCT04967586,Medical Students and Risk of COVID-19 Infection,Observational Model: Cohort|Time Perspective: Cross-Sectional,2021/47,"The University of Jordan, Amman, Jordan",https://ClinicalTrials.gov/show/NCT04967586
NCT04389840,Dociparstat for the Treatment of Severe COVID-19 in Adults at High Risk of Respiratory Failure,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",CMX-DS-004,"University of Alabama at Birmingham, Birmingham, Alabama, United States|Advanced Pulmonary Research Institute/Wellington Regional Medical Center, Loxahatchee Groves, Florida, United States|Augusta University, Augusta, Georgia, United States|Our Lady of the Lake, Baton Rouge, Louisiana, United States|Tulane University, New Orleans, Louisiana, United States|University Medical Center, New Orleans, Louisiana, United States|William Beaumont Hospital, Royal Oak, Michigan, United States|Wake Forest Baptist Health, Winston-Salem, North Carolina, United States|Texas Health Harris Methodist Hospital Fort Worth, Dallas, Texas, United States|Ascension St. Francis Hospital, Milwaukee, Wisconsin, United States|Ascension All Saints Hospital, Racine, Wisconsin, United States",https://ClinicalTrials.gov/show/NCT04389840
NCT04485338,Chest Radiography in COVID-19 Patients,Observational Model: Cohort|Time Perspective: Retrospective,RALE-COVID,"Amsterdam UMC location AMC, Amsterdam, Netherlands",https://ClinicalTrials.gov/show/NCT04485338
NCT04843787,SLV213 Treatment in COVID-19 Patients,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",SLV213-02,NA,https://ClinicalTrials.gov/show/NCT04843787
NCT04662073,COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Camostat Sub-Protocol,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",COPPS-Camostat,"ValleyCare Medical Center, Pleasanton, California, United States|Stanford University, Stanford, California, United States",https://ClinicalTrials.gov/show/NCT04662073
NCT04836806,Cetirizine and Famotidine for COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",STUDY00001722,"Emory University Hospital at Wesley Woods COVID-19 Testing Facility, Atlanta, Georgia, United States|Emory Healthcare Network Peachtree Immediate Care COVID-19 Testing Centers, Atlanta, Georgia, United States",https://ClinicalTrials.gov/show/NCT04836806
NCT04961255,Effects of Post-COVID-19 on Quadriceps Femoral Muscle-tendon Unit,Observational Model: Cohort|Time Perspective: Prospective,CAAE: 45043821.0.0000.8093,"University of Brasilia, Brasília, Distrito Federal, Brazil",https://ClinicalTrials.gov/show/NCT04961255
NCT04853108,Remote Monitoring of COVID-19 Positive Outpatients,Observational Model: Case-Only|Time Perspective: Retrospective,STUDY00001408,"Emory Clinic, Emory University Hospital, Atlanta, Georgia, United States",https://ClinicalTrials.gov/show/NCT04853108
NCT04494893,ImmuneRACE - Immune Response Action to COVID-19 Events,Observational Model: Cohort|Time Perspective: Prospective,ADAP-006,"Adaptive Biotechnologies, Seattle, Washington, United States",https://ClinicalTrials.gov/show/NCT04494893
NCT04568122,"Rapid Turnaround, Home-based Saliva Testing for COVID-19",Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,58629,"Stanford University, Stanford, California, United States",https://ClinicalTrials.gov/show/NCT04568122
NCT04662060,COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Acebilustat Sub-Protocol,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",COPPS-Acebilustat,"Stanford University, Stanford, California, United States",https://ClinicalTrials.gov/show/NCT04662060
NCT04477668,Helmet Non-Invasive Ventilation for COVID-19 Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,RC20/306/R,"Intensive Care Department, King Abdulaziz Medical City, National Guard Health Affairs, Riyadh, Saudi Arabia",https://ClinicalTrials.gov/show/NCT04477668
NCT04483830,Suloexide in the Treatment of Early Stages of COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,Clidm/Vas/2020-05-01,"Clinedem, San Luis Rio Colorado, Sonora, Mexico",https://ClinicalTrials.gov/show/NCT04483830
NCT04877808,Bacterial Surinfections in COVID-19 ICU Patients,Observational Model: Cohort|Time Perspective: Retrospective,f2021/037,NA,https://ClinicalTrials.gov/show/NCT04877808
NCT04728828,COVADIAL - Immunogenicity of COVID-19 Vaccine in Hemodialysis Patients,Observational Model: Cohort|Time Perspective: Prospective,COVADIAL,"Centre Hospitalier de Quimper, Quimper, France",https://ClinicalTrials.gov/show/NCT04728828
NCT04892979,3R Rehabilitation Management of COVID-19 Survivors,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,HSEARS20200912001,"Pamela Youde Eastern Hospital, Hong Kong, Hong Kong|Princess Margaret Hospital, Hong Kong, Hong Kong|Queen Elizabeth Hospital, Hong Kong, Hong Kong|Tuen Mun Hospital, Hong Kong, Hong Kong",https://ClinicalTrials.gov/show/NCT04892979
NCT03305341,Proof-of-Concept Clinical Pharmacology Trial for COVID-19 Antigen Presentation Therapeutic Biologics,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,PDP-153210-215451-761218|FWA00015357|IRB00009424|IORG0007849|IND153210|NDA215451|BLA761218,"Medicine Invention Design Incorporation (MIDI) - IORG0007849, North Bethesda, Maryland, United States",https://ClinicalTrials.gov/show/NCT03305341
NCT04840966,A Simplified Test to Assess Flavor in COVID-19 Patients,Observational Model: Cohort|Time Perspective: Prospective,PM0001/2020,"Dipartimento di Medicina Clinica e Chirurgia, Napoli, Italy",https://ClinicalTrials.gov/show/NCT04840966
NCT04766788,Studying Students at Risk for COVID-19,Observational Model: Cohort|Time Perspective: Prospective,HUM00185391,"Michigan Medicine, Ann Arbor, Michigan, United States",https://ClinicalTrials.gov/show/NCT04766788
NCT04847102,A Phase III Clinical Study of a SARS-CoV-2 Messenger Ribonucleic Acid (mRNA) Vaccine Candidate Against COVID-19 in Population Aged 18 Years and Above,"Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention",ARCoV-005,NA,https://ClinicalTrials.gov/show/NCT04847102
NCT04982263,Blood Coagulation Abnormalities in COVID-19 (Corona Virus Disease-19) Patients,Observational Model: Cohort|Time Perspective: Prospective,Soh-Med-21-07-34,"Sohag University, Sohag, Egypt|Sohag University, Sohag, Egypt",https://ClinicalTrials.gov/show/NCT04982263
NCT04501458,Western Kenya Integrated COVID-19 Response,Allocation: Non-Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,1,"Surgical Systems Research Group/Tropical Institute of Community Health, Kisumu, Kenya",https://ClinicalTrials.gov/show/NCT04501458
NCT04424004,MURDOCK Cabarrus County COVID-19 Prevalence and Immunity (C3PI) Study,Observational Model: Ecologic or Community|Time Perspective: Cross-Sectional,Pro00105703,"Duke CTSI Translational Population Health Office, Kannapolis, North Carolina, United States",https://ClinicalTrials.gov/show/NCT04424004
NCT04824677,Risk Factors and Prognoses in Patients Hospitalized for COVID-19,Observational Model: Case-Only|Time Perspective: Prospective,COVID-Ponent,"Hospital Universitari Arnau de Vilanova, Lleida, Spain|Hospital Universitari Santa Maria, Lleida, Spain",https://ClinicalTrials.gov/show/NCT04824677
NCT04635241,Inhaled Heparin for Hospitalised COVID-19 Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment",INHALE-HEP meta-trial,"San Camilo Clinic, Buenos Aires, Argentina|15th May hospital, Cairo, Egypt",https://ClinicalTrials.gov/show/NCT04635241
NCT04629183,Risk Stratification of COVID-19 Patients Discharged From the Emergency Department,Observational Model: Cohort|Time Perspective: Prospective,COVID-ED-IntRisk,"Ospedale Maria Vittoria, D.E.A., Torino, Piemonte, Italy|A.O.U.C. Azienda Ospedaliero-Universitaria Careggi, D.E.A., Firenze, Toscana, Italy|Ospedale U. Parini, Medicina e Chirurgia d'accettazione e Urgenza (MeCAU), Aosta, Italy|A.O. S. Croce e Carle, Medicina e Chirurgia d'Urgenza, Cuneo, Italy|A.O.U. Careggi, Medicina e Chirurgia d'Urgenza e Accettazione, Firenze, Italy|A.O.U. Città della Salute e della Scienza di Torino, Ospedale Molinette, S.C. Medicina d'Urgenza U (MECAU), Torino, Italy|Ospedale San Giovanni Bosco, Medicina e Chirurgia d'accettazione e urgenza (MeCAU), Torino, Italy",https://ClinicalTrials.gov/show/NCT04629183
NCT04606498,Blood Purification With Seraph 100 Microbind Affinity Blood Filter for Treatment of Severe COVID19 Observational Study,Observational Model: Cohort|Time Perspective: Other,PURIFY-OBS-1,"VA Greater Los Angeles Healthcare System, Los Angeles, California, United States|University of Colorado Hospital, Aurora, Colorado, United States|Advent Health, Orlando, Florida, United States|Southeast Georgia Health System - Brunswick Campus, Brunswick, Georgia, United States|Eisenhower Army Medical Center (EAMC), Fort Gordon, Georgia, United States|Uniformed Services University, Bethesda, Maryland, United States|Walter Reed National Military Medical Center, Bethesda, Maryland, United States|Forrest General Hospital, Hattiesburg, Mississippi, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|Baylor Scott & White, Dallas, Texas, United States|University of Texas Southwestern Medical Center, Dallas, Texas, United States|Methodist Hospital, San Antonio, Texas, United States|University Of Texas Health San Antonio (UTHSA)- University Health, San Antonio, Texas, United States|Brooke Army Medical Center, San Antonio, Texas, United States",https://ClinicalTrials.gov/show/NCT04606498
NCT04892459,Study on Sequential Immunization of Inactivated SARS-CoV-2 Vaccine and Recombinant SARS-CoV-2 Vaccine (Ad5 Vector),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",JSVCT116,"Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, Jiangsu, China",https://ClinicalTrials.gov/show/NCT04892459
NCT04834128,TCB008 in Patients With COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,TCB008-002,NA,https://ClinicalTrials.gov/show/NCT04834128
NCT04555148,COVIDIG (COVID-19 Hyper-ImmunoGlobulin),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,GC5131A-HIG_P0201,"Samsung Medical Center, Seoul, Korea, Republic of|Samsung Medical Center, Seoul, Korea, Republic of",https://ClinicalTrials.gov/show/NCT04555148
NCT04558203,"The Relationship Between COVID-19 and Autoimmune Diseases, Lessons From Practice",Observational Model: Cohort|Time Perspective: Cross-Sectional,PR0014,"Asalam, Maadi, Cairo, Egypt",https://ClinicalTrials.gov/show/NCT04558203
NCT04828135,Dual MRI for Cardiopulmonary COVID-19 Long Haulers,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,Pro00107681,"Duke Asthma, Allergy, and Airway Center, Durham, North Carolina, United States",https://ClinicalTrials.gov/show/NCT04828135
NCT04387760,Favipiravir vs Hydroxychloroquine vs Control in COVID -19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,40 / 07-May-2020,"Royal College of Surgeons in Ireland - Bahrain, Manama, Bahrain",https://ClinicalTrials.gov/show/NCT04387760
NCT04524715,LLLT Treatment of Lung Inflammation in COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,CP19-02,"Wellness Junction, Millsboro, Delaware, United States",https://ClinicalTrials.gov/show/NCT04524715
NCT04743908,Community Network-driven COVID-19 Testing of Vulnerable Populations in the Central US,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,20-1494,NA,https://ClinicalTrials.gov/show/NCT04743908
NCT04591613,Late Clinical Events Associated With COVID-19 Infection,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,RIPH_2020_09,"Ch Auxerre, Auxerre, France|CHU Caen, Caen, France|CHRU Lille, Lille, France|CH Melun Marc Jacquet, Melun, France|AP-HP Hôpital Hôtel-Dieu, Paris, France|CHU de Saint-Etienne, Saint-Priest-en-Jarez, France|CH Tourcoing, Tourcoing, France|CHRU Tours, Tours, France|CHRU Nancy, Vandœuvre-lès-Nancy, France|Centre Hospitalier Bretagne Atlantique, Vannes, France|CH André Rosemon de Cayenne, Cayenne, French Guiana",https://ClinicalTrials.gov/show/NCT04591613
NCT04523831,Clinical Trial of Ivermectin Plus Doxycycline for the Treatment of Confirmed Covid-19 Infection,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",ERC-DMC/ECC/2020/117,"Dhaka Medical College, Dhaka, Bangladesh",https://ClinicalTrials.gov/show/NCT04523831
NCT04762628,"Trial Efficacy of Saisei Pharma Dietary Supplements MAF Capsules, 148 mg and M Capsules, 148 mg in Hospitalized COVID-19 Patients",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,SaiseiMAF supplements COVID,"The Central Hospital of Rubizhne, Infection Disease Department, Rubizhne, Luhansk Region, Ukraine|Municipal Kharkiv Regional Infectious Diseases Clinical Hospital, Kharkiv, Ukraine",https://ClinicalTrials.gov/show/NCT04762628
NCT04403672,Performance Evaluation of RealDetect™ COVID-19 RT-PCR Kit for the Detection of SARS-CoV-2 Virus,Observational Model: Case-Control|Time Perspective: Prospective,30005052020,"Institute of Epidemiology, Disease Control and Research (IEDCR), Mohakhali, Dhaka (For sample collection & sample storage), Institute for Developing Science & Health Initiatives (ideSHi); Mohakhali, Dhaka (For sample analysis, data collection, data analys, Dhaka, Bangladesh",https://ClinicalTrials.gov/show/NCT04403672
NCT04650035,The Impact of COVID-19 on Surgical Practice in Jordan During the Second Outbreak,Observational Model: Other|Time Perspective: Retrospective,The Impact of COVID-19 Jordan,"Yarmouk University, Irbid, Jordan",https://ClinicalTrials.gov/show/NCT04650035
NCT04344730,Dexamethasone and Oxygen Support Strategies in ICU Patients With Covid-19 Pneumonia,"Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",APHP200388|2020-001457-43,"Hopital Bichat - Aphp, Paris, France",https://ClinicalTrials.gov/show/NCT04344730
NCT04575168,Clinical Study Spartan COVID-19 V2 System,Observational Model: Cohort|Time Perspective: Cross-Sectional,VNV-00615,"Wake Research Mt. Vernon, Sandy Springs, Georgia, United States|Clinical Chemistry Research Lab, University of Maryand-Baltimore, Baltimore, Maryland, United States|Wake Research ClinSearch, Chattanooga, Tennessee, United States",https://ClinicalTrials.gov/show/NCT04575168
NCT04904510,Evaluation of the INDICAID™ COVID-19 Rapid Antigen Test,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Diagnostic,Pro00047510,"CityHealth Urgent Care Oakland, Oakland, California, United States",https://ClinicalTrials.gov/show/NCT04904510
NCT04599959,COVID-19 Tests: Nasopharyngeal Swab vs Saliva Collected With Salivette® Cortisol for Viral RNA Sampling for RT-qPCR,Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,0352-2150,"Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico, Mexico",https://ClinicalTrials.gov/show/NCT04599959
NCT04957940,Lipid Emulsion Infusion and COVID-19 Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment",17300631,"Assiut university hospital, Assiut, Assuit, Egypt",https://ClinicalTrials.gov/show/NCT04957940
NCT04502069,Treatment of COVID-19 With Opaganib in Patients With Pneumonia Requiring Oxygen,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,ABC-112,"Shaare Zedek Medical Center, Jerusalem, Israel",https://ClinicalTrials.gov/show/NCT04502069
NCT04665245,Symptom-Based Markers for COVID-19 Transmission,Observational Model: Cohort|Time Perspective: Prospective,202007450,"University of Iowa Hospitals & Clinics, Iowa City, Iowa, United States",https://ClinicalTrials.gov/show/NCT04665245
NCT04689542,Surgical Face Mask Effects in Patients With COVID-19,"Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double (Care Provider, Outcomes Assessor)|Primary Purpose: Supportive Care",COSIT,"Cliniques universitaires Saint-Luc, Brussels, Belgium",https://ClinicalTrials.gov/show/NCT04689542
NCT04529525,Ivermectin to Prevent Hospitalizations in COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",IVERCORCOVID19MSPICC,"Ministry of Public Health of the Province of Corrientes, Corrientes, Argentina",https://ClinicalTrials.gov/show/NCT04529525
NCT04433325,COVID-19 Critically Ill Patients' Evolution After Medical Transport by Train From Paris Intensive Care Units to West of France Intensive Care Units,Observational Model: Case-Control|Time Perspective: Retrospective,35RC20_3091_TOCCIP,"CHU Poitiers, Poitiers, France|CHU Tours, Tours, France",https://ClinicalTrials.gov/show/NCT04433325
NCT04741178,PAtterns and Extension in COVID-19 Related Interstitial Pneumonia: CT Analysis,Observational Model: Cohort|Time Perspective: Other,Paesi-COV-19,"Morgagni Pierantoni Hospital, Forlì, FC, Italy",https://ClinicalTrials.gov/show/NCT04741178
NCT04376580,Use of the Nasal Cannula During COVID-19,Observational Model: Ecologic or Community|Time Perspective: Prospective,Nasal cannulas flow rate,"Carolina Frederico, Buenos Aires, Caba, Argentina",https://ClinicalTrials.gov/show/NCT04376580
NCT04355247,Prophylactic Corticosteroid to Prevent COVID-19 Cytokine Storm,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,CCAM 20-01,"San Juan City Hospital / Puerto Rico Medical Center, San Juan, Puerto Rico|Hospital Auxilio Mutuo Cancer Center, San Juan, Puerto Rico",https://ClinicalTrials.gov/show/NCT04355247
NCT04536363,Cri Analog PG1 Effectiveness and Safety in Covid-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,CEIS-2020-089,NA,https://ClinicalTrials.gov/show/NCT04536363
NCT04816071,Essential Amino Acid Supplementation in Older Adult COVID-19 Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment",261678,"University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States",https://ClinicalTrials.gov/show/NCT04816071
NCT04860232,Risks and Outcomes Among COVID-19 Patients Admitted to Assiut University Hospital.,Observational Model: Cohort|Time Perspective: Prospective,Risks and Outcomes of COVID19,NA,https://ClinicalTrials.gov/show/NCT04860232
NCT04476602,Ambulatory Management of Moderate to High Risk COVID-19 (SARS-CoV-2) Patients - The Coronavirus Related Outpatient Work Navigators (CROWN) Protocol,Observational Model: Cohort|Time Perspective: Retrospective,20-0618,"410 Lakeville Road, Suite 107, New Hyde Park, New York, United States",https://ClinicalTrials.gov/show/NCT04476602
NCT04827160,Prediction of Thrombosis Using D-dimer Trends in COVID-19,Observational Model: Cohort|Time Perspective: Retrospective,2020308,"CHRU Nancy, Nancy, France",https://ClinicalTrials.gov/show/NCT04827160
NCT04652115,Defibrotide for the Treatment of Severe COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2020P003203,"Brigham and Women's Hospital, Boston, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT04652115
NCT04860245,Risks and Outcomes Among COVID-19 Patients Admitted to Assiut University Hospitals.,Observational Model: Cohort|Time Perspective: Prospective,Risks and Outcomes ofCOVID-,"Assiut University, Assiut, Egypt",https://ClinicalTrials.gov/show/NCT04860245
NCT04494867,Core Warming in COVID-19 Patients Undergoing Mechanical Ventilation,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,COVID-19 Core Warming,"Sharp Memorial Hospital, San Diego, California, United States",https://ClinicalTrials.gov/show/NCT04494867
NCT04361435,Lung Recruitment Device for COVID-19,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,MP-21-2020-2871,NA,https://ClinicalTrials.gov/show/NCT04361435
NCT04701996,Transmission Dynamics of COVID-19 in a Rural Setting of the Democratic Republic of the Congo,Observational Model: Cohort|Time Perspective: Prospective,B3002020000141,"Centre de Recherche en Santé de Kimpese, Kimpese, Congo, The Democratic Republic of the",https://ClinicalTrials.gov/show/NCT04701996
NCT04659707,Hyperpolarized 129Xe MRI of Survivors of COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,146646,"University of Kansas Medical Center, Kansas City, Kansas, United States",https://ClinicalTrials.gov/show/NCT04659707
NCT04631861,Physical Activity and the Risk of COVID-19 Infection and Mortality,Observational Model: Case-Control|Time Perspective: Retrospective,2020AN0292,NA,https://ClinicalTrials.gov/show/NCT04631861
NCT04487665,Oral Manifestations of Coronavirus Disease 2019(COVID-19) :a Multicentre Study,Observational Model: Ecologic or Community|Time Perspective: Cross-Sectional,8791,NA,https://ClinicalTrials.gov/show/NCT04487665
NCT04670003,Spread Analysis of COVID-19 Outbreak in France by Self-assessment Web-application,Observational Model: Cohort|Time Perspective: Prospective,WP-2020-05,"Institut Interrégional de Cancérologie, Le Mans, France",https://ClinicalTrials.gov/show/NCT04670003
NCT04539795,COVID-19 Study of Safety and Tolerability of Alvelestat,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",IRB-300005845,"UAB Lung Health Center, Birmingham, Alabama, United States",https://ClinicalTrials.gov/show/NCT04539795
NCT04725097,A Study to Evaluate Rapid Throughput Screening for Human COVID-19 Infection,Observational Model: Cohort|Time Perspective: Prospective,20-011415,"Mayo Clinic, Rochester, Minnesota, United States|Sri Jayadeva, Bengaluru, Karnataka, India|Gregorio Marañon Hospital, Madrid, Spain|Imperial College, London, England, United Kingdom",https://ClinicalTrials.gov/show/NCT04725097
NCT04920773,Community-based Post-exposure Prophylaxis for COVID-19,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,NMP/CARE/01,"NMP Medical Research Institute, Jaipur, Rajasthan, India|Padmnabham Ayurveda Hospital & Research Center, Jaipur, Rajasthan, India",https://ClinicalTrials.gov/show/NCT04920773
NCT04847141,A Study to Evaluate the Safety and Efficacy of C19-IG 20% in SARS-CoV-2 Infected Asymptomatic Ambulatory Outpatients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",GC2010|2021-000269-34,"CAP Gornal, L'Hospitalet de Llobregat, Barcelona, Spain|CAP Navàs, Navàs, Barcelona, Spain|CAP Sant Fèlix, Sabadell, Barcelona, Spain|CAP Manso, Barcelona, Spain|CAP Maluquer Salvador, Girona, Spain|Centro de Salud Hacienda de Pavones Sureste, Madrid, Spain|Centro de Salud Isla de Oza Noroeste, Madrid, Spain|Hospital Sant Pau i Santa Tecla, Tarragona, Spain",https://ClinicalTrials.gov/show/NCT04847141
NCT04519502,Maternal Morbidity and Mortality During the COVID-19 Pandemic,Observational Model: Cohort|Time Perspective: Retrospective,HD36801 - MFMU COVID-19|U01HD036801,"University of Alabama - Birmingham, Birmingham, Alabama, United States|Northwestern University, Chicago, Illinois, United States|Columbia University-St. Luke's Hospital, New York, New York, United States|University of North Carolina-Chapel Hill, Chapel Hill, North Carolina, United States|Case Western Reserve University, Cleveland, Ohio, United States|Ohio State University, Columbus, Ohio, United States|Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States|Magee Women's Hospital, Pittsburgh, Pennsylvania, United States|Brown Univeristy, Providence, Rhode Island, United States|University of Texas Medical Branch, Galveston, Texas, United States|University of Texas - Houston, Houston, Texas, United States|University of Utah Medical Center, Salt Lake City, Utah, United States",https://ClinicalTrials.gov/show/NCT04519502
NCT04584606,Ain Shams University Experience: Clinical Determinants of Hospitalized COVID-19 Patients,Observational Model: Case-Only|Time Perspective: Retrospective,FMASU P30/ 2020,"Faculty of Medicine Ain Shams University Research Institute- Clinical Research Center, Cairo, Non-US, Egypt",https://ClinicalTrials.gov/show/NCT04584606
NCT04581928,Patients Reactions Towards Their Diagnosis as Having COVID-19,Observational Model: Cohort|Time Perspective: Other,PR0020,"Asalam, Maadi, Cairo, Egypt",https://ClinicalTrials.gov/show/NCT04581928
NCT04643054,Efficacy and Safety of Ovotransferrin in COVID-19 Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,20201116,"Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone, Palermo, Italy",https://ClinicalTrials.gov/show/NCT04643054
NCT04521036,Convalescent Plasma for COVID-19 Patients (CPCP),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,ISC.20.11.2,"Vinmec Research Institute of Stem Cell and Gene Technology, Hanoi, Vietnam",https://ClinicalTrials.gov/show/NCT04521036
NCT04709068,Risk Stratification and Early Alerting Regarding COVID-19 Hospitalization,Observational Model: Cohort|Time Perspective: Prospective,Pro00047371,"Current Health, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04709068
NCT04358926,Hyperbaric Oxygen Therapy Effect in COVID-19 RCT (HBOTCOVID19),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,120-20-ASF,"Amir Hadanny, Zerifin, Israel",https://ClinicalTrials.gov/show/NCT04358926
NCT04470999,Changes in Cellular Immune Profile During COVID-19 Infection,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science,SRPH-CVD-01,"Seraph Research Institute, Los Angeles, California, United States",https://ClinicalTrials.gov/show/NCT04470999
NCT04499300,Elderly Patients and COVID-19 Infection: a Cohort of Fifty Patients Over Ninety Years of Age,Observational Model: Cohort|Time Perspective: Retrospective,CHUB-COVID-19-90+,"CHU Brugmann, Brussels, Belgium",https://ClinicalTrials.gov/show/NCT04499300
NCT04877704,Symprove (Probiotic) as an add-on to COVID-19 Management,"Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",290407,"Institute of Liver Studies, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04877704
NCT04832828,Sensitivity and Specificity of the Roth Test in Patients With COVID-19 Positive,Observational Model: Case-Only|Time Perspective: Prospective,PI-4321,"CS Entrevías, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04832828
NCT04887272,"Weathering the Storm: Lung, Heart, and Brain Vascular Rehabilitation for COVID-19",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Basic Science,2021-0185|UL1TR002003,"University of Illinois at Chicago, Chicago, Illinois, United States",https://ClinicalTrials.gov/show/NCT04887272
NCT04703036,"Glutathione, Oxidative Stress and Mitochondrial Function in COVID-19","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Other",H48057,"Baylor College of Medicine, Houston, Texas, United States",https://ClinicalTrials.gov/show/NCT04703036
NCT04898985,The Leukemia and Lymphoma Society (LLS) T-cells in Blood Cancer and COVID-19,Observational Model: Case-Control|Time Perspective: Prospective,LLSC19-002,"Lymphoma and Leukemia Society, Rye Brook, New York, United States",https://ClinicalTrials.gov/show/NCT04898985
NCT04590053,"Allocetra-OTS in COVID-19, Phase II",Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,DM004,"Barzilai Medical Center, Ashkelon, Israel|Hadassah Medical Center, Jerusalem, Israel|Tel Aviv Sourasky Medical Center, Tel Aviv, Israel",https://ClinicalTrials.gov/show/NCT04590053
NCT04388527,COVID-19 Convalescent Plasma for Mechanically Ventilated Population,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,842996 (PennCCP-01),"Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04388527
NCT04496141,Evaluation of Commercial SARS-CoV-2 Antibody Immunoassays for COVID-19,Observational Model: Cohort|Time Perspective: Retrospective,RC-2020-12,"Hong Kong Sanatorium & Hospital, Hong Kong, Hong Kong",https://ClinicalTrials.gov/show/NCT04496141
NCT04793243,Vitamin D3 Levels in COVID-19 Outpatients From Western Mexico,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,CI-07620,"Universidad de Guadalajara, Guadalajara, Jalisco, Mexico",https://ClinicalTrials.gov/show/NCT04793243
NCT04847518,Assessment of Efficacy of KAN-JANG® in Mild COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",SHIRD-2021-02|Nr3-2021/87,"The First University Clinic of Tbilisi State Medical University, Tbilisi, Georgia",https://ClinicalTrials.gov/show/NCT04847518
NCT04949035,Mental Status and Quality of Life of Post-COVID-19 Patients,Observational Model: Cohort|Time Perspective: Prospective,COVID-19 Pre-,"The Ministry of the Interior and Administration Hospital, Głuchołazy, Poland",https://ClinicalTrials.gov/show/NCT04949035
NCT04387292,Ocular Sequelae of Patients Hospitalized for Respiratory Failure During the COVID-19 Epidemic,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,MMT_2020_12,"Fondation A de Rothschild, Paris, France",https://ClinicalTrials.gov/show/NCT04387292
NCT04335305,Checkpoint Blockade in COVID-19 Pandemic,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,MedOPP376|2020-001160-28,"Hospital Quirónsalud Barcelona, Barcelona, Spain|Hospital de la Santa Creu i Sant Pau, Barcelona, Spain|Hospital Universitari Arnau de Vilanova de Lleida, Lleida, Spain|Hospital Universitario Ramón y Cajal, Madrid, Spain|Hospital Ruber Juan Bravo, Madrid, Spain|Hospital Ruber Internacional, Madrid, Spain|Hospital Arnau de Vilanova-Lliria, Valencia, Spain|Hospital Universitario Doctor Peset, Valencia, Spain",https://ClinicalTrials.gov/show/NCT04335305
NCT04655586,"Assessing Safety, Hospitalization and Efficacy of rNAPc2 in COVID-19","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment",NAPc-201/301,"ARCA Investigational Site #119, Fairhope, Alabama, United States|ARCA Investigational Site #104, Aurora, Colorado, United States|ARCA Investigational Site #101, Jacksonville, Florida, United States|ARCA Investigational Site #113, New Orleans, Louisiana, United States|ARCA Investigational Site #105, Falls Church, Virginia, United States|ARCA Investigational Site #114, Richmond, Virginia, United States|ARCA Investigational Site #103, Tacoma, Washington, United States",https://ClinicalTrials.gov/show/NCT04655586
NCT04386239,Study on the Use of Sarilumab in Patients With COVID-19 Infection,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,COVID-SARI-001,"Divisione Clinicizzata di Malattie Infettive, ASST FBF-Sacco, Milano, MI, Italy",https://ClinicalTrials.gov/show/NCT04386239
NCT04497272,Assesment of the Metabolomic Signature in COVID-19 Patients,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,20-PP-18,"CHU de nice, Nice, Alpes-Maritimes, France",https://ClinicalTrials.gov/show/NCT04497272
NCT04952857,"Short Term, High Dose Vitamin D Supplementation in Moderate to Severe COVID-19 Disease","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",INT/2020/001068,NA,https://ClinicalTrials.gov/show/NCT04952857
NCT04558749,Anxiety and Depression Among Pregnant Women During COVID-19 Pandemic,Observational Model: Other|Time Perspective: Cross-Sectional,ADCOVID,"Assiut Faculty of Medicine, Assiut, Egypt",https://ClinicalTrials.gov/show/NCT04558749
NCT04920760,Vitamin A Supplementation in Children With Moderate to Severe COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Supportive Care,99-01-14-23475,NA,https://ClinicalTrials.gov/show/NCT04920760
NCT04756128,Impact of Colchicine and Low-dose Naltrexone on COVID-19,Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,X2103400,"Park Nicollet Methodist Hospital, Saint Louis Park, Minnesota, United States|Regions Hospital, Saint Paul, Minnesota, United States",https://ClinicalTrials.gov/show/NCT04756128
NCT04849585,Evaluation of the Impact of Hospitalization in Intensive Care for COVID-19 Infection,Observational Model: Cohort|Time Perspective: Prospective,RIPH_2020_11,"CH Tourcoing, Tourcoing, France",https://ClinicalTrials.gov/show/NCT04849585
NCT04801940,HElping Alleviate the Longer-term Consequences of COVID-19 (HEAL-COVID),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,A095848,"Addenbrookes Hospital, Cambridge, United Kingdom",https://ClinicalTrials.gov/show/NCT04801940
NCT04487444,Thymalfasin (Thymosin Alpha 1) to Treat COVID-19 Infection,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,SCN-16130571-2,"The Miriam Hospital, Providence, Rhode Island, United States",https://ClinicalTrials.gov/show/NCT04487444
NCT04951388,A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Adolescents,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention",CT-COV-22,"Mackay Memorial Hospital Hsinchu, Hsinchu, Taiwan|Chang-Guang Memorial Hospital Lin-Kou, Taipei, Taiwan|MacKay Memorial Hospital, Taipei, Taiwan|National Taiwan University Hospital-HsinChu, Taipei, Taiwan|National Taiwan University Hosptial, Taipei, Taiwan",https://ClinicalTrials.gov/show/NCT04951388
NCT04896606,SARS-CoV-2 CTLS for Mild to Moderate COVID-19 Disease,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,NYMC 604,"Nationwide Children's Hosptial, Columbus, Ohio, United States|Children's Hospital of Pennsylvania, Philadelphia, Pennsylvania, United States|Medical College of Wisconsin/Children's Hospital of Wisconsin, Milwaukee, Wisconsin, United States",https://ClinicalTrials.gov/show/NCT04896606
NCT04338828,Nitric Oxide Inhalation Therapy for COVID-19 Infections in the ED,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",2019P00XXXX,"Massachusetts General Hospital, Boston, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT04338828
NCT04912895,Detection of SARS-CoV-2 RNA in Coughed Droplets From Patients With COVID-19,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,STUDY00000863,"Emory University Hospital Midtown, Atlanta, Georgia, United States|Emory Children's Center, Atlanta, Georgia, United States|Emory University Hospital, Atlanta, Georgia, United States|Wesley Woods Center, Atlanta, Georgia, United States",https://ClinicalTrials.gov/show/NCT04912895
NCT04709744,Impact of Vitamin D Level and Supplement on SLE Patients During COVID-19 Pandemic,Observational Model: Case-Only|Time Perspective: Prospective,RP.21.01.91,"Mansoura University Hospital, Mansoura, DK, Egypt",https://ClinicalTrials.gov/show/NCT04709744
NCT04871789,Optimization of Patients Long-term Management After the Coronavirus Infection COVID-19,Observational Model: Case-Control|Time Perspective: Cross-Sectional,COVID_2020_01,"Russian Clinical Research Center for Gerontology, Moscow, Russian Federation",https://ClinicalTrials.gov/show/NCT04871789
NCT04628208,Clinical Study Spartan COVID-19 V2 System (Canada Alternate),Observational Model: Case-Only|Time Perspective: Cross-Sectional,VNV-00635,"The Ottawa hospital, Ottawa, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04628208
NCT04647669,World Health Organization (WHO) COVID-19 Solidarity Trial for COVID-19 Treatments,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,SRD/ETH/20,"Univeristy of the West Indies, Kingston, Jamaica",https://ClinicalTrials.gov/show/NCT04647669
NCT04504734,Bucillamine in Treatment of Patients With COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",RT-003,"Cullman Clinical Trials, Cullman, Alabama, United States|HealthStar Research LLC, Hot Springs, Arkansas, United States|ASCADA Research, Huntington Beach, California, United States|Samuel Ross MD Inc., Los Angeles, California, United States|Amicis Research Center, Northridge, California, United States|Optimus Medical Group, San Francisco, California, United States|C & R Research Services USA, Coral Gables, Florida, United States|Sweet Hope Research Specialty Inc, Hialeah, Florida, United States|Encore Medical Research, Hollywood, Florida, United States|Entrust Clinical Research, Kendall, Florida, United States|Columbus Clinical Services, Miami, Florida, United States|Verus Clinical Research, Miami, Florida, United States|Nuren Medical & Research Center, Miami, Florida, United States|Advance Medical Research Services Corp, Miami, Florida, United States|Amavita Clinical Research, North Miami Beach, Florida, United States|C & R Research Services USA, Tampa, Florida, United States|Encore Medical Research of Weston LLC, Weston, Florida, United States|Clinical Site Partners LLC, Winter Park, Florida, United States|American Clinical Trials LLC, Acworth, Georgia, United States|Quad Clinical Research LLC, Chicago, Illinois, United States|Koch Family Medicine, Morton, Illinois, United States|Revive Research Institute Inc., Farmington Hills, Michigan, United States|Revival Research Institute LLC, Sterling, Michigan, United States|Machuca Family Medicine, Las Vegas, Nevada, United States|Prime Global Research, Bronx, New York, United States|OnSite Clinical Solutions, Charlotte, North Carolina, United States|OnSite Clinical Solutions, LLC, Charlotte, North Carolina, United States|Monroe Biomedical Research, Monroe, North Carolina, United States|Superior Clinical Research, Smithfield, North Carolina, United States|Superior Clinical Research, Yanceyville, North Carolina, United States|Dayton Clinical Research, Dayton, Ohio, United States|Pharmacorp Clinical Trials Inc., Charleston, South Carolina, United States|Physicians Quality Care, Jackson, Tennessee, United States|Inquest Clinical Research, Baytown, Texas, United States|C & R Research Services USA, Houston, Texas, United States|Encore Imaging and Medical Research, Houston, Texas, United States|R & H Clinical Research Inc., Katy, Texas, United States|FMC Science, Lampasas, Texas, United States|Family Practice Center, McAllen, Texas, United States|R & H Clinical Research Inc., Stafford, Texas, United States|Renovatio Clinical, The Woodlands, Texas, United States|Dr. Orvil Martínez-Rivera, San Juan, Puerto Rico",https://ClinicalTrials.gov/show/NCT04504734
NCT04786249,Impact of Rapid Screening for COVID-19 in Delocalized Biology in the Emergency Department,Observational Model: Cohort|Time Perspective: Retrospective,DELOCOVID,"Groupe Hospitalier Paris Saint-Joseph, Paris, Ile De France, France",https://ClinicalTrials.gov/show/NCT04786249
NCT04523051,Rehabilitation After Admission in Intensive Care Unit for COVID-19,Observational Model: Cohort|Time Perspective: Prospective,2020-05Obs-CHRMT,"Etablissement de santé Filieris, Freyming-Merlebach, Moselle, France|Hopital Legouest, Metz, Moselle, France|CHR Metz Thionville, Metz, Moselle, France",https://ClinicalTrials.gov/show/NCT04523051
NCT04936503,Support for the Resumption of Training of High-level Athletes Post-epidemic COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,CHUBX 2020/16,"Training center Soyaux Angoulême XV Rugby, Angoulême, France|Training Center Stade Aurillacois, Aurillac, France|Aviron Bayonnais Rugby Pro Training Center, Bayonne, France|Biarritz Olympique Pays Basque training center, Biarritz, France|Bordeaux University Hospital - CRB medical office - Hôpital du Tondu, Bordeaux, France|Bordeaux University Hospital - Service UDH - Hôpital Pellegrin, Bordeaux, France|CABCL Rugby Training Center, Brive-la-Gaillarde, France|Union Bordeaux-Bègles training center, Bègles, France|US Carcassonne Rugby training center, Carcassonne, France|Union Sportive Colomiers Rugby training center, Colomiers, France|FC Grenoble Rugby training center, Grenoble, France|Stade Rochelais Rugby training center, La Rochelle, France|Racing92 training center, Le Plessis-Robinson, France|AS Montauban Rugby training center, Montauban, France|US Nevers Rugby training center, Nevers, France|Stade Français training center, Paris, France|Section Paloise Rugby training center, Pau, France|USAP Training Center, Perpignan, France|Training center Valence Romans Drôme Rugby, Romans-sur-Isère, France|Castres Olympique training center, Saix, France|Stade Toulousain Rugby training center, Toulouse, France",https://ClinicalTrials.gov/show/NCT04936503
NCT04371952,DYNAMIC Study (DoxycYcliNe AMbulatoIre COVID-19),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",RC20_0191,"CHU Avicenne - APHP, Bobigny, France|CHU Bordeaux, Bordeaux, France|CHU Caen, Caen, France|CHU Dijon, Dijon, France|CHU Grenoble, Grenoble, France|CHU Nantes, Nantes, France",https://ClinicalTrials.gov/show/NCT04371952
NCT04784468,DNA Damage and Oxidative Stress in Hospitalized COVID-19 Patients,Observational Model: Case-Control|Time Perspective: Prospective,UNIVIE_Covid_Oxstress,"Klinik Donaustadt, Vienna, Austria",https://ClinicalTrials.gov/show/NCT04784468
NCT04614948,A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in Adults,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention",CR108916|2020-003643-29|VAC31518COV3009,"Achieve Clinical Research, LLC, Vestavia Hills, Alabama, United States|Hope Research Institute, Phoenix, Arizona, United States|Central Phoenix Medical Clinic, Phoenix, Arizona, United States|Quality of Life Medical & Research Center, LLC, Tucson, Arizona, United States|Synexus Clinical Research US, Inc, Tucson, Arizona, United States|Woodland International Research Group, Little Rock, Arkansas, United States|Synexus Clinical Research US, Inc, Cerritos, California, United States|eStudySite, Chula Vista, California, United States|Ark Clinical Research, Long Beach, California, United States|Anthony Mills Medical, Inc, Los Angeles, California, United States|Benchmark Research, Sacramento, California, United States|Artemis Institute for Clinical Research, San Diego, California, United States|Paradigm Clinical Research Centers, Inc., Wheat Ridge, Colorado, United States|JEM Research, LLC, Atlantis, Florida, United States|Prestige Clinical Research Center, Inc., Coral Gables, Florida, United States|Avail Clinical Research, LLC, DeLand, Florida, United States|Velocity Clinical Research, Hallandale Beach, Hallandale Beach, Florida, United States|Health Awareness inc., Jupiter, Florida, United States|Altus Research, Inc, Lake Worth, Florida, United States|Compass Research, Melbourne, Melbourne, Florida, United States|Suncoast Research Group, Miami, Florida, United States|Behavioral Clinical Research , Inc, North Miami, Florida, United States|Clinical NeuroScience Solutions, Inc, Orlando, Florida, United States|Progressive Medical Research, Port Orange, Florida, United States|Meridien Research, Saint Petersburg, Florida, United States|Palm Beach Research Center, West Palm Beach, Florida, United States|Atlanta Center for Medical Research, Atlanta, Georgia, United States|Accel Research Sites, Eatonton, Georgia, United States|The University Of Chicago Medicine, Chicago, Illinois, United States|Great Lakes Clinical Trials, Chicago, Illinois, United States|The South Bend Clinic Center for Research, South Bend, Indiana, United States|Heartland Research Associates, LLC, Newton, Kansas, United States|University of Kentucky, Lexington, Kentucky, United States|Centex Studies, Inc., Lake Charles, Louisiana, United States|Ochsner Clinic Foundation, New Orleans, Louisiana, United States|Centennial Medical Group, Elkridge, Maryland, United States|Optimal Research, Rockville, Maryland, United States|Meridian Clinical Research, LLC, Rockville, Maryland, United States|Henry Ford Health Systems, Detroit, Michigan, United States|Cherry Street Services, Inc., Grand Rapids, Michigan, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|Hassman Research Institute, LLC., Berlin, New Jersey, United States|Jersey Shore University Medical Center, Neptune, New Jersey, United States|Medpharmics, LLC, Albuquerque, New Mexico, United States|Meridian Clinical Research, LLC, Endwell, New York, United States|Regional Clinical Research, Inc., Endwell, New York, United States|Allergy Asthma Immunology of Rochester, PC (AAIR) - Research Center, Rochester, New York, United States|Richmond Behavioral Associates, Staten Island, New York, United States|American Health Network, LLC, Charlotte, North Carolina, United States|Wilmington Health Associates, Wilmington, North Carolina, United States|CTI Clinical Trial and Consulting Services, Cincinnati, Ohio, United States|Lynn Health Science Institute, Oklahoma City, Oklahoma, United States|Medical University of South Carolina, Charleston, South Carolina, United States|Coastal Carolina Research Center, Mount Pleasant, South Carolina, United States|Centennial Medical Center, Nashville, Tennessee, United States|Centex Studies, Inc., Houston, Texas, United States|Centex Studies, Inc., Houston, Texas, United States|Texas Center for Drug Development, Inc, Houston, Texas, United States|Centex Studies, Inc., McAllen, Texas, United States|Endeavor Clinical Trials, LLC, San Antonio, Texas, United States|JBR Clinical Research, Salt Lake City, Utah, United States|Alliance for Multispeciality Research, Norfolk, Virginia, United States|Anima, Alken, Belgium|Institute of Tropical Medicine Antwerp, Antwerpen, Belgium|Center for Vaccinology (CEVAC), Gent, Belgium|UZ Leuven, Leuven, Belgium|Az Sint-Maarten, Mechelen, Belgium|Private Practice RESPISOM Namur, Namur, Belgium|Hospital Nossa Senhora da Conceicao, Porto Alegre, Brazil|Hospital federal dos servidores do estado, Rio de Janeiro, Brazil|Instituto Nacional de Infectologia Evandro Chagas (INI) - FIOCRUZ, Rio de Janeiro, Brazil|Centro de Referencia E Treinamento Dst/Aids, Sao Paulo, Brazil|Instituto de infectologia Emilio Ribas, São Paulo, Brazil|Fundacion Cardiomet CEQUIN, Armenia, Colombia|IPS Centro Cientifico Asisitencial Jose Luis Accini S.A.S., Barranquilla, Colombia|Asistencia Cientifica de Alta Complejidad S.A.S, Bogota, Colombia|Centro Medico Imbanaco de Cali S.A., Casanare, Colombia|T Y C Inversiones S A S Grupsalud, Santa Marta, Colombia|CHU de Montpellier, Hopital Saint-Eloi, Montpellier, France|Hopital Saint-Antoine, Paris Cedex 12, France|Hopital Cochin, Paris, France|Groupe Hospitalier Sud Hôpital Haut-Leveque Service d'hematologie, Pessac, France|CHU Saint-Etienne - Hôpital Nord, Saint-Etienne Cedex 2, France|Hopital Purpan, Toulouse Cedex 09, France|Hopital Rangueil, Toulouse, France|Hôpital de Brabois Adultes, Vandoeuvre les Nancy, France|Klinikum rechts der Isar der TU Munchen, München, Germany|Riverside Medical Center, Bacolod, Philippines|West Visayas State University Medical Center, Iloilo City, Philippines|Tropical Disease Foundation, Makati, Philippines|Makati Medical Center, Manila, Philippines|Medical Center Manila, Manila, Philippines|TREAD Research Tygerberg Hospital, Cape Town, South Africa|Centre of Tuberculosis Research Innovation, Cape Town, South Africa|Worthwhile Clinical trials, Johannesburg, South Africa|Peermed Clinical Trial Centre, Kempton Park, South Africa|Dr AA Mahomed Medical Centre, Moloto, South Africa|VX Pharma, Pretoria, South Africa|Dr J.M. Engelbrecht Trial Site, Somerset West, South Africa|Be Part Yoluntu Centre, Western Cape, South Africa|Hosp. Univ. Germans Trias I Pujol, Badalona, Spain|Hospital Quiron Barcelona, Barcelona, Spain|Hosp. Clinic I Provincial de Barcelona, Barcelona, Spain|Hosp. Univ. Vall D Hebron, Barcelona, Spain|Hosp. Univ. de La Princesa, Madrid, Spain|Clinica Univ. de Navarra, Madrid, Spain|Hosp. Univ. de La Paz, Madrid, Spain|Hosp. Quiron Madrid Pozuelo, Madrid, Spain|Clinica Univ. de Navarra, Pamplona, Spain|Queen Elizabeth Hospital, Birmingham, United Kingdom|Powys Teaching Local Health Board - Bronllys Hospital, Brecon, United Kingdom|Brighton & Sussex University Hospitals NHS Trust, Brighton, United Kingdom|University Hospitals Bristol NHS Trust, Bristol, United Kingdom|Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom|Ninewells Hospital, Dundee, United Kingdom|Royal Free Hospital, Hampstead, United Kingdom|Leicester Royal Infirmary, Leicester, United Kingdom|Guy's and St Thomas' Hospital, London,, United Kingdom|Imperial College London and Imperial College Healthcare NHS Trust, London, United Kingdom|Central Manchester University Hospitals NHS Foundation Trust, Manchester, United Kingdom|Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom|University of Oxford, Oxford, United Kingdom|Derriford Hospital, Plymouth, United Kingdom|Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom|Southampton General Hospital, Southampton, United Kingdom",https://ClinicalTrials.gov/show/NCT04614948
NCT04576351,The Norwegian Study of Nervous System Manifestations and Sequelae After COVID-19,Observational Model: Cohort|Time Perspective: Prospective,152727,"Sørlandet Hospital Trust, Arendal, Norway|Haukeland University Hospital, Bergen, Norway|Nordlandssykehuset, Bodo, Norway|Vestre Viken Hospital Trust Drammen, Drammen, Norway|Østfold Hospital Trust Kalnes, Grålum, Norway|Sørlandet Hospital Trust, Kristiansand, Kristiansand, Norway|Innlandet Hospital Trust, Lillehammer, Norway|Akershus University Hospital, Lørenskog, Norway|Møre og Romsdal Hospital Trust, Molde, Norway|Oslo University Hospital, Oslo, Norway|Ostfold Hospital Trust, Sarpsborg, Norway|Skien Hospital, Skien, Norway|Stavanger University Hospital, Stavanger, Norway|University Hospital of North Norway, Tromsø, Norway|St. Olav Hospital, Trondheim, Norway",https://ClinicalTrials.gov/show/NCT04576351
NCT04730427,Safety and Preliminary Efficacy Study of GX-I7 in Patients With COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,GX-I7-COV-009,"Borame Medical Center, Seoul, Korea, Republic of",https://ClinicalTrials.gov/show/NCT04730427
NCT04793984,Efficacy and Safety Evaluation of Inhaleen Inhalation in Hospitalized COVID-19 Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",COVID-19/TCP_20_05,"Gesundheitsverbund, Klinik Floridsdorf, Vienna, Austria",https://ClinicalTrials.gov/show/NCT04793984
NCT04634799,Study To antagOnize Plasminogen Activator Inhibitor-1 in Severe COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",STU00213262,"Northwestern University, Chicago, Illinois, United States",https://ClinicalTrials.gov/show/NCT04634799
NCT04636320,Prevalence of Myocardial Scars on CMR After COVID-19 Infection,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,CHUBX 2020/22,"Bordeaux University Hospital, Pessac, France",https://ClinicalTrials.gov/show/NCT04636320
NCT04568889,Minnesota COVID-19 Testing Project,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Health Services Research",IRB20-1444,"Volunteers Enlisted to Assist People, Bloomington, Minnesota, United States|Southern Anoka Community Assistance, Columbia Heights, Minnesota, United States|People Reaching Out to People Food Shelf, Eden Prairie, Minnesota, United States|Fridley Covenant Church, Fridley, Minnesota, United States|Calvary Lutheran Church Food Shelf, Minneapolis, Minnesota, United States|NorthPoint Health and Wellness, Minneapolis, Minnesota, United States|Community Emergency Assistance Programs, Minneapolis, Minnesota, United States|Intercongregation Communities Association, Minnetonka, Minnesota, United States|Valley Outreach, Stillwater, Minnesota, United States|White Bear Area Foodshelf, White Bear Lake, Minnesota, United States",https://ClinicalTrials.gov/show/NCT04568889
NCT04695652,A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Adult,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention",CT-COV-21,"Changhua Christian Hospital, Changhua, Taiwan|Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Taiwan|China Medical University Hospital, Taichung, Taiwan|National Cheng Kung University Hospital, Tainan, Taiwan|National Taiwan University Hospital, Taipei, Taiwan|Taipei Medical University Hospital, Taipei, Taiwan|Taipei Municipal Wan Fang Hospital, Taipei, Taiwan|Taipei Veteran General Hospital, Taipei, Taiwan|Tri-Service General Hospital, Taipei, Taiwan|Chang-Guang Memorial Hospital Lin-Kou, Taoyuan, Taiwan|Tao-Yuan General Hospital, Taoyuan, Taiwan|National Institute of Hygiene and Epidemiology, Hanoi, Vietnam",https://ClinicalTrials.gov/show/NCT04695652
NCT04573855,TREATMENT WITH ANTI-SARS-COV-2 IMMUNOGLOBULIN IN PATIENTS WITH COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,PCL04/2020,NA,https://ClinicalTrials.gov/show/NCT04573855
NCT04529447,Response of Korean Medicine Hospital to COVID-19,Observational Model: Other|Time Perspective: Retrospective,JMA-CT-2020-01,"Jaseng Hospital of Korean Medicine, Seoul, Korea, Republic of",https://ClinicalTrials.gov/show/NCT04529447
NCT04860284,Hydroxychloroquine for Treatment of Non-Severe COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,MAKRIF/DVCFA/016/20,"Namboole COVID-19 treatment unit, Kampala, Uganda",https://ClinicalTrials.gov/show/NCT04860284
NCT04643561,Using Travelan to Boost Immune Response in Vitro to COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,healthytravelancov19- HMO-CTIL,"Hadassah Medical Organization, Jerusalem, Israel, Jerusalem, Israel",https://ClinicalTrials.gov/show/NCT04643561
NCT04896060,The Impact of the COVID-19 Pandemic on Eating Behavior and Weight Change,Observational Model: Ecologic or Community|Time Perspective: Prospective,10000172|000172-DK,"NIDDK, Phoenix, Phoenix, Arizona, United States",https://ClinicalTrials.gov/show/NCT04896060
NCT04584450,Investigation of Validity and Reliability of Post-COVID-19 Functional Status Scale,Observational Model: Other|Time Perspective: Prospective,GO 20/788,"Hacettepe University, Ankara, Turkey",https://ClinicalTrials.gov/show/NCT04584450
NCT04828915,Early Detection of Clinical Deterioration in Patients With COVID-19 Using Machine Learning,Observational Model: Cohort|Time Perspective: Prospective,TEDDI,"University Hospital of Tuebingen, Tuebingen, Germany",https://ClinicalTrials.gov/show/NCT04828915
NCT04780555,Evaluation of Musculoskeletal System Symptoms and Biochemical Parameters in COVID-19,Observational Model: Cohort|Time Perspective: Prospective,AIBU-FTR-EY-02,"Elif Yakşi, Merkez, Bolu, Turkey",https://ClinicalTrials.gov/show/NCT04780555
NCT04570462,Mild Hypothermia for COVID-19 ARDS,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,Protocol 5.18.2020 Approved,"North Shore University Hospital, Manhasset, New York, United States",https://ClinicalTrials.gov/show/NCT04570462
NCT04779749,Pregnancy Outcomes According to the Gestational Age of Acquiring COVID-19,Observational Model: Case-Control|Time Perspective: Retrospective,PregOutCOV,"CHU Brugmann, Brussels, Belgium|Antoine Béclère Hospital, Clamart, France|Hôpital Louis Mourier, Colombes, France|Fondazione Policlinico Universitario Agostino Gemelli, Roma, Italy",https://ClinicalTrials.gov/show/NCT04779749
NCT04419571,Outcomes in Emergency Laparotomies During COVID-19 Pandemic,Observational Model: Cohort|Time Perspective: Retrospective,133196,"Queen's Hospital, Romford, United Kingdom",https://ClinicalTrials.gov/show/NCT04419571
NCT04386265,Compassionate Use of Hyperbaric Oxygen Therapy,Observational Model: Case-Only|Time Perspective: Prospective,HBOT-COVID-19,"White River Wound Healing Center, Batesville, Arkansas, United States|Community Hospital, Monterey, California, United States|Innovative Healing Systems, Tampa, Florida, United States|Decatur Memorial Hospital, Decatur, Indiana, United States|Providence Medical Wound Care Center, Kansas City, Kansas, United States|West Jefferson Medical Center, Marrero, Louisiana, United States|The Wound Treatment Center, Opelousas, Louisiana, United States|Christus Shreveport Bossier Hyperbaric & Wound Care Center, Shreveport, Louisiana, United States|Ascension Providence Rochester Hospital Wound Care Center, Rochester, Michigan, United States|CHI, Chattanooga, Tennessee, United States|Klinika Baromedical, Poznan, Wielkopolskie, Poland",https://ClinicalTrials.gov/show/NCT04386265
NCT04619719,Hyperbaric Oxygen for COVID-19 Patients With Moderate to Severe Hypoxemia,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,20-00897,"Greenwich Hospital - Yale New Haven Health, Greenwich, Connecticut, United States|Bozeman Health, Bozeman, Montana, United States|NYU Winthrop Hospital, Mineola, New York, United States|Legacy Emanuel Medical Center, Portland, Oregon, United States",https://ClinicalTrials.gov/show/NCT04619719
NCT04390477,Study to Evaluate the Effect of a Probiotic in COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,COVID.PROB,"Hospital Universitario del Vinalopó, Elche, Alicante, Spain|Hospital Universitario de Torrevieja, Torrevieja, Alicante, Spain",https://ClinicalTrials.gov/show/NCT04390477
NCT04858620,A Study to Evaluate the Efficacy of Xlear vs. Placebo for Acute COVID-19 Infection,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Care Provider)|Primary Purpose: Treatment,LCH-3-032020,"Larkin Community Hospital, Miami, Florida, United States",https://ClinicalTrials.gov/show/NCT04858620
NCT04409483,Evaluation of Additional Treatments for COVID-19: a Randomized Trial in Niger,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,Trascov,NA,https://ClinicalTrials.gov/show/NCT04409483
NCT04549922,Antisense Therapy to Block the Kallikrein-kinin Pathway in COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",ASKCOV_Trial,"Hospital Naval Marcílio Dias, Rio De Janeiro, Brazil|BP-A Beneficiência Portuguesa de São Paulo, São Paulo, Brazil|Hospital São Paulo - UNIFESP, São Paulo, Brazil",https://ClinicalTrials.gov/show/NCT04549922
NCT04534621,How Brazilian Chiropractors Are Facing the COVID-19 Pandemic,Observational Model: Other|Time Perspective: Cross-Sectional,TrateTE,NA,https://ClinicalTrials.gov/show/NCT04534621
NCT04597047,Research & Evaluation of LumiraDx SARS-CoV-2 (COVID-19) Point of Care Ab Test,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,S-CLIN-PROT-0031,"Eclipse Clinical Research, Tucson, Arizona, United States|Centura Health Physician Group, Northglenn Office, Northglenn, Colorado, United States|Professional Research Network of Kansas, Wichita, Kansas, United States|Physicians Quality Care of Jackson, Jackson, Tennessee, United States",https://ClinicalTrials.gov/show/NCT04597047
NCT04960215,Coenzyme Q10 as Treatment for Long Term COVID-19,"Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",QVID-001,"Department of Infectious Diseases, Aarhus, Aarhus N, Denmark",https://ClinicalTrials.gov/show/NCT04960215
NCT04801056,Study of TB006 in Outpatient Patients With Mild to Moderate COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",TB006C1101,NA,https://ClinicalTrials.gov/show/NCT04801056
NCT04799444,LATE-COVID/LATE-COVID-Kids - Observational Study in Children and Adults,Observational Model: Cohort|Time Perspective: Prospective,LATE-COVID,"Polish Mother Memorial Research Institute (PMMHRI) in Lodz, Poland, Lodz, Poland",https://ClinicalTrials.gov/show/NCT04799444
NCT04500626,Hyperbaric Versus Normobaric Oxygen Therapy for COVID-19 Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,OHRI-HBOT-001,"The Ottawa Hospital, Ottawa, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04500626
NCT04769245,The Effectiveness of ACB-IP 1.0 Convalescent Plasma in COVID-19 Infection,Observational Model: Case-Only|Time Perspective: Retrospective,Acibadem Healthcare Group,"Acıbadem Labcell Cellular Therapy Laboratories, Istanbul, Turkey|Acibadem Altunizade Hospital, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04769245
NCT04822025,A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Elderly Adults,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention",CT-COV-23,"Hualien Tzu Chi Hospital, Hualien City, Taiwan|Shuang H Hospital, New Taipei City, Taiwan|National Taiwan University Hospital, Taipei, Taiwan|Chang Gung Medical Hospital Linkou, Taoyuan, Taiwan",https://ClinicalTrials.gov/show/NCT04822025
NCT04480060,Experience of an Emergency Intensive Care Unit During COVID-19 Pandemic,Observational Model: Cohort|Time Perspective: Retrospective,KSSEAH--EDCC,"Seda Yilmaz Semerci, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04480060
NCT04285190,The Effect of T89 on Improving Oxygen Saturation and Clinical Symptoms in Patients With COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,T89-NCP-01,NA,https://ClinicalTrials.gov/show/NCT04285190
NCT04780659,COVID-19 Vaccination of Immunodeficient Persons (COVAXID),Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,2021-000175-37,"Karolinska University Hospital, Stockholm, Huddinge, Sweden",https://ClinicalTrials.gov/show/NCT04780659
NCT04387643,Protecting Health Care Workers During the COVID-19 Outbreak,Observational Model: Other|Time Perspective: Prospective,AU/SA/01,"Samta Ayurveda Prakoshtha, Jaipur, Rajasthan, India",https://ClinicalTrials.gov/show/NCT04387643
NCT04488562,Home Monitoring and Evaluation After Admission for COVID-19 in the Netherlands,Observational Model: Cohort|Time Perspective: Prospective,MEC-2020-0318,"Amsterdam University Center - location VUmc, Amsterdam, Netherlands|Leiden University Medical Center, Leiden, Netherlands|Erasmus MC, Rotterdam, Netherlands",https://ClinicalTrials.gov/show/NCT04488562
NCT04892797,Understanding Immunology and Patient Outcomes of COVID-19 in Hospitalized Patients,Observational Model: Cohort|Time Perspective: Prospective,1369,"University of Vermont, Burlington, Vermont, United States",https://ClinicalTrials.gov/show/NCT04892797
NCT04479319,Decision Support System Algorithm for COVID-19 Diagnosis,Observational Model: Case-Only|Time Perspective: Retrospective,9081,"Ankara University Faculty of Medicine, Ankara, Turkey",https://ClinicalTrials.gov/show/NCT04479319
NCT04723537,"Upamostat, a Serine Protease Inhibitor, or Placebo for Treatment of COVID-19 Disease","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",RHB-107-01,"South Florida Research Phase I-IV, Inc., Miami Springs, Florida, United States|Henry Ford Hospital, emergency department, Detroit, Michigan, United States|University Hospitals Cleveland, Cleveland, Ohio, United States",https://ClinicalTrials.gov/show/NCT04723537
NCT04347538,Impact of Nasal Saline Irrigations on Viral Load in Patients With COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,200693,"Vanderblt University Medical Center, Nashville, Tennessee, United States",https://ClinicalTrials.gov/show/NCT04347538
NCT04469647,COVID 19 Seroprevalence Amongst Healthcare Workers in JHAH,Observational Model: Cohort|Time Perspective: Cross-Sectional,IRB20-09,"Johns Hopkins Aramco Healthcare, Dhahran, Eastern, Saudi Arabia",https://ClinicalTrials.gov/show/NCT04469647
NCT04710303,COVID-19 Vaccination Using a 2nd Generation (E1/E2B/E3-Deleted) Adenoviral Platform in Healthy South African Adults,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,AW_001_ProVIVA-SA-1,"Khayelitsha Clinical Research Site, Khayelitsha, South Africa",https://ClinicalTrials.gov/show/NCT04710303
NCT04568525,Passive Microwave Radiometry (MWR) and AI for COVID-19 Complications Early Diagnostics of Lungs,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Diagnostic,01-2/141 27,"Educational - clinical - scientific medical center of KSMA, Bishkek, Chui, Kyrgyzstan",https://ClinicalTrials.gov/show/NCT04568525
NCT04918927,Favipiravir +/- Nitazoxanide: Early Antivirals Combination Therapy in COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",2021-785-018,"Hospital de Infectología ""Daniel Méndez Hernández"" del Centro Médico Nacional La Raza, Ciudad de Mexico, Azcapotzalco, Mexico",https://ClinicalTrials.gov/show/NCT04918927
NCT04838119,Preop COVID Testing Patterns,Observational Model: Ecologic or Community|Time Perspective: Retrospective,IRB00071985,"Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States",https://ClinicalTrials.gov/show/NCT04838119
NCT04813939,Is Bio-adrenomedullin (Bio-ADM) a Prognostic Factor in Patients With COVID-19 Treated in the ICU?,Observational Model: Cohort|Time Perspective: Prospective,42021,"Medical University of Warsaw, Warszawa, Poland",https://ClinicalTrials.gov/show/NCT04813939
NCT04623255,Randomised Study of Plasma Exchange in Severe COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,132796,"University College London Hospital, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04623255
NCT04355026,Use of Bromhexine and Hydroxychloroquine for Treatment of COVID-19 Pneumonia,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,SBCebromhexinCovid-19,"SB Celje, Celje, Slovenia",https://ClinicalTrials.gov/show/NCT04355026
NCT04910542,Epidemiologic Intelligence Network (EpI-Net) to Promote COVID-19 Testing,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,3R21MD013674-02S2,"Ponce Medical School Foundation, Ponce, Puerto Rico",https://ClinicalTrials.gov/show/NCT04910542
NCT04555213,A Dose Escalation and Dose Expansion Study of NOX66 in the Treatment of COVID-19,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,NOX66-007,"Institute of Emergency Medicine, Chisinau, Moldova, Republic of",https://ClinicalTrials.gov/show/NCT04555213
NCT04673214,Evaluation of Prognostic Modification in COVID-19 Patients in Early Intervention Treatment,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,R-2020-785-176,"Alma Italia Guerrero Martinez, Mexico, Distrito Federal, Mexico",https://ClinicalTrials.gov/show/NCT04673214
NCT04338360,Expanded Access to Convalescent Plasma for the Treatment of Patients With COVID-19,NA,20-003312,"Mayo Clinic in Arizona, Scottsdale, Arizona, United States|Mayo Clinic in Florida, Jacksonville, Florida, United States|Mayo Clinic Health System in Albert Lea, Albert Lea, Minnesota, United States|Mayo Clinic Health System in Austin, Austin, Minnesota, United States|Mayo Clinic Health System in Cannon Falls, Cannon Falls, Minnesota, United States|Mayo Clinic Health System in Lake City, Lake City, Minnesota, United States|Mayo Clinic Health System in Mankato, Mankato, Minnesota, United States|Mayo Clinic Health System in Owatonna, Owatonna, Minnesota, United States|Mayo Clinic Health System in Red Wing, Red Wing, Minnesota, United States|Mayo Clinic in Rochester, Rochester, Minnesota, United States|Mayo Clinic Health System - Eau Claire, Eau Claire, Wisconsin, United States|Mayo Clinic Health System - Franciscan Healthcare, La Crosse, Wisconsin, United States",https://ClinicalTrials.gov/show/NCT04338360
NCT04847661,"Efficacy of Mefloquine as Prophylaxis Against COVID-19: A Placebo-control, Randomized Clinical Trial",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Prevention,32,"Helwan University, Cairo, Egypt",https://ClinicalTrials.gov/show/NCT04847661
NCT04733170,Clinical Performance Evaluation of KnowNow SARS-CoV-2 Test for the Detection of COVID-19 Antigen,Observational Model: Case-Only|Time Perspective: Prospective,VATIC-0101,NA,https://ClinicalTrials.gov/show/NCT04733170
NCT04765449,Transfer of Infection Fighting Immune Cells Generated in the Laboratory to High Risk Patients With COVID-19 Infection,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,21P.015,"Thomas Jefferson University, Philadelphia, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04765449
NCT04764747,Effectiveness of Convalescent Plasma in Hospitalized Patients With COVID-19,Observational Model: Cohort|Time Perspective: Retrospective,CP in COVID-19 patients,"Al-Amal Hospital, Najaf, Iraq|Al-Hakeem Hospital, Najaf, Iraq",https://ClinicalTrials.gov/show/NCT04764747
NCT04526717,Heat Shock Protein Inhibitor- MPT0B640 for COVID-19 Infection,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,JO201901-02,NA,https://ClinicalTrials.gov/show/NCT04526717
NCT04594356,"Assessment of Netosis During COVID-19, Under Treatment With Anakinra, an Interleukin-1 Receptor Antagonist",Observational Model: Cohort|Time Perspective: Retrospective,NET_COV,"Groupe Hospitalier Paris Saint-Joseph, Paris, France|CHU Bichat Claude Bernard, Paris, France",https://ClinicalTrials.gov/show/NCT04594356
NCT04631536,Managing Endothelial Dysfunction in COVID-19 : A Randomized Controlled Trial at LAUMC,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment",Lebanese American University,"LAUMCRH, Beirut, Lebanon",https://ClinicalTrials.gov/show/NCT04631536
NCT04767958,The RAPID COVID Study - Application of Point-of-Care COVID-19 Testing,Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,20200858-01T,"University of Ottawa Heart Institute, Ottawa, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04767958
NCT04530656,Phase I Trial of a Recombinant SARS-CoV-2 Vaccine (Sf9 Cell),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention",JSVCT098,"Jiangsu Provincial Center for Diseases Control and Prevention, Nanjing, Jiangsu, China",https://ClinicalTrials.gov/show/NCT04530656
NCT04666753,Retrospective Study of ImmunoFormulation for COVID-19,Observational Model: Cohort|Time Perspective: Retrospective,IMUNO TF STUDY,"Clinic Bascoy, Barcelona, Spain|Clínica Arvila Magna, Barcelona, Spain",https://ClinicalTrials.gov/show/NCT04666753
NCT04880447,Special Investigation of COMIRNATY in the Population With Underlying Diseases,Observational Model: Case-Only|Time Perspective: Prospective,C4591019,"Pfizer Local County, Tokyo, Japan",https://ClinicalTrials.gov/show/NCT04880447
NCT04966013,Evaluation of the RD-X19 Treatment Device in Individuals With Mild to Moderate COVID-19,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",EB-P20-01,"Site 2, Clearwater, Florida, United States|Site 1, Miami, Florida, United States",https://ClinicalTrials.gov/show/NCT04966013
NCT04400058,Octagam 10% Therapy in COVID-19 Patients With Severe Disease Progression,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",GAM10-10,"Octapharma Research Site, Sheffield, Alabama, United States|Octapharma Research Site, Loma Linda, California, United States|Octapharma Research Site, Loma Linda, California, United States|Octapharma Research Site, Newport Beach, California, United States|Octapharma Research Site, Orange, California, United States|Octapharma Research Site, San Diego, California, United States|Octapharma Research Site, Washington, District of Columbia, United States|Octapharma Research Site, Honolulu, Hawaii, United States|Octapharma Research Site, Iowa City, Iowa, United States|Octapharma Research Site, Covington, Louisiana, United States|Octapharma Research Site, Midland, Michigan, United States|Octapharma Research Site, Las Vegas, Nevada, United States|Octapharma Research Site, Minot, North Dakota, United States|Octapharma Research Site, Charleston, South Carolina, United States|Octapharma Research Site, Tyler, Texas, United States|Octapharma Research Site, Ivanovo, Russian Federation|Octapharma Research Site, Moscow, Russian Federation|Octapharma Research Site, Moscow, Russian Federation|Octapharma Research Site, Ryazan', Russian Federation|Octapharma Research Site, Ivano-Frankivs'k, Ukraine|Octapharma Research Site, Kharkiv, Ukraine|Octapharma Research Site, Kremenchuk, Ukraine",https://ClinicalTrials.gov/show/NCT04400058
NCT04843722,COVID-19 Supplemental Vaccine Boost to Enhance T Cell Protection in Those Who Have Already Received EUA S-Based Vaccines,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",COVID-4.006,"Chan Soon-Shiong Institute for Medicine, El Segundo, California, United States",https://ClinicalTrials.gov/show/NCT04843722
NCT04446104,A Preventive Treatment for Migrant Workers at High-risk of COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,2020/00561,"Tuas South Dormitory, Singapore, Singapore",https://ClinicalTrials.gov/show/NCT04446104
NCT04898062,"CRP-Apheresis for Attenuation of Pulmonary, MYocardial and/or Kidney Injury in COvid-19",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,21-10018-BO,"West-German Heart and Vascular Center, University Duisburg-Essen, Essen, NRW, Germany",https://ClinicalTrials.gov/show/NCT04898062
NCT04450277,Delivery of Protocolised Emergency Surgical Care During COVID-19 Pandemic,Observational Model: Cohort|Time Perspective: Prospective,2020/00660,"Khoo Teck Puat Hospital, Singapore, Singapore",https://ClinicalTrials.gov/show/NCT04450277
NCT04800120,Use of Hyperbaric Oxygen Therapy to Treat COVID-19 Patients With Respiratory Distress,Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,IRB Protocol #00800,"Morton Hospital, Taunton, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT04800120
NCT04374461,A Study of N-acetylcysteine in Patients With COVID-19 Infection,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,20-168,"Memorial Sloan Kettering Cancer Center, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04374461
NCT04469114,Tofacitinib in Hospitalized Patients With COVID-19 Pneumonia,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",34810620.0.1001.0071,"Centro de Pesquisa Clínica do Coração, Aracaju, Brazil|Hospital Universitário São Francisco de Assis Na Providência de Deu, Bragança Paulista, Brazil|Irmandade do Sr. Bom Jesus dos Passos da Santa Casa de Misericórdia de Bragança Paulista, Bragança Paulista, Brazil|Hospital do Coração do Brasil, Brasilia, Brazil|Instituto de Pesquisa Clínica de Campinas, Campinas, Brazil|Hospital Regional do Litoral Norte, Caraguatatuba, Brazil|Unimed Fortaleza Sociedade Corporativa Médica LTD, Fortaleza, Brazil|Hospital Regional Jorge Rossmann, Itanhaem, Brazil|Hospital Bruno Born, Lajeado, Brazil|Hospital São Vicente de Paulo, Passo Fundo, Brazil|Hospital Israelita Albert Einstein, Sao Paulo, Brazil|Fundação Faculdade Regional de Medicina de São José do Rio Preto, São José Do Rio Preto, Brazil|Hospital Regional de Registro, São José Dos Campos, Brazil|Hospital Regional de São José dos Campos, São José Dos Campos, Brazil|Beneficência Portuguesa, São Paulo, Brazil|BP Mirante, São Paulo, Brazil|Instituto do Coração, São Paulo, Brazil",https://ClinicalTrials.gov/show/NCT04469114
NCT04604704,Pilot Study Into LDN and NAD+ for Treatment of Patients With Post-COVID-19 Syndrome,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment",ALRx004,"AgelessRx, Ann Arbor, Michigan, United States",https://ClinicalTrials.gov/show/NCT04604704
NCT04448145,Determinants of SARS-COV2 (COVID-19) Persistence After Convalescence,Observational Model: Cohort|Time Perspective: Prospective,AAAS9722,"Columbia University Medical Center, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04448145
NCT04603690,Study to Investigate the Benefits of Colchicine in Patients With COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,LUMHS/REC/893,NA,https://ClinicalTrials.gov/show/NCT04603690
NCT04391309,COVID-19 and Anti-CD14 Treatment Trial,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",DAIT COVID-19-003|NIAID CRMS ID#: 38756|UM1AI109565,"Harbor - UCLA Medical Center, Torrance, California, United States|University of Miami Medical Center, Miami Beach, Florida, United States|Sarasota Memorial Health Care System, Sarasota, Florida, United States|Emory University Medical Center, Atlanta, Georgia, United States|Ochsner Health, New Orleans, Louisiana, United States|University of Maryland Medical Center, Baltimore, Maryland, United States|Baystate Medical Center, Springfield, Massachusetts, United States|Cleveland Clinic, Cleveland, Ohio, United States|Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States|Virginia Mason Medical Center, Seattle, Washington, United States|Harborview Medical Center, Seattle, Washington, United States|Swedish Medical Center, Seattle, Washington, United States|University of Washington Medical Center-Montlake, Seattle, Washington, United States|University of Washington Medical Center, Seattle, Washington, United States",https://ClinicalTrials.gov/show/NCT04391309
NCT04353336,Efficacay of Chloroquine or Hydroxychloroquine in COVID-19 Treatment,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,chloroquine covid,"Tanta University, Assiut University, Tanta, Egypt",https://ClinicalTrials.gov/show/NCT04353336
NCT04377802,Safe Return to Regular Clinical Operation After COVID-19 Pandemic,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,KFSH-ONC-02,"king Fahad specialist hospital, Dammam, Eastern Province, Saudi Arabia",https://ClinicalTrials.gov/show/NCT04377802
NCT04729595,Study to Evaluate the Effects of Tempol (MBM-02) in COVID-19 Patients.,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",APC400-03,NA,https://ClinicalTrials.gov/show/NCT04729595
NCT04927182,Impact of Moderate Exercise Training on Vitals and Peak VO2 in Different Age Categories of Adult in COVID-19.,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,REC/00877 Nayab Saleem,"General Population, Rawalpindi, Punjab, Pakistan",https://ClinicalTrials.gov/show/NCT04927182
NCT04779047,Comparative Therapeutic Efficacy and Safety of Different Antiviral and Anti Inflammatory Drugs in COVID-19 Patients.,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,REC-H-PhBSU-21011,"Beni-suef University, Banī Suwayf, Egypt",https://ClinicalTrials.gov/show/NCT04779047
NCT04732468,COVID-19 Oral and Subcutaneous Vaccination Using a 2nd Generation (E1/E2B/E3-Deleted) Adenovirus Platform in Healthy Volunteers in USA,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,COVID-4.005,"Chan Soon - Shiong Institute for Medicine, El Segundo, California, United States|Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States",https://ClinicalTrials.gov/show/NCT04732468
NCT04481646,Novel Face Mask Sampling for COVID-19: A Diagnostic and Public Health Tool,Observational Model: Cohort|Time Perspective: Prospective,775,"University Hospitals of Leicester NHS Trust, Leicester, United Kingdom",https://ClinicalTrials.gov/show/NCT04481646
NCT04708912,Nasopharynx Microbiota Component and in Vitro Cytokines Production in Coronavirus Disease (COVID-19),Observational Model: Case-Control|Time Perspective: Cross-Sectional,8796,"Bakirkoy Dr.sadi Konuk Training and Research Hospital, Istanbul, Turkey|Bakirkoy Dr.sadi Konuk Training and Research Hospital, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04708912
NCT04328272,Effectiveness of Hydroxychloroquine in Covid-19 Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,Ath/ct101/22/3,"Ayub Teaching Institution, Abbottābād, K.p.k, Pakistan",https://ClinicalTrials.gov/show/NCT04328272
NCT04378777,Immunophenotyping Assessment in a COVID-19 Cohort,Observational Model: Cohort|Time Perspective: Prospective,DAIT-COVID-19-002|NIAID CRMS ID#: 38733,"University of Arizona (UA) College of Medicine - Tucson: UA Health Sciences Asthma and Airway Disease Research Center, Tucson, Arizona, United States|University of California, Los Angeles: Department of Medicine, Los Angeles, California, United States|University of California San Francisco School of Medicine, San Francisco, California, United States|Stanford Medicine: Sean N. Parker Center for Allergy & Asthma Research, Stanford, California, United States|Yale School of Medicine, New Haven, Connecticut, United States|University of Florida Health Gainesville, Gainesville, Florida, United States|University of Florida Health Jacksonville, Jacksonville, Florida, United States|University of South Florida Health Tampa, Tampa, Florida, United States|Emory University School of Medicine, Atlanta, Georgia, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States|Icahn School of Medicine at Mount Sinai, New York, New York, United States|University Hospitals Case Medical Center, Cleveland, Ohio, United States|University of Oklahoma ,Oklahoma Health Sciences Center: Pulmonary/Critical Care, Department of Medicine, Oklahoma City, Oklahoma, United States|Oregon Health & Science University, Portland, Oregon, United States|Drexel University College of Medicine, Philadelphia, Pennsylvania, United States|University of Texas at Austin: UT Health Austin, Austin, Texas, United States|Baylor College of Medicine: Department of Medicine, Houston, Texas, United States",https://ClinicalTrials.gov/show/NCT04378777
NCT04771052,Minimizing the Effects of COVID-19 Hospitalization With the COVID Rehabilitation Program for the Elderly,Observational Model: Case-Control|Time Perspective: Retrospective,MP-31-2021-3770,"CIUSSS de l'Estrie-Centre hospitalier universitaire de Sherbrooke (CHUS), Sherbrooke, Quebec, Canada|Centre hospitalier affilié universitaire régional (CHAUR), Trois-Rivières, Quebec, Canada",https://ClinicalTrials.gov/show/NCT04771052
NCT04659304,Study Evaluating Safety and Tolerability of Allocetra-OTS in Patients With COVID-19,Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,ENX-CL-03-001,NA,https://ClinicalTrials.gov/show/NCT04659304
NCT04516915,IMU-838 and Oseltamivir in the Treatment of COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,RA486120,"University Hospital Coventry and Warwickshire NHS Trust, Coventry, West Midlands, United Kingdom",https://ClinicalTrials.gov/show/NCT04516915
NCT04674553,Effect of Obesity Among COVID-19 Patients in Critical Care Settings,Observational Model: Other|Time Perspective: Cross-Sectional,16021982,"Mehwish Iftikhar, Lahore, Punjab, Pakistan",https://ClinicalTrials.gov/show/NCT04674553
NCT04689672,Predictivity of Hemogasanalysis and Lung UltraSound in Determining COVID-19 Severity,Observational Model: Cohort|Time Perspective: Other,COVID-PEGALUS,"IRCCS San Raffaele, Milan, MI, Italy",https://ClinicalTrials.gov/show/NCT04689672
NCT04973462,Evaluation of The Efficacy of Triazavirin Versus Oseltamivir in Egyptian Patients Infected With COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment",Antiviral therapy in COVID-19,"Fever Hospital of the Egyptian Armed Forces, Cairo, Egypt",https://ClinicalTrials.gov/show/NCT04973462
NCT04714515,Montelukast - a Treatment Choice for COVID-19,Observational Model: Cohort|Time Perspective: Retrospective,01032020-7,"Department of Critical Care Medicine, Shanghai General Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, China, Shanghai, China|Shaukat Khanum Memorial Cancer Hospital & Research Centre, Johar Town, Lahore, Pakistan, Lahore, Punjab, Pakistan",https://ClinicalTrials.gov/show/NCT04714515
NCT04343092,Effectiveness of Ivermectin as add-on Therapy in COVID-19 Management,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,PRO20040001,"General Directorate of Medical City, Bagdad, Baghdad, Iraq",https://ClinicalTrials.gov/show/NCT04343092
NCT04864535,"A Pilot Study for the Collection Of Vocalized, Individual Digital Cough Sound Recordings to Screen for COVID-19",Observational Model: Cohort|Time Perspective: Prospective,21001,"Strategy Health LLC, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04864535
NCT04505774,Anti-thrombotics for Adults Hospitalized With COVID-19 (ACTIV-4),Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,ACTIV-4 ACUTE,"University of Alabama, Birmingham, Alabama, United States|Ronald Reagan UCLA Medical Center, Los Angeles, California, United States|UC San Diego Hillcrest, San Diego, California, United States|Zuckerberg San Francisco General Hospital, San Francisco, California, United States|UCSF San Francisco, San Francisco, California, United States|Stanford University Medical Center, Stanford, California, United States|Denver Health and Hospital Authority, Denver, Colorado, United States|Saint Francis Hospital and Medical Center, Hartford, Connecticut, United States|University of Florida, Gainesville, Florida, United States|Cook County Health, Chicago, Illinois, United States|University of Illinois at Chicago Health (UIH), Chicago, Illinois, United States|Kansas University Medical Center, Kansas City, Kansas, United States|Boston University, Boston, Massachusetts, United States|Baystate Medical Center, Springfield, Massachusetts, United States|University of Michigan, Ann Arbor, Michigan, United States|Wayne State University, Detroit, Michigan, United States|Hennepin County Medical Center, Minneapolis, Minnesota, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|Washington University School of Medicine, ACCS Research, Saint Louis, Missouri, United States|Rutgers New Jersey Medical School, Newark, New Jersey, United States|Albany Medical College, Albany, New York, United States|Jacobi Medical Center, Bronx, New York, United States|Montefiore Medical Center, Bronx, New York, United States|VA New York Harbor Healthcare System, New York, New York, United States|NYU Langone, New York, New York, United States|Duke University Hospital, Durham, North Carolina, United States|University of Cincinnati Medical Center, Cincinnati, Ohio, United States|The MetroHealth System, Cleveland, Ohio, United States|Cleveland Clinic Foundation, Cleveland, Ohio, United States|Ascension St. John Clinical Research Institute, Tulsa, Oklahoma, United States|Oregon Health and Science University, Portland, Oregon, United States|Penn State Health Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States|Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States|UPMC Presbyterian, Pittsburgh, Pennsylvania, United States|Sarah Cannon and HCA Research Institute, Nashville, Tennessee, United States|University of Texas Southwestern Medical Center, Dallas, Texas, United States|Baylor Scott and White Medical Center - Temple, Temple, Texas, United States|Swedish Hospital, Seattle, Washington, United States|University of Wisconsin Hospital; Meriter Hospital (UW affiliated), Madison, Wisconsin, United States|Hospital Universitario Ramon Y Cajal, Madrid, Spain|Hospital Clínico Universitario de Salamanca, Salamanca, Spain",https://ClinicalTrials.gov/show/NCT04505774
NCT04418206,Validating an ELISpot for Early Detection of an Active Immune Response Against COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,20-PP-10,"CH Antibes, Antibes, Alpes Maritimes, France|Ch Cannes, Pneumologie, Cannes, Alpes Maritimes, France|Ch Grasse, Grasse, Alpes Maritimes, France|CHU de nice, Nice, Alpes-Maritimes, France",https://ClinicalTrials.gov/show/NCT04418206
NCT04868890,A Study of Inhaled Ampion in Adults With Respiratory Distress Due to COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",AP-019,"Ampio Pharmaceuticals, Englewood, Colorado, United States",https://ClinicalTrials.gov/show/NCT04868890
NCT04878913,Retrospective Evaluation of Lung Pathology in Subjects With COVID-19,Observational Model: Cohort|Time Perspective: Retrospective,VP-C21-007,NA,https://ClinicalTrials.gov/show/NCT04878913
NCT04584710,A Phase 2 Study of RTB101 as COVID-19 Post-Exposure Prophylaxis in Older Adults,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",RTB101-211|3R01AG064802-02S1,"University of Connecticut, UConn Center on Aging, Farmington, Connecticut, United States|Hebrew Senior Life, Marcus Institute for Aging Research, Roslindale, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT04584710
NCT04387786,Dornase Alfa Administered to Patients With COVID-19 (DACOVID),Observational Model: Case-Only|Time Perspective: Retrospective,216,"Feinstein Insitute for Medical Research at Northwell Health, Manhasset, New York, United States",https://ClinicalTrials.gov/show/NCT04387786
NCT04507256,AZD7442 - a Potential Combination Therapy for the Prevention and Treatment of COVID-19,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",D8850C00001,"Research Site, Harrow, United Kingdom",https://ClinicalTrials.gov/show/NCT04507256
NCT04734223,Neuroimaging Findings in Patients With COVID-19,Observational Model: Case-Control|Time Perspective: Retrospective,09.25.2020/587,"Sağlik Bilimleri Üniversitesi Training and Research Hospital, Di̇yarbakir, Turkey",https://ClinicalTrials.gov/show/NCT04734223
NCT04506229,Genetic Mechanisms Underlying SARS-CoV-2 Infection and the Impact of COVID-19 on Cognitive Function,Observational Model: Case-Only|Time Perspective: Prospective,TCAI_GenCov,"Texas Cardiac Arrhythmia Institute, Austin, Texas, United States",https://ClinicalTrials.gov/show/NCT04506229
NCT04669990,Remdesivir and Convalescent Plasma Therapy for Treatment of COVID-19 Infection in Nepal : A Registry Study,Observational Model: Case-Only|Time Perspective: Prospective,749-2020,"Narayani Hospital, Birgunj, Nepal|Seti Provincial Hospital, Dhangadi, Nepal|BP Koirala Institute of Health Sciences (BPKIHS), Dharān Bāzār, Nepal|Bheri Provincial Hospital, Nepalgunj, Nepal",https://ClinicalTrials.gov/show/NCT04669990
NCT04878068,Study to Evaluate the Performance of the Therma COVID-19 Rapid Antigen Test for Detection of SARS-CoV-2,Observational Model: Cohort|Time Perspective: Retrospective,TB20,NA,https://ClinicalTrials.gov/show/NCT04878068
NCT04981743,The Efficacy of Nigella Sativa Versus VitaminD3 as Supplement Therapy in Coronavirus Disease 2019 (COVID-19),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,supplement therapy in COVID-19,"Respiratory System specialized hospital at Kobry Elobba Military Medical hospitals., Cairo, Egypt",https://ClinicalTrials.gov/show/NCT04981743
NCT04713852,Predictive Value of SOFA and APACHE Scores for In-hospital Mortality in COVID-19 ICU Patients,Observational Model: Cohort|Time Perspective: Retrospective,2020-174,"Jessa hospital, Hasselt, Belgium",https://ClinicalTrials.gov/show/NCT04713852
NCT04880642,A Trial to Investigate Recovery From COVID-19 With C21 in Adult Subjects,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",VP-C21-008,"Johns Hopkins, Baltimore, Maryland, United States|Clinica Somer, Medellín, Antioquia, Colombia|Fundación Santa Fe de Bogotá, Bogotá, Cundinamarca, Colombia|Hospital Universitario San Ignacio, Bogotá, Cundinamarca, Colombia",https://ClinicalTrials.gov/show/NCT04880642
NCT04610489,Diagnostic Performance of an Antigen Test for SARS-CoV-2 Infection (COVID-19),Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,IRB-20-1088|Epling-533,NA,https://ClinicalTrials.gov/show/NCT04610489
NCT04334252,Descriptive Study Regarding Ambulant Screening During COVID-19 Pandemia,Observational Model: Cohort|Time Perspective: Prospective,JessaH_COVID19_prescreening,"Jessa hospital, Hasselt, Belgium",https://ClinicalTrials.gov/show/NCT04334252
NCT04594343,Clinical Study to Evaluate the Effects of Disulfiram in Patients With Moderate COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",SPR-001-201,"ETICA, Salvador, Bahia, Brazil",https://ClinicalTrials.gov/show/NCT04594343
NCT04941053,Seroprevalence of COVID-19,Observational Model: Case-Control|Time Perspective: Cross-Sectional,Soh-Med-21-04-33,"Sohag University, Sohag, Egypt",https://ClinicalTrials.gov/show/NCT04941053
NCT04770740,Randomized Controlled Clinical Trial to Investigate Effects of Vitamin K2 in COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Other",KOVIT,"Canisius Wilhelmina Hospital, Nijmegen, Gelderland, Netherlands",https://ClinicalTrials.gov/show/NCT04770740
NCT04724629,Survival TRial Using CytoKines in COVID-19 (STRUCK Trial),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,402422/2020-1,"Faculdade de Medicina de Ribeirão Preto - USP, Ribeirão Preto, SP, Brazil|Hospital e Maternidade Christovão da Gama, Santo André, SP, Brazil",https://ClinicalTrials.gov/show/NCT04724629
NCT04627584,A Phase 2 Clinical Trial of MW33 Injection in Patients With COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",MW33-2020-CP201,"Shanghai Public Health Clinical Center, Shanghai, China",https://ClinicalTrials.gov/show/NCT04627584
NCT04694612,Efficacy of Favipiravir in Treatment of Mild & Moderate COVID-19 Infection in Nepal,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,683-2020,"Armed Police Force Hospital, Kathmandu, Bagmati, Nepal|Charak Memorial Hospital, Pokhara, Gandaki, Nepal",https://ClinicalTrials.gov/show/NCT04694612
NCT04565392,Remotely-conducted Trial of Famotidine vs Placebo for Patients at Home With Coronavirus (COVID) of 2019 (COVID-19),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",Pykonsult 201,"Pykonsult headquarters, New Fairfield, Connecticut, United States",https://ClinicalTrials.gov/show/NCT04565392
NCT04703478,RespiraConNosotros:a Mobile Application for COVID-19 Respiratory Rehabilitation.,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,CovidSal02,"Ines Llamas-Ramos, Salamanca, Spain",https://ClinicalTrials.gov/show/NCT04703478
NCT04526990,Phase III Trial of A COVID-19 Vaccine of Adenovirus Vector in Adults 18 Years Old and Above,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",CS-CTP-AD5NCOV-Ⅲ,"Fundación Socolinsky Centro de Vacunación Proteger - Recoleta, Caba, Buenos Aires, Argentina|Hospital Pirovano, Caba, Buenos Aires, Argentina|Htal de Alta Complejidad Cuenca Alta Néstor Kirchner, Cañuelas, Buenos Aires, Argentina|Hospital Interzonal de Agudos ""San Juan de Dios"" de La Plata, La Plata, Buenos Aires, Argentina|Hospital Rossi, La Plata, Buenos Aires, Argentina|Inst. Médico Platense, La Plata, Buenos Aires, Argentina|Instituto de Investigaciones Clínicas, Mar Del Plata, Buenos Aires, Argentina|Htal Mariano y Luciano de la Vega, Moreno, Buenos Aires, Argentina|Hospital Houssay, Vicente López, Buenos Aires, Argentina|Hospital Zonal General de Agudos ""Cetrangolo"", Vicente López, Buenos Aires, Argentina|Instituto Cer, Vicente López, Quilmes, Argentina|Previvax Centro de Vacunación, Córdoba, Argentina|Hospital Dr. Hernan Henriquez Aravena Temuco, Temuco, IX Region, Chile|CIMER Centro de Investigaciones Medicas Respiratorias Santiago, Providencia, Region Metropolitana, Chile|Hospital San Borja Arriarán Santiago, Santiago, Region Metropolitana, Chile|Clínica Andes Salud Concepción, Concepción, VII Región, Chile|Hospital de Puerto Montt Dr. Eduardo Schütz Schoroeder Puerto Montt, Puerto Montt, X Región De Los Lagos, Chile|Hospital Base de Osorno, Osorno, XIV Región, Chile|Clinica Alemana de Valdivia Valdivia, Valdivia, XIV Región, Chile|Centro de investigación Médica Aguascalientes (CIMA), Aguascalientes, Ags, Mexico|Instituto de Servicios de Salud del Estado de Baja California, Mexicali, Baja California Norte, Mexico|Instuto de Ciencias Médicas y de la Nutrición Salvador Subirán (INCMNSZ), Tlalpan, Cdmx, Mexico|Instituto Nacional de Medicina Genómica, Tlalpan, Cdmx, Mexico|Centro de Investigacion Integral MEDIVEST SC, Chihuahua, Chhihuahia, Mexico|Centro de Investigacion Clinica Chapultepec SA de CV (Hidra), Coyoacán, Ciudad De Mexico, Mexico|Instituto Mexicano del Seguro Social (IMSS), Cuahtemoc, Ciudad De Mexico, Mexico|Clinical Research Institute Saltillo SA de CV, Saltillo, Cuahuila, Mexico|Centro de Investigación Clínica del Pacifico S.A. de C.V. (CICPA), Acapulco, Guerrero, Mexico|Asociación Mexicana para la investigación clínica (AMIC), Pachuca de Soto, Hidalgo, Mexico|Instituto Jaliscience de Metabolismo, S. C., Guadalajara, Jalisco, Mexico|Asociación de investigación pediátrica y adultos (AINPAD), Morelia, Mochoacán De Ocampo, Mexico|JM Research, Cuernavaca, Morelos, Mexico|Hospital Metropolitano ""Dr. Bernardo Sepúlveda"", San Nicolás De Los Garza, Nuevo León, Mexico|Oaxaca site management organization (OSMO), Oaxaca, Oax, Mexico|Centro de Investigación y Avances Médicos Especializados (CIAME), Cancún, Quintana Roo, Mexico|FAICIC, Veracruz, Veracrua, Mexico|Kohler & Milstein Research, Mérida, Yucatan, Mexico|PEMEX, Ciudad de mexico, Mexico|Instituto Nacional de Pediatría (INP), Ciudad de México, Mexico|Instituto de Investigaciones aplicada a las Neurociencias (IIAN), Durango, Mexico|Administración de Especialistas de Puebla S.C. (UDEP), Puebla, Mexico|Shifa International Hospital, Islamabad, Islamabad Capital Territory, Pakistan|Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Punajb, Pakistan|University of Health Scinces, Lahore, Lahore, Punjab, Pakistan|Aga Khan University Hospital, Karachi, Sindh, Pakistan|The Indus Hospital, Karachi, Sindh, Pakistan|Research Center Eco-safety, Saint Petersburg, Saint-Petersburg, Russian Federation|OOO Meditsinskie Tekhnologii, Saint Petersburg, Saint-Petersburg, Russian Federation|OOO ""Baltijskaya Meditsina"", Saint Petersburg, Saint-Petersburg, Russian Federation|Research Center Eco-safety, Saint Petersburg, Saint-Petersburg, Russian Federation|Federal State Budgetary Institution ""Scientific Research Institute of Influenza named after A. A. Smorodintsev"" of the Ministry of Healthcare of the Russian Federation named after A. A. Smorodintsev"" of the Ministry of Healthcare of the Russian Federation, Saint Petersburg, Saint-Petersburg, Russian Federation|Saint Petersburg State Budgetary Healthcare Institution ""City Polyclinic #106"", Saint Petersburg, Saint-Petersburg, Russian Federation|Saint-Petersburg State Healthcare Institution ""Nikolaev Hospital"", Saint Petersburg, Saint-Petersburg, Russian Federation|OOO ""Piterclinica"", Saint Petersburg, Saint-Petersburg, Russian Federation|State Budgetary Healthcare Institution of Sverdlovsk Region ""Aramil City Hospital"", Aramil, Sverdlovsk, Russian Federation|Non-state Institution of Healthcare ""Road Clinical Hospital at Chelyabinsk station of open corporate society ""Russian Railways"", Chelyabinsk, Russian Federation|State Budgetary Educational Institution of Higher Professional Education ""Chita State Medical Academy"" of the Ministry of Healthcare of the Russian Federation, Chita, Russian Federation|Federal State Budgetary Institution ""Main Military Clinical Hospital n.a. N.N. Burdenko"" Ministry of Defense of Russian Federation, Moscow, Russian Federation|Moscow State Budgetary Healthcare Institution ""City Polyclinic #2 of the Moscow City Healthcare Department"", Moscow, Russian Federation|Health Central Clinical Hospital of Russian Academy of Sciences, Moscow, Russian Federation|Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of Ministry of Healthcare of the Russian Federation (Sechenovsky University), Moscow, Russian Federation|Private Healthcare Institution ""Central Clinical Hospital ""RZhD-Medicine"", Moscow, Russian Federation|State Regional Budgetary Healthcare Institution ""Murmansk Regional Clinical Hospital n.a.P.A. Bayandin"", Murmansk, Russian Federation|State Regional Autonomous Healthcare Institution ""Monchegorsk Central District Hospital"", Murmansk, Russian Federation|Private Healthcare Institution ""Clinical Hospital ""RZHD-Meditsina"" of Nizhniy Novgorod"", Nizhniy Novgorod, Russian Federation|""Life Benefits Service, Ltd', Novosibirsk, Russian Federation|Budgetary Institution of Heathcare of Omsk region ""City Clinical Hospital #1 n.a. Kabanova A.N."", Omsk, Russian Federation|Federal State Budgetary Educational Institution of Higher Education ""Perm State Medical University named after E.A. Vagnera"" Ministry of Healthcare of Russian Federation, Perm, Russian Federation|OOO Zvyezdnaya Klinika, Saint Petersburg, Russian Federation|Limited Liability Company ""Hospital ""OrKli"", Saint-Petersburg, Russian Federation|OOO ""Tsentr DNK issledivaniy"", Saratov, Russian Federation|Federal State Budgetary Educational Institution of Higher Education ""Saratov State Medical University named after V.I. Razumovsky"" the Ministry of Health of the Russian Federation - Clinical hospital n.a. S.R.Mirotvortseva, Saratov, Russian Federation|OOO ""Zdorovye"", Tomsk, Russian Federation|State Autonomous Healthcare Institution of Yaroslavl region ""Clinical Emergency Hospital named after N.V. Solovyev"", Yaroslavl, Russian Federation",https://ClinicalTrials.gov/show/NCT04526990
NCT04438070,COVID Screening Strategies in Homeless Shelters,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Screening,2020-10864-T,"Various Homeless Shelters, Hamilton, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04438070
NCT04327531,"Evaluation of Covid 19 Knowledge Anxiety and Expectation Levels of Turkish Physicians, Survey Study",Observational Model: Ecologic or Community|Time Perspective: Prospective,turkishcovid19,"Pinar Yalcin Bahat, Istanbul, İ̇stanbul, Turkey",https://ClinicalTrials.gov/show/NCT04327531
NCT04589949,Early Convalescent Plasma Therapy for High-risk Patients With COVID-19 in Primary Care (the CoV-Early Study),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",NL74972.078.20,"Erasmus Medical Center, Rotterdam, Zuid-Holland, Netherlands|Meander Medisch Centrum, Amersfoort, Netherlands|Rijnstate Ziekenhuis, Arnhem, Netherlands|Amphia Ziekenhuis, Breda, Netherlands|Groene Hart Ziekenhuis, Gouda, Netherlands|University Medical Center Groningen (UMCG), Groningen, Netherlands|Spaarne Gasthuis, Haarlem, Netherlands|Medisch Centrum Leeuwarden, Leeuwarden, Netherlands|Leids Universitair Medisch Centrum, Leiden, Netherlands|Sint Antonius Ziekenhuis, Nieuwegein, Netherlands|Bernhoven Hospital, Uden, Netherlands",https://ClinicalTrials.gov/show/NCT04589949
NCT04738045,Comparison of Remdesivir Versus Lopinavir/ Ritonavir and Remdesivir Combination in COVID-19 Patients,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,REC-H-PhBSU-21001,"Beni-suef University, Banī Suwayf, Egypt",https://ClinicalTrials.gov/show/NCT04738045
NCT04570501,Angiotensin (1-7) for the Treatment of COVID-19 in Hospitalized Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",58189,"Stanford University, Stanford, California, United States",https://ClinicalTrials.gov/show/NCT04570501
NCT04605952,Study to Find the Percentage of Cases Retaining COVID-19 IgG Antibodies 45-65 After They Have Tested Positive,Observational Model: Cohort|Time Perspective: Retrospective,152473,"Dr.Deb Sanjay Nag, Jamshedpur, Jharkhand, India",https://ClinicalTrials.gov/show/NCT04605952
NCT04480138,Pegylated Interferon - α2b With SARSCoV- 2 (COVID-19),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,PEGI.20.003,"Avant Sante site 2, Zapopan, Jalisco, Mexico|Avant Sante Site 1, Monterrey, Mexico",https://ClinicalTrials.gov/show/NCT04480138
NCT04613297,HLA-G Immuno-Inhibitor Checkpoint Study in Patients With COVID-19 Infection: Molecular and Cellular Assessment,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,2020_0082,"Foch hospital, Suresnes, France",https://ClinicalTrials.gov/show/NCT04613297
NCT04339426,Atovaquone and Azithromycin Combination for Confirmed COVID-19 Infection,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,HRI-COVID-19-Anti-Malarial-001,"HonorHealth, Scottsdale, Arizona, United States",https://ClinicalTrials.gov/show/NCT04339426
NCT04542876,Efficacy and Safety of Guduchi Ghan Vati in the Management of Asymptomatic COVID-19 Infection,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,AYU/DSSR/03,"Dr. Sarvepalli Radhakrishnan Rajasthan Ayurved University, Jodhpur, Rajasthan, India",https://ClinicalTrials.gov/show/NCT04542876
NCT04651413,PCR Cycle Threshold Values and COVID-19 Outcomes,Observational Model: Other|Time Perspective: Retrospective,286389,"University Hospitals of North Midlands NHS Trust, Stoke-on-Trent, Staffordshire, United Kingdom",https://ClinicalTrials.gov/show/NCT04651413
NCT04544033,IL- 6 Gene (174G/C) Single Nucleotide Polymorphism as an Indicator of COVID-19 Severity in Egyptian Patients,Observational Model: Case-Only|Time Perspective: Prospective,IL6 in egyptian COVID patients,"Bsant Safwat Kasem, Tanta, El Gharbyia, Egypt",https://ClinicalTrials.gov/show/NCT04544033
NCT04817397,The Lymphocyte/Neutrophil Ratio as a Prognostic Index for Short Term Outcome in the ICU Admitted COVID-19 Adult Patients,Observational Model: Cohort|Time Perspective: Prospective,ICU admitted COVID-19 patients,"Assuit University, Assiut, Egypt",https://ClinicalTrials.gov/show/NCT04817397
NCT04506268,COVID-19 SAFE Enrollment,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Screening",843565,"Penn Medicine, Philadelphia, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04506268
NCT04325412,Cardiac complicAtions in Patients With SARS Corona vIrus 2 (COVID-19) regisTrY,Observational Model: Cohort|Time Perspective: Prospective,20-161/C,"University Medical Center Utrecht, Utrecht, Netherlands",https://ClinicalTrials.gov/show/NCT04325412
NCT04840459,Use of Monoclonal Antibodies for the Treatment of Mild to Moderate COVID-19 in Non-Hospitalized Setting,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,1686206,"DHR Health Institute for Research and Development, Edinburg, Texas, United States|DHR Health, Edinburg, Texas, United States|Starr County Memorial Hospital, Rio Grande City, Texas, United States",https://ClinicalTrials.gov/show/NCT04840459
NCT04341103,AlloSure Guided Immuno-Optimization for COVID-19: An Early Experience,Observational Model: Case-Only|Time Perspective: Prospective,Al-COVE,NA,https://ClinicalTrials.gov/show/NCT04341103
NCT04341285,Early Versus Late ECMO Therapy in COVID-19 Induced ARDS (ECMO-VID),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,ECMO-VID,"University Hospital Tuebingen, Tuebingen, Germany",https://ClinicalTrials.gov/show/NCT04341285
NCT04418245,CT Biomarkers Identification by Artificial Intelligence for COVID-19 Prognosis,Observational Model: Case-Only|Time Perspective: Retrospective,NIMAO/2020/COVID 19-IA/JF-01,"CHU la Timone, Marseille, France|CHU Montpellier, Montpellier, France|CHU de Nimes, Nîmes, France|CHU Poitiers, Poitiers, France|CHU Strasbourg, Strasbourg, France|CHU Martinique, Fort-de-France, Martinique",https://ClinicalTrials.gov/show/NCT04418245
NCT04350320,Trial to Study the Benefit of Colchicine in Patients With COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,IMIB-COLVID-2020-03,"Virgen de la Arrixaca University Clinical Hospital, Murcia, Spain",https://ClinicalTrials.gov/show/NCT04350320
NCT04840992,Phase I/II Clinical Trial of Recombinant Novel Coronavirus (COVID-19) Vaccine (Adenovirus Type 5 Vector) for Inhalation,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",JSVCT092,"Jiangsu Provincal Center for Disease Control and Prevention, Nanjing, Jiangsu, China",https://ClinicalTrials.gov/show/NCT04840992
NCT04380987,Luxembourg Cohort of Positive Patients for COVID-19: a Stratification Study to Predict Patient Prognosis,Observational Model: Cohort|Time Perspective: Prospective,Predi-Covid,"Luxembourg Institute of Health, Luxembourg, Luxembourg",https://ClinicalTrials.gov/show/NCT04380987
NCT04864015,COVID-19 Aerosol in EGD Using a Droplet Reduction Mouthpiece,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,s65197,"University Hospitals Leuven, Leuven, Flemish Brabant, Belgium",https://ClinicalTrials.gov/show/NCT04864015
NCT04733651,Study to Investigate the Clinical Efficacy of Isoquercetin in Patients With COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,22-2021,NA,https://ClinicalTrials.gov/show/NCT04733651
NCT04680819,Evaluation of the Effect of Anatolian Propolis on Covid-19 in Healthcare Professionals,Observational Model: Cohort|Time Perspective: Prospective,AtaturkU2,NA,https://ClinicalTrials.gov/show/NCT04680819
NCT04714138,Remote Video Consultation for Quality of Life Assessment in Patients Hospitalised After COVID-19 Infection,Observational Model: Cohort|Time Perspective: Prospective,2020-A03110-39,"Groupe Hospitalier Du Havre, Montivilliers, Normandie, France",https://ClinicalTrials.gov/show/NCT04714138
NCT04950803,A Randomised-controlled Trial of an Oral Microbiome Immunity Formula in Recovered COVID-19 Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention",RECOVERY,"Prince of Wales Hospital, Hong Kong, Hong Kong",https://ClinicalTrials.gov/show/NCT04950803
NCT04466241,Combination Therapies to Reduce Carriage of SARS-Cov-2 and Improve Outcome of COVID-19 in Ivory Coast: a Phase Randomized IIb Trial,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,ANRS COV01 INTENSE COV,"Service des Maladies Infectieuses et Tropicales, Centre Hospitalier et Universitaire (CHU) Treichville, Abidjan, Côte D'Ivoire|Centre de Traitement des Maladies Infectieuses (CTMI), CHU de Yopougon, Abidjan, Côte D'Ivoire",https://ClinicalTrials.gov/show/NCT04466241
NCT04859244,First-in-Human Study of Orally Administered GS-441524 for COVID-19,Allocation: Non-Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,CC-2021-001,"Copycat Sciences Study Site, Houston, Texas, United States",https://ClinicalTrials.gov/show/NCT04859244
NCT04354584,Compartmental Inflammation in Mechanically Ventilated Patients With COVID-19,Observational Model: Case-Only|Time Perspective: Prospective,COV2ICU-DK|H-20023159|R349-2020-540,"Dept. of Intensive Care 542, University Hospital Hvidovre, Hvidovre, Copenhagen, Denmark",https://ClinicalTrials.gov/show/NCT04354584
NCT04909476,Tracheal Intubation in COVID-19 Patients,Observational Model: Cohort|Time Perspective: Prospective,125/20,"San Matteo Hospital, Pavia, Lombardia, Italy|San Bortolo Hospital, Vicenza, Veneto, Italy",https://ClinicalTrials.gov/show/NCT04909476
NCT04780685,A Phase II Study in Patients With Moderate to Severe ARDS Due to COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",STEM-107-COVID-19,"Providence Saint John's Health Center - Saint John's Cancer Institute, Santa Monica, California, United States|PRX Research, Dallas Regional Medical Center, Mesquite, Texas, United States",https://ClinicalTrials.gov/show/NCT04780685
NCT04343651,Study to Evaluate the Efficacy and Safety of Leronlimab for Mild to Moderate COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",CD10_COVID-19,"University of California, Los Angeles, Los Angeles, California, United States|Palmtree Clinical Research, Inc., Palm Springs, California, United States|Eisenhower Health, Rancho Mirage, California, United States|Yale, New Haven, Connecticut, United States|Center for Advanced Research & Education (CARE), Gainesville, Georgia, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Atlantic Health System Hospital, Morristown, New Jersey, United States|Montefiore Medical Center, Bronx, New York, United States|White Plains Hospital, White Plains, New York, United States|Novant Health, Charlotte, North Carolina, United States|Ohio Health, Columbus, Ohio, United States|Oregon Health and Science University, Portland, Oregon, United States",https://ClinicalTrials.gov/show/NCT04343651
NCT04716647,Feasibility of Ayurveda in Patients With Mild-to-Moderate COVID-19: A Community-Based Participatory Research,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,AU/2187,"Aarogyam UK, Leicester, Leicestershire, United Kingdom",https://ClinicalTrials.gov/show/NCT04716647
NCT04809389,A Study to Evaluate Safety and Immunogenicity of DelNS1-nCoV-RBD LAIV for COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",CTC2038,"HKU Phase 1 Clinical Trials Centre, Hong Kong, Hong Kong",https://ClinicalTrials.gov/show/NCT04809389
NCT04656444,Parental Compliance After Telephone Triage Advice During and After Confinement During the COVID-19 Epidemic in France,Observational Model: Cohort|Time Perspective: Prospective,20-HPNCL-03,"Hôpitaux Pédiatrique de Nice CHU Lenval, Nice, France",https://ClinicalTrials.gov/show/NCT04656444
NCT04368221,Characterization of Fungal Infections in COVID-19 Infected and Mechanically Ventilated Patients in ICU,Observational Model: Cohort|Time Perspective: Other,35RC20_8885_MY_CO_VID,"CHU Angers, Angers, France|CHU de Brest, Brest, France|CHU de Dijon, Dijon, France|CHU Grenoble, Grenoble, France|CHU Lille, Lille, France|CHU Lyon, Lyon, France|CHU Marseille, Marseille, France|CHU Nantes, Nantes, France|CHU de Nice, Nice, France|CHU Paris - Avicenne, Paris, France|CHU Paris - Bichat, Paris, France|CHU Paris - HEGP, Paris, France|CHU Paris - Mondor, Paris, France|CHU Paris - Tenon, Paris, France|Hôpital Lariboisière/ St Louis, Paris, France|Hôpital Necker-Enfants Malades, Paris, France|Hôpital Pitié-Salpêtrière, Paris, France|CHU Poitiers, Poitiers, France|CHU Rennes, Rennes, France|CHU Strasbourg, Strasbourg, France|CHU Toulouse, Toulouse, France|CHU Tours, Tours, France",https://ClinicalTrials.gov/show/NCT04368221
NCT04708327,Phase 2 Trial to Evaluate Safety and Efficacy of CYTO-205 in Mild COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",CYTO-001,NA,https://ClinicalTrials.gov/show/NCT04708327
NCT04343794,Using Biovitals® Sentinel to Monitor Disease Progression in Subjects Quarantined for Suspected COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,COVID19_Biovitals_Protocol_1,"The University of Hong Kong, Queen Mary Hospital, Hong Kong, Hong Kong",https://ClinicalTrials.gov/show/NCT04343794
NCT04525911,Assessment of Long-term Impact Post COVID-19 for Patients and Health Care Professionals of the European Hospital,Observational Model: Cohort|Time Perspective: Prospective,2020- A01647-32,"BENNANI, Marseille, France",https://ClinicalTrials.gov/show/NCT04525911
NCT04629157,The LAVA (Lateral Flow Antigen Validation and Applicability) Study for COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,290989,"Alder Hey in the Park, Liverpool, United Kingdom|Royal Manchester Children's Hospital, Manchester, United Kingdom",https://ClinicalTrials.gov/show/NCT04629157
NCT04519034,Vitamin D Status and Immune-inflammatory Status in Different UK Populations With COVID-19 Infection,Observational Model: Other|Time Perspective: Retrospective,285176,"GSTT NHS Trust, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04519034
NCT04566770,A Clinical Trial of A COVID-19 Vaccine Named Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",JSVCT093,"Taixing City center for Disease Control and Prevention, Taizhou, Jiangsu, China",https://ClinicalTrials.gov/show/NCT04566770
NCT04845191,COVID-19 Subcutaneously and Orally Administered Supplemental Vaccine Boost to Enhance T Cell Protection in Those Who Have Already Received EUA S-Based Vaccines,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",COVID-4.009,"Chan Soon-Shiong Institute for Medicine, El Segundo, California, United States",https://ClinicalTrials.gov/show/NCT04845191
NCT04331665,Study of the Efficacy and Safety of Ruxolitinib to Treat COVID-19 Pneumonia,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,U-DEPLOY: RUX-COVID|20-5315,"Princess Margaret Cancer Centre, Toronto, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04331665
NCT04591015,Dulce Digital-COVID Aware (DD-CA) Discharge Texting Platform for US/Mexico Border Hispanics With Diabetes + COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention,3R01DK112322-05S1,"Scripps Mercy Hospital Chula Vista, Chula Vista, California, United States",https://ClinicalTrials.gov/show/NCT04591015
NCT04524663,Oral Camostat Compared With Standard Supportive Care in Mild-Moderate COVID-19 Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",56029,"Stanford University, Stanford, California, United States",https://ClinicalTrials.gov/show/NCT04524663
NCT04373759,Cardiac Arrest Incidence and Outcome Among Patients With COVID-19 in French ICUs,Observational Model: Cohort|Time Perspective: Prospective,2020-CHITS-004,"CHU Caen, Caen, Calvados, France|Hôpital Privé St Martin, Caen, Calvados, France|CH Angoulème, Angoulême, Charente, France|CH Brive, Brive-la-Gaillarde, Corrèze, France|CHU Dijon, Dijon, Côte-d'Or, France|CH Etampes, Étampes, Essonne, France|CHU Antoine Béclère AP-HP, Clamart, Haut-de-Seine, France|CHU Ambroise Paré AP-HP, Boulogne-Billancourt, Hauts-de-Seine, France|CH Louis Mourier AP-HP, Colombes, Hauts-de-Seine, France|CHU Montpellier, Montpellier, Hérault, France|CHU Lariboisière AP-HP, Paris, Ile-de-France, France|CHU Saint Louis AP-HP, Paris, Ile-de-France, France|CHU St Antoine, Paris, Ile-de-France, France|Groupe Hospitalier Saint Joseph, Paris, Ile-de-France, France|CHU Necker Enfants Malades, Paris, Ile-de-France, France|CHU Pitié Salpétrière, Paris, Ile-de-France, France|CHU Felix Guyon, Saint-Denis, La Reunion, France|CHR Orléans, Orléans, Loiret, France|CH Cahors, Cahors, Lot, France|CHRU Roger Salengro, Lille, Nord, France|CH Bethune, Beuvry, Pas-de-Calais, France|CH Lens, Lens, Pas-de-Calais, France|Grand Hôpital de l'Est Francilien, Jossigny, Seine-et-Marne, France|CHU Meaux, Meaux, Seine-et-Marne, France|Groupe Hospitalier Sud Ile de France, Melun, Seine-et-Marne, France|CHU Rouen, Rouen, Seine-Maritime, France|CHU Amiens Picardie, Amiens, Somme, France|Hôpital Nord Franche Comté, Trévenans, Territoire De Belfort, France|CH Argenteuil, Argenteuil, Val-d'Oise, France|CHU Henri Mondor AP-HP, Créteil, Val-de-Marne, France|CHU Kremlin Bicêtre, Le Kremlin-Bicêtre, Val-de-Marne, France|CH de la Dracénie, Draguignan, Var, France|CHI Frejus St Raphael, Fréjus, Var, France|Centre Hospitalier Intercommunal Toulon La Seyne sur Mer, Toulon, Var, France|CH Versailles, Le Chesnay, Yvelines, France|CHU Martinique - Fort de France, Fort-de-France, Martinique",https://ClinicalTrials.gov/show/NCT04373759
NCT04927169,InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection (Brazil Cohort),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",ILIAD-7 BRAZIL,"Hospital de Clinicas de Porto Alegre, Porto Alegre, RIO Grande DO SUL, Brazil|Hospital Sao Jose, São José, Santa Catarina, Brazil|Upeclin-Unesp, Botucatu, SAO Paolo, Brazil|Hospital Das Clinicas de Ribeirao Preto, Monte Alegre, SAO Paolo, Brazil|Universidade Federal de Sao Paolo, São Paulo, SAO Paolo, Brazil|Hospital Edmundo Vasconcelos, Vila Clementino, SAO Paolo, Brazil",https://ClinicalTrials.gov/show/NCT04927169
NCT04621903,A Pilot Study on Efficacy and Safety of Ayurveda Combination in Patients With Mild-to-Moderate COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,AU/WU/ 06,"Aarogyam (UK) CIC, Leicester, United Kingdom",https://ClinicalTrials.gov/show/NCT04621903
NCT04606784,Study of Nebulized Ampion for the Treatment of Adult COVID-19 Patients With Respiratory Distress,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,AP-014,"Research Site, Colorado Springs, Colorado, United States",https://ClinicalTrials.gov/show/NCT04606784
NCT04368260,Clinical Validation of New Injection Molded Flocked Nasopharyngeal Swabs in Response to the COVID-19 Pandemic,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,HSR200127,"University of Virginia, Charlottesville, Virginia, United States",https://ClinicalTrials.gov/show/NCT04368260
NCT04625114,The Potential of Oral Camostat in Early COVID-19 Disease in an Ambulatory Setting to Reduce Viral Load and Disease Burden,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",EudraCT number: 2020-003475-18,"Ghent University Hospital, Algemene Inwendige Ziekten, Gent, Belgium",https://ClinicalTrials.gov/show/NCT04625114
NCT04832880,Factorial Randomized Trial of Rendesivir and Baricitinib Plus Dexamethasone for COVID-19 (the AMMURAVID Trial),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,The AMMURAVID trial|2020-001854-23,"Ospedali Riuniti delle Marche, Ancona, Italy|Ospedale Parini, Aosta, Italy|Ospedale SS Annunziata -Chieti, Chieti, Italy|Ospedale S Anna, Como, Italy|Ospedale di Ferrara, Ferrara, Italy|Ospedale di Firenze and Empoli, Firenze, Italy|Ospedali Galliera, Genova, Italy|H Goretti, Latina, Italy|Ospedale Manzoni, Lecco, Italy|Ospedale di Legnago, Legnago, Italy|Ospedale di Legnano, Legnano, Italy|ASST Fatebenefratelli-Sacco, Milan, Italy|ASST Santi Paolo e Carlo, Milan, Italy|IRCCS San Raffaele, Milan, Italy|Ospedale di Perugia, Perugia, Italy|Ospedale San Salvatore, Pesaro, Italy|Ospedali di Prato e Pistoia, Prato, Italy|Policlinico Tor Vergata, Roma, Italy|Ospedale Cattinara e Maggiore, Trieste, Italy|Ospedale di Udine, Udine, Italy|Azienda Ospedaliera Integrata -Verona, Verona, Italy",https://ClinicalTrials.gov/show/NCT04832880
NCT04560608,"Elucidating the Symptomatic, Explanatory and Prognostic Characteristics of GERIAtric Patients Hospitalized for COVID-19",Observational Model: Cohort|Time Perspective: Other,2020/100|ar20-0087v0,"Angers University Hospital, Angers, France",https://ClinicalTrials.gov/show/NCT04560608
NCT04406038,"Study of the Spread of COVID-19 in Saint Petersburg, Russia",Observational Model: Cohort|Time Perspective: Prospective,CDRU-001,"Clinic ""Scandinavia"", Saint Petersburg, Russian Federation",https://ClinicalTrials.gov/show/NCT04406038
NCT04503434,Patients' Experiences in a Medicalized Hotel for COVID-19 Acute Care Support,Observational Model: Cohort|Time Perspective: Cross-Sectional,Medicalitzed Hotel COVID-19,"Carme Hernández, Barcelona, Spain",https://ClinicalTrials.gov/show/NCT04503434
NCT04371679,Changes in Cardiac and Pulmonary Hemodynamics as Predictor of Outcome in Hospitalized COVID-19 Patients,Observational Model: Cohort|Time Perspective: Retrospective,Covid-HO,"Jessa Hospital, Hasselt, Belgium",https://ClinicalTrials.gov/show/NCT04371679
NCT04373096,Enhanced Hood PPE to Minimize COVID-19 Transmission to Front-line Health Care Workers,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention,20-5448,"Toronto Western Hospital, Toronto, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04373096
NCT04560855,Secure Self-monitoring Through a Combination of Connected Objects: Implementation in COVID-19 Patients Monitored at Home,Observational Model: Cohort|Time Perspective: Prospective,2020-A00981-38,"CHU Grenoble-Alpes, Grenoble, Auvergne-Rhône-Alpes, France|CHU d'Amiens, Amiens, Hauts-de-France, France|Hôpital d'Instruction des Armées Bégin, Saint-Mandé, Ile De France, France|Hôpital d'Instruction des Armées Percy, Clamart, Ile-de-France, France",https://ClinicalTrials.gov/show/NCT04560855
NCT04409509,Treatment With CSL312 in Adults With Coronavirus Disease 2019 (COVID-19),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",CSL312_COVID-19,"Nova Clinical Research, LLC, Bradenton, Florida, United States|Theia Clinical Research, LLC, Saint Petersburg, Florida, United States|MercyOne North Iowa Medical Center, Mason City, Iowa, United States|Northeast Iowa Medical Education Foundation, Waterloo, Iowa, United States|Lahey Hospital and Medical Center, Burlington, Massachusetts, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|Holy Name Hospital, Teaneck, New Jersey, United States|Inspira Health Center Vineland, Vineland, New Jersey, United States|Sisters of Charity Hospital/ St. Joseph's Campus, Buffalo, New York, United States|Carolina Institute for Clinical Research, Fayetteville, North Carolina, United States|Monument Health Clinical Research, Rapid City, South Dakota, United States|PharmaTex Research, Amarillo, Texas, United States|UT Health Science Center, McGovern Medical School, Houston, Texas, United States|Inova Alexandria Hospital, Alexandria, Virginia, United States",https://ClinicalTrials.gov/show/NCT04409509
NCT04379375,Nudges to Improve Health Behaviors That Limit COVID-19 Spread,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,PRO00037864,"Medical College of Wisconsin, Milwaukee, Wisconsin, United States",https://ClinicalTrials.gov/show/NCT04379375
NCT04880161,A Study to Evaluate Ampion in Patients With Prolonged Respiratory Symptoms Due to COVID-19 (Long COVID),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",AP-018,"Ampio Pharmaceuticals, Englewood, Colorado, United States",https://ClinicalTrials.gov/show/NCT04880161
NCT04542200,Workforce Serosurveillance to Track Long-term Modifications to COVID-19 Exposure Due to Factors in the Built Environment,Observational Model: Cohort|Time Perspective: Prospective,20-0668,"Feinstein Institutes for Medical Research, Northwell Health, Great Neck, New York, United States",https://ClinicalTrials.gov/show/NCT04542200
NCT04537806,A Study of Brexanolone for Acute Respiratory Distress Syndrome Due to COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",547-ARD-301,"Sage Investigational Site, Fresno, California, United States|Sage Investigational Site, Augusta, Georgia, United States|Sage Investigational Site, Boston, Massachusetts, United States|Sage Investigational Site, Burlington, Massachusetts, United States|Sage Investigational Site, Lansing, Michigan, United States|Sage Investigational Site, Las Vegas, Nevada, United States|Sage Investigational Site, Charlotte, North Carolina, United States|Sage Investigational Site, Charleston, South Carolina, United States|Sage Investigational Site, Richmond, Virginia, United States|Sage Investigational Site, Seattle, Washington, United States",https://ClinicalTrials.gov/show/NCT04537806
NCT04818463,Characterization and Verification of the Intensive Care Standard Operating Procedure (SOP) Adherence of the Treated COVID-19 Patients,Observational Model: Cohort|Time Perspective: Retrospective,QUALITY COVID-19,"Department of Anesthesiology and Operative Intensive Care Medicine (CCM/CVK), Campus Virchow-Klinikum, Berlin, Germany",https://ClinicalTrials.gov/show/NCT04818463
NCT04352491,An Online Survey to Understand Feelings Related to COVID-19 Among ILBS Patients With Liver Disease,Observational Model: Case-Only|Time Perspective: Cross-Sectional,ILBS-COVID-03,"Institute of Liver and Biliary Sciences, New Delhi, Delhi, India",https://ClinicalTrials.gov/show/NCT04352491
NCT04372589,Antithrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,ATTACC|OZM-113,"Emory University Hospital Midtown, Atlanta, Georgia, United States|University of Chicago, Chicago, Illinois, United States|Ochsner Clinic, Jefferson, Louisiana, United States|Maine Medical Center, Portland, Maine, United States|Henry Ford University, Dearborn, Michigan, United States|Beaumont Hospital, Royal Oak, Michigan, United States|Mayo Clinic, Rochester, Minnesota, United States|Saint Louis University School of Medicine/Saint Louis Veterans Affairs Medical Center, Saint Louis, Missouri, United States|Cooper University Health Care, Camden, New Jersey, United States|Hackensack University Medical Center, Hackensack, New Jersey, United States|Saint Barnabas Medical Center, Livingston, New Jersey, United States|Montefiore-Einstein Center for Heart and Vascular Care, New York, New York, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|Santa Casa de Misericordia de Itabuna, Itabuna, BA, Brazil|Hospital Unimed do Cariri, Juazeiro do Norte, CE, Brazil|Instituto Goiano de Oncologia e Hematologia - INGOH, Goiania, Goias, Brazil|Centro de Pesquisas Clínicas Humap - UFMS, Campo Grande, Mato Grosso Do Sul, Brazil|Hospital Felício Rocho, Belo Horizonte, MG, Brazil|Clinica de Campo Grande S/A, Campo Grande, MS, Brazil|Unimed Campo Grande, Campo Grande, MS, Brazil|Hospital Agamenon Magalhaes, Recife, Pernanbuco, Brazil|Hospital das Clinicas da UFPR, Curitiba, PR, Brazil|Pontifícia Universidade Católica do Paraná, Curitiba, PR, Brazil|Parana Medical Research Center, Maringa, PR, Brazil|Hospital Sao Vicente de Paulo, Passo Fundo, Rio Grande Do Sul, Brazil|Hospital Universitario Pedro Ernesto, Rio de Janeiro, RJ, Brazil|Hospital de Clinicas de Porto Alegre, Porto Alegre, RS, Brazil|Instituto de Cardiologia do Rio Grande do Sul, Porto Alegre, RS, Brazil|Instituto de Medicina Vascular, Porto Alegre, RS, Brazil|AngioCor Blumenau, Blumenau, Santa Catarina, Brazil|Instituto de Cardiologia de Santa Catarina, Sao Jose, Santa Catarina, Brazil|Instituto de Pesquisa Clínica de Campinas, Campinas, Sao Paulo, Brazil|Praxis Pesquisa Medica, Santo Andre, Sao Paulo, Brazil|Santa Casa de Votuporanga, Votuporanga, Sao Paulo, Brazil|Casa de Saúde Santa Marcelina, Sao Paulo, SP, Brazil|Instituto de Molestias Cardio Vasculares de Tatui, Tatui, SP, Brazil|Hospital 9 de Julho, São Paulo, Brazil|Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil|Instituto de Infectologia Emilio Ribas, São Paulo, Brazil|Instituto do Coração do Estado de São Paulo, São Paulo, Brazil|Sociedade Beneficente Israelita Hospital Albert Einstein, São Paulo, Brazil|Victoria General Hospital, Victoria, British Columbia, Canada|Health Sciences Center Winnipeg, Winnipeg, Manitoba, Canada|Grace General Hospital, Winnipeg, Manitoba, Canada|St. Boniface General Hospital, Winnipeg, Manitoba, Canada|Hamilton Health Sciences, Hamilton, Ontario, Canada|St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada|Hôpital Montfort, Ottawa, Ontario, Canada|The Ottawa Hospital, Ottawa, Ontario, Canada|University Health Network, Toronto, Ontario, Canada|McGill University Health Centre, Montréal, Quebec, Canada|Centre Hospitalier de l'université de Montréal (CHUM), Montréal, Quebec, Canada|Jewish General Hospital, Montréal, Quebec, Canada|CHU de Quebec-University Laval, Québec, Quebec, Canada|Institut universitaire de cardiologie et de pneumologie de Québec (CRIUCPQ), Québec, Quebec, Canada|Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Quebec, Canada|Regina General Hospital, Regina, Saskatchewan, Canada|Hospital de Infectolog´ñia Centro Médico Nacional La Raza, Azcapotzalco, Mexico City, Mexico|Hospital General Regional 1 Carlos MacGregor Sánchez Navarro, Benito Juárez, Mexico City, Mexico|Hospital General regional 2 El Marqués, Querétaro, Mexico",https://ClinicalTrials.gov/show/NCT04372589
NCT04318444,Hydroxychloroquine Post Exposure Prophylaxis for Coronavirus Disease (COVID-19),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",AAAS9676,"Columbia University Irving Medical Center, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04318444
NCT04644185,The Efficacy and Safety of SCTA01 in Hospitalized Patients With Severe COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",SCTA01-B301,"SCT study site, Somers Point, New Jersey, United States|SCT study site, Ciudad Autonoma de Buenos aires, Argentina|SCT study site, Uberlândia, Brazil|SCT study site, Talca, Chile|SCT study site, Rionegro, Colombia|SCT study site, Monterrey, Mexico|SCT study site, Lima, Peru",https://ClinicalTrials.gov/show/NCT04644185
NCT04932915,Safety and Efficacy of Intranasal Administration of Niclosamide (UNI91103) in Adults With Asymptomatic or Mild COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",UNI91103-201|2021-001036-25,"Klinische Forschung Berlin-Mitte GmbH, Berlin, Germany|Klinische Forschung Dresden GmbH, Dresden, Germany|Klinische Forschung Hamburg GmbH, Hamburg, Germany",https://ClinicalTrials.gov/show/NCT04932915
NCT04537858,Virtual Reality Therapy Influence on Heart Rate Variability of Inpatients With COVID-19,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,33244620.5.0000.5505,"Comitê de Ética da Universidade Federal, São Paulo, Brazil",https://ClinicalTrials.gov/show/NCT04537858
NCT04477213,Risk Profiling of the Occupational Exposure of COVID-19 to Healthcare Workers.,Observational Model: Cohort|Time Perspective: Retrospective,NMCHCW-COVID,NA,https://ClinicalTrials.gov/show/NCT04477213
NCT04474340,COVID-19 Convalescent Plasma Treatment in SARS-CoV-2 Infected Patients,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,MOHKuwait,"Ministry Of Health, Kuwait, Kuwait",https://ClinicalTrials.gov/show/NCT04474340
NCT04790240,Medical Herbs Inhibit Inflammation Directing T Cells to Kill the COVID-19 Virus (COVID),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment",CHM2282395-1,"All Natural Medicine Clinic, LLC, Rockville, Maryland, United States",https://ClinicalTrials.gov/show/NCT04790240
NCT04740658,Organizational Measures to Prevent and Control COVID-19 Infection in Nursing Homes on the Risk of Death of Residents,Observational Model: Cohort|Time Perspective: Retrospective,RC31/20/0300,"University Hospital Toulouse - Gérontopôle, Toulouse, France",https://ClinicalTrials.gov/show/NCT04740658
NCT04402203,Study on Safety and Efficacy of Favipiravir (Favipira) for COVID-19 Patient in Selected Hospitals of Bangladesh,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment",29318042020,"Mahanagar General Hospital, Dhaka (Site-1), Mugda Medical College Hospital, Dhaka (Site-2), Kurmitola General Hospital, Dhaka (Site-3), Dhaka Medical College Hospital, Dhaka (Site-4), Dhaka, Bangladesh",https://ClinicalTrials.gov/show/NCT04402203
NCT04462393,Characteristics and Outcomes of Patients Admitted to Swedish Intensive Care Units for COVID-19,Observational Model: Cohort|Time Perspective: Other,SweCOVID,"Department of Anaesthesia and Intensive Care, Linkoeping University Hospital, Region Östergötland, Linköping, Östergötland, Sweden",https://ClinicalTrials.gov/show/NCT04462393
NCT04435717,Efficacy of Tocilizumab in Modifying the Inflammatory Parameters of Patients With COVID-19 (COVITOZ-01),Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,COVITOZ-01,"Hospital Universitario Ramón y Cajal, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04435717
NCT04454398,Study to Evaluate STI-1499 (COVI-GUARD) in Patients With Moderate COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",GRD-COV-101,NA,https://ClinicalTrials.gov/show/NCT04454398
NCT04887129,Testing for COVID-19 in High Risk Children With Intellectual and Developmental Disabilities (COV-IDD),Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,STUDY00005294|OT2HD107553-01,"Mary Cariola Center, Rochester, New York, United States",https://ClinicalTrials.gov/show/NCT04887129
NCT04357574,Assessing the System for High-Intensity Evaluation During Radiotherapy During Changes in Response to COVID-19,Observational Model: Other|Time Perspective: Prospective,Pro00105266,"Duke Cancer Center, Durham, North Carolina, United States",https://ClinicalTrials.gov/show/NCT04357574
NCT04505722,A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adult Participants,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",CR108876|VAC31518COV3001,"Synexus Clinical Research US, Inc, Birmingham, Alabama, United States|University of Alabama Birmingham, Birmingham, Alabama, United States|Alabama Vaccine Research Clinic at UAB, Birmingham, Alabama, United States|Optimal Research, Huntsville, Alabama, United States|Synexus Clinical Research US, Inc, Glendale, Arizona, United States|VA Medical Center, Phoenix, Arizona, United States|Central Phoenix Medical Clinic, Phoenix, Arizona, United States|Quality of Life Medical & Research Center, LLC, Tucson, Arizona, United States|Synexus Clinical Research US, Inc, Tucson, Arizona, United States|University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States|Central Arkansas Veterans Healthcare System, Little Rock, Arkansas, United States|Anaheim Clinical Trials, LLC, Anaheim, California, United States|Ark Clinical Research, Long Beach, California, United States|Anthony Mills Medical, Inc, Los Angeles, California, United States|Stanford University Medical Center, Palo Alto, California, United States|UCSD Antiviral Research Center AVRC, San Diego, California, United States|Wr-McCr, Llc, San Diego, California, United States|VA Medical Center, San Francisco, California, United States|Childrens Hospital Colorado, Aurora, Colorado, United States|Rocky Mountain Regional VA Medical Center, Denver, Colorado, United States|Avail Clinical Research, LLC, DeLand, Florida, United States|North Florida South Georgia Veteran Health System, Gainesville, Florida, United States|Velocity Clinical Research, Hallandale Beach, Hallandale Beach, Florida, United States|Research Centers of America, LLC, Hollywood, Florida, United States|Suncoast Research Group, Miami, Florida, United States|University of Miami - Miller School of Medicine, Miami, Florida, United States|Orlando Immunology Center, Orlando, Florida, United States|Advent Health Orlando, Orlando, Florida, United States|Synexus Clinical Research US, Inc, Orlando, Florida, United States|Synexus Clinical Research US, Inc, Pinellas Park, Florida, United States|James A Haley VA Hospital GNS, Tampa, Florida, United States|Synexus Clinical Research US, Inc, The Villages, Florida, United States|Emory University of Medicine, Atlanta, Georgia, United States|The Hope Clinic at Emory University, Decatur, Georgia, United States|Atlanta VA Medical Center, Decatur, Georgia, United States|Northwestern University, Chicago, Illinois, United States|Jesse Brown VAMC Department of Surgery, Chicago, Illinois, United States|Rush University Medical Center, Chicago, Illinois, United States|University of IL Chicago, Chicago, Illinois, United States|The University Of Chicago Medicine, Chicago, Illinois, United States|Optimal Research, Peoria, Illinois, United States|Buynak Clinical Research, Valparaiso, Indiana, United States|Johnson County Clin-Trials, Lenexa, Kansas, United States|Central Kentucky Research Associates, Inc., Lexington, Kentucky, United States|University of Kentucky, Lexington, Kentucky, United States|University of Louisville, Louisville, Kentucky, United States|Benchmark Research, Metairie, Louisiana, United States|Clinical Trials Management, LLC, Metairie, Louisiana, United States|New Orleans Adolescent Trials Unit CRS, New Orleans, Louisiana, United States|Southeast Louisiana Veterans Health Care Center, New Orleans, Louisiana, United States|Ochsner Clinic Foundation, New Orleans, Louisiana, United States|Baltimore VA Medical Center, Baltimore, Maryland, United States|Optimal Research, Rockville, Maryland, United States|Meridian Clinical Research, LLC, Rockville, Maryland, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|The Brigham and Women's Hospital, Inc., Boston, Massachusetts, United States|University of Michigan Neuorsurgery A. Alfred Taubman Health Care Center, Ann Arbor, Michigan, United States|Henry Ford Health System, Detroit, Michigan, United States|Cherry Street Services, Inc., Grand Rapids, Michigan, United States|Abbott Northwestern Hospital Clinic, Minneapolis, Minnesota, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|MediSync Clinical Research, Petal, Mississippi, United States|The Center For Pharmaceutical Research, Kansas City, Missouri, United States|Saint Louis University, Saint Louis, Missouri, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|Synexus Clinical Research US, Inc, Saint Louis, Missouri, United States|Clinical Research Center of Nevada, Las Vegas, Nevada, United States|Clinical Research Consortium, an AMR company, Las Vegas, Nevada, United States|VA Sierra Nevada Health Care System, Reno, Nevada, United States|Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States|Saint Michael's Medical Center, Newark, New Jersey, United States|Raymond G. Murphy VA Medical Center, Albuquerque, New Mexico, United States|Bronx Veterans Affairs Medical Center, Bronx, New York, United States|Meridian Clinical Research, LLC, Endwell, New York, United States|Icahn School of Medicine at Mount Sinai, New York, New York, United States|Harlem Hospital Center, New York, New York, United States|New York Blood Center, New York, New York, United States|Rochester Clinical Research, Inc, Rochester, New York, United States|Tryon Medical Group, Charlotte, North Carolina, United States|Carolina Institute for Clinical Research, Fayetteville, North Carolina, United States|Durham VAMC, Raleigh, North Carolina, United States|Wake Research Associates, Raleigh, North Carolina, United States|Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States|Synexus Clinical Research US, Inc, Akron, Ohio, United States|CTI Clinical Trial and Consulting Services, Cincinnati, Ohio, United States|Synexus Clinical Research US, Inc, Cincinnati, Ohio, United States|New Horizons Clinical Research, Cincinnati, Ohio, United States|Rapid Medical Research, Cleveland, Ohio, United States|Synexus Clinical Research US, Inc, Columbus, Ohio, United States|Corvallis Clinic PC, Corvallis, Oregon, United States|Clinical Research Institute of Southern Oregon, P.C., Medford, Oregon, United States|Oregon Health & Science University, Portland, Oregon, United States|University of Pennsylvania, Philadelphia, Pennsylvania, United States|Temple University Hospital, Philadelphia, Pennsylvania, United States|University of Pittsburgh, Pittsburgh, Pennsylvania, United States|Synexus Clinical Research US, Inc, Anderson, South Carolina, United States|VA Medical Center, Columbia, South Carolina, United States|Coastal Carolina Research Center, Mount Pleasant, South Carolina, United States|PMG Research of Charleston, LLC, Mount Pleasant, South Carolina, United States|Spartanburg Medical Research, Spartanburg, South Carolina, United States|St Jude Children's Research Hospital, Memphis, Tennessee, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|Benchmark Research, Austin, Texas, United States|Optimal Research, LLC, Austin, Texas, United States|AIDS Arms Incorporated Trinity Health and Wellness Center, Dallas, Texas, United States|Synexus Clinical Research US, Inc, Dallas, Texas, United States|Baylor Scott & White Research Institute, Dallas, Texas, United States|North Texas Infectious Diseases Consultants, Dallas, Texas, United States|Texas Center for Drug Development, Inc, Houston, Texas, United States|Gordon Crofoot, MD, Houston, Texas, United States|Clinical Trials of Texas, Inc, San Antonio, Texas, United States|Synexus Clinical Research US, Inc, San Antonio, Texas, United States|Synexus Clinical Research US, Inc, Murray, Utah, United States|University of Utah, Salt Lake City, Utah, United States|Advanced Clinical Research, West Jordan, Utah, United States|Kaiser Permanente Washington Health Research Institute, Seattle, Washington, United States|CIPREC, Buenos Aires, Argentina|Helios Salud Sa, Buenos Aires, Argentina|CEMEDIC, Buenos Aires, Argentina|Centro Medico Viamonte SRL, Ciudad Autonoma Buenos Aires, Argentina|Clinical Trials Division-Stamboulian Servicios de Salud, Ciudad Autonoma Buenos Aires, Argentina|Clínica y Maternidad Suizo Argentina, Ciudad Autonoma de Buenos Aires, Argentina|Fundacion Huesped, Ciudad Autonoma De Buenos Aire, Argentina|CEMIC Saavedra, Ciudad de Buenos Aires, Argentina|Hospital J. M. Ramos Mejía, Ciudad de Buenos Aires, Argentina|Instituto Medico Platense, La Plata, Argentina|DIM Clinica Privada, Ramos Mejia, Argentina|Faculdade de Medicina Barretos FACISB, Barretos, Brazil|Hospital Das Clinicas Da Universidade Federal De Minas Gerais, Belo Horizonte, Brazil|Santa Casa de Misericordia de Belo Horizonte, Belo Horizonte, Brazil|L2IP - Instituto de Pesquisas Clínicas, Brasília, Brazil|HMCP - Hospital e Maternidade Celso Pierro - PUC-Campinas, Campinas, Brazil|Hospital São José, Criciúma, Brazil|Oncovida - Centro de Onco-Hematologia de Mato Grosso, Cuiabá, Brazil|Hospital Nossa Senhora Das Gracas, Curitiba, Brazil|Centro de Estudos e Pesquisas em Moléstias Infecciosas, Natal, Brazil|Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil|Hospital Nossa Senhora da Conceicao, Porto Alegre, Brazil|Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo, Ribeirão Preto, Brazil|Hospital federal dos servidores do estado, Rio de Janeiro, Brazil|Instituto Brasil de Pesquisa Clinica, Rio de Janeiro, Brazil|Instituto Nacional de Infectologia Evandro Chagas (INI) - FIOCRUZ, Rio de Janeiro, Brazil|Hospital Geral De Nova Igaucu Brazil, Rio de Janeiro, Brazil|Fundação Bahiana De Infectologia, Salvador, Brazil|Universidade Municipal de Sao Caetano do Sul, Sao Caetano do Sul, Brazil|Fundacao Faculdade Regional De Medicina De Sao Jose Do Rio Preto, Sao Jose do Rio Preto, Brazil|Centro de Referencia E Treinamento Dst/Aids, Sao Paulo, Brazil|CPQuali Pesquisa Clinica LTDA ME, São Paulo, Brazil|Instituto de infectologia Emilio Ribas, São Paulo, Brazil|Hospital Sirio Libanes, São Paulo, Brazil|Real e Benemérita Associação Portuguesa de Beneficência, São Paulo, Brazil|CEPIC - Centro Paulista de Investigação Clínica e Serviços Médicos, São Paulo, Brazil|Hospital Das Clinicas Da Faculdade De Medicina Da USP, São Paulo, Brazil|Centro de Estudios Clínicos e Investigación Médica (CeCim), Santiago, Chile|Facultad de Medicina Universidad de Chile, Santiago, Chile|Centro de Investigacion del Maule, Talca, Chile|Hospital Dr Hernan Henriquez Aravena, Temuco, Chile|Clinica de la Costa, Barranquilla, Colombia|Centro de Reumatologia y Ortopedia, Barranquilla, Colombia|Hospital Universidad del Norte, Barranquilla, Colombia|Centro de Atencion e Investigacion Medica S.A. - CAIMED, Bogota, Colombia|Medplus Medicina Prepagada S.A., Bogota, Colombia|Solano y Terront Servicios Médicos Ltda., Bogota, Colombia|Centro de Investigaciones Clinicas S.A.S., Cali, Colombia|Fundación Valle del Lili, Cali, Colombia|Fundación Cardiovascular de Colombia - Instituto del Corazón Floridablanca, Floridablanca, Colombia|Fundacion Oftalmologica de Santander - FOSCAL, Floridablanca, Colombia|Programa de Estudio y Control de Enfermedades Tropicales, Medellin, Colombia|Fundacion Centro de Investigacion Clinica CIC, Medellin, Colombia|Hospital Pablo Tobon Uribe, Medellín, Colombia|Instituto Nacional de Salud Publica, Cuernavaca, Mexico|Unidad de Atención Medica e Investigacion en Salud (UNAMIS), Merida, Mexico|CAIMED Investigacion en salud S.A de C.V., Mexico, Mexico|Hospital Universitario de Nuevo Leon 'Dr Jose Eleuterio Gonzalez', Monterrey, Mexico|Centro de Invetigaciones Medicas, Callao, Peru|Centro de Investigaciones Tecnologicas, Biomedica y medio ambientales (CITBM), Callao, Peru|Asociacion Civil Selva Amazonica (ACSA), Iquitos, Peru|Asociacion Civil Impacta Salud y Educacion - Barranco, Lima - Barranco, Peru|Hospital Nacional Edgardo Rebagliati Martins, Lima, Peru|Hospital Nacional Arzobispo Loayza, Lima, Peru|Asociacion Civil Via Libre, Lima, Peru|Asociacion Civil Impacta Salud y Educacion- San Miguel CRS, Lima, Peru|Josha Research, Bloemfontein, South Africa|Synexus Helderberg Clinical Research Centre, Cape Town, South Africa|Family Clinical Research Unit FAM-CRU, Cape Town, South Africa|TASK Central, Cape Town, South Africa|Desmond Tutu HIV Foundation, Cape Town, South Africa|University of Cape Town IDM/CIDRI Research Site, Cape Town, South Africa|Desmond Tutu Hiv Foundation - University of Cape Town, Cape Town, South Africa|Masiphumelele Research Centre, Cape Town, South Africa|Ndlovu Elandsdoorn Site, Dennilton, South Africa|SA Medical Research Council, Durban, South Africa|SA Medical Research Council, Durban, South Africa|CRISMO Bertha Gxowa Research Centre, Johannesburg, South Africa|Shandukani Research Centre, Johannesburg, South Africa|The Aurum Institute Klerksdorp Clinical Research Centre, Klerksdorp, South Africa|Qhakaza Mbokodo Research Centre, KwaZulu-Natal, South Africa|South African Medical Research Council Chatsworth Clinical Research Site, KwaZulu-Natal, South Africa|Centre for the AIDS Programme of Research in South Africa, KwaZulu-Natal, South Africa|Stanza Clinical Research Centre : Mamelodi, Mamelodi East, South Africa|Mzansi Ethical Research Centre, Middelburg, South Africa|Nelson Mandela Academic Clinical Research Unit 'NeMACRU', Mthatha, South Africa|PHOENIX PHARMA (Pty) Ltd, Port Elizabeth, South Africa|MeCRU Clinical Research Unit, Pretoria, South Africa|Synexus Watermeyer, Pretoria, South Africa|The Aurum Institute Rustenburg Clinical Research Site, Rustenburg, South Africa|Setshaba Research Centre, Soshanguve, South Africa|Perinatal HIV Research Unit (PHRU), Kliptown, Soweto, South Africa|Perinatal HIV Research Unit, Chris Hani Baragwanath Hospital, Soweto, South Africa|The Aurum Institute: Tembisa - Clinic 4, Tembisa, South Africa|CAPRISA Vulindlela Clinic, Vulindlela, South Africa|University of Witwatersrand - Helen Joseph Hospital - Themba Lethu Hiv Research Centre, Westdene Johannesburg Gauteng, South Africa|SATVI, Brewelskloof Hospital, Worcester, South Africa",https://ClinicalTrials.gov/show/NCT04505722
NCT04370288,Clinical Application of Methylene Blue for Treatment of Covid-19 Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,IR.MUMS.REC.1399.122,"Imam Reza Hospital, Mashhad, Razavi Khorasan, Iran, Islamic Republic of",https://ClinicalTrials.gov/show/NCT04370288
NCT04704388,Study Project Comparing the Sequelae of COVID-19 Infection in Patients Who Have and Have Not Received Ventilatory Support in Critical Care,Observational Model: Cohort|Time Perspective: Retrospective,COMEBAC,"Bicêtre Hospital, Le Kremlin-Bicêtre, France",https://ClinicalTrials.gov/show/NCT04704388
NCT04776317,Chimpanzee Adenovirus and Self-Amplifying mRNA Prime-Boost Prophylactic Vaccines Against SARS-CoV-2 in Healthy Adults,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,20-0034|5UM1AI148684-02,"Emory Vaccine Center - The Hope Clinic, Decatur, Georgia, United States|Saint Louis University - Center for Vaccine Development, Saint Louis, Missouri, United States|Baylor College of Medicine - Molecular Virology and Microbiology, Houston, Texas, United States|The University of Washington - Virology Research Clinic, Seattle, Washington, United States",https://ClinicalTrials.gov/show/NCT04776317
NCT04898127,Antigen Rapid Test Screening to Prevent SARS-CoV-2 Transmission (COVID-19) at Mass Gathering Events.,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Screening,CristinID2510078,NA,https://ClinicalTrials.gov/show/NCT04898127
NCT04467840,"Opaganib, a Sphingosine Kinase-2 (SK2) Inhibitor in COVID-19 Pneumonia","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",ABC-201,"ABC-201 Site 901, Detroit, Michigan, United States|ABC-201 Site 408, Belo Horizonte, Brazil|ABC-201 Site 411, Belo Horizonte, Brazil|ABC-201 Site 405, Joinville, Brazil|ABC-201 Site 404, Paraná, Brazil|ABC-201 Site 410, Passo Fundo, Brazil|ABC-201 Site 409, Porto Alegre, Brazil|ABC-201 Site 401, Sao Paulo, Brazil|ABC-201 Site 402, São Bernardo Do Campo, Brazil|ABC-201 Site 403, São Paulo, Brazil|ABC-201 Site 407, Tubarão, Brazil|ABC-201 Site 604, Medellín, Antioquia, Colombia|ABC-201 Site 603, Bogotá, Colombia|ABC-201 Site 605, Cundinamarca, Colombia|ABC-201 Site 602, Medellín, Colombia|ABC-201 Site 601, Santiago de Cali, Colombia|ABC-201 Site 708, Ashkelon, Ashketon, Israel|ABC-201 Site 702, Ashdod, Israel|ABC-201 Site 704, Holon, Israel|ABC-201 Site 701, Jerusalem, Israel|ABC-201,Site 709, Kfar Saba, Israel|ABC-201 Site 705, Nahariya, Israel|ABC-201 Site 706, Nazareth, Israel|ABC-201 Site 703, Safed, Israel|ABC-201 Site 203, Alessandria, Italy|ABC-201 Site 201, Lecco, Italy|ABC-201 Site 202, Milano, Italy|ABC-201 Site 204, Torino, Italy|ABC-201 Site 501, Mexico City, Mexico|ABC-201 Site 503, Sinaloa, Mexico|ABC-201 Site 655, Lima, Peru|ABC-201 Site 303, Bolesławiec, Poland|ABC-201 Site 306, Katowice, Poland|ABC-201 Site 304, Koszalin, Poland|ABC-201 Site 307, Lublin, Poland|ABC-201 Site 302, Ostróda, Poland|ABC-201 Site 301, Racibórz, Poland|ABC-201 Site 305, Wrocław, Poland|ABC-201 Site 308, Łódź, Poland|ABC-201 Site 110, Barnaul, Russian Federation|ABC-201 Site 122, Kirovsk, Russian Federation|ABC-201 Site 101, Moscow, Russian Federation|ABC-201 Site 132, Moscow, Russian Federation|ABC-201 Site 120, Murmansk, Russian Federation|ABC-201 Site 103, Ryazan, Russian Federation|ABC-201 Site 114, Ryazan, Russian Federation|ABC-201 Site 129, Saint Petersburg, Russian Federation|ABC-201 Site 108, Saratov, Russian Federation|ABC-201 Site 102, Smolensk, Russian Federation|ABC-201 Site 109, St Petersburg, Russian Federation|ABC-201 Site 111, St Petersburg, Russian Federation|ABC-201 Site 104, Tver, Russian Federation|ABC-201 Site 118, Volgograd, Russian Federation|ABC-201 Site 112, Yaroslavl, Russian Federation|ABC-201 Site 253, Antrim, United Kingdom|ABC-201 Site 251, Gillingham, United Kingdom|ABC-201 Site 252, Taunton, United Kingdom",https://ClinicalTrials.gov/show/NCT04467840
NCT04866589,COVID-19: The Effectiveness of Free Face Mask Distribution,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,FaceMaskRCT Stovner,NA,https://ClinicalTrials.gov/show/NCT04866589
NCT04352751,Experimental Use of Convalescent Plasma for Passive Immunization in Current COVID-19 Pandemic in Pakistan in 2020,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,PIPK- 0000 /NIBD-0000/2020,"National Institute of Blood Diseases and Bone Marrow Transplantation (NIBD), Karachi, Sindh, Pakistan",https://ClinicalTrials.gov/show/NCT04352751
NCT04596839,Antiviral Activity and Safety of Remdesivir in Bangladeshi Patients With Severe Coronavirus Disease (COVID-19),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,BEX-06001,"Combined Military Hospital, Dhaka, Bangladesh",https://ClinicalTrials.gov/show/NCT04596839
NCT04869397,Treatment of Respiratory Complications Associated With COVID-19 Using Umbilical Cord Mesenchymal Stromal Cells,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",2021-6954,"McGill University Health Centre, Montreal, Quebec, Canada",https://ClinicalTrials.gov/show/NCT04869397
NCT04950725,Covid-19 Virtual Recovery Study,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science,21-000953,"Mayo Clinic in Arizona, Scottsdale, Arizona, United States",https://ClinicalTrials.gov/show/NCT04950725
NCT04623385,Clinical Role of Testosterone and Dihydrotestosterone and Which of Them Should be Inhibited in COVID-19 Patients - A Double-edged Sword?,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,SARS -2,NA,https://ClinicalTrials.gov/show/NCT04623385
NCT04903184,Exploratory Study to Evaluate the Efficacy of RUTI® Against SARS-COV-2 Infection (COVID-19) in Healthcare Workers,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",RUTICOVID19-ARG,"Hospital General de Agudos Dr. Ignacio Pirovano, Buenos Aires, Argentina|Hospital Italiano de Buenos Aires, Buenos Aires, Argentina|Hospital General, Mendoza, Argentina|Hospital José Néstor Lencinas, Mendoza, Argentina|Hospital Materno Infantil ""Dr. Héctor Quintana"", San Salvador De Jujuy, Argentina|Hospital de Clínicas Presidente Dr. Nicolás Avellaneda, Tucumán, Argentina",https://ClinicalTrials.gov/show/NCT04903184
NCT04777981,(CBDRA60) to Prevent or Reduce Symptoms of COVID-19 and Prevention of Post-Acute Sequelae of SARS-CoV-2 Infection PASC,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",1001,"Anewsha Therapeutics / Comco R&D, Hanover, Michigan, United States",https://ClinicalTrials.gov/show/NCT04777981
NCT04388670,Epidemiological and Clinical Characteristics of Critically Ill Patients With COVID-19,Observational Model: Cohort|Time Perspective: Other,PoliclinicoH,"Fondazione IRCCS Ca'Granda - Ospedale Maggiore Policlinico, Milan, Italy",https://ClinicalTrials.gov/show/NCT04388670
NCT04498377,Study of F-652 (IL-22:IgG2 Fusion Protein) in Patients With Moderate to Severe COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",GC-652-04,"Tulane University School of Medicine, New Orleans, Louisiana, United States",https://ClinicalTrials.gov/show/NCT04498377
NCT04363502,Use of the Interleukin-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",IRB00247932,"Johns Hopkins Hospital, Baltimore, Maryland, United States",https://ClinicalTrials.gov/show/NCT04363502
NCT04783311,"Safety, Tolerance and Immunogenicity of EuCorVac-19 for the Prevention of COVID-19 in Healthy Adults","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",EuSNAP_COV101,"The Catholic University of Eunpyeong St.Mary's Hospital, Seoul, Korea, Republic of",https://ClinicalTrials.gov/show/NCT04783311
NCT04435314,Efficacy and Safety of Nitazoxanide for Post Exposure Prophylaxis of COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",NITFQM0620OR,NA,https://ClinicalTrials.gov/show/NCT04435314
NCT04384731,Curosurf® in Adult Acute Respiratory Distress Syndrome Due to COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,P20/06,"CH Francois Quesnay, Mantes la Jolie, France",https://ClinicalTrials.gov/show/NCT04384731
NCT04914377,To Evaluate the Safety and Efficacy of TQ Formula in Covid-19 Participants,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",BOSS-001,"Respire Research, San Diego, California, United States|United Memorial Medical Center, Houston, Texas, United States",https://ClinicalTrials.gov/show/NCT04914377
NCT04374487,Assess the Safety and Efficacy of Convalescent Plasma to Limit COVID-19 Associated Complications,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,MHC-COVID-19-CP,"Max Super Speciality hospital, Saket (A unit of Devki Devi Foundation), New Delhi, Delhi, India",https://ClinicalTrials.gov/show/NCT04374487
NCT04640181,Factor Xa Inhibitor Versus Standard of Care Heparin in Hospitalized Patients With COVID-19 (XACT),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2020-001708-41,"St. David's Medical Center, Austin, Texas, United States",https://ClinicalTrials.gov/show/NCT04640181
NCT04902183,Safety and Efficacy of Exosomes Overexpressing CD24 in Two Doses for Patients With Moderate or Severe COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,NS3,"3rd Department of Medicine, ""Sotiria"" Thoracic Diseases General Hospital of Athens, Athens, Attica, Greece|Attikon University Hospital, Athens, Attica, Greece|7th Respiratory Medicine Department, ""Sotiria"" Thoracic Diseases General Hospital of Athens, Athens, Attika, Greece",https://ClinicalTrials.gov/show/NCT04902183
NCT04502472,Open-label Treatment of Severe Coronavirus Disease 2019 (COVID-19) With Convalescent Plasma,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,Inova COVID-19 CCP,"Inova Fairfax Medical Campus, Falls Church, Virginia, United States",https://ClinicalTrials.gov/show/NCT04502472
NCT04584411,Patterns of Arrhythmias and Conduction Block in COVID-19 Patients and Its Relation to Myocardial Injury Detected by Cardiac Magnetic Resonance,Observational Model: Cohort|Time Perspective: Prospective,arrhythmias in COVID-19,NA,https://ClinicalTrials.gov/show/NCT04584411
NCT04848441,Risk of COVID-19 Infection After Vaccination,Observational Model: Cohort|Time Perspective: Retrospective,VACC-COV-19,NA,https://ClinicalTrials.gov/show/NCT04848441
NCT04377685,Prediction of Clinical Course in COVID19 Patients,Observational Model: Cohort|Time Perspective: Retrospective,20CH109|IRBN652020/CHUSTE,"Chu Saint-Etienne, Saint-Étienne, France",https://ClinicalTrials.gov/show/NCT04377685
NCT04563689,Pilot Study to Evaluate Effect of CHX0.12/CPC 0.05 of SARS-CoV-2 Viral Load in COVID-19 Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Other,COVID-POC1,"Escuela odontologia. Facultad de Salud Hospital del Valle, Cali, Colombia",https://ClinicalTrials.gov/show/NCT04563689
NCT04418128,Clinical Efficacy of Nafamostat Mesylate for COVID-19 Pneumonia,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2020-04-012,NA,https://ClinicalTrials.gov/show/NCT04418128
NCT04685655,RescuE pLAsma eXchange in Severe COVID-19,Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,S-911/2020,"Heidelberg University Hospital, Heidelberg, Baden-Württemberg, Germany|Klinikum Stuttgart, Stuttgart, Baden-Württemberg, Germany|University Hospital Essen, Essen, Nordrhein-Westfalen, Germany",https://ClinicalTrials.gov/show/NCT04685655
NCT04810637,A Study to Evaluate the Safety and Efficacy of GX-I7 in Elderly Patients With Asymptomatic or Mild Symptoms of COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",GXI7KGBio-001,"Mitra Keluarga Kelapa Gading, Jakarta Pusat, Indonesia|Mitra Keluarga Kemayoran, Jakarta Pusat, Indonesia",https://ClinicalTrials.gov/show/NCT04810637
NCT04964583,Hidroxicloroquina With Azitromicina Versus Hidroxicloroquina and Placebo Int Patients With Mild COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",2020-785-138,"UMF 28, Benito Juárez, Mexico City, Mexico|Fundación IMSS, Cuauhtémoc, Mexico City, Mexico|UMF 52, Cuautitlán Izcalli, State Of Mexico, Mexico",https://ClinicalTrials.gov/show/NCT04964583
NCT04412018,An Investigation on the Effects of Icosapent Ethyl (VascepaTM) on Inflammatory Biomarkers in Individuals With COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,Pro00043601,"North York Diagnostic and Cardiology Clinic, Toronto, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04412018
NCT04625738,Efficacy of Infusions of MSC From Wharton Jelly in the SARS-Cov-2 (COVID-19) Related Acute Respiratory Distress Syndrome,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",2020-002772-12,NA,https://ClinicalTrials.gov/show/NCT04625738
NCT04366154,Impact of the COVID-19 Infectious Epidemic on the Management of Oncology and Onco-hematology Patients and on the Psychological Consequences for Patients and Caregivers,Observational Model: Cohort|Time Perspective: Prospective,2020-A00879-30,"Centre François Baclesse, Caen, France|Centre Henri Becquerel, Rouen, France",https://ClinicalTrials.gov/show/NCT04366154
NCT04865133,Efficacy and Safety of COVID-19 Vaccine in Cancer Patients,Observational Model: Case-Only|Time Perspective: Other,21-001818|NCI-2021-03137|P30CA015083,"Mayo Clinic in Florida, Jacksonville, Florida, United States",https://ClinicalTrials.gov/show/NCT04865133
NCT04614883,Analysis of Volatile Organic Compounds in Exhaled Air and in Sweat in the Context of Suspicion of COVID-19 Infection,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,2020_0143,"Foch hospital, Suresnes, France",https://ClinicalTrials.gov/show/NCT04614883
NCT04683328,The Safety and Efficacy of SCTA01 Against COVID-19 in Patients Admitted to High Dependence or Intensive Care,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",SCTA01-C301,NA,https://ClinicalTrials.gov/show/NCT04683328
NCT04980508,Effects of COVID-19 on Cavernous Smooth Muscle,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,AnkaraYBU-URO-SU-02,"Ankara Yildirim Beyazit University, Schhol of Medicine, Ankara, Turkey",https://ClinicalTrials.gov/show/NCT04980508
NCT04318015,Hydroxychloroquine Chemoprophylaxis in Healthcare Personnel in Contact With COVID-19 Patients (PHYDRA Trial),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",ProfilaxisCOVID,"Instituto Nacional de Enfermedades Respiratorias, ""Ismael Cosío Villegas"", Mexico, City, Mexico",https://ClinicalTrials.gov/show/NCT04318015
NCT04468139,"The Study of Quadruple Therapy Zinc, Quercetin, Bromelain and Vitamin C on the Clinical Outcomes of Patients Infected With COVID-19",Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,20-95M,"Ministry of health.First health cluster ,Riaydh, Riyadh, Saudi Arabia",https://ClinicalTrials.gov/show/NCT04468139
NCT04581291,The Effect of Aerobic Exercise on Immune Biomarkers and Symptoms Severity and Progression in Patients With COVID-19: A Pilot Randomized Control Trial,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Prevention,"Aerobic exercise, COVID-19","Motaz Alawna, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04581291
NCT04522076,Prospective Hospital Registry of Patients With Suspected or Confirmed Coronavirus Infection (COVID-19) and Community-acquired Pneumonia,Observational Model: Cohort|Time Perspective: Prospective,2002/7/20,"National Research Center for Preventive Medicine of the Ministry of Health, Moscow, Russian Federation|National Medical and Surgical Center named after N.I.Pirogov of the Ministry of Health of Russian Federation, Moscow, Russian Federation",https://ClinicalTrials.gov/show/NCT04522076
NCT04387890,Serologic Surveillance for SARS-CoV-2 (COVID-19) in a Prospective Cohort of Health Care Workers,Observational Model: Cohort|Time Perspective: Prospective,5566,NA,https://ClinicalTrials.gov/show/NCT04387890
NCT04408170,Facilitating AcceLerated Clinical Validation Of Novel Diagnostics for COVID-19 (FALCON-C19),Observational Model: Cohort|Time Perspective: Prospective,B00944,"Sandwell General Hospital Birmingham NHS Trust, Birmingham, United Kingdom|University Hospitals of Derby and Burton NHS FT, Derby, United Kingdom|Frimley Health NHS FT, Frimley, United Kingdom|Airedale NHS FT, Keighley, United Kingdom|Leeds Teaching Hospital NHS FT, Leeds, United Kingdom|St George's University Hospitals NHS FT, London, United Kingdom|Manchester University NHS FT, Manchester, United Kingdom|Newcastle upon Tyne Hospitals NHS FT, Newcastle Upon Tyne, United Kingdom|Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom|Oxford University Hospitals NHS FT, Oxford, United Kingdom|Royal Berkshire Hospital NHS FT, Reading, United Kingdom|Barking, Havering & Redbridge Hospitals NHS FT, Romford, United Kingdom|Salford Royal NHS FT, Salford, United Kingdom|University Hospital Southampton NHS FT, Southampton, United Kingdom|University Hospitals of North Midlands NHS Trust, Stoke-on-Trent, United Kingdom",https://ClinicalTrials.gov/show/NCT04408170
NCT04341038,Clinical Trial to Evaluate Methylprednisolone Pulses and Tacrolimus in Patients With COVID-19 Lung Injury,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,TACRO-BELL-COVID|2020-001445-39,"Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain",https://ClinicalTrials.gov/show/NCT04341038
NCT04828668,Study to Evaluate Benefits & Safety of Endourage Formula C™ Oral Drops in People With Post-Acute COVID-19 Syndrome.,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Participant)|Primary Purpose: Other,ENDO-402-2021,"Thomas P Young, PhD, NP, Novato, California, United States",https://ClinicalTrials.gov/show/NCT04828668
NCT04558021,A Study To Evaluate The Efficacy And Safety Of a Novel Niclosamide Suspension Formulation For COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",NOV2020/01930,"Akdeniz Üniversitesi Tıp Fakültesi Hastanesi, Antalya, Turkey|Antalya Eğitim ve Araştırma Hastanesi, Antalya, Turkey|Gaziantep Üniversitesi Tıp Fakültesi Hastanesi, Gaziantep, Turkey|Gaziosmanpaşa Taksim Eğitim ve Araştırma Hastanesi, Istanbul, Turkey|Dokuz Eylül Üniversitesi Hastanesi, İzmir, Turkey|İzmir SBÜ Tepecik Eğitim ve Araştırma Hastanesi, İzmir, Turkey|SBÜ Dr. Suat Seren Göğüs Hastalıkları ve Cerrahisi Eğitim ve Araştırma Hastanesi, İzmir, Turkey|İzmir Katip Çelebi Üniversitesi Atatürk Eğitim ve Araştırma Hastanesi, İzmir, Turkey",https://ClinicalTrials.gov/show/NCT04558021
NCT04667442,Investigational Performance Evaluation of the Nanomix eLab® COVID-19 Rapid Antigen Panel With Samples From COVID-19 Positive and Negative Human Subjects,Observational Model: Other|Time Perspective: Cross-Sectional,Nanomix CVAG-202,"Nanomix, Emeryville, California, United States",https://ClinicalTrials.gov/show/NCT04667442
NCT04336657,Corona-Like Illness: Did we Got it Before WHO Announcement of the Disease?,Observational Model: Ecologic or Community|Time Perspective: Prospective,AssiutU11,"AssiutU, Assiut, Egypt",https://ClinicalTrials.gov/show/NCT04336657
NCT04362137,Study to Assess the Efficacy and Safety of Ruxolitinib in Patients With COVID-19 Associated Cytokine Storm,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",CINC424J12301|INCB 18424-368|2020-001662-11,"Novartis Investigative Site, Fullerton, California, United States|Novartis Investigative Site, Aurora, Colorado, United States|Novartis Investigative Site, Denver, Colorado, United States|Novartis Investigative Site, Atlanta, Georgia, United States|Novartis Investigative Site, Idaho Falls, Idaho, United States|Novartis Investigative Site, Ann Arbor, Michigan, United States|Novartis Investigative Site, Newark, New Jersey, United States|Novartis Investigative Site, Bronx, New York, United States|Novartis Investigative Site, Mesquite, Texas, United States|Novartis Investigative Site, Seattle, Washington, United States|Novartis Investigative Site, Madison, Wisconsin, United States|Novartis Investigative Site, C A B A, Buenos Aires, Argentina|Novartis Investigative Site, Buenos Aires, Argentina|Novartis Investigative Site, Buenos Aires, Argentina|Novartis Investigative Site, Rio de Janeiro, RJ, Brazil|Novartis Investigative Site, Blumenau, Santa Catarina, Brazil|Novartis Investigative Site, Barretos, SP, Brazil|Novartis Investigative Site, Sao Paulo, SP, Brazil|Novartis Investigative Site, Sao Paulo, SP, Brazil|Novartis Investigative Site, Sorocaba, SP, Brazil|Novartis Investigative Site, Rionegro, Antioquia, Colombia|Novartis Investigative Site, Barranquilla, Atlantico, Colombia|Novartis Investigative Site, Barranquilla, Colombia|Novartis Investigative Site, Colombes Cedex, France|Novartis Investigative Site, Eaubonne, France|Novartis Investigative Site, Nantes Cedex 1, France|Novartis Investigative Site, Pessac, France|Novartis Investigative Site, Pierre Benite, France|Novartis Investigative Site, Lubeck, Germany|Novartis Investigative Site, Muenchen, Germany|Novartis Investigative Site, Nuernberg, Germany|Novartis Investigative Site, México, Distrito Federal, Mexico|Novartis Investigative Site, Ciudad de Mexico, Mexico CP, Mexico|Novartis Investigative Site, Estado de Mexico, Mexico|Novartis Investigative Site, San Isidro, Lima, Peru|Novartis Investigative Site, San Miguel, Lima, Peru|Novartis Investigative Site, Lima, Peru|Novartis Investigative Site, Lima, Peru|Novartis Investigative Site, Barnaul, Russian Federation|Novartis Investigative Site, Moscow, Russian Federation|Novartis Investigative Site, Moscow, Russian Federation|Novartis Investigative Site, Ryazan, Russian Federation|Novartis Investigative Site, S-Petersburg, Russian Federation|Novartis Investigative Site, Saint Petersburg, Russian Federation|Novartis Investigative Site, Saint Petersburg, Russian Federation|Novartis Investigative Site, Sestroretsk, Russian Federation|Novartis Investigative Site, St Petersburg, Russian Federation|Novartis Investigative Site, Salamanca, Castilla Y Leon, Spain|Novartis Investigative Site, Barcelona, Cataluna, Spain|Novartis Investigative Site, Badalona, Catalunya, Spain|Novartis Investigative Site, Madrid, Spain|Novartis Investigative Site, Madrid, Spain|Novartis Investigative Site, Istanbul, TUR, Turkey|Novartis Investigative Site, Ankara, Turkey|Novartis Investigative Site, Istanbul, Turkey|Novartis Investigative Site, Yenisehir/Izmir, Turkey|Novartis Investigative Site, Harrow, United Kingdom|Novartis Investigative Site, Leeds, United Kingdom|Novartis Investigative Site, London, United Kingdom|Novartis Investigative Site, London, United Kingdom|Novartis Investigative Site, Manchester, United Kingdom",https://ClinicalTrials.gov/show/NCT04362137
NCT04363008,COVID 19 Biomarkers,Observational Model: Cohort|Time Perspective: Prospective,H20-00971,"Vancouver General Hospital, Vancouver, British Columbia, Canada",https://ClinicalTrials.gov/show/NCT04363008
NCT04347239,Study to Evaluate the Efficacy and Safety of Leronlimab for Patients With Severe or Critical Coronavirus Disease 2019 (COVID-19),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",CD12_COVID-19,"Advanced Cardiovascular, LLC, Alexander City, Alabama, United States|St. Jude Medical Center, Fullerton, California, United States|UCLA, Los Angeles, California, United States|James A. Haley Veterans' Hospital, Tampa, Florida, United States|Center for Advanced Research & Education (CARE), Gainesville, Georgia, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|St. Barnabas, Livingston, New Jersey, United States|Atlantic Health System Hospital, Morristown, New Jersey, United States|Holy Name Medical Center, Teaneck, New Jersey, United States|Montefiore Medical Center, Bronx, New York, United States|New York Community Hospital of Brooklyn, Brooklyn, New York, United States|Novant Health, Winston-Salem, North Carolina, United States|Ohio Health, Columbus, Ohio, United States|Good Samaritan Hospital Corvallis, Corvallis, Oregon, United States|Oregon Health and Sciences University, Portland, Oregon, United States|Baylor Scott & White Research Institute, Dallas, Texas, United States|Baylor College of Medicine, Houston, Texas, United States|University of Texas, Houston, Texas, United States",https://ClinicalTrials.gov/show/NCT04347239
NCT04389671,The Safety and Preliminary Tolerability of Lyophilized Lucinactant in Adults With Coronavirus Disease 2019 (COVID-19),Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,02-CL-2001a,"University California San Diego - Jacobs Medical Center, La Jolla, California, United States|University of California San Diego - Medical Center, Hillcrest, San Diego, California, United States|Augusta University Health, Augusta, Georgia, United States|University of Kentucky, Lexington, Kentucky, United States|Brigham and Womens, Boston, Massachusetts, United States|Duke University Medical Center, Durham, North Carolina, United States",https://ClinicalTrials.gov/show/NCT04389671
NCT04558424,"RCT,Double Blind, Placebo to Evaluate the Effect of Zinc and Ascorbic Acid Supplementation in COVID-19 Positive Hospitalized Patients in BSMMU","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Supportive Care",BSMMU 2020,"Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh",https://ClinicalTrials.gov/show/NCT04558424
NCT04383886,Evaluation of Emergency Department (ED) Staff Stress Level During COVID-19 Pandemic,Observational Model: Cohort|Time Perspective: Prospective,69HCL20_0330,"SAMU Hospices Civils de Lyon, Lyon, France|Service d'accueil des urgences, Hôpital Edouard Herriot, Hospices Civlis de Lyon, Lyon, France|Service d'accueil des urgences, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, Lyon, France|Service d'accueil des urgences, Hôpital Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite, France|Hôpital de Villefranche-sur-Saône, Villefranche-sur-Saône, France",https://ClinicalTrials.gov/show/NCT04383886
NCT04440007,Study of the Efficacy and Safety of STI-5656 (Abivertinib Maleate) in Subjects Hospitalized With COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,STI-5656-2001,"MedStar Washington Hospital Center, Washington, District of Columbia, United States|Teradan Clinical Trials, Brandon, Florida, United States|Alexandria Cardiology Clinic, Alexandria, Louisiana, United States|Clinical Trials of SWLA, Lake Charles, Louisiana, United States|Quality Clinical Research, Omaha, Nebraska, United States|Memorial Hermann Memorial City Hospital, Houston, Texas, United States",https://ClinicalTrials.gov/show/NCT04440007
NCT04518969,Determination of the Hemoadsorption Impact as Adjunctive Treatment Upon the Support Therapy of COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,BrugmannUH 1066,"CHU Brugmann, Brussels, Belgium",https://ClinicalTrials.gov/show/NCT04518969
NCT04551768,Study to Evaluate the Safety and Efficacy of VIRAZOLE® in Hospitalized Adult Participants With Respiratory Distress Due to COVID-19,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,BHC-RIB-5401-GL,"Bausch Health Site 201, Athens, Attika, Greece|Bausch Health Site 203, Athens, Attika, Greece|Bausch Health Site 204, Alexandroupoli, Evros, Greece|Bausch Site 304, Tijuana, Zona Rio, Mexico",https://ClinicalTrials.gov/show/NCT04551768
NCT04403932,Increased Risk of Severe Coronavirus Disease 2019 in Patients With Vitamin D Deficiency,Observational Model: Cohort|Time Perspective: Prospective,20/428-E_COVID,"Hospital Clínico San Carlos, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04403932
NCT04366024,A Novel Nomogram to Predict Severity of COVID-19,Observational Model: Case-Only|Time Perspective: Retrospective,XQonc-016,"Xinqiao Hospital of Chongqing, Chongqing, Chongqing, China",https://ClinicalTrials.gov/show/NCT04366024
NCT04551781,Short Term Low Dose Corticosteroids for Management of Post covid19 Pulmonary Fibrosis,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,SVU-MED-CHT019420861,"south-Vally University faculty of medicine, Qena, Kena, Egypt",https://ClinicalTrials.gov/show/NCT04551781
NCT04930770,Study About the Response to the Administration of a Third Dose of mRNA-1273 Vaccine (COVID-19 Vaccine Moderna) in Renal Transplants With Immunological Failure Initial to Vaccination,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,2021-002356-37,NA,https://ClinicalTrials.gov/show/NCT04930770
NCT04847544,"A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial to Evaluate the Safety, Tolerability, Efficacy, and Pharmacodynamics for the Treatment of COVID-19.","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",ADX-629-COVID-19-001,"Medical Research Center of Miami II, Inc., Miami, Florida, United States",https://ClinicalTrials.gov/show/NCT04847544
NCT04497246,"Psychological Impact, Mental Health and Sleep Disorder Among Patients Hospitalized and Health Care Workers During the 2019 Coronavirus Outbreak (COVID-19)",Observational Model: Cohort|Time Perspective: Prospective,CHU-COVIDIMPACT,"CHU Brugmann, Brussels, Belgium",https://ClinicalTrials.gov/show/NCT04497246
NCT04651400,"Observational, Retrospective Study to Evaluate Coagulation Changes and the Influence of Antithrombin III Treatment in Patients With Severe COVID-19 Infection",Observational Model: Cohort|Time Perspective: Retrospective,ATN01,"Octapharma Research Site, Innsbruck, Austria|Octapharma Research Site, Wien, Austria|Octapharma Research Site, Strasbourg, France|Octapharma Research Site, Aachen, Germany|Octapharma Research Site, Essen, Germany",https://ClinicalTrials.gov/show/NCT04651400
NCT04475120,Efficacy and Safety of Liposomal Lactoferrin in COVID-19 Patients With Mild-to-Moderate Disease and in COVID-19 Asymptomatic Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,4220,"University of Rome Tor Vergata, Rome, Italy",https://ClinicalTrials.gov/show/NCT04475120
NCT04441398,Efficacy and Safety of Nitazoxanide 600 mg to Treat Mild Ambulatory COVID-19 Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",NITFQM0720OR,NA,https://ClinicalTrials.gov/show/NCT04441398
NCT04884295,"Dose-Finding, Safety, and Efficacy Study of XVR011 Added to Standard of Care in Patients Hospitalised for COVID-19","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",EXEVIR0101|2020-005299-36,"Investigative Site, Ghent, Belgium|Investigative Site, Liège, Belgium|Investigative site, Mechelen, Belgium",https://ClinicalTrials.gov/show/NCT04884295
NCT04358029,Cardiac Arrhythmias In Patients With Coronavirus Disease (COVID-19),Observational Model: Cohort|Time Perspective: Other,GCO 20-0931,"Icahn School of Medicine at Mount Sinai, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04358029
NCT04486508,Intermediate-dose vs Standard Prophylactic Anticoagulation and Statin vs Placebo in ICU Patients With COVID-19,Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,99060,"Masih Daneshvari Hospital, Tehran, Iran, Islamic Republic of",https://ClinicalTrials.gov/show/NCT04486508
NCT04742946,Telerehabilitation in Covid-19 After Hospital Discharge,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,TRCovidAndalucía,"Facultad Ciencias de la Salud, Melilla, Spain",https://ClinicalTrials.gov/show/NCT04742946
NCT04900129,"Inhalation of Vapor With Medication (Diclofenac Sodium, Menthol, Methyl Salicylate and N-Acetyl Cysteine) Reduces Oxygen Need and Hospital Stay in COVID-19 Patients - A Case Control Study","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",SBMC Barisal 2020 1896,"HN Sarker, Barisal, Bangladesh",https://ClinicalTrials.gov/show/NCT04900129
NCT04416139,Mesenchymal Stem Cell for Acute Respiratory Distress Syndrome Due for COVID-19,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,SCI-3354-20-21-1,"Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico",https://ClinicalTrials.gov/show/NCT04416139
NCT04662671,"Phase I/II Randomized, Dose Escalation Study to Evaluate the Safety and Antiviral Activity of the RD-X19 Device in SARS-CoV-2 Infected Individuals With Uncomplicated COVID-19","Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",EB-P12-01,"Site 2, Miami, Florida, United States|Site 1, College Station, Texas, United States",https://ClinicalTrials.gov/show/NCT04662671
NCT04429334,Efficacy and Safety Study of Nangibotide in Patients With COVID-19 Receiving Ventilatory Support and Features of Systemic Inflammation.,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",MOT-C-204,"Clinique universitaire Saint-Luc, Brussels, Belgium|Ziekenhuis Oost-Limburg, Genk, Belgium|CHU Angers, Angers, France|Centre hospitalier Victor Dupouy, Argenteuil, France|Centre Hospitalier Germont et Gauthier, Bethune, France|CHU Dijon - Bourgogne - Hôpital François Mitterrand, Dijon, France|CHD Site la Roche sur Yon, les Oudairies, La Roche sur Yon, France|Centre hospitalier le Manas, Le Mans, France|Centre Hospitalier Universitaire Dupuytren, Limoges, France|Centre hospitalier de Melun, Melun, France|Hôpital Saint Eloi CHU Montpellier, Montpellier, France|Réanimation Médicale, Hôpital Central, Nancy, France|Hôpital Dieu - CHU Nanates, Nantes, France|Hôpital Cochin, Paris, France|Hôpital Civil - Nouvel Hôpital civil, Strasbourg, France|CHRU - Hôpital Bretonneau, Tours, France|Hôpital Franch-Comté Site Trevenans, Trevenans, France",https://ClinicalTrials.gov/show/NCT04429334
NCT04805892,"Open Label, Single-Center Study Utilizing BIOZEK COVID-19 Antigen Rapid Test.",Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,#Biozek-ARTC-US,"Mobile Covid Services LLC, Flushing, New York, United States",https://ClinicalTrials.gov/show/NCT04805892
NCT04356677,Study to Evaluate the Safety and Efficacy of VIRAZOLE® in Hospitalized Adult Participants With Respiratory Distress Due to COVID-19,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,BHC-RIB-5401-HC,NA,https://ClinicalTrials.gov/show/NCT04356677
NCT04646044,A Placebo Controlled Trial of Bempegaldesleukin (BEMPEG; NKTR-214) With Standard of Care in Patients With Mild COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",20-214-34,"A G A Clinical Trials - HyperCore - PPDS, Hialeah, Florida, United States|New Generation Medical Research, Hialeah, Florida, United States|Clinical Site Partners - Winter Park - HyperCore -PPDS, Winter Park, Florida, United States|SMS Clinical Research, LLC, Mesquite, Texas, United States",https://ClinicalTrials.gov/show/NCT04646044
NCT04407689,InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection FR BL Cohort,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",CLI107 COVID FR (ILIAD-7-FR),"University Hospital of Limoges, Limoges, France|Hôpital Edouard Herriot, Lyon, France|hopital Edouard Herriot, Lyon, France|Chr Orleans La Source, Orléans, France|hopital COCHIN, Paris, France|Chru Tours, Tours, France",https://ClinicalTrials.gov/show/NCT04407689
NCT04812327,Capturing Infectious COVID-19 Asymptomatic Cases in Singapore,Observational Model: Case-Only|Time Perspective: Prospective,SGP-21AsymVer-01,"Changi General Hospital, Singapore, Singapore",https://ClinicalTrials.gov/show/NCT04812327
NCT04386668,Let It Out (LIO) and COVID19: Testing an Online Emotional Disclosure-based Intervention During the COVID19 Pandemic,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Other",15281/003,"University College London, London, Kent, United Kingdom",https://ClinicalTrials.gov/show/NCT04386668
NCT04379076,InterLeukin-7 (CYT107) to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection UK Cohort,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",CLI107 COVID UK (ILIAD-7-UK),"Sandwell Birmingham Hospital, Birmingham, United Kingdom|Sandwell Birmingham Hospital, Birmingham, United Kingdom|Bradford Institute for Health Research, Bradford, United Kingdom|ST JAMES's UNIVERSITY HOSPITAL, Leeds, United Kingdom|Medway Maritime Hospital, London, United Kingdom|Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom|King'S College Hospital, London, United Kingdom|Wythenshawe Hospital/ Manchester Royal Infirmary, Manchester, United Kingdom|North Manchester General Hospital, Manchester, United Kingdom|Royal Victoria Infirmary and Freeman Hospital, Newcastle, United Kingdom|Royal Preston Hospital, Preston, United Kingdom|Sunderland Royal Hospital, Sunderland, United Kingdom|Watford General Hospital, Watford, United Kingdom",https://ClinicalTrials.gov/show/NCT04379076
NCT04423861,Efficacy and Safety of Nitazoxanide 600 mg BID Versus Placebo for the Treatment of Hospitalized Patients With COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",NITFQM0920OR-III,NA,https://ClinicalTrials.gov/show/NCT04423861
NCT04545541,Nebulised Heparin in Patients With Severe COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment",CHARTER meta-trial,"Frederick Health Hospital, Frederick, Maryland, United States",https://ClinicalTrials.gov/show/NCT04545541
NCT04885478,Professional's Health in Epidemiological Crisis Covid-19,Observational Model: Cohort|Time Perspective: Prospective,4R20-105,"Jordi Gol i Gurina Foundation, Mataró, Barcelona, Spain",https://ClinicalTrials.gov/show/NCT04885478
NCT04592510,"Impact of COVID-19 on Pediatric Dental Practice During First, Second And Third Wave.",Observational Model: Ecologic or Community|Time Perspective: Cross-Sectional,y66cyyg6,"Faculty of Oral and Dental Medicine, Cairo University, Cairo, Egypt",https://ClinicalTrials.gov/show/NCT04592510
NCT04577378,Efficacy and Safety of Drug Combination Therapy of Isotretinoin and Some Antifungal Drugs as A Potential Aerosol Therapy for COVID-19 : An Innovative Therapeutic Approach COVID-19,Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,Isotretinoin,"Kafr El-sheikh University, Cairo, Kafr El-sheikh, Egypt",https://ClinicalTrials.gov/show/NCT04577378
NCT04752085,Prognosis and Course of COVID-19 Infection in Hospitalised Patients,Observational Model: Cohort|Time Perspective: Prospective,3月21日,"University Hospital #1, Moscow, Russian Federation|University Hospital #4, Moscow, Russian Federation",https://ClinicalTrials.gov/show/NCT04752085
NCT04568876,Micronized and Ultramicronized Palmitoylethanolamide in COVID-19 Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,NORM_MPS-COVID|NORM_MPS_11,"Anestesia e Rianimazione Azienda Ospedaliera Universitaria Sant'Andrea, Roma, Italy",https://ClinicalTrials.gov/show/NCT04568876
NCT04551898,Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Neutralizing Antibody BGB-DXP593 in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",BGB-DXP593-102,"Elixia, Hollywood, California, United States|Midland Florida Clinical Research Center, LLC, DeLand, Florida, United States|Baptist Medical Center, Jacksonville, Florida, United States|Homestead Associates in Research Inc., Miami, Florida, United States|Medical Research Center of Miami II, Inc., Miami, Florida, United States|US Associates in Research, Miami, Florida, United States|Continental Research Network, Miami, Florida, United States|Omega Research Orlando, Orlando, Florida, United States|Revival Research Institute, LLC., Dearborn, Michigan, United States|New Phase Research & Development, Knoxville, Tennessee, United States|Amarillo Center for Clinical Research, Amarillo, Texas, United States|PanAmerican Clinical Research, Brownsville, Texas, United States|The Royal Prince Alfred Hospital, Camperdown, Australia|Fundação Universidade de Caxias do Sul - Instituto de Pesquisas em Saúde, Petropolis, Caxias Do Sul, Brazil|Hospital das Clínicas da Faculdade de Medicina de Botucatu, Botucatu, Brazil|Irmandade da Santa Casa de Misericórdia de Porto Alegre, Porto Alegre, Brazil|Hospital Universitáro de Santa Maria / UFSM, Santa Maria, Brazil|CMPC Pesquisa Clinica, Sorocaba, Brazil|Hospital Cardiologica Aguascalientes, Aguascalientes, Mexico|JM Research, Cuernavaca, Mexico|Hospital General Dr. Manuel Gea Gonzalez, Mexico, Mexico|Iecsi S.C., Monterrey, Mexico|Clinica de Enfermedades Cronicas y de Procedimientos Especiales, S.C., Morelia, Mexico|Kohler & Milstein Research, Mérida, Mexico|PanAmerican Clinical Research, Querétaro, Mexico|East Rand Research T/A Worthwhile Clinical Trials, Benoni, South Africa|TASK, Cape Town, South Africa|TREAD Research CC, Cape Town, South Africa|Langeberg Clinical Trials, Cape Town, South Africa|Wits Clinical Research, Soweto, South Africa",https://ClinicalTrials.gov/show/NCT04551898
NCT04952805,Study to Select the Dose and Evaluate Safety and Efficacy of Monoclonal Antibody in Adult With Recently Diagnosed Asymptomatic to Moderately Severe COVID-19.,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",A0001B,"IRCCS INMI Lazzaro Spallanzani - Istituto nazionale Malattie Infettive, Roma, RM, Italy|Az. Ospedaliera San Giuseppe Moscati, Avellino, Italy|Azienda Ospedaliero-Universitaria Careggi di Firenze, Firenze, Italy|A.O. Ospedali Riuniti di Foggia - Università degli Studi di Fog, Foggia, Italy|Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Milano, Italy|Az. Ospedaliera dei Colli - P.O. ""D. Cotugno"", Napoli, Italy|Azienda Ospedaliero-Universitaria di Parma, Parma, Italy|Fondazione IRCCS Policlinico San Matteo di Pavia, Pavia, Italy|Azienda USL Ospedale ""Guglielmo da Saliceto"", Piacenza, Italy|A.O.U. Pisana - Ospedale di Cisanello, Pisa, Italy|Policlinico Santa Maria alle Scotte - Università di Siena, Siena, Italy|Ospedale di Cattinara, Trieste, Italy|ASL di Vercelli - Ospedale Sant'Andrea, Vercelli, Italy|A.O.U. Integrata di Verona, Verona, Italy",https://ClinicalTrials.gov/show/NCT04952805
NCT04338568,Screening COVID-19 by Point-of-care Lung Ultrasound: a Validation Study,Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,CTU2020032,"Ziekenhuis Oost Limburg, Genk, Limburg, Belgium",https://ClinicalTrials.gov/show/NCT04338568
NCT04352764,ANTIBODY BASED TESTS FOR SARSCoV-2 COVID-19) - Evaluation of Patients and Healthcare Providers in the Confines of Healthcare Settings,Observational Model: Case-Control|Time Perspective: Prospective,TCAI_COVID-19,"St. David's Medical Center, Austin, Texas, United States",https://ClinicalTrials.gov/show/NCT04352764
NCT04445220,A Study of Cell Therapy in COVID-19 Subjects With Acute Kidney Injury Who Are Receiving Renal Replacement Therapy,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",SBI-101-02,"University of New Mexico School of Medicine, Albuquerque, New Mexico, United States",https://ClinicalTrials.gov/show/NCT04445220
NCT04377997,Safety and Efficacy of Therapeutic Anticoagulation on Clinical Outcomes in Hospitalized Patients With COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2020P001136,NA,https://ClinicalTrials.gov/show/NCT04377997
NCT04275245,Clinical Study of Anti-CD147 Humanized Meplazumab for Injection to Treat With 2019-nCoV Pneumonia,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,20200101,"Tangdu Hospital, Xi'an, Shaanxi, China",https://ClinicalTrials.gov/show/NCT04275245
NCT04760743,Safety and Immunogenicity of a SARS-CoV-2 Vaccine (NBP2001) in Healthy Adults (COVID-19),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention",NBP2001_001,"Seoul National University Bundang Hospital, Seongnam-si, Bundang, Korea, Republic of|Seoul National University Hospital, Seoul, Korea, Republic of",https://ClinicalTrials.gov/show/NCT04760743
NCT04930120,Assessing the Impact of COVID-19 Patients Long Distance Transfers Between Intensive Care Units,Observational Model: Cohort|Time Perspective: Retrospective,20 CO 015 CZ,"EHESP, Rennes, France",https://ClinicalTrials.gov/show/NCT04930120
NCT04375709,Quality of Life and Physical Performance After Novel Coronavirus Infection (COVID-19);,Observational Model: Cohort|Time Perspective: Prospective,2020_00899 / COV19_2020,"Kantonsspital Winterthur, Winterthur, Zürich, Switzerland",https://ClinicalTrials.gov/show/NCT04375709
NCT04445493,EPISODE-PS-COVID: hEad Pulse for Ischemic StrOke DEtection Prehospital Study During the COVID-19 Pandemic ( EPISODEPSCOVID ),Observational Model: Cohort|Time Perspective: Prospective,EPISODE-PH-COVID,"Wayne State University, Detroit, Michigan, United States",https://ClinicalTrials.gov/show/NCT04445493
NCT04474288,The COVID-19 PUI Reality Check (CPRC) Study,Observational Model: Case-Control|Time Perspective: Other,1613182,"Bassett Medical Center, Cooperstown, New York, United States",https://ClinicalTrials.gov/show/NCT04474288
NCT04886362,Ivermectina Colombia (IVERCOL),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",IVERCOL01,NA,https://ClinicalTrials.gov/show/NCT04886362
NCT04445610,Measles Vaccine: Is There a Protective Role in COVID 19 Pandemic?,Observational Model: Case-Only|Time Perspective: Prospective,FMASU P31a/ 2020,"Faculty of Medicine Ain Shams University Research Institute- Clinical Research Center, Cairo, Non-US, Egypt",https://ClinicalTrials.gov/show/NCT04445610
NCT04348474,Efficacy and Safety of Hydroxychloroquine and Azithromycin for the Treatment of Ambulatory Patients With Mild COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,HIAPRE0420OR,"Prevent Senior Private Operadora de Saúde LTDA., São Paulo, Brazil",https://ClinicalTrials.gov/show/NCT04348474
NCT04887246,Monitoring the Effectiveness and Safety of COVID-19 Vaccines at National University of Colombia,Observational Model: Other|Time Perspective: Prospective,52932,"Universidad Nacional de Colombia, Bogotá, Colombia",https://ClinicalTrials.gov/show/NCT04887246
NCT04579289,Managerial and Environmental Risk for COVID 19 in French Long Term Care Institutions,Observational Model: Ecologic or Community|Time Perspective: Retrospective,35RC20_8898_REMPAR-EHPAD,"Centre Hospitalier Universitaire de Rennes, Rennes, France",https://ClinicalTrials.gov/show/NCT04579289
NCT04380714,Changes in the Consumption of Psychoactive Substances During Containment Linked to COVID-19,Observational Model: Ecologic or Community|Time Perspective: Cross-Sectional,RECHMPL20_0273,"UH Montpellier, Montpellier, France",https://ClinicalTrials.gov/show/NCT04380714
NCT04583410,Efficacy of Nicotine in Preventing COVID-19 Infection,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",APHP200538|2020-003722-23,"Centre Hospitalier Gonesse, Gonesse, France|Groupe Hospitalier de la Région de Mulhouse Sud Alsace, Mulhouse, France|Hôpital Pitié Salpêtrière - Service de Médecine Interne, Paris, France|Hôpital Sainte-Anne, Paris, France",https://ClinicalTrials.gov/show/NCT04583410
NCT04784689,Host Immune Response to Novel RNA COVID-19 Vaccination,Observational Model: Cohort|Time Perspective: Prospective,CTMS 21-0012,"Mays Cancer Center, UT Health San Antonio, San Antonio, Texas, United States",https://ClinicalTrials.gov/show/NCT04784689
NCT04894266,An Open-Label Study of Apabetalone in Covid Infection,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,RVX222-CS-023,"Mike Sweeney, MD, San Francisco, California, United States",https://ClinicalTrials.gov/show/NCT04894266
NCT04537208,Study of Recombinant Protein Vaccine Formulations Against COVID-19 in Healthy Adults 18 Years of Age and Older,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",VAT00001|U1111-1250-4757,"Investigational Site Number 8400004, Birmingham, Alabama, United States|Investigational Site Number 8400012, Rolling Hills Estates, California, United States|Investigational Site Number 8400011, Hollywood, Florida, United States|Investigational Site Number 8400019, Melbourne, Florida, United States|Investigational Site Number 8400016, Boston, Massachusetts, United States|Investigational Site Number 8400002, Omaha, Nebraska, United States|Investigational Site Number 8400001, Rochester, New York, United States|Investigational Site Number 8400007, Rochester, New York, United States|Investigational Site Number 8400008, Cleveland, Ohio, United States|Investigational Site Number 8400003, Philadelphia, Pennsylvania, United States|Investigational Site Number 8400014, Mount Pleasant, South Carolina, United States",https://ClinicalTrials.gov/show/NCT04537208
NCT04898205,Cardiopulmonary Rehabilitation in COVID-19 Longhaulers,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,PLM UD 2021,"Post-COVID Rehabilitation and Recovery Clinic at H&D Physical Therapy, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04898205
NCT04396067,Aerosol Combination Therapy of All-trans Retinoic Acid and Isotretinoin as A Novel Treatment for Inducing Neutralizing Antibodies in COVID -19 Infected Patients Better Than Vaccine : An Innovative Treatment,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,COVID-19,NA,https://ClinicalTrials.gov/show/NCT04396067
NCT04534712,Lymphocyte - Monocyte Ratio As An Independent Predictor For Progression Of Illness In Patients With Covid-19,Observational Model: Cohort|Time Perspective: Prospective,yet to be assigned,"Sir Ganga Ram Hospital, New delhi, Delhi, India",https://ClinicalTrials.gov/show/NCT04534712
NCT04751669,Efficacy of a Dietary Supplementation in Reducing Hospital Admissions for COVID-19. Randomized Clinical Trial,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",CoVIT Clinical Trial,"Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain",https://ClinicalTrials.gov/show/NCT04751669
NCT04922957,"A Phase 2b Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study, Evaluating Efficacy and Safety of Allocetra-OTS in Patients With Severe or Critical COVID-19 With Associated Acute Respiratory Distress Syndrome (ARDS)","Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",ENX-CL-03-002,NA,https://ClinicalTrials.gov/show/NCT04922957
NCT04492358,"Treatment for Moderate/Severe COVID-19 in a Fragile and Vulnerable Population, Admitted to a Geriatric Hospital Unit or in a Transicional Care Center",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2020-002462-14,"Centre Blauclínic Dolors Aleu, Barcelona, Spain|Hospital Clinic, Department of Internal Medicine, Barcelona, Spain|Clinica Sant Antoni, Barcelona, Spain",https://ClinicalTrials.gov/show/NCT04492358
NCT04678700,Implementation of a Respiratory Physiotherapy Program in Post COVID-19 Patients Through Tele-assistance,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,20/139,"Marta de la plaza, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04678700
NCT04799600,The Effect of the Severity of COVID-19 Disease on the Incidence of Acute Renal Failure in ICU,Observational Model: Cohort|Time Perspective: Cross-Sectional,E1-20-1443,"Ankara City Hospital, Ankara, Turkey",https://ClinicalTrials.gov/show/NCT04799600
NCT04438837,Hydroxychloroquine Post-Exposure Prophylaxis for Coronavirus Disease (COVID-19) Among Health-Care Workers,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,0193-20-RMB CTIL,"Rambam Health Care Campus, Haifa, Israel",https://ClinicalTrials.gov/show/NCT04438837
NCT04302519,Novel Coronavirus Induced Severe Pneumonia Treated by Dental Pulp Mesenchymal Stem Cells,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,KT005HB001,NA,https://ClinicalTrials.gov/show/NCT04302519
NCT04603677,Northern Colorado COVID-19 Biobank,Observational Model: Cohort|Time Perspective: Prospective,20-10063H,"Colorado State University, Fort Collins, Colorado, United States|Poudre Valley Hospital, UCHealth, Fort Collins, Colorado, United States|Greeley Hospital, UCHealth, Greeley, Colorado, United States|Medical Center of the Rockies, UCHealth, Loveland, Colorado, United States",https://ClinicalTrials.gov/show/NCT04603677
NCT04900337,"Safety, Tolerability and Efficacy of Amorphous Calcium Carbonate (ACC) Compared to Placebo and Best Available Care (BAT), for the Treatment of Moderate to Severe COVID-19 Patients.","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",AMCS-COVID-001,"Shamir MC, Be'er Ya'aqov, Israel|Tel-Aviv Sourasky MC, Tel Aviv, Israel|Ziv MC, Tsefat, Israel",https://ClinicalTrials.gov/show/NCT04900337
NCT04482361,SERO-EPIDEMIOLOGY OF SARS-COV2 INFECTION IN THE AUTONOMOUS CITY OF BUENOS AIRES,Observational Model: Ecologic or Community|Time Perspective: Prospective,SEROEPIDEMIOLOGY COVID IN CABA,"Ministerio de Salud de la Ciudad Autónoma de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina",https://ClinicalTrials.gov/show/NCT04482361
NCT04349202,Beaumont Health Large-scale Automated Serologic Testing for COVID-19,Observational Model: Cohort|Time Perspective: Prospective,2020-134,"Beaumont Health System, Royal Oak, Michigan, United States|Beaumont Health, Royal Oak, Michigan, United States",https://ClinicalTrials.gov/show/NCT04349202
NCT04403880,Characterizing SARS-CoV-2-specific Immunity in Individuals Who Have Recovered From COVID-19,Observational Model: Cohort|Time Perspective: Other,HVTN 405/HPTN 1901|5UM1AI068614-14,"Alabama Vaccine CRS, Birmingham, Alabama, United States|UCLA CARE Center CRS, Los Angeles, California, United States|Bridge HIV CRS, San Francisco, California, United States|George Washington University CRS, Washington, District of Columbia, United States|The Ponce de Leon Center CRS, Atlanta, Georgia, United States|The Hope Clinic of the Emory Vaccine Center CRS, Decatur, Georgia, United States|Adolescent & Young Adult Research at The CORE Center (AYAR at CORE), Chicago, Illinois, United States|New Orleans Adolescent Trials Unit CRS, New Orleans, Louisiana, United States|Johns Hopkins University CRS, Baltimore, Maryland, United States|Brigham and Women's Hospital Vaccine CRS (BWH VCRS), Boston, Massachusetts, United States|Fenway Health Clinical Research Site CRS, Boston, Massachusetts, United States|New Jersey Medical School Clinical Research Center CRS, Newark, New Jersey, United States|Bronx Prevention Research Center CRS, Bronx, New York, United States|Harlem Prevention Center CRS, New York, New York, United States|Columbia P&S CRS, New York, New York, United States|New York Blood Center CRS, New York, New York, United States|University of Rochester Vaccines to Prevent HIV Infection CRS, Rochester, New York, United States|Chapel Hill CRS, Chapel Hill, North Carolina, United States|Penn Prevention CRS, Philadelphia, Pennsylvania, United States|Vanderbilt Vaccine CRS, Nashville, Tennessee, United States|Seattle Vaccine and Prevention CRS, Seattle, Washington, United States|Malawi CRS, Lilongwe, Malawi|CITBM - UNIDEC, Centro de Investigaciones Tecnológicas, Biomédicas y Medioambientales CRS, Bellavista, Callao, Peru|San Miguel CRS, San Miguel, Lima, Peru|Asociacion Civil Selva Amazonica (ACSA) CRS, Iquitos, Maynas, Peru|Via Libra CRS, Lima, Peru|Barranco CRS, Lima, Peru|Josha Research CRS, Bloemfontein, South Africa|Emavundleni CRS, Cape Town, South Africa|Groote Schuur HIV CRS, Cape Town, South Africa|Khayelitsha CRS / (CIDRI UCT), Cape Town, South Africa|Masiphumelele Clinical Research Site (MASI) CRS, Cape Town, South Africa|Chatsworth CRS, Chatsworth, South Africa|Botha's Hill CRS, Durban, South Africa|CAPRISA eThekwini CRS, Durban, South Africa|Vulindlela CRS, Durban, South Africa|Isipingo CRS, Isipingo, South Africa|Kliptown Soweto CRS, Johannesburg, South Africa|Soweto HVTN CRS, Johannesburg, South Africa|Aurum Institute Klerksdorp CRS, Klerksdorp, South Africa|Qhakaza Mbokodo Research Clinic CRS, Ladysmith, South Africa|Nelson Mandela Academic Research Unit CRS, Mthatha, South Africa|Synexus Stanza Clinical Research Centre CRS, Pretoria, South Africa|Rustenburg CRS, Rustenburg, South Africa|Setshaba Research Centre CRS, Soshanguve, South Africa|Tembisa Clinic 4 CRS, Tembisa, South Africa|The Aurum Institute Tembisa Clinical Research Centre CRS, Tembisa, South Africa|Tongaat CRS, Tongaat, South Africa|Verulam CRS, Verulam, South Africa|Matero Reference Clinic CRS, Lusaka, Zambia|St Mary's CRS, Chitungwiza, Zimbabwe|Zengeza CRS, Chitungwiza, Zimbabwe|Seke South CRS, Harare, Zimbabwe",https://ClinicalTrials.gov/show/NCT04403880
NCT04907994,Containment Impact on Primary Care & Adverse Events Unrelated to COVID-19 in Older Patients and/or With Chronic Diseases,Observational Model: Cohort|Time Perspective: Retrospective,APHP201045,"Assistance Publique Hôpitaux de Paris - CHU Henri Mondor, Créteil, France",https://ClinicalTrials.gov/show/NCT04907994
NCT04451317,Physical Activity Following the Containment Period Imposed by the COVID-19 Pandemic in Patients,Observational Model: Case-Control|Time Perspective: Prospective,RC31/20/0203,"CHU Toulouse, Toulouse, France",https://ClinicalTrials.gov/show/NCT04451317
NCT04854837,Safety of Remdesivir Treatment in COVID-19 Patients Requiring Hemodialysis,Observational Model: Case-Control|Time Perspective: Prospective,REM-HD,"Semmelweis University - Department of Internal Medicine and Oncology, Budapest, Hungary",https://ClinicalTrials.gov/show/NCT04854837
NCT04563156,Follow-up and Rehabilitation of Survivors of Severe Coronavirus Disease 2019 (COVID-19) Infection,Observational Model: Cohort|Time Perspective: Prospective,4047553,"Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo-HCFMUSP, São Paulo, Brazil",https://ClinicalTrials.gov/show/NCT04563156
NCT04519125,Daily Regimen of Tenofovir/Emtricitabine as Prevention for COVID-19 in Health Care Personnel in Colombia,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention",2020 /143|77389,NA,https://ClinicalTrials.gov/show/NCT04519125
NCT04622826,plasmApuane CoV-2 : Efficacy and Safety of Immune Covid-19 Plasma in Covid-19 Pneumonia in Non ITU Patients,Allocation: N/A|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,ATNONordOvest,"Ospedale delle Apuane, Massa, Toscana, Italy",https://ClinicalTrials.gov/show/NCT04622826
NCT04535063,Convalescent Plasma as Potential Therapy for Severe COVID-19 Pneumonia,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,RValentini,"Centro de Educación Médica e Investigaciones Clínicas, Buenos Aires, Argentina",https://ClinicalTrials.gov/show/NCT04535063
NCT04390061,TOFAcitinib Plus Hydroxycloroquine vs Hydroxycloroquine in Patients With COVID-19 Interstitial Pneumonia,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2020-002035-30,NA,https://ClinicalTrials.gov/show/NCT04390061
NCT04528901,Study of seroPREvalence Vis-à-vis SARS-CoV2 and Correlation With Clinical Forms of COVID-19 in Patients Followed in Pneumology in the Cluster Area of the Grand-Est Region (Strasbourg University Hospital),Observational Model: Cohort|Time Perspective: Prospective,7879,"Les Hôpitaux Universitaires de Strasbourg, Strasbourg, Bas-Rhin, France",https://ClinicalTrials.gov/show/NCT04528901
NCT04750343,Safety and Immunogenicity Study of SARS-CoV-2 Nanoparticle Vaccine (GBP510) Adjuvanted With or Without AS03 (COVID-19),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",GBP510_002,"Korea University Ansan Hospital, Ansan, Korea, Republic of|Dong-A University Hospital, Busan, Korea, Republic of|Kyungpook National University Chilgok Hospital, Daegu, Korea, Republic of|Kyungpook National University Hospital, Daegu, Korea, Republic of|Chonnam National University Hospital, Gwangju, Korea, Republic of|Gachon University Gil Medical Center, Incheon, Korea, Republic of|Inha University Hospital, Incheon, Korea, Republic of|Korea University Anam Hospital, Seongnam-si, Korea, Republic of|Ewha Womans University Medical Center, Seoul, Korea, Republic of|Hallym University Medical Center, Seoul, Korea, Republic of|Korea University Guro Hospital, Seoul, Korea, Republic of|Severance Hospital, Seoul, Korea, Republic of|Ajou University Hospital, Suwon, Korea, Republic of|Wonju Severance Christian Hospital, Wonju, Korea, Republic of",https://ClinicalTrials.gov/show/NCT04750343
NCT04816682,Silymarin in COVID-19 Patients Admitted to Hospital With Elevated Liver Enzymes,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,SIL-COVINT-21,"F.D.Roosevelt Teaching Hospital, Banska Bystrica, Slovakia|University Hospital Bratislava, Bratislava, Slovakia",https://ClinicalTrials.gov/show/NCT04816682
NCT04350580,Polyvalent Immunoglobulin in COVID-19 Related ARds,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment",D20-P013|2020-001570-30,"CHU Sud Amiens, Amiens, France|CHU Angers, Angers, France|Service de réanimation polyvalente, rond point de Girac, Angoulême, France|CH Aulnay, Aulnay-sous-Bois, France|Centre hospitalier de Béthune, Beuvry, France|Hopital Avicenne, Bobigny, France|CH Chalons en champagne, Chalons en champagne, France|CH-Nord-Ardennes, Charleville-Mézières, France|Hopital d'instruction des armées Percy, Clamart, France|Centre Hospitalier de Dieppe, Dieppe, France|Hôpital Raymond Poincaré, Garches, France|CHU de Grenoble, Grenoble, France|Grand hopital de l'est Francilien - site de Jossigny, Jossigny, France|Hopital Robert Boulin, Libourne, France|Pôle de Médecine intensive/réanimation Hôpital Salengro, CHRU de Lille, Lille, France|Groupement Hospitalier Edouar Herriot, Lyon, France|Hôpital de la Croix Rousse Novembre 2019, Lyon, France|Hopital Jacques Cartier, Massy, France|Hopital Jacques Monod, Montivilliers, France|Service de Médecine Intensive-Réanimation, CHU, Nantes, France|CHR Orléans, Orléans, France|Centre Hospitalier Sainte-Anne, Paris, France|CHU Lariboisiere, Paris, France|CHU Pitié Salpétriere Service de réanimation chirurgicale, Paris, France|CHU Saint Antoine, Paris, France|Fondation ophtalmologique Rotschild, Paris, France|Hôpital Paris Saint-Joseph, Paris, France|Hôpital Pitié Salpêtrière, Paris, France|Institut Mutualiste Montsouris, Paris, France|CHU Robert Débré, Reims, France|CH Poissy, Saint-Germain-en-Laye, France|Groupe hospitalier Saint Vincent, Strasbourg, France|Hôpital de Hautepierre, Strasbourg, France|Hopital de Tarbes, Tarbes, France|Hôpital Nord Franche-Comté, Trévenans, France|CH Valenciennes, Valenciennes, France|Chu Nancy - Brabois, Vandœuvre-lès-Nancy, France|Hopital de Vannes, Vannes, France|Institut Gustave Roussy, Villejuif, France|CH Etampes, Étampes, France",https://ClinicalTrials.gov/show/NCT04350580
NCT04700163,RU Anti-SARS-CoV-2 (COVID-19) mAbs in Healthy Volunteers,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,RUCOV1|CGA-1015,"The Rockefeller University, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04700163
NCT04435275,Virtual Assistant for COVID-19 PPE,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Other,20-5399,"University Health Network, Toronto, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04435275
NCT04742738,Safety and Immunogenicity Study of SARS-CoV-2 Nanoparticle Vaccine (GBP510) Adjuvanted With Aluminum Hydroxide (COVID-19),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",GBP510_001,"Korea University Ansan Hospital, Ansan, Korea, Republic of|Dong-A University Hospital, Busan, Korea, Republic of|Kyungpook National University Chilgok Hospital, Daegu, Korea, Republic of|Kyungpook National University Hospital, Daegu, Korea, Republic of|Chonnam National University Hospital, Gwangju, Korea, Republic of|Gachon University Gil Medical Center, Incheon, Korea, Republic of|Inha University Hospital, Incheon, Korea, Republic of|Ewha Womans University Medical Center, Seoul, Korea, Republic of|Hallym University Medical Center, Seoul, Korea, Republic of|Korea University Anam Hospital, Seoul, Korea, Republic of|Korea University Guro Hospital, Seoul, Korea, Republic of|Ajou University Hospital, Suwon, Korea, Republic of",https://ClinicalTrials.gov/show/NCT04742738
NCT04537572,A Comparison of Sample Collection Methods for SARS-COV-2 Antibody Testing,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,R2020-1002,NA,https://ClinicalTrials.gov/show/NCT04537572
NCT04724538,Inhalation Low Dose Radionuclide Therapy in Treatment COVID-19,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,RNT COVID-19,"P. Hertsen Moscow Oncology Research Institute, Moscow, Russian Federation",https://ClinicalTrials.gov/show/NCT04724538
NCT04898738,"Prospective COVID-19 Cohort Study, Dominican Republic",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,2021p001294,NA,https://ClinicalTrials.gov/show/NCT04898738
NCT04674644,Analysing the Psychosocial Effects of COVID-19 Pandemic on Dental Professionals Using the Turkish Version of the Fear of COVID-19 and Coronavirus Anxiety Scales,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,355,"Suleyman Demirel University Faculty of Dentistry Pediatric Dentistry Department, Isparta, Turkey",https://ClinicalTrials.gov/show/NCT04674644
NCT04481685,"A Trial of Aclaris Therapeutics, Inc. (ATI)-450 in Patients With Moderate-severe Novel Coronavirus Disease 2019 (COVID-19)","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment",IIT-2020-ATI-450-COVID-19,"The University of Kansas Medical Center, Kansas City, Kansas, United States",https://ClinicalTrials.gov/show/NCT04481685
NCT04895371,Tele-Physiotherapy After COVID-19 Hospitalization,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,99-2-246-49892,"Imam Khomeini Hospital Complex, Tehran, Iran, Islamic Republic of",https://ClinicalTrials.gov/show/NCT04895371
NCT04333589,Corona Virus Disease 2019 Patients Whose Nucleic Acids Changed From Negative to Positive,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2020 research 112,"The Second People's Hospital of Fuyang, Fuyang, Anhui, China|Ezhou Hospital of Traditional Chinese Medicine, Ezhou, Hubei, China|Ezhou Central Hospital, Wuhan, Hubei, China|Huoshenshan Hospital of Wuhan, Wuhan, Hubei, China|Jinyintan Hospital of Wuhan, Wuhan, Hubei, China|Wuhan Pulmonary Hospital, Wuhan, Hubei, China|Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China|Wenzhou Medical University Affiliated First Hospital, Wenzhou, Zhejiang, China",https://ClinicalTrials.gov/show/NCT04333589
NCT03348670,Discovery Stage (Proof-of-concept) COVID-19 Antigen Presentation Therapeutic Biologics (COVID-19--AP),Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,BLA761214|FWA00015357|IRB00009424|IORG0007849|IND153116|NDA215432,"Medicine Invention Design, Inc. (MIDI) - c/o - MIDINC Clinical Investigator Working Site, North Bethesda, Maryland, United States",https://ClinicalTrials.gov/show/NCT03348670
NCT04442165,Characterising Transmission of SARS-CoV-2 in a Peri-urban Population in Mozambique,Observational Model: Cohort|Time Perspective: Prospective,AfriCoVER,"INS, Maputo, Mozambique",https://ClinicalTrials.gov/show/NCT04442165
NCT04762680,Study of Recombinant Protein Vaccines With Adjuvant as a Primary Series and as a Booster Dose Against COVID-19 in Adults 18 Years of Age and Older,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",VAT00002|U1111-1251-4616,"Investigational Site Number :8400251, Chandler, Arizona, United States|Investigational Site Number :8400220, Los Angeles, California, United States|Investigational Site Number :8400094, Rolling Hills Estates, California, United States|Investigational Site Number :8400173, San Diego, California, United States|Investigational Site Number :8400239, New Haven, Connecticut, United States|Investigational Site Number :8400212, Washington, District of Columbia, United States|Investigational Site Number :8400089, Hollywood, Florida, United States|Investigational Site Number :8400057, Melbourne, Florida, United States|Investigational Site Number :8400179, Orlando, Florida, United States|Investigational Site Number :8400201, Decatur, Georgia, United States|Investigational Site Number :8400187, Peoria, Illinois, United States|Investigational Site Number :8400048, Rockville, Maryland, United States|Investigational Site Number :8400199, Boston, Massachusetts, United States|Investigational Site Number :8400030, Omaha, Nebraska, United States|Investigational Site Number :8400230, New York, New York, United States|Investigational Site Number :8400203, New York, New York, United States|Investigational Site Number :8400207, Rochester, New York, United States|Investigational Site Number :8400233, Pittsburgh, Pennsylvania, United States|Investigational Site Number :8400097, North Charleston, South Carolina, United States|Investigational Site Number :8400191, Austin, Texas, United States|Investigational Site Number :3400002, Municipio Del Distrito Central, Honduras|Investigational Site Number :3400001, San Pedro Sula, Honduras|Investigational Site Number :5910001, Panamá, Panama",https://ClinicalTrials.gov/show/NCT04762680
NCT04495816,COVID-19 Anosmia Study,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",GCO 20-1132,"Mount Sinai Hospital, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04495816
NCT04448756,Study of M5049 in Participants With COVID-19 Pneumonia (ANEMONE),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",MS200569_0026|2020-002248-22,"LAC-USC Medical Center, Los Angeles, California, United States|Sharp Chula Vista Medical Center, San Diego, California, United States|Henry Ford Medical Center, Detroit, Michigan, United States|Holy Name Hospital - Dept of Multiple Sclerosis Comp Care Center, Teaneck, New Jersey, United States|Christus Spohn Hospital Corpus Christi-Memorial, Corpus Christi, Texas, United States|Santa Casa de Misericórdia de Belo Horizonte, Belo Horizonte, Brazil|Hospital Dia do Pulmão, Blumenau, Brazil|Hospital São José - Sociedade Literária e Caritativa Santo Agostinho, Criciúma, Brazil|Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil|HMCG - Hospital e Maternidade Dr. Christovão da Gama, Santo André, Brazil|Pesquisare, Santo André, Brazil|Hospital Leforte Morumbi, Sao Paulo, Brazil|Hospital Alemão Oswaldo Cruz, São Paulo, Brazil|Hospital Bandeirantes / Hospital Leforte Liberdade, São Paulo, Brazil|Instituto de Infectologia Emílio Ribas, São Paulo, Brazil|Manila Doctors Hospital, Manila, Philippines|Medical Center Manila - Medicine, Manila, Philippines|East Avenue Medical Center, Quezon City, Philippines|Lung Center of the Philippines - Medicine, Quezon, Philippines|Quirino Memorial Medical Center, Quezon, Philippines|Veterans Memorial Medical Center, Quezon, Philippines",https://ClinicalTrials.gov/show/NCT04448756
NCT04400032,Cellular Immuno-Therapy for COVID-19 Acute Respiratory Distress Syndrome,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,20200243-01H,"The Ottawa Hospital, Ottawa, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04400032
NCT04695457,Correlation Between the Incidence of COVID-19 in Nursing-homes and the Profile of Nursing Homes in the French Alps,Observational Model: Cohort|Time Perspective: Retrospective,20-13,"Ch Annecy Genevois, Pringy, France",https://ClinicalTrials.gov/show/NCT04695457
NCT04569227,Prevention of COVID-19 Infection to Severe Pneumonia or ARDS,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",EC-18-204,"Lincoln Medical Center, Bronx, New York, United States|Kent County Memorial Hospital, Warwick, Rhode Island, United States",https://ClinicalTrials.gov/show/NCT04569227
NCT04900259,The Effect of the COVID-19 Pandemic on Primary Bladder Cancer Presentations,Observational Model: Case-Control|Time Perspective: Retrospective,COVIDBC2021,"Ankara Training and Research Hospital, Ankara, Altindag, Turkey",https://ClinicalTrials.gov/show/NCT04900259
NCT04447222,Impact of the COVID-19 Pandemic and HRQOL in Cancer Patients and Survivors,Observational Model: Cohort|Time Perspective: Cross-Sectional,2020-0425|NCI-2020-03900|P30CA016672,"M D Anderson Cancer Center, Houston, Texas, United States",https://ClinicalTrials.gov/show/NCT04447222
NCT04366141,COVID-19 (Coronavirus Disease 2019) Intubation Barrier Box,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,H20-01270,"Providence Health Care, Vancouver, British Columbia, Canada",https://ClinicalTrials.gov/show/NCT04366141
NCT04416438,COVID-19 Epidemic and Patients With Myeloproliferative Neoplasias,Observational Model: Cohort|Time Perspective: Retrospective,COVIM,"Paris Saint Louis, Paris, France",https://ClinicalTrials.gov/show/NCT04416438
NCT04554433,New Treatment for COVID-19 Using Ethanol Vapor Inhalation .,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,20.08.79,NA,https://ClinicalTrials.gov/show/NCT04554433
NCT04357327,Rapid Salivary Test to Detect SARS-CoV-2 (COVID-19),Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Diagnostic,68/2020,"ASST dei Sette Laghi, Varese, VA, Italy",https://ClinicalTrials.gov/show/NCT04357327
NCT04564716,"Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19 in Belarus","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention",04-Gam-COVID-Vac-2020-RB,"Health Institution ""14th Central Regional Polyclinic of the Partisan district of Minsk"", Minsk, Belarus|Health Institution ""19th Central Regional Polyclinic of the Pervomaysk district of Minsk"", Minsk, Belarus|Health Institution ""1st Central Regional Clinical Polyclinic of the Central district of Minsk"", Minsk, Belarus|Health Institution ""28th Regional Polyclinic of Minsk"", Minsk, Belarus|Health Institution ""4th City Polyclinic of Minsk"", Minsk, Belarus|Health Institution ""5th City Clinical Polyclinic of Minsk"", Minsk, Belarus|Health Institution ""Minsk Order of the Red Banner of Labor Regional Clinical Hospital, Minsk, Belarus|Health Institution ""Vitebsk Regional Clinical Hospital"", Vitebsk, Belarus",https://ClinicalTrials.gov/show/NCT04564716
NCT04898946,Serological Response to mRNA and Inactivated COVID-19 Vaccine in Health Care Workers in Hong Kong,Observational Model: Cohort|Time Perspective: Prospective,Covid-19 Vaccine Antibody,"Hong Kong Sanatorium & Hospital, Hong Kong, Hong Kong",https://ClinicalTrials.gov/show/NCT04898946
NCT04668911,"Oral Health, Microbial Burden and COVID-19",Observational Model: Cohort|Time Perspective: Cross-Sectional,EDGE 132868|283766,"University College Hospital (UCH), UCL Eastman Dental Institute, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04668911
NCT04706260,Clinical Evolution and Becoming of Adult Patients Infected With Covid-19 Hospitalized at Strasbourg University Hospitals,Observational Model: Case-Control|Time Perspective: Retrospective,7839,"Adult Emergency Department - Strasbourg University Hospitals, Strasbourg, France",https://ClinicalTrials.gov/show/NCT04706260
NCT04884685,Safety of an Inactivated SARS-CoV-2 Vaccine (CoronaVac) in Children and Adolescents,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention",PRO-nCOV-2001,"Zanhuang county Center for Disease Control and Prevention, Shijiazhuang, Hebei, China",https://ClinicalTrials.gov/show/NCT04884685
NCT04383535,Convalescent Plasma and Placebo for the Treatment of COVID-19 Severe Pneumonia,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",5565,"Hospital Italiano de Buenos Aires, Ciudad Autonoma de Buenos Aire, Ciudad Autonoma De Buenos Aires, Argentina",https://ClinicalTrials.gov/show/NCT04383535
NCT04442178,InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection ( ILIAD-7-US-I ),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",ILIAD-7 COVID US INFECTIOUS,"University of Florida College of Medicine, Gainesville, Florida, United States|Missouri Baptist Medical Center, Saint Louis, Missouri, United States|Rutgers Health, New Brunswick, New Jersey, United States|Stony Brook Medicine, Stony Brook, New York, United States|Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio, United States",https://ClinicalTrials.gov/show/NCT04442178
NCT04426201,InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic Patients With COVID-19 Infection ( ILIAD-7-US-O ),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",ILIAD-7 COVID US ONCO,"Memorial sloan kettering, New York, New York, United States|MD Anderson cancer center, Houston, Texas, United States",https://ClinicalTrials.gov/show/NCT04426201
NCT04361565,Frequency and Clinical Evolution of Olfactory and Taste Disorders in COVID-19 Patients,Observational Model: Case-Only|Time Perspective: Retrospective,20odontocovid01,"CHU de Nice, Nice, France",https://ClinicalTrials.gov/show/NCT04361565
NCT04728698,Study of Intravenous Administration of Allogeneic Adipose-Derived Mesenchymal Stem Cells for COVID-19-Induced Acute Respiratory Distress,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",MSC-COV-201,"Fresno Community Hospital, Fresno, California, United States",https://ClinicalTrials.gov/show/NCT04728698
NCT04981392,Intervention to Promote COVID-19 Vaccination,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Prevention,H00023254|1R01MD016883-01,NA,https://ClinicalTrials.gov/show/NCT04981392
NCT04982068,Phase I Clinical Trial of Recombinant SARS-CoV-2 Spike Protein Vaccine (CHO Cell),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",202-COV-1001,"Xiangcheng Center for Disease Control and Prevention, Xuchang, China",https://ClinicalTrials.gov/show/NCT04982068
NCT04477083,"Development and Validation of ""Ready-to-Use"" Inhalable Forms of Hydroxychloroquine for Treatment of COVID-19",Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,inhalable HCQ,"Mansoura University Hospital, Mansoura, Outside U.S./Canada, Egypt",https://ClinicalTrials.gov/show/NCT04477083
NCT04345653,Hydroxychloroquine as Chemoprevention for COVID-19 for High Risk Healthcare Workers,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,Pro2020-0356,"Hackensack Meridian Health - JFK Medical Center, Edison, New Jersey, United States",https://ClinicalTrials.gov/show/NCT04345653
NCT04548895,Non-invasive Biometric Monitoring in Nursing Homes to Fight COVID-19,Observational Model: Ecologic or Community|Time Perspective: Prospective,HSA-001,"Avalon Health & Rehabilitation Center, Pasco, Washington, United States",https://ClinicalTrials.gov/show/NCT04548895
NCT04293692,Therapy for Pneumonia Patients iInfected by 2019 Novel Coronavirus,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Treatment",Pr20200225,"Puren Hospital Affiliated to Wuhan University of Science and Technology, Wuhan, Hubei, China",https://ClinicalTrials.gov/show/NCT04293692
NCT04474301,Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 Pandemic,Observational Model: Case-Only|Time Perspective: Cross-Sectional,2020-0470|NCI-2020-04587|P30CA016672,"M D Anderson Cancer Center, Houston, Texas, United States",https://ClinicalTrials.gov/show/NCT04474301
NCT04805645,Risk Factors for Mortality for COVID-19 Admitted to an Intensive Care Unit,Observational Model: Cohort|Time Perspective: Retrospective,ICUCOVID-KK,NA,https://ClinicalTrials.gov/show/NCT04805645
NCT04954131,Immunogenicity and Safety Study of Adjuvanted SARS-CoV-2 (SCB-2019) Vaccine in Adultsin China,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",CLO-SCB-2019-010,"Shanxi Center for Disease Control and prevention, Taiyuan, Shanxi, China|Sichuan Center for disease control, Chengdu, Sichuan, China",https://ClinicalTrials.gov/show/NCT04954131
NCT04590794,SuPAR in Adult Patients With Covid-19,Observational Model: Cohort|Time Perspective: Prospective,UTHDA-AC03,"University Hospital of Larisa, Department of Anesthesiology, Larissa, Thessaly, Greece",https://ClinicalTrials.gov/show/NCT04590794
NCT04584593,Pilot Study to Detect SARS-CoV-2 Virus in Sperm,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,RC31/20/0202|2020-A01610-39,"University Hospital Toulouse, Toulouse, France",https://ClinicalTrials.gov/show/NCT04584593
NCT04730401,Convalescent Plasma in the Treatment of Covid-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",Plasma_Covid-19,"Helsinki University Central Hospital, Helsinki, Uusimaa, Finland",https://ClinicalTrials.gov/show/NCT04730401
NCT04393324,The Critical Care Response to the COVID-19 Pandemic in Madrid,Observational Model: Cohort|Time Perspective: Other,Madrid COVID Tetrix,"Hospital Clinico San Carlos, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04393324
NCT04366271,Clinical Trial of Allogeneic Mesenchymal Cells From Umbilical Cord Tissue in Patients With COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,MESCEL-COVID19|2020-001450-22,"Hospital Universitario de Getafe, Getafe, Madrid, Spain|Hospital Universitario de Cruces, Barakaldo, Spain|Hospital Universitario de La Princesa, Madrid, Spain|Hospital Infantil Universitario Niño Jesus, Madrid, Spain|Hospital Ramón Y Cajal, Madrid, Spain|Complejo Universitario La Paz, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04366271
NCT04394793,Low Dose Radiation Therapy for Covid-19 Pneumonia,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,COVID-AIIMS,"All India Institute of Medical Sciences, New Delhi, New Delhi, Delhi, India",https://ClinicalTrials.gov/show/NCT04394793
NCT04521322,Efficacy of a Nasal Spray Containing Iota-Carrageenan in the Prophylaxis of COVID-19 Disease in Health Personnel Dedicated to Patients Care With COVID-19 Disease,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention",CEMIC,"centro de educación médica e investigaciones clinicas (CEMIC), Buenos Aires, Capital Federal, Argentina",https://ClinicalTrials.gov/show/NCT04521322
NCT04854876,"Pilot Study to Evaluate the Safety, Tolerability, and Efficacy of 5-ALA-Phosphate + SFC as an Immune System Enhancer Along With Vaccination Against COVID-19",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,BDF/R&REC/2021-566,NA,https://ClinicalTrials.gov/show/NCT04854876
NCT04753619,Effectiveness of Niclosamide as Add-on Therapy to the Standard of Care Measures in COVID-19 Management,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,PRO2021070003,"Ahmed S. Abdulamir, Baghdad, Baghdada, Iraq",https://ClinicalTrials.gov/show/NCT04753619
NCT04500639,Over-the-counter Medications & COVID-19,Observational Model: Case-Control|Time Perspective: Prospective,Pro00100243,"University of Alberta, Edmonton, Alberta, Canada",https://ClinicalTrials.gov/show/NCT04500639
NCT04366232,Efficacy of Intravenous Anakinra and Ruxolitinib During COVID-19 Inflammation,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2020-CHITS-003|2020-001963-10,"AP-HM, Hôpital de la Conception, Marseille, Bouches-du-Rhône, France|Hôpital Sainte-Musse, Toulon, VAR, France|Sainte Anne Teaching Military Hospital, Toulon, Var, France",https://ClinicalTrials.gov/show/NCT04366232
NCT04338009,Elimination or Prolongation of ACE Inhibitors and ARB in Coronavirus Disease 2019,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,842810,"University of Pennsylvania Health System, Philadelphia, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04338009
NCT04524520,"COVID19-OR (SARS-CoV-2): Observation,Risk & Recovery",Observational Model: Cohort|Time Perspective: Prospective,20/YH/0157,"Dr Luke Hodgson, Worthing, United Kingdom",https://ClinicalTrials.gov/show/NCT04524520
NCT04470297,Melatonin Agonist on Hospitalized Patients With Confirmed or Suspected COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",MELCOV2020,NA,https://ClinicalTrials.gov/show/NCT04470297
NCT04980560,Gut Microbiota Profile and Its Impact on Immunity Status in COVID-19 Vaccinated Cohorts,Observational Model: Cohort|Time Perspective: Prospective,MicVAC,"Prince of Wales Hospital, Hong Kong, Hong Kong",https://ClinicalTrials.gov/show/NCT04980560
NCT04528771,S-Nitrosylation Therapy of COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",STUDY20200453,"University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States",https://ClinicalTrials.gov/show/NCT04528771
NCT04956913,Macintosh Versus Macgrath for Laryngoscopy in COVID 19 Hypoxemic ICU Patients,Observational Model: Case-Control|Time Perspective: Prospective,macintosh versus Mac Grath,NA,https://ClinicalTrials.gov/show/NCT04956913
NCT04345276,Efficacy and Safety of Ganovo (Danoprevir) Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,ASC-CTP-HS-01,"Huoshenshan Hostipal, Wuhan, Hubei, China",https://ClinicalTrials.gov/show/NCT04345276
NCT04291729,Evaluation of Ganovo （Danoprevir ） Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,ASC-CTP-NC-01,"The Ninth Hospital of Nanchang, Nanchang, Jiangxi, China",https://ClinicalTrials.gov/show/NCT04291729
NCT04743011,Enriched Heparin Anti COVID-19 Trial,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",UPECLIN-MB-2,"School of Medicine at Botucatu- Paulista State University- UNESP, São Paulo, Brazil, Botucatu, SP, Brazil",https://ClinicalTrials.gov/show/NCT04743011
NCT04342663,"A Double-blind, Placebo-controlled Clinical Trial of Fluvoxamine for Symptomatic Individuals With COVID-19 Infection","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",202004023,"BJC, Belleville, Illinois, United States|Washington University School of Medicine, Saint Louis, Missouri, United States",https://ClinicalTrials.gov/show/NCT04342663
NCT04739020,Respiratory Aerosols in Patients With COVID-19 and Healthy Controls,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,20-1001,"Johann Wolfgang Goethe University Hospital, Frankfurt, Hessen, Germany",https://ClinicalTrials.gov/show/NCT04739020
NCT04405466,A Study to Assess the Feasibility of Screening for SARS-CoV-2 Among Healthy Workers,Observational Model: Cohort|Time Perspective: Prospective,M-2020-360,"Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, NRW, Germany",https://ClinicalTrials.gov/show/NCT04405466
NCT04694703,"Changing of Trace Element, Homocysteine, Oxidative Stress Parameters and Physical Activity Levels in Covid-19",Observational Model: Cohort|Time Perspective: Prospective,2020-12-142,"Kadirhan Ozdemir, İzmir, Turkey",https://ClinicalTrials.gov/show/NCT04694703
NCT04608266,CAMOVID : Evaluation of Efficacy and Safety of Camostat Mesylate for the Treatment of SARS-CoV-2 Infection - COVID-19 in Ambulatory Adult Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",APHP200702,"Centre Hospitalier Victor Dupouy, Argenteuil, France|AP-HP Hôpital Henri Mondor, Créteil, France|Centre Hospitalier Sud Ile de France - Melun, Melun, France|AP-HP Hôpital Bichat, Paris, France|APHP - Saint Louis, Paris, France|Centre de Santé Richerand, Paris, France",https://ClinicalTrials.gov/show/NCT04608266
NCT04824222,The Impact of Fecal Microbiota Transplantation as an Immunomodulation on the Risk Reduction of COVID-19 Disease Progression With Escalating Cytokine Storm and Inflammatory Parameters,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",FeMToCOVID|2020-003915-84,NA,https://ClinicalTrials.gov/show/NCT04824222
NCT04780126,Sarco-COVID Study: Measuring the Loss of Skeletal Muscle Mass in the Hospitalized Patient With the Diagnosis of COVID-19,Observational Model: Ecologic or Community|Time Perspective: Prospective,21/090-E_COVID,"Hospital de Emergencias Isabel Zendal, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04780126
NCT04507282,Eosinophil and Anticoagulation in COVID-19 Patients,Observational Model: Cohort|Time Perspective: Prospective,Bursa Postgraduate Hospital,"Bursa Yüksek İhtisas Hastanesi, Yıldırım, Turkey",https://ClinicalTrials.gov/show/NCT04507282
NCT04334265,Efficacy and Safety of Anluohuaxian in the Treatment of Rehabilitation Patients With Corona Virus Disease 2019,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2020 research 110,"The Second People's Hospital of Fuyang, Fuyang, Anhui, China|Ezhou Central Hospital, Wuhan, Hubei, China|Huoshenshan Hospital of Wuhan, Wuhan, Hubei, China|Jinyintan Hospital of Wuhan, Wuhan, Hubei, China|Tongji Hospital of Huazhong University of Science and Technology, Wuhan, Hubei, China|West Hospital Union Hospital Huazhong University of Science and Technology, Wuhan, Hubei, China|Wuhan Pulmonary Hospital, Wuhan, Hubei, China|Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China|Wenzhou Medical University Affiliated First Hospital, Wenzhou, Zhejiang, China",https://ClinicalTrials.gov/show/NCT04334265
NCT04371640,Sirolimus in COVID-19 Phase 1,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",15680,"Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04371640
NCT04732819,Improving COVID-19 Vaccine Uptake in Nursing Homes,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Health Services Research,2012002872|3U54AG063546-02S2|Pro00048627,"Mission Health, Tampa, Florida, United States|Nexion Health, Sykesville, Maryland, United States|Vetter Senior Living, Elkhorn, Nebraska, United States|Genesis HealthCare, Kennett Square, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04732819
NCT04885543,COVID-19 STAndard of Care in Sub-Saharan Africa,Observational Model: Cohort|Time Perspective: Prospective,ALIMA02,"Chu Tengandogo, Ouagadougou, Burkina Faso|Clinique Princesse Sarah, Ouagadougou, Burkina Faso|Chu Donka, Conakry, Guinea",https://ClinicalTrials.gov/show/NCT04885543
NCT04587375,Diagnosis of Endocrine Dysfunctions in Covid-19,Observational Model: Cohort|Time Perspective: Prospective,RECHMPL20_0205,"Uhmontpellier, Montpellier, France",https://ClinicalTrials.gov/show/NCT04587375
NCT04553705,"Omega-3, Nigella Sativa, Indian Costus, Quinine, Anise Seed, Deglycyrrhizinated Licorice, Artemisinin, Febrifugine on Immunity of Patients With (COVID-19)","Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment",TQ/Omega-3 on COVID-19|DOI: 10.31219/osf.io/u56fc,"Maternity and Children hospital, Mecca, Makkah, Saudi Arabia",https://ClinicalTrials.gov/show/NCT04553705
NCT04910113,Bronchiactasis as Atypical Presentation in COVID-19,Observational Model: Case-Control|Time Perspective: Cross-Sectional,COVID in Bronchiactasis,"Maha Ahmed Okasha, Assiut, Egypt",https://ClinicalTrials.gov/show/NCT04910113
NCT04467008,Covid-19 Rapid Diagnostic Tests on Blood Drop,Observational Model: Cohort|Time Perspective: Retrospective,20-May,"CMC Ambroise Paré, Neuilly-sur-Seine, France",https://ClinicalTrials.gov/show/NCT04467008
NCT04805203,Analysis of the Immune Parameters of COVID-19 Infection in Patients With Multiple Myeloma,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,IFM 2020-08,"CHU Amiens SUD, Amiens, France|CHRU Hôpital du Bocage, Angers, France|Ch Annecy Genevois, Annecy, France|CH Victor Dupouy, Argenteuil, France|CH d'ARRAS, Arras, France|CH Auch, Auch, France|Centre Hospitalier H.Duffaut, Avignon, France|Centre Hospitalier Simone Veil de Blois, Blois, France|CHU Bordeaux-hopital haut leveque, Bordeaux, France|Centre hospitalier Pierre Oudot, Bourgoin-Jallieu, France|Hôpital A.Morvan, Brest, France|CHU de Caen, Caen, France|CH de Cannes, Cannes, France|Clinique du Parc, Castelnau-le-Lez, France|Centre Hospitalier William Morey, Chalon Sur Saone, France|Centre Hospitalier Métropole de Savoie, Chambéry, France|Centre Hospitalier Sud Francilien, Corbeil-Essonnes, France|CHU Henri Mondor, Créteil, France|CH de Dax côte d'Argent, Dax, France|CHU François Mitterand, Dijon, France|CH de Dunkerque, Dunkerque, France|CHU grenoble, Grenoble, France|Institut Daniel Hollard - Groupe Hospitalier Mutualiste de Grenoble, Grenoble, France|CH de Lens, Lens, France|Hopital Claude Huriez-CHRU LILLE, Lille, France|CHU Limoges, Limoges, France|Centre Hospitalier Lyon sud, Lyon, France|Centre Léon Bérard, Lyon, France|Institut Paoli Calmettes, Marseille, France|GHT des Landes, Mont-de-Marsan, France|CHU saint Eloi, Montpellier, France|Hôpital E. MULLER, Mulhouse, France|Hôpitaux de Brabois - CHRU de Nancy, Nancy, France|CHRU Nantes, Nantes, France|Hopital Archet 1, Nice, France|Hopital Cochin, Paris, France|Hopital Saint Antoine, Paris, France|Hôpital Necker Enfants Malades, Paris, France|Hôpital Pitié-Salpêtrière, Paris, France|CHU Poitiers, Poitiers, France|CH René Dubos, Pontoise, France|CHU de Reims, Reims, France|Chu Pontchaillou, Rennes, France|CH Roubaix, Roubaix, France|Centre Henri Becquerel, Rouen, France|Centre Hospitalier Yves Le Foll, Saint brieuc, France|Institut de Cancérologie Lucien Neuwirth, Saint-Priest, France|Centre Hospitalier, Saint-Quentin, France|ICANS, Strasbourg, France|CH Tarbes, Tarbes, France|CHU Toulouse, Toulouse, France|CHRU Bretonneau, Tours, France|CH de valenciennes, Valenciennes, France|CH Bretagne Atlantique Vannes et Auray-P.Chubert, Vannes, France|CHV André Mignot, Versailles, France",https://ClinicalTrials.gov/show/NCT04805203
NCT04874740,Seroprevalence of the Anti-SARS-CoV-2 Antibodies (Causing COVID-19) in Kidney Transplant Recipients in Severely Affected Region,Observational Model: Cohort|Time Perspective: Other,2/IK-FNO/2021,"University Hospital Ostrava, Ostrava, Czechia",https://ClinicalTrials.gov/show/NCT04874740
NCT04703140,COVIDISC: Rapid Diagnostic Tests on Nasopharyngeal Swabs for the Detection of COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,20-Sep,"CHI Robert Ballanger, Aulnay-sous-Bois, France",https://ClinicalTrials.gov/show/NCT04703140
NCT04548557,Intravenous Immunoglobulins for the Treatment of Covid-19 Patients: a Clinical Trial,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment",UniversityHSL-IVIG,"University of Health Sciences, Lahore, Punjab, Pakistan",https://ClinicalTrials.gov/show/NCT04548557
NCT04497389,Safety and Feasibility of Amniotic Fluid as a Treatment for COVID-19 Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",132922,"University of Utah Health, Salt Lake City, Utah, United States",https://ClinicalTrials.gov/show/NCT04497389
NCT04791072,Tele-coaching in Patients With COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,IKCSS,NA,https://ClinicalTrials.gov/show/NCT04791072
NCT04952402,SARS-CoV-2 Immune Responses After COVID-19 Therapy and Subsequent Vaccine,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,A5404,"Rush University CRS (Site ID: 2702), Chicago, Illinois, United States|Chapel Hill CRS (Site ID: 3201), Chapel Hill, North Carolina, United States|Penn Therapeutics, CRS (Site ID: 6201), Philadelphia, Pennsylvania, United States|Puerto Rico AIDS Clinical Trials Unit, CRS, San Juan, Puerto Rico",https://ClinicalTrials.gov/show/NCT04952402
NCT04368988,Evaluation of the Safety and Immunogenicity of a SARS-CoV-2 rS Nanoparticle Vaccine With/Without Matrix-M Adjuvant,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",2019nCoV-101,"Meridian Clinical Research-(Savannah Georgia) - Platinum - PPDS - Phase 2, Savannah, Georgia, United States|Advanced Clinical Research - Meridian - ERN-PPDS - Phase 2, Meridian, Idaho, United States|Alliance for Multispecialty Research, LLC - Phase 2, Newton, Kansas, United States|Alliance for Multispecialty Research, LLC - Phase 2, Wichita, Kansas, United States|Central Kentucky Research Associates Inc - Phase 2, Lexington, Kentucky, United States|Meridian Clinical Research-(Rockville Maryland) - Platinum - PPDS - Phase 2, Rockville, Maryland, United States|Synexus Clinical Research US, Inc. - Cincinnati - Phase 2, Cincinnati, Ohio, United States|Rapid Medical Research Inc - ERN-PPDS - Phase 2, Cleveland, Ohio, United States|Paratus Clinical Research - Canberra - Phase 2, Bruce, Australian Capital Territory, Australia|Paratus Clinical Research - Western Sydney - Phase 2, Blacktown, New South Wales, Australia|Paratus Clinical Research - Central Coast - Phase 2, Kanwal, New South Wales, Australia|Australian Clinical Research Network - Phase 2, Maroubra, New South Wales, Australia|Scientia Clinical Research Limited - Phase 2, Randwick, New South Wales, Australia|Q Pharm Pty Limited - Phase 1, Herston, Queensland, Australia|University of the Sunshine Coast, Health Hub Morayfield - Phase 2, Morayfield, Queensland, Australia|University of the Sunshine Coast - Phase 2, Sippy Downs, Queensland, Australia|Barwon Health - Phase 2, Geelong, Victoria, Australia|Center for Clinical Studies - Phase 1 and Phase 2, Melbourne, Victoria, Australia",https://ClinicalTrials.gov/show/NCT04368988
NCT04540926,Cyclosporine A Plus Low-steroid Treatment in COVID-19 Pneumonia,Allocation: N/A|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,135.202,"Jose Luis Jl Galvez-Romero, Puebla, Mexico",https://ClinicalTrials.gov/show/NCT04540926
NCT04632355,Musculoskeletal Pain in Patients With Covid-19 Who Have Hospital Care,Observational Model: Cohort|Time Perspective: Prospective,Covid19-Pain,"Jorge Hugo Villafañe, Milan, Italy",https://ClinicalTrials.gov/show/NCT04632355
NCT04922931,Post-COVID 19 Patients Undergoing Surgery,Observational Model: Case-Control|Time Perspective: Prospective,PR(AG)346/2020,"Vall d´Hebron Research Institute VHIR, Barcelona, Spain",https://ClinicalTrials.gov/show/NCT04922931
NCT04668222,Changing Susceptible Body Constitution for COVID-19 Prevention by Chinese Medicine in Hong Kong Residents,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",UW20-480,"The University of Hong Kong, Hong Kong, Hong Kong, China, Hong Kong",https://ClinicalTrials.gov/show/NCT04668222
NCT04347278,Observational Study of Follow-up of Hospitalized Patients Diagnosed With COVID-19 to Evaluate the Effectiveness of the Drug Treatment Used to Treat This Disease. COVID-19 Registry,Observational Model: Other|Time Perspective: Other,IDI-REM-2020-1,"Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, Spain",https://ClinicalTrials.gov/show/NCT04347278
NCT04416113,Photodynamic Therapy for the Treatment of COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,Cu-NILES/16/20,NA,https://ClinicalTrials.gov/show/NCT04416113
NCT04476940,COVID-19 Breastfeeding Guideline for African-Americans,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,330875,"Meharry Medical College, Nashville, Tennessee, United States",https://ClinicalTrials.gov/show/NCT04476940
NCT04561063,COVID-19 Prophylaxis South Africa (COVER HCW),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,EZ-SS-025,"Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, Gauteng, South Africa|Sunnyside Office Park, Johannesburg, Gauteng, South Africa",https://ClinicalTrials.gov/show/NCT04561063
NCT04800133,Covid-19 Vaccination in Adolescents,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,COVA01,"Queen Mary Hospital, Hong Kong, Hong Kong, China",https://ClinicalTrials.gov/show/NCT04800133
NCT04527224,Study to Evaluate the Efficacy and Safety of AstroStem-V in Treatment of COVID-19 Pneumonia,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,ASVP1N2A-US,NA,https://ClinicalTrials.gov/show/NCT04527224
NCT04652102,A Study to Determine the Safety and Efficacy of SARS-CoV-2 mRNA Vaccine CVnCoV in Adults for COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention",CV-NCOV-004|2020-003998-22,"Instituto de Investigaciones Clinicas Quilmes, Buenos Aires, Argentina|Hospital Interzonal General Agudos Prof. Dr. Ramon Carrillo, Buenos Aires, Argentina|Hospital Interzonal General de Agudos Vicente Lopez y Planes, Buenos Aires, Argentina|Hospital Zonal General de Agudos Descentralizado Evita Pueblo de Berazategui, Buenos Aires, Argentina|Fundación Cenit Para La Investigación En Neurociencias, Buenos Aires, Argentina|Instituto de Investigaciones Clínicas Mar del Plata, Mar Del Plata, Argentina|Sanatorio Parque, Rosario, Argentina|Corporación Médica Sanatorio, San Martín, Argentina|Instituto De Investigaciones Clinica Zarate, Zárate, Argentina|Cohezio - Bruxelles, Brussels, Belgium|Mensura, Brussel, Belgium|Universitair Ziekenhuis Gent, Gent, Belgium|Centre for Vaccinology - Ghent University Hospital, Ghent, Belgium|Clínica de la Costa, Barranquilla, Colombia|CAIMED - Bogota Clinical Research Center, Bogotá, Colombia|Centro de Estudios en Infectología Pediátrica (CEIP), Cali, Colombia|Fundacion Dominicana de Perinatologia Pro Bebe, Santo Domingo, Dominican Republic|Instituto Dermatológico Dominicano y Cirugía de Piel Dr. Huberto Bogaert Díaz, Santo Domingo, Dominican Republic|Clínica Cruz Jiminian, Santo Domingo, Dominican Republic|Hospital General Regional Marcelino Vélez Santana, Santo Domingo, Dominican Republic|University Hospital, Cologne, Germany|Uniklinik Köln, Köln, Germany|Ludwig-Maximilians-Universität München, München, Germany|University Hospital Tübingen Institut für Tropenmedizin, Tübingen, Germany|Universitätsklinikum Tübingen - Institut für Tropenmedizin, Reisemedizin und Humanparasitologie, Tübingen, Germany|Instituto Nacional De Ciencias Medicas Y Nutricion Salvador Zubiran, Ciudad de mexico, Mexico|CAIMED - México, Ciudad de mexico, Mexico|Panamerican Clinical research Mexico (Guadalajara), Guadalajara, Mexico|Panamerican Clinical Research Mexico S.A. DE C.V., Juriquilla, Mexico|Unidad de Medicina Especializada SMA, San Juan Del Río, Mexico|Centro Medico Zambrano Hellion TecSalud, San Pedro Garza Garcia, Mexico|Noordwest Ziekenhuisgroep, Alkmaar, Netherlands|Amsterdam Universitair Medische Centra - Academisch Medisch Centrum, Amsterdam, Netherlands|Universitair Medische Centra - Vrije Universiteit Medisch Centrum, Amsterdam, Netherlands|Amphia Ziekenhuis - Breda Molengracht, Breda, Netherlands|Amphia Ziekenhuis, Breda, Netherlands|The Julius Center - Utrecht Science Park - Stratenum, Utrecht, Netherlands|University of Utrecht, Utrecht, Netherlands|Centro De Vacunacion Internacional - CEVAXIN Chorreras, Panama city, Panama|Centro De Vacunacion Internacional - CEVAXIN 24 Diciembre, Panama City, Panama|Centro de Vacunacion Internacional - CEVAXIN Avenida Mexico, Panama city, Panama|Instituto de Investigaciones Científicas y Servicios de Alta Tecnología, Panamá, Panama|Centro de Investigaciones Tecnológicas, Biomédicas y Medioambientales, Callao, Peru|Hospital de Chancay y Servicios básicos de Salud, Chancay, Peru|Clinica Medica San Martin, Ica, Peru|Instituto de Investigación Nutricional - Las Gardenias, Lima, Peru|Instituto de Investigación Nutricional - San Carlos, Lima, Peru|Instituto de Investigación Nutricional, Lima, Peru|Asociación Civil Impacta Salud y Educación, Lima, Peru|Centro de Investigación para ensayos Clínicos UPCH, Lima, Peru|OSI Eskerraldea-Enkarterri-Cruces/Hospital Universitario Cruces, Barakaldo, Spain|Hospital Universitario Donostia, Donostia-San Sebastián, Spain|Hospital Clínico San Carlos, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04652102
NCT04363749,COVID-19 Infection: Exploration of Respiratory Control Center Abnormalities,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science,APHP200476,"Département R3S, hôpital de la pitié-salpêtrière, Paris, France",https://ClinicalTrials.gov/show/NCT04363749
NCT04730895,Investigating the Role of 13cis Retinoic Acid in the Treatment of COVID-19 and Enhancement of Its Spike Protein Based Vaccine Efficacy and Safety.,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,COVID vaccine,NA,https://ClinicalTrials.gov/show/NCT04730895
NCT04519372,SARS-CoV-2 /COVID-19 Admission Screening in a University Hospital Setting,Observational Model: Other|Time Perspective: Retrospective,2020-00808,"University Hospital Basel, Division of Infectious Diseases and Hospital Epidemiology, Basel, Switzerland",https://ClinicalTrials.gov/show/NCT04519372
NCT04379284,Risks of COVID19 in the Pregnant Population,Observational Model: Case-Only|Time Perspective: Prospective,20-003251,"Mayo Clinic Rochester, Rochester, Minnesota, United States",https://ClinicalTrials.gov/show/NCT04379284
NCT04905888,Hyperbaric Oxygen for Long COVID-19 Pulmonary Sequela,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,HRPP210260,"Univeristy of California San Diego, La Jolla, California, United States",https://ClinicalTrials.gov/show/NCT04905888
NCT04568863,Efficacy of Intravenous Melatonin on Mortality in Adult Patients Admitted to the Intensive Care Unit With COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",PHM-2020-001,"Hospital Universitario La Paz, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04568863
NCT04382053,Study of Efficacy and Safety of DV890 in Patients With COVID-19 Pneumonia,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,CDFV890D12201|2020-001870-32,"Novartis Investigative Site, Caba, Buenos Aires, Argentina|Novartis Investigative Site, Buenos Aires, Argentina|Novartis Investigative Site, Porto Alegre, RS, Brazil|Novartis Investigative Site, Sao Paulo, SP, Brazil|Novartis Investigative Site, Hvidovre, Denmark|Novartis Investigative Site, Regensburg, Bavaria, Germany|Novartis Investigative Site, Hannover, Germany|Novartis Investigative Site, Wuerzburg, Germany|Novartis Investigative Site, Budapest, Hungary|Novartis Investigative Site, Coimbatore, Tamil Nadu, India|Novartis Investigative Site, Kolkata, West Bengal, India|Novartis Investigative Site, New Delhi, India|Novartis Investigative Site, New Delhi, India|Novartis Investigative Site, Ciudad de Mexico, Mexico CP, Mexico|Novartis Investigative Site, Monterrey, Nuevo Leon, Mexico|Novartis Investigative Site, Harderwijk, Netherlands|Novartis Investigative Site, San Martin de Porres, Lima, Peru|Novartis Investigative Site, San Miguel, Lima, Peru|Novartis Investigative Site, Barnaul, Russian Federation|Novartis Investigative Site, Chelyabinsk, Russian Federation|Novartis Investigative Site, Ekaterinburg, Russian Federation|Novartis Investigative Site, Krasnoyarsk, Russian Federation|Novartis Investigative Site, Moscow, Russian Federation|Novartis Investigative Site, Ryazan, Russian Federation|Novartis Investigative Site, Saint Petersburg, Russian Federation|Novartis Investigative Site, St Petersburg, Russian Federation|Novartis Investigative Site, George, Western Cape, South Africa|Novartis Investigative Site, Barcelona, Catalunya, Spain|Novartis Investigative Site, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04382053
NCT04565379,Clinical Trial to Investigate the Efficacy and Safety of NuSepin® in COVID-19 Pneumonia Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",Shaperon001|2020-003107-34,"""Leon Daniello"" Clinical Hospital of Pneumophtisiology Cluj-Napoca Pneumology Clinic, Cluj-Napoca, Romania|Clinical Hospital for Infectious Diseases and Pneumophtisiology ""Victor Babes"", Craiova Infectious Diseases Clinic for Adults, Craiova, Romania|""Sf. Parascheva"" Infectious Diseases Clinical Hospital Iasi Infectious Diseases Department, Iaşi, Romania|Ramnicu Sarat Clinical Hospital, Ramnicu Sarat, Romania|""Sf. Ioan cel Nou"" Suceava County Emergency Hospital Infectious Diseases Department, Suceava, Romania",https://ClinicalTrials.gov/show/NCT04565379
NCT04834869,COVID-19 Vaccines Safety Tracking (CoVaST),Observational Model: Other|Time Perspective: Prospective,CoVaST,"American College of Physicians, Philadelphia, Pennsylvania, United States|McMaster University, Hamilton, Ontario, Canada|University of Split, Split, Croatia|Masaryk University, Brno, Czechia|University of Tartu, Tartu, Estonia|Jimma University, Jimma, Ethiopia|Justus-Liebig University Giessen, Giessen, Germany|University of Ghana, Accra, Ghana|Sinaloa's Pediatric Hospital, Culiacán, Mexico|Medical University of Silesia, Katowice, Poland|Nursing School of Coimbra, Coimbra, Portugal|Irkutsk Scientific Center of Siberian Branch of Russian Academy of Sciences, Irkutsk, Russian Federation|University of Belgrade, Belgrade, Serbia|University of Ljubljana, Ljubljana, Slovenia",https://ClinicalTrials.gov/show/NCT04834869
NCT04733807,Antibodies Response to mRNA Vaccine Against Covid-19,Observational Model: Ecologic or Community|Time Perspective: Prospective,SCAREAID,"ICOT-Sapienza University Hospital, Latina, LT, Italy",https://ClinicalTrials.gov/show/NCT04733807
NCT04740320,COVID-19 SARS-CoV-2 Screening Protocol,Observational Model: Cohort|Time Perspective: Prospective,20IC6378,"hVIVO Services Ltd, QMB Bioenterprise building, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04740320
NCT04370275,Accuracy of Lung Ultrasound in the Diagnosis of covid19 Pneumonia,Observational Model: Cohort|Time Perspective: Prospective,CEUR-2020-Os-086,"SC Pronto Soccorso e Medicina d'Urgenza, Latisana, Udine, Italy",https://ClinicalTrials.gov/show/NCT04370275
NCT04533399,A Study Looking at the Effectiveness and Safety of a COVID-19 Vaccine in South African Adults,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",2019nCoV-501,"ZA018, Bloemfontein, Free State Of South Africa, South Africa|ZA003, Hillbrow, Gauteng, South Africa|Site ZA001, Johannesburg, Gauteng, South Africa|ZA012, Johannesburg, Gauteng, South Africa|Site ZA015, Pretoria, Gauteng, South Africa|ZA023, Pretoria, Gauteng, South Africa|ZA019, Durban, KwaZulu-Natal, South Africa|ZA020, Durban, KwaZulu-Natal, South Africa|ZA021, Durban, KwaZulu-Natal, South Africa|ZA024, Durban, KwaZulu-Natal, South Africa|ZA007, Thabazimbi, Limpopo, South Africa|ZA022, Madibeng, North-West, South Africa|ZA013, Cape Town, Western Cape, South Africa|ZA014, Worcester, Western Cape, South Africa",https://ClinicalTrials.gov/show/NCT04533399
NCT04746443,Effect of Covid-19 Affliction on Psychological and Mental Health Among College Going Students: Cross-Sectional Survey,Observational Model: Case-Only|Time Perspective: Cross-Sectional,ECM#2020-2501,"King Khalid University, Abha, Aseer, Saudi Arabia",https://ClinicalTrials.gov/show/NCT04746443
NCT04484493,Corticosteroid Nasal Spray in COVID-19 Anosmia,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,RC 4-7-2020,"Benha University Hospital, Faculty of Medicine, Banhā, Qalubia, Egypt",https://ClinicalTrials.gov/show/NCT04484493
NCT04364893,Angiotensin Receptor Blockers and Angiotensin-converting Enzyme Inhibitors and Adverse Outcomes in Patients With COVID19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,PRJ_2003,"Idor, São Paulo, Brazil",https://ClinicalTrials.gov/show/NCT04364893
NCT04379297,COvid-19 National Survey for Assessing VIral Spread by Nonaffected CarriErs (CON-VINCE),Observational Model: Cohort|Time Perspective: Prospective,CNER 202004/01|831x6ce0d|FNR/CON-VINCE,"Luxembourg Institute of Health, Strassen, Luxembourg",https://ClinicalTrials.gov/show/NCT04379297
NCT04530409,Timing of Corticosteroids in COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,PR0012,"Asalam, Maadi, Cairo, Egypt",https://ClinicalTrials.gov/show/NCT04530409
NCT04335019,Interest of the Use of Pulmonary Ultrasound in the Referral of Patients With or Suspected COVID-19 +,Observational Model: Other|Time Perspective: Prospective,APHP200390|2020-A00768-31,NA,https://ClinicalTrials.gov/show/NCT04335019
NCT04710316,"Study of COVID-19 Outbreak in Hospital Departments of Bamako, Mali",Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Screening,C20-41,"Hopital du Point-G, Bamako, Mali|Hopital Gabriel Toure, Bamako, Mali|Hôpital dermatologique de Bamako, Bamako, Mali|Hôpital du Mali, Bamako, Mali",https://ClinicalTrials.gov/show/NCT04710316
NCT04584567,"OD-doxy-PNV-COVID-19 Old Drug "" DOXY "" for Prevention of New Virus "" COVID-19 ""","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention",UR17DN05,"Military Hospital of Tunis, Tunis, Montfleury, Tunisia",https://ClinicalTrials.gov/show/NCT04584567
NCT04583995,"A Study Looking at the Effectiveness, Immune Response, and Safety of a COVID-19 Vaccine in Adults in the United Kingdom","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",2019nCoV-302,"Belfast Health and Social Care Trust (BHSCT) (Site UK011), Belfast, Antrim, United Kingdom|Synexus Midlands Clinical Research Centre (Site UK024), Edgbaston, Birmingham, United Kingdom|The Royal Cornwall Hospitals NHS Trust (Site UK036), Truro, Cornwall, United Kingdom|Royal Devon and Exeter Hospital (Site UK013), Exeter, Devon, United Kingdom|""Maidstone Hospital - Central Research and Development Office Above Breast Care Centre - 1st Floor"" (Site UK028), Maidstone, Kent, United Kingdom|Queen Elizabeth University Hospital (Site UK008), Glasgow, Lanarkshire, United Kingdom|Blackpool Teaching Hospitals (Site UK010), Blackpool, Lancashire, United Kingdom|Salford Hospital (Site UK030), Oldham, Lancashire, United Kingdom|Synexus Merseyside Clinical Research Centre (Site UK026), Waterloo, Liverpool, United Kingdom|Royal Free (Site UK012), Hampstead, London, United Kingdom|St. George's University Hospitals NHS Foundation Trust Clinical Research Facility (Site UK001), Tooting, London, United Kingdom|North Wales Clinical Research Centre (NWCRC) (Site UK027), Wrexham, North Wales, United Kingdom|Lakeside Healthcare, Lakeside Surgery (Site UK005), Corby, Northants, United Kingdom|Warneford Hospital (Site UK016), Oxford, Oxfordshire, United Kingdom|Aberdeen Royal Infirmary (Site UK007), Foresterhill, Aberdeen, United Kingdom|Bradford Teaching Hospitals NHS Trust (Site UK018), Bradford, United Kingdom|Synexus Wales Clinical Research Centre (Site UK025), Cardiff, United Kingdom|Synexus Lancashire Clinical Research Centre (Site UK022), Chorley, United Kingdom|Colchester Hospital (Site UK034), Colchester, United Kingdom|AES - Glasgow (Site UK033), Glasgow, United Kingdom|University Hartlepool Hospital (Site UK021), Hartlepool, United Kingdom|Synexus Hexham Clinical Research Centre (Site UK023), Hexham, United Kingdom|Royal Lancaster Infirmary (Site UK029), Lancaster, United Kingdom|Research & Innovation Centre, St. James's University Hospital (Site UK019), Leeds, United Kingdom|St. Thomas' Hospital (Site UK020), London, United Kingdom|Chelsea & Westminster NHS Foundation Trust (Site UK006), London, United Kingdom|AES - Synexus Manchester (Site UK032), Manchester, United Kingdom|Norfolk and Norwich University Hospital NHS Foundation Trust, Norfolk and Norwich University Hospital (Site UK015), Norwich, United Kingdom|Wansford and Kingscliffe Practice (Site UK035), Peterborough, United Kingdom|AES - Synexus Thames Valley (Site UK031), Reading, United Kingdom|University Hospital Southampton NHS Foundation Trust (UHS) (Site UK014), Southampton, United Kingdom|Midlands Partnership NHS Foundation Trust Headquarters (Site UK017), Stafford, United Kingdom|Stockport NHS Foundation Trust (Site UK009), Stockport, United Kingdom",https://ClinicalTrials.gov/show/NCT04583995
NCT04653831,Treatment With Pirfenidone for COVID-19 Related Severe ARDS,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,SCRC20007,"Soroka Medical Center, Be'er Sheva, Israel",https://ClinicalTrials.gov/show/NCT04653831
NCT04610801,Evaluation of the Efficacy of Xylitol Nasal Spray Against SARS-CoV-2,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Care Provider)|Primary Purpose: Treatment,LCH-3-082020,"Larkin Community Hospital Palm Springs Campus, Miami, Florida, United States|Larkin Community Hospital, Miami, Florida, United States",https://ClinicalTrials.gov/show/NCT04610801
NCT04344756,"Trial Evaluating Efficacy and Safety of Anticoagulation in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,APHP200389-6,"Réanimation hôpital Louis Mourier, Colombes, Hauts De Seine, France|réanimation hôpital Cochin, Paris, France|Médecine vasculaire, Hôpital Européen Georges Pompidou, Paris, France",https://ClinicalTrials.gov/show/NCT04344756
NCT04512027,Prolectin-M in COVID-19 Patients Having Mild to Moderate Symptoms Not Requiring Oxygen Support.,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,CIMED - 002- 2020,"Mazumdar Shaw Medical Centre, Bangalore, Karnataka, India",https://ClinicalTrials.gov/show/NCT04512027
NCT04666246,Inspiratory Effort in COVID-19,Observational Model: Cohort|Time Perspective: Prospective,UModenaReggio17,"University Hospital of Modena, Modena, Italy",https://ClinicalTrials.gov/show/NCT04666246
NCT04405921,"Hydroxychloroquine, Azithromycin in the Treatment of Covid-19","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment",PACTT,"University Hospital Farhat Hached, Sousse, Tunisia",https://ClinicalTrials.gov/show/NCT04405921
NCT04979858,Reducing Spread of COVID-19 in a University Community Setting: Role of a Low-Cost Reusable Form-Fitting Fabric Mask,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Prevention,H21218|75D30121C10545,"Georgia Institute of Technology - Main Campus, Atlanta, Georgia, United States",https://ClinicalTrials.gov/show/NCT04979858
NCT04437719,"Prospective Cohort Study to Describe the Clinical Characteristics of COVID-19, the Acquired Immune Response and the Biological and Clinical Parameters of Patients Followed in Oncology by the Saint-Joseph Hospital Group for a Period of 6 Months During the COVID-19 Pandemic",Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,OBVIONCO,"Groupe Hospitalier Paris Saint-Joseph, Paris, France",https://ClinicalTrials.gov/show/NCT04437719
NCT04406090,Endovascular Thrombectomy in COVID-19 Infected Patients,Observational Model: Cohort|Time Perspective: Retrospective,RECHMPL20_0322,"Uhmontpellier, Montpellier, France",https://ClinicalTrials.gov/show/NCT04406090
NCT04381013,Emergency Ventilator Splitting Between Two or More Patients (COVID-19),Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Device Feasibility,57573,"Stanford University, Stanford, California, United States",https://ClinicalTrials.gov/show/NCT04381013
NCT04711863,Fluvoxamine for Adults With Mild to Moderate COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,S2020-3124-0001,"Asan Medical Center, Seoul, Korea, Republic of",https://ClinicalTrials.gov/show/NCT04711863
NCT04405986,Exploring Brain Damages After COVID-19 Infection,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,CHUBX 2020/20,"CHU de Bordeaux, Bordeaux, France",https://ClinicalTrials.gov/show/NCT04405986
NCT04449042,The PAWS-COVID-19 (Pediatric AirWay complicationS COVID-19) Registry,Observational Model: Cohort|Time Perspective: Prospective,IRB-P00035427,"Boston Children's Hopsital, Boston, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT04449042
NCT04723459,Efficacy of Nano-Ivermectin Impregnated Masks in Prevention of Covid-19 Among Healthy Contacts and Medical Staff,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,SVU MED CIT0 23 4 21 1 121,"Zaky Aref, Qina, Egypt",https://ClinicalTrials.gov/show/NCT04723459
NCT04351711,Immunological Profiling of Patients With COVID-19 in Respiratory Distress,Observational Model: Case-Control|Time Perspective: Prospective,NIMAO/2020-01/PC-01,"CHU de Nimes, Nîmes, France",https://ClinicalTrials.gov/show/NCT04351711
NCT04501822,One-year Cardiac Follow-up of Patients With COVID-19 Pneumonia,Observational Model: Cohort|Time Perspective: Prospective,TCRC-COVID,"Tyumen Cardiology Research Center, Tomsk National Research Medical Center, Russian Academy of Science, Tyumen, Russian Federation",https://ClinicalTrials.gov/show/NCT04501822
NCT04342884,COVID-19 Community Research Partnership,Observational Model: Cohort|Time Perspective: Prospective,IRB00064912,"Tulane University School of Public Health and Tropical Medicine, New Orleans, Louisiana, United States|University of Maryland School of Medicine, Baltimore, Maryland, United States|Medstar Health, Columbia, Maryland, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|Atrium Health, Charlotte, North Carolina, United States|Vidant Health, Greenville, North Carolina, United States|Campbell University School of Osteopathic Medicine, Lillington, North Carolina, United States|New Hanover Regional Medical Center, Wilmington, North Carolina, United States|Wake Forest Baptist Health, Winston-Salem, North Carolina, United States|Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States|WakeMed Health and Hospitals, Winston-Salem, North Carolina, United States",https://ClinicalTrials.gov/show/NCT04342884
NCT04355897,CoVID-19 Plasma in Treatment of COVID-19 Patients,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,20-23,"The Christ Hospital, Cincinnati, Ohio, United States|University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States",https://ClinicalTrials.gov/show/NCT04355897
NCT04626076,International Registry of Healthcare Workers Exposed to COVID-19 Patients,Observational Model: Other|Time Perspective: Prospective,CER-HCW-001,"Aga Khan University, Karachi, Pakistan",https://ClinicalTrials.gov/show/NCT04626076
NCT04344782,"Trial Evaluating Efficacy and Safety of Bevacizumab (Avastin®/Zeribev®) in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,APHP200389-7,NA,https://ClinicalTrials.gov/show/NCT04344782
NCT04581083,"Validation of Laboratory Techniques, Strategies, and Types of Samples for Epidemiological Control in the Covid-19 Pandemic",Observational Model: Other|Time Perspective: Cross-Sectional,PROY - UAJMS001/2020,"Universidad Autónoma Juan Misael Saracho, Tarija, Bolivia",https://ClinicalTrials.gov/show/NCT04581083
NCT04603651,Expanded Access Program to Provide Bamlanivimab (LY3819253) for the Treatment of COVID-19,NA,18165|J2X-MC-Y001,NA,https://ClinicalTrials.gov/show/NCT04603651
NCT04961229,Booster Dose of mRNA SARS-CoV-2 Vaccine for Kidney Transplant Recipients Without Adequate Humoral Response With or Without Immunosuppression Reduction,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,0192-21-RMC,NA,https://ClinicalTrials.gov/show/NCT04961229
NCT04408157,A Research Study to Evaluate the Benefits of a Self-management Booklet to Promote Wellbeing During the COVID-19 Pandemic,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,v1.1 06.05.2020,"Online recruitment through Qualtrics, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04408157
NCT04780061,Dietary Supplements for COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",20210072-01H,"The Centre for Health Innovation, Ottawa, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04780061
NCT04867213,Breath Analysis of Patients Diagnosed With COVID-19 Using Infrared Spectroscopy,Observational Model: Cohort|Time Perspective: Prospective,12815,"Hamilton Health Sciences, Hamilton, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04867213
NCT04531111,Glycemic Control Among Children and Adolescents With Type 1 Diabetes During COVID-19 Pandemic in Egypt,Observational Model: Case-Only|Time Perspective: Cross-Sectional,FMASU P66/2020,"Pediatrics and Adolescents Diabetes Unit (PADU), Pediatrics Hospital, Faculty of Medicine, Ain Shams University, Cairo, Egypt",https://ClinicalTrials.gov/show/NCT04531111
NCT04630015,Expanded Evaluation of the Survivorship Wellness Group Program in the Context of COVID-19 and Telehealth,Observational Model: Cohort|Time Perspective: Prospective,20805|NCI-2020-08530,"University of California, San Francisco, San Francisco, California, United States",https://ClinicalTrials.gov/show/NCT04630015
NCT04545749,"A Study to Evaluate the Safety, Tolerability, and Immunogenicity of UB-612 COVID-19 Vaccine",Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,V-122,"China Medical University Hospital, Taichung, Taiwan",https://ClinicalTrials.gov/show/NCT04545749
NCT04557241,Brief Informational Intervention for COVID-19 Misinformation Prophylaxis,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Prevention",Indiana_CTSI_Agley_2020,"Digital Intervention (Prolific Study Panel), Bloomington, Indiana, United States",https://ClinicalTrials.gov/show/NCT04557241
NCT04497623,"Clinical Evaluation of Ventilador Innovation Product in Colombia in the SARS COVID 19 Pandemic, Unisabana Herons.",Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Device Feasibility,202006-25502,"Fundacion Neumologica Colombiana, Bogotá, Bogota, Colombia|Universidad de la Sabana, Chia, Cundinamarca, Colombia|Clinica Universidad de la Sabana, Chía, Cundinamarca, Colombia",https://ClinicalTrials.gov/show/NCT04497623
NCT04779541,National Survey Concerning Vaccination Against COVID-19 in Nursing Homes and Long-Term Care Units,Observational Model: Cohort|Time Perspective: Retrospective,2021-028|ar21-0004v0,"Angers University Hospital, Angers, France",https://ClinicalTrials.gov/show/NCT04779541
NCT04940182,A Study to Assess the Efficacy and Safety of XC221 in Patients With Mild COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",XC221-03-03-2020,"Regional State Budgetary Institution of Healthcare ""City Hospital No. 5, Barnaul"", Barnaul, Altai Region, Russian Federation|State Budgetary Institution of Healthcare of Moscow Region ""Zhukovskaya City Clinical Hospital"", Zhukovskiy, Moscow Region, Russian Federation|Municipal Budgetary Institution of Healthcare ""Central City Hospital of Novoshakhtinsk"", Novoshakhtinsk, Rostov Region, Russian Federation|Regional Budgetary Institution of Healthcare ""Ivanovskaya Clinical Hospital named after Kuvaevykh"", Ivanovo, Russian Federation|State Budgetary Institution of Healthcare of Moscow ""City Polyclinic No. 2 of the Moscow Department of Healthcare"", Moscow, Russian Federation|Federal Budgetary Institution of Science ""Moscow Research Institute of Epidemiology and Microbiology named after G.N. Gabrichevsky"" of the Federal Service for the Oversight of Consumer Protection and Welfare, Moscow, Russian Federation|Limited Liability Company ""Medical Center ""Capital-Policy"", Saint Petersburg, Russian Federation|Saint Petersburg State Budgetary Institution of Healthcare ""City Hospital No. 40 of Kurortny District"", Saint Petersburg, Russian Federation|Saint Petersburg State Budgetary Institution of Healthcare ""City Polyclinic No. 106"", Saint Petersburg, Russian Federation|Saint Petersburg State Budgetary Institution of Healthcare ""City Pokrovskaya Hospital"" (4th Cardiology Department), Saint Petersburg, Russian Federation|Saint Petersburg State Budgetary Institution of Healthcare ""City Pokrovskaya Hospital"" (Intensive Care Department for Cardiac Patients), Saint Petersburg, Russian Federation|Saint Petersburg State Budgetary Institution of Healthcare ""City Polyclinic No. 4"", Saint Petersburg, Russian Federation|Regional State Budgetary Institution of Healthcare ""Medical-Sanitary Unit No. 2"", Tomsk, Russian Federation",https://ClinicalTrials.gov/show/NCT04940182
NCT04780295,COvid-19 REgistry on THROMBOSIS Complications,Observational Model: Cohort|Time Perspective: Retrospective,CTH C010|DRKS00022277,"Unicamp (Universidade Estadual de Campinas; University of Campinas), Campinas, Brazil|Hospital Sírio-Libanês, São Paulo, Brazil|Hospital de Campanha Anhembi, São Paulo, Brazil|Amager and Hvidovre Hospital, Hvidovre, Denmark|DRK Kliniken Berlin Köpenick, Berlin Köpenick, Germany|DRK Kliniken Berlin Westend, Berlin Westend, Germany|Universitätsklinikum Koeln, Cologne, Germany|Augusta-Krankenhaus Duesseldorf, Duesseldorf, Germany|Universitäts-Herzzentrum Freiburg, Freiburg, Germany|Universitätsklinikum des Saarlandes und Medizinische Fakultät der Universität des Saarlandes, Homburg, Germany|Universitätsmedizin Mainz, Mainz, Germany|Krankenhaus Neuwittelsbach, Munich, Germany|Paracelsus Medizinische Privatuniversität am Klinikum Nuernberg, Nuremberg, Germany|Mater Misericordiae University Hospital, Dublin, Ireland|University of Bologna, Bologna, Italy|Azienda Socio Sanitaria Territoriale (ASST) Lariana, Como, Italy|Ospedale Sacra Famiglia Fatebenefratelli, Erba, Italy|Presidio Ospedaliero Santa Croce di Fano, Fano, Italy|IRCCS Ospedale Policlinico San Martino, Genova, Italy|Ospedale Civile di Guastalla - Azienda Unità Sanitaria Locale (AUSL) Reggio Emilia, Guastalla, Italy|Azienda Ospedaliera di Padova, Padova, Italy|Ospedale Maggiore di Parma - Azienda Ospedaliero Universitaria di Parma, Parma, Italy|Ospedale Maggiore di Parma - Azienda Ospedaliero Universitaria di Parma, Parma, Italy|Fondazione IRCCS Policlinico San Matteo, Pavia, Italy|Ospedale Civile di Castel San Giovanni - Azienda Unità Sanitaria Locale (AUSL) di Piacenza, Piacenza, Italy|Santa Maria Nuova Hospital - Azienda Unità Sanitaria Locale (AUSL) IRCCS di Reggio Emilia, Reggio Emilia, Italy|IRCCS Humanitas Clinical and Research Hospital, Rozzano, Italy|Università degli studi dell' Insubria (University of Insubria), Varese, Italy|Instituto Nacional de Cardiologia Ignacio Chavez (National Institute of Cardiology Igancio Chavez), Mexico City, Mexico|Hospital Quirónsalud, Málaga, Spain|Erdem Medical Center, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04780295
NCT04689490,Prospective Study of Persistent Dyspnea in Recovered COVID-19 Patients,Observational Model: Cohort|Time Perspective: Prospective,CASVE PI-20-1894,"Hospital Clínico Universitario de Valladolid, Valladolid, Spain",https://ClinicalTrials.gov/show/NCT04689490
NCT04494646,BARCONA: A Study of Effects of Bardoxolone Methyl in Participants With SARS-Corona Virus-2 (COVID-19),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",20-00591,"HSHS St. John's Hospital (Prairie Education and Research Cooperative), Springfield, Illinois, United States|SIU School of Medicine, Springfield, Illinois, United States|NYU Langone Hospital - Brooklyn, Brooklyn, New York, United States|Coney Island Hospital, Brooklyn, New York, United States|Elmhurst Hospital Center, Elmhurst, New York, United States|NYU Winthrop Hospital, Mineola, New York, United States|NYU Bellevue Hospital Center, New York, New York, United States|NYU Langone Health, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04494646
NCT04348877,Plasma Rich Antibodies From Recovered Patients From COVID19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,FMASU P15/ 2020,"Faculty of Medicine Ain Shams University Research Institute- Clinical Research Center, Cairo, Non-US, Egypt",https://ClinicalTrials.gov/show/NCT04348877
NCT04385069,COVID-19 Hyperinflammation Syndrome (COV-HI): Protocol for a Rapidly Executed Cohort Study,Observational Model: Cohort|Time Perspective: Retrospective,132388,"The Leeds Teaching Hospitals NHS Trust, St James University Hospital, Leeds, United Kingdom|University College London Hospitals NHS Foundation Trust, London, United Kingdom|The Newcastle Upon Tyne Hospitals NHS Foundation Trust, Freeman Hospital, Newcastle Upon Tyne, United Kingdom|Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom|Sheffield Teaching Hospitals NHS Trust, Northern General Hospital, Sheffield, United Kingdom",https://ClinicalTrials.gov/show/NCT04385069
NCT04425850,USEFULNESS of Topic Ivermectin and Carrageenan to Prevent Contagion of Covid 19,Observational Model: Cohort|Time Perspective: Prospective,IVERCAR,"Hospital Eurnekian, Buenos Aires, Argentina",https://ClinicalTrials.gov/show/NCT04425850
NCT04981249,Chronic Multimorbidity Patterns in Relation to COVID-19 Severe Infection,Observational Model: Cohort|Time Perspective: Retrospective,CIR 2020/023,"Corporacio Parc Taulí, Sabadell, Spain",https://ClinicalTrials.gov/show/NCT04981249
NCT04595110,Hemostatic Profile in Patients Affected by COVID-19,Observational Model: Cohort|Time Perspective: Prospective,EMO-COVID-ASSTPG23,"Papa Giovanni XXIII Hospital - S.I.M.T., Bergamo, Italy",https://ClinicalTrials.gov/show/NCT04595110
NCT04979923,"Efficacy of Nebulized Lidocaine, Salbutamol, and Beclomethasone Plus Salbutamol in the Covid-19 Patients With ARDS on Non-invasive Ventilation; Randomized Control Trial","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Supportive Care",227/IRB/SZMC/SZH,"Sheikh zayed medical college & hospital, Rahim Yar Khan, Punjab, Pakistan",https://ClinicalTrials.gov/show/NCT04979923
NCT04757831,Coronavirus-19 (COVID-19) and Related Outcomes in School Aged Children (ABC Health Outcomes in Children),Observational Model: Cohort|Time Perspective: Prospective,Pro00107647,NA,https://ClinicalTrials.gov/show/NCT04757831
NCT04881305,Characterizing Long-term Cognitive and Emotional Impairment in Post-COVID-19 Sequelae,Observational Model: Case-Control|Time Perspective: Retrospective,RMC-0939-20,"Rabin Medical Center - Beilinson Hospital, Petah Tikva, Israel",https://ClinicalTrials.gov/show/NCT04881305
NCT04435223,Lipid Metabolism in COVID-19 Severe Pneumonia Compared With Severe Pneumonia Caused by Other Pathogen,Observational Model: Cohort|Time Perspective: Prospective,NGUYEN AOIc 2020,"Chu Dijon Bourgogne, Dijon, France",https://ClinicalTrials.gov/show/NCT04435223
NCT04760990,A Study to Assess the Potential Impact of Disease Modifying Therapies on COVID-19 Outcomes and the Antibody Response Following an Infection With SARS-CoV-2 in Patients With Multiple Sclerosis Within the Swiss Multiple Sclerosis Cohort.,Observational Model: Cohort|Time Perspective: Prospective,2020-02604; me20Mehling,"Kantonsspital Aarau, Aarau, Switzerland|University Hospital Basel, Department of Neurology and Department of Biomedicine, Basel, Switzerland|Inselspital Bern, Bern, Switzerland|Hôpitaux Universitaires Genève, Genève, Switzerland|Lausanne University Hospital (CHUV), Lausanne, Switzerland|Ospedale Regionale di Lugano, Lugano, Switzerland|Kantonsspital St. Gallen, St. Gallen, Switzerland",https://ClinicalTrials.gov/show/NCT04760990
NCT04390191,Early CPAP in COVID-19 Confirmed or Suspected Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,GCO 20-0900,"Icahn School of Medicine at Mount Sinai, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04390191
NCT04786041,the Impact of COVID-19 Pandemic on the Incidence and Outcome of Complicated Appendicitis,Observational Model: Cohort|Time Perspective: Retrospective,MMC-0223-20,"Meir medical center, Kfar Saba, Israel",https://ClinicalTrials.gov/show/NCT04786041
NCT04590170,French Cohort of COVID-19 Patients With Post-intensive Care Syndrome,Observational Model: Cohort|Time Perspective: Retrospective,APHP200812,"Department of Physical Medicine and Rehabilitation, Issy-les-Moulineaux, France|Department of Rehabilitation, Institute of Rheumatology Cochin, Paris, France",https://ClinicalTrials.gov/show/NCT04590170
NCT04721535,A Study of DWJ1248 in Prevention of COVID-19 Infection After the Exposure of SARS-COV-2,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention",DW_DWJ1248303,NA,https://ClinicalTrials.gov/show/NCT04721535
NCT04714333,Detection of Covid-19 by Volatile Organic Compounds in Exhaled Breath,Observational Model: Cohort|Time Perspective: Prospective,H20-01234,"BC Cancer Research Centre, Vancouver, British Columbia, Canada|British Columbia Research Centre, Vancouver, British Columbia, Canada",https://ClinicalTrials.gov/show/NCT04714333
NCT04435795,Inhaled Ciclesonide for Outpatients With COVID19,"Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",2021-6696,"University of British Columbia, Vancouver, British Columbia, Canada|Sunnybrook Hospital, Toronto, Ontario, Canada|McGill University Health Center, Montreal, Quebec, Canada",https://ClinicalTrials.gov/show/NCT04435795
NCT04469491,Treatment of COVID-19 by Nebulization of Inteferon Beta 1b Efficiency and Safety Study,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",PI2020_843_0041,"CH d'Abbeville, Abbeville, France|CHU Amiens, Amiens, France|CH Compiègne-Noyon, Compiegne, France|CH de l'Arrondissement de Montreuil-sur-mer, Rang-du-Fliers, France|CH de Saint-Quentin, Saint-Quentin, France|CH de Tourcoing, Tourcoing, France|CH de valenciennes, Valenciennes, France",https://ClinicalTrials.gov/show/NCT04469491
NCT04903834,Identification of Novel Factors Leading to Activated Macrophage Expansion in COVID19 - INFLAME Study,Observational Model: Cohort|Time Perspective: Retrospective,RHM MED1717,"University Hospitals Southampton NHS Foundation Trust, Southampton, Hampshire, United Kingdom",https://ClinicalTrials.gov/show/NCT04903834
NCT04910282,Impact of COVID-19 on Quality of Life of Seniors With Eye Disease and Implementations to Improve Wellness,Observational Model: Cohort|Time Perspective: Cross-Sectional,115875,NA,https://ClinicalTrials.gov/show/NCT04910282
NCT04636086,Effect of Vitamin D on Hospitalized Adults With COVID-19 Infection,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",D-COVID,"CHU Liège, Liège, Belgium",https://ClinicalTrials.gov/show/NCT04636086
NCT04397614,Mobile Health Study and Enhanced Symptom Monitoring in COVID-19 Cancer Patients,Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Screening,COVID-19 Mobile Health,"Stephenson Cancer Center, Oklahoma City, Oklahoma, United States",https://ClinicalTrials.gov/show/NCT04397614
NCT04908007,COvid Pandemic Institutional maNaGement,Observational Model: Other|Time Perspective: Prospective,69HCL20_0466,"CHU Clermont-Ferrand , Pôle de Santé Publique, unité d'Epidémiologie, Economie de la Santé et Prévention, Clermont-Ferrand, France|CHU Grenoble, Pôle Santé Publique, service de veille sanitaire, Grenoble, France|Hospices Civils de Lyon, DOQ-RU, Lyon, France|CHU Saint-Etienne , Unité de gestion du risque infectieux, Saint-Étienne, France",https://ClinicalTrials.gov/show/NCT04908007
NCT04726098,Low or High Dose of Dexamethasone in Patients With Respiratory Failure by COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,HIGHLOWDEXA-COVID|2020-005702-25,"University Clinical Hospital of Santiago de Compostela, Santiago de Compostela, A Coruña, Spain",https://ClinicalTrials.gov/show/NCT04726098
NCT04913116,Generic Testing of Antigen Tests for COVID-19 in Denmark,Observational Model: Other|Time Perspective: Prospective,Nat COVID Ag Project,"Aarhus University Hospital, Aarhus, Denmark|Hvidovre University Hospital, Hvidovre, Denmark|Odense University Hospital, Odense, Denmark",https://ClinicalTrials.gov/show/NCT04913116
NCT04847791,Lactoferrin in Covid-19 Hospitalized Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",2020/279,"ASL BI Ospedale degli Infermi, Ponderano, Biella, Italy|AOU Ospedale Maggiore della Carità, Novara, Italy",https://ClinicalTrials.gov/show/NCT04847791
NCT04753762,Multimodal IMAgery Characterization of Cardiac Damage and Severity After COVID-19 Infection,Observational Model: Other|Time Perspective: Retrospective,2020PI086,"Laura FILIPPETTI, Vandœuvre-lès-Nancy, France",https://ClinicalTrials.gov/show/NCT04753762
NCT04896905,Rehabilitation After Covid19-Clinical Results and Predictive Factors,Observational Model: Case-Control|Time Perspective: Other,Covid19_2020,"Rehabilitationszentrum Klinik Valens, Valens, SG, Switzerland",https://ClinicalTrials.gov/show/NCT04896905
NCT04488484,Medical and Serological Follow-up of the Staff of the Paris Saint-Joseph Hospital Group Infected With Severe Acute Respiratory Syndrome Coronavirus 2.,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,PERSO-COVID,"Groupe Hospitalier Paris Saint-Joseph, Paris, France",https://ClinicalTrials.gov/show/NCT04488484
NCT04647994,Exploratory Study: COVID-19 and Pregnancy,Observational Model: Cohort|Time Perspective: Prospective,30270820.3.0000.0068,"Rossana P Fracisco, São Paulo, Brazil",https://ClinicalTrials.gov/show/NCT04647994
NCT04581915,PHRU CoV01 A Trial of Triazavirin (TZV) for the Treatment of Mild-moderate COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",PHRU CoV01,"The Perinatal HIV Research Unit - Matlosana, Klerksdorp, North West Province, South Africa",https://ClinicalTrials.gov/show/NCT04581915
NCT04561024,Evaluation of a COVID-19 Pneumonia CXR AI Detection Algorithm,Observational Model: Cohort|Time Perspective: Retrospective,EN-092020,"University of Hong Kong, Hong Kong, Hong Kong",https://ClinicalTrials.gov/show/NCT04561024
NCT04456101,"Study on the Recovery of Pulmonary Function, Chest CT, Hematologic, and Immune & Inflammatory Conditions in COVID-19 Rehabilitation Patients",Observational Model: Cohort|Time Perspective: Prospective,NCIP03,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China",https://ClinicalTrials.gov/show/NCT04456101
NCT04581044,Impact of COVID-19 on Psoriasis Practice,Observational Model: Case-Crossover|Time Perspective: Cross-Sectional,KAPU2020 10,"Department of Dermatology, Cairo University, Cairo, Egypt",https://ClinicalTrials.gov/show/NCT04581044
NCT04604249,Prevalence of COVID-19 in High Altitude : Insights From the Highest City of the World,Observational Model: Ecologic or Community|Time Perspective: Cross-Sectional,RINCOVID,"La Rinconada, Puno, Peru",https://ClinicalTrials.gov/show/NCT04604249
NCT04967430,TOGETHER - Toronto: Trial to Evaluate the Effect of Peginterferon Lambda for the Treatment of COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",JF-12-2020|21-5018,"Toronto General Hospital, Toronto, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04967430
NCT04312100,Sequential Oxygen Therapy Strategy for Patients With COVID-19,Observational Model: Cohort|Time Perspective: Prospective,SOT-C,"Henan Provincial People's Hospital, Zhengzhou, Henan, China",https://ClinicalTrials.gov/show/NCT04312100
NCT04379310,Evaluation of Clinical Parameters on Admission and Medications in Covid-19 Pneumonia (Corona Virus Disease 2019),Observational Model: Cohort|Time Perspective: Retrospective,20200504441,"Vital Hospital, Bahcelievler, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04379310
NCT04623619,Efficacy and Safety of Acetyl L-Carnitine in COVID-19 Patients With Mild-to-Moderate Disease,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,20201109,NA,https://ClinicalTrials.gov/show/NCT04623619
NCT04503447,COVID-19 Seroprevalence Study in ITM Staff,Observational Model: Other|Time Perspective: Cross-Sectional,SARSCOV2SEROPREVALENCEITMSTAFF,"Institute of Tropical Medicine, Antwerp, Belgium",https://ClinicalTrials.gov/show/NCT04503447
NCT04395976,Ayurveda as Prophylaxis for Suspected COVID-19 Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,BAMC01,"British Ayurvedic Medical Council, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04395976
NCT04685512,Effect of Tenofovir/Emtricitabine in Patients Recently Infected With SARS-COV2 (Covid-19) Discharged Home,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,20-070,"Caen University Hospital, Caen, Calvados, France|Regional Hospital, Orléans, France",https://ClinicalTrials.gov/show/NCT04685512
NCT04910230,Nicotinamide-based Supportive Therapy in Lymphopenia for Patients With COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Supportive Care",N2020-12,"General Hospital of Northern Theater Command, Shenyang, Liaoning, China",https://ClinicalTrials.gov/show/NCT04910230
NCT04789512,Respiratory Muscle Strength in Volleyball Players Suffered From COVID-19,Observational Model: Case-Control|Time Perspective: Prospective,2021-189,"Gazi University, Ankara, Çankaya, Turkey",https://ClinicalTrials.gov/show/NCT04789512
NCT04407559,COVID-SErology in Rheumatoid Arthritis (COVID-19),Observational Model: Cohort|Time Perspective: Retrospective,RECHMPL20_0330,"Uhmontpellier, Montpellier, France",https://ClinicalTrials.gov/show/NCT04407559
NCT04879251,The Impact of the COVID-19 Pandemic on Cardiovascular Risk Factors in Patients With Diabetes,Observational Model: Cohort|Time Perspective: Other,3/IK-FNO/2021,"University Hospital Ostrava, Ostrava, Czechia",https://ClinicalTrials.gov/show/NCT04879251
NCT04691934,Obstetric Anesthesia Experiences in COVID-19 Positive Patients,Observational Model: Cohort|Time Perspective: Retrospective,U1111-1263-2201,"University of Health Sciences Turkey, Bursa Yuksek Ihtisas Training and Research Hospital, Bursa, Yıldırım, Turkey",https://ClinicalTrials.gov/show/NCT04691934
NCT04607941,"Study of Socio-demographic Factors, Behaviors and Practices Associated With Infection With SARS-CoV-2 Responsible for COVID-19",Observational Model: Case-Control|Time Perspective: Prospective,2020-047|2020-A02560-39,"Caisse Nationale d'Assurance Maladie, Paris, France|IPSOS, Paris, France",https://ClinicalTrials.gov/show/NCT04607941
NCT04983446,In-patient COVID-19 Study of Intranasal Foralumab,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",TILS-016,NA,https://ClinicalTrials.gov/show/NCT04983446
NCT04377646,A Study of Hydroxychloroquine and Zinc in the Prevention of COVID-19 Infection in Military Healthcare Workers,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention",UR17DN02-001|TN2020-NAT-INS-38,"Military Hospital of Tunis, Tunis, Tunisia",https://ClinicalTrials.gov/show/NCT04377646
NCT04407299,COVID-19 Impact on Rheumatic Patients,Observational Model: Other|Time Perspective: Cross-Sectional,COVID-19Rheum,"Kasr Alainy Hospital, Cairo, Non-US/Non-Canadian, Egypt",https://ClinicalTrials.gov/show/NCT04407299
NCT04544150,Gastrointestinal Manifestations Among Patients With COVID19,Observational Model: Case-Only|Time Perspective: Prospective,COVID19 and GUT,"Ahmed, Al Minyā, Alminya, Egypt",https://ClinicalTrials.gov/show/NCT04544150
NCT04349631,A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) to Provide Protection Against COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,HBCOV01,"Hope Biosciences Stem Cell Research Foundation, Sugar Land, Texas, United States",https://ClinicalTrials.gov/show/NCT04349631
NCT04563247,Seroprevalence of SARS-CoV-2 in Asymptomatic Frontline COVID-19 HCWs,Observational Model: Cohort|Time Perspective: Retrospective,LGH002,"Lahore General Hospital, Lahore, Punjab, Pakistan",https://ClinicalTrials.gov/show/NCT04563247
NCT04939402,SARS-COV-2 Seroprevalence and Seroconversion Among Employees of the UZ Brussel Following COVID-19 Vaccination Using an Adenoviral Vector,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,COVEMUZ-3,"UZ Brussel, Brussels, Belgium",https://ClinicalTrials.gov/show/NCT04939402
NCT04546191,Symptoms and Wellbeing of People Infected With Covid-19 Virus in Iceland,Observational Model: Cohort|Time Perspective: Cross-Sectional,LSH-20-002,"Landspitali National University Hospital, Reykjavík, Ísland, Iceland",https://ClinicalTrials.gov/show/NCT04546191
NCT04625075,Manganese-Enhanced Magnetic Resonance Imaging of MyOcardial injuRY in COVID 19 (COVID-19),Observational Model: Case-Control|Time Perspective: Retrospective,20/NW/0249,"University of Edinburgh, Edinburgh, Scotland, United Kingdom",https://ClinicalTrials.gov/show/NCT04625075
NCT04399733,EMPOWER - BAME vs COVID,Observational Model: Cohort|Time Perspective: Prospective,EMPOWER-BAME vs COVID,"Future Genetics Limited, Birmingham, West Midlands, United Kingdom",https://ClinicalTrials.gov/show/NCT04399733
NCT04920916,Safety and Efficacy of Dupilumab for Treatment of Hospitalized COVID-19 Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",HSR210184,"UVA Health, Charlottesville, Virginia, United States",https://ClinicalTrials.gov/show/NCT04920916
NCT04424771,Post-traumatic Stress Disease in Health Workers During COVID-19 Pandemia,Observational Model: Cohort|Time Perspective: Prospective,PTSD-COVID-19,"Ospedale Perrino Asl Brindisi, Brindisi, Italy|Piazza della Vittoria 14 Studio medico - Ginecologia e Ostetricia, Genoa, Italy",https://ClinicalTrials.gov/show/NCT04424771
NCT04663555,Effect of Two Different Doses of Dexamethasone in Patients With ARDS and COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,CZECRIN No. 2020/47|2020-005887-70,"University Hospital Brno, Brno, Czechia",https://ClinicalTrials.gov/show/NCT04663555
NCT04542980,Qualitative Evaluation of Tear Fluid and Blood for Auto Antibodies Produced in Response to COVID-19,Observational Model: Case-Control|Time Perspective: Retrospective,CVDTRS001,NA,https://ClinicalTrials.gov/show/NCT04542980
NCT04334460,Safety and Antiviral Activity of BLD-2660 in COVID-19 Hospitalized Subjects,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",B-2660-204,"Blade Research Site, Irvine, California, United States|Blade Research Site, Los Angeles, California, United States|Blade Reseach Site, San Jose, California, United States|Blade Research Site, Washington, District of Columbia, United States|Blade Research Site, Washington, District of Columbia, United States|Blade Research Site, Brandon, Florida, United States|Blade Research Site, Fort Pierce, Florida, United States|Blade Research Site, Panama City, Florida, United States|Blade Research Site, Tampa, Florida, United States|Blade Research Site, Idaho Falls, Idaho, United States|Blade Research Site, Peoria, Illinois, United States|Blade Research Site, Ames, Iowa, United States|Blade Research Site, Lexington, Kentucky, United States|Blade Research Site, Louisville, Kentucky, United States|Blade Research Site, Baltimore, Maryland, United States|Blade Research Site, Detroit, Michigan, United States|Blade Research Site, Farmington Hills, Michigan, United States|Blade Research Site, Omaha, Nebraska, United States|Blade Research Site, Ridgewood, New Jersey, United States|Blade Research Site, Charleston, North Carolina, United States|Blade Research Site, Durham, North Carolina, United States|Blade Research Site, Fayetteville, North Carolina, United States|Blade Research Site, Philadelphia, Pennsylvania, United States|Blade Research Site, Charleston, South Carolina, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|Blade Research Site, Dallas, Texas, United States|Blade Research Site, Spokane, Washington, United States|Blade Research Site, Campinas, Sao Paulo, Brazil|Blade Research Site, Bahia, Brazil|Blade Research Site, Belo Horizonte, Brazil|Blade Research Site, Botucatu, Brazil|Blade Research Site, Porto Velho, Brazil|Blade Research Site, Ribeirão Preto, Brazil|Blade Research Site, São José Do Rio Preto, Brazil|Blade Research Site, Vitória, Brazil",https://ClinicalTrials.gov/show/NCT04334460
NCT04387955,Analysis of Chilblains pROfile During coVID-19 Epidemic (ACROVID),Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,ACROVID,"CHU de Poitiers, Poitiers, France",https://ClinicalTrials.gov/show/NCT04387955
NCT04849611,Covid-19 Fear and Compliance With Protective Measures of Students,Observational Model: Other|Time Perspective: Prospective,q9wrjg2p,"Ordu University, Ordu, Ordu Province, Turkey",https://ClinicalTrials.gov/show/NCT04849611
NCT04509973,Higher vs. Lower Doses of Dexamethasone for COVID-19 and Severe Hypoxia,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",RH-ITA-009|2020-003363-25|2020-07-16|H-20051056,"Dept. of Anaesthesia and Intensive Care, Aalborg University Hospital, Denmark., Aalborg, Denmark|Dept. of Intensive care, Aarhus University Hospital, Aarhus, Denmark|Dept. of Intensive Care, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark|Dept. of Neuroanaesthesiology, Copenhagen, Denmark|Dept. of Thoracic Anaesthesiology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark|Dept of Infectious diseases, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark|Dept. of Intensive Care, Gentofte Hospital, Hellerup, Denmark|Dept. of Anaesthesia and Intensive Care, Herlev Hospital, Herlev, Denmark|Dept. of Anaesthesia, Regional Hospital West Jutland, Herning, Herning, Denmark|Dept. of Intensive Care, Nordsjællands Hospital - Hillerød, Denmark., Hillerød, Denmark|Hvidovre Hospital - Dept of Infectious diseases, Hvidovre, Denmark|Hvidovre Hospital - Dept of Intensive Care, Hvidovre, Denmark|Hvidovre Hospital - Dept of Pulmonary Medicine, Hvidovre, Denmark|Dept. of Anaesthesia and Intensive Care, Lillebaelt Hospital, Kolding, Denmark|Dept. of Intensive Care, Køge University Hospital, Køge, Denmark|Dept of Intensive Care, Odense University Hospital, Odense, Denmark|Dept. of Anaesthesia and Intensive Care, Zealand University Hospital Roskilde, Roskilde, Denmark|Dept. of Anaesthesia, Slagelse Hospital, Slagelse, Denmark|Dept. of Anaesthesia and Intensive Care, Viborg Hospital, Viborg, Denmark|Jawahar Lal Nehru Medical Collega, AMU, Aligarh, India|Apollo Hospital, Chennai, India|Amrita Institute of Medical Sciences, Kochi, India|Bombay Hospital & Medical Research Centre, Mumbai, India|K. J. Somaiya Super Specialty Hospital, Mumbai, India|P. D. Hinduja National Hospital & Medical Research Centre, Mumbai, India|S L Raheja Fortis Hospital, Mumbai, India|Tata Memorial Hospital, Mumbai, India|Wockhardt hospitals, Mumbai, India|Indraprastha Apollo Hospital, New Delhi, India|Max Super Specialty Hospital, Saket, New Delhi, India|Symbiosis University Hospital and Research Centre, Pune, India|Vishwaraj Hospital, Pune, India|Rajendra Institute of Medical Sciences, Ranchi, India|Gotri General Hospital, Vadodara, India|Christian Medical College Vellore, Vellore, India|Dept. of Anaesthesia and Intensive Care, Sahlgranska Universitetssjukhuset, Göteborg, Sweden|Dept. of Infectious Diseases, Sahlgranska Universitetssjukhuset, Göteborg, Sweden|Dept. of Anaesthesia and Intensive Care, Universitetssjukhuset i Linköping, Linköping, Sweden|Dept. of Anaesthesia and Intensive Care, Skånes Universitetssjukhus (SUS) Malmö, Malmö, Sweden|Dept. of Infectious Diseases, Skånes Universitetssjukhus (SUS) Malmö, Malmö, Sweden|Dept. of Anaesthesia and Intensive Care, Vrinnevisjukhuset, Norrköping, Norrköping, Sweden|Dept. of Anaesthesia and Intensive Care, Capio St Görans Sjukhus, Stockholm, Sweden|Dept. of Anaesthesia and Intensive Care, Danderyds Sjukhuset, Stockholm, Sweden|Dept. of Anaesthesia and Intensive Care, Karolinska Universitetssjukhuset, Huddinge, Stockholm, Sweden|Dept. of Anaesthesia and Intensive Care, Karolinska Universitetssjukhuset, Solna, Stockholm, Sweden|Dept. of Cardiology, Södersjukhuset, Stockholm, Sweden|Dept. of Infectious Diseases, Danderyds Sjukhuset, Stockholm, Sweden|Dept. of Infectious Diseases, Karolinska Universitetssjukhuset, Solna, Stockholm, Sweden|Dept. of Infectious Diseases, Södersjukhuset, Stockholm, Sweden|Dept. of Internal Medicine, Danderyds Sjukhuset, Stockholm, Sweden|Dept. of Internal Medicine, Södersjukhuset, Stockholm, Sweden|Södersjukhuset, Stockholm, Sweden|Dept. of Intensive Care Medicine, Bern University Hospital (Inselspital), Bern, Switzerland",https://ClinicalTrials.gov/show/NCT04509973
NCT04472728,Testing the Efficacy and Safety of BIO101 for the Prevention of Respiratory Deterioration in COVID-19 Patients,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",BIO101-CL05,"Abrazo Health, Phoenix, Arizona, United States|University of California, Irvine, Irvine, California, United States|Barnum Medical Research, Inc. 1029 Keyser Ave Suite H, Natchitoches, Louisiana, United States|Beaumont Health, Royal Oak, Michigan, United States|United Health Services Hospitals, Johnson City, New York, United States|WellSpan Health, York, Pennsylvania, United States|CHU Saint-Pierre, Brussels, Belgium|CHU Saint-Pierre, Brussel, Belgium|AZ-Sint Maarten, Mechelen, Belgium|CHU CLU Namur (Saint-Elisabeth) Place Louise Godin, Namur, Belgium|Hospital Vera Cruz, Belo Horizonte, Minas Gerais, Brazil|Santa Casa de Porto Alegre, Porto Alegre, Rio Grande Do Sul, Brazil|Hospital Municipal de Barueri Dr. Francisco Moran, Barueri, São Paulo, Brazil|Hospital e Maternidade Celso Pierro - PUCCAMP, Campinas, São Paulo, Brazil|Hospital de Base Da Faculdade de Medicina de São José Do Rio Preto, São José Do Rio Preto, São Paulo, Brazil|Avenida Dr. Enéas de Carvalho Aguiar, 44 - Centro de Pesquisa Clínica Prof. Dr. Fúlvio Pileggi - Bloco 1 - 1º Andar, São Paulo, Brazil|Unité ambulatoire Service de Pneumologie, Médecine Intensive et Réanimation (SPMIR) 47-83 Boulevard de l'Hôpital, Paris, Paris Cedex 13, France|Centre Hospitalier Argenteuil, Argenteuil, France|Centre Hospitalier Universitaire Bordeaux, Bordeaux, France|Centre Hospitalier Rene Dubos, Cergy-Pontoise, France|Centre Hospitalier Départemental de Vendée, La Roche-sur-Yon, France|Hôpital Pitié-Salpêtrière, 47 bd de l'Hôpital, 75013 Paris, Paris, France|FDI Clinical Research - San Juan City Hospital, San Juan, Puerto Rico",https://ClinicalTrials.gov/show/NCT04472728
NCT04668404,Study of Coagulation Profile and Role of Heparin Like Effect in Patients With COVID-19,Observational Model: Case-Only|Time Perspective: Prospective,IEC-04/2020-1641,"PGIMER, Chandigarh, India",https://ClinicalTrials.gov/show/NCT04668404
NCT04893070,"Impact of SARS-CoV-2 (COVID-19) Infection, Treated in Ambulatory Care, on Long-term Quality of Life in a Parisian Military Population",Observational Model: Case-Control|Time Perspective: Prospective,2020-COVID19-38|2021-A01038-33,"1er Centre Médical des Armées, Paris, France",https://ClinicalTrials.gov/show/NCT04893070
NCT04756518,COVID-19 Infection and Machine Learning Using Artificial Intelligence (AI),Observational Model: Cohort|Time Perspective: Other,20/053,"East Suffolk and North Essex NHS Foundation Trust, Ipswich, United Kingdom",https://ClinicalTrials.gov/show/NCT04756518
NCT04700462,COVID-19 Preventive Behavior in African Americans,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,IRB00250644|3R01AG056587-03S1,"Johns Hopkins School of Nursing, Baltimore, Maryland, United States",https://ClinicalTrials.gov/show/NCT04700462
NCT04530396,"Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention",04-Gam-COVID-Vac-2020,"ARCHIMED V Clinic of new medical technologies limited liability company, Moscow, Russian Federation|Hadassah LTD, Moscow, Russian Federation|Medsi Group of companies joint-stock company"", Moscow, Russian Federation|Niarmedic Plus, Moscow, Russian Federation|State budgetary healthcare institution of the city of Moscow ""City clinical hospital No. 52 of the Moscow city health Department"", Moscow, Russian Federation|State Budgetary Healthcare Institution, Moscow, Consultation and Diagnosis Polyclinic No. 121, Moscow Healthcare Department, Moscow, Russian Federation|State Budgetary Healthcare Institution, Moscow, M. Konchalovsky Municipal Clinical Hospital, Moscow Healthcare Department, Moscow, Russian Federation|State Budgetary Healthcare Institution, Moscow, M. Zhadkevich Municipal Clinical Hospital, Moscow Healthcare Department, Moscow, Russian Federation|State Budgetary Healthcare Institution, Moscow, Municipal Polyclinic No. 115, Moscow Healthcare Department, Moscow, Russian Federation|State Budgetary Healthcare Institution, Moscow, Municipal Polyclinic No. 2, Moscow Healthcare Department, Moscow, Russian Federation|State Budgetary Healthcare Institution, Moscow, Municipal Polyclinic No. 210, Moscow Healthcare Department, Moscow, Russian Federation|State Budgetary Healthcare Institution, Moscow, Municipal Polyclinic No. 212, Moscow Healthcare Department, Moscow, Russian Federation|State Budgetary Healthcare Institution, Moscow, Municipal Polyclinic No. 219, Moscow Healthcare Department, Moscow, Russian Federation|State Budgetary Healthcare Institution, Moscow, Municipal Polyclinic No. 220, Moscow Healthcare Department, Moscow, Russian Federation|State Budgetary Healthcare Institution, Municipal Polyclinic No. 62, Moscow Healthcare Department, Moscow, Russian Federation|State budgetary institution of health care of the city of Moscow "" city polyclinic No. 109 Of the Department of health of the city of Moscow"", Moscow, Russian Federation|State budgetary institution of health care of the city of Moscow "" city polyclinic No. 170 Of the Department of health of the city of Moscow"", Moscow, Russian Federation|State budgetary institution of health care of the city of Moscow "" city polyclinic No. 36 Of the Department of health of the city of Moscow"", Moscow, Russian Federation|State budgetary institution of health care of the city of Moscow "" city polyclinic No. 46 Of the Department of health of the city of Moscow"", Moscow, Russian Federation|State budgetary institution of health care of the city of Moscow "" city polyclinic No. 6 Of the Department of health of the city of Moscow"", Moscow, Russian Federation|State budgetary institution of health care of the city of Moscow "" city polyclinic No. 68 Of the Department of health of the city of Moscow"", Moscow, Russian Federation|State budgetary institution of health care of the city of Moscow ""Diagnostic center No. 5 with polyclinic Department Of the Department of health of the city of Moscow"", Moscow, Russian Federation|State budgetary institution of health care of the city of Moscow ""Diagnostic clinical center No. 1 Of the Department of health of the city of Moscow"", Moscow, Russian Federation",https://ClinicalTrials.gov/show/NCT04530396
NCT04979949,Booster Vaccination Against SARS-CoV-2,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention",Hybrid COV-Rapel TR,"Ankara City Hospital Internal Medicine Clinic, Ankara, Turkey",https://ClinicalTrials.gov/show/NCT04979949
NCT04323644,Outcomes of Surgery in COVID-19 Infection: International Cohort Study (CovidSurg),Observational Model: Cohort|Time Perspective: Other,CS-20200324,"Hospital del Henares, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04323644
NCT04841681,Video-based Psychotherapy for COVID-19 Patients in Isolation Ward in Jakarta,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,20-05-0546,"dr. Cipto Mangunkusumo National General Hospital, Jakarta Pusat, DKI Jakarta, Indonesia",https://ClinicalTrials.gov/show/NCT04841681
NCT04354259,Interferon Lambda for Immediate Antiviral Therapy at Diagnosis in COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",20-5334,"Hospital das Clínicas da Faculdade de Medicina de Botucatu, Botucatu, Brazil|Hospital das Clínicas São Paulo, Sao Paulo, Brazil|Hospital Alemão Oswaldo Cruz, São Paulo, Brazil|University of Calgary, Calgary, Alberta, Canada|Michael Garron Hospital, Toronto, Ontario, Canada|Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada|University Health Network, Toronto, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04354259
NCT04910360,Embolism in COVID-19 Positive Patients,Observational Model: Case-Control|Time Perspective: Cross-Sectional,21-Jan,"INTERGEN Genetics and Rare Diseases Diagnosis Research & Application Center, Ankara, Cankaya, Turkey",https://ClinicalTrials.gov/show/NCT04910360
NCT04444401,Registry on NEN Patients and COVID-19,Observational Model: Case-Only|Time Perspective: Other,IEO-1291,"European Institute of Oncology, IEO, IRCCS, Milan, MI, Italy",https://ClinicalTrials.gov/show/NCT04444401
NCT04703114,Study of the Immunological and Virological Response of Patients With COVID-19 and Presenting an Asymptomatic or Pauci-symptomatic Form (AMBUCOV),Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,AMBUCOV|2020-A03102-37,"Hôpital Cochin, Paris, Île-de-France, France",https://ClinicalTrials.gov/show/NCT04703114
NCT04928469,Clinical Impact of COVID-19 by P.1 SARS-CoV-2 Lineage,Observational Model: Cohort|Time Perspective: Retrospective,2020-0163,"Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil",https://ClinicalTrials.gov/show/NCT04928469
NCT04575064,An International Randomized Trial of Additional Treatments for COVID-19 in Hospitalized Patients Who Are All Receiving the Local Standard of Care - WHO-SOLIDARITY-GERMANY,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,WHO-SOLIDARITY-GERMANY|2020-001549-38,"Gesundheit Nord gGmbH, Bremen, Germany|Universitätsklinikum Gießen, Gießen, Germany|Medizinische Hochschule Hannover (MHH), Hannover, Germany|Technische Universität München (TUM), München, Germany",https://ClinicalTrials.gov/show/NCT04575064
NCT04354519,The United Kingdom Multiple Sclerosis Register Covid-19 Substudy,Observational Model: Cohort|Time Perspective: Prospective,16SW0194,"Swansea Univeristy, Swansea, United Kingdom",https://ClinicalTrials.gov/show/NCT04354519
NCT04831853,Self- Versus Conventional-swabbing for COVID-19 Screening (COVISWAB),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,RBHP 2020 MOISSET 2|2020-A02913-36,"CHU de Clermont-Ferrand, Clermont-Ferrand, France",https://ClinicalTrials.gov/show/NCT04831853
NCT04807699,Collaborative Network for Generating Scientific Evidence in COVID-19 For the Unified Health System in Brazil - RECOVER SUS-BRASIL,Observational Model: Cohort|Time Perspective: Prospective,32449420.4.1001.5262,"Hospital Couto Maia/SES/BA, Salvador, Bahia, Brazil|Hospital São José de Doenças Infecciosas - HSJ / Secretaria de Saúde Fortaleza, Fortaleza, Ceará, Brazil|Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil|Hospital Nossa Senhora da Conceição, Porto Alegre, Rio Grande Do Sul, Brazil|Universidade Federal de Santa Maria/ Pró-Reitoria de PósGraduação e Pesquisa, Santa Maria, Rio Grande Do Sul, Brazil|Hospital dos Servidores do Estado/RJ, Rio de Janeiro, RJ, Brazil|Hospital Universitário Gaffree e Guinle/HUGG/UNIRIO, Rio de Janeiro, RJ, Brazil|Hospital Universitário Pedro Ernesto/UERJ, Rio de Janeiro, RJ, Brazil|Instituto Nacional de Infectologia Evandro Chagas (Fiocruz), Rio de Janeiro, RJ, Brazil|Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil|Hospital Regional de São José, São José, Santa Catarina, Brazil|Hospital Estadual Sumaré Dr. Leandro Francheschini, Sumaré, São Paulo, Brazil|Instituto de Infectologia Emílio Ribas, São Paulo, Brazil",https://ClinicalTrials.gov/show/NCT04807699
NCT04716998,Safety and the Efficacy of MesenCure for the Treatment of Pulmonary Manifestations of COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,CP-MCS-01,"Rambam Health campus, Haifa, Israel",https://ClinicalTrials.gov/show/NCT04716998
NCT04799743,The Anti-fibrotic Therapeutic Effects of Resveratrol for Discharged COVID-19 Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",HKCOVID19Resveratrol,"Linda Zhong, Kowloon Tong, Kowloon, Hong Kong",https://ClinicalTrials.gov/show/NCT04799743
NCT04352842,Echocardiographic Manifestation in Patient With COVID-19 （EARLY-MYO COVID-19）,Observational Model: Cohort|Time Perspective: Prospective,COVID19-Echocardiography,"Ren Ji Hospital Affliated to School of Medicine, Shanghai Jiao Tong University, Shanghai, Shanghai, China",https://ClinicalTrials.gov/show/NCT04352842
NCT04888949,A Study of ADR-001 in Patients With Severe Pneumonia Caused by SARS-CoV-2 Infection (COVID-19),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",ADR-001-1921,"Osaka University Hospital, Suita, Osaka, Japan",https://ClinicalTrials.gov/show/NCT04888949
NCT04393961,At-Home COVID-19 Antibody Test Usability Assessment & Behavior Change Study,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Device Feasibility,2458,"ProofPilot Online App (https://p.proofpilot.com), New York, New York, United States",https://ClinicalTrials.gov/show/NCT04393961
NCT04909918,Impact of Steroids on Inflammatory Response in Covid-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment",17300610,"Assiut university hospital, Assiut, Assuit, Egypt",https://ClinicalTrials.gov/show/NCT04909918
NCT04734873,CPI-006 Plus Standard of Care Versus Placebo Plus Standard of Care in Mild to Moderately Symptomatic Hospitalized Covid-19 Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",CPI-006-003,"Sharp Chula Vista Medical Center, Chula Vista, California, United States|El Centro Regional Medical Center, El Centro, California, United States|Sharp Grossmont Hospital, La Mesa, California, United States|Torrance Memorial Medical Center, Torrance, California, United States|Mayo Clinic - Jacksonville, Jacksonville, Florida, United States|Cambridge Medical Trials, Alexandria, Louisiana, United States|MedPharmics, Metairie, Louisiana, United States|Holy Cross Hospital, Silver Spring, Maryland, United States|Mayo Clinic - Rochester, Rochester, Minnesota, United States|Stony Brook University Medical Center, Stony Brook, New York, United States|Cape Fear Valley Medical Center, Fayetteville, North Carolina, United States|Lehigh Valley Health Network, Allentown, Pennsylvania, United States|Temple University Hospital, Philadelphia, Pennsylvania, United States|Clinica Zabala, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina|Clínica Adventista Belgrano, Estomba, Buenos Aires, Argentina|Instituto Medico Platense, La Plata, Buenos Aires, Argentina|Clinica Independencia, Munro, Buenos Aires, Argentina|Instituto Médico Río Cuarto, Río Cuarto, Córdoba, Argentina|Centro de Investigación Clínica - Clínica Viedma, Viedma, Río Negro, Argentina|Centro Médico IPAM, Rosario, Santa Fe, Argentina|Hospital Provincial Del Centenario, Rosario, Santa Fe, Argentina|Clinica Mayo de U.M.C.B. S.R.L, San Miguel de Tucumán, Tucumán, Argentina|Hospital de Clínicas Presidente Dr. Nicolás Avellaneda, San Miguel De Tucumán, Tucumán, Argentina|Fundación Sanatorio Güemes, Ciudad Autónoma de Buenos Aires, Argentina|Sanatorio Finochietto, Ciudad Autónoma de Buenos Aires, Argentina|Hospital Rawson, Córdoba, Argentina|Hospital Vera Cruz, Belo Horizonte, Minas Gerais, Brazil|Hospital Agamenon Magalhães, Recife, Pernambuco, Brazil|Santa Casa de Porto Alegre, Porto Alegre, Rio Grande Do Sul, Brazil|Hospital Dia do Pulmão, Blumenau, Santa Catarina, Brazil|Clínica Supera, Chapecó, Santa Catarina, Brazil|Centro Hospitalar Nossa Saúde, Curitiba, Brazil|Universidade Municipal São Caetano do Sul, São Caetano do Sul, Brazil|Conjunto Hospitalar do Mandaqui, São Paulo, Brazil|Hospital Anchieta, São Paulo, Brazil|Hospital de Base Da Faculdade de Medicina de São José Do Rio Preto, São Paulo, Brazil|Hospital E Maternidade Celso Pierro PUCCAMP, São Paulo, Brazil|Universidade Federal Do Espirito Santo - Hospital Universitário Cassiano Antônio de Moraes - HUCAM, Vitória, Brazil|Toronto General Hospital, Toronto, Ontario, Canada|Hôpital Maisonneuve-Rosemont, Montréal, Quebec, Canada|Hospital Base de Osorno, Concepción, Chile|Clinica Vespucio, La Florida, Chile|Research Network Consulting, Linares, Chile|Clínica Dávila Y Servicios Médicos SA, Santiago, Chile|Rodrigo Botero S.A.S, Medellín, Antioquia, Colombia|Fundacion Santa Fe de Bogota, Bogotá, Cundinamarca, Colombia|Clínica Universidad De la Sabana, Chía, Cundinamarca, Colombia|Fundacion Centro de Excelencia en Enfermedades Cronicas No Transmisibles, Monteria, Córdoba, Colombia|Clínica de la Mujer S.A.S., Bogotá, Colombia|Hospital Universitario Clinica San Rafael, Bogotá, Colombia|Fundacion Hospitalaria San Vicente de Paul, Medellín, Colombia|Promotora Medica Las Américas S.A- Clínica Las Américas, Medellín, Colombia|Fundación Valle Del Lili, Santiago de Cali, Colombia|Medizinische Hochschule Hannover, Hannover, Niedersachsen, Germany|Azienda Ospedaliera Cotugno, Napoli, Campania, Italy|ASST Fatebenefratelli Sacco - Ospedale Luigi Sacco, Milano, Lombardia, Italy|ASST Grande Ospedale Metropolitano Niguarda - Presidio Ospedaliero Ospedale Niguarda Ca' Granda, Milano, Lombardia, Italy|ASST Santi Paolo e Carlo - Azienda Universitaria-Polo Universitario San Paolo, Milano, Lombardia, Italy|Ospedale San Raffaele S.r.l., Milano, Lombardia, Italy|ASST di Monza - Azienda Ospedaliera San Gerardo, Monza, Lombardia, Italy|Fondazione IRCCS Policlinico San Matteo di Pavia, Pavia, Lombardia, Italy|ASST della Valle Olona - Azienda Ospedaliera Ospedale Di Circolo Di Busto Arsizio, Busto Arsizio, Italy|Hospital Civil Fray Antonio Alcalde, Guadalajara, Jalisco, Mexico|Hospital Universitario Dr. Jose Eleuterio González, Monterrey, Nuevo Leon, Mexico|Hospital Civil de Culiacán, Culiacán, Sinaloa, Mexico|Hospital General de Culiacán, Culiacán, Sinaloa, Mexico|Hospital Nacional Sergio E. Bernales, Comas, Lima, Peru|Hospital Chancay y Servicios Basicos de Salud, Huaral, Lima, Peru|Hospital Central Fuerza Aérea del Perú, Miraflores, Lima, Peru|Hospital María Auxiliadora, San Juan De Miraflores, Lima, Peru|Clínica Providencia, San Miguel, Lima, Peru|Clínica San Pablo, Santiago De Surco, Lima, Peru|Hospital Alberto Sabogal Sologuren, Callao, Peru|Hospital Nacional Adolfo Guevara Velasco Essalud, Cusco, Peru|Hospital Militar Central, Lima, Peru|Hospital Nacional Guillermo Almenara Irigoyen, Lima, Peru|Hospital Costa del Sol, Marbella, Málaga, Spain|Complejo Hospitalario de Navarra, Pamplona, Navarra, Spain|Hospital del Mar, Barcelona, Spain|Hospital General Universitario de Guadalajara, Guadalajara, Spain|Complejo Asistencial Universitario de Salamanca - H. Clinico, Salamanca, Spain|Hospital Universitario A Coruña, Santiago de Compostela, Spain|Municipal Institution City Clinical Hospital #6 of Dnipropetrovsk Regional Council, Dnipro, Dnipropetrovs'ka Oblast, Ukraine|Kharkiv Regional Clinical Infectious Diseases Hospital, Kharkiv, Kharkivs'ka Oblast, Ukraine|Poltava Regional Clinical Infectious Hospital, Poltava, Poltavs'ka Oblast, Ukraine|Communal Non-Commercial Enterprise Vinnytsia City Clinical Hospital 1, Vinnytsya, Vinnytsia Oblast, Ukraine|Municipal enterprise Volyn Regional Clinical Hospital of Volyn Regional Council, Lutsk, Volyn Oblast, Ukraine|MNPE City Hospital No. 6 of Zaporizhzhia City Council, Zaporizhzhia, Zaporiz'ka Oblast, Ukraine|Municipal Institution City Hospital #7, Zhaporizhzhya, Zaporiz'ka Oblast, Ukraine|CNPE City Clinical Hospital #3 of Chernivtsi City Council, Chernivtsi, Ukraine|Municipal Non-profit Enterprise ""City Clinical Hospital # 4"" of Dnipro City Council, Dnipro, Ukraine",https://ClinicalTrials.gov/show/NCT04734873
NCT04398290,iNOPulse for COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",20200449,"University of Miami Hospitals & Clinics, Miami, Florida, United States",https://ClinicalTrials.gov/show/NCT04398290
NCT04824664,The ALIGHIERI Survey: an Italian Overview of Global Impact of tHe COVID-19 pandemIc on General surgERy practIce,Observational Model: Other|Time Perspective: Prospective,Survey_ACOI_COVID19,"ACOI, Roma, Lazio, Italy",https://ClinicalTrials.gov/show/NCT04824664
NCT04922905,Nervous System Symptoms Associated With COVID 19,Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,RC31/20/0178,"CHU Toulouse, Toulouse, France",https://ClinicalTrials.gov/show/NCT04922905
NCT04410549,Pulmonary Optical Coherence Tomography in COVID-19 Patients,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,OCT COVID,"Incor - Heart Institute - University of Sao Paulo, São Paulo, Brazil|IRCCS San Raffaele, Milano, Italy",https://ClinicalTrials.gov/show/NCT04410549
NCT04577235,Correlation Between Thoracic Ultrasound and Thorax Computed Tomography Scores.,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Diagnostic",AyşeV,"Gaziosmanpasa Taksim Research and Education Hospital, Istanbul, Gazi̇osmanpaşa, Turkey",https://ClinicalTrials.gov/show/NCT04577235
NCT04517123,"Prone Position and Respiratory Outcomes in Non-Intubated COVID-19 PatiEnts The ""PRONE"" Study",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,IRB00249663,"Johns Hopkins Univeristy, Baltimore, Maryland, United States|University of North Carolina, Chapel Hill, North Carolina, United States|Duke University, Durham, North Carolina, United States|UPMC, Pittsburgh, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04517123
NCT04330300,Coronavirus (COVID-19) ACEi/ARB Investigation,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,C.A. 2348,"University Hospital Galway, Galway, Ireland",https://ClinicalTrials.gov/show/NCT04330300
NCT04741386,The REnal Patients COVID-19 VACcination Immune Response (RECOVAC IR) Study,Observational Model: Cohort|Time Perspective: Prospective,NL76215.042.20,"Radboud university medical center, Nijmegen, Gelderland, Netherlands|Amsterdam University Medical Center, Amsterdam, Noord-Holland, Netherlands|Erasmus Medical Center, Rotterdam, Zuid-Holland, Netherlands|University Medical Center Groningen, Groningen, Netherlands",https://ClinicalTrials.gov/show/NCT04741386
NCT04684446,AstraZeneca Vax - Sputnik V Combination Study,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,D8111C00003,"Research Site, Vitebsk, Belarus|Research Site, Moscow, Russian Federation|Research Site, Moscow, Russian Federation|Research Site, Moscow, Russian Federation|Research Site, Saint-Petersburg, Russian Federation|Research Site, Saint-Petersburg, Russian Federation|Research Site, St. Petersburg, Russian Federation",https://ClinicalTrials.gov/show/NCT04684446
NCT04889365,COVID-19 Antigen Rapid Test Kit,Observational Model: Cohort|Time Perspective: Prospective,PTMK_2021_01,"Maria Sklodowska-Curie Medical Academy, Warsaw, Poland",https://ClinicalTrials.gov/show/NCT04889365
NCT04465513,Investigation of the Efficacy of CARDIO Softgels PLUS Best-standard-of-care in the Recovery of Patients With COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,20CCHH,"Hospital Universitario Cassiano Antonio de Morais, Vitória, Espírito Santo, Brazil|- Instituto de Pesquisa Clínica de Campinas, Campinas, Brazil|Instituto Santa Marta de Ensino e Pesquisa, Taguatinga, Brazil|KGK Science Inc., London, Ontario, Canada|Markhot Ferenc Oktatókórház és Rendelőintézet, Eger, Eger, Hungary|Albert Schweitzer Kórház-Rendelőintézet, Hatvan, Hatvan, Hungary|The American British Cowdray Medical Center I.A.P., Ciudad de México, Mexico|General Hospital Paracin, Paracin, Serbia",https://ClinicalTrials.gov/show/NCT04465513
NCT04843930,Improving Cognitive Health in COVID-19 Survivors,"Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment",20-11022977,"Weill Cornell Medicine, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04843930
NCT04523012,COVID-19 and HIV Patients,Observational Model: Cohort|Time Perspective: Retrospective,CREPATS 013,"Valérie POURCHER, Paris, Ile De France, France",https://ClinicalTrials.gov/show/NCT04523012
NCT04389489,Postpartum Sexual Function in Pregnant Women With COVID-19,Observational Model: Ecologic or Community|Time Perspective: Prospective,MTalmacCarol,"Kanuni Sultan Suleyman Training and Research Hospital, Istanbul, Halkali, Turkey",https://ClinicalTrials.gov/show/NCT04389489
NCT04834726,COVID-19 Vaccine Text Outreach,"Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Health Services Research",848696,"Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04834726
NCT04527315,COVID-19 Survivorship Registry,Observational Model: Case-Control|Time Perspective: Prospective,20-00909,"NYU Langone Health, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04527315
NCT04909905,Glutamine Supplementation and Short-term Mortality in Covid-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment",17300609,"Omar Soliman, Assiut, Assuit, Egypt",https://ClinicalTrials.gov/show/NCT04909905
NCT04498299,Stress Echocardiography in Patients Recovery From Mild COVID-19 Illness,Observational Model: Cohort|Time Perspective: Prospective,Cardiology-004,"Hospital Beneficencia Española de Puebla, Puebla, Mexico",https://ClinicalTrials.gov/show/NCT04498299
NCT04952350,Atorvastatin for Reduction of 28-day Mortality in COVID-19: RCT,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",R.21.04.1300.R1,NA,https://ClinicalTrials.gov/show/NCT04952350
NCT04341870,"Study of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients: Sarilumab, Azithromycin, Hydroxychloroquine Trial - CORIMUNO-19 - VIRO",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,APHP200375-3,"AP-HP Hôpital Avicenne, Bobigny, France|AP-HP Hôpital Ambroise Paré, Boulogne-Billancourt, France|AP-HP Hôpital Beaujon, Clichy, France|AP-HP Hôpital Pitié Salpétrière, Paris, France|AP-HP Hôpital Saint Antoine, Paris, France",https://ClinicalTrials.gov/show/NCT04341870
NCT04471519,Whole-Virion Inactivated SARS-CoV-2 Vaccine (BBV152) for COVID-19 in Healthy Volunteers,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",BBIL/BBV152-A/2020|Protocol No:BBIL/BBV152-A/2020,"King George Hospital, Visakhapatnam, Andhra Pradesh, India|All India Institute of Medical Sciences, Patna, Bihar, India|Pt BD SHARMA,PGIMS/UHS, Rohtak, Haryana, India|Jeevan Rekha Hospital, Belgaum, Karnataka, India|Gillukar Multispeciality Hospital, Nagpur, Maharastra, India|All India Institute of Medical Sciences, Delhi, New Delhi, India|Institute of Medical Sciences and SUM Hospital, Bhubaneswar, Orissa, India|SRM Hospital & Research center, Chennai, Tamilnadu, India|Nizam's Institute of Medical Sciences, Hyderabad, Telangana, India|Rana Hospital and Trauma Center, Gorakhpur, Uttar Pradesh, India|Prakhar Hospital, Kanpur, Uttar Pradesh, India|Redkar Hospital and Research Centre, Goa, India",https://ClinicalTrials.gov/show/NCT04471519
NCT04476953,COVID-FISETIN: Pilot in SARS-CoV-2 of Fisetin to Alleviate Dysfunction and Inflammation,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",20-003936,"Mayo Clinic in Rochester, Rochester, Minnesota, United States",https://ClinicalTrials.gov/show/NCT04476953
NCT04883190,Fatigue a Long COVID-19 Symptom Substudy of FSC19-KN Trial,Observational Model: Cohort|Time Perspective: Prospective,21-1340,"Hegau Bodensee Klinikum Singen, Singen, BW, Germany",https://ClinicalTrials.gov/show/NCT04883190
NCT04606732,CardioVascular Disease Progression and Prognosis in COVID-19,Observational Model: Cohort|Time Perspective: Cross-Sectional,CV_SPP_COVID19,"Policlinico Sant'Orsola, Bologna, Italy",https://ClinicalTrials.gov/show/NCT04606732
NCT04818489,Colchicine and Post-COVID-19 Pulmonary Fibrosis,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,PR00202,"El-Demerdash Hospital, Cairo, Egypt",https://ClinicalTrials.gov/show/NCT04818489
NCT04462120,IL-12RB and TNF-alpha Gene Polymorphism and Susceptibility and Progress of Covid-19 SARS-CoV-2: A Case Control Study,Observational Model: Cohort|Time Perspective: Prospective,AssiutU15,"AssiutU, Assiut, Egypt|Assiut University Hospitals, Assiut, Egypt",https://ClinicalTrials.gov/show/NCT04462120
NCT04482673,Vitamin D Supplementation in the Prevention and Mitigation of COVID-19 Infection,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",99939,"Medical University of South Carolina, Charleston, South Carolina, United States",https://ClinicalTrials.gov/show/NCT04482673
NCT04457349,Therapeutic Plasma Exchange in Resistant Cytokine Storm of COVID 19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,plasma exchange in COVID 19,"Faculty of Medicine, Alexandria university, Egypt, Alexandria, Egypt",https://ClinicalTrials.gov/show/NCT04457349
NCT04438850,COVidIVERmectin: Ivermectin for Treatment of Covid-19,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",cover_1,"IRCCS Sacro Cuore Don Calabria hospital, Negrar, Verona, Italy|Policlinico S. Orsola, Bologna, Italy|Ospedale Luigi Sacco, Milan, Italy|Ospedale di Rovereto, Rovereto, Italy|Ospedale Amedeo di Savoia, Turin, Italy",https://ClinicalTrials.gov/show/NCT04438850
NCT04377308,Fluoxetine to Reduce Intubation and Death After COVID19 Infection,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,FRIDA COVID19,"University of Toledo, Toledo, Ohio, United States",https://ClinicalTrials.gov/show/NCT04377308
NCT04363099,Multicentre Observational Study on Management COVID 19 Positive Outpatients in a French Cluster.,Observational Model: Cohort|Time Perspective: Other,2020-A01059-30,"Msp de Creil, Creil, France",https://ClinicalTrials.gov/show/NCT04363099
NCT04542447,To Evaluate Safety and Efficacy of Nuvastatic as an Immunomodulator Adjuvant Therapy in COVID-19 Patients.,Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,BIAG-CSP-037,"Navin Hospital, Ghaziabad, Uttar Pradesh, India",https://ClinicalTrials.gov/show/NCT04542447
NCT04944368,Phase II Clinical Trial of CinnaGen COVID-19 Vaccine (SpikoGen),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention",VAC.CIN.PT.II|IRCT20150303021315N23,"Espinas Palace Hotel, Tehran, Iran, Islamic Republic of",https://ClinicalTrials.gov/show/NCT04944368
NCT04589936,Prone Position to Improve Oxygenation in COVID-19 Patients Outside Critical Care,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,284061,"Cambridge University Hospitals NHS Foundation Trust, Cambridge, Cambridgeshire, United Kingdom",https://ClinicalTrials.gov/show/NCT04589936
NCT04746339,Apixaban for PrOphyLaxis of thromboemboLic Outcomes in COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",004/2020,"Hospital Maternidade São Vicente de Paulo, Barbalha, Ceará, Brazil|Hospital Israelita Albert Einstein, São Paulo, SP, Brazil|Hospital Universitário São Francisco de Assis, Bragança Paulista, São Paulo, Brazil|Hospital Santa Paula, São Paulo, Brazil",https://ClinicalTrials.gov/show/NCT04746339
NCT04495933,"A Study on the Safety, Tolerability and Immune Response of SARS-CoV-2 Sclamp (COVID-19) Vaccine in Healthy Adults","Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention",UQ-1-SARS-CoV-2-Sclamp|ACTRN12620000674932p,"Nucleus Network Brisbane (Q-Pharm Pty Ltd), Herston, Queensland, Australia",https://ClinicalTrials.gov/show/NCT04495933
NCT04530578,Nebulized Heparin in Severe Acute Respiratory Syndrome COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,CSanCamilo,"Clinica San Camilo, Ciudad Autonoma de Buenos Aire, Buenos Aires, Argentina",https://ClinicalTrials.gov/show/NCT04530578
NCT04477954,Hyperbaric Oxygen as an Adjuvant Treatment for Patients With Covid-19 Severe Hypoxemia,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,AAMHEI2020-1,"Hospital Central de San Isidro Dr. Angel Melchor Posse, San Isidro, Buenos Aires, Argentina|Hospital de Infecciosas F. J. Muñiz, Ciudad Autonoma de Buenos AIres, Caba, Argentina|Hospital General de Agudos D.F Santojanni, Ciudad Autonoma de Buenos AIres, Caba, Argentina",https://ClinicalTrials.gov/show/NCT04477954
NCT04649424,COVID-19 Nasal Swab Trial,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Other,B2020:121,"St. Boniface General Hospital, Winnipeg, Manitoba, Canada|Health Sciences Centre, Winnipeg, Manitoba, Canada",https://ClinicalTrials.gov/show/NCT04649424
NCT04692129,Prone Positioning Short-term Effects on Tissue Oxygen Saturation in Critical COVID-19 Patients,Observational Model: Cohort|Time Perspective: Prospective,2020/591,"Hospital de Clñinicas da UNICAMP, Campinas, Sao Paulo, Brazil|Hospital General de México, México, Mexico|Parc Taulí Hospital Universitari, Sabadell, Barcelona, Spain|Hospital Clínic i Provincial de Barcelona, Barcelona, Spain|Hospital Parc Salut Mar, Barcelona, Spain|Hospital Vall d'Hebron, Barcelona, Spain",https://ClinicalTrials.gov/show/NCT04692129
NCT04375735,London's Exogenous Surfactant Study for COVID19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,9890,NA,https://ClinicalTrials.gov/show/NCT04375735
NCT04344951,"Chloroquine Phosphate Against Infection by the Novel Coronavirus SARS-CoV-2 (COVID-19): The HOPE Open-Label, Non Randomized Clinical Trial",Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,UNIKINON-01/HOPE,"Divine Providence Hospital ""Pammakaristos"", Athens, Greece|Athens General Hospital ""Hippokrateio"", Athens, Greece|Athens General Hospital of Thoracic Diseases ""SOTIRIA"", 1st University Pulmonary Clinic, Athens, Greece|Athens General Hospital of Thoracic Diseases ""SOTIRIA"", 3rd University Pathology Clinic, Athens, Greece|Corfu General Hospital Agia Irini, Corfu, Greece|University General Hospital of Ioannina, Ioánnina, Greece|General Hospital of Athens ""Sismanoglio"", Maroúsi, Greece|University General Hospital of Thessaloniki AHEPA, Thessaloníki, Greece",https://ClinicalTrials.gov/show/NCT04344951
NCT04407585,Testing the Accuracy of a Digital Test to Diagnose Covid-19,Observational Model: Cohort|Time Perspective: Prospective,Covid-19 Validation Study,"King's College London, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04407585
NCT04381988,A Study of Hydroxychloroquine vs Placebo to Prevent COVID-19 Infection in Patients Receiving Radiotherapy,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention",20-176,"Memoral Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge, New Jersey, United States|Memoral Sloan Kettering Monmouth (All protocol activities), Middletown, New Jersey, United States|Memorial Sloan Kettering Bergen (All protocol Activities), Montvale, New Jersey, United States|Memorial Sloan Kettering Commack (All Protocol Activities), Commack, New York, United States|Memoral Sloan Kettering Westchester (All protocol activities), Harrison, New York, United States|Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States|Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale, New York, United States",https://ClinicalTrials.gov/show/NCT04381988
NCT04328480,The ECLA PHRI COLCOVID Trial. Effects of Colchicine on Moderate/High-risk Hospitalized COVID-19 Patients.,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,COLCOVID version 2.0,"Sanatorio Parque, Rosario, Santa Fe, Argentina",https://ClinicalTrials.gov/show/NCT04328480
NCT04906850,Evaluation of the New Variant 501Y.V2 of COVID-19,Observational Model: Cohort|Time Perspective: Retrospective,2021-05Obs-CHRMT,"CHRU Nancy, Nancy, Meurthe-et-moselle, France|CHR Metz Thionville, Metz, Moselle, France",https://ClinicalTrials.gov/show/NCT04906850
NCT04771611,COVFIS-HOME: COVID-19 Pilot Study of Fisetin to Alleviate Dysfunction and Decrease Complications,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",20-009705,"Mayo Clinic, Rochester, Minnesota, United States",https://ClinicalTrials.gov/show/NCT04771611
NCT04344288,Corticosteroids During Covid-19 Viral Pneumonia Related to SARS-Cov-2 Infection,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,69HCL20_0321|2020-001553-48,"Hôpital Pneumologique et Cardiovasculaire Louis Pradel, Bron, France|Groupement Hospitalier Nord, Lyon, France|Hôpital Edouard Herriot, Lyon, France|Hôpital St Joseph Saint Luc, Lyon, France|Hôpital St Joseph, Marseille, France|Centre hospitalier Lyon Sud, Pierre-Bénite, France|CHU St Etienne, Saint-Étienne, France|Clinique Charcot, Sainte-Foy-lès-Lyon, France|CHG Vienne, Vienne, France|Médipôle, Villeurbanne, France|Clinique des Portes du Sud, Vénissieux, France|CH Annecy-Genevois, Épagny, France",https://ClinicalTrials.gov/show/NCT04344288
NCT04392128,Study Evaluating the Efficacy of Hydroxychloroquine and Azithromycine in Patients With COVID-19 and Hematological Malignancies (HYACINTHE),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",2020-005|2020-002002-45,"Institut de Cancérologie Strasbourg Europe, Strasbourg, France",https://ClinicalTrials.gov/show/NCT04392128
NCT04615975,Ketogenic Diet as Protective Factor During COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,KDSARS0120,"Ospedale San Bortolo, Vicenza, Italy",https://ClinicalTrials.gov/show/NCT04615975
NCT04343001,Coronavirus Response - Active Support for Hospitalised Covid-19 Patients,Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2020-KEP-420,"University College Hospital, Ibadan, Oyo, Nigeria|Shifa Tameer-e-Millat University, Rawalpindi, Pakistan",https://ClinicalTrials.gov/show/NCT04343001
NCT04751721,"Oxidative Stress Parameters, Trace Element and Quality of Life in Women Before and After Covid-19 Vaccines",Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Screening,2021-01-173,"Kadirhan Ozdemir, İzmir, Turkey",https://ClinicalTrials.gov/show/NCT04751721
NCT04836767,Evaluation of Physical and Functional Status in Patients With COVID-19 in Long Term,Observational Model: Case-Control|Time Perspective: Prospective,GO21-178,"Hacettepe University, Ankara, Turkey",https://ClinicalTrials.gov/show/NCT04836767
NCT04828460,Monitoring of COVID-19 Vaccine Response in Organ Transplant Patients,Observational Model: Cohort|Time Perspective: Retrospective,8133,"Hôpitaux Universitaires de Strasbourg, Strasbourg, France",https://ClinicalTrials.gov/show/NCT04828460
NCT04738695,SARS-CoV-2 Seroprevalence Among Nursing Home Staff and Residents (COVID-19),Observational Model: Cohort|Time Perspective: Prospective,BC-08719,"Ghent University, Ghent, Oost-Vlaanderen, Belgium",https://ClinicalTrials.gov/show/NCT04738695
NCT04409327,Phase 2 Study to Determine if RTB101 Reduces the Severity of COVID-19 in Older Adults Residing in Nursing Homes,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",RTB101-210,"Nursing Home, Middletown, Rhode Island, United States",https://ClinicalTrials.gov/show/NCT04409327
NCT04945577,"The Relationship Between Vitamin D Levels, Inflammatory Parameters and Disease Severity of COVID-19 Infection",Observational Model: Other|Time Perspective: Retrospective,Gulcanozturk,"Gulcan Ozturk, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04945577
NCT04502342,"Add on to Azythromycine, Phytomedicine and/or Antimalarial Drug vs Hydroxychloroquine in Uncomplicated COVID-19 Patients",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,RDIMFPG,"Donka; Kenien; Gbessia, Conakry, Guinea",https://ClinicalTrials.gov/show/NCT04502342
NCT04554979,COVID-19 Disease Duration and GIT Manifestations. A New Disease Severity Classification. An Egyptian Experience,Observational Model: Cohort|Time Perspective: Retrospective,1004,"Faculty of Medicine Cairo University, Cairo, Egypt",https://ClinicalTrials.gov/show/NCT04554979
NCT04261517,Efficacy and Safety of Hydroxychloroquine for Treatment of COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,HC-COVID-19,"Shanghai Public Health Clinical Center, Shanghai, Shanghai, China|Shanghai Public Health Clinical Center, Shanghai, Shanghai, China",https://ClinicalTrials.gov/show/NCT04261517
NCT04488575,Safety and Efficacy of EDP1815 in the Treatment of Patients Hospitalized With COVID-19 Infection,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",EDP1815-205,"Robert Wood Johnson University Hospital, New Brunswick, New Jersey, United States|The University Hospital, Newark, New Jersey, United States",https://ClinicalTrials.gov/show/NCT04488575
NCT04348500,Clazakizumab (Anti-IL- 6 Monoclonal) Compared to Placebo for COVID19 Disease,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",644,"Cedars-Sinai Medical Center, Los Angeles, California, United States",https://ClinicalTrials.gov/show/NCT04348500
NCT04615871,Semaglutide to Reduce Myocardial Injury in PATIents With COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,UHNSEMPATICO1,"Instituto Prevent Senior, São Paulo, Brazil|State University of Campinas, São Paulo, Brazil|Trillium Health Partners, Mississauga, Ontario, Canada|St. Michael's Hospital, Toronto, Ontario, Canada|University Health Network - Peter Munk Cardiac Centre, Toronto, Ontario, Canada|McGill University Health Centre, Montréal, Quebec, Canada|Hospital de Infectologia, Mexico City, Mexico|Hospital General Regional, Mexico City, Mexico|Hospital Regional 2, Querétaro, Mexico|Sandwell and West Birmingham NHS Trust, Birmingham, United Kingdom",https://ClinicalTrials.gov/show/NCT04615871
NCT04802408,SARS-Cov-2 (COVID-19) Nasal Pharyngeal and Oral Pharyngeal Wash (SNOW) Trial,Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,STUDY00016947,NA,https://ClinicalTrials.gov/show/NCT04802408
NCT04536285,Hospitalized Children and Adolescent Patients With Type 1 Diabetes During the COVID-19 Pandemic in Egypt,Observational Model: Case-Only|Time Perspective: Cross-Sectional,FMASU P59/2020,"Pediatrics and Adolescents Diabetes Unit (PADU), Pediatrics Hospital, Faculty of Medicine, Ain Shams University, Cairo, Egypt",https://ClinicalTrials.gov/show/NCT04536285
NCT04762056,CPAx for Assessing Functional Status of COVID-19 Patients After Intensive Care Unit Discharge,Observational Model: Other|Time Perspective: Prospective,1,"Koç Univercity Hospital, Istanbul, None Selected, Turkey|Gaziosmanpasa Training and Research Hospital, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04762056
NCT04481477,Results of Emotional Support Activities During Hospital Admission With a Diagnosis of COVID19,Observational Model: Case-Only|Time Perspective: Cross-Sectional,2020664,"CorporacionPT, Sabadell, Barcelona, Spain",https://ClinicalTrials.gov/show/NCT04481477
NCT04411667,Study of SOC Plus IVIG Compared to SOC Alone in the Treatment of COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,COVID-IVIG|2004902,"Sharp Grossmont Hospital, La Mesa, California, United States|Sharp Memorial Hospital, San Diego, California, United States",https://ClinicalTrials.gov/show/NCT04411667
NCT04941105,Impact of PCSK9 Inhibition on Clinical Outcome in Patients During the Inflammatory Stage of the COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",IMPACT-SIRIO 5,"Antoni Jurasz University Hospital No. 1, Bydgoszcz, Poland",https://ClinicalTrials.gov/show/NCT04941105
NCT04361786,Acral Cutaneous Thrombotic Vasculopathy and Covid-19 Infection,Observational Model: Case-Only|Time Perspective: Prospective,RECHMPL20_0211,"Uh Montpellier, Montpellier, France",https://ClinicalTrials.gov/show/NCT04361786
NCT04642950,A Phase II/III Study of Sargramostim,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",NPC-26-1,"IUHW Narita Hospital, Narita City, Chiba, Japan|Kanagawa Cardiovascular and Respiratory Center, Yokohama City, Kanagawa, Japan|Japanese Red Cross Society Saitama Red Cross Hospital, Saitama City, Saitama, Japan|St. Luke's International Hospital, Chuo-ku, Tokyo, Japan|Mishuku Hospital, Meguro-ku, Tokyo, Japan|Japanese Red Cross Medical Center, Shibuya-ku, Tokyo, Japan|Center Hospital of the National Center for Global Health and Medicine, Shinjuku-Ku, Tokyo, Japan",https://ClinicalTrials.gov/show/NCT04642950
NCT04433000,Reliability of a Pocket Sized Ultrasound Scanner in the Evaluation Covid-19 Pneumonia,Observational Model: Case-Only|Time Perspective: Retrospective,USCovid,"Azienda Ospedaliera Universitaria Senese, Siena, Si, Italy",https://ClinicalTrials.gov/show/NCT04433000
NCT04386083,Neurologic Manifestations of COVID-19,Observational Model: Cohort|Time Perspective: Retrospective,RGAO-2020-0348,"Philippine General Hospital - University of the Philippines Manila, Manila, Philippines",https://ClinicalTrials.gov/show/NCT04386083
NCT04355351,Study of Immune Response During SARS-CoV-2 Infection - (COVID-19),Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science,20-PP-05,"Antibes Hospital, Antibes, France|Cannes Hospital, Cannes, France|Nice Hospital, Nice, France",https://ClinicalTrials.gov/show/NCT04355351
NCT04463706,COVID19 Severity Prediction and Health Services Research Evaluation,Observational Model: Cohort|Time Perspective: Retrospective,COVID19_0459,"Hospital Galdakao-Usansolo, Galdakao, Bizkaia, Spain|Hospital Galdakao-Usansolo, Galdakao, Bizkaia, Spain",https://ClinicalTrials.gov/show/NCT04463706
NCT04646590,A Phase III Clinical Trial to Determine the Safety and Efficacy of ZF2001 for Prevention of COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",LKM-2020-NCV-GJ01,"Hunan Provincial Center for Disease Control and Prevention, Changsha, Hunan, China|Biodimed Guayaquil Clinical Research Center, Guayaquil, Guayas, Ecuador|Biodimed Alemania Clinical Research Center, Quito, Pichincha, Ecuador|Biodimed Eloy Alfaro Clinical Research Center, Quito, Pichincha, Ecuador|Fkui-Rscm, Jakarta, Daerah Khusus Ibukota Jakarta, Indonesia|FK Unpad/RSHS, Bandung, Jawa Barat, Indonesia|Aziz Fatimah Hospital, Faisalabad, Punjab, Pakistan|Al-Shifa Trust Eye Hospital, Lahore, Punjab, Pakistan|Avicenna Hospital, Lahore, Punjab, Pakistan|Central Park Medical college, Lahore, Punjab, Pakistan|National Hospital & Medical Center, Lahore, Punjab, Pakistan|University of Health Sciences, Lahore, Punjab, Pakistan|Indus Hospital, Karachi, Sindh, Pakistan|Shaheed Zulfiqar Ali Bhutto Medical University, Islamabad, Pakistan|Family Hospital No.15, Tashkent, Uzbekistan|GUVD Poliklinika, Tashkent, Uzbekistan|IIV Markaziy Poliklinika, Tashkent, Uzbekistan|Toshkent viloyat IIV Poliklinika, Tashkent, Uzbekistan",https://ClinicalTrials.gov/show/NCT04646590
NCT04693026,Efficacy of Ramdicivir and Baricitinib for the Treatment of Severe COVID 19 Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,M.A.R.M.C.D./2020/2637,"M. Abdur Rahim Medical College Hospital, Dinajpur, Bangladesh",https://ClinicalTrials.gov/show/NCT04693026
NCT04895085,"ReSET Aim 1a: Restarting Safe Education and Testing for Children With Medical Complexity - Feasibility of In-home Cohort COVID-19 Testing Strategies, and Associations With CMC Parent Perceptions About In-person School Attendance",Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,2021-0462|1OT2HD107558-01|A536771|SMPH/PEDIATRICS|Protocol Version 04/12/21,"University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, United States",https://ClinicalTrials.gov/show/NCT04895085
NCT04355364,Efficacy and Safety of aerosolizedDornase Alfa Administration in Patients With COVID19 Induced ARDS (COVIDORNASE),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,CGE_2020_9,"Hôpital Fondation A. de Rotschhild, Paris, France",https://ClinicalTrials.gov/show/NCT04355364
NCT04458363,Convalescent Plasma in Pediatric COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,STUDY00000789,"Children's Healthcare of Atlanta, Atlanta, Georgia, United States",https://ClinicalTrials.gov/show/NCT04458363
NCT04367831,Intermediate or Prophylactic-Dose Anticoagulation for Venous or Arterial Thromboembolism in Severe COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,AAAS8980,"Columbia University Medical Center, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04367831
NCT04732637,Concordance Between Buccal Cavity Swab and Nasopharyngeal Swab for SARS-CoV-2 (COVID-19) Detection by RT-PCR and ELISA,Observational Model: Cohort|Time Perspective: Prospective,U1111-1264-2742,"Datar Cancer Genetics, Nashik, Maharashtra, India",https://ClinicalTrials.gov/show/NCT04732637
NCT04717011,Case Series Study to Detect SARS-CoV-2 in Semen of COVID-19 Patients,Observational Model: Case-Only|Time Perspective: Prospective,IGX1-COV-NA-20-05,"Hospital Ruber Internacional, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04717011
NCT04383626,Fear Among Dentists During COVID-19 Pandemic,Observational Model: Other|Time Perspective: Cross-Sectional,COVID-19 pandemic,"Cairo University, Cairo, Egypt",https://ClinicalTrials.gov/show/NCT04383626
NCT04414059,Protein Electrophoresis as a Tool for Complications Prediction in COVID-19 Hospitalised Patients,Observational Model: Case-Only|Time Perspective: Prospective,COVELEC|2020-A01376-33,"Clinique de l'Estrée, Stains, France",https://ClinicalTrials.gov/show/NCT04414059
NCT04494204,Effect of a Combination of Treatment of Reginmune Capsule and Immunofree Tablets in the Treatment of Mild to Moderate COVID-19 Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,MGCTS/20/105,"Govt Medical College and Govt General Hospital (Old RIMSGGH), Srikakulam, Andhra Pradesh, India|Parul Institute of Ayurveda and Research Parul University, Vadodara, Gujrat, India|Lokmanya Hospital, Pune, Maharashtra, India",https://ClinicalTrials.gov/show/NCT04494204
NCT04389515,"Postoperative Recovery Index, Patient Expectations and Satisfaction With Prenatal Care Instrument in Pregnant Patients With COVID-19",Observational Model: Ecologic or Community|Time Perspective: Prospective,MTalmac3,"Kanuni Sultan Suleyman Training and Research Hospital, Istanbul, Halkali, Turkey",https://ClinicalTrials.gov/show/NCT04389515
NCT04639427,Benefits of Using a Transparent Visor to Replace the Face Mask in Speech Therapy Rehabilitation of Oral-Linguo-Facial Praxies in the Context of COVID-19: a Series of Cases,Observational Model: Case-Only|Time Perspective: Prospective,APHP200876|IDRCB,"Unité de Soins de Rééducation Post Réanimation, Service de Médecine Physique et de Réadaptation, Hôpital Raymond Poincaré, APHP, Garches, France",https://ClinicalTrials.gov/show/NCT04639427
NCT04961476,Use of 1-MNA to Improve Exercise Tolerance and Fatigue in Patients After COVID-19,Observational Model: Other|Time Perspective: Prospective,Stop-Covid/1/2020,"Medical Center, Saint Family Hospital, Łódź, Poland",https://ClinicalTrials.gov/show/NCT04961476
NCT04611841,Medical-biological Research of the Pathogenesis of COVID-19 Disease Caused by SARS-CoV-2,Observational Model: Cohort|Time Perspective: Cross-Sectional,COV2020,"Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow, Russian Federation",https://ClinicalTrials.gov/show/NCT04611841
NCT04565080,Clinical Correlates of COVID-19 Pandemic in Patients With Functional Movement Disorder (FMD) and Parkinson's Disease (PD),Observational Model: Ecologic or Community|Time Perspective: Cross-Sectional,10000159|000159-N,"National Institute of Neurological Disorders and Stroke (NINDS), Bethesda, Maryland, United States",https://ClinicalTrials.gov/show/NCT04565080
NCT04505592,Tenecteplase in Patients With COVID-19,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",GCO 20-1764,"Mount Sinai Hospital, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04505592
NCT04346446,Efficacy of Convalescent Plasma Therapy in Severely Sick COVID-19 Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,ILBS-COVID-02,"Maulana Azad medical College, New Delhi, Delhi, India|Institute of Liver and Biliary Sciences, New Delhi, Delhi, India",https://ClinicalTrials.gov/show/NCT04346446
NCT04395872,Psychiatric Consultation for COVID-19 Patients,Observational Model: Case-Only|Time Perspective: Retrospective,CR-20-062,NA,https://ClinicalTrials.gov/show/NCT04395872
NCT04371601,Safety and Effectiveness of Mesenchymal Stem Cells in the Treatment of Pneumonia of Coronavirus Disease 2019,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,MSC-CoViD-2020,"Fuzhou General Hospital, Fuzhou, Fujian, China",https://ClinicalTrials.gov/show/NCT04371601
NCT04328012,COVID MED Trial - Comparison Of Therapeutics for Hospitalized Patients Infected With COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",1581969,"Bassett Medical Center, Cooperstown, New York, United States",https://ClinicalTrials.gov/show/NCT04328012
NCT04447469,Study of Mavrilimumab (KPL-301) in Participants Hospitalized With Severe Corona Virus Disease 2019 (COVID-19) Pneumonia and Hyper-inflammation,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",KPL-301-C203,"UCLA Medical Center, Los Angeles, California, United States|Sharp Health Care, San Diego, California, United States|Affinity Health, Oak Brook, Illinois, United States|Tulane Medical Center, New Orleans, Louisiana, United States|Allina Health System, Minneapolis, Minnesota, United States|Mercy Hospital, Springfield, Missouri, United States|University of Cincinnati, Cincinnati, Ohio, United States|Bryn Mawr, Bryn Mawr, Pennsylvania, United States|University of Texas Health Sciences, Houston, Texas, United States|Instituto Mário Penna, Belo Horizonte, Brazil|Hospital Adventista de Belem, Belém, Brazil|UPECLIN - Unidade de Pesquisa Clínica, Botucatu, Brazil|IPECC - Instituto de Pesquisa Clínica de Campinas, Campinas, Brazil|IEP HGF - Instituto de Estudos e Pesquisas Clinicas do Ceará, Fortaleza, Brazil|Hospital Bruno Born, Lajeado, Brazil|Centro de Pesquisas Clínicas, Natal, Brazil|Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo, Ribeirão Preto, Brazil|Hospital Cardio Pulmonar, Salvador, Brazil|Fundação Faculdade Regional de Medicina de São José do Rio Preto, São José, Brazil|Hospital Alemão Oswaldo Cruz, São Paulo, Brazil|Clinica Providencia, Santiago, Chile|Clinica Las Condes, Santiago, Chile|Hospital Essalud Alberto Sabogal Sologuren, Bellavista, Peru|Essalud - Hospital de Emergencias Grau, Lima Cercado, Peru|Hospital Nacional Cayetano Heredia, San Martín De Porres, Peru|Clinica Providencia, San Miguel, Peru|IATROS International, Bloemfontein, South Africa|Tiervlei Trial Center, Cape Town, South Africa|TASK Eden, George, South Africa|Into Research - Little Company of Mary Medical Center, Pretoria, South Africa|Limpopo Clinical Research Initiative, Rustenburg, South Africa",https://ClinicalTrials.gov/show/NCT04447469
NCT04550403,Clinical Phenotype and Outcomes of Inpatients With COVID-19 and Diabetes,Observational Model: Cohort|Time Perspective: Retrospective,27557,"Endocrinology and metabolic diseases Unit, Parma, Italy",https://ClinicalTrials.gov/show/NCT04550403
NCT04710329,High-Dose Vitamin C Treatment in Critically Ill COVID-19 Patients,Observational Model: Cohort|Time Perspective: Retrospective,CVIT-3334,"Sisli etfal training and resource hospital, Sisli, İstanbul, Turkey",https://ClinicalTrials.gov/show/NCT04710329
NCT04657445,"EFFECT OF COVID-19 DISEASE IN SMELL AND TASTE OF PATIENTS WITH MILD, MODERATE OR SEVERE SYMPTOMATOLOGY",Observational Model: Cohort|Time Perspective: Prospective,931/17-11-2020,"University General Hospital of Ioannina, Ioannina, Epirus, Greece",https://ClinicalTrials.gov/show/NCT04657445
NCT04642339,"Clinical Trial of the Immunogenicity, Safety, and Efficacy of the Gam-COVID-Vac Vaccine Against COVID-19 in Venezuela","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention",01V-Gam-COVID-Vac-2020,NA,https://ClinicalTrials.gov/show/NCT04642339
NCT04473547,COVID 19 Preventive Measures Among Mansoura Nursing Students,Observational Model: Other|Time Perspective: Prospective,p.0203,"Faculty of Nursing Mansoura University, Mansoura, Egypt",https://ClinicalTrials.gov/show/NCT04473547
NCT04768244,Impact of Maternal COVID-19 Disease on Breast Milk and Infant Health,Observational Model: Case-Control|Time Perspective: Prospective,covid1,"Fundacion Investigacion Sanitaria INCLIVA, Valencia, Spain|Hospital Universitario y Politecnico la Fe, Valencia, Spain",https://ClinicalTrials.gov/show/NCT04768244
NCT04479293,Post COVID-19 Functional Status in Egypt,Observational Model: Cohort|Time Perspective: Prospective,AssiutU16,"Aliaa Hussein, Assiut, Egypt",https://ClinicalTrials.gov/show/NCT04479293
NCT04352400,Efficacy of Nafamostat in Covid-19 Patients (RACONA Study),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",RACONA Nafamostat,"Azienda Ospedale Università di Padova, Padova, Italy",https://ClinicalTrials.gov/show/NCT04352400
NCT04359251,Different PEEP Settings of COVID-19 Induced ARDS,Allocation: Non-Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,COVID-19 PEEP titration,"Zhongda Hospital, Southeast University, Nanjing, Jiangsu, China",https://ClinicalTrials.gov/show/NCT04359251
NCT04499313,Dexamethasone Vs Methylprednisolone for the Treatment of Patients With ARDS Caused by COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,10000753,"Chattogram General Hospital, Chittagong, Bangladesh|M. Abdur Rahim Medical College Hospital, Dinajpur, Bangladesh",https://ClinicalTrials.gov/show/NCT04499313
NCT04387656,"NCI COVID-19 in Cancer Patients, NCCAPS Study",Observational Model: Cohort|Time Perspective: Prospective,NCI-2020-02986|NCICOVID,"University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States|Veterans Administration Medical Center - Birmingham, Birmingham, Alabama, United States|USA Health Strada Patient Care Center, Mobile, Alabama, United States|Anchorage Associates in Radiation Medicine, Anchorage, Alaska, United States|Anchorage Radiation Therapy Center, Anchorage, Alaska, United States|Alaska Breast Care and Surgery LLC, Anchorage, Alaska, United States|Alaska Oncology and Hematology LLC, Anchorage, Alaska, United States|Alaska Women's Cancer Care, Anchorage, Alaska, United States|Anchorage Oncology Centre, Anchorage, Alaska, United States|Katmai Oncology Group, Anchorage, Alaska, United States|Providence Alaska Medical Center, Anchorage, Alaska, United States|Fairbanks Memorial Hospital, Fairbanks, Alaska, United States|Kingman Regional Medical Center, Kingman, Arizona, United States|Banner Children's at Desert, Mesa, Arizona, United States|Cancer Center at Saint Joseph's, Phoenix, Arizona, United States|Mayo Clinic Hospital in Arizona, Phoenix, Arizona, United States|Mayo Clinic in Arizona, Scottsdale, Arizona, United States|Mercy Hospital Fort Smith, Fort Smith, Arkansas, United States|CHI Saint Vincent Cancer Center Hot Springs, Hot Springs, Arkansas, United States|Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro, Jonesboro, Arkansas, United States|NEA Baptist Memorial Hospital, Jonesboro, Arkansas, United States|University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States|Kaiser Permanente-Anaheim, Anaheim, California, United States|Kaiser Permanente-Deer Valley Medical Center, Antioch, California, United States|Mission Hope Medical Oncology - Arroyo Grande, Arroyo Grande, California, United States|PCR Oncology, Arroyo Grande, California, United States|Kaiser Permanente-Baldwin Park, Baldwin Park, California, United States|Kaiser Permanente-Bellflower, Bellflower, California, United States|Providence Saint Joseph Medical Center/Disney Family Cancer Center, Burbank, California, United States|Enloe Medical Center, Chico, California, United States|UC Irvine Health Cancer Center-Newport, Costa Mesa, California, United States|Kaiser Permanente Dublin, Dublin, California, United States|Kaiser Permanente-Fontana, Fontana, California, United States|Kaiser Permanente-Fremont, Fremont, California, United States|Fresno Cancer Center, Fresno, California, United States|Kaiser Permanente-Fresno, Fresno, California, United States|Kaiser Permanente - Harbor City, Harbor City, California, United States|Kaiser Permanente-Irvine, Irvine, California, United States|UC San Diego Moores Cancer Center, La Jolla, California, United States|Veterans Affairs Loma Linda Healthcare System, Loma Linda, California, United States|Kaiser Permanente Los Angeles Medical Center, Los Angeles, California, United States|Kaiser Permanente West Los Angeles, Los Angeles, California, United States|UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States|Valley Children's Hospital, Madera, California, United States|Fremont - Rideout Cancer Center, Marysville, California, United States|Kaiser Permanente-Modesto, Modesto, California, United States|Kaiser Permanente Oakland-Broadway, Oakland, California, United States|Kaiser Permanente-Oakland, Oakland, California, United States|Kaiser Permanente-Ontario, Ontario, California, United States|UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California, United States|Kaiser Permanente - Panorama City, Panorama City, California, United States|Kaiser Permanente-Rancho Cordova Cancer Center, Rancho Cordova, California, United States|Kaiser Permanente- Marshall Medical Offices, Redwood City, California, United States|Kaiser Permanente-Redwood City, Redwood City, California, United States|Kaiser Permanente-Richmond, Richmond, California, United States|Kaiser Permanente-Riverside, Riverside, California, United States|Rohnert Park Cancer Center, Rohnert Park, California, United States|Kaiser Permanente-Roseville, Roseville, California, United States|The Permanente Medical Group-Roseville Radiation Oncology, Roseville, California, United States|Kaiser Permanente Downtown Commons, Sacramento, California, United States|University of California Davis Comprehensive Cancer Center, Sacramento, California, United States|Kaiser Permanente-South Sacramento, Sacramento, California, United States|South Sacramento Cancer Center, Sacramento, California, United States|Salinas Valley Memorial, Salinas, California, United States|Kaiser Permanente-San Diego Mission, San Diego, California, United States|Kaiser Permanente-San Diego Zion, San Diego, California, United States|Sharp Memorial Hospital, San Diego, California, United States|Kaiser Permanente-San Francisco, San Francisco, California, United States|UCSF Medical Center-Mission Bay, San Francisco, California, United States|Kaiser Permanente-Santa Teresa-San Jose, San Jose, California, United States|Kaiser Permanente San Leandro, San Leandro, California, United States|Pacific Central Coast Health Center-San Luis Obispo, San Luis Obispo, California, United States|Kaiser Permanente-San Marcos, San Marcos, California, United States|Kaiser San Rafael-Gallinas, San Rafael, California, United States|Kaiser Permanente Medical Center - Santa Clara, Santa Clara, California, United States|Mission Hope Medical Oncology - Santa Maria, Santa Maria, California, United States|Kaiser Permanente-Santa Rosa, Santa Rosa, California, United States|Kaiser Permanente Cancer Treatment Center, South San Francisco, California, United States|Kaiser Permanente-South San Francisco, South San Francisco, California, United States|Kaiser Permanente-Stockton, Stockton, California, United States|Gene Upshaw Memorial Tahoe Forest Cancer Center, Truckee, California, United States|Kaiser Permanente Medical Center-Vacaville, Vacaville, California, United States|Kaiser Permanente-Vallejo, Vallejo, California, United States|Kaiser Permanente-Walnut Creek, Walnut Creek, California, United States|Kaiser Permanente-Woodland Hills, Woodland Hills, California, United States|Rocky Mountain Cancer Centers-Aurora, Aurora, Colorado, United States|The Medical Center of Aurora, Aurora, Colorado, United States|Rocky Mountain Regional VA Medical Center, Aurora, Colorado, United States|Boulder Community Hospital, Boulder, Colorado, United States|Boulder Community Foothills Hospital, Boulder, Colorado, United States|Rocky Mountain Cancer Centers-Boulder, Boulder, Colorado, United States|Rocky Mountain Cancer Centers - Centennial, Centennial, Colorado, United States|Penrose-Saint Francis Healthcare, Colorado Springs, Colorado, United States|Rocky Mountain Cancer Centers-Penrose, Colorado Springs, Colorado, United States|Cancer Center of Colorado at Sloan's Lake, Denver, Colorado, United States|Kaiser Permanente-Franklin, Denver, Colorado, United States|National Jewish Health-Main Campus, Denver, Colorado, United States|The Women's Imaging Center, Denver, Colorado, United States|Porter Adventist Hospital, Denver, Colorado, United States|Colorado Blood Cancer Institute, Denver, Colorado, United States|Presbyterian - Saint Lukes Medical Center - Health One, Denver, Colorado, United States|Rocky Mountain Cancer Centers-Midtown, Denver, Colorado, United States|SCL Health Saint Joseph Hospital, Denver, Colorado, United States|Rocky Mountain Cancer Centers-Rose, Denver, Colorado, United States|Rose Medical Center, Denver, Colorado, United States|Western Surgical Care, Denver, Colorado, United States|Mercy Medical Center, Durango, Colorado, United States|Southwest Oncology PC, Durango, Colorado, United States|Mountain Blue Cancer Care Center - Swedish, Englewood, Colorado, United States|Swedish Medical Center, Englewood, Colorado, United States|National Jewish Health-Western Hematology Oncology, Golden, Colorado, United States|Saint Mary's Hospital and Regional Medical Center, Grand Junction, Colorado, United States|North Colorado Medical Center, Greeley, Colorado, United States|Good Samaritan Medical Center, Lafayette, Colorado, United States|Kaiser Permanente-Rock Creek, Lafayette, Colorado, United States|Saint Anthony Hospital, Lakewood, Colorado, United States|Rocky Mountain Cancer Centers-Littleton, Littleton, Colorado, United States|Littleton Adventist Hospital, Littleton, Colorado, United States|Kaiser Permanente-Lone Tree, Lone Tree, Colorado, United States|Rocky Mountain Cancer Centers-Sky Ridge, Lone Tree, Colorado, United States|Sky Ridge Medical Center, Lone Tree, Colorado, United States|Longmont United Hospital, Longmont, Colorado, United States|Rocky Mountain Cancer Centers-Longmont, Longmont, Colorado, United States|McKee Medical Center, Loveland, Colorado, United States|Parker Adventist Hospital, Parker, Colorado, United States|Saint Mary Corwin Medical Center, Pueblo, Colorado, United States|National Jewish Health-Northern Hematology Oncology, Thornton, Colorado, United States|SCL Health Lutheran Medical Center, Wheat Ridge, Colorado, United States|Veterans Affairs Connecticut Healthcare System-West Haven Campus, West Haven, Connecticut, United States|Beebe South Coastal Health Campus, Frankford, Delaware, United States|Beebe Medical Center, Lewes, Delaware, United States|Delaware Clinical and Laboratory Physicians PA, Newark, Delaware, United States|Helen F Graham Cancer Center, Newark, Delaware, United States|Medical Oncology Hematology Consultants PA, Newark, Delaware, United States|Christiana Care Health System-Christiana Hospital, Newark, Delaware, United States|Beebe Health Campus, Rehoboth Beach, Delaware, United States|TidalHealth Nanticoke / Allen Cancer Center, Seaford, Delaware, United States|Christiana Care Health System-Wilmington Hospital, Wilmington, Delaware, United States|Kaiser Permanente-Capitol Hill Medical Center, Washington, District of Columbia, United States|Children's National Medical Center, Washington, District of Columbia, United States|Sibley Memorial Hospital, Washington, District of Columbia, United States|Mount Sinai Comprehensive Cancer Center at Aventura, Aventura, Florida, United States|Florida Cancer Specialists - Bradenton, Bradenton, Florida, United States|Broward Health North, Deerfield Beach, Florida, United States|Holy Cross Hospital, Fort Lauderdale, Florida, United States|Broward Health Medical Center, Fort Lauderdale, Florida, United States|Golisano Children's Hospital of Southwest Florida, Fort Myers, Florida, United States|University of Florida Health Science Center - Gainesville, Gainesville, Florida, United States|Mount Sinai Medical Center, Miami Beach, Florida, United States|Florida Cancer Specialists - Sarasota, Sarasota, Florida, United States|Florida Cancer Specialists - Sarasota Downtown, Sarasota, Florida, United States|Sarasota Memorial Hospital, Sarasota, Florida, United States|Tampa General Hospital, Tampa, Florida, United States|Moffitt Cancer Center-International Plaza, Tampa, Florida, United States|Moffitt Cancer Center - McKinley Campus, Tampa, Florida, United States|Moffitt Cancer Center, Tampa, Florida, United States|Florida Cancer Specialists - Venice Island, Venice, Florida, United States|Florida Cancer Specialists - Venice Healthpark, Venice, Florida, United States|Saint Mary's Hospital, West Palm Beach, Florida, United States|Phoebe Putney Memorial Hospital, Albany, Georgia, United States|University Cancer and Blood Center LLC, Athens, Georgia, United States|Children's Healthcare of Atlanta - Egleston, Atlanta, Georgia, United States|Augusta Oncology Associates PC-D'Antignac, Augusta, Georgia, United States|Augusta Oncology Associates PC-Wheeler, Augusta, Georgia, United States|Augusta University Medical Center, Augusta, Georgia, United States|Northeast Georgia Medical Center Braselton, Braselton, Georgia, United States|Atlanta VA Medical Center, Decatur, Georgia, United States|Northeast Georgia Medical Center-Gainesville, Gainesville, Georgia, United States|Memorial Health University Medical Center, Savannah, Georgia, United States|Lewis Cancer and Research Pavilion at Saint Joseph's/Candler, Savannah, Georgia, United States|Kaiser Permanente Moanalua Medical Center, Honolulu, Hawaii, United States|Saint Alphonsus Cancer Care Center-Boise, Boise, Idaho, United States|Saint Luke's Cancer Institute - Boise, Boise, Idaho, United States|Saint Alphonsus Cancer Care Center-Caldwell, Caldwell, Idaho, United States|Kootenai Health - Coeur d'Alene, Coeur d'Alene, Idaho, United States|Walter Knox Memorial Hospital, Emmett, Idaho, United States|Saint Luke's Cancer Institute - Fruitland, Fruitland, Idaho, United States|Idaho Urologic Institute-Meridian, Meridian, Idaho, United States|Saint Luke's Cancer Institute - Meridian, Meridian, Idaho, United States|Saint Alphonsus Medical Center-Nampa, Nampa, Idaho, United States|Saint Luke's Cancer Institute - Nampa, Nampa, Idaho, United States|Kootenai Clinic Cancer Services - Post Falls, Post Falls, Idaho, United States|Kootenai Cancer Clinic, Sandpoint, Idaho, United States|Saint Luke's Cancer Institute - Twin Falls, Twin Falls, Idaho, United States|Saint Anthony's Health, Alton, Illinois, United States|Rush - Copley Medical Center, Aurora, Illinois, United States|Illinois CancerCare-Bloomington, Bloomington, Illinois, United States|Loyola Center for Health at Burr Ridge, Burr Ridge, Illinois, United States|Illinois CancerCare-Canton, Canton, Illinois, United States|Memorial Hospital of Carbondale, Carbondale, Illinois, United States|SIH Cancer Institute, Carterville, Illinois, United States|Illinois CancerCare-Carthage, Carthage, Illinois, United States|Centralia Oncology Clinic, Centralia, Illinois, United States|Lurie Children's Hospital-Chicago, Chicago, Illinois, United States|Northwestern University, Chicago, Illinois, United States|University of Illinois, Chicago, Illinois, United States|University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States|Carle on Vermilion, Danville, Illinois, United States|Cancer Care Specialists of Illinois - Decatur, Decatur, Illinois, United States|Decatur Memorial Hospital, Decatur, Illinois, United States|Illinois CancerCare-Dixon, Dixon, Illinois, United States|Carle Physician Group-Effingham, Effingham, Illinois, United States|Crossroads Cancer Center, Effingham, Illinois, United States|Illinois CancerCare-Eureka, Eureka, Illinois, United States|Illinois CancerCare-Galesburg, Galesburg, Illinois, United States|Western Illinois Cancer Treatment Center, Galesburg, Illinois, United States|Ingalls Memorial Hospital, Harvey, Illinois, United States|Edward Hines Jr VA Hospital, Hines, Illinois, United States|Loyola Medicine Homer Glen, Homer Glen, Illinois, United States|Illinois CancerCare-Kewanee Clinic, Kewanee, Illinois, United States|Illinois CancerCare-Macomb, Macomb, Illinois, United States|Carle Physician Group-Mattoon/Charleston, Mattoon, Illinois, United States|Loyola University Medical Center, Maywood, Illinois, United States|Marjorie Weinberg Cancer Center at Loyola-Gottlieb, Melrose Park, Illinois, United States|Good Samaritan Regional Health Center, Mount Vernon, Illinois, United States|UC Comprehensive Cancer Center at Silver Cross, New Lenox, Illinois, United States|Cancer Care Center of O'Fallon, O'Fallon, Illinois, United States|University of Chicago Medicine-Orland Park, Orland Park, Illinois, United States|Illinois CancerCare-Ottawa Clinic, Ottawa, Illinois, United States|Advocate Lutheran General Hospital, Park Ridge, Illinois, United States|Illinois CancerCare-Pekin, Pekin, Illinois, United States|Illinois CancerCare-Peoria, Peoria, Illinois, United States|Methodist Medical Center of Illinois, Peoria, Illinois, United States|Saint Jude Midwest Affiliate, Peoria, Illinois, United States|Illinois CancerCare-Peru, Peru, Illinois, United States|Valley Radiation Oncology, Peru, Illinois, United States|Illinois CancerCare-Princeton, Princeton, Illinois, United States|West Suburban Medical Center, River Forest, Illinois, United States|Southern Illinois University School of Medicine, Springfield, Illinois, United States|Springfield Clinic, Springfield, Illinois, United States|Memorial Medical Center, Springfield, Illinois, United States|Southwest Illinois Health Services LLP, Swansea, Illinois, United States|Carle Cancer Center, Urbana, Illinois, United States|The Carle Foundation Hospital, Urbana, Illinois, United States|Rush-Copley Healthcare Center, Yorkville, Illinois, United States|IU Health North Hospital, Carmel, Indiana, United States|Goshen Center for Cancer Care, Goshen, Indiana, United States|Indiana University/Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, United States|IU Health Methodist Hospital, Indianapolis, Indiana, United States|Richard L. Roudebush Veterans Affairs Medical Center, Indianapolis, Indiana, United States|Riley Hospital for Children, Indianapolis, Indiana, United States|Sidney and Lois Eskenazi Hospital, Indianapolis, Indiana, United States|Saint Vincent Hospital and Health Care Center, Indianapolis, Indiana, United States|Reid Health, Richmond, Indiana, United States|Memorial Hospital of South Bend, South Bend, Indiana, United States|Saint Anthony Regional Hospital, Carroll, Iowa, United States|Physicians' Clinic of Iowa PC, Cedar Rapids, Iowa, United States|Mercy Hospital, Cedar Rapids, Iowa, United States|Oncology Associates at Mercy Medical Center, Cedar Rapids, Iowa, United States|Medical Oncology and Hematology Associates-West Des Moines, Clive, Iowa, United States|Mercy Cancer Center-West Lakes, Clive, Iowa, United States|Alegent Health Mercy Hospital, Council Bluffs, Iowa, United States|Greater Regional Medical Center, Creston, Iowa, United States|Blank Children's Hospital, Des Moines, Iowa, United States|Iowa Methodist Medical Center, Des Moines, Iowa, United States|Medical Oncology and Hematology Associates-Des Moines, Des Moines, Iowa, United States|Broadlawns Medical Center, Des Moines, Iowa, United States|Medical Oncology and Hematology Associates-Laurel, Des Moines, Iowa, United States|Mercy Medical Center - Des Moines, Des Moines, Iowa, United States|Iowa Lutheran Hospital, Des Moines, Iowa, United States|Trinity Regional Medical Center, Fort Dodge, Iowa, United States|Methodist West Hospital, West Des Moines, Iowa, United States|Mercy Medical Center-West Lakes, West Des Moines, Iowa, United States|University of Kansas Clinical Research Center, Fairway, Kansas, United States|Central Care Cancer Center - Garden City, Garden City, Kansas, United States|Central Care Cancer Center - Great Bend, Great Bend, Kansas, United States|HaysMed University of Kansas Health System, Hays, Kansas, United States|University of Kansas Cancer Center, Kansas City, Kansas, United States|Lawrence Memorial Hospital, Lawrence, Kansas, United States|Olathe Health Cancer Center, Olathe, Kansas, United States|University of Kansas Cancer Center-Overland Park, Overland Park, Kansas, United States|University of Kansas Hospital-Indian Creek Campus, Overland Park, Kansas, United States|Ascension Via Christi - Pittsburg, Pittsburg, Kansas, United States|Salina Regional Health Center, Salina, Kansas, United States|University of Kansas Health System Saint Francis Campus, Topeka, Kansas, United States|University of Kansas Hospital-Westwood Cancer Center, Westwood, Kansas, United States|Flaget Memorial Hospital, Bardstown, Kentucky, United States|Commonwealth Cancer Center-Corbin, Corbin, Kentucky, United States|Saint Joseph Radiation Oncology Resource Center, Lexington, Kentucky, United States|Saint Joseph Hospital East, Lexington, Kentucky, United States|Saint Joseph London, London, Kentucky, United States|Jewish Hospital, Louisville, Kentucky, United States|The James Graham Brown Cancer Center at University of Louisville, Louisville, Kentucky, United States|Saints Mary and Elizabeth Hospital, Louisville, Kentucky, United States|Jewish Hospital Medical Center Northeast, Louisville, Kentucky, United States|Jewish Hospital Medical Center South, Shepherdsville, Kentucky, United States|LSU Health Baton Rouge-North Clinic, Baton Rouge, Louisiana, United States|Louisiana Hematology Oncology Associates LLC, Baton Rouge, Louisiana, United States|Mary Bird Perkins Cancer Center, Baton Rouge, Louisiana, United States|Our Lady of the Lake Physicians Group - Medical Oncology, Baton Rouge, Louisiana, United States|Medical Center of Baton Rouge, Baton Rouge, Louisiana, United States|Louisiana Hematology Oncology Associates, Baton Rouge, Louisiana, United States|Our Lady of the Lake Medical Oncology, Baton Rouge, Louisiana, United States|Woman's Hospital, Baton Rouge, Louisiana, United States|Ochsner High Grove, Baton Rouge, Louisiana, United States|Mary Bird Perkins Cancer Center - Covington, Covington, Louisiana, United States|Northshore Oncology Associates-Covington, Covington, Louisiana, United States|Ochsner Hematology Oncology North Shore - Covington (West Region), Covington, Louisiana, United States|Women's Cancer Care-Covington, Covington, Louisiana, United States|Mary Bird Perkins Cancer Center - Houma, Houma, Louisiana, United States|Terrebonne General Medical Center, Houma, Louisiana, United States|Ochsner Medical Center Kenner, Kenner, Louisiana, United States|East Jefferson General Hospital, Metairie, Louisiana, United States|LSU Healthcare Network / Metairie Multi-Specialty Clinic, Metairie, Louisiana, United States|Ochsner LSU Health Monroe Medical Center, Monroe, Louisiana, United States|Louisiana State University Health Science Center, New Orleans, Louisiana, United States|Tulane University Health Sciences Center, New Orleans, Louisiana, United States|University Medical Center New Orleans, New Orleans, Louisiana, United States|Ochsner Medical Center Jefferson, New Orleans, Louisiana, United States|Ochsner LSU Health Saint Mary's Medical Center, Shreveport, Louisiana, United States|LSU Health Sciences Center at Shreveport, Shreveport, Louisiana, United States|Harold Alfond Center for Cancer Care, Augusta, Maine, United States|Eastern Maine Medical Center, Bangor, Maine, United States|Waldo County General Hospital, Belfast, Maine, United States|MaineHealth/SMHC Cancer Care and Blood Disorders-Biddeford, Biddeford, Maine, United States|Southern Maine Health Center/Biddeford Medical Center, Biddeford, Maine, United States|Lafayette Family Cancer Center-EMMC, Brewer, Maine, United States|Maine Medical Center-Bramhall Campus, Portland, Maine, United States|Penobscot Bay Medical Center, Rockport, Maine, United States|MaineHealth/SMHC Cancer Care and Blood Disorders-Sanford, Sanford, Maine, United States|Maine Children's Cancer Program, Scarborough, Maine, United States|Maine Medical Center- Scarborough Campus, Scarborough, Maine, United States|Maine Medical Partners - South Portland, South Portland, Maine, United States|University of Maryland/Greenebaum Cancer Center, Baltimore, Maryland, United States|Mercy Medical Center, Baltimore, Maryland, United States|Greater Baltimore Medical Center, Baltimore, Maryland, United States|Sinai Hospital of Baltimore, Baltimore, Maryland, United States|Kaiser Permanente-Woodlawn Medical Center, Baltimore, Maryland, United States|Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland, United States|FMH James M Stockman Cancer Institute, Frederick, Maryland, United States|Kaiser Permanente-Gaithersburg Medical Center, Gaithersburg, Maryland, United States|Kaiser Permanente - Kensington Medical Center, Kensington, Maryland, United States|Kaiser Permanente - Largo Medical Center, Largo, Maryland, United States|Beverly Hospital, Beverly, Massachusetts, United States|Tufts Medical Center, Boston, Massachusetts, United States|Lahey Hospital and Medical Center, Burlington, Massachusetts, United States|Addison Gilbert Hospital, Gloucester, Massachusetts, United States|Lowell General Hospital, Lowell, Massachusetts, United States|Lahey Medical Center-Peabody, Peabody, Massachusetts, United States|Mercy Medical Center, Springfield, Massachusetts, United States|Baystate Medical Center, Springfield, Massachusetts, United States|Winchester Hospital, Winchester, Massachusetts, United States|Saint Joseph Mercy Hospital, Ann Arbor, Michigan, United States|C S Mott Children's Hospital, Ann Arbor, Michigan, United States|University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States|Bronson Battle Creek, Battle Creek, Michigan, United States|McLaren Cancer Institute-Bay City, Bay City, Michigan, United States|IHA Hematology Oncology Consultants-Brighton, Brighton, Michigan, United States|Saint Joseph Mercy Brighton, Brighton, Michigan, United States|Henry Ford Cancer Institute-Downriver, Brownstown, Michigan, United States|IHA Hematology Oncology Consultants-Canton, Canton, Michigan, United States|Saint Joseph Mercy Canton, Canton, Michigan, United States|Caro Cancer Center, Caro, Michigan, United States|IHA Hematology Oncology Consultants-Chelsea, Chelsea, Michigan, United States|Saint Joseph Mercy Chelsea, Chelsea, Michigan, United States|Hematology Oncology Consultants-Clarkston, Clarkston, Michigan, United States|McLaren Cancer Institute-Clarkston, Clarkston, Michigan, United States|Newland Medical Associates-Clarkston, Clarkston, Michigan, United States|Henry Ford Macomb Hospital-Clinton Township, Clinton Township, Michigan, United States|Beaumont Hospital - Dearborn, Dearborn, Michigan, United States|Henry Ford Medical Center-Fairlane, Dearborn, Michigan, United States|Wayne State University/Karmanos Cancer Institute, Detroit, Michigan, United States|Henry Ford Hospital, Detroit, Michigan, United States|Ascension Saint John Hospital, Detroit, Michigan, United States|Great Lakes Cancer Management Specialists-Doctors Park, East China Township, Michigan, United States|Michigan State University Clinical Center, East Lansing, Michigan, United States|Weisberg Cancer Treatment Center, Farmington Hills, Michigan, United States|Beaumont Hospital - Farmington Hills, Farmington Hills, Michigan, United States|Genesee Cancer and Blood Disease Treatment Center, Flint, Michigan, United States|Genesee Hematology Oncology PC, Flint, Michigan, United States|Genesys Hurley Cancer Institute, Flint, Michigan, United States|Hurley Medical Center, Flint, Michigan, United States|McLaren Cancer Institute-Flint, Flint, Michigan, United States|Singh and Arora Hematology Oncology PC, Flint, Michigan, United States|Helen DeVos Children's Hospital at Spectrum Health, Grand Rapids, Michigan, United States|Mercy Health Saint Mary's, Grand Rapids, Michigan, United States|Spectrum Health at Butterworth Campus, Grand Rapids, Michigan, United States|Academic Hematology Oncology Specialists, Grosse Pointe Woods, Michigan, United States|Great Lakes Cancer Management Specialists-Van Elslander Cancer Center, Grosse Pointe Woods, Michigan, United States|Michigan Breast Specialists-Grosse Pointe Woods, Grosse Pointe Woods, Michigan, United States|Allegiance Health, Jackson, Michigan, United States|Bronson Methodist Hospital, Kalamazoo, Michigan, United States|West Michigan Cancer Center, Kalamazoo, Michigan, United States|Borgess Medical Center, Kalamazoo, Michigan, United States|McLaren-Greater Lansing, Lansing, Michigan, United States|Mid-Michigan Physicians-Lansing, Lansing, Michigan, United States|Sparrow Hospital, Lansing, Michigan, United States|Hope Cancer Clinic, Livonia, Michigan, United States|Saint Mary Mercy Hospital, Livonia, Michigan, United States|Great Lakes Cancer Management Specialists-Macomb Medical Campus, Macomb, Michigan, United States|Michigan Breast Specialists-Macomb Township, Macomb, Michigan, United States|Saint Mary's Oncology/Hematology Associates of Marlette, Marlette, Michigan, United States|Mid-Michigan Medical Center - Midland, Midland, Michigan, United States|McLaren Cancer Institute-Macomb, Mount Clemens, Michigan, United States|McLaren Cancer Institute-Central Michigan, Mount Pleasant, Michigan, United States|Mercy Health Mercy Campus, Muskegon, Michigan, United States|Lakeland Hospital Niles, Niles, Michigan, United States|Cancer and Hematology Centers of Western Michigan - Norton Shores, Norton Shores, Michigan, United States|Ascension Providence Hospitals - Novi, Novi, Michigan, United States|Henry Ford Medical Center-Columbus, Novi, Michigan, United States|McLaren Cancer Institute-Northern Michigan, Petoskey, Michigan, United States|21st Century Oncology-Pontiac, Pontiac, Michigan, United States|Hope Cancer Center, Pontiac, Michigan, United States|Newland Medical Associates-Pontiac, Pontiac, Michigan, United States|Saint Joseph Mercy Oakland, Pontiac, Michigan, United States|McLaren-Port Huron, Port Huron, Michigan, United States|Spectrum Health Reed City Hospital, Reed City, Michigan, United States|Great Lakes Cancer Management Specialists-Rochester Hills, Rochester Hills, Michigan, United States|Beaumont Children's Hospital-Royal Oak, Royal Oak, Michigan, United States|William Beaumont Hospital-Royal Oak, Royal Oak, Michigan, United States|Ascension Saint Mary's Hospital, Saginaw, Michigan, United States|Oncology Hematology Associates of Saginaw Valley PC, Saginaw, Michigan, United States|Lakeland Medical Center Saint Joseph, Saint Joseph, Michigan, United States|Marie Yeager Cancer Center, Saint Joseph, Michigan, United States|Henry Ford Macomb Health Center - Shelby Township, Shelby, Michigan, United States|Ascension Providence Hospitals - Southfield, Southfield, Michigan, United States|Bhadresh Nayak MD PC-Sterling Heights, Sterling Heights, Michigan, United States|Ascension Saint Joseph Hospital, Tawas City, Michigan, United States|Munson Medical Center, Traverse City, Michigan, United States|William Beaumont Hospital - Troy, Troy, Michigan, United States|Advanced Breast Care Center PLLC, Warren, Michigan, United States|Great Lakes Cancer Management Specialists-Macomb Professional Building, Warren, Michigan, United States|Macomb Hematology Oncology PC, Warren, Michigan, United States|Michigan Breast Specialists-Warren, Warren, Michigan, United States|Saint John Macomb-Oakland Hospital, Warren, Michigan, United States|Henry Ford West Bloomfield Hospital, West Bloomfield, Michigan, United States|Saint Mary's Oncology/Hematology Associates of West Branch, West Branch, Michigan, United States|Metro Health Hospital, Wyoming, Michigan, United States|Huron Gastroenterology PC, Ypsilanti, Michigan, United States|IHA Hematology Oncology Consultants-Ann Arbor, Ypsilanti, Michigan, United States|Sanford Joe Lueken Cancer Center, Bemidji, Minnesota, United States|Fairview Ridges Hospital, Burnsville, Minnesota, United States|Minnesota Oncology - Burnsville, Burnsville, Minnesota, United States|Cambridge Medical Center, Cambridge, Minnesota, United States|Mercy Hospital, Coon Rapids, Minnesota, United States|Fairview Southdale Hospital, Edina, Minnesota, United States|Unity Hospital, Fridley, Minnesota, United States|Mayo Clinic Health Systems-Mankato, Mankato, Minnesota, United States|Fairview Clinics and Surgery Center Maple Grove, Maple Grove, Minnesota, United States|Minnesota Oncology Hematology PA-Maplewood, Maplewood, Minnesota, United States|Saint John's Hospital - Healtheast, Maplewood, Minnesota, United States|Abbott-Northwestern Hospital, Minneapolis, Minnesota, United States|Hennepin County Medical Center, Minneapolis, Minnesota, United States|Health Partners Inc, Minneapolis, Minnesota, United States|University of Minnesota/Masonic Cancer Center, Minneapolis, Minnesota, United States|Monticello Cancer Center, Monticello, Minnesota, United States|New Ulm Medical Center, New Ulm, Minnesota, United States|Fairview Northland Medical Center, Princeton, Minnesota, United States|North Memorial Medical Health Center, Robbinsdale, Minnesota, United States|Mayo Clinic in Rochester, Rochester, Minnesota, United States|Coborn Cancer Center at Saint Cloud Hospital, Saint Cloud, Minnesota, United States|Park Nicollet Clinic - Saint Louis Park, Saint Louis Park, Minnesota, United States|Regions Hospital, Saint Paul, Minnesota, United States|United Hospital, Saint Paul, Minnesota, United States|Saint Francis Regional Medical Center, Shakopee, Minnesota, United States|Lakeview Hospital, Stillwater, Minnesota, United States|Ridgeview Medical Center, Waconia, Minnesota, United States|Rice Memorial Hospital, Willmar, Minnesota, United States|Minnesota Oncology Hematology PA-Woodbury, Woodbury, Minnesota, United States|Fairview Lakes Medical Center, Wyoming, Minnesota, United States|Baptist Memorial Hospital and Cancer Center-Golden Triangle, Columbus, Mississippi, United States|",https://ClinicalTrials.gov/show/NCT04387656
NCT04527601,Extremely Premature Births During the Peak of the COVID-19 Pandemic: an International Study of the Active SafeBoosC III Departments,Observational Model: Cohort|Time Perspective: Retrospective,SafeBoosC COVID-19 ELGAN study,"Neonatalklinikken, Rigshospitalet, Copenhagen, Denmark",https://ClinicalTrials.gov/show/NCT04527601
NCT04487574,A Study to Assess the Efficacy and Safety of XC221 in Patients With COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",XC221-03-02-2020,"Regional State Budgetary Institution of Healthcare ""City Hospital No. 5, Barnaul"", Barnaul, Altai Region, Russian Federation|State Budgetary Institution of Healthcare of Moscow Region ""Zhukovskaya City Clinical Hospital"", Zhukovskiy, Moscow Region, Russian Federation|Municipal Budgetary Institution of Healthcare ""Central City Hospital of Novoshakhtinsk"", Novoshakhtinsk, Rostov Region, Russian Federation|State Budgetary Institution of Healthcare of Moscow ""City Clinical Hospital No. 15 of the Moscow Department of Healthcare"", Moscow, Russian Federation|Federal State Autonomous Educational Institution of Higher Education First Moscow State Medical University named after I.M. Sechenov of the Ministry of Health of the Russian Federation (Sechenov University), Department of Faculty Therapy No. 2, Moscow, Russian Federation|State Budgetary Institution of Healthcare of Moscow ""City Clinical Hospital No. 52 of the Moscow Department of Healthcare"", Moscow, Russian Federation|State Budgetary Institution of Healthcare of Moscow ""City Clinical Hospital No. 40 of the Moscow Department of Healthcare"", Moscow, Russian Federation|Saint Petersburg State Budgetary Institution of Healthcare ""City Multidisciplinary Hospital"", Saint Petersburg, Russian Federation|Saint Petersburg State Budgetary Institution of Healthcare ""City Hospital No. 40 of Kurortny District"", Saint Petersburg, Russian Federation|Saint Petersburg State Budgetary Institution of Healthcare ""City Hospital No. 15"", Saint Petersburg, Russian Federation|Saint Petersburg State Budgetary Institution of Healthcare ""City Pokrovskaya Hospital"" (4th Cardiology Department), Saint Petersburg, Russian Federation|Saint Petersburg State Budgetary Institution of Healthcare ""City Pokrovskaya Hospital"", Saint Petersburg, Russian Federation|Regional State Budgetary Institution of Healthcare ""Medical-Sanitary Unit No. 2"", Tomsk, Russian Federation",https://ClinicalTrials.gov/show/NCT04487574
NCT04375098,Efficacy and Safety of Early COVID-19 Convalescent Plasma in Patients Admitted for COVID-19 Infection,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,200415015,"Hospital Clínico Universidad Católica, Santiago, Chile",https://ClinicalTrials.gov/show/NCT04375098
NCT04348383,Defibrotide as Prevention and Treatment of Respiratory Distress and Cytokine Release Syndrome of Covid 19.,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",IMIB-DFC-2020-02,"Hospital General Universitario Santa Lucía, Cartagena, Murcia, Spain|Hospital Clinico y Provincial de Barcelona, Barcelona, Spain|Virgen de la Arrixaca University Clinical Hospital, Murcia, Spain|Hospital General Universitario Morales Meseguer, Murcia, Spain|Hospital General Universitario Reina Sofía, Murcia, Spain|Hospital Universitario Salamanca, Salamanca, Spain",https://ClinicalTrials.gov/show/NCT04348383
NCT04642638,"Safety, Immunogenicity, and Efficacy of INO-4800 for COVID-19 in Healthy Seronegative Adults at High Risk of SARS-CoV-2 Exposure","Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",COVID19-311|INNOVATE,"Synexus Clinical Research US, Inc - Phoenix Southeast, Chandler, Arizona, United States|Central Phoenix Synexus Clinical Research, Phoenix, Arizona, United States|AMR Tempe, Tempe, Arizona, United States|Optimal Research, LLC, San Diego, California, United States|AMR South Florida, Coral Gables, Florida, United States|Clinical Research Trials of Florida, Inc, Tampa, Florida, United States|AMR Lexington, Lexington, Kentucky, United States|Walter Reed Army Institute of Research, Silver Spring, Maryland, United States|Ascension St. John Hospital, Detroit, Michigan, United States|AMR Kansas City, Kansas City, Missouri, United States|AMR, Clinical Research Consortium- Las Vegas, Las Vegas, Nevada, United States|University of Pennsylvania, Philadelphia, Pennsylvania, United States|Thomas Jefferson University, Philadelphia, Pennsylvania, United States|Tekton Research, San Antonio, Texas, United States|DM Clinical Research, Tomball, Texas, United States|Advanced Clinical Research, West Jordan, Utah, United States",https://ClinicalTrials.gov/show/NCT04642638
NCT04429854,Donated Antibodies Working Against nCoV,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,S63992,"ZNA, Antwerpen, Belgium|Imelda Ziekenhuis Bonheiden, Bonheiden, Belgium|Institut Bordet, Brussel, Belgium|UMC Sint-Pieter, Brussel, Belgium|CHU Brugmann, Brussel, Belgium|Erasmus Ziekenhuis, Brussel, Belgium|UZ Brussel, Brussel, Belgium|Cliniques Universitaires St Luc, Brussel, Belgium|AZ Sint-Vincentius, Deinze, Belgium|AZ Maria Middelares, Gent, Belgium|AZ Sint-Lucas, Gent, Belgium|AZ Groeninge, Kortrijk, Belgium|UZ Leuven, Leuven, Belgium|CHC Liège Mont Légia, Liège, Belgium|CHR Citadelle Liège, Liège, Belgium|CHU Liège Sart-Tilman, Liège, Belgium|CHU Ambroise Paré, Mons, Belgium|CHR Jolimont Mons-Hainaut, Mons, Belgium|AZ Delta, Roeselare, Belgium|Sint-Trudo Ziekenhuis, Sint-Truiden, Belgium|Centre Hospitalier de Wallonie Picarde (CHwapi), Tournai, Belgium",https://ClinicalTrials.gov/show/NCT04429854
NCT04670094,Comorbidities and Risk Score in COVID-19 Patients,Observational Model: Cohort|Time Perspective: Retrospective,Comorbidities,"ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy|ASST Spedali Civili, Montichiari, Italy|ASST Monza-Ospedale San Gerardo, Monza, Italy|Humanitas Clinical and Research Hospital, Rozzano, Italy|Centre for Tropical and Infectious Diseases and Microbiology, IRCCS Sacro Cuore, Verona, Italy",https://ClinicalTrials.gov/show/NCT04670094
NCT04450017,Clinical Features of Severe Patients With COVID-19,Observational Model: Case-Only|Time Perspective: Retrospective,COVID-ICU,"Federal Research Clinical Center of Federal Medical & Biological Agency, Moscow, Russian Federation",https://ClinicalTrials.gov/show/NCT04450017
NCT04655638,HFNT vs. COT in COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,1th Dec 2020,"Department of Emergency Medicine, Faculty of Medicine, University of Thessaly, Larisa, Greece|Department of Anesthesiology, University of Thessaly, School of Health Sciences, Faculty of Medicine, Larissa, Greece|UO di Pronto Soccorso e Medicina d'Urgenza Humanitas Research Hospital, Rozzano, Milano, Italy|U.O. di Medicina interna AULSS 7 Pedemontana, Bassano del Grappa, VI, Italy|Pulmonology and Respiratory Intensive Care Unit, S. Donato Hospital, Arezzo, Italy, Arezzo, Italy|Institute of Respiratory Disease, Department of Basic Medical Science, Neuroscience and Sense Organs, University of Bari, Bari, Italy|Ospedale di Carpi, Carpi, Italy|Respiratory Medicine Unit, ""Policlinico-Vittorio Emanuele San Marco"" University Hospital, Catania, Italy, Catania, Italy|UO di Medicina d'Urgenza AOU Policlinico Vittorio Emanuele San Marco di Catania, Catania, Italy|Department of Surgical, Oncological and Oral Science (Di.Chir.On.S.), University of Palermo, Italy G. Giglio Foundation, Cefalù, Italy, Cefalù, Italy|Department of Medical and Surgical Sciences, University of Foggia. Institute of Respiratory Diseases, University Hospital 'Policlinico Riuniti', Foggia, Italy|Department of Human Pathology of the Adult and Evolutive Age ""Gaetano Barresi"", Division of Anesthesia and Intensive Care, University of Messina, Policlinico ""G. Martino"", Messina, Italy, Messina, Italy|UO di Pneumologia ASST Fatebenefratelli Sacco, Milano, Italy|IRCCS MultiMedica, Value-Based Healthcare Unit, Sesto San Giovanni, Milan, Italy, Milan, Italy|University Hospital of Modena Policlinico, Respiratory Diseases Unit, Department of Medical and Surgical Sciences SMECHIMAI, University of Modena Reggio Emilia, Italy, Modena, Italy|AOU San Luigi Gonzaga, Orbassano, Italy|Department of Surgical, Oncological and Oral Science (Di.Chir.On.S.), University of Palermo, Italy Department of Anesthesia Intensive Care and Emergency, Policlinico Paolo Giaccone, Palermo, Italy, Palermo, Italy|Department of Surgical, Oncological and Oral Science (Di.Chir.On.S.), University of Palermo, Italy Department of Anesthesia Intensive Care and Emergency, Policlinico Paolo Giaccone, Palermo, Italy, Palermo, Italy|Department of Medicina e Chirurgia Università Insubria Varese-Como, Italy, Pavia, Italy|Emergency Department, ""S. Maria della Misericordia"" Hospital, Perugia, Italy., Perugia, Italy|U.O. di Pneumologia Azienda USL di Pescara, Pescara, Italy|U.O. di PneumoCovid Azienda Ospedaliera San Giovanni di Roma, Roma, Italy|Department of Pneumology, A.O.U. Città della Salute e della Scienza of Turin, Italy., Turin, Italy|U.O. di Pneumologia ASST Settelaghi Ospedale Circolo Fondazione Macchi, Varese, Italy|U.O. Medicina Respiratoria del Policlinico G.B. Rossi, Verona, Italy|Hospital Prof. Doutor Fernando Fonseca, Pneumologia, Amadora, Portugal|Hospital Parc Taulí de Sabadell, Pneumologia, Sabadell, Spain",https://ClinicalTrials.gov/show/NCT04655638
NCT04469153,Interest of the Dosage of Ferritin / Glycosylated Ferritin in COVID-19,Observational Model: Cohort|Time Perspective: Retrospective,2020_FerriGly COVID,"hopital de la Croix Rousse, Lyon 4, Rhone Alpes, France",https://ClinicalTrials.gov/show/NCT04469153
NCT04570982,Clinical Protocol for Convalescent Plasma and Remdesivir Therapy in Nepal,Observational Model: Case-Crossover|Time Perspective: Prospective,NHRC2020-001,"Narayani Hospital, Birgunj, Nepal|Seti Provincial Hospital, Dhangadi, Nepal|BP Koirala Institute of Health Sciences (BPKIHS), Dharān Bāzār, Nepal|Sukraraj Tropical Disease Hospital, Kathmandu, Nepal|TU Teaching Hospital, Kathmandu, Nepal|Bheri Provincial Hospital, Nepalgunj, Nepal",https://ClinicalTrials.gov/show/NCT04570982
NCT04570189,"Evaluating Auscul-X, a Touch Free Digital Stethoscope",Observational Model: Cohort|Time Perspective: Retrospective,Auscul-X,"The University of Ottawa Heart Institute, Ottawa, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04570189
NCT04723290,COVID-19 Seroconversion Study Among GHdC Staff Members - Summer 2020,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,SERO-SARS-CoV-2 GHdC,"Grand Hôpital de Charleroi, Charleroi, Hainaut, Belgium",https://ClinicalTrials.gov/show/NCT04723290
NCT04334291,"International COVID19 Clinical Evaluation Registry,",Observational Model: Cohort|Time Perspective: Cross-Sectional,20/241-E|EUPAS34399,"Hospital Lclinico San Carlos, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04334291
NCT04420286,Study of the Increase in ICU Beds Capacity During COVID-19 Pandemic in France,Observational Model: Other|Time Perspective: Retrospective,30RC20_0117,"CHU de Nîmes, Hôpital Universitaire Carémeau, Nimes, France",https://ClinicalTrials.gov/show/NCT04420286
NCT04398004,Anti-inflammatory Clarithromycin for Improving COVID-19 Infection Early,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,ACHIEVE|2020-001882-36,"COVID-19 Department, General Hospital of Attica SISMANOGLEIO-AMALIA FLEMING, Marousi, Athens, Greece|2nd Department of Internal Medicine, General Hospital of Nikaia, Piraeus, Attica, Greece|2nd Department of Internal Medicine, University General Hospital of Alexandroupolis, Alexandroupolis, Greece|1st University Department of Internal Medicine, LAIKO General Hospital of Athens, Athens, Greece|2nd University Department of Internal Medicine, IPPOKRATEION General Hospital of Athens, Athens, Greece|3rd University Department of Internal Medicine, General Hospital of Chest Diseases of Athens I SOTIRIA, Athens, Greece|1st Department of Internal Medicine, General University Hospital of Ioannina, Ioánnina, Greece|2nd Department of Internal Medicine, General Hospital of Piraeus ""Tzaneio"", Piraeus, Greece|1st Department of Internal Medicine, AHEPA University General Hospital of Thessaloniki, Thessaloníki, Greece",https://ClinicalTrials.gov/show/NCT04398004
NCT04453280,Antibody Detection in COVID-19 Cured Patients (SARS-CoV-2-CZ-Immunity),Observational Model: Cohort|Time Perspective: Cross-Sectional,UZIS 2020/2,"Institute of Health Information and Statistics of the Czech Republic, Prague, Czechia",https://ClinicalTrials.gov/show/NCT04453280
NCT04598256,Endoscopic Procedures of Children in the Normalization Process of Covid-19 Pandemic,Observational Model: Other|Time Perspective: Prospective,TepecikTRH1,"Tepecik Trh, İzmir, İ̇zmi̇r, Turkey",https://ClinicalTrials.gov/show/NCT04598256
NCT04499677,FLARE: Favipiravir +/- Lopinavir: A RCT of Early Antivirals,"Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",132084,"Royal Free Hospital, London, United Kingdom|University College London Hospital (UCLH), London, United Kingdom",https://ClinicalTrials.gov/show/NCT04499677
NCT04602351,Communication in ICU During COVID-19,Observational Model: Case-Only|Time Perspective: Cross-Sectional,ComICU,"NMC Specialty Hospital, Dubai, United Arab Emirates",https://ClinicalTrials.gov/show/NCT04602351
NCT04729374,COVID-19 Vaccine Induced Adaptive Immune Responses,Observational Model: Cohort|Time Perspective: Prospective,NJGLVAC-001,"Nanjing Drum Tower Hospital, Nanjing, Jiangsu, China",https://ClinicalTrials.gov/show/NCT04729374
NCT04360824,Covid-19 Associated Coagulopathy,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,202004235,"University of Iowa, Iowa City, Iowa, United States|Gundersen Health System, La Crosse, Wisconsin, United States",https://ClinicalTrials.gov/show/NCT04360824
NCT04662684,Medically Ill Hospitalized Patients for COVID-19 THrombosis Extended ProphyLaxis With Rivaroxaban ThErapy: The MICHELLE Trial,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,21589 Michelle Trial,"Science Valley Research Institute, Santo André, São Paulo, Brazil",https://ClinicalTrials.gov/show/NCT04662684
NCT04847804,Large-scale COVID-19 Population Screening,Observational Model: Case-Control|Time Perspective: Cross-Sectional,CRE2021.188,"The Hong Kong University of Sciences and Technology, Sai Kung, Hong Kong|Chinese University of Hong Kong, Shatin, Hong Kong|Prince of Wales Hospital, Shatin, Hong Kong",https://ClinicalTrials.gov/show/NCT04847804
NCT04473261,Efficacy of Iodine Complex Against COVID-19 Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",SZMC/IRB/Internal/216/2020,"Shaikh Zayed Hospital, Lahore, Pakistan",https://ClinicalTrials.gov/show/NCT04473261
NCT04458948,Open Label Non-comparative Trial of the Combination of Hydroxychloroquine and Azithromycin in the Treatment of Hospitalized Patients,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,20-156,"University of New Mexico Health Sciences Center, Albuquerque, New Mexico, United States",https://ClinicalTrials.gov/show/NCT04458948
NCT04633980,Hydrogen Therapy in Patients With Moderate Covid-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,38RC20.277,NA,https://ClinicalTrials.gov/show/NCT04633980
NCT04808895,Acetylsalicylic Acid in the Prevention of Severe SARS-CoV2 Pneumonia in Hospitalised Patients With COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",EudraCT 2020-006130-12,"Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy",https://ClinicalTrials.gov/show/NCT04808895
NCT04924855,Immunity After COVID-19 Vaccination,Observational Model: Cohort|Time Perspective: Cross-Sectional,UR17DN05-3,"HMPIT vaccination committee, Tunis, Please Select..., Tunisia",https://ClinicalTrials.gov/show/NCT04924855
NCT04945564,Covid-19 Patients Management During Home Isolation,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,REC/036-2021,"A. Sedky, Cairo, Egypt",https://ClinicalTrials.gov/show/NCT04945564
NCT04640233,Clinical Trial to Assess Safety and Immunogenicity of Gam-COVID-Vac Combined Vector Vaccine for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Сov-2) Infection,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention",RDI-GCV-001|CTRI/2020/11/029234,"S N Medical College, Agra, India|MGM Medical College and Hospital, Aurangabad, India|KLE Prabhakar Kore Hospital, Belgaum, India|Apollo Hospital, Delhi, India|Batra Hospital, Delhi, India|HIMSR with CHRD-SAS, Delhi, India|ESIC Medical College & Hospital, Faridabad, India|AIG hospital, Hyderabad, India|Maharaja Agrasen Superspecialty Hospital, Jaipur, India|GSVM Medical College, Kanpur, India|Peerless Hospital, Kolkata, India|Atharva Hospital, Lucknow, India|St. George's Hospital, Mumbai, India|JSS Hospital, Mysore, India|INCLEN trust and Gurunanak Hospital, Palwal, India|PIMS, Puducherry, India|BJ Sassoon Hospital, Pune, India|KEM Hospital, Pune, India|Noble Hospital Private Limited, Pune, India|BAPS hospital, Sūrat, India|Rhythm Heart Institute, Vadodara, India|Sumandeep Vidyapeeth, Vadodara, India|Christian Medical College, Vellore, India",https://ClinicalTrials.gov/show/NCT04640233
NCT04690413,NOWDx Test for the Detection of Antibodies to COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,NOWDx COVID-19 Antibody POC,"Del Sol Research Management, LLC, Tucson, Arizona, United States|Comprehensive Clinical Research, LLC, West Palm Beach, Florida, United States|Clinical Research Solutions, LLC, Jackson, Tennessee, United States",https://ClinicalTrials.gov/show/NCT04690413
NCT04578132,Description of the Population With Genitourinary Tumors and COVID-19,Observational Model: Ecologic or Community|Time Perspective: Other,SOG-INM-2020-04,"Institut Català d'Oncologia L'Hospitalet, Hospitalet de Llobregat, Barcelona, Spain|Althaia, Manresa, Barcelona, Spain|Hospital Universitari Parc Taulí, Sabadell, Barcelona, Spain|Hospital Universitario Puerta de Hierro-Majadahonda, Majadahonda, Madrid, Spain|Hospital Universitario de Badajoz, Badajoz, Spain|Hospital del Mar, Barcelona, Spain|Hospital Santa Creu i Sant Pau, Barcelona, Spain|Hospital Universitario Vall d Hebron, Barcelona, Spain|Hospital Universitario de Burgos, Burgos, Spain|Hospital de Ciudad Real, Ciudad Real, Spain|Hospital Universitario Reina Sofía, Córdoba, Spain|Instituto Catalán de Oncología- Girona, Girona, Spain|Hospital Universitario Lucus Augusti, Lugo, Spain|Fundación Jiménez Díaz, Madrid, Spain|Hospital 12 de Octubre, Madrid, Spain|Hospital Clínico San Carlos de Madrid, Madrid, Spain|Hospital Infanta Leonor,, Madrid, Spain|Hospital Universitario Gregorio Marañón, Madrid, Spain|Hospital Universitario HM Sanchinarro, Madrid, Spain|Hospital Universitario La Paz, Madrid, Spain|Hospital Universitario La Princesa, Madrid, Spain|Hospital Universitario Quironsalud, Madrid, Spain|Hospital Universitario Ramón y Cajal, Madrid, Spain|Complejo Hospitalario Universitario Ourense, Orense, Spain|Clinica Universidad de Navarra, Pamplona, Spain|Hospital Universitario Virgen Macarena, Sevilla, Spain|Hospital Nuestra Señora del Prado, Talavera De La Reina, Spain|Hospital Virgen de la Salud, Toledo, Spain|Hospital Universitario Dr. Peset, Valencia, Spain|Instituto Valenciano de Oncología, Valencia, Spain|Hospital Txagorritxu, Vitoria, Spain|Hospital Miguel Servet, Zaragoza, Spain",https://ClinicalTrials.gov/show/NCT04578132
NCT04959747,Acupuncture for Olfactory Dysfunction in Infected COVID-19 Patients,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,Acupuncture for OD,"Linda Zhong, Kowloon Tong, Kowloon, Hong Kong",https://ClinicalTrials.gov/show/NCT04959747
NCT04542993,Can SARS-CoV-2 Viral Load and COVID-19 Disease Severity be Reduced by Resveratrol-assisted Zinc Therapy,Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: Single (Participant)|Primary Purpose: Supportive Care,SHS KAPH NSWE 20090,"Swedish Medical Center, Seattle, Washington, United States",https://ClinicalTrials.gov/show/NCT04542993
NCT04699227,Can RIC Prevent Deterioration to Critical Care in Covid19,Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: Single (Participant)|Primary Purpose: Prevention,20/SC/0192,"Royal Free London NHS Foundation Trust,, London, United Kingdom|East and North Hertfordshire NHS TrusEast and North Hertfordshire NHS Trus, Stevenage, United Kingdom",https://ClinicalTrials.gov/show/NCT04699227
NCT04740372,"Development of an International COVID-19 Specific Quality of Life Questionnaire, Phase III. The OSLO COVID-19 QLQ",Observational Model: Other|Time Perspective: Other,REK Norway: 171640,"Oslo University Hospital, Oslo, Norway",https://ClinicalTrials.gov/show/NCT04740372
NCT04569344,COVID-19 and Venous Thromboembolism Risk,Observational Model: Cohort|Time Perspective: Retrospective,NOACs-1510-32651_enhancement,"Kaiser Permanente Northern California, Oakland, California, United States|Kaiser Permanente Southern California, Pasadena, California, United States",https://ClinicalTrials.gov/show/NCT04569344
NCT04479150,Complications and Mortality Following Emergency Digestive Surgery During the COVID-19 Pandemic,Observational Model: Cohort|Time Perspective: Cross-Sectional,COVIDCIR,"Hospital Universitari de Bellvitge, L'Hospitalet De Llobregat, Barcelona, Spain",https://ClinicalTrials.gov/show/NCT04479150
NCT04479488,Brazilian Registry for Clinical Presentation of Individuals With COVID-19 (SARS-Brazil),Observational Model: Cohort|Time Perspective: Prospective,30047620.3.0000.0071,"Hospital de Emergencia Dr. Daniel Houly, Arapiraca, Alagoas, Brazil|Universidade Federal da Bahia, Vitória Da Conquista, Bahia, Brazil|Alencar Serviços Médicos Ltda, Barbalha, Ceará, Brazil|Hospital Estadual Jayme dos Santos Neves, Serra, Espirito Santo, Brazil|Hospital Santa Rita de Cássia, Vitória, Espirito Santo, Brazil|Fundação Educacional Lucas Machado, Belo Horizonte, Minas Gerais, Brazil|Fundação Hopitalar São Francisco de Assis, Belo Horizonte, Minas Gerais, Brazil|Hospital Santa Lucia, Poços De Caldas, Minas Gerais, Brazil|Hospital Giselda Trigueiro, Natal, Rio Grande Do Norte, Brazil|Hospital São Vicente de Paulo, Passo Fundo, Rio Grande Do Sul, Brazil|Santa Casa de Votuporanga, Votuporanga, São Paulo, Brazil|Hospital Municipal Vila Santa Catarina, São Paulo, Brazil|Hospital São Camilo - Ipiranga, São Paulo, Brazil|Hospital São Camilo - Pompéia, São Paulo, Brazil",https://ClinicalTrials.gov/show/NCT04479488
NCT04379037,Vagus Nerve Stimulation ARDS Prevention Trial for COVID-19 Hospitalized Patients,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,NCM-001,"Hospital Zonal Virgen del Carmen de Zárate, Zárate, Buenos Aires, Argentina",https://ClinicalTrials.gov/show/NCT04379037
NCT04380662,Risk Factors Worsening COVID19 for Out-patient With Home Monitoring,Observational Model: Cohort|Time Perspective: Prospective,38RC20.135|2020-A01040-39,"Grenoble University Hospital, Grenoble, France",https://ClinicalTrials.gov/show/NCT04380662
NCT04636203,Burden of COVID-19 Infection in Populations With High or Low Risk of Infection,Observational Model: Cohort|Time Perspective: Cross-Sectional,DEP_032020,"IRCCS INM Neuromed, Department of Epidemiology and Prevention, Pozzilli, IS, Italy|ASST Settelaghi, Varese, VA, Italy",https://ClinicalTrials.gov/show/NCT04636203
NCT04374045,Testing for Dysautonomia in Patients Hospitalized for SARS-CoV-2 Infection (COVID-19) : COVIDANS Study,Observational Model: Cohort|Time Perspective: Prospective,20CH095|2020-A01082-37,"CHU Hopital nord, Saint-Étienne, France",https://ClinicalTrials.gov/show/NCT04374045
NCT04800224,Brazilian Green Propolis Extract (EPP-AF) as an Adjunct Treatment for Hospitalized COVID-19 Patients (BeeCovid2),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",31099320.6.0000.0049,"Hospital Sao Rafael, Salvador, BA, Brazil",https://ClinicalTrials.gov/show/NCT04800224
NCT04362813,Study of Efficacy and Safety of Canakinumab Treatment for CRS in Participants With COVID-19-induced Pneumonia,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",CACZ885D2310|2020-001370-30,"Novartis Investigative Site, Birmingham, Alabama, United States|Novartis Investigative Site, Glendale, California, United States|Novartis Investigative Site, San Francisco, California, United States|Novartis Investigative Site, San Francisco, California, United States|Novartis Investigative Site, Chicago, Illinois, United States|Novartis Investigative Site, Baltimore, Maryland, United States|Novartis Investigative Site, Boston, Massachusetts, United States|Novartis Investigative Site, Boston, Massachusetts, United States|Novartis Investigative Site, Brooklyn, New York, United States|Novartis Investigative Site, Chapel Hill, North Carolina, United States|Novartis Investigative Site, Cleveland, Ohio, United States|Novartis Investigative Site, Philadelphia, Pennsylvania, United States|Novartis Investigative Site, Houston, Texas, United States|Novartis Investigative Site, Richmond, Virginia, United States|Novartis Investigative Site, Tacoma, Washington, United States|Novartis Investigative Site, Toulouse Cedex 4, France|Novartis Investigative Site, Bergamo, BG, Italy|Novartis Investigative Site, Cona, FE, Italy|Novartis Investigative Site, Barnaul, Russian Federation|Novartis Investigative Site, Moscow, Russian Federation|Novartis Investigative Site, Moscow, Russian Federation|Novartis Investigative Site, Moscow, Russian Federation|Novartis Investigative Site, Moscow, Russian Federation|Novartis Investigative Site, Ryazan, Russian Federation|Novartis Investigative Site, S-Petersburg, Russian Federation|Novartis Investigative Site, Saint Petersburg, Russian Federation|Novartis Investigative Site, Sestroretsk, Russian Federation|Novartis Investigative Site, St Petersburg, Russian Federation|Novartis Investigative Site, Hospitalet de Llobregat, Barcelona, Spain|Novartis Investigative Site, Barcelona, Catalunya, Spain|Novartis Investigative Site, San Sebastian de los Reyes, Madrid, Spain|Novartis Investigative Site, Madrid, Spain|Novartis Investigative Site, Madrid, Spain|Novartis Investigative Site, Madrid, Spain|Novartis Investigative Site, Barnet, United Kingdom|Novartis Investigative Site, Coventry, United Kingdom|Novartis Investigative Site, Leeds, United Kingdom|Novartis Investigative Site, London, United Kingdom|Novartis Investigative Site, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04362813
NCT04738331,Analysing the French COVID-19 Epidemic Using a National SARS-CoV-2 RT-PCR Database,Observational Model: Other|Time Perspective: Retrospective,RECHMPL21_0051,"Uh Montpellier, Montpellier, France",https://ClinicalTrials.gov/show/NCT04738331
NCT04894214,Flow-controlled Ventilation (FCV) in Moderate Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19,Observational Model: Case-Crossover|Time Perspective: Prospective,1533,"Antwerp University Hospital, Edegem, Antwerp, Belgium",https://ClinicalTrials.gov/show/NCT04894214
NCT04533360,Prevalence of COVID-19 Antibodies Kingman AZ,Observational Model: Ecologic or Community|Time Perspective: Prospective,KRMC 0205,"Kingman Regional Medical Center, Kingman, Arizona, United States",https://ClinicalTrials.gov/show/NCT04533360
NCT04962893,Study of a Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Virus-like Particle (VLP) Vaccine,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention",VLP-58-1023-Al-K3-PII,"Dr. Abdurahman Yurtaslan Ankara Oncology Training and Research Hospital Phase I Clinical Study Center, Ankara, Turkey|Health Sciences University İstanbul Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital, İstanbul, Turkey|Kocaeli University Research and Application Hospital Infectious Disease and Clinical Microbiology Department, Kocaeli, Turkey",https://ClinicalTrials.gov/show/NCT04962893
NCT04362345,Clinical Features and Risk Factors Associated With Worse Outcome in Patients Hospitalized for Covid-19 Pneumonia,Observational Model: Case-Only|Time Perspective: Other,7773,"Service des Maladies Infectieuses et Tropicales, Strasbourg, France",https://ClinicalTrials.gov/show/NCT04362345
NCT04698993,Dräger COVID-19 Antigen Test Clinical Performance Study,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,Dräger Antigen Test SARS-CoV-2,"Charité - Universitätsmedizin Berlin, Berlin, Germany",https://ClinicalTrials.gov/show/NCT04698993
NCT04911777,"Proof of Principle Study to Evaluate the Safety, PK, Viral Shedding and Efficacy of Pentarlandir™ UPPTA for Patients With Early COVID-19","Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",SNR08-Covid19,NA,https://ClinicalTrials.gov/show/NCT04911777
NCT04899245,ReSET Aim 1b: Restarting Safe Education and Testing for Children With Medical Complexity - COVID-19 Testing in School With Children and Staff,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,2021-0488|A536771|SMPH/PEDIATRICS|Protocol Version 04/02/21|1OT2HD107558-01,"University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, United States",https://ClinicalTrials.gov/show/NCT04899245
NCT04598594,Evaluation of the Efficacy of Nicotine Patches in SARS-CoV2 (COVID-19) Infection in Intensive Care Unit Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",APHP200537|2020-003723-42,"Centre Hospitalier Victor Dupouy - Service de Réanimation polyvalente et USC, Argenteuil, France|CHRU de Besançon - Service de Médecine Intensive Réanimation, Besançon, France|Centre Hospitalier Sud Francilien - Service de réanimation, Corbeil-Essonnes, France|CHU Dijon - Hôpital François Miterrand Service de Médecine Intensive Réanimation, Dijon, France|Hôpital Simone VEIL - Service d'Anesthésie-Réanimation, Eaubonne, France|Grand Hôpital de l'Est Francilien - Site Jossigny - Réanimation, Jossigny, France|Hôpital Bicêtre - Service de Médecine Intensive Réanimation, Le Kremlin-Bicêtre, France|Grand Hôpital de l'Est Francilien Site Meaux - Service de Réanimation Médico-Chirurgicale, Meaux, France|Groupement Hospitalier de la Région de Mulhouse Sud Alsace - Hop Emile MULLER, Mulhouse, France|CHU Nice - Hôpital L'Archet 1 - Service de Médecine Intensive Réanimation, Nice, France|CHR Orléans Service de Médecine Intensive Réanimation, Orléans, France|Hôpital Pitié Salpêtrière - ICU, Paris, France|Hôpital Pitié Salpêtrière - Intensive care unit, Paris, France|Institut Mutualiste Montsouris Service de Réanimation Polyvalente, Paris, France|Hôpital Tenon - Service de Médecine Intensive Réanimation, Paris, France|Centre Hospitalier René Dubos - Service de Réanimation Médico-Chirurgicale, Pontoise, France|Hôpital DELAFONTAINE Service de Médecine Intensive Réanimation, Saint-Denis, France|Médipôle Hôpital Privé - MHP Service de Médecine Intensive Réanimation, Villeurbanne, France",https://ClinicalTrials.gov/show/NCT04598594
NCT04516811,Therapeutic Use of Convalescent Plasma in the Treatment of Patients With Moderate to Severe COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",PROTECT-Patient trial,"Universitas Hospital, Bloemfontein, Free State, South Africa|Mitchells Plain Hospital, Cape Town, Western Cape, South Africa",https://ClinicalTrials.gov/show/NCT04516811
NCT04707664,Sargramostim Use in COVID-19 to Recover Patient Health,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",PTX-001-003,"West Valley Research Clinic, LLC, Phoenix, Arizona, United States|Hope Clinical Research, Canoga Park, California, United States|Benchmark Research, Colton, California, United States|Synergy Healthcare, Bradenton, Florida, United States|Invesclinic US, LLC., Fort Lauderdale, Florida, United States|Indago Research & Health Center, Inc. (Subject Visits Only), Hialeah, Florida, United States|Encore Medical Research, Hollywood, Florida, United States|IMIC Inc., Palmetto Bay, Florida, United States|Encore Medical Research of Weston, Weston, Florida, United States|Gwinnett Research Institute, LLC, Buford, Georgia, United States|Paramount Research Solutions, College Park, Georgia, United States|TidalHealth Peninsula Regional, Inc., Salisbury, Maryland, United States|Revive Research Institute, Inc., Farmington Hills, Michigan, United States|Revival Research Institute, LLC., Sterling Heights, Michigan, United States|Olive Branch Family Medical Center, Olive Branch, Mississippi, United States|Great Plains Health, North Platte, Nebraska, United States|Excel Clinical Research, Las Vegas, Nevada, United States|Hometown Urgent Care and Research, Cincinnati, Ohio, United States|Hometown Urgent Care and Research, Columbus, Ohio, United States|Urgent Care Specialists, LLC DBA Hometown Urgent Care and Research, Dayton, Ohio, United States|University Diabetes & Endocrine Consuttants, Chattanooga, Tennessee, United States|Encore Imaging & Medical Research, Houston, Texas, United States|SMS Clinical Research, LLC, Mesquite, Texas, United States",https://ClinicalTrials.gov/show/NCT04707664
NCT04944121,Phase 2 Study of RSLV-132 in Subjects With Long COVID,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",132-05,"Resolve Clinical Center, Mobile, Alabama, United States|Resolve Clinical Center, Coral Gables, Florida, United States|Resolve Clinical Center, Pompano Beach, Florida, United States|Resolve Clinical Center, Knoxville, Tennessee, United States",https://ClinicalTrials.gov/show/NCT04944121
NCT04401254,Recovery of Patients From COVID-19 After Critical Illness,Observational Model: Cohort|Time Perspective: Prospective,COVID-Recovery V1.0 01May2020,"Canberra Hospital, Garran, Australian Capital Territory, Australia|Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia|Concord Hospital, Concord, New South Wales, Australia|St Vincent's Hospital Sydney, Darlinghurst, New South Wales, Australia|Nepean Hospital, Kingswood, New South Wales, Australia|St George Hospital, Kogarah, New South Wales, Australia|John Hunter Hospital, New Lambton Heights, New South Wales, Australia|Prince of Wales Hospital, Randwick, New South Wales, Australia|Royal North Shore Hospital, Saint Leonards, New South Wales, Australia|Westmead Hospital, Westmead, New South Wales, Australia|The Prince Charles Hospital, Chermside, Queensland, Australia|Royal Brisbane and Women's Hospital, Herston, Queensland, Australia|Ipswich Hospital, Ipswich, Queensland, Australia|Redcliffe Hospital, Redcliffe, Queensland, Australia|Gold Coast Hospital, Southport, Queensland, Australia|Princess Alexandra Hospital, Woolloongabba, Queensland, Australia|Royal Adelaide Hospital, Adelaide, South Australia, Australia|Launceston Hospital, Launceston, Tasmania, Australia|Casey Hospital, Berwick, Victoria, Australia|Box Hill Hospital (Eastern Health), Box Hill, Victoria, Australia|Monash Medical Centre, Clayton, Victoria, Australia|Dandenong Hospital, Dandenong, Victoria, Australia|Northern Health, Epping, Victoria, Australia|St Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia|Footscray Hospital, Footscray, Victoria, Australia|Frankston Hospital, Frankston, Victoria, Australia|Austin Hospital, Heidelberg, Victoria, Australia|Cabrini Health, Malvern, Victoria, Australia|Australian New Zealand Intensive Care Research Centre, Melbourne, Victoria, Australia|Royal Melbourne Hospital, Parkville, Victoria, Australia|Alfred Hospital, Prahran, Victoria, Australia|Epworth Richmond, Richmond, Victoria, Australia|Sunshine Hospital, St Albans, Victoria, Australia",https://ClinicalTrials.gov/show/NCT04401254
NCT04515108,Perinatal Outcomes and Hematologic Parameters in COVID-19 Pregnancies,Observational Model: Cohort|Time Perspective: Retrospective,E1-20-672,"Ankara City Hospital, Ankara, Turkey",https://ClinicalTrials.gov/show/NCT04515108
NCT04860895,Detection of SARS-CoV-2 in Nasopharyngeal Swabs by Using Multi-Spectral Screening System,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,SNCKTP_AP-23,"Sancaktepe Şehit Prof.Dr. İlhan Varank Training and Research Hospital, Sancaktepe, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04860895
NCT04552483,Effects of Early Use of Nitazoxanide in Patients With COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment",SARITA-2|RBR-4nr86m|32258920.0.1001.5257,"Universidade Federal do Rio de Janeiro, Rio De Janeiro, Brazil",https://ClinicalTrials.gov/show/NCT04552483
NCT04299724,Safety and Immunity of Covid-19 aAPC Vaccine,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,GIMI-IRB-20002,"Shenzhen Geno-immune Medical Institute, Shenzhen, Guangdong, China",https://ClinicalTrials.gov/show/NCT04299724
NCT04681092,Anti-COVID19 AKS-452 - ACT Study,Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,NL2020-005997-82,"University Medical Center Groningen, Groningen, Netherlands",https://ClinicalTrials.gov/show/NCT04681092
NCT04568356,A Clinical Evaluation of COVID-19 Rapid Point of Care Antigen Tests,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,E25001_NEU2012,"JFK Medical Center, Miami, Florida, United States|Kendall Regional, Miami, Florida, United States|Aventura Hospital and Medical Center, Miami, Florida, United States",https://ClinicalTrials.gov/show/NCT04568356
NCT04799392,NOWDx Test for the Detection of Antibodies to COVID-19 in Lay Persons,Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,NOWDx COVID-19 Antibody OTC,"Goodrich Pharmacy, Anoka, Minnesota, United States|Bremo Pharmacy, Richmond, Virginia, United States|Kirk's Pharmacy, Eatonville, Washington, United States",https://ClinicalTrials.gov/show/NCT04799392
NCT04863573,COVID-19 Antibody Responses In Cystic Fibrosis,Observational Model: Cohort|Time Perspective: Prospective,B21/07,"University Hospital Southampton Nhs Foundation Trust, Southampton, Engladn, United Kingdom|University Hospitals Birmingham Nhs Foundation Trust, Birmingham, England, United Kingdom|Birmingham Women'S and Children'S Nhs Foundation Trust, Birmingham, England, United Kingdom|Leeds Teaching Hospitals Nhs Trust, Leeds, England, United Kingdom|King'S College Hospital Nhs Foundation Trust, London, England, United Kingdom|Royal Brompton & Harefield Nhs Foundation Trust, London, England, United Kingdom|Nottingham University Hospitals Nhs Trust, Nottingham, England, United Kingdom|Queens University Belfast, Belfast, Northern Ireland, United Kingdom|NHS Greater Glasgow and Clyde, Glasgow, Scotland, United Kingdom|Cardiff & Vale University Lhb, Cardiff, Wales, United Kingdom|Cardiff & Vale University Lhb, Cardiff, Wales, United Kingdom",https://ClinicalTrials.gov/show/NCT04863573
NCT04622865,Masitinib Combined With Isoquercetin and Best Supportive Care in Hospitalized Patients With Moderate and Severe COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",AB20001|2020-001635-27,"Centre Hospitalier du Pays d'Aix, Aix-en-Provence, France|Le Tripode, Groupe hospitalier Pellegrin CHU de Bordeaux, Bordeaux, France|CHU Clermont-Ferrand: Site Gabriel-Montpied, Clermont-Ferrand, France|Hopital Nord, AP-HM, Marseille, France|CHR Orleans, Hopital de la Source, Orléans, France|Hopital Larrey, CHU du Toulouse, Toulouse, France",https://ClinicalTrials.gov/show/NCT04622865
NCT04505605,Study of a Possible Respiratory Degradation Prognosis Caused by Biomarkers in Severe Forms of COVID-19 Pneumonia,Observational Model: Other|Time Perspective: Prospective,LPSARS2,"Groupe Hospitalier Paris Saint-Joseph, Paris, Ile De France, France",https://ClinicalTrials.gov/show/NCT04505605
NCT04517188,Halodine Nasal Antiseptic in Patients With COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,HDN-N02-COV24A,NA,https://ClinicalTrials.gov/show/NCT04517188
NCT04765436,"PTX-COVID19-B, an mRNA Humoral Vaccine, is Intended for Prevention of COVID-19 in a General Population. This Study is Designed to Evaluate Safety, Tolerability, and Immunogenicity of PTX-COVID19-B Vaccine in Healthy Seronegative Adults Aged 18-64","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",PRO-CL-001,"Manna Research, Toronto, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04765436
NCT04605757,Long-term Evolution of Pulmonary Involvement of Novel SARS-COV-2 Infection (COVID-19): Follow the Covid Study,Observational Model: Cohort|Time Perspective: Other,714/2020/Oss/AOUBo,"Respiratory and Critical Care Unit - S.Orsola-Malpighi University Hospital, Bologna, Italy",https://ClinicalTrials.gov/show/NCT04605757
NCT04457817,Compensatory Reserve Index (CRI) for Management of COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,20-1406,"University of Colorado, Aurora, Colorado, United States",https://ClinicalTrials.gov/show/NCT04457817
NCT04397939,Myocardial Injury and Major Adverse Outcomes in Patients With COVID-19,Observational Model: Cohort|Time Perspective: Retrospective,GCO 20-0965,"Mount Sinai Hospital, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04397939
NCT04534725,COVID-19 Prevention and Treatment in Cancer; a Sequential Multiple Assignment Randomised Trial;,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",Peter Mac ID 20/135,"Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia",https://ClinicalTrials.gov/show/NCT04534725
NCT04871841,Study of Sputnik V COVID-19 Vaccination in Adults in Kazakhstan,Observational Model: Case-Only|Time Perspective: Prospective,128/36-21-23,"Karaganda Medical University, Karaganda, Kazakhstan",https://ClinicalTrials.gov/show/NCT04871841
NCT04603729,Comparison of Efficacy of Dexamethasone and Methylprednisolone in Moderate to Severe Covid 19 Disease,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,FMH-06-2020-IRB-763-M,"Fatima Memorial Hospital, Lahore, Punjab, Pakistan",https://ClinicalTrials.gov/show/NCT04603729
NCT04424901,Trial of Open Label Dipyridamole- In Hospitalized Patients With COVID-19,Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,20-192-2.F,"UConn Health, Farmington, Connecticut, United States",https://ClinicalTrials.gov/show/NCT04424901
NCT04421612,COVID-19 - No Health Without Mental Health,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,126376,"Haukeland University Hospital, Bergen, Norway",https://ClinicalTrials.gov/show/NCT04421612
NCT04811664,A Study of SARS CoV-2 Infection and Potential Transmission in Individuals Immunized With Moderna COVID-19 Vaccine,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,CoVPN 3006,"Alabama CRS, Birmingham, Alabama, United States|Headlands Research Scottsdale, Scottsdale, Arizona, United States|AMR Phoenix, Tempe, Arizona, United States|University of Arizona, Tucson, Arizona, United States|Charles Drew University, Los Angeles, California, United States|UC Davis, Sacramento, California, United States|University of California, San Diego, San Diego, California, United States|University of Colorado- Boulder, Boulder, Colorado, United States|JEM Headlands LLC, Atlantis, Florida, United States|University of Florida, Gainesville, Florida, United States|UF CARES, Jacksonville, Florida, United States|Headlands Research Sarasota, Sarasota, Florida, United States|University of South Florida, Tampa, Florida, United States|Morehouse University, Atlanta, Georgia, United States|The Hope Clinic of the Emory Vaccine Center CRS, Decatur, Georgia, United States|Champaign-Urbana Public Health District, Champaign, Illinois, United States|Rush University CRS, Chicago, Illinois, United States|Northwestern University, Evanston, Illinois, United States|Indiana University, Bloomington, Indiana, United States|Univ, of Kansas School of Medicine CRS, Wichita, Kansas, United States|University of Kentucky, Lexington, Kentucky, United States|Centex Studies, Inc. - Lake Charles, Lake Charles, Louisiana, United States|University of Maryland College Park, College Park, Maryland, United States|Fenway Health (FH) CRS, Boston, Massachusetts, United States|Wayne State - Harper Hospital, Detroit, Michigan, United States|University of Minnesota, Minneapolis, Minnesota, United States|Columbia - Missouri VTEU, Columbia, Missouri, United States|The Children's Mercy Hospital, Kansas City, Missouri, United States|Washington University Therapeutics CRS, Saint Louis, Missouri, United States|University of Nebraska, Omaha, Nebraska, United States|AMR Las Vegas, Las Vegas, Nevada, United States|University of New Mexico, Albuquerque, New Mexico, United States|Bronx Prevention Research Center CRS, Bronx, New York, United States|NYU Long Island Vaccine Center, Mineola, New York, United States|NYU Bellevue Vaccine Center, New York, New York, United States|Harlem Prevention Center CRS, New York, New York, United States|New York Blood Center CRS, New York, New York, United States|Stony Brook University, Stony Brook, New York, United States|University of North Carolina, Chapel Hill, North Carolina, United States|Wake Forest University, Winston-Salem, North Carolina, United States|Penn Prevention CRS, Philadelphia, Pennsylvania, United States|The Miriam Hopsital CRS, Providence, Rhode Island, United States|Clemson University, Clemson, South Carolina, United States|Vanderbilt Vaccine CRS, Nashville, Tennessee, United States|Texas Tech, Amarillo, Texas, United States|Centex Studies, Inc. - Brownsville, Brownsville, Texas, United States|Texas A&M University, College Station, Texas, United States|Centex Studies, Inc. - Houston, Houston, Texas, United States|Centex Studies, Inc. - Westfield, Houston, Texas, United States|Texas A&M - Kingsville, Kingsville, Texas, United States|Centex Studies, Inc. - McAllen, McAllen, Texas, United States|University of Virginia, Charlottesville, Virginia, United States|University of Washington, Seattle, Washington, United States|West Virginia University, Morgantown, West Virginia, United States",https://ClinicalTrials.gov/show/NCT04811664
NCT04893057,SARS-CoV2 Seroprevalence in Pregnant Women and Blood Donors,Observational Model: Cohort|Time Perspective: Cross-Sectional,2021/601,NA,https://ClinicalTrials.gov/show/NCT04893057
NCT04452630,Cardiovascular Consequences After COVID-19,Observational Model: Cohort|Time Perspective: Prospective,2020-36,"Assistance Publique Hôpitaux de Marseille, Marseille, France",https://ClinicalTrials.gov/show/NCT04452630
NCT04445597,ANalyzing Olfactory Dysfunction Mechanisms In COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science,S64042,"UZ Leuven, Leuven, Vlaams-Brabant, Belgium",https://ClinicalTrials.gov/show/NCT04445597
NCT04719208,[COVID-19] Reduction of Sars-CoV-2 Oral Viral Load With Prophylactic Mouth Rinse,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Prevention",[1607808,"Augusta University, Augusta, Georgia, United States|Augusta University-Dental College of Georgia, Augusta, Georgia, United States",https://ClinicalTrials.gov/show/NCT04719208
NCT04924829,Safety and Effectiveness Study of Tocilizumab in Patients With Severe COVID-19,Observational Model: Cohort|Time Perspective: Retrospective,6052,"Hospital Italiano de Buenos AIres, Ciudad autónoma de Buenos Aires, Caba, Argentina",https://ClinicalTrials.gov/show/NCT04924829
NCT04348513,Triiodothyronine for the Treatment of Critically Ill Patients With COVID-19 Infection,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",T3inj-02/ThySupport,"Attikon University General Hospital, Haidari/Athens, Greece",https://ClinicalTrials.gov/show/NCT04348513
NCT04794920,Post-Covid-19 Emotional Aspects of Hospital Staff,Observational Model: Cohort|Time Perspective: Prospective,EMOCOV,"Groupe Hospitalier Paris Saint-Joseph, Paris, Ile De France, France",https://ClinicalTrials.gov/show/NCT04794920
NCT04540120,Safety and Efficacy of Dapansutrile for Treatment of Moderate COVID-19 Symptoms and Evidence of Early Cytokine Release Syndrome,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",OLT1177-10,"National Jewish Health, Denver, Colorado, United States|C&R Research Services USA, Coral Gables, Florida, United States|Invesclinic U.S. LLC, Fort Lauderdale, Florida, United States|Sunrise Research Institute, Sunrise, Florida, United States|DBC Research Corp, Tamarac, Florida, United States|Atrium Health/Charlotte-Mecklenburg Hospital Authority, Charlotte, North Carolina, United States|PanAmerican Clinical Research LLC, Brownsville, Texas, United States|J & S Studies, Inc., College Station, Texas, United States|C&R Research Services USA, Houston, Texas, United States|Texas Research Alliance LLC, McAllen, Texas, United States|VieCuri Medisch Centrum, Venlo, Netherlands|University Hospital Basel, Basel, Switzerland",https://ClinicalTrials.gov/show/NCT04540120
NCT04351516,Test and Treat COVID 65plus+,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",COVID65plus|2020-001482-37,"Uniklinikum Tuebingen, Tuebingen, Germany|Uniklinikum Ulm, Ulm, Germany",https://ClinicalTrials.gov/show/NCT04351516
NCT04787588,COVID-19 Infection and Epithelial Cell Markers,Observational Model: Cohort|Time Perspective: Retrospective,11033-T,"McMaster Cardio-Respiratory Research Lab, Hamilton, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04787588
NCT04864938,Recovery After Critical Covid-19 Infection,Observational Model: Case-Control|Time Perspective: Prospective,HUS/1949/2020,"Helsinki University Hospital, Helsinki, Capital Province Of Finland, Finland",https://ClinicalTrials.gov/show/NCT04864938
NCT04544176,COVID-19 Risk From Attending Outpatient Radiology Appointments,Observational Model: Cohort|Time Perspective: Retrospective,20NS031,"Nottingham University Hospitals, NHS Trust, Nottingham, Nottinghamshire, United Kingdom",https://ClinicalTrials.gov/show/NCT04544176
NCT04404218,The Açaí Berry COVID-19 Anti-Inflammation Trial,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",CTO3176,"Instituto de Pesquisas em Saude (IPS)/ Universidade de Caxias do Sul (UCS), Caxias Do Sul, RS, Brazil|Instituto Prevent Senior (IPS) - Hospital Sancta Maggiore, Sao Paulo, SP, Brazil|Heart Health Institute Research Inc, Toronto, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04404218
NCT04403646,Tannin Specific Natural Extract for COVID-19 Infection,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",HCJSM-20-005,"Hospital de Clinicas, Buenos Aires, Argentina",https://ClinicalTrials.gov/show/NCT04403646
NCT04502056,Covid-19 Messaging to Underserved Communities - 2nd Experiment,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,2029880,"JPAL North America, Cambridge, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT04502056
NCT04423770,COVID-19 Related Health and Infection Control Practices Among Dentists,Observational Model: Ecologic or Community|Time Perspective: Prospective,8月20日,"American Dental Association, Chicago, Illinois, United States",https://ClinicalTrials.gov/show/NCT04423770
NCT04358510,COVID-19 Mortality Prediction Model,Observational Model: Cohort|Time Perspective: Retrospective,4202001,"Dascena, Oakland, California, United States",https://ClinicalTrials.gov/show/NCT04358510
NCT04811859,The Effect of Inspiratory Muscle Training in Post COVID-19 Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",ISUCPR,"Istinye University, İstanbul, Turkey",https://ClinicalTrials.gov/show/NCT04811859
NCT04377568,Efficacy of Human Coronavirus-immune Convalescent Plasma for the Treatment of COVID-19 Disease in Hospitalized Children,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,1000070143,"Alberta Children's Hospital, Calgary, Alberta, Canada|Stollery Children's Hospital, Edmonton, Alberta, Canada|BC Children's Hospital, Vancouver, British Columbia, Canada|Winnipeg Children's Hospital, Winnipeg, Manitoba, Canada|IWK Health Centre, Halifax, Nova Scotia, Canada|McMaster Children's Hospital, Hamilton, Ontario, Canada|Kingston Health Sciences Centre, Kingston, Ontario, Canada|Children's Hospital, London, Ontario, Canada|Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada|The Hospital for Sick Children, Toronto, Ontario, Canada|CHU Sainte-Justine, Montréal, Quebec, Canada|McGill Univ Health Ctr - Montreal Children's Hospital, Montréal, Quebec, Canada|Jim Pattison Children's Hospital, Saskatoon, Saskatchewan, Canada",https://ClinicalTrials.gov/show/NCT04377568
NCT04813731,COVID-19 And Lingering Symptoms In Primary Care Patients,Observational Model: Cohort|Time Perspective: Prospective,2020-05448,"Department of General Practice, Melbourne Medical School, University of Melbourne, Vic., Melbourne, Australia|Centre for General Practice, Department of Family Medicine & Population Health (FAMPOP), Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium|the Academic Centre for General Practice (ACHG), Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium|Centro de Saúde ""Ana Rodrigues Matoso"", Campinas, Brazil|Center for General Practice at Aalborg University, Aalborg, Denmark|Département de Santé Publique, Université Côte d'Azur, Centre Hospitalier Universitaire de Nice, Nice, France, Nice, France|R. Lugar Center for Public Health Research, Tbilisi, Georgia|Institut für Allgemeinmedizin Universitätsklinikum Würzburg Josef-Schneider-Str. 2/D7 97080 Würzburg, Würzburg, Germany|School of Medicine, National University of Ireland, Galway, Ireland|Covid-19 primary care special unit Sassuolo, Azienda Unità Sanitaria locale di Modena, Modena, Italy, Modena, Italy|Julius Center, University Medical Center Utrecht, Utrecht, Netherlands|Medical University of Lodz, Lodz, Łódź, Poland|Balan Medfam SRL, Cluj Napoca, Romania|Wetterhälsan Primary Health Care Centre, Jönköping, Sweden|Kärna Primary Health Care Centre, Linköping, Sweden|CPHC of Mukachevo United Territorial Community, Practice Mukachevo, Mukačeve, Ukraine|School of Medicine, University of St Andrews North Haugh, St Andrews KY16 9TF, Saint Andrews, United Kingdom",https://ClinicalTrials.gov/show/NCT04813731
NCT04359810,Plasma Therapy of COVID-19 in Severely Ill Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment",AAAS9924,"Columbia University Irving Medical Center/NYP, New York, New York, United States|Hospital Federal dos Servidores do Estado, Rio De Janeiro, Brazil|Hospital Geral de Nova Iguaçu, Rio De Janeiro, Brazil|Instituto Nacional de Infectologia Evandro Chagas, Rio De Janeiro, Brazil",https://ClinicalTrials.gov/show/NCT04359810
NCT04578197,NeuroCovid - a Study of Intensive Care-requiring Covid-19 Patients,Observational Model: Cohort|Time Perspective: Prospective,Dnr 2020-02760,"Karolinska Universitetssjukhuset Solna, Stockholm, Sweden",https://ClinicalTrials.gov/show/NCT04578197
NCT04559009,COVID-19 Amyotrophic Lateral Sclerosis (ALS) Registry,Observational Model: Case-Control|Time Perspective: Prospective,AH-NSI-COVID19-ALS,"Neurosciences Institute, Neurology - Charlotte, Charlotte, North Carolina, United States",https://ClinicalTrials.gov/show/NCT04559009
NCT04491994,Clearing the Fog: Is Hydroxychloroquine Effective in Reducing COVID-19 Progression,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,Sultan Mehmood Kamran 2,"Pak Emirates Military Hospital, Rawalpindi, Punjab, Pakistan",https://ClinicalTrials.gov/show/NCT04491994
NCT04673149,GLS-5310 Vaccine for the Prevention of SARS-CoV-2 (COVID-19),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention",CoV2-001,"Korea University Guro Hospital, Seoul, Korea, Republic of",https://ClinicalTrials.gov/show/NCT04673149
NCT04531345,Cytokine Status of Covid-19 Patients,Observational Model: Case-Control|Time Perspective: Prospective,Covid Cytokine,"Istanbul Training and Reseach Hospital, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04531345
NCT04470648,COVID-19 Infection at Samusocial in Paris: Descriptive and Serological Survey,Observational Model: Other|Time Perspective: Prospective,C20-50,"Haltes pour femmes, Paris, France|LHSS Saint-Michel, Paris, France|LHSS Ridder-Plaisance, Paris, France",https://ClinicalTrials.gov/show/NCT04470648
NCT04602949,Detection of COVID-19 Using Breath Analysis - Validation Study,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,Cov-2-SMC-2020,"Shamir Medical Center, Be'er Ya'aqov, Israel",https://ClinicalTrials.gov/show/NCT04602949
NCT04521400,"the Investigation Into Beneficial Effects of High-dose Interferon Beta 1-a, Compared to Low-dose Interferon Beta 1-a in Moderate to Severe Covid-19",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,Interferon in COVID,NA,https://ClinicalTrials.gov/show/NCT04521400
NCT04597034,Efficacy and Safety of a Highly Selective Semipermeable Membrane (AN-69 Oxiris) vs (Standard AN-69) in COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,NMM-3401-20-20-1,"Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico",https://ClinicalTrials.gov/show/NCT04597034
NCT04346797,"CORIMUNO19-ECU: Trial Evaluating Efficacy and Safety of Eculizumab (Soliris) in Patients With COVID-19 Infection, Nested in the CORIMUNO-19 Cohort",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,APHP200375-4,"Saint Louis, Paris, Ile De France, France|Réanimation médicale, Paris, France|saint Louis, Paris, France",https://ClinicalTrials.gov/show/NCT04346797
NCT04361344,Neurodegeneration Markers and Neurological Course in Severe Covid-19 Infection,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,CHPAU2020/02,"CH de Pau, Pau, France",https://ClinicalTrials.gov/show/NCT04361344
NCT04407429,Vienna Versus SARS-CoV-2 Virus Study,Observational Model: Cohort|Time Perspective: Prospective,EK 1387/2020,"Medical University of Vienna, Vienna, Austria",https://ClinicalTrials.gov/show/NCT04407429
NCT04907916,Sirtuin1 in COVID19 Patients,Observational Model: Other|Time Perspective: Other,SIRTUIN1 in COVID19,NA,https://ClinicalTrials.gov/show/NCT04907916
NCT04602884,Early Detection of COVID-19 Using Breath Analysis,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,Cov-2-IDF,"IDF COVID 19 Isolation Facility, Ashkelon, Israel",https://ClinicalTrials.gov/show/NCT04602884
NCT04760639,COVID Breath Test - Ancon,Observational Model: Cohort|Time Perspective: Prospective,Pro00102970,"Medical University of South Carolina, Charleston, South Carolina, United States",https://ClinicalTrials.gov/show/NCT04760639
NCT04853940,"Respiratory Muscle Function, Dyspnea, Exercise Capacity and Quality of Life in Severe COVID19 Patients",Observational Model: Cohort|Time Perspective: Prospective,419/20,"ICU. Ramón y Cajal University Hospital, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04853940
NCT04342104,NIV and CPAP Failure Predictors in COVID-19 Associated Respiratory Failure,Observational Model: Cohort|Time Perspective: Prospective,08-04-2020,"Hospital General Universitario Morales Meseguer, Murcia, Spain",https://ClinicalTrials.gov/show/NCT04342104
NCT04654325,Prevalence of SARS-CoV-2 Genome in Tears of Asymptomatic and Moderately Symptomatic COVID-19 Patients,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,APHP201268|2020-A02996-33,NA,https://ClinicalTrials.gov/show/NCT04654325
NCT04347681,Potential Efficacy of Convalescent Plasma to Treat Severe COVID-19 and Patients at High Risk of Developing Severe COVID-19,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,HAEM0321,"John Hopkins Aramco Healthcare, Dhahran, Eastern Provence, Saudi Arabia|Dammam Medical Complex, Dammam, Saudi Arabia|Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia|king Fahad specialist hospital, Dammam, Saudi Arabia|DHahran Military Medical Complex, Dhahran, Saudi Arabia|International Medical Center, Jeddah, Saudi Arabia|Madinah General Hospital, Medina, Saudi Arabia|Ohud Hospital, Medina, Saudi Arabia|Taibah University, Medina, Saudi Arabia|Qatif Central Hospital, Qatif, Saudi Arabia|King Abdulaziz Medical City, Riyadh, Saudi Arabia|King Fahad Medical City, Riyadh, Saudi Arabia|King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia|King Khalid University Hospital, Riyadh, Saudi Arabia",https://ClinicalTrials.gov/show/NCT04347681
NCT04787510,COVID-19 Disease and Coagulopathy: Assessment of Clotting Factor Levels in Patients With SARS-CoV-2 Infection,Observational Model: Cohort|Time Perspective: Prospective,895/23-12-2020,"University General Hospital of Ioannina, Ioánnina, Epirus, Greece",https://ClinicalTrials.gov/show/NCT04787510
NCT04840940,Presepsin Biomarker for Ventilator-associated Pneumonia Diagnosis in COVID-19 Patients,Observational Model: Cohort|Time Perspective: Prospective,MACOSX,"SCDU Anestesia e Rianimazione, AOU San Luigi Gonzaga, Orbassano, Turin, Italy",https://ClinicalTrials.gov/show/NCT04840940
NCT04608201,Evaluation of the Efficacy of Nicotine Patches in SARS-CoV2 (COVID-19) Infection in Hospitalized Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",APHP200529|2020-003743-28,"Hospital Pitié-Salpêtrière - AP-HP, Paris, France",https://ClinicalTrials.gov/show/NCT04608201
NCT04446286,Bicentric Study on the Use of ECMO-VV or VA for Severe ARDS Associated With Covid-19,Observational Model: Case-Only|Time Perspective: Other,7904,"Service de Chirurgie Thoracique Nouvel Hôpital Civil Hôpitaux Universitaires de Strasbourg, Strasbourg, France",https://ClinicalTrials.gov/show/NCT04446286
NCT04806061,Urine Alkalinisation in COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,GSTT COVID-AKI,NA,https://ClinicalTrials.gov/show/NCT04806061
NCT04703452,poSt Covid-19 Infection centraL sENsitisaTion,Observational Model: Case-Only|Time Perspective: Cross-Sectional,SILENT 1,"Universitair Ziekenhuis Brussel, Jette, Brussel, Belgium",https://ClinicalTrials.gov/show/NCT04703452
NCT04330144,Hydroxychloroquine as Post Exposure Prophylaxis for SARS-CoV-2(HOPE Trial),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention,3-2020-0036,NA,https://ClinicalTrials.gov/show/NCT04330144
NCT04815096,Imaging Immune Activation in COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science,20-32477,"University of California, San Francisco, San Francisco, California, United States",https://ClinicalTrials.gov/show/NCT04815096
NCT04385095,Trial of Inhaled Anti-viral (SNG001) for SARS-CoV-2 (COVID-19) Infection,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",SG016,"Belfast City Hospital, Belfast, United Kingdom|Queen Elizabeth Hospital,, Birmingham, United Kingdom|Bradford Royal Infirmary, Bradford, United Kingdom|Park and St Francis Surgery, Chandler's Ford, United Kingdom|Hull and East Yorkshire NHS Trust, Castle Hill Hospital,, Hull, United Kingdom|Glenfield Hospital,, Leicester, United Kingdom|Wythenshawe Hospital, Manchester, United Kingdom|City Campus of Nottingham University, Nottingham, United Kingdom|John Radcliffe Hospital, Oxford, United Kingdom|The Adam Practice, Poole, United Kingdom|The Virtual Team, Southampton, United Kingdom|University Hospital Southampton Nhs Foundation Trust, Southampton, United Kingdom|Oaks Healthcare, Waterlooville, United Kingdom",https://ClinicalTrials.gov/show/NCT04385095
NCT04359654,Nebulised Dornase Alfa for Treatment of COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,132333,"University College London Hospital, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04359654
NCT04459390,Association of Comorbidities With COVID19,Observational Model: Case-Control|Time Perspective: Prospective,COVID19,"Faculty of Medicine, Assiut, Egypt",https://ClinicalTrials.gov/show/NCT04459390
NCT04786197,Detection of SARS-CoV-2 (COVID-19) by SERS Spectroscopy Combined With Artificial Intelligence,Observational Model: Cohort|Time Perspective: Prospective,Kaïssa Covid,"Groupe Hospitalier Paris Saint-Joseph, Paris, Ile De France, France",https://ClinicalTrials.gov/show/NCT04786197
NCT04401436,COVID-19 Associated Lymphopenia Pathogenesis Study in Blood,Observational Model: Cohort|Time Perspective: Prospective,200111|20-I-0111,"MedStar Georgetown University Hospital, Washington, District of Columbia, United States|Washington Hospital Center, Washington, District of Columbia, United States|National Institutes of Health Clinical Center, Bethesda, Maryland, United States",https://ClinicalTrials.gov/show/NCT04401436
NCT04406532,Home-Based Covid-19 Rehabilitation Program,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,2020-11535,NA,https://ClinicalTrials.gov/show/NCT04406532
NCT04361903,Ruxolitinib for the Treatment of Acute Respiratory Distress Syndrome in Patients With COVID-19 Infection,Observational Model: Cohort|Time Perspective: Retrospective,2020.COVID-19.RUXO106,NA,https://ClinicalTrials.gov/show/NCT04361903
NCT04343144,"Trial Evaluating Efficacy and Safety of Nivolumab (Optivo®) in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort.",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,APHP200389-5,"Pneumologie hôpital Tenon, Paris, France",https://ClinicalTrials.gov/show/NCT04343144
NCT04915781,Tobacco Use and COVID-19 Incidence in the Finnish General Population,Observational Model: Cohort|Time Perspective: Prospective,THL/713/6.00.00/2021,"Finland, Helsinki, Finland",https://ClinicalTrials.gov/show/NCT04915781
NCT04357782,Administration of Intravenous Vitamin C in Novel Coronavirus Infection (COVID-19) and Decreased Oxygenation,Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,Davis 001,"Hunter Holmes Mcguire Veteran Affairs Medical Center, Richmond, Virginia, United States",https://ClinicalTrials.gov/show/NCT04357782
NCT04517396,FEnofibRate as a Metabolic INtervention for COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",843729,"University of Pennsylvania Health System, Philadelphia, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04517396
NCT04602507,Ivermectin in Adults With Severe COVID-19.,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",ECA-COVID-CES,"Clinica CES, Medellín, Antioquia, Colombia",https://ClinicalTrials.gov/show/NCT04602507
NCT04347928,Respiratory and Hemodynamic Changes Induced in Mechanically Ventilated Patients for COVID-19,Observational Model: Cohort|Time Perspective: Prospective,2020_32|2020-A00957-32,"Hopital Roger Salengro, CHU Lille, Lille, France",https://ClinicalTrials.gov/show/NCT04347928
NCT04468971,REgulatory T Cell infuSion fOr Lung Injury Due to COVID-19 PnEumonia,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",CK0802.501.1,"Johns Hopkins Hospital, Baltimore, Maryland, United States|Columbia University, New York, New York, United States|University of North Carolina, Chapel Hill, North Carolina, United States|Wake Forest University, Winston-Salem, North Carolina, United States|Baylor College of Medicine, St Luke's Hospital, Houston, Texas, United States",https://ClinicalTrials.gov/show/NCT04468971
NCT04954040,Prevention and Treatment With Hydroxychloroquine + Azithromycin of Acute Respiratory Syndrome Induced by COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,AMBUCOV,"Centro de Salud Priego de Córdoba, Priego de Córdoba, Córdoba, Spain",https://ClinicalTrials.gov/show/NCT04954040
NCT04653844,RT-PCR Database Analysis for COVID-19 Infections and Re-infection,Observational Model: Other|Time Perspective: Retrospective,RECHMPL20_0640,"Uh Montpellier, Montpellier, France",https://ClinicalTrials.gov/show/NCT04653844
NCT04591158,COVID-19 and Lung Ultrasound Utility,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,1,"Markham Stouffville Hospital, Markham, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04591158
NCT04898140,The Evaluation of Cellular and Humoral Immunity to COVID-19 in Moscow Residents,Observational Model: Cohort|Time Perspective: Prospective,1027739482649/0908/4_9,"Clinical City Hospital named after I.V. Davydovsky of Moscow Department of Healthcare, Moscow, Russian Federation",https://ClinicalTrials.gov/show/NCT04898140
NCT04602871,Early Detection of COVID-19 Using Breath Analysis - Feasibility Study,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,Cov-2-2020,"Soroka Medical Center, Be'er Sheva, Israel|Meir Medical Center, Kfar Saba, Israel",https://ClinicalTrials.gov/show/NCT04602871
NCT04701892,poSt Covid-19 Infection centraL Sensitisation 2,Observational Model: Cohort|Time Perspective: Prospective,SILENT 2,"Universitair Ziekenhuis Brussel, Jette, Brussel, Belgium",https://ClinicalTrials.gov/show/NCT04701892
NCT04480515,Does COVID-19 Pandemic Reduce In-hospital Mortality?,Observational Model: Cohort|Time Perspective: Other,KSSEAH--IHM,"Kanuni Sultan Suleyman Training and Research Hospital, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04480515
NCT04510454,Evaluation of a ddPCR Technology for the SARS-CoV-2 Detection in Symptomatic Patients With Suspicion of COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,ONCOVID-21 - ET20-118,"Centre Leon Berard, Lyon, France",https://ClinicalTrials.gov/show/NCT04510454
NCT04251767,Washed Microbiota Transplantation for Patients With 2019-nCoV Infection,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",WMT-YJ-202001,"Medical Center for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China",https://ClinicalTrials.gov/show/NCT04251767
NCT04257656,A Trial of Remdesivir in Adults With Severe COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",CAP-China remdesivir 2,"Bin Cao, Beijing, Beijing, China",https://ClinicalTrials.gov/show/NCT04257656
NCT04425044,AiM Covid Self Monitoring,Observational Model: Cohort|Time Perspective: Prospective,Au015,"Mothers Touch Foundation, Mumbai, Maharashtra, India|NMP Medical Research Institite, Jaipur, Rajasthan, India",https://ClinicalTrials.gov/show/NCT04425044
NCT04636294,Borderline COVID-19 PCR Test Result,Observational Model: Case-Control|Time Perspective: Retrospective,f/2020/166,"Clinical Laboratory Jessa Hospital, Hasselt, Limburg, Belgium",https://ClinicalTrials.gov/show/NCT04636294
NCT04685629,Covid-19 Long-term Revalidation Follow-up,Observational Model: Cohort|Time Perspective: Prospective,Colonel,"Antwerp University Hospital, Edegem, Antwerpen, Belgium",https://ClinicalTrials.gov/show/NCT04685629
NCT04881253,COVID-19 Patient Cohort: Retinal Damage in Non-invasive Retinal Imaging (OCTA),Observational Model: Cohort|Time Perspective: Prospective,COVID-RET,NA,https://ClinicalTrials.gov/show/NCT04881253
NCT04860869,"Endocrine, Metabolic and Microbiome Influence on the Post COVID-19 Syndrome",Observational Model: Cohort|Time Perspective: Cross-Sectional,20-0361,"The University of Texas Medical Branch, Galveston, Texas, United States",https://ClinicalTrials.gov/show/NCT04860869
NCT04629001,Effect of Covid-19 on Outcomes of Pregnancy,Observational Model: Cohort|Time Perspective: Prospective,12789,"Medicine, Assiut, Egypt",https://ClinicalTrials.gov/show/NCT04629001
NCT04393155,COVID Cohort Study,Observational Model: Cohort|Time Perspective: Prospective,16-540,"University of Vermont College of Medicine, Burlington, Vermont, United States",https://ClinicalTrials.gov/show/NCT04393155
NCT04794062,Myocardial Injury and Quality of Life After COVID-19,Observational Model: Cohort|Time Perspective: Prospective,8092020,"Voronezh Region Clinical, Consultative and Diagnostic Center, Voronezh, Voronezh Region, Russian Federation",https://ClinicalTrials.gov/show/NCT04794062
NCT04630054,Face Masks to Reduce COVID-19 in Bangladesh,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Prevention,2000028482,"Innovations for Poverty Action, Dhaka, Bangladesh",https://ClinicalTrials.gov/show/NCT04630054
NCT04825093,Vitamin D Supplementarion in Pregnant Women at Risk and COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,SVD-COVID-2020,"Maria Jose Aguilar Cordero, Granada, Spain",https://ClinicalTrials.gov/show/NCT04825093
NCT04367714,Antibody Response Against SARS-CoV-2 in Dialysis Patients During COVID-19,Observational Model: Cohort|Time Perspective: Prospective,FHM-1-2020,"Godstrup Hospital, Herning, Denmark",https://ClinicalTrials.gov/show/NCT04367714
NCT04368923,Management of Covid-19 Patients During Home Isolation,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,REC/012-2020,"M. Sedky, Cairo, Egypt",https://ClinicalTrials.gov/show/NCT04368923
NCT04871815,Effects of Sodium Pyruvate Nasal Spray in COVID-19 Long Haulers.,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,CSI-COVID-19_009,"Missouri State University, Springfield, Missouri, United States",https://ClinicalTrials.gov/show/NCT04871815
NCT04709146,The Influence of Covid-19 on the Audio-vestibular System,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,0226-20-EMC,NA,https://ClinicalTrials.gov/show/NCT04709146
NCT04384055,Predicting Outcomes for Covid-19 Using Sonography,Observational Model: Case-Control|Time Perspective: Prospective,IRB-55621,"University of California San Francisco, San Francisco, California, United States|Stanford University, Stanford, California, United States",https://ClinicalTrials.gov/show/NCT04384055
NCT04347824,Predict Adverse Events by Covid-19 Nephritis,Observational Model: Case-Only|Time Perspective: Retrospective,UMG_Co19-Nephritis,"University Medical Center Goettingen, Göttingen, Germany",https://ClinicalTrials.gov/show/NCT04347824
NCT04414410,Echocardiography in Critically-ill Patients With COVID-19 Pneumonia,Observational Model: Cohort|Time Perspective: Retrospective,RedCap19,"University Hospital Ambroise Pare, Boulogne-Billancourt, Hauts De Seine, France",https://ClinicalTrials.gov/show/NCT04414410
NCT04412473,COVID-19 Respiratory Distress and Antithrombotic Drugs in Subject's Habits,Observational Model: Case-Only|Time Perspective: Retrospective,7837,"Service Médecine Intensive et Réanimation, Strasbourg, France",https://ClinicalTrials.gov/show/NCT04412473
NCT04775134,Residual SARS-CoV-2 Presence in the Respiratory Tract and Lung Parenchyma (After SARS-CoV-2 Infection or COVID-19),Observational Model: Cohort|Time Perspective: Prospective,S64988,"UZ Leuven, Leuven, Belgium",https://ClinicalTrials.gov/show/NCT04775134
NCT04912778,Profiling of Post Covid-19 Infection Patients: an Online Survey,Observational Model: Case-Only|Time Perspective: Cross-Sectional,PRESTO,"Universitair Ziekenhuis Brussel, Jette, Belgium",https://ClinicalTrials.gov/show/NCT04912778
NCT04678687,COVID-19 and Tissue Damage in Vital Organs,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,COVID-19.PMB,"Dokuz Eylul University, İzmir, Balçova, Turkey",https://ClinicalTrials.gov/show/NCT04678687
NCT04554992,Convalescent Plasma for the Treatment of COVID-19 (Coronavirus Disease 2019),Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,25121,"Houston Methodist Hopsital, Houston, Texas, United States",https://ClinicalTrials.gov/show/NCT04554992
NCT04871958,"Individualized, Technological Interventions for Diabetes Care in the COVID-19 Ward",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,Initiator,"Federico II University Hospital, Naples, Italy",https://ClinicalTrials.gov/show/NCT04871958
NCT04568850,Waxing and Waning of Serum SARS CoV-2-IgG Level in COVID-19 Exposed Population,Observational Model: Case-Only|Time Perspective: Prospective,LGH007,"Lahore General Hospital, Lahore, Punjab, Pakistan|Lahore General Hospital, Lahore, Punjab, Pakistan",https://ClinicalTrials.gov/show/NCT04568850
NCT04590378,Pulmonary Embolism and COVID-19,Observational Model: Cohort|Time Perspective: Retrospective,UU-PE001,"Uşak University, Usak, Turkey",https://ClinicalTrials.gov/show/NCT04590378
NCT04595240,Semen Analysis Changes in Covid-19 Positivepatients,Observational Model: Other|Time Perspective: Prospective,Semen analysis post covid-19,"Mostafa Kamel, Assiut, Egypt",https://ClinicalTrials.gov/show/NCT04595240
NCT04354753,AiM COVID for Covid 19 Tracking and Prediction,Observational Model: Case-Only|Time Perspective: Retrospective,AU12,"Aarogyam (UK), Leicester, United Kingdom",https://ClinicalTrials.gov/show/NCT04354753
NCT04746365,Ivermectin Role in Covid-19 Clinical Trial,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment",1029076|2101001,"Shebin-Elkom teaching hospital, Shibīn Al Kawm, Menoufia, Egypt",https://ClinicalTrials.gov/show/NCT04746365
NCT04982328,COVID-19 and Nonalcoholic Fatty Liver Disease,Observational Model: Case-Control|Time Perspective: Prospective,UHID07,"University Hospital for Infectious Diseases Zagreb, Zagreb, Croatia",https://ClinicalTrials.gov/show/NCT04982328
NCT04738136,"Safety, Tolerability and Efficacy Of S-1226 in Moderate Severity Covid-19 Bronchiolitis/Pneumonia",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,SAMi-05-1-01,NA,https://ClinicalTrials.gov/show/NCT04738136
NCT04948190,Canine COVID-19 Detection Phase 2 and 3,Observational Model: Case-Control|Time Perspective: Other,LSH1394,"Arctec at London School of Hygiene & Tropical Medicine, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04948190
NCT04392531,Clinical Trial to Assess Efficacy of cYclosporine Plus Standard of Care in Hospitalized Patients With COVID19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,FJD-COVID19-20-01,"Complejo Hospitalario Universitario La Coruña, La Coruña, Galicia, Spain|Hospital Quiron La Coruña, La Coruña, Galicia, Spain|Hospital Rey Juan Carlos, Mostoles, Madrid, Spain|Hospital Infanta Elena, Valdemoro, Madrid, Spain|Hospital General de Villalba, Villalba, Madrid, Spain|Fundacion Jimenez Diaz, Madrid, Spain|Clinica Universitaria de Navarra, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04392531
NCT04410328,Aggrenox To Treat Acute Covid-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,Pro2020001469,"Rutgers New Jersey Medical School University Hospital, Newark, New Jersey, United States",https://ClinicalTrials.gov/show/NCT04410328
NCT04807075,"A Wearable, Battery-free Screening System for SARS-CoV-2, the Virus Causing COVID-19, Infection",Observational Model: Case-Control|Time Perspective: Prospective,027-21-EP,NA,https://ClinicalTrials.gov/show/NCT04807075
NCT04531319,Immune Cell Subgroups in Covid 19 Patients,Observational Model: Case-Control|Time Perspective: Prospective,Covid Cell,"Istanbul Training and Reseach Hospital, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04531319
NCT04734171,"Social Activity, Loneliness and Stigma During COVID-19 Outbreak",Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,AAAT0067,"Columbia University, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04734171
NCT04717024,The Nanowear Wearable Covid-19 Observational and Analysis Trend,Observational Model: Cohort|Time Perspective: Prospective,NWCT20-SS-002,"Hackensack University Medical Center, Hackensack, New Jersey, United States|Maimonides Medical Center, Brooklyn, New York, United States",https://ClinicalTrials.gov/show/NCT04717024
NCT04694768,Implementation of Rehabilitation Program for Post COVID-19,Observational Model: Cohort|Time Perspective: Prospective,AssiutU19,"Aliae AR Mohamed-Hussein, Assiut, Egypt|Aliae AR Mohamed-Hussein, Assiut, Egypt",https://ClinicalTrials.gov/show/NCT04694768
NCT04568044,Evaluation of Humoral Immunity Following COVID-19 in Pregnancy,Observational Model: Cohort|Time Perspective: Prospective,20SM6089,"Chelsea and Westminster NHS Foundation Trust, London, United Kingdom|Imperial College Healthcare NHS Trust, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04568044
NCT04944095,Change in Antibody Levels Following SARS-CoV-2 (Covid-19) Vaccinations,Observational Model: Case-Only|Time Perspective: Prospective,SARS-CoV-2 Antibodies Levels,"Southlake Diagnostics, Inc., Southlake, Texas, United States",https://ClinicalTrials.gov/show/NCT04944095
NCT04462627,Reduction of COVID 19 Transmission to Health Care Professionals,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,CHUB-BDS-COVID19,"CHU Brugmann, Brussels, Belgium",https://ClinicalTrials.gov/show/NCT04462627
NCT04518410,ACTIV-2: A Study for Outpatients With COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",A5401/ACTIV-2|38742,"Pinnacle Research Group (Site 1082), 321 E. 10th Street, Anniston, Alabama, United States|North Alabama Research Center LLC (Site 1194), 721 W. Market St., Ste. B, Athens, Alabama, United States|University of Alabama at Birmingham (Site 1005), 908 20th Street South, Birmingham, Alabama, United States|Cullman Clinical Trials (Site 1140), 501 Clark St. NE., Cullman, Alabama, United States|Jasper Summit Research, LLC. (Site 1056), 1280 Summit, Jasper, Alabama, United States|Absolute Clinical Research, LLC. (Site 1186), 7725 North 43rd Avenue, Ste. 211, Phoenix, Arizona, United States|University of Arizona (Site 1043), 1501 N. Campbell Ave., Rm. 6410, Tucson, Arizona, United States|Omnibus Clinical Research (Site 1253), 3340 W. Ball Road, Ste. I, Anaheim, California, United States|Franco A. Felizarta MD (Site 1174), 3535 San Dimas St., Bakersfield, California, United States|Clearview Medical Research LLC. (Site 1251), 2714 Hidaway Ave., Ste. 103, Canyon Country, California, United States|St. Jude Heritage Medical Group (Site 1093), 2151 N. Harbor Blvd., Fullerton, California, United States|University of California San Diego (Site 1160), 9350 Campus Point Drive, Perlman Cancer Cancer, La Jolla, California, United States|Fadi A. Haddad, MD, Inc. (Site 1146), 8860 Center Dr., Ste. 320, La Mesa, California, United States|Atella Clinical Research (Site 1111), 5451 La Palma Avenue, La Palma, California, United States|Loma Linda University Health (Site 1110), 11374 Mountain View, Dover Bldg, Ste. C, Loma Linda, California, United States|University of Southern California (Site 1057), 1300 N. Mission Rd., Rm 349, Los Angeles, California, United States|UCLA CARE Center (Site 1003), 11075 Santa Monica Blvd., Suite 100, Los Angeles, California, United States|Science 37, Inc. (Site 1124), 12121 Bluff Creek Dr., Ste. 100, Los Angeles, California, United States|VA Northern California Health Care System (NAVREF) (Site 1137), 10535 Hospital Way, Mather, California, United States|Central Valley Research, LLC (Site 1085), 400 E. Orangeburg Ave., Ste. 5, Modesto, California, United States|Hoag Memorial Hospital Presbyterian (Site 1200), 1 Hoag Dr., Newport Beach, California, United States|Valley Clinical Research, Inc. (Site 1059), 18433 Roscoe Blvd., Ste 210, Northridge, California, United States|University of California Irvine (Site 1083), 843 Health Sciences Road, Orange, California, United States|FOMAT Medical Research (Site 1136), 300 South A Street, Oxnard, California, United States|Eisenhower Medical Center (Site 1040), 39000 Bob Hope Drive, Rancho Mirage, California, United States|Paradigm Research (Site 1150), 3652 Eureka Way, Redding, California, United States|Riverside Medical Clinic (Site 1232), 7117 Brockton Ave., Riverside, California, United States|University of California Davis Medical Center (Site 1097), 2315 Stockton Blvd., Sacramento, California, United States|Premier Urgent Care Centers of California, Inc. (Site 1176), 284 E. Highland Ave., San Bernardino, California, United States|University of California San Diego (Site 1002), 220 Dickinson Street, San Diego, California, United States|Zion Medical Center (Site 1063), 4647 Zion Avenue, San Diego, California, United States|VA San Diego Health System (Stie 1127), 3350 La Jolla, San Diego, California, United States|University of California San Francisco (Site 1009), 995 Potrero Ave., Building 80, Ward 84, San Francisco, California, United States|San Francisco Research Institute (Site 1210), 2435 Ocean Ave., San Francisco, California, United States|Stanford University (Site 1213), 1201 Welch Road, Stanford, California, United States|Millennium Clinical Trials (Site 1260), 550 Saint Charles Dr., Ste. 208, Thousand Oaks, California, United States|Office of Ramesh V. Nathan, MD (Site 1073), 2220 Lynn Rd., Ste. 301, Thousand Oaks, California, United States|Harbor UCLA (Site 1022), 1124 West Carson Street, Torrance, California, United States|Allianz Research Institute Inc. (Site 1159), 14120 Beach Blvd., Ste. 101, Westminster, California, United States|University of Colorado (Site 1007), 12401 East 17th Avenue, Aurora, Colorado, United States|UConn - Institute for Collaboration on Health (Site 1169), 2006 Hillside Rd., Unit 1248, Storrs, Connecticut, United States|Whitman-Walker Health (Site 1027), 1337 R Street NW., Washington, District of Columbia, United States|Imagine Research of Palm Beach County (Site 1157), 709 S. Federal Hwy., Ste. 2, Boynton Beach, Florida, United States|Bradenton Research Center Inc. (Site 1109), 3924 9th Ave. W, Bradenton, Florida, United States|Synergy Healthcare (Site 1099), 300 Riverside Drive E., Ste. 1350, Bradenton, Florida, United States|Cardiology Physicians, P.A. (Site 1180), 305 Memorial Medical Pkwy., Ste. 301, Daytona Beach, Florida, United States|Midland Florida Clinical Research Center LLC (Site 1130), 665 Peachwood Drive, DeLand, Florida, United States|Integrity Clinical Research (Site 1214), 3901 NW 79th Ave., Doral, Florida, United States|Universal Axon Clinical Research (Site 1077), 3650 NW 82nd Ave., Doral, Florida, United States|EMINAT Research (Site 1202), 2500 E. Commercial Blvd., Fort Lauderdale, Florida, United States|Holy Cross Health (Site 1072), 4725 North Federal Highway, Fort Lauderdale, Florida, United States|North Florida / South Georgia Veterans Health System (Site 1133), 1601 SW Archer Rd., Gainesville, Florida, United States|University of Florida (Site 1047), 1600 SW. Archer Rd., Gainesville, Florida, United States|NW FL Clinical Research Group, LLC. (Site 1046), 400 Gulf Breeze Parkway, Gulf Breeze, Florida, United States|Indago Research and Health Center (Site 1050), 3700 W. 12th Ave., Ste. 300, Hialeah, Florida, United States|AGA Clinical Trials (Site 1026), 900 West 49th Street, Hialeah, Florida, United States|Community Research of South Florida (Site 1197), 7100 W. 20th Ave., Ste. 403, Hialeah, Florida, United States|New Generation Medical Research (Site 1204), 7600 W. 20th Ave., Ste. 106, Hialeah, Florida, United States|Best Quality Research, Inc. (Site 1237), 2387 W. 68th St., Ste. 403, Hialeah, Florida, United States|Innovative Health Medical Center (Site 1222), 6750 Taft Street, Hollywood, Florida, United States|University of Florida Jacksonville (Site 1039), 655 West 8th Street, Jacksonville, Florida, United States|Mayo Clinic Jacksonville (Site 1149), 4500 San Pablo Rd. S., Jacksonville, Florida, United States|QC Trials (Site 1117), 300 W. 41st Street, Ste. 203, Miami Beach, Florida, United States|Lakes Research (Site 1037), 5801 NW 151 Street, Miami Lakes, Florida, United States|Savin Medical Group, LLC. (Site 1212), 5789B NW. 151st Street, Miami Lakes, Florida, United States|Amber Clinical Research, LLC. (Site 1206), 9000 NE. 2nd Avenue, Miami Shores, Florida, United States|Gonzalez MD & Aswad MD Health Services (Site 1238), 3401 NW. 7th Street, Miami, Florida, United States|Clintex Research Group, Inc. (Site 1231), 590 SW. 27th Ave., Miami, Florida, United States|Advance Medical Research Center (Site 1193) 330 SW. 27th Ave., Ste. 701, Miami, Florida, United States|University of Miami Miller School of Medicine CoVID Unit (Site 1068), 1425 NW. 10th Ave., Miami, Florida, United States|Florida International Medical Research (Site 1239), 1890 S. Red Rd., Ste. 103, Miami, Florida, United States|D&H National Research Centers (Site 1205), 8485 Bird Road, Miami, Florida, United States|Allied Biomedical Research Institute (Site 1227), 7100 SW. 47th St., Ste. 220, Miami, Florida, United States|Miami Clinical Research (Site 1089), 2400 SW. 69th Ave., Miami, Florida, United States|Research Institute of South Florida, Inc. (Site 1201), 9835 SW. 72nd Street, Ste. 201, Miami, Florida, United States|RM Medical Research, Inc. (Site 1230), 10346 W. Flagler St., Miami, Florida, United States|Pro Live Medical Research Corp (Site 1219), 12781 SW. 42nd Street, Miami, Florida, United States|Miami Dade Medical Research Institute, LLC (Site 1223), 8955 SW. 87th Ct., Miami, Florida, United States|Bravo Health Care Center (Site 1221), 1440 79 Street, North Bay Village, Florida, United States|Orlando Immunology Center (Site 1045), 1707 North Mills Avenue, Orlando, Florida, United States|Clintheory (Site 1203), 7350 Sandlake Commons Blvd., Orlando, Florida, United States|IMIC, Inc. (Site 1141), 18320 Franjo Rd, Palmetto Bay, Florida, United States|Family Clinical Trials (Site 1236), 1601 N. Palm Ave., Ste. 102, Pembroke Pines, Florida, United States|Physician Care Clinical Research, LLC. (Site 1242), 1617 S. Tuttle Ave., Ste. 1A, Sarasota, Florida, United States|Bassetti Medical Research, Inc. (Site 1158), 5825 US Highway 27 N., Sebring, Florida, United States|DBC Research (Site 1188), 7707 N. University Dr., Ste. 106, Tamarac, Florida, United States|ETNA Medical Center (Site 1225), 7401 N. University Drive, Tamarac, Florida, United States|Moore Clinical Research, Inc. (Site 1164), 4257 W. Kennedy Blvd., Tampa, Florida, United States|Tampa General Hospital Family Care Center Healthpark (Site 1088), 5802 N. 30th Street, Tampa, Florida, United States|Infectious Disease Consultants of the Treasure Coast (Site 1171), 3735 11th Cir., Ste. 201, Vero Beach, Florida, United States|AIDS Research and Treatment Center of the Treasure Coast (Site 1095), 981 37th Place, Vero Beach, Florida, United States|Triple O Research Institute PA (Site 1121), 2580 Metrocentre Blvd., Ste. 4, West Palm Beach, Florida, United States|The Ponce de Leon Center (site 1015), 341 Ponce De Leon Avenue Northeast, Atlanta, Georgia, United States|Rare Disease Research, LLC. (Site 1248), 1891 Howell Mill Rd.NW, Ste. B, Atlanta, Georgia, United States|Agile Clinical Rsearch Trials, LLC (Site 1051), 750 Hammond Drive, Atlanta, Georgia, United States|Balanced Life Health Care Solutions/SKYCRNG (Site 1191), 2033 Buford Hwy., Ste. 109, Buford, Georgia, United States|IACT Health (Site 1035), 800 Talbotton Road, Columbus, Georgia, United States|Clintheory (Site 1254), 4300 Pleasant Hill Road, Duluth, Georgia, United States|One Health Research Clinic, Inc. (Site 1250), 5880 Live Oak Pkwy, Ste. 160, Norcross, Georgia, United States|Renew Health Clinical Research, LLC. (Site 1161), 1550 Janmar Rd., Snellville, Georgia, United States|John A. Burns School of Medicine UH Clinics at Kakaako (Site 1177), 651 Ilalo St., Honolulu, Hawaii, United States|Snake River Research, PLLC (Site 1120), 2900 Cortez Ave., Idaho Falls, Idaho, United States|Metro Infectious Disease Consultants (Site 1106), 901 McClintock Dr., Ste. 201, Burr Ridge, Illinois, United States|Chicago Clinical Research Institute (Site 1132), 611 W. Roosevelt Rd., Chicago, Illinois, United States|Northwestern University (Site 1025), 645 North Michigan Ave, Chicago, Illinois, United States|Rush University Medical Center (Site 1017), 600 Paulina St., Chicago, Illinois, United States|University of Illinois at Chicago (Site 1147), 835 South Wood Street, Chicago, Illinois, United States|University of Chicago (Site 1064), 5841 S. Maryland Ave., Chicago, Illinois, United States|Great Lakes Clinical Trials (Site 1049), 5149 N. Ashland Ave., Chicago, Illinois, United States|Investigators Research Group, LLC. (Site 1170), 321 E. Northfield Dr., Ste. 100, Brownsburg, Indiana, United States|Roudebush VA Medical Center (Site 1217), 550 University Blvd, Indianapolis, Indiana, United States|University of Kansas Medical Center (Site 1042), 3901 Rainbow Boulevard, Kansas City, Kansas, United States|MedPharmics (Site 1065), 3800 Houma Blvd., Metairie, Louisiana, United States|Clinical Trials of America, LLC. (Site 1245) 3201 Armand Street, Monroe, Louisiana, United States|New Orleans Adolescent Trials Unit (Site 1028), 1440 Canal St., Suite 904, New Orleans, Louisiana, United States|Louisiana State University Health Sciences Center (Site 1153), 2000 Canal Street, New Orleans, Louisiana, United States|Ochsner Clinic Foundation (Site 1218), 1514 Jefferson Highway, New Orleans, Louisiana, United States|Baltimore VA Medical Center (Site 1258), 10 N. Greene St., Baltimore, Maryland, United States|Johns Hopkins University (Site 1006), 1830 East Monument Street, Baltimore, Maryland, United States|Walter Reed Army Institute of Research (Site 1118), 503 Robert Grant Ave., Silver Spring, Maryland, United States|Massachusetts General Hospital (Site 1016), 55 Fruit Street, Boston, Massachusetts, United States|Beth Israel Deaconess Medical Center (Site 1166), 110 Francis Street, Boston, Massachusetts, United States|Brigham and Women's Hospital - Therapeutics Clinical Research Site (Site 1023), 75 Francis Street, Boston, Massachusetts, United States|University of Massachusetts Medical School (Site 1054), 55 Lake Avenue N., Worcester, Massachusetts, United States|Vida Clinical Studies (Site 1244), 3815 Pelham Street, Dearborn, Michigan, United States|Revive Research Institute (Site 1257), 32255 Northwestern Hwy., Farmington Hills, Michigan, United States|Revival Research Corporation (Site 1256), 13409 East 14 Mile Road, Sterling Heights, Michigan, United States|Memorial Hospital at Gulfport (Site 1104), 4500 13th Street, Gulfport, Mississippi, United States|MedPharmics, LLC. (Site 1032), 15190 Community Rd., Gulfport, Mississippi, United States|University of Missouri Health Care System (Site 1224), 1 Hospital Drive, Columbia, Missouri, United States|Hannibal Clinic (Site 1129), 100 Medical Drive, Hannibal, Missouri, United States|Washington University School of Medicine (Site 1008), 620 South Taylor, Suite 200, Saint Louis, Missouri, United States|Bozeman Health Deaconess Hospital (Site 1115), 931 Highland Blvd, Ste. 3103, Bozeman, Montana, United States|Mercury Street Medical Group (Site 1074), 300 W. Mercury St., Butte, Montana, United States|Quality Clinical Research (Site 1112), 10040 Regency Circle, Omaha, Nebraska, United States|Las Vegas Medical Research (Site 1048), 8530 W. Sunset Rd., Las Vegas, Nevada, United States|AXCES Research Group (Site 1152), 531 Harkle Road, Santa Fe, New Mexico, United States|Bronx Prevention Research Center (Site 1108), 390 East 158th Street, Bronx, New York, United States|Lincoln Hospital (Site 1092), 249 East 149th Street, Bronx, New York, United States|Urban Health Plan, Inc. (Site 1243), 1065 Southern Blvd, Bronx, New York, United States|Jacobi Medical Center (Site 1105), 1400 Pelham Parkway South, Bronx, New York, United States|James J. Peters VA Medical Center (Site 1053), 130 West Kingsbridge Road, Bronx, New York, United States|Maimonides Medical Center (Site 1138), 4802 10th Avenue, Brooklyn, New York, United States|University at Buffalo, Emergency Medicine (Site 1172), 77 Goodell Street, Buffalo, New York, United States|Flushing Hospital Medical Center (Site 1067), 4500 Parsons Blvd, Flushing, New York, United States|Jamaica Hospital Medical Center (Site 1066), 8900 Van Wyck Expressway, Jamaica, New York, United States|Columbia Partnership for Prevention and Control of HIV/AIDS CTU (Site 1019), Columbia University Irving Medical Center, Department of Medicine - Division of Infectious Diseases, 180 Fort Washington Avenue, HP6 - Rm 604, New York, New York, United States|Cornell Clinical Trials Unit (Site 1011), NewYork-Presbyterian Hospital-Weill Cornell Medical Center, 525 East 68th Street, New York, New York, United States|Canton-Potsdam Hospital (Site 1076), 50 Leroy Street, Potsdam, New York, United States|University of Rochester (Site 1010), 601 Elmwood Ave, Rochester, New York, United States|SUNY Stony Brook NICHD (Site 1094), HSC L-02, Rm. 142 C, Stony Brook, New York, United States|University of North Carolina at Chapel Hill (Site 1001), 130 Mason Farm Rd., Bioinformatics Bldg, 2nd Floor, Chapel Hill, North Carolina, United States|Carolina Clinical Research (Site 1167), 9040 Nations Ford Rd., Charlotte, North Carolina, United States|Research Carolina Elite (Site 1247), 7480 Waterside Loop Road, Suite 201, Denver, North Carolina, United States|Duke University Medical Center (Site 1041), 40 Duke Medicine Circle, Durham, North Carolina, United States|Carteret Medical Group, LLC. (Site 1249), 302 Medical Park Ct., Morehead City, North Carolina, United States|Wake Forest University Health Sciences (Site 1038), 1 Medical Center Boulevard, Winston-Salem, North Carolina, United States|Sanford Health (Site 1084), 801 Broadway N., Fargo, North Dakota, United States|The Christ Hospital (Site 1119), 2123 Auburn Avenue, Cincinnati, Ohio, United States|Case Western Reserve University (Site 1033), 2061 Cornell Road, Cleveland, Ohio, United States|MetroHealth Medical Center (Site 1195), 2500 Metrohealth Dr., Cleveland, Ohio, United States|Ohio State University Medical Center (Site 1020), 480 Medical Center Drive, Columbus, Ohio, United States|Cincinnati CRS (Site 1004), University of Cincinnati, University Hospital, 200 Albert Sabin Way, Ohio City, Ohio, United States|STAT Research (Site 1107), 66 Remick Blvd., Springboro, Ohio, United States|Ascension St. John Clinical Research Institute (Site 1090), 1725 East 19th Street, Tulsa, Oklahoma, United States|Providence Portland Medical Center (Site 1098), 4805 NE. Glisan Street, Portland, Oregon, United States|Kaiser Permanente Center for Health Research (Site 1079), 3800 N. Interstate Ave., Portland, Oregon, United States|Portland VA Medical Center (Site 1131), 3710 SW US Veterans Hospital Rd., Portland, Oregon, United States|Oregon Health and Science University (Site 1259), 3181 SW. 10th Avenue, Portland, Oregon, United States|Doylestown Hospital (Site 1122), 595 W. State Street, Doylestown, Pennsylvania, United States|University of Pennsylvania (Site 1031), 3400 Spruce Street, Philadelphia, Pennsylvania, United States|The University of Pittsburgh (Site 1018), 3471 5th Ave., Pittsburgh, Pennsylvania, United States|Veterans Affairs Pittsburgh Healthcare System (Site 1070), University Drive C., Pittsburgh, Pennsylvania, United States|The Miriam Hospital Clinical Research Site (1142), 164 Summit Avenue, Providence, Rhode Island, United States|Medtrial, LLC (Site 1134), 1718 Saint Julian Pl., Ste. 2, Columbia, South Carolina, United States|Clinovacare Medical Clinical Research Center (Site 1211), 160 Medical Circle Suite D, West Columbia, South Carolina, United States|American Indian Clinical Trials Research Network (Site 1148), 717 Meade Street, Rapid City, South Dakota, United States|Sanford USD Medical Center (Site 1078), 1305 W. 18th St., Sioux Falls, South Dakota, United States|Clinical Trials Center of Middle Tennessee (Site 1183), 100 Covey Drive, Franklin, Tennessee, United States|Vanderbilt Therapeutics Clinical Research (Site 1013), Vanderbilt Health One Hundred Oaks, 719 Thompson Ln., Ste 47183, Nashville, Tennessee, United States|Saint Hope Foundation Inc. (Site 1100), 6800 West Loop Street, Ste. 560, Bellaire, Texas, United States|South Texas Medical Research Institute, Inc./TTS Research (Site 1198), 1420 River Road, Boerne, Texas, United States|PanAmerican Clinical Research, LLC. (Site 1069), 1416 Palm Blvd., Brownsville, Texas, United States|Trinity Health and Wellness Center (Site 1030), 219 Sunset Avenue, Dallas, Texas, United States|UT Southwestern HIV/ID Clinical Trials Unit (Site 1208), 1936 Amelia Court, Dallas, Texas, United States|Doctors Hospital at Renaissance Health Institute for Research and Development (Site 1145), 5323 S. McColl Rd., Edinburg, Texas, United States|Sealy Institute for Vaccine Sciences Clincial Trials Program (Site 1044), 400 Harborside Drive, Galveston, Texas, United States|Rheumatology Center of Houston (Site 1252), 1200 Binz St., Ste. 1495, Houston, Texas, United States|Lyndon B. Johnson Hospital (Site 1014), 5656 Kelley Street, Houston, Texas, United States|University of Texas Health Science Center at Houston (Site 1055), 6431 Fannin Street, Ste. 2.112, Houston, Texas, United States|Houston Methodist Hospital (Site 1123), 6565 Fannin Street, Houston, Texas, United States|Dynamic Medical Research Group (Site 1081), 8314 Southwest Fwy, Houston, Texas, United States|Fairway Medical Clinic (Site 1156), 4910 Telephone Road, Houston, Texas, United States|Houston Heart and Vascular Associates (Site 1215), 1485 FM 1960 Bypass R. E., Ste. 100, Humble, Texas, United States|SMS Clincial Research, LLC. (Site 1060), 1210 N. Galloway Ave., Mesquite, Texas, United States|Epic Medical Research, LLC (Site 1233), 106 Plaza Drive, Red Oak, Texas, United States|San Antonio Military Medical Center (Site 1173), 3551 Roger Brooke Dr., San Antonio, Texas, United States|Inova Fairfax Medical Campus (Site 1029), 3300 Gallows Road, Falls Church, Virginia, United States|Clinical Research Partners LLC (Site 1196), 7110 Forest Ave., Ste. 201, Richmond, Virginia, United States|EvergreenHealth (Site 1080), 12040 NE 128th Street, Ste MS-77, Kirkland, Washington, United States|University of Washington ACTU (Site 1012), Harborview Medical Center, 325 9th Ave., Seattle, Washington, United States|Providence Medical Research Center (Site 1075), 105 W. 8th Ave., Ste. 6050W, Spokane, Washington, United States|Hershel Woody Williams VA Medical Center (Site 1128), 1540 Spring Valley Drive, Huntington, West Virginia, United States|West VA University, Mary Babb Randolph Cancer Center (Site 1178), 1 Medical Center Drive, Morgantown, West Virginia, United States|Vida Clinical Studies (Site 1246), 5757 West Oklahoma Avenue, Milwaukee, Wisconsin, United States|Medical College of Wisconsin, Inc. (Site 1036), 8701 Watertown Plank Road, Milwaukee, Wisconsin, United States|Allegiance Research Specialists (Site 1162), 2645 N. Mayfair Rd., Ste. 200, Wauwatosa, Wisconsin, United States|Instituto Médico Platense (Site 3011), Avenida 51 335, La Plata, Buenos Aires, Argentina|Fundación Sanatorio Güemes (Site 3001), Francisco Acuña de Figueroa 1240, Buenos Aires, Ciudad Autónoma De Buenos Aires, Argentina|Instituto Médico Río Cuarto (Site 3005), Hipólito Yrigoyen 1020, Río Cuarto, Córdoba, Argentina|Clínica Adventista Belgrano (Site 3007), Estomba 1710, Ciudad Autonoma de Buenos Aires, Argentina|Instituto Ave Pulmo (Site 3006), Carlos M. Alvear 3345, Mar Del Plata, Argentina|Hospital Universitario Austral (Site 3004), Av. Juan Domingo Peron, Derqui, Pilar, Argentina|L2 Ip - Instituto de Pesquisas Clinicas Ltda (Site 4008), SGAS 613, Conjunto E, Lote 95, Sala 6, Brasília, Distrito Federal, Brazil|Hospital Das Clinicas Da Universidade Federal de Minas Gerais (Site 4001), Avenida Alfredo Balena 190, Belo Horizonte, Minas Gerais, Brazil|Hospital Nossa Senhora da Conceicao (Site 4004), Avenida Francisco Trein 596, Porto Alegre, Rio Grande Do Sul, Brazil|Hospital Das Clinicas da Faculdade de Medicina de Ribeirão Preto (Site 4003), Avenida Bandeirantes 3900, Campus Universitário, Ribeirão Preto, São Paulo, Brazil|Instituto de Pesquisa Clínica Evandro Chagas (Site 4005), Avenida Brasil, 4365, Rio De Janeiro, Brazil|Medical Arts Health Research Group (Site 2003), 360-1855 Kirschner Rd., Kelowna, British Columbia, Canada|Vancouver ID Research and Care Centre Society (Site 2006), Infectious Disease Clinic Downtown, Vancouver, British Columbia, Canada|Dr. Anil K. Gupta Medicine Professional Corporation (Site 2004), 1620 Albion Rd., Suite 106, Toronto, Ontario, Canada|De La Salle Health Sciences Institute (Site 9504), Gov. Mangubat Avenue, Cavite City, Cavite, Philippines|Puerto Rico AIDS Clinical Trials Unit (Site 1024), Proyecto ACTU Biomedical Building II, San Juan, Puerto Rico|Peermed Clinical Trial Center (Site 9215), Corner of Voortrekker and Monument Roads, Kempton Park, Ekurhuleni, Gauteng, South Africa|Worthwhile Clinical Trials (Site 9214), No. 1 Mowbray Avenue, Benoni, Gauteng, South Africa|The Aurum Institute Tembisa Clinical Research Site (Site 9217), Cnr Flint Mazibuko / Rev RTJ Namane Drive, Johannesburg, Gauteng, South Africa|Soweto ACTG CRS (Site 9203), Chris Hani Road, Johannesburg, Gauteng, South Africa|Helen Joseph Hospital (Site 9201), Perth Road, Johannesburg, Gauteng, South Africa|Setshaba Research Centre (Site 9205), 2088 Block H, Pretoria, Gauteng, South Africa|Into Research (Site 9210), Totius Street, Tshwane, Gauteng, South Africa|Durban International Clinical Research Site (Site 9208), Sidmouth Avenue, Durban, Kwazulu - Natal, South Africa|Welkom Clinical Trial Centre (Site 9211), 189 Power Road, Welkom, Matjhabeng, Free State, South Africa|The Aurum Institute Klerksdorp Clinical Research Center (Site 9204), Corner Margaretha Prinsloo St. and O.R. Tambo St., Klerksdorp, North-West, South Africa|The Aurum Institute Rustenburg Clinical Research Site (Site 9202), 50 Steen St., c/o Pretorius St., Rustenburg, North-West, South Africa|TASK Eden (Site 9218), G, 4 Victoria St., George, South Africa|CLINRESCO, ARWYP Medical Suites (Site 9209), 22 Pine Avenue, Johannesburg, South Africa|Mzansi Ethical Research Centre (Site 9212), 184 Cowen Ntuli Street, Steve Tschwete, Mpumalanga, South Africa|Global Clinical Trials Sunnyside (Site 9216), 175 Steve Biko Street, Pretoria, South Africa",https://ClinicalTrials.gov/show/NCT04518410
NCT04420312,Prevalence and Characteristics of Pulmonary Embolism on COVID-19 Patients Presenting Respiratory Symptoms,Observational Model: Case-Control|Time Perspective: Retrospective,COVID-EP|MR 4516150520,"Groupe Hospitalier Paris Saint-Joseph, Paris, France",https://ClinicalTrials.gov/show/NCT04420312
NCT04488588,Survival and 30-days Hospital Outcome in COVID-19 Patients in Upper Egypt,Observational Model: Cohort|Time Perspective: Retrospective,AssiutU17,"AssiutU, Assiut, Egypt|Aliae Mohamed-Hussein, Assiut, Egypt",https://ClinicalTrials.gov/show/NCT04488588
NCT04894760,Evaluation of a COVID-19 Rapid Diagnostic Test in ER Departments in Mexico: a Multi-center Study,Observational Model: Ecologic or Community|Time Perspective: Cross-Sectional,Rapid Test COVID,"Instituto Nacional de Enfermedades Respiratorias, ""Ismael Cosío Villegas"", Mexico, City, Mexico",https://ClinicalTrials.gov/show/NCT04894760
NCT04487873,COVID-19 Phobia in Patients With Bronchiectasis During Covid-19 Pandemic,Observational Model: Case-Control|Time Perspective: Prospective,GO 20/602,"Hacettepe University, Faculty of Physical Therapy and Rehabilitation, Ankara, Turkey",https://ClinicalTrials.gov/show/NCT04487873
NCT04696601,Rapid Screening for Olfactory Disorders in Covid-19 Infection,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Screening,20-PP-27,"CHU de Nice, Nice, France",https://ClinicalTrials.gov/show/NCT04696601
NCT04691895,Gastrointestinal Symptoms in COVID-19,Observational Model: Case-Control|Time Perspective: Prospective,GI-COVID19_01,"IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy",https://ClinicalTrials.gov/show/NCT04691895
NCT04395300,Sleep Quality in Healthcare Personnel During COVID-19,Observational Model: Ecologic or Community|Time Perspective: Cross-Sectional,AssiutU14,"AssiutU, Assiut, Egypt",https://ClinicalTrials.gov/show/NCT04395300
NCT04463004,Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation,"Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",HM20019145,"Virginia Commonwealth University, Richmond, Virginia, United States",https://ClinicalTrials.gov/show/NCT04463004
NCT04860193,Audio Vestibular Functions in COVID 19 Patients in Sohag Governate,Observational Model: Case-Control|Time Perspective: Prospective,Soh-Med-21-04-14,"Sohag faculty of medicine, Sohag, Egypt",https://ClinicalTrials.gov/show/NCT04860193
NCT04432272,ANTIBODY-LEVEL BASED ANALYSIS OF COVID-19 CONVALESCENT SERUM (ABACCuS),Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2020-198,"William Beaumont Hospital, Royal Oak, Michigan, United States",https://ClinicalTrials.gov/show/NCT04432272
NCT04955626,Study to Evaluate the Safety and Efficacy of a Booster Dose of BNT162b2 Against COVID-19 in Participants ≥16 Years of Age.,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention",C4591031,"North Alabama Research Center, Athens, Alabama, United States|Alliance for Multispecialty Research, LLC, Mobile, Alabama, United States|Hope Research Institute, Phoenix, Arizona, United States|The Pain Center of Arizona, Phoenix, Arizona, United States|HOPE Research Institute, Phoenix, Arizona, United States|Anaheim Clinical Trials, LLC, Anaheim, California, United States|National Research Institute ? Wilshire, Los Angeles, California, United States|Paradigm Clinical Research Centers, Inc, Redding, California, United States|California Research Foundation, San Diego, California, United States|Bayview Research Group, LLC, Valley Village, California, United States|Diablo Clinical Research, Inc., Walnut Creek, California, United States|Lynn Institute of Denver, Aurora, Colorado, United States|Clinical Research Consulting, Milford, Connecticut, United States|Alliance for Multispecialty Research, LLC, Coral Gables, Florida, United States|Indago Research & Health Center, Inc, Hialeah, Florida, United States|Research Centers of America ( Hollywood ), Hollywood, Florida, United States|Jacksonville Center for Clinical Research, Jacksonville, Florida, United States|Clinical Neuroscience Solutions, Inc. dba CNS Healthcare, Jacksonville, Florida, United States|Acevedo Clinical Research Associates, Miami, Florida, United States|Clinical Neuroscience Solutions, Orlando, Florida, United States|IACT Health, Columbus, Georgia, United States|Meridian Clinical Research, LLC, Savannah, Georgia, United States|Clinical Research Atlanta, Stockbridge, Georgia, United States|East-West Medical Research Institute, Honolulu, Hawaii, United States|Solaris Clinical Research, Meridian, Idaho, United States|Meridian Clinical Research, LLC, Sioux City, Iowa, United States|Alliance for Multispecialty Research, LLC, Newton, Kansas, United States|Alliance for Multispecialty Research, LLC, Wichita, Kansas, United States|Kentucky Pediatric/ Adult Research, Bardstown, Kentucky, United States|Ochsner Clinic Foundation, New Orleans, Louisiana, United States|Ochsner Medical Center-Jefferson Highway, New Orleans, Louisiana, United States|University of Massachusetts Medical School, Worcester, Massachusetts, United States|Michigan Center of Medical Research (MICHMER), Farmington Hills, Michigan, United States|MedPharmics, Gulfport, Mississippi, United States|Clinical Research Professionals, Chesterfield, Missouri, United States|Sundance Clinical Research, Saint Louis, Missouri, United States|Methodist Physicians Clinic/CCT Research, Fremont, Nebraska, United States|Meridian Clinical Research, LLC, Norfolk, Nebraska, United States|Quality Clinical Research, Omaha, Nebraska, United States|Meridian Clinical Research, LLC, Omaha, Nebraska, United States|Clinical Research Center of Nevada, Las Vegas, Nevada, United States|Wake Research ? Clinical Research Center of Nevada, Las Vegas, Nevada, United States|Alliance for Multispecialty Research, LLC, Las Vegas, Nevada, United States|Amici Clinical Research LLC, Raritan, New Jersey, United States|South Jersey Infectious Disease, Somers Point, New Jersey, United States|Meridian Clinical Research LLC, Binghamton, New York, United States|Meridian Clinical Research, LLC, Endwell, New York, United States|Rochester Clinical Research, Inc., Rochester, New York, United States|Accellacare, Cary, North Carolina, United States|Accellacare, Charlotte, North Carolina, United States|PharmQuest, Greensboro, North Carolina, United States|Accellacare, Hickory, North Carolina, United States|Accellacare, Raleigh, North Carolina, United States|M3 Wake Research, Inc, Raleigh, North Carolina, United States|Accellacare US Inc., Salisbury, North Carolina, United States|Accellacare, Wilmington, North Carolina, United States|Accellacare, Winston-Salem, North Carolina, United States|Lillestol Research, Fargo, North Dakota, United States|Sterling Research Group, Ltd., Cincinnati, Ohio, United States|Sterling Research Group, Ltd., Cincinnati, Ohio, United States|Aventiv Research Inc, Columbus, Ohio, United States|Dayton Clinical Research, Dayton, Ohio, United States|PriMED Clinical Research, Dayton, Ohio, United States|Lynn Institute of Norman, Norman, Oklahoma, United States|Kaiser Permanente Center for Health Research, Portland, Oregon, United States|Velocity Clinical Research, Providence, Warwick, Rhode Island, United States|Main Street Physician's Care, Little River, South Carolina, United States|Holston Medical Group, Bristol, Tennessee, United States|Holston Medical Group, Kingsport, Tennessee, United States|Alliance for Multispecialty Research - Weisgarber Medical Park, Knoxville, Tennessee, United States|Clinical Neuroscience Solutions, Inc. dba CNS Healthcare, Memphis, Tennessee, United States|Clinical Research Associates Inc, Nashville, Tennessee, United States|Trinity Clinical Research, Tullahoma, Tennessee, United States|Benchmark Research, Austin, Texas, United States|ARC Clinical Research at Wilson Parke, Austin, Texas, United States|Tekton Research, Inc., Austin, Texas, United States|Benchmark Research, Fort Worth, Texas, United States|HG Pediatrics, Houston, Texas, United States|Renu Garg, MD Pediatrics, Houston, Texas, United States|Van Tran Family Practice, Houston, Texas, United States|Ventavia Research Group, LLC, Houston, Texas, United States|Texas Center for Drug Development, Inc., Houston, Texas, United States|Ventavia Research Group, Keller, Texas, United States|SMS Clinical Research, Mesquite, Texas, United States|LinQ Research, LLC, Pearland, Texas, United States|Clinical Trials of Texas, Inc., San Antonio, Texas, United States|Diagnostics Research Group, San Antonio, Texas, United States|DM Clinical Research, Tomball, Texas, United States|Martin Diagnostic Clinic, Tomball, Texas, United States|J. Lewis Research, Inc. / Foothill Family Clinic, Salt Lake City, Utah, United States|J. Lewis Research, Inc. / Foothill Family Clinic South, Salt Lake City, Utah, United States|Clinical Alliance for Research and Education, Annandale, Virginia, United States|Virginia Research Center, Midlothian, Virginia, United States|Benaroya Research Institute at Virginia Mason, Seattle, Washington, United States|Virginia Mason Franciscan Health, Seattle, Washington, United States|Wenatchee Valley Hospital, Wenatchee, Washington, United States|Obras Sociais Irma Dulce, Salvador, Bahia, Brazil|CEPIC - Centro Paulista de Investigação Clínica, São Paulo, Brazil|MIC Medial Imaging Consultants, Edmonton, Alberta, Canada",https://ClinicalTrials.gov/show/NCT04955626
NCT04425707,Ivermectin In Treatment of COVID 19 Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,14-2020/3,"isolation and referal hospitals for COVID 19 patients, Cairo, Egypt",https://ClinicalTrials.gov/show/NCT04425707
NCT04384471,Covid-19 Pandemic: Patients' Experience in T1D,Observational Model: Case-Only|Time Perspective: Cross-Sectional,2021-1079,"Institut de Recherches Cliniques de Montréal, Montreal, Quebec, Canada",https://ClinicalTrials.gov/show/NCT04384471
NCT04931004,Oral Rinse to Reduced Expelled Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) During COVID-19 Infection,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Prevention",Pro2020003236,NA,https://ClinicalTrials.gov/show/NCT04931004
NCT04773899,COVID-19 Associated Endothelial Dysfunction Study,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,2021-A00330-41,NA,https://ClinicalTrials.gov/show/NCT04773899
NCT04453748,"The Assessment of the Prevalence, Clinical Course and Treatment of COVID-19 Complications",Observational Model: Cohort|Time Perspective: Prospective,COVID-19 Complications Study,"Silesian Centre for Heart Disease, Zabrze, Silesia, Poland",https://ClinicalTrials.gov/show/NCT04453748
NCT04734886,The Effect of Probiotic Supplementation on SARS-CoV-2 Antibody Response After COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Basic Science",Provid,"Örebro University, Örebro, Örebro Län, Sweden",https://ClinicalTrials.gov/show/NCT04734886
NCT04500067,"Intravenous Immunoglobulin (IVIG, Bioven) Efficacy Assess for COVID-19 / SARS-CoV-2 Severe Pneumonia Complex Treatment",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2020-BV-BP,"Site 08 - ""Central City Clinical Hospital of Ivano-Frankivsk City Council"", Ivano-Frankivs'k, Ivano-Frankivs'k Region, Ukraine|Site 02 - ""Bila Tserkva City Hospital №3"", Bila Tserkva, Kyiv Region, Ukraine|Site 03 - ""Lviv Regional Infectious Diseases Clinical Hospital"", Lviv, Lviv Region, Ukraine|Site 04 - ""City Clinical Infectious Diseases Hospital"", Odesa, Odesa, Odesa Region, Ukraine|Site 07 - ""Ternopil City Municipal Ambulance Hospital"", Ternopil', Ternopil' Region, Ukraine|Site 06 - ""Vinnytsia City Clinical Hospital №1"", Vinnitsia, Vinnitsia Region, Ukraine|Site 09 - ""Volyn Regional Clinical Hospital"", Luts'k, Volyn Region, Ukraine|Site 01 - ""Kyiv City Clinical Hospital №17"", Kyiv, Ukraine|Site 05 - ""Kyiv City Clinical Hospital №4"", Kyiv, Ukraine",https://ClinicalTrials.gov/show/NCT04500067
NCT04532554,Growth Hormone in Obese Cases With Covid-19,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,PR0015,"Asalam, Maadi, Cairo, Egypt",https://ClinicalTrials.gov/show/NCT04532554
NCT04344977,Collection of Anti-SARS-CoV-2 Immune Plasma,Observational Model: Case-Only|Time Perspective: Prospective,200081|20-I-0081,"Lundquist Institute for Biomedical Innovation at Harbor - UCLA Medical Center, Torrance, California, United States|University of Miami Infectious Diseases Research Unit, Miami, Florida, United States|Bloodworks Northwest, Seattle, Washington, United States",https://ClinicalTrials.gov/show/NCT04344977
NCT04746430,COVID-19 Primary Care Platform for Early Treatment and Recovery (COPPER) Study,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,GPRI-21001-COV|2021-000235-30,"GPRI, Groningen, Netherlands",https://ClinicalTrials.gov/show/NCT04746430
NCT04646551,Covid-19 Risk Factors and Pattern Between Healthcare Workers,Observational Model: Other|Time Perspective: Other,Covid-19 patterrn,NA,https://ClinicalTrials.gov/show/NCT04646551
NCT04542031,COVID-19 in a Single Large UK Rheumatology Centre and Impact on QOL,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,2020COV113,"The Royal Wolverhampton NHS Trust, Wolverhampton, West Midlands, United Kingdom",https://ClinicalTrials.gov/show/NCT04542031
NCT04669938,"Role of the Microbiota in the Evolution of the SARS-CoV-2 Disease,COVID-19, in Hospitalized Patients",Observational Model: Case-Only|Time Perspective: Prospective,APHP201083,"LESCURE, Paris, France",https://ClinicalTrials.gov/show/NCT04669938
NCT04853134,Proxalutamide Treatment for COVID-19 Female Outpatients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",AB-DRUG-SARS-005,"Corpometria Institute, Brasilia, Brazil",https://ClinicalTrials.gov/show/NCT04853134
NCT04335071,Tocilizumab in the Treatment of Coronavirus Induced Disease (COVID-19),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",2020-00691|2020DR2044,"University Hospital Bern (Inselspital), Bern, Switzerland|Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland|Ospedale Regionale di Lugano (EOC), Viganello, Switzerland|University Hospital Zurich, Zurich, Switzerland",https://ClinicalTrials.gov/show/NCT04335071
NCT04666207,"Viral Shedding, Symptoms and Exposure of SARS-CoV-2 in Non-hospitalized Children With COVID-19",Observational Model: Cohort|Time Perspective: Prospective,H-20028631-1,"Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark",https://ClinicalTrials.gov/show/NCT04666207
NCT04545008,Trial of Famotidine & N-Acetyl Cysteine for Outpatients With COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,Pro00100394,"Prisma Health Baptist Easley Hospital, Easley, South Carolina, United States|Prisma Health Greenville Memorial Hospital, Greenville, South Carolina, United States|Prisma Health Greer Memorial Hospital, Greer, South Carolina, United States",https://ClinicalTrials.gov/show/NCT04545008
NCT04863534,Ultrasound Grayscale Analysis in ARDS covid19,Observational Model: Cohort|Time Perspective: Prospective,Umilan1,"ASST-Santi Paolo e Carlo, San Paolo Hospital, Milan, Italy",https://ClinicalTrials.gov/show/NCT04863534
NCT04459962,Covid-19 Breath Test,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,2020ATL01,"Ashford and St Peter's Hospitals NHS Foundation Trust, Chertsey, Surrey, United Kingdom",https://ClinicalTrials.gov/show/NCT04459962
NCT04393428,Urinary Biomarkers for AKI Diagnosis in Patients With SARS-CoV-2 (COVID-19),Observational Model: Cohort|Time Perspective: Retrospective,RECHMPL20_0294,"Uhmontpellier, Montpellier, France",https://ClinicalTrials.gov/show/NCT04393428
NCT04945590,The VIDA After COVID Study,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,21-002083,"Mayo Clinic in Rochester, Rochester, Minnesota, United States",https://ClinicalTrials.gov/show/NCT04945590
NCT04924803,Community Developed Technology-Based Messaging to Increase COVID-19 Vaccine Uptake Among People Who Inject Drugs,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Other,COVID Vaccination,NA,https://ClinicalTrials.gov/show/NCT04924803
NCT04465058,Characteristics of Critically Ill COVID 19 Patients,Observational Model: Other|Time Perspective: Prospective,yte,"Assiut university, Assiut, Egypt",https://ClinicalTrials.gov/show/NCT04465058
NCT04623697,Covid-19 Infection and New Onset Type 1 Diabetes,Observational Model: Case-Control|Time Perspective: Prospective,S-20200119,"Hospital of South West Jutland, Esbjerg, Denmark",https://ClinicalTrials.gov/show/NCT04623697
NCT04706403,Views on COVID-19 and Vaccination,Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,H00022244,"Meyers Primary Care Institute, Worcester, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT04706403
NCT04526821,Lactoferrin for Prevention of COVID-19 in Health Care Workers,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention",SIDISI 202110,"Hospital Nacional Arzobispo Loayza, Lima, Lim, Peru|Hospital Cayetano Heredia, Lima, Peru",https://ClinicalTrials.gov/show/NCT04526821
NCT04748588,Treatment of Nosocomial COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,REB21-0096,"University of Calgary, Calgary, Alberta, Canada|University of Alberta, Edmonton, Alberta, Canada",https://ClinicalTrials.gov/show/NCT04748588
NCT04561154,Identifying Functional and Psycho-social Complaints After Hospitalization for SARS-CoV-2 Infection( COVID 19)- REPERCOV,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,CHM-2020/S10/04,"Centre Hospitalier du Mans, Le Mans, France",https://ClinicalTrials.gov/show/NCT04561154
NCT04353011,Psychological Impact of Quarantine in Chronic Pain Patient During COVID-19 Outbreak,Observational Model: Family-Based|Time Perspective: Cross-Sectional,2020_45|2020-A00912-37,"Hopital Roger Salengro, CHU Lille, Lille, France",https://ClinicalTrials.gov/show/NCT04353011
NCT04351633,Psychological Impact of Quarantine in Osteoporosis Patient During COVID-19 Outbreak,Observational Model: Family-Based|Time Perspective: Cross-Sectional,2020_31|2020-A00911-38,"Hopital Roger Salengro, CHU Lille, Lille, France",https://ClinicalTrials.gov/show/NCT04351633
NCT04392323,Incidence of COVID-19 Test Conversion in Post-surgical Patients,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,IRB #20-0404,"North Shore University Hospital, Manhasset, New York, United States|Long Island Jewish Medical Center, New Hyde Park, New York, United States",https://ClinicalTrials.gov/show/NCT04392323
NCT04703205,Study in COvid-19 Patients With iveRmectin (CORVETTE-01),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",CORVETTE-01,"Kitasato University, Sagamihara, Kanagawa, Japan",https://ClinicalTrials.gov/show/NCT04703205
NCT04631367,mHealth Intervention for Increasing COVID-19 Prevention Practices With Urban Refugee and Displaced Youth in Uganda,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,idrc_covid,NA,https://ClinicalTrials.gov/show/NCT04631367
NCT04386447,Phase II RCT to Assess Efficacy of Intravenous Administration of Oxytocin in Patients Affected by COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,OsCOVID19,"CNRS, Lyon, France|Azienda Ospedaliero Universitaria di Parma, Parma, PR, Italy|Ospedale San Francesco, Nuoro, Italy",https://ClinicalTrials.gov/show/NCT04386447
NCT04522466,Evaluation of the Pharmacokinetics and Pharmacodynamics of Hydroxychloroquine in COVID-19 Intensive Care Unit Patients,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,20CH065|2020-001281-11,"Groupement Hospitalier des Portes de Province, Montélimar, France|Centre Hospitalier de Roanne, Roanne, France|CHU Saint-Etienne, Saint-Étienne, France|Clinique Mutualiste, Saint-Étienne, France",https://ClinicalTrials.gov/show/NCT04522466
NCT04817371,Analysis of Volatile Organic Compounds in Exhaled Air and Sweat: Interest in Rapid Screening for COVID-19 Infection.,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,2021_0013,"Foch hospital, Suresnes, France",https://ClinicalTrials.gov/show/NCT04817371
NCT04757870,Macro-scale Estimators of Covid-19's Worldwide Cases and Deaths,Observational Model: Other|Time Perspective: Other,KCU_16022021,NA,https://ClinicalTrials.gov/show/NCT04757870
NCT04871802,Effect of the Dietary Supplement Taxifolin Aqua on the Recovery Period After COVID-19 Pneumonia,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,COVID-AQUA-1,"Russian Clinical Research Center for Gerontology, Moscow, Russian Federation",https://ClinicalTrials.gov/show/NCT04871802
NCT04346264,CoVid-19 - Infection and Antibody Formation in the Viennese Population,Observational Model: Cohort|Time Perspective: Prospective,LEAD CoVid-19,"The LEAD Study Center, Vienna, Austria",https://ClinicalTrials.gov/show/NCT04346264
NCT04358614,Baricitinib Therapy in COVID-19,Allocation: Non-Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,HPrato-4,"Fabrizio Cantini, Prato, Tuscany, Italy",https://ClinicalTrials.gov/show/NCT04358614
NCT04324190,DIgital Online SuPport for COVID-19 StrEss,Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Single (Care Provider)|Primary Purpose: Treatment,IPUB_2020_01,"Selfapy GmbH, Berlin, Germany",https://ClinicalTrials.gov/show/NCT04324190
NCT04784767,SARS-COV-2-Spike-Ferritin-Nanoparticle (SpFN) Vaccine With ALFQ Adjuvant for Prevention of COVID-19 in Healthy Adults,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",S-20-03|WRAIR # 2847|EID030|IND 27301,"WRAIR Clinical Trials Center, Silver Spring, Maryland, United States",https://ClinicalTrials.gov/show/NCT04784767
NCT04563442,Comorbidities And Complications Associated With Covid-19 Infection,Observational Model: Case-Crossover|Time Perspective: Cross-Sectional,covid 19,NA,https://ClinicalTrials.gov/show/NCT04563442
NCT04403035,Comparison of the ID NOW and Accula Point-of-Care Assays for Detection of COVID-19,Observational Model: Cohort|Time Perspective: Prospective,1599159,"Ascension St. John Hospital, Detroit, Michigan, United States",https://ClinicalTrials.gov/show/NCT04403035
NCT04386369,Evaluation of Airway Pressure Release Ventilation in COVID-19 ARDS,Observational Model: Cohort|Time Perspective: Retrospective,2020PI076,"Centre Hospitalier Régional Universitaire de Nancy, Nancy, France",https://ClinicalTrials.gov/show/NCT04386369
NCT04842708,Evaluation of Anti-COVID 19 Pfizer Vaccination Effect on COVID 19 Detection Using Breath Analysis,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,Cov-2-SMC-V-2020,"Shamir Medical Center, Be'er Ya'aqov, Israel",https://ClinicalTrials.gov/show/NCT04842708
NCT04561180,Study to Evaluate the Efficacy and Safety of EG-HPCP-03a Compared to DEX in Patients With COVID-19 Pneumonia,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",HPC-EG-009A-2.1,NA,https://ClinicalTrials.gov/show/NCT04561180
NCT04534803,BCG Against Covid-19 for Prevention and Amelioration of Severity Trial (BAC to the PAST),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",IRB20-1243,NA,https://ClinicalTrials.gov/show/NCT04534803
NCT04808986,Seroprevalence of IgG Antibodies to SARS-CoV-2 (COVID-19) in Primary Health Care Workers and Their Household Contacts,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,C20-72|ID RCB : 2020-A03298-31,NA,https://ClinicalTrials.gov/show/NCT04808986
NCT04944082,Remdesivir- Ivermectin Combination Therapy in Severe Covid-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,Remdesivir-Ivermectin,NA,https://ClinicalTrials.gov/show/NCT04944082
NCT04356586,Immune Response to Covid-19 in 300 Health Care Workers With Mild Symptoms,Observational Model: Cohort|Time Perspective: Prospective,Jessa300,"Sciensano, Brussels, Belgium",https://ClinicalTrials.gov/show/NCT04356586
NCT04727424,Repurposed Approved and Under Development Therapies for Patients With Early-Onset COVID-19 and Mild Symptoms,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",TOGETHER_2,"City of Betim, Betim, MG, Brazil|Hospital e Maternidade Santa Rita, Contagem, MG, Brazil|City of Governador Valadares, Governador Valadares, MG, Brazil|City of Ibirité, Ibirité, MG, Brazil|City of Nova Lima, Nova Lima, MG, Brazil|City of Santa Luzia, Santa Luzia, MG, Brazil|City of Sete Lagoas, Sete Lagoas, MG, Brazil|CARDRESEARCH - Cardiologia Assistencial e de Pesquisa, Belo Horizonte, Minas Gerais, Brazil|City of Brumadinho, Brumadinho, Minas Gerais, Brazil|Centro Universitário FIPMOC, Montes Claros, Minas Gerais, Brazil|Universidade Federal de Ouro Preto, Ouro Preto, Minas Gerais, Brazil",https://ClinicalTrials.gov/show/NCT04727424
NCT04771000,A Study of Micro Dose Ambrisentan in Hospitalized Patients With Respiratory Insufficiency Due to COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",N-003-CRD008,"Hospital Universitario de Cabueñes, Gijón, Asturias, Spain|Hospital Universitario Virgen de las Nieves, Granada, Comunidad De Andalucia, Spain|Hospital Universitario San Cecilio, Granada, Comunidad De Andalucia, Spain|Hospital Universitario de Jaén, Jaén, Comunidad De Andalucía, Spain|Hospital Universitario de Galdakao-Usansolo, Galdakao, Comunidad De Bizkaia, Spain|Complejo Hospitalario de Navarra, Pamplona, Comunidad De Navarra, Spain|Hospital Rey Juan Carlos, Móstoles, Madrid, Spain|Hospital Universitario Infanta Leonor, Madrid, Spain|University Hospital 12 de Octubre, Madrid, Spain|Hospital Universitario La Paz, Madrid, Spain|Hospital de Emergencias Enfermera Isabel Zendal, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04771000
NCT04338906,Combination Therapy With Camostat Mesilate + Hydroxychloroquine for COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",CLOCC-2020,NA,https://ClinicalTrials.gov/show/NCT04338906
NCT04606563,Host Response Mediators in Coronavirus (COVID-19) Infection - Is There a Protective Effect of Losartan on Outcomes of Coronavirus Infection?,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,H20-01984,"University of Nebraska, Omaha, Nebraska, United States|Brown University, Providence, Rhode Island, United States|Vanderbilt University, Nashville, Tennessee, United States|St. Luc University Hospital, Brussels, Belgium|Clinique Saint-Pierre, Ottignies, Belgium|University of Calgary - Foothills, Calgary, Alberta, Canada|Royal Columbian Hospital, New Westminster, British Columbia, Canada|Surrey Memorial Hospital, Surrey, British Columbia, Canada|St Paul's Hospital, Vancouver, British Columbia, Canada|Vancouver General Hospital, Vancouver, British Columbia, Canada|Queens University, Kingston, Ontario, Canada|The Ottawa Hospital, Ottawa, Ontario, Canada|St Michael's Hospital, Toronto, Ontario, Canada|Sunnybrook Hospital, Toronto, Ontario, Canada|McGill University Health Center, Montréal, Quebec, Canada|Université de Sherbrooke, Sherbrooke, Quebec, Canada|Centre Hospitalier Universitaire d'Angers, Angers, France|Chiba University, Chiba, Japan|Hospital Clínico San Carlos, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04606563
NCT04334850,Use of a Respiratory Multiplex PCR and Procalcitonin to Reduce Antibiotics Exposure in Patients With Severe Confirmed COVID-19 Pneumonia,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,APHP200392|2020-001324-33,"Intensive care department-Hospital Tenon, Paris, France",https://ClinicalTrials.gov/show/NCT04334850
NCT04373460,Convalescent Plasma to Limit SARS-CoV-2 Associated Complications,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",IRB00247590,"University of Alabama at Birmingham, Birmingham, Alabama, United States|Center for American Indian Health - Chinle Office, Chinle, Arizona, United States|Mayo Clinic, Phoenix, Phoenix, Arizona, United States|University of Arizona, Phoenix, Tucson, Arizona, United States|University of Arizona, Tuscon, Tucson, Arizona, United States|Center for American Indian Health - Whiteriver Office, Whiteriver, Arizona, United States|University of California, Los Angeles, Los Angeles, California, United States|University of California, Irvine Health, Orange, California, United States|University of California, Davis, Sacramento, California, United States|Western Connecticut Health Netowrk, Danbury Hospital, Danbury, Connecticut, United States|Western Connecticut Health Network, Norwalk Hospital, Norwalk, Connecticut, United States|University of Miami, Coral Gables, Florida, United States|University of Miami Clinical Translational Research Site, Miami, Florida, United States|NorthShore University HealthSystem, Evanston, Illinois, United States|Tulane University, New Orleans, Louisiana, United States|Anne Arundel Medical Center, Annapolis, Maryland, United States|The Johns Hopkins University, Baltimore, Maryland, United States|MedStar Washington Hospital Center, Hyattsville, Maryland, United States|University of Massachusetts Worcester, Worcester, Massachusetts, United States|Wayne State University, Detroit, Michigan, United States|University of New Mexico Health Sciences Center, Albuquerque, New Mexico, United States|Center for American Indian Health - Gallup Office, Gallup, New Mexico, United States|Center for American Indian Health - Shiprock Office, Shiprock, New Mexico, United States|Vassar Brothers Medical Center, Poughkeepsie, New York, United States|University of Rochester, Rochester, New York, United States|University of Cincinnati Medical Center, Cincinnati, Ohio, United States|Lifespan/BrownUniversity (Rhode Island Hospital), Providence, Rhode Island, United States|Baylor College of Medicine, Houston, Texas, United States|University of Texas Health Science Center at Houston, Houston, Texas, United States|The University of Utah, Salt Lake City, Utah, United States",https://ClinicalTrials.gov/show/NCT04373460
NCT04712175,Diagnostic Validation of Rapid Detection of the COVID-19 Causative Virus (SARS-CoV-2) in Saliva Samples by Mass Spectrometry,Observational Model: Case-Control|Time Perspective: Prospective,LOCAL-COVID/2020/AS-01,"CHU de Nîmes, Nîmes, France",https://ClinicalTrials.gov/show/NCT04712175
NCT04842292,Nebulized Heparin for COVID19-associated Acute Respiratory Failure,Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,65139,"UK Healthcare, Lexington, Kentucky, United States",https://ClinicalTrials.gov/show/NCT04842292
NCT04494399,IFN Beta-1b and Ribavirin for Covid-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,UW 20-513,"The University of Hong Kong, Queen Mary Hospital, Hong Kong, Hong Kong",https://ClinicalTrials.gov/show/NCT04494399
NCT04373486,Incidence of Acute Pulmonary Embolism in Covid-19 Patients on CT Angiography and Relationship to D-dimer Levels,Observational Model: Case-Only|Time Perspective: Other,7840,"Service de Radiologie B - NHC, Strasbourg, France",https://ClinicalTrials.gov/show/NCT04373486
NCT04794361,Management of Patients Suspected of COVID 19 With Ultra Low Dose Thoracic Scanner,Observational Model: Case-Only|Time Perspective: Retrospective,Local 2020/JF1,"Julien FRANDON, Nîmes, France",https://ClinicalTrials.gov/show/NCT04794361
NCT04516941,CorONa Virus edoxabaN ColchicinE (CONVINCE) COVID-19,Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,CONVINCE Version 1.0 12052020,"Jessa Ziekenhuis, Hasselt, Belgium|Azienda ULSS n.4 ""Veneto Orientale"", Jesolo, Veneto, Italy|ASST Papa Giovanni XXIII, Bergamo, Italy|ASST Rhodense, Garbagnate Milanese, Italy|Azienda Socio Sanitaria Territoriale di Lecco, Lecco, Italy|ASST Grande Ospedal Metropolitano Niguardia, Milan, Italy|IRCCS Policlinico San Matteo, Pavia, Italy|Azienda Unita' Sanitaria Locale della Romagna, Ravenna, Italy|Hospital Clinic de Barcelona, Barcelona, Spain|Ospedale regionale Lugano, Lugano, Ticino, Switzerland|Bern University Hospital, Bern, Switzerland",https://ClinicalTrials.gov/show/NCT04516941
NCT04556318,Identification of Differences in Breath Components Detected With IMS in Patients Tested on SARS-CoV-2 (COVID-19),Observational Model: Cohort|Time Perspective: Prospective,HC-N-H-2004,"Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany|Technical University of Munich, Klinikum rechts der Isar, Munich, Germany",https://ClinicalTrials.gov/show/NCT04556318
NCT04895267,Low-field Thoracic Magnetic Stimulation Increases Peripheral Oxygen Saturation Levels in COVID-19 Patients,"Allocation: Non-Randomized|Intervention Model: Crossover Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Basic Science",Registration number: 818,"Benemérita Universidad Autónoma de Puebla, Puebla, Mexico",https://ClinicalTrials.gov/show/NCT04895267
NCT04852718,Rehabilitation Program for the Sequelae of COVID 19 Infection,Observational Model: Cohort|Time Perspective: Prospective,IIBSP-COV-2020-155,"Hospital de la Santa Creu i Sant Pau, Barcelona, Spain",https://ClinicalTrials.gov/show/NCT04852718
NCT04522310,ProAdrenomedullin Assessment of Multi-Organ Failure in COvid-19 Sepsis,Observational Model: Case-Only|Time Perspective: Prospective,20-May,"Hospital of Arras, Arras, France|Hospital of Boulogne/mer, Boulogne-sur-Mer, France|Hospital of DOUAI, Douai, France|Hospital of Dunkerque, Dunkerque, France|Hospital Dr Schaffner, Lens, France|Hospital of Roubaix, Roubaix, France|Hospital of Tourcoing, Tourcoing, France|Hospitalier of Valenciennes, Valenciennes, France",https://ClinicalTrials.gov/show/NCT04522310
NCT04543006,Persistence of Neutralizing Antibodies 6 and 12 Months After a Covid-19,Allocation: N/A|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,EssaiClinique_PANCOLIN,NA,https://ClinicalTrials.gov/show/NCT04543006
NCT04937556,Evaluation of a Probiotic Supplementation in the Immune Response of Participants With COVID-19 (Coronavirus Disease).,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",COV/21.02,NA,https://ClinicalTrials.gov/show/NCT04937556
NCT04839042,"A Phase 1, First-In-Human Study of the Investigational COVID-19 Vaccine SC-Ad6-1 in Healthy Volunteers",Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,SC-Ad6-1-002,"Tetherex Study Site, Brisbane, Queensland, Australia",https://ClinicalTrials.gov/show/NCT04839042
NCT04824625,Incidence of Infection Reported by COVID-19 in Attendees of a Commercial Music Concert,Observational Model: Cohort|Time Perspective: Prospective,StJordi-CoV,"Germans Trias i Pujol Hospital, Badalona, Barcelona, Spain",https://ClinicalTrials.gov/show/NCT04824625
NCT04728802,Proxalutamide Treatment for Hospitalized COVID-19 Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment",KP-DRUG-SARS-003,"Hospital Regional José Mendes, Itacoatiara, Amazonas, Brazil|Hospital de Campanha de Manacapuru, Manacapuru, Amazonas, Brazil|Hospital Oscar Nicolau, Manaus, Amazonas, Brazil|Hospital Prontocord, Manaus, Amazonas, Brazil|Hospital Samel, Manaus, Amazonas, Brazil|Hospital Regional Dr. Hamilton Maia Cidae, Manicore, Amazonas, Brazil|Hospital Raimunda Francisca Dinelli da Silva, Maues, Amazonas, Brazil|Hospital Regional Jofre Cohen, Parintins, Amazonas, Brazil",https://ClinicalTrials.gov/show/NCT04728802
NCT04530500,COVID-19 In-vitro Diagnostic Test and Androgen Receptor Gene Expression,Observational Model: Cohort|Time Perspective: Prospective,2020-5907,"Applied Biology, Inc, Irvine, California, United States|University of California, Irvine - Dermatology Clinical Research, Irvine, California, United States",https://ClinicalTrials.gov/show/NCT04530500
NCT04540419,Clinical Trial of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) Against COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",Prometheus_Rus,"Municipal budgetary institution ""Central City Hospital No. 7"", Ekaterinburg, Russian Federation|Federal budgetary institution of science ""Central Research Institute of Epidemiology"" of the Federal Service for Surveillance on Consumer Rights Protectionand Human Welfare, Moscow, Russian Federation|State Budgetary Institution of Healthcare of the City of Moscow ""City Polyclinic No. 2of the Department of Healthcare of the City of Moscow"", Moscow, Russian Federation|Federal State Autonomous Educational Institution of Higher Education ""First MoscowState Medical University named after I.M. Sechenov ""of the Ministry of Health of the Russian Federation, Moscow, Russian Federation|Limited Liability Company ""Research Center Eco-safety"", Saint Petersburg, Russian Federation|Federal State Budgetary Institution ""Research Institute of Influenza named after A.A.Smorodintsev ""of the Ministry of Health of the Russian Federation, Saint Petersburg, Russian Federation|Private health care institution ""Clinical hospital 'Russian Railways - Medicine' of the city of Yaroslavl"", Yaroslavl, Russian Federation",https://ClinicalTrials.gov/show/NCT04540419
NCT04951349,Safety and Efficacy of Intranasal Application of GX-03 as a Treatment and Prevention for COVID-19.,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",GX-03 for COVID-19,"Gorgas Memorial Research Hospital, Panama City, Panama|Hospital Modular COVID-19, Panama City, Panama|Hospital Santo Tomas, Panama City, Panama",https://ClinicalTrials.gov/show/NCT04951349
NCT04390139,Efficacy and Safety Evaluation of Mesenchymal Stem Cells for the Treatment of Patients With Respiratory Distress Due to COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",BST-COVID-01,"Hospital de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain|Mútua de Terrassa, Terrassa, Barcelona, Spain|Hospital del Mar, Barcelona, Spain|Hospital Vall d'Hebron, Barcelona, Spain|Hospital Clínic de Barcelona, Barcelona, Spain",https://ClinicalTrials.gov/show/NCT04390139
NCT04761107,Impact of COVID-19 on GU Disease,Observational Model: Other|Time Perspective: Prospective,GCO 20-1053|STUDY-20-01467,"Icahn School of Medicine at Mount Sinai, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04761107
NCT04854785,Neuroinflammation in COVID-19 and Depression,Observational Model: Other|Time Perspective: Prospective,177/2020,"Centre for Addiction and Mental Health, Toronto, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04854785
NCT04673318,Physical Rehabilitation of COVID-19 Survivors by Heat Therapy,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science,2151,"Institute of Applied Life Sciences, Amherst, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT04673318
NCT04817293,Prolonged Symptoms and Reasons for Consultation in Town Medicine Associated With COVID-19 Infection in the Hauts de France Region,Observational Model: Case-Control|Time Perspective: Prospective,RIPH_2021_01,"CH Tourcoing, Tourcoing, France",https://ClinicalTrials.gov/show/NCT04817293
NCT04333693,Outcomes of Vascular Surgery in COVID-19 Infection: National Cohort Study,Observational Model: Cohort|Time Perspective: Prospective,RIV-2020-1,"Spanish Society for Angiology and Vascular Surgery, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04333693
NCT04338958,Ruxolitinib in Covid-19 Patients With Defined Hyperinflammation,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,RuxCoFlam,"Universitätsmedizin Göttingen - Klinik für Hämatologie und Onkologie, Göttingen, Germany|University Hospital Jena, Jena, Germany|Klinikum der Landeshauptstadt Stuttgart gKöR, Stuttgart, Germany|Universitätsklinikum Ulm, Ulm, Germany|Schwarzwald-Baar Klinikum Villingen-Schwenningen GmbH, Villingen-Schwenningen, Germany|Universitätsklinikum Würzburg, Würzburg, Germany",https://ClinicalTrials.gov/show/NCT04338958
NCT04646655,Enoxaparin at Prophylactic or Therapeutic Doses in COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,HLS-02COVID19/2020,"ASST Fatebenefratelli Sacco, Milan, Italy",https://ClinicalTrials.gov/show/NCT04646655
NCT04930731,Risk Factors and Characteristics of COVID 19 Infection in Patients With Haematological Diseases,Observational Model: Cohort|Time Perspective: Prospective,COVID 19 &haematological pts,NA,https://ClinicalTrials.gov/show/NCT04930731
NCT04798001,Safety and Immunogenicity of an Intranasal RSV Vaccine Expressing SARS-CoV-2 Spike Protein (COVID-19 Vaccine) in Adults,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,MV-101,"Johnson County Clin-Trials, Lenexa, Kansas, United States",https://ClinicalTrials.gov/show/NCT04798001
NCT04494984,"A Study to Investigate the Pharmacokinetics, Efficacy and Safety of INM005 in Patients With COVID-19.","Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",CT-INM005-01,"Hospital de Cuenca Alta, Cañuelas, Buenos Aires, Argentina|Hospital Alta Complejidad ""El Cruce"" Dr. Néstor Carlos Kirchner, Florencio Varela, Buenos Aires, Argentina|Hospital Prof. Dr. Bernardo A. Houssay, Florida, Buenos Aires, Argentina|Instituto Medico Platense, La Plata, Buenos Aires, Argentina|Hospital Italiano de La Plata, La Plata, Buenos Aires, Argentina|Hospital Municipal Emilio Zerboni, San Antonio de Areco, Buenos Aires, Argentina|Hospital Municipal Dr. Diego E. Thompson, San Martín, Buenos Aires, Argentina|Hospital Pablo Soria, San Salvador De Jujuy, Jujuy, Argentina|Hospital Provincial Neuquén ""Dr. Eduardo Castro Rendón"", Neuquén, Neuquen, Argentina|Hospital Centro de Salud Zenón J. Santillán, San Miguel De Tucumán, Tucuman, Argentina|Sanatorio Guemes, Ciudad Autonoma de Buenos Aires, Argentina|Hospital Italiano de Buenos Aires, Ciudad Autonoma de Buenos Aires, Argentina|Hospital Muñiz, Ciudad Autonoma de Buenos Aires, Argentina|Hospital Pirovano, Ciudad Autonoma de Buenos Aires, Argentina|Centro Gallego de Buenos Aires, Ciudad Autonoma de Buenos Aire, Argentina|Clínica Adventista Belgrano, Ciudad Autonoma de Buenos Aire, Argentina|Clínica Pasteleros, Ciudad Autonoma de Buenos Aire, Argentina|Clínica Zabala, Ciudad Autonoma de Buenos Aire, Argentina|Fundación Favaloro, Ciudad Autonoma de Buenos Aire, Argentina|Hospital Español de Buenos Aires, Ciudad Autonoma de Buenos Aire, Argentina|Hospital G. A. Carlos G. Durand, Ciudad Autonoma de Buenos Aire, Argentina|Sanatorio Agote, Ciudad Autonoma de Buenos Aire, Argentina|Sanatorio Sagrado Corazón, Ciudad Autonoma de Buenos Aire, Argentina",https://ClinicalTrials.gov/show/NCT04494984
NCT04452643,Efficacy of BACMUNE (MV130) in the Prevention of Disease Due to COVID-19 Infection in Healthcare Personnel,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention",MV130-SLG-037,"Instituto Nacional de Enfermedades Respiratorias (INER), Ciudad de México, Mexico|Hospital General de Pachuca, Pachuca de Soto, Mexico|Hospital de Ciudad Valles, San Luis Potosí, Mexico",https://ClinicalTrials.gov/show/NCT04452643
NCT04695704,Efficacy of Montelukast in Mild-moderate Respiratory Symptoms in Patients With Long-COVID-19:,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",4R21/006,NA,https://ClinicalTrials.gov/show/NCT04695704
NCT04497649,Sofosbuvir Containing Regimens in Treatment of COVID 19 Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",Tanta sofosbuvir covid,"Cairo and Tanta Universitities, Tanta, Egypt",https://ClinicalTrials.gov/show/NCT04497649
NCT04513964,Impact of COVID-19 on the Benefit of Cardiac Rehabilitation,Observational Model: Case-Control|Time Perspective: Cross-Sectional,READCARDIOCOVID,"Groupe Hospitalier Paris Saint-Joseph, Paris, Groupe Hospitalier Paris Saint-Joseph, France|Hôpital Corentin Celton, Issy-les-Moulineaux, France",https://ClinicalTrials.gov/show/NCT04513964
NCT04853927,Proxalutamide Treatment for COVID-19 Patients in Intensive Care Unit,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",KP-DRUG-SARS-004,"Samel Hospital, Manaus, Amazonas, Brazil",https://ClinicalTrials.gov/show/NCT04853927
NCT04345601,Mesenchymal Stromal Cells for the Treatment of SARS-CoV-2 Induced Acute Respiratory Failure (COVID-19 Disease),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,H-47561 MSC for COVID-19,"Houston Methodist Hospital, Houston, Texas, United States",https://ClinicalTrials.gov/show/NCT04345601
NCT04543760,Effect of Prone Positioning Combined With High Flow Oxygen Therapy on Oxygenation During Acute Respiratory Failure Due to COVID-19,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Other,2020/4/3,"Hopital Saint Joseph, Marseille, France",https://ClinicalTrials.gov/show/NCT04543760
NCT04698083,"Electrocardiographic QRS Axis Shift ,Rotation and COVİD-19",Observational Model: Case-Only|Time Perspective: Retrospective,22/7/2020-2152,"Şahbender Koç, Ankara, Turkey",https://ClinicalTrials.gov/show/NCT04698083
NCT04980573,Essential Oils and Post COVID-19 Fatigue,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Supportive Care",21-07-0300,"Franklin Health Research Center, Franklin, Tennessee, United States",https://ClinicalTrials.gov/show/NCT04980573
NCT04473105,Optimising Resource Allocation Via Prediction of Outcomes for Covid-19,Observational Model: Other|Time Perspective: Prospective,20GA039,"Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom",https://ClinicalTrials.gov/show/NCT04473105
NCT04452773,Clinical Trial to Evaluate the Efficacy of Food Supplement Manremyc® Against SARS- COV-2 Infection (COVID-19) in Healthcare Workers,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",MANRECOVID19,"CAP Cornellà (La Gavarra), Cornellà De Llobregat, Barcelona, Spain|CAP Maresme, Mataró, Barcelona, Spain|Cap Sant Fèlix, Sabadell, Barcelona, Spain|EAP Riu Nord, Santa Coloma De Gramenet, BArcelona, Spain|Hospital Universitari Germans Trias i Pujol UBP Riscos Laborals, Badalona,, Badalona, Spain",https://ClinicalTrials.gov/show/NCT04452773
NCT04401371,Distance Learning for Dental Student During COVID-19 Pandemic,Observational Model: Other|Time Perspective: Cross-Sectional,Distance learning environment,"Faculty of Dentistry, Cairo, Egypt",https://ClinicalTrials.gov/show/NCT04401371
NCT04957082,Culturally-Targeted COVID-19 Communication and SARS-CoV-2 Antibody Testing Evaluation and Uptake,Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: Single (Participant)|Primary Purpose: Screening,MSUSeronet1|U01CA260469,"Flint Journal Building, Flint, Michigan, United States",https://ClinicalTrials.gov/show/NCT04957082
NCT04695158,Blood Sample Measurements and Physical Activity Levels in Type II Diabetes and/or COVID-19,Observational Model: Cohort|Time Perspective: Prospective,2020-12-143,"Kadirhan Ozdemir, İzmir, Turkey",https://ClinicalTrials.gov/show/NCT04695158
NCT04563702,Safety and Immunogenicity Trial of an Oral SARS-CoV-2 Vaccine (VXA-CoV2-1) for Prevention of COVID-19 in Healthy Adults,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,VXA-COV2-101,"WCCT, Cypress, California, United States",https://ClinicalTrials.gov/show/NCT04563702
NCT04433871,COVID-19 in Pediatric Oncology and Hematology Centers in France,Observational Model: Cohort|Time Perspective: Prospective,20-065,"Jérémie Rouger-Gaudichon, Caen, France",https://ClinicalTrials.gov/show/NCT04433871
NCT04595097,Inspiratory Muscle Training in COVID-19 Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment",CNPQ092020,"Secretaria de Saúde do Distrito Federal, Brasilia, DF, Brazil",https://ClinicalTrials.gov/show/NCT04595097
NCT04466800,Functional and Respiratory Rehabilitation and Nutritional Care of COVID-19 Patients (RECOVER-19),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,35RC20_9875_RECOVER-19,"Hôtel Dieu Paris, Paris, France|Centre Hospitalier de Cornouaille, Quimper, France|CHU Rennes, Rennes, France|Centre Hospitalier de Saint-Brieuc, Saint-Brieuc, France|Centre Hospitalier Bretagne Atlantique, Vannes, France",https://ClinicalTrials.gov/show/NCT04466800
NCT04724850,Evolution of Coronavirus Disease 2019 (COVID-19) Patients in Extremadura,Observational Model: Cohort|Time Perspective: Other,1/2020,NA,https://ClinicalTrials.gov/show/NCT04724850
NCT04352803,Adipose Mesenchymal Cells for Abatement of SARS-CoV-2 Respiratory Compromise in COVID-19 Disease,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,COVID-MSCIV,NA,https://ClinicalTrials.gov/show/NCT04352803
NCT04858581,Prospective Clinical and Virological Analysis of Healthcare Workers Diagnosed Positive for Covid-19.,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,2020-A02720-39,"Hopital privé d'Antony, Paris, France",https://ClinicalTrials.gov/show/NCT04858581
NCT04842721,Effect of Hypertonic Saturated Saline Mouth Rinse on Covid-19 Virus in Vivo.,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,2,"Rafik Batroussy, Calgary, Alberta, Canada",https://ClinicalTrials.gov/show/NCT04842721
NCT04786353,Long COVID Kids DK - Investigating Long-term Covid-19,Observational Model: Cohort|Time Perspective: Other,Long COVID-19 Kids DK,NA,https://ClinicalTrials.gov/show/NCT04786353
NCT04729153,Impact of Previous Treatment of HCV Patients by DAADs on Covid-19 Disease Frequency and Severity,Observational Model: Case-Control|Time Perspective: Retrospective,DAADs and covid-19,NA,https://ClinicalTrials.gov/show/NCT04729153
NCT04530370,Efficacy and Safety of Recovered Covid 19 Plasma Transfusion to Covid 19 Severly Ill Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",ossamahamdyresearcher7,"South Valley University, Qinā, Egypt",https://ClinicalTrials.gov/show/NCT04530370
NCT04640038,Contrast Enhanced Ultrasound in COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,20-017501,"The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04640038
NCT04948203,Assessing the Efficacy of Sirolimus in Patients With COVID-19 Pneumonia for Prevention of Post-COVID Fibrosis,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,IRB21-0400,"University of Chicago, Chicago, Illinois, United States",https://ClinicalTrials.gov/show/NCT04948203
NCT04510194,"Outpatient Treatment of SARS-CoV-2 With Ivermectin, Fluvoxamine, and Metformin (COVID-19)","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",GIM-2020-29324,"Olive View UCLA Medical Center, Sylmar, California, United States|Anschutz Health and Wellness Center, Aurora, Colorado, United States|New West Physicians, Golden, Colorado, United States|Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States|American Health Network of Indiana, Greenfield, Indiana, United States|Hennepin County Medical Center, Minneapolis, Minnesota, United States|University of Minnesota, Minneapolis, Minnesota, United States",https://ClinicalTrials.gov/show/NCT04510194
NCT04530539,The Effect of Melatonin and Vitamin C on COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Supportive Care",2020-68,"Lancaster General Health, Lancaster, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04530539
NCT04679272,Prognostic Evaluation of COVID-19 in Rheumatoid Arthritis Patients,Observational Model: Cohort|Time Perspective: Retrospective,RECHMPL20_0682,"UH Montpellier, Montpellier, France",https://ClinicalTrials.gov/show/NCT04679272
NCT04468035,Early Cognitive Assessment and Evolutionary Monitoring of Patients With Severe ARDS on COVID-19 Pneumonia Requiring Mechanical Ventilation,Observational Model: Cohort|Time Perspective: Cross-Sectional,CognitiVID,"Groupe Hospitalier Paris Saint-Joseph, Paris, France",https://ClinicalTrials.gov/show/NCT04468035
NCT04338126,Tranexamic Acid (TXA) and Corona Virus 2019 (COVID19) in Inpatients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",TXACOVID2,"University of Alabama at Birmingham, Birmingham, Alabama, United States",https://ClinicalTrials.gov/show/NCT04338126
NCT04276896,Immunity and Safety of Covid-19 Synthetic Minigene Vaccine,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,GIMI-IRB-20001,"Shenzhen Geno-immune Medical Institute, Shenzhen, Guangdong, China|Shenzhen Second People's Hospital, Shenzhen, Guangdong, China|Shenzhen Third People's Hospital, Shenzhen, Guangdong, China",https://ClinicalTrials.gov/show/NCT04276896
NCT04802642,"Evaluation of COVID-19 Fear, Anxiety and Their Effects in Physiotherapy Technician Students",Observational Model: Other|Time Perspective: Cross-Sectional,2020/4/25,"Ufuk University, Ankara, Çankaya, Turkey",https://ClinicalTrials.gov/show/NCT04802642
NCT04830020,Use of Inhaled High-molecular Weight Hyaluronan in Patients With Severe COVID19: Feasibility and Outcomes,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,CampusBioMedico|1ZIDES102465,"Università Campus Biomedico di Roma, Roma, Italy",https://ClinicalTrials.gov/show/NCT04830020
NCT04775407,COVID-19 Serological Testing of Patients With a Mental Disorder From the Catchment Area of the Capital Region of Denmark,Observational Model: Cohort|Time Perspective: Prospective,COVID-19 RHP,"Psychiatric Centre Copenhagen, Copenhagen, Denmark",https://ClinicalTrials.gov/show/NCT04775407
NCT04913779,Study to Evaluate the Safety and Effectiveness of an Immunobiological Drug (Anti SARS-CoV-2) in the Treatment of CoViD-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",INPB001|PRIISA.BA 2578|RENIS IS003268|DI-2021-2196-APN-ANMAT#MS,"Hospital General de Agudos Donación Francisco J. Santojanni, Ciudad Autónoma De Buenos Aires, Argentina",https://ClinicalTrials.gov/show/NCT04913779
NCT04794400,The Application of a Mask in Patients With Severe Covid-19 Already Treated With High-flow Nasal Cannula.,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,2020-07078,"Skåne University Hospital, Malmö, Skåne, Sweden",https://ClinicalTrials.gov/show/NCT04794400
NCT04784481,Ivermectin Reproposing for Mild Stage COVID-19 Outpatients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,5077-410-CH2020,"SI.PRO.SA, Ministerio de Salud Pública, Tucumán, Argentina",https://ClinicalTrials.gov/show/NCT04784481
NCT04348305,Hydrocortisone for COVID-19 and Severe Hypoxia,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",RH-ITA-008|2020-001395-15,"Aarhus University Hospital - Dept of Intensive care, Aarhus, Denmark|Rigshospitalet, Copenhagen, Denmark|Dept of Infectious diseases, Rigshospitalet, Copenhagen, Denmark|Herlev Hospital - Dept. of Intensive Care, Herlev, Denmark|North Zealand Hospital, Hillerød, Denmark|Hvidovre Hospital - Dept of Infectious diseases, Hvidovre, Denmark|Hvidovre Hospital - Dept of Intensive Care, Hvidovre, Denmark|Hvidovre Hospital - Dept of Pulmonary Medicine, Hvidovre, Denmark|Kolding Hospital, Kolding, Denmark|Køge Hospital, Køge, Denmark|Dept of Intensive Care, Odense University Hospital, Odense, Denmark|Roskilde Hospital, Roskilde, Denmark|Slagelse Hospital, Slagelse, Denmark|Viborg Hospital, Viborg, Denmark",https://ClinicalTrials.gov/show/NCT04348305
NCT04401098,Changing Of Egyptian Population Behaviour Towards COVID 19 Outbreak,Observational Model: Other|Time Perspective: Prospective,covid 19,"Damanhour University, Damanhūr, Beheira, Egypt",https://ClinicalTrials.gov/show/NCT04401098
NCT04865107,Cellular Immuno-Therapy for COVID-19 ARDS Randomized Clinical Trial,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",CIRCA-19 RCT,"Lakeridge Health, Oshawa, Ontario, Canada|The Ottawa Hospital, Ottawa, Ontario, Canada|St. Michael's Hospital, Toronto, Ontario, Canada|Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada",https://ClinicalTrials.gov/show/NCT04865107
NCT04573634,A Registry Study of COVID-19 Serologic and Virologic Testing to Accelerate Recovery and Transition,Observational Model: Cohort|Time Perspective: Prospective,PHARM-20-COVID19-START,"University of Kentucky, Lexington, Kentucky, United States",https://ClinicalTrials.gov/show/NCT04573634
NCT04958681,Changes in Physical Activity Status: Comparison of Older Adults With Versus Without a History of Covid-19 Infection,Observational Model: Case-Control|Time Perspective: Cross-Sectional,2020-305,"Gulhane training and research hospital, Ankara, Turkey",https://ClinicalTrials.gov/show/NCT04958681
NCT04445337,Stellate Ganglion Blockade in COVID-19 Positive Patients,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,603.20.FB,NA,https://ClinicalTrials.gov/show/NCT04445337
NCT04365582,OUTpatient Treatment of COVID-19 in Patients With Risk Factor for Poor Outcome,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,OUTCOV,NA,https://ClinicalTrials.gov/show/NCT04365582
NCT04453670,Neuropathology in Adults Intensive Care Unit Patients With COVID 19,Observational Model: Case-Only|Time Perspective: Prospective,Obs2020,"Hôpital Raymond Poincaré, Garches, France",https://ClinicalTrials.gov/show/NCT04453670
NCT04377724,Spread and Course of COVID-19 Infections,Observational Model: Cohort|Time Perspective: Prospective,5月20日,"ETH, Zürich, Switzerland",https://ClinicalTrials.gov/show/NCT04377724
NCT04567810,"Safety, Tolerability, and Pharmacokinetics of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Chicken Egg Antibody (IgY) (COVID-19)","Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention",CVR001,"Linear Clinical Research - Harry Perkins Research Institute, Nedlands, Western Australia, Australia",https://ClinicalTrials.gov/show/NCT04567810
NCT04592055,The Effect of COVID-19 on Diabetes Mellitus,Observational Model: Case-Only|Time Perspective: Retrospective,UU-DM002,"Usak University Training and Research Hospital, Usak, Turkey",https://ClinicalTrials.gov/show/NCT04592055
NCT04479982,Microbial Infection and AMR in Hospitalized Patients With Covid 19,Observational Model: Other|Time Perspective: Prospective,Microbial infection with covid,"Assiut hopital, Assiut, Egypt",https://ClinicalTrials.gov/show/NCT04479982
NCT04853966,The Effects of Physical Activity Counseling on Physical Activity and Quality of Life in Covid-19 Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Supportive Care,219,"Gazi University, Ankara, Emek, Turkey",https://ClinicalTrials.gov/show/NCT04853966
NCT03376854,Pilot RCT of Therapeutic Hypothermia Plus Neuromuscular Blockade in COVID-19 Patients With ARDS,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,HP-00078506,"University of Maryland Medical Center, Baltimore, Maryland, United States",https://ClinicalTrials.gov/show/NCT03376854
NCT04401072,Attitude of Egyptian Population Toward COVID 19 in Ramadan,Observational Model: Other|Time Perspective: Prospective,covid 19 in ramadan,"Damanhour University, Damanhūr, Beheira, Egypt",https://ClinicalTrials.gov/show/NCT04401072
NCT04487990,CoV-Hep Study: Regional Anticoagulation Modalities in Continuous Venous Venous Hemodialysis in Patients With COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,U1111-1252-0194|33351120.0.0000.0068,"University of São Paulo General Hospital, São Paulo, SP, Brazil",https://ClinicalTrials.gov/show/NCT04487990
NCT04391686,Resting Energy Expenditure of the COronaVirus (COVID19) Patient in Reanimation Context,Observational Model: Cohort|Time Perspective: Other,20-Apr,"Arras general hospital, Arras, France",https://ClinicalTrials.gov/show/NCT04391686
NCT04531254,Back to School COVID-19 Simulation Study,Observational Model: Cohort|Time Perspective: Prospective,1000071861,"The Hospital for Sick Children, Toronto, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04531254
NCT04560530,The Role of CT Chest Scan in the Pre-anesthetic Assessment of Suspected or Confirmed COVID -19 Patients,Observational Model: Cohort|Time Perspective: Retrospective,chest CT scan in COVID-19,"Security Forces Hospital, Riyadh, Saudi Arabia",https://ClinicalTrials.gov/show/NCT04560530
NCT04902976,Evaluation of SARS-COV-2 Viral Load of Covid-19 Patients After Rinsing With Oral Antimicrobial Mouthwashes,"Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Supportive Care",4560-21,"Hospital israelita Albert Einstein, Sao Paulo, Brazil",https://ClinicalTrials.gov/show/NCT04902976
NCT04325646,Sero-epidemiological Study of the SARS-CoV-2 Virus Responsible for COVID-19 in France,Observational Model: Cohort|Time Perspective: Prospective,2020-007,"CHU Amiens-Picardie, Amiens, France|EHPAD Villa Concorde, Asnieres sur seine, France|CHU François Mitterand, Dijon, France|Centre Hospitalier Départemental de Vendée, La Roche-sur-Yon, France|CHU Limoges, Limoges, France|Hôpital de la Croix Rousse, Lyon, France|EHPAD Les Etangs, Mennecy, France|CHRU de Nancy, Nancy, France|Hôpitaux de Brabois, Nancy, France|CHR Orléans, Orléans, France|Institut Mutualiste, Paris, France|Institut Pasteur, Paris, France|EHPAD Villa Lecourbe, Paris, France|Hôpital la Pitié Salpetrière, Paris, France|CHU Poitiers, Poitiers, France|Hôpital Pontchaillou, Rennes, France|CHU Saint-Etienne, Saint-Étienne, France|CHRU de Strasbourg, Strasbourg, France|CH de Tourcoing, Tourcoing, France|Hôpital Bretonneau, Tours, France",https://ClinicalTrials.gov/show/NCT04325646
NCT04519411,Transpulmonary Pressure Measurements in Intubated Children With Covid-19 Respiratory Failure,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,20-003743,"Mayo Clinic in Rochester, Rochester, Minnesota, United States",https://ClinicalTrials.gov/show/NCT04519411
NCT04878900,Effects of COVID-19 in Chronic Pain,Observational Model: Other|Time Perspective: Cross-Sectional,2020/3/16,"Ufuk University, Ankara, Çankaya, Turkey",https://ClinicalTrials.gov/show/NCT04878900
NCT04363385,Collection of Biological Samples With Clinical Characterization of Covid-19 Patients,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,COVIGENET,"Centre hospitalier intercommunal de Créteil, Créteil, France",https://ClinicalTrials.gov/show/NCT04363385
NCT04696913,Does COVID-19 Infection Increase the Risk of Pulmonary Embolism?,Observational Model: Case-Control|Time Perspective: Retrospective,1-073-20,NA,https://ClinicalTrials.gov/show/NCT04696913
NCT04384614,Covid-19 In Tunisia: An Observational Cross-Sectional Registry Study,Observational Model: Other|Time Perspective: Cross-Sectional,ECC2020-07,"Eshmoun Clinical Research Centre, Tunis, Tunisia",https://ClinicalTrials.gov/show/NCT04384614
NCT04362111,Early Treatment of Cytokine Storm Syndrome in Covid-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",Chatham-Cytokine Covid-19,"University of Alabama at Birmingham, Birmingham, Alabama, United States",https://ClinicalTrials.gov/show/NCT04362111
NCT04579549,Repeat Testing for SARS-CoV-2,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,2020-1142|A536300|SMPH/PATHOL-LAB MED/ANAT PATH|Protocol Version 8/17/2020|5P51OD011106-59,"University of Wisconsin, Madison, Wisconsin, United States",https://ClinicalTrials.gov/show/NCT04579549
NCT04637906,Short and Long-term Effects of Adding Oral L-arginine to Standard Therapy in Patients With COVID-19 (SARS-CoV-2),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention",Bioarginina,"Azienda Ospedaliera Specialistica Dei Colli, Napoli, Italy",https://ClinicalTrials.gov/show/NCT04637906
NCT04806620,Comparison of ME/CFS and Long COVID-19 Patients,Observational Model: Cohort|Time Perspective: Prospective,1,"Solve ME/CFS Initiative, Los Angeles, California, United States",https://ClinicalTrials.gov/show/NCT04806620
NCT04716179,Prospective Two-arm Study of Fertility in Men With COVID-19,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science,COVID-MFert-20,"Sechenov University., Moscow, Russian Federation",https://ClinicalTrials.gov/show/NCT04716179
NCT04390464,mulTi-Arm Therapeutic Study in Pre-ICu Patients Admitted With Covid-19 - Repurposed Drugs (TACTIC-R),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,TACTIC-R,"Cambridge University Hospitals NHS Foundation Trust, Cambridge, Cambridgeshire, United Kingdom",https://ClinicalTrials.gov/show/NCT04390464
NCT04579393,Fostamatinib for Hospitalized Adults With COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",10000110|000110-H,"National Institutes of Health Clinical Center, Bethesda, Maryland, United States|INOVA Health Systems, Falls Church, Virginia, United States",https://ClinicalTrials.gov/show/NCT04579393
NCT04333862,Assessment of Covid-19 Infection Rates in Healthcare Workers Using a Desynchronization Strategy,Observational Model: Cohort|Time Perspective: Prospective,2020-00563,"Guido Beldi, Bern, Switzerland",https://ClinicalTrials.gov/show/NCT04333862
NCT04368156,Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,SAVIOR,"Hospital Clínico Universitario de Valencia, Valencia, Spain",https://ClinicalTrials.gov/show/NCT04368156
NCT04847622,Study to Evaluate the Clinical Outcomes in Adults With Covid-19 Who Have Been Treated With Remdesivir.,Observational Model: Cohort|Time Perspective: Retrospective,NEAT ID 909REM,"CHU de Nantes, Nantes, France|Hospital Lariboisiere, Paris, France|Hopital Saint-Louis, Paris, France|Tel Aviv Sourasky Medical Center, Tel Aviv, Israel|Erasmus Medical Center, Rotterdam, Netherlands|Hospital Germans Trias i Pujol, Barcelona, Spain|Hospital Clínic de Barcelona, Barcelona, Spain|Hospital Universitari Vall d'Herbon, Barcelona, Spain|Hospital Clinico Universitario San Carlos, Madrid, Spain|Hospital Universitario 12 de Octubre, Madrid, Spain|Royal Free Hospital, London, United Kingdom|Chelsea & Westminster Hospital, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04847622
NCT04551755,Safety and Efficacy of Ivermectin and Doxycycline in Treatment of Covid-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",31211062020,NA,https://ClinicalTrials.gov/show/NCT04551755
NCT04438694,Assessment of the Effect of Convalescent Plasma Therapy in Patients With Life-threatening COVID19 Infection,Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,N39-2020,"Cairo University Hospital, Cairo, Egypt",https://ClinicalTrials.gov/show/NCT04438694
NCT04623138,A Virtual Prospective Study Exploring Activity Trackers and COVID-19 Infections,Observational Model: Cohort|Time Perspective: Prospective,COVID Signals,NA,https://ClinicalTrials.gov/show/NCT04623138
NCT04751630,Effects of COVID-19 Hospitalization on Physical Performance,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,CBAS-21-22,NA,https://ClinicalTrials.gov/show/NCT04751630
NCT04532294,"Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Neutralizing Antibody in Healthy Participants","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Basic Science",BGB-DXP593-101,"Q Pharm Pty Limited, Herston, Queensland, Australia",https://ClinicalTrials.gov/show/NCT04532294
NCT04490824,Inhalation of KELEA Excellerated Water in Covid-19 Infected Individuals,Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,KELEA-1,"Institute of Progressive Medicine, South Pasadena, California, United States",https://ClinicalTrials.gov/show/NCT04490824
NCT04741282,Pulmonary Tele-rehabilitation and Progressive Muscle Relaxation on Discharged Covid-19 Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Supportive Care",18225,NA,https://ClinicalTrials.gov/show/NCT04741282
NCT04754594,"Study to Evaluate the Safety, Tolerability, and Immunogenicity of SARS CoV-2 RNA Vaccine Candidate (BNT162b2) Against COVID-19 in Healthy Pregnant Women 18 Years of Age and Older","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention",C4591015|2020-005444-35,"Children's of Alabama, Birmingham, Alabama, United States|University of Alabama at Birmingham Women & Infant Center, Birmingham, Alabama, United States|University of Alabama at Birmingham/Center for Women's Reproductive Health, Birmingham, Alabama, United States|MedPharmics, Mobile, Alabama, United States|Arrowhead Hospital, Glendale, Arizona, United States|Abrazo West Campus Hospital, Goodyear, Arizona, United States|St. Joseph Hospital, Phoenix, Arizona, United States|MedPharmics, LLC, Phoenix, Arizona, United States|Matrix Clinical Research., Huntington Park, California, United States|Matrix Clinical Research, Huntington Park, California, United States|Chemidox Clinical Trials Inc., Lancaster, California, United States|East LA Doctors Hospital, Los Angeles, California, United States|Matrix Clinical Research, Los Angeles, California, United States|Axcess Medical Research, Loxahatchee Groves, Florida, United States|Idaho Falls Pediatrics, Ammon, Idaho, United States|Bingham Memorial Hospital, Blackfoot, Idaho, United States|Idaho Falls Pediatrics, Idaho Falls, Idaho, United States|Clinical Research Prime, Idaho Falls, Idaho, United States|Eastern Idaho Regional Medical Center, Idaho Falls, Idaho, United States|Mountain View Hospital, Idaho Falls, Idaho, United States|Northwestern Medicine, Prentice Women's Hospital, Chicago, Illinois, United States|Northwestern Medicine, Chicago, Illinois, United States|Northwestern Memorial Hospital Clinical Research Unit, Chicago, Illinois, United States|Northwestern Memorial Hospital, Pharmacy, Chicago, Illinois, United States|Ann & Robert H Lurie Children's Hospital of Chicago, Lurie Children's Special Infectious Disease, Chicago, Illinois, United States|Covenant Healthcare, Saginaw, Michigan, United States|Saginaw Valley Medical Research Group, LLC, Saginaw, Michigan, United States|Community Hospital of Anaconda, Anaconda, Montana, United States|Boeson Research (BUT), Butte, Montana, United States|SCL St. James Healthcare Hospital, Butte, Montana, United States|Benefis Hospital, Great Falls, Montana, United States|Boeson Research (GTF), Great Falls, Montana, United States|Marcus Daly Memorial Hospital, Hamilton, Montana, United States|Boeson Research (HLN), Helena, Montana, United States|St. Peter's Health Hospital, Helena, Montana, United States|Providence St. Patrick Hospital, Missoula, Montana, United States|The Birth Center, Missoula, Montana, United States|Boeson Research, Missoula, Montana, United States|Community Medical Center, Missoula, Montana, United States|Community Physicians Group-Maternal Fetal Medicine, Missoula, Montana, United States|St. Luke Community Healthcare Hospital, Ronan, Montana, United States|Meridian Clinical Research, LLC, Hastings, Nebraska, United States|Meridian Clinical Research, LLC, Norfolk, Nebraska, United States|Allegheny Health and Wellness Pavilion, Erie, Pennsylvania, United States|OBGYN Associates of Erie, Erie, Pennsylvania, United States|Liberty Family Practice, Erie, Pennsylvania, United States|Saint Vincent Hospital, Erie, Pennsylvania, United States|Reading Hospital - Children's Health Center, West Reading, Pennsylvania, United States|Reading Hospital Clinical Trials Office, West Reading, Pennsylvania, United States|Reading Hospital-Family Health Care Center, West Reading, Pennsylvania, United States|Reading Hospital-Womens Health Center, West Reading, Pennsylvania, United States|Tower Health Medical Group-Maternal Fetal Medicine, West Reading, Pennsylvania, United States|Tekton Research, Inc., Austin, Texas, United States|Tekton Research, Inc., Austin, Texas, United States|Texas Health Harris Methodist Hospital Hurst-Euless-Bedford, Bedford, Texas, United States|Ventavia Research Group LLC, Dallas, Texas, United States|DHR Health Institute for Research and Development, Edinburg, Texas, United States|8th Avenue Obstetrics & Gynecology, Fort Worth, Texas, United States|Baylor Scott & White All Saints Medical Center, Fort Worth, Texas, United States|Ventavia Research Group, LLC, Fort Worth, Texas, United States|Dr. Ruben Aleman & Associates, McAllen, Texas, United States|Ventavia Research Group, LLC, Plano, Texas, United States|Ventavia Research Group, LLC, Weatherford, Texas, United States|Weatherford OBGYN, Weatherford, Texas, United States|University of Utah Hospital, Salt Lake City, Utah, United States|University of Utah, Salt Lake City, Utah, United States|The Group for Women- MAWC, Norfolk, Virginia, United States|Tidewater Physicians for Women- MAWC, Norfolk, Virginia, United States|Hospital das Clínicas da Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil|School of Medicine Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil|Hospital de Clinicas de Porto Alegre - HCPA, Porto Alegre, RIO Grande DO SUL, Brazil|Hospital Santa Casa de Misericordia de Sorocaba, Sorocaba, SAO Paulo, Brazil|Unimed Sorocaba-Hospital Dr. Miguel Soeiro (HMS), Sorocaba, SAO Paulo, Brazil|Clinica de Alergia Martti Antila S/S Ltda./ CMPC - Consultoria Medica e Pesquisa Clinica, Sorocaba, SP, Brazil|HMU SBC - Hospital Municipal Universitário de São Bernardo, São Bernardo do Campo, SÃO Paulo, Brazil|CEMEC - Centro Multidisciplinar de Estudos Clínicos, São Bernardo do Campo, SÃO Paulo, Brazil|WorthWhile Clinical Trials, Benoni, Gauteng, South Africa|Wits Reproductive Health and HIV Institute (Wits RHI) Shandukani Research Centre, Johannesburg, Gauteng, South Africa|Botho Ke Bontle Health Services, Pretoria, Gauteng, South Africa|Vaccines and Infectious Diseases Analytics (VIDA), Soweto, Gauteng, South Africa|Dr. TJ De Villiers, Cape Town, Western CAPE, South Africa|Tiervlei Trial Centre, Cape Town, Western CAPE, South Africa|Hospital Clínico Universitario Santiago de Compostela, Santiago de Compostela, A Coruna, Spain|Hospital Universitario HM Monteprincipe, Boadilla del Monte, Madrid, Spain|Hospital de Antequera, Antequera, Malaga, Spain|Hospital Universitari Vall d'Hebron, Barcelona, Spain|Hospital de la Santa Creu i Sant Pau, Barcelona, Spain|Hospital Madrid Puerta del Sur Mostoles, Mostoles, Spain|Hospital Quironsalud Sagrado Corazon, Sevilla, Spain|Instituto Hispalense de Pediatria- IHP1, Sevilla, Spain|St George's Vaccine Institute, London, Greater London, United Kingdom|Hampshire Research Hub, Royal South Hants Hospital, Southampton, Hampshire, United Kingdom|University Hospital Southampton NHS Foundation Trust, Southampton, Hampshire, United Kingdom|Medway NHS Foundation Trust, Gillingham, Kent, United Kingdom|St Mary's Hospital (Manchester University NHS Foundation Trust), Manchester, Lancashire, United Kingdom|Royal Infirmary of Edinburgh - NHS Lothian, Edinburgh, Midlothian, United Kingdom|Royal Hospital for Children and Young People, NHS Lothian, Edinburgh, Scotland, United Kingdom|Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom|St Thomas' Hospital - Guy's & St Thomas' NHS Foundation Trust, London, United Kingdom|King's College Hospital (King's College Hospital NHS Foundation Trust), London, United Kingdom|St George's University Hospitals NHS Foundation Trust, London, United Kingdom|University College London Hospitals NHS Foundation Trust, London, United Kingdom|University College London Hospitals, London, United Kingdom|Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom|John Radcliffe Hospital, Oxford, United Kingdom",https://ClinicalTrials.gov/show/NCT04754594
NCT04830683,Endothelial Dysfunction in Covid-19,Observational Model: Cohort|Time Perspective: Prospective,2020/27AVR/247,"Cliniques Universitaires Saint Luc, Brussels, Belgique, Belgium",https://ClinicalTrials.gov/show/NCT04830683
NCT04682873,A Clinical Study to Assess the Efficacy and Safety of Amizon® Max in the Treatment of Moderate Covid-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",FK/FAV00А-CoV/2020,"Municipal Enterprise ""Volyn Regional Clinical Hospital"" of Volyn Regional Council, Dept. Pulmonology, Lutsk, Volynsk, Ukraine|Municipal Non-Commercial Enterprise 'City Clinical Hospital #3' Chernivtsi City Council, Dept. Therapeutics #1, Dept. Therapeutics #2, Higher State Educational Institution of Ukraine 'Bukovinian State University', Chernivtsi, Ukraine|Municipal Non-Commercial Enterprise 'Regional Clinical Infection Hospital Ivano-Frankivsk Regional Council', Dept. #2, Ivano-Frankivsk National Medical University, Ivano-Frankivsk, Ukraine|Municipal Non-Commercial Enterprise 'Regional Clinical Hospital Ivano-Frankivsk Regional Council', Dept. Allergology, Ivano-Frankivsk, Ukraine|Municipal Non-Commercial Enterprise 'City Clinical Hospital #1 Ivano-Frankivsk City Council', Dept. Therapeutics, Ivano-Frankivsk, Ukraine|Municipal Non-Commercial Enterprise Kharkiv Regional Council 'Regional Clinical Infection Hospital', 1st Department, Kharkiv National Medical University, Chair of Infectious Diseases, Kharkiv, Ukraine|Municipal Non-Commercial Enterprise 'Olexandrivska Clinical Hospital of Kyiv' Executive Authority of Kyiv City Council, Dept. Infections, Kyiv, Ukraine|Municipal Non-Commercial Enterprise ""Kyiv City Clinical Hospital #9"" Executive Authority of Kyiv City Council, Dept. Infections, Kyiv, Ukraine|Municipal Non-Commercial Enterprise Lviv Regional Council 'Lviv Regional Infection Hospital', Fourth Diagnostic Department, Lviv, Ukraine|Ukraine Medical Stomatological Academy, Chair of Infectious Diseases with Epidemiology, Municipal Non-Commercial Enterprise 'Poltava Regional Infection Hospital Poltava Regional Council', Dept. Respiratory Infections, Poltava, Ukraine|Municipal Non-Commercial Enterprise 'Central Clinical Hospital' of Rivne City Council, Hepatic Centre - Infections, Rivne, Ukraine|Municipal Non-Commercial Enterprise 'Regional Clinical Infectional Hospital' Transcarpathian Regional Council, Dept. Infections (Adult), Uzhhorod, Ukraine|Municipal Non-Сommercial Enterprise 'Vinnytsya City Clinical Hospital #1', Infectious Department, National Pirogov Memorial Medical University, Dept. Infections, Vinnytsya, Ukraine",https://ClinicalTrials.gov/show/NCT04682873
NCT04871646,Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of CKD-314,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",A108_02CVD2105,"Korea University Guro Hospital, Seoul, Korea, Republic of",https://ClinicalTrials.gov/show/NCT04871646
NCT04445376,Effect of Physical Therapy Exercises on Cardiorespiratory Fitness Level in COVID19 Patients After Recovery.,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,313,"Bin Inam Rehabilitation Center., Faisalābad, Punjab, Pakistan",https://ClinicalTrials.gov/show/NCT04445376
NCT04377503,Tocilizumab Versus Methylprednisolone in the Cytokine Release Syndrome of Patients With COVID-19,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,covid-19 hsd,NA,https://ClinicalTrials.gov/show/NCT04377503
NCT04764721,Characterization in 18F-FDG PET-CT of Brain and Lung Lesions in Subjects With a History of Severe COVID,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,A2021-01-01,NA,https://ClinicalTrials.gov/show/NCT04764721
NCT04743232,COVID-19 Resuscitation Plans and Decisions on Escalation and Limitation of Treatment,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Screening,NL76435,"OLVG, Amsterdam, Noord-Holland, Netherlands|Maasstad Ziekenhuis, Rotterdam, Zuid-Holland, Netherlands|Amsterdam UMC, Amsterdam, Netherlands|Rijnstate, Arnhem, Netherlands|Medisch Spectrum Twente, Enschede, Netherlands|Radboud UMC, Nijmegen, Netherlands|Erasmus MC, Rotterdam, Netherlands",https://ClinicalTrials.gov/show/NCT04743232
NCT04298814,Safety Related Factors of Endotracheal Intubation in Patients With Severe Covid-19 Pneumonia,Observational Model: Case-Only|Time Perspective: Prospective,COVEI,"Tongji Hospital, Wuhan, Hubei, China",https://ClinicalTrials.gov/show/NCT04298814
NCT04681755,Rehabilitation Required Due to Clinical Disorders After Severe Covid-19 Infection,Observational Model: Case-Only|Time Perspective: Retrospective,7725,"Strasbourg University Hospitals - Anesthesia and surgical resuscitation service, Strasbourg, France",https://ClinicalTrials.gov/show/NCT04681755
NCT04910295,Immunogenicity and Safety of COVID-19 Vaccine in Cancer Patients,Observational Model: Cohort|Time Perspective: Prospective,H-2013-121-1206,"Seoul National University Hospital, Seoul, Korea, Republic of",https://ClinicalTrials.gov/show/NCT04910295
NCT04864561,"Study To Compare The Immunogenicity Against COVID-19, Of VLA2001 Vaccine To AZD1222 Vaccine","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",VLA2001-301,"Barnsley Hospital NHS FT, Barnsley, United Kingdom|University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom|Blackpool Teaching Hospitals NHS Foundation Trust, Blackpool, United Kingdom|North Bristol NHS Trust, Bristol, United Kingdom|University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, United Kingdom|Cambridge Biomedical Research Centre, Cambridge, United Kingdom|Cheadle Community Hospital, Cheadle, United Kingdom|University Hospitals Coventry & Warwickshire, Coventry, United Kingdom|Western General Hospital, Edinburgh - NHS Lothian, Edinburgh, United Kingdom|Queen Elizabeth University Hospital-Glasgow- NHS Greater Glasgow, Glasgow, United Kingdom|Royal Surrey County Hospital NHS Foundation Trust, Guildford, United Kingdom|NHS Foundation Trust Royal Liverpool University Hospital, Liverpool, United Kingdom|Panthera London, London, United Kingdom|Royal Free London NHS Foundation Trust, London, United Kingdom|Chelsea and Westminster Hospital NHS Trust, London, United Kingdom|St George's University Hospitals NHS Foundation Trust, London, United Kingdom|NIHR UCLH Clinical Research Facility, London, United Kingdom|The Newcastle upon Tyne Hospitals NHS Foundation Trust, Freeman Hospital Newcastle, Newcastle, United Kingdom|Northumbria Healthcare NHS Foundation Trust - North Tyneside General Hospital, North Shields, United Kingdom|Lakeside Healthcare Research, Northampton, United Kingdom|Nottingham University Hospitals NHS Trus, Nottingham, United Kingdom|University Hospital Plymouth NHS Trust, Plymouth, United Kingdom|Panthera Biopartners Preston, Preston, United Kingdom|Panthera Biopartners Manchester, Rochdale, United Kingdom|Northern Care Alliance NHS Group, Salford Royal NHS Foundation Trust, Salford, United Kingdom|Southampton University Hospitals NHS Trust, Southampton, United Kingdom",https://ClinicalTrials.gov/show/NCT04864561
NCT04359537,Efficacy of Various Doses of Hydroxychloroquine in Pre-Exposure Prophylaxis for COVID 19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Prevention,F.1-1/2015/ERB/SZABMU/549,"Shaheed Zulfiaqar Ali Bhutto Medical University, Islamabad, Federal Capital, Pakistan",https://ClinicalTrials.gov/show/NCT04359537
NCT04747574,Evaluation of the Safety of CD24-Exosomes in Patients With COVID-19 Infection,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,0254-20-TLV,"Tel Aviv Medical Center, Tel Aviv, Israel",https://ClinicalTrials.gov/show/NCT04747574
NCT04364737,CONTAIN COVID-19: Convalescent Plasma to Limit COVID-19 Complications in Hospitalized Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",20-00541,"Yale University School of Medicine, New Haven, Connecticut, United States|University of Miami Hospital and Clinics, Miami, Florida, United States|Montefiore Medical Center, Bronx, New York, United States|NYU Langone Health, New York, New York, United States|University of Texas Rio Grande Valley, Edinburg, Texas, United States|The University of Texas Health Science Center, Houston, Texas, United States|The University of Texas Health Science Center, Tyler, Texas, United States|Aurora St. Luke's Medical Center, Milwaukee, Wisconsin, United States|Medical College of Wisconsin / Froedtert Memorial Lutheran Hospital, Milwaukee, Wisconsin, United States",https://ClinicalTrials.gov/show/NCT04364737
NCT04438863,Daily Home Spirometry for Early Detection of Pulmonary Complications in Patients With COVID19,Observational Model: Cohort|Time Perspective: Prospective,SHEBA-20-7022-SMC-LL-CTIL,"Sheba Medical Center, Ramat Gan, Israel",https://ClinicalTrials.gov/show/NCT04438863
NCT04335097,Sensor Based Vital Signs Monitoring of Covid 19 Patients During Home Isolation,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,127157,"Lillestrom legevakt, Lillestrom, Norway",https://ClinicalTrials.gov/show/NCT04335097
NCT04397796,Study of the Safety of Therapeutic Tx With Immunomodulatory MSC in Adults With COVID-19 Infection Requiring Mechanical Ventilation,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",QUILT-COVID-19-MSC,"St. Francis Medical Center, Lynwood, California, United States",https://ClinicalTrials.gov/show/NCT04397796
NCT04732663,Understanding Exertional Dyspnea and Exercise Intolerance in COVID-19,Observational Model: Case-Control|Time Perspective: Cross-Sectional,Pro00107436,"Clinical Physiology Laboratory, Edmonton, Alberta, Canada",https://ClinicalTrials.gov/show/NCT04732663
NCT04647656,Hyperbaric Oxygen Therapy for Post-COVID-19 Syndrome,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",332-20-ASF,"Assaf-Harofeh medical center, Zerifin, Israel",https://ClinicalTrials.gov/show/NCT04647656
NCT04659356,NOSOcomial COVID-19 in ICU (NOSOCOVID),Observational Model: Cohort|Time Perspective: Prospective,MR_NOSOCOVID,"Nantes University Hospital, Nantes, France",https://ClinicalTrials.gov/show/NCT04659356
NCT04647747,Silent Hypoxia and Awake Proning in COVID-19 Patients,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,SHYCOV2020,"Ostfold Hospital, Sarpsborg, Grålum, Norway",https://ClinicalTrials.gov/show/NCT04647747
NCT04743401,Feasibility of a Tele-game-based Exercise (Tele-exergame) Program to Prevent Deconditioning in Hospitalized COVID-19 Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,F3731-P|42402,"Michael E. DeBakey VA Medical Center, Houston, TX, Houston, Texas, United States",https://ClinicalTrials.gov/show/NCT04743401
NCT04771559,Evaluation of the Effect and Side Effect Profile of Covid-19 Vaccine in Cancer Patients,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,132620,"Bezmialem University, Istanbul, Fatih, Turkey|Okmeydani Research Hospital, Istanbul, Fatih, Turkey|Acibadem University, Istanbul, Turkey|Medeniyet University, Istanbul, Turkey|Medipol University, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04771559
NCT04627194,Characteristics of COVID-19 Patients in Kazakhstan in Early 2020,Observational Model: Cohort|Time Perspective: Retrospective,76.29.31_48.04.06-01,"Semey Medical University, Semey, East Kazakhstan, Kazakhstan",https://ClinicalTrials.gov/show/NCT04627194
NCT04567576,Predictive Factors for COVID-19 in Rheumatology,Observational Model: Cohort|Time Perspective: Prospective,FPColCOVIDReuma2020,NA,https://ClinicalTrials.gov/show/NCT04567576
NCT04575545,Prevalence of COVID-19 Infection in a Cohort of Patients Infected by the HIV and Patients Taking PrEP,Observational Model: Cohort|Time Perspective: Prospective,2020-A02018-31,"BENNANI, Marseille, France",https://ClinicalTrials.gov/show/NCT04575545
NCT04583189,Evaluation of the Performance of the Covid-19 Ag BSS Rapid Antigenic Test in Symptomatic Children in a Pediatric Emergency Department,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,SPEEDYCOVI,"Centre hospitalier intercommunal de Créteil, Créteil, France|Cabinet de ville, Nogent sur Marne, France|Cabinet Dr Cohen, Saint-Maur-des-Fossés, France|Cabinet de ville 13 Villa Beauséjour, Vincennes, France",https://ClinicalTrials.gov/show/NCT04583189
NCT04422340,Senior-COVID-Rea Multicentric Survey,Observational Model: Cohort|Time Perspective: Other,69HCL20_0386,"Resuscitation unit at Hospital Emile Roux, Le Puy-en-Velay, France|- Resuscitation unit of the Groupement Hospitalier Nord - Hospices Civils de Lyon, Lyon, France|- Resuscitation unit of the Groupement Hospitalier Sud - Hospices Civils de Lyon, Lyon, France|Resuscitation unit of the Groupement Hospitalier Centre - Hospices Civils de Lyon, Lyon, France|Resuscitation unit of the Groupement Hospitalier Sud - Hospices Civils de Lyon, Lyon, France|Service de Réanimation de l'Hôpital Nord Ouest, Villefranche-sur-Saône, France|Medipole Resuscitation unit, Villeurbanne, France",https://ClinicalTrials.gov/show/NCT04422340
NCT04381871,Potential Role of Gum Arabic as Immunomodulatory Agent Among COVID 19 Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",GA& COVID19,"Omdurman Teaching Hospital, Khartoum, Omdurman, Sudan|Jabra Hospital,, Khartoum, Sudan",https://ClinicalTrials.gov/show/NCT04381871
NCT04778033,Semen Analysis Parameters Following Pfizer's COVID-19 Vaccine,Observational Model: Cohort|Time Perspective: Prospective,SHEBA - 21 - 8079- JH - CTIL,"Sheba medical center, Ramat Gan, Israel",https://ClinicalTrials.gov/show/NCT04778033
NCT04389801,Use of Desferal for Prevention of ARDS in Hospitalised Cases Documented With Covid 19 Infection,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,12,NA,https://ClinicalTrials.gov/show/NCT04389801
NCT04513210,Reliability of Standardized Protocol of Ultrasound of the Lungs in Prediction of Severity of Covid-19 Infection,Observational Model: Case-Control|Time Perspective: Prospective,JagiellonianU67,"Jagiellonian University Medical College, Department of Neurology, Kraków, Poland",https://ClinicalTrials.gov/show/NCT04513210
NCT04873336,Closed Loop Ventilation in Patients With COVID-19,Observational Model: Cohort|Time Perspective: Prospective,IGHCEAH-ICU-5,"1University of Health Sciences Turkey, Dr Suat Seren Chest Diseases and Chest Surgery Training and Research Hospital, Intensive Care Unit, İzmir, Turkey",https://ClinicalTrials.gov/show/NCT04873336
NCT04677283,"Study of Symptoms Linked to Covid-19 in Residents and Professionals in EHPAD, Associated With a Dual Diagnostic Approach by PCR and Serology: a Cohort in Île-de-France.",Observational Model: Cohort|Time Perspective: Retrospective,2020-A01027-32,"Autonomy Department; ARS Île-de-France, Paris, ARS Île-de-France, France",https://ClinicalTrials.gov/show/NCT04677283
NCT04834115,Efficacy of Ivermectin in Outpatients With Non-severe COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",PINV20-387,"Facultad de Ciencias Médicas - Universidad Nacional de Asunción, Asunción, Paraguay",https://ClinicalTrials.gov/show/NCT04834115
NCT04365959,The Prone Position in Covid-19 Affected Patients,Observational Model: Case-Only|Time Perspective: Prospective,PRON-COVID,"ASST Monza, Monza, MB, Italy",https://ClinicalTrials.gov/show/NCT04365959
NCT04604223,Effect of Pioglitazone on T2DM Patients With COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",RA HM-2020- 011,"Al-Amiri Hospital, Kuwait City, (Pick From List), Kuwait|Jaber Al Ahmad Al Sabah Hospital, Kuwait City, (Pick From List), Kuwait|Mishrif Field Hospital, Kuwait City, (Pick From List), Kuwait|Mubarak Al-Kabeer Hospital, Kuwait City, (Pick From List), Kuwait|Hamad Medical Corporation, Doha, Qatar",https://ClinicalTrials.gov/show/NCT04604223
NCT04501965,Phytomedicines Versus Hydroxychloroquine as an Add on Therapy to Azythromycin in Asymptomatic Covid-19 Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,IRDPMAG,"Support Centers of Donka, Kenien and Gbessia, Conakry, Guinea",https://ClinicalTrials.gov/show/NCT04501965
NCT04398147,Phase I/II Clinical Trial of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) in Canada,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",Ad5-nCoV-2020003,"Canadian Center for Vaccinology, Halifax, Canada",https://ClinicalTrials.gov/show/NCT04398147
NCT04377334,Mesenchymal Stem Cells (MSCs) in Inflammation-Resolution Programs of Coronavirus Disease 2019 (COVID-19) Induced Acute Respiratory Distress Syndrome (ARDS),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,RESCOVID,"University Hospital Tuebingen, Tuebingen, Germany",https://ClinicalTrials.gov/show/NCT04377334
NCT04695197,Malaria as a Risk Factor for COVID-19 in Western Kenya and Burkina Faso,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,20-063|202009642148520,"Ouagadougou Hospitals, Ouagadougou, Burkina Faso|Kisumu County Referral Hospital, Kisumu, Kenya",https://ClinicalTrials.gov/show/NCT04695197
NCT04465981,Investigation of Antibody and Immune Responses to SARS-CoV-2 Proteins,Observational Model: Cohort|Time Perspective: Other,INANO-CV1,"TMC HealthCare, Tucson, Arizona, United States",https://ClinicalTrials.gov/show/NCT04465981
NCT04354610,Cardiovascular and Renal Biomarkers to Predict Acute Heart or Kidney Injury in Severe Covid-19 Infection,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,2020PI072,"CHRU de Nancy, Nancy, France|CHRU de Nancy, Vandœuvre-lès-Nancy, France",https://ClinicalTrials.gov/show/NCT04354610
NCT04948242,Characteristics of Critically Ill Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection (COVID-19),Observational Model: Cohort|Time Perspective: Prospective,COVID-19/SEMICYUC,"Hospital Universitario de Tarragona Joan XXIII, Tarragona, Spain",https://ClinicalTrials.gov/show/NCT04948242
NCT04745923,Physical Activity Level in Patients With Chronic Kidney Disease During COVID-19 Pandemic,Observational Model: Case-Control|Time Perspective: Prospective,GO 21/127,"Hacettepe University, Faculty of Physical Therapy and Rehabilitation, Ankara, Turkey",https://ClinicalTrials.gov/show/NCT04745923
NCT04695756,Liver Transplantation and Coronavirus Disease 2019 (COVID-19),Observational Model: Ecologic or Community|Time Perspective: Retrospective,1405,"Hospital Italiano de Buenos Aires, Buenos Aires, Argentina",https://ClinicalTrials.gov/show/NCT04695756
NCT04642326,Study Investigating the Effects of UVC Beam and Laser Beam Therapy According to Standard Therapy in Patients With Covid-19 Diagnosis,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,MD2020/001,"Diyarbakır SBÜ Gazi Yaşargil Eğitim Ve Araştırma Hastanesi, Diyarbakır, Kayapınar, Turkey",https://ClinicalTrials.gov/show/NCT04642326
NCT04371471,Covid-19 Pandemic Triage Score,Observational Model: Cohort|Time Perspective: Retrospective,2020/P04/288,"Groupe Hospitalier de la Rochelle Ré Aunis, La Rochelle, France",https://ClinicalTrials.gov/show/NCT04371471
NCT04424056,"A Trial Using ANAKINRA, TOCILIZUMAB Alone or in Association With RUXOLITINIB in Severe Stage 2b and 3 of COVID19-associated Disease",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2020-23,"Assistance Publique Hôpitaux de Marseille, Marseille, France",https://ClinicalTrials.gov/show/NCT04424056
NCT04411446,Cholecalciferol to Improve the Outcomes of COVID-19 Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",1,"Hospital de Alta Complejidad en Red El Cruce, Florencio Varela, Buenos Aires, Argentina",https://ClinicalTrials.gov/show/NCT04411446
NCT04375644,Impact of the COVID-19 Pandemic on the Quality of Psychological Life (COVID-PRO-IMPACT),Observational Model: Cohort|Time Perspective: Prospective,69HCL20_0413,"Gynécologie-Obstétrique CHU de Angers, Angers, France|Gynécologie-Obstétrique Hôpital Pellegrin, Bordeaux, France|Gynécologie-Obstétrique CHRU de Brest, Brest, France|Gynaecology Department, Hôpital Femme Mère Enfant, Hospices Civils de Lyon, Bron, France|Gynécologie-Obstétrique Hôpital Antoine Béclère (APHP), Clamart, France|Gynécologie-Obstétrique CHU Grenoble-Alpes, Hôpital Couple Enfant, La Tronche, France|Gynécologie-Obstétrique Hôpital BICETRE (APHP), Le Kremlin-Bicêtre, France|Gynécologie-Obstétrique Hôpital Jeanne de Flandre - CHRU Lille, Lille, France|Gynécologie-Obstétrique Hôpital de la Mère et de l'Enfant, Limoges, France|Gynécologie-Obstétrique Hôpital de la Croix Rousse, Lyon, France|Gynécologie-Obstétrique Hôpital La Conception, Marseille, France|Gynécologie-Obstétrique Hôpital de la Pitié Salpêtrière (APHP), Paris, France|Gynécologie-Obstétrique Maternité Port-Royal, Groupe Hospitalier Cochin-Broca- Hotel Dieu (APHP), Paris, France|Gynécologie-Obstétrique CHU de Poitiers, Poitiers, France|Gynécologie-Obstétrique CHU Reims - Institut Mère Enfant Alix de Champagne, Reims, France|Gynécologie-Obstétrique CHU de Rennes, Rennes, France|Gynécologie-Obstétrique CHU de Saint Etienne, Saint-Étienne, France|Gynécologie-Obstétrique Hôpital de Hautepierre, Strasbourg, France",https://ClinicalTrials.gov/show/NCT04375644
NCT04681157,Retrospective Study on Anosmias and Ageusias Linked to Infection by Covid-19,Observational Model: Case-Only|Time Perspective: Retrospective,7754,"Strasbourg University Hospitals - Otorhino-Laryngology Department, Strasbourg, Starsbourg, France",https://ClinicalTrials.gov/show/NCT04681157
NCT04522830,A Study in Adults to Test the Effects of Low Dose Thimerosal on Symptoms of COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",2020-04-0311,"Intermountain Clinical Reserach, Draper, Utah, United States",https://ClinicalTrials.gov/show/NCT04522830
NCT04395456,A Study of the C3 Inhibitor AMY-101 in Patients With ARDS Due to COVID-19 (SAVE),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,AMY-101_SAVE,NA,https://ClinicalTrials.gov/show/NCT04395456
NCT04828629,Complications and the Influence of COVID-19 on Myocardial Function and Exercise Capacity,Observational Model: Other|Time Perspective: Prospective,PMMHRI-BCO.75/2020,"Heart Failure Unit; Department of Cardiology and Congenital Diseases of Adults, Polish Mother's Memorial Hospital Research Institute, Łódź, Polska, Poland",https://ClinicalTrials.gov/show/NCT04828629
NCT04809948,Effects of COVID 19 Vaccine on Egyptian Population,Observational Model: Other|Time Perspective: Prospective,COVID 19 Vaccine,NA,https://ClinicalTrials.gov/show/NCT04809948
NCT04588792,Furosemide as Supportive Therapy for COVID-19 Respiratory Failure,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",FaST-1,"University of Alberta, Edmonton, Alberta, Canada|Dalhousie University, Halifax, Nova Scotia, Canada|Kingston Health Sciences Center, Kingston, Ontario, Canada|Hôpital Maisonneuve-Rosemont, Montréal, Quebec, Canada",https://ClinicalTrials.gov/show/NCT04588792
NCT04854980,Serologic Response to the SARS-CoV-2 (COVID-19) mRNA-1273 Vaccine in Select Subsets of Oncology Patients,Observational Model: Other|Time Perspective: Prospective,UMLT21037,"University of Rochester, Rochester, New York, United States",https://ClinicalTrials.gov/show/NCT04854980
NCT04590222,Impact of a Monoamine Oxidase Inhibitor on the Phenotype of Blood Mononucleated Cells in Patients With COVID-19,Observational Model: Case-Control|Time Perspective: Prospective,APHP200989|2020-A02398-31,"CHU Bicêtre, Le Kremlin-Bicêtre, France",https://ClinicalTrials.gov/show/NCT04590222
NCT04535154,Patient-reported Outcomes and Lung Function After Hospitalization for COVID-19,Observational Model: Cohort|Time Perspective: Prospective,PROLUN,"Dept Pulmonary Medicine, Lørenskog, Viken, Norway",https://ClinicalTrials.gov/show/NCT04535154
NCT04872738,Patient Experiences With the COVID-19 Vaccination After Breast Cancer Treatment,Observational Model: Cohort|Time Perspective: Prospective,21-528,"Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT04872738
NCT04753476,Treatment of Severe COVID-19 Patients Using Secretome of Hypoxia-Mesenchymal Stem Cells in Indonesia,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,SCCR_Secretome,"RSUD Bantul, Bantul, Central Java, Indonesia|RS PKU Muhammadiyah Gamping, Yogyakarta, Central Java, Indonesia|RS Primaya Bekasi Timur, Bekasi, Jakarta, Indonesia|Bhayangkara Hospital, Makassar, South Celebes, Indonesia|Gatot Soebroto Army Hospital, Jakarta, Indonesia|Dr. Esnawan Antariksa Air Force Hospital, Jakarta, Indonesia",https://ClinicalTrials.gov/show/NCT04753476
NCT04600440,Convalescent Plasma in the Treatment of Covid-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,Covid convalescent plasma,"Skåne University Hospital, Lund, Sweden",https://ClinicalTrials.gov/show/NCT04600440
NCT04730206,The DAWN Camostat Trial for Ambulatory COVID-19 Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",S64445,"KU Leuven, Leuven, Belgium",https://ClinicalTrials.gov/show/NCT04730206
NCT04401228,Predictive Models for Intensive Care Admission and Death of COVID-19,Observational Model: Cohort|Time Perspective: Retrospective,410508057,"Clinique Saint-Pierre, Ottignies, Brabant Wallon, Belgium",https://ClinicalTrials.gov/show/NCT04401228
NCT04681859,Evaluation of a Low-cost CPAP Device on Hospitalized COVID-19 Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,BME-BUET-003,"Dhaka Medical College, Dhaka, Bangladesh",https://ClinicalTrials.gov/show/NCT04681859
NCT04932967,Use of nMoABs for the Treatment of COVID-19 in Patients With HM.,Observational Model: Case-Only|Time Perspective: Retrospective,EMATO0321,NA,https://ClinicalTrials.gov/show/NCT04932967
NCT04780334,Rapid Detection of COVID-19 by Portable and Connected Biosensor : Biological Proof of Concept,Observational Model: Case-Control|Time Perspective: Prospective,2021_0063|2021-A00387-34,NA,https://ClinicalTrials.gov/show/NCT04780334
NCT04944147,Cognitive Training and Brain Stimulation in Patients With Post-COVID19 Cognitive Impairment,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",Neuromod-COV,"University Medicine Greifswald, Greifswald, Germany",https://ClinicalTrials.gov/show/NCT04944147
NCT04871776,Use of Construal Level Theory to Inform Messaging to Increase Vaccination Against COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Health Services Research,2021P001308,NA,https://ClinicalTrials.gov/show/NCT04871776
NCT04591704,The Effect of Diabetes Mellitus on the Prognosis of Patients With COVID-19,Observational Model: Case-Control|Time Perspective: Retrospective,UU-DM003,"Usak University Training and Research Hospital, Usak, Turkey",https://ClinicalTrials.gov/show/NCT04591704
NCT04874818,CD8+ T-cell PET/CT Imaging in COVID-19 Patients,Observational Model: Cohort|Time Perspective: Prospective,NL76248.091.20|2020-005984-29,NA,https://ClinicalTrials.gov/show/NCT04874818
NCT04578236,"Efficacy of Aerosol Combination Therapy of 13 Cis Retinoic Acid and Captopril for Treating Covid-19 Patients Via Indirect Inhibition of Transmembrane Protease, Serine 2 (TMPRSS2)",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,SARS,NA,https://ClinicalTrials.gov/show/NCT04578236
NCT04547283,Awake-Prone Positioning Strategy for Hypoxic Patients With COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,06-20-03E,"Carolinas Medical Center, Charlotte, North Carolina, United States",https://ClinicalTrials.gov/show/NCT04547283
NCT04525287,Prediction Models for Diagnosis and Prognosis of Severe COVID-19,Observational Model: Case-Crossover|Time Perspective: Cross-Sectional,2020-12020001231,"2nd Affiliated Hospital, School of Medicine, Zhejiang University, China, Hangzhou, Zhejiang, China",https://ClinicalTrials.gov/show/NCT04525287
NCT04695821,Feasibility of Remote Evaluation and Monitoring of Acoustic Pathophysiological Signals With External Sensor Technology in Covid-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Device Feasibility,Senti-REMAP-WEST-COV-1,"Senti Tech, Liverpool, Merseyside, United Kingdom",https://ClinicalTrials.gov/show/NCT04695821
NCT04351490,Impact of Zinc and Vitamin D3 Supplementation on the Survival of Aged Patients Infected With COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2020_30|2020-A00873-36,NA,https://ClinicalTrials.gov/show/NCT04351490
NCT04403477,Convalescent Plasma Therapy in Severe COVID-19 Infection,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,BSMMU/2020/6104,"Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh",https://ClinicalTrials.gov/show/NCT04403477
NCT04412369,Multi-modality Imaging & Immunophenotyping of COVID-19 Related Myocardial Injury,Observational Model: Case-Only|Time Perspective: Prospective,A09565,"Cambridge Univeristy Hospitals NHS Foundation Trust, Cambridge, United Kingdom",https://ClinicalTrials.gov/show/NCT04412369
NCT04628000,Baseline Vitamin D Deficiency and COVID-19 Disease Severity,Observational Model: Cohort|Time Perspective: Retrospective,PIRB78,"Parkview Medical Center, Pueblo, Colorado, United States",https://ClinicalTrials.gov/show/NCT04628000
NCT04598620,Non-invasive Prognostication of COVID-19 Patients by Use of Biomarkers in Exhaled Breath Condensate,Observational Model: Case-Only|Time Perspective: Prospective,ILG-VTE-COVID-19-2020|N-20200069,"Aalborg Hospital, Aalborg, Denmark",https://ClinicalTrials.gov/show/NCT04598620
NCT04371029,Impact of Neck Inspiratory Muscle Activation During Sleep in ICU Patients After a COVID 19 ARDS,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,CHUBX 2020/14,"Hopital Pellegrin, Bordeaux, France",https://ClinicalTrials.gov/show/NCT04371029
NCT04823234,Lung Ultrasound Signs and Patterns in COVID-19 Pregnant Women,Observational Model: Cohort|Time Perspective: Retrospective,CEUR-2021-223,"Anesthesiology and Intensive Care Clinic - Department of Medicine - ASUIUD, Udine, Italy",https://ClinicalTrials.gov/show/NCT04823234
NCT04817553,Impact of COVID-19 on the Clinical Outcomes and Management of IgG4 Related Disease Patients,Observational Model: Cohort|Time Perspective: Retrospective,IgG4-COVID,"Prince of Wales Hospital, The Chinese University of Hong Kong, Sha Tin, New Territories, Hong Kong",https://ClinicalTrials.gov/show/NCT04817553
NCT04595136,Study to Evaluate the Efficacy of COVID19-0001-USR in Patients With Mild/or Moderate COVID-19 Infection in Outpatient,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",COVID19-0001-USR,"Cimedical, Barranquilla, Atlantico, Colombia",https://ClinicalTrials.gov/show/NCT04595136
NCT04349540,Role of Immune and Inflammatory Response in Recipients of Allogeneic Haematopoietic Stem Cell Transplantation (SCT) Affected by Severe COVID19,Observational Model: Case-Only|Time Perspective: Prospective,20BO08,"Great Ormond Street Hospital NHS Foundation Trust, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04349540
NCT04622748,Neurocognitive Functions of Recovered COVID-19 Patients,Observational Model: Case-Control|Time Perspective: Cross-Sectional,NIDD-2020-Neurocognition,"Wuhan Wuchang Hospital, Wuhan, Hubei, China",https://ClinicalTrials.gov/show/NCT04622748
NCT04953091,Evaluation of the Sofia SARS Antigen FIA Assay for COVID-19,Observational Model: Cohort|Time Perspective: Prospective,ESADEC ( 29BRC21.0117),"Centre de dépistage - CHRU BREST, Brest, France|CHRU de brest, Brest, France",https://ClinicalTrials.gov/show/NCT04953091
NCT04708158,Novaferon for COVID-19 Treatment Trial (NCTT-005),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",JH-COR-005,NA,https://ClinicalTrials.gov/show/NCT04708158
NCT04581018,An Evaluation of a Synbiotic Formula for Patients With COVID-19 Infection,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,Synbiotic COV study,"The Chinese University of Hong Kong, Sha Tin, Hong Kong",https://ClinicalTrials.gov/show/NCT04581018
NCT04372472,SQuISH-COVID: A Pilot Study,Observational Model: Cohort|Time Perspective: Prospective,CV-CLN-003,"Our Lady of the Lake Regional Medical Center, Baton Rouge, Louisiana, United States",https://ClinicalTrials.gov/show/NCT04372472
NCT04537299,COVID-FIS: Pilot in COVID-19 (SARS-CoV-2) of Fisetin in Older Adults in Nursing Homes,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",20-008867|1R01AG072301-01,"Mayo Clinic, Rochester, Minnesota, United States",https://ClinicalTrials.gov/show/NCT04537299
NCT04930965,Impact of LA-CEAL HALT COVID-19 Ambassador Program on Likelihood to Vaccinate,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,2020-1600,NA,https://ClinicalTrials.gov/show/NCT04930965
NCT04712045,Rational Use of Personal Protective Equipment During COVID-19 Pandemic,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,IRAS287865,"Professor Peter McCulloch, Oxford, Oxfordshire, United Kingdom",https://ClinicalTrials.gov/show/NCT04712045
NCT04525378,MSC-based Therapy in COVID-19-associated Acute Respiratory Distress Syndrome,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,PCL02/2020,"Hospital São Rafael, Salvador, Bahia, Brazil",https://ClinicalTrials.gov/show/NCT04525378
NCT04479202,The Effect of Berberine on Intestinal Function and Inflammatory Mediators in Severe Patients With Covid-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment",Berberine treats COVID-19|XJ2020005101,"Nanjing Drum Tower Hospital, Nanjing, Jiangsu, China",https://ClinicalTrials.gov/show/NCT04479202
NCT04343963,Pyridostigmine in Severe SARS-CoV-2 Infection,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",Inf-3323,"Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Ciudad de México, Tlalpan, Mexico",https://ClinicalTrials.gov/show/NCT04343963
NCT04469634,Are SARS-CoV-2 Specific Antibodies a Correlate for Protection?,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science,1412/20,"University Hospital Antwerp, Antwerpen, Belgium|Jessa Hospital, Hasselt, Belgium",https://ClinicalTrials.gov/show/NCT04469634
NCT04411576,Current and Past SARS-CoV-2 Infection and COVID-19 in Healthcare,Observational Model: Cohort|Time Perspective: Prospective,COVID-19 Studien,"Karolinska University Hospital, Stockholm, Sweden",https://ClinicalTrials.gov/show/NCT04411576
NCT04834934,Artificial Intelligence - SARS-CoV-2 Risk Evaluation,Observational Model: Cohort|Time Perspective: Retrospective,AI-SCoRE,"IRCCS San Raffaele, Milano, Italy",https://ClinicalTrials.gov/show/NCT04834934
NCT04882670,COVID-19 Pandemic on Health Care and Rehabilitation Outcomes,Observational Model: Cohort|Time Perspective: Retrospective,1531,"IRCCS Istituto Ortopedico Rizzoli, Bologna, BO, Italy",https://ClinicalTrials.gov/show/NCT04882670
NCT04402944,Pulmozyme to Improve COVID-19 ARDS Outcomes,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",P00035140,"Boston Children's Hospital, Boston, Massachusetts, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT04402944
NCT04573335,Diabetes Outcomes in COVID-19 Pandemic,Observational Model: Cohort|Time Perspective: Cross-Sectional,16102019,"Services Hospital, Lahore, Punjab, Pakistan",https://ClinicalTrials.gov/show/NCT04573335
NCT04376944,Barrier Measures to Limit Covid-19.Nosocomial Transmission: a Cross-sectional Evaluation,Observational Model: Case-Control|Time Perspective: Cross-Sectional,RECHMPL20_0261,"Uh Montpellier, Montpellier, France",https://ClinicalTrials.gov/show/NCT04376944
NCT04663659,The Effect of Diabetes Mellitus on Mortality of Patients With COVID-19,Observational Model: Case-Control|Time Perspective: Retrospective,1559,"SisliHamidiye Etfal Education and Training Hospital, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04663659
NCT04844567,Virtual Reality Intervention to Alleviate Breathlessness (COVID-19),Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,COVVR_LNCO2020,"Hopitaux Universitaires de Geneve (HUG), Geneva, Switzerland",https://ClinicalTrials.gov/show/NCT04844567
NCT04507893,Comparison Between Positive and Negative COVID-19 Pneumonia,Observational Model: Case-Only|Time Perspective: Retrospective,ACPM26,"Infectious diseases Unit of the ""Cervello-Villa Sofia"" Hospital, Palermo, PA, Italy|Internal Medicine Division of the ""Cervello-Villa Sofia"" Hospital, Palermo, PA, Italy|Pulmonology Unit Dedicated to COVID-19 Patients, Palermo, PA, Italy",https://ClinicalTrials.gov/show/NCT04507893
NCT04854863,Respiratory Muscles After Hospitalisation for COVID-19,Observational Model: Cohort|Time Perspective: Prospective,CTCA 20-515,NA,https://ClinicalTrials.gov/show/NCT04854863
NCT04616950,Impact of the COVID-19 Epidemic on the Hospital Journey of Patients With Cancer of the Digestive System,Observational Model: Cohort|Time Perspective: Retrospective,KOVID,"Groupe Hospitalier Paris Saint-Joseph, Paris, Groupe Hospitalier Paris Saint-Joseph, France",https://ClinicalTrials.gov/show/NCT04616950
NCT04405973,Clinical Scores for Outcome Prediction in Patients With Severe COVID-19 Pneumonia Requiring ECMO,Observational Model: Cohort|Time Perspective: Retrospective,EK-FR 329/20,"University Clinic Freiburg, Freiburg, Germany",https://ClinicalTrials.gov/show/NCT04405973
NCT04813471,Managing Endothelial Dysfunction in Critically Ill COVID-19 Patients at LAUMCRH,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,LAUMCRH,"LAUMCRH, Beirut, Lebanon",https://ClinicalTrials.gov/show/NCT04813471
NCT04373200,Human Ab Response & immunoMONItoring of COVID-19 Patients,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,35RC20_9795_HARMONICOV|2020-A01100-39,"CHU Rennes, Rennes, France",https://ClinicalTrials.gov/show/NCT04373200
NCT04574869,A Study of RLS-0071 in Patients With Acute Lung Injury Due to COVID-19 Pneumonia in Early Respiratory Failure,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",RLS-0071-102,"Prestige Clinical Research Center, Coral Gables, Florida, United States",https://ClinicalTrials.gov/show/NCT04574869
NCT04335188,COVID-19 Registry Rhineland-Palatinate (Germany),Observational Model: Other|Time Perspective: Prospective,COVID-19 Registry,"Klinikum der Stadt Ludwigshafen am Rhein GmbH, Klinik für Herzchirurgie, Ludwigshafen, RLP, Germany",https://ClinicalTrials.gov/show/NCT04335188
NCT04390412,Low Dose Radiotherapy in COVID-19 Pneumonia,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,23568|IRCT20200509047366N1,"Imam Hossein Hospital, Tehran, Iran, Islamic Republic of",https://ClinicalTrials.gov/show/NCT04390412
NCT04358588,Pulsed Inhaled Nitric Oxide for the Treatment of Patients With Mild or Moderate COVID-19,NA,PULSE-EAP-001,NA,https://ClinicalTrials.gov/show/NCT04358588
NCT04593654,Dosing of Thromboprophylaxis and Mortality in Critically Ill COVID-19 Patients,Observational Model: Cohort|Time Perspective: Retrospective,Thromboprophylaxis COVID-19,"Södersjukhuset, Stockholm, Sweden",https://ClinicalTrials.gov/show/NCT04593654
NCT04373811,One-Year Quality of Life and Functional Prognosis of COVID-19 Patients in Post-ICU Setting,Observational Model: Cohort|Time Perspective: Prospective,COVENTRY,"Centre Hospitalier de Béthune, Beuvry, Hauts-de-France, France|APHP - Hôpital Universitaire Pitié-Salpétrière, Paris, Ile De France, France|Hôpital Forcilles, Férolles-Attilly, Ile-de-France, France",https://ClinicalTrials.gov/show/NCT04373811
NCT04949386,"Safety, Tolerability and Efficacy of S-1226 in Post-COVID-19 Subjects With Persistent Respiratory Symptoms.","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",SAMi-06-1-01,NA,https://ClinicalTrials.gov/show/NCT04949386
NCT04667286,Awake Pronation for Covid-19 Treatment,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,1117/2020/Sper/AOUBo,"Sant'Orsola Malpighi, Bologna, Italy|Bolzano Hospital, Bolzano, Italy|University of Modena, Modena, Italy",https://ClinicalTrials.gov/show/NCT04667286
NCT04801836,Estetrol (E4) for the Treatment of Patients With Confirmed SARS-COV-2 Infection,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",MIT-Co001-C101|2020-003403-33,"ERASME Hospital, Brussels, Belgium|CHR Citadelle, Liège, Belgium|Koranyi National Institute of Pulmonology, Budapest, Hungary|University of Pecs Medical Center, Pécs, Hungary|University of Szeged Medical Center, Szeged, Hungary|Szent Borbala Korhaz, Tatabánya, Hungary|Wojewódzki Szpital Specjalistyczny w Białej Podlaskiej Oddział Kardiologiczny Pododdział Kardiologii Zachowawczej, Biała Podlaska, Poland|Zespół Opieki Zdrowotnej w Bolesławcu Oddział Chorób Wewnętrznych, Boleslawiec, Poland|Arion Med. Sp z o.o. Zespół Opieki Zdrowotnej w Gostyninie Oddział Chorób Wewnętrznych, Gorzewo, Poland|Samodzielny Publiczny Zakad Opieki Zdrowotnej w Pulawach Oddział Obserwacyjno-Zakaźny, Puławy, Poland|Samodzielny Publiczny Zespół Zakładów Opieki Zdrowotnej w Staszowie Oddział Chorób Wewnętrznych, Staszów, Poland|Wielospecjalistycznego Szpitala im. J. Strusia z Zakładem Opiekuńczo - Leczniczym SP ZOZ Oddział Chorób Wewnętrznych, Szczecin, Poland|Szpital Matki Bożej Nieustającej Pomocy w Wołominie Oddział Chorób Wewnętrznych, Wołomin, Poland|Wojewódzki Szpital Specjalistyczny im. J. Gromkowskiego I Oddział Chorób Zakaźnych, Wrocław, Poland|City Clinical Hospital #15 n.a. Filatov, Moscow, Russian Federation|State budgetary healthcare institution of Moscow ""City Clinical Hospital No 52 of the Department of Healhcare of Moscow"", Moscow, Russian Federation|State Budgetary Healthcare Institution ""Clinical Infectious Disease Hospital No. 1 of the Moscow City Health Department"", Moscow, Russian Federation|Saint-Petersburg state budgetary healthcare institution ""Clinical infectious hospital n.a. S.P. Botkin"", Saint Petersburg, Russian Federation|City Hospital #15, Saint Petersburg, Russian Federation|Saint-Petersburg state budgetary healthcare institution ""Pokrovskaya City Hospital"", Saint Petersburg, Russian Federation|Saint-Petersburg state budgetary healthcare institution ""Alexandrovskaya City Hospital"", Saint-Petersburg, Russian Federation|Saint-Petersburg state budgetary healthcare institution ""City hospital No 40 of resort region"", Sestroretsk, Russian Federation|Budgetary healthcare institution of Voronezh Region ""Voronezh regional clinical hospital"", Voronezh, Russian Federation|State budgetary healthcare institution of the Yaroslavl Region ""Yaroslavl regional clinical hospital of the war veterans - international center for health problems of aged people ""Healthy longevity"", Yaroslavl, Russian Federation|State budgetary healthcare institution of Moscow Region ""Zhukovskaya City Clinical Hospital"", Zhukovskiy, Russian Federation",https://ClinicalTrials.gov/show/NCT04801836
NCT04573270,Mesenchymal Stem Cells for the Treatment of COVID-19,"Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",Pro00043080,"Southern California Hospital at Culver City / Southern California Hospital at Hollywood, Culver City, California, United States",https://ClinicalTrials.gov/show/NCT04573270
NCT04714008,Covid-19 and ONline GAmbling,Observational Model: Ecologic or Community|Time Perspective: Retrospective,RC21_0010,"Nantes University Hospital, Nantes, France",https://ClinicalTrials.gov/show/NCT04714008
NCT04863586,COVID-19 and Multiple Sclerosis Disease Modifying Therapies,Observational Model: Case-Control|Time Perspective: Cross-Sectional,20NS041,"Nottingham University Hospitals NHS Trust, Nottingham, Nottinghamshire, United Kingdom",https://ClinicalTrials.gov/show/NCT04863586
NCT04510038,Colchicine vs Current Standard of Care in Hospitalized Patients With COVID-19 and Cardiac Injury,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,152247,"Baptist Health South Florida, Miami, Florida, United States",https://ClinicalTrials.gov/show/NCT04510038
NCT04475562,Can the Electronic Nose Smell COVID-19?,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,eNoseCOVID,"Maastricht University Medical Center, Maastricht, Netherlands",https://ClinicalTrials.gov/show/NCT04475562
NCT04616001,IVIG in Patients With Severe COVID-19 Requiring Mechanical Ventilation,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,COVID-IVIG VENT|2010902,"Sharp Memorial Hospital, San Diego, California, United States",https://ClinicalTrials.gov/show/NCT04616001
NCT04526405,Frequency of COVID-19 Antibodies in Patients With Hereditary Hematological Diseases,Observational Model: Cohort|Time Perspective: Prospective,ThalaCoV,"ASST Monza - Ospedale San Gerardo, Monza, MB, Italy",https://ClinicalTrials.gov/show/NCT04526405
NCT04900415,Olfactory and Neurosensory Rehabilitation in COVID-19-related Olfactory Dysfunction,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment",UW 20-454,"Pamela Youde Nethersole Eastern Hospital, Hong Kong, Hong Kong|The University of Hong Kong, Queen Mary Hospital, Hong Kong, Hong Kong",https://ClinicalTrials.gov/show/NCT04900415
NCT04401527,Treatment of Lung Injury From COVID-19 Infection With Intravenous Sodium Nitrite,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",SN02-01,"Participating Research Facility, Tampa, Florida, United States|Participating Research Facility, Fort Worth, Texas, United States",https://ClinicalTrials.gov/show/NCT04401527
NCT04858607,Humoral and Cellular Immune Response to COVID-19 Vaccines in Immunocompromised and Healthy Individuals,Observational Model: Cohort|Time Perspective: Prospective,CoVVac,"Medical University of Graz, Graz, Austria",https://ClinicalTrials.gov/show/NCT04858607
NCT04550325,"Safety, PK and PD of Kamada Anti-SARS-CoV-2 in COVID-19",Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,Kamada Anti-SARS-CoV-2-001,"Wolfson Medical Center, Holon, Israel|Hadassah Medical Center, Jerusalem, Israel|Sheba Medical Center Hospital- Tel Hashomer, Ramat Gan, Israel|Kaplan Medical Center, Reẖovot, Israel",https://ClinicalTrials.gov/show/NCT04550325
NCT04385199,Convalescent Plasma for Patients With COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,13807,"Henry Ford Hospital, Detroit, Michigan, United States",https://ClinicalTrials.gov/show/NCT04385199
NCT04337320,"Maternal And Neonatal Outcome of Pregnant Patients With COVID-19 in Istanbul, Turkey: A Single-Center, Retrospective, Descriptive Study",Observational Model: Cohort|Time Perspective: Retrospective,covid19pregnancynewborn,"Pinar Yalcin Bahat, Istanbul, İ̇stanbul, Turkey",https://ClinicalTrials.gov/show/NCT04337320
NCT04514874,Assessment of the Prevalence and the Impact of the COVID-19 Epidemic in the French Flight Crew in 2020,Observational Model: Cohort|Time Perspective: Prospective,2020-COVID19-26|2020-A01459-30,"Centre d'Expertise Medicale du Personnel Navigant (CEMPN) de l'Hôpital d'Instruction des Armées Percy, Clamart, France|Centre d'Expertise Medicale du Personnel Navigant (CEMPN) de l'Hôpital d'Instruction des Armées Sainte-Anne, Toulon, France",https://ClinicalTrials.gov/show/NCT04514874
NCT04394000,Impact of an Intensified Thromboprofylaxis Protocol in COVID-19,Observational Model: Cohort|Time Perspective: Other,Jessa_20.48,"Jessa hospital, Hasselt, Belgium",https://ClinicalTrials.gov/show/NCT04394000
NCT04586140,Operation of the GHPSJ Clinical Ethical Reflection Assistance Group During the COVID-19 Period,Observational Model: Cohort|Time Perspective: Cross-Sectional,ETHICOVID,"Groupe Hospitalier Paris Saint-Joseph, Paris, France",https://ClinicalTrials.gov/show/NCT04586140
NCT04470739,Is Thymus Size of Infants Who Born to COVID-19 Positive Mothers Associated With Neonatal Morbidities?,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,KSSEAH--CT,"Kanuni Sultan Suleyman Training and Research Hospital, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04470739
NCT04758299,Understanding Communications Included With COVID-19 (Corona Virus Disease of 2019) Home Testing Kits,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Other,STUDY2020_501,"Carnegie Mellon University, Pittsburgh, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04758299
NCT04706416,N-Acetyl Glucosamine as Therapeutic Intervention for Coronavirus Disease-19 (COVID-19),Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,IRB #2020-106,"Valley Baptist Medical Center, Harlingen, Texas, United States",https://ClinicalTrials.gov/show/NCT04706416
NCT04597853,Assessment of Lung Mechanics in COVID-19 Acute Respiratory Distress Syndrome,Observational Model: Cohort|Time Perspective: Prospective,2020-01999,"Institute of Intensive Care Medicine, University Hospital Zurich, Zurich, Switzerland",https://ClinicalTrials.gov/show/NCT04597853
NCT04899232,Antithrombin III in Infectious Disease Caused by COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,20201048,"University of Miami, Miami, Florida, United States",https://ClinicalTrials.gov/show/NCT04899232
NCT04392713,Efficacy of Ivermectin in COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,IVE-COV,"Combined Military Hospital Lahore, Lahore, Punjab, Pakistan",https://ClinicalTrials.gov/show/NCT04392713
NCT04735757,"Effects of COVID-19 Infection and Critical Illness on Diaphragm Tissue Characteristics and Movement, Visualized With MRI",Observational Model: Case-Control|Time Perspective: Prospective,NL 72271.029.19,"Amsterdam UMC, location VUmc, Amsterdam, Noord-Holland, Netherlands",https://ClinicalTrials.gov/show/NCT04735757
NCT04800146,A Study on the Immune-response to COVID-19 Vaccination in Cancer Patients - the IOSI-COVID-19-001 Study,Observational Model: Case-Only|Time Perspective: Prospective,IOSI-COVID19-001,"Oncology Institute of Southern Switzerland, Bellinzona, Switzerland",https://ClinicalTrials.gov/show/NCT04800146
NCT04700137,"Mental Health Among Patients, Providers, and Staff During the COVID-19 Era",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,20-0052|PCORI HIS-2018C3-14695,"St. Luke's Health System, Boise, Idaho, United States",https://ClinicalTrials.gov/show/NCT04700137
NCT04374123,COVID-19 Serology Screening and Strict Protocol in the Endoscopy Unit,Observational Model: Cohort|Time Perspective: Prospective,IECED-04-15-covid,"Ecuadorian Institute of Digestive Diseases, Guayaquil, Guayas, Ecuador",https://ClinicalTrials.gov/show/NCT04374123
NCT04479124,The Impact of COVID-19 Pandemic to Trauma Patients in Emergency Department: A Multicenter Experience of Istanbul,Observational Model: Cohort|Time Perspective: Retrospective,KSSTHR-TPED,"Istanbul Kanuni Sultan Suleyman Training and Research Hospital, Istanbul, Kucukcekmece, Turkey",https://ClinicalTrials.gov/show/NCT04479124
NCT04483375,"Safety, Tolerability and Pharmacokinetics of SCTA01, an Anti-SARS-CoV-2 Monoclonal Antibody, in Healthy Chinese Subjects","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",SCTA01-X101,"Beijing SHIJITAN Hospital, Beijing, Beijing, China",https://ClinicalTrials.gov/show/NCT04483375
NCT04824365,Sodium Pyruvate Nasal Spray Treatment of COVID-19 and Influenza Infections,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Treatment",CSI-COVID-19_007,"Family First Medical Research Center, Virginia Gardens, Florida, United States|Missouri State University, Springfield, Missouri, United States",https://ClinicalTrials.gov/show/NCT04824365
NCT04333953,COVID-19 in Patients With HIV,Observational Model: Case-Only|Time Perspective: Prospective,2021341,"University of Missouri-Columbia, Columbia, Missouri, United States",https://ClinicalTrials.gov/show/NCT04333953
NCT04531202,CORE Study COVID-19,Observational Model: Cohort|Time Perspective: Prospective,29496920.8.0000.5262,"D'Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil",https://ClinicalTrials.gov/show/NCT04531202
NCT04395105,"Dexamethasone for COVID-19 Related ARDS: a Multicenter, Randomized Clinical Trial",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,1264,"Hospital Universitario Sede Saaveda - IUC CEMIC, Caba, Argentina|Hospital Universitario Sede Pombo - IUC CEMIC, Ciudad Autonoma de Buenos Aires, Argentina|Sanatorio Sagrado Corazon, Ciudad Autonoma de Buenos Aires, Argentina|Clínica Bazterrica, Ciudad Autónoma de Buenos Aires, Argentina",https://ClinicalTrials.gov/show/NCT04395105
NCT04322188,An Observational Study of the Use of Siltuximab (SYLVANT) in Patients Diagnosed With COVID-19 Infection Who Have Developed Serious Respiratory Complications,Observational Model: Cohort|Time Perspective: Retrospective,v 2 22nd April 2020,"ASST - Papa Giovanni XXIII, Bergamo, Italy",https://ClinicalTrials.gov/show/NCT04322188
NCT04603963,Inspiratory Muscle Training in Patients With COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Treatment,34931220.1.0000.0071,"Municipal Hospital Vila Santa Catarina, São Paulo, Brazil",https://ClinicalTrials.gov/show/NCT04603963
NCT04495803,Augmented CBGT for Perinatal Anxiety During a Global Pandemic (COVID-19),Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,CBT-COVID,"St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04495803
NCT04818892,Immunogenicity of COVID-19 Vaccine in Patients With Inflammatory Bowel Disease,Observational Model: Case-Control|Time Perspective: Prospective,2021-0043|A534250|SMPH/MEDICINE/GASTROENT|Protocol Version 3/31/2021|MSN252947,"University of Wisconsin, Madison, Wisconsin, United States",https://ClinicalTrials.gov/show/NCT04818892
NCT04408391,Brain MRI Imaging in Patients With SARS-Cov2 (COVID-19) Infection With or Without Anosmia,Observational Model: Case-Only|Time Perspective: Prospective,NIMAO/2020-01/BL-001,"CHU de Nimes, Nîmes, France",https://ClinicalTrials.gov/show/NCT04408391
NCT04542044,Evaluation of the Safety and Outcomes of Outpatient Management With Mild to Moderate COVID-19 Pneumonia,Observational Model: Cohort|Time Perspective: Prospective,CCER2020-01518,"Geneva University Hospital, Geneva, Switzerland",https://ClinicalTrials.gov/show/NCT04542044
NCT04659772,A Study to Evaluate Clazakizumab in Patients With Life-threatening COVID-19 Infection,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",20-008170,"Mayo Clinic in Arizona, Phoenix, Arizona, United States",https://ClinicalTrials.gov/show/NCT04659772
NCT04357431,COVID-19 Among Egyptian Health Care Providers,Observational Model: Other|Time Perspective: Cross-Sectional,COVIDQ,"Ahmed Abbas, Assiut, Cairo, Egypt",https://ClinicalTrials.gov/show/NCT04357431
NCT04567979,Prospective Determination of COVID-19 Infection Rate in a Chemotherapy Unit in Mexico.,Observational Model: Cohort|Time Perspective: Prospective,HEM-3412-20-20-1,"Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico",https://ClinicalTrials.gov/show/NCT04567979
NCT04383548,Clinical Study for Efficacy of Anti-Corona VS2 Immunoglobulins Prepared From COVID19 Convalescent Plasma Prepared by VIPS Mini-Pool IVIG Medical Devices in Prevention of SARS-CoV-2 Infection in High Risk Groups as Well as Treatment of Early Cases of COVID19 Patients,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,Mini-pooled IVIG in COVID19,NA,https://ClinicalTrials.gov/show/NCT04383548
NCT04629989,Comparison of the Surgical Facemask With the Double-trunk Mask on Oxygenation in COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Supportive Care,DTM-003,"Cliniques universitaires Saint-Luc, Brussels, Belgium",https://ClinicalTrials.gov/show/NCT04629989
NCT04585945,COVID-19 on Placental Gene Expression and Pathology,Observational Model: Case-Control|Time Perspective: Prospective,Pro00101090,"Prisma Health Upstate, Greenville, South Carolina, United States",https://ClinicalTrials.gov/show/NCT04585945
NCT04617119,The Effects of Multi-modality Physiotherapy in Delaying or Preventing COVID-19 Patient From Admitting to ICU,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Prevention",JALGHAITH,"Jaber Al-Ahmed Hospital, Kuwait city, Kuwait",https://ClinicalTrials.gov/show/NCT04617119
NCT04884477,COVID-19 Infection in Patients Receiving Anti-CD20 Therapy,Observational Model: Cohort|Time Perspective: Retrospective,21-001374,"Mayo Clinic, Rochester, Minnesota, United States",https://ClinicalTrials.gov/show/NCT04884477
NCT04393948,Lung Irradiation for COVID-19 Pneumonia,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2020P001494,"Brigham and Women's Hospital, Boston, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT04393948
NCT04345848,Preventing COVID-19 Complications With Low- and High-dose Anticoagulation,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,2020-00794,"Geneva University Hospitals, Geneva, Switzerland|Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland|Ospedale Regionale di Locarno, Locarno, Switzerland|Hôpital du Valais, Sion, Switzerland",https://ClinicalTrials.gov/show/NCT04345848
NCT04534608,COVID-19 Child Health Investigation of Latent Disease in Hamburg,Observational Model: Family-Based|Time Perspective: Prospective,PV7336,"Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany",https://ClinicalTrials.gov/show/NCT04534608
NCT04445207,Experimental Expanded Access Treatment With Convalescent Plasma for the Treatment of Patients With COVID-19,NA,H000020420,"UMass Medical School, Worcester, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT04445207
NCT04445311,Ivermectin in Treatment of COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,ZU-IRB#6151/31-5-2020,"Waheed Shouman, Zagazig, Sharkia, Egypt",https://ClinicalTrials.gov/show/NCT04445311
NCT04581746,Impact of the Epidemic of COVID-19 Infection Among People Living With HIV (SARS-CoV-2),Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,RIPH_2020_7,"CHU Amiens Picardie, Amiens, France|CH Lens, Lens, France|CH Tourcoing, Tourcoing, France",https://ClinicalTrials.gov/show/NCT04581746
NCT04912921,Effect of Palmitoylethanolamide on Proinflammatory Markers in Adults Recently Diagnosed With COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Supportive Care",STUDY00012462,"Arizona Biomedical Collaborative, Phoenix, Arizona, United States",https://ClinicalTrials.gov/show/NCT04912921
NCT04510402,Phase I/II Trial of Povidone-iodine (PVP-I) Nasal Swab For Preventing COVID-19 Spread in Healthy Subjects,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,2020p002323,NA,https://ClinicalTrials.gov/show/NCT04510402
NCT04410562,Hydroxychloroquine Efficacy and Safety in Preventing SARS-CoV-2 Infection and COVID-19 Disease Severity During Pregnancy and Postpartum,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",2020-001587-29,"Hospital General de Segovia, Segovia, Cartilla Y León, Spain|Hospital del Mar, Barcelona, Catalunya, Spain|Hospital Clínic de Barcelona, Barcelona, Catalunya, Spain|Hospital de la Sant Creu i Sant Pau, Barcelona, Catalunya, Spain|Hospital Sant Joan de Déu, Esplugues De Llobregat, Catalunya, Spain|Hospital Universitario Fundación Alcorcón, Alcorcón, Madrid, Spain|HM Puerta del Sur, Móstoles, Madrid, Spain|Hospital Universitario de Torrejón, Torrejón De Ardoz, Madrid, Spain|Hospital Universitario Infanta Leonor, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04410562
NCT04388436,Post Covid-19 Cardiopulmonary and Immunological Changes,Observational Model: Cohort|Time Perspective: Prospective,20.05.67,"Mansoura faculty of medicine, Mansoura, Dakahlia, Egypt",https://ClinicalTrials.gov/show/NCT04388436
NCT04873349,Standardized Olive Leaf Capsules; as a Co-therapy in the Treatment of COVID-19 Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment",EC 2121,NA,https://ClinicalTrials.gov/show/NCT04873349
NCT04967742,"A Extension Study to Evaluate the Safety, Tolerability, and Immunogenicity of UB-612 COVID-19 Vaccine",Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,V-123,"China Medical University Hospital, Taichung, Taiwan",https://ClinicalTrials.gov/show/NCT04967742
NCT04409249,Prognosis in Pregnant With COVID-19,Observational Model: Other|Time Perspective: Retrospective,Mtalmacprognosis,"Kanuni Sultan Suleyman Training and Research Hospital, Istanbul, Halkali, Turkey",https://ClinicalTrials.gov/show/NCT04409249
NCT04667923,Noninvasive Ventilation in Moderate-to-severe COVID-19-associated Acute Respiratory Distress-syndrome,Observational Model: Case-Only|Time Perspective: Prospective,002-NIV-COVID,"Sechenov University clinic #4, Moscow, Russian Federation",https://ClinicalTrials.gov/show/NCT04667923
NCT04349410,The Fleming [FMTVDM] Directed CoVid-19 Treatment Protocol,Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Single (Investigator)|Primary Purpose: Treatment,FMTVDM2020,"FHHI-OI-Camelot; QME, Los Angeles, California, United States",https://ClinicalTrials.gov/show/NCT04349410
NCT04682548,Estimating Prevalence of COVID-19 Infection and SARS-CoV-2 Antibodies in MS Patients,Observational Model: Cohort|Time Perspective: Prospective,20-01799,"NYU Langone Health, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04682548
NCT04475575,Can the Electronic Nose Smell COVID-19 Antibodies?,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,eNoseCOVIDantibodies,"Maastricht University Medical Center, Maastricht, Netherlands",https://ClinicalTrials.gov/show/NCT04475575
NCT04370249,Construction of a Composite Clinical-echo Score Predictive of a Risk of Short-term Aggravation of Respiratory Impairment in Patients Suspected of Covid-19,Observational Model: Case-Only|Time Perspective: Retrospective,RC20_0164,"Chu de Nantes, Nantes, France",https://ClinicalTrials.gov/show/NCT04370249
NCT04664309,Understanding Immunity to the COVID-19 Vaccines,Observational Model: Case-Only|Time Perspective: Prospective,IRB-60171,"Stanford University, Hospital, and Clinics, Stanford, California, United States",https://ClinicalTrials.gov/show/NCT04664309
NCT04341415,Impact of Auricular Vagus Nerve Neuromodulation on COVID-19 Positive Inpatients Outcome,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment",CRN_2020_8,"Centre Hospitalier Simone Veil, Beauvais, France|Fondation Adolphe de Rothschild, Paris, France",https://ClinicalTrials.gov/show/NCT04341415
NCT04414293,Low Dose Pulmonary Irradiation in Patients With COVID-19 Infection of Bad Prognosis,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,FHPCS-20-001,"Hospital Provincial de Castellon, Castellón De La Plana, Castellon, Spain",https://ClinicalTrials.gov/show/NCT04414293
NCT04633915,Antibody Response in Hemodialysis and Non-dialysis Patients Diagnosed With COVID-19.,Observational Model: Cohort|Time Perspective: Prospective,COVID,"Saint-Petersburg State University Hospital, Saint Petersburg, Russian Federation",https://ClinicalTrials.gov/show/NCT04633915
NCT04383587,Seroprevalence of SARS CoV 2 Antibodies in Previously Undiagnosed Healthcare Workers,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,20-004054,"Mayo Clinic in Florida, Jacksonville, Florida, United States",https://ClinicalTrials.gov/show/NCT04383587
NCT04579640,Trial of Vitamin D to Reduce Risk and Severity of COVID-19 and Other Acute Respiratory Infections,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,289515,"Queen Mary University of London, London, County (optional), United Kingdom",https://ClinicalTrials.gov/show/NCT04579640
NCT04436458,Niclosamide In Moderate COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",FW-COV-002,NA,https://ClinicalTrials.gov/show/NCT04436458
NCT04583449,Mental Imagery to Increase Face Covering Use in UK-based Public Places During the COVID-19 Pandemic,Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Single (Participant)|Primary Purpose: Prevention,ETH2021-0006,"University of East London, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04583449
NCT04584437,Treatment of Covid-19 Infections Using Vitality Therapy or the Bible Cure,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,GAADMRI,"GAAD Medical Research Institute Inc. O/A The Centre for Incurable Diseases, Toronto, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04584437
NCT04724707,Russian Cardiovascular Registry of COVID-19,Observational Model: Cohort|Time Perspective: Prospective,0509-20-2020,"Almazov National Medical Research Centre, Saint Petersburg, Russian Federation",https://ClinicalTrials.gov/show/NCT04724707
NCT04366206,Factors Associated With Clinical Outcomes in Patients Hospitalized for Covid-19 in GHT-93 Est,Observational Model: Cohort|Time Perspective: Prospective,GHTRB-2020-01,"Centre Hospitalier Intercommunal Robert Ballanger, Aulnay-sous-Bois, France|Groupe Hospitalier Pitie Salpetriere, Paris, France",https://ClinicalTrials.gov/show/NCT04366206
NCT04441502,Identification of Predictors for the Evolution of COVID-19 Related Pneumonia by Transcriptomic and Seroproteomic,Observational Model: Cohort|Time Perspective: Prospective,COVID19_OMICS,"IRCCS Policlinico San Donato, San Donato Milanese, MI, Italy",https://ClinicalTrials.gov/show/NCT04441502
NCT04811339,Studies of COVID-19 Patients Treated With Oral Bismuth Subsalicylate (Pepto-Bismol),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,SABER-C 20.0636,"University of Louisville, Louisville, Kentucky, United States",https://ClinicalTrials.gov/show/NCT04811339
NCT04516928,Study of SARS-CoV2 Virus (COVID-19) Seroprevalence Among Lyon-Bron Military Health Schools Personnel,Observational Model: Cohort|Time Perspective: Prospective,2020-COVID19-29|2020-A02125-34,"Antenne Médicale des Ecoles Militaires de Santé de Lyon-Bron (EMSLB), Bron, France",https://ClinicalTrials.gov/show/NCT04516928
NCT04736901,Effect of Prophylactic and Therapeutic Anticoagulants in Egyptian Patients With COVID-19,Observational Model: Cohort|Time Perspective: Other,COVID-Anticoagulants,"Teachers Hospital, Cairo, Please Select, Egypt",https://ClinicalTrials.gov/show/NCT04736901
NCT04978038,Third Dose of COVID-19 Vaccine in LTCF Residents,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",mRNA-1273-D3-2021,"McMaster University, Hamilton, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04978038
NCT04590261,Myeloid Cells in Patients With Covid-19 Pneumonia,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Screening,APHP201138|2020-A02700-39,NA,https://ClinicalTrials.gov/show/NCT04590261
NCT04479137,Possible Predictors of Mortality Based on COVID-19 for Patients Under 50 Years Old: A Multi-Center Experience of Istanbul,Observational Model: Cohort|Time Perspective: Retrospective,KSSEAH--PPC,"Kanuni Sultan Suleyman Training and Research Hospital, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04479137
NCT04910243,The Practice of Providing Palliative Care in the Situation of the COVID-19 (Coronavirus Disease 2019) Pandemic in Czech Republic,Observational Model: Cohort|Time Perspective: Cross-Sectional,PEOpLe-C19 study,"University Hospital Brno, Brno, Czechia",https://ClinicalTrials.gov/show/NCT04910243
NCT04864899,Clinical Significance of Subclinical Myocardial Involvement in Recovered COVID-19 Patients Using Cardiovascular Magnetic Resonance (R-COVID-CMR),Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,UW21-005,"The University of Hong Kong, Hong Kong, Hong Kong",https://ClinicalTrials.gov/show/NCT04864899
NCT04610541,REMdesivir-HU Clinical Study and Severe Covid-19 Patients,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,REM-ENY-01,"Department of Pulmonology Semmelweis University, Budapest, Hungary|National Korányi Institute for Pulmonology, Budapest, Hungary|North - Central Buda Center New St. János Hospital, Budapest, Hungary|Institute of Infectology, University of Debrecen, Debrecen, Hungary|1st Department of Medicine, University of Pécs, Pécs, Hungary|Department of Internal Medicine University of Szeged, Szeged, Hungary|First Department of Internal Medicine, University of Szeged, Szeged, Hungary",https://ClinicalTrials.gov/show/NCT04610541
NCT04358042,PSYCHIATRIC Disorders and Covid-19,Observational Model: Cohort|Time Perspective: Prospective,RC20_0165,"Nantes University Hospital - IFAC, Nantes, France",https://ClinicalTrials.gov/show/NCT04358042
NCT04392427,New Antiviral Drugs for Treatment of COVID-19,Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,20.05.69,"Mansoura University, Mansoura, Select A State Or Province, Egypt",https://ClinicalTrials.gov/show/NCT04392427
NCT04720235,A Follow On Community Testing Study To Evaluate The Performance of the Lucira COVID-19 All-In-One Test Kit,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,07A-CLI-007,"Neeraj Kochhar Family Medicine, Los Gatos, California, United States",https://ClinicalTrials.gov/show/NCT04720235
NCT04672291,Nasal Poly-ICLC (Hiltonol®) in Healthy COVID-19 Vaccinated Adults,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",ONV2020-003,"Health Research Innovation Centre, Calgary, Alberta, Canada",https://ClinicalTrials.gov/show/NCT04672291
NCT04730856,Standard vs High Prophylactic Doses or Anticoagulation in Patients With High Risk of Thrombosis Admitted With COVID-19 Pneumonia (PROTHROMCOVID),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,PROTHROMCOVID,"Complejo Hospitalario Universitario A Coruña, A Coruña, Spain|Hospital Universitario del Vinalopó, Alicante, Spain|Hospital Clínic Barcelona, Barcelona, Spain|Hospital Universitario Vall d'Hebron, Barcelona, Spain|Hospital Universitario de Burgos, Burgos, Spain|Hospital Virgen de la Luz, Cuenca, Spain|Hospital Universitari de Girona Doctor Josep Trueta, Girona, Spain|Hospital Clínico San Carlos, Madrid, Spain|Hospital de Emergencias Enfermera Isabel Zendal, Madrid, Spain|Hospital General Universitario Gregorio Marañón, Madrid, Spain|Hospital Universitario 12 Octubre, Madrid, Spain|Hospital Universitario Infanta Leonor, Madrid, Spain|Hospital Universitario Infanta Sofía, Madrid, Spain|Hospital Universitario Ramón y Cajal, Madrid, Spain|Complexo Hospitalario Universitario de Pontevedra, Pontevedra, Spain|Hospital Clínico Universitario de Valencia, Valencia, Spain|Hospital Clínico Universitario de Valladolid, Valladolid, Spain|Hospital Álvaro Cunqueiro, Vigo, Spain",https://ClinicalTrials.gov/show/NCT04730856
NCT04677478,Impact of the Respiratory Isolation on the Quality of Life in Patients Hospitalized for Tuberculosis or COVID-19,Observational Model: Cohort|Time Perspective: Prospective,APHP200227,NA,https://ClinicalTrials.gov/show/NCT04677478
NCT04841746,Efficacy of FES Cycling After a Severe Form of COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,69HCL21_0354,NA,https://ClinicalTrials.gov/show/NCT04841746
NCT04724434,Follow-up Study of COVID-19 Patients in the District Konstanz,Observational Model: Cohort|Time Perspective: Prospective,20-1020,"Hegau-Bodensee-Klinikum Singen, Singen, Baden-Württemberg, Germany",https://ClinicalTrials.gov/show/NCT04724434
NCT04356508,COVID-19: A Pilot Study of Adaptive Immunity and Anti-PD1,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,UW20213,NA,https://ClinicalTrials.gov/show/NCT04356508
NCT04456361,Use of Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Caused by COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,MSC-ARDS-001,"Instituto de Medicina Regenerativa, Tijuana, Baja California, Mexico",https://ClinicalTrials.gov/show/NCT04456361
NCT04563676,Physiopathology and Sequelae of COVID-19 Infection,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Screening,PI2020_843_0096,"CHU Amiens, Amiens, France",https://ClinicalTrials.gov/show/NCT04563676
NCT04421508,A Study to Assess Pulsed Inhaled Nitric Oxide vs Placebo in Subjects With Mild or Moderate COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",PULSE-CVD19-001,"Banner University Medical Center, Phoenix, Arizona, United States|Kaiser Permanente - Zion Medical Center, San Diego, California, United States|Kaiser Permanente - San Diego Medical Center, San Diego, California, United States|University of Miami Health System, Miami, Florida, United States|The Lung Research Center (St. Luke's), Chesterfield, Missouri, United States|University of New Mexico Hospital, Albuquerque, New Mexico, United States|The Ohio State University Wexner Medical Center, Columbus, Ohio, United States|Mercy Health St. Vincent Medical Center, Toledo, Ohio, United States|Temple University Hospital, Philadelphia, Pennsylvania, United States|Houston Methodist, Houston, Texas, United States|INOVA, Falls Church, Virginia, United States|St. Francis Medical Center, Richmond, Virginia, United States|Memorial Regional Medical Center, Richmond, Virginia, United States|Chippenham Medical Center, Richmond, Virginia, United States|Pulmonary Associates of Richmond, Richmond, Virginia, United States|St. Mary's Hospital, Richmond, Virginia, United States|Johnston-Willis Hospital, Richmond, Virginia, United States",https://ClinicalTrials.gov/show/NCT04421508
NCT04689724,Covid-19 Airway Management,Observational Model: Cohort|Time Perspective: Retrospective,20-5620,"University Health Network, Toronto, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04689724
NCT04422561,Prophylactic Ivermectin in COVID-19 Contacts,Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,ZU-IRB#6150/31-5-2020,"Zagazig University, Zagazig, Sharkia, Egypt",https://ClinicalTrials.gov/show/NCT04422561
NCT04401293,Full Dose Heparin Vs. Prophylactic Or Intermediate Dose Heparin in High Risk COVID-19 Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",20-0340,"Beth Israel Newark, Newark, New Jersey, United States|Southside Hospital, Bay Shore, New York, United States|Huntington Hospital, Huntington, New York, United States|Lenox Hill Hospital, New York, New York, United States|Long Island Jewish Medical Center, Queens, New York, United States|Staten Island University Hospital, Staten Island, New York, United States",https://ClinicalTrials.gov/show/NCT04401293
NCT04354155,COVID-19 Anticoagulation in Children - Thromboprophlaxis (COVAC-TP) Trial,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,COVAC-TP,"Children's of Alabama, Birmingham, Alabama, United States|Children's Hospital Los Angeles, Los Angeles, California, United States|Hemostasis and Thrombosis Center UC Davis, Sacramento, California, United States|Rady Children's Hospital, San Diego, California, United States|Johns Hopkins All Children's Hospital, Saint Petersburg, Florida, United States|Children's Hospital of Atlanta, Atlanta, Georgia, United States|Lurie Children's Hospital, Chicago, Illinois, United States|Rush University Medical Center, Chicago, Illinois, United States|Children's Hospital New Orleans, New Orleans, Louisiana, United States|Johns Hopkins Hospital and Children's Center, Baltimore, Maryland, United States|Boston Children's Hospital, Boston, Massachusetts, United States|Children's Hospital of Michigan, Detroit, Michigan, United States|Cohen Children's Medical Center, New Hyde Park, New York, United States|Akron Children's Hospital, Akron, Ohio, United States|Children's Hospital Pittsburgh, Pittsburgh, Pennsylvania, United States|Children's Medical Center of Dallas, Dallas, Texas, United States",https://ClinicalTrials.gov/show/NCT04354155
NCT04881227,The Impact of a Chatbot on COVID-19 Vaccine Perceptions and Intentions in ESPERES Cohort (ESPERES-COVID-19-CHATBOT),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,APHP210173.2,"Pitié-Salpêtrière - Charles Foix, AP-HP, Paris, ILE DE France, France",https://ClinicalTrials.gov/show/NCT04881227
NCT04362150,Long-term Impact of Infection With Novel Coronavirus (COVID-19),Observational Model: Cohort|Time Perspective: Prospective,20-30479,"Zuckerberg San Francisco General Hospital (ZSFG), San Francisco, California, United States",https://ClinicalTrials.gov/show/NCT04362150
NCT04323514,Use of Ascorbic Acid in Patients With COVID 19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,3143,"A.R.N.A.S. Civico - Di Cristina - Benfratelli, Palermo, Italy",https://ClinicalTrials.gov/show/NCT04323514
NCT04647305,Effectiveness and Adherence to Closed Face Shields to Prevent COVID-19 Transmission,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,1010166518,"Universidad de los Andes, Bogotá, Colombia",https://ClinicalTrials.gov/show/NCT04647305
NCT04844710,The Effects of Acupuncture in Overcoming Inflammatory Response to COVID-19 Mild-moderate Symptoms,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,KET-845/UN2.F1/ ETIK/PPM.2020,"Medical Acupuncture Department FKUI-RSCM, Jakarta, Indonesia",https://ClinicalTrials.gov/show/NCT04844710
NCT04403555,Ivermectin as a Novel Therapy in COVID-19 Treatment,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,tanta covid treatment,"Sherief Abd-Elsalam, Tanta, Egypt",https://ClinicalTrials.gov/show/NCT04403555
NCT04581161,Proportional Open Ventilation (POV) Device and Its Efficacy in Managing Acute Respiratory Failure in COVID-19 Patients,Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,CR-RR-2020-004,"Park Nicolette, Bloomington, Minnesota, United States",https://ClinicalTrials.gov/show/NCT04581161
NCT04328961,Hydroxychloroquine for COVID-19 Post-exposure Prophylaxis (PEP),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention",STUDY00009750|INV-016204,"University of California Los Angeles, Los Angeles, California, United States|Tulane, New Orleans, Louisiana, United States|University of Maryland, Baltimore, Baltimore, Maryland, United States|Boston University, Boston, Massachusetts, United States|NYU Langone Health, New York, New York, United States|SUNY Upstate Medical University, Syracuse, New York, United States|University of Washington, Coordinating Center, Seattle, Washington, United States|UW Virology Research Clinic, Seattle, Washington, United States",https://ClinicalTrials.gov/show/NCT04328961
NCT04351295,Efficacy of Faviprevir in COVID-19 Treatment,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,faviprevir covid,"Tanta University, Ainshams University, Tanta, Egypt",https://ClinicalTrials.gov/show/NCT04351295
NCT04460651,PREPARE-IT. Prevention and Treatment of COVID19 With EPA in Subjects at Risk - Intervention Trial,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",PREPARE-IT. Version 3.0,"Instituto de Investigaciones Clínicas - Rosario, Rosario, Santa Fe, Argentina",https://ClinicalTrials.gov/show/NCT04460651
NCT04629105,Regenerative Medicine for COVID-19 and Flu-Elicited ARDS Using Longeveron Mesenchymal Stem Cells (LMSCs) (RECOVER),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",00-006,"Miami VA Healthcare System, Miami, Florida, United States|University of Maryland Medical Center, Baltimore, Maryland, United States|Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States",https://ClinicalTrials.gov/show/NCT04629105
NCT04598347,Evaluation of the Possible Vertical Transmission of SARS-CoV-2 Through Study of Amniotic Fluid and Chorionic Villi of Affected Pregnant Women for the COVID-19,Observational Model: Case-Only|Time Perspective: Prospective,IIBSP-COV-2020-59,"Hospital de la Santa Creu i Sant Pau, Barcelona, Spain",https://ClinicalTrials.gov/show/NCT04598347
NCT04429529,"Safety of TY027, a Treatment for COVID-19, in Humans","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",SCT-001,"SingHealth Investigational Medicine Unit, Singapore, Singapore",https://ClinicalTrials.gov/show/NCT04429529
NCT04780373,Prognostic Score in Covid-19,Observational Model: Cohort|Time Perspective: Prospective,prot. N. 71726,"University of L'Aquila, L'Aquila, Italy",https://ClinicalTrials.gov/show/NCT04780373
NCT04383652,Collection of Coronavirus COVID-19 Outbreak Samples in New South Wales,Observational Model: Cohort|Time Perspective: Prospective,VISP2005,"NSW Health Pathology, Randwick, New South Wales, Australia|Prince of Wales Hospital, Randwick, New South Wales, Australia|Sydney Children's Hospital, Randwick, New South Wales, Australia|Blacktown Hospital, Blacktown, Australia|Royal Prince Alfred Hospital, Camperdown, Australia|St Vincent's Hospital, Darlinghurst, Australia|Northern Beaches Hospital, Frenchs Forest, Australia|Royal North Shore Hospital, Saint Leonards, Australia|Westmead Hospital, Westmead, Australia",https://ClinicalTrials.gov/show/NCT04383652
NCT04380896,COVID-19 Staff Testing of Antibody Responses Study (Co-Stars),Observational Model: Cohort|Time Perspective: Prospective,20CB17,"Great Ormond Street Hospital, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04380896
NCT04374552,Asymptomatic COVID-19 Trial,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",Pro2020000872,"Robert Wood Johnson University Hospital, New Brunswick, New Jersey, United States",https://ClinicalTrials.gov/show/NCT04374552
NCT04745442,Pilot Study of Antithrombin as Prophylaxis of Acute Respiratory Distress Syndrome in Patients With COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,ANTITROMBINA,"Hospital Universitario Reina Sofía, Córdoba, Spain",https://ClinicalTrials.gov/show/NCT04745442
NCT04596098,Immune Responses to COVID-19; Isolation of Neutralizing Antibodies for Therapeutics and Vaccine.,Observational Model: Cohort|Time Perspective: Prospective,38RC20.132|2020-A00904-35,"UniversityGrenobleHospital, Grenoble, France",https://ClinicalTrials.gov/show/NCT04596098
NCT04425720,Use of Remote Monitoring for COVID-19 Patient,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,2020-11824,"Montefiore Medical Center, Bronx, New York, United States",https://ClinicalTrials.gov/show/NCT04425720
NCT04350099,Emotional Burden of Healthcare Professionals and Covid Infection 19,Observational Model: Cohort|Time Perspective: Prospective,87RI20_0015/Emocovid,"CH Esquirol, Limoges, France|CHU de Limoges, Limoges, France|HCL LYON, Lyon, France",https://ClinicalTrials.gov/show/NCT04350099
NCT04542213,Dipeptidyl Peptidase-4 Inhibitor (DPP4i) for the Control of Hyperglycemia in Patients With COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",CEI-22-2020,"Hospital Regional de Alta Especialidad del Bajìo, Leòn, Guanajuato, Mexico",https://ClinicalTrials.gov/show/NCT04542213
NCT04672564,Study to Evaluate Safety and Efficacy of Carrimycin for Treatment of Severe Coronavirus Disease 2019 (COVID-19) in Hospitalized Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",TLKLXG202001,"Central DuPage Hospital, Winfield, Illinois, United States|Medpharmics, LLC, Metairie, Louisiana, United States|Temple University Health System, Philadelphia, Pennsylvania, United States|PharmaTex Research, LLC, Amarillo, Texas, United States|Instituto Médico Platense, La Plata, Buenos Aires, Argentina|Clínica Monte Grande, Monte Grande, Buenos Aires, Argentina|Instituto Medico Rio Cuarto, Rio Cuarto, Córdoba, Argentina|Hospital General de Agudos Donación F. Santojanni, Buenos Aires, Argentina|Sanatorio Mayo Privado SA, Córdoba, Argentina|Hospital Cardio Pulmonar, Salvador, Bahia, Brazil|Hospital Municipal de Aparecida de Goiânia - HMAP, Aparecida de Goiânia, Goiás, Brazil|Hospital Luxemburgo - Associação Mário Penna, Belo Horizonte, Minas Gerais, Brazil|Instituto de Pesquisa Clínica de Campinas, Campinas, São Paulo, Brazil|Fundacao Faculdade Regional de Medicina de Sao Jose do Rio Preto - Hospital de Base, São José do Rio Preto, São Paulo, Brazil|Rede Dor São Luiz S.A. - Hospital São Luiz Jabaquara, São Paulo, Brazil|Corporación para Estudios en Salud Clinica ""CES"", Medellin, Antioquia, Colombia|Clinica SOMER, Rionegro, Antioquia, Colombia|Clinica de la Mujer, Bogotá, Cundinamarca, Colombia|Hospital Universitario San Ignacio, Bogotá, Cundinamarca, Colombia|Fundacion Cardiovascular de Colombia (FCV), Floridablanca, Santander, Colombia|Hospital Universitario Clínica San Rafael, Bogota, Colombia|Paarthiv Lung Care Centre - Internal Medicine, Hyderabad, Andhra Pradesh, India|King George Hospital, Visakhapatnam, Andhra Pradesh, India|Unity Hospital, Surat, Gujarat, India|Rhythm Heart Institute, Vadodara, Gujarat, India|K.L.E.S. Dr. Prabhakar Kore Hospital & Medical Research Cent, Belgaum, Karnataka, India|Adichunchanagiri Hospital and Research Centre, Mandya, Karnataka, India|Government Medical College - Department of Internal Medicine, Nagpur, Maharashtra, India|Suretech Hospital and Research Centre - Internal Medicine, Nagpur, Maharashtra, India|Shalinitai Meghe Hospital & Research centre, Nagpur, Maharashtra, India|Universal Hospital, Pune, Maharashtra, India|Sawai Man Singh Medical College & Attached Hospitals, Jaipur, Rajasthan, India|Saveetha Medical College & Hospital, Chennai, Tamil Nadu, India|St.Theresa's Hospital, Hyderabad, Telangana, India|Nuevo Hospital Civil de Guadalajara ""Juan I. Menchaca"", Guadalajara, Jalisco, Mexico|Hospital Universitario ""Dr. Jose Eleuterio Gonzalez"", Nuevo Leon, Nuevo León, Mexico|Hospital General de Culiacán, Culiacán, Sinaloa, Mexico|Kohler & Milstein Research, Merida, Yucatán, Mexico|EME RED Hospitalaria, Mérida, Yucatán, Mexico|Hospital Español de Veracruz, Veracruz, Mexico|Complejo Hospitalario San Pablo, Lima, Peru|Clinica Ricardo Palma, Lima, Peru|Hospital Central FAP, Lima, Peru|De La Salle Health Sciences Institute, Cavite City, Cavite, Philippines|St. Paul's Hospital of Iloilo, Inc., Iloilo City, Iloilo, Philippines|Makati Medical Center - Infectious Diseases, Makati City, National Capital Region, Philippines|San Juan De Dios Hospital, Pasay, National Capital Region, Philippines|Veterans Memorial Medical Center, Quezon City, National Capital Region, Philippines|St. Lukes Hospital, Quezon City, National Capital Region, Philippines|Quirino Memorial Medical Center, Quezon, National Capital Region, Philippines|Chernihivska miska likarnia #2, Chernihiv, Chernihivs'ka Oblast', Ukraine|Ivano-Frankivsk Central City Clinical Hospital, Ivano-Frankivsk, Ivano-Frankivs'ka Oblast', Ukraine|Oblasnyi klinichnyi ftyziopulmonolohichnyi tsentr, Ivano-Frankivsk, Ivano-Frankivs'ka Oblast', Ukraine|Municipal Non-Profit Enterprise of Kharkiv Regional Council, Kharkiv, Kharkivs'ka Oblast', Ukraine|Kharkiv National Medical University, Kharkiv, Kharkivs'ka Oblast', Ukraine|Kyivska miska likarnia #8, Kyiv, Kyïv, Ukraine|Komunalne Pidpryiemstvo ""Poltavska Oblasna Klinichna Infektsiina Likarnia"" Poltavskoi Oblasnoi Rady, Poltava, Poltavs'ka Oblast', Ukraine|Vinnytskyi natsionalnyi medychnyi universytet imeni M.I. Pyr, Vinnytsia, Vinnyts'ka Oblast, Ukraine|Volyn Regional Clinical Hospital, Lutsk, Volyns'ka Oblast', Ukraine",https://ClinicalTrials.gov/show/NCT04672564
NCT04706156,Oral Side Effects of COVID-19 Vaccine,Observational Model: Ecologic or Community|Time Perspective: Cross-Sectional,OSECV,"Department of Public Health, Faculty of Medicine, Masaryk University, Brno, South-Moravia, Czechia|Department of Cranio-Maxillofacial Surgery, Justus-Liebig University Giessen, Giessen, Hesse, Germany|Clinic for Conservative Dentistry and Periodontology, School of Dental Medicine, Christian-Albrecht's University, Kiel, Schleswig-Holstein, Germany|Department of Maxillofacial Surgery, F. D. Roosevelt University Hospital, Banská Bystrica, Banska Bystrica, Slovakia",https://ClinicalTrials.gov/show/NCT04706156
NCT04751695,"Oxidative Stress Parameters, Trace Element and Quality of Life in Men Before and After Covid-19 Vaccines",Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Screening,2021-01-174,"Kadirhan Ozdemir, İzmir, Turkey",https://ClinicalTrials.gov/show/NCT04751695
NCT04368338,Lung Ultrasound to Diagnose COVID-19,Observational Model: Case-Only|Time Perspective: Prospective,PI2020_843_0030,"BAR, Amiens, France",https://ClinicalTrials.gov/show/NCT04368338
NCT04729075,"Associations Between COVID-19 ARDS Treatment, Clinical Trajectories and Liberation From Mechanical Ventilator - an Analysis of the NorthCARDS Dataset",Observational Model: Cohort|Time Perspective: Other,19-0598,"Feinstein Institutes for Medical Research, Manhasset, New York, United States",https://ClinicalTrials.gov/show/NCT04729075
NCT04798716,The Use of Exosomes for the Treatment of Acute Respiratory Distress Syndrome or Novel Coronavirus Pneumonia Caused by COVID-19,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment",20582,"Mission Community Hospital, Panorama City, California, United States",https://ClinicalTrials.gov/show/NCT04798716
NCT04448717,Longitudinal Study of Seroprevalence of SARS-CoV-2 Antibodies and Development of Immunity in School Children,Observational Model: Cohort|Time Perspective: Prospective,2020-01336,"Epidemiology, Biostatistics and Prevention Institute (EBPI), University of Zurich, Zurich, Switzerland",https://ClinicalTrials.gov/show/NCT04448717
NCT04917549,Prevalence of Oral Lesions in COVID-19 Patients,Observational Model: Other|Time Perspective: Cross-Sectional,KD/04/20,"Dalia Rasheed Issa, Kafr Ash Shaykh, Kafr El-sheikh, Egypt",https://ClinicalTrials.gov/show/NCT04917549
NCT04834908,Evaluation of Equine Antibody Treatment in Patients With COVID 19 Infection,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,BSV_EQ-AB_20_08,"Jehangir Hospital, Pune, Maharashtra, India",https://ClinicalTrials.gov/show/NCT04834908
NCT04347460,Establishing a COVID-19 Prospective Cohort for Identification of Secondary HLH,Observational Model: Cohort|Time Perspective: Prospective,161/20 S,"Department of nephrology, Klinikum rechts der Isar, München, Bavaria, Germany",https://ClinicalTrials.gov/show/NCT04347460
NCT04387240,Evaluating the Efficacy of Artesunate in Adults With Mild Symptoms of COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",20-0192,"Princess Nourah Bint Abdulrahman Univeristy, Riyadh, Central, Saudi Arabia",https://ClinicalTrials.gov/show/NCT04387240
NCT04866069,Study of a Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) Adjuvanted Inactivated Vaccine in Healthy Adults,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention",ISV2AOH3ODN,"Ankara City Hospital Phase I Drug Research Center, Ankara, Turkey",https://ClinicalTrials.gov/show/NCT04866069
NCT04590274,Safety and Efficacy of Hydroxychloroquine for the Treatment & Prevention of Coronavirus Disease 2019 (COVID-19) Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2),Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,CTP-HCQ-COVID19,NA,https://ClinicalTrials.gov/show/NCT04590274
NCT04750629,"Clinical Evaluation of a Point-of-Care (POC), COVID-19 Rapid Antigen Test (CoviDx™)",Observational Model: Other|Time Perspective: Prospective,21 0115,"Doral Medical Research, Hialeah, Florida, United States|Comprehensive Clinical Research, West Palm Beach, Florida, United States",https://ClinicalTrials.gov/show/NCT04750629
NCT04800770,The Effect of COVID-19 Patients' Serum Phosphate Level on Mortality in ICU,Observational Model: Cohort|Time Perspective: Cross-Sectional,E1-21-1584,"Ankara City Hospital, Ankara, Turkey",https://ClinicalTrials.gov/show/NCT04800770
NCT04661930,Fenofibrate for Patients With COVID-19 Requiring Hospitalization,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",0105-20-BRZ,"Barzilai Medical Center, Ashkelon, Israel",https://ClinicalTrials.gov/show/NCT04661930
NCT04528927,"Evaluation of the Efficacy and Safety of Treatments for Patients Hospitalized for COVID-19 Infection Without Signs of Acute Respiratory Failure, in Tunisia",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,ECC2020-05,"Eshmoun Clinical Research Centre, Tunis, Tunisia",https://ClinicalTrials.gov/show/NCT04528927
NCT04374019,Novel Agents for Treatment of High-risk COVID-19 Positive Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,MCC-20-COVID-01-PMC,"University of Kentucky Markey Cancer Center, Lexington, Kentucky, United States",https://ClinicalTrials.gov/show/NCT04374019
NCT04374149,Therapeutic Plasma Exchange Alone or in Combination With Ruxolitinib in COVID-19 Associated CRS,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,PHU COVID-19-001,"Prisma Health, Greenville, South Carolina, United States",https://ClinicalTrials.gov/show/NCT04374149
NCT04933864,COVID-19 Treatment Using Methylene Blue and Photodynamic Therapy,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,2206,"I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russian Federation",https://ClinicalTrials.gov/show/NCT04933864
NCT04608305,"Evaluate the Safety, Immunogenicity and Potential Efficacy of an rVSV-SARS-CoV-2-S Vaccine","Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",IIBR 20-001,"Assuta - University Hospital, Ashdod, Israel|Barzilai MC, Ashkelon, Israel|Rambam MC, Haifa, Israel|Hadassah Medical Center, Jerusalem, Israel|Meir MC, Kfar Saba, Israel|Rabin MC, Petach Tikva, Israel|Sheba Medical Center Hospital- Tel Hashomer, Ramat Gan, Israel|Sourasky MC, Tel Aviv, Israel",https://ClinicalTrials.gov/show/NCT04608305
NCT04428073,Therapeutic Vaccine Trial of COVID-19 for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,GC004,NA,https://ClinicalTrials.gov/show/NCT04428073
NCT04381364,Inhalation of Ciclesonide for Patients With COVID-19: A Randomised Open Treatment Study (HALT COVID-19),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2020-02183,"Danderyd Hospital, Danderyd, Sweden|Capio S:t Görans Hospital, Stockholm, Sweden|Karolinska University Hospital, Stockholm, Sweden|Visby Hospital, Visby, Sweden|Västmanland County Hospital Västerås, Västerås, Sweden|Örebro University Hospital, Örebro, Sweden",https://ClinicalTrials.gov/show/NCT04381364
NCT04568148,COVID-19 Biorepository,Observational Model: Other|Time Perspective: Other,STUDY#00145602,"University of Kansas Medical Center, Kansas City, Kansas, United States",https://ClinicalTrials.gov/show/NCT04568148
NCT04613050,Effect of Respiratory Versus Aerobic Training on Respiratory and Immunity Efficiency in Recovered COVID- 19 Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,MAHA2020,"Police hospital-Nasr city, Cairo, Egypt",https://ClinicalTrials.gov/show/NCT04613050
NCT04840953,"Negative Pressure Therapy, Minimally Invasive and Accessible Technique in the Treatment of Massive Subcutaneous Emphysema in COVID-19 or Non Infected Critical Patients",Observational Model: Case-Only|Time Perspective: Prospective,ENFIVAC,"Hospital General Universitario de Elche, Elche, Alicante, Spain",https://ClinicalTrials.gov/show/NCT04840953
NCT04958889,COVID-19 Recovery Study: Symptoms and Biomarkers of Long COVID-19 in People Living With and Without HIV,Observational Model: Cohort|Time Perspective: Prospective,IRB00278774,"Johns Hopkins University, Baltimore, Maryland, United States",https://ClinicalTrials.gov/show/NCT04958889
NCT04403607,Cardiac Imaging in SARS-CoV-2 (COVID-19),Observational Model: Cohort|Time Perspective: Prospective,GN20ID164,"Royal Alexandra Hospital, Paisley, Renfrewshire, United Kingdom|Royal Infirmary, Glasgow, United Kingdom|Queen Elizabeth University Hospital, Glasgow, United Kingdom",https://ClinicalTrials.gov/show/NCT04403607
NCT04675086,Aralast NP With Antiviral Treatment and Standard of Care Versus Antiviral Treatment With Standard of Care in Hospitalized Patients With Pneumonia and COVID-19 Infection,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,CCR-2020-103188,"Blessing Corporate Services, Inc, Hannibal, Missouri, United States",https://ClinicalTrials.gov/show/NCT04675086
NCT04363853,Tocilizumab Treatment in Patients With COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,INF-3343-20-22-1,"National Cancer Institute of Mexico, Mexico city, Distrito Federal, Mexico",https://ClinicalTrials.gov/show/NCT04363853
NCT04462783,Emergency Department (ED) Self-Monitoring Pilot COVID-19,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,HUM00181946,NA,https://ClinicalTrials.gov/show/NCT04462783
NCT04854798,UNITE Study (UMN-SW) for COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,Pro00050829,"M Health Fairview Ridges Hospital, Burnsville, Minnesota, United States|M Health Fairview St. Joseph's Hospital, Saint Paul, Minnesota, United States",https://ClinicalTrials.gov/show/NCT04854798
NCT04871828,The Efficacy of Leukotriene Inhibitor in Adult Patients With Moderate SARS-COV-2 Symptoms (COVID19),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",RC20/206/R,"King Abdulaziz Medical city, MNGHA, Riyadh, Saudi Arabia",https://ClinicalTrials.gov/show/NCT04871828
NCT04375397,Study of Oral Ibrutinib Capsules to Assess Respiratory Failure in Adult Participants With Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and Pulmonary Injury,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",M20-310,"Stanford Univ School Medicine /ID# 221954, Stanford, California, United States|Medstar Washington Hospital Center /ID# 221886, Washington, District of Columbia, United States|GW Medical Faculty Associates /ID# 222023, Washington, District of Columbia, United States|Midway Immunology and Research /ID# 222004, Fort Pierce, Florida, United States|University of Miami /ID# 223227, Miami, Florida, United States|Triple O Research Institute /ID# 222944, West Palm Beach, Florida, United States|Brigham & Women's Hospital /ID# 221847, Boston, Massachusetts, United States|Beth Israel Deaconess Medical Center /ID# 222994, Boston, Massachusetts, United States|Intermountain Healthcare /ID# 221955, Salt Lake City, Utah, United States",https://ClinicalTrials.gov/show/NCT04375397
NCT04441489,Assessment of Lung Inflammation With FDG PET/CT in COVID-19,Observational Model: Case-Only|Time Perspective: Prospective,PET-COVID,"Centre Hospitalier Princesse Grace, Monaco, Monaco",https://ClinicalTrials.gov/show/NCT04441489
NCT04367142,Rapid Detection of COVID-19 by Portable and Connected Biosensor,Observational Model: Case-Control|Time Perspective: Prospective,2020_36|2020-A01147-32,"CHU lille, Lille, France",https://ClinicalTrials.gov/show/NCT04367142
NCT04562285,Sustained Immunity to SARS-CoV-2,Observational Model: Cohort|Time Perspective: Retrospective,13978,"Henry Ford Health System, Detroit, Michigan, United States",https://ClinicalTrials.gov/show/NCT04562285
NCT04304690,"COVID-19 Seroconversion Among Front Line Medical and Paramedical Staff in Emergency, Intensive Care Units and Infectious Disease Departments During the 2020 Epidemic",Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,APHP200310,"Hopital Pitié Salpetrière, Paris, France",https://ClinicalTrials.gov/show/NCT04304690
NCT04364711,EuRopean Study of MAjor Infectious Disease Syndromes Related to COVID-19,Observational Model: Cohort|Time Perspective: Prospective,ReCoVer - MERMAIDS 2.0,NA,https://ClinicalTrials.gov/show/NCT04364711
NCT04445246,Inhaled Iloprost for Suspected COVID-19 Respiratory Failure,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,MRC-05-026,"Hamad Medical Corporation, Doha, Qatar",https://ClinicalTrials.gov/show/NCT04445246
NCT04695301,Functional Outcomes in COVID-19 Survivors and Use of a Digital Platform for Rehabilitation,Allocation: Non-Randomized|Intervention Model: Crossover Assignment|Masking: Single (Participant)|Primary Purpose: Other,34170820.0.1001.0071,"Instituto Israelita de Ensino e Pesquisa Albert Einstein 's (IIEP), São Paulo, Brazil",https://ClinicalTrials.gov/show/NCT04695301
NCT04535791,Efficacy of Vitamin D Supplementation to Prevent the Risk of Acquiring COVID-19 in Healthcare Workers,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",R-2020-785-090,"Hospital Centro Medico Nacional Siglo XXI, Mexico City, Distrito Federal, Mexico",https://ClinicalTrials.gov/show/NCT04535791
NCT04363671,Adolescents and Health Professionals Faced With the Necessity for Changing to Remote Care During the COVID-19 Outbreak Quarantine (AdoPro-Cov19),Observational Model: Other|Time Perspective: Prospective,P20-670,"Maison de Solenn, Cochin Hospital, Paris, France",https://ClinicalTrials.gov/show/NCT04363671
NCT04785157,Neurotropism and Neuroinflammation in COVID-19 Patients With Delirium.,Observational Model: Cohort|Time Perspective: Prospective,RC31/20/0441|2020-005827-35,"University Hospital of Toulouse, Toulouse, France|CHRU Tours, Tours, France",https://ClinicalTrials.gov/show/NCT04785157
NCT04453488,Clinical Trial to Evaluate the Efficacy of RUTI® Against SARS-COV-2 Infection (COVID-19) in Healthcare Workers,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",RUTICOVID19,"Hospital Universitari Germans Trias i Pujol UBP Riscos Laborals, Badalona, Barcelona, Spain|Hospital de la Santa Creu i Sant Pau, Barcelona, Spain",https://ClinicalTrials.gov/show/NCT04453488
NCT04344600,Peginterferon Lambda-1a for the Prevention and Treatment of SARS-CoV-2 (COVID-19) Infection,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Prevention,IRB00248163,"Johns Hopkins Hospital, Baltimore, Maryland, United States",https://ClinicalTrials.gov/show/NCT04344600
NCT04916574,Clinical Trial of BioBlock COVID-19 Nasal Spray Containing Anti-SARS-CoV-2 Antibodies Derived From Bovine Colostrum,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,Ico-CT001,"Icosagen AS, Tartu, Estonia",https://ClinicalTrials.gov/show/NCT04916574
NCT04495907,COVID-19 Progression in End-Stage Kidney Disease,Observational Model: Cohort|Time Perspective: Other,20-M-0047-00,"DCR Victorville, Victorville, California, United States|DCR Connecticut, Bridgeport, Connecticut, United States|DCR Twin Cities, Minneapolis, Minnesota, United States|DCR Las Vegas, Las Vegas, Nevada, United States|DCR Bronx, Bronx, New York, United States|DCR Canton, Canton, Ohio, United States|DCR El Paso, El Paso, Texas, United States|DCR Lewisville, Lewisville, Texas, United States|DCR San Antonio, San Antonio, Texas, United States|DCR Norfolk, Norfolk, Virginia, United States|DCR Milwaukee, Milwaukee, Wisconsin, United States",https://ClinicalTrials.gov/show/NCT04495907
NCT04408040,Use of Convalescent Plasma for COVID-19,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,NSH 1281,"Northside Hospital, Atlanta, Georgia, United States",https://ClinicalTrials.gov/show/NCT04408040
NCT04359901,Sarilumab for Patients With Moderate COVID-19 Disease,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,IRB 3305,"VA Connecticut Healthcare System, West Haven, Connecticut, United States|VA Maine Healthcare System, Augusta, Maine, United States|VA Boston Healthcare System, Boston, Massachusetts, United States|Providence VA Medical Center, Providence, Rhode Island, United States|VA Medical Center - White River Junction, White River Junction, Vermont, United States",https://ClinicalTrials.gov/show/NCT04359901
NCT04395924,Maternal-foetal Transmission of SARS-Cov-2,Observational Model: Cohort|Time Perspective: Prospective,CHRO-2020-10,"CHR Orléans, Orléans, France",https://ClinicalTrials.gov/show/NCT04395924
NCT04445467,An Adaptive Clinical Trial of Antivirals for COVID-19 Infection,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",66223,"Alfred Health, Melbourne, Victoria, Australia",https://ClinicalTrials.gov/show/NCT04445467
NCT04338945,Impact of Pandemic COVID-19 on Surgical Specialities Residents in Italy,Observational Model: Cohort|Time Perspective: Prospective,COVID-ItaliansurgRES-SPIGC,"U.O.C. Chirurgia Generale Universitaria ""V. Bonomo"", Bari, Italy|Ospedale Perrino Asl Brindisi, Brindisi, Italy|Dipartimento di scienze mediche e chirurgiche, Università di Catanzaro, Catanzaro, Italy|Ospedale Policlinico San Martino, Genova, Italy|Azienda Ospedaliera San Camillo-Forlanini, Roma, Italy|IRCCS Fondazione Policlinico Universitario Agostino Gemelli, Roma, Italy|Ospedale Cristo re, Roma, Italy",https://ClinicalTrials.gov/show/NCT04338945
NCT04801134,Interventions to Manage Food Insecurity and Inappropriate Feeding Practices Related to the COVID-19 Pandemic,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,HRP-UT901,"CommUnityCare Health Center, Austin, Texas, United States",https://ClinicalTrials.gov/show/NCT04801134
NCT04459247,"Short Term, High Dose Vitamin D Supplementation for COVID-19","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment",121/20,"Deptt of Endocrinology, Chandigarh, India",https://ClinicalTrials.gov/show/NCT04459247
NCT04342195,Acquiring Convalescent Specimens for COVID-19 Antibodies,Observational Model: Case-Only|Time Perspective: Cross-Sectional,AAAS9517,"Columbia University Irving Medical Center/NYP, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04342195
NCT04351347,The Efficacy of Ivermectin in Larger Doses in COVID-19 Treatment,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,ivermecin covid,"Tanta University, Tanta, Egypt",https://ClinicalTrials.gov/show/NCT04351347
NCT04425915,Efficacy of Convalescent Plasma Therapy in Patients With COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,ILBS-COVID-04,"Maulana Azad Medical College, New Delhi, Delhi, India|Institute of Liver & Biliary Sciences, New Delhi, Delhi, India|Rajiv Gandhi Super Speciality Hospital, New Delhi, Delhi, India",https://ClinicalTrials.gov/show/NCT04425915
NCT04460638,SARS-CoV2 (COVID-19) Diagnosis in Human Saliva by MALDI-TOF MS Profiling,Observational Model: Cohort|Time Perspective: Prospective,2020-COVID19-15|2020-A01249-30,"Hôpital d'Instruction des Armées Laveran, Marseille, France",https://ClinicalTrials.gov/show/NCT04460638
NCT04761718,Covid-19 Epidemic Lockdown Impact on Psychomotor Performance,Observational Model: Cohort|Time Perspective: Cross-Sectional,Covid-19 Epidemic impact,NA,https://ClinicalTrials.gov/show/NCT04761718
NCT04357834,WAVE. Wearable-based COVID-19 Markers for Prediction of Clinical Trajectories,Observational Model: Other|Time Perspective: Prospective,WAVE,"Emergency Department, University Hospital Bern, Inselspital, Bern, Switzerland",https://ClinicalTrials.gov/show/NCT04357834
NCT04505631,Follow-up of Respiratory Sequelae of Hospitalized Patients With COVID-19,Observational Model: Cohort|Time Perspective: Prospective,GHR 1052|IDRCB 2020-A01089-30,"Groupe Hospitalier de Mulhouse et de la Région Sud-Alsace, Mulhouse, Alsace, France|Centre Hospitalier de la Côte Basque - Bayonne, Bayonne, France|Centre Hospitalier Métropole Savoie, Chambéry, France|Centre Hospitalier Colmar, Colmar, France|Centre Hospitalier Douai, Douai, France|Centre Hospitalier de Dunkerque, Dunkerque, France|Centre Hospitalier Départemental Vendée - La Roche sur Yon, La Roche-sur-Yon, France|Centre Hospitalier du Mans, Le Mans, France|Centre Hospitalier Robert Boulin - Libourne, Libourne, France|Centre Hospitalier Annecy Genevois, Metz-Tessy, France|Centre Hospitalier Régional Metz-Thioville, Metz, France|Centre Hospitalier Le Raincy Montfermeil, Montfermeil, France|Centre Hospitalier Régional Orléans, Orléans, France|Centre Hospitalier de Soissons, Soissons, France",https://ClinicalTrials.gov/show/NCT04505631
NCT04346186,COVID-19: Investigation of Transmission and Immunisation Among Hospital Staff,Observational Model: Cohort|Time Perspective: Prospective,RegHCOVIDScreening,"Herlev Hospital, Herlev, Region Hovedstaden, Denmark|Bispebjerg Hospital, København NV, Region Hovedstaden, Denmark|Psykiatrisk Center Ballerup, Ballerup, Denmark|Psykiatrisk Center København, Copenhagen, Denmark|Rigshospitalet, Copenhagen, Denmark|Psykiatrisk Center Amager, Copenhagen, Denmark|Psykiatrisk Center Stolpegaard, Gentofte, Denmark|Børne- og Ungdomspsykiatrisk Center, Glostrup, Denmark|Psykiatrisk Center Glostrup, Glostrup, Denmark|Nordsjaellands Hospital, Hillerød, Denmark|Psykiatrisk Center Nordsjælland, Hillerød, Denmark|Psykiatrisk Center Sankt Hans, Roskilde, Denmark|Bornholms Hospital, Rønne, Denmark|Psykiatrisk Center Bornholm, Rønne, Denmark",https://ClinicalTrials.gov/show/NCT04346186
NCT04416893,Part 2 on the Study Prevalence of SARS -Cov2 Carriage in Asymptomatic and Mildly-symptomatic Children (COVILLE2) (WHO),Observational Model: Cohort|Time Perspective: Prospective,COVILLE2,NA,https://ClinicalTrials.gov/show/NCT04416893
NCT04839068,the Impact of Covid-19 Pandemic Stress on Pregnancy Outcomes,Observational Model: Cohort|Time Perspective: Cross-Sectional,covid2021,"The Clinical Obstetrics and Gynaecology department, Assuit University Hospital, Egypt, Assiut, Egypt",https://ClinicalTrials.gov/show/NCT04839068
NCT04823182,Study of HEarT DiseAse and ImmuNiTy After COVID-19 in Ireland,Observational Model: Case-Only|Time Perspective: Prospective,SETANTA_Study_Protocol_V2.0,"Cardiovascular Research Institute Dublin, Dublin, Ireland",https://ClinicalTrials.gov/show/NCT04823182
NCT04658433,The Effect of Omega -3 Supplements on the Serum Levels of ACE/ACE2 Ratio as a Potential Key in Cardiovascular Disease and COVID-19; A Randomized Clinical Trial in the Covid-19 Uninfected Jordanian People,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Prevention,2020-PHA-22,"Mahmoud S Abu-Samak, Amman, Jordan",https://ClinicalTrials.gov/show/NCT04658433
NCT04394390,Do Vitamin D Levels Really Correlated With Disease Severity in COVID-19 Patients?,Observational Model: Case-Control|Time Perspective: Prospective,1,"Bursa City Hospital, Bursa, Dogankoy, Turkey",https://ClinicalTrials.gov/show/NCT04394390
NCT04482712,Effects of mTOR Inhibition With Sirolimus (RAPA) in Patients With COVID-19 to Moderate the Progression of ARDS,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",HSC20200489H,"University Hospital System, San Antonio, Texas, United States|Audie L Murphy Memorial Veterans Hospital, San Antonio, Texas, United States",https://ClinicalTrials.gov/show/NCT04482712
NCT04420260,Primary Prevention of Infection by COVID-19 in Workers,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",UNIGEM PT-IC-02,"Beatriz Aristizabal, Medellin, Antioquia, Colombia",https://ClinicalTrials.gov/show/NCT04420260
NCT04402814,IgG/IgM Antibody Test in Patients Who Have Tested Negative or Positive for COVID-19 With the Standard Method of COVID19 Testing.,Observational Model: Cohort|Time Perspective: Prospective,IgG/IgM COVID19|2005801,"Fadi A. Haddad MD Inc., La Mesa, California, United States|Sharp Grossmont Hospital, La Mesa, California, United States|Sharp Memorial Hosptial, San Diego, California, United States",https://ClinicalTrials.gov/show/NCT04402814
NCT04447534,Zinc With Chloroquine/Hydroxychloroquine in Treatment of COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment",tanta zinc chloroquine,"Tanta university hospital, Assuit University, Ainshams University, Tanta, Egypt",https://ClinicalTrials.gov/show/NCT04447534
NCT04431414,A Study of Immune Responses to the Virus That Causes COVID-19,Observational Model: Cohort|Time Perspective: Prospective,CoVPN 5001|5UM1AI068614-14,"Alabama CRS, Birmingham, Alabama, United States|Bridge HIV CRS, San Francisco, California, United States|University of Miami Infectious Disease Research Unit at Jackson Memorial Hospital CRS, Miami, Florida, United States|The Ponce de Leon Center CRS, Atlanta, Georgia, United States|The Hope Clinic of the Emory Vaccine Center CRS, Decatur, Georgia, United States|New Orleans Adolescent Trials Unit CRS, New Orleans, Louisiana, United States|Johns Hopkins University CRS, Baltimore, Maryland, United States|Brigham and Women's Hospital Vaccine CRS (BWH VCRS), Boston, Massachusetts, United States|Fenway Health (FH) CRS, Boston, Massachusetts, United States|New Jersey Medical School Clinical Research Center CRS, Newark, New Jersey, United States|Columbia P&S CRS, New York, New York, United States|New York Blood Center CRS, New York, New York, United States|University of Rochester Vaccines to Prevent HIV Infection CRS, Rochester, New York, United States|Chapel Hill CRS, Chapel Hill, North Carolina, United States|Case CRS, Cleveland, Ohio, United States|Penn Prevention CRS, Philadelphia, Pennsylvania, United States|Seattle Vaccine and Prevention CRS, Seattle, Washington, United States|Fundacion Huesped CRS, Buenos Aires, Argentina|Hospital General de Agudos JM Ramos Mejía CRS, Buenos Aires, Argentina|Gaborone CRS, Gaborone, Botswana|SOM Federal University Minas Gerais Brazil NICHD CRS, Belo Horizonte, Brazil|Instituto de Pesquisa Clinica Evandro Chagas (IPEC) CRS, Rio de Janeiro, Brazil|Kisumu Crs, Kisumu, Kenya|Malawi CRS, Lilongwe, Malawi|Merida CRS, Mérida, Mexico|Polana Canico Health Research and Training Center (CISPOC), National Institute of Health (INS) CRS, Maputo, Mozambique|CITBM - UNIDEC, Centro de Investigaciones Tecnológicas, Biomédicas y Medioambientales CRS, Bellavista, Peru|Asociacion Civil Selva Amazonica (ASCA) CRS, Iquitos, Peru|Barranco CRS, Lima, Peru|San Miguel CRS, Lima, Peru|Via Libre CRS, Lima, Peru|Groote Schuur HIV CRS, Cape Town, South Africa|Khayelitsha CRS / (CIDRI UCT), Cape Town, South Africa|Masiphumelele Clinical Research Site (MASI) CRS, Cape Town, South Africa|Chatsworth CRS, Chatsworth, South Africa|Botha's Hill CRS, Durban, South Africa|CAPRISA eThekwini CRS, Durban, South Africa|Vulindlela CRS, Durban, South Africa|Ndlovu Research Centre CoVPN CRS, Elandsdoorn, South Africa|Isipingo CRS, Isipingo, South Africa|Kliptown Soweto CRS, Johannesburg, South Africa|Soweto HVTN CRS, Johannesburg, South Africa|Aurum Institute Klerksdorp CRS, Klerksdorp, South Africa|Qhakaza Mbokodo Research Clinic CRS, Ladysmith, South Africa|MeCRU CRS, Medunsa, South Africa|Nelson Mandela Academic Research Unit CRS, Mthatha, South Africa|Rustenburg CRS, Rustenburg, South Africa|Setshaba Research Centre CRS, Soshanguve, South Africa|Tembisa Clinic 4 CoVPN CRS, Tembisa, South Africa|Tongaat CRS, Tongaat, South Africa|Verulam CRS, Verulam, South Africa|National Institute for Medical Research (NIMR) - Mbeya Medical Research Center (MMRC) Network CRS, Mbeya, Tanzania|Matero Reference Clinic CRS, Lusaka, Zambia|Zambia Emory HIV Research Project - Lusaka CoVPN CRS, Lusaka, Zambia|Zambia Emory HIV Research Project - Ndola CoVPN CRS, Ndola, Zambia|St Mary's CRS, Chitungwiza, Zimbabwe|Milton Park CRS, Harare, Zimbabwe|Seke South CRS, Harare, Zimbabwe",https://ClinicalTrials.gov/show/NCT04431414
NCT04409821,Tele-based Psychological Emotional Support for Informal CARegivers of COVID-19 Patients in Intensive Care,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,P-2020-544|0216-00030B,"Skejby Hospital, Aarhus, Denmark|Rigshospitalet, Copenhagen, Denmark|Hospitalsenheden Vest, Horsens, Horsens, Denmark|Hvidovre Hospital, Hvidovre, Denmark|Sygehus Lillebælt, Kolding, Kolding, Denmark|Odense University Hospital, Odense, Denmark",https://ClinicalTrials.gov/show/NCT04409821
NCT04390217,LB1148 for Pulmonary Dysfunction Associated With COVID-19 Pneumonia,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",LBS-COVID19-201,NA,https://ClinicalTrials.gov/show/NCT04390217
NCT04415060,SedAting With Volatile Anesthetics Critically Ill COVID-19 Patients in ICU: Effects On Ventilatory Parameters And Survival,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2149,"University of Alberta Hospital, Edmonton, Alberta, Canada|London Health Sciences Centre - University Hospital, London, Ontario, Canada|London Health Sciences Centre - Victoria Hospital, London, Ontario, Canada|The Ottawa Hospital, Ottawa, Ontario, Canada|Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada|University Health Network - Toronto General Hospital, Toronto, Ontario, Canada|University Health Network - Toronto Western Hopsital, Toronto, Ontario, Canada|Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada|McGill University Health Centre - Royal Victoria Hospital, Montréal, Quebec, Canada|Hôpital Sacré-Coeur de Montréal, Montréal, Quebec, Canada|Institut Universitaire de Cardiologie et de Pneumologie de Quebec (IUCPQ), Québec, Quebec, Canada|Universite de Sherbrooke, Sherbrooke, Quebec, Canada",https://ClinicalTrials.gov/show/NCT04415060
NCT04383678,Outcome of COVID-19 Patients After Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome,Observational Model: Cohort|Time Perspective: Retrospective,COVID-19 ECMO,"Helsinki University Hospital, Helsinki, Finland|University Hospital Jean Minjoz, Besançon, France|Nancy University Hospital, Nancy, France|Henri Mondon Unoversity Hospital, Paris, France|Robert Debré University Hospital, Reims, France|Hamburg University Heart Center, Hamburg, Germany|Münster University Hospital, Münster, Germany|S. Orsola Hospital, Bologna, Italy|Lecco Hospital, Lecco, Italy|Karolinska University Hospital, Stockholm, Sweden|University Hospitals of Leicester, Leicester, United Kingdom",https://ClinicalTrials.gov/show/NCT04383678
NCT04399746,Ivermectin-Azithromycin-Cholecalciferol (IvAzCol) Combination Therapy for COVID-19,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,IvAzCol,"Outpatient treatment, Mexico City, Mexico",https://ClinicalTrials.gov/show/NCT04399746
NCT04818853,COVID-19 Associated Pulmonary Aspergillosis (CAPA) and Other Invasive Fungal Infections (IFI),Observational Model: Cohort|Time Perspective: Prospective,IRB-300006311,"The University of Alabama at Birmingham, Birmingham, Alabama, United States",https://ClinicalTrials.gov/show/NCT04818853
NCT04385810,Description of Ophthalmologic Injuries in Intensive Care During the SARS-CoV2 Epidemic - COVID19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,JDS_2020_13,"Fondation Adolphe de Rothschild, Paris, France",https://ClinicalTrials.gov/show/NCT04385810
NCT04870593,What Works to Get the Elderly Vaccinated Against COVID-19? Experimental Evidence From India,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,1702861995A021,"JPAL SA at IFMR, Chennai, Tamil Nadu, India",https://ClinicalTrials.gov/show/NCT04870593
NCT04493268,HYPONATREMIA IN COVID-19 PATIENTS,Observational Model: Cohort|Time Perspective: Prospective,HYPONATREMIA IN COVID PATIENTS,"Hospital Posadas, Buenos Aires, Argentina",https://ClinicalTrials.gov/show/NCT04493268
NCT04353271,Trial of Hydroxychloroquine In Covid-19 Kinetics,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",[1582736-1],"University of South Alabama, Mobile, Alabama, United States",https://ClinicalTrials.gov/show/NCT04353271
NCT04480580,Seroprevalence of SARS-Cov-2 in the Setting of a Non-dedicated COVID-19 Hospital in a Low CoV-2 Incidence Area: Implications for Surgery,Observational Model: Cohort|Time Perspective: Retrospective,COVID-SURG,"AOU Cagliari, Cagliari, CA, Italy",https://ClinicalTrials.gov/show/NCT04480580
NCT04582214,Oscillation and Lung Expansion Therapy in Patients With COVID-19,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,CR-RR-2020-002,"Emory University, Atlanta, Georgia, United States|Northwestern University, Evanston, Illinois, United States",https://ClinicalTrials.gov/show/NCT04582214
NCT04416061,The Role of a Private Hospital in Hong Kong Amid COVID-19 Pandemic,Observational Model: Cohort|Time Perspective: Retrospective,RC-2020-08,"Hong Kong Sanatorium & Hospital, Hong Kong, Hong Kong",https://ClinicalTrials.gov/show/NCT04416061
NCT04607928,Pirfenidone Compared to Placebo in Post-COVID19 Pulmonary Fibrosis COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention",2020-002518-42,"University Hospital of Bellvitge, Hospitalet de Llobregat, Barcelona, Spain|Hospital Germans Trias i Pujol, Badalona, Spain|Hospital Clínic, Barcelona, Spain|Hospital del Mar, Barcelona, Spain|Hospital Sant Pau, Barcelona, Spain|Hospital La Princes, Madrid, Spain|Hospital Puerta de Hierro, Madrid, Spain|Hospital Ramón y Cajal, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04607928
NCT04643860,Differential Leucocyte Count and Covid-19 Diagnosis,Observational Model: Cohort|Time Perspective: Cross-Sectional,DEP_042020,"IRCCS INM Neuromed, Department of Epidemiology and Prevention, Pozzilli, IS, Italy",https://ClinicalTrials.gov/show/NCT04643860
NCT04616846,Thromboembolic Risk Screening in Patients With Cancer and COVID-19,Allocation: Non-Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Screening,2020/20,"Clinique Saint-Jean, Cagnes-sur-Mer, Alpes-Maritimes, France|Centre Azuréen de Cancérologie, Mougins, Alpes-Maritimes, France|CHU Nice, Nice, Alpes-Maritimes, France|Clinique Saint-Georges, Nice, Alpes-Maritimes, France|Centre Antoine Lacassagne, Nice, Alpes-Maritimes, France|CHPG, Monaco, Monaco",https://ClinicalTrials.gov/show/NCT04616846
NCT04554264,Complicated Grief in ICU in the Aftermath of COVID-19,Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,PI2020_843_0071,"CHU Amiens, Amiens, France",https://ClinicalTrials.gov/show/NCT04554264
NCT04498936,Sofosbuvir/Ledipasvir and Nitazoxanide for Treatment of COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,COVID-19 treatment,"15th May Hospital, Helwan, Cairo, Egypt|Assiut University Hospital, Assiut, Egypt",https://ClinicalTrials.gov/show/NCT04498936
NCT04596943,RGD PET/CT Imaging in COVID-19 Patients,Observational Model: Cohort|Time Perspective: Prospective,NL73551.091.20|2020-001325-31,"Radboudumc, Nijmegen, Netherlands",https://ClinicalTrials.gov/show/NCT04596943
NCT04819165,Healthcare-associated Infections in Severe COVID-19 During 2020,Observational Model: Cohort|Time Perspective: Retrospective,5/2021,"Sanatorio Anchorena de San Martin, San Martín, Buenos Aires, Argentina",https://ClinicalTrials.gov/show/NCT04819165
NCT04531618,Mother-infant Bonding During COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,AAAT0140,"Morgan Stanley Children's Hopspital, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04531618
NCT04764032,Right Ventricular Dysfunction in Ventilated Patients With COVID-19,Observational Model: Cohort|Time Perspective: Prospective,20/COVID/17,"Aberdeen Royal Infirmary, Aberdeen, United Kingdom|Univeristy Hospital, Ayr, Ayr, United Kingdom|Golden Jubilee National Hospital, Clydebank, United Kingdom|Dumfries and Galloway Royal Infirmary, Dumfries, United Kingdom|University Hospital Hairmyres, East Kilbride, United Kingdom|Queen Elizabeth University Hospital, Glasgow, United Kingdom|Glasgow Royal Infirmary, Glasgow, United Kingdom|Raigmore Hospital, Inverness, United Kingdom|University Hospital, Crosshouse, Kilmarnock, United Kingdom|Royal Alexandra hospital, Paisley, United Kingdom|University Hospital, Wishaw, Wishaw, United Kingdom",https://ClinicalTrials.gov/show/NCT04764032
NCT04393051,Baricitinib Compared to Standard Therapy in Patients With COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,BARICIVID-19,"Azienda Ospedaliero Universitaria Pisana, Pisa, Italy",https://ClinicalTrials.gov/show/NCT04393051
NCT04472611,Colchicine/Statins for the Prevention of COVID-19 Complications (COLSTAT) Trial,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2000027950,"Bridgeport Hospital, Bridgeport, Connecticut, United States|Greenwich Hospital, Greenwich, Connecticut, United States|Yale New Haven Hosptial System, New Haven, Connecticut, United States|Lawrence & Memorial Hospital, New London, Connecticut, United States",https://ClinicalTrials.gov/show/NCT04472611
NCT04525742,COVID-19 Pandemic and Parents of Disabled Children,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Screening,105,"Health Science University Gaziosmanpasa Training and Research Hospital, İstanbul, Gaziosmanpasa, Turkey",https://ClinicalTrials.gov/show/NCT04525742
NCT04898179,Support for COVID19 Patients at Home,Observational Model: Case-Control|Time Perspective: Prospective,ICS Maugeri CE2455,"Azienda Socio Sanitaria Territoriale (ASST) BERGAMO EST, Ospedale Bolognini di Seriate, Seriate, Bergamo, Italy|Ics Maugeri, Lumezzane, Brescia, Italy|Ics Maugeri, Tradate, Varese, Italy|Istituto Auxologico Italiano, Milano, Italy",https://ClinicalTrials.gov/show/NCT04898179
NCT04344548,Adoptive Cell Transfer for the Immunotherapy of COVID-19 in Colombia,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,UNAL FSA COVID|Estudio Clinico,"Fundacion Salud De Los Andes, Bogotá, Bogotá Distrito Capital, Colombia|Universidad Nacional de Colombia, Bogota, Cundinamarca, Colombia",https://ClinicalTrials.gov/show/NCT04344548
NCT04883216,Investigation of the Characteristics of Chronic Pain Developing After COVID-19,Observational Model: Case-Only|Time Perspective: Prospective,2021/389,"Istanbul University Istanbul Faculty of Medicine, İstanbul, Turkey",https://ClinicalTrials.gov/show/NCT04883216
NCT04384588,COVID19-Convalescent Plasma for Treating Patients With Active Symptomatic COVID 19 Infection (FALP-COVID),Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,FALP 001-2020,"Fundacion Arturo Lopez Perez, Providencia, Santiago, Chile",https://ClinicalTrials.gov/show/NCT04384588
NCT04356937,Efficacy of Tocilizumab on Patients With COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",2020P001159,"Massachusetts General Hospital, Boston, Massachusetts, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States|Newton-Wellesley Hospital, Newton, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT04356937
NCT04316299,Acute Kidney Injury in Patients Hospitalized With COVID-19,Observational Model: Case-Control|Time Perspective: Retrospective,hkyy2020-005 AKI,"Hankou Hospital, Wuhan, Hubei, China",https://ClinicalTrials.gov/show/NCT04316299
NCT04786808,Risk Factors for COVID-19 Mortality,Observational Model: Cohort|Time Perspective: Prospective,RF-COVID-AUSLPC,"Azienda USL di Piacenza, Piacenza, Emilia-Romagna, Italy",https://ClinicalTrials.gov/show/NCT04786808
NCT04362969,"COVID-EC Study: Clinical Characteristics of Patients With COVID-19 in Guayaquil, Ecuador",Observational Model: Cohort|Time Perspective: Retrospective,1,"GastroMuñoz, Guayaquil, Guayas, Ecuador",https://ClinicalTrials.gov/show/NCT04362969
NCT04913142,About Oral and Gut Microbiota in Intensive Care Unit : SARS-CoV-2 (COVID-19) Infection Impact.,Observational Model: Cohort|Time Perspective: Prospective,RC31/21/0019|2021-A00096-35,"University Hospital of Toulouse, Toulouse, France",https://ClinicalTrials.gov/show/NCT04913142
NCT04654442,Feasibility and Analytic Performance of TestNPass (IVDMD) for CoViD-19 Diagnosis on Saliva Sample,Observational Model: Case-Control|Time Perspective: Cross-Sectional,38RC20.378|2020-A03087-32,"Grenoble University Hospital, Grenoble cedex 9, France",https://ClinicalTrials.gov/show/NCT04654442
NCT04967781,Autoimmunity Contributes to the Severe Progression of COVID-19,Observational Model: Case-Control|Time Perspective: Retrospective,AUTO001,"Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China",https://ClinicalTrials.gov/show/NCT04967781
NCT04364594,COVID-19 Search in Conjunctival Cells,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,0013008/20,"Maria Cristina Savastano, Roma, Italy",https://ClinicalTrials.gov/show/NCT04364594
NCT04858412,Study of HMB-enriched Amino Acid Supplementation in Patients With Alcoholic Liver Disease and COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Basic Science",20-1194,"Cleveland Clinic Foundation, Cleveland, Ohio, United States",https://ClinicalTrials.gov/show/NCT04858412
NCT04896970,Risk of SARS-CoV-2 Infection (COVID-19) in a Standing Concert in a Closed Performance Hall,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,RECHMPL21_0110,NA,https://ClinicalTrials.gov/show/NCT04896970
NCT04713488,"An Open Study on the Safety, Tolerability, and Immunogenicity of ""Sputnik Light"" Vaccine",Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,06 - Sputnik Light - 2020,"ECO-Safety, Sankt Peterburg, Russian Federation",https://ClinicalTrials.gov/show/NCT04713488
NCT04753463,Assessment of the Impact of COVID-19 Pandemic on Residents Training and Mental Health in Poland,Observational Model: Cohort|Time Perspective: Prospective,1775,"Medical University, Białystok, Poland|Ophthalmology Clinic Medical University of Bialystok, Białystok, Poland",https://ClinicalTrials.gov/show/NCT04753463
NCT04883177,Effectiveness and Safety of the COVID-19 Vaccination for Patients With Liver Disease (CHESS2101),Observational Model: Cohort|Time Perspective: Prospective,CHESS2101,"The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China|Beijing You'an Hospital, Beijing, Beijing, China|Chongqing Fuling Central Hospital, Chongqing, Chongqing, China|The First Affiliated Hospital of Chongqing Medical University, Chongqing, Chongqing, China|The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China|Jinchang Central Hospital, Jinchang, Gansu, China|The First Hospital of Lanzhou University, Lanzhou, Gansu, China|Qingyang People's Hospital, Qingyang, Gansu, China|The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China|Xingtai People's Hospital, Xingtai, Hebei, China|Baoding People's Hospital, Baoding, Heibei, China|Henan Provincial People's Hospital, Zhengzhou, Henan, China|Wuhan Jinyintan Hospital, Wuhan, Hubei, China|The First People's Hospital of Taicang, Taicang, Jiangsu, China|Wuxi Fifth People's Hospital, Wuxi, Jiangsu, China|The Affiliated Third Hospital of Jiangsu University, Zhenjiang, Jiangsu, China|Jinzhou Central Hospital, Jinzhou, Liaoning, China|Sixth People's Hospital of Shenyang, Shenyang, Liaoning, China|People's Hospital of Ningxia Hui Autonomous Region, Yinchuan, Ningxia Hui Autonomous Region, China|Shandong Provincial Hospital, Jinan, Shandong, China|Qingdao Sixth People's Hospital, Qingdao, Shandong, China|Qishan Hospital of Yantai City, Yantai, Shandong, China|Huashan Hospital Affiliated to Fudan University, Shanghai, Shanghai, China|Jincheng People's Hospital, Jincheng, Shanxi, China|The Third People's Hospital of Linfen City, Linfen, Shanxi, China|Shanxi Bethune Hospital, Taiyuan, Shanxi, China|Taiyuan Third People's Hospital, Taiyuan, Shanxi, China|Hospital of the Chengdu Office of the People's Government of Tibet Autonomous Region, Chengdu, Sichuan, China|Yibin First People's Hospital, Yibin, Sichuan, China|Tianjin Second People's Hospital, Tianjin, Tianjin, China|Tianjin Third Central Hospital, Tianjin, Tianjin, China|The Third People's Hospital of Tibet Autonomous Region, Lasa, Tibet, China|Affiliated Hospital of Yunnan University, Kunming, Yunnan, China|The First People's Hospital of Yunnan Province, Kunming, Yunnan, China|The Central Hospital of Lishui City, Lishui, Zhejiang, China|Beilun Hospital of Traditional Chinese Medicine, Ningbo, Zhejiang, China|The Fourth Affiliated Hospital of Zhejiang University, Yiwu, Zhejiang, China",https://ClinicalTrials.gov/show/NCT04883177
NCT04361032,"Assessment of Efficacy and Safety of Tocilizumab Compared to DefeROxamine, Associated With Standards Treatments in COVID-19 (+) Patients Hospitalized In Intensive Care in Tunisia",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,ECC2020-06,"Eshmoun Clinical Research Centre/ Hôpital Abderrahmane Mami-Ariana, Ariana, Tunisia",https://ClinicalTrials.gov/show/NCT04361032
NCT04495764,Registry of Sustained Immunity to COVID-19 Among ESKD Patients,Observational Model: Cohort|Time Perspective: Prospective,20-M-0044-00,"DCR Victorville, Victorville, California, United States|DCR Connecticut, Bridgeport, Connecticut, United States|DCR Twin Cities, Minneapolis, Minnesota, United States|DCR Las Vegas, Las Vegas, Nevada, United States|DCR Bronx, Bronx, New York, United States|DCR Canton, Canton, Ohio, United States|DCR El Paso, El Paso, Texas, United States|DCR Lewisville, Lewisville, Texas, United States|DCR San Antonio, San Antonio, Texas, United States|DCR San Antonio, San Antonio, Texas, United States|DCR Norfolk, Norfolk, Virginia, United States|DCR Milwaukee, Milwaukee, Wisconsin, United States",https://ClinicalTrials.gov/show/NCT04495764
NCT04387279,The Impact of COVID-19 on the Health Care Utilization of Inflammatory Bowel Disease,Observational Model: Cohort|Time Perspective: Cross-Sectional,2020-04-070,"KeimyungUniversity, Daegu, Jung-gu, Korea, Republic of",https://ClinicalTrials.gov/show/NCT04387279
NCT04678024,Sensitivity Evaluation of Serological Tests for Covid-19,Observational Model: Cohort|Time Perspective: Retrospective,COVIDIAGNOSTIX,"Istituto Ortopedico Galeazzi, Milan, Italy",https://ClinicalTrials.gov/show/NCT04678024
NCT04379661,SUNLIGHT Study: Online Support Groups for MS to Address COVID-19,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,AAAS9939,"Columbia University Medical Center, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04379661
NCT04336345,Outcomes of Patients With COVID-19 in the Intensive Care Unit,Observational Model: Cohort|Time Perspective: Cross-Sectional,3336,"Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico|All centres from Mexico willing to contribute are Welcome., Mexico, Mexico",https://ClinicalTrials.gov/show/NCT04336345
NCT04529408,EARSATS-19: In-ear Measurement of Blood Oxygen Saturation in COVID-19 Follow up,Observational Model: Cohort|Time Perspective: Prospective,285603,"Imperial College Healthcare NHS Trust, London, Non-US/Non-Canadian, United Kingdom",https://ClinicalTrials.gov/show/NCT04529408
NCT04903132,Cellular Senescence and COVID-19 Long-Hauler Syndrome,Observational Model: Case-Only|Time Perspective: Prospective,20-011877,"Mayo Clinic in Rochester, Rochester, Minnesota, United States",https://ClinicalTrials.gov/show/NCT04903132
NCT04806815,"Menstrual Cycle-induced Pain, Fatigue and Anxiety in Women Suffered From COVID-19",Observational Model: Cohort|Time Perspective: Other,2021/47-45,"Biruni University, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04806815
NCT04834739,Comparison of Functional Capacities of Healthcare Workers With and Without Covid-19,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Health Services Research,208,"Gaziosmanpasa Training and Research Hospital, Istanbul, Turkey|Gaziosmanpasa Training and Research Hospital, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04834739
NCT04387838,Study of the SARS-COV-2 (COVID-19) Serological Profile of an Army Training Hospital Staff,Observational Model: Cohort|Time Perspective: Prospective,2020-COVID19-10|2020-A01028-31,"Hôpital d'Instuction des Armées Sainte-Anne, Toulon, France|Hôpital d'Instruction des Armées Robert Picqué, Villenave-d'Ornon, France",https://ClinicalTrials.gov/show/NCT04387838
NCT04368871,Radiographic Findings and Their Temporal Changes in COVID-19 Positive Changes Patients: A Prospective Study,Observational Model: Cohort|Time Perspective: Prospective,Covid-19/RFTC/MHC/2020,"Max Super Speciality Hospital, A Unit of Devki Devi Foundation, New Delhi, India",https://ClinicalTrials.gov/show/NCT04368871
NCT04475302,BCG Vaccine in Reducing Morbidity and Mortality in Elderly Individuals in COVID-19 Hotspots,Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,2020010,"Tuberculosis Research Centre, Chennai, Tamilnadu, India",https://ClinicalTrials.gov/show/NCT04475302
NCT04344535,Convalescent Plasma vs. Standard Plasma for COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",SBU-COVID19-ConvalescentPlasma,"Stony Brook University Hospital, Stony Brook, New York, United States",https://ClinicalTrials.gov/show/NCT04344535
NCT04371367,"Avdoralimab an Anti-C5aR Antibody, in Patients With COVID-19 Severe Pneumonia ( FORCE )","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",2020-21,"Assistance Publique Hôpitaux de Marseille, Marseille, France",https://ClinicalTrials.gov/show/NCT04371367
NCT04408001,Study of Kinetics and Efficacy of the Immune Response Against COVID-19 Among Hospital Staff,Observational Model: Cohort|Time Perspective: Prospective,2020-COVID19-04|2020-A01019-30,"Hôpital d'Instuction des Armées Percy, Clamart, France",https://ClinicalTrials.gov/show/NCT04408001
NCT04407507,"Efficacy, Safety and Tolerability of Ivermectin in Subjects Infected With SARS-CoV-2 With or Without Symptoms",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Care Provider)|Primary Purpose: Treatment,SARS-COV-IverMX-01,"Investigacion Biomédica para el Desarrollo de Fármacos S.A. de C.V., Zapopan, Jalisco, Mexico",https://ClinicalTrials.gov/show/NCT04407507
NCT04957017,Effect of Hand-Washing Training in Covid-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Supportive Care,GO 2020/192,"Burdur Mehmet Akif Ersoy university, Burdur, Turkey",https://ClinicalTrials.gov/show/NCT04957017
NCT04360954,Evaluation of Antibody Tests for COVID-19,Observational Model: Case-Only|Time Perspective: Retrospective,202004088,"Washington University School of Medicine, Saint Louis, Missouri, United States",https://ClinicalTrials.gov/show/NCT04360954
NCT04406688,Prediction of Acute Kidney Injury in Patients With COVID-19,Observational Model: Cohort|Time Perspective: Prospective,04-AnIt-20,"University Hospital Münster, Münster, Germany|Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal|Centro Hospitalar e Universitário do Porto, Porto, Portugal|Hospital de la Vall d'Hebron, Barcelona, Spain|Hospital Germans Trias i Pujol, Barcelona, Spain|Hospital Sant Pau, Barcelona, Spain|Complejo Hospitalario de Navarra, Pamplona, Spain|Hospital Universitario Mutua Terrassa, Terrassa, Spain|Hospital la Fe, Valencia, Spain|Guy's & St. Thomas Hospital, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04406688
NCT04364009,Anakinra for COVID-19 Respiratory Symptoms,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,ANACONDA-COVID-19|2020-001734-36|DR200111,"CHRU de TOURS, Tours, France",https://ClinicalTrials.gov/show/NCT04364009
NCT04355728,Use of UC-MSCs for COVID-19 Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",20200671|20200370,"Diabetes Research Institute, University of Miami Miller School of Medicine, Miami, Florida, United States",https://ClinicalTrials.gov/show/NCT04355728
NCT04651790,"Efficacy, Safety, and Immunogenicity of Two Vaccination Schedules of an Inactivated Vaccine Against COVID-19 in Adults",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,200708006,"Centro de Especialidades Médicas, Red de Salud UC Christus, Santiago, RM, Chile",https://ClinicalTrials.gov/show/NCT04651790
NCT04497194,Registry of COVID-19 Patients at AOUI Verona,Observational Model: Cohort|Time Perspective: Other,COVID19-VR,"University Hospital of Verona, Verona, Italy",https://ClinicalTrials.gov/show/NCT04497194
NCT04615949,Cannabidiol in Patients With COVID-19 and Cardiovascular Disease or Risk Factors,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",CARDIOL 100-03,"Valleywise Health Medical Center, Phoenix, Arizona, United States|Westchester General Hospital, Miami, Florida, United States|Med-Care Research, Miami, Florida, United States|University of South Florida, Tampa, Florida, United States|Prairie Education and Research Cooperative, Springfield, Illinois, United States|Lutheran Health Physicians, Fort Wayne, Indiana, United States|Montefiore Medical Center (MMC), Bronx, New York, United States|PRX Research/Dallas Regional Medical Center, Mesquite, Texas, United States|University of Texas Health Science Center, San Antonio, Texas, United States|Baylor Scott & White Health - Temple, Temple, Texas, United States",https://ClinicalTrials.gov/show/NCT04615949
NCT04741061,"Study to Evaluate Efficacy, Immunogenicity and Safety of the Sputnik-Light","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention",01 - Sputnik Light - 2021,"Federal State Autonomous Educational Institution for Higher Education ""Immanuel Kant Baltic Federal University"", Kaliningrad, Russian Federation|State Budgetary Healthcare Institution, Moscow, Consultation and Diagnosis Polyclinic No. 121, Moscow Healthcare Department, Moscow, Russian Federation|State Budgetary Healthcare Institution, Moscow, Municipal Polyclinic No. 210, Moscow Healthcare Department, Moscow, Russian Federation|State Budgetary Healthcare Institution, Moscow, Municipal Polyclinic No. 219, Moscow Healthcare Department, Moscow, Russian Federation|State budgetary institution of health care of the city of Moscow ""diagnostic centre № 5 associated with policlinic department of Moscow Healthcare Department"", Moscow, Russian Federation|State budgetary institution of health care of the city of Moscow ""diagnostic clinical centre № 1 Moscow Healthcare Department "", Moscow, Russian Federation|State budgetary institution of health care of the city of Moscow ""Municipal Polyclinic № 2 Moscow Healthcare Department"", Moscow, Russian Federation|State budgetary institution of health care of the city of Moscow ""Municipal Polyclinic № 36 Moscow Healthcare Department"", Moscow, Russian Federation|State budgetary institution of health care of the city of Moscow ""Municipal Polyclinic № 6 Moscow Healthcare Department"", Moscow, Russian Federation|State budgetary institution of health care of the city of Moscow ""Municipal Polyclinic № 62 Moscow Healthcare Department"", Moscow, Russian Federation|State budgetary institution of health care of the city of Moscow ""Municipal Polyclinic № 64 Moscow Healthcare Department"", Moscow, Russian Federation|St. Petersburg's state budgetary health care Institution ""Municipal hospital № 40 of Kurortniy area"", Saint Petersburg, Russian Federation|St. Petersburg's state budgetary health care Institution ""Municipal hospital №117"", Saint Petersburg, Russian Federation|Federal state budgetary educational Institution for Higher Education ""Saratov State Medical University named after V.I. Razumovskiy"" Ministry of Health of Russian Federation, Saratov, Russian Federation|LLC ""Uromed"", Smolensk, Russian Federation",https://ClinicalTrials.gov/show/NCT04741061
NCT04659876,Factors Affecting Mortality in Critical Patients Admitted to Intensive Care Unit Due to COVID 19,Observational Model: Cohort|Time Perspective: Retrospective,"September 11, 2020: 550","Diyarbakır Gazi Yaşargil Training and Research Hospital, Diyarbakır, Turkey",https://ClinicalTrials.gov/show/NCT04659876
NCT04885452,Prevention of COVID-19 Complications in High-risk Subjects Infected by SARS-CoV-2 and Eligible for Treatment Under a Cohort ATU ('Autorisation Temporaire d'Utilisation'). A Prospectvie Cohort.,Observational Model: Cohort|Time Perspective: Prospective,ANRS0003S COCOPREV,"CH Agen-Nerac, Agen, France|CHR Metz-Thionville, Ars-Laquenexy, France|CHU Gabriel Montpied, Clermont-Ferrand, France|Hospices Civils de Lyon (HCL), Lyon, France|CHU de Nantes, Nantes, France|CHU de Nîmes, Nîmes, France|Hôpital Bichat Claude-Bernard, Paris, France|Hôpital Lariboisière, Paris, France|Hôpital Pitié-Salpêtrière, Paris, France|Hôpital Saint Antoine, Paris, France|Hôpital Saint-Louis, Paris, France|Hôpital Universitaire Necker Enfants Malades, Paris, France|Hôpitaux Cochin - Port Royal, Paris, France|CHI Poissy St Germain en Laye, Poissy, France|CHU de Rennes, Rennes, France|CHU de Toulouse, Toulouse, France",https://ClinicalTrials.gov/show/NCT04885452
NCT04901624,Use of Behavioral Economics in Repeat SARS-CoV-2 (COVID-19) Antibody Testing in Disadvantaged Communities,Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,HS-20-00793|3R33AG057395-04S1,"AltaMed Health, Los Angeles, California, United States",https://ClinicalTrials.gov/show/NCT04901624
NCT04657510,Femoral frACturEs and COVID-19.,Observational Model: Cohort|Time Perspective: Retrospective,FACE COVID-19,"IRCCS Istituto Ortopedico Galeazzi, Milano, Italy",https://ClinicalTrials.gov/show/NCT04657510
NCT04527354,Pilot Study to Assess Efficacy and Safety of Treamid in the Rehabilitation of Patients After COVID-19 Pneumonia,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",COVID-TRE-03,"Federal State-Funded Research Institution ""Research Institute of Complex Cardiovascular Diseases"", Kemerovo, Russian Federation|Federal State Budgetary Institution ""N.N. Burdenko Military Clinical Hospital"", Moscow, Russian Federation|SBEI HPE The First Moscow State Medical University n.a. Sechenov of Ministry of Health of Russian Federation, University Hospital #2, Department of Development of New Medicines, Moscow, Russian Federation|Moscow State Medical-Dentist University n.a. A.I. Evdokimov on basis of SMHI ""City Hospital № 62"", branch 5, Moscow, Russian Federation|State Budgetary Health Institution ""Republican Hospital named V.A.Baranov"", Petrozavodsk, Russian Federation|Federal State Budgetary Educational Institution of Higher Education ""Rostov State Medical University"", Rostov-on-Don, Russian Federation|LLC ""Medical Center ""Reavita Med St. Petersburg"", Saint Petersburg, Russian Federation|State autonomous healthcare institution of Yaroslavl Region ""Сlinical hospital for emergency medical care n. a. N.V. Solovyov"", Yaroslavl, Russian Federation",https://ClinicalTrials.gov/show/NCT04527354
NCT04376710,Surgical Telemedicine in the COVID-19 Pandemic Era,Observational Model: Other|Time Perspective: Prospective,20-1177,"Children's Hospital Colorado, Aurora, Colorado, United States",https://ClinicalTrials.gov/show/NCT04376710
NCT04344002,LunG and Melanoma canceR pAtients coVId19 Disease (GRAVID),Observational Model: Cohort|Time Perspective: Other,GECP 20/02_GRAVID,"Complejo Hospitalario Universitario de Ferrol, Ferrol, A Coruña, Spain|H. Clínica Benidorm, Benidorm, Alicante, Spain|Hospital de Elche, Elche, Alicante, Spain|Hospital General Universitario de Elda, Elda, Alicante, Spain|Hospital de Torrevieja, Torrevieja, Alicante, Spain|Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain|Cetir Centre Mèdic, Esplugues De Llobregat, Barcelona, Spain|Hospital General de Granollers, Granollers, Barcelona, Spain|Hospital Universitario de Galdakao, Galdakao, Bizkaia, Spain|Complejo Hospitalario de la Coruña, La Coruña, Coruña, Spain|H. Insular de Gran Canarias, Las Palmas De Gran Canaria, Gran Canarias, Spain|Hospital San Pedro, Logroño, La Rioja, Spain|Hospital Universitario Fundación Alcorcón, Alcorcón, Madrid, Spain|Hospital Severo Ochoa, Leganés, Madrid, Spain|Hospital Universitario de Móstoles, Móstoles, Madrid, Spain|Hospital de Manacor, Manacor, Mallorca, Spain|Hospital Costa del Sol, Marbella, Málaga, Spain|Clínica Universidad de Navarra, Pamplona, Navarra, Spain|Clínica Universitaria de Navarra, Pamplona, Navarra, Spain|Complejo Hospitalario de Navarra, Pamplona, Navarra, Spain|Hospital Instituto Onkologikoa, San Sebastián, País Vasco, Spain|Hospital Sant Joan de Reus, Reus, Tarragona, Spain|Hospital Verge de la Cinta, Tortosa, Tarragona, Spain|H. Universitario de Canarias, La Laguna, Tenerife, Spain|Hospital Universitario de La Ribera, Alzira, Valencia, Spain|Hospital de Manises, Manises, Valencia, Spain|Hospital de Cruces, Baracaldo, Vizcaya, Spain|Hospital de Basurto, Bilbao, Vizcaya, Spain|H. Gen. Universitario Alicante, Alicante, Spain|H. Universitario Quirón Dexeus, Barcelona, Spain|Hospital Clínic de Barcelona, Barcelona, Spain|H. Duran i Reynals-ICO, Barcelona, Spain|Hospital de la Santa Creu i Sant Pau, Barcelona, Spain|Hospital del Mar, Barcelona, Spain|Hospital La Mancha Centro, Ciudad Real, Spain|Hospital Virgen de la Luz, Cuenca, Spain|Hospital Universitario de Puerto Real, Cádiz, Spain|Hospital Dr. Josep Trueta, Girona, Spain|Hospital Universitario Virgen de las Nieves, Granada, Spain|Hospital de Guadalajara, Guadalajara, Spain|Complejo Asistencial Universitario de León, León, Spain|Hospital San Millan Y San Pedro, Logroño, Spain|Hospital Universitario Lucus Augusti, Lugo, Spain|MD Anderson, Madrid, Spain|H.U. Puerta de Hierro, Madrid, Spain|Fundación Jimenez Diaz, Madrid, Spain|Hospital Universitario Infanta Sofía, Madrid, Spain|Hospital 12 de Octubre, Madrid, Spain|Hospital Clínico San Carlos, Madrid, Spain|Hospital de Sanchinarro, Madrid, Spain|Hospital General Universitario Gregorio Marañón, Madrid, Spain|Hospital Universitario de Fuenlabrada, Madrid, Spain|Hospital Universitario del Henares, Madrid, Spain|Hospital Universitario Infanta Leonor, Madrid, Spain|Hospital General Universitario Morales Meseguer, Murcia, Spain|Hospital Carlos Haya, Málaga, Spain|Hospital Santa María Naí, Ourense, Spain|Hospital Son Espases, Palma de Mallorca, Spain|H. Son Llàtzer, Palma de Mallorca, Spain|Hospital Clinico de Salamanca, Salamanca, Spain|Hospital General de Segovia, Segovia, Spain|Hospital Virgen del Rocío, Sevilla, Spain|Hospital Sant Pau i Santa Tecla, Tarragona, Spain|Hospital universitario Nuestra Señora Candelaria, Tenerife, Spain|H. General U. de Valencia, Valencia, Spain|Hospital Arnau de Vilanova, Valencia, Spain|Hospital Clínico Universitario de Valencia, Valencia, Spain|Hospital Dr. Peset, Valencia, Spain|Hospital Politècnic i Universitari La Fe, Valencia, Spain|Hospital Universitario Dr. Peset, Valencia, Spain|Instituto Valenciano de Oncología, Valencia, Spain|Hospital Clínico Universitario de Valladolid, Valladolid, Spain|H. Miguel Servet, Zaragoza, Spain|Hospital Ntra. Sra. Sónsoles, Ávila, Spain|Hospital Universitario de Áraba, Vitoria, Áraba, Spain",https://ClinicalTrials.gov/show/NCT04344002
NCT04404270,Study of SARS-CoV2 Virus (COVID-19) Seroprevalence in the Population of Creil Air Force Base (BA110),Observational Model: Cohort|Time Perspective: Prospective,2020-COVID19-22|2020-A01368-31,"24e antenne médicale de Creil, Creil, France",https://ClinicalTrials.gov/show/NCT04404270
NCT04497818,Correlation Fear of COVID-19 & Dental Treatment Anxiety,Observational Model: Other|Time Perspective: Prospective,QassimU2,"Dr Bugude Shiva Shankar, Ar Rass, Al Qassim, Saudi Arabia",https://ClinicalTrials.gov/show/NCT04497818
NCT04643522,Semen Parameters and COVID-19 in Infertile Men,Observational Model: Cohort|Time Perspective: Retrospective,E1-20-1237,"Ankara City Hospital, Ankara, Turkey",https://ClinicalTrials.gov/show/NCT04643522
NCT04421391,QuadraMune(TM) for Prevention of COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,QuadraMune002,"Therapeutic Solutions International, Oceanside, California, United States",https://ClinicalTrials.gov/show/NCT04421391
NCT04876898,High Body Mass Index and Severity of Coronavirus,Observational Model: Cohort|Time Perspective: Prospective,BMI_COVID19,"Gad sayed Gad, Qinā, Qena, Egypt",https://ClinicalTrials.gov/show/NCT04876898
NCT04341207,Epidemiology of SARS-CoV-2 and Mortality to Covid19 Disease in French Cancer Patients,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2020-001250-21|2020/3078,"Gustave Roussy, Villejuif, Val De Marne, France",https://ClinicalTrials.gov/show/NCT04341207
NCT04452097,Use of hUC-MSC Product (BX-U001) for the Treatment of COVID-19 With ARDS,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,BXU001-COVID19,NA,https://ClinicalTrials.gov/show/NCT04452097
NCT04872725,The Effect of Covid-19 Process,Observational Model: Cohort|Time Perspective: Prospective,Covid-19 OT,"Istanbul Medipol University, Beykoz, İstanbul, Turkey",https://ClinicalTrials.gov/show/NCT04872725
NCT04914767,Nigella 5 in the Treatment of SARS COV2 (COVID-19),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",Nigella Sativa,"HU Sahloul, sousse, Tunisia, Sousse, Itinéraire Ceinture Cité Sahloul, Tunisia|Riadh Boukef, Sahloul, Sousse, Tunisia",https://ClinicalTrials.gov/show/NCT04914767
NCT04663906,Oral Isotretinoin and Covid-19 Infection,Observational Model: Other|Time Perspective: Retrospective,1/095/20,NA,https://ClinicalTrials.gov/show/NCT04663906
NCT04493359,Switch of Renin-Angiotensin System Inhibitors in Patients With Covid-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,33575220.9.0000.0068,"Instituto do Coração - Incor HCFMUSP, São Paulo, SP, Brazil",https://ClinicalTrials.gov/show/NCT04493359
NCT04902911,Point of Care Evaluation of Novir 2019-nCoV Immunoglobulin G/ Immunoglobulin M (IgG/IgM) Antibody Test (Collodial Gold),Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,PRO00039709,"Froedtert Health WAC, Wauwatosa, Wisconsin, United States",https://ClinicalTrials.gov/show/NCT04902911
NCT04397510,Nebulized Heparin for the Treatment of COVID-19 Induced Lung Injury,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",FHHep518,"Frederick Health Hospital, Frederick, Maryland, United States",https://ClinicalTrials.gov/show/NCT04397510
NCT04329546,Understanding COVID-19,Observational Model: Cohort|Time Perspective: Prospective,2020-00516,"University Hospitals of Geneva, Geneva, Switzerland",https://ClinicalTrials.gov/show/NCT04329546
NCT04555187,Cardiovascular Risk Stratification in Covid-19,Observational Model: Cohort|Time Perspective: Retrospective,STUDY00021368,"Oregon Health and Science University, Portland, Oregon, United States",https://ClinicalTrials.gov/show/NCT04555187
NCT04853004,Current and Past SARS-CoV-2 Infection and COVID-19 in Healthcare With Regard to Vaccinations,Observational Model: Cohort|Time Perspective: Prospective,Covid19_7,"Karolinska University Hospital, Stockholm, Sweden",https://ClinicalTrials.gov/show/NCT04853004
NCT04535856,Therapeutic Study to Evaluate the Safety and Efficacy of DW-MSC in COVID-19 Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",DW_DWP710101|U1111-1263-1723,"Site 550: University of Hassanudin/ Dr. Wahidin Sudirohusodo Hospital, Makassar, Indonesia",https://ClinicalTrials.gov/show/NCT04535856
NCT04652674,Impact of Postoperative Telemedicine Visit vs In-person Visit on Patient Satisfaction During the COVID-19 Pandemic,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,STUDY00000944,"Cedars Sinai Medical Center, Los Angeles, California, United States",https://ClinicalTrials.gov/show/NCT04652674
NCT04395482,Lung CT Scan Analysis of SARS-CoV2 Induced Lung Injury,Observational Model: Cohort|Time Perspective: Retrospective,TAC-COVID19,"Ospedale Papa Giovanni XXIII, Bergamo, Italy|Policlinico San Marco-San Donato group, Bergamo, Italy|Azienda Ospedaliero-Universitaria di Ferrara, Ferrara, Italy|ASST di Lecco Ospedale Alessandro Manzoni, Lecco, Italy|ASST Melegnano-Martesana, Ospedale Santa Maria delle Stelle, Melzo, Italy|ASST Monza, Monza, Italy|AUSL Romagna-Ospedale Infermi di Rimini, Rimini, Italy|Istituto per la Sicurezza Sociale-Ospedale della Repubblica di San Marino, San Marino, San Marino",https://ClinicalTrials.gov/show/NCT04395482
NCT04603742,"Anakinra, COVID-19, Cytokine Storm","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",20-07022396,"Weill Cornell Medcine, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04603742
NCT04945811,Role of Interleukin-6 and Procalcitonin as Novel Inflammatory Biomarkers in Evaluating COVID 19 Disease Severity - an Experience at CMH Quetta,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,CMHQ3,"Cmh Quetta, Quetta, Balochistan, Pakistan",https://ClinicalTrials.gov/show/NCT04945811
NCT04915989,"Safety and Immunogenicity of GX-19N, a COVID-19 Preventive DNA Vaccine in Elderly Individuals",Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,GX-19N-HV-003,"Severance hospital, Seoul, Korea, Republic of|Gangnam Severance hospital, Seoul, Korea, Republic of",https://ClinicalTrials.gov/show/NCT04915989
NCT04371562,Predicting Death and ICU Admission in COVID-19 Patients in ED,Observational Model: Cohort|Time Perspective: Retrospective,0017055/20,"Marcello Covino, Roma, RM, Italy",https://ClinicalTrials.gov/show/NCT04371562
NCT04853979,Awake Prone Positioning in COVID-19 Suspects With Hypoxemic Respiratory Failure,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,MRC-01-20-1227,"Hamad Medical Corporation, Doha, Qatar",https://ClinicalTrials.gov/show/NCT04853979
NCT04609865,Impact of Intravenous Lidocaine on Clinical Outcomes of Patients With ARDS During COVID-19 Pandemia,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",7820,"University Hospital of Hautepierre, Strasbourg, Bas-Rhin, France",https://ClinicalTrials.gov/show/NCT04609865
NCT04685447,Effects of Different Dialysis Strategies on Inflammation in COVID-19 Maintenance Hemodialysis Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,CER Liguria: 135/20,"Ospedale IRCCS San Martino, Genova, Italy|Policlinico IRCCS Ospedale San Matteo, Pavia, Italy",https://ClinicalTrials.gov/show/NCT04685447
NCT04318431,Prevalence of SARS -Cov2 Carriage in Asymptomatic and Mildly-symptomatic Children,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,COVILLE|2020-A00724-35,"Cabinet du Dr Belaroussi, Boulogne, France|Cabinet du Dr Derkx, Champigny-sur-Marne, France|Cabinet du Dr Coicadan, Chennevières-sur-Marne, France|14 Av rené Samuel, Clamart, France|Cabinet du Dr Corrard, Combs-la-Ville, France|10 rue Delambre, Lagny-sur-Marne, France|157 Avenue du Général Leclerc, Maisons-Alfort, France|21 Grande Rue Charles de Gaulle, Nogent-sur-Marne, France|Cabinet du Dr Deberdt, Nogent-sur-Marne, France|Cabinet du Dr Wollner, Nogent-sur-Marne, France|4 allée des Norottes, Noisy-le-Grand, France|Cabinet du Dr D'acremont, Paris, France|146 Avenue Ledru Rollin, Paris, France|132 Boulevard du Montparnasse, Paris, France|Cabinet du Dr Romain, Paris, France|Cabinet du Dr Turberg-Romain, Paris, France|15 Quai Louis Blériot, Paris, France|Cabinet du Dr Michot, Paris, France|24 rue Volta, Puteaux, France|Cabinet du Dr Cohen, Saint-Maur-des-Fossés, France|Cabinet de Pédiatrie des Docteurs Ravilly et Bessa, Villejuif, France|13 Villa Beauséjour, Vincennes, France",https://ClinicalTrials.gov/show/NCT04318431
NCT04367064,To Study the Clinical Characteristics and Treatment Outcome of COVID-19 Patients Admitted in Hospitals of Max Healthcare (SCOPe Study),Observational Model: Cohort|Time Perspective: Prospective,SCOPe/MHC/Covid-19/2020,"Max Super Speciality hospital, Saket (A unit of Devki Devi Foundation), New Delhi, Delhi, India",https://ClinicalTrials.gov/show/NCT04367064
NCT04423991,Identification of a Responsive Subpopulation to Hydroxychloroquine in COVID-19 Patients Using Machine Learning,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,60820,"Dascena, Oakland, California, United States",https://ClinicalTrials.gov/show/NCT04423991
NCT04382924,Safety and Efficacy of NP-120 (Ifenprodil) for the Treatment of Hospitalized Patient With Confirmed COVID-19 Disease,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,AGN120-3,"Westchester Research Center, Miami, Florida, United States|Affinity Health - Loretto Hospital, Chicago, Illinois, United States|Heartland Regional Medical Center, Saint Joseph, Missouri, United States|Promedica Health: Toledo Hospital and BayPark Hospital, Toledo, Ohio, United States|Princess Alexandra Hospital, Woolloongabba, Queensland, Australia|Royal Melbourne Hospital, Parkville, Victoria, Australia|Makati Medical Center, Manila, Philippines|Philippine General Hospital, Manila, Philippines|Lung Center of the Philippines, Quezon City, Philippines|National Institute of Infectious Diseases, Bucharest, Romania",https://ClinicalTrials.gov/show/NCT04382924
NCT04378712,Hydrogen/Oxygen Mixed Gas Inhalation for Coronavirus Disease 2019 (COVID-19),Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,JT202005LZ,"First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China",https://ClinicalTrials.gov/show/NCT04378712
NCT04636671,Methylprednisolone vs. Dexamethasone in COVID-19 Pneumonia (MEDEAS RCT),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,MEDEAS1,"Marco Confalonieri, Trieste, TS, Italy",https://ClinicalTrials.gov/show/NCT04636671
NCT04868903,Low vs. Moderate to High Dose Vitamin D for Prevention of COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",UChicagoBSDIRB20-1302,"Rush University Medical Center, Chicago, Illinois, United States|University of Chicago, Chicago, Illinois, United States",https://ClinicalTrials.gov/show/NCT04868903
NCT04406233,Muscle Mass and Strength as Predictors of Time to Discharge in Patients With COVID-19,Observational Model: Cohort|Time Perspective: Prospective,31303720.7.0000.0068,"Univsersity of Sao Paulo, Sao Paulo, Brazil",https://ClinicalTrials.gov/show/NCT04406233
NCT04793269,Characteristics of Long COVID-19 Syndrome,Observational Model: Cohort|Time Perspective: Retrospective,2021-00280,"University Hospital Zurich, Zurich, Switzerland",https://ClinicalTrials.gov/show/NCT04793269
NCT04556565,MIND/COVID-19: Mental Health Impact and NeeDs Associated With COVID-19: a Comprehensive National Evaluation in Spain,Observational Model: Cohort|Time Perspective: Prospective,2020/9203/I,"Hospital Universitario Príncipe Asturias, Alcalá De Henares, Spain|Hospital Universitario Torrecárdenas, Almería, Spain|Agència de Salut Pública Barcelona, Barcelona, Spain|Fundació Clínic per a la Recerca Biomèdica, Barcelona, Spain|Hospital Universitari Vall d'Hebron, Barcelona, Spain|Institut d'Investigación en Atenció Primària, IDIAP Jordi Gol, Barcelona, Spain|Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau, Barcelona, Spain|Parc Sanitari Sant Joan de Déu, Barcelona, Spain|Psmar-Imim, Barcelona, Spain|Sistema de Emergencias Médicas de Cataluña, Barcelona, Spain|Hospital Universitario Cruces, Bilbao, Spain|Hospital El Bierzo, León, Spain|Gerencia de Atención Primaria de Madrid-FIIBAP, Madrid, Spain|Hospital General Universitario Gregorio Marañón, Madrid, Spain|Hospital Universitario 12 Octubre, Madrid, Spain|Hospital Universitario Donostia, San Sebastián, Spain|Hospital Clínic Universitari, Valencia, Spain|Hospital Universitario Araba-Santiago, Vitoria, Spain",https://ClinicalTrials.gov/show/NCT04556565
NCT04360837,PEEP Incremental and Decremental Alveolar Recruitment of Critically Ill Corona Virus Disease-19 (COVID-19) Patients,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,COVID-19EIT,"University of Szeged, Szeged, Hungary",https://ClinicalTrials.gov/show/NCT04360837
NCT04399109,Evaluation of a Remote Monitoring Smartphone Application and Care Model of COVID-19 Patients in the Community (ReCOVER),Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,PID00770,"The Sutherland Hospital, Caringbah, New South Wales, Australia|St George Hospital, Kogarah, New South Wales, Australia|Prince of Wales Hospital, Randwick, New South Wales, Australia",https://ClinicalTrials.gov/show/NCT04399109
NCT04341441,Will Hydroxychloroquine Impede or Prevent COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention",1410401,"Henry Ford Hospital, Detroit, Michigan, United States|Detroit Department of Transportation (DDOT), Detroit, Michigan, United States|Detroit Fire Department & Detroit EMS, Detroit, Michigan, United States|Detroit Police Department, Detroit, Michigan, United States",https://ClinicalTrials.gov/show/NCT04341441
NCT04391881,Oral Manifestation of COVID 19 Patient: A Cross Sectional Study on Egyptian Population,Observational Model: Other|Time Perspective: Cross-Sectional,54678,"Cairo university, Cairo, Egypt",https://ClinicalTrials.gov/show/NCT04391881
NCT04390022,Sars-CoV-2/COVID-19 Ivermectin Navarra-ISGlobal Trial,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",SAINT,"Clinica Universidad de Navarra, Pamplona, Navarra, Spain",https://ClinicalTrials.gov/show/NCT04390022
NCT04466462,Cross-sectional Study of COVID-19 Infection in Hospital Health Personnel,Observational Model: Case-Crossover|Time Perspective: Other,COVID-Hosp,"Germans Trias i Pujol Hospital, Badalona, Barcelona, Spain|Hospital Municipal de Badalona, Badalona, Barcelona, Spain",https://ClinicalTrials.gov/show/NCT04466462
NCT04910269,Safety and Efficacy of Anti-Coronavirus Hyperimmune Intravenous Immunoglobulin for the Treatment of Adult Outpatients in Early Stages of COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",INSIGHT12,NA,https://ClinicalTrials.gov/show/NCT04910269
NCT04441918,"Tolerability,Safety,Pharmacokinetic Profile and Immunogenicity of a Recombinant Humanized Anti-SARS-CoV-2 Monoclonal Antibody (JS016) for Injection in Chinese Health Subjects","Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",JS016-001-I,"Huashan Hospital affiliated to Fudan University, Shanghai, China",https://ClinicalTrials.gov/show/NCT04441918
NCT04409834,Prevention of Arteriovenous Thrombotic Events in Critically-Ill COVID-19 Patients Trial,Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,CCCTN/TIMI COVID-PACT,"Brigham and Women's Hospital, Boston, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT04409834
NCT04567836,Screening of Health-care Workers in an University Hospital for SARS-CoV-2,Observational Model: Cohort|Time Perspective: Prospective,STORM-HCW,"ASST Monza-Ospedale San Gerardo, Monza, Italy",https://ClinicalTrials.gov/show/NCT04567836
NCT04815031,Drug Use Investigation of COMIRNATY Intramuscular Injection,Observational Model: Case-Only|Time Perspective: Prospective,C4591006,"PfizerLocal Country Office, Tokyo, Japan",https://ClinicalTrials.gov/show/NCT04815031
NCT04442048,Immunization With IMM-101 vs Observation for Prevention of Respiratory and Severe COVID-19 Related Infections in Cancer Patients at Increased Risk of Exposure,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,IC8,"Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario, Canada|London Regional Cancer Program, London, Ontario, Canada|Ottawa Hospital Research Institute, Ottawa, Ontario, Canada|Odette Cancer Centre, Toronto, Ontario, Canada|University Health Network, Toronto, Ontario, Canada|CHUM-Centre Hospitalier de l'Universite de Montreal, Montreal, Quebec, Canada|The Research Institute of the McGill University, Montreal, Quebec, Canada|CIUSSS de l'Estrie - Centre hospitalier, Sherbrooke, Quebec, Canada",https://ClinicalTrials.gov/show/NCT04442048
NCT04652765,Camostat With Bicalutamide for COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,COV2005|IRB00254142,"Johns Hopkins Hospital, Baltimore, Maryland, United States",https://ClinicalTrials.gov/show/NCT04652765
NCT04439071,A Study to Evaluate Efficacy and Safety of PTC299 (Emvododstat) in Hospitalized Participants With Coronavirus (COVID-19),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",PTC299-VIR-015-COV19|2020-001872-13,"University of California, Irvine, Orange, California, United States|Augusta University, Augusta, Georgia, United States|Johns Hopkins Hospital, Baltimore, Maryland, United States|University of Massachusetts Memorial Health Care, Worcester, Massachusetts, United States|Salisbury VA Medical Center, Salisbury, North Carolina, United States|University Hospitals Cleveland, Cleveland, Ohio, United States|Ralph H. Johnson VA Medical Center, Charleston, South Carolina, United States|Columbia VA Health Care System, Columbia, South Carolina, United States|Westmead Hospital, Westmead, New South Wales, Australia|Monash Medical Centre, Clayton, Victoria, Australia|Sunshine Hospital, St. Albans, Victoria, Australia|St. Pierre University Hospital, Brussels, Belgium|Clinique Saint Pierre, Ottignies, Belgium|Hospital Vera Cruz, Belo Horizonte, MG, Brazil|Hospital Guilherme Alvaro, Santos, SP, Brazil|Hospital Santa Casa de Misecórdia de Sorocoba, Sorocaba, SP, Brazil|Hospital Alemao Oswaldo Cruz, São Paulo, SP, Brazil|Escola Paulista de Medicina (UNIFESP), São Paulo, SP, Brazil|Hôpital Pitié-Salpêtrière, Paris, France|Hospital General Dr. Manuel Gea González, Ciudad de Mexico, Cdmx, Mexico|Centro Hospitalario MAC, Irapuato, Guanajuato, Mexico|Hospital Universitario Dr. José Eleuterio Gonzalez, Monterrey, Nuevo León, Mexico|Integra RGH Centro de Investigación/ Hospital MAC Puebla, Puebla, Mexico|SOMECO - Sociedad de Metabolismo y Corazón S.C., Veracruz, Mexico|Centro Hospitalar Universitário de Lisboa Norte (CHULN), E.P.E - Hospital de Santa Maria, Lisboa, Portugal|Centro Hospitalar de Entre o Douro e Vouga, EPE (CHEDV), Santa Maria da Feira, Portugal|Centro Hospitalar de Vila Nova de Gaia/Espinho, EPE (CHVNG/E), Vila Nova de Gaia, Portugal|Hospital Del Mar, Barcelona, Spain|Hospital Universitario de Bellvitge, Barcelona, Spain|Hospital Universitario Infanta Leonor, Madrid, Spain|Hospital Universitario Ramón y Cajal, Madrid, Spain|Hospital 12 de Octubre, Madrid, Spain|Hospital Universitario Infanta Sofía, San Sebastián de los Reyes, Spain",https://ClinicalTrials.gov/show/NCT04439071
NCT04395742,"1,3,7-Trimethylxanthine as a Treatment of COVID-19: Results of a Controlled Study",Observational Model: Other|Time Perspective: Retrospective,TMX COVID,NA,https://ClinicalTrials.gov/show/NCT04395742
NCT04715997,"Safety and Immunogenicity Study of GX-19N, a COVID-19 Preventive DNA Vaccine in Healthy Adults","Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention",GX-19N-HV-002,"KyungHee University Medical Center, Seoul, Korea, Republic of|Severance Hospital, Seoul, Korea, Republic of|Hanyang University Hospital, Seoul, Korea, Republic of|Gangnam Severance Hospital, Seoul, Korea, Republic of|Ajou University Hospital, Suwon, Korea, Republic of",https://ClinicalTrials.gov/show/NCT04715997
NCT04594460,Hydrogen-oxygen Gas Mixture Inhalation in Patients With Convalescent Coronavirus Disease 2019 (COVID-19),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",AMS-H-03-101,"Guangzhou Institute of Respiratory Disease, Guangzhou, Guangdong, China|First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China",https://ClinicalTrials.gov/show/NCT04594460
NCT04357457,Efficacy of Intravenous Almitrine in Reducing the Need for Mechanical Ventilation in Patients With Hypoxemic Acute Respiratory Failure Due to Covid-19-related Pneumonia,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",APHP200461|2020-001909-22,"Hospital Pitié-Salpêtrière, Paris, France",https://ClinicalTrials.gov/show/NCT04357457
NCT04426292,SARS-COV-2 Seroprevalence and Seroconversion Among Employees of the Universitair Ziekenhuis Brussel During the 2020 COVID-19 Outbreak,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,COVEMUZ,"UZ Brussel, Jette, Brussel, Belgium",https://ClinicalTrials.gov/show/NCT04426292
NCT04863131,Safety and Immunogenicity of EXG-5003,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",EXG-5003-J01,"Fujita Health University Hospital, Toyoake, Aichi, Japan",https://ClinicalTrials.gov/show/NCT04863131
NCT04918888,COVID-19 Vaccination in Oncologic Patients,Observational Model: Cohort|Time Perspective: Prospective,ECS 1048/2021,"Ordensklinikum Linz GmbH, Barmherzige Schwestern, Linz, Oberösterreich, Austria|Department of Radiooncology, Ordensklinikum Linz GmbH Barmherzige Schwestern, Linz, Upper Austria, Austria",https://ClinicalTrials.gov/show/NCT04918888
NCT04423640,Analysis of the Inflammatory Response and the Development of Humoral and Cellular Immunity in Patients With COVID-19,Observational Model: Cohort|Time Perspective: Prospective,"R-2020, 3601-043","UMAE Hospital de Especialidades del Centro Médico Nacional Siglo XXI, IMSS., México, Ciudad De México, Mexico",https://ClinicalTrials.gov/show/NCT04423640
NCT04615676,Prospective Evaluation of the Predictive Criteria of Severity for Respiratory Infection Due to COVID-19 Virus,Observational Model: Cohort|Time Perspective: Prospective,RC31/20/0141,"University Hospital of Toulouse, Toulouse, France",https://ClinicalTrials.gov/show/NCT04615676
NCT04403269,"NORMAL HUMAN IMMUNOGLOBULINS (IVIG) IN PATIENTS AGED 75 YEARS AND OVER, COVID-19 WITH SEVERE ACUTE RESPIRATORY FAILURE",Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,P20/07 GERONIMO 19,"Centre Hospitalier de Versailles, Le Chesnay, France",https://ClinicalTrials.gov/show/NCT04403269
NCT04512300,Parental Attitude Toward Children Dental Treatment During COVID-19 Pandemic,Observational Model: Other|Time Perspective: Cross-Sectional,Covid -19 and dental visit,"faculty of dentistry, Cairo university , Egypt, Cairo, Egypt",https://ClinicalTrials.gov/show/NCT04512300
NCT04555005,Mindfulness-based Crisis Intervention for COVID-19 Frontline Healthcare Workers During COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,Mind-COVID-19,"La Paz University Hospital, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04555005
NCT04359303,Indirect Endovenous Systemic Ozone for New Coronavirus Disease (COVID19) in Non-intubated Patients,"Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",P.Inv. Ozono-COVID19 Ver.1.2,"SEOT, Valencia, Spain",https://ClinicalTrials.gov/show/NCT04359303
NCT04834102,COVID-19 Induced Telogen Effluvium,Observational Model: Other|Time Perspective: Retrospective,2021/0123,"Istanbul Medeniyet University, Istanbul, Kadıköy, Turkey",https://ClinicalTrials.gov/show/NCT04834102
NCT04445389,"Safety and Immunogenicity Study of GX-19, a COVID-19 Preventive DNA Vaccine in Healthy Adults","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention",GX-19-HV-001,"Severance hospital, Seoul, Korea, Republic of",https://ClinicalTrials.gov/show/NCT04445389
NCT04408183,GLS-1200 Topical Nasal Spray to Prevent SARS-CoV-2 Infection (COVID-19),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention",T2R-002,"Sinus and Nasal Specialists of Louisiana, Baton Rouge, Louisiana, United States|University of Pennsylvania, Philadelphia, Pennsylvania, United States|Conroe Willis Medical Reasearch, Conroe, Texas, United States",https://ClinicalTrials.gov/show/NCT04408183
NCT04800731,Study of Lymphopenia as a Specific Biomarker or Prognostic Risk Factor for Disease Severity in Elderly Patients With COVID-19,Observational Model: Other|Time Perspective: Retrospective,Lymfopenia,NA,https://ClinicalTrials.gov/show/NCT04800731
NCT04537975,C2Rx Hemofiltration Treatment in Severe or Critically Ill Adults With COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,CP-01-004,NA,https://ClinicalTrials.gov/show/NCT04537975
NCT04615390,Recovery Profiles in Patients With SARS-CoV-2 Outcomes Undergoing Rehabilitation,Observational Model: Cohort|Time Perspective: Prospective,Covid19_rehabilitation,"Department of Neuroscience and Rehabilitation, University Hospital of Ferrara, Ferrara, Emilia Romagna, Italy",https://ClinicalTrials.gov/show/NCT04615390
NCT04769700,"Post-partum Depression, Breastfeeding Adherence and Fear in COVID-19",Observational Model: Cohort|Time Perspective: Cross-Sectional,Lactancia1,"Instituto Mexicano del Seguro Social, Guadalajara, Jalisco, Mexico",https://ClinicalTrials.gov/show/NCT04769700
NCT04734678,Comparison of Tocilizumab Versus Tocilizumab/Infliximab in Patients With COVID-19-associated Cytokine Storm Syndrome,Observational Model: Cohort|Time Perspective: Other,COVID-Infliximab,"Teachers Hospital, Cairo, Please Select, Egypt",https://ClinicalTrials.gov/show/NCT04734678
NCT04537130,Vaccination of Ex-acute COVID-19 Patients With Fibrosing Lung Syndrome at Discharge,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,PANIN3BIO/IN01_COVID19_01|2020-002874-28,"Hospital El Pilar, Barcelona, Spain",https://ClinicalTrials.gov/show/NCT04537130
NCT04418557,COVID-19 and Obstetric Transmission,Observational Model: Case-Control|Time Perspective: Prospective,20200479,"University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States",https://ClinicalTrials.gov/show/NCT04418557
NCT04485169,Therapeutic Plasma Exchange for Coronavirus Disease-2019 Triggered Cytokine Release Storm;,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,Sultan Mehmood Kamran,"Pak Emirates Military Hospital, Rawalpindi, Punjab, Pakistan",https://ClinicalTrials.gov/show/NCT04485169
NCT04581148,SARS-CoV2 Antibodies in Pediatric Patients (COVID-19),Observational Model: Cohort|Time Perspective: Prospective,405_20 Bc,NA,https://ClinicalTrials.gov/show/NCT04581148
NCT04382950,Combination of Recombinant Bacterial ACE2 Receptors -Like Enzyme of B38-CAP and Isotretinoin Could be Promising Treatment for COVID-19 Infection- and Its Inflammatory Complications,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,COV-2019 Treatment This is,NA,https://ClinicalTrials.gov/show/NCT04382950
NCT04805931,VEText Message Framing and Covid-19 Vaccine Uptake Among at Risk Veterans,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Health Services Research,COVID-19 Vaccine Rollout,"VA Puget Sound Health Care System, Seattle, Washington, United States",https://ClinicalTrials.gov/show/NCT04805931
NCT04844554,Protocol of Assistance to Patients With Covid-19 Submitted to Treatment With HD-tDCS,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,COVID/hd-tDCS,"Federal University of Paraíba,Department of Psychology, João Pessoa, Paraíba, Brazil",https://ClinicalTrials.gov/show/NCT04844554
NCT04645407,Effects of Fuzheng Huayu Tablets on COVID-19,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,Fzhy-ncp-1,"Shuguang Hospital, Shanghai, Shanghai, China",https://ClinicalTrials.gov/show/NCT04645407
NCT04351919,Assessment of Efficacy and Safety of HCQ and Antibiotics Administrated to Patients COVID19(+),Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,ECC2020-04,"Eshmoun Clinical Research Centre/ Hôpital Abderrahmen Mami-Ariana, Tunis, Tunisia",https://ClinicalTrials.gov/show/NCT04351919
NCT04352959,COVID-19: Nasal and Salivary Detection of the SARS-CoV-2 Virus After Antiviral Mouthrinses,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention",BBCovid,"Clinic of the Protestant Infirmary in Lyon, Caluire-et-Cuire, France|Hospital Center Emile Roux, Le Puy en Velay, France|Hospital Center Saint Luc Saint Joseph, Lyon, France|Intercommunal Hospital Center of Mont de Marsan, Mont de Marsan, France",https://ClinicalTrials.gov/show/NCT04352959
NCT04937621,Study of Arrhythmia and ECG Abnormalities in Patients With COVID-19,Observational Model: Cohort|Time Perspective: Other,CHUBX 2020/18,"Bordeaux University Hospital, Pessac, France",https://ClinicalTrials.gov/show/NCT04937621
NCT04798053,Impact of COVID-19 Pandemic and Social Distancing on Mental Health of Chronic Inflammatory Rheumatism Affected Patients,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,CHUBX 2020/36,"CHU de Bordeaux - service de rhumatologie, Bordeaux, France|AP-HP - Hopital Henri Mondor - service de rhumatologie, Créteil, France|CHRU de Lille - Service de rhumatologie, Lille, France|CHU de Montpellier - service de rhumatologie, Montpellier, France|AP-HP - Hopital Cochin - service de rhumatologie, Paris, France|CHU de Saint-Etienne - service de rhumatologie, Saint-Étienne, France|CHU de Toulouse - service de rhumatologie, Toulouse, France",https://ClinicalTrials.gov/show/NCT04798053
NCT04569786,Dose Ranging Trial to Assess Safety and Immunogenicity of V590 (COVID-19 Vaccine) in Healthy Adults (V590-001),"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention",V590-001,"Celerion ( Site 0002), Tempe, Arizona, United States|Clinical Pharmacology of Miami ( Site 0003), Miami, Florida, United States|QPS Miami Research Associates ( Site 0005), South Miami, Florida, United States|Bio-Kinetic Clinical Applications (QPS) ( Site 0006), Springfield, Missouri, United States|Celerion ( Site 0001), Lincoln, Nebraska, United States|Alliance for Multispecialty Reseach, LLC ( Site 0004), Knoxville, Tennessee, United States|Worldwide Clinical Trials ( Site 0007), San Antonio, Texas, United States",https://ClinicalTrials.gov/show/NCT04569786
NCT04526977,Differences in Immune Response Among HIV-1-infected Individuals With Previous or Current COVID-19 (CoVIHDis).,Observational Model: Case-Control|Time Perspective: Cross-Sectional,EC 273/20,"Hospital Ramon y Cajal, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04526977
NCT04405570,"A Safety, Tolerability and Efficacy of Molnupiravir (EIDD-2801) to Eliminate Infectious Virus Detection in Persons With COVID-19","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",EIDD-2801-2003,"Benchmark Research, Colton, California, United States|Valley Clinical Trials, Inc., Northridge, California, United States|FOMAT Medical Research, Oxnard, California, United States|Indago Research and Health Center, Inc., Hialeah, Florida, United States|NOLA Research, New Orleans, Louisiana, United States|University of North Carolina School of Medicine, Chapel Hill, North Carolina, United States|Duke, Durham, North Carolina, United States|Wake Forest Baptist Health, Winston-Salem, North Carolina, United States|Care United Research, LLC, Forney, Texas, United States|Laguna Clinical Research, Laredo, Texas, United States|Fred Hutch, Seattle, Washington, United States",https://ClinicalTrials.gov/show/NCT04405570
NCT04551378,The Effect of COVID-19 Pandemic on Adolescent and Young Adult Cancer Patients and Survivors,Observational Model: Cohort|Time Perspective: Prospective,2020-0504|NCI-2020-06609,"M D Anderson Cancer Center, Houston, Texas, United States",https://ClinicalTrials.gov/show/NCT04551378
NCT04950751,Immunogenicity and Safety of Adjuvanted SCB-2020S Vaccines in Adults,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",CLO-SCB-2020-001,NA,https://ClinicalTrials.gov/show/NCT04950751
NCT04869072,Convalescent Plasma Therapy - Zurich Protocol,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2020-00787,"University Hospital Zurich, Zürich, Switzerland",https://ClinicalTrials.gov/show/NCT04869072
NCT04890626,Clinical Trial to Evaluate the Efficacy of Different Treatments in Patients With COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,PanCOVID,"Hospital Universitario La Paz, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04890626
NCT04336384,Impact of Covid-19 in Congenital Heart Disease,Observational Model: Cohort|Time Perspective: Prospective,RECHMPL20_0155,"Uh Montpellier, Montpellier, France",https://ClinicalTrials.gov/show/NCT04336384
NCT04366245,Clinical Trial to Evaluate the Efficacy of Treatment With Hyperimmune Plasma Obtained From Convalescent Antibodies of COVID-19 Infection,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,PC/COVID-19,"Hospital U. Jerez de la Frontera, Jerez de la Frontera, Cádiz, Spain|Hospital U. Puerto Real, Puerto Real, Cádiz, Spain|Hospital Costa del Sol, Marbella, Málaga, Spain|Hospital U. Torrecárdenas, Almería, Spain|Hospital U. Puerta del Mar, Cádiz, Spain|Hospital U. Virgen de las Nieves, Granada, Spain|Hospital U. San Cecilio, Granada, Spain|Hospital Juan Ramón Jiménez, Huelva, Spain|Hospital Regional U. de Málaga, Málaga, Spain|Hospital U. Virgen de la Victoria, Málaga, Spain|Hospital Unversitario Virgen Macarena, Sevilla, Spain|Hospital Universitario Virgen del Rocío, Sevilla, Spain|Hospital U. Nuestra Señora de Valme, Sevilla, Spain|Hospital San Juan de Dios, Sevilla, Spain",https://ClinicalTrials.gov/show/NCT04366245
NCT04952844,Functional Capacity in Survivors of COVID-19 Related ARDS,Observational Model: Other|Time Perspective: Retrospective,2021.014.IRB1.008,"Koc University School of Medicine, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04952844
NCT04832945,SARS-CoV-2 Pre-exposure Prophylaxis With Ivermectin Retrospective Cohort Study,Observational Model: Cohort|Time Perspective: Retrospective,8953,"Centro Medico Bournigal, Puerto Plata, Dominican Republic|Centro Médico Punta Cana, Punta Cana, Dominican Republic",https://ClinicalTrials.gov/show/NCT04832945
NCT04713111,Stress and Recovery in Frontline COVID-19 Workers,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Screening,4UCOVID1901,"4YouandMe, Seattle, Washington, United States",https://ClinicalTrials.gov/show/NCT04713111
NCT04872075,Study on Prevention of SARS-CoV-2 Transmission During a Large Indoor Gathering Event,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,APHP210504|2021-A01264-37,"AccorHotels Arena, Paris, France",https://ClinicalTrials.gov/show/NCT04872075
NCT04435015,The Utility of Camostat Mesylate in Patients With COVID-19 Associated Coagulopathy (CAC) and Cardiovascular Complications,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",2000028279,NA,https://ClinicalTrials.gov/show/NCT04435015
NCT04355494,SOLIRIS® (Eculizumab) Treatment of Participants With COVID-19,NA,ECU-COV-401,"Cedars-Sinai Medical Center, Los Angeles, California, United States|Boston Medical Center, Boston, Massachusetts, United States|Newton-Wellesley Hospital, Newton, Massachusetts, United States|Mayo Clinic, Rochester, Minnesota, United States|Robert Wood Johnson University Hospital, New Brunswick, New Jersey, United States|Icahn School of Medicine at Mount Sinai, New York, New York, United States|The Ohio State University Wexner Medical Center, Columbus, Ohio, United States|Hôpital Henri Mondor, Creteil, France|Hôpital Garches Raymond Poincaré, Garches, France|Hôpital de Bicêtre, Le Kremlin Bicêtre, France|Hôpital Saint Louis, Paris, France|Hôpital Paul Brousse, Villejuif, France",https://ClinicalTrials.gov/show/NCT04355494
NCT04485364,Place of Circulating Biomarkers and Respiratory Eicosanoids in the Prognosis of Severe Forms of Covid-19 Pneumonia,Observational Model: Other|Time Perspective: Prospective,BIOCOVID,"Groupe Hospitalier Paris Saint-Joseph, Paris, France",https://ClinicalTrials.gov/show/NCT04485364
NCT04600999,Clinical Trial of Favipiravir Treatment of Patients With COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,HUN-AVI-01,"Department of Pulmonology Semmelweis University, Budapest, Hungary|National Korányi Institute for Pulmonology, Budapest, Hungary|Institute of Infectology, University of Debrecen, Debrecen, Hungary|1st Department of Medicine, University of Pécs, Pécs, Hungary|First Department of Internal Medicine, University of Szeged, Szeged, Hungary",https://ClinicalTrials.gov/show/NCT04600999
NCT04490486,Umbilical Cord Tissue (UC) Derived Mesenchymal Stem Cells (MSCs) Versus Placebo to Treat Acute Pulmonary Inflammation Due to COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",20200575,"University of Miami, Miami, Florida, United States",https://ClinicalTrials.gov/show/NCT04490486
NCT04691180,"A Phase 1 Study of Human Monoclonal Antibodies, BRII-196 and BRII-198",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,BRII-196-198-001,"Investigative Site, Beijing, Beijing, China",https://ClinicalTrials.gov/show/NCT04691180
NCT04338100,Point Of Care UltraSonography for Risk-stratification of COVID-19 Patients,Observational Model: Case-Only|Time Perspective: Prospective,2020-A00782-37,NA,https://ClinicalTrials.gov/show/NCT04338100
NCT04500600,Well-Being and Health-Related Quality of Life in Cancer Patients and Survivors During the COVID-19 Pandemic,Observational Model: Case-Only|Time Perspective: Cross-Sectional,2020-0473|NCI-2020-04604,"M D Anderson Cancer Center, Houston, Texas, United States",https://ClinicalTrials.gov/show/NCT04500600
NCT04895449,"Safety, Tolerability and Immunogenicity of the Candidate Vaccine MVA-SARS-2-ST Against COVID-19","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",UKE-SARS-CoV-2-ST,"CTC North, Hamburg, Germany",https://ClinicalTrials.gov/show/NCT04895449
NCT04350086,Use of Dexmedetomidine in Light to Moderate Sedation in the Patient in the Palliative Situation of a Sars-cov-2 / COVID-19 Infection,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,87RI20_0011 (PRODEX),"University Hospital, Limoges, France",https://ClinicalTrials.gov/show/NCT04350086
NCT04443140,Preeclampsia-like Syndrome Induced by COVID-19: Is it a Real Public Health Issue in Pregnancy During the Pandemic?,Observational Model: Cohort|Time Perspective: Prospective,70/2020,"Zeynep Kamil Maternity and Childrens Training and Research Hospital, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04443140
NCT04273763,Evaluating the Efficacy and Safety of Bromhexine Hydrochloride Tablets Combined With Standard Treatment/ Standard Treatment in Patients With Suspected and Mild Novel Coronavirus Pneumonia (COVID-19),Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2019NCP1.0,"The Second AffIliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China",https://ClinicalTrials.gov/show/NCT04273763
NCT04473157,COVID-19 in Patients With Anosmia in Egypt,Observational Model: Case-Only|Time Perspective: Prospective,FMASU P45a/2020,"Ain Shams University, Cairo, Egypt",https://ClinicalTrials.gov/show/NCT04473157
NCT04638634,"Pharmacokinetics, Safety, and Tolerability of CSL760, an Intravenous Anti-SARS-CoV-2 Hyperimmune Globulin, in Healthy Adult Subjects",Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Other,CSL760_1001,"CMAX Clinical Research, Adelaide, Australia",https://ClinicalTrials.gov/show/NCT04638634
NCT04416347,COVID19 Clinical Predictors and Outcome,Observational Model: Cohort|Time Perspective: Retrospective,2020.0115,"St. George's University Hospitals Foundation Trust., London, United Kingdom",https://ClinicalTrials.gov/show/NCT04416347
NCT04479644,"Safety, Tolerability, and Pharmacokinetics Study of Human Monoclonal Antibody BRII-198",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,BRII-198-001,"Investigative Site, Beijing, Beijing, China",https://ClinicalTrials.gov/show/NCT04479644
NCT04479631,"Safety, Tolerability, and Pharmacokinetics Study of Human Monoclonal Antibody BRII-196",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,BRII-196-001,"Investigative Site, Beijing, Beijing, China",https://ClinicalTrials.gov/show/NCT04479631
NCT04492514,Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflation,"Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",IND 149353,"University of Cincinnati, Cincinnati, Ohio, United States",https://ClinicalTrials.gov/show/NCT04492514
NCT04872764,Acute Kidney Injury in Patients With CoVID-19,Observational Model: Case-Control|Time Perspective: Retrospective,UsakU3,"Usak University, Usak, Turkey",https://ClinicalTrials.gov/show/NCT04872764
NCT04832022,Longitudinal Follow-up of Patients With Chronic Inflammatory Rheumatisms (CIRs) Vaccinated Against COVID-19 Compared to Patients Refusing Vaccination,Observational Model: Case-Control|Time Perspective: Prospective,RECHMPL21_0021,"Centre hospitalier universitaire de Montpellier, Montpellier, Occitanie, France",https://ClinicalTrials.gov/show/NCT04832022
NCT04563208,Study of Oral Administration of Ribavirin and Nitazoxamide Versus Placebo in COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment",DUACT-101,"Sunnyside Office Park, Johannesburg, Gauteng, South Africa",https://ClinicalTrials.gov/show/NCT04563208
NCT04457609,Administration of Allogenic UC-MSCs as Adjuvant Therapy for Critically-Ill COVID-19 Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",ISMMSCCOVID19,"Cipto Mangunkusumo General Hospital, Jakarta Pusat, DKI Jakarta, Indonesia|Persahabatan General Hospital, Jakarta, DKI Jakarta, Indonesia|Sulianti Saroso Center for Infectious Disease, Jakarta, DKI Jakarta, Indonesia|Universitas Indonesia Hospital, Depok, West Java, Indonesia",https://ClinicalTrials.gov/show/NCT04457609
NCT04939506,COVID-19 Vaccine Education at the Point of Testing to Increase Vaccine Uptake in Vulnerable Communities in SE Louisiana,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,001SA,"Xavier University of Louisiana, New Orleans, Louisiana, United States",https://ClinicalTrials.gov/show/NCT04939506
NCT04369365,"A Single-blinded, Randomized, Placebo Controlled Phase II Trial of Prophylactic Treatment With Oral Azithromycin Versus Placebo in Cancer Patients Undergoing Antineoplastic Treatment During the Corona Virus Disease 19 (COVID-19) Pandemic",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Prevention,OnCoVID-19 Trial,"AKH Vienna, Department for Internal Medicine I, Oncology, Vienna, Austria",https://ClinicalTrials.gov/show/NCT04369365
NCT04916821,Investigation of Clinical Effectiveness of Propolis Extracts as Food Supplements in Patients With SARS-CoV-2(COVID-19),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,1,"Trabzon Faculty of Medicine , Health Science University, Trabzon, Turkey",https://ClinicalTrials.gov/show/NCT04916821
NCT04355481,Dissemination of SARS-COV-2 (COVID-19) in the Environment of Infected Patients Admitted to Intensive Care Unit,Observational Model: Cohort|Time Perspective: Prospective,APHP200411|2020-A00897-32,"Service de réanimation Hôpital Avicenne, Bobigny, France|Service de réanimation Hôpital Bichat, Paris, France|Service de réanimation Hôpital Tenon, Paris, France",https://ClinicalTrials.gov/show/NCT04355481
NCT04575558,HOPE: A Trial of Hydroxichloroquine Plus Azithromycin in High Risk COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",LACOG 0220,"Núcleo de Oncologia da Bahia - NOB, Salvador, BA, Brazil|Oncoclínicas BH, Belo Horizonte, MG, Brazil|Centro Oncológico do Triângulo - COT, Uberlândia, MG, Brazil|Multihemo, Recife, PE, Brazil|Oncoclinicas RJ, Rio De Janeiro, RJ, Brazil|Centro de Pesquisa em Oncologia PUCRS, Porto Alegre, RS, Brazil|Centro Paulista de Oncologia, São Paulo, SP, Brazil",https://ClinicalTrials.gov/show/NCT04575558
NCT04569383,"Safety, Tolerability and Immunogenicity of the Candidate Vaccine MVA-SARS-2-S Against COVID-19",Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,UKE-DZIF-SARS-CoV-2,"CTC North GmbH & Co KG at the University Medical Center Hamburg-Eppendorf, Hamburg, Germany",https://ClinicalTrials.gov/show/NCT04569383
NCT04933929,Personalized Dietary Advice 3 Months After Discharge From Hospitalization in Geriatrics: Effect on Nutritional Status According to Coronavirus Disease 2019 (COVID-19) Status (Positive or Negative) During Hospitalization,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,2020-A02168-31,"Geriatric Department, Bichat, Beaujon and Bretonneau hospitals, Paris, IIe-de-France, France",https://ClinicalTrials.gov/show/NCT04933929
NCT04475211,LILLE COVID RESEARCH NETWORK (Covid-19),Observational Model: Cohort|Time Perspective: Retrospective,2020_54|2020-A01514-35,"Hop Claude Huriez Chr Lille, Lille, France",https://ClinicalTrials.gov/show/NCT04475211
NCT04771117,Defiances to Face COVID-19 Pandemic in Mexico,Observational Model: Cohort|Time Perspective: Cross-Sectional,Fear5,"Instituto Mexicano del Seguro Social, Guadalajara, Jalisco, Mexico",https://ClinicalTrials.gov/show/NCT04771117
NCT04666064,Validation of COVILUS Score in Patients Suspected of COVID-19 Infection in the Emergency Room,Observational Model: Case-Only|Time Perspective: Prospective,PI2020_843_0129,"BAR, Amiens, France",https://ClinicalTrials.gov/show/NCT04666064
NCT04789226,Psychological Impact of Covid-19 Assiut University Hospital Experience,Observational Model: Other|Time Perspective: Prospective,Psychology and covid 19,NA,https://ClinicalTrials.gov/show/NCT04789226
NCT04652505,"Effect of the COVID-19 Public Health Crisis on the Mental Health and Physical Well-Being of Cancer Patients, the Coping With COVID Study",Observational Model: Cohort|Time Perspective: Cross-Sectional,2020-0451|NCI-2020-06556,"M D Anderson Cancer Center, Houston, Texas, United States",https://ClinicalTrials.gov/show/NCT04652505
NCT04409886,Hyperbaric Oxygen Therapy in Non-ventilated COVID-19 Patients,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,120-20-ASF,"Maimonides Medical Center, Brooklyn, New York, United States",https://ClinicalTrials.gov/show/NCT04409886
NCT04716569,Evaluation of Ivermectin Mucoadhesive Nanosuspension as Nasal Spray in Management of Early Covid-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,SVU MED CIT0 23 4 21 1 120,"Zaky Aref, Qinā, Qina, Egypt",https://ClinicalTrials.gov/show/NCT04716569
NCT04690920,Theranostic Implication of Complementary Medicines Against Interleukin Receptors and Gp-130 Proteins,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,UOL/IMBB/2020/118,"The University of Lahore, Lahore, Punjab, Pakistan",https://ClinicalTrials.gov/show/NCT04690920
NCT04794829,Natural History of Systemic and Nasal Mucosal Immunity to Influenza and SARS-CoV-2 in Adults After Vaccination,Observational Model: Case-Only|Time Perspective: Prospective,10000256|000256-I,"National Institutes of Health Clinical Center, Bethesda, Maryland, United States",https://ClinicalTrials.gov/show/NCT04794829
NCT04391400,"The Use of Peripheral Blood Specimens From Patients Suspected of Having SARS-CoV-2 Infections in Research Studies Intended to Support the Development of COVID-19 Detection Methods, Treatments, and/or Vaccines",Observational Model: Case-Only|Time Perspective: Prospective,IVS-000-002,NA,https://ClinicalTrials.gov/show/NCT04391400
NCT04627233,Ezrin Peptide (HEP-1) for Treatment of Coronavirus Disease (COVID-19) Infection,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",IR.SBMU.REC.1399.023,"Shahid Beheshti University of Medical Sciences, Tehran, Iran, Islamic Republic of",https://ClinicalTrials.gov/show/NCT04627233
NCT04399980,Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",IND 149324|IRB 20-523,"Cleveland Clinic Florida, Weston, Florida, United States|Cleveland Clinic Health System, Cleveland, Ohio, United States",https://ClinicalTrials.gov/show/NCT04399980
NCT04492228,Eucaloric Ketogenic Diet in COVID-19 Cytokine Storm Syndrome,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,KETOCOV-1,"Samir Giuseppe Sukkar, Genova, Italy",https://ClinicalTrials.gov/show/NCT04492228
NCT04320017,Joint Use of Electrocardiogram and Transthoracic Echocardiography With Other Clinico-biological Parameters in an Observational Study to Monitor Cardio-vascular Events and Predict Outcomes in Patients Diagnosed With COVID-19,Observational Model: Cohort|Time Perspective: Prospective,CIC1421-20-05,"Clinical Investigation Center Pitié-Salpêtrière, Paris, France",https://ClinicalTrials.gov/show/NCT04320017
NCT04366323,Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Allogeneic Adult Mesenchymal Stem Cells of Expanded Adipose Tissue in Patients With Severe Pneumonia Due to COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,AdiQure/COVID-19,"Hospital Universitario de Jerez de la Frontera, Jerez de la Frontera, Cádiz, Spain|Hospital Reina Sofía, Córdoba, Spain|Hospital Universitario Virgen de las Nieves, Granada, Spain|Hospital Universitario Virgen Macarena, Sevilla, Spain|Hospital Unversitario Virgen del Rocío, Sevilla, Spain|Hospital Nuestra Señora de Valme, Sevilla, Spain",https://ClinicalTrials.gov/show/NCT04366323
NCT04742842,The Safety and Immunogenicity of a DNA-based Vaccine (COVIGEN) in Healthy Volunteers,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",COV101,"Scientia Clinical Research, Randwick, New South Wales, Australia|Vaccinology and Immunology Research Trials Unit, Women's and Children's Hospital, Adelaide, South Australia, Australia|Wesfarmers Centre of Vaccines and Infectious Diseases Telethon Kids Institute, Perth, Western Australia, Australia",https://ClinicalTrials.gov/show/NCT04742842
NCT04715360,Management of Cytokine Storms in Severe COVID-19 Patients With Autologous Activated Platelet-rich Plasma Therapy,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,20-12-1526,"Koja Regional Public Hospital, Jakarta, DKI Jakarta, Indonesia",https://ClinicalTrials.gov/show/NCT04715360
NCT04636697,Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",CP-PRO-CoVLP-021,"Achieve Clinical Research, LLC dba Accel Research Sites, Birmingham, Alabama, United States|Fiel Family and Sports Medicine/CCT, Tempe, Arizona, United States|Hope Clinical Research, Canoga Park, California, United States|CNS Network, Garden Grove, California, United States|Long Beach Clinical Trial Services Inc., Long Beach, California, United States|Pharmacology Research Institute, Newport Beach, California, United States|Wr-McCr, Llc, San Diego, California, United States|Ascension Providence Health System, Washington, District of Columbia, United States|Alliance for Multispecialty Research, Coral Gables, Florida, United States|Research Centers of America, Hollywood, Florida, United States|AppleMed Research Inc, Miami, Florida, United States|Elixia COVID-19, Palm Beach, Florida, United States|Precision Clinical Research, Sunrise, Florida, United States|Meridian Clinical Research, Savannah, Georgia, United States|ASR, LLC, Nampa, Idaho, United States|Affinity Health, Chicago, Illinois, United States|Meridian Clinical Research, Sioux City, Iowa, United States|Benchmark Research, Covington, Louisiana, United States|Ascension St. John Vaccine Research Unit, Grosse Pointe Woods, Michigan, United States|Methodist Physicians, Fremont, Nebraska, United States|Be Well Clinical Studies, LLC, Lincoln, Nebraska, United States|Meridian Clinical Research LLC, Norfolk, Nebraska, United States|Meridian Clinical Research LLC, Omaha, Nebraska, United States|Forte Family Practice/ CCT Research, Las Vegas, Nevada, United States|Excel Clinical Research, Las Vegas, Nevada, United States|Las Vegas Clinical Trials, North Las Vegas, Nevada, United States|Hassman Research Institute, Berlin, New Jersey, United States|Meridian Clinical Research, Endwell, New York, United States|Carolina Institute for Clinical Research, Fayetteville, North Carolina, United States|M3 Wake Research, Inc, Raleigh, North Carolina, United States|Trial Management Associates LLC, Wilmington, North Carolina, United States|Velocity Clinical Research - Cincinnati, Cincinnati, Ohio, United States|Velocity Clinical Research, Cleveland, Ohio, United States|Aventiv Research Inc, Columbus, Ohio, United States|Velocity Clinical Research Providence, Warwick, Rhode Island, United States|Benchmark Research, Austin, Texas, United States|Tekton Research, Austin, Texas, United States|Global Medical Research, Dallas, Texas, United States|Benchmark Research, Fort Worth, Texas, United States|Research Your Health, Plano, Texas, United States|Mt. Olympus Medical Research, LLC, Sugar Land, Texas, United States|Sugar Lakes Family Practice, Sugar Land, Texas, United States|DM Clinical Research/Martin Diagnostic Clinic, Tomball, Texas, United States|South Ogden Family Medicine, Ogden, Utah, United States|Advanced Clinical Research, Inc., West Jordan, Utah, United States|Mautalen Salud e Investigación (Expertia SA), Buenos Aires, Argentina|Fundación FunDaMos, Buenos Aires, Argentina|Hospital Militar Central Cirujano Mayor Dr. Cosme Argerich, Buenos Aires, Argentina|Sanatorio Allende, Córdoba, Argentina|Clinica Mayo de UMCB SRL, San Miguel De Tucumán, Argentina|Instituto de Pesquisas Clinicas L2IP, Brasília, Brazil|Unidade Hospital do Rocio, Campo Largo, Brazil|Santa Casa De Misericordia De Belo Horizonte, Minas Gerais, Brazil|Centro de Pesquisa Clinica - Hospital Moinhos de Vento, Porto Alegre, Brazil|IBPClin Instituto Brasil de Pequisa Clinica, Rio De Janeiro, Brazil|Fundação Faculdade Regional de Medicina de Sao Jose do Rio Preto, São Paulo, Brazil|Azidus Brasil Pesquisa e Desenvolvimento Ltda, Valinhos, Brazil|CARe Clinic, Red Deer, Alberta, Canada|IWK Health Centre- Dalhousie University-Canadian Center for Vaccinology, Halifax, Nova Scotia, Canada|Aggarwal and Associates Ltd, Brampton, Ontario, Canada|Dawson Clinical Research Inc., Guelph, Ontario, Canada|SKDS Research Inc., Newmarket, Ontario, Canada|LMC Clinical Research Inc. (CPU), Toronto, Ontario, Canada|Manna Research Toronto, Toronto, Ontario, Canada|Manna Research (Quebec), Lévis, Quebec, Canada|Manna Research (Mirabel), Mirabel, Quebec, Canada|McGill University Health Centre Vaccine Study Centre, Pierrefonds, Quebec, Canada|CHU de Québec-Université Laval, Québec City, Quebec, Canada|Diex Research Quebec Inc., Québec, Quebec, Canada|Diex Recherche Joliette, Saint-Charles-Borromée, Quebec, Canada|Q&T Research Sherbrooke Inc., Sherbrooke, Quebec, Canada|Diex Recherche Sherbrooke, Sherbrooke, Quebec, Canada|NHS Grampian, Aberdeen, United Kingdom|Synexus Midlands Clinical Research Centre, Birmingham, United Kingdom|University Hospital Southampton NHS Foundation Trust (UHS), Bournemouth, United Kingdom|Public Health Wales, Cardiff, United Kingdom|Synexus Wales DRS, Cardiff, United Kingdom|Mid and South Essex NHS Foundation Trust, Chelmsford, United Kingdom|Synexus Lancashire DRS, Chorley, United Kingdom|University Hospitals Derby and Burton, Derby, United Kingdom|London North West University Healthcare NHS Trust, Harrow, United Kingdom|Kings College Hospital, London, United Kingdom|Synexus Manchester DRS, Manchester, United Kingdom|University of York/York Teaching Hospital, York, United Kingdom",https://ClinicalTrials.gov/show/NCT04636697
NCT04608214,Evaluation of Alisporivir for the Treatment of Hospitalised Patients With Infections Due to SARS-CoV-2 (COVID-19),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,APHP200552|2020-002295-13,"Assistance Publique Hôpitaux de Paris - CHU Henri Mondor, Créteil, France",https://ClinicalTrials.gov/show/NCT04608214
NCT04439045,Efficacy and Safety of VPM1002 in Reducing SARS-CoV-2 (COVID-19) Infection Rate and Severity,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Prevention",20-5413,"University Health Network, Toronto, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04439045
NCT04341766,Evolution of Pulmonary Ultrasound in Patients Hospitalized for Covid (Coronavirus Disease) 19,Observational Model: Cohort|Time Perspective: Prospective,COVID-ECHO,"CHU Amiens, Amiens, France|CH de la Côte Basque, Bayonne, France|CHU Ambroise Paré, Boulogne-Billancourt, France|CHU Caen, Caen, France|CHG de Chambery, Chambéry, France|Centre Hospitalier Intercommunal de Créteil, Créteil, France|CHU de Limoges, Limoges, France|APHM - Hopital Nord, Marseille, France|CHU de Nancy, Nancy, France|CHU Nîmes, Nîmes, France|CHR Orléans, Orléans, France|CHU Cochin, Paris, France|CHU Poitiers, Poitiers, France|CHU Rouen, Rouen, France|CH Saint-Quentin, Saint-Quentin, France|CHU Larrey - Toulouse, Toulouse, France|CHU de Tours, Tours, France",https://ClinicalTrials.gov/show/NCT04341766
NCT04656613,A Phase III Clinical Trial of the Immunogenicity and Safety of the Gam-COVID-Vac Vaccine Against COVID-19 in the UAE,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Prevention",06-Gam-COVID-Vac-2020,NA,https://ClinicalTrials.gov/show/NCT04656613
NCT04453501,Anti Infective Agents Impact in COVID-19 Pneumonia,Observational Model: Cohort|Time Perspective: Retrospective,AZITHROVID|INDS,"Benjamin Davido, Garches, France",https://ClinicalTrials.gov/show/NCT04453501
NCT04818281,Study of a Severe Acute Respiratory Syndrome CoV-2 (SARS-CoV-2) Virus-like Particle (VLP) Vaccine in Healthy Adults,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention",VLP-58-1023-Al-K3,"Dr. Abdurahman Yurtaslan Ankara Oncology Training and Research Hospital Phase I Clinical Study Center, Ankara, Turkey",https://ClinicalTrials.gov/show/NCT04818281
NCT04944342,Breathing After COVID-19,Observational Model: Other|Time Perspective: Prospective,2021/64,NA,https://ClinicalTrials.gov/show/NCT04944342
NCT04824313,Vascular Abnormalities Detected With Chest CT in COVID-19,Observational Model: Cohort|Time Perspective: Other,2020-1469,"CHUV, Lausanne, Vaud, Switzerland",https://ClinicalTrials.gov/show/NCT04824313
NCT04729491,EAT-DUTA AndroCoV Trial,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",CORPO-AB-DRUG-SARS-004B,"Corpometria Institute, Brasília, DF, Brazil",https://ClinicalTrials.gov/show/NCT04729491
NCT04510662,Telmisartan in Respiratory Failure Due to COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,CI/HRAEZ2020/05,"Hospital Regional de Alta Especialidad de Zumpango, Zumpango, Estado De Mexico, Mexico",https://ClinicalTrials.gov/show/NCT04510662
NCT04834947,Hemodynamic Effect of Prone Position in Non-intubated Patient With COVID 19,Observational Model: Cohort|Time Perspective: Prospective,69HCL21_0063,"Service d'Anesthésie-Réanimation, Hôpital Louis Pradel,, Bron, France",https://ClinicalTrials.gov/show/NCT04834947
NCT04876885,The Future of Viral Communications: Video-Based Health Promotion Strategies for COVID-19 Vaccinations,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,12902,NA,https://ClinicalTrials.gov/show/NCT04876885
NCT04466371,Perceptions of Undergraduate Students and Teaching Staff on Online Teaching,Observational Model: Case-Only|Time Perspective: Cross-Sectional,PUB 1114005,NA,https://ClinicalTrials.gov/show/NCT04466371
NCT04493242,Extracellular Vesicle Infusion Treatment for COVID-19 Associated ARDS,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",DB-001,"Helen Keller Hospital, Sheffield, Alabama, United States|St. Joseph Hospital Heritage, Fullerton, California, United States|Donald Guthrie Foundation/ Robert Packer Hospital, Sayre, Pennsylvania, United States|Covenant Health, Lubbock, Texas, United States|PRX Research, Mesquite, Texas, United States",https://ClinicalTrials.gov/show/NCT04493242
NCT04594668,Senicapoc in COVID-19 Patients With Severe Respiratory Insufficiency,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2020-001420-34,"Aalborg University Hospital, Aalborg, Denmark|Aarhus University Hospital, Aarhus, Denmark|Hvidovre Hospital, Hvidovre, Denmark|Odense University Hospital, Odense, Denmark",https://ClinicalTrials.gov/show/NCT04594668
NCT04433949,Best Supportive Care With or Without Low Dose Whole Lung Radiation Therapy for the Treatment of COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,STUDY00000781|NCI-2020-04061|RAD5049-20|P30CA138292,"Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States",https://ClinicalTrials.gov/show/NCT04433949
NCT04527471,Study of Ensifentrine or Placebo Delivered Via pMDI in Hospitalized Patients With COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",RPL554-COV-201,"The University of Alabama at Birmingham, Birmingham, Alabama, United States",https://ClinicalTrials.gov/show/NCT04527471
NCT04701710,Prophylaxis Covid-19 in Healthcare Agents by Intensive Treatment With Ivermectin and Iota-carrageenan,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,5076-410-CH2020,"SI.PRO.SA, Ministerio de Salud Pública, Tucumán, Argentina",https://ClinicalTrials.gov/show/NCT04701710
NCT04344938,Covid 19 Pandemic. Emerging Legal and Ehical Disputes Over Patient Confidentiality,Observational Model: Ecologic or Community|Time Perspective: Cross-Sectional,2020A10,NA,https://ClinicalTrials.gov/show/NCT04344938
NCT04969991,Study of Varespladib in Patients Hospitalized With Severe COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",OPX-PR-02|W81XWH20C0066,"Ventura Clinical Trials, Ventura, California, United States|University of Miami Miller School of Medicine, Miami, Florida, United States|Cordova Research Institute, Miami, Florida, United States|Westchester Research Center at Westchester General Hospital, Miami, Florida, United States|Franciscan Alliance, Munster, Indiana, United States|The Brigham and Women's Hospital Emergency Medicine, Boston, Massachusetts, United States|Ascension St. John Clinical Research Institute, Tulsa, Oklahoma, United States",https://ClinicalTrials.gov/show/NCT04969991
NCT04432779,Impact of COVID-19 Infection During Pregnancy on Newborns and Young Children,Observational Model: Cohort|Time Perspective: Prospective,Elikya Covid,"CHU SAINT Pierre, Brussels, Belgium",https://ClinicalTrials.gov/show/NCT04432779
NCT04699903,"Clinical Evaluation of a Point-of-Care (POC), SARS-CoV-2 (COVID-19) IgG Antibody Test in Fingerstick Whole Blood",Observational Model: Cohort|Time Perspective: Prospective,20-1106,"Benchmark - SoCal, Colton, California, United States|Comprehensive Clinical Research, West Palm Beach, Florida, United States|Great Lakes Clinical Trials (GLCT), Chicago, Illinois, United States",https://ClinicalTrials.gov/show/NCT04699903
NCT04756141,CGM Use in COVID19 Patients (Infection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)),Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,20-010816,"Mayo Clinic in Florida, Jacksonville, Florida, United States",https://ClinicalTrials.gov/show/NCT04756141
NCT04399889,hCT-MSCs for COVID19 ARDS,"Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",Pro00105410,"Duke Hospital, Durham, North Carolina, United States",https://ClinicalTrials.gov/show/NCT04399889
NCT04427878,Is Adipose Tissue a Reservoir for SARS-Cov2 Spread in Covid-19 Patients?,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,20-PP-15,"CHU de Nice, Nice, France",https://ClinicalTrials.gov/show/NCT04427878
NCT04360486,Treatment Of CORONAVIRUS DISEASE 2019 (COVID-19) With Anti-Sars-CoV-2 Convalescent Plasma (ASCoV2CP),NA,S-20-02|IND 19930,"Naval Hospital Camp Pendleton, Oceanside, California, United States|Navy Medical Center San Diego, San Diego, California, United States|USS Abraham Lincoln, San Diego, California, United States|USS Carl Vinson, San Diego, California, United States|USS Essex, San Diego, California, United States|USS Makin Island, San Diego, California, United States|USS Nimitz, San Diego, California, United States|USS Theodore Roosevelt, San Diego, California, United States|Evans Army Community Hospital, Fort Carson, Colorado, United States|Eglin Air Force Base, Eglin Air Force Base, Florida, United States|Naval Hospital Jacksonville, Jacksonville, Florida, United States|Martin Army Community Hospital, Fort Benning, Georgia, United States|Eisenhower Army Medical Center, Fort Gordon, Georgia, United States|Tripler Army Medical Center, Honolulu, Hawaii, United States|Keesler Medical Center, Biloxi, Mississippi, United States|Nellis Air Force Base, Las Vegas, Nevada, United States|Naval Medical Center Camp Lejeune, Camp Lejeune, North Carolina, United States|Wright Patterson Medical Center, Wright-Patterson Air Force Base, Ohio, United States|William Beaumont Army Medical Center, El Paso, Texas, United States|Brooke Army Medical Center, Fort Sam Houston, Texas, United States|Fort Belvoir Community Hospital, Fort Belvoir, Virginia, United States|Naval Surface Force Atlantic, Norfolk, Virginia, United States|USS Dwight D. Eisenhower, Norfolk, Virginia, United States|USS Gerald R. Ford, Norfolk, Virginia, United States|Naval Medical Center Portsmouth, Portsmouth, Virginia, United States|Madigan Army Medical Center, Lakewood, Washington, United States|Craig Joint Theatre Hospital Bagram AFGH, Bagram, Afghanistan|Djibouti Expeditionary Medical Facility, Djibouti, Djibouti|Landstuhl Regional Medical Center, Landstuhl, Germany|Naval Hospital Guam, Agaña, Guam|Baghdad Diplomat Support Center Iraq, Baghdad, Iraq|Misawa Air Force Base, Aomori, Japan|Yokota Air Base, Fussa, Japan|US Naval Hospital Okinawa, Okinawa, Japan|Naval Hospital Yokosuka, Yokosuka, Japan|USS America, Yokosuka, Japan|USS Ronald Reagan, Yokosuka, Japan|US Military Hospital Kuwait, Kuwait, Kuwait",https://ClinicalTrials.gov/show/NCT04360486
NCT04471649,Hydroxy Chloroquine and Covid in RA Patients,Observational Model: Case-Control|Time Perspective: Retrospective,2,"Tanta University Hospital, Tanta, Egypt",https://ClinicalTrials.gov/show/NCT04471649
NCT04516564,"A Study of AK119 (Anti-CD73 Antibody), a Treatment for COVID-19, in Healthy Subjects","Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Other",AK119-101,"Christchurch Clinical Studies Trust, Christchurch, New Zealand",https://ClinicalTrials.gov/show/NCT04516564
NCT04643444,Police COVID-19 Serosurvey,Observational Model: Cohort|Time Perspective: Prospective,2020-02650,"University of Bern, Institute for Infectious Diseases, Bern, BE, Switzerland",https://ClinicalTrials.gov/show/NCT04643444
NCT04412278,Impact of COVID-19 Pandemic on Perceived Exercise Benefits and Barriers,Observational Model: Ecologic or Community|Time Perspective: Cross-Sectional,500600127,"Istanbul Okan University, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04412278
NCT04826588,Randomised Evaluation of COVID-19 Therapy (RECOVERY) in Children With PIMS-TS in Switzerland (SWISSPED-RECOVERY),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2021-00362; ks21Bielicki2,"Cantonal Hospital Aarau, Department of Paediatrics, Aarau, Switzerland|University of Basel Children's Hospital, Basel, Switzerland|Ente Ospedaliero Cantonale Ticino (EOC) Pediatrica, Bellinzona, Switzerland|Department of Pediatrics, University of Bern, Bern, Switzerland|Department of Child, Woman and, Adolescent Medecine, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland|Department of Pediatrics,University Hospital of Lausanne (CHUV), Lausanne, Switzerland|Department of Pediatrics, Cantonal Hospital Luzern, Luzern 16, Switzerland|Children's Hospital of Eastern Switzerland, St. Gallen, Switzerland|Department of Pediatrics, Cantonal Hospital Fribourg, Villars-sur-Glâne, Switzerland|University Children's Hospital Zuerich, Zuerich, Switzerland",https://ClinicalTrials.gov/show/NCT04826588
NCT04731051,The Potential Use of Inhaled Hydroxychloroquine for the Treatment of COVID-19 in Cancer Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,HYDR0121/CCO,"King Hussein Cancer Center, Amman, Jordan",https://ClinicalTrials.gov/show/NCT04731051
NCT04351191,PRophylaxis of Exposed COVID-19 Individuals With Mild Symptoms Using choloroquinE Compounds,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",NBC-COVID1902,"Expo Covid Isolation Center / Mayo Hospital Field Hospital, Lahore, Punjab, Pakistan|Mayo Hospital / King Edward Medical University, Lahore, Punjab, Pakistan|Pakistan Kidney and Liver Institute, Lahore, Punjab, Pakistan|Services Hospital, Lahore, Punjab, Pakistan",https://ClinicalTrials.gov/show/NCT04351191
NCT04472585,Efficacy of Subcutaneous Ivermectin With or Without Zinc in COVID-19 Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",SZMC/IRB/Internal/215/2020,"Ali Clinic, Lahore, MA, Pakistan|Shaikh Zayed Hospital, Lahore, Punjab, Pakistan",https://ClinicalTrials.gov/show/NCT04472585
NCT04378244,CORONA: A Study Using DeltaRex-G Gene Therapy for Symptomatic COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,AF20-203,NA,https://ClinicalTrials.gov/show/NCT04378244
NCT04873141,Tocilizumab and Cytokine Release Syndrome (CRS) In Covid-19 Pneumonia,Observational Model: Case-Only|Time Perspective: Prospective,Tocilizumab and CRS,"Shaheed Zulfiqar Ali Bhutto Medical University, Islamabad, Pakistan",https://ClinicalTrials.gov/show/NCT04873141
NCT04655521,Dynamics of the Immune Response to COVID-19 / Infection by SARS-CoV-2,Observational Model: Case-Control|Time Perspective: Prospective,109/20,"Saarland University, Homburg, Germany",https://ClinicalTrials.gov/show/NCT04655521
NCT04789447,Initial CT Findings and CO-RADS Stage in COVID-19,Observational Model: Cohort|Time Perspective: Retrospective,CT-19,"Sultan Abdülhamid Han Training and Research Hospital, Istanbul, Turkey|Sultan Abdülhamid Han Training and Research Hospital, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04789447
NCT04936997,Immune Response to the COVID-19 Vaccine,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2012325795-B,"University of Arizona, Tucson, Arizona, United States",https://ClinicalTrials.gov/show/NCT04936997
NCT04924790,The Effect of the COVID-19 on Patient Preferences and Decision Making for Obstructive Urinary Stone Interventions,Observational Model: Cohort|Time Perspective: Prospective,COVIDUS2021,"Ankara Training and Research Hospital, Ankara, Altindag, Turkey",https://ClinicalTrials.gov/show/NCT04924790
NCT04471636,Telemedicine in Outpatient Covid-19 Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,20-448,"LMU Klinikum, Munich, BY, Germany",https://ClinicalTrials.gov/show/NCT04471636
NCT04527211,Effectiveness and Safety of Ivermectin for the Prevention of Covid-19 Infection in Colombian Health Personnel,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",Epi1JaveCali,"Pontificia Universidad Javeriana, Cali, Valle Del Cauca, Colombia",https://ClinicalTrials.gov/show/NCT04527211
NCT04836754,The Effect of Covid-19 on Breast Milk Microbiome and Its Bioactive Components,Observational Model: Case-Control|Time Perspective: Cross-Sectional,Covid-19,"Haseki Training and Research Hospital, Sultangazi, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04836754
NCT04736004,Hearts of Athletes,Observational Model: Case-Control|Time Perspective: Prospective,Pro00106943,"Duke University, Durham, North Carolina, United States",https://ClinicalTrials.gov/show/NCT04736004
NCT04321265,Outcomes and Prognostic Factors in COVID-19,Observational Model: Cohort|Time Perspective: Prospective,20-004,"Department of Intensive Care, Aarhus University Hospital, Aarhus, Denmark|Hôpitaux de Paris, Hôpital Saint-Antoine, service de réanimation médicale, Paris, France|INSERM, UMR_S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France|Sorbonne Universités, UPMC Univ Paris 06, UMR_S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France|Division of Cardiology, Pulmonary Disease and Vascular Medicine, Duesseldorf, Germany|Department of Anaestesia and Intensive Care, Haukeland University Hospital, Bergen, Norway|Department of Clinical Medecine,University of Bergen, Bergen, Norway",https://ClinicalTrials.gov/show/NCT04321265
NCT04883788,The Impact of COVID-19 Pandemic on Hip and Knee Replacement,Observational Model: Cohort|Time Perspective: Retrospective,Codice AVEC 352/2021/Oss/IOR,"Istituto Ortopedico Rizzoli, Bologna, Italy",https://ClinicalTrials.gov/show/NCT04883788
NCT04812496,Tenofovir-DF Versus Hydroxychloroquine in the Treatment of Hospitalized Patients With COVID-19 (TEDHICOV),Observational Model: Cohort|Time Perspective: Retrospective,TEDHICOV,"Hospital Nacional CASE - EsSalud, Arequipa, Peru",https://ClinicalTrials.gov/show/NCT04812496
NCT04957953,Pregnant Women Vaccinated Against Covid-19.,Observational Model: Cohort|Time Perspective: Prospective,69HCL21_0627|2021-A01523-38,"Service Hospitalo-Universitaire de Pharmacotoxicologie, Lyon, France",https://ClinicalTrials.gov/show/NCT04957953
NCT04525417,Rapid Screening Test for Covid-19 Antibodies in Healthcare Workers,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,GERES20200409|ID RCB 2020-A01031-38,"Bichat University Hospital, Paris, France",https://ClinicalTrials.gov/show/NCT04525417
NCT04447144,"Nutritional Habits, and Coronavirus Disease 2019 (COVID-19) Outcome",Observational Model: Cohort|Time Perspective: Prospective,1003,"Faculty of Medicine Cairo University, Cairo, Egypt",https://ClinicalTrials.gov/show/NCT04447144
NCT04942249,Long COVID in Military Organisations,Observational Model: Cohort|Time Perspective: Prospective,2021-00256,"Epidemiology, Biostatistics and Prevention Institute at the University of Zurich, Zürich, Switzerland",https://ClinicalTrials.gov/show/NCT04942249
NCT04347694,Study to Determine the Immunization Status Among Nephrological Health Care Personnel Against SARS-CoV-2 in a Single Center Over the Course of 12 Months During the Worldwide COVID-19 Pandemic.,Observational Model: Other|Time Perspective: Prospective,1357/2020,"Medical University of Vienna, Division for Nephrology and Dialysis, Vienna, Austria",https://ClinicalTrials.gov/show/NCT04347694
NCT04378920,"A Study of Liposomal Trans Crocetin, LEAF-4L6715, in Patients With Acute Respiratory Distress Syndrome Due to COVID-19, Sepsis or Other Causes",Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2020-003|2020-001393-30|2020-A00900-39,"Hôpitaux Universitaires de Strasbourg, Strasbourg, France|Institut de cancérologie Strasbourg Europe, Strasbourg, France",https://ClinicalTrials.gov/show/NCT04378920
NCT04357366,suPAR-guided Anakinra Treatment for Validation of the Risk and Management of Respiratory Failure by COVID-19 (SAVE),Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,SAVE|2020-001466-11,"COVID-19 Department, General Hospital of Attica SISMANOGLEIO-AMALIA FLEMING, Marousi, Athens, Greece|2nd Department of Internal Medicine, University General Hospital of Alexandroupolis, Alexandroupolis, Greece|Department of Internal Medicine, I PAMMAKARISTOS Hospital, Athens, Greece|1st Department of InternalMedicine, General Hospital of Athens KORGIALENIO-BENAKIO E.E.S., Athens, Greece|1st Department of Internal Medicine, General Hospital of Athens G. GENNIMATAS, Athens, Greece|1st University Department of Internal Medicine, General Hospital of Athens LAIKO, Athens, Greece|1st University Departmentof Pulmonary Medicine, SOTIRIA General Hospital of Chest Diseasesof Athens, Athens, Greece|2nd University Department of Internal Medicine, IPPOKRATEION General Hospital of Athens, Athens, Greece|3rd University Department of Internal Medicine, General Hospital of Chest Diseases of Athens I SOTIRIA, Athens, Greece|Department of Internal Medicine, General Hospital of Chest Diseases of Athens I SOTIRIA, Athens, Greece|Department of Clinical Therapeutics, ALEXANDRA General Hospital of Athens, Athens, Greece|1st Department of Internal Medicine, General Hospital of Eleusis THRIASIO, Athens, Greece|1st Department of Internal Medicine, General Hospital of Nea Ionia CONSTANTOPOULIO-PATISION, Athens, Greece|1st Department of Internal Medicine, General Hospital of Voula ASKLEPIEIO, Athens, Greece|2nd Department of Internal Medicine, 251 Air Force General Hospital, Athens, Greece|2nd Department of Internal Medicine, General Hospital of Eleusis THRIASIO, Athens, Greece|3rd Department of Internal Medicine, General Hospital of Athens KORGIALENEIO-BENAKEIO E.E.S., Athens, Greece|5th Department of Pulmonary Medicine, SOTIRIA General Hospital of Chest Diseases of Athens, Athens, Greece|Department of Internal Medicine, General Hospital of Athens ELPIS, Athens, Greece|Department of Infectious Diseases, General Hospital of Kerkira, Corfu, Greece|1st Department of Internal Medicine, General University Hospital of Ioannina, Ioánnina, Greece|Department of Internal Medicine, General Hospital of Katerini, Kateríni, Greece|Department of Internal Medicine, University General Hospital of Larissa, Larissa, Greece|Department of Internal Medicine, General Hospital of Larisa KOUTLIMBANEIO & ΤΡΙΑΝΤΑFΥLLΕΙΟ, Larissa, Greece|Department of Internal Medicine, University General Hospital of Patras PANAGIA I VOITHIA, Patra, Greece|2nd Department of Internal Medicine, General Hospital of Piraeus TZANEIO, Piraeus, Greece|1st Department of Internal Medicine, AHEPA University General Hospital of Thessaloniki, Thessaloníki, Greece",https://ClinicalTrials.gov/show/NCT04357366
NCT04359329,Estrogen Patch for COVID-19 Symptoms,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,SBU-EstrogenPatch-COVID19,"Stony Brook University Hospital, Stony Brook, New York, United States",https://ClinicalTrials.gov/show/NCT04359329
NCT04459689,COVID-19 in PID Survey,Observational Model: Case-Only|Time Perspective: Prospective,COPID19,"Imagine Institute, Paris, France",https://ClinicalTrials.gov/show/NCT04459689
NCT04457570,Excess Risk of Morbi-mortality Due to COVID-19 in Patients With Cancer,Observational Model: Case-Control|Time Perspective: Retrospective,69HCL20_0509,"Centre de lutte contre le Cancer JEAN PERRIN, Clermont-Ferrand, France|Centre Hospitalier Uniersitaire de Clermont-Ferrand, Clermont-Ferrand, France|Centre Leon Berard, Lyon, France|Institut de Cancérologie de la Loire Lucien Neurwirth, Saint-Priest-en-Jarez, France|Centre Hospitalier Universitaire de St Etienne, Saint-Étienne, France",https://ClinicalTrials.gov/show/NCT04457570
NCT04581954,Inflammatory Signal Inhibitors for COVID-19 (MATIS),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,20HH5926|2020-001750-22,"Imperial College Healthcare NHS Trust, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04581954
NCT04747782,COVID-19 Longitudinal Biomarkers in Lung Injury,Observational Model: Cohort|Time Perspective: Prospective,COLOBILI v4.2,"St Michael's Hospital, Toronto, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04747782
NCT04414657,USZ BioResource COVID,Observational Model: Cohort|Time Perspective: Prospective,CTC HFV2,"University Hospital Zurich, Clinical Trials Center, Zurich, Switzerland",https://ClinicalTrials.gov/show/NCT04414657
NCT04619693,Biomarkers for Dexamethasone Response in Sars-Cov-2 / COVID-19 Pneumonia,Observational Model: Cohort|Time Perspective: Prospective,RECHMPL20_0292|2020-A0206-33|PHRCI-20-013,"Clinique du Parc, Montpellier, France|University Hospitals of Montpellier, Montpellier, France",https://ClinicalTrials.gov/show/NCT04619693
NCT04737161,Safety of T Regulatory Cell Therapy in Subjects With COVID-19 Induced Acute Respiratory Distress Syndrome,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,56248,"Stanford University, Stanford, California, United States",https://ClinicalTrials.gov/show/NCT04737161
NCT04477473,Perceived Impact of the COVID-19 Pandemic on Medical Management and Symptoms in a High Risk Group,Observational Model: Other|Time Perspective: Prospective,2020-01509,"Centre antituberculeux; Geneva University Hospital, Geneva, Geneva 14, Switzerland",https://ClinicalTrials.gov/show/NCT04477473
NCT04602312,How Does Mindfulness Meditation Buffer the Negative Effects of Pain and Suffering in the COVID-19 World? (Healthy Sample),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",2019000347-S4C,"Health and Behavioural Sciences, Brisbane, Queensland, Australia",https://ClinicalTrials.gov/show/NCT04602312
NCT04441684,"Seroprevalence of SARS-CoV-2 in Strasbourg University Hospital, Strasbourg, France (COVID-19)",Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Screening,7782,"Hôpitaux Universitaires de Strasbourg - Centre d'Investigation Clinique - Nouvel Hôpital Civil et Hautepierre, Strasbourg, France",https://ClinicalTrials.gov/show/NCT04441684
NCT04388709,Interferon Lambda Therapy for COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,GCO 20-0820,NA,https://ClinicalTrials.gov/show/NCT04388709
NCT04401085,COVID-19: Herd Immunity Study in the Czech Republic,Observational Model: Cohort|Time Perspective: Cross-Sectional,UZIS 2020/1,"Institute of Health Information and Statistics of the Czech Republic, Prague, Czechia",https://ClinicalTrials.gov/show/NCT04401085
NCT04509713,Canine COVID-19 Detection,Observational Model: Cohort|Time Perspective: Other,LSH1285,"ARCTEC, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04509713
NCT04333914,Prospective Study in Patients With Advanced or Metastatic Cancer and SARS-CoV-2 Infection,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,ET20-076 - IMMUNONCOVID-20|2020-001373-70,"Centre Léon Bérard, Lyon, Rhône, France|CHU Clermont Ferrand, Clermont Ferrand, France|Centre Oscar Lambret, Lille, France|AP-HP Hôpital Saint Antoine, Paris, France|AP-HP La Pitié Salpétrière, Paris, France|Hôpital Saint-Joseph, Paris, France|AP-HP Tenon, Paris, France|AP-HP Hôpital Bichat Claude Bernard, Paris, France|GH Diaconesses Croix Saint Simon, Paris, France|Institut Gustave Roussy, Villejuif, France",https://ClinicalTrials.gov/show/NCT04333914
NCT04490850,COVID-19 Seroprevalence Study in French Guiana,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,2020-048,"Centre Hospitalier Andrée Rosemon, Cayenne, French Guiana|Laboratoire de biologie méicale, Institut Pasteur de la Guyane, Cayenne, French Guiana|Laboratoires Eurofins Guyane, Cayenne, French Guiana|Laboratoire de biologie médicale de Kourou, Kourou, French Guiana|Laboratoire de biologie médicale du Centre hospitalier de Saint-Laurent du Maroni, Saint-Laurent du Maroni, French Guiana",https://ClinicalTrials.gov/show/NCT04490850
NCT04649736,Home-based Respiratory Physiotherapy and Telephone-Based Psychological Support in Severe COVID-19 Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,202852,"Hospital Nacional Cayetano Heredia, Lima, Peru",https://ClinicalTrials.gov/show/NCT04649736
NCT04573322,Safety and Efficacy of Trans Sodium Crocetinate (TSC) in SARS-CoV-2 (COVID-19) Infected Subjects,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",100-303,"National Institute of Infectious Diseases- Prof. Dr. Matei Balş, Bucharest, Romania",https://ClinicalTrials.gov/show/NCT04573322
NCT04400929,Using GM-CSF as a Host Directed Therapeutic Against COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",SH-Leuk-01,"Singapore General Hospital, Singapore, Singapore",https://ClinicalTrials.gov/show/NCT04400929
NCT04932837,"Level of Immunity, Neutralization of the COVID-19 Virus and Reinfections in Residents of 2 Migrant Workers' Residences",Observational Model: Ecologic or Community|Time Perspective: Prospective,811562,"Foyer de travailleurs migrants, Montreuil, Ile De France, France|Foyer de travailleurs migrants, Villemomble, Ile De France, France",https://ClinicalTrials.gov/show/NCT04932837
NCT04433039,COVID19 Versus H1N1: Radiological Challenge During Next Influenza Season Rising,Observational Model: Case-Crossover|Time Perspective: Retrospective,"IRB (00012098), SN (0304669)","Faculty of Medicine, University of Alexandria, Alexandria, Egypt",https://ClinicalTrials.gov/show/NCT04433039
NCT04984408,"Efficacy, Immunogenicity and Safety of BBIBP-CorV Vaccine Against SARS-CoV-2 Infection.","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention",IVI-ECOVA-01,NA,https://ClinicalTrials.gov/show/NCT04984408
NCT04446338,Immune Status SARS-CoV-2 in a Sample of a Tertiary Eye Health Centre,Observational Model: Cohort|Time Perspective: Prospective,292/2020BO2,"University Tuebingen, Tuebingen, BW, Germany",https://ClinicalTrials.gov/show/NCT04446338
NCT04371354,Outcomes of Covid-19 Protective Measures in Endoscopy,Observational Model: Other|Time Perspective: Prospective,2020-COCHE,"Complejo Hospitalario de Navarra, Pamplona, Navarra, Spain",https://ClinicalTrials.gov/show/NCT04371354
NCT04893031,"Effect of Tocilizumab on Intensive Care Patients With COVID-19 Pneumonia, a Retrospective Cohort Study",Observational Model: Cohort|Time Perspective: Other,2021/24|2021-01-24T17_19_44,"Karadeniz Technical University, Trabzon, Turkey",https://ClinicalTrials.gov/show/NCT04893031
NCT04948515,Gene Polymorphism of IL17 and IL 23,Observational Model: Case-Control|Time Perspective: Cross-Sectional,Soh-Med-21-04-35,"Sohag University, Sohag, Egypt",https://ClinicalTrials.gov/show/NCT04948515
NCT04954651,Assessment of the Immunization Levels Against Sars-Cov2 Virus in Subjects Who Have Received EU-approved COVID-19 Vaccines,Observational Model: Other|Time Perspective: Prospective,99-25/2/2021,"University Hospital of Patras, Patras, Greece",https://ClinicalTrials.gov/show/NCT04954651
NCT04561219,Nitazoxanide Therapy for Patients With COVID-19 Pneumonia,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment",SARITA-1|RBR-88bs9x|30662420.0.1001.0008,"Universidade Federal do Rio de Janeiro, Rio De Janeiro, Brazil",https://ClinicalTrials.gov/show/NCT04561219
NCT04327206,BCG Vaccination to Protect Healthcare Workers Against COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Prevention",62586|U1111-1256-4104|INV-017302,"St Vincent's Hospital, Sydney, Sydney, New South Wales, Australia|Prince of Wales Hospital, Sydney, New South Wales, Australia|Sydney Children's Hospital, Randwick, Sydney, New South Wales, Australia|The Children's Hospital at Westmead, Sydney, New South Wales, Australia|Westmead Hospital, Sydney, New South Wales, Australia|Royal Adelaide Hospital, Adelaide, South Australia, Australia|Women's and Children's Hospital, North Adelaide, South Australia, Australia|Royal Children's Hospital, Melbourne, Victoria, Australia|Epworth Richmond, Melbourne, Victoria, Australia|Monash Health- Monash Medical Centre, Melbourne, Victoria, Australia|Fiona Stanley Hospital, Murdoch, Western Australia, Australia|Perth Children's Hospital, Perth, Western Australia, Australia|Sir Charles Gairdner Hospital, Perth, Western Australia, Australia|Fundação de Medicina Tropical Dr Heitor Vieira Dourado (FMT-HVD), Manaus, Amazonas, Brazil|Santa Casa Hospital, Campo Grande, Mato Grosso Do Sul, Brazil|CASSEMS Hospital, Campo Grande, Mato Grosso Do Sul, Brazil|Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso Do Sul, Brazil|Hospital Regional de Mato Grosso do Sul, Campo Grande, Mato Grosso Do Sul, Brazil|Centro de Estudos da Saúde do Trabalhador e Ecologia Humana, Rio de Janeiro, RJ, Brazil|Centro de Referência Prof Hélio Fraga, Rio de Janeiro, RJ, Brazil|Noord West Ziekenhuis, Alkmaar, Netherlands|Rijnstate Hospital, Arnhem, Netherlands|Amphia Hospital, Breda, Netherlands|St Antonius Hospital, Nieuwegein, Netherlands|Radboud UMC, Nijmegen, Netherlands|University hospital in Utrecht (UMCU), Utrecht, Netherlands|University Hospital German Trias I Pujol, Badalona, Barcelona, Spain|Mutua Terrassa Univeristy Hospital, Terrassa, Barcelona, Spain|University Hospital Cruces, Barakaldo, Bizkaia, Spain|Marqués de Valdecilla University Hospital, Santander, Spain|University Hospital Virgen Macarena, Sevilla, Spain|Teign Estuary Medical Group, Teignmouth, Devon, United Kingdom|Ide Lane Surgery, Alphington, Exeter, United Kingdom|St Leonard's Practice, St Leonards, Exeter, United Kingdom|Travel Clinic, Exeter, United Kingdom|Royal Devon and Exeter NHS Foundation Trust, Exeter, United Kingdom",https://ClinicalTrials.gov/show/NCT04327206
NCT04716985,Evaluation of the Daily Intake of 0.5 L of Water Saturated With Molecular Hydrogen for 21 Days in COVID-19 Patients Treated in Ambulatory Care,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",2020-A03137-32,"Timc-Imag (Umr5525 Uga-Cnrs), Grenoble, France|Casablanca center, Casablanca, Morocco|Public Health Center, Sremska Kamenica, Serbia",https://ClinicalTrials.gov/show/NCT04716985
NCT04716088,Rapid Antigen Testing for SARS-CoV-2 Among Healthcare Workers to Prevent Spread of COVID-19,Observational Model: Case-Only|Time Perspective: Prospective,RADT for COVID-19 Golnik,"Universitiy Clinic for respiratory and allergic diseases, Golnik, Slovenia",https://ClinicalTrials.gov/show/NCT04716088
NCT04649086,Muscular Rehabilitation by Eccentric Exercise After Severe COVID-19 Infection,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,PHRCI 2020 COSTE (CovExc)|2020-A01201-38,"CHU de Clermont-Ferrand, Clermont-Ferrand, France|CHU de Dijon, Dijon, France|CHU de Saint-Etienne, Saint-Étienne, France",https://ClinicalTrials.gov/show/NCT04649086
NCT04370171,Management of Diabetic Patients With Telemedicine in the Context of the Covid-19 Epidemic,Observational Model: Cohort|Time Perspective: Prospective,7775,"Hôpitaux Universitaires de Strasbourg, Strasbourg, France",https://ClinicalTrials.gov/show/NCT04370171
NCT04409847,COVID-19 Blood Pressure Endothelium Interaction Study (OBELIX),Observational Model: Cohort|Time Perspective: Prospective,GN20CA245,"NHS Greater Glasgow and Clyde, Glasgow, United Kingdom",https://ClinicalTrials.gov/show/NCT04409847
NCT04358406,Rhu-pGSN for Severe Covid-19 Pneumonia,"Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",BTI-202,"Spitalul Clinic de Boli Infecţioase şi Pneumoftiziologie, Timişoara, Romania|Sant Joan de Reus SAM University Hospital, Reus, Spain|Hospital Universitari de Tarragona Joan XXIII, Tarragona, Spain",https://ClinicalTrials.gov/show/NCT04358406
NCT04584684,Mouth Rinses for Inactivation of COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Treatment",20-2040,"General and Oral Health Center, Chapel Hill, North Carolina, United States",https://ClinicalTrials.gov/show/NCT04584684
NCT04951323,Impact of the Immune System on Response to Anti-Coronavirus Disease 19 (COVID-19) Vaccine in Allogeneic Stem Cell Recipients (Covid Vaccin Allo),Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,TJB2101,"CHU Liège, Domaine du Sart-Tilman, Liège, Belgium",https://ClinicalTrials.gov/show/NCT04951323
NCT04597736,Relationship Between Biological Profiles and Clinical Evolutions Within the Same Cluster COVID-19 (COVIDCOLLECT),Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,RBPH 2020 HENQUELL|2020-A02381-38,"CHU de Clermont-Ferrand, Clermont-Ferrand, France",https://ClinicalTrials.gov/show/NCT04597736
NCT04492371,COVID-19 Infection and Multiple Myeloma,Observational Model: Cohort|Time Perspective: Other,EMN-COVID,"General Hopspital Vienna/Medical University, Vienna, Austria|UCL Saint-Luc, Brussels, Belgium|University Hospital Ostrava, Ostrava, Czechia|University Hospital Würzburg, Würzburg, Germany|Alexandra Clinical Terapeutics, Athens, Greece|AOU Consorziale Policlinico di Bari, Bari, Italy|Amsterdam UMC, Amsterdam, Netherlands|St James's University Hospital, Leeds, United Kingdom",https://ClinicalTrials.gov/show/NCT04492371
NCT04782700,P-Co-Li (Pulmonary Covid-19 Study),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment",IRB # 21-0076,"Northwell Health, Manhasset, New York, United States",https://ClinicalTrials.gov/show/NCT04782700
NCT04377490,Thrombo Embolic Events in Hospitalized Patients With Covid-19 Serious Acute Pneumopathy,Observational Model: Case-Only|Time Perspective: Prospective,PI2020_843_0040,"CHU Amiens, Amiens, France",https://ClinicalTrials.gov/show/NCT04377490
NCT04863547,Severity of the New UK SARS-Cov2 Variant in COVID-19 Infection,Observational Model: Other|Time Perspective: Other,ANRS 0007S SEVASAR,"CHU Amiens Picardie Site Nord, Amiens, France|CHU Angers, Angers, France|hôpital Avicenne, Bobigny, France|Hôpital Pellegrin, Bordeaux, France|Hôpital Ambroise Paré, Boulogne-Billancourt, France|Centre hospitalier de Béziers, Béziers, France|Centre hospitalier métropole Savoie, Chambéry, France|Centre Hospitalier Châteaubriant Nozay Pouancé, Châteaubriant, France|Hôpital Beaujon, Clichy, France|Hôpitaux Civils de Colmar, Colmar, France|Centre Hospitalier Alpes Léman, Contamine-sur-Arve, France|Centre hopsitalier Sud Francilien, Corbeil-Essonnes, France|Centre Hospitalier Intercommunal, Creteil, France|Hôpital Henry Mondor, Créteil, France|CHU Dijon Bourgogne, Dijon, France|Hôpital de Garches, Garches, France|Hôpital Kremlin Bicêtre, Le Kremlin-Bicêtre, France|Hôpital SALENGRO, Lille, France|CHU Limoges, Limoges, France|Hospices Civils de Lyon, Lyon, France|Centre Hospitalier François Quesnay, Mantes-la-Jolie, France|Hôpital André Grégoire, Montreuil, France|Hopital Confluent, Nantes, France|CHU Nantes, Nantes, France|American Hospital of Paris, Neuilly-sur-Seine, France|Hôpital Archet, Nice, France|Centre Hospitalier du Centre-Bretagne, Noyal-Pontivy, France|Hôpital Carémeau, Nîmes, France|Groupe Hospitalier Diaconesses Croix Saint-Simon, Paris, France|HôpitalSaint Antoine, Paris, France|hôpital Cochin, Paris, France|Hôpital Necker, Paris, France|Hôpital Bichat, Paris, France|Hôpital Tenon, Paris, France|Hôpital Saint Louis, Paris, France|CHI de Poissy/Saint-Germain-en-Laye, Poissy, France|Centre hospitalier de Perigueux, Périgueux, France|CHU, Reims, France|Hôpital Pontchaillou, Rennes, France|Hôpital Charles Nicoll, Rouen, France|Hôpital d'Instruction des Armées Bégin, Saint-Mandé, France|Nouvel Hopital Civil, Strasbourg, France|Hôpital Foch, Suresnes, France|Hôpital Purpan, Toulouse, France|Centre hospitalier de Tourcoing, Tourcoing, France|CHU Tours, Tours, France|Centre Hospitalier de Valence, Valence, France|Centre hospitalier de Valenciennes, Valenciennes, France|CHRU Nancy Brabois, Vandœuvre-lès-Nancy, France|Centre Hospitalier Bretagne Atlantique, Vannes, France|Institut Gustave Roussy, Villejuif, France|Centre Hospitalier Intercommunal, Villeneuve-Saint-Georges, France|André Zobda Cabié, Fort-de-France, Martinique France, Martinique",https://ClinicalTrials.gov/show/NCT04863547
NCT04361591,COVID-19 in Liver Transplant Recipients,Observational Model: Cohort|Time Perspective: Prospective,HCB/2020/0384,"SETH-affiliated Liver Transplant Programs in Spain, Barcelona, Spain",https://ClinicalTrials.gov/show/NCT04361591
NCT04648800,Clinical Trial Evaluating the Effect of BCG Vaccination on the Incidence and Severity of SARS-CoV-2 Infections Among Healthcare Professionals During the COVID-19 Pandemic in Poland,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",BCG/COVID-19/UR/04/2020|2020-002111-22,"Department of Anesthesiology and Intensive Care, University Clinical Center, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland|Stefan Żeromski Specialist Hospital, Kraków, Poland|Voivodeship Hospital nr 2 in the Name of The Saint Queen Jadwiga, University of Rzeszów, Poland, Rzeszów, Poland|Saint Jadwiga Śląska Hospital, Trzebnica, Poland|Department of Pediatrics, Bielanski Hospital,, Warsaw, Poland|Praski Hospital, Warsaw, Poland",https://ClinicalTrials.gov/show/NCT04648800
NCT04570397,Ravulizumab and COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,92420,"Brigham and Women's Hospital, Boston, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT04570397
NCT04921241,In Utero Exposure to SARS-CoV-2 (COVID-19) and Cardiovascular and Metabolic Endpoints in Early Life,Observational Model: Cohort|Time Perspective: Cross-Sectional,2021P001107,"Massachusetts General Hospital, Boston, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT04921241
NCT04382846,Novel Regimens in COVID-19 Treatment,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,tanta covid treatment,"Tanta University, Assiut University, Tanta, Egypt|Sherief Abd-Elsalam, Tanta, Egypt",https://ClinicalTrials.gov/show/NCT04382846
NCT04347382,Honey & Nigella Sativa Trial Against COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",SZMC/IRB/Internal/0026/2020|IRB/2020/658/SIMS,"Federal Post-Graduate Medical Institute, Shaikh Zayed Hospital, Lahore, Punjab, Pakistan|Services Institute of Medical Sciences, Services Hospital, Lahore, Punjab, Pakistan",https://ClinicalTrials.gov/show/NCT04347382
NCT04824443,Exercise Therapy in Cancer Patients Who Are Recovering From COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,21-101,"Memoral Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States|Memoral Sloan Kettering Monmouth (Limited protocol activities), Middletown, New Jersey, United States|Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States|Memorial Sloan Kettering Cancer Center @ Suffolk - Commack (Limited Protocol Activities), Commack, New York, United States|Memoral Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York, United States|Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States|Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale, New York, United States",https://ClinicalTrials.gov/show/NCT04824443
NCT04944381,Study of Ameliorating Effect of COVID-19 mRNA Vaccine in Individuals Immunized With Inactivated Vaccine,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,20210624,NA,https://ClinicalTrials.gov/show/NCT04944381
NCT04973488,Therapeutic Plasma Exchange Followed by Convalescent Plasma Transfusion in Severe and Critically Ill COVID-19 Patients,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,STUDYTPECVP20,"Municipal Hospital ""Dr. Teodor Andrei"" Lugoj, Lugoj, Timis, Romania",https://ClinicalTrials.gov/show/NCT04973488
NCT04368351,Bacteriotherapy in the Treatment of COVID-19,Observational Model: Case-Control|Time Perspective: Retrospective,DPHID-UniRoma05,"Department of Public Heath and Infectious Diseases. University of Rome ""Sapienza"" (Italy), Rome, Italy",https://ClinicalTrials.gov/show/NCT04368351
NCT04668313,COVID-19 Advanced Respiratory Physiology (CARP) Study,Observational Model: Cohort|Time Perspective: Prospective,INGN20RM136,"NHS Greater Glasgow and Clyde, Glasgow, United Kingdom",https://ClinicalTrials.gov/show/NCT04668313
NCT04424992,The Natural History of Hospitalized COVID-19 Patients,Observational Model: Cohort|Time Perspective: Prospective,STORM,"ASST Monza-Ospedale San Gerardo, Monza, Italy",https://ClinicalTrials.gov/show/NCT04424992
NCT04904731,Effects of Body Position on Diaphragmatic Activity in Patients Requiring Noninvasive Ventilation for Acute Respiratory Failure COVID-19 Related,Observational Model: Cohort|Time Perspective: Prospective,3658/20,"Gianmaria Cammarota, Perugia, Umbria, Italy",https://ClinicalTrials.gov/show/NCT04904731
NCT04426006,Serological Response to SARS-Cov-2 Virus in Personnel of the Institut Bergonié in the Context of the COVID-19 Pandemic,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,IB 2020-01|2020-A01355-34,"Institut Bergonié, Bordeaux, France",https://ClinicalTrials.gov/show/NCT04426006
NCT04613986,Therapeutic Plasma Exchange as an Adjunctive Strategy to Treat Coagulopathy and Inflammation in Severe Covid-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,SD01,NA,https://ClinicalTrials.gov/show/NCT04613986
NCT04331574,Renin-Angiotensin System Inhibitors and COVID-19,Observational Model: Case-Only|Time Perspective: Cross-Sectional,SARS-RAS,"Spedali Civili di Brescia, Brescia, Italy",https://ClinicalTrials.gov/show/NCT04331574
NCT04362176,Passive Immunity Trial for Our Nation to Treat COVID-19 in Hospitalized Adults,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Treatment",200738|3UL1TR002243-04S3,"University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States|Scripps Health, La Jolla, California, United States|University of Colorado Denver, Aurora, Colorado, United States|MedStar Health Research Institute/MedStar Washington Hospital Center, Washington, District of Columbia, United States|Cleveland Clinic Florida, Weston, Florida, United States|University of Chicago, Chicago, Illinois, United States|Loyola University Medical Center, Maywood, Illinois, United States|The University of Kansas Medical Center, Kansas City, Kansas, United States|Our Lady of the Lake Regional Medical Center, Baton Rouge, Louisiana, United States|University of Maryland, Baltimore (University of Maryland Medical Center), Baltimore, Maryland, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Newton-Wellelsey Hospital, Newton, Massachusetts, United States|University of Minnesota, Minneapolis, Minnesota, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|University of New Mexico Health Sciences Center, Albuquerque, New Mexico, United States|University at Buffalo/Buffalo General Medical Center, Buffalo, New York, United States|Rochester General Hospital, Rochester, New York, United States|Cleveland Clinic Ohio, Cleveland, Ohio, United States|The Ohio State University Wexner Medical Center and James Cancer Hospital, Columbus, Ohio, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|Meharry Medical College, Nashville, Tennessee, United States|Utah Valley Hospital, Provo, Utah, United States|University of Utah Health, Salt Lake City, Utah, United States|Sentara Norfolk General Hospital, Norfolk, Virginia, United States|Virginia Commonwealth University, Richmond, Virginia, United States|University of Washington, Seattle, Washington, United States",https://ClinicalTrials.gov/show/NCT04362176
NCT04365153,Canakinumab in Covid-19 Cardiac Injury (The Three C Study),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",IND 149328,"Cleveland Clinic Florida, Weston, Florida, United States|Cleveland Clinic, Cleveland, Ohio, United States",https://ClinicalTrials.gov/show/NCT04365153
NCT04487769,Lung Ultrasound in COVID-19 Patients,Observational Model: Cohort|Time Perspective: Retrospective,LUS-COVID,"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), Amsterdam, Netherlands",https://ClinicalTrials.gov/show/NCT04487769
NCT04419610,RAS and Coagulopathy in COVID19,"Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Health Services Research",283093,"Imperial College NHS Trust, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04419610
NCT04802382,Clinical Study Designed to Evaluate the Effect of CimetrA in Patients Diagnosed With COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",MGC-008,"Nazareth Hospital EMMS, Nazareth, North, Israel|Rambam Medical Center, Haifa, Israel",https://ClinicalTrials.gov/show/NCT04802382
NCT04581070,"The COVID-IYON Study - Study Examining Data Pertaining to Clinical Outcomes and Organisational Responses to the 2020 SARS-CoV-2 Pandemic""",Observational Model: Cohort|Time Perspective: Prospective,CTRIAL-IE 20-01,"Mater Misericordiae University Hospital, Dublin, Ireland|University Hospital Limerick, Limerick, Ireland|University Hospital Waterford, Waterford, Ireland",https://ClinicalTrials.gov/show/NCT04581070
NCT04979897,"Impact on Mental, Physical, And Cognitive Functioning of a Critical Care sTay During the COVID-19 Pandemic",Observational Model: Cohort|Time Perspective: Prospective,2020-78,"Hospital Regional Dr. Leonardo Guzmán de Antofagasta, Antofagasta, Chile|Hospital San Pablo de Coquimbo, Coquimbo, Chile|Clínica Alemana de Santiago, Santiago, Chile|Clínica BUPA, Santiago, Chile|Clínica INDISA, Santiago, Chile|Hospital del Salvador, Santiago, Chile|Hospital Metropolitano, Santiago, Chile",https://ClinicalTrials.gov/show/NCT04979897
NCT04609462,High-Flow Nasal Cannula in Severe COVID-19 With Acute Hypoxemic Respiratory Failure.,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,1635,"Fundacion Valle del Lili, Cali, Valle Del Cauca, Colombia",https://ClinicalTrials.gov/show/NCT04609462
NCT04853316,Asymptomatic SARS-CoV-2 Detection in Children,Observational Model: Case-Control|Time Perspective: Prospective,REB20-0609,"Children's of Alabama, Birmingham, Alabama, United States|University of California, San Diego - Rady Children's Hospital, San Diego, California, United States|Boston Children's Hospital, Boston, Massachusetts, United States|Children's Medical Center of Dallas - UT Southwestern, Dallas, Texas, United States|Alberta Children's Hospital, Calgary, Alberta, Canada",https://ClinicalTrials.gov/show/NCT04853316
NCT04389294,HSS Covid-19 Antibody Serology Among Surgeons & Anesthesiologists,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,2020-0850,"Hospital for Special Surgery, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04389294
NCT04910633,Medical Treatment of Solid Tumors at the Lyon University Hospital Cancer Institute During the First Wave of COVID-19 in France: A Conservative Approach,Observational Model: Case-Only|Time Perspective: Retrospective,69HCL21_0005,"Lyon University Hospital Cancer Institute, Bron, France",https://ClinicalTrials.gov/show/NCT04910633
NCT04562246,SARS-CoV-2 IgG and IgM Serologic Assays,Observational Model: Cohort|Time Perspective: Prospective,13839,"Henry Ford Health System, Detroit, Michigan, United States",https://ClinicalTrials.gov/show/NCT04562246
NCT04561141,Post Covid Syndrome: Clinical Pattern and Functional Assessment,Observational Model: Other|Time Perspective: Cross-Sectional,postcovid syndrome,NA,https://ClinicalTrials.gov/show/NCT04561141
NCT04981769,POC SARS-CoV-2 Diagnostic PCR Device Comparison to FDA Approved Reference PCR Test,Observational Model: Cohort|Time Perspective: Prospective,3,NA,https://ClinicalTrials.gov/show/NCT04981769
NCT04460664,Coagulation Changes Associated With COVID-19 Infection,Observational Model: Cohort|Time Perspective: Prospective,HEMCS-035,"Texas Tech University Health Sciences Center El Paso, El Paso, Texas, United States",https://ClinicalTrials.gov/show/NCT04460664
NCT04413864,Immunomodulatory Profile of Dexmedetomidine Sedation in Patients Recovering After ARDS Covid-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,APHP200413|2020-A00799-30,"Intensive Care Unit and Respiratory division ; Groupe hospitalier Pitie-Salpetriere and Universite Pierre et Marie Curie Paris 6, Paris, France",https://ClinicalTrials.gov/show/NCT04413864
NCT04546581,Inpatient Treatment of COVID-19 With Anti-Coronavirus Immunoglobulin (ITAC),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",INSIGHT 013,"Penrose Hospital, Colorado Springs, Colorado, United States|St. Francis Health Services, Colorado Springs, Colorado, United States|St. Anthony Hospital, Lakewood, Colorado, United States|Saint Anthony North Health Campus, Westminster, Colorado, United States|Washington VA Medical Center, Washington, District of Columbia, United States|Redmond Regional Medical Center, Rome, Georgia, United States|National Institutes of Health Clinical Center, Bethesda, Maryland, United States|University of Massachusetts, Worcester, Massachusetts, United States|Hennepin Healthcare Research Institute/HCMC, Minneapolis, Minnesota, United States|University of Missouri, Columbia, Missouri, United States|Cox Medical Centers, Springfield, Missouri, United States|FirstHealth Moore Regional Hospital, Pinehurst, North Carolina, United States|Ohio Health Research Institute, Columbus, Ohio, United States|Hendrick Medical Center, Abilene, Texas, United States|CHRISTUS Spohn Shoreline Hospital, Corpus Christi, Texas, United States|University of Texas Southwestern Medical Center, Dallas, Texas, United States|CJW Chippenham Medical Center, Richmond, Virginia, United States|Henrico Doctors' Hospital (HCA), Richmond, Virginia, United States|Aarhus Universitetshospital, Skejby, Aarhus, Denmark|Bispebjerg Hospital, Copenhagen, Denmark|CHIP, Department of Infectious Diseases, Section 2100, Copenhagen, Denmark|Herlev-Gentofte Hospital, Hellerup, Denmark|Nordsjællands Hospital, Hillerød, Hillerød, Denmark|Hvidovre University Hospital, Department of Infectious Diseases, Hvidovre, Denmark|Kolding Sygehus, Kolding, Denmark|Odense University Hospital, Odense, Denmark|Democritus University of Thrace, Alexandroupoli, Thrace, Greece|3rd Dept of Medicine, Medical School, NKUA, Athens, Greece|1st Respiratory Medicine Dept, Athens University Medical School, Athens, Greece|Attikon University General Hospital, Athens, Greece|Dept. of Critical Care & Pulmonary Medicine, Evangelismos General Hospital, Athens, Greece|NCGM, Tokyo, Japan|Fujita Health University Hospital, Toyoake, Japan|Institute of Human Virology-Nigeria (IHVN), Abuja, Nigeria|Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain|Hospital Universitari Vall d'Hebron, Barcelona, Catalonia, Spain|Hospital del Mar, Barcelona, Spain|Hospital Clínic de Barcelona, Barcelona, Spain|Royal Free Hospital, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04546581
NCT04623177,Thromboprophylaxis for Patients in ICU With COVID-19,Observational Model: Cohort|Time Perspective: Prospective,RegCoVid-19,"Hospital Clínico Universitario Lozano Blesa, Zaragoza, Aragón, Spain|Hospital General de Ciudad Real, Ciudad Real, Castilla La Mancha, Spain|Complejo Asistencial Universitario de León, León, Castilla Y León, Spain|Hospital Universitario Rio Ortega, Valladolid, Castilla Y León, Spain|Hospital Clinic Barcelona, Barcelona, Cataluña, Spain|Hospital de la Santa Creu i Sant Pau, Barcelona, Cataluña, Spain|Hospital de Terrasa, Barcelona, Cataluña, Spain|Hospital General Universitario de Alicante, Alicante, Comunidad Valenciana, Spain|Hospital Universitario San Juan de Alicante, Alicante, Comunidad Valenciana, Spain|Complejo Hospitalario de Cáceres, Cáceres, Extramedura, Spain|Hospital Unversitario A Coruña, A Coruña, Galicia, Spain|Complexo Hospitalario Universitario de Ferrol, A Coruña, Galicia, Spain|Complexo Hospitalario Universitario de Pontevedra, Pontevedra, Galicia, Spain|Hospital Povisa, Pontevedra, Galicia, Spain|Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas, Gran Canaria, Spain|Hospital Universitario Severo Ochoa, Leganés, Madrid, Spain|Clínica Universidad de Navarra, Pamplona, Navarra, Spain|Hospital Universitario de Araba, Álava, País Vasco, Spain|Hospital del Mar, Barcelona, Spain|Hospital Sanitas Cima, Barcelona, Spain|Hospital Sant Joan Despí, Barcelona, Spain|Hospital Universitario La Princesa, Madrid, Spain|Hospital Universitario Infanta Leonor, Madrid, Spain|Hospital Clínico San Carlos, Madrid, Spain|Hospital Universitario La Paz, Madrid, Spain|Hospital Universitario Infanta Sofia, Madrid, Spain|Hospital Rafael Méndez, Murcia, Spain|Hospital Clínico Universitario de Valencia, Valencia, Spain|Hospital Arnau de Vilanova, Valencia, Spain|Hospital Universitario Doctor Peset, Valencia, Spain|Hospital Universitari La Fe, Valencia, Spain",https://ClinicalTrials.gov/show/NCT04623177
NCT04491240,Evaluation of Safety and Efficiency of Method of Exosome Inhalation in SARS-CoV-2 Associated Pneumonia.,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Other",COVID-19 EXO,"Medical Centre Dinasty, Samara, Russian Federation",https://ClinicalTrials.gov/show/NCT04491240
NCT04345406,Angiotensin Converting Enzyme Inhibitors in Treatment of Covid 19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,ACEIS COVID 19,"Tanta University, Tanta, Egypt",https://ClinicalTrials.gov/show/NCT04345406
NCT04391829,Detection of SARS-CoV-2 in Semen of COVID-19 Positive Males,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,COVIDSPERM,"UZ Brussel, Brussels, Belgium",https://ClinicalTrials.gov/show/NCT04391829
NCT04871737,Study of a Live rNDV Based Vaccine Against COVID-19,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,AVX-SARS-CoV-2-VAC-001,"Hospital Medica Sur, Mexico City, Ciudad De Mexico, Mexico",https://ClinicalTrials.gov/show/NCT04871737
NCT04401150,Lessening Organ Dysfunction With VITamin C - COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",MP-31-2021-3741,"Research Center of the CHUS, Sherbrooke, Quebec, Canada|Research Centre of the CHUS, Sherbrooke, Quebec, Canada",https://ClinicalTrials.gov/show/NCT04401150
NCT04391101,Convalescent Plasma for the Treatment of Severe SARS-CoV-2 (COVID-19),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2,"Hospital San Vicente Fundacion, Medellín, Antioquia, Colombia",https://ClinicalTrials.gov/show/NCT04391101
NCT04780594,Impact of the COVID-19 Pandemic on the Surgical Activity of Bellvitge University Hospital,Observational Model: Case-Crossover|Time Perspective: Retrospective,COVID19 surgical impact,"Marta Caballero, Hospitalet de Llobregat, Barcelona, Spain",https://ClinicalTrials.gov/show/NCT04780594
NCT04346342,PRactice of VENTilation in COVID-19 Patients (PRoVENT-COVID),Observational Model: Cohort|Time Perspective: Retrospective,PRoVENT-COVID,"Flevoziekenhuis, Almere, Netherlands|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), Amsterdam, Netherlands|Onze Lieve Vrouwe Gasthuis, Amsterdam, Netherlands|Gelre ziekenhuizen, Apeldoorn, Netherlands|Rijnstate Ziekenhuis, Arnhem, Netherlands|Amphia Ziekenhuis, Breda, Netherlands|Reinier de Graaf Gasthuis, Delft, Netherlands|Haaglanden Medisch Centrum, Den Haag, Netherlands|HagaZiekenhuis, Den Haag, Netherlands|Ziekenhuis Gelderse Vallei, Ede, Netherlands|Catharina Ziekenhuis, Eindhoven, Netherlands|Maxima Medical Center, Eindhoven, Netherlands|St Anna Ziekenhuis, Geldrop, Netherlands|Universitair Medisch Centrum Groningen, Groningen, Netherlands|Spaarne Gasthuis, Haarlem, Netherlands|Dijklander Ziekenhuis, Hoorn, Netherlands|Leeuwarden Medisch Centrum, Leeuwarden, Netherlands|Maastricht Universitair Medisch Centrum, Maastricht, Netherlands|St Antonius Ziekenhuis, Nieuwegein, Netherlands|Maasstad Hospital, Rotterdam, Netherlands|Zuyderland Medisch Centrum, Sittard, Netherlands|Isala Ziekenhuis, Zwolle, Netherlands",https://ClinicalTrials.gov/show/NCT04346342
NCT04613817,Sero-prevalence COVID-19 Among Belgian Children,Observational Model: Cohort|Time Perspective: Prospective,SC_044A,"Sciensano, Brussels, Belgium",https://ClinicalTrials.gov/show/NCT04613817
NCT04849598,Automatic Oxygen Titration in Patients After SARS-CoV-2 Infection,"Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",O2matic_COVID,"Klinikum Berchtesgadener Land, Schön Kliniken, Schönau a.Königssee, Bavaria, Germany",https://ClinicalTrials.gov/show/NCT04849598
NCT04748783,Antiviral Efficacy and Acceptability of Mouth Rinses for Inactivation of COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Treatment",20-3046|COL Study,"Adams School of Dentistry, Chapel Hill, North Carolina, United States",https://ClinicalTrials.gov/show/NCT04748783
NCT04374422,COVID-19 Pandemic and Female Sexual Behavior,Observational Model: Cohort|Time Perspective: Prospective,AcibademU cov,"Haseki Training and Research Hospital, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04374422
NCT04381338,Rehabilitation for People With COVID-19 in ICU,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,UPadova_1,"Teaching Hospital, University of Padova, Padova, Italy|Teaching Hospital, University of Verona, Verona, Italy",https://ClinicalTrials.gov/show/NCT04381338
NCT04631666,SARS-CoV-2-Neutralizing Monoclonal COVID-19 Antibody DZIF-10c by Infusion,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",Uni-Koeln-4288,"University Hospital Cologne, Cologne, NRW, Germany",https://ClinicalTrials.gov/show/NCT04631666
NCT04443712,Screening for Patients Admitted to Ain-Shams University Hospitals for SARS-COV-2 (COVID19),Observational Model: Cohort|Time Perspective: Cross-Sectional,FMASU P29 /2020,"Faculty of Medicine Ain Shams University Research Institute- Clinical Research Center, Cairo, Non-US, Egypt",https://ClinicalTrials.gov/show/NCT04443712
NCT04372082,Hydroxychloroquine or Diltiazem-Niclosamide for the Treatment of COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Treatment,2020_40|2020-002188-72,NA,https://ClinicalTrials.gov/show/NCT04372082
NCT04382040,"A Phase II, Controlled Clinical Study Designed to Evaluate the Effect of ArtemiC in Patients Diagnosed With COVID-19","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",MGC-006,"Mahatma Gandhi Mission Medical College and Hospital, Aurangabad, Maharashtra, India|Hillel Yaffe Medical Center, Hadera, Haifa, Israel|Nazareth Hospital EMMS, Nazareth, North, Israel|Rambam Health Care Campus, Haifa, Israel",https://ClinicalTrials.gov/show/NCT04382040
NCT04922814,Comparison for the Effect of Neuromuscular Blocking Agents Versus Sedation Alone on Severe ARDS Patients Due to COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,Covid-19 ICU,NA,https://ClinicalTrials.gov/show/NCT04922814
NCT04631705,SARS-CoV-2-Neutralizing Monoclonal COVID-19 Antibody DZIF-10c by Inhalation,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",Uni-Koeln-4370,"University Hospital Gießen and Marburg, Gießen, Hesse, Germany|University Hospital Cologne, Cologne, NRW, Germany|University Hospital Düsseldorf, Düsseldorf, Germany|University Hospital Frankfurt, Frankfurt am Main, Germany|University Medical Center Hamburg-Eppendorf, Hamburg, Germany|LMU Munich University Hospital, Munich, Germany",https://ClinicalTrials.gov/show/NCT04631705
NCT04415879,Effects of a N95 Respirator vs Cloth Mask on Exercise Capacity During Treadmill Exercise.,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,20-538,"Cleveland Clinic, Cleveland, Ohio, United States",https://ClinicalTrials.gov/show/NCT04415879
NCT04765254,COVID-19 Infection in Diabetic Patients,Observational Model: Case-Control|Time Perspective: Prospective,ITH00131,"Cairo University teaching hospitals, Cairo, Kasr Al Ainy, Egypt",https://ClinicalTrials.gov/show/NCT04765254
NCT04738435,"Safety of the Sputnik V Vaccine in Health Personnel of Private Effectors of the City of Buenos Aires, Argentina",Observational Model: Cohort|Time Perspective: Prospective,3876,"Hospital Italiano de Buenos Aires, Buenos Aires, Caba, Argentina",https://ClinicalTrials.gov/show/NCT04738435
NCT04409899,The Utility of Enhanced Pre and Post-surgical Work-out to Prevent the Spread of COVID-19 in a Large Urology Department,Observational Model: Cohort|Time Perspective: Prospective,FundacióPuigvert,"Fundacio Puigvert, Barcelona, Spain",https://ClinicalTrials.gov/show/NCT04409899
NCT04526769,Detecting SARS-CoV-2 in Tears,Observational Model: Case-Only|Time Perspective: Prospective,STUDY00009512,"University of Minnesota, Minneapolis, Minnesota, United States",https://ClinicalTrials.gov/show/NCT04526769
NCT04351503,A Systems Approach to Predict the Outcome of SARS-CoV-2 in the Population of a City; COVID-19,Observational Model: Other|Time Perspective: Retrospective,2020-00769; qu20Egli2,"Viollier AG, Allschwil, Switzerland|University Hospital Basel, Basel, Switzerland|Biozentrum University of Basel, Basel, Switzerland|sciCore University of Basel, Basel, Switzerland|Department of Biosystems Science and Engineering ETH Zurich, Basel, Switzerland|Swiss Institute of Bioinformatics, Geneva, Switzerland",https://ClinicalTrials.gov/show/NCT04351503
NCT04335552,"Pragmatic Factorial Trial of Hydroxychloroquine, Azithromycin, or Both for Treatment of Severe SARS-CoV-2 Infection",Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,PRO00105339,"Duke Regional Hospital, Durham, North Carolina, United States|Duke University Hospital, Durham, North Carolina, United States|Durham VA Medical Center, Durham, North Carolina, United States|Duke Raleigh Hospital, Raleigh, North Carolina, United States",https://ClinicalTrials.gov/show/NCT04335552
NCT04619290,Outpatient Treatment With CoVid-19 With Prexablu,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,064.I.2020,"Hospital Regional Lic Adolfo Lopez Mateos, Mexico City, Ciudad De Mexico CDMX (Mexico City), Mexico",https://ClinicalTrials.gov/show/NCT04619290
NCT04381286,Transpulmonary Driving Pressure in ARDS COVID19 Patients,Observational Model: Cohort|Time Perspective: Prospective,RECHMPL20_0194,"Uhmontpellier, Montpellier, France",https://ClinicalTrials.gov/show/NCT04381286
NCT04615026,Prevalence of Thrombosis in COVID-Patients,Observational Model: Case-Only|Time Perspective: Prospective,COVID Thrombose,"University Hospital Augsburg, Augsburg, Germany",https://ClinicalTrials.gov/show/NCT04615026
NCT04375176,Monocytes and NK Cells Activity in Covid-19 Patients,Observational Model: Case-Only|Time Perspective: Prospective,67/2020,"ATS Insubria, Varese, Italy",https://ClinicalTrials.gov/show/NCT04375176
NCT04339712,Personalised Immunotherapy for SARS-CoV-2 (COVID-19) Associated With Organ Dysfunction,Allocation: Non-Randomized|Intervention Model: Factorial Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,ESCAPE|2020-001039-29,"2nd Department of Critical Care Medicine, ATTIKON University Hospital, Athens, Haidari, Greece|Intensive Care Unit, Ioannina University Hospital, Ioánnina, Ioannina, Greece|Department of Internal Medicine, Patras University Hospital, Patras, Rion, Greece|Department of Internal Medicine, I PAMMAKARISTOS Hospital, Athens, Greece|Intensive Care Unit, General Hospital of Athens KORGIALENIO-BENAKIO E.E.S., Athens, Greece|1st Department of Pulmonary Medicine and Intensive Care Unit, Athens, Greece|Intensive Care Unit, General Hospital of Athens IPPOKRATEIO, Athens, Greece|4th Department of Internal Medicine, Attikon University Hospital, Athens, Greece|Intensive Care Unit, General Hospital ASKLEPIEIO Voulas, Athens, Greece|Intensive Care Unit, ""Latsio"", Thriasio Elefsis General Hospital, Elefsína, Greece|Intensive Care Unit, ""Koutlimbaneio & Triantafylleio"" Larissa General Hospital, Larissa, Greece|Department of Internal Medicine, Larissa University Hospital, Larissa, Greece|Intensive Care Unit, AGIOS DIMITRIOS General Hospital of Thessaloniki, Thessaloniki, Greece|Intensive Care Unit, G. GENNIMATAS General Hospital of Thessaloniki, Thessaloniki, Greece|Intensive Care Unit, Theageneio Oncological Hospital of Thessaloniki, Thessaloniki, Greece|Intensive Care Unit, General Hospital of Thessaloniki IPPOKRATEIO, Thessaloniki, Greece|Department of Anesthesiology and Intensive Care Medicine, University General Hospital of Thessaloniki AHEPA, Thessaloniki, Greece",https://ClinicalTrials.gov/show/NCT04339712
NCT04540484,COVID-19 IgG Formation in Physicians at ALGH and Their Household Members,Observational Model: Cohort|Time Perspective: Prospective,1606472-1|M5500436,"Advocate Lutheran General Hospital, Park Ridge, Illinois, United States",https://ClinicalTrials.gov/show/NCT04540484
NCT04468412,Influence of COVID-19 on Vascular Endothelial Function,Observational Model: Cohort|Time Perspective: Prospective,NL2020-6555,"Bernhoven, Uden, Netherlands",https://ClinicalTrials.gov/show/NCT04468412
NCT04401540,Characteristics of Neonatal Covid-19 in Turkey,Observational Model: Cohort|Time Perspective: Prospective,NICU-COVID-TR,"Recep Tayyip Erdogan University Medical School, Rize, Turkey",https://ClinicalTrials.gov/show/NCT04401540
NCT04377672,Human Convalescent Plasma for High Risk Children Exposed or Infected With SARS-CoV-2 (COVID-19),Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,IRB00247557,"Johns Hopkins Hospitals, Baltimore, Maryland, United States",https://ClinicalTrials.gov/show/NCT04377672
NCT04661839,A COVID-19 Study to Evaluate Safety and Pharmacokinetics of COVID-HIGIV Administered in Healthy Adults,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",EBS-CVH-003,"Icahn School of Medicine at Mount Sinai, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04661839
NCT04445623,Prasugrel in Severe COVID-19 Pneumonia,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment",MGI-COVID-19-prasugrel,"Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy",https://ClinicalTrials.gov/show/NCT04445623
NCT04697030,Burnout Among Adolescent Population During Covid-19 Lockdown in Pakistan,Observational Model: Other|Time Perspective: Cross-Sectional,129,"Sialkot College of Physical Therapy, Amin Welfare & Teaching Hospital, Sialkot, Punjab, Pakistan",https://ClinicalTrials.gov/show/NCT04697030
NCT04801030,COVID-19 Vaccine Hesitancy Among African Americans,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Prevention,21-03-1076,NA,https://ClinicalTrials.gov/show/NCT04801030
NCT04326790,The GReek Study in the Effects of Colchicine in Covid-19 cOmplications Prevention,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,906295542,"National and Kapodistrian University of Athens, Athens, Greece",https://ClinicalTrials.gov/show/NCT04326790
NCT04729452,Characterisation of the Immune Response to SARS-CoV-2,Observational Model: Cohort|Time Perspective: Other,CT 269506,"Cwm Taf Morgannwg University Health board, Llantrisant, Rhondda Cynon Taf, United Kingdom",https://ClinicalTrials.gov/show/NCT04729452
NCT04945863,COVID-19 in Nursing Homes 2020 and 2021,Observational Model: Cohort|Time Perspective: Retrospective,NH COVID 19,"Anestesi- och operationskliniken, Universitetssjukhuset, Linköping, Sweden",https://ClinicalTrials.gov/show/NCT04945863
NCT04860219,Lactoferrin Use in (SARS-CoV-2) Management,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,COVID-1937,"Faculty of Medicine -Zagazig University, Zagazig, Egypt",https://ClinicalTrials.gov/show/NCT04860219
NCT04444609,PROSAIC-19 - Prospective Longitudinal Assessment in a COVID-19 Infected Cohort,Observational Model: Cohort|Time Perspective: Prospective,20IC5943,"Royal Brompton & Harefileld NHS Trusts, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04444609
NCT04472052,Frequency of Perforated Appendicitis in Times of COVID-19,Observational Model: Cohort|Time Perspective: Other,AZ: 324/2020BO2,"University Hospital of Tuebingen, Tuebingen, Germany",https://ClinicalTrials.gov/show/NCT04472052
NCT04716543,Epidemiological Investigation of COVID-19 in Laos Using a One-Health Approach in Human and Animals,Observational Model: Cohort|Time Perspective: Prospective,ANRS COV20 LACOVISS,NA,https://ClinicalTrials.gov/show/NCT04716543
NCT04974177,A Prospective Observational Study to Determine the Role of Physician Gestalt in Clinical Prediction of COVID 19,Observational Model: Other|Time Perspective: Prospective,13/21/IEC/JMMC&RI,"Jubilee Mission Medical College, Thrissur, Kerala, India",https://ClinicalTrials.gov/show/NCT04974177
NCT04609774,Aerosol Transmission of Severe Acute Respiratory Syndrome Coronavirus of Coronavirus Disease 2019,Observational Model: Case-Crossover|Time Perspective: Cross-Sectional,1345,"Hospital Italiano de Buenos Aires, Ciudad autónoma de Buenos Aires, Argentina",https://ClinicalTrials.gov/show/NCT04609774
NCT04331054,Protective Role of Inhaled Steroids for Covid-19 Infection,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,P 200394|2020-001306-35,"Hôpital Bichat - Service de Pneumologie, Paris, France",https://ClinicalTrials.gov/show/NCT04331054
NCT04397380,COVID-19 Thales Thermography Triage : Thermal Camera Feasibility Study,Observational Model: Cohort|Time Perspective: Prospective,INGC20AE209,"Queen Elizabeth University Hospital, Glasgow, United Kingdom",https://ClinicalTrials.gov/show/NCT04397380
NCT04468646,To Determine the Efficacy of Neurokinin 1 Receptor Antagonist as a Therapeutic Tool Against Cytokine Storm and Respiratory Failure in Covid-19 Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",UniversityHSL-NK1R,"Bahria International Hospital, Lahore, Punjab, Pakistan",https://ClinicalTrials.gov/show/NCT04468646
NCT04334512,A Study of Quintuple Therapy to Treat COVID-19 Infection,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",PRG-044,"ProgenaBiome, Ventura, California, United States",https://ClinicalTrials.gov/show/NCT04334512
NCT04847375,Exogenous Surfactant Through Nebulizer Mask on Clinical Outcomes in Covid-19 Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,27348,NA,https://ClinicalTrials.gov/show/NCT04847375
NCT04743349,Steam Inhalations in COVID-19 Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,Steam-COVID,"Meyer Children's Hospital, Florence, Italy",https://ClinicalTrials.gov/show/NCT04743349
NCT04506632,Burden for STaff Working in the NHS,Observational Model: Ecologic or Community|Time Perspective: Prospective,STH21373,"Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom",https://ClinicalTrials.gov/show/NCT04506632
NCT04929691,The CircumVent Project: A CPAP/O2 Helmet Solution for Non-Invasive Ventilation Among Patients With COVID-19,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,CDC Foundation Award 1085.1,"Nigerian Institute of Medical Research, Yaba, Lagos, Nigeria|Federal Medical Center, Abeokuta, Abeokuta, Nigeria|Alex Ekwueme Federal University Teaching Hospital, Enugu, Nigeria|Enugu State University Teaching Hospital, Enugu, Nigeria|University College Hospital, Ibadan, Nigeria|Aminu Kano Teaching Hospital, Kano, Nigeria|Federal Medical Center, Ebute Metta, Lagos, Nigeria|Lagos University Teaching Hospital, Lagos, Nigeria|Delta State University Teaching Hospital, Oghara, Nigeria",https://ClinicalTrials.gov/show/NCT04929691
NCT04508556,Performance Assessment of SARS-CoV-2 Detection Breath Biopsy - SARS-CoV-2 Study,Observational Model: Cohort|Time Perspective: Cross-Sectional,SARS-CoV-2 study,"OLVG, Amsterdam, Netherlands",https://ClinicalTrials.gov/show/NCT04508556
NCT04356495,Trial of COVID-19 Outpatient Treatment in Individuals With Risk Factors for Aggravation,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,CHUBX 2020/12,"CH de Bastia, Bastia, France|Bordeaux university Hospital, Bordeaux, France|CHU de Dijon-Bourgogne, Dijon, France|CHU de Montpellier, Montpellier, France|CHRU de Nancy, Nancy, France|Groupe hospitalier Paris Saint Joseph, Paris, France|IMEA, Paris, France|CHU de Toulouse, Toulouse, France",https://ClinicalTrials.gov/show/NCT04356495
NCT04907981,Eye Detection to Identify Novel Coronavirus Infection,Observational Model: Case-Control|Time Perspective: Other,COVID-19,"Shijiazhuang Fifth Hospital, Shijiazhuang, Hebei, China",https://ClinicalTrials.gov/show/NCT04907981
NCT04883528,Protecting With ARNI Against Cardiac Consequences of Coronavirus Disease 2019,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",Pro00108314,"Duke University Medical Center, Durham, North Carolina, United States",https://ClinicalTrials.gov/show/NCT04883528
NCT04805970,REsearching Covid-19 Outcomes in Diabetes (RECODE),Observational Model: Other|Time Perspective: Prospective,1605203,"AdventHealth Translational Research Institute, Orlando, Florida, United States",https://ClinicalTrials.gov/show/NCT04805970
NCT04738760,Clinical Outcomes of High Dose Vitamin D Versus Standard Dose in COVID-19 Egyptian Patients,Observational Model: Cohort|Time Perspective: Other,COVID-VIT-D,"Teachers Hospital, Cairo, Please Select, Egypt",https://ClinicalTrials.gov/show/NCT04738760
NCT04412317,Use of PCR-Sars-CoV-2 in Children,Observational Model: Cohort|Time Perspective: Prospective,VIGIL,"ACTIV network, Créteil, France|PARI network, Créteil, France",https://ClinicalTrials.gov/show/NCT04412317
NCT04365439,Convalescent Plasma for COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2020-00895,"Ospedale Regionale Locarno, Locarno, Ticino, Switzerland",https://ClinicalTrials.gov/show/NCT04365439
NCT04584580,D-dimer Adjusted Versus Therapeutic Dose Low-molecular-weight Heparin in Patients With COVID-19 Pneumonia,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Supportive Care,FMASU P35/ 2020,"Faculty of Medicine Ain Shams University Research Institute- Clinical Research Center, Cairo, Non-US, Egypt",https://ClinicalTrials.gov/show/NCT04584580
NCT04830943,Cerebrolycin for Treatment of Covid-related Anosmia and Ageusia,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,COVID-NGF/AUH_SAH/2020,"Assiut University Hospitals, Faculty of Medicine, Assiut, Egypt",https://ClinicalTrials.gov/show/NCT04830943
NCT04952389,Acupuncture Therapy for COVID-Related Olfactory Loss,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,21-003531,"Mayo Clinic in Rochester, Rochester, Minnesota, United States",https://ClinicalTrials.gov/show/NCT04952389
NCT04411602,Intermediate IND Severe Illness COVID-19 CP,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,1589349,"Ascension Providence Hospital, Novi Campus, Novi, Michigan, United States|Ascension Providence Hospital, Southfield Campus, Southfield, Michigan, United States|Ascension Macomb-Oakland Hospital, Warren Campus, Warren, Michigan, United States",https://ClinicalTrials.gov/show/NCT04411602
NCT04362995,St. Jude Tracking of Viral and Host Factors Associated With COVID-19,Observational Model: Cohort|Time Perspective: Prospective,SJTRC,"St. Jude Children's Research Hospital, Memphis, Tennessee, United States",https://ClinicalTrials.gov/show/NCT04362995
NCT04775784,Determination of COVID-19 Related Virus in Central Nervous System,Observational Model: Cohort|Time Perspective: Prospective,NCH08-2020,"IRCCS San Raffaele Scientific Institute, Milan, Italy",https://ClinicalTrials.gov/show/NCT04775784
NCT04657458,Expanded Access Protocol on Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicle Infusion Treatment for Patients With COVID-19 Associated ARDS,NA,DB-EAP-001,NA,https://ClinicalTrials.gov/show/NCT04657458
NCT04379518,Rintatolimod and IFN Alpha-2b for the Treatment of COVID-19 in Cancer Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,I 659920|NCI-2020-02317|P30CA016056,"Roswell Park Cancer Institute, Buffalo, New York, United States",https://ClinicalTrials.gov/show/NCT04379518
NCT04621123,Plasma for Early Treatment in Non-hospitalised Mild or Moderate COVID-19 Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",COnV-ert,"Germans Trias i Pujol Hospital, Badalona, Barcelona, Spain",https://ClinicalTrials.gov/show/NCT04621123
NCT04355702,Covid-19 in Lupus Patients,Observational Model: Cohort|Time Perspective: Retrospective,RECHMPL20_0219,"Uhmontpellier, Montpellier, France",https://ClinicalTrials.gov/show/NCT04355702
NCT04847349,Live Microbials to Boost Anti-Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Immunity Clinical Trial,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Basic Science",Pro2021000186,"Rutgers University, New Brunswick, New Jersey, United States",https://ClinicalTrials.gov/show/NCT04847349
NCT04422691,Ultrasonography in Norwegian Emergency Department Patients With Suspected Covid-19 Infection,Observational Model: Cohort|Time Perspective: Cross-Sectional,REK129805,"Haukeland universitetssykehus, Bergen, Norway|Nordland Hospital, Bodø, Norway|Drammen sykehus, Drammen, Norway|Sørlandet sykehus, Kristiansand, Kristiansand, Norway|Akershus University Hospital, Oslo, Norway|Ullevål University Hospital, Oslo, Norway|Sykehuset Telemark HF, Skien, Norway|Stavanger Universitetssjukehus, Stavanger, Norway|St Olavs Hospital, Trondheim, Norway",https://ClinicalTrials.gov/show/NCT04422691
NCT04331886,An Observational Study of Patients With Coronavirus Disease 2019,Observational Model: Cohort|Time Perspective: Other,TARGET-COVID-19,"University of Washington, Seattle, Washington, United States",https://ClinicalTrials.gov/show/NCT04331886
NCT04771624,Assessment of Executive Functions After Covid-19,Observational Model: Cohort|Time Perspective: Prospective,21022021,"Sağlık Bilimleri Üniversitesi Gazi Yaşargil Training and Research Hospital, Diyarbakır, Turkey",https://ClinicalTrials.gov/show/NCT04771624
NCT04601012,OCTA Study: Retinal Vascular Changes in Patients With SARS-CoV-2 Infection,Observational Model: Case-Control|Time Perspective: Cross-Sectional,20-Mar,"University of Naples ""Federico II"", Naples, Italy",https://ClinicalTrials.gov/show/NCT04601012
NCT04708340,Tolerability and Efficacy of RJX in Patients With COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",RPI015,"Memorial Hermann Memorial City Medical Center, Houston, Texas, United States|Memorial Hermann Southeast Hospital, Houston, Texas, United States|Christus Santa Rosa Hospital, New Braunfels, Texas, United States",https://ClinicalTrials.gov/show/NCT04708340
NCT04461379,"Prevention, Efficacy and Safety of BCG Vaccine in COVID-19 Among Healthcare Workers","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Prevention",EN20-00011,"Hospital Universitario ""José E. González"", Monterrey, Nuevo León, Mexico",https://ClinicalTrials.gov/show/NCT04461379
NCT04913701,COVID-19 Epidemiological Surveillance on Healthcare Workers and Patients in a Rehabilitation Medicine Facility,Observational Model: Cohort|Time Perspective: Prospective,9月20日,"IRCCS San Raffaele Pisana, Rome, Italy",https://ClinicalTrials.gov/show/NCT04913701
NCT04463849,Effects of COVID-19 Infection on Beta-cell Function in Euglycemic Patients,Allocation: Non-Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,6/2020,"Sacco University Hospital, Milan, MI, Italy",https://ClinicalTrials.gov/show/NCT04463849
NCT04983394,The Effect of Virtual Reality Exercises on Patients With Post-SARS-CoV-2 Syndrome,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment",Sivas Cumhuriyet University,NA,https://ClinicalTrials.gov/show/NCT04983394
NCT04625985,"Metformin Glycinate, Treatment of Patients With COVID-19 and Severe Acute Respiratory Syndrome Secondary to SARS-CoV-2.","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",SIL-30000-II-20(2),"The American British Cowdray Medical Center, I.A.P, Mexico City, Mexico",https://ClinicalTrials.gov/show/NCT04625985
NCT04631380,Prayer in Commbate to Corona Virus - Covid -19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Other,PRAYER-COVID19,"Hospital do Coracao, Sao Paulo, SP, Brazil",https://ClinicalTrials.gov/show/NCT04631380
NCT04858763,MS Relapses During COVID-19 Pandemic,Observational Model: Cohort|Time Perspective: Retrospective,21NS011,NA,https://ClinicalTrials.gov/show/NCT04858763
NCT04779021,Caracterisation of COVID-19 Patients Hospitalized in Infectious Disease Department,Observational Model: Cohort|Time Perspective: Retrospective,21infectiocovid01,"CHU de NICE - Infectiologie, Nice, France|CHU de NICE - Urgences, Nice, France",https://ClinicalTrials.gov/show/NCT04779021
NCT04451694,Nutritional Follow up After Hospital Discharge for Coronavirus Disease-19,Observational Model: Cohort|Time Perspective: Prospective,2020PI097,"Quilliot, VANDOEUVRE LES Nancy, France",https://ClinicalTrials.gov/show/NCT04451694
NCT04568707,Evaluation of Biological Response to SARS-COV2 (COVID-19) in Patients With Pre-existing Neurological Disease or Newly Neurological Symptoms (BIO-COCO-NEUROSCIENCES),Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science,APHP200845,"Hôpital Pitié Salpétrière, Paris, France",https://ClinicalTrials.gov/show/NCT04568707
NCT04410510,P2Et Extract in the Symptomatic Treatment of Subjects With COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Supportive Care",CS002-COVID19,"Hospital Universitario San Ignacio, Bogotá, Colombia",https://ClinicalTrials.gov/show/NCT04410510
NCT04350450,Hydroxychloroquine Treatment of Healthcare Workers With COVID19 Illness at Montefiore,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2020-11445,"Montefiore Medical Center, Bronx, New York, United States",https://ClinicalTrials.gov/show/NCT04350450
NCT04506528,The C3I COVID-19 Project,Observational Model: Cohort|Time Perspective: Other,2020-069|OISE-20-66590-1|A534253|SMPH/MEDICINE|CTRI,"University of Wisconsin School of Medicine and Public Health Center for Tobacco Research and Intervention, Madison, Wisconsin, United States",https://ClinicalTrials.gov/show/NCT04506528
NCT04885764,Profiling Antibody Status and Vaccine Effectiveness in Post Vaccination With SARS CoV2 in Ain Shams University,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,FMASU P01b / 2021,"Faculty of Medicine Ain Shams University Research Institute- Clinical Research Center, Cairo, Non-US, Egypt",https://ClinicalTrials.gov/show/NCT04885764
NCT04610567,Treatment of Patients With Mild Coronavirus-19 (COVID-19) Disease With Methotrexate Associated to LDL Like Nanoparticles (Nano-COVID19),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Treatment",36746020.5.1001.0068,"Heart Institute (InCor) - University of São Paulo Medical School, São Paulo, Brazil, São Paulo, SP, Brazil|Hospital Santa Marcelina, São Paulo, SP, Brazil|Institute Prevent Senior, São Paulo, SP, Brazil",https://ClinicalTrials.gov/show/NCT04610567
NCT04349371,Saved From COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",AAAS9992,"Columbia University Irving Medical Center/NYP, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04349371
NCT04659486,Adolescents With COVID-19/MIS-C at HCFMUSP,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment",37460620.8.0000.0068,"Hospital das Clinicas Faculdade de Medicina USP, Sao Paulo, SP, Brazil",https://ClinicalTrials.gov/show/NCT04659486
NCT04438941,Contribution of a Prone Team in Intensive Care During the Covid-19 Epidemic,Observational Model: Case-Only|Time Perspective: Other,7911,"Service d'Anesthésie-Réanimation - Nouvel Hôpital Civil, Strasbourg, France",https://ClinicalTrials.gov/show/NCT04438941
NCT04346212,Oropharyngeal Dysphagia in Patients With COVID-19,Observational Model: Cohort|Time Perspective: Prospective,COVID_OD,"Consorci Sanitari del Maresme (Hospital de Mataró), Mataró, Barcelona, Spain",https://ClinicalTrials.gov/show/NCT04346212
NCT04392973,FAvipiravir and HydroxyChloroquine Combination Therapy,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,RC20/174,"King Abdulaziz Hospital - Al Ahsa, Hasa, Eastern Region, Saudi Arabia|AlMadina General Hospital, Al Madīnah, Saudi Arabia|Al-Qatif Central Hospital, Al-Qatif, Saudi Arabia|Imam Abdulrahman Al Faisal Hospital - Dammam, Dammam, Saudi Arabia|King Abdulaziz Medical City, Jeddah, Saudi Arabia|King Abdulaziz Hospital - Makkah, Mecca, Saudi Arabia|King Abdulaziz Medical City, National Guard Health Affairs, Riyadh, Saudi Arabia|Imam Abdulrahman Alfaisal Hospital, Riyadh, Saudi Arabia",https://ClinicalTrials.gov/show/NCT04392973
NCT04292964,Prognostic Factors of Patients With COVID-19,Observational Model: Cohort|Time Perspective: Retrospective,2020/2/2,"The First Affiliated Hospital of Chongqing Medical University, Chongqing, China",https://ClinicalTrials.gov/show/NCT04292964
NCT04372199,SEVERITY SCORE FOR COVID-19 PNEUMONIA,Observational Model: Cohort|Time Perspective: Prospective,3112,"Massimo Montalto, Roma, Italy",https://ClinicalTrials.gov/show/NCT04372199
NCT04532372,Leflunomide for the Treatment of Severe COVID-19 in Patients With a Concurrent Malignancy,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",20291|NCI-2020-05746|P30CA033572,"City of Hope Medical Center, Duarte, California, United States",https://ClinicalTrials.gov/show/NCT04532372
NCT04425733,MK-5475 in Participants With Hypoxemia Due to COVID-19 Pneumonia (MK-5475-009),"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",5475-009|2020-002062-14|MK-5475-009,NA,https://ClinicalTrials.gov/show/NCT04425733
NCT04344249,Cohort of Patients With Inflammatory Bowel Disease During COVID-19 Pandemic,Observational Model: Cohort|Time Perspective: Prospective,RC20_0150,"Chu Nantes, Nantes, France",https://ClinicalTrials.gov/show/NCT04344249
NCT04563650,COVID-19 Serology and Immunosenescence,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Screening,PI2020_843_0079,"CHU Amiens, Amiens, France",https://ClinicalTrials.gov/show/NCT04563650
NCT04517695,Blood Volume Assessment in COVID-19 ICU Patients - BVAC19,Observational Model: Cohort|Time Perspective: Prospective,20-00896,"NYU Langone Health, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04517695
NCT04337346,Evaluation of Covid 19 Anxiety in Endometriosis Patients,Observational Model: Case-Control|Time Perspective: Prospective,endocovid19,"Pinar Yalcin Bahat, Istanbul, İ̇stanbul, Turkey",https://ClinicalTrials.gov/show/NCT04337346
NCT04615052,Home-based Exercise in COVID-19 Survivors,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment",4.342.082,"University of Sao Paulo, Sao Paulo, Brazil",https://ClinicalTrials.gov/show/NCT04615052
NCT04375670,COVID19-FOIE National Observatory,Observational Model: Cohort|Time Perspective: Other,IRB00006477,"Ganne, Bondy, France",https://ClinicalTrials.gov/show/NCT04375670
NCT04522037,Measurement of the Efficacy of MORPHINE in the Early Management of Dyspnea in COVID-19 Positive Patients,Observational Model: Cohort|Time Perspective: Retrospective,CODYS_2020,"Hôpital de la Croix Rousse / GHN, Lyon, France|Hôpital Edouard Herriot, Lyon, France|Hôpital Lyon Sud, Pierre-Bénite, France",https://ClinicalTrials.gov/show/NCT04522037
NCT04709302,Effects of COVID-19 on Endothelium in HIV-Positive Patients in Sub-Saharan Africa,Observational Model: Cohort|Time Perspective: Prospective,ENDOCOVID,"University of Ilorin Teaching Hospital, Ilorin, Kwara State, Nigeria|Lagos Stae University Teaching Hospital Ikeja, Lagos, Nigeria|Walter Sisulu University, Mthatha, South Africa",https://ClinicalTrials.gov/show/NCT04709302
NCT04809974,Clinical Trial of Niagen to Examine Recovery in People With Persistent Cognitive and Physical Symptoms After COVID-19 Illness (Long-COVID),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",2021P000158,"Clinical Translational Research Unit, Boston, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT04809974
NCT04516850,HSD3B1 Gene Polymorphisms With Outcomes in SARS-CoV-2 Infected Patients,Observational Model: Other|Time Perspective: Retrospective,COVID19-GeneExp,"Oncology Institute of Southern Switzerland (IOSI), Bellinzona, Switzerland|Clinica Luganese Moncucco, Lugano, Switzerland",https://ClinicalTrials.gov/show/NCT04516850
NCT04405999,Prevention of Infection and Incidence of COVID-19 in Medical Personnel Assisting Patients With New Coronavirus Disease,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,05-20-02-С,"Almazov National Medical Research Centre, Saint Petersburg, Russian Federation",https://ClinicalTrials.gov/show/NCT04405999
NCT04673279,Long-term COVID-19 Immune Response in a Vulnerable Neighbourhood in Argentina,Observational Model: Cohort|Time Perspective: Cross-Sectional,3545,"Hospital de Niños Ricardo Gutierrez, Buenos Aires, Ciudad De Buenos Aires, Argentina",https://ClinicalTrials.gov/show/NCT04673279
NCT04889261,External Validation of the CHOD Risk Scale,Observational Model: Cohort|Time Perspective: Cross-Sectional,IIBSP-COV-2021-53,"Hospital de la Santa Creu i Sant Pau, Barcelona, Spain",https://ClinicalTrials.gov/show/NCT04889261
NCT04498442,"A Study on Prevalence, Protection and Recovery From COVID-19 in Seasoned Yoga Practitioners in Comparison to Age and Gender Matched Controls",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,2020P000433,"Beth Israel Deaconess Medical Centre, Boston, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT04498442
NCT04703608,Prevention and Treatment for COVID -19 (Severe Acute Respiratory Syndrome Coronavirus 2 SARS-CoV-2) Associated Severe Pneumonia in the Gambia,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,LEO 22628,"Mrcg@Lshtm, Fajara, Gambia",https://ClinicalTrials.gov/show/NCT04703608
NCT04954235,Effectiveness and Safety Study of Specific Hyperimmune Equine Serum for the Treatment of Severe Hospitalized SARS-CoV-2 in Adults: Retrospective Cohort Study,Observational Model: Cohort|Time Perspective: Retrospective,4484,"Hospital de Campaña ""Escuela Hogar"", Corrientes, Argentina",https://ClinicalTrials.gov/show/NCT04954235
NCT04701489,UNITE Study (UMN-GE) for COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,STUDY00011290,"M Health Fairview St. Joseph's Hospital, Saint Paul, Minnesota, United States",https://ClinicalTrials.gov/show/NCT04701489
NCT04836780,DEXamethasone EARLY Administration in Hospitalized Patients With Covid-19 Pneumonia,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,EARLY-DEX Covid-19,"Hospital Universitario Infanta Leonor, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04836780
NCT04937608,Impact of the Coronavirus Disease 2019 (COVID-19) on Sperm Parameters,Observational Model: Case-Control|Time Perspective: Prospective,COVID-19 and sperm parameters,NA,https://ClinicalTrials.gov/show/NCT04937608
NCT04374071,Early Short Course Corticosteroids in COVID-19,Observational Model: Cohort|Time Perspective: Retrospective,HFH IRB # 13739,"Henry Ford Hospital, Detroit, Michigan, United States",https://ClinicalTrials.gov/show/NCT04374071
NCT04416334,PREEMPTIVE THERAPY WITH COLCHICINE IN PATIENTS OLDER THAN 60 YEARS WITH HIGH RISK OF SEVERE PNEUMONIAE DUE TO CORONAVIRUS,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,COLCHICOVID,"Atención primaria (Área 2), Laredo, Cantabria, Spain|Gerencia de atención primaria (Área 3), Reinosa, Cantabria, Spain|Atencion primaria (AREA 1), Santander, Cantabria, Spain|Gerencia de atención primaria (área 4), Torrelavega, Cantabria, Spain",https://ClinicalTrials.gov/show/NCT04416334
NCT04450004,"Safety, Tolerability and Immunogenicinity of a Coronavirus-Like Particle COVID-19 Vaccine in Adults Aged 18-55 Years.",Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,CP-PRO-COVLP-019,"Syneos Health, Montréal, Quebec, Canada|Syneos Health, Québec, Quebec, Canada",https://ClinicalTrials.gov/show/NCT04450004
NCT04552340,"Epidemiologic, Clinical and Molecular Characteristics of Patients With Acute Respiratory Failure Affected by 2019-NCOV.",Observational Model: Cohort|Time Perspective: Prospective,2485,"Humanitas Research Hospital, Rozzano, Milan, Italy",https://ClinicalTrials.gov/show/NCT04552340
NCT04801888,Study on Combined Vaccination With SARS-CoV-2 Inactivated Vaccine and Quadrivalent Influenza Vaccine,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,PRO-QINF-4001,"Kaihua county Center for Disease Control and Prevention, Quzhou, Zhejiang, China",https://ClinicalTrials.gov/show/NCT04801888
NCT04586114,Effect of Corticosteroid Treatment on Prognosis in ARDS Secondary to Covid-19,Observational Model: Cohort|Time Perspective: Retrospective,2020PI109,"Hopital Central, Service de Reanimation Medicale, Nancy, France",https://ClinicalTrials.gov/show/NCT04586114
NCT04385160,Myeloproliferative Neoplasms (MPN) and COVID-19,Observational Model: Cohort|Time Perspective: Other,FROM - O-MPN-COVID-2020,"New York-Presbyterian/Weill Cornell Medical Center, New York, New York, United States|Hopital Saint-Louis, Paris, France|University Medical Center RWTH, Aachen, Germany|University Clinic for Hematology, Oncology, Hemostaseology and Palliative Care, Johannes Wesling Medical Center, Minden, Germany|Ospedale San Gerardo di Monza, Monza, Monza Brianza, Italy|A.S.O. SS. Antonio e Biagio e C.Arrigo di Alessandria, Alessandria, Italy|ASST-Papa Giovanni XXIII, Bergamo, Italy|Policlinico S.Orsola-Malpighi, Bologna, Italy|ASST-Spedali Civili, Brescia, Italy|AOU Ospedale Careggi, Firenze, Italy|Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milano, Italy|IRCCS Ospedale San Raffaele, Milano, Italy|Azienda Ospedaliero Universitaria Maggiore della Carità, Novara, Italy|IRCCS Policlinico San Matteo, Pavia, Italy|Policlinico Universitario Fondazione Agostino Gemelli, Roma, Italy|A.O.U. Città della Salute e della Scienza di Torino, Torino, Italy|Ospedale Policlinico ""G.B. Rossi"" Borgo Roma, Verona, Italy|Ospedale San Bortolo, Vicenza, Italy|Sobas Wroclaw Medical University ·, Wrocław, Poland|Hospital Clínic De Barcelona, Barcelona, Barcellona, Spain|Hospital del Mar, Barcelona, Barcellona, Spain|Institut Català d' Oncologia - Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain|ICO L'Hospitalet - Hospital Moisès Broggi, Sant Joan Despí, Barcelona, Spain|Hospital Universitario Príncipe de Asturias, Alcalá De Henares, Madrid, Spain|Hospital General de La Palma, Breña Alta, Santa Cruz De Tenerife, Spain|Servicio de Hematología Hospital General Universitario de Albacete, Albacete, Spain|Hospital General de Elche, Alicante, Spain|Hospital Vall d'Hebron, Barcelona, Spain|Hospital Universitario de Burgos, Burgos, Spain|ICO Girona Hospital Josep Trueta Servei d'hematologia, Girona, Spain|FEA Hematología Hospital Universitario de Móstoles, Madrid, Spain|Hospital 12 de octubre, Madrid, Spain|Hospital Clínico San Carlos, Madrid, Spain|Hospital Gregorio Marañón, Madrid, Spain|Hospital Moncloa, Madrid, Spain|Hospital Ramón y Cajal, Madrid, Spain|Hospital Universitario Infanta Leonor, Madrid, Spain|Hospital Universitario La Paz, Madrid, Spain|Hospital Clínico Universitario, Valencia, Spain|Guy's and St. Thomas' NHS Foundation Trust., London, United Kingdom",https://ClinicalTrials.gov/show/NCT04385160
NCT04703790,Acceptability of a COVID-19 Vaccine Among US Adults Over Two Time Periods,Observational Model: Other|Time Perspective: Prospective,AAAT5154,"Columbia University Irving Medical Center, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04703790
NCT04395781,Pediatric Acute and Critical Care COVID-19 Registry of Asia,Observational Model: Cohort|Time Perspective: Other,2020/2094,"Chongqing Hospital Children's Medical Center, Chongqing, China|Zhengzhou Children's hospital, Zhengzhou, China|Post Graduate Institute of Medical Education and Research, Chandigarh, India|General Hospital H. Adam Malik, Medan, Indonesia|Murni Teguh Memorial Hospital, Medan, Indonesia|St. Marianna University School of Medicine, Kanagawa, Japan|Universiti Kebangsaan Malaysia Medical Centre, Bandar Tun Razak, Kuala Lumpur, Malaysia|Hospital Enche' Besar Hajjah Khalsom, Kluang, Malaysia|University Malaya Medical Centre, Kuala Lumpur, Malaysia|Penang General Hospital, Pulau Pinang, Malaysia|Hospital Tuanku Ja'afar, Seremban, Malaysia, Seremban, Malaysia|Aga Khan University Hospital, Karachi, Pakistan|KK Women's and Children's Hospital, Singapore, Singapore|National University Hospital, Singapore, Singapore, Singapore",https://ClinicalTrials.gov/show/NCT04395781
NCT04958954,Post-Marketing Safety Study of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA-1273 COVID-19 Vaccine in the United States,Observational Model: Cohort|Time Perspective: Retrospective,mRNA-1273-P903,NA,https://ClinicalTrials.gov/show/NCT04958954
NCT04361123,Atrium COVID-19 Syndromic and Serologic Surveillance,Observational Model: Cohort|Time Perspective: Prospective,04-20-11A,"Atrium Health, Charlotte, North Carolina, United States",https://ClinicalTrials.gov/show/NCT04361123
NCT04359927,Long-term Effects of Coronavirus Disease 2019 on the Cardiovascular System: CV COVID-19 Registry,Observational Model: Case-Control|Time Perspective: Cross-Sectional,HCB/2020/0457,"Hospital Clínic of Barcelona, Barcelona, Catalonia, Spain",https://ClinicalTrials.gov/show/NCT04359927
NCT04715607,"COVID-19: SARS-CoV-2 Detection in Saliva, Oropharyngeal and Nasopharyngeal Specimens","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Diagnostic",21-Jan,"Valby COVID-19 teststed, Copenhagen, Valby, Denmark",https://ClinicalTrials.gov/show/NCT04715607
NCT04408339,COVID-19 in Cancer Patients: Evaluation of Clinical Course and Impact on Oncological Care Including Biobanking,Observational Model: Cohort|Time Perspective: Prospective,PV7313,"University Hospital Hamburg Eppendorf, Hamburg, Germany",https://ClinicalTrials.gov/show/NCT04408339
NCT04397900,Blood Collection Study From COVID-19 Convalescents Previously Hospitalized to Identify Immunogenic Viral Epitopes,Observational Model: Other|Time Perspective: Retrospective,1586788,"Ochsner Clinic Foundation, New Orleans, Louisiana, United States|Atlantic Health System, Morristown, New Jersey, United States",https://ClinicalTrials.gov/show/NCT04397900
NCT04760184,Impact of COVID-19 After Autologous Hematopoietic Stem Cell Transplantation in Sweden,Observational Model: Cohort|Time Perspective: Retrospective,2020-03433,"Uppsala Universitet, Uppsala, Sweden",https://ClinicalTrials.gov/show/NCT04760184
NCT04361604,Clinical Characterisation Protocol for COVID-19 in People Living With HIV,Observational Model: Cohort|Time Perspective: Other,2020-A00984-35,"Department of Internal Medicine and Clinical Immunology of Professor Cécile Goujard, Le Kremlin-Bicêtre, France",https://ClinicalTrials.gov/show/NCT04361604
NCT04554251,Global Impact of COVID-19 on Pulmonology Special Units,Observational Model: Cohort|Time Perspective: Prospective,Assiut20,"Aliae Mohamed-Hussein, Assiut, Egypt",https://ClinicalTrials.gov/show/NCT04554251
NCT04565522,Transmission of COVID-19 Virus Among Patients and Staff in Dialysis Centers,Observational Model: Cohort|Time Perspective: Prospective,DIAL-COVID-19,"Cannizzaro, Catania, Italy|AOU Mater Domini, Catanzaro, Italy|AOU Careggi, Firenze, Italy|Policlinico, Foggia, Italy|CEM-Mazara, Mazara Del Vallo, Italy|Osp. San Francesco, Nuoro, Italy|SOS Nefrologia di Pescia, Pescia, Italy|Ospedale di Santo Stefano, Prato, Italy|Ambulatorio Dialisi di Tivoli, Roma, Italy|Geramed Srl, Roma, Italy",https://ClinicalTrials.gov/show/NCT04565522
NCT04874753,The Effect of COVID-19 Pandemia on Follow up of Patients With Chronic Kidney Disease,Observational Model: Case-Only|Time Perspective: Retrospective,UsakU4,"Usak University, Usak, Turkey",https://ClinicalTrials.gov/show/NCT04874753
NCT04395807,Helmet CPAP Versus HFNC in COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,COVID HELMET,"Helsingborg's Hospital, Helsingborg, Region Skane, Sweden",https://ClinicalTrials.gov/show/NCT04395807
NCT04355624,Kidney Involvement in COVID-19 Disease (COVKID),Observational Model: Cohort|Time Perspective: Prospective,20reamedcovid02,"Centre hospitalier d'Antibes Juan les pins, Antibes, France|Centre hospitalier de Cannes, Cannes, France|Centre hospitalier de Grasse, Grasse, France|CHU de Nice, Nice, France",https://ClinicalTrials.gov/show/NCT04355624
NCT04686539,Synthetic CBD as a Therapy for COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment",SHEBA-20-7526-HA-CTIL,NA,https://ClinicalTrials.gov/show/NCT04686539
NCT04406493,Monitoring COVID-19 Patients' Lung Fluid Using Impedance Technique,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,0059-20-HYMC,"Hillel Yaffe MC,, Hadera, Israel",https://ClinicalTrials.gov/show/NCT04406493
NCT04756479,Mortality Due to COVID-19 in the COVID-AGEBRU Study,Observational Model: Case-Only|Time Perspective: Retrospective,COVID-19 AGE-BRUGMANN 2022/111,"CHU Brugmann, Brussels, Belgium",https://ClinicalTrials.gov/show/NCT04756479
NCT04927065,A Study to Evaluate the Immunogenicity and Safety of mRNA-1273.211 Vaccine for COVID-19 Variants,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,mRNA-1273-P205,"Meridian Clinical Research, Rockville, Maryland, United States|Meridian Clinical Research, Omaha, Nebraska, United States|Meridian Clinical Research, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04927065
NCT04592705,Measurement of IL-6 and Secondary Inflammatory Markers Before and After Therapeutic Plasma Exchange (TPE) in Hospitalized Patients,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Device Feasibility,LCH-1-092020,"Larkin Community Hospital, South Miami, Florida, United States",https://ClinicalTrials.gov/show/NCT04592705
NCT04852770,"Efficacy of TBCT, MBHP and PPT for PTSD During the Covid-19 Pandemics","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment",FundacaoBI,"Universidade Federal da Bahia, Salvador, Bahia, Brazil|Universidade Federal da Bahia, Salvador, Bahia, Brazil|Universidade Federal de Pernambuco, Recife, Pernambuco, Brazil|Universidade Federal de São Paulo, São Paulo, Brazil",https://ClinicalTrials.gov/show/NCT04852770
NCT04401410,Anti-SARS Cov-2 T Cell Infusions for COVID 19,Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,H-47739 BAT IT,"Houston Methodist Hospital, Houston, Texas, United States",https://ClinicalTrials.gov/show/NCT04401410
NCT04860297,A Study to Evaluate Safety and Immunogenicity of mRNA-1273 Vaccine to Prevent COVID-19 in Adult Organ Transplant Recipients and in Healthy Adult Participants,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,mRNA-1273-P304,"Piedmont Transplant Institute, Atlanta, Georgia, United States|University of Washington Medical Center, Seattle, Washington, United States",https://ClinicalTrials.gov/show/NCT04860297
NCT04910958,Impact of COVID-19 Pandemic on Early Spontaneous Abortions and Early Termination of Pregnancy,Observational Model: Cohort|Time Perspective: Retrospective,0199-20-HYMC,"Hillel Yaffe Medical Center, Hadera, Israel",https://ClinicalTrials.gov/show/NCT04910958
NCT04946162,The Use of Tadalafil in Confirmed COVID-19 Pneumonia.,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,20-63mrx,NA,https://ClinicalTrials.gov/show/NCT04946162
NCT04669054,Hospital Interns Psychological State During the COVID-19,Observational Model: Cohort|Time Perspective: Prospective,RECHMPL20_0665,"University hospital, Montpellier, France",https://ClinicalTrials.gov/show/NCT04669054
NCT04438993,The COVID-19 Disease and CARdiac Events Study,Observational Model: Cohort|Time Perspective: Prospective,COVI-RW-2020,"University Hospital Hairmyres, Glasgow, Scotland, United Kingdom",https://ClinicalTrials.gov/show/NCT04438993
NCT04723446,Efficacy of Mouthwashes in Reducing Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Viral Load in the Saliva,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Other,TBC,"Newham Hospital, London, United Kingdom|Royal London Hospital, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04723446
NCT04495842,The Effect of Aromatherapy on COVID-19-induced Anxiety,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Supportive Care,20-7-5600,"Franklin Health Research Center, Franklin, Tennessee, United States",https://ClinicalTrials.gov/show/NCT04495842
NCT04384042,Malaysian COVID-19 Anosmia Study (Phase 2) - A Nationwide Multicentre Case-Control Study,Observational Model: Case-Control|Time Perspective: Retrospective,MCO-002|NMRR-20-934-54803,"Hospital Enche' Besar Hajjah Khalsom, Kluang, Johor, Malaysia|Hospital Sultanah Bahiyah, Alor Setar, Kedah, Malaysia|Hospital Raja Perempuan Zainab II, Kota Bharu, Kelantan, Malaysia|Hospital Tuanku Jaafar, Seremban, Negeri Sembilan, Malaysia|Hospital Tengku Ampuan Afzan, Kuantan, Pahang, Malaysia|Penang Hospital, George Town, Penang, Malaysia|Hospital Raja Permaisuri Bainun, Ipoh, Perak, Malaysia|Hospital Tuanku Fauziah, Kangar, Perlis, Malaysia|Hospital Queen Elizabeth, Kota Kinabalu, Sabah, Malaysia|Sarawak General Hospital, Kuching, Sarawak, Malaysia|Hospital Sungai Buloh, Sungai Buloh, Selangor, Malaysia|Hospital Sultanah Nur Zahirah, Kuala Terengganu, Terengganu, Malaysia|Kuala Lumpur General Hospital, Kuala Lumpur, Malaysia|Hospital Melaka, Melaka, Malaysia",https://ClinicalTrials.gov/show/NCT04384042
NCT04477993,Ruxolitinib for Acute Respiratory Disorder Syndrome Due to COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",32894720.3.0000.0068,"Hospital das Clínicas, Sao Paulo, Brazil",https://ClinicalTrials.gov/show/NCT04477993
NCT04581200,Lift Mobile Mindfulness for COVID-19 Distress Symptoms,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Supportive Care",Pro00106306|3U01AT009974-03S1,"University of Colorado - Denver, Aurora, Colorado, United States|University of Michigan, Ann Arbor, Michigan, United States|Duke University Medical Center, Durham, North Carolina, United States|Oregon Health & Sciences University, Portland, Oregon, United States",https://ClinicalTrials.gov/show/NCT04581200
NCT04791423,Study of GRAd-COV2 for the Prevention of COVID-19 in Adults,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",RT-CoV-2_01,"Ospedale Vittorio Emanuele Ii, Bisceglie, Barletta- Andria-Trani, Italy|Istituto per le Malattie Infettive Lazzaro Spallanzani IRCCS, Roma, RM, Italy|Azienda Ospedaliera San Giuseppe Moscati, Avellino, Italy|A.O. Sant'Anna E San Sebastiano Caserta, Caserta, Italy|Asst Di Cremona, Cremona, Italy|Azienda Ospedaliero-Universitaria Di Ferrara, Ferrara, Italy|Ao Ospedali Riuniti - Foggia, Foggia, Italy|E.O. Ospedali Galliera, Genova, Italy|Presidio Ospedaliero Nord-Ospedale Santa Maria Goretti Latina, Latina, Italy|Fondaz.Irccs Ca' Granda - Ospedale Maggiore Policlinico, Milano, Italy|Asst Fatebenefratelli Sacco, Milano, Italy|Ospedale S.Gerardo - Monza, Monza, Italy|Azienda Ospedaliera Dei Colli - P Cotugno, Napoli, Italy|Azienda Ospedaliera Universitaria Della Universita' Vanvitelli I Di Napoli, Napoli, Italy|Az.Osp.Univ.P.Giaccone, Palermo, Italy|Azienda Ospedaliero-Universitaria Di Parma, Parma, Italy|Policlinico S. Matteo - Pavia, Pavia, Italy|Azienda Usl Di Piacenza, Piacenza, Italy|Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy|Azienda Ospedaliera Policlinico Umberto I, Roma, Italy|Policlinico A. Gemelli E C.I.C.- Policlinico Universitario A. Gemelli, Roma, Italy|Ospedale Amedeo Di Savoia, Torino, Italy|Azienda Sanitaria Universitaria Integrata Di Trieste, Trieste, Italy|Asst Dei Sette Laghi, Varese, Italy|Ospedale Unico Del Vercellese - Ospedale Sant'Andrea, Vercelli, Italy|Centro Ricerche Cliniche Di Verona Srl, Verona, Italy",https://ClinicalTrials.gov/show/NCT04791423
NCT04384406,COVID-19 Outbreak Consequences for Outpatients Followed in PRM,Observational Model: Cohort|Time Perspective: Retrospective,RECHMPL20_0262,"Uh Montpellier, Montpellier, France",https://ClinicalTrials.gov/show/NCT04384406
NCT04649151,"A Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273 Vaccine in Adolescents 12 to <18 Years Old to Prevent COVID-19","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",mRNA-1273-P203,"Velocity Clinical Research - Banning, Banning, California, United States|Paradigm Clinical Research, La Mesa, California, United States|Accel Research Sites - Nona Pediatric Center, DeLand, Florida, United States|Tekton Research, Chamblee, Georgia, United States|Clinical Research Atlanta, Stockbridge, Georgia, United States|Velocity Clinical Research - Boise, Meridian, Idaho, United States|Velocity Clinical Research - Valparaiso, Valparaiso, Indiana, United States|Johnson County Clinical Trials, Lenexa, Kansas, United States|Medpharmics - Metairie, Metairie, Louisiana, United States|University of Massachusetts Medical School, Worcester, Massachusetts, United States|Clinical Research Institute, Minneapolis, Minnesota, United States|Medpharmics - Gulfport, Gulfport, Mississippi, United States|Medpharmics - Albuquerque, Albuquerque, New Mexico, United States|Child Healthcare Associates, Liverpool, New York, United States|Velocity Clinical Research - Cincinnati, Cincinnati, Ohio, United States|Lynn Health Sciences Institute, Oklahoma City, Oklahoma, United States|Velocity Clinical Research - Providence, Warwick, Rhode Island, United States|Coastal Pediatric Associates, Charleston, South Carolina, United States|Benchmark Research, Austin, Texas, United States|Crossroads Clinical Research, Corpus Christi, Texas, United States|Kool Kids Pediatrics, Houston, Texas, United States|ACRC Trials, Plano, Texas, United States|Tekton Research, San Antonio, Texas, United States|Tekton Research, San Antonio, Texas, United States|Velocity Clinical Research - Salt Lake City - Jordan Valley, West Jordan, Utah, United States",https://ClinicalTrials.gov/show/NCT04649151
NCT04470427,"A Study to Evaluate Efficacy, Safety, and Immunogenicity of mRNA-1273 Vaccine in Adults Aged 18 Years and Older to Prevent COVID-19","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",mRNA-1273-P301|75A50120C00034,"Ascension St. Vincent Birmingham, Birmingham, Alabama, United States|Synexus Clinical Research US, Inc. - Birmingham, Birmingham, Alabama, United States|Hope Research Institute, Chandler, Arizona, United States|Synexus Clinical Research US, Inc. - Phoenix West, Glendale, Arizona, United States|Hope Research Institute, Peoria, Arizona, United States|Hope Research Institute, Phoenix, Arizona, United States|Quality of Life Medical and Research Center, Tucson, Arizona, United States|Baptist Health Center for Clinical Research, Little Rock, Arkansas, United States|Advanced Clinical Research - Rancho Paseo, Banning, California, United States|University of California San Diego, La Jolla, California, United States|eStudySite - La Mesa, La Mesa, California, United States|UCLA Vine Street Clinic CRS, Los Angeles, California, United States|VA Greater Los Angeles Healthcare (veterans only), Los Angeles, California, United States|Paradigm Clinical Research Institute Inc, Redding, California, United States|Benchmark Research - Sacramento, Sacramento, California, United States|Medical Center For Clinical Research - M3 Wake Research, San Diego, California, United States|University of Colorado Hospital, Aurora, Colorado, United States|Lynn Institute of The Rockies, Colorado Springs, Colorado, United States|George Washington University, Washington, District of Columbia, United States|Accel Research Site, DeLand, Florida, United States|Research Centers of America, Hollywood, Florida, United States|Jacksonville Center for Clinical Research, Jacksonville, Florida, United States|Synexus - Optimal Research - Melbourne, Melbourne, Florida, United States|Suncoast Research Group, Miami, Florida, United States|University of Miami, Miami, Florida, United States|Synexus Clinical Research US, Inc. - Orlando, Orlando, Florida, United States|Palm Beach Research Center, West Palm Beach, Florida, United States|Grady Health System, Atlanta, Georgia, United States|Children's Healthcare of Atlanta, Atlanta, Georgia, United States|Hope Clinic of The Emory Vaccine Center, Decatur, Georgia, United States|Meridian Clinical Research, Savannah, Georgia, United States|Clinical Research Atlanta, Stockbridge, Georgia, United States|Synexus Clinical Research US, Inc. - Chicago, Chicago, Illinois, United States|UIC Project WISH CRS, Chicago, Illinois, United States|University of Chicago-Hospital, Chicago, Illinois, United States|Johnson County Clin-Trials, Lenexa, Kansas, United States|Alliance for Multispecialty Research, Newton, Kansas, United States|Alliance for Multispecialty Research- East Wichita, Wichita, Kansas, United States|Meridian Clinical Research, Baton Rouge, Louisiana, United States|Benchmark Research - Metairie, Metairie, Louisiana, United States|University of Maryland School of Medicine, Baltimore, Maryland, United States|Synexus - Optimal Research - Rockville, Rockville, Maryland, United States|Meridian Clinical Research, Rockville, Maryland, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States|Henry Ford Health System, Detroit, Michigan, United States|MediSync Clinical Research Hattiesburg Clinic, Petal, Mississippi, United States|Saint Louis University, Saint Louis, Missouri, United States|Sundance Clinical Research, Saint Louis, Missouri, United States|Meridian Clinical Research, Grand Island, Nebraska, United States|Meridian Clinical Research, Norfolk, Nebraska, United States|Meridian Clinical Research, Omaha, Nebraska, United States|Clinical Research Center of Nevada, Las Vegas, Nevada, United States|AB Clinical Trials, Las Vegas, Nevada, United States|Hackensack University Medical Center, Hackensack, New Jersey, United States|New Jersey Medical School, Newark, New Jersey, United States|Meridian Clinical Research, Binghamton, New York, United States|Weill Cornell Chelsea - (CRS), New York, New York, United States|Weill Cornell Medical College, New York, New York, United States|University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States|Tryon Medical Partners, Charlotte, North Carolina, United States|Carolina Institute for Clinical Research - M3 Wake Research, Fayetteville, North Carolina, United States|M3 Wake Research, Inc - M3 Wake, Raleigh, North Carolina, United States|Trial Management Associates, Wilmington, North Carolina, United States|Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States|Synexus Clinical Research US, Inc. - Cincinnati, Cincinnati, Ohio, United States|New Horizons Clinical Research, Cincinnati, Ohio, United States|Cincinnati CRS, Cincinnati, Ohio, United States|Rapid Medical Research Inc, Cleveland, Ohio, United States|Lynn Health Science Institute, Oklahoma City, Oklahoma, United States|Crisor, Medford, Oregon, United States|University of Pennsylvania, Philadelphia, Pennsylvania, United States|UPMC University Center, Pittsburgh, Pennsylvania, United States|Keystone VitaLink Research, Anderson, South Carolina, United States|Keystone VitaLink Research - Greenville, Greenville, South Carolina, United States|Coastal Carolina Research Center, Mount Pleasant, South Carolina, United States|Keystone VitaLink Research - Spartanburg, Spartanburg, South Carolina, United States|Meridian Clinical Research, Dakota Dunes, South Dakota, United States|WR-ClinSearch, Chattanooga, Tennessee, United States|Alliance for Multispecialty Research, Knoxville, Tennessee, United States|Vanderbilt University Medical Center, Medical Arts Building, Nashville, Tennessee, United States|Vanderbilt University Medical Center, Medical Center North, Nashville, Tennessee, United States|Benchmark Research - Austin, Austin, Texas, United States|Synexus - Optimal Research - Austin, Austin, Texas, United States|Tekton Research, Austin, Texas, United States|Advanced Clinical Research - Be Well MD, Cedar Park, Texas, United States|Global Medical Research - M3 Wake Research, Dallas, Texas, United States|Synexus Clinical Research US, Inc. - Dallas, Dallas, Texas, United States|Benchmark Research - Fort Worth, Fort Worth, Texas, United States|University of Texas Medical Branch at Galveston, Galveston, Texas, United States|Baylor College of Medicine, Houston, Texas, United States|DM Clinical Research - Texas Center For Drug Development, Houston, Texas, United States|Laguna Clinical Research, Laredo, Texas, United States|Centex Studies, McAllen, Texas, United States|Benchmark Research - San Angelo, San Angelo, Texas, United States|Clinical Trials of Texas, Inc, San Antonio, Texas, United States|DM Clinical Research, Tomball, Texas, United States|Synexus Clinical Research US, Inc. - Salt Lake City, Murray, Utah, United States|Foothill Family Clinic - North, Salt Lake City, Utah, United States|Foothill Family Clinic-South Clinic, Salt Lake City, Utah, United States|Kaiser Permanente - Seattle, Seattle, Washington, United States",https://ClinicalTrials.gov/show/NCT04470427
NCT04390165,Malaysian COVID-19 Anosmia Study (Phase 1) - A Nationwide Multicentre Cross-Sectional Study,Observational Model: Case-Only|Time Perspective: Cross-Sectional,MCO-001|NMRR-20-934-54803,"Hospital Enche' Besar Hajjah Khalsom, Kluang, Johor, Malaysia|Hospital Sultanah Bahiyah, Alor Setar, Kedah, Malaysia|Hospital Raja Perempuan Zainab II, Kota Bharu, Kelantan, Malaysia|Hospital Tuanku Jaafar, Seremban, Negeri Sembilan, Malaysia|Hospital Tengku Ampuan Afzan, Kuantan, Pahang, Malaysia|Penang Hospital, George Town, Penang, Malaysia|Hospital Raja Permaisuri Bainun, Ipoh, Perak, Malaysia|Hospital Tuanku Fauziah, Kangar, Perlis, Malaysia|Hospital Queen Elizabeth, Kota Kinabalu, Sabah, Malaysia|Sarawak General Hospital, Kuching, Sarawak, Malaysia|Hospital Sungai Buloh, Sungai Buloh, Selangor, Malaysia|Hospital Sultanah Nur Zahirah, Kuala Terengganu, Terengganu, Malaysia|Kuala Lumpur General Hospital, Kuala Lumpur, Malaysia|Hospital Melaka, Melaka, Malaysia",https://ClinicalTrials.gov/show/NCT04390165
NCT04372680,WeanINg From Mechanical Ventilation for ARDS CovId-19 Patients Guided by Combined Thoracic UltraSound,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,RC31/20/0138|2020-A00916-33,"CHU de LIMOGES, Limoges, France|CHU de TOULOUSE, Toulouse, France",https://ClinicalTrials.gov/show/NCT04372680
NCT04603664,Role of NGAL and Cystatin C in Prediction of Acute Kidney Injury Covid-19 Infection,Observational Model: Case-Only|Time Perspective: Prospective,FMASU P82b/2020,"Ainshams hospitals, Cairo, Egypt|Sanaa Wasfy, New Cairo, Egypt",https://ClinicalTrials.gov/show/NCT04603664
NCT04366791,Radiation Eliminates Storming Cytokines and Unchecked Edema as a 1-Day Treatment for COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,STUDY00000476|NCI-2020-02676|RAD5002-20|P30CA138292,"Emory University Hospital Midtown/Winship Cancer Institute, Atlanta, Georgia, United States|Emory Saint Joseph's Hosptial, Atlanta, Georgia, United States",https://ClinicalTrials.gov/show/NCT04366791
NCT04341792,Predictive Biomarkers of Secondary Aggravation in Covid-19 Suspect Patient,Observational Model: Cohort|Time Perspective: Prospective,2020_33|2020-A00906-33,"Hôpital Roger Salengro, CHU Lille, Lille, France",https://ClinicalTrials.gov/show/NCT04341792
NCT04719234,Lung Ultrasonography in COVID-19 Pneumonia,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,2011-KAEK-25 2020/5-21,"University of Health Sciences, Bursa Yuksek Ihtisas Training and Research Hospital, Bursa, Turkey",https://ClinicalTrials.gov/show/NCT04719234
NCT04617483,"Study of the Commercial Scale SARS-CoV-2 Vaccine Against the Pilot Scale Among Adults, and Bridging Study of the Immunogenicity in Elderly Against That in Adults","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention",PRO-nCOV-3001,"Dafeng District Center for Disease Prevention and Control, Yancheng, Jiangsu, China",https://ClinicalTrials.gov/show/NCT04617483
NCT04714125,Prognostic Value of Flow-mediated Dilation in Hospitalized COVID-19 Patients,Observational Model: Cohort|Time Perspective: Prospective,FMDCOVID,"Hospital das Clínicas da Faculdade de Medicina da USP - HCFMUSP, Sao Paulo, Brazil",https://ClinicalTrials.gov/show/NCT04714125
NCT04591184,A Clinical Trial of a Prophylactic Plasmid DNA Vaccine for COVID-19 [Covigenix VAX-001] in Adults,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",ENTVAX01-101,"Canadian Centre for Vaccinology, Dalhousie University, Halifax, Nova Scotia, Canada",https://ClinicalTrials.gov/show/NCT04591184
NCT04806867,Selection of Patients With Chronic Inflammatory Rheumatism Requiring Management During the COVID-19 Pandemia,Observational Model: Cohort|Time Perspective: Retrospective,87RI20_0044 (SePaRIC),"Service de Rhumatologie, CHu de Limoges, Limoges, France",https://ClinicalTrials.gov/show/NCT04806867
NCT04617535,Compassionate Use of REGN-COV2 for the Treatment of COVID-19,NA,R10933-10987-COV,NA,https://ClinicalTrials.gov/show/NCT04617535
NCT04369066,"COVID-19 Study of the Serological Response Against the Severe Acute Respiratory Syndrome (SARS) Coronavirus 2 (CoV-2) Virus in 2 Types of Employees, Hospital and Non-hospital, at Institute Curie and Institute Pasteur",Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,IC 2020-07,"Institut Curie, Paris, France|Institut Pasteur, Paris, France",https://ClinicalTrials.gov/show/NCT04369066
NCT04347226,Anti-Interleukin-8 (Anti-IL-8) for Patients With COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,AAAS9881,"Columbia University Irving Medical Center, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04347226
NCT04813796,"A Study to Evaluate Safety, Reactogenicity, and Immunogenicity of mRNA-1283 and mRNA-1273 Vaccines in Healthy Adults Between 18 Years and 55 Years of Age to Prevent COVID-19","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",mRNA-1283-P101,"Synexus Clinical Research US Phoenix Southeast, Inc., Chandler, Arizona, United States|Optimal Research San Diego, LLC, San Diego, California, United States|Optimal Research Melbourne, LLC, Melbourne, Florida, United States|Optimal Research Illinois, LLC, Peoria, Illinois, United States|Optimal Research Texas, LLC, Austin, Texas, United States",https://ClinicalTrials.gov/show/NCT04813796
NCT04353128,Efficacy of Melatonin in the Prophylaxis of Coronavirus Disease 2019 (COVID-19) Among Healthcare Workers.,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",MeCOVID,"Hospital Universitario La Paz, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04353128
NCT04865900,Prevalence of Perimyocarditis After Covid-19 Vaccine,Observational Model: Cohort|Time Perspective: Prospective,HYMC-0046-21,"Hillel Yaffe Medical Center, Hadera, Israel",https://ClinicalTrials.gov/show/NCT04865900
NCT04455958,Lopinavir/Ritonavir for the Treatment of COVID-19 Positive Patients With Cancer and Immune Suppression in the Last Year,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",STUDY00021444|NCI-2020-02877,NA,https://ClinicalTrials.gov/show/NCT04455958
NCT04766983,Incidence of VAP in Patients With Severe COVID-19,Observational Model: Cohort|Time Perspective: Other,20/01/2021-0002005-U,"IRCCS Ca' Granda Ospedale Maggiore Policlinico Foundation, Milan, MI, Italy",https://ClinicalTrials.gov/show/NCT04766983
NCT04796896,A Study to Evaluate Safety and Effectiveness of mRNA-1273 COVID-19 Vaccine in Healthy Children Between 6 Months of Age and Less Than 12 Years of Age,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",mRNA-1273-P204,"Children's of Alabama, Birmingham, Alabama, United States|MedPharmics, LLC, Phoenix, Arizona, United States|Emmaus Research Center Inc, Anaheim, California, United States|Velocity Clinical Research - Banning - ERN- PPDS, Banning, California, United States|Family Medical Clinic, El Monte, California, United States|Sera Collection Research Services LLC, El Monte, California, United States|Altman Clinical and Translation Research Institute, La Jolla, California, United States|Kaiser Permanente Los Angeles Medical Center, Los Angeles, California, United States|SeroCollection Research Services LLC, Montebello, California, United States|Carey Chronis MD Pediatric, Infant and Adolescent Medicine - FOMAT, Ventura, California, United States|Yale University School of Medicine, New Haven, Connecticut, United States|Prohealth Research Center, Doral, Florida, United States|University of Florida Jacksonville, Jacksonville, Florida, United States|Kissimmee Clinical Research (KCR), Kissimmee, Florida, United States|Allied Biomedical Research Institute, Miami, Florida, United States|Emory University School of Medicine, Atlanta, Georgia, United States|Iresearch Atlanta, LLC, Decatur, Georgia, United States|Velocity Clinical Research - Boise - ERN - PPDS, Meridian, Idaho, United States|Alliance for Multispecialty Research -El Dorado, El Dorado, Kansas, United States|Michael W Simon, MD PSC, Lexington, Kentucky, United States|Pennington Biomedical Research Center, Baton Rouge, Louisiana, United States|MedPharmics - Platinum, Metairie, Louisiana, United States|Tulane Medical Center, New Orleans, Louisiana, United States|University of Maryland School of Medicine, Baltimore, Maryland, United States|The Pediatric Centre of Frederick, Frederick, Maryland, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Pediatric Associates of Fall River, Fall River, Massachusetts, United States|University of Massachusetts Medical School, Worcester, Massachusetts, United States|Henry Ford Health System, Detroit, Michigan, United States|Clinical Research Institute, Inc - CRN - PPDS, Minneapolis, Minnesota, United States|MediSync Clinical Research Hattiesburg Clinic, Petal, Mississippi, United States|Washington University in St. Louis, Saint Louis, Missouri, United States|Meridian Clinical Research (Hastings, Nebraska), Hastings, Nebraska, United States|Quality Clinical Research - PPDS, Omaha, Nebraska, United States|MedPharmics, LLC, Albuquerque, New Mexico, United States|Certified Research Associates, Cortland, New York, United States|Child Healthcare Associates - East Syracuse, East Syracuse, New York, United States|Stony Brook University Medical Center, Stony Brook, New York, United States|OnSite Clinical Solutions, LLC, Charlotte, North Carolina, United States|Javara Inc. - Winston-Salem, Winston-Salem, North Carolina, United States|Lynn Health Science Institute - ERN - PPDS, Oklahoma City, Oklahoma, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States|Pittsburgh Vaccine Trials Unit - University Center, Pittsburgh, Pennsylvania, United States|Velocity Clinical Research - Providence - ERN - PPDS, Warwick, Rhode Island, United States|Coastal Pediatric Associates, Charleston, South Carolina, United States|Medical University of South Carolina- PPDS, Charleston, South Carolina, United States|Palmetto Pediatrics, North Charleston, South Carolina, United States|Meharry Medical College - Clinical and Translational Research Center & Meharry Medical College - Pediatric Department, Nashville, Tennessee, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|Javara Inc., Dallas, Texas, United States|BRCR Global Texas, Edinburg, Texas, United States|HD Research Corp, El Paso, Texas, United States|Ventavia Research Group - Platinum - PPDS, Houston, Texas, United States|Baylor College of Medicine, Houston, Texas, United States|West Houston Clinical Research - Hunt, Houston, Texas, United States|Texas Center for Drug Development, Inc, Houston, Texas, United States|Cyfair Clinical Research Center - ERN- PPDS, Houston, Texas, United States|Village Health Partners - HUNT, Plano, Texas, United States|Victoria Clinical Research, Port Lavaca, Texas, United States|Crossroads Clinical Research (Victoria), Port Lavaca, Texas, United States|Port Lavaca Clinic, Port Lavaca, Texas, United States|Javara, Inc., The Woodlands, Texas, United States|DM Clinical Research - Pediatric Healthcare of NW Houston, Tomball, Texas, United States|Crossroads Clinical Research (Victoria), Victoria, Texas, United States|Tanner Clinic, Layton, Utah, United States|Advanced Clinical Research/Velocity Clinical Research, West Jordan, Utah, United States|Velocity Clinical Research, Salt Lake City, West Jordan, Utah, United States|PI-Coor Clinical Research, LLC, Burke, Virginia, United States|Clinical Research Partners, LLC, Richmond, Virginia, United States",https://ClinicalTrials.gov/show/NCT04796896
NCT04893668,Depression and Anxiety in Long Term Coronavirus Disease COVID-19,Observational Model: Cohort|Time Perspective: Prospective,1105211301,"Hasanuddin University Medical Research Center / HUMRC, Makasar, South Sulawesi, Indonesia",https://ClinicalTrials.gov/show/NCT04893668
NCT04701528,Anti-Viral Effects of Voclosporin in COVID-19 Positive Kidney Transplant Recipients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,NL73762.058.20,"Leiden University Medical Center, Leiden, Netherlands",https://ClinicalTrials.gov/show/NCT04701528
NCT04956887,Cognitive Training in Survivors of Covid-19: A Randomized Trial,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,210121,"Vanderbilt University Medical Center, Nashville, Tennessee, United States",https://ClinicalTrials.gov/show/NCT04956887
NCT04587258,Improving Cancer Screening and Prevention During the COVID-19 Pandemic in Underserved Populations of Rhode Island,Observational Model: Ecologic or Community|Time Perspective: Prospective,1613494-3,"Blackstone Valley Community Health Center, Pawtucket, Rhode Island, United States",https://ClinicalTrials.gov/show/NCT04587258
NCT04834401,Effect of Disease Modifying Therapy on Antibody Response to COVID19 Vaccination in Multiple Sclerosis,Observational Model: Cohort|Time Perspective: Prospective,US-TYS-11909,"Saint Barnabas Medical Center, Livingston, New Jersey, United States",https://ClinicalTrials.gov/show/NCT04834401
NCT04452682,The Impact of COVID-19 Pandemic on Critical Limb Threatening Ischemia and Emergency Vascular Practice,Observational Model: Case-Only|Time Perspective: Retrospective,R.20.06.898 - 2020/06/16,"Mansoura university, Mansoura, Egypt",https://ClinicalTrials.gov/show/NCT04452682
NCT04412031,Prediction of Unfavourable Outcome in Newly Covid-19 Hospitalized Patient,Observational Model: Cohort|Time Perspective: Retrospective,20_185,"Hôpital E Herriot - Hospices Civils de LYON, Lyon, France",https://ClinicalTrials.gov/show/NCT04412031
NCT04346420,Impact of the Double-Trunk Mask on Oxygenation Titration in COVID-19,Allocation: Non-Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,DTM-001,"Cliniques universitaires Saint-Luc, Brussels, Brussels Capital, Belgium",https://ClinicalTrials.gov/show/NCT04346420
NCT04891250,The Zambia Ivermectin Trial for the Treatment and Prevention of COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,ZIT,"University of Zambia, Lusaka, Zambia",https://ClinicalTrials.gov/show/NCT04891250
NCT04424017,Sero-prevalence of Coronavirus Disease 2019 (COVID-19) in Healthcare Workers,Observational Model: Other|Time Perspective: Cross-Sectional,COVID-19\004,"ECRRM, Cairo, Egypt|Faculty of Medicine, Cairo University, Cairo, Egypt",https://ClinicalTrials.gov/show/NCT04424017
NCT04732767,Evaluation of COVID-19 IgG Antibodies in Maternal and Cord Blood Samples,Observational Model: Cohort|Time Perspective: Prospective,08-20-20E,NA,https://ClinicalTrials.gov/show/NCT04732767
NCT04932889,Musculoskeletal Symptoms in Post Acute Covid-19 Patients,Observational Model: Case-Control|Time Perspective: Retrospective,EskisehirCityH,"Eskişehir City Hospital, Eskişehir, Turkey",https://ClinicalTrials.gov/show/NCT04932889
NCT04668196,Noninvasive Respiratory Support in COVID-19 (CATCOVID-AIR),Observational Model: Cohort|Time Perspective: Retrospective,PR(AG)265/2020,"Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain|Hospital General de Granollers, Granollers, Barcelona, Spain|Hospital de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain|Fundació Althaia, Manresa, Barcelona, Spain|Corporació Sanitària Parc Taulí, Sabadell, Barcelona, Spain|Hospital Universitari Mútua Terrassa, Terrassa, Bardelona, Spain|Hospital del Mar, Parc de Salut Mar, Barcelona, Spain|Hospital de la Santa Creu i Sant Pau, Barcelona, Spain|Hospital Vall d'Hebron, Barcelona, Spain|Hospital Dr.Josep Trueta, Girona, Spain",https://ClinicalTrials.gov/show/NCT04668196
NCT04848493,"National Project on Vaccines, COVID-19 and Frail Patients",Observational Model: Cohort|Time Perspective: Prospective,VAX4FRAIL study,"IRCCS Azienda Ospedaliera Universitaria, Bologna, Bologhna, Italy|IRCCS Istituto Tumori Giovanni Paolo II, Bari, Italy|Ospedale Policlinico San Martino IRCCS, Genova, Italy|Foindazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy|Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy|IRCCS Istituto Clinico Humanitas, Milano, Italy|IRCCS Ospedale San Raffaele, Milano, Italy|Fondazione IRCCS Policlinico San Matteo, Pavia, Italy|Azienda USL IRCCS di Reggio Emilia, Reggio Emilia, Italy|IRCCS Istituto Nazionale Tumori Regina Elena, Roma, Italy|IRCCS Istituto per le Malattie Infettive Lazzaro Spallanzani, Roma, Italy|Istituto Dermatologico San Gallicano, Roma, Italy",https://ClinicalTrials.gov/show/NCT04848493
NCT04839094,Dry Versus Wet Nasopharyngeal Rapid Test for the Detection of COVID-19.,Observational Model: Case-Only|Time Perspective: Prospective,Q2059,"Centre Hospitalier Universitaire Vaudois, Lausanne, Vaud, Switzerland",https://ClinicalTrials.gov/show/NCT04839094
NCT04354441,Effect of Hydroxychloroquine in COVID-19 Positive Pregnant Women,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","1, March 30, 2020",NA,https://ClinicalTrials.gov/show/NCT04354441
NCT04407286,Vitamin D Testing and Treatment for COVID 19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,STUDY00011960,"Arizona State University, Tempe, Arizona, United States",https://ClinicalTrials.gov/show/NCT04407286
NCT04326075,Early CPAP in COVID-19 Patients With Respiratory Failure.,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,EC-COVID-RCT-Fenice,"Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy",https://ClinicalTrials.gov/show/NCT04326075
NCT04852796,Efficacy and Safety of the Anti- COVID-19 Vaccin in Clinical Hematology Patients,Observational Model: Cohort|Time Perspective: Cross-Sectional,QP2021-PPD,"Centre Hospitalier de Quimper Cornouaille, Quimper, France",https://ClinicalTrials.gov/show/NCT04852796
NCT04878796,Effectiveness of mRNA Covid-19 Vaccines on Cancer Patients:Observational Study. (ANTICOV),Observational Model: Other|Time Perspective: Other,ASST CR-01-2021,"UO Oncologia, ASST di Cremona, Cremona, Lombardia, Italy",https://ClinicalTrials.gov/show/NCT04878796
NCT04628637,High GRP78 Levels in Covid-19 Infection: A Case-Control Study,Observational Model: Case-Control|Time Perspective: Prospective,Clinical-2,"Aylin Koseler, Denizli, Outside Of The US, Turkey",https://ClinicalTrials.gov/show/NCT04628637
NCT04590352,Mucosal Immunity Against SARS-CoV-2 Infection in COVID-19 Patients,Observational Model: Cohort|Time Perspective: Prospective,2020-6342|NL73418.091.20,"Radboudumc, Nijmegen, Gelderland, Netherlands",https://ClinicalTrials.gov/show/NCT04590352
NCT04344561,Incline Positioning in COVID-19 Patients for Improvement in Oxygen Saturation,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,IRB00246834,"Johns Hopkins Bayview Hospital, Baltimore, Maryland, United States|Johns Hopkins Hospital, Baltimore, Maryland, United States",https://ClinicalTrials.gov/show/NCT04344561
NCT04420247,Efficacy of Chloroquine or Hydroxychloroquine in Treating Pneumonia Caused by SARS-Cov-2 - COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,CLOROTRIAL,"Centro de Estudos e Pesquisa em Emergencias Clinicas e Terapia Intensiva, Curitiba, Parana, Brazil",https://ClinicalTrials.gov/show/NCT04420247
NCT04386395,Immune Changes in Severe COVID-19 Pulmonary Infections,Observational Model: Cohort|Time Perspective: Prospective,CHRU NANCY : 2020PI080_1,"Centre Hospitalier Universitaire NANCY, Vandoeuvre-les-Nancy, France",https://ClinicalTrials.gov/show/NCT04386395
NCT04399681,The Utility of Bedside Lung Ultrasonography on Diagnosis of COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,KSSEAH--,"Istanbul Kanuni Sultan Suleyman Training and Research Hospital, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04399681
NCT04895462,Acute Revascularization Treatment in Ischemic Stroke Patients With COVID-19,Observational Model: Cohort|Time Perspective: Retrospective,CHUV - Stroke&COVID,"Lausanne University Hospital, Lausanne, Switzerland",https://ClinicalTrials.gov/show/NCT04895462
NCT04365517,The Effect of Sitagliptin Treatment in COVID-19 Positive Diabetic Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,Sacco FBF,"ASST FBF Sacco, Milan, Italy",https://ClinicalTrials.gov/show/NCT04365517
NCT04408365,"Endothelial Function, Inflammation and Organ Dysfunction in COVID-19",Observational Model: Cohort|Time Perspective: Prospective,282930,"Guy's & St Thomas' Hospital, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04408365
NCT04941144,Long-Term Follow-up Survey of COVID-19 Vaccine After Vaccination,Observational Model: Cohort|Time Perspective: Prospective,PNR-1474,NA,https://ClinicalTrials.gov/show/NCT04941144
NCT04663945,Predictors of Recovery and the App-Facilitated Tele-Rehabilitation (AFTER) Program for COVID-19 Survivors,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,20-2415,"University of Colorado Hospital, Aurora, Colorado, United States",https://ClinicalTrials.gov/show/NCT04663945
NCT04510012,Characterizing the Immune Response and Neuronal Damage in COVID-19,Observational Model: Cohort|Time Perspective: Prospective,nCOV19,"Bern University Hospital, Bern, Switzerland",https://ClinicalTrials.gov/show/NCT04510012
NCT04367207,African Covid-19 Critical Care Outcomes Study,Observational Model: Cohort|Time Perspective: Prospective,ACCCOS,"Groote Schuur Hospital, Cape Town, Western Cape, South Africa",https://ClinicalTrials.gov/show/NCT04367207
NCT04476589,Prognostication of Recovery in Early Disorders of Consciousness After COVID-19,Observational Model: Cohort|Time Perspective: Prospective,2020P001616,"Massachusetts General Hospital, Boston, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT04476589
NCT04844242,MISC COVID-19 Study in Pediatric Population,Observational Model: Case-Control|Time Perspective: Cross-Sectional,2020 034,"National Institute for Research in Tuberculosis, Chennai, Tamilnadu, India",https://ClinicalTrials.gov/show/NCT04844242
NCT04416100,Development of Interstitial Lung Disease (ILD) in Patients With Severe SARS-CoV-2 Infection (COVID-19),Observational Model: Cohort|Time Perspective: Prospective,20200429-2255,"Medical University of Innsbruck, Innsbruck, Austria",https://ClinicalTrials.gov/show/NCT04416100
NCT04632706,Exploratory Ph I Trial of the Active IMP in Healthy Volunteers in Relation to COVID-19,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Other",mdc-TTG-CT-001,"MAC Clinical Research Manchester (Early Phase Unit), Neuroscience Centre of Excellence, Manchester, Greater Mancherster, United Kingdom",https://ClinicalTrials.gov/show/NCT04632706
NCT04898166,Association of Androgenetic Alopecia and Severity of Coronavirus Disease 2019 (COVID-19).,Observational Model: Cohort|Time Perspective: Prospective,NO.F.2-81/2021-GEN/56923/JPMC,"Jinnah postgraduate medical center, Karachi, Sindh, Pakistan",https://ClinicalTrials.gov/show/NCT04898166
NCT04366986,International Registry of Coronavirus (COVID-19) Exposure in Pregnancy,Observational Model: Cohort|Time Perspective: Prospective,1,"Pregistry, Los Angeles, California, United States",https://ClinicalTrials.gov/show/NCT04366986
NCT04348461,BAttLe Against COVID-19 Using MesenchYmal Stromal Cells,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",BALMYS-19,"Fundacion Jimenez Diaz, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04348461
NCT04412057,Clinical Trial to Evaluate CERC-002 in Adults With COVID-19 Pneumonia and Acute Lung Injury,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",CERC-002-CVID-201,"Hoag Memorial Hospital, Newport Beach, California, United States|Midway Immunology and Research Center, Fort Pierce, Florida, United States|Triple O Research Institute, P.A., West Palm Beach, Florida, United States|Parkview Research Center, Fort Wayne, Indiana, United States|MedPharmics, LLC, Metairie, Louisiana, United States|LSUHSC - Shreveport, Shreveport, Louisiana, United States|Cape Fear Valley Medical Center, Fayetteville, North Carolina, United States|Temple University Hospital, Philadelphia, Pennsylvania, United States|AnMed Health Medical Center, Anderson, South Carolina, United States|Lowcountry Infectious Diseases, P.A., Charleston, South Carolina, United States|BRCR Global Texas, McAllen, Texas, United States",https://ClinicalTrials.gov/show/NCT04412057
NCT04860258,"A Study to Evaluate Safety, Reactogenicity and Immunogenicity of the SARS-CoV-2 mRNA Vaccine CVnCoV in Adults With Co-morbidities for COVID-19",Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,CV-NCOV-003|2020-004070-22,"Centre Hospitalier Universitaire Saint-Pierre, Brussels, Belgium|Université Libre de Bruxelles (ULB) - Hopital Erasme, Brussels, Belgium|Universite Catholique de Louvain (UCL) - Cliniques Universitaires Saint-Luc, Brussels, Belgium|Centre Hospitalier Universitaire (CHU) de Liege - Domaine Universitaire du Sart Tilman, Liège, Belgium",https://ClinicalTrials.gov/show/NCT04860258
NCT04357860,Clinical Trial of Sarilumab in Adults With COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,SARICOR,"Hospital Universitario Reina Sofía, Córdoba, Spain",https://ClinicalTrials.gov/show/NCT04357860
NCT04422444,Post Intensive Care Syndrome in COVID19 Patients,Observational Model: Cohort|Time Perspective: Prospective,2020/577,"Corporació Parc Taulí, Sabadell, Barcelona, Spain",https://ClinicalTrials.gov/show/NCT04422444
NCT04525404,MOIST Study: Multi-Organ Imaging With Serial Testing in COVID-19 Infected Patients,Observational Model: Cohort|Time Perspective: Prospective,Pro00102389,"University of Alberta, Edmonton, Alberta, Canada",https://ClinicalTrials.gov/show/NCT04525404
NCT04640428,COVID-19 Stroke Apical Lung Examination Study,Observational Model: Cohort|Time Perspective: Prospective,COVID SALES 2,"Royal United Hospitals Bath NHS Foundation Trust, Bath, United Kingdom|North Bristol NHS Trust, Bristol, United Kingdom|University Hospitals Bristol NHS Foundation Trust, Bristol, United Kingdom|Frimley Health NHS Foundation Trust, Camberley, United Kingdom|Cardiff and Vale University Health Board, Cardiff, United Kingdom|University Hospitals Coventry and Warwickshire NHS Trust, Coventry, United Kingdom|Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom|Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom|Imperial College Healthcare NHS Foundation Trust, London, United Kingdom|King's College Hospital NHS FT (KCH), London, United Kingdom|King's College Hospital NHS FT (PRUH), London, United Kingdom|University College London NHS Foundation Trust, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04640428
NCT04873401,Leveraging Social Networks to Increase COVID-19 Testing Uptake,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,8098|UG1DA050071,"New York State Psychiatric Institute, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04873401
NCT04904484,A Safety Assessment of the iZephyr Hood for NIV in COVID-19 Patients,Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,292573,NA,https://ClinicalTrials.gov/show/NCT04904484
NCT04699851,Optimization of the Management of COVID-19 Through Tailored Recommendations to the Citizens,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Prevention,vigie-covid,"Laval University, Quebec, Canada",https://ClinicalTrials.gov/show/NCT04699851
NCT04405544,Determination of Acute Encephalopathy Predictors in Patients With COVID-19,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,NMSC-01-20,"N.I. Pirogov National Medical and Surgical Center, Moscow, Russian Federation",https://ClinicalTrials.gov/show/NCT04405544
NCT04762771,Colchicine for the Treatment of Cardiac Injury in Hospitalized Patients With COVID-19 (COLHEART-19),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,152247,"Baptist Hospital of Miami, Miami, Florida, United States",https://ClinicalTrials.gov/show/NCT04762771
NCT04668950,Fluvoxamine for Early Treatment of Covid-19 (Stop Covid 2),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",202011101,"Northwestern University, Chicago, Illinois, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|University of Utah, Salt Lake City, Utah, United States|Fred Hutchinson, Seattle, Washington, United States|McGill University Health Center, Montreal, Quebec, Canada",https://ClinicalTrials.gov/show/NCT04668950
NCT04641858,BCG to Reduce Absenteeism Among Health Care Workers During the COVID-19 Pandemic,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Prevention",BCG-COVID-RCT,"Cape Verde, Praia, Santiago, Cape Verde|Bandim Health Project, Bissau, SAB, Guinea-Bissau|Manhiça Health Research Centre, Manhiça, Maputo, Mozambique",https://ClinicalTrials.gov/show/NCT04641858
NCT04400799,Enoxaparin for Primary Thromboprophylaxis in Ambulatory Patients With COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,OVID Trial,"Universitätsklinikum Freiburg, Freiburg, Germany|Johannes Gutenberg-Universität Mainz, Mainz, Germany|University Hospital Basel, Basel, Switzerland|Clinic of Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland|University Hospital Bern, Bern, Switzerland|Hôpitaux Universitaires Genève, Geneva, Switzerland|Clinica Luganese Moncucco, Lugano, Switzerland|University hospital zurich, Zürich, Switzerland",https://ClinicalTrials.gov/show/NCT04400799
NCT04579458,Assessment of COVID-19 in Tearfilm,Observational Model: Case-Only|Time Perspective: Prospective,201127,"Vanderbilt University Medical Center, Nashville, Tennessee, United States",https://ClinicalTrials.gov/show/NCT04579458
NCT04579627,"Facial Hair, PPE and COVID-19",Observational Model: Cohort|Time Perspective: Cross-Sectional,283609,"Royal Cornwall Hospital, Truro, Cornwall, United Kingdom",https://ClinicalTrials.gov/show/NCT04579627
NCT04634214,The Severity of COVID 19 in Diabetes and Non-diabetes Patients,Observational Model: Case-Control|Time Perspective: Retrospective,IDRFARH015,"Orthomed Hospital, Chennai, Tamil Nadu, India|Medway Hospital, Chennai, Tamil Nadu, India|Venkateswara Hospital, Chennai, Tamil Nadu, India|Dr. Rela Institute & Medical Center, Chennai, Tamil Nadu, India",https://ClinicalTrials.gov/show/NCT04634214
NCT04712110,A Study of TAK-019 in Healthy Japanese Adults (COVID-19),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",TAK-019-1501|U1111-1262-6244|jRCT2071200084,"Sumida Hospital, Sumida-ku, Tokyo, Japan|Nishi Kumamoto Hospital, Kumamoto, Japan",https://ClinicalTrials.gov/show/NCT04712110
NCT04699097,The Effect of Azithromycin Use on Conduction System of Heart in COVID-19 Positive Children,Observational Model: Case-Only|Time Perspective: Prospective,139,"Süleyman Sunkak, Kayseri, In The USA Or Canada, Please Select..., Turkey",https://ClinicalTrials.gov/show/NCT04699097
NCT04910880,Personal Protective Equipment Comfort and User Attitude During COVID-19,Observational Model: Other|Time Perspective: Cross-Sectional,335561,"Istanbul University-Cerrahpasa, Istanbul, Bakırkoy, Turkey",https://ClinicalTrials.gov/show/NCT04910880
NCT04674566,Evaluation of Safety and Tolerability of COR-101 in Hospitalized Patients With Moderate to Severe COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",COR-101/001,"University Hospital Tübingen, Tübingen, Germany",https://ClinicalTrials.gov/show/NCT04674566
NCT04677660,A Study of TAK-919 in Healthy Japanese Adults (COVID-19),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",TAK-919-1501|U1111-1261-9040|jRCT2071200069,"Sumida Hospital, Sumida-ku, Tokyo, Japan|PS Clinic, Fukuoka, Japan",https://ClinicalTrials.gov/show/NCT04677660
NCT04674189,A Study to Evaluate the Safety and Immunogenicity of Vaccine CVnCoV in Healthy Adults in Germany for COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention",CV-NCOV-005,"Universitätsmedizin der Johannes Gutenberg-Universität Mainz Langenbeckstr. 1, Mainz, Germany",https://ClinicalTrials.gov/show/NCT04674189
NCT04511780,Psychological Impact of COVID-19 Outbreak on Caregivers,Observational Model: Cohort|Time Perspective: Prospective,Local/2020/JYL-03,"Intensive Care Unit, CHU d'Amiens, Amiens, France|Intensive Care Unit, CHU d'Angers, Angers, France|CHU de Besançon, Besançon, France|CHU de Bordeaux, Hôpital Pellegrin, Bordeaux, France|Intensive care Unit CHU de Brest Hôpital Cavale Blanche, Brest, France|CHU de Caen, Caen, France|CHU de Clermont Ferrand, Clermont-Ferrand, France|AP-HP, Hôpital Henri Mondor, Créteil, France|CHU de dijon, Dijon, France|CHU de Grenoble, Hôpital Michalon, La Tronche, France|AP_HP, Hôpital du Kremlin Bicêtre, Le Kremlin-Bicêtre, France|Intensive Care Unit, CHRU de Lille, Lille, France|Intensive Care Unit, CHU de Limoges, Limoges, France|Hôpitaux civils de Lyon, Hôpital de la Croix Rousse, Lyon, France|Hôpitaux civils de Lyon, Hôpital Louis Pradel, Lyon, France|Hôpitaux civils de Lyon, Hôpital Edouard Herriot, Lyon, France|AP-HM, Hôpital Nord, Marseille, France|AP-HM, Hôpital Timone adultes, Intensive Care Unit, Marseille, France|AP-HM, Hôpital Timone adultes, Neurotraumatology, Marseille, France|AP-HM, Hôpital e la Conception, Marseille, France|CHU de Montpellier, Hôpital Guy de chauliac, Montpellier, France|CHU de Montpellier, Hôpital Lapeyronie, Montpellier, France|CHU de Montpellier, Hôpital St Eloi SAR B, Montpellier, France|CHU De Montpellier, Hôpital St Eloi-DAR B, Montpellier, France|CHU De Montpellier, Hôpital St Eloi, Montpellier, France|Intensive Care Unit, CHU de Mulhouse, Mulhouse, France|Intensive CAre Unit CHRU de Nancy, Hôpital Central, Nancy, France|Intensive Care Unit, CHU de Nantes, Hôtel Dieu, Nantes, France|Intensive Care Unit, CHU de Nantes, Nantes, France|CHU de Nice, Nice, France|Intensive care Unit CHU Nîmes, Nîmes, France|AP-HP, Hôpital de la Pitié, Paris, France|AP-HP, Hôpital Bichât, Paris, France|AP-HP, Hôpital Lariboisière, Paris, France|AP6HP, Hôpital St Loui, Paris, France|AP_HP, Hôpital G Pompidou, Paris, France|AP-HP, Hôpital St Antoine, Paris, France|CH de Perpignan, Perpignan, France|CHU de Bordeaux, Hôpital Haut Leveque, Pessac, France|Intensive care Unit, Hôpitaux civils de Lyon, Lyon Sud, Pierre-Bénite, France|CHU de Poitiers, Poitiers, France|Intensive care Unit CHU de Rennes, Rennes, France|CHU de Rouen, Rouen, France|Intensive Care Unit, CHU de Nantes, Hôpital Laennec, Saint-Herblain, France|CHU de St Etienne, Hôpital Nord, Saint-Étienne, France|Intesive Care Unit CHRU de Strasbourg, Hôpital civil, Strasbourg, France|Intesive Care Unit CHRU de Strasbourg, Hôpital Hautepierre, Strasbourg, France|CHU de Toulouse, Toulouse, France|Intensive care unit CHU de Tours, Tours, France|Intensive CAre Unit CHRU de Nancy, Hôpital de Brabois, Vandœuvre-lès-Nancy, France|CH de Vesoul, Vesoul, France",https://ClinicalTrials.gov/show/NCT04511780
NCT04754633,Comparison of Chest CT Findings Related to COVID-19 With RSNA and BSTI Guidelines,Observational Model: Case-Control|Time Perspective: Retrospective,2020/588,"Sağlik Bilimleri Üniversitesi Training and Research Hospital, Diyarbakır, Turkey",https://ClinicalTrials.gov/show/NCT04754633
NCT04379492,A Study of Hydroxycholoroquine Compared to Placebo as Treatment for People With COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",20-187,"Memorial Sloan - Kettering Cancer Center, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04379492
NCT04896944,Is Precariousness a Risk Factor for COVID-19 Mortality in Intensive Care?,Observational Model: Cohort|Time Perspective: Retrospective,Centre Hospitalier Saint Denis,"Centre Hospitalier de Saint Denis, Saint-Denis, France",https://ClinicalTrials.gov/show/NCT04896944
NCT04354766,COVID-19 : Neutralizing Human Monoclonal Antibodies Against SARS-Cov-2,Observational Model: Cohort|Time Perspective: Prospective,69HCL20_0340|2020-A01038-31,"Hôpital de la Croix-Rousse, Lyon, France",https://ClinicalTrials.gov/show/NCT04354766
NCT04502667,Efficacy of Vitamin D Treatment in Pediatric Patients Hospitalized by COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,R-2020-3603-020,"Hospital Centro Medico Nacional Siglo XXI, Mexico City, Distrito Federal, Mexico",https://ClinicalTrials.gov/show/NCT04502667
NCT04641481,An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",BBIL/BBV152-C/2020,"Pt BD SHARMA,PGIMS/UHS, Rohtak, Haryana, India",https://ClinicalTrials.gov/show/NCT04641481
NCT04629638,Maternal Attachment and Depression Anxiety Score Evaluation in COVID-19 Positive Pregnant Women,Observational Model: Case-Control|Time Perspective: Prospective,maternalattachmentcovid,"Pinar Yalcin Bahat, Istanbul, İ̇stanbul, Turkey",https://ClinicalTrials.gov/show/NCT04629638
NCT04435587,Ivermectin vs Combined Hydroxychloroquine and Antiretroviral Drugs (ART) Among Asymptomatic COVID-19 Infection,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,323/2563 (IRB3),"Siriraj Hospital, Bangkok Noi, Bangkok, Thailand|Siriaj Hospital, Bangkok, N/A = Not Applicable, Thailand|Sireethorn Nimitvilai, Amphoe Maueng, Nakhonpathom, Thailand|Golden Jubilee Medical Center, Phutthamonthon District, Nakhonpathom, Thailand",https://ClinicalTrials.gov/show/NCT04435587
NCT04349982,ICU Trial in Critical Ill COVID-19 Patients,Observational Model: Cohort|Time Perspective: Prospective,250320,"Medical University of Graz, Graz, Styria, Austria",https://ClinicalTrials.gov/show/NCT04349982
NCT04641182,Prone Position for Nonintubated Patients With COVID-19 and Hypoxemic Respiratory Failure,Observational Model: Cohort|Time Perspective: Prospective,1,"Hospital Clinico Red de Salud UC - Christus, Santiago, Region Metropolitana, Chile",https://ClinicalTrials.gov/show/NCT04641182
NCT04407143,Study of the Immunity of Patients With Lung Cancer and COVID-19 Infection,Observational Model: Cohort|Time Perspective: Prospective,GECP 20/04_SOLID,"Hospital General Universitario de Elche, Elche, Alicante, Spain|ICO Hospitalet, Hospitalet de Llobregat, Barcelona, Spain|Hospital Universitario Insular de Gran canaria, Las Palmas De Gran Canaria, Gran Canaria, Spain|Hospital Universitario de Torrejón, Torrejón, Madrid, Spain|Hospital Universitario Son Llàtzer, Palma De Mallorca, Mallorca, Spain|Complexo Hospitalario Universitario de Vigo, Vigo, Pontevedra, Spain|Complejo Hospitalario de A Coruña, A Coruña, Spain|Hospital La Esperanza, A Coruña, Spain|Hospital Universitario de Ferrol, A Coruña, Spain|Hospital Virgen de los Lirios, Alicante, Spain|Hospital Germans Trias i Pujol, Badalona, Spain|Hospital Clínic de Barcelona, Barcelona, Spain|Hospital de la Santa Creu i Sant Pau, Barcelona, Spain|Hospital Universitari Dexeus, Barcelona, Spain|Hospital Universitario Cruces, Bilbao, Spain|Hospital Universitario de Burgos, Burgos, Spain|Hospital Universitario Puerto Real, Cadiz, Spain|Hospital General La Mancha Centro, Ciudad Real, Spain|Hospital Universitario San Pedro de Alcántara, Cáceres, Spain|Hospital Universitario Puerta del Mar, Cádiz, Spain|Hospital Universitario Reina Sofía, Córdoba, Spain|Hospital Universitario de Vinalopó, Elche, Spain|Hospital Dr. Josep Trueta, Girona, Spain|Hospital Universitario de Guadalajara, Guadalajara, Spain|Complejo Hospitalario de Jaén, Jaén, Spain|Complejo Asistencial Universitario de León, León, Spain|Hospital universitari Arnau de Vilanova, Lleida, Spain|Hospital San Pedro, Logroño, Spain|Hospital Universitario Lucus Augusti, Lugo, Spain|Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain|Hospital Universitario 12 de Octubre, Madrid, Spain|Hospital Universitario La Paz, Madrid, Spain|Hospital Puerta de Hierro, Madrid, Spain|Clínica Universidad de Navarra, Madrid, Spain|Hospital de Sanchinarro, Madrid, Spain|Hospital General Universitario Gregorio Marañón, Madrid, Spain|Hospital Severo Ochoa, Madrid, Spain|Hospital Universitario de Móstoles, Madrid, Spain|Hospital Universitario del Henares, Madrid, Spain|Hospital Universitario Fundación Alcorcón, Madrid, Spain|Hospital Universitario Infanta Cristina, Madrid, Spain|Hospital Universitario Infanta Leonor, Madrid, Spain|Hospital Universitario Infanta Sofía, Madrid, Spain|Hospital Universitario Príncipe de Asturias, Madrid, Spain|Hospital General Universitario de Málaga, Málaga, Spain|Hospital Costa del Sol, Málaga, Spain|Complejo Hospitalario Universitario de Ourense Santa María Nai, Ourense, Spain|Hospital Universitario Son Espases, Palma De Mallorca, Spain|Clínica Universidad de Navarra, Pamplona, Spain|Complejo Hospitalario de Navarra, Pamplona, Spain|Hospital Universitario Sant Joan de Reus, Reus, Spain|Hospital Universitario de Salamanca, Salamanca, Spain|Hospital Universitario de Canarias, Santa Cruz De Tenerife, Spain|Hospital General de Segovia, Segovia, Spain|Hospital Virgen del Rocío, Sevilla, Spain|Hospital Sant Pau i Santa Tecla, Tarragona, Spain|Hospital Universitario Nuestra Señora de Candelaria, Tenerife, Spain|Hospital Universitari i Politécnic La Fe, Valencia, Spain|Hospital Clínico Universitario de Valencia, Valencia, Spain|Hospital General de Valencia, Valencia, Spain|Hospital Arnau de Vilanova, Valencia, Spain|Hospital de Manises, Valencia, Spain|Hospital General Universitario de Valencia, Valencia, Spain|Hospital Lluís Alcanyís, Valencia, Spain|Hospital Universitario Dr. Peset, Valencia, Spain|Hospital Clínico Universitario de Valladolid, Valladolid, Spain|Hospital Universitario Río Ortega, Valladolid, Spain|Complejo Hospitalario Zamora, Zamora, Spain",https://ClinicalTrials.gov/show/NCT04407143
NCT04467931,ACEI or ARB and COVID-19 Severity and Mortality in US Veterans,Observational Model: Cohort|Time Perspective: Retrospective,132408,"University of Utah, Salt Lake City, Utah, United States",https://ClinicalTrials.gov/show/NCT04467931
NCT04405076,"Dose-Confirmation Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1273 COVID-19 Vaccine in Adults Aged 18 Years and Older","Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention",mRNA-1273-P201|75A50120C00034,"Meridian Clinical Research, Savannah, Georgia, United States|Alliance for Multispecialty Research, Newton, Kansas, United States|Alliance for Multispecialty Research, Kansas City, Missouri, United States|Meridian Clinical Research, Norfolk, Nebraska, United States|Trial Management Associates, Wilmington, North Carolina, United States|Meridian Clinical Research, Dakota Dunes, South Dakota, United States|Benchmark Research, Austin, Texas, United States|Benchmark Research, San Angelo, Texas, United States",https://ClinicalTrials.gov/show/NCT04405076
NCT04311697,Intravenous Aviptadil for Critical COVID-19 With Respiratory Failure,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",COVID-AIV,"St. Jude Medical Center, Fullerton, California, United States|University of California - Irvine, Irvine, California, United States|Miller School of Medicine / University of Miami Medical Center, Miami, Florida, United States|Baptist Hospital of Miami, Miami, Florida, United States|University of Louisville Hospital, Louisville, Kentucky, United States|Heartland/Mosaic Health, Saint Joseph, Missouri, United States|Hendrick Health, Abilene, Texas, United States|Texas Health Harris Methodist Hospital, Fort Worth, Texas, United States|Texas Health Hospital Frisco, Frisco, Texas, United States|Houston Methodist Hospital, Houston, Texas, United States",https://ClinicalTrials.gov/show/NCT04311697
NCT04432922,"Perceptions, Representations and Experiences of Septic Isolation of Hospitalized Patients for COVID-19 Infection",Observational Model: Other|Time Perspective: Prospective,ISOCOV,"Centre hospitalier intercommunal de Villeneuve St Georges, Villeneuve St Georges, France",https://ClinicalTrials.gov/show/NCT04432922
NCT04581811,Prolonged Prone Positioning for COVID-19-induced Acute Respiratory Distress Syndrome (ARDS),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,IRB-300005979,"University of Alabama at Birmingham, Birmingham, Alabama, United States",https://ClinicalTrials.gov/show/NCT04581811
NCT04726176,COVID-19 and the Brain,Observational Model: Cohort|Time Perspective: Prospective,1.43E+12,"Vrije Universiteit Brussel, Brussels, Belgium",https://ClinicalTrials.gov/show/NCT04726176
NCT04530617,Camostat and Artemisia Annua vs Placebo in COVID-19 Outpatients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",3421,"Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, None - Non-US/Canada, Mexico",https://ClinicalTrials.gov/show/NCT04530617
NCT04422873,The Impact of COVID-19 on Dialysis Users,Observational Model: Cohort|Time Perspective: Cross-Sectional,4,"School of Sport, Health and Exercise Science, Portsmouth, Outside The United States Or Canada, United Kingdom",https://ClinicalTrials.gov/show/NCT04422873
NCT04338698,"Hydroxychloroquine, Oseltamivir and Azithromycin for the Treatment of COVID-19 Infection: An RCT","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment",12(06)/2016-Coord,"Faislabad Medical University, Faisalābad, Pakistan|Gujranwala Medical College, Gujrānwāla, Pakistan|Nawaz Sharif Medical College, Gujrāt, Pakistan|Szabmu-Pims, Islamabad, Pakistan|Akram Medical Complex, Lahore, Pakistan|Fatima Jinnah Medical University, Lahore, Pakistan|King Edward Medical University-Mayo Hospital, Lahore, Pakistan|Lahore General Hospital, Lahore, Pakistan|Khyber Teaching Hospital, Peshawar, Pakistan|Rawalpindi Medical University, Rawalpindi, Pakistan|Sargodha Medical College, Sargodha, Pakistan",https://ClinicalTrials.gov/show/NCT04338698
NCT04892888,Survey of the Moderna COVID-19 Vaccine in People at High-Risk of Developing Severe COVID-19 Symptoms,Observational Model: Cohort|Time Perspective: Prospective,PNR-1475,"Takeda Selected Site, Tokyo, Japan",https://ClinicalTrials.gov/show/NCT04892888
NCT04346667,Post-Exposure Prophylaxis for Asymptomatic SARS-CoV-2 COVID-19 Patients With choloroquinE Compounds,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment",NBC-COVID19-02,"Expo Covid Center, Lahore, Punjab, Pakistan|Mayo Hospital, Lahore, Punjab, Pakistan|Pakistan Kidney and Liver Institute, Lahore, Punjab, Pakistan",https://ClinicalTrials.gov/show/NCT04346667
NCT04756193,Evaluate Long Term Cardiovascular and Pulmonary Complications After COVID-19 With Point of Care Ultrasound,Observational Model: Cohort|Time Perspective: Prospective,20.0836,"University of Louisville Health, Louisville, Kentucky, United States",https://ClinicalTrials.gov/show/NCT04756193
NCT04922632,Data-driven Approaches to Healthcare Provider Resilience & Burnout During COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,Pro00106079,"Duke University Medical Center, Durham, North Carolina, United States",https://ClinicalTrials.gov/show/NCT04922632
NCT04525716,The Effect of Covid-19 on Patient Outcomes Among Operated Patients,Observational Model: Cohort|Time Perspective: Prospective,CovidKirurgi,"Samtliga akutsjukhus i Region Stockholm, Stockholm, Sweden",https://ClinicalTrials.gov/show/NCT04525716
NCT04480398,Efficacy and Safety of Guduchi Ghan Vati for Covid-19 Asymptomatic Patients,Observational Model: Cohort|Time Perspective: Retrospective,AYU/DSSR/02,"Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University, Jodhpur, Rajasthan, India",https://ClinicalTrials.gov/show/NCT04480398
NCT04431310,Seroconversion Among Staff at a Large Acute Care Hospital in Denmark During the COVID-19 Pandemic,Observational Model: Cohort|Time Perspective: Prospective,Journal-nr.: H-20022312,"Nordsjællands Hospital, Hillerød, Capital Region, Denmark|Nykøbing Falster County Hospital, Nykøbing Falster, Southern Region, Denmark",https://ClinicalTrials.gov/show/NCT04431310
NCT04609423,Cod Liver Oil for Covid-19 Prevention Study,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",REK-172796,"Oslo University Hospital, Oslo, Norway",https://ClinicalTrials.gov/show/NCT04609423
NCT04961541,Evaluation of the Safety and Immunogenicity of Influenza and COVID-19 Combination Vaccine,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention",2019nCoV-ICC-E-101,"Q-Pharm, Herston, Queensland, Australia",https://ClinicalTrials.gov/show/NCT04961541
NCT04930003,"Reactogenicity, Safety and Immunogenicity of QazCoVac-P COVID-19 Vaccine",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Prevention,QAZCOVAC-P-I/II-01/2020,"Research Institute for Biological Safety Problems Committee of Science of the Ministry of Education and Science of the Republic of Kazakhstan, Gvardeyskiy, Jambul, Kazakhstan",https://ClinicalTrials.gov/show/NCT04930003
NCT04644159,"Longitudinal Follow-up of a Population Cohort in a French City With High SARS-CoV-2 Circulation, in Early 2020 [COVID-19]",Observational Model: Cohort|Time Perspective: Prospective,2020-060,"Hôpital de Crépy en Valois, Crépy-en-Valois, France|Institut Pasteur, Paris, France",https://ClinicalTrials.gov/show/NCT04644159
NCT04935463,Mucormycosis in COVID-19,Observational Model: Cohort|Time Perspective: Retrospective,2021-13086,"Montefiore Medical Center, Bronx, New York, United States",https://ClinicalTrials.gov/show/NCT04935463
NCT04885907,Third Dose of Moderna COVID-19 Vaccine in Transplant Recipients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Prevention",21-5324.0,"University Health Network, Toronto General Hospital, Toronto, Ontario, Canada|University Health Network, Toronto General Hospital, Multi-Organ Transplant, Toronto, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04885907
NCT04813770,The Impact of Theory-based Messaging on Covid-19 Vaccination Intentions,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Health Services Research,200200052,"University of Glasgow, Glasgow, United Kingdom",https://ClinicalTrials.gov/show/NCT04813770
NCT04378829,"Platelet Count, Platelet, Mean Platelet Volume and Platelet Distribution Width in COVID-19",Observational Model: Case-Only|Time Perspective: Retrospective,COVID-19,"Yasin Tire, Konya, Turkey",https://ClinicalTrials.gov/show/NCT04378829
NCT04860687,Quality of Life After COVID-19 Related Acute respIratory Distress Syndrome Among ICU Survivors Patients in Italy: the ODISSEA Study.,Observational Model: Cohort|Time Perspective: Prospective,ODISSEA 1.0,"Anesthesia and Intensive Care, Academic Hospital of Catanzaro, Catanzaro, Calabria, Italy|Anesthesia, Intensive Care and Pain Therapy, Academic Hospital ""Federico II"" of Naples, Naples, Campania, Italy|Anesthesia and Intensive Care, Academic Hospital of Ferrara, Ferrara, Emilia Romagna, Italy|Anesthesia and Intensive Care 2, Academic Hospital of Parma, Parma, Emilia Romagna, Italy|Anesthesia and Intensive Care Department, Ravenna Hospital, Ravenna, Emilia Romagna, Italy|Department of Anesthesia and Intensive Care, Academic Hospital of Udine, Udine, Friuli Venezia Giulia, Italy|Anesthesia and Intensive Care 1, Hospital of Trento, Trento, Trentino Alto Adige, Italy|Anesthesia and Intensive Care 2, Perugia Hospital, Perugia, Umbria, Italy",https://ClinicalTrials.gov/show/NCT04860687
NCT04366063,Mesenchymal Stem Cell Therapy for SARS-CoV-2-related Acute Respiratory Distress Syndrome,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,991919|IRCT20200217046526N2,"Royan Institute, Tehran, Iran, Islamic Republic of",https://ClinicalTrials.gov/show/NCT04366063
NCT04671017,"Dose Finding Study to Evaluate Safety, Tolerability and Immunogenicity of an Inactiviated Adjuvanted Sars-Cov-2 Virus Vaccine Candidate Against Covid-19 in Healthy Adults","Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",VLA2001-201,"Queen Elizabeth Hospital, Birmingham, United Kingdom|University Hospital Bristol and Weston NHS Foundation Trust, Bristol, United Kingdom|Newcastle University Medical School, Newcastle, United Kingdom|Southampton NIHR Clinical Research Facility, Southampton, United Kingdom",https://ClinicalTrials.gov/show/NCT04671017
NCT04653727,Effects of Integrative Medicine on Infectious Respiratory Diseases Including COVID-19,Observational Model: Other|Time Perspective: Cross-Sectional,AtemNHK,"Charite University, Berlin, Germany",https://ClinicalTrials.gov/show/NCT04653727
NCT04834882,"Burnout, Stress and Coping Strategies: Impact of the Covid-19 Epidemic",Observational Model: Cohort|Time Perspective: Cross-Sectional,PO20152*,"Chu Reims, Reims, France",https://ClinicalTrials.gov/show/NCT04834882
NCT04920357,"Immune Response to Vaccination Against Covid-19, a Follow up Study",Observational Model: Case-Control|Time Perspective: Prospective,Eudra-CT2021-000683-30,"Mälarsjukhuset, Eskilstuna, Sweden|Karlstad Central hospital, Karlstad, Sweden|Umeå University hospital, Umeå, Sweden|Örebro University hospital, Örebro, Sweden|Östersund hospital, Östersund, Sweden",https://ClinicalTrials.gov/show/NCT04920357
NCT04982770,Moral Judgements and Choices of Healthcare Professionals in the Time of COVID-19 Pandemic,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Other",1475,"Caen University Hospital, Caen, Calvados, France",https://ClinicalTrials.gov/show/NCT04982770
NCT04385901,Long Term Functional Outcomes of COVID-19 Patients Treated by Rehabilitation Services viaTelehealth,"Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment",COVID19Recovery,"Missouri Orthopedic Institute, Columbia, Missouri, United States",https://ClinicalTrials.gov/show/NCT04385901
NCT04394429,Endotracheal Tube Obstruction in Covid-19 Patients Requiring Mechanical Ventilation,Observational Model: Case-Only|Time Perspective: Other,7803,"Service d'Anesthésie-Réanimation - Nouvel Hôpital Civil, Strasbourg, France",https://ClinicalTrials.gov/show/NCT04394429
NCT04964414,Treatment of Pediatric Patients That Lost Sense of Smell Due to COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,STUDY21050012,"UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04964414
NCT04492202,"Knowledge, Attitudes, and Practices Towards COVID-19 Among Health Care Professionals Among Healthcare Professionals",Observational Model: Other|Time Perspective: Other,10,NA,https://ClinicalTrials.gov/show/NCT04492202
NCT04615000,SeroCovid<19: A Prospective Covid-19 Seroconversion Study in a Tertiary Pediatric Patient Cohort,Observational Model: Cohort|Time Perspective: Prospective,BC-08104,"Ghent University Hospital, Ghent, Belgium",https://ClinicalTrials.gov/show/NCT04615000
NCT04572438,A Cohort Study of Mechanically Ventilated COVID-19 Patients Undergoing Tracheostomy,Observational Model: Cohort|Time Perspective: Prospective,Z6364106/0000/00/00,"University College London NHS Foundation Trust, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04572438
NCT04749173,"To Assess the Safety, Tolerability and Pharmacokinetic Properties of Niclosamide Injectable (DWRX2003) Which is the Treatment of COVID-19 in Healthy Volunteers.","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",DW_DWJ1516101,"Chungnam National university hospital, Daejeon, Korea, Republic of",https://ClinicalTrials.gov/show/NCT04749173
NCT04454333,COVID-19 in Pain Perspective,Observational Model: Cohort|Time Perspective: Retrospective,2811,"Şişli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04454333
NCT04565106,Automatic Oxygen Titration With O2matic® to Patients Admitted With COVID-19 and Hypoxemic Respiratory Failure,Observational Model: Cohort|Time Perspective: Prospective,O2matic-COVID,"Hvidovre University Hospital, Copenhagen, Denmark",https://ClinicalTrials.gov/show/NCT04565106
NCT04838847,A Study to Evaluate the Immunogenicity and Safety of the SARS-CoV-2 mRNA Vaccine CVnCoV in Elderly Adults Compared to Younger Adults for COVID-19,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,CV-NCOV-012|2020-005064-54,NA,https://ClinicalTrials.gov/show/NCT04838847
NCT04361253,Evaluation of SARS-CoV-2 (COVID-19) Antibody-containing Plasma thErapy,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",2020P001215,"Brigham and Women's Hospital, Boston, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT04361253
NCT04365764,Effect of Treatments in Patients Hospitalized for Severe COVID-19 Pneumonia: a Multicenter Cohort Study,Observational Model: Case-Control|Time Perspective: Cross-Sectional,CIC1421-20-06,"Centre Hospitalier Intercommunal Robert Ballanger, Aulnay-sous-Bois, France|Centre Hospitalier Intercommunal Le Raincy-Montfermeil, Montfermeil, France",https://ClinicalTrials.gov/show/NCT04365764
NCT04691908,"Immunogenicity, Efficacy and Safety of QazCovid-in® COVID-19 Vaccine",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Prevention,QAZCOV-III-01/2020,"Research Institute for Biological Safety Problems Committee of Science of the Ministry of Education and Science of the Republic of Kazakhstan, Gvardeyskiy, Jambul, Kazakhstan",https://ClinicalTrials.gov/show/NCT04691908
NCT04624503,Prognostic and Clinical Impact of Cardiovascular Involvement in Patients With COVID-19,Observational Model: Cohort|Time Perspective: Prospective,CARDIOCOVID,"Humanitas Research Hospital, Rozzano, Milan, Italy|Centro Cardiologico Monzino, Milan, Italy|IRCCS Auxologico San Luca, Milan, Italy|IRCCS San Donato, Milan, Italy|IRCCS Istituti Clinici Scientifici Maugeri, Pavia, Italy",https://ClinicalTrials.gov/show/NCT04624503
NCT04367545,Development of a Molecular Diagnostic Strategy for SARS-CoV2 Based on Saliva in the Context of the COVID-19 Pandemic,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,2020/0094/OB,"Rouen University Hospital, Rouen, France",https://ClinicalTrials.gov/show/NCT04367545
NCT04805086,The MONACO Cell Therapy Study: Monocytes as an Anti-fibrotic Treatment After COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,289624,"Guy's & St Thomas' NHS Foundation Trust, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04805086
NCT04383613,Prone Positioning for Patients on General Medical Wards With COVID19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,20-Jan,"William Osler Health System, Brampton, Ontario, Canada|William Osler Health System, Etobicoke, Ontario, Canada|Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada|St. Michael's Hospital, Toronto, Ontario, Canada|Sinai Health System, Toronto, Ontario, Canada|Toronto General Hospital, Toronto, Ontario, Canada|Toronto Western Hospital, Toronto, Ontario, Canada|St. Joseph's Health Centre, Toronto, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04383613
NCT04434118,Anti-rheumatic Drug Use and Risk of COVID-19 Infection in Rheumatoid Arthritis Patients,Observational Model: Case-Control|Time Perspective: Retrospective,IRB: RC-5-2020,"Faculty of Medicine, Shibīn Al Kawm, Egypt",https://ClinicalTrials.gov/show/NCT04434118
NCT04812041,Relationship Between Delirium Severity by CAM-ICU 7 and 4C Mortality Score of the COVID-19 Patients in ICU,Observational Model: Cohort|Time Perspective: Cross-Sectional,E1-21-1461,"Ankara City Hospital, Ankara, Turkey",https://ClinicalTrials.gov/show/NCT04812041
NCT04614025,Open-label Multicenter Study to Evaluate the Efficacy of PLX-PAD for the Treatment of COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,PLX-COV-03,"University of hospital Bonn, Bonn, Germany|Hospital Cologne-Merheim, Köln, Germany|Emek Medical Center, Afula, Israel|University Hospital Samson Assuta Ashdod, Ashdod, Israel|Bnai Zion Medical Center, Haifa, Israel|Rambam Health Care Campus, Haifa, Israel|Galilee Medical Center, Nahariya, Israel|Baruch Padeh Medical Center, Poriya, Tiberias, Israel",https://ClinicalTrials.gov/show/NCT04614025
NCT04556513,Functional Recovery From Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19: Influence of Socio-Economic Status,Observational Model: Cohort|Time Perspective: Prospective,QUENOT 2020,"Chu Dijon Bourgogne, Dijon, France",https://ClinicalTrials.gov/show/NCT04556513
NCT04530357,"Reactogenicity, Safety and Immunogenicity of QazCovid-in® COVID-19 Vaccine",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Prevention,QAZCOV-I/II-01/2020,"Research Institute for Biological Safety Problems Committee of Science of the Ministry of Education and Science of the Republic of Kazakhstan, Gvardeyskiy, Jambul, Kazakhstan",https://ClinicalTrials.gov/show/NCT04530357
NCT04475588,Efficacy and Safety of Itolizumab in COVID-19 Complications,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,ITOLI-C19-02-I-00,"Topiwala National Medical College & B. Y. L. Nair Charitable Hospital,, Mumbai, India|Seth GS Medical College and KEM Hospital, Mumbai, India|MAMC medical college and Lok Nayak Jai Prakash Narayan Hospital hospital, New Delhi, India|All India Institute Of Medical Sciences, New Delhi, India",https://ClinicalTrials.gov/show/NCT04475588
NCT04761913,Paediatric Inflammatory Multisystem Syndrome During COVID-19 Pandemic,Observational Model: Case-Only|Time Perspective: Retrospective,19/20/048,"Mid Essex Hospital Trust, Chelmsford, Essex, United Kingdom|East Suffolk and north Essex NHS Foundation Trust, Colchester, Essex, United Kingdom|The Princess Alexandra Hospital NHS Trust, Harlow, Essex, United Kingdom|James Paget University Hospitals NHS Foundation Trust, Great Yarmouth, Norfolk, United Kingdom|Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, Norfolk, United Kingdom|East Suffolk and North Essex Foundation Trust, Ipswich, Suffolk, United Kingdom",https://ClinicalTrials.gov/show/NCT04761913
NCT04760704,Covid-19 Vaccine Response in Elderly Subjects,Observational Model: Case-Control|Time Perspective: Prospective,2021_02|2021-A00119-32,"CHU lille, Lille, France",https://ClinicalTrials.gov/show/NCT04760704
NCT04356482,CONVALESCENT PLASMA FOR ILL PATIENTS BY COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,TERAPLASCOV2,"Hospital Del Issste Regional En Guadalajara Jalisco, Guadalajara, Jalisco, Mexico|Secretaria de Salud Del Estado de Sonora, Hospital General Del Estado, Hermosillo, Sonora, Mexico|Hospital Central Norte Pemex, Mexico City, Mexico",https://ClinicalTrials.gov/show/NCT04356482
NCT04534569,Expert Panel Statement for the Respiratory Management of COVID-19 Related Acute Respiratory Failure (C-ARF),Observational Model: Other|Time Perspective: Prospective,C19ARFstudy,"NMC Specialty Hospital, Dubai, United Arab Emirates",https://ClinicalTrials.gov/show/NCT04534569
NCT04720794,A Study To Evaluate The Performance of the Lucira Health All-In-One COVID-19 Test Kit vs Hologic Panther Fusion,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,07A-CLI-006,"Neeraj Kochhar Family Medicine, Los Gatos, California, United States",https://ClinicalTrials.gov/show/NCT04720794
NCT04747249,Psychological Care of Oncology Patients With Post-traumatic Stress in the Context of a COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2020-A03234-35,"Centre Francois Baclesse, Caen, France",https://ClinicalTrials.gov/show/NCT04747249
NCT04360759,Chloroquine Outpatient Treatment Evaluation for HIV-Covid-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,HIV-COVID-19 CQOTE,"Khayelitsha Hospital, Cape Town, Western Cape, South Africa|Groote Schuur Hospital, Cape Town, Western Cape, South Africa",https://ClinicalTrials.gov/show/NCT04360759
NCT04513314,Valproate Alone or in Combination With Quetiapine for Severe COVID-19 Pneumonia With Agitated Delirium,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment",20200851,"Jackson Memorial Hospital, Miami, Florida, United States",https://ClinicalTrials.gov/show/NCT04513314
NCT04609501,"Delivery During Covid-19 Pandemic: Implications for Obstetrics, Maternal Psychopathology, and Mother-Infant Relationship",Observational Model: Cohort|Time Perspective: Prospective,0082-20-HYMC,"Department of Obstetrics and Gynecology, Hillel-Yaffe Medical Center, Hadera, Israel",https://ClinicalTrials.gov/show/NCT04609501
NCT04504877,Burnout and Distress preventiOn With caNnabidiol in Front-line Health Care workerS deAling wIth COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",BONSAI Study,"Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto - USP, Ribeirão Preto, SP, Brazil",https://ClinicalTrials.gov/show/NCT04504877
NCT04948255,Measuring Work-Related Stress in Primary Care in the Covid-19 Pandemic,Observational Model: Cohort|Time Perspective: Prospective,302893,"The Gill Medical Centre, Salford, Greater Manchester, United Kingdom",https://ClinicalTrials.gov/show/NCT04948255
NCT04278963,Yinhu Qingwen Decoction for the Treatment of Mild / Common CoVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment",YHQW-V3.0,"Jingzhou Hospital of Traditional Chinese Medicine, Jingzhou, Hubei, China|Wuhan Leishenshan (Thunder God Mountain) Hospital/The First Affiliated Hospital of Dalian Medical University, Wuhan, Hubei, China|Xiangyang Hospital of Traditional Chinese Medicine, Xiangyang, Hubei, China",https://ClinicalTrials.gov/show/NCT04278963
NCT04649931,Differences in Exhaled Breath by Using Ion Mobility Spectrometry (IMS) in Subjects Tested for SARS-CoV-2 Infection (COVID-19 Disease),Observational Model: Cohort|Time Perspective: Prospective,HC-N-H-2006,"University Hospital Gießen and Marburg (UKGM), site Marburg, Marburg, Germany",https://ClinicalTrials.gov/show/NCT04649931
NCT04480411,Use of Technology and Telemedicine to Improve Quality of Care in COVID 19 Patients,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,56472,"Stanford University, Stanford, California, United States",https://ClinicalTrials.gov/show/NCT04480411
NCT04342806,"Healthcare Worker Exposure Response and Outcomes (HERO) Registry Study, COVID-19",Observational Model: Cohort|Time Perspective: Prospective,Pro00105284,"Duke Clinical Research Institute, Durham, North Carolina, United States",https://ClinicalTrials.gov/show/NCT04342806
NCT04380935,Effectiveness and Safety of Convalescent Plasma Therapy on COVID-19 Patients With Acute Respiratory Distress Syndrome,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,convalescent plasma RSCM-FKUI,"Dr. Cipto Mangunkusumo General Hospital, Jakarta, DKI Jakarta, Indonesia|St. Carolus Hospital, Jakarta, DKI Jakarta, Indonesia|Ciputra Hospital CitraRaya, Jakarta, DKI Jakarta, Indonesia",https://ClinicalTrials.gov/show/NCT04380935
NCT04919031,Inspiratory Muscle Trainer and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) COVID-19 Persistent Symptoms,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,P.T.REC/012/003228,"Faculty of Physical Therapy, Giza, Dokki, Egypt",https://ClinicalTrials.gov/show/NCT04919031
NCT04851561,Post-coronavirus Disease-2019 Fatigue,Observational Model: Case-Control|Time Perspective: Retrospective,RMC-0834-20,"Rabin Medical Center - Beilinson Hospital, Petah Tikva, Israel",https://ClinicalTrials.gov/show/NCT04851561
NCT04351854,Registry for Clinical Presentation and Management of Patients With COVID-19 in the Emergency Room,Observational Model: Case-Control|Time Perspective: Retrospective,ReCovER,"University Hospital of Cologne, Cologne, Germany",https://ClinicalTrials.gov/show/NCT04351854
NCT04365595,SARS-CoV-2 Associated Respiratory Failure Recovery (COVID-19 CAir),Observational Model: Case-Only|Time Perspective: Prospective,2020-00745,"University Hospital Zurich, Zurich, Switzerland",https://ClinicalTrials.gov/show/NCT04365595
NCT04641806,Clinical and Immunological Evolution of Covid-19 Occurring in a Context of Non-Hodgkin Lymphoma,Observational Model: Case-Control|Time Perspective: Prospective,P20/21_LYMPHO-Cov-2,NA,https://ClinicalTrials.gov/show/NCT04641806
NCT04407468,Awake Prone Positioning and Oxygen Therapy in Patients With COVID-19,Observational Model: Cohort|Time Perspective: Retrospective,1178/SESEQ-HSGJR/08-05-20/UTI,"Hospital Materno Celaya, Celaya, Guanajuato, Mexico|Hospital Santo Tomas, Querétaro City, Queretaro, Mexico|Hospital General San Juan del Rio, Querétaro City, Queretaro, Mexico|ISSSTE Hospital Regional Merida, Mérida, Yucatan, Mexico|Hospital General de Zona 48 San PEDRO Xalpa IMSS, Estado De México, Mexico|Hospital Fernando Quiroz Gutierrez, Mexico City, Mexico",https://ClinicalTrials.gov/show/NCT04407468
NCT04361526,Pilot Study on Cytokine Filtration in COVID-19 ARDS,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,HCB/2020/0464,"Hospital Clínic de Barcelona, Barcelona, Spain",https://ClinicalTrials.gov/show/NCT04361526
NCT04389450,"Double-Blind, Multicenter, Study to Evaluate the Efficacy of PLX PAD for the Treatment of COVID-19","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",PLX-COV-01,"University of California Irvine, Irvine, California, United States|University of Southern California (USC) - Keck School of Medicine (KSOM), Los Angeles, California, United States|University Of California Davis,4860 Y Street, Sacramento, California, United States|Baptist Health Medical Center, Jacksonville, Florida, United States|Medical College of Georgia at Augusta University, Augusta, Georgia, United States|Sarah Cannon Research Institute, LLC (Mercer University School of Medicine), Macon, Georgia, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|Cooper Research Institute, Camden, New Jersey, United States|Holy Medical Center, Teaneck, New Jersey, United States|Montefiore Medical Center, New York, New York, United States|Maimonides Medical Center, New York, New York, United States|Mercy Medical Center, New York, New York, United States|Thomas Jefferson University, Philadelphia, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04389450
NCT04412304,Anticoagulant Therapy and 28-days Mortality in Critically Ill COVID-19 Patients,Observational Model: Cohort|Time Perspective: Retrospective,Anticoagulant therapy Covid-19,"South General Hospital, Stockholm, Stockholms Län, Sweden",https://ClinicalTrials.gov/show/NCT04412304
NCT04636034,The Effect of Ganglion Sphenopalatine Block Versus Placebo on Persistent Headache Following COVID-19 Infection,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",GSPB-COVID-2020,"Bispebjerg and Frederiksberg Hospital, University of Copenhagen, Copenhagen, Denmark",https://ClinicalTrials.gov/show/NCT04636034
NCT04635605,Methylene Blue Treatment of COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",MB treatment of COVID19,"Fondazione Epatocentro Ticino, Lugano, Ticino, Switzerland",https://ClinicalTrials.gov/show/NCT04635605
NCT04303507,Chloroquine/ Hydroxychloroquine Prevention of Coronavirus Disease (COVID-19) in the Healthcare Setting,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention",VIR20001,"Chattogram Medical College Hospital, Chittagong, Chattogram, Bangladesh|Centre Hospitalier et Universitaire de Zone Abomey-Calavi, Abomey-Calavi, Benin|Alert Hospital, Addis Ababa, Ethiopia|The St. Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia|Zewditu Memorial Hospital, Addis Ababa, Ethiopia|Airlangga University Hospital (UNAIR), Surabaya, East Java, Indonesia|Husada Utama Hospital, Surabaya, East Java, Indonesia|Metropolitan Medical Care Hospital, Jakarta, Jakarta Selatan, Indonesia|RSUPN Cipto Mangunkusumo Hospital, Jakarta Pusat, Jakarta, Indonesia|Bunda Thamrin Hospital, Medan, North Sumatra, Indonesia|Adam Malik Hospital, Medan, North Sumatra, Indonesia|Murni Teguh Memorial Hospital, Medan, North Sumatra, Indonesia|Dadi Hospital, Makassar, South Sulawesi, Indonesia|Hasanuddin University Hospital (UNHAS), Makassar, South Sulawesi, Indonesia|Wahidin Hospital, Makassar, South Sulawesi, Indonesia|Sardjito Hospital, Yogyakarta, Indonesia|Istituto Sacro Cuore Don Calabria, Negrar, Negrar Di Valpolicella VR, Italy|Fountain Healthcare Hospital, Eldoret, Kenya|Coast General Teaching and Referral Hospital, Mombasa, Kenya|Mbagathi County Hospital, Nairobi, Kenya|Mahosot hospital, Vientiane, Lao People's Democratic Republic|Centre for Vaccine Development-Mali, Bamako, Mali|Koshi Hospital, Biratnagar, Nepal|B.P. Koirala Institute of Health Sciences, Dharān Bāzār, Nepal|Niamey (Epicentre France), Maradi, Niger|The Aga Khan University Hospital, Karachi, Pakistan|Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand|University Hospitals Of Morecambe Bay NHS Foundation Trust, Kendal, Cumbria, United Kingdom|The Princess Alexandra Hospital NHS Trust, Harlow, Essex, United Kingdom|Lewisham and Greenwich NHS Trust, Woolwich, London, United Kingdom|The Dudley Group NHS Foundation Trust, Dudley, West Midlands, United Kingdom|Northern devon healthcare NHS trust, Barnstaple, United Kingdom|Birmingham & Solihull Mental Health NHS Trust, Birmingham, United Kingdom|Brighton and Sussex University Hospitals NHS Trust, Brighton, United Kingdom|University Hospitals Coventry and Warwickshire NHS Trust, Coventry, United Kingdom|Rotherham, Doncaster And South Humber NHS Foundation Trust, Doncaster, United Kingdom|Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom|Imperial College Healthcare NHS Trust, London, United Kingdom|Oxford University Hospital NHS Foundation Trust, Oxford, United Kingdom|Zambart, Lusaka, Zambia",https://ClinicalTrials.gov/show/NCT04303507
NCT04382417,Prospective Observational Cohort Study of Critically Ill Patients With Covid-19 in Sweden,Observational Model: Cohort|Time Perspective: Prospective,RegionVastmanland,"Intensive Care Unit, Västerås Hospital, Västerås, Västmanland, Sweden",https://ClinicalTrials.gov/show/NCT04382417
NCT04466098,Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",2020LS075|MT2020-12,"University of Minnesota, Minneapolis, Minnesota, United States|University of Pittsburgh, Pittsburgh, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04466098
NCT04475068,Postural Recruitment Maneuver in Patients With Acute Respiratory Distress Syndrome Due to COVID-19 Infection,Observational Model: Cohort|Time Perspective: Prospective,HNEdgardoRebagliatiMartins,"Hospital Rebagliati, Jesús María, Lima, Peru",https://ClinicalTrials.gov/show/NCT04475068
NCT04769154,Airway Management in the Intensive Care and Regular Hospital Units During COVID-19 Pandemic,Observational Model: Cohort|Time Perspective: Prospective,BIO-2020-0049,NA,https://ClinicalTrials.gov/show/NCT04769154
NCT04785807,STRESS From in Charge Relative Facing the Announcement of Decisions Limiting or Stopping Treatments in Emergency Room During the COVID-19 Epidemic,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,69HCL20_0678,NA,https://ClinicalTrials.gov/show/NCT04785807
NCT04583228,"Evaluate the Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of HLX71 (Recombinant Human Angiotensin-converting Enzyme 2-Fc Fusion Protein for COVID-19) in Healthy Adult Subjects","Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Other",HLX71-001US-253460,NA,https://ClinicalTrials.gov/show/NCT04583228
NCT04635943,Randomized Phase IIA Clinical Trial to Evaluate the Efficacy of Ivermectin to Obtain Negative PCR Results in Patients With Early Phase COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",EC-CNTEI-014-2020,"Hospital Nacional Cayetano Heredia, Lima, Peru",https://ClinicalTrials.gov/show/NCT04635943
NCT04399603,Mechanisms of Multi-organ Failure in COVID-19,Observational Model: Other|Time Perspective: Prospective,283783,"Chelsea and Westminster Hospital NHS Foundation Trust, London, United Kingdom|Imperial College NHS Trust, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04399603
NCT04587921,Feasibility and Impact of Remote Oximetry in Patients Hospitalized With Covid-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,5058/20/087,"Fundação Zerbini - Instituto do Coração (InCor), São Paulo, SP, Brazil",https://ClinicalTrials.gov/show/NCT04587921
NCT04611269,Clinical Characteristics and Outcomes of Patients With COVID-19 on Mechanical Ventilation in Argentina,Observational Model: Cohort|Time Perspective: Prospective,SATI,"Hospital Interzonal General de Agudos Gral. San Martín, La Plata, BA, Argentina|Sanatorio Las Lomas, san Isidro, BA, Argentina|Hospital General de Agudos Juan A. Fernández, Buenos Aires, Caba, Argentina|Sanatorio Anchorena Recoleta, Buenos Aires, Caba, Argentina|Sanatorio Otamendi, Buenos Aires, Ciudad Autonoma De Buenos Aires, Argentina",https://ClinicalTrials.gov/show/NCT04611269
NCT04646642,"Psychological Health, Coping Strategies and Preferences of Military COVID-19 Deployers",Observational Model: Cohort|Time Perspective: Prospective,FWH20200203E,"David Grant Medical Center (DGMC), Travis Air Force Base, California, United States",https://ClinicalTrials.gov/show/NCT04646642
NCT04347941,Awake Prone Positioning to Reduce Invasive VEntilation in COVID-19 Induced Acute Respiratory failurE,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment",APPROVE-CARE-2020,"Galway University Hospital, Galway, Ireland|Galway University Hospital, Galway, Ireland",https://ClinicalTrials.gov/show/NCT04347941
NCT04496128,COVID19 Neurological Manifestation,Observational Model: Cohort|Time Perspective: Prospective,STUDY20040037,"University of Pittsburgh, Pittsburgh, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04496128
NCT04407390,Effects of Nicotinamide Riboside on the Clinical Outcome of Covid-19 in the Elderly,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",H-20026601,"Bispebjerg Hospital, Copenhagen NV, Denmark",https://ClinicalTrials.gov/show/NCT04407390
NCT04391738,Association Between BMI and COVID-19,Observational Model: Cohort|Time Perspective: Retrospective,DEC20-095,"Centre Hospitalier Régional & Universitaire de Lille (CHRU), Lille, France",https://ClinicalTrials.gov/show/NCT04391738
NCT04700254,"Anxiety, Depression and Eating Attitudes of Diabetes Mellitus Patients During COVID-19 Lockdown in Greece",Observational Model: Case-Control|Time Perspective: Cross-Sectional,Diabetes and COVID-19,"General Hospital of Chania, Chania, Crete, Greece",https://ClinicalTrials.gov/show/NCT04700254
NCT04453982,Is COVID-19 Transmitted Through Human Milk? Implications for Breastfeeding and Human Milk Banking-Study 1b,Observational Model: Cohort|Time Perspective: Prospective,39373-b,"Sinai Health System, Toronto, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04453982
NCT04453969,Is COVID-19 Transmitted Through Human Milk? Implications for Breastfeeding and Human Milk Banking-Study 1a,Observational Model: Cohort|Time Perspective: Prospective,39373-a,"Sinai Health System, Toronto, Ontario, Canada|University of Toronto, Toronto, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04453969
NCT04392388,"Health, Perception, Practices, Relations and Social Inequalities in the General Population During the Covid-19 Crisis",Observational Model: Cohort|Time Perspective: Prospective,C20-26|2020-A01195-34,"Inserm, Paris, France",https://ClinicalTrials.gov/show/NCT04392388
NCT04371692,Prevalence of COVID-19 Infection Among HCW in a French University Hospital,Observational Model: Cohort|Time Perspective: Prospective,2020_35|2020-A00951-38,"Hop Claude Huriez Chu Lille, Lille, France",https://ClinicalTrials.gov/show/NCT04371692
NCT04496245,Reducing Acute Severe Respiratory Events in Health Care Workers During the Covid-19 Pandemic With OM85,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,BV-2020/19,"The Prince Charles Hospital, Brisbane, Queensland, Australia|The Princess Alexandra Hospital, Brisbane, Queensland, Australia|Queensland Children's Hospital, South Brisbane, Queensland, Australia",https://ClinicalTrials.gov/show/NCT04496245
NCT04609722,Effect of Solution-Focused Support Program on Anxiety Levels of Parents During the COVID-19 Pandemic,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Supportive Care,2020/751,"Online- Data will be collected through the form created with the Google-Forms, Adıyaman, Turkey",https://ClinicalTrials.gov/show/NCT04609722
NCT04497311,Tomographic Findings in COVID-19 and Influenza,Observational Model: Cohort|Time Perspective: Prospective,HGL-ENSE-00743-20,"Hospital General León-Milenio, León, Guanajuato, Mexico",https://ClinicalTrials.gov/show/NCT04497311
NCT04654481,Study of AffloVest in At-Risk Respiratory Patients During COVID-19 Pandemic,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Supportive Care,GCO 20-2667|ISMMS-AFF-20,"Mount Sinai Beth Israel, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04654481
NCT04515147,"A Dose-Confirmation Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults for COVID-19","Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",CV-NCOV-002,"Centro de vacunación internacional - CEVAXIN Panama Clinic, Panama city, Panama|Instituto de Investigación Nutricional, Lima, Peru",https://ClinicalTrials.gov/show/NCT04515147
NCT04954248,Pilot Study for Simultaneous PET-MR Imaging of Covid-19 Associated Neurological Complications Using a Brain Dedicated PET Insert,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,IRB-59616,"Stanford University, Palo Alto, California, United States",https://ClinicalTrials.gov/show/NCT04954248
NCT04872751,Immune Response of Haemodialysis Patients Post Covid-19 Vaccination,Observational Model: Cohort|Time Perspective: Prospective,NMRR-21-634-59445,"Penang Hospital, George Town, Penang, Malaysia",https://ClinicalTrials.gov/show/NCT04872751
NCT04435522,Maraviroc in Patients With Moderate and Severe COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,1611471-1,"Rhode Island Hospital, Providence, Rhode Island, United States",https://ClinicalTrials.gov/show/NCT04435522
NCT04460443,Sofosbuvir in Treatment of COVID 19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,sofosbuvir,"Sherief Abd-Elsalam, Tanta, Egypt",https://ClinicalTrials.gov/show/NCT04460443
NCT04460534,Detection of COVID-19 (SARS-CoV-2) in the Semen of COVID+ Patients (Positive RT-PCR on a Nasopharyngeal Swab),Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,2020-A01206-33,"Hôpital Privé de Parly II, Le Chesnay, France",https://ClinicalTrials.gov/show/NCT04460534
NCT04558645,Evaluation of Quality of Life in Patients With Type 1 Diabetes Mellitus During the Covid-19 Pandemic,Observational Model: Case-Control|Time Perspective: Prospective,91610558-604.01.02,"Zeliha ÇELİK, Ankara, Çankaya, Turkey",https://ClinicalTrials.gov/show/NCT04558645
NCT04340479,The Use of Ultrasound in Establishing COVID-19 Infection as Part of a Trauma Evaluation,Observational Model: Cohort|Time Perspective: Prospective,20-0751,"Children's Hospital Colorado, Aurora, Colorado, United States",https://ClinicalTrials.gov/show/NCT04340479
NCT04408014,Seroepidemiological Study of SARS-CoV-2 (COVID-19) Infection in Population Subgroups in the State of São Paulo,Observational Model: Other|Time Perspective: Cross-Sectional,COVID-19-Epi-01,NA,https://ClinicalTrials.gov/show/NCT04408014
NCT04632173,Head and Neck cancERs International cOviD-19 collabOraTion,Observational Model: Cohort|Time Perspective: Retrospective,HERODOTUS,NA,https://ClinicalTrials.gov/show/NCT04632173
NCT04830852,Pediatric COVID-19 and MIS-C Long-term Follow-up,Observational Model: Cohort|Time Perspective: Prospective,Pro00015510|21X125F1,"Children's National Hospital, Washington, District of Columbia, United States|Nih/Niaid, Rockville, Maryland, United States",https://ClinicalTrials.gov/show/NCT04830852
NCT04359693,Impact of COVID-19 Infection on the Incidence of Ventilator-acquired Infections,Observational Model: Cohort|Time Perspective: Prospective,2020_27|2020-A00995-34,"Hôpital Roger Salengro, ICU, CHU Lille, Lille, France",https://ClinicalTrials.gov/show/NCT04359693
NCT04402853,SARS Cov-2 in Conjunctival Secretion in COVID-19 Patients,Observational Model: Case-Crossover|Time Perspective: Prospective,72/2020,"ASST Sette Laghi, Varese, Italy",https://ClinicalTrials.gov/show/NCT04402853
NCT04414267,Bacillus Calmette-guérin Vaccination to Prevent COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",Activate II|2020-002448-21,"General Hospital of Argolida - Nafplion Unit, Náfplio, Argos, Greece|2nd Department of Internal Medicine, University General Hospital of Alexandroupolis, Alexandroupolis, Greece|Department of Therapeutics, Alexandra General Hospital, Athens, Greece|1st Department of Internal Medicine, General Hospital of Athens G. GENNIMATAS, Athens, Greece|2nd University Department of Internal Medicine, IPPOKRATEION General Hospital of Athens, Athens, Greece|3rd University Department of Internal Medicine, General Hospital of Chest Diseases of Athens I SOTIRIA, Athens, Greece|4th Department of Internal Medicine, ""Attikon"" University Hospital, National and Kapodistrian University of Athens, Medical School, Athens, Greece|Department of Pulmonary Medicine- General Hospital of Kerkyra, Corfu, Greece|1st Department of Internal Medicine, General University Hospital of Ioannina, Ioánnina, Greece|Department of Internal Medicine, General Hospital of Karditsa, Kardítsa, Greece|General Hospital of Korinthos, Kórinthos, Greece|Department of Internal Medicine, Patras University Hospital, Patras, Greece|General Hospital of Ptolemaida MPODOSAKEIO, Ptolemaḯda, Greece|1st Department of Internal Medicine, AHEPA University General Hospital of Thessaloniki, Thessaloníki, Greece|General Hospital of Imathia - Veria Unit, Véria, Greece",https://ClinicalTrials.gov/show/NCT04414267
NCT04916561,Detection of Covid-19 in Tissue Samples of Orthopedic Origin,Observational Model: Cohort|Time Perspective: Prospective,CovidOS_2020,"Université de Paris, Paris, France",https://ClinicalTrials.gov/show/NCT04916561
NCT04376840,Prevalence of Long-term Respiratory Complications of Severe SARS-CoV-2 Pneumonia - COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,PO20066,"Damien JOLLY, Reims, France",https://ClinicalTrials.gov/show/NCT04376840
NCT04588363,COVID-19: Pediatric Research Immune Network on SARS-CoV-2 and MIS-C,Observational Model: Cohort|Time Perspective: Prospective,DAIT PRISM-01|NIAID CRMS ID#: 38772,"Loma Linda University Health, Loma Linda, California, United States|Cedars-Sinai Medical Center, Los Angeles, California, United States|Children's Hospital Los Angeles, Los Angeles, California, United States|Lucile Packard Children's Hospital Stanford, Palo Alto, California, United States|Children's Healthcare of Atlanta, Atlanta, Georgia, United States|Mayo Clinic Rochester, Rochester, Minnesota, United States|St. Louis Children's Hospital, Saint Louis, Missouri, United States|Children's Hospital at Montefiore, Bronx, New York, United States|NewYork-Presbyterian Brooklyn Methodist Hospital, Brooklyn, New York, United States|NewYork-Presbyterian Queens Hospital, Flushing, New York, United States|Cohen Children's Medical Center - Northwell Health, New Hyde Park, New York, United States|Hassenfeld Children's Hospital at NYU Langone, New York, New York, United States|NewYork-Presbyterian Komansky Children's Hospital, New York, New York, United States|Mount Sinai Kravis Children's Hospital, New York, New York, United States|Duke University Children's Health Center, Durham, North Carolina, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States|UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States|Medical University of South Carolina, Pediatric Rheumatology, Charleston, South Carolina, United States|Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville, Tennessee, United States",https://ClinicalTrials.gov/show/NCT04588363
NCT04365309,Protective Effect of Aspirin on COVID-19 Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,Xi jingH,"Cai Yue, Xi'an, Shaanxi, China",https://ClinicalTrials.gov/show/NCT04365309
NCT04373109,Stroke Rehabilitation Outcome During COVID-19 Lockdown,Observational Model: Cohort|Time Perspective: Prospective,BASEC-Nr. 2020-00761,"University Hospital Zurich, Zurich, Switzerland",https://ClinicalTrials.gov/show/NCT04373109
NCT04900155,Evaluation of the Effect of Long-term Lipid-lowering Therapy in STEMI Patients With Coronavirus Infection COVID-19,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,PSU/T-487,"Valentin Oleynikov, Penza, Russian Federation",https://ClinicalTrials.gov/show/NCT04900155
NCT04360733,Precision Immunology to Determine the Immune Response in Patients With COVID-19,Observational Model: Other|Time Perspective: Prospective,BOST-03,"University Hospital Bonn, Bonn, Germany",https://ClinicalTrials.gov/show/NCT04360733
NCT04403009,The Clinical Difference Between the Nonfatal Patients and the Fatal Patients With Severe COVID-19,Observational Model: Cohort|Time Perspective: Cross-Sectional,YLS2020(112),"The First Affiliated Hospital of Guangzhou Medical University, Guanzhou, Guangdong, China|Hankou Hospital, Wuhan, Hubei, China",https://ClinicalTrials.gov/show/NCT04403009
NCT04739345,New Immune-inflammation Index for Predicting Prognosis of Coronavirus Disease 2019 (COVID- 19) Infection,Observational Model: Cohort|Time Perspective: Other,COVID-IL-6,"Teachers Hospital, Cairo, Please Select, Egypt",https://ClinicalTrials.gov/show/NCT04739345
NCT04537663,Prevention Of Respiratory Tract Infection And Covid-19 Through BCG Vaccination In Vulnerable Older Adults,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",BCG-PRIME,"Meander Medical Center, Amersfoort, Netherlands|Amsterdam University Medical Center, Amsterdam, Netherlands|OLVG, Amsterdam, Netherlands|Rijnstate hospital, Arnhem, Netherlands|Amphia hospital, Breda, Netherlands|Hagahospital, Den Haag, Netherlands|Catharina hospital, Eindhoven, Netherlands|Zuyderland Hospital, Geleen, Netherlands|Martini hospital, Groningen, Netherlands|University Medical Center Groningen, Groningen, Netherlands|Leiden University Medical Center, Leiden, Netherlands|Maastricht University Medical Center, Maastricht, Netherlands|St. Antonius hospital, Nieuwegein, Netherlands|Canisius-Wilhelmina Hospital, Nijmegen, Netherlands|Radboud University Medical Center, Nijmegen, Netherlands|Erasmus Medical Center, Rotterdam, Netherlands|Ikazia Hospital, Rotterdam, Netherlands|Maasstad Hospital, Rotterdam, Netherlands|Bernhoven hospital, Uden, Netherlands|University Medical Center Utrecht, Utrecht, Netherlands",https://ClinicalTrials.gov/show/NCT04537663
NCT04611802,"A Study to Evaluate the Efficacy, Immune Response, and Safety of a COVID-19 Vaccine in Adults ≥ 18 Years With a Pediatric Expansion in Adolescents (12 to < 18 Years) at Risk for SARS-CoV-2","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",2019nCoV-301,"Alabama Clinical Therapeutics, Llc (Pediatric Site), Birmingham, Alabama, United States|Accel Research Sites (Adult Site), Birmingham, Alabama, United States|Central Research Associates, Inc (Pediatric Site), Birmingham, Alabama, United States|HOPE Research Institute (Adult Site), Phoenix, Arizona, United States|AMR Tempe Clinical Research Consortium (Adult Site), Tempe, Arizona, United States|Lynn Institute of the Ozarks (Adult Site), Little Rock, Arkansas, United States|Preferred Research Partners, Inc. (Adult Site), Little Rock, Arkansas, United States|Anaheim Clinical Trials (Adult Site), Anaheim, California, United States|Advanced Clinical Research - Rancho Paseo (Pediatric & Adult Site), Banning, California, United States|Coast Clinical Research, LLC (Pediatric Site), Bellflower, California, United States|eStudy Site (Pediatric & Adult Site), Chula Vista, California, United States|Premier Health Research Center, Llc (Pediatric Site), Downey, California, United States|eStudySite - Corporate Offices (Adult Site), La Mesa, California, United States|Paradigm Clinical Research Centers, Inc (Pediatric Site), La Mesa, California, United States|WR-PRI, LLC (Adult Site), Los Alamitos, California, United States|National Research Institute (Pediatric & Adult Site), Los Angeles, California, United States|Transitional Research Group, Inc. (Pediatric & Adult Site), North Hollywood, California, United States|Orange County Research Institute (Pediatric Site), Ontario, California, United States|Empire Clinical Research (Pediatric & Adult Site), Pomona, California, United States|University of California Davis Health (Pediatric & Adult Site), Sacramento, California, United States|Benchmark Research (Pediatric & Adult Site), Sacramento, California, United States|California Research Foundation (Pediatric & Adult Site), San Diego, California, United States|Synexus Clinical Research US, Inc. (Adult Site), Vista, California, United States|Dignity Health Medical Foundation - Woodland (Adult Site), Woodland, California, United States|University of Colorado Hospital CRS (Pediatric & Adult Site), Aurora, Colorado, United States|Lynn Institute of the Rockies (Adult Site), Colorado Springs, Colorado, United States|Howard University Hospital Howard/ University College of Medicine (Adult Site), Washington, District of Columbia, United States|Meridian Clinical Research (Pediatric Site), Washington, District of Columbia, United States|University Clinical Research-Deland, LLC dba Accel Research Sites (Pediatric & Adult Site), DeLand, Florida, United States|SIMED Health, LLC / SIMED Research (Adult Site), Gainesville, Florida, United States|M D Clinical (Adult Site), Hallandale Beach, Florida, United States|Research Centers of America (Pediatric & Adult Site), Hollywood, Florida, United States|Jacksonville Center for Clinical Research (Pediatric & Adult Site), Jacksonville, Florida, United States|Meridien Research/Accel Research (Pediatric & Adult site), Lakeland, Florida, United States|Miami Veterans Affairs Medical Center (Adult Site), Miami, Florida, United States|Suncoast Research Associates, LLC (Adult Site), Miami, Florida, United States|Acevedo Clinical Research Associates (Pediatric Site), Miami, Florida, United States|Clinical Neuroscience Solutions Inc (Pediatric & Adult Site), Orlando, Florida, United States|Synexus Clinical Research US, Inc (Adult Site), Pinellas Park, Florida, United States|Asclepes Research Centers (Pediatric Site), Spring Hill, Florida, United States|University of South Florida (Adult Site), Tampa, Florida, United States|Jedidiah Clinical Research (Adult Site), Tampa, Florida, United States|Synexus Clinical Research US, Inc. (Adult Site), The Villages, Florida, United States|Comprehensive Clinical Trials, Llc (Pediatric & Adult site), West Palm Beach, Florida, United States|Atlanta - Morehouse School of Medicine (Adult Site), Atlanta, Georgia, United States|Ponce CRS Emory University (Adult Site), Atlanta, Georgia, United States|Synexus Clinical Research US, Inc. (Adult Site), Atlanta, Georgia, United States|Atlanta Center for Medical Research (Adult Site), Atlanta, Georgia, United States|Tekton Research, Inc. (Pediatric Site), Chamblee, Georgia, United States|IACT Health (DBA John B. Amos Cancer Center) (Adult Site), Columbus, Georgia, United States|Clinical Research Atlanta (Adult Site), Stockbridge, Georgia, United States|Advanced Clinical Research (Pediatric & Adult Site), Meridian, Idaho, United States|Synexus (Adult Site), Chicago, Illinois, United States|Cedar Crosse Research Center (Adult Site), Chicago, Illinois, United States|Providea Health Partners LLC (Adult Site), Mokena, Illinois, United States|Synexus USA (Adult Site), Evansville, Indiana, United States|Velocity Clinical Research (Pediatric & Adult Site), Valparaiso, Indiana, United States|University of Iowa Medical Center (Adult Site), Iowa City, Iowa, United States|Meridian Clinical Research (Adult Site), Sioux City, Iowa, United States|Johnson County Clin-Trials, Inc. (Pediatric & Adult Site), Lenexa, Kansas, United States|Alliance for Multispecialty Research (AMR) (Pediatric Site), Newton, Kansas, United States|AMR Wichita East (Formerly Heartland Research Associates) (Pediatric SIte), Wichita, Kansas, United States|Kentucky Pediatric/Adult Research (Pediatric Site), Bardstown, Kentucky, United States|Brownsboro Park Pediatrics (Pediatric Site), Louisville, Kentucky, United States|Meridian Clinical Research, LLC (Adult Site), Baton Rouge, Louisiana, United States|Med Pharmics, LLC (Pediatric & Adult Site), Metairie, Louisiana, United States|Willis-Knighton Physician Network (Adult Site), Shreveport, Louisiana, United States|c/o The Pediatric Center of Frederick LLC (Adult Site), Frederick, Maryland, United States|Beth Israel Deaconess Medical Center (Adult Site), Boston, Massachusetts, United States|VA Ann Arbor Healthcare System (Adult Site), Ann Arbor, Michigan, United States|Wayne State University/ Children's Hospital of Michigan (Adult Site), Detroit, Michigan, United States|University of Minnesota (Adult Site), Minneapolis, Minnesota, United States|Synexus Clinical Research US, Inc. (Adult Site), Richfield, Minnesota, United States|MedPharmics, LLC-Biloxi (Pediatric & Adult Site), Gulfport, Mississippi, United States|The Curators of University of Missouri (Adult Site), Columbia, Missouri, United States|Sundance Clinical Research, LLC (Pediatric & Adult Site), Saint Louis, Missouri, United States|Meridian Clinical Research (Adult Site), Norfolk, Nebraska, United States|Meridian Clinical Research Associates, LLC (Pediatric & Adult Site), Omaha, Nebraska, United States|University Of Nebraska Medical Center (Pediatric & Adult Site), Omaha, Nebraska, United States|Synexus Clinical Research US, Inc. (Adult Site), Henderson, Nevada, United States|Clinical Research Center of Nevada (Pediatric Site), Las Vegas, Nevada, United States|Clinical Research Consortium (Adult Site), Las Vegas, Nevada, United States|Meridian Clinical Research (Pediatric Site), Binghamton, New York, United States|Stony Brook Responder Vaccine Program (Adult Site), Commack, New York, United States|Weill Cornell Chelsea CRS (Adult Site), New York, New York, United States|Rochester Clinical Research (Pediatric & Adult Site), Rochester, New York, United States|University of North Carolina (Pediatric & Adult Site), Chapel Hill, North Carolina, United States|The Charlotte-Mecklenburg Hospital Authority d/b/a Atrium Health (Pediatric & Adult Site), Charlotte, North Carolina, United States|M3-Emerging Medical Research, LLC (Pediatric & Adult Site), Durham, North Carolina, United States|Carolina Institute for Clinical Research (Adult Site), Fayetteville, North Carolina, United States|Womack Army Medical Center (Adult Site), Fort Bragg, North Carolina, United States|M3 Wake Research, Inc (Adult Site), Raleigh, North Carolina, United States|PMG Research of Rocky Mount, LLC (Adult Site), Rocky Mount, North Carolina, United States|Wake Forest Health Network - Pediatrics - Ford, Simpson, Lively & Rice (Pediatric Site), Salem, North Carolina, United States|PMG Research of Wilmington, LLC (Adult Site), Wilmington, North Carolina, United States|Synexus Clinical Research, US, Inc. (Adult Site), Akron, Ohio, United States|Sterling Research Group, Ltd. (Adult Site), Cincinnati, Ohio, United States|Synexus Clinical Research US, Inc. (Adult Site), Cincinnati, Ohio, United States|Sterling Research Group, Ltd (Pediatric & Adult Site), Cincinnati, Ohio, United States|Dr. Shelly David Senders MD Inc. dba Senders Pediatrics (Pediatric Site), Cleveland, Ohio, United States|Rapid Medical Research, Inc. (Pediatric & Adult Site), Cleveland, Ohio, United States|Aventiv Research Inc (Pediatric Site), Columbus, Ohio, United States|Medical Research International (Adult Site), Oklahoma City, Oklahoma, United States|Lynn Health Science Institute (Pediatric & Adult Site), Oklahoma City, Oklahoma, United States|CRISOR, LLC - Clinical Research Institute of Southern Oregon, PC (Pediatric & Adult Site), Medford, Oregon, United States|Preferred Primary Care Physicians, Inc. (Pediatric Site), Pittsburgh, Pennsylvania, United States|The Miriam Hospital (TMH) (Adult Site), Providence, Rhode Island, United States|Velocity Clinical Research, Providence (Pediatric & Adult Site), Warwick, Rhode Island, United States|Synexus Clinical Research US, Inc. (Adult Site), Anderson, South Carolina, United States|Medical University of South Carolina, SCTR Research Nexus (Adult Site), Charleston, South Carolina, United States|Coastal Carolina Research Center (Pediatric Site), North Charleston, South Carolina, United States|Spartanburg Medical Research (Pediatric Site), Spartanburg, South Carolina, United States|Missouri Breaks Industries Research Inc. (Pediatric & Adult Site), Eagle Butte, South Dakota, United States|PMG Research of Bristol (Pediatric & Adult Site), Bristol, Tennessee, United States|WR Clinsearch, LLC (Pediatric & Adult Site), Chattanooga, Tennessee, United States|Holston Medical Group (Pediatric Site), Kingsport, Tennessee, United States|PMG Research, Inc. d/b/a PMG Research of Knoxville (Adult Site), Knoxville, Tennessee, United States|Clinical Neurosciecne Solutions, Inc. dba CNS Healthcare (Pediatric & Adult Site), Memphis, Tennessee, United States|Clinical Research Associates (Pediatric Site), Nashville, Tennessee, United States|Clinical and Translational Research Center at Meharry Medical College (Adult Site), Nashville, Tennessee, United States|Benchmark Research (Pediatric & Adult Site), Austin, Texas, United States|Ventavia Research Group, LLC (Pediatric Site), Fort Worth, Texas, United States|Benchmark Research (Pediatric & Adult Site), Fort Worth, Texas, United States|Ventavia Research Group, LLC (Pediatric Site), Houston, Texas, United States|Baylor College of Medicine (Adult Site), Houston, Texas, United States|DM Clinical Research - Pediatric Healthcare of NW Houston, P.A. (Pediatric Site), Houston, Texas, United States|Texas Center for Drug Development, Inc (Pediatric & Adult Site), Houston, Texas, United States|The University Of Texas Medical Branch (Utmb) (Pediatric Site), League City, Texas, United States|Centex Studies, Inc (Adult Site), McAllen, Texas, United States|Research Your Health (Pediatric & Adult site), Plano, Texas, United States|Synexus, US - San Antonio (Adult Site), San Antonio, Texas, United States|University of Texas Health Science Center San Antonio (Adult Site), San Antonio, Texas, United States|DM Clinical Research (Pediatric & Adult Site), Tomball, Texas, United States|Wee Care Pediatrics (Pediatric Site), Layton, Utah, United States|Wee Care Pediatrics (Pediatric Site), Syracuse, Utah, United States|Advanced Clinical Research (Adult Site), West Jordan, Utah, United States|Pediatric Research of Charlottesville, LLC (Pediatric Site), Charlottesville, Virginia, United States|Health Research of Hampton Roads, Inc (Pediatric & Adult Site), Newport News, Virginia, United States|MultiCare Institute for Research & Innovation (Adult Site), Cheney, Washington, United States|University of Washington VTEU (Adult Site), Seattle, Washington, United States|PanAmerican Clinical Research Mexico (Adult Site), Juriquilla, Queretaro, Mexico|Unidad de Atencion Medica e Investigacion en Salud (UNAMIS) (Adult Site), Merida, Yucatan, Mexico|Instituto Nacional de Salud Publica (INSP) - Cuernavaca - Centro de Investigacion en Salud Poblacional (CISP) (Adult Site), Cuernavaca, Mexico|CAIMED Investigacion en Salud S.A de C.V (Adult Site), Mexico City, Mexico|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran (Adult Site), Mexico City, Mexico|FAICIC S. DE R.L. DE C.V. (Adult Site), Veracruz, Mexico|Ponce Medical School Foundation Inc. / CAIMED Cneter (Pediatric & Adult Site), Ponce, Puerto Rico|University of Puerto Rico Medical Sciences Campus Maternal Infant Studies Center (Adult Site), San Juan, Puerto Rico",https://ClinicalTrials.gov/show/NCT04611802
NCT04619407,"Screening for COVID-19 in Teachers, Childcare Educators, Pupils and Preschoolers",Observational Model: Cohort|Time Perspective: Prospective,BB 179/20,"Greifswald University Medicine, Greifswald, Germany",https://ClinicalTrials.gov/show/NCT04619407
NCT04463823,"""NORPLASMA"" Covid-19 Convalescent Plasma Treatment Monitoring Study",Observational Model: Case-Only|Time Perspective: Prospective,148622,"Helse Fonna, Haugesund, Norway|Sorlandet hospital, Kristiansand, Norway|Akershus University Hospital, Lørenskog, Norway|Oslo University Hospital, Oslo, Norway|Sykehuset Ostfold, Sarpsborg, Norway|Sykehuset Telemark, Skien, Norway|St.Olavs Hospital, Trondheim, Norway",https://ClinicalTrials.gov/show/NCT04463823
NCT04750278,"A Phase 2/3, Randomized, Double Blind, Placebo Controlled, Multicenter Study to Evaluate the Efficacy and Safety of FP-025 in Patients With Severe to Critical COVID 19 With Associated Acute Respiratory Distress Syndrome (ARDS)","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",FP02C-20-001,"Velocity Chula Vista, Chula Vista, California, United States|Velocity San Diego, La Mesa, California, United States|Shady Grove Medical Center, Rockville, Maryland, United States",https://ClinicalTrials.gov/show/NCT04750278
NCT04535128,"COVID-19 Registry to Assess Frequency, Risk Factors, Management, and Outcomes of Arterial and Venous Thromboembolic Complications",Observational Model: Cohort|Time Perspective: Cross-Sectional,2020P000848,"Brigham and Women's Hospital, Boston, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT04535128
NCT04391179,Dipyridamole to Prevent Coronavirus Exacerbation of Respiratory Status (DICER) in COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,HUM00179783,"University of Michigan, Ann Arbor, Michigan, United States",https://ClinicalTrials.gov/show/NCT04391179
NCT04779346,Immunity Against Severe Acute Respiratory Syndrome Coronavirus 2 Disease (COVID-19) in the Oncology Outpatient Setting,Observational Model: Cohort|Time Perspective: Prospective,2020-10275-BO-ff,"Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany",https://ClinicalTrials.gov/show/NCT04779346
NCT04885491,"A Study to Evaluate the Efficacy, Safety and Tolerability of PDNO Infusion in Covid-19 Patients With aPH",Allocation: Non-Randomized|Intervention Model: Crossover Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,2020-PDNO-002,"Danderyd Hospital, Danderyd, Sweden|Örebro University Hospital, Örebro, Sweden",https://ClinicalTrials.gov/show/NCT04885491
NCT04362930,Cohort of Patients With Covid-19 Presenting Neurological or Psychiatric Disorders (CoCo-Neurosciences),Observational Model: Cohort|Time Perspective: Retrospective,APHP200525,"Hôpital Pitié Salpétrière, Paris, France",https://ClinicalTrials.gov/show/NCT04362930
NCT04430608,Remote Continues Glucose Monitoring During the COVID-19 Pandemic in Quarantined Hospitalized Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,H-20025305,"Nordsjællands Hospital, Hillerød, Denmark",https://ClinicalTrials.gov/show/NCT04430608
NCT04834583,Corona And Manual Professions,Observational Model: Cohort|Time Perspective: Prospective,KIIMMRIAII,"Karolinska Institutet, Stockholm, Sweden",https://ClinicalTrials.gov/show/NCT04834583
NCT04934215,Evaluation of Post-vaccination Anti-SARS-CoV-2 Serological Response in Health Care Workers With a History of COVID-19.,Observational Model: Cohort|Time Perspective: Retrospective,VACCICOVID,"Groupe Hospitalier Paris Saint Joseph, Paris, Ile-de-France, France",https://ClinicalTrials.gov/show/NCT04934215
NCT04434261,Oncological Surgery in Times of COVID-19: Effectiveness of Preoperative Screening for Sars-Cov-2,Observational Model: Cohort|Time Perspective: Prospective,33467320.0.0000.0072,"Instituto Brasileiro de Controle do Cancer - IBCC, Sao Paulo, Brazil",https://ClinicalTrials.gov/show/NCT04434261
NCT04437940,Evaluation of Vaginal Fluid for Covid-19 Positivity in Women With Positive Nasofarengeal Covid-19 Test,Observational Model: Cohort|Time Perspective: Prospective,Acibadem Maslak Ob&Gyn,"Acibadem Maslak Hospital, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04437940
NCT04320472,Acute Encephalopathy in Critically Ill Patients With COVID-19,Observational Model: Cohort|Time Perspective: Prospective,Neuro-COVID-19,"Jackson Memorial Health System; University of Miami, Miller School of Medicine, Miami, Florida, United States|Wellstar Atlanta Medical Center, Atlanta, Georgia, United States|Universidade Federal de São Paulo, São Paulo, Brazil|Fundación Valle del Lili, University Hospital, Cali, Colombia|Cairo University Hospitals, Cairo, Egypt|Centre Hospitalier d'Argenteuil, Argenteuil, France|Centre Hospitalier de Beauvais, Beauvais, France|Centre Hospitalier Universitaire Ambroise Paré, Boulogne, France|Centre Hospitalier de Bourg en Bresse, Bourg-en-Bresse, France|Centre Hospitalier Régional Universitaire de Brest, Brest, France|Centre Hospitalier de Brives, Brive-la-Gaillarde, France|Centre Hospitalier Universitaire Beaujon, Clichy, France|Centre Hospitalier Universitaire Louis Mourier, Colombes, France|Centre Hospitalier Universitaire Henri Mondor, Créteil, France|Centre hospitalier de Dieppe, Dieppe, France|Centre Hospitalier Universitaire de Dijon, Dijon, France|Centre Hospitalier d'Etampes, Etampes, France|Grand Hôpital de l'Est Francilien - Site de Marne-la-Vallée, Jossigny, France|Centre Hospitalier de la Roche-sur-Yon, La Roche-sur-Yon, France|Centre Hospitalier de La Rochelle, La Rochelle, France|Centre Hospitalier de Versailles, Le Chesnay, France|Centre Hospitalier Universitaire de Lille, Lille, France|Centre Hospitalier Universitaire Hôpital Edouard Herriot, Lyon, France|Hôpital privé Jacques Cartier, Massy, France|Groupe Hospitalier Sud Ile-de-France, Melun, France|Centre Hospitalier Régional d'Orléans, Orléans, France|Centre Hospitalier Universitaire Cochin, Paris, France|Groupe hospitalier Paris Saint-Joseph, Paris, France|Hôpital Fondation Adolphe de Rothschild, Paris, France|Hopital Privé Claude Galien, Quincy-sous-Sénart, France|Centre Hospitalier Universitaire de Rennes, Rennes, France|Centre Hospitalier de Roanne, Roanne, France|Hopital Foch, Suresnes, France|Centre Hospitalier de Toulon, Toulon, France|Centre Hospitalier Universitaire de Toulouse, Toulouse, France|Centre Hospitalier Universitaire de Tours, Tours, France|Gustave-Roussy, Villejuif, France|Hospital Regional De Alta Especialidad Del Bajío, Guanajuato, Mexico|Hospital Clinic Universitari, Valencia, Spain",https://ClinicalTrials.gov/show/NCT04320472
NCT04405726,Prognostic Factors of COVID19,Observational Model: Case-Only|Time Perspective: Other,7760,"Service de Virologie - Hôpital Civil, Strasbourg, France",https://ClinicalTrials.gov/show/NCT04405726
NCT04577105,Risk Factors and Computed Tomography Findings in COVID-19.,Observational Model: Cohort|Time Perspective: Retrospective,20-1177,"Instituto Nacional Ignacio Chavez, Ciudad de mexico, Mexico",https://ClinicalTrials.gov/show/NCT04577105
NCT04937088,Outpatient Liquid Aspirin (OLA),"Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Other",1658,NA,https://ClinicalTrials.gov/show/NCT04937088
NCT04370119,Screening for COVID-19 and Monitoring of Serological Responses to SARS-CoV-2 in Healthcare Workers,Observational Model: Cohort|Time Perspective: Prospective,BB 068/20,"Greifswald University Medicine, Greifswald, Germany",https://ClinicalTrials.gov/show/NCT04370119
NCT04880720,Deciphering a Specific Signature of the Immunosenescence Induced in COVID-19+ Patients Versus Rheumatoid Arthritis Patients,Observational Model: Other|Time Perspective: Prospective,RECHMPL20_0454,NA,https://ClinicalTrials.gov/show/NCT04880720
NCT04430322,Covid-19 at the Regional Medical Center Metz-Thionville: a Descriptive Study,Observational Model: Other|Time Perspective: Retrospective,2020-02Obs-CHRMT,"CHR Metz Thionville, Metz, France",https://ClinicalTrials.gov/show/NCT04430322
NCT04953039,Use of Saliva for COVID-19 Diagnosis,Observational Model: Cohort|Time Perspective: Prospective,SALIVA-01,"ASST MONZA - Ospedale San Gerardo, Monza, MB, Italy",https://ClinicalTrials.gov/show/NCT04953039
NCT04365985,Study of Immunomodulation Using Naltrexone and Ketamine for COVID-19,"Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",2020-097,"William Beaumont Hospital, Royal Oak, Michigan, United States",https://ClinicalTrials.gov/show/NCT04365985
NCT04710836,NoRCoRP Assessment Clinic,Observational Model: Cohort|Time Perspective: Cross-Sectional,20RM056,"Nottingham City Hospital, Nottingham, United Kingdom",https://ClinicalTrials.gov/show/NCT04710836
NCT04369469,Efficacy and Safety Study of IV Ravulizumab in Patients With COVID-19 Severe Pneumonia,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,ALXN1210-COV-305,"Central Arkansas Veterans Healthcare System, Little Rock, Arkansas, United States|LAC/USC Health Center, Los Angeles, California, United States|UC Irvine Medical Center, Orange, California, United States|MedStar Georgetown University Hospital, Washington, District of Columbia, United States|University of Florida, Jacksonville, Florida, United States|Mayo Clinic Florida, Jacksonville, Florida, United States|Rush University Medical Center, Chicago, Illinois, United States|Norton Healthcare, Louisville, Kentucky, United States|Baltimore VA Medical Center, Baltimore, Maryland, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States|Boston Medical Center, Boston, Massachusetts, United States|Henry Ford Hospital, Detroit, Michigan, United States|Mayo Clinic Health System, Mankato, Minnesota, United States|Mayo Clinic, Rochester, Minnesota, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|NYU Langone Health Center, New York, New York, United States|Icahn School of Medicine at Mount Sinai, New York, New York, United States|Westchester Medical Center, Valhalla, New York, United States|Medical University of South Carolina, Charleston, South Carolina, United States|Baptist Memorial Hospital, Memphis, Tennessee, United States|Houston Methodist Hospital, Houston, Texas, United States|Mayo Clinic Health System in Eau Claire, Eau Claire, Wisconsin, United States|Mayo Clinic Health System, La Crosse, Wisconsin, United States|Hôpital Raymond Poincaré, Garches, Hauts De Seine, France|Hôpital Henri Mondor, Créteil, Val De Marne, France|Hôpital Bicêtre, Le Kremlin-Bicêtre cedex, Val De Marne, France|Medical Hospital, Tokyo Medical and Dental University, Bunkyō-Ku, Tokyo-To, Japan|Jikei University Hospital, Minato-Ku, Tokyo, Japan|Tokyo Medical University Hospital, Shinjuku-Ku, Tokyo, Japan|Hospital Universitari de Bellvitge, L'Hospitalet De Llobregat, Barcelona, Spain|Hospital Universitari Vall d'Hebron, Barcelona, Spain|Hospital Clinic de Barcelona, Barcelona, Spain|Hospital Universitario Ramon y Cajal, Madrid, Spain|King's College Hospital, London, Greater London, United Kingdom|Hammersmith Hospital, London, Greater London, United Kingdom|Royal Liverpool University Hospital, Liverpool, Merseyside, United Kingdom|Queen Elizabeth Hospital, Birmingham, West Midlands, United Kingdom|St James's University Hospital, Leeds, West Yorkshire, United Kingdom",https://ClinicalTrials.gov/show/NCT04369469
NCT04420637,Impact of the Covid-19 Pandemic on Gastrointestinal and Liver Diseases,Observational Model: Cohort|Time Perspective: Retrospective,RetroCov,"Department of Internal Medicine, Medical University of Graz, Graz, Austria",https://ClinicalTrials.gov/show/NCT04420637
NCT04615936,Nasal Photodisinfection COVID Proof of Concept Study,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,NasalPDF001,"Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04615936
NCT04757818,"Double-blind, Randomized, Parallel, Placebo-controlled Clinical Study to Evaluate the Viral Load of SARS-CoV-2 (COVID-19) in the Oral Cavity of SARS-CoV-2 Positive Subjects After the Use of a Mouthwash Containing Cetylpyridinium Chloride 0,07%.","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Other",CPC COVID,"CAP Gorg, Badalona, Barcelona, Spain|CAP Gran Sol, Badalona, Barcelona, Spain|CAP St Roc, Badalona, Barcelona, Spain|CAP Barri Llatí, Santa Coloma De Gramenet, Barcelona, Spain|CAP Fondo, Santa Coloma De Gramenet, Barcelona, Spain|CAP Santa Rosa, Santa Coloma De Gramenet, Barcelona, Spain|CAP Singuerlin, Santa Coloma De Gramenet, Barcelona, Spain|CAP Dr Robert, Badalona, Spain|CAP Les Franqueses del Vallès, Bellavista, Spain|CAP Canovelles/Granollers Oest, Canovelles, Spain|CAP Granollers Centre, Granollers, Spain|ABS Gatassa, Mataró, Spain|EAP Mollet Est, Mollet Del Vallès, Spain|CAP Montornés/Montmeló, Montornés del Vallès, Spain|CAP Palau, Palau-solità i Plegamans, Spain|EAP Parets del Vallès, Parets del Vallès, Spain|CAP Sant Celoni, Sant Celoni, Spain|CAP Santa Perpètua, Santa Perpètua de Mogoda, Spain|EAP Vilassar de Mar, Vilassar de Mar, Spain",https://ClinicalTrials.gov/show/NCT04757818
NCT04466839,Evaluation of the Containment Impact Linked to the Covid-19 Pandemic in a Population of Parkinson Patients,Observational Model: Case-Only|Time Perspective: Prospective,RC31/20/0193,"Centre Hospitalier Régionale Universitaire de Besançon, Besançon, France|Centre Hospitalier Universitaire Lille, Lille, France|Centre Hospitalier Universitaire de Marseille, Marseille, France|Centre Hospitalier Universitaire de Nîmes - Caremeau, Nimes, France|Centre Hospitalier Universitaire de la Pitié-Salpêtrière, Paris, France|Centre Hospitalier Universitaire de Reims, Reims, France|Centre Hospitalier Universitaire de Rouen, Rouen, France|CHU Toulouse, Toulouse, France",https://ClinicalTrials.gov/show/NCT04466839
NCT04401163,Long-term Pulmonary Outcomes After Infection With Sars-CoV-2,Observational Model: Cohort|Time Perspective: Prospective,33510,"Aarhus University Hospital, Aarhus, Denmark",https://ClinicalTrials.gov/show/NCT04401163
NCT04393974,COVID-19 and Cancer Patients,Observational Model: Case-Only|Time Perspective: Retrospective,282140,"Imperial College Healthcare NHS Trust, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04393974
NCT04881214,"COVID-19 Pneumonia: Pulmonary Physiology, Health-related Quality of Life and Benefit of a Rehabilitation Program",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2020-001457,"Hôpitaux Universitaires de Genève, Geneva, Switzerland",https://ClinicalTrials.gov/show/NCT04881214
NCT04272710,Prognositc Factors in COVID-19 Patients Complicated With Hypertension,Observational Model: Cohort|Time Perspective: Retrospective,20-Feb,"The First Affiliated Hospital of Chongqing Medical University, Chongqing, China",https://ClinicalTrials.gov/show/NCT04272710
NCT04339998,Assessment of Exam Findings in Coronavirus Disease 2019 (COVID-19) With Point-of-Care Ultrasonography (POCUS),Observational Model: Cohort|Time Perspective: Prospective,GIM-2020-28740,"University of Minnesota Medical Center (UMMC), Minneapolis, Minnesota, United States|M Health Fairview Bethesda Hospital, Saint Paul, Minnesota, United States",https://ClinicalTrials.gov/show/NCT04339998
NCT04357340,The Effects of Pulmonary Physiotherapy Treatments on Patients With COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,99-1-103-47429,"Imam Khomeini Hospital Complex, Tehran, Iran, Islamic Republic of",https://ClinicalTrials.gov/show/NCT04357340
NCT04689464,COVID 19 and Psychological Health: a Cross Sectional Study to Evaluate Anxiety and Depression in Covid-19 Patients,Observational Model: Case-Only|Time Perspective: Cross-Sectional,1120,"AlFayhaa Teaching hospital, Basra, Iraq",https://ClinicalTrials.gov/show/NCT04689464
NCT04939155,Methylation Effects of COV-19 Infection and Vaccinations,Observational Model: Cohort|Time Perspective: Retrospective,TD-ME-001,"TruDiagnostic, Lexington, Kentucky, United States",https://ClinicalTrials.gov/show/NCT04939155
NCT04435080,Physical Rehabilitation in ICU in ARDS Patients With COVID-19,Observational Model: Cohort|Time Perspective: Retrospective,2020.169.IRB1.037,"Koc University School of Medicine, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04435080
NCT04476680,Influence of Military Preventive Policy for reCruit Training on COVID-19 Seroconversion,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,1070MODREC20,"Headingley and City campuses, Leeds Beckett University, Leeds, Yorkshire, United Kingdom|Infantry Training Centre Catterick, Catterick Garrison, United Kingdom",https://ClinicalTrials.gov/show/NCT04476680
NCT04388618,Investigating Anosmia and Ageusia in COVID-19 Adult Patients in Saudi Arabia,Observational Model: Case-Control|Time Perspective: Prospective,H-01-R-059,"Princess Nourah Bint Abdulrahman Univeristy, Riyadh, Central, Saudi Arabia|prince Mohammed bin Abdulaziz Hospital, Riyadh, Central, Saudi Arabia",https://ClinicalTrials.gov/show/NCT04388618
NCT04449094,Emergence of the COVID 19 Epidemic in the City of Nice,Observational Model: Ecologic or Community|Time Perspective: Retrospective,20dspcovid01,"CHU de Nice, Nice, France",https://ClinicalTrials.gov/show/NCT04449094
NCT04405362,Consequences of the QUARANTINE Relating to the COvid-19 Epidemic on the Mental Health of the Patients Followed in PSYchiatry,Observational Model: Cohort|Time Perspective: Prospective,2020_39|2020-A01186-33,NA,https://ClinicalTrials.gov/show/NCT04405362
NCT04396197,Physical Activity Levels in COVID-19 Patients Admitted to Intensive Care,Observational Model: Cohort|Time Perspective: Prospective,PhysioCOVID-19,"UHB NHS Foundation Trust, Birmingham, United Kingdom",https://ClinicalTrials.gov/show/NCT04396197
NCT04659889,Clinical and Haematological Phenotypes in Long COVID,Observational Model: Case-Control|Time Perspective: Cross-Sectional,LCV,"The Physicians' Clinic, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04659889
NCT04371107,Proactive Care of Ambulatory COVID19 Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,PI2020_843_0039,"CHU Amiens, Amiens, France",https://ClinicalTrials.gov/show/NCT04371107
NCT04456075,Risk Prediction and Therapy Monitoring in Patients With SARS-Cov-2 Infection / COVID 19,Observational Model: Cohort|Time Perspective: Prospective,CROWNLESS,"Thoraxklinik at Heidelberg University, Heidelberg, Germany",https://ClinicalTrials.gov/show/NCT04456075
NCT04357418,Psychological Outcome of COVID-19 Lockdown on Psychiatric Hospital Staff and Close Relatives,Observational Model: Other|Time Perspective: Retrospective,10477M-ICOS,"URC Ville Evrard, Neuilly-sur-Marne, France",https://ClinicalTrials.gov/show/NCT04357418
NCT04836260,Preemptive Use of Convalescent Plasma for High-risk Patients With COVID-19,Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,2020-02989,"Universitätsspital Basel, Basel, Switzerland|HFR-Fribourg Hôpital Cantonal, Fribourg, Switzerland|Geneva University Hospitals, Geneva, Switzerland|Ospedale Regionale di Lugano, Lugano, Switzerland",https://ClinicalTrials.gov/show/NCT04836260
NCT04605965,WEAICOR: Wearables to Investigate the Long Term Cardiovascular and Behavioral Impacts of COVID-19,Observational Model: Case-Only|Time Perspective: Prospective,2020-678,"Tulane University, TRIAD Center, New Orleans, Louisiana, United States|Tulane University, New Orleans, Louisiana, United States",https://ClinicalTrials.gov/show/NCT04605965
NCT04359706,Bacterial and Fungal Microbiota of Patients With Severe Viral Pneumonia With COVID-19,Observational Model: Cohort|Time Perspective: Prospective,2020_28|2020-A01042-37,"Hôpital Roger Salengro, CHU Lille, Lille, France",https://ClinicalTrials.gov/show/NCT04359706
NCT04379089,Neurologic Manifestations of COVID 19 in Children,Observational Model: Cohort|Time Perspective: Prospective,STUDY20060012|STUDY20040154|STUDY20040278,"UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04379089
NCT04433988,Efficacy of Pentoxifylline as Add on Therapy in COVID19 Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",RC-6-2020,"Faculty of Medicine, Shibīn Al Kawm, Egypt",https://ClinicalTrials.gov/show/NCT04433988
NCT04393402,Lung Ultrasound Score in Covid 19 Infectious Disease in Critical Care (LUS-COVID19),Observational Model: Cohort|Time Perspective: Prospective,20reamedcovid03,"CHU de Nice, Nice, France",https://ClinicalTrials.gov/show/NCT04393402
NCT04346329,Immune Monitoring of Prophylactic Effect of Hydroxychloroquine in Healthcare Providers Highly Exposed to COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Prevention",UNAL-COVID-CP,"Facultad de Medicina - Universidad Nacional de Colombia, Bogota, Cundinamarca, Colombia|Universidad Nacional de Colombia, Bogota, Cundinamarca, Colombia",https://ClinicalTrials.gov/show/NCT04346329
NCT04613271,Efficacy and Safety of Favipiravir in Covid-19 Patients in Indonesia,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,FVR|U1111-1263-1797,"RSJ Soerodjo, Magelang, Central Java, Indonesia|RSUP Dr. Kariadi, Semarang, Central Of Java, Indonesia|RSPI Sulianti Saroso, Jakarta, DKI Jakarta, Indonesia",https://ClinicalTrials.gov/show/NCT04613271
NCT04445402,Pediatrics HOT COVID-19 Database in NY Tristate,Observational Model: Other|Time Perspective: Prospective,AAAT0268,"Connecticut Children's Hospital, Hartford, Connecticut, United States|Yale New Haven Children's Hospital, New Haven, Connecticut, United States|Hackensack Meridian Health, Hackensack, New Jersey, United States|Steven Halpern, Morristown, New Jersey, United States|Archana Sharma, New Brunswick, New Jersey, United States|Mount Sinai Beth Israel, Newark, New Jersey, United States|St. Joseph's Regional Medical Center, New Jersey, Paterson, New Jersey, United States|Montefiore Medical Center, Bronx, New York, United States|Maimondes Medical Center, Brooklyn, New York, United States|Mount Sinai, New York, New York, United States|NYU Langone Health, New York, New York, United States|Columbia University Irving Medical Center, New York, New York, United States|Stephen Roberts, New York, New York, United States|Weill Cornell Medicine, New York, New York, United States|Cohen Children's Northwell Health, Queens, New York, United States|Stony Brook University Hospital, Stony Brook, New York, United States|Westchester Medical Center, Valhalla, New York, United States",https://ClinicalTrials.gov/show/NCT04445402
NCT04335032,EPA-FFA to Treat Hospitalised Patients With COVID-19 (SARS-CoV-2),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",EPA-COV-001,NA,https://ClinicalTrials.gov/show/NCT04335032
NCT04447235,Early Treatment With Ivermectin and LosarTAN for Cancer Patients With COVID-19 Infection,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment",NP 1677/20,"Instituto do Cancer do Estado de Sao Paulo, SAo Paulo, Brazil",https://ClinicalTrials.gov/show/NCT04447235
NCT04880122,Dried Blood Spots for SARS-CoV-2 Serology (COVID-19).,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,BC-07665,"Ghent University, Ghent, Oost-Vlaanderen, Belgium",https://ClinicalTrials.gov/show/NCT04880122
NCT04924881,Chinese Medicine for Patients With LCOVID-19 Symptoms,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",LCOVID study,"The Chinese University of Hong Kong, Shatin, Hong Kong",https://ClinicalTrials.gov/show/NCT04924881
NCT04366778,Thrombosis and Covid-19,Observational Model: Cohort|Time Perspective: Prospective,69HCL20_0401 - COVBIO|ID-RCB,"Hôpital Louis Pradel, Bron, France",https://ClinicalTrials.gov/show/NCT04366778
NCT04579471,Prevalence and Outcome of SARS-CoV-2 Infection & COVID-19 in Transplant Recipients: The COVITRA Study,Observational Model: Cohort|Time Perspective: Prospective,s64036,"UZ Leuven, Leuven, Vlaams Brabant, Belgium",https://ClinicalTrials.gov/show/NCT04579471
NCT04369794,"COVID-19: BCG As Therapeutic Vaccine, Transmission Limitation, and Immunoglobulin Enhancement","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",COVID-19 BATTLE trial,"Hospital das Clínicas Unicamp, Campinas, SP, Brazil",https://ClinicalTrials.gov/show/NCT04369794
NCT04565249,"Evaluation of the Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Participants With Acute Respiratory Distress Syndrome (ARDS) Associated With at Least Severe COVID-19","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",PLN-74809-ARDS-204,"Valleywise Health Medical Center, Phoenix, Arizona, United States|Cedars-Sinai Medical Center, Los Angeles, California, United States|National Jewish Health, Denver, Colorado, United States|Advent Health, Orlando, Florida, United States|Augusta University Medical Center, Augusta, Georgia, United States|Atlantic Health System, Summit, New Jersey, United States",https://ClinicalTrials.gov/show/NCT04565249
NCT04756466,Effect of the Consumption of a Lactobacillus Strain on the Incidence of Covid-19 in the Elderly,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Other",P055,"Residencia San Marcos, Santiago De Compostela, A Coruña, Spain|Residencia Santa Olalla, Santiago De Compostela, A Coruña, Spain|Residencia San Simon de Ons, Santiago De Compostela, A Coruña, Spain",https://ClinicalTrials.gov/show/NCT04756466
NCT04681430,Reconvalescent Plasma/Camostat Mesylate Early in SARS-CoV-2 Q-PCR (COVID-19) Positive High-risk Individuals,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",RES-Q-HR|2020-004695-18,"Abteilung Infektiologie Klinik für Innere Medizin II Department Innere Medizin Universitätsklinikum Freiburg, Freiburg im Breisgau, Baden-Württemberg, Germany|Klinik und Poliklinik für Innere Medizin II Klinikum rechts der Isar Technische Universität München, München, Bavaria, Germany|Universitätsklinikum Frankfurt Medizinische Klinik 2: Hämatologie, Onkologie, Hämostaseologie, Rheumatologie, Infektiologie/HIV, Frankfurt am Main, Hessen, Germany|Universitätsklinikum Düsseldorf Klinik für Hepatologie und Infektiologie, Duesseldorf, North Rhine Westphalia, Germany|Klinikum Dortmund, Dortmund, North Rhine-Westphalia, Germany|Universitätsklinikum Essen, Essen, North Rhine-Westphalia, Germany",https://ClinicalTrials.gov/show/NCT04681430
NCT04429620,Prospective Assay for SARS-CoV-2 (COVID-19) Antibody Detection Indirectly by Immunofluorescence: SARS-CoV2 IIF Method,Observational Model: Case-Control|Time Perspective: Other,SARS-CoV-2-IIF-002,"University of Szeged, Albert Szent-Györgyi Health Center, Szeged, Hungary",https://ClinicalTrials.gov/show/NCT04429620
NCT04639375,Polio Vaccine (IPV) for SARS-CoV-2 and Prevention of Coronavirus Disease (COVID-19),Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,EMO-001,"Rac Ii Md, National City, California, United States",https://ClinicalTrials.gov/show/NCT04639375
NCT04930978,"Effect of SARS-CoV-2 Disease on Immune Responses, Disease Severity and Treatment Outcomes in Pulmonary Tuberculosis",Observational Model: Case-Control|Time Perspective: Prospective,2020 041,"National Institute for Research in Tuberculosis, Chennai, Tamilnadu, India",https://ClinicalTrials.gov/show/NCT04930978
NCT04395755,Impact of COVID-19 on Psychological Status in Case of IVF Interrupted or Postponed,Observational Model: Cohort|Time Perspective: Prospective,COVID-19-NOIVF,"IRCCS Ospedale Policlinico San Martino, Genoa, Italy",https://ClinicalTrials.gov/show/NCT04395755
NCT04280224,NK Cells Treatment for COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,xinxiangM,"The First Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, China",https://ClinicalTrials.gov/show/NCT04280224
NCT04551690,Prevalence of COVID-19 (Coronavirus Disease 19) in Pregnant Women on Labor in a Public Hospital in Chile (COroNavirus diSease Covid-19 pandEmic iN ChilE),Observational Model: Case-Control|Time Perspective: Cross-Sectional,COVID 19 Pregnancy HSJD Chile,"Hospital San Juan de Dios, Santiago, Chile",https://ClinicalTrials.gov/show/NCT04551690
NCT04705753,"Assessment of the Clinical Effectiveness of a Herbal Extract (Cretan IAMA) in Patients With Viral Respiratory Infections, Including COVID-19, in Primary Healthcare Settings, and Co-assessment of Its Prophylactic Effect in People Cohabiting With These Patients",Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,78/26.03.2020,"Cretan Medicare, Heraklion, Crete, Greece",https://ClinicalTrials.gov/show/NCT04705753
NCT04397172,Intensive Care Associated Complications and Outcome of Acute Respiratory Distress Syndrome Due to COVID-19,Observational Model: Cohort|Time Perspective: Prospective,2020-00730,"Inselspital Bern, Bern, Switzerland",https://ClinicalTrials.gov/show/NCT04397172
NCT04352946,HEalth Care Worker pROphylaxis Against COVID-19: The HERO Trial,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",GFICOVID-19-1,"The New York Center for Travel and Tropical Medicine, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04352946
NCT04920890,Radiofrequency Intervention in Post COVID-19 Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment",ART-GLB-RF-COVID,"Gema León Physiotherapy and Rehabilitation Clinic, Córdoba, Andalucía, Spain",https://ClinicalTrials.gov/show/NCT04920890
NCT04357028,Measles Vaccine in HCW,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Prevention,N-30-2020,"Cairo University Hospital, Cairo, Egypt",https://ClinicalTrials.gov/show/NCT04357028
NCT04384926,Outcomes of Elective Cancer Surgery During the COVID-19 Pandemic Crisis,Observational Model: Cohort|Time Perspective: Other,CSC-20200324,"Hospital del Henares, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04384926
NCT04395833,National Survey on the Lockdown of Children With Disabilities,Observational Model: Family-Based|Time Perspective: Cross-Sectional,CHRU de BREST ECHO,"CHRU de Brest, Brest, France",https://ClinicalTrials.gov/show/NCT04395833
NCT04823351,Clinical Efficiency of Surgical Masks and Filtering Face-piece 2 Masks,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,4078P0_198258,"Gesundheitszentren für das Alter, Zürich, Switzerland",https://ClinicalTrials.gov/show/NCT04823351
NCT04394026,Imaging Feature of SARS-CoV2 Infection,Observational Model: Cohort|Time Perspective: Other,COVID-19 IF,"Deaprtment of Radiology, IRCCS Ospedale San Raffaele, Milano, Italy",https://ClinicalTrials.gov/show/NCT04394026
NCT04344210,Impact of Tele-interventions During the COVID-19 Pandemic in Patients With Diabetes Mellitus,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,2020241093,"Hospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande Do Sul, Brazil",https://ClinicalTrials.gov/show/NCT04344210
NCT04379258,Analysis of Mortality of Critically Ill Patients With COVID-19,Observational Model: Cohort|Time Perspective: Prospective,COVID-UCI_Spain,"Hospital Universitario de Getafe, Getafe, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04379258
NCT04355611,Epidemiological Characteristics of COVID-19 in Patients With MS or NMO,Observational Model: Cohort|Time Perspective: Retrospective,APHP200482,"Hôpital Pitié Salpétrière, Paris, France",https://ClinicalTrials.gov/show/NCT04355611
NCT04405934,COG-UK Project Hospital-Onset COVID-19 Infections Study,Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,CTU/2020/353|283014|20/EE/0118,NA,https://ClinicalTrials.gov/show/NCT04405934
NCT04542941,Assessment of Safety and Efficacy of CCP,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,CCP,"Mulago Specialised Hospital, Kampala, Uganda",https://ClinicalTrials.gov/show/NCT04542941
NCT04386070,Preventing Pulmonary Complications in Surgical Patients at Risk of COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,RG_20-029 COVID-19|2020-001448-24,NA,https://ClinicalTrials.gov/show/NCT04386070
NCT04627675,CORVax12: SARS-CoV-2 Spike (S) Protein Plasmid DNA Vaccine Trial for COVID-19 (SARS-CoV-2),Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,2020000320 CORVax12,"Providence Portland Medical Center, Portland, Oregon, United States",https://ClinicalTrials.gov/show/NCT04627675
NCT04519320,Medium and Long Term Follow-up of COVID-19 Infected Patients: Research and Characterization of Pulmonary Sequelae,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,2020/499,"CHU Besançon, Besançon, Franche-Comté, France",https://ClinicalTrials.gov/show/NCT04519320
NCT04376905,Extra Vascular Lung Water and Pulmonary Permeability in Critically Ill Patients With SARS-CoV-2 (COVID-19),Observational Model: Cohort|Time Perspective: Prospective,RECHMPL20_0193,"Uhmontpellier, Montpellier, France",https://ClinicalTrials.gov/show/NCT04376905
NCT04715763,INvestigating TELmisartin Study,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",H053,NA,https://ClinicalTrials.gov/show/NCT04715763
NCT04335786,Valsartan for Prevention of Acute Respiratory Distress Syndrome in Hospitalized Patients With SARS-COV-2 (COVID-19) Infection Disease,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",NL73547.091.20|2020-001320-34,"Jeroen Bosch Ziekenhuis, 's-Hertogenbosch, Netherlands|Rijnstate, Arnhem, Netherlands|Radboudumc, Nijmegen, Netherlands|Laurentius Ziekenhuis, Roermond, Netherlands|Erasmus MC, Rotterdam, Netherlands|Franciscus Gasthuis, Rotterdam, Netherlands|Ikazia Ziekenhuis, Rotterdam, Netherlands",https://ClinicalTrials.gov/show/NCT04335786
NCT04408235,High Versus Low LMWH Dosages in Hospitalized Patients With Severe COVID-19 Pneumonia and Coagulopathy,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Treatment,EudraCT N°: 2020-001972-13,"Azienda Ospedaliero-Universitaria, Modena, Italy",https://ClinicalTrials.gov/show/NCT04408235
NCT04716023,Physiology and Structure of the Small Airways in Patients With Chronic Airflow Obstruction or COVID-19,Observational Model: Case-Only|Time Perspective: Prospective,18IC4688,"The Royal Brompton, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04716023
NCT04394078,Impact of COVID-19 Pandemic on Depression and Quality of Life,Observational Model: Ecologic or Community|Time Perspective: Cross-Sectional,56665618-204.01.07,"Okan University, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04394078
NCT04351399,Psychological Impact of Quarantine in Rheumatoid Arthritis Patient During COVID-19 Outbreak,Observational Model: Family-Based|Time Perspective: Cross-Sectional,2020_29|2020-A00907-32,"Hopital Roger Salengro, CHU Lille, Lille, France",https://ClinicalTrials.gov/show/NCT04351399
NCT04472078,"Seroprevalence of Coronavirus Disease 2019 (COVID-19) Antibodies in a Vulnerable Neighbourhood, Buenos Aries Argentina",Observational Model: Cohort|Time Perspective: Cross-Sectional,1831,"Hospital de Niños Ricardo Gutierrez, Buenos Aires, Caba, Argentina",https://ClinicalTrials.gov/show/NCT04472078
NCT04409184,Whole Blood Collection From Individuals in the Convalescent Phase of SARS-CoV-2 Infection,Observational Model: Cohort|Time Perspective: Retrospective,PRO00037957,NA,https://ClinicalTrials.gov/show/NCT04409184
NCT04497441,Netizens' Perception of COVID-19 Information & Information Sources.,Observational Model: Other|Time Perspective: Prospective,QassimU3,"Dr Bugude Shiva Shankar, Ar Rass, Al Qassim, Saudi Arabia",https://ClinicalTrials.gov/show/NCT04497441
NCT04397835,Psychological Impact of COVID-19 Quarantine and Worsening of Cardiovascular Risk in the French General Population,Observational Model: Cohort|Time Perspective: Prospective,RC31/20/0135,"CHU de Toulouse, Toulouse, Occitanie, France",https://ClinicalTrials.gov/show/NCT04397835
NCT04384445,Zofin (Organicell Flow) for Patients With COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",19881,"Larkin Community Hospital, Miami, Florida, United States|Larkin Community Hospital, South Miami, Florida, United States",https://ClinicalTrials.gov/show/NCT04384445
NCT04977050,The Role of Frequent Point-of-care Molecular Workplace Surveillance for Miners,Observational Model: Other|Time Perspective: Prospective,HRPO 20-680|U01GM132175-02S1,"University of New Mexico, Albuquerque, New Mexico, United States",https://ClinicalTrials.gov/show/NCT04977050
NCT04839146,Safety and Tolerability of COVID-19 Vaccine (ABNCoV2),Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,NL76192.000.20,"Radboud univserity medical center, Nijmegen, Gelderland, Netherlands",https://ClinicalTrials.gov/show/NCT04839146
NCT04635787,Vital Sensor Monitors for CV19 Detection,Observational Model: Cohort|Time Perspective: Prospective,STU00213040,"Northwestern Memorial Hospital, Chicago, Illinois, United States",https://ClinicalTrials.gov/show/NCT04635787
NCT04453566,"Effect of COVID-19 Pandemic on Perceived Stress, Anxiety, Mood, and Training Quality in Elite Athletes.",Observational Model: Other|Time Perspective: Retrospective,61351342/ 2020-286,"Uskudar University, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04453566
NCT04402918,Study of Viral Load and Maternal-fetal Serology in the Interpretation of the Vertical Transmission of SARS Cov-2 (COVID-19) During Pregnancy,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,2020/500,"Chu Besancon, Besancon, France",https://ClinicalTrials.gov/show/NCT04402918
NCT04407169,Prevalence of Critical Forms of CoVid-19 in Patients With Chronic Respiratory Disease,Observational Model: Cohort|Time Perspective: Retrospective,2020PI081,"Valentin Simon, Vandoeuvre Les Nancy, France",https://ClinicalTrials.gov/show/NCT04407169
NCT04420676,Synbiotic Therapy of Gastrointestinal Symptoms During Covid-19 Infection,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",SynCov,"Department of Internal Medicine, Medical University of Graz, Graz, Austria",https://ClinicalTrials.gov/show/NCT04420676
NCT04818801,"Safety, Reactogenicity and Immunogenicity Study of ReCOV","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",CT61101,"Auckland Clinical Studies, Auckland, New Zealand|Christchurch Clinical Studies Trust, Christchurch, New Zealand",https://ClinicalTrials.gov/show/NCT04818801
NCT04331613,Safety and Efficacy of CAStem for Severe COVID-19 Associated With/Without ARDS,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,ChineseASZQ-006,"Beijing YouAn Hospital, Capital Medical University, Beijing, Beijing, China, China",https://ClinicalTrials.gov/show/NCT04331613
NCT04479163,Prevention of Severe Covid-19 in Infected Elderly by Early Administration of Convalescent Plasma With High-titers of Antibody Against SARS-CoV2,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",FundacionINFANT-Plasma,"Hospital Militar Central, Caba, Buenos Aires, Argentina|CEMIC, Caba, Buenos Aires, Argentina|Centro de Investigacion Clinica OSECAC, Caba, Buenos Aires, Argentina|Centro Gallego de Buenos Aires, Caba, Buenos Aires, Argentina|Sanatorio Anchorena, Caba, Buenos Aires, Argentina|Sanatorio de Los Arcos, Caba, Buenos Aires, Argentina|Hospital ""Simplemente Evita"", González Catán, Buenos Aires, Argentina|Hospital Especializado de Agudos y Crónicos ""San Juan de Dios"", La Plata, Buenos Aires, Argentina|Clinica Olivos, Buenos Aires, Argentina|Hospital Central de San Isidro, Buenos Aires, Argentina|Hospital General de Agudos ""Dr. Carlos Bocalandro"", Buenos Aires, Argentina",https://ClinicalTrials.gov/show/NCT04479163
NCT04750759,Safety and Preliminary Efficacy of the Combination of Niclosamide and Camostat,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,201741,"Charité Research Organisation GmbH, Berlin, Germany",https://ClinicalTrials.gov/show/NCT04750759
NCT04477902,Long-Term Experience and Health Effects of COVID-19,Observational Model: Ecologic or Community|Time Perspective: Prospective,altcovid-192020,"Altura, Mission Viejo, California, United States",https://ClinicalTrials.gov/show/NCT04477902
NCT04860518,Human Intravenous Interferon Beta-Ia Safety and Preliminary Efficacy in Hospitalized Subjects With CoronavirUS,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Other",FP1CLI017,NA,https://ClinicalTrials.gov/show/NCT04860518
NCT04462367,Northeast COVID-19 and Pregnancy Study Group,Observational Model: Cohort|Time Perspective: Other,NCOVIP,"Instituto Materno Infantil Prof. Fernando Figueira, Recife, Pernambuco, Brazil",https://ClinicalTrials.gov/show/NCT04462367
NCT04310865,Yinhu Qingwen Granula for the Treatment of Severe CoVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",YHQW-Severe-V2.0,"Wuhan No.7 Hospital/Jizhong Energy Fengfeng Group Hospital, Wuhan, Hubei, China|Wuhan No.7 Hospital/North China University of Science and Technology Affiliated Hospital, Wuhan, Hubei, China|Zhongnan Hospital of Wuhan University/Tanshan People's Hospital, Wuhan, Hubei, China|Wuhan Leishenshan (Thunder God Mountain) Hospital/The First Affiliated Hospital of Dalian Medical University, Wuhan, Hubei, China",https://ClinicalTrials.gov/show/NCT04310865
NCT04359862,Sedation With Sevoflurane Versus Propofol in Patients With Acute Respiratory Distress Syndrome Caused by COVID19 Infection,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,SEVO-COVID19,"Hospital Universitario Cruces, Barakaldo, Bizkaia, Spain|Hospital Universitario Ramón y Cajal, Madrid, Spain|Hospital Universitario La Paz, Madrid, Spain|Hospital Clínico Universitario de Valencia, Valencia, Spain|Hospital General Universitario de Valencia, Valencia, Spain",https://ClinicalTrials.gov/show/NCT04359862
NCT04346810,Burnout Among Caregivers Facing COVID-19 Health Crisis at a Non-conventional Intensive Care Unit Compared to a Conventional Intensive Care Unit,Observational Model: Ecologic or Community|Time Perspective: Prospective,CSC19APR,NA,https://ClinicalTrials.gov/show/NCT04346810
NCT04910607,Social and Psychological Impacts of SARS-Cov-2 Pandemic Period in the Obese Population.,Observational Model: Other|Time Perspective: Prospective,CHUBX 2020/38,"CHU de Limoges, Limoges, France|Hôpitam Haut-Lévêque, Pessac, France|CHU de Poitiers, Poitiers, France",https://ClinicalTrials.gov/show/NCT04910607
NCT04456010,COVID-19 in ART: Perception and Experience,Observational Model: Other|Time Perspective: Prospective,RECHMPL20_0351,"Uhmontpellier, Montpellier, France",https://ClinicalTrials.gov/show/NCT04456010
NCT04483973,SPI-1005 Treatment in Severe COVID-19 Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",SPI-1005-292,"Yale University, New Haven, Connecticut, United States",https://ClinicalTrials.gov/show/NCT04483973
NCT04459351,PHenotyping patiENts Admitted to Hospital With cOvid-19 Infection and idenTifYing Prognostic markErs,Observational Model: Cohort|Time Perspective: Other,C&W20/035,"Chelsea and Westminster Hospital, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04459351
NCT04476667,"Online Delivery of Psychotherapy, Tailored to Patients' Suffering From Mental Health Problems Due to COVID-19",Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,PSIY-683-20,"Hotel Dieu Hospital, Kingston, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04476667
NCT04519255,Study for Quantitative Analysis of the Recovered COVID-19 Patients by 18F-FDG-PET/CT,Observational Model: Case-Control|Time Perspective: Cross-Sectional,ZDWY.FZYX.008,"Hongjun Jin, Zhuhai, Guangzhou, China",https://ClinicalTrials.gov/show/NCT04519255
NCT04484025,SPI-1005 Treatment in Moderate COVID-19 Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",SPI-1005-291,"Yale University, New Haven, Connecticut, United States",https://ClinicalTrials.gov/show/NCT04484025
NCT04609085,SARS-COV2 Pandemic Serosurvey in a Rare Disease Population,Observational Model: Case-Only|Time Perspective: Prospective,10000210|000210-I,"National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, Maryland, United States|University of Pittsburgh, Pittsburgh, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04609085
NCT04487171,Screening for Postpartum Depression and Associated Risk Factors Among Women Who Deliver in Four Hospital in France During the COVID-19 Epidemic,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,PI2020_843_0049,"CHU Amiens, Amiens, France",https://ClinicalTrials.gov/show/NCT04487171
NCT04466683,Low-Dose Radiotherapy For Patients With SARS-COV-2 (COVID-19) Pneumonia,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,PREVENT,"Boca Raton Regional Hospital Lynn Cancer Institute, Boca Raton, Florida, United States|Miami Cancer Institute, Miami, Florida, United States|Loyola University Chicago, Maywood, Illinois, United States|Indiana University School of Medicine, Indianapolis, Indiana, United States|Lowell General Hospital Cancer Center, Lowell, Massachusetts, United States|Beaumont Hospital, Royal Oak, Michigan, United States|Ohio State University James Cancer Hospital, Columbus, Ohio, United States|Hospital Universitario San Ignacio, Bogotá, Colombia",https://ClinicalTrials.gov/show/NCT04466683
NCT04351789,Impact of a Minimal Psychoeducational Intervention on Anxiety Among Hospitalized COVID-19 Patients in Denmark,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention,PISCA Study,"Copenhagen University Hospital, Hvidovre, Hvidovre, Denmark",https://ClinicalTrials.gov/show/NCT04351789
NCT04392232,A Study of COVID 19 Convalescent Plasma in High Risk Patients With COVID 19 Infection,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,20-045,"Good Samaritan Hospital, Cincinnati, Ohio, United States|Bethesda North Hospital, Cincinnati, Ohio, United States",https://ClinicalTrials.gov/show/NCT04392232
NCT04451577,"Epidemiologic, Clinical, Molecular Characteristics of Hospital Employees With or Without Covid-19 Infection",Observational Model: Case-Control|Time Perspective: Other,UNICODE,"Humanitas reseach hospital (ICH), Rozzano, Milan, Italy",https://ClinicalTrials.gov/show/NCT04451577
NCT04945837,Psychologic Impact of COVID-19 Pandemic on the Hospital Staff of the Nouvelle Aquitaine Area,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,2020-A02592-37,NA,https://ClinicalTrials.gov/show/NCT04945837
NCT04378842,COVID-19 and ICU-acquired MDR Bacteria,Observational Model: Cohort|Time Perspective: Prospective,2020_37|2020-A01157-32,"Hôpital Roger Salengro, ICU, CHU Lille, Lille, France",https://ClinicalTrials.gov/show/NCT04378842
NCT04474236,Lung Ultrasound for COVID-19 Initial Triage and Monitoring,Observational Model: Cohort|Time Perspective: Prospective,RC31/20/0182|2020-A01445-34,"University Hospital Toulouse, Toulouse, France",https://ClinicalTrials.gov/show/NCT04474236
NCT04343261,Convalescent Plasma in the Treatment of COVID 19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,SFH-20-23,"Trinity Health Of New England, Hartford, Connecticut, United States",https://ClinicalTrials.gov/show/NCT04343261
NCT04816656,An Integrated Digital PROM-platform for Cancer Patients During the COVID-19 Pandemic,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,20.60-onco20.07,"Hasselt University, Hasselt, Limburg, Belgium|Jessa Ziekenhuis, Hasselt, Limburg, Belgium",https://ClinicalTrials.gov/show/NCT04816656
NCT04650178,Well-being in Cancer Patients With Neuropathy During COVID-19 Who Participated in Prior Clinical Trials,Observational Model: Cohort|Time Perspective: Other,2020-0508|NCI-2020-06014,"M D Anderson Cancer Center, Houston, Texas, United States",https://ClinicalTrials.gov/show/NCT04650178
NCT04792021,Effect of N-acetylcysteine on Oxidative Stress in COVID-19 Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment",N-acetylcysteine in COVID 19,"Al Assema Hospital, Cairo, Egypt",https://ClinicalTrials.gov/show/NCT04792021
NCT04319445,Mindfulness During COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,IRB00064587,"Wake Forest Health Sciences, Winston-Salem, North Carolina, United States",https://ClinicalTrials.gov/show/NCT04319445
NCT04361448,Performance of 3 Sampling Methods for the Detection of SARS-CoV-2 (COVID-19) With Real-time Reverse Transcriptase PCR,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,20.43,"Jessa Hospital, Hasselt, Belgium",https://ClinicalTrials.gov/show/NCT04361448
NCT04374656,Prevalence of SARS-CoV-2 in Conjunctival Swab Samples Among Patients With Conjunctivitis During the COVID-19 Pandemic,Observational Model: Cohort|Time Perspective: Prospective,IRB00249598,"Wilmer Eye Institute, Baltimore, Maryland, United States",https://ClinicalTrials.gov/show/NCT04374656
NCT04425759,Prevalence and Risk Factors of SARS-CoV-2 Antibody Responses (COVID-19),Observational Model: Cohort|Time Perspective: Prospective,SERO-MARES (56/20),"Hospital de Mataró, Mataró, Barcelona, Spain",https://ClinicalTrials.gov/show/NCT04425759
NCT04876573,Pilot Study for Cyproheptadine in Hospitalized Patient for COVID-19,Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2022-2669,NA,https://ClinicalTrials.gov/show/NCT04876573
NCT04883801,Clinical Outcomes of Newborns Born to Pregnant Women With and Without COVID-19,Observational Model: Case-Control|Time Perspective: Retrospective,Newborns outcomes,"Denizli State Hospital, Denizli, Turkey",https://ClinicalTrials.gov/show/NCT04883801
NCT04536350,Inhaled Aviptadil for the Treatment of COVID-19 in Patients at High Risk for ARDS,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",2020-01902,"Cantonal Hospital Baselland Liestal, Liestal, BL, Switzerland|Cantonal Hospital St.Gallen, St.Gallen, Switzerland",https://ClinicalTrials.gov/show/NCT04536350
NCT04357496,COVID-19 Epidemic Response Study,Observational Model: Cohort|Time Perspective: Prospective,COVER-2020,NA,https://ClinicalTrials.gov/show/NCT04357496
NCT04468009,Treatment of Critically Ill Patients With Covid-19 With Convalescent Plasma,Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,1725,"Hospital Francisco Javier Muñiz, Ciudad Autonoma de Buenos Aire, Argentina",https://ClinicalTrials.gov/show/NCT04468009
NCT04508959,The McMaster Multi-Regional COVID-19 Hospital Case Registry,Observational Model: Cohort|Time Perspective: Prospective,172754,"Hamilton General Hospital, Hamilton, Ontario, Canada|St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada|Grand River Hospital, Kitchener, Ontario, Canada|St. Mary's General Hospital, Kitchener, Ontario, Canada|Niagara Health System, St. Catharines, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04508959
NCT04314232,Mechanisms for Covid-19 Disease Complications,Observational Model: Cohort|Time Perspective: Prospective,117589,"Akershus University Hospital, Lørenskog, Norway",https://ClinicalTrials.gov/show/NCT04314232
NCT04932876,The Response of the Immune System of Patients With End Stage Kidney Disease on Dialysis and Kidney Transplant Recipients Vaccinated for COVID-19,Observational Model: Case-Control|Time Perspective: Prospective,RESCOMUOI82152,"Evangelia Ntounousi, Ioannina, Epirus, Greece",https://ClinicalTrials.gov/show/NCT04932876
NCT04324021,Efficacy and Safety of Emapalumab and Anakinra in Reducing Hyperinflammation and Respiratory Distress in Patients With COVID-19 Infection.,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,Sobi.IMMUNO-101|2020-001167-93,"Regions hospital, Saint Paul, Minnesota, United States|The Valley hospital, Ridgewood, New Jersey, United States|NewYork-Presbyterian Queens, Flushing, New York, United States|Temple University Hospital, Philadelphia, Pennsylvania, United States|University of Utah Health, Salt Lake City, Utah, United States|ASST Spedali Civili di Brescia Dipartimento di Reumatologia e Immunologia Clinica, Brescia, Italy|S.C. Malattie Infettive, Ospedale Galliera, Genova, Italy|Ospedale Maggiore Policlinico, Dipartimento di Anestesia-Rianimazione e Medicina di Urgenza, Milano, Italy|Dipartimento di Medicina - DIMED, Azienda Ospedale - Università Padova, Padova, Italy|Azienda Ospedaliero-Universitaria di Parma, Dipartimento di Malattie infettive ed epatologia, Parma, Italy|Ospedale Lazzaro Spallanzani, Dipartimento di Malattie Infettive ad alta Intensità di cura ed altamente contagiose,Ospedale Lazzaro Spallanzani, Roma, Italy|ASL Città di Torino, Unit of Infectious Diseases, Medicine, Rheumatology, Torino, Italy",https://ClinicalTrials.gov/show/NCT04324021
NCT04365530,Become of Patients Infected or Suspected of Being Infected by Covid-19 and Supported by the GHPSJ and the Establishments of the Paris Plaisance Hospital City,Observational Model: Cohort|Time Perspective: Other,Cohorte COVID GHPSJ CiteH,"Hôpital Marie Lannelongue, Le Plessis-Robinson, France|AURA Paris Plaisance, Paris, France|Fondation Sainte-Marie, Paris, France|Groupe Hospitalier Paris Saint-Joseph, Paris, France|Hôpital Bellan, Paris, France",https://ClinicalTrials.gov/show/NCT04365530
NCT04511429,COVID-19 in Immunosuppressed Children,Observational Model: Cohort|Time Perspective: Prospective,062-2020,"Hospital Federal de Bonsucesso, Rio de Janeiro, RJ, Brazil|Hospital Estadual da Criança, Rio De Janeiro, RJ, Brazil",https://ClinicalTrials.gov/show/NCT04511429
NCT04551911,Safety and Efficacy of Rayaldee for Treating Mild to Moderate COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",CTAP101-CL-2014,"OPKO Investigative Site, San Francisco, California, United States|OPKO Investigative Site, Miami, Florida, United States|OPKO Investigative Site, Miami, Florida, United States|OPKO Investigative Site, Evanston, Illinois, United States|OPKO Investigative Site, Laurel, Maryland, United States|OPKO Investigative Site, Farmington Hills, Michigan, United States|OPKO Investigative Site, Jackson, Michigan, United States|OPKO Investigative Site, Sterling Heights, Michigan, United States|OPKO Investigative Site, Brookhaven, Mississippi, United States|OPKO Investigative Site, Omaha, Nebraska, United States",https://ClinicalTrials.gov/show/NCT04551911
NCT04788407,Efficacy and Safety of Nitazoxanide for Post Exposure Prophylaxis of COVID-19 in Household Contacts,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention",FH-53,"Fundación Huésped., Buenos Aires, Ciudad Autonoma De Buenos Aires, Argentina",https://ClinicalTrials.gov/show/NCT04788407
NCT04329195,ACE Inhibitors or ARBs Discontinuation in Context of COVID-19 Pandemic,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,APHP200409,"Cardiologie, Groupe Hospitalier Pitié-Salpêtrière, Paris, France",https://ClinicalTrials.gov/show/NCT04329195
NCT04508439,Effect of the Use of Anticoagulant Therapy During Hospitalization and Discharge in Patients With COVID-19 Infection,"Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment",NR-CEI-HRAEI-19-2020,"Hospital Regional de Alta Especialidad de Ixtapaluca, Mexico City, Ixtapaluca, Mexico",https://ClinicalTrials.gov/show/NCT04508439
NCT04381273,Oral Health and Psychosocial Factors During the Covid-19 Pandemic,Observational Model: Cohort|Time Perspective: Cross-Sectional,S-303/2020,"University Hospital Heidelberg, Heidelberg, Baden-Württemberg, Germany",https://ClinicalTrials.gov/show/NCT04381273
NCT04756674,The Impact of Covid-19 on Skeletal Muscle,Observational Model: Cohort|Time Perspective: Prospective,20065|Sponsor ID: 20065,"Royal Derby Hospital, Derby, Derbyshire, United Kingdom",https://ClinicalTrials.gov/show/NCT04756674
NCT04365322,Study of Specific Viral Immune Responses Induced by SARS-CoV-2 (COVID-19),Observational Model: Cohort|Time Perspective: Prospective,2020/502,"CHU Jean Minjoz, Besançon, France",https://ClinicalTrials.gov/show/NCT04365322
NCT04492501,Investigational Treatments for COVID-19 in Tertiary Care Hospital of Pakistan,Allocation: Non-Randomized|Intervention Model: Factorial Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,Sultan Mehmood Kamran 3,"Pak Emirates Military Hospital, Rawalpindi, Punjab, Pakistan",https://ClinicalTrials.gov/show/NCT04492501
NCT04419025,Efficacy of N-Acetylcysteine (NAC) in Preventing COVID-19 From Progressing to Severe Disease,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,CHA-IRB-1139/05/20,"CHA Cambridge Hospital, Cambridge, Massachusetts, United States|CHA Everett Hospital, Everett, Massachusetts, United States|CHA Respiratory Clinic, Somerville, Massachusetts, United States|CHA Somerville campus, Somerville, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT04419025
NCT04556864,Hemodynamic Impact on Critical Care Patients With Lung Damage Secondary to COVID-19,Observational Model: Cohort|Time Perspective: Prospective,FAB-HEM-2020-01,"1. A.H. Juan Ramón Jiménez., Huelva, Andalucia, Spain|5. Hospital Virgen de la Victoria, Málaga, Andalucía, Spain|3. Hospital Universitario. Jerez de la Frontera., Jerez De La Frontera, Cádiz, Spain|4. Hospital Universitario de Álava., Alava, País Vasco, Spain|2. Hospital Universitario Infanta Leonor, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04556864
NCT04407273,Statin Therapy and COVID-19 Infection,Observational Model: Case-Only|Time Perspective: Prospective,106/2020,"Facultat de Medicina i Ciències de la Salut de Reus, Reus, Tarragona, Spain",https://ClinicalTrials.gov/show/NCT04407273
NCT04371393,MSCs in COVID-19 ARDS,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",GCO 08-1078-0014,"Dignity Health, Gilbert, Arizona, United States|University of Southern California, Los Angeles, California, United States|Stanford University, Stanford, California, United States|Emory University, Atlanta, Georgia, United States|Lutheran Hospital, Fort Wayne, Indiana, United States|Ochsner Clinic, New Orleans, Louisiana, United States|Maine Medical Center, Portland, Maine, United States|University of Maryland, Baltimore, Maryland, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States|University of Michigan, Ann Arbor, Michigan, United States|Dartmouth-Hitchcock, Lebanon, New Hampshire, United States|New York University Langone Health, New York, New York, United States|Mount Sinai Health, New York, New York, United States|Northwell Health, New York, New York, United States|Duke University Medical Center, Durham, North Carolina, United States|WakeMed, Raleigh, North Carolina, United States|Cleveland Clinic Foundation, Cleveland, Ohio, United States|University of Pennsylvania Health System, Philadelphia, Pennsylvania, United States|Houston Methodist Hospital, Houston, Texas, United States|Baylor, Smith & White, Plano, Texas, United States|University of Virginia, Charlottesville, Virginia, United States",https://ClinicalTrials.gov/show/NCT04371393
NCT04382469,Egyptian Initial Experience About 2019 Novel Corona Virus: Study of 48 Patients in Alexandria-Egypt Using Chest CT,Observational Model: Case-Crossover|Time Perspective: Retrospective,"IRB (00012098), FWA (00018699)","Faculty of Medicine, University of Alexandria, Alexandria, Egypt",https://ClinicalTrials.gov/show/NCT04382469
NCT04705831,Study to Evaluate the Benefit of RUCONEST in Improving Neurological Symptoms in Post COVID-19 Infection,"Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment",IIS202001-Neuroimmune,"IMMUNOe Research Centers, Centennial, Colorado, United States",https://ClinicalTrials.gov/show/NCT04705831
NCT04806113,COVID-19 Vaccine in Immunosuppressed Adults With Autoimmune Diseases,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,MP-37-2021-7562,"McGill University Health Centre, Montreal, Quebec, Canada",https://ClinicalTrials.gov/show/NCT04806113
NCT04742595,SARS-CoV-2 Specific Cytotoxic T Lymphocytes for the Treatment of COVID-19 in Patients With Cancer,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2020-0759|NCI-2020-13875,"M D Anderson Cancer Center, Houston, Texas, United States",https://ClinicalTrials.gov/show/NCT04742595
NCT04441372,Prognostication of Oxygen Requirement in Non-severe SARS-CoV-2 Infection,Observational Model: Cohort|Time Perspective: Prospective,MSF0001,"All India Institute of Medical Sciences Patna (AIIMS), Patna, Bihar, India|Christian Medical College, Vellore, Vellore, Tamil Nadu, India",https://ClinicalTrials.gov/show/NCT04441372
NCT04570254,Antioxidants as Adjuvant Therapy to Standard Therapy in Patients With COVID-19,"Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",09-CEI-011-20160627,"Unidad Temporal COVID-19 en Centro Citibanamex, Mexico City, Mexico",https://ClinicalTrials.gov/show/NCT04570254
NCT04527614,Influence of Prior Infection With COVID-19 on Occurrence of Influenza-like Illness or Acute Respiratory Infection,"Allocation: N/A|Intervention Model: Single Group Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Diagnostic",PICOV2021,"Sciensano, Brussels, Belgium",https://ClinicalTrials.gov/show/NCT04527614
NCT04813575,COVID-19 Pathophysiology of Long Term Implications,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,2200055,"King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia",https://ClinicalTrials.gov/show/NCT04813575
NCT04363268,ACCESS A Master Digital Surveillance Protocol for COVID-19,Observational Model: Cohort|Time Perspective: Prospective,Pro00041635,"Medable Inc., Palo Alto, California, United States",https://ClinicalTrials.gov/show/NCT04363268
NCT04982042,Post COVID-19 Pulmonary Rehabilitation Program (COVID-19REHAB),Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,COVID-19 PULMONARY REHAB,"Centro Universitário de Anápolis - UniEVANGÉLICA, Anápolis, GO, Brazil",https://ClinicalTrials.gov/show/NCT04982042
NCT04323761,Expanded Access Treatment Protocol: Remdesivir (RDV; GS-5734) for the Treatment of SARS-CoV2 (CoV) Infection (COVID-19),NA,GS-US-540-5821|2020-001453-49,"University of Alabama- Birmingham, Birmingham, Alabama, United States|Banner- University Medical Center Phoenix, Phoenix, Arizona, United States|Community Regional Medical Centers (CRMC), Fresno, California, United States|St. Jude Medical Center, Fullerton, California, United States|Scripps Memorial Hospital La Jolla, La Jolla, California, United States|Long Beach Memorial Medical Center, Long Beach, California, United States|Huntington Hospital, Pasadena, California, United States|Scripps Mercy Hospital, San Diego, California, United States|California Pacific Medical Center, San Francisco, California, United States|University of California, Medical Center (Parnassus Campus), San Francisco, California, United States|Regional Medical Center, San Jose, California, United States|San Mateo Medical Center, San Mateo, California, United States|Santa Rosa Memorial Hospital, Santa Rosa, California, United States|Los Robles Regional Medical Center, Thousand Oaks, California, United States|PIH Health Whittier Hospital, Whittier, California, United States|The Medical Center Of Aurora, Aurora, Colorado, United States|Rose Medical Center, Denver, Colorado, United States|Swedish Medical Center, Englewood, Colorado, United States|Greenwich Hospital, Greenwich, Connecticut, United States|Middlesex Health, Middletown, Connecticut, United States|The Hospital of Central Connecticut, New Britain, Connecticut, United States|The Stamford Health Medical Group- Pulmonary Associates, Stamford, Connecticut, United States|George Washington University Hospital, Washington, District of Columbia, United States|Aventura Hospital and Medical Center, Aventura, Florida, United States|Lawnwood Regional Medical Center, Fort Pierce, Florida, United States|Memorial Regional Hospital, Hollywood, Florida, United States|Mayo Clinic in Florida, Jacksonville, Florida, United States|Mount Sinai Medical Center, Miami Beach, Florida, United States|AdventHealth Orlando, Investigational Drug Services, Orlando, Florida, United States|Sarasota Memorial Hospital, Sarasota, Florida, United States|Piedmont Atlanta Hospital, Atlanta, Georgia, United States|Wellstar Atlanta Medical Center, Atlanta, Georgia, United States|Piedmont Columbus Regional-Midtown Hospital, Columbus, Georgia, United States|Grady Health System- Grady Memorial Hospital, Decatur, Georgia, United States|Piedmont Fayette Hospital, Fayetteville, Georgia, United States|Memorial Health University Medical Center, Savannah, Georgia, United States|John D. Archbold Memorial Hospital, Thomasville, Georgia, United States|Swedish Hospital, Chicago, Illinois, United States|Mercy Hospital & Medical Center, Chicago, Illinois, United States|Northwestern Lake Forest Hospital, Lake Forest, Illinois, United States|Loyola University Medical Center, Maywood, Illinois, United States|Northwestern Medicine Central DuPage Hospital, Winfield, Illinois, United States|St. Vincent Hospital and Health Care Center, Inc., Carmel, Indiana, United States|Richard L Roudebush Indianapolis VA, Indianapolis, Indiana, United States|Riverview Health, Noblesville, Indiana, United States|Our Lady of the Lakes Regional Medical Center, Baton Rouge, Louisiana, United States|Touro Infirmary, New Orleans, Louisiana, United States|Ochsner Clinic Foundation, New Orleans, Louisiana, United States|Slidell Memorial Hospital, Slidell, Louisiana, United States|University of Maryland, Baltimore, Maryland, United States|Mercy Medical Center, Baltimore, Maryland, United States|CalvertHealth Medical Center, Prince Frederick, Maryland, United States|University of Maryland St. Joseph Medical Center, Towson, Maryland, United States|Steward St. Elizabeth's Medical Center of Boston, Inc., Boston, Massachusetts, United States|Cambridge Health Alliance, Cambridge, Massachusetts, United States|Charlton Memorial Hospital, Fall River, Massachusetts, United States|Lawrence General Hospital, Lawrence, Massachusetts, United States|Lowell General Hospital, Lowell, Massachusetts, United States|South Shore Hospital, South Weymouth, Massachusetts, United States|UMass Memorial Medical Center, Worcester, Massachusetts, United States|St. Joseph Mercy Hospital, Ann Arbor, Michigan, United States|Huron Valley-Sinai Hospital, Commerce, Michigan, United States|Wayne Statue University/ Detroit Receiving Hospital, Detroit, Michigan, United States|Henry Ford Health System, Detroit, Michigan, United States|McLaren Health Care Corporation, Flint, Michigan, United States|Bronson Methodist Hospital, Kalamazoo, Michigan, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|CarePoint Health Bayonne Medical Center, Bayonne, New Jersey, United States|Clara Maass Medical Center, Belleville, New Jersey, United States|Cooper University Hospital, Camden, New Jersey, United States|Hackensack Meridian Health - JFK Medical Center, Edison, New Jersey, United States|Trinitas Regional Medical Center, Elizabeth, New Jersey, United States|Englewood Health, Englewood, New Jersey, United States|Hunterdon Medical Center, Flemington, New Jersey, United States|CentraState Medical Center, Freehold, New Jersey, United States|Robert Wood Johnson University Hospital Hamilton, Hamilton, New Jersey, United States|Jersey City Medical Center, Jersey City, New Jersey, United States|Christ Hospital- Carepoint Health, Jersey City, New Jersey, United States|Monmouth Medical Center, Long Branch, New Jersey, United States|Atlantic Health System/ Morristown Medical Center, Morristown, New Jersey, United States|Jersey Shore University Medical Center, Neptune, New Jersey, United States|Saint Peter's University Hospital, New Brunswick, New Jersey, United States|Saint Michael's Medical Center, Newark, New Jersey, United States|University Hospital, Newark, New Jersey, United States|Ocean Medical Center, Oakhurst, New Jersey, United States|Bayshore Medical Center, Red Bank, New Jersey, United States|The Valley Hospital, Ridgewood, New Jersey, United States|Atlantic Health System/Overlook Medical Center, Summit, New Jersey, United States|Holy Name Medical Center, Teaneck, New Jersey, United States|Capital Health, Trenton, New Jersey, United States|Virtua Health Voorhees Campus, Voorhees, New Jersey, United States|St. Peter's Hospital, Albany, New York, United States|Mount Sinai Queens, Astoria, New York, United States|Good Samaritan Hospital Medical Center, Bay Shore, New York, United States|Southside Hospital, Bay Shore, New York, United States|Lincoln Medical Center, Bronx, New York, United States|St Barnabus Hospital, Bronx, New York, United States|Montefiore Medical Center, Weiler Campus, Bronx, New York, United States|Montefiore Health System Moses Medical Center, Bronx, New York, United States|The Brooklyn Hospital Center, Brooklyn, New York, United States|Kingsbrook Jewish Medical Center, Brooklyn, New York, United States|University Hospital Brooklyn (SUNY Downstate), Brooklyn, New York, United States|Woodhull Medical Center, Brooklyn, New York, United States|Kings County Hospital Center, Brooklyn, New York, United States|New York Harbor VA Medical Center, Brooklyn, New York, United States|Brookdale University Hospital and Medical Center, Brooklyn, New York, United States|Interfaith Medical Center, Brooklyn, New York, United States|NewYork-Presbyterian Brooklyn Methodist Hospital, Brooklyn, New York, United States|Maimonides Medical Center, Brooklyn, New York, United States|NYU Langone Hospital - Brooklyn, Brooklyn, New York, United States|Mount Sinai Brooklyn, Brooklyn, New York, United States|New York City Health and Hospitals - Coney Island, Brooklyn, New York, United States|Kaleida Health System, Buffalo, New York, United States|Nassau University Medical Center, East Meadow, New York, United States|New York Presbyterian- Queens, Flushing, New York, United States|Glens Falls Hospital, Glens Falls, New York, United States|Queens Hospital Center, Jamaica, New York, United States|NYU Langone Health, New York, New York, United States|Hospital for Special Surgery, New York, New York, United States|New York City Health and New York City Health and Hospitals - Metropolitan- Metropolitan, New York, New York, United States|NewYork-Presyterian/Columbia University Irving Medical Center- Milstein Hospital, New York, New York, United States|New York City Health + Hospitals / Harlem, New York, New York, United States|New York Presbyterian Lower Manhattan Hospital, New York, New York, United States|Memorial Sloan-Kettering Cancer Center, New York, New York, United States|Mount Sinai South Nassau, Oceanside, New York, United States|Vassar Brothers Medical Center, Poughkeepsie, New York, United States|Rochester General Hospital, Rochester, New York, United States|St. Francis Hospital, Roslyn, New York, United States|Ellis Hospital, Schenectady, New York, United States|Staten Island University Hospital- Northwell Health (North Campus), Staten Island, New York, United States|Stony Brook University Hospital/ Stony Brook Children's, Stony Brook, New York, United States|Samaritan Hospital, Troy, New York, United States|UNC Hospitals, Chapel Hill, North Carolina, United States|Atrium Health- Carolinas Medical Center, Charlotte, North Carolina, United States|MetroHealth Medical Center, Cleveland, Ohio, United States|The Ohio State University College of Medicine, Columbus, Ohio, United States|Kettering Medical Center, Kettering, Ohio, United States|Saint Francis Hospital, Tulsa, Oklahoma, United States|St. Luke's Hospital - Bethlehem Campus, Bethlehem, Pennsylvania, United States|Mercy Catholic Medical Center - Fitzgerald Campus, Darby, Pennsylvania, United States|St Mary Medical Center, Langhorne, Pennsylvania, United States|Philadelphia VA Medical Center, Philadelphia, Pennsylvania, United States|Einstein Medical Center Philadelphia, Philadelphia, Pennsylvania, United States|Allegheny Health Network, Pittsburgh, Pennsylvania, United States|UPMC, Pittsburgh, Pennsylvania, United States|Roger Williams Medical Center, Providence, Rhode Island, United States|Kent Hospital, Warwick, Rhode Island, United States|St. Francis Hospital, Greenville, South Carolina, United States|Lexington Medical Center, West Columbia, South Carolina, United States|TriStar Centennial Medical Center, Nashville, Tennessee, United States|St. David's South Austin Medical Center, Austin, Texas, United States|Texas Health Presbyterian Hospital Dallas, Dallas, Texas, United States|Texas Department of Criminal Justice Hospital (Hospital Galveston)/University of Texas Medical Branch, Galveston, Texas, United States|HCA Houston Healthcare West, Houston, Texas, United States|Covenant Medical Center, Lubbock, Texas, United States|Methodist Mansfield Medical Center, Mansfield, Texas, United States|Methodist Healthcare System of San Antonio, Ltd. LLP, dha, Methodist Hospital, San Antonio, Texas, United States|Saint Mark's Hospital, Salt Lake City, Utah, United States|Inova Fairfax Medical Campus, Falls Church, Virginia, United States|Henrico Doctors Hospital, Richmond, Virginia, United States|Carilion Medical Center, Roanoke, Virginia, United States|Overlake Hospital Medical Center, Bellevue, Washington, United States|University of Washington Medical Center- Montlake Campus, Seattle, Washington, United States|Medical College of Wisconsin, Milwaukee, Wisconsin, United States|St. Vincent's Hospital Sydney, Darlinghurst, New South Wales, Australia|Royal Brisbane and Women's Hospital, Herston, Queensland, Australia|The Alfred Hospital, Melbourne, Victoria, Australia|The Royal Melbourne Hospital, Parkville, Victoria, Australia|Gold Coast Hospital, Southport, Australia|Landeskrankenhaus Graz West, Graz, Austria|Universitätsklinik für Innere Medizin II, Innsbruck, Austria|Kepler Universitätsklinikum, Linz, Austria|Medical University and General Hospital Vienna, Vienna, Austria|Sozialmedizinisches Zentrum Süd - Kaiser-Franz-Josef-Spital, Wien, Austria|Centre Hospitalier Universitaire Saint Pierre, Brussels, Belgium|Ghent University Hospital, Ghent, Belgium|Jessa Ziekenhuis, Hasselt, Belgium|AZ Groeninge, Kortrijk, Belgium|Universitair Ziekenhuis Leuven, Leuven, Belgium|Centre Hospitalier Universitaire de Liège, Liège, Belgium|Hôpital Civil Marie Curie, Lodelinsart, Belgium|William Osler Health System, Brampton, Ontario, Canada|The Ottowa Hospital, Ottawa, Ontario, Canada|Nicosia General Hospital, Nicosia, Cyprus|Všeobecná fakultní nemocnice v Praze, Prague, Czechia|Eticka komise pro multicentircke klinicke hodnoceni Fakultni nemocnice v Motole, Praha 5, Czechia|Nemocnice Na Bulovce, Praha 8 - Liben, Czechia|Rigshospitalet, Copenhagen, Denmark|Põhja-Eesti Regionaalhaigla, Tallinn, Estonia|Vilnius University, Tartu, Estonia|Hopital Avicenne, Bobigny, France|Centre Hospitalier Regional Universitaire Brest Hôpital de la Cavale Blanche à Brest, Brest Cedex, France|Centre Hospitalier Universitaire Gabriel-Montpied, Clermont Ferrand, France|Hôpitaux Civils de Colmar, Colmar, France|Centre Hospitalier Sud Francilien, Corbeil Essonnes, France|Hôpital Raymond Poincaré, Garches, France|Centre Hospitalier Régional d'Orléans, Orléans, France|Centre Hospitalier Universitaire de Poitiers, Poitiers, France|Hôpital Charles-Nicolle, Rouen, France|Hôpital Purpan, Toulouse, France|Saint Josef Hospital Ruhr Universitaet Bochum, Bochum, Germany|Universitätsklinikum Carl Gustav Carus Dresden, Dresden, Germany|Universitatsklinikum, Essen, Germany|Universitätsklinikum Freiburg, Freiburg, Germany|Universitätsmedizin Göttingen, Göttingen, Germany|Medizinische Hochschule Hannover, Hannover, Germany|Universitätsklinikum Heidelberg, Heidelberg, Germany|Universitätsklinikum des Saarlandes, Homburg, Germany|Caritas-Krankenhaus St. Josef, Regensburg, Germany|Klinikum Würzburg Mitte, Würzburg, Germany|University General Hospital of Patras Panagia I Voithia, Patra, Greece|General Hospital of Thessaloniki George Papanikolaou, Thessaloniki, Greece|Kenézy Gyula Kórház És Rendelőintézet, Debrecen, Hungary|Landspítali, Reykjavik, Iceland|Kerry University Hospital, Tralee, Ireland|Shaare Zedek Medical Center, Jerusalem, Israel|Hasharon Hospital, Petah Tikva, Israel|Sheba Medical Center at Tel Hashomer, Ramat Gan, Israel|Azienda Ospedaliero Universitaria Ospedali Riuniti di Ancona, Ancona, Italy|Azienda Universitaria Ospedaliera Consorziale - Policlinico di Bari, Bari, Italy|Azienda Ospedaliero Universitaria, Bologna, Italy|ASST Spedali Civili di Brescia, Brescia, Italy|Presidio Ospedaliero Garibaldi-Nesima, Catania, Italy|Azienda Ospedaliero - Universitaria Careggi, Florence, Italy|Ospedale Policlinico San Martino, Genova, Italy|Ospedale Maggiore Policlinico, Milano, Italy|Ospedale San Gerardo di Monza, Monza, Italy|Azienda Ospedaliera dei Colli, Napoli, Italy|Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy|IRCCS Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani, Roma, Italy|Azienda Ospedaliero Universitaria, Turin, Italy|Hospital of Lithuanian University of Health Sciences Kauno klinikos, Kaunas, Lithuania|Vilnius University, Vilnius, Lithuania|Radboud Universitair Medisch Centrum, Nijmegen, Netherlands|HagaZiekenhuis, The Hague, Netherlands|Szpital Uniwersytecki w Krakowie, Krakow, Poland|Wojewódzki Specjalistyczny Szpital im. dr. Wł. Biegańskiego, Lodz, Poland|Wielospecjalistyczny Szpital Miejski Im Józefa Strusia Zakład Opiekuńczo Leczniczy, Poznan, Poland|Wojewódzki Szpital Specjalistyczny Megrez Sp. z o.o., Tychy, Poland|Centro Hospitalar Universitário de Lisboa Central - Hospital Curry Cabral, Lisboa, Portugal|Centro Hospitalar Universitário do Porto E.P.E., Porto, Portugal|Centro Hospitalar Universitário De São João, Porto, Portugal|Centro Hospitalar de Vila Nova de Gaia/Espinho, Vila Nova de Gaia, Portugal|Institutul National de Boli Infectioase Prof. Dr. Matei Bals, Bucharest, Romania|Spitalul Clinic de Boli Infecţioase Sfânta Parascheva Iaşi, Iasi, Romania|Clinical hospital for infectious disease, Timisoara, Romania|Univerzitná Nemocnica L. Pasteura Košice - Pracovisko Rastislavova 43, Košice, Slovakia|Univerzitetni Klinicni Center Ljubljana, Ljubljana, Slovenia|Univerzitetni Klinicni Center Maribor, Maribor, Slovenia|Hospital Universitari Germans Trias i Pujol, Badalona, Spain|Hospital General Universitario Gregorio Maranon, Madrid, Spain|Hospital Universitario Central de Asturias, Oviedo, Spain|Hospital Universitario Son Espases, Palma de Mallorca, Spain|Hospital Clinico Universitario de Salamanca, Salamanca, Spain|Hospital Universitario Donostia, San Sebastian, Spain|Hospital Virgen De La Salud, Santa Cruz de Tenerife, Spain|Hospital Virgen De La Salud, Toledo, Spain|Hospital Clinico Universitario de Valladolid, Valladolid, Spain|Hospital Universitario Miguel Servet, Zaragoza, Spain|Kantonsspital Aarau, Aarau, Switzerland|University Hospital Basel, Basel, Switzerland|Spitalzentrum Biel, Biel, Switzerland|Kantonsspital Graubünden, Chur, Switzerland|Centre Hospitalier Universitaire Vaudois Lausanne, Lausanne, Switzerland|Luzerner Kantonsspital, Luzern, Switzerland|Hôpital du Valais -Hôpital de Sion, Sion, Switzerland|University Hospital of Wales, Cardiff and Vale NHS Trust, Cardiff, United Kingdom|Barts Health NHS Trust, London, United Kingdom|Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom|St. George's Hospital, London, United Kingdom|Southampton University Hospital, Southampton, United Kingdom",https://ClinicalTrials.gov/show/NCT04323761
NCT04558476,Efficacy of CONvalescent Plasma in Patients With COVID-19 Treated With Mechanical Ventilation,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2020-003102-31,"Clinique Saint Pierre Ottignies, Ottignies, Brabant Wallon, Belgium|Centre Hospitalier Wallonie Picarde, Tournai, Hainaut, Belgium|OLVZ Aalst, Aalst, Belgium|UZ Antwerpen, Antwerp, Belgium|Imelda ZH Bonheiden, Bonheiden, Belgium|AZ Sint-Jan Brugge, Bruges, Belgium|CHU Saint Pierre, Brussels, Belgium|Erasme, Brussels, Belgium|UZ Brussel, Brussel, Belgium|CHU Charleroi Marie Curie, Charleroi, Belgium|AZ Sint Blasius, Dendermonde, Belgium|UZ Gent, Gent, Belgium|AZ Groeningen Kortrijck, Kortrijk, Belgium|CHR Citadelle, Liège, Belgium|CHU Liège, Liège, Belgium|UC Louvain, Louvain, Belgium|AZ Delta, Roeselare, Belgium|CHU UCL Namur-Godinne, Yvoir, Belgium",https://ClinicalTrials.gov/show/NCT04558476
NCT04929964,COVID-19 Pandemic: Effect on Management of Patients With Breast Cancer,Observational Model: Case-Only|Time Perspective: Other,COV-19 BUMDC,"Bahria University Medical and Dental College Karachi, Karachi, Sindh, Pakistan",https://ClinicalTrials.gov/show/NCT04929964
NCT04366934,Study of the Pathogenesis of Olfactory Disorders in COVID-19,Observational Model: Case-Control|Time Perspective: Cross-Sectional,2020-021,"Hôpital Lariboisière, Policlinique, Paris, France|Hôpital Lariboisière, Service ORL, Paris, France",https://ClinicalTrials.gov/show/NCT04366934
NCT04373824,Max Ivermectin- COVID 19 Study Versus Standard of Care Treatment for COVID 19 Cases. A Pilot Study,Allocation: Non-Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,MHC-COVID-19- INV- ACT-BHR,"Max Super Speciality hospital, Saket (A unit of Devki Devi Foundation), New Delhi, Delhi, India",https://ClinicalTrials.gov/show/NCT04373824
NCT04335773,"COVID-19 in Hospitalised Norwegian Children - Risk Factors, Outcomes and Immunology",Observational Model: Case-Control|Time Perspective: Prospective,20/03794,"Akershus universistetssykehus, Lørenskog, Norway",https://ClinicalTrials.gov/show/NCT04335773
NCT04355442,Evolution of Facial Trauma During COVID Containment Measures,Observational Model: Cohort|Time Perspective: Retrospective,RECHMPL20_0228,"Uh Montpellier, Montpellier, France",https://ClinicalTrials.gov/show/NCT04355442
NCT04524156,COVID-19 : Transcutaneous pO2 and pCO2 as Predictive Factors for Acute Respiratory Destress Syndrome in Patients Affected With SARS-Cov-2,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science,P2020/238,"Erasme Hospital, Bruxelles, Belgium",https://ClinicalTrials.gov/show/NCT04524156
NCT04520880,Antibodies Responses to COVID-19 Infection in Hospitalized Patients,Observational Model: Other|Time Perspective: Prospective,ICU-06072020,"Imam Abdulrahman Bin Faisal University, Dammam, Eastern, Saudi Arabia",https://ClinicalTrials.gov/show/NCT04520880
NCT04444687,COVID 19: Is SARS-CoV-2 Contaminating Surgical Aerosols From Laparoscopy and Open Abdominal Surgery?,Observational Model: Case-Control|Time Perspective: Prospective,52020,NA,https://ClinicalTrials.gov/show/NCT04444687
NCT04334148,Healthcare Worker Exposure Response and Outcomes of Hydroxychloroquine,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention",Pro00105274,"Children's Hospital Colorado/University of Colorado Denver, Aurora, Colorado, United States|University of Florida, Gainesville, Florida, United States|University of Florida Jacksonville, Jacksonville, Florida, United States|University of Florida Health Central Florida, Leesburg, Florida, United States|University of Miami Florida, Miami, Florida, United States|Advent Health, Orlando, Florida, United States|University of South Florida, Tampa, Florida, United States|Northwestern Medicine, Chicago, Illinois, United States|Rush University, Chicago, Illinois, United States|University of Iowa, Iowa City, Iowa, United States|University of Kansas Medical Center, Kansas City, Kansas, United States|University Medical Center New Orleans, New Orleans, Louisiana, United States|Ochsner Clinic Foundation, New Orleans, Louisiana, United States|Johns Hopkins, Baltimore, Maryland, United States|University of Michigan, Ann Arbor, Michigan, United States|Allina Health, Minneapolis, Minnesota, United States|Mayo Clinic Hospital Rochester, Rochester, Minnesota, United States|University of Missouri-Columbia, Columbia, Missouri, United States|University of Nebraska Medical Center, Omaha, Nebraska, United States|Hospital for Special Surgery, New York, New York, United States|Columbia University, Irving Medical Center, New York, New York, United States|Weill Cornell Medicine, New York, New York, United States|University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States|Duke University Medical Center, Durham, North Carolina, United States|Wake Forest Baptist Health Sciences, Winston-Salem, North Carolina, United States|The Ohio State University Wexner Medical Center, Columbus, Ohio, United States|Temple University Hospital, Philadelphia, Pennsylvania, United States|University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States|Clinical Trials Center of Middle Tennessee, Franklin, Tennessee, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|University of Texas Southwestern Medical Center, Dallas, Texas, United States|Baylor Scott & White Medical Center-Temple, Temple, Texas, United States|Seattle Children's Hospital, Seattle, Washington, United States|Marshfield Clinic Health System, Marshfield, Wisconsin, United States",https://ClinicalTrials.gov/show/NCT04334148
NCT04319731,A Pilot Study of Human Amniotic Fluid for COVID19 Associated Respiratory Failure,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,131618,"University of Utah Health, Salt Lake City, Utah, United States",https://ClinicalTrials.gov/show/NCT04319731
NCT04334967,Hydroxychloroquine in Patients With Newly Diagnosed COVID-19 Compared to Standard of Care,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,2020000186,"Portland Providence Medical Center, Portland, Oregon, United States",https://ClinicalTrials.gov/show/NCT04334967
NCT04321928,Personalized Health Education Against the Health Damage of Novel Coronavirus (COVID-19) Outbreak in Hungary,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Prevention",IV/2428- 2 /2020/EKU,"Institute for Translational Medicine, University of Pécs, Pécs, Hungary",https://ClinicalTrials.gov/show/NCT04321928
NCT04681040,Risk Stratification of COVID-19 Using Urine Biomarkers,Observational Model: Cohort|Time Perspective: Prospective,NCGM-G-003654-00,"MD Mount Sinai, Baltimore, Maryland, United States|Hospital das Clinicas Ribeirao Preto, Ribeirão Preto, San Paulo, Brazil|Danish National Biobank, København, Denmark|Shonan General Hospital, Kamakura, Kanagawa, Japan|National Center Global Health and Medicine, Shinjuku, Tokyo, Japan|Yamanashi Prefectural Central Hospital, Kōfu, Yamanashi, Japan|Unilab Group, Manila, Philippines",https://ClinicalTrials.gov/show/NCT04681040
NCT04972708,Genetics of COVID-19 Risks & Resilience in Bipolar Disorder,Observational Model: Cohort|Time Perspective: Prospective,25-335 ex 12/13,"Medical University Graz, Graz, Styria, Austria",https://ClinicalTrials.gov/show/NCT04972708
NCT04602000,To Evaluate the Safety and Efficacy of CT-P59 in Patients With Mild to Moderate Syptoms of Severe Acute Respiratory Syndrome COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",CT-P59 3.2,"Chungnam National University Hospital, Daejeon, Jung-gu, Korea, Republic of",https://ClinicalTrials.gov/show/NCT04602000
NCT04922944,Post COVID-19 Vaccination Analysis in Healthcare Worker Recipients,Observational Model: Cohort|Time Perspective: Prospective,Pro00050032,"Huntington Hospital, Pasadena, California, United States",https://ClinicalTrials.gov/show/NCT04922944
NCT04618861,Surfactant Protein D Levels in Covid-19 Infection: Case-Control Study,Observational Model: Case-Control|Time Perspective: Cross-Sectional,Clinical-1,"Aylin Koseler, Denizli, Outside Of The US, Turkey",https://ClinicalTrials.gov/show/NCT04618861
NCT04725084,Comparison of Non-invasive Oxygenation Strategies in Patients Admitted for Covid-19 Acute Respiratory Distress Syndrome,Observational Model: Cohort|Time Perspective: Retrospective,2021-CHITS-001,"Centre Hospitalier de Bethune, Béthune, Nord-Pas-de-Calais, France|Grand Hôpital de l'Est Francilien, Jossigny, Seine-et-Marne, France|Groupe Hospitalier Sud Ile de France, Melun, Seine-et-Marne, France|Centre Hospitalier Intercommunal Toulon La Seyne sur Mer, Toulon, Var, France",https://ClinicalTrials.gov/show/NCT04725084
NCT04441710,Caregiver Serological Monitoring Extended Secondarily to Patients With the SARS-CoV-2 Coronavirus,Observational Model: Cohort|Time Perspective: Prospective,69HCL20_0395,"CHU de Grenoble - Hôpital Nord, La Tronche, France|Hôpital de la Croix Rousse, Lyon, France|Hôpital Henry Gabrielle, Saint-Genis-Laval, France|CHU de Saint Etienne, Saint-Étienne, France",https://ClinicalTrials.gov/show/NCT04441710
NCT04620798,Longitudinal COVID-19 Antibody Testing in Indiana University Undergraduate Students,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Screening",2008293852,"Indiana University, Bloomington, Indiana, United States",https://ClinicalTrials.gov/show/NCT04620798
NCT04602260,Functional Recovery of Hospitalised Patients With COVID-19: The COREG Extension Study,Observational Model: Cohort|Time Perspective: Other,COREG-Extension_14567,"McMaster University, Hamilton, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04602260
NCT04593641,"This is a Phase 1 Study to Evaluate the Safety,Tolerability and Virology of CT P59 in Patients With Mild Symptoms of Symptoms of Coronavirus Disease (COVID-19)","Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",CT-P59 1.2|2020-003165-19,"Incheon Medical Center, Incheon, Korea, Republic of",https://ClinicalTrials.gov/show/NCT04593641
NCT04542512,Risk Factors for Necrotic Cholecystitis During COVID-19 Pandemic.,Observational Model: Case-Only|Time Perspective: Prospective,6012020,"Centre Hospitalier Intercommunal Poissy-Saint Germain en Laye, Poissy, France",https://ClinicalTrials.gov/show/NCT04542512
NCT04628195,Cardiac Performance in Mechanically Ventilated COVID-19 Patients,Observational Model: Cohort|Time Perspective: Prospective,200422002,"Pontificia Universidad Católica de Chile, Santiago, Región Metropolitana, Chile",https://ClinicalTrials.gov/show/NCT04628195
NCT04342728,Coronavirus 2019 (COVID-19)- Using Ascorbic Acid and Zinc Supplementation,Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,IRB 20-361,"Cleveland Clinic, Weston, Florida, United States|Cleveland Clinic, Cleveland, Ohio, United States",https://ClinicalTrials.gov/show/NCT04342728
NCT04456088,Inhaled NO for the Treatment of COVID-19 Caused by SARS-CoV-2 (CANADA Trial),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,BAI_COV19_01_CAN,NA,https://ClinicalTrials.gov/show/NCT04456088
NCT04739449,'4C' Intervention to Reduce SARS-CoV-2 (Covid-19) Transmission,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,HUM00186126|3P30AG024824-16S1,NA,https://ClinicalTrials.gov/show/NCT04739449
NCT04904523,Blood Markers for Identifying & Investigating Infection With COVID19 & Sepsis in Children.,Observational Model: Cohort|Time Perspective: Prospective,pSEP-COVID ChYP 263530,"Cardiff University, Cardiff, United Kingdom",https://ClinicalTrials.gov/show/NCT04904523
NCT04355429,Efficacy of Captopril in Covid-19 Patients With Severe Acute Respiratory Syndrome (SARS) CoV-2 Pneumonia (CAPTOCOVID),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,APHP200410,"CH Victor Dupuy- Argenteuil, Argenteuil, France|Hôpital Avicenne,, Bobigny, France|Hôpital Avicenne, Bobigny, France|Hôpital Avicenne, Bobigny, France|Hôpital Antoine Béclère, Clamart, France|CH de Compiègne-Noyon, Compiègne, France|Groupe hospitalier Sud Ile de France, Melun, France|Hôpital de la Pitié- Salpêtrière, Paris, France|Hôpital Tenon, Paris, France|CHRU de Tours, Hôpital Bretonneau, Tours, France|Hôpital de Tours, Tours, France",https://ClinicalTrials.gov/show/NCT04355429
NCT04401033,Increased Risk of SARS-CoronaVirus-2 (SARS-CoV-2) Infection Associated With Endoscopy (DECORE Study),Observational Model: Cohort|Time Perspective: Prospective,3,"Hospital Rio Hortega, Valladolid, Spain",https://ClinicalTrials.gov/show/NCT04401033
NCT04363450,Hydroxychloroquine as Prophylaxis for COVID-19 in Healthcare Workers (HCQPreP),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",LSU NO HSC IRB 20-050,"Lafayette General Medical Center, Lafayette, Louisiana, United States|University Hospital and Clinics, Lafayette, Louisiana, United States",https://ClinicalTrials.gov/show/NCT04363450
NCT04385147,Advanced Endoscopy During COVID-19,Observational Model: Cohort|Time Perspective: Prospective,Global-Endo-COVID,"Kings County Hospital Center, Brooklyn, NY, USA, Albertson, New York, United States|Al-Azhar Univerisity, Cairo, Egypt|University Medicine Greifswald, Greifswald, Germany|2- Hospital Guillermo Kaelin De la Fuente - EsSalud, Lima, Peru|Singapore General Hospital, Singapore, Singapore",https://ClinicalTrials.gov/show/NCT04385147
NCT04669509,Effect of Liver Injury on Mortality in Coronavirus Disease-2019 Patients Admitted to Intensive Care Unit,Observational Model: Cohort|Time Perspective: Retrospective,CKKacar,"Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital, Diyarbakır, Turkey",https://ClinicalTrials.gov/show/NCT04669509
NCT04432948,Maternal Psychological Implications of Covid-19 Pandemic and Possible Effect on Anaesthetic Management.,Observational Model: Other|Time Perspective: Prospective,Maternal Covid 19,"""Elena Venizelou"" General and Maternity Hospital of Athens, Athens, Attica, Greece",https://ClinicalTrials.gov/show/NCT04432948
NCT04403685,Safety and Efficacy of Tocilizumab in Moderate to Severe COVID-19 With Inflammatory Markers,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,TOCIBRAS,"UNIFESP, São Paulo, Sao Paulo, Brazil|HCOR -Hospital do Coracao, Sao Paulo, SP, Brazil|HAOC - Hospital Alemao Oswaldo Cruz, Sao Paulo, Brazil|Beneficência Portuguesa de Sao Paulo, Sao Paulo, Brazil|HAOC - Hospital Alemao Oswaldo Cruz - unidade Vergueiro, Sao Paulo, Brazil|HIAE - Hospital Israelita Albert Einstein, Sao Paulo, Brazil|HSL - Hospital Sírio Libanês, Sao Paulo, Brazil",https://ClinicalTrials.gov/show/NCT04403685
NCT04704466,Impact of Covid-19 Pandemic on Management of Head and Neck Cancers,Observational Model: Cohort|Time Perspective: Retrospective,PI2021_843_0003,"CHU Amiens, Amiens, France",https://ClinicalTrials.gov/show/NCT04704466
NCT04549636,COVID-19 Related Lung Ventilation and Perfusion Injury,Observational Model: Cohort|Time Perspective: Prospective,FIRH002,"St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04549636
NCT04366167,Patient Recovery From Heart Surgery During the Covid-19 Pandemic,Observational Model: Cohort|Time Perspective: Prospective,132127,"St Bartholomew's Hospital, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04366167
NCT04782336,"Sample Collection Study to Aid Evaluation of an Influenza A/B, Respiratory Syncytial Virus & COVID-19 Virus POC Test",Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,S-CLIN-PROT-00018,"Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom|Leicester Royal Infirmary, Leicester, United Kingdom|Barts Health NHS Trust, London, United Kingdom|Homerton University Hospital NHS Foundation Trust, London, United Kingdom|University College London Hospitals NHS Foundation Trust, London, United Kingdom|St George's University Hospitals NHS Foundation, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04782336
NCT04582318,"A Phase 1/2 Study to Assess the Safety, Tolerability and Pharmacokinetics of NGM621 in Healthy Subjects, and to Assess the Safety, PK and Efficacy in Subjects With Moderate to Severe ARDS Caused by COVID-19","Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",621-CP-102,"NGM Clinical Study Site, Brisbane, Australia",https://ClinicalTrials.gov/show/NCT04582318
NCT04414241,Hydroxychloroquine to Prevent SARS-CoV-2 Infection,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,202087|20923,"Centro Médico Naval ""Cirujano Mayor Santiago Távara"", Callao, Peru|Hospital Nacional Hipólito Unanue, Lima, Peru|Hospital Nacional Arzobispo Loayza, Lima, Peru|Hospital Cayetano Heredia, Lima, Peru",https://ClinicalTrials.gov/show/NCT04414241
NCT04528888,Steroids and Unfractionated Heparin in Critically Ill Patients With Pneumonia From COVID-19 Infection,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,Staunch-19-1.1-26-04-20,"ICU- University Hospital Modena, Modena, Italy",https://ClinicalTrials.gov/show/NCT04528888
NCT04884776,Modulation of Gut Microbiota to Enhance Health and Immunity,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Prevention",IMPACT Study,"Prince of Wales Hospital, Shatin, Hong Kong, Hong Kong",https://ClinicalTrials.gov/show/NCT04884776
NCT04749121,Ultraviolet Germicidal Irradiation on the New Silicone Half-Piece Elastometric Respirators,Allocation: N/A|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,059/63,"Faculty of Medicine ,Vajira hospital,Navamindradhiraj University, Bangkok, Thailand",https://ClinicalTrials.gov/show/NCT04749121
NCT04386512,Clinical Epidemiology and Characteristics Of Covid-19 Cases Occurred In A Lymphoma Setting In The First Epidemic Phase (LymphoCov1),Observational Model: Case-Only|Time Perspective: Retrospective,P20/12_LymphoCov,"CH de Versailles, Le Chesnay, France",https://ClinicalTrials.gov/show/NCT04386512
NCT04685213,Electrical Stimulation for Critically Ill Covid-19 Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Supportive Care",H-47781,"Baylor College of Medicine, Houston, Texas, United States",https://ClinicalTrials.gov/show/NCT04685213
NCT04655612,Seroprevalence Study of CoV-2-SARS (COVID-19) Infection in Patients With Chronic Inflammatory Rheumatic Diseases,Observational Model: Cohort|Time Perspective: Prospective,RECHMPL20_0624,"Centre hopsitalier universitaire de Montpellier, Montpellier, Occitanie, France",https://ClinicalTrials.gov/show/NCT04655612
NCT04401449,Cardiopulmonary Inflammation and Multi-System Imaging During the Clinical Course of COVID-19 Infection in Asymptomatic and Symptomatic Persons,Observational Model: Cohort|Time Perspective: Prospective,200113|20-CC-0113,"MedStar Health Research Institute /MedStar Washington Hospital Center, Washington, District of Columbia, United States|National Institutes of Health Clinical Center, Bethesda, Maryland, United States",https://ClinicalTrials.gov/show/NCT04401449
NCT04357769,COVID-19 Pandemic Burden in Severe Mental Disease Patients,Observational Model: Case-Control|Time Perspective: Cross-Sectional,152/20,"University of Naples ""Federico II"", Napoli, Italy",https://ClinicalTrials.gov/show/NCT04357769
NCT04452565,"NA-831, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",NATADEX,"Coronavirus Research Institute- Testing Site, Los Angeles, California, United States|Coronavirus Research Institute, Orange, California, United States|Coronavirus Research Institute-Testing Site, Palo Alto, California, United States|Coronavirus Research Institute-Testing Site, Sacramento, California, United States|Coronavirus Research Institute-Testing Site, San Diego, California, United States|Coronavirus Research Testing Site, San Francisco, California, United States|Coronavirus Research Institute-Testing Site, Sunnyvale, California, United States|Coronavirus Research Institute-Testing Site, Washington, District of Columbia, United States|Coronavirus Research Institute-Testing Site, Washington, District of Columbia, United States|Coronavirus Research Institute-Testing Site, Fort Lauderdale, Florida, United States|Coronavirus Research Institute-Testing Site, Tampa, Florida, United States|Coronavirus Research Institute- Testing Site, Chicago, Illinois, United States|Coronavirus Research Institute-Testing Site, Naperville, Illinois, United States|Coronavirus Research Institute-Testing Site, Baltimore, Maryland, United States|Coronavirus Research Institute-Testing Site, Bethesda, Maryland, United States|Coronavirus Research Institute-Testing Site, Boston, Massachusetts, United States|Coronavirus Research Institute-Testing Site, Worcester, Massachusetts, United States|Coronavirus Research Institute-Testing Site, Ann Arbor, Michigan, United States|Coronavirus Research Institute-Testing Site, Detroit, Michigan, United States|Coronavirus Research Institute-Testing Site, Newark, New Jersey, United States|Coronavirus Research Institute-Testing Site-, Bronx, New York, United States|Coronavirus Research Institute-Testing Site, New York, New York, United States|Coronavirus Research Institute- Testing Site, Rochester, New York, United States|Coronavirus Research Institute-Testing Site, Durham, North Carolina, United States|Coronavirus Research Institute-Testing Site, Philadelphia, Pennsylvania, United States|Coronavirus Research Institute- Testing Site, Fort Sam Houston, Texas, United States|Coronavirus Research Institute-Testing Site, Galveston, Texas, United States|Coronavirus Research Institute-Testing Site, Houston, Texas, United States|Coronavirus Research Institute-Testing Site, Kirkland, Washington, United States|Coronavirus Research Institute-Testing Site, Seattle, Washington, United States|Coronavirus Research Institute-Testing Site, Tacoma, Washington, United States",https://ClinicalTrials.gov/show/NCT04452565
NCT04371289,Predictors of Cardiovascular Risk in Covid-19 Patients During Acute Disease and at Short Term Follow-up,Observational Model: Cohort|Time Perspective: Prospective,CE_2020_03_26_02,"Istituto Auxologico Italiano, Milan, Italy",https://ClinicalTrials.gov/show/NCT04371289
NCT04761822,COVID19 SARS Vaccinations: Systemic Allergic Reactions to SARS-CoV-2 Vaccinations,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",DAIT COVID-19-004|NIAID CRMS ID#: 38814,"University of Arizona Health Sciences, College of Medicine Tucson, Department of Medicine, Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Tucson, Arizona, United States|Arkansas Children's, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States|University of California, Los Angeles Medical Center, Los Angeles, California, United States|Stanford Medicine, Sean N. Parker Center for Allergy & Asthma Research, Stanford, California, United States|National Jewish Health, Denver, Colorado, United States|University Health, University of Miami Health System, Miami, Florida, United States|University of South Florida Asthma Allergy and Immunology Clinical Research Unit, Tampa, Florida, United States|Emory University School of Medicine, Emory Healthcare: Emory Clinic Allergy and Immunology, Atlanta, Georgia, United States|Sinus and Allergy Center of Northwestern University, Chicago, Illinois, United States|NorthShore University HealthSystem, Dermatology Clinical Trials Unit, Skokie, Illinois, United States|University of Iowa Health Care, Iowa City, Iowa, United States|Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States|University of Michigan Health, Ann Arbor, Michigan, United States|Henry Ford Hospital and Health System, Detroit, Michigan, United States|Saint Louis University Care Center for Specialized Medicine, Saint Louis, Missouri, United States|Mount Sinai Hospital, Department of Medicine, Division of Clinical Immunology, New York, New York, United States|Columbia University Irving Medical Center, New York, New York, United States|Rochester Regional Health, Rochester, New York, United States|North Carolina Translational and Clinical Sciences Institute-Clinical & Translational Research Center (CTRC) at the University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States|Cleveland Clinic, Allergy & Clinical Immunology, Cleveland, Ohio, United States|Penn State Health Allergy, Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|University of Texas Southwestern Medical Center, Dallas, Texas, United States|Baylor College of Medicine Medical Center, Houston, Texas, United States|University of Virginia Health System: Department of Medicine, Division of Allergy and Immunology, Charlottesville, Virginia, United States|Virginia Commonwealth University, Department of Internal Medicine, Division of Rheumatology, Allergy & Immunology, Richmond, Virginia, United States|University of Wisconsin Asthma Allergy Pulmonary Research, Madison, Wisconsin, United States",https://ClinicalTrials.gov/show/NCT04761822
NCT04979884,Safety and Effectiveness of Cyclosporin in the Management of COVID19 ARDS Patients in Alexandria University Hospital,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,cyclosporine in COVID-19,NA,https://ClinicalTrials.gov/show/NCT04979884
NCT04941092,ARDS COVID vs ARDS Influenza,Observational Model: Case-Control|Time Perspective: Retrospective,2021PI076,"CHRU Nancy, Nancy, France",https://ClinicalTrials.gov/show/NCT04941092
NCT04435457,Cardiovascular Implications of COVID-19,Observational Model: Cohort|Time Perspective: Cross-Sectional,STU-2020-0359,"University of Texas Southwestern Medical Center, Dallas, Texas, United States",https://ClinicalTrials.gov/show/NCT04435457
NCT04370015,Hydroxychloroquine Chemoprophylaxis for COVID-19 Infection in High-risk Healthcare Workers.,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",16082019,NA,https://ClinicalTrials.gov/show/NCT04370015
NCT04463758,Covid-19 in Pregnancy: a French Population-based Cohort of Women and Newborns,Observational Model: Cohort|Time Perspective: Prospective,APHP200513,"AP-HP Cochin, Paris, France",https://ClinicalTrials.gov/show/NCT04463758
NCT04841785,Long Term Efficacy and Safety of COVID-19 (SARS-CoV-2) Vaccination in Kidney Disease Patients,Observational Model: Cohort|Time Perspective: Prospective,NL76839.042.21,"University Medical Center Groningen, Groningen, Netherlands",https://ClinicalTrials.gov/show/NCT04841785
NCT04916873,Rehabilitation Status of Children With Cerebral Palsy and Anxiety of Their Caregivers During the Covid19 Pandemic,Observational Model: Other|Time Perspective: Other,FSMEAH-KAEK 2020/56,"Pinar Akpinar, Istanbul, Atasehir, Turkey",https://ClinicalTrials.gov/show/NCT04916873
NCT04530604,Defibrotide Therapy for SARS-CoV2 (COVID-19) Acute Respiratory Distress Syndrome (ARDS),Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,HUM00182089,"University of Michigan, Ann Arbor, Michigan, United States",https://ClinicalTrials.gov/show/NCT04530604
NCT04346160,"A Study to Assess the Virus RNA, and miRNA Levels Related to Viral Infection, and Inflammatory Response in Tears of Patients Affected by COVID-19 Disease",Observational Model: Case-Control|Time Perspective: Prospective,UChieti03,"Ophtalmology Clinic, G.d'Annunzio University, Chieti, Italy",https://ClinicalTrials.gov/show/NCT04346160
NCT04912934,The Relationship Between COVID-19 Anxiety Level and Emotional Eating in Individuals With Metabolic Syndrome,Observational Model: Case-Control|Time Perspective: Cross-Sectional,KAEK-228,"Dilek alemdar, Ordu, Turkey",https://ClinicalTrials.gov/show/NCT04912934
NCT04896541,"Phase I Double-blind, Placebo-controlled Study of AZD7442","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention",D8850C00005,"Research Site, Fukuoka-shi, Japan",https://ClinicalTrials.gov/show/NCT04896541
NCT04735588,"Investigation on the Incidence and Course of COVID-19 in Patients With Prior, Ongoing or de Novo ITP. Evaluation of the Impact of COVID-19 Pandemic on the Management of ITP",Observational Model: Case-Only|Time Perspective: Prospective,ITP1021,NA,https://ClinicalTrials.gov/show/NCT04735588
NCT04397848,Mental Health Outcomes in Healthcare Workers During COVID-19,Observational Model: Cohort|Time Perspective: Prospective,3189,"University Health Network, Toronto, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04397848
NCT04400877,Prevalence and Severity of Venous Thromboembolism in a General Population During the COVID-19 Pandemic,Observational Model: Cohort|Time Perspective: Retrospective,SE2020-02701,"University Hospital Linköping, Linköping, Östergötland, Sweden",https://ClinicalTrials.gov/show/NCT04400877
NCT04327505,Safety and Efficacy of Hyperbaric Oxygen for ARDS in Patients With COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,COVID-19-HBO|2020-001349-37|K-1199/2020,"Krankenhaus St. Joesf, Regensburg, Germany|Blekingesjukhuset, Karlskrona, Blekinge, Sweden|Sahlgrenska University hospital, Östra sjukhuset, Gothenburg, Sweden|Karolinska University Hospital, Stockholm, Sweden",https://ClinicalTrials.gov/show/NCT04327505
NCT04368143,COVID-19 Immune Repertoire Sequencing,Observational Model: Cohort|Time Perspective: Prospective,IMSEQ,"Universitairy hospital of Antwerp, Antwerp, Belgium",https://ClinicalTrials.gov/show/NCT04368143
NCT04697654,"The Safety, Tolerability, and Pharmacokinetics of Inhaled TLC19 in Healthy Volunteers","Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",TLC19A1001,"Scientia Clinical Reserach, Ltd, Randwick, Australia|Mackay Memorial Hospital Tamsui Branch, Taipei, Taiwan",https://ClinicalTrials.gov/show/NCT04697654
NCT04665258,COVID-19 Vaccine and Impact on Fertility Study,Observational Model: Case-Only|Time Perspective: Prospective,20201451,"University of Miami, Miami, Florida, United States",https://ClinicalTrials.gov/show/NCT04665258
NCT04683484,A Clinical Trial to Assess the Safety and Immunogenicity of Nanocovax in Heathy Volunteers,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention",NNG26,"Military Medical Academy, Hanoi, Ha Dong, Vietnam",https://ClinicalTrials.gov/show/NCT04683484
NCT04967807,Myocardial Injury and Outcomes Following COVID-19 Vaccination (MYOVAX Study),Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,21-5621,NA,https://ClinicalTrials.gov/show/NCT04967807
NCT04940208,Chronic Pain in COVID-19 Patients Discharged From Intensive Care Unit,Observational Model: Cohort|Time Perspective: Cross-Sectional,2020-A02929-30,"Hôpital Raymond Poincare - AP-HP, Garches, Hauts-de-Seine, France|Hôpital Bicêtre AP-HP, Le Kremlin-Bicêtre, France|Hopital de la Croix Rousse - Hospices Civils de Lyon, Lyon, France",https://ClinicalTrials.gov/show/NCT04940208
NCT04397497,Mavrilimumab in Severe COVID-19 Pneumonia and Hyper-inflammation (COMBAT-19),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",COMBAT-19,"IRCCS Policlinico San Donato, San Donato, MI, Italy|IRCCS Ospedale San Raffaele, Milano, Italy|IRCCS Istituto Ortopedico Galeazzi, Milano, Italy",https://ClinicalTrials.gov/show/NCT04397497
NCT04472793,Repeated Employee Testing for Understanding Our Recovery to Normal,Observational Model: Case-Control|Time Perspective: Prospective,RETURN,"Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States",https://ClinicalTrials.gov/show/NCT04472793
NCT04515199,Home Management of Adult Egyptian Mild COVID-19 Cases,Observational Model: Cohort|Time Perspective: Prospective,Telemedicine in Mild COVID-19,"Faculty of Medicine Cairo University, Cairo, Egypt",https://ClinicalTrials.gov/show/NCT04515199
NCT04953052,A Randomized Study to Investigate the Effect of Intravenous Imatinib on the Amount of Oxygen in the Lungs and Blood of Adults With COVID-19 Needing Mechanical Ventilation and Supportive Care.,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",EX003|959310,"Sir Sayajirao General Hospital (SSG Hospital), Medical College Baroda, Jail Road Indira Avenue)Anandpura, Vadodara, Gujarat, India|St George's Hospital, P D Mello Road, Fort Road, CST Terminal,, Mumbai, Maharashtra, India",https://ClinicalTrials.gov/show/NCT04953052
NCT04524234,Cardiac Dysfunction in Critically Ill Patients With COVID-19,Observational Model: Cohort|Time Perspective: Prospective,CARDY CRIT COVID,"Södersjukhuset, Stockholm, Region Stockholm, Sweden|North Älvsborg County Hospital, Trollhättan, Västra Götalandsregionen, Sweden|Sahlgrenska University Hospital/Mölndal, Gothenburg, Västra Götaland, Sweden|Sahlgrenska University Hospital/Östra, Gothenburg, Västra Götaland, Sweden|Sahlgrenska University Hospital, Gothenburg, Västra Götaland, Sweden",https://ClinicalTrials.gov/show/NCT04524234
NCT04389580,Combination Therapy With Isotretinoin and Tamoxifen Expected to Provide Complete Protection Against Severe Acute Respiratory Syndrome Coronavirus,Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,COV-19 Treatment This is,NA,https://ClinicalTrials.gov/show/NCT04389580
NCT04491214,Post ICU Follow up in Patients With Severe SARS-CoV-2 Infection (Covid-19),Observational Model: Cohort|Time Perspective: Prospective,7890,"Hôpitaux Universitaires de Strasbourg (Nouvel Hôpital Civil), Strasbourg, France",https://ClinicalTrials.gov/show/NCT04491214
NCT04357106,COPLA Study: Treatment of Severe Forms of COronavirus Infection With Convalescent PLAsma,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,CHMI-030420-01,"Centro de Hematología y Medicina Interna, Puebla, Mexico",https://ClinicalTrials.gov/show/NCT04357106
NCT04311398,Development and Verification of a New Coronavirus Multiplex Nucleic Acid Detection System,Observational Model: Cohort|Time Perspective: Retrospective,KY2020-COVID-19,"Huashan Hospital of Fudan University, Shanghai, Shanghai, China",https://ClinicalTrials.gov/show/NCT04311398
NCT04295551,Multicenter Clinical Study on the Efficacy and Safety of Xiyanping Injection in the Treatment of New Coronavirus Infection Pneumonia (General and Severe),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,QF-XYP1990-1,NA,https://ClinicalTrials.gov/show/NCT04295551
NCT04384887,"""Investigation of the Relationship Between New Coronary Virus Disease (COVID-19) and Anxiety and Depressive Symptoms in Pregnant Women""",Observational Model: Case-Control|Time Perspective: Prospective,beckcovid,"Pinar Yalcin Bahat, Istanbul, İ̇stanbul, Turkey",https://ClinicalTrials.gov/show/NCT04384887
NCT04573062,Natural History of Post-Coronavirus Disease 19 Convalescence at the National Institutes of Health,Observational Model: Case-Only|Time Perspective: Prospective,10000089|000089-N,"National Institutes of Health Clinical Center, Bethesda, Maryland, United States",https://ClinicalTrials.gov/show/NCT04573062
NCT04877496,Responses to COVID19 Vaccination in Patients With a Treatment History of Rituximab.,Observational Model: Cohort|Time Perspective: Prospective,4749,"University Hospital Bern Inselspital, Bern, BE, Switzerland",https://ClinicalTrials.gov/show/NCT04877496
NCT04448418,The Impact of COVID-19 Outbreak on Trans-population's Health in Italy,Observational Model: Cohort|Time Perspective: Cross-Sectional,TRANSCOVID-19,"1Gynecology and Physiopathology of Human Reproduction, S. Orsola-Malpighi Hospital, Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy",https://ClinicalTrials.gov/show/NCT04448418
NCT04538456,Impact of COVID-19 on Lung Cancer Patients,Observational Model: Cohort|Time Perspective: Prospective,CFTSp189,"The Christie NHS Foundation, Manchester, United Kingdom",https://ClinicalTrials.gov/show/NCT04538456
NCT04360538,Long Term Outcomes of Patients With COVID-19,Observational Model: Cohort|Time Perspective: Prospective,20-0538,"University of Chicago Medical Center, Chicago, Illinois, United States",https://ClinicalTrials.gov/show/NCT04360538
NCT04395599,Risk of Air Contamination During Visceral Surgery in COVID19 Patients,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,2020_44|2020-A01461-38,NA,https://ClinicalTrials.gov/show/NCT04395599
NCT04270383,Clinical Characteristics and Long-term Prognosis of 2019-nCoV Infection in Children,Observational Model: Cohort|Time Perspective: Prospective,BCH Lung 012,"Beijing Children's Hospital,, Beijing, China",https://ClinicalTrials.gov/show/NCT04270383
NCT04816318,Policy Responses Against the COVID-19 Pandemic in Latin America,Observational Model: Ecologic or Community|Time Perspective: Prospective,ANID-COVID 0960,"Escuela de Salud Pública, Santiago, Región Metropolitana, Chile",https://ClinicalTrials.gov/show/NCT04816318
NCT04922918,Ligilactobacillus Salivarius MP101 for Elderly in a Nursing Home,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,CEIC 20/263-E_COVID,"Centro Para Mayores Santa Isabel, S.L., Moralzarzal, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04922918
NCT04376476,Host-pathogen Interactions During SARS-CoV-2 Infection,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,69HCL20_0342|2020-A01102-37,"Groupement Hospitalier Nord-Daupine, Bourgoin-Jallieu, France|Hôpital femme-mère-enfant, Bron, France|Hôpital Louis Pradel, Bron, France|Hôpital Louis Mourier, Colombes, France|Centre Hospitalo-Universitaire de Grenoble, La Tronche, France|Hopital de la Croix-Rousse, Lyon, France|Hôpital Edouard Herriot, Lyon, France|Hôpital mère - enfant Nantes, Nantes, France|Centre Hospitalier Lyon Sud, Pierre-Bénite, France|Hôpital Nord de Saint Etienne, Saint-Priest-en-Jarez, France|Hôpital Nord-Ouest, Villefranche-sur-Saône, France|Centre Hospitalier D'Annecy-Genevois, Épagny, France",https://ClinicalTrials.gov/show/NCT04376476
NCT04402229,Psychological Impact of the Covid-19 Pandemic on Student Nurses,Observational Model: Other|Time Perspective: Prospective,P17/04_StudentCov,"Versailles hospital, Le Chesnay, France|Toulouse University Hospital, Toulouse, France",https://ClinicalTrials.gov/show/NCT04402229
NCT04386551,Detection of COVID-19 in Saliva Collection,Observational Model: Case-Only|Time Perspective: Prospective,PI2020_843_0045,"CHU Amiens, Amiens, France",https://ClinicalTrials.gov/show/NCT04386551
NCT04340921,The Role of Adaptive Immunity in COVID-19 Associated Myocardial Injury,Observational Model: Cohort|Time Perspective: Prospective,282289,"Barts Health Nhs Trust, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04340921
NCT04494776,SARS-COV-2 Infection in Kidney Transplant Recipients: a Brazilian Multicenter Study,Observational Model: Cohort|Time Perspective: Retrospective,30631820.0.1001.8098,"Hospital do Rim, São Paulo, Aão Paulo, Brazil",https://ClinicalTrials.gov/show/NCT04494776
NCT04849624,Body Composition Study in Critically Ill Patients-Extended to COVID-19,Observational Model: Cohort|Time Perspective: Prospective,2019615-7520-3,"Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia",https://ClinicalTrials.gov/show/NCT04849624
NCT04828148,Incidence of Infection and Mortality by COVID-19 in Specialists,Observational Model: Cohort|Time Perspective: Cross-Sectional,Mortality Physicians,"Centro Médico Nacional de Occidente, Guadalajara, Jalisco, Mexico",https://ClinicalTrials.gov/show/NCT04828148
NCT04378452,Assessment of the Psycho-social Impact of COVID-19 Outbreak,Observational Model: Cohort|Time Perspective: Cross-Sectional,COM-COVID,"Fundació Institut Germans Trias i Pujol, Badalona, Catalonia, Spain|Fundació Lluita contra la Sida (FLS, Fight AIDS Foundation), Badalona, Catalonia, Spain|Anaxomics biotech, Barcelona, Spain|Fundació Privada per a la Recerca i la Docència Sant Joan de Déu, Esplugues De Llobregat, Spain",https://ClinicalTrials.gov/show/NCT04378452
NCT04789395,Evaluation of Post-covid 19 Patients Who Receive Ozonetheraphy With Thorax CT,Observational Model: Cohort|Time Perspective: Prospective,08.092.r1.125,"Gaziosmanpaşa TREH, Istanbul, Gaziosmanpaşa, Turkey",https://ClinicalTrials.gov/show/NCT04789395
NCT04794803,Reparixin in COVID-19 Pneumonia - Efficacy and Safety,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,REPAVID-19|2020-001645-40,"Instituto do Coração do Hospital das Clínicas da Faculdade de Medicina de São Paulo, São Paulo, Brazil|Ospedale San Paolo, Milan, Lombardy, Italy|Ospedale San Raffaele, Milan, Lombardy, Italy|Ospedale di Varese, Varese, Lombardy, Italy",https://ClinicalTrials.gov/show/NCT04794803
NCT04401111,One-year Outcomes in Survivors of the Severe COVID-19 Pneumonia (CO-Qo-ICU),Observational Model: Cohort|Time Perspective: Prospective,20reamedcovid04,"CHU de Nice, Nice, France",https://ClinicalTrials.gov/show/NCT04401111
NCT04411459,Risk Factors for Prolonged Invasive Mechanical Ventilation in COVID-19 Acute Respiratory Distress Syndrome,Observational Model: Cohort|Time Perspective: Prospective,273/2020/OSS/AUSLBO,"Ospedale Santa Maria Annunziata - Anestesia e Rianimazione, Bagno A Ripoli, FI, Italy|A.O. SS. Antonio, Biagio e Cesare Arrigo - Anestesia e Rianimazione, Alessandria, Italy|Anestesia e Rianimazione - Ospedale Civile di Baggiovara, Baggiovara, Italy|Anestesia e Rianimazione - Ospedale di Bentivoglio, Bentivoglio, Italy|Azienda Unità Sanitaria Locale, Bologna, Italy|Anestesia e Rianimazione - Ospedale Bellaria, Bologna, Italy|Anestesia e Rianimazione - Policlinico Universitario S.Orsola - Malpighi, Bologna, Italy|Anestesia e Terapia intensiva dei trapianti addominali e chirurgia epatobiliare - Policlinico Universitario S.Orsola - Malpighi, Bologna, Italy|Anestesia e Terapia Intensiva Polivalente - Policlinico Universitario S.Orsola - Malpighi, Bologna, Italy|Ospedale SS. Trinità - Anestesia e Rianimazione, Borgomanero, Italy|Anestesia e Rianimazione - Ospedale M. Bufalini, Cesena, Italy|Anestesia e Rianimazione - Ospedale degli Infermi, Faenza, Italy|Anestesia e Rianimazione Universitaria - Arcispedale Sant'Anna Ferrara, Ferrara, Italy|Anestesia e Rianimazione - Ospedale Morgagni - Pierantoni, Forlì, Italy|Anestesia e Rianimazione - Ospedale di Imola S.Maria della Scaletta, Imola, Italy|Ospedale Santo Stefano - Anestesia e Rianimazione, Prato, Italy|Anestesia e Rianimazione - Ospedale S. Maria delle Croci, Ravenna, Italy|Anestesia e Rianimazione - Arcispedale Santa Maria Nuova, Reggio Emilia, Italy|Anestesia e Rianimazione - Ospedale di Riccione, Riccione, Italy|Anestesia e Rianimazione - Ospedale Infermi, Rimini, Italy",https://ClinicalTrials.gov/show/NCT04411459
NCT04434144,A Comparative Study on Ivermectin and Hydroxychloroquine on the COVID19 Patients in Bangladesh,Observational Model: Case-Only|Time Perspective: Prospective,10000918,"Chakoria Upazilla Health Complex, Cox's Bazar, Bangladesh",https://ClinicalTrials.gov/show/NCT04434144
NCT04779944,Impact of SARS-CoV-2 Pandemic on Psychological State of Health Care Workers,Observational Model: Cohort|Time Perspective: Prospective,AssiutU1235,"heba Yassa, Assiut, Egypt",https://ClinicalTrials.gov/show/NCT04779944
NCT04393727,Transfusion of Convalescent Plasma for the Early Treatment of Patients With COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,TSUNAMI,"Azienda Ospedaliero Universitaria Pisana, Pisa, Italy",https://ClinicalTrials.gov/show/NCT04393727
NCT04336215,Rutgers COVID-19 Cohort Study,Observational Model: Cohort|Time Perspective: Prospective,2020000679,"Clinical Research Center Rutgers-Robert Wood Johnson Medical School RWJUH East Tower -, New Brunswick, New Jersey, United States|Robert Wood Johnson University Hospital, New Brunswick, New Jersey, United States|Clinical Research Unit Rutgers New Jersey Medical School, Newark, New Jersey, United States|Rutgers School of Dental Medicine, Newark, New Jersey, United States|University Hospital, Newark, New Jersey, United States|Environmental and Occupational Health Sciences Institute, Piscataway, New Jersey, United States|RUCDR Infinite Biologics, Piscataway, New Jersey, United States",https://ClinicalTrials.gov/show/NCT04336215
NCT04871945,Protective Antibody Level After COVID-19 Vaccination Among Patients Under Hemodialysis,Observational Model: Case-Control|Time Perspective: Prospective,2021-02-033,"Hanyang University Seoul Hospital, Seoul, Korea, Republic of",https://ClinicalTrials.gov/show/NCT04871945
NCT04713150,HEALthy Brain and Child Development Study - COVID-19 Supplement,Observational Model: Cohort|Time Perspective: Cross-Sectional,P00035929,"Massachusetts General Hospital, Boston, Massachusetts, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States|Laboratories of Cognitive Neuroscience, Boston Children's Hospital, Boston, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT04713150
NCT04826731,Effect of Respiratory Exerciser on Pulmonary Functions of COVID-19 Patients,Observational Model: Case-Control|Time Perspective: Prospective,104/18,"Dışkapı Yıldırım Beyazıt Training and Research Hospital Pulmonary Medicine Clinic, Ankara, Çankaya, Turkey",https://ClinicalTrials.gov/show/NCT04826731
NCT04764981,Olfactory Training for Olfactory Dysfunction After Coronavirus Disease - 19 (COVID-19),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment",OLFATO001,"Unidade de Ensino E Assistência Em Fisioterapia E Terapia Ocupacional, Belém, PA, Brazil",https://ClinicalTrials.gov/show/NCT04764981
NCT04916834,Impact of SARS-CoV-2/COVID-19 Related Pneumonia on Lung Function and Structure.,Observational Model: Case-Control|Time Perspective: Prospective,IGICHP/7.52,"National Institute for Tuberculosis and Lung Diseases, Warsaw, Mazowieckie, Poland",https://ClinicalTrials.gov/show/NCT04916834
NCT04425382,Darunavir/Cobicistat vs. Lopinavir/Ritonavir in COVID-19 Pneumonia in Qatar,Observational Model: Other|Time Perspective: Retrospective,MRC-05-069,"Hamad Medical Corporation, Doha, Qatar",https://ClinicalTrials.gov/show/NCT04425382
NCT04362267,Longitudinal Study of Covid-19 Infection Among HCW in a French University Hospital,Observational Model: Cohort|Time Perspective: Cross-Sectional,2020_34|2020-A00950-39,"Hôpital Claude Huriez, CHU, Lille, France",https://ClinicalTrials.gov/show/NCT04362267
NCT04378881,Simulation of Risk of Adverse Drug Events Associated With the Initiation of Drugs Repurposed for the Treatment of COVID-19 in Adults With Polypharmacy Using Data From Large Medicare and Commercially Insured Populations,Observational Model: Cohort|Time Perspective: Retrospective,COVID19-TRHC-2020-002,"Tabula Rasa HealthCare Precision Pharmacotherapy Research and Development Institute, Orlando, Florida, United States",https://ClinicalTrials.gov/show/NCT04378881
NCT04390516,Respiratory Decompensation and Model for the Triage of COVID-19 Patients,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,51420,"Dascena, Oakland, California, United States",https://ClinicalTrials.gov/show/NCT04390516
NCT04402879,CORONA (COvid pRONe hypoxemiA): Prone Positioning for Hypoxemic COVID-19 Patients With Do-not-intubate Goals,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,REB20-0518,"Peter Lougheed Centre (PLC), Calgary, Alberta, Canada|Foothills Hospital Intensive Care Unit, Calgary, Alberta, Canada|Rockyview General Hospital, Calgary, Alberta, Canada|South Health Campus, Calgary, Alberta, Canada",https://ClinicalTrials.gov/show/NCT04402879
NCT04769284,Psychological State of Students of Health Sciences During COVID-19,Observational Model: Other|Time Perspective: Prospective,Mental health student,"Faculty of Health Sciences. Zaragoza's University, Zaragoza, Spain",https://ClinicalTrials.gov/show/NCT04769284
NCT04445259,Study of the Treatment and Outcomes in Critically Ill Patients With COVID-19 and High Risk of Acute Kidney Injury,Observational Model: Cohort|Time Perspective: Retrospective,283672,"Guy's & St Thomas' Hospital, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04445259
NCT04598581,"Low Dose Radiation Therapy for Severe-Acute-Respiratory-Syndrome-Coronavirus-2 (SARS-CoV-2), COVID-19","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment",2020-02047qu20Papachristofilou,"Department of Radiooncology, University Hospital Basel, Basel, Switzerland",https://ClinicalTrials.gov/show/NCT04598581
NCT04320511,Beaumont Quantitative Lung Function Imaging to Characterize Patients With SARS-COV 2,Observational Model: Cohort|Time Perspective: Prospective,2020-087,"Beaumont Health, Royal Oak, Michigan, United States",https://ClinicalTrials.gov/show/NCT04320511
NCT04420364,Maintenance Versus Reduction of Immunosuppression for Renal Transplant Patients Hospitalized With COVID-19 Disease,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,2020P001516,NA,https://ClinicalTrials.gov/show/NCT04420364
NCT04382534,A Cross-sectional and Cohort Study of COVID-19 Patients With Post - Discharge Dysfunction,Observational Model: Cohort|Time Perspective: Prospective,M20200421,"Huarunwugang general hospital, Wuhan, Hubei, China",https://ClinicalTrials.gov/show/NCT04382534
NCT04649775,AirFLO2 Treatment for Hypoxia and/or Tachypnea in Patients With COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,Pro00105246,"Duke University Health System, Durham, North Carolina, United States",https://ClinicalTrials.gov/show/NCT04649775
NCT04346277,Compassionate Use Open-Label Anti-CD14 Treatment in Patients With SARS-CoV-2 (COVID-19),NA,COV02,"IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milano, Italy",https://ClinicalTrials.gov/show/NCT04346277
NCT04460469,Anxiety Level and Oral Hygiene Practice in Dental Students During Covid-19 Pandemic,Observational Model: Other|Time Perspective: Cross-Sectional,Mai Zakaria 4,"Faculty of Dentistry, Cairo University, Cairo, Egypt",https://ClinicalTrials.gov/show/NCT04460469
NCT04910971,Quantification of Binding and Neutralizing Antibody Levels in COVID-19 Vaccinated Health Care Workers Over 1 Year,Observational Model: Case-Crossover|Time Perspective: Prospective,1707882,"Sinai Hospital, Baltimore, Maryland, United States",https://ClinicalTrials.gov/show/NCT04910971
NCT04366856,PROne Positioning in coVID-19 Oxygeno-dependent Patients in Spontaneous Ventilation (PROVID Study),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,APHP200504,"Département d'Anesthésie Réanimation - Kremlin Bicêtre, Le Kremlin-Bicêtre, France",https://ClinicalTrials.gov/show/NCT04366856
NCT04359836,A Study to Explore the Role of Gut Flora in COVID-19 Infection,Observational Model: Other|Time Perspective: Other,PRG-041,"ProgenaBiome, Ventura, California, United States",https://ClinicalTrials.gov/show/NCT04359836
NCT04539834,Electrolyte State in Patients With COVID-19,Observational Model: Case-Only|Time Perspective: Retrospective,(ZU-IRB#: 6328-23-8-2020),"Zagazig University, Zagazig, Egypt",https://ClinicalTrials.gov/show/NCT04539834
NCT04452604,Multicentric Registry of Patients With Acute Leukemia Infected by COVID-19,Observational Model: Cohort|Time Perspective: Retrospective,COVLA,"Chu Amiens, Amiens, France|CHU ANGERS - Maladies du sang, Angers, France|Ch Avignon, Avignon, France|CH de la Côte Basque - Hématologie, Bayonne, France|CHU Caen - IHBN - Hématologie Clinique, Caen, France|Centre Hospitalier Sud Francilien, Corbeil-essonnes, France|Centre Hospitalier de Dunkerque, Dunkerque, France|CHU de Grenoble - Hopital Michallon, Grenoble, France|Centre Hospitalier du Mans, Le Mans, France|Hôpital Saint Vicent de Paul, Lille, France|Chu Limoges, Limoges, France|Institut Paoli-Calmettes - Hématologie 2, Marseille, France|HOPITAL SAINT ELOI - Hematologie, Montpellier, France|HOPITAL E. MULLER - Hématologie, Mulhouse, France|CHU HOTEL DIEU - Hématologie Clinique, Nantes, France|CHU Caremeau, Nîmes, France|CENTRE HOSPITALIER SAINTJEAN - Hématologie Clinique, Perpignan, France|Bordeaux Pessac, Pessac, France|Centre Hospitalier Lyon Sud, Pierre-Bénite, France|CHU Reims - Hôpital Robert Debré - Hématologie Clinique, Reims, France|CHU Pontchaillou - Hématologie, Rennes, France|Chu de La Reunion - Site Sud, Saint-pierre, France|Institut de Cancérologie Lucien Neuwirth, Saint-Priest-en-Jarez, France|Institut Universitaire du Cancer de Toulouse Oncopole - Service d'Hématologie, Toulouse, France|CHU de Brabois, Vandœuvre-lès-Nancy, France|Centre Hospitalier de Versailles, Versailles, France|Institut Gustave Roussy, Villejuif, France",https://ClinicalTrials.gov/show/NCT04452604
NCT04724616,CARTOON: CoronAviRus (COVID-19) educaTional prOgram fOr childreN,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,2128/2020,"Medical University of Vienna, Vienna, Austria",https://ClinicalTrials.gov/show/NCT04724616
NCT04498507,Psychosocial Outcomes in Families of COVID-19 ICU Patients,Observational Model: Cohort|Time Perspective: Prospective,Family COVID,"University Hospital of Liège, Liège, Belgium",https://ClinicalTrials.gov/show/NCT04498507
NCT04816630,Feasibility Study of Hematology Parameters in COVID-19 Disease,Observational Model: Cohort|Time Perspective: Prospective,C71934,"Washington University, Saint Louis, Missouri, United States",https://ClinicalTrials.gov/show/NCT04816630
NCT04844307,Comparing Inpatient COVID-19 Outcomes in 2 Different PT Dosing Groups,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2021-12937,NA,https://ClinicalTrials.gov/show/NCT04844307
NCT04779827,Improving Health Equity for COVID-19 Vaccination for At-risk Populations Using Online Social Networks,Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science,827141,"Annenberg School for Communication, Philadelphia, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04779827
NCT04446429,Anti-Androgen Treatment for COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",AB-DRUG-SARS-004,"Corpometria Institute, Brasilia, Brazil",https://ClinicalTrials.gov/show/NCT04446429
NCT04967768,The Influence and Effects of the COVID-19 Pandemic on Orthopaedic Resident Training,Observational Model: Other|Time Perspective: Cross-Sectional,Dec-99,"Diskapi Yildirim Beyazit Research and Training Hospital, Ankara, Turkey",https://ClinicalTrials.gov/show/NCT04967768
NCT04760561,Self-prone Positioning for Awake Non-intubated Patients With COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Supportive Care",proning for COVID-19 patients,NA,https://ClinicalTrials.gov/show/NCT04760561
NCT04334954,SARS-COV2 Pandemic Serosurvey and Blood Sampling,Observational Model: Case-Only|Time Perspective: Cross-Sectional,200083|20-I-0083,"University of Alabama, Birmingham, Alabama, United States|National Institutes of Health Clinical Center, Bethesda, Maryland, United States|University of Pittsburgh, Pittsburgh, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04334954
NCT04657406,Expanded Access to ZofinTM (OrganicellTM Flow) for Patients With COVID-19,NA,19881-EA,NA,https://ClinicalTrials.gov/show/NCT04657406
NCT04595175,Changes in Seroprevalence and Wellness Over Time in Healthcare Workers (CONSERVE-HCW),Observational Model: Cohort|Time Perspective: Prospective,20-510-157-66-21,"Chandler Regional Medical Center, Chandler, Arizona, United States",https://ClinicalTrials.gov/show/NCT04595175
NCT04344327,Early Risk Stratification of Patient Hospitalized for SARS-CoV2 Infection: Critical COVID-19 France CCF,Observational Model: Cohort|Time Perspective: Retrospective,20-Feb,"CHU d'Amiens, Amiens, France|CHU Annecy, Annecy, France|CHU de Bordeaux, Bordeaux, France|CHU de Caen, Caen, France|Cotentin hospital, Cherbourg, France|CHU Dijon, Dijon, France|Elbeuf Louviers Val de Reuil, Elbeuf, France|CHU de Fréjus / Saint-Raphael, Fréjus, France|Lille Catholic Institute Hospital Group, Lille, Lille, France|CHU de Lyon, Lyon, France|APHM, Marseille, France|Jacques Cartier Private Hospital, Massy, Massy, France|CHR d'Orléans, Orléans, France|Bichat (APHP), Paris, France|Georges Pompidou European Hospital (AP-HP), Paris, France|Institut Mutualiste Montsouris, Paris, Paris, France|CHU de Reims, Reims, France|CHU de Rouen, Rouen, France|CHU Saint Etienne, Saint-Étienne, France|CHU de Strasbourg, Strasbourg, France|CHU de Toulouse, Toulouse, France|Saint Gatien hospital, Tours, France|CHU de Nancy, Vandœuvre-lès-Nancy, France",https://ClinicalTrials.gov/show/NCT04344327
NCT04359290,Ruxolitinib for Treatment of Covid-19 Induced Lung Injury ARDS,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,KKS-278,"Andreas Neubauer, Marburg, Germany",https://ClinicalTrials.gov/show/NCT04359290
NCT04649918,Short and Medium-term Effects of Pulmonary Rehabilitation in Mild to Critical Post-acute COVID-19,Observational Model: Cohort|Time Perspective: Prospective,COVID-Rehab,"Schön Klinik Berchtesgadener Land, Schönau Am Königssee, Bavaria, Germany",https://ClinicalTrials.gov/show/NCT04649918
NCT04425317,Detection of SARS-CoV-2 in Follicular Fluid and Cumulus-oocyte-complexes in COVID-19 Patients,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,COVIDOFF001,"Uz Brussels, Brussels, Belgium",https://ClinicalTrials.gov/show/NCT04425317
NCT04459364,The Prevalence of Pulmonary Hypertension in Patients With COVID-19.,Observational Model: Cohort|Time Perspective: Other,20200422PA,"Karolinska University Hospital, Stockholm, Sweden",https://ClinicalTrials.gov/show/NCT04459364
NCT04568421,Argentinian Registry of Patients With Rheumatic Diseases and COVID-19 Infection,Observational Model: Cohort|Time Perspective: Prospective,1,"Sociedad Argentina de Reumatología, Ciudad Autónoma de Buenos Aires, Caba, Argentina",https://ClinicalTrials.gov/show/NCT04568421
NCT04611243,"Lung Function, Exercise Capacity, and Serology Responses in Patients With COVID-19",Observational Model: Cohort|Time Perspective: Prospective,2020.229,"Prince of Wales Hospital, Hong Kong, Hong Kong",https://ClinicalTrials.gov/show/NCT04611243
NCT04332991,Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among In-patients With Symptomatic Disease,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",PETAL 05 Orchid,"University of Arizona, Tucson, Arizona, United States|UCSF Fresno, Fresno, California, United States|Ronald Reagan UCLA Medical Center, Los Angeles, California, United States|UC Davis Medical Center, Sacramento, California, United States|UCSF Medical Center, San Francisco, California, United States|Stanford University, Stanford, California, United States|Medical Center of Aurora, Aurora, Colorado, United States|University of Colorado Hospital, Aurora, Colorado, United States|Denver Health Medical Center, Denver, Colorado, United States|St. Joseph Hospital, Denver, Colorado, United States|University of Florida, Gainesville, Florida, United States|University of Kentucky, Lexington, Kentucky, United States|University Medical Center, New Orleans, Louisiana, United States|Maine Medical Center, Portland, Maine, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States|Baystate Medical Center, Springfield, Massachusetts, United States|St. Vincent's Hospital, Worcester, Massachusetts, United States|University of Michigan Medical Center, Ann Arbor, Michigan, United States|Henry Ford Medical Center, Detroit, Michigan, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|Montefiore Medical Center-Weiler, Bronx, New York, United States|Montefiore Medical Center-Moses, Bronx, New York, United States|Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States|University of Cincinnati Medical Center, Cincinnati, Ohio, United States|Cleveland Clinic Foundation, Cleveland, Ohio, United States|Ohio State University Wexner Medical Center, Columbus, Ohio, United States|Oregon Health and Science University, Portland, Oregon, United States|Penn State Hershey Medical Center, Hershey, Pennsylvania, United States|Temple University Hospital, Philadelphia, Pennsylvania, United States|UPMC Presbyterian/Mercy/Shadyside, Pittsburgh, Pennsylvania, United States|Medical University of South Carolina, Charleston, South Carolina, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|University of Texas Health Science Center, Houston, Texas, United States|Intermountain Medical Center, Murray, Utah, United States|University of Utah Hospital, Salt Lake City, Utah, United States|VCU Medical Center, Richmond, Virginia, United States|Harborview Medical Center, Seattle, Washington, United States|Swedish Hospital First Hill, Seattle, Washington, United States",https://ClinicalTrials.gov/show/NCT04332991
NCT04645563,Using Whatsapp for the Consultation,Observational Model: Case-Control|Time Perspective: Retrospective,Clinical-3,"Ramazan Sabirli, Kars, Outside Of The US, Turkey",https://ClinicalTrials.gov/show/NCT04645563
NCT04818970,Photo-Protection Trial (NB-UVB vs. Placebo) in High-risk Hospitalized COVID-19 Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",TPL0001-02,"West Jefferson Medical Center and LSUHSC-NO, New Orleans, Louisiana, United States",https://ClinicalTrials.gov/show/NCT04818970
NCT04881266,"Long-Term Functional, Quality-of-Life, Neuropsychological and Cognitive Outcomes in COVID-19 Critical Illness Survivors",Observational Model: Cohort|Time Perspective: Prospective,2021-00209,"University Hospital Zurich, Zurich, Switzerland",https://ClinicalTrials.gov/show/NCT04881266
NCT04335630,Cardiovascular Manifestations of COVID-19,Observational Model: Case-Control|Time Perspective: Retrospective,HSC-MS-20-0286,"Memorial Hermann Hospital-Texas Medical Center, Houston, Texas, United States",https://ClinicalTrials.gov/show/NCT04335630
NCT04552379,The Containing Coronavirus Disease 19 (COVID-19) Trial,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,200703013,"Pontificia Universidad Católica de Chile, Santiago, Chile",https://ClinicalTrials.gov/show/NCT04552379
NCT04690114,COVID-10 in the Pediatric Population: SARS-CoV-2 Seropositivity,Observational Model: Ecologic or Community|Time Perspective: Prospective,0387-20-SZMC,"Shaare Zedek Medical Center, Jerusalem, Israel",https://ClinicalTrials.gov/show/NCT04690114
NCT04734561,Effects of Respiratory Muscle Training in People Who Have Had COVID-19 Disease,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment",20/715-E_BS,"UComplutenseMadrid, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04734561
NCT04826718,SARS-CoV-2/COVID-19 Infection Among Health Care Workers,Observational Model: Other|Time Perspective: Other,RIA2020ER-3049,"Universidade de Cabo Verde, Praia, Santiago, Cape Verde",https://ClinicalTrials.gov/show/NCT04826718
NCT04815304,Clinical Features of COVID-19 Patients,Observational Model: Cohort|Time Perspective: Retrospective,26100/21,"San Salvatore Academic Hospital, L'Aquila, Italy",https://ClinicalTrials.gov/show/NCT04815304
NCT04488510,Pathogens Involved in Secondary Infections During Severe Forms of Covid-19 Pneumonia:,Observational Model: Other|Time Perspective: Prospective,COVAP,"Groupe Hospitalier Paris Saint-Joseph, Paris, France",https://ClinicalTrials.gov/show/NCT04488510
NCT04374110,Drug Safety and the Occurrence of Complications During Hospitalization in Patients With COVID-19,Observational Model: Case-Control|Time Perspective: Prospective,1860/2020,"National Institute of Cardiology, Warsaw, Poland",https://ClinicalTrials.gov/show/NCT04374110
NCT04433364,COPE - COVID-19 in Pregnancy and Early Childhood,Observational Model: Cohort|Time Perspective: Prospective,2020-02848 0604,"Falu Hospital, Falun, Dalarna, Sweden|Halmstad lasarett, Halmstad, Halland, Sweden|Varbergs sjukhus, Varberg, Halland, Sweden|Helsingborgs lasarett, Helsingborg, Skåne, Sweden|Skåne Universitetssjukhus, Lund, Skåne, Sweden|Eskiltuna hospital, Eskilstuna, Södermanland, Sweden|Boras hospital, Boras, VGR, Sweden|Sahlgrenska Univeristy Hospital, Gothenburg, VGR, Sweden|Ryhovs sjukhus, Jönköping, Sweden|Kalmar Lasarett, Kalmar, Sweden|Karlstad lasarett, Karlstad, Sweden|Kristiandstad länssjukhus, Kristianstad, Sweden|Skaraborgs sjukhus Skövde, Skövde, Sweden|BB Stockholm, Stockholm, Sweden|Danderyd, Stockholm, Sweden|Karolinska University Hospital Solna, Stockholm, Sweden|Karolinska University Hospital- Huddinge, Stockholm, Sweden|Södersjukhuset, Stockholm, Sweden|Södertälje, Stockholm, Sweden|Sundsvall, Sundsvall, Sweden|Umeå University Hospital, Umeå, Sweden|Uppsala University Hospital, Uppsala, Sweden|Västerås, Västerås, Sweden|Ystad, Ystad, Sweden|Örebro University Hospital, Örebro, Sweden|Linköping University Hospital, Linköping, Östergötland, Sweden|Vrinnevisjukhuset, Norrköping, Östergötland, Sweden",https://ClinicalTrials.gov/show/NCT04433364
NCT04565509,Supporting the Health and Well-being of Children With Intellectual and Developmental Disability During COVID-19 Pandemic,Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,202009060|3P50HD103525-01S1,"Hugo W. Moser Research Institute at Kennedy Krieger, Inc., Baltimore, Maryland, United States|University of Missouri, Kansas City, Missouri, United States|Special School District, Saint Louis, Missouri, United States",https://ClinicalTrials.gov/show/NCT04565509
NCT04706299,"Effects of Surgical Mask Use on Peak Torque, Total Work and Interset Fatigability During Isokinetic Strength Testing",Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,20-1303,"Cleveland Clinic Sports Health, Garfield Heights, Ohio, United States",https://ClinicalTrials.gov/show/NCT04706299
NCT04836299,"Clinical Trial to ""Study the Efficacy and Therapeutic Safety of Ivermectin: (SAINTBO)","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment",RCT01,"Universidad Mayor de San Simón, Cochabamba, Bolivia",https://ClinicalTrials.gov/show/NCT04836299
NCT04706533,"Michigan Medicine COVID-19 Cohort: Clinical Characteristics, Inflammatory Markers and Outcomes of Patients Hospitalized for COVID-19",Observational Model: Cohort|Time Perspective: Prospective,HUM00178971,"University of Michigan, Ann Arbor, Michigan, United States",https://ClinicalTrials.gov/show/NCT04706533
NCT04466306,Pediatric Acute Kidney Injury in COVID-19,Observational Model: Cohort|Time Perspective: Prospective,ChildrensHA,"Children's Hospital of Alabama, Birmingham, Alabama, United States|Arkansas Children's Research Institute, Little Rock, Arkansas, United States|Cedars-Sinai Maxine Dunitz Children's Health Center, Los Angeles, California, United States|UCLA Mattel Children's Hospital, Los Angeles, California, United States|Lucile Packard Children's Hospital Standford, Palo Alto, California, United States|Rady Children's Hospital San Diego, San Diego, California, United States|Children's Hospital Colorado, Aurora, Colorado, United States|Yale New Haven Children's Hospital, New Haven, Connecticut, United States|UF Health Shands Children's Hospital, Gainesville, Florida, United States|Children's Healthcare of Atlanta, Atlanta, Georgia, United States|Comer Children's Hospital - UChicago Medicine, Chicago, Illinois, United States|Riley Hospital for Children, Indianapolis, Indiana, United States|University of Iowa Stead Family Children's Hospital, Iowa City, Iowa, United States|Children's Mercy, Kansas City, Kansas, United States|John Hopkins Children's Center, Baltimore, Maryland, United States|Boston Children's Hospital, Boston, Massachusetts, United States|C.S. Mott Children's Hospital, Ann Arbor, Michigan, United States|Helen DeVos Children's Hospital, Grand Rapids, Michigan, United States|Beaumont Children's Hospital, Royal Oak, Michigan, United States|St. Louis Children's Hospital of Washington University, Saint Louis, Missouri, United States|Oishei Children's Hospital of Buffalo, Buffalo, New York, United States|Golisano Children's Hospital - University of Rochester Medicine, Rochester, New York, United States|Stony Brook Children's Hospital, Stony Brook, New York, United States|Levine Children's Hospital, Charlotte, North Carolina, United States|Duke Children's Hospital and Health Center, Durham, North Carolina, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|Nationwide Children's Hospital, Columbus, Ohio, United States|Penn State Children's Hospital, Hershey, Pennsylvania, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States|UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States|Lifespan Hasbro Children's Hospital, Providence, Rhode Island, United States|Medical University of South Carolina Shawn Jenkins Children's Hospital, Charleston, South Carolina, United States|Seattle Children's Hospital, Seattle, Washington, United States|Stollery Children's Hospital, Edmonton, Alberta, Canada|McMaster Children's Hospital, Hamilton, Ontario, Canada|The Hospital for Sick Children (SickKids), Toronto, Ontario, Canada|Soroka University Medical Center, Be'er Sheva, Israel|Dana-Dwek Children's Hospital, Tel Aviv, Israel|Shizuoka Children's Hospital, Shizuoka, Japan|Institute for Mother and Child Healthcare, Belgrade, Serbia|University Children's Hospital, Belgrade, Serbia|Hospital 12 de Octubre, Madrid, Spain|Birmingham Children's Hospital NHS, Birmingham, United Kingdom|Alder Hey Children's Hospital NHS, Liverpool, United Kingdom|King's College Hospital NHS, London, United Kingdom|St. George's University Hospital NHS, London, United Kingdom|Great Ormond Street Hospital NHS, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04466306
NCT04381923,COVIDNOCHE Trial (HFNO Versus CPAP Helmet) in COVID-19 Pneumonia,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Supportive Care,843124,"University of Pennsylvania, Philadelphia, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04381923
NCT04720378,Safety and Tolerability Study of IV ST266 in COVID-19 Subjects,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,ST266-CRS-101,"Innovative Research of West Florida, Clearwater, Florida, United States|WR-ClinSearch, LLC, Chattanooga, Tennessee, United States",https://ClinicalTrials.gov/show/NCT04720378
NCT04751643,Therapeutic Plasma Exchange to Alleviate Hyperinflammatory Condition During Severe Covid-19 Infections,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,69HCL20_0518|2020-A03039-30,"Centre Hospitalier William Morey, Chalon-sur-Saône, France|Hôpital Edouard Herriot, Lyon, France|Hôpital Edouard Herriot, Lyon, France|Hôpital Croix Rousse, Lyon, France|Clinique de la Sauvegarde, Lyon, France|Groupement Hospitalier Porte de Valence - Montélimar, Montelimar, France|Hôpital Pitié Salpétrière - Assistante Publique des Hôpitaux de Paris, Paris, France|Centre Hospitalier Lyon Sud, Pierre-Bénite, France|Medipole Villeurbanne, Villeurbanne, France",https://ClinicalTrials.gov/show/NCT04751643
NCT04583345,Physical Activity Levels of Hypertensive and Healthy Individuals Under Social Isolation During the COVID-19 Pandemic,Observational Model: Case-Control|Time Perspective: Cross-Sectional,GO 20/610,"Hacettepe University, Ankara, Turkey",https://ClinicalTrials.gov/show/NCT04583345
NCT04396353,EXercise TRAining and Sedentary Lifestyle on Clinical Outcomes in Patients With COVID-19,Observational Model: Cohort|Time Perspective: Cross-Sectional,COVID-19,"Marcelo Rodrigues dos Santos, São Paulo, Sao Paulo, Brazil",https://ClinicalTrials.gov/show/NCT04396353
NCT04873388,Early Predictors of Prognostic Course in Patients With COVID-19 in Critical or Semi-intensive Area.,Observational Model: Cohort|Time Perspective: Retrospective,BIO-COVID-19,"AOU Città della Salute e della Scienza di Torino, Torino, Italy",https://ClinicalTrials.gov/show/NCT04873388
NCT04546737,"Study of Morphological, Spectral and Metabolic Manifestations of Neurological Complications in Covid-19 Patients",Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,PI2020_843_0087,"CHU Amiens, Amiens, France",https://ClinicalTrials.gov/show/NCT04546737
NCT04725110,Direct Topical Lung T3 Treatment to Improve Outcome & Sequelae of COVID-19 Acute Respiratory Distress Syndrome,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",ARDS,NA,https://ClinicalTrials.gov/show/NCT04725110
NCT04280913,Clinical Outcomes of Patients With COVID19,Observational Model: Cohort|Time Perspective: Retrospective,GZHZ-COVID19,"HuiZhou Municipal Central Hospital, Huizhou, Guangdong, China",https://ClinicalTrials.gov/show/NCT04280913
NCT04442087,Study of Seroprevalence of Anti-SARS-CoV2 Among Children of Hospital Workers in AP-HP,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science,APHP200627|2020-A01480-39,"Centre d'investigation clinique (CIC) Necker Cochin in Necker Children's Hospital, Paris, France",https://ClinicalTrials.gov/show/NCT04442087
NCT04810065,SingStrong: Strong Lungs Through Song - Long COVID-19 Study,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,SingStrong,"University of Limerick, Limerick, Ireland",https://ClinicalTrials.gov/show/NCT04810065
NCT04632381,Intravenous Zotatifin in Adults With Mild or Moderate COVID-19,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",eFT226-0003,"Synergy Healthcare, Bradenton, Florida, United States|Global Health Research Center, Miami Lakes, Florida, United States|Tampa General Hospital, Tampa, Florida, United States|National Institutes of Health Clinical Center, Bethesda, Maryland, United States",https://ClinicalTrials.gov/show/NCT04632381
NCT04352517,Influence Physical Activity Psychological Responses COVID-19 Pandemic,Observational Model: Ecologic or Community|Time Perspective: Cross-Sectional,3.954.038,"Universidade da Sao Paulo, Ribeirão Preto, Sao Paulo, Brazil|Universidad Autonoma de Chile, Santiago, Región Metropolitana, Chile|Universidad de la República, Rivera, Uruguay",https://ClinicalTrials.gov/show/NCT04352517
NCT04395911,Safety and Efficacy of SCD in AKI or ARDS Patients Associated With COVID-19 Infections,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,SCD-005,"University of Kentucky, Lexington, Kentucky, United States|University of Michigan, Ann Arbor, Michigan, United States|Henry Ford Health System, Detroit, Michigan, United States",https://ClinicalTrials.gov/show/NCT04395911
NCT04517136,Impact of Perceived Control on Operational Strain: a Study of COVID-19 Pandemic Caregivers and Military Personnel on Operational Missions,Observational Model: Cohort|Time Perspective: Prospective,2020-COVID19-28|2020-A01937-32,"Groupement Hospitalier Régional de Mulhouse Sud Alsace, Mulhouse, France",https://ClinicalTrials.gov/show/NCT04517136
NCT04412395,Clinical Assessment of Oral Lactoferrin as a Safe Antiviral and Immunoregulatory in Treating COVID-19 Disease,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",COVID-19_LF,"National Research Center, Egypt (Clinical and Molecular Pharmacology), Cairo, Giza, Egypt|Clinmax CRO (Clinical Research Organization), Cairo, Egypt|Clinical Trial Unit National Research Center, Cairo, Egypt|Egyptian Military Medical Services (Hospitals), Cairo, Egypt",https://ClinicalTrials.gov/show/NCT04412395
NCT04366089,Oxygen-Ozone as Adjuvant Treatment in Early Control of COVID-19 Progression and Modulation of the Gut Microbial Flora,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,110/2020,"Francesco Pugliese, Rome, RM, Italy",https://ClinicalTrials.gov/show/NCT04366089
NCT04896866,Efficacy and Safety of Antimicrobial Stewardship Intervention in Hospitalized COVID-19 Patients (COVASP),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,Pro00105598,"Misericordia Community Hospital, Edmonton, Alberta, Canada|Mazankowski Alberta Heart Institute, Edmonton, Alberta, Canada|University of Alberta Hospital, Edmonton, Alberta, Canada|Grey Nuns Community Hospital, Edmonton, Alberta, Canada",https://ClinicalTrials.gov/show/NCT04896866
NCT04345289,Efficacy and Safety of Novel Treatment Options for Adults With COVID-19 Pneumonia,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",25032020|2020-001367-88,"Aalborg University Hospital, Aalborg, Denmark|Aarhus University Hospital, Arhus, Denmark|Bispebjerg Hospital, Copenhagen, Denmark|Rigshospitalet, Copenhagen, Denmark|Herlev Gentofte Hospital, Herlev, Denmark|Herning Hospital, Herning, Denmark|Nordsjællands Hospital, Hillerød, Denmark|Hvidovre Hospital, Hvidovre, Denmark|Kolding Hospital, Kolding, Denmark|Odense University Hospital, Odense, Denmark|Roskilde Hospital, Roskilde, Denmark|Vejle Hospital, Vejle, Denmark",https://ClinicalTrials.gov/show/NCT04345289
NCT04582201,An Experiment to Evaluate the Safety of agenT-797 in COVID-19 Patients With Severe Difficulty Breathing.,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,C-1300-01,"Norton Cancer Institute, St. Matthews Campus, Louisville, Kentucky, United States|Weill Cornell Medicine New York Presbyterian, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04582201
NCT04367857,ARMOR Study: COVID-19 Seroprevalence Among Healthcare Workers,Observational Model: Cohort|Time Perspective: Prospective,AAAS9998,"NewYork-Presbyterian Hosptial/Columbia University Irving Medical Center, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04367857
NCT04726137,European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC) SARS-CoV-2 Antibody Study Protocol. Covid-19,Observational Model: Cohort|Time Perspective: Prospective,17493/002,NA,https://ClinicalTrials.gov/show/NCT04726137
NCT04340050,COVID-19 Convalescent Plasma,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,IRB20-0523,"University of Chicago Medicine, Chicago, Illinois, United States",https://ClinicalTrials.gov/show/NCT04340050
NCT04452695,Acceptability of Telehealth Triage Using Robotic Systems in COVID-19,Observational Model: Cohort|Time Perspective: Prospective,2020P000957,"Brigham and Women's Hospital, Boston, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT04452695
NCT04348864,COVID-19 Diagnostic Self-testing Using Virtual Point-of-care,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,2020/3/18,"Neuroganics, Northglenn, Colorado, United States",https://ClinicalTrials.gov/show/NCT04348864
NCT04430049,"Impact of Covid-19 Restrictive Measure on Anxiety, Depression and PTSD for Relatives of ICU Patients",Observational Model: Case-Control|Time Perspective: Prospective,2020 HAD-Covid,"University hospital, Clermont-Ferrand, Clermont-Ferrand, Auvergne, France|CH Aurillac, Aurillac, France|CH Cannes, Cannes, France|Centre Jean Perrin, Clermont-Ferrand, France|CH Grenoble, Grenoble, France|CH Le Puy-en-Velay, Le Puy-en-Velay, France|University hopistal, Lyon, Lyon, France|CH Moulins, Moulins, France|CH Périgueux, Périgueux, France|CH Rodez, Rodez, France|CH Vichy, Vichy, France",https://ClinicalTrials.gov/show/NCT04430049
NCT04298060,DAS181 for Patients With Severe Hospitalized Flu and SAD-RVs (COVID-19),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",DAS181-2-07,"Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China",https://ClinicalTrials.gov/show/NCT04298060
NCT04350281,Double Therapy With IFN-beta 1b and Hydroxychloroquine,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,UW 20-211,"The University of Hong Kong, Queen Mary Hospital, Hong Kong, Hong Kong",https://ClinicalTrials.gov/show/NCT04350281
NCT04507230,COVID-19 Associated Coagulopathy in Egypt,Observational Model: Cohort|Time Perspective: Cross-Sectional,17300413,"Assiut University Hospitals, Assiut, Egypt",https://ClinicalTrials.gov/show/NCT04507230
NCT04352699,Outcomes of Urological Surgery During Periods of Social COVID-19 Containemnt: is it Reasonable to Limit Access to Surgical Care for All?,Observational Model: Cohort|Time Perspective: Retrospective,20urocovid01,"CHU de Nice, Nice, France",https://ClinicalTrials.gov/show/NCT04352699
NCT04357275,The RIsk Stratification in COVID-19 Patients in the ICU Registry,Observational Model: Cohort|Time Perspective: Prospective,KEK-ZH-req-2020-00322,"University Hospital of Zurich, Zurich, Switzerland",https://ClinicalTrials.gov/show/NCT04357275
NCT04363827,Protect: Study With Hydroxychloroquine for Prevention and Early Phase Treatment of Coronavirus Disease (COVID-19),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,IRST100.47,"Irst Irccs, Meldola, FC, Italy",https://ClinicalTrials.gov/show/NCT04363827
NCT04772703,DNA Damage in Critically Ill COVID-19 Patients,Observational Model: Cohort|Time Perspective: Prospective,CVV_COVID-19_DNA,"University Hospital Hradec Kralove, Hradec Králové, Třebeš, Czechia",https://ClinicalTrials.gov/show/NCT04772703
NCT04747405,Evaluation of Psychological Impact of Group Therapy for Patients Who Have Been Hospitalized in Intensive Care During COVID-19 Pandemic: Exploratory Study,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,CHMS20009,NA,https://ClinicalTrials.gov/show/NCT04747405
NCT04661631,Surgery and Lung Ultrasound in COVID-19 Infection,Observational Model: Other|Time Perspective: Prospective,1601,"Fundación Valle del Lili, Cali, Valle Del Cauca, Colombia",https://ClinicalTrials.gov/show/NCT04661631
NCT04336787,"Physical Activity Level, Stress Level, Sleep Quality in Pregnant Women During Covid-19 Quarantine",Observational Model: Ecologic or Community|Time Perspective: Prospective,FADP-2,"Istanbul University - Cerrahpaşa, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04336787
NCT04394169,Early Care Program for the Management of Post-ICU Syndrome and Chronic Pain After COVID-19 Infection.,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Prevention,HCB/2020/0549,"Tomás Cuñat, Barcelona, Spain",https://ClinicalTrials.gov/show/NCT04394169
NCT04402957,LSALT Peptide vs. Placebo to Prevent ARDS and Acute Kidney Injury in Patients Infected With SARS-CoV-2 (COVID-19),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",AB002,"VA San Diego Healthcare System, San Diego, California, United States|Broward Health Medical Center, Fort Lauderdale, Florida, United States|LSU Health Shreveport, Shreveport, Louisiana, United States|University of Calgary - Foothills Medical Centre, Calgary, Alberta, Canada|University of Calgary - Peter Lougheed Centre, Calgary, Alberta, Canada|Ankara City Hospital, Ankara, Turkey|Istanbul University Cerrahpasa, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04402957
NCT04374370,SARSCoV2 (COVID-19) Convalescent Plasma (CP) Expanded Access Protocol (EAP),NA,1596191,"AdventHealth Orlando, Orlando, Florida, United States",https://ClinicalTrials.gov/show/NCT04374370
NCT04851821,The Effectiveness of Phytotherapy in SARS-COV2(COVID-19),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment",Quercetix,"Riadh Boukef, Sahloul, Sousse, Tunisia",https://ClinicalTrials.gov/show/NCT04851821
NCT04508933,"Comparison of Extra Vascular Lung Water Index in Covid-19 ARDS and ""Typical""ARDS Patients",Observational Model: Case-Control|Time Perspective: Prospective,308202247,"Istanbul University-Cerrahpaşa, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04508933
NCT04890600,COVID-19 and Psycological Well-being in Healthcare Workers,Observational Model: Ecologic or Community|Time Perspective: Other,RP 20/14,"IRCCS San Raffaele Roma, Rome, Italy",https://ClinicalTrials.gov/show/NCT04890600
NCT04359914,Neurocognitive Impairment in Patients With COVID-19,Observational Model: Case-Control|Time Perspective: Prospective,COVID-BRAIN,"Department of Anesthesiology and Intensive Care Medicine, University Medical Center Rostock, Rostock, Mecklenburg-Vorpommern, Germany",https://ClinicalTrials.gov/show/NCT04359914
NCT04453852,Monovalent Recombinant COVID19 Vaccine,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",13110,"PARC,, Adelaide, South Australia, Australia",https://ClinicalTrials.gov/show/NCT04453852
NCT04949230,A Retrospective Study of COVID-19 Treatments,Observational Model: Case-Only|Time Perspective: Retrospective,PRG-051,"Ginger Aurella, Ventura, California, United States",https://ClinicalTrials.gov/show/NCT04949230
NCT04699578,COVID-19 Infection and Fetal-neonatal Outcomes,Observational Model: Cohort|Time Perspective: Prospective,8453,"University of Campania Luigi Vanvitelli, Naples, Italy",https://ClinicalTrials.gov/show/NCT04699578
NCT04808921,Performance Evaluation of SARS-COV-2 (Covid-19) Antigen Rapid Test,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,SKYCOV001,"D&H National Research Centers INC, Miami, Florida, United States",https://ClinicalTrials.gov/show/NCT04808921
NCT04398277,A Daily Coping Toolkit for Medical Personnel and First-Responders During COVID-19 Pandemic,"Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Supportive Care",20-183,"Akron Children's Hospital, Akron, Ohio, United States|Summa Health Systems, Akron, Ohio, United States|Kent State University, Kent, Ohio, United States",https://ClinicalTrials.gov/show/NCT04398277
NCT04456426,"Characteristics of Patients and Healthcare Workers With COVID-19 in Meta State, Colombia",Observational Model: Ecologic or Community|Time Perspective: Retrospective,GRIVI_2020_01COVID,NA,https://ClinicalTrials.gov/show/NCT04456426
NCT04893694,the Prevalence of Oral Manifestation in Patients With SARS-CoV2 Infection,Observational Model: Other|Time Perspective: Cross-Sectional,Oral SARS 2,"Faculty of Dentistry, Fayoum, Egypt",https://ClinicalTrials.gov/show/NCT04893694
NCT04283825,Humanistic Care in Patients With Coronavirus Disease 2019,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,XJTU2H-WH1,NA,https://ClinicalTrials.gov/show/NCT04283825
NCT04349618,Ultraprotective Ventilation Without Extracorporeal Circulation During COVID 19 Pneumonia,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,69HCL20_0322,"Service de Médecine Intensive Réanimation CHU Gabriel Montpied, Clermont-Ferrand, France|Service de Médecine Intensive Réanimation Hôpital Michallon - CHU Grenoble Alpes, La Tronche, France|Service de Médecine Intensive Réanimation Hôpital Edouard Herriot Hospices Civils de Lyon, Lyon, France|Service de Réanimation Chirurgicale Hôpital Edouard Herriot Hospices Civils de Lyon, Lyon, France|Service de Médecine Intensive Réanimation Hôpital de la Croix Rousse Hospices Civils de Lyon, Lyon, France|Service de Réanimation Chirurgicale Hôpital de la Croix Rousse Hospices Civils de Lyon, Lyon, France|Service de réanimation Polyvalente Centre Hospitalier Saint Joseph-Saint Luc, Lyon, France|Service de Réanimation Clinique de la Sauvegarde, Lyon, France|Service de Réanimation Polyvalente Centre Hospitalier Lyon Sud Hospices Civils de Lyon, Pierre-Bénite, France|Service de Réanimation Centre hospitalier Annecy Genevois, Pringy, France|Service de Médecine Intensive Réanimation Hôpital Nord - CHU Saint-Etienne, Saint-Priest-en-Jarez, France",https://ClinicalTrials.gov/show/NCT04349618
NCT04565197,Convalescent Plasma Therapy for COVID-19 Patients,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,LGH008,"Muhammad Irfan Malik, Lahore, Punjab, Pakistan",https://ClinicalTrials.gov/show/NCT04565197
NCT04443673,Glycine Supplement for Severe COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,C40-20,"Instituto Nacional de Enfermedades Respiratorias, Mexico DF, Mexico",https://ClinicalTrials.gov/show/NCT04443673
NCT04384380,Efficacy and Tolerability of Hydroxychloroquine in Adult Patients With COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,TYGH109014,"Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan City, Taiwan",https://ClinicalTrials.gov/show/NCT04384380
NCT04344379,Prevention of SARS-CoV-2 in Hospital Workers s Exposed to the Virus,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention",APHP200386|2020-001273-73,"Hopial Avicenne, Bobigny, France|Hôpital GHU Paris Saclay, Le Kremlin-Bicêtre, France|Hôpital Saint Antoine, Paris, France|Hôpital Broca, Paris, France|Hôpital La Pitié-Salpétrière, Paris, France|Hôpital Cochin, Paris, France|Hôpital européen Georges Pompidou, Paris, France|Hôpital Necker, Paris, France",https://ClinicalTrials.gov/show/NCT04344379
NCT04385121,Psychological Impact of the Hospitalization of a Family Member in Intensive Care for Covid-19 Infection,Observational Model: Cohort|Time Perspective: Prospective,7761,"Les Hôpitaux Universitaires de Strasbourg, Strasbourg, France",https://ClinicalTrials.gov/show/NCT04385121
NCT04969263,COVID-19 Protection After Transplant Pilot Study,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,DAIT COVID19-TB-02|NIAID CRMS ID#: 38865,"Johns Hopkins Hospital, Baltimore, Maryland, United States",https://ClinicalTrials.gov/show/NCT04969263
NCT04649021,Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (BNT162b2) in Chinese Healthy Population,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",BNT162-06,"Jiangsu Provincial Center for Disease Control and Prevention, Jiangsu, China",https://ClinicalTrials.gov/show/NCT04649021
NCT04325048,Clinical Evaluation of Cordio Application in Adult COVID-19 Virus Positive Patients,Observational Model: Cohort|Time Perspective: Prospective,COV001,"Rambam Medical Center, Haifa, Israel",https://ClinicalTrials.gov/show/NCT04325048
NCT04517162,Intramuscular Effect of Polymerized Type I Collagen on the Cytokine Storm in COVID-19 Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",IRE-3412-20-21-1,"Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico, Cdmx, Mexico",https://ClinicalTrials.gov/show/NCT04517162
NCT04324606,A Study of a Candidate COVID-19 Vaccine (COV001),Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,COV001,"University Hospital Southampton NHS Foundation Trust, Southampton, Hampshire, United Kingdom|University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, United Kingdom|St Georges University Hospital NHS Foundation Trust, London, United Kingdom|Imperial College Healthcare NHS Trust, London, United Kingdom|CCVTM, University of Oxford, Churchill Hospital, Oxford, United Kingdom|John Radcliffe Hospital, Oxford, United Kingdom",https://ClinicalTrials.gov/show/NCT04324606
NCT04324528,Cytokine Adsorption in Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation,Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,CYCOV,"University Clinic Freiburg, Freiburg, Germany",https://ClinicalTrials.gov/show/NCT04324528
NCT04860206,Post COVID19 Functional and Cognitive Assessments,Observational Model: Cohort|Time Perspective: Prospective,PC-ZRS-SBI,"SB Izola, Izola, Slovenia",https://ClinicalTrials.gov/show/NCT04860206
NCT04388631,Detection Rate of SARS-CoV-2 in Male Genitourinary System and Its Impact on Male Reproductive Health.,Observational Model: Cohort|Time Perspective: Prospective,2020-S073,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China",https://ClinicalTrials.gov/show/NCT04388631
NCT04412460,Echocardiography in Patients With Covid-19,Observational Model: Cohort|Time Perspective: Prospective,CovidEcho,"University Hospital Tubingen, Tubingen, BW, Germany",https://ClinicalTrials.gov/show/NCT04412460
NCT04332380,Convalescent Plasma for Patients With COVID-19: A Pilot Study,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,ABN011-1,"Universidad del Rosario, Bogota, Cundinamarca, Colombia",https://ClinicalTrials.gov/show/NCT04332380
NCT04969614,Safety and Immunogenicity of 2-dose Inactivated COVID-19 Vaccine in Kidney Transplant Recipients,Observational Model: Cohort|Time Perspective: Prospective,WestChina-COVID,NA,https://ClinicalTrials.gov/show/NCT04969614
NCT04397692,Inhaled NO for the Treatment of COVID-19 Caused by SARS-CoV-2 (US Trial),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Device Feasibility,BAI_COV19_01_US,"Baptist Health Center for Clinical Research, Little Rock, Arkansas, United States",https://ClinicalTrials.gov/show/NCT04397692
NCT04597242,Expanded Access Study of Exebacase in COVID-19 Patients With Persistent MRSA Bacteremia,NA,CF-301-107,"CF-301-107 Study Site, Butte, Montana, United States",https://ClinicalTrials.gov/show/NCT04597242
NCT04709003,Covid-19 Vaccine Effectiveness in Healthcare Personnel in Clalit Health Services in Israel (CoVEHPI),Observational Model: Cohort|Time Perspective: Prospective,1051-20-RMC-C,"Haemek Medical Center, Afula, Israel|Soroka Medical Center, Be'er Sheva, Israel|Meir Medical Center, Kefar Saba, Israel|Beilinson hospital, Petach Tikva, Israel|Schneider Children's Medical Center of Israel, Petah tikva, Israel|Kaplan Medical Center, Reẖovot, Israel",https://ClinicalTrials.gov/show/NCT04709003
NCT04344912,Impact of COVID19 Outbreak in Cardiac Acute Care,Observational Model: Cohort|Time Perspective: Other,APHP200524|0522070420,"Unité de Soins Intensifs de Cardiologie, Pitié Salpêtrière Hospital, AP-HP, Paris, France",https://ClinicalTrials.gov/show/NCT04344912
NCT04958304,Moderna COVID-19 Vaccine mRNA-1273 Observational Pregnancy Outcome Study,Observational Model: Cohort|Time Perspective: Prospective,mRNA-1273-P902,"IQVIA Call Center for United States and Canada, Durham, North Carolina, United States",https://ClinicalTrials.gov/show/NCT04958304
NCT04498065,MYocardial DOmmages Related to COVID-19,Observational Model: Cohort|Time Perspective: Prospective,COTTIN AOIc 2020,"Chu Dijon Bourgogne, Dijon, France",https://ClinicalTrials.gov/show/NCT04498065
NCT04378686,Serological Testing for COVID-19 (SARS-CoV-2) in ESKD,Observational Model: Cohort|Time Perspective: Prospective,S64000,"Jessa Ziekenhuis, Hasselt, Limburg, Belgium|University Hospitals Leuven, Leuven, Belgium",https://ClinicalTrials.gov/show/NCT04378686
NCT04775017,Delirium in Covid-19: Germany-wide Covid-19 Intensive Register,Observational Model: Cohort|Time Perspective: Retrospective,COVID-19-Delirium,"Department of Anesthesiology and Operative Intensive Care Medicine Campus Virchow-Klinikum, Berlin, Germany",https://ClinicalTrials.gov/show/NCT04775017
NCT04366908,Prevention and Treatment With Calcifediol of COVID-19 Induced Acute Respiratory Syndrome,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,COVIDIOL,"Hospital Universitario Reina Sofía, Cordoba, Spain",https://ClinicalTrials.gov/show/NCT04366908
NCT04629703,"Double-Blind, Randomized, Placebo-Controlled, Adaptive Design, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 Subjects","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",C-935788-061,"University of California Irvine, Orange, California, United States|Loyola University Medical School, Maywood, Illinois, United States|Harvard Medical School- Bringham and Women's Hospital, Boston, Massachusetts, United States|Ascension Medical Group- St. John Clinic Infectious Disease, Tulsa, Oklahoma, United States|Providence Portland Medical Center, Portland, Oregon, United States|Houston Methodist Research Institute, Houston, Texas, United States|Hospital de Alta Complejidad Cuenta Alta, Buenos Aires, Argentina|Hospital Del Bicentenario - Dr. Luis Federico Leloir, Buenos Aires, Argentina|Clinica Zabala, Buenos Aires, Argentina|Clinica Adventista Belgrano, Buenos Aires, Argentina|Clinica Monte Grande, Buenos Aires, Argentina|Hospital de Infecciosas "" Dr.Francisco Javier Muñiz"", Buenos Aires, Argentina|Sanatorio Guemes, Buenos Aires, Argentina|Sanatorio Sagrado Corazon, Buenos Aires, Argentina|Hospital San Roque, Córdoba, Argentina|Sanatorio Mayo Privado, Córdoba, Argentina|Hospital das Clínicas da Universidade Federal de Goiás (HC/UFG), Goiânia, Goiás, Brazil|Hospital Luxenburgo-Associação Mário Penna, Belo Horizonte, Minas Gerais, Brazil|Hospital Universitario de Maringa, Maringá, Parana, Brazil|Irmandade da Santa Casa de Misericórdia de Porto Alegre - ISCMPA, Porto Alegre, Rio Grande Do Sul, Brazil|Complexo de Prevenção, Diagnóstico, Terapia e Reabilitação Respiratória LTDA, Blumenau, Santa Catarina, Brazil|Hospital Alemão Oswaldo Cruz (HAOC), Bela Vista, Sao Paolo, Brazil|Pontificia Universidade Catolica de Campinas (PUC-CAMP) - Hospital e Maternidade Celso Pierro (HMCP), Campinas, Sao Paolo, Brazil|Hospital Bandeirantes (LeForte), Liberdade, Sao Paolo, Brazil|Clinica de Alergia Martti Antila S/S Ltda, Sorocaba, Sao Paulo, Brazil|Fundação Faculdade Reg. de Med de SJRP, São José Do Rio Preto, Sao Paulo, Brazil|Unidad Medica para la Salud Integral (UMSI), Monterrey, Nuevo Leon, Mexico|Hospital Cardiologica Aguascalientes, Aguascalientes, Mexico|Nuevo Hospital Civil de Guadalajara, Guadalajara, Mexico|Centro Medico Issemym Toluca, Metepec, Mexico|The American British Cowdray Medical Center I.A.P., Mexico City, Mexico|Hospital Ángeles Roma, Mexico, Mexico|CEPREP Centro de Prevención y Rehabilitación de Enfermedades Pulmonares Crónicas, Nuevo León, Mexico|Hospital Civil de Culiacan, Sinaloa, Mexico|Hospital Civil de Culiacan, Sinaloa, Mexico|EsSalud - Hospital Nacional Alberto Sabogal Sologuren, Lima, Peru|Hospital de Chancay, Lima, Peru|Hospital Maria Auxiliadora, Lima, Peru|Hospital Nacional Arzobispo Loayza, Lima, Peru|Hospital Nacional Cayetano Heredia, Lima, Peru|Hospital Nacional Hipolito Unanue, Lima, Peru",https://ClinicalTrials.gov/show/NCT04629703
NCT04523571,Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (BNT162b1) in Chinese Healthy Subjects,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",BNT162-03,"Jiangsu Provincial Center for Disease Control and Prevention, Jiangsu, China",https://ClinicalTrials.gov/show/NCT04523571
NCT04381377,Efficacy and Safety of Polyoxidonium® in Hospitalized Patients With Coronavirus Disease COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",PО-COV-III-20,"Regional state budgetary institution of public health ""City hospital No. 5 of Barnaul"", Barnaul, Russian Federation|Central Research Institute of Epidemiology of Rospotrebnadzor, Moscow, Russian Federation|The state healthcare institution of the city of Moscow ""City Clinical Hospital No. 15 named after OM Filatov"" in ""Moscow City Department of Health"", Moscow, Russian Federation|Moscow State Budgetary Healthcare Institution ""Infectious Clinical Hospital No. 1 of the Moscow Department of Healthcare"", Moscow, Russian Federation|Moscow State Budgetary Healthcare Institution ""City Clinical Hospital No. 24 of the Moscow Department of Healthcare"", Moscow, Russian Federation|State budgetary institution ""Research Institute of Emergency Care named after N.V. Sklifosovsky in Department of Health of the city of Moscow"", Moscow, Russian Federation|Moscow State Budgetary Healthcare Institution ""City Clinical Hospital No. 40 of the Moscow Department of Healthcare"", Moscow, Russian Federation|State budgetary institution of health care of the Nizhny Novgorod region ""Infectious clinical hospital No. 2 of Nizhny Novgorod"", Nizhny Novgorod, Russian Federation|Federal State Budgetary Educational Institution of Higher Education ""Orenburg State Medical University"" of the Ministry of Health of the Russian Federation, Orenburg, Russian Federation|Federal State Budgetary Educational Institution of Higher Education ""First St. Petersburg State Medical University named after Academician I.P. Pavlov, Saint Petersburg, Russian Federation|State budgetary health institution of the Vladimir region ""Regional Clinical Hospital"", Vladimir, Russian Federation|Yaroslavl State Medical University of Ministry of Health of the Russian Federation, Yaroslavl, Russian Federation|Clinics of Infectious Diseases, University Hospital in Nitra, Nitra, Slovakia|Clinics of Infectious Diseases, University Hospital in Trnava, Trnava, Slovakia",https://ClinicalTrials.gov/show/NCT04381377
NCT04443257,REassessement After Hospitalization for Sars-COV-2 disordER,Observational Model: Cohort|Time Perspective: Prospective,RECHMPL20_0340,"University hospital of Montpellier, Montpellier, France",https://ClinicalTrials.gov/show/NCT04443257
NCT04979065,"Nutrition, Immunity, and Covid-19 in Obese People","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",NICO,"Human Nutrition Research Center, Indonesian Medical Education Research Institute (HNRC-IMERI) Faculty of Medicine, Universitas Indonesia, Jakarta Pusat, DKI Jakarta, Indonesia",https://ClinicalTrials.gov/show/NCT04979065
NCT04698044,Anxiety and Depression Perceived by Individuals With and Without Cancer During the COVID-19 Pandemic Period,Observational Model: Cohort|Time Perspective: Cross-Sectional,COVFAIROFALL,"Sultan Abdülhamid Han Training and Research Hospital, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04698044
NCT04426305,Community Health Workers Against COVID19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Care Provider)|Primary Purpose: Supportive Care,BC-07744.,"Department of Public Health and Primary Care, Ghent, Belgium",https://ClinicalTrials.gov/show/NCT04426305
NCT04362956,Clinical and Immunologic Impact of Perinatal SARS-CoV-2 (COVID-19) Infection,Observational Model: Case-Control|Time Perspective: Prospective,Perinatal COVID-19,"Hospital Italiano, Buenos Aires, Argentina",https://ClinicalTrials.gov/show/NCT04362956
NCT04522128,Does Quality of Life Decline During the COVID-19 Pandemic and Can we Change Behaviour to Improve Poor Quality of Life?,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Other",2020-9463-15184,"University of Manchester - online, Manchester, Cheshire, United Kingdom",https://ClinicalTrials.gov/show/NCT04522128
NCT04913948,"Assessing the Mother-to-infant Transmission Capabilities of COVID-19 Infection Among Pregnant Women in Ontario, Canada",Observational Model: Cohort|Time Perspective: Prospective,CTO 2168,"Hamilton Health Sciences Corporation, Hamilton, Ontario, Canada|Kingston Health Sciences Centre, Kingston, Ontario, Canada|Grand River Hospital, Kitchener, Ontario, Canada|London Health Sciences, London, Ontario, Canada|North York General Hospital, North York, Ontario, Canada|Humber River Hospital, North York, Ontario, Canada|The Ottawa Hospital - General Campus, Ottawa, Ontario, Canada|Hôpital Montfort, Ottawa, Ontario, Canada|The Ottawa Hospital - Civic Campus, Ottawa, Ontario, Canada|Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada|St. Michael's Hospital, Toronto, Ontario, Canada|Mount Sinai Hospital, Toronto, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04913948
NCT04384029,The Geneva Covid-19 CVD Study,Observational Model: Cohort|Time Perspective: Other,CCER-2020-00610,"Geneva University Hospital (HUG), Geneva, Switzerland",https://ClinicalTrials.gov/show/NCT04384029
NCT04368897,In-vitro Diagnostic Test to Predict COVID-19 Mortality and Disease Severity,Observational Model: Case-Control|Time Perspective: Prospective,AB-IVD-CoV-001,"Hospital Universitario Ramon y Cajal, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04368897
NCT04508075,"Efficacy, Safety and Immunogenicity Study of SARS-CoV-2 Inactivated Vaccine","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention",CoV2-0320,"Hasan Sadikin Hospital/School of Medicine, Padjadjaran University, Bandung, West Java, Indonesia",https://ClinicalTrials.gov/show/NCT04508075
NCT04944329,Hip Fracture and COVID-19,Observational Model: Cohort|Time Perspective: Retrospective,LOCAL/2021/PC-02,"CHU de NIMES, Nimes, France",https://ClinicalTrials.gov/show/NCT04944329
NCT04425213,Obesity and Mortality of Critically Ill Patients With COVID-19,Observational Model: Cohort|Time Perspective: Prospective,2020PI082,"Centre hospitalo-universitaire régional de Nancy, Vandœuvre-lès-Nancy, France",https://ClinicalTrials.gov/show/NCT04425213
NCT04805216,Covid-19 Vaccine Response in Immunocompromised Haematology Patients,Observational Model: Other|Time Perspective: Prospective,3025,"University Hospitals of North Midlands NHS Trust, Stoke-on-Trent, United Kingdom",https://ClinicalTrials.gov/show/NCT04805216
NCT04339634,Simulation of Risk of Adverse Drug Events Associated With the Initiation of Drugs Repurposed for the Treatment of COVID-19 in Frail Elderly Adults With Polypharmacy,Observational Model: Cohort|Time Perspective: Retrospective,COVID-PACE-2020-001,"Tabula Rasa HealthCare Precision Pharmacotherapy Research and Development Institute, Orlando, Florida, United States",https://ClinicalTrials.gov/show/NCT04339634
NCT04397237,Prevalence and Seroconversion of COVID-19 in Autoimmune Diseases in Europe,Observational Model: Cohort|Time Perspective: Cross-Sectional,2020-A01371-38,"Saadoun, Paris, Ile De France, France",https://ClinicalTrials.gov/show/NCT04397237
NCT04355962,Sevoflurane in COVID-19 ARDS (SevCov),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment",2020-00719,"Kantonsspital Münsterlingen, Münsterlingen, Switzerland|Cantonal Hospital of St. Gallen, Sankt Gallen, Switzerland|Stadtspital Triemli, Zurich, Switzerland|University Hospital Zuirch, Zurich, Switzerland",https://ClinicalTrials.gov/show/NCT04355962
NCT04409873,Antiseptic Mouthwash / Pre-Procedural Rinse on SARS-CoV-2 Load (COVID-19),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Supportive Care",20-30874|R00RG2901,"University Of California, San Francisco, San Francisco, California, United States",https://ClinicalTrials.gov/show/NCT04409873
NCT04455451,Intensive Care Therapy of Covid-19 Disease in Germany,Observational Model: Cohort|Time Perspective: Other,DCIR,"RWTH Aachen - Department for operative Intensive Care Medicine and intermediate Care, Aachen, Germany|Zollernalbklinikum, Balingen, Germany|Charité Universitätsmedizin Berlin, Berlin, Germany|UH Bochum - Department for Anesthesiology and Intensive Care Medicine, Bochum, Germany|Universitätsklinikum Bonn, Bonn, Germany|Universitätsklinikum Carl Gustav Carus Dresden, Dresden, Germany|Ev. Krankenhaus Bethesda Duisburg Klinik für Anästhesiologie und Intensivmedizin, Duisburg, Germany|Univerrsitätsklinikum Düsseldorf, Düsseldorf, Germany|Universitätsklinikum Essen, Essen, Germany|Universitätsklinikum Frankfurt, Frankfurt, Germany|University Hospital Freiburg - Department for Anesthesiology and Intensive Care Medicine, Freiburg, Germany|Universitätsklinikum Giessen Klinik für Anaesthesiologie und operative Intensivmedizin, Gießen, Germany|Universitätsklinikum Greifswald, Greifswald, Germany|Universitätsmedizin Göttingen Klinik für Anästhesiologie, Göttingen, Germany|Universitätsklinikum Halle, Halle/Saale, Germany|University Hospital Heidelberg - Department for Anesthesiologie and Intensive Care Medicine, Heidelberg, Germany|Universitätsklinikum des Saarlandes, Homburg/Saar, Germany|Klinikum der Universität Witten/Herdecke - Köln / Klinik für Anästhesiologie und operative Intensivmedizin, Köln, Germany|Universitätsklinikum Leipzig, Leipzig, Germany|UKSH Campus Lübeck - Department for Anesthesiology and Intensive Care Medicine, Lübeck, Germany|University Hospital Magdeburg - Department for Anesthesiology and Intensive Care Medicine, Magdeburg, Germany|Universitätsklinikum Marburg, Marburg, Germany|Technische Universität München, München, Germany|Oberschwabenklinik Ravensburg Klinik für Anästhesie-, Intensiv-, Notfall- und Schmerzmedizin, Ravensburg, Germany|University Hospital Tübingen - Department for Anesthesiology and Intensive Care Medicine, Tübingen, Germany|Universitätsklinikum Ulm, Ulm, Germany|Universitätsklinikum Würzburg Klinik und Poliklinik für Anästhesiologie, Intensivmedizin und Schmerztherapie, Würzburg, Germany",https://ClinicalTrials.gov/show/NCT04455451
NCT04385771,Cytokine Adsorption in Patients With Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,CYCOV-II,"University Clinic Freiburg, Freiburg, Germany|Klinikum Ibbenbueren, Ibbenbueren, Germany|Klinikum Ludwigsburg, Ludwigsburg, Germany",https://ClinicalTrials.gov/show/NCT04385771
NCT04805684,Different Lung Ultrasound Imaging Protocols in COVID-19 Pneumonia,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Diagnostic,2011-KAEK-25 2021,"University of Health Sciences, Bursa Yuksek Ihtisas Training and Research Hospital, Bursa, Turkey",https://ClinicalTrials.gov/show/NCT04805684
NCT04710394,Visual-OLfactory Training in Participants With COVID-19 Resultant Loss of Smell,"Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment",7011897206,"Washington University School of Medicine in Saint Louis, Saint Louis, Missouri, United States",https://ClinicalTrials.gov/show/NCT04710394
NCT04321096,The Impact of Camostat Mesilate on COVID-19 Infection,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",2020-001200-42,"Region Hospital North Jutland, Hjørring, Region Nord, Denmark|Department of Infectious Diseases, Aalborg, Denmark|Department for Infectious Diseases, Aarhus University Hospital, Aarhus N, Denmark|Herning Regional Hospital, Herning, Denmark|Northzealands hospital - Hillerød, Hillerød, Denmark|Horsens Regional Hospital, Horsens, Denmark|Bispebjerg hospital, København, Denmark|Dept. of Infectious Diseases, Odense University Hospital, Odense, Denmark|Randers Regional Hospital, Randers, Denmark|Silkeborg Hospital, Silkeborg, Denmark|Örebro Hsopital, Örebro, Örebrolan, Sweden",https://ClinicalTrials.gov/show/NCT04321096
NCT04642703,Mortality in Patients With Severe COVID-19 Pneumonia Who Underwent Tracheostomy,Observational Model: Cohort|Time Perspective: Retrospective,65/20,"Intensive Care Unit, Hospital Clínico Universidad de Chile, Santiago, Chile",https://ClinicalTrials.gov/show/NCT04642703
NCT04356950,Analysis of the Coagulopathy Developed by COVID-19 Infected Patients,Observational Model: Other|Time Perspective: Prospective,PHRC-I/2020/JCG-01,"CHU de Bordeaux, Bordeaux, France|CHU de Limoges, Limoges, France|CHU de Montpellier, Montpellier, France|CHU de Nimes, Nîmes, France",https://ClinicalTrials.gov/show/NCT04356950
NCT04871672,Effects of Pilates Exercises on Core Stability After Recovery From COVID -19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,Sponsor-Investigator:,NA,https://ClinicalTrials.gov/show/NCT04871672
NCT04560205,Tocilizumab in COVID-19 Lahore General Hospital,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,LGH001,"Lahore General Hospital, Lahore, Punjab, Pakistan",https://ClinicalTrials.gov/show/NCT04560205
NCT04716556,TranSfUsion of coNvalescent plAsma for the Early Treatment of pneuMonIa in COVID-19 Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,TSUNAMI,"SOD Clinica Malattie Infettive Tropicali, Parassitologia, Epatiti Croniche - AOU Ospedali Riuniti di Ancona, Ancona, Italy|Ospedale di Arezzo, Arezzo, Italy|Clinica Malattie Infettive, Università degli Studi di Bari, Bari, Italy|Ospedale Papa Giovanni XXIII-Dip. emergenza, Urgenza e area critica, Bergamo, Italy|UOC Malattie Infettive - AOU Bologna, Bologna, Italy|UO PID Tossicologia Applicata - Dip. Scienze Biomediche e Biotecnologiche - Università di Catania - AOU Policlinico Vittorio Emanuele, Catania, Italy|Ospedale Città di Castello, Città Di Castello, Italy|Ospedale di Empoli, Empoli, Italy|UOC Malattie Infettive - ASUR Marche Area Vasta 4, Fermo, Italy|UOC Malattie Infettive - AOU Ferrara, Ferrara, Italy|Ospedale Santa Maria Annunziata, Firenze, Italy|SOD Malattie Infettive e Tropicali - AOU Careggi, Firenze, Italy|Dip.Medicina Clinica e Sperimentale - Policlinico ""Riuniti"" di Foggia, Foggia, Italy|Nuovo Ospedale S. Giovanni Battista Usl Umbria2, Foligno, Italy|U.O.C. Malattie Infettive ASL Frosinone, Frosinone, Italy|U.O. Malattie Infettive IRCCS-Ospedale Policlinico San Martino, Genova, Italy|Ospedale di Grosseto, Grosseto, Italy|ASL 5 Spezzina - SC Malattie Infettive, La Spezia, Italy|ASST Lecco - Malattie Infettive, Lecco, Italy|Ospedale di Livorno, Livorno, Italy|Ospedale di Lucca, Lucca, Italy|S.C. Pneumologia e Utir ASST Mantova - Ospedale Carlo Poma, Mantova, Italy|Ospedale Dell'Angelo - UOC Malattie Infettive, Mestre, Italy|ASST Santi Paolo e Carlo, Milano, Italy|Ospedale Luigi Sacco, Milano, Italy|SC Malattie Infettive ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy|Ospedale San Gerardo, Monza, Italy|Malattie Infettive - AOU Federico II di Napoli, Napoli, Italy|UOC Malattie Infettive ad indirizzo Respiratorio - PO Cotugno - AORN ""Dei Colli"", Napoli, Italy|UOC Malattie Infettive e Tropicali - AOU Policlinico, Palermo, Italy|Dip. Medicina Diagnost. e Servizi Fondazione IRCCS Policlinico San Matteo, Pavia, Italy|Azienda Ospedaliero-Universitaria di Perugia, Perugia, Italy|UOC Malattie Infettive - Azienda Ospedali Riuniti Marche Nord, Pesaro, Italy|AOU Pisana, Pisa, Italy|Ospedale Pistoia, Pistoia, Italy|Ospedale Prato, Prato, Italy|Malattie Infettive Ravenna, Ravenna, Italy|UOC Malattie Infettive - AUSL Reggio Emilia, Reggio Emilia, Italy|Malattie Infettive - Rimini Forlì Cesena, Rimini, Italy|Campus Bio Medico - UO Anestesia e Rianimazione, Roma, Italy|ASL 1 Imperiese - SC Malattie Infettive, Sanremo, Italy|ASL 2 Savonese - SC Malattie Infettive, Savona, Italy|Ospedale di Siena, Siena, Italy|Ospedale di Sondrio - dipartimento di Medicina, Sondrio, Italy|AOU di Terni, Terni, Italy|Ospedale Ca Foncello - UOC Malattie Infettive, Treviso, Italy|A.O. Integrata Università di Verona, Verona, Italy|Ospedale Viareggio, Viareggio, Italy",https://ClinicalTrials.gov/show/NCT04716556
NCT04356443,Non-Invasive Monitoring of Respiratory Function in Spontaneously Breathing Patients With COVID-19 Infection,Observational Model: Cohort|Time Perspective: Prospective,2020P000881,"Massachusetts General Hospital, Boston, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT04356443
NCT04618796,Effect of COVID-19 Pandemic on Vaccination Compliance,Observational Model: Case-Crossover|Time Perspective: Cross-Sectional,Effect of COVID on vaccination,NA,https://ClinicalTrials.gov/show/NCT04618796
NCT04820751,Cyproheptadine in Severe COVID-19 : A Unblinded Randomized Trial,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,25584,NA,https://ClinicalTrials.gov/show/NCT04820751
NCT04954092,Study of Gam-COVID-Vac in Adolescents,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,OLSTAD,"Children's City Clinical Hospital named after Z.A. Bashlyaeva of the Moscow Department of Health, Moscow, Russian Federation|Morozovskaya Children's City Clinical Hospital of the Moscow Department of Health, Moscow, Russian Federation",https://ClinicalTrials.gov/show/NCT04954092
NCT04363463,Impact of Prone Position in Patients Under Spontaneous Breathing on Intubation or Non-invasive Ventilation or Death Incidence During COVID-19 Acute Respiratory Distress,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,CHRO-2020-09,"CH de Blois, Blois, France|CH de DAX, Dax, France|CHD de VENDEE, La Roche sur Yon, France|CH de LA ROCHELLE, La Rochelle, France|CH Le Mans, Le Mans, France|CH Mont de MArsan, Mont-de-Marsan, France|CHR d'Orléans - Service Pneumologie, Orléans, France|CHR d'Orleans - Service Maladies Infectieuses, Orléans, France|HOPITAL LARIBOISIERE - Service diabétologie, endocrinologie, nutrition, Paris, France|Hopital Européen Georges Pompidou, Paris, France|Hopital Lariboisiere - Medecine Interne, Paris, France|Hopital Lariboisiere, Paris, France|CH de PERPIGNAN - Service Maladies infectieuses, Perpignan, France|Centre Hospitalier Intercommunal de Cornouaille - Quimper Concarneau, Quimper, France|CHRU de Tours - Service Médecine interne et immunologie Clinique, Tours, France|CHRU de Tours - Service Pneumologie, Tours, France|CHRU DE TOURS - Service Médecine interne et maladies infectieuses, Tours, France|CH Bretagne Atlantique, Vannes, France|centre Hospitalier Princesse Grace, Monaco, Monaco",https://ClinicalTrials.gov/show/NCT04363463
NCT04468802,Do Childhood Measles and DTaP Vaccination Decrease the Mortality Rate Caused by COVID-19 in OECD Countries?,Observational Model: Case-Only|Time Perspective: Prospective,KSSEAH--0965,"Istanbul Kanuni Sultan Suleyman Training and Research Hospital, Istanbul, Kucukcekmece, Turkey",https://ClinicalTrials.gov/show/NCT04468802
NCT04446169,COVID-19 (SARS-CoV-2) in Urine and Semen,Observational Model: Cohort|Time Perspective: Prospective,17104_oss/2020,"AOU Careggi, Florence, Tuscany, Italy",https://ClinicalTrials.gov/show/NCT04446169
NCT04403100,"Hydroxychloroquine and Lopinavir/ Ritonavir to Improve the Health of People With COVID-19: ""The Hope Coalition - 1""","Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",COVID19_AMB_Brasil,"CARDRESEARCH - Cardiologia Assistencial e de Pesquisa, Belo Horizonte, Minas Gerais, Brazil|Pontificia Universidade Catolica de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil|Fundo Municipal de Saúde de Betim, Betim, Minas Gerais, Brazil|Universidade Federal de Ouro Preto, Ouro Preto, Minas Gerais, Brazil",https://ClinicalTrials.gov/show/NCT04403100
NCT04734717,Coordination and Locomotor Problems in Patients With Covid-19 Virus,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Treatment,IKEB2021/02,"Dr. József Tollár, Kaposvár, Somogy, Hungary",https://ClinicalTrials.gov/show/NCT04734717
NCT04573348,T Cells Response to SARS COV 2 Peptides,Observational Model: Other|Time Perspective: Prospective,PBMC _COVID 19,"Carmel Medical Center, Haifa, North, Israel",https://ClinicalTrials.gov/show/NCT04573348
NCT04745416,Clinical Characteristics of Patients With Leukemia and COVID-19,Observational Model: Cohort|Time Perspective: Retrospective,DECS/JPO-CT-400-2020,"Hospital Regional de Alta Especialidad de Ixtapaluca, Ixtapaluca, State Of Mexico, Mexico|Hospital General de México ""Dr. Eduardo Liceaga"", Mexico City, Mexico",https://ClinicalTrials.gov/show/NCT04745416
NCT04497454,Mechanical Ventilation Strategy for Coronavirus Disease 2019 (COVID-19),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,CAAE: 30938720800000068,"USP Instituto do Coração, São Paulo, Brazil",https://ClinicalTrials.gov/show/NCT04497454
NCT04642040,Effectiveness of Pulmonary Rehabilitation Program in Patients With SARS-CoV-2 Pneumonia,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2857,"Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04642040
NCT04592835,"To Evaluate the Safety, Tolerability and Pharmacokinetic Properties of DWRX2003","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",DW_DWJ1516101_Australia,NA,https://ClinicalTrials.gov/show/NCT04592835
NCT04354818,Coronavirus (COVID-19) Outcomes Registries in Immunocompromised Individuals Australia (CORIA),Observational Model: Cohort|Time Perspective: Prospective,2020-04-CORIA,"St Vincent's Hospital, Darlinghurst, New South Wales, Australia|East Sydney Doctors, Sydney, New South Wales, Australia|Royal North Shore Hospital, Sydney, New South Wales, Australia|Blacktown Hospital, Sydney, New South Wales, Australia|Liverpool Hospital, Sydney, New South Wales, Australia|St George Hospital, Sydney, New South Wales, Australia|Concord Hospital, Sydney, New South Wales, Australia|Holdsworth House Medical Practice, Sydney, New South Wales, Australia|Melanoma Institute Australia, Sydney, New South Wales, Australia|Nepean Hospital, Sydney, New South Wales, Australia|Westmead Hospital, Sydney, New South Wales, Australia",https://ClinicalTrials.gov/show/NCT04354818
NCT04896710,COVID-19 Rapid Testing for Self-Administration Among an Asymptomatic Sample,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Screening,331297,"Orchard Commons, Vancouver, British Columbia, Canada",https://ClinicalTrials.gov/show/NCT04896710
NCT04802044,"COVID-19, Aging, and Cardiometabolic Risk Factors Study",Observational Model: Cohort|Time Perspective: Prospective,CARAMEL,"Dr. Cipto Mangunkusumo National General Hospital, Jakarta Pusat, DKI Jakarta, Indonesia|Metabolic Disorder, Cardiovascular, and Aging Research Cluster IMERI-FKUI, Research Tower, 5th Floor, Jakarta Pusat, DKI Jakarta, Indonesia",https://ClinicalTrials.gov/show/NCT04802044
NCT04346602,A Study on the Clinical and Psychological Characteristics of Patients With COVID-2019,Observational Model: Cohort|Time Perspective: Prospective,130004,"the First Hospital of Jilin University, Chang chun, Jilin, China",https://ClinicalTrials.gov/show/NCT04346602
NCT04760821,Prevention of Acute Myocardial Injury by Trimetazidine in Patients Hospitalized for COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,SDC5100/20/129,"Heart Institute (InCor-HCFMUSP), Sao Paulo, SP, Brazil",https://ClinicalTrials.gov/show/NCT04760821
NCT04392401,COVID-19 - Study of the Kinetics of the Immune Response During the Intensive Care Unit Stay in Adult Patients Infected With SARS-CoV-2: Multicentric Non Interventional Study,Observational Model: Cohort|Time Perspective: Prospective,69HCL20_0358|2020-A01079-30,"Hôpital Pierre Wertheimer, Bron, France|Hôpital Gabriel Montpied, Clermont-Ferrand, France|Centre hospitalier universitaire de Grenoble Alpes, Grenoble, France|Hôpital Edouard Herriot, Lyon, France|Hôpital Edouard Herriot, Lyon, France|Hôpial de la Croix Rousse, Lyon, France|Hôpital Lyon Sud, Pierre-Bénite, France|CH de St Etienne, Saint-Étienne, France",https://ClinicalTrials.gov/show/NCT04392401
NCT04407156,Epidemiology of Acute Kidney Injury in COVID19 Disease in United Kingdom,Observational Model: Case-Control|Time Perspective: Retrospective,UHDB/2020/050,"Derby Hospital NHS Foundation Trust, Derby, Derbyshire, United Kingdom",https://ClinicalTrials.gov/show/NCT04407156
NCT04733625,The Effect of Vitamin D Therapy on Morbidity and Moratlity in Patients With SARS-CoV 2 Infection,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",KA-2020/151,"Cairo university hospitals, Cairo, Egypt",https://ClinicalTrials.gov/show/NCT04733625
NCT04376814,Favipiravir Plus Hydroxychloroquine and Lopinavir/Ritonavir Plus Hydroxychloroquine in COVID-19,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,IR.BMSU.REC.1399.017,"Mohammad Sadegh Bagheri Baghdasht, Tehran, Iran, Islamic Republic of",https://ClinicalTrials.gov/show/NCT04376814
NCT04805632,Immune Response in Dialysis Patients Vaccinated Against SARS-CoV-2,Observational Model: Cohort|Time Perspective: Prospective,Sputnik_HD,"Saint-Petersburg State University Hospital, Saint Petersburg, Russian Federation",https://ClinicalTrials.gov/show/NCT04805632
NCT04952337,"Clinical, Molecular and Functional Biomarkers for PROgnosis, Pathomechanisms and Treatment Strategies of COVID-19 (PROVID) - (PROVID-CAPNETZ)",Observational Model: Cohort|Time Perspective: Prospective,PROVID-CAPNETZ,"Krankenhaus Bad Arolsen, Bad Arolsen, Germany|Charité - Universitätsmedizin Berlin, Berlin, Germany|HELIOS Klinikum Emil von Behring Berlin, Berlin, Germany|Vivantes Klinikum Neukölln, Berlin, Germany|Carl-Thiem-Klinikum Cottbus, Cottbus, Germany|Klinikum Dortmund gGmbH, Dortmund, Germany|Universitätsklinikum Dresden, Dresden, Germany|Universitätsklinikum Frankfurt, Frankfurt, Germany|Klinik Schillerhöhe, Gerlingen, Germany|Hannover Medical School, Hannover, Germany|Universitätsklinikum Jena, Jena, Germany|Krankenhaus der Augustinerinnen, Köln, Germany|Universitätsklinikum Schleswig-Holstein Campus Lübeck, Lübeck, Germany|Universitätsklinikum rechts der Isar, München, Germany|Agaplesion Diakonieklinikum Rotenburg, Rotenburg, Germany",https://ClinicalTrials.gov/show/NCT04952337
NCT04382495,The Impact of COVID-19 Pandemic on Cancer Care,Observational Model: Other|Time Perspective: Cross-Sectional,Cancer Care during Covid-19,"EgyBrit Medical Centre, Cairo, Egypt",https://ClinicalTrials.gov/show/NCT04382495
NCT04905862,Assessment of Immune Response After Vaccination Against COVID-19 in Dialyzed Patients,Observational Model: Case-Control|Time Perspective: Prospective,COViNEPH-1,"Medical University of Gdansk, Gdansk, Pomorskie, Poland|7th Naval Hospital in Gdansk, Gdańsk, Poland|NZOZ Diaverum Gdynia, Gdynia, Poland|The University Centre of Maritime and Tropical Medicine in Gdynia, Gdynia, Poland",https://ClinicalTrials.gov/show/NCT04905862
NCT04605926,A Study to Evaluate the Efficacy and Safety of Itolizumab in Subjects Hospitalized With COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",EQ001-20-001,"Inv Site CO01, Medellín, Colombia",https://ClinicalTrials.gov/show/NCT04605926
NCT04385251,International SARS-CoV-2 (COVID-19) Infection Observational Study,Observational Model: Cohort|Time Perspective: Prospective,ICOS|75N91019D00024,"Denver Public Health, Denver, Colorado, United States|Hospital General de Agudos JM Ramos Mejia Servicio de Inmunocomprometidos, Buenos Aires, Argentina|CHIP Department of Infectious Diseases, Copenhagen, Denmark|University College London Medical School Centre for Sexual Health and HIV Research, London, England, United Kingdom",https://ClinicalTrials.gov/show/NCT04385251
NCT04360707,Solid Organ Transplant Recipients With SARS-CoV-2 French Registry,Observational Model: Case-Only|Time Perspective: Prospective,7766,"Service de Néphrologie et Transplantation, Strasbourg, France",https://ClinicalTrials.gov/show/NCT04360707
NCT04826640,Observational Maternal COVID-19 Vaccination Study,Observational Model: Cohort|Time Perspective: Prospective,Pro00107518,"Centers for Disease Control and Prevention, Atlanta, Georgia, United States|Boston Medical Center, Boston, Massachusetts, United States|Duke University, Durham, North Carolina, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States",https://ClinicalTrials.gov/show/NCT04826640
NCT04874805,Oxygen Saturation: Analytical Comparison for COVID,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,APHP210142,"Service de Pneumologie, Médecine Intensive et Réanimation (SPMIR-R3S) Hôpital Pitié-Salpêtrière, Paris, France",https://ClinicalTrials.gov/show/NCT04874805
NCT04373291,Using BCG Vaccine to Protect Health Care Workers in the COVID-19 Pandemic,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Prevention",BCG-DENMARK-COVID|2020-001888-90,"University of Southern Denmark, Odense, Region Of Southern Denmark, Denmark",https://ClinicalTrials.gov/show/NCT04373291
NCT04434417,Validation of an Immunochromatographic Assay for IgG/IgM Antibodies to 2019- nCoV,Observational Model: Cohort|Time Perspective: Prospective,I-GLOBAL,"Papa Giovanni XXIII Hospital, Bergamo, Italy|Azienda Socio-Sanitaria Territoriale di Cremona, Cremona, Italy|Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta, Milano, Italy|Azienda Ospedaliera Niguarda Cà Granda, Milano, Italy|European IO, Division of Early Drug Development for Innovative Therapies, Milan, Italy",https://ClinicalTrials.gov/show/NCT04434417
NCT04486729,Respiratory Mechanics and Gas Exchange Characteristics in Patient With SARS-CoV-2,Observational Model: Case-Crossover|Time Perspective: Cross-Sectional,10.202,"Sanatorio Anchorena San Martin, San Martin, Buenos Aires, Argentina",https://ClinicalTrials.gov/show/NCT04486729
NCT04845984,Evaluation of the Prevalence of SARS-CoV-2 Infection in the Healthcare Workers (HCWs) in Four Hospital of the Alpine Region,Observational Model: Cohort|Time Perspective: Retrospective,12月20日,"Ch Annecy Genevois, Pringy, France",https://ClinicalTrials.gov/show/NCT04845984
NCT04584424,Prognostic Factors and Outcomes of COVID-19 Cases in Ethiopia,Observational Model: Cohort|Time Perspective: Prospective,EPHI National Cohort,"Saro Abdella, Addis Ababa, Ethiopia",https://ClinicalTrials.gov/show/NCT04584424
NCT04750265,Robotic Assisted Early Mobilization in Ventilated ICU Patients With COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,ROBEM II,"Charité - Univiversitätsmedizin Berlin, Berlin-Mitte, Berlin, Germany",https://ClinicalTrials.gov/show/NCT04750265
NCT04604119,Anxiety and Burnout in Anesthetists and Intensive Care Unit Nurses During Covid-19 Pandemic,Observational Model: Other|Time Perspective: Cross-Sectional,1577,"Sisli Hamidiye Etfal Education and Training Hospital, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04604119
NCT04979416,Video Messages and Vaccination Intention,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Health Services Research,UP-21-00587,NA,https://ClinicalTrials.gov/show/NCT04979416
NCT04380961,A Study to Evaluate the Efficacy and Safety of Sirukumab in Confirmed Severe or Critical Confirmed Coronavirus Disease (COVID)-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",CR108820|CNTO136COV2001|2020-003056-32,"MemorialCare Research Miller Children's and Women's Hospital Long Beach, Long Beach, California, United States|Hoag Memorial Hospital, Newport Beach, California, United States|Holy Cross Hospital - Michael and Dianne Bienes Comprehensive Cancer Center, Fort Lauderdale, Florida, United States|Great Lakes Clinical Trials, Chicago, Illinois, United States|Loyola University Medical Center, Maywood, Illinois, United States|University of Illinois College of Medicine at Peoria, Peoria, Illinois, United States|Louisiana State University Health Sciences Center, New Orleans, Louisiana, United States|Henry Ford Hospital, Detroit, Michigan, United States|Beaumont Health Systems, Royal Oak, Michigan, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|Mercury Street Medical Group, PLLC, Butte, Montana, United States|Saint Michael's Medical Center - Infectious Disease, Newark, New Jersey, United States|SUNY Upstate Medical University, Syracuse, New York, United States|East Carolina University, Greenville, North Carolina, United States|Baylor Scott & White Research Institute, Dallas, Texas, United States|Baylor All Saints Medical Center at Fort Worth, Fort Worth, Texas, United States",https://ClinicalTrials.gov/show/NCT04380961
NCT04930185,Reducing Vaccine Hesitancy (VH) And Vaccine Refusal (VR): Its' Correlation Factors and an Educational Intervention Programme,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,SRB/IIR/SMC/F/21/001,"Sunway University, Petaling Jaya, Selangor Darul Ehsan, Malaysia",https://ClinicalTrials.gov/show/NCT04930185
NCT04431856,CO-PARENT: COVID-19 - Parent Action in Response to Emotions and Needs for Treatment,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,20200484,"University of Miami, Miami, Florida, United States",https://ClinicalTrials.gov/show/NCT04431856
NCT04402983,The Effectiveness of Telerehabilitation-Based Physiotherapy in COVID 19 Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,Telerehab_Covid19,"University of Health Sciences Turkey, İstanbul, Turkey",https://ClinicalTrials.gov/show/NCT04402983
NCT04779996,Antibodies Production After Covid-19 Vaccination Among Patients With Medical History of Cancer and Anti-CD-20 Treatment,Observational Model: Case-Control|Time Perspective: Cross-Sectional,CCAM 21-01,"Auxilio Mutuo Cancer Center, San Juan, Puerto Rico",https://ClinicalTrials.gov/show/NCT04779996
NCT04491227,Global Assessment of Acute and Chronic Kidney Disease Incidence and Outcomes in Patients With COVID-19 Infection,Observational Model: Cohort|Time Perspective: Retrospective,295,"University of Alabama, Birmingham, Birmingham, Alabama, United States|University of California, San Diego, San Diego, California, United States|University of Colorado, Aurora, Colorado, United States|St. Peter's Hospital, Albany, New York, United States|Jacobi Medical Center, New York, New York, United States|Hospital Obrero #2, Cochabamba, Bolivia|Hopital Sacre Coeur & Universite de Montreal, Montreal, Quebec, Canada|Universidad de Los Andes, Santiago, Chile|Postgraduate Institute of Research, Chandigarh, Chandigarh, India|Royal Free Hospital, London, United Kingdom|Guy's & St Thomas's Hospital, London, United Kingdom|University of Nottingham, Nottingham, United Kingdom",https://ClinicalTrials.gov/show/NCT04491227
NCT04332835,"Convalescent Plasma for Patients With COVID-19: A Randomized, Single Blinded, Parallel, Controlled Clinical Study",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,ABN011-2,"Universidad del Rosario, Bogota, Cundinamarca, Colombia",https://ClinicalTrials.gov/show/NCT04332835
NCT04268537,Immunoregulatory Therapy for 2019-nCoV,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,2020YFC0841300-03,NA,https://ClinicalTrials.gov/show/NCT04268537
NCT04558125,Low-Dose Tenecteplase in Covid-19 Diagnosed With Pulmonary Embolism,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",ML42522,"Cedars-Sinai Medical Center, Los Angeles, California, United States",https://ClinicalTrials.gov/show/NCT04558125
NCT04395794,SARS-CoV-2 Disguise Study,Observational Model: Cohort|Time Perspective: Prospective,CS-COVID-19,"Meshalkin National Medical Research Center, Novosibirsk, Russian Federation",https://ClinicalTrials.gov/show/NCT04395794
NCT04659109,Glenzocimab in SARS-Cov-2 Acute Respiratory DistrEss syNdrome Related to COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",ACT-CS-006|2020-002733-15,"Hôpital de Hautepierre, Strasbourg, France",https://ClinicalTrials.gov/show/NCT04659109
NCT04369989,Observational Study of COVID-19 Treatment Efficacy,Observational Model: Cohort|Time Perspective: Other,1589936,"OSF HealthCare St Francis Medical Center, Peoria, Illinois, United States",https://ClinicalTrials.gov/show/NCT04369989
NCT04351139,Impact of the COVID-19 Pandemic in Gynecological Oncology,Observational Model: Case-Control|Time Perspective: Other,69HCL20_0346|2020-A01036-33,"Service de Gynécologie, HFME, Hospices Civils de Lyon, Bron, France|Service de Gynécologie, Croix-Rousse, Hospices Civils de Lyon, Lyon, France|Service Gynécologie, CHLS, Hospices Civils de Lyon, Pierre-Bénite, France",https://ClinicalTrials.gov/show/NCT04351139
NCT04442230,NasoVAX in Patients With Early Coronavirus Infectious Disease 2019 (COVID-19),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",ALT-601-201,"Miami Dade Medical Research Institute, Miami, Florida, United States|Infinite Clinical Trials, Morrow, Georgia, United States|Cedar Crosse Research Center, Chicago, Illinois, United States|Carolina Institute for Clinical Research, Fayetteville, North Carolina, United States|Next Level Urgent Care, Houston, Texas, United States|Centex Studies, Houston, Texas, United States|Centex Studies, McAllen, Texas, United States",https://ClinicalTrials.gov/show/NCT04442230
NCT04843917,Immunity Against COVID-19 Vaccine in Healthcare Workers in Argentine,Observational Model: Cohort|Time Perspective: Prospective,3913,"Hospital Italiano de Buenos Aires, Buenos Aires, Caba, Argentina",https://ClinicalTrials.gov/show/NCT04843917
NCT04615728,MANAGEMENT OF APPENDICITIS DURING THE COVID-19 PANDEMIC,Observational Model: Cohort|Time Perspective: Prospective,PRN8996,"Addenbrooke's University Hospital, Cambridge, Cambridgeshire, United Kingdom",https://ClinicalTrials.gov/show/NCT04615728
NCT04618042,FX06 to Rescue Acute Respiratory Distress Syndrome During Covid-19 Pneumonia,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",APHP200495|2020-002056-20,"Service de Médecine Intensive Réanimation - CHU Angers, Angers, France|Service de Médecine Intensive Réanimation - CHI de Poissy, Chambourcy, France|Hôpital Pitié Salpêtrière, Paris, France",https://ClinicalTrials.gov/show/NCT04618042
NCT04794088,Intravenous Imatinib in Mechanically Ventilated COVID-19 Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",INVENT COVID,"Amsterdam Universitair Medische Centra, location VUmc, Amsterdam, Noord-Holland, Netherlands|Amsterdam Universitair Medische Centra, location AMC, Amsterdam, Noord-Holland, Netherlands",https://ClinicalTrials.gov/show/NCT04794088
NCT04358380,Liver Injury in Patients With COVID-19,Observational Model: Cohort|Time Perspective: Prospective,CIE N° P 20-011,"Universidad Austral, Pilar, Buenos Aires, Argentina",https://ClinicalTrials.gov/show/NCT04358380
NCT04375774,Verification of Alternative Do-it-yourself Equipment Respirators for the COVID-19 Personal Protective Equipment (PPE),Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,2020/15AVR/226,"Cliniques Universitaires Saint-Luc, Brussels, Belgium",https://ClinicalTrials.gov/show/NCT04375774
NCT04681001,"Prophylactic Treatment With Carragelose Nasal Spary to Prevent SARS-CoV-2, COVID-19, Infections in Health Care Workers","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",COVID-19/CHC_20_04,"Gesundheitsverbund, Klinik Favoriten, Vienna, Austria|Gesundheitsverbund Klinik Floridsdorf, Vienna, Austria",https://ClinicalTrials.gov/show/NCT04681001
NCT04449978,TARGet Kids! COVID-19 Study of Children and Families,Observational Model: Cohort|Time Perspective: Prospective,1000069701,"St Michael's Hospital, Toronto, Ontario, Canada|The Hospital for Sick Children, Toronto, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04449978
NCT04784403,SCREENING AND SEROEPIDEMIOLOGY OF SARS-CoV-2 INFECTION AT THE UNIVERSITY OF BARCELONA: A CROSS-SECTIONAL STUDY,Observational Model: Ecologic or Community|Time Perspective: Prospective,UB-EPI-2020-01,"Francisco Ciruela Alférez, L'Hospitalet De Llobregat, Barcelona, Spain",https://ClinicalTrials.gov/show/NCT04784403
NCT04668209,Silmitasertib (CX-4945) in Patients With Severe Coronavirus Disease 2019 (COVID-19),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,CX4945-AV02-IIT,"Banner University Medical Center Phoenix, Phoenix, Arizona, United States|Banner University Medical Center Tucson, Tucson, Arizona, United States",https://ClinicalTrials.gov/show/NCT04668209
NCT04941079,Safety and Efficacy of Inactivated SARS-CoV-2 Vaccine in Immune-related Myopathy (Myasthenia Gravis and Inflammatory Myopathy) Patients ：a Prospective Observational Study,Observational Model: Other|Time Perspective: Prospective,2021-296,NA,https://ClinicalTrials.gov/show/NCT04941079
NCT04349098,Evaluation of Activity and Safety of Oral Selinexor in Participants With Severe COVID-19 Infection,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,XPORT-CoV-1001|2020-001411-25,"UCLA, Los Angeles, California, United States|Kaiser Permanente Oakland, Oakland, California, United States|UC Davis Health, Sacramento, California, United States|Kaiser Permanente Sacramento, Sacramento, California, United States|Kaiser Permanente San Francisco, San Francisco, California, United States|Miami Cancer Institute at Baptist Health, Miami, Florida, United States|Emory University, Atlanta, Georgia, United States|Advocate Christ Medical Center, Oak Lawn, Illinois, United States|University of Kansas Medical Center, Kansas City, Kansas, United States|Norton Healthcare, Louisville, Kentucky, United States|Boston Medical Center, Boston, Massachusetts, United States|Karmanos, Detroit, Michigan, United States|Michigan Center of Medical Research, Farmington Hills, Michigan, United States|Michigan Center of Medical Research, Royal Oak, Michigan, United States|Columbia University, New York, New York, United States|Weill Cornell Medical College, New York, New York, United States|Levine Cancer Institute-Atrium Health University City, Charlotte, North Carolina, United States|Lehigh Valley Hospital, Allentown, Pennsylvania, United States|Baylor Scott & White Dallas, Dallas, Texas, United States|MultiCare Institute for Research & Innovation (Puget Sound), Tacoma, Washington, United States|Hospital Hietzing, 2. Medical department - Center for Diagnosis and Therapy of Rheumatic Diseases, Vienna, Austria|CHU Bordeaux, Bordeaux, France|CHU Lyon, Lyon, France|CHU Nantes, Nantes, France|Hadassah MC, Jerusalem, Israel|Hasharon Medical Center, Petah Tiqva, Israel|Sheba Medical Center, Tel HaShomer, Israel|Hospital Universitari Vall d'Hebron, Barcelona, Spain|Servicio de Medicina Interna, Hospital Universitario de Salamanca, Universidad de Salamanca, Salamanca, Spain|Princess Royal University Hospital, Kent, United Kingdom|Kings College Hospital, London, United Kingdom|The Royal Marsden Hospital, London, United Kingdom|University Hospitals Plymouth NHS Trust, Plymouth, United Kingdom",https://ClinicalTrials.gov/show/NCT04349098
NCT04778059,Safety and Efficacy of USB002 for Respiratory Distress Due to COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",USB002-2020-001,NA,https://ClinicalTrials.gov/show/NCT04778059
NCT04830800,A Phase 1/2 Safety and Immunogenicity Trial of COVID-19 Vaccine COVIVAC,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",COVIVAC-0102,"Hanoi Medical University, Hanoi, Vietnam|Thai Binh Center of Disease Control, Thai Binh, Vietnam",https://ClinicalTrials.gov/show/NCT04830800
NCT04355052,"Open Label Study to Compare Efficacy, Safety and Tolerability of Hydroxychloroquine Combined With Azithromycin Compared to Hydroxychloroquine Combined With Camostat Mesylate and to ""no Treatment"" in SARS CoV 2 Virus",Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,7092-20-SMC,"Sheba Medical Center, Ramat Gan, Israel|Sheba Medical Center, Tel HaShomer, Israel",https://ClinicalTrials.gov/show/NCT04355052
NCT04293887,Efficacy and Safety of IFN-α2β in the Treatment of Novel Coronavirus Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,Zhaojp,NA,https://ClinicalTrials.gov/show/NCT04293887
NCT04611425,"REmimazolam Infusion in the Context of Hypnotic Shortage in the Critical Care Unit During the Pandemic of COVID-19, the REHSCU Study",Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,RC20_0319,"CHU de Nantes, Nantes, France",https://ClinicalTrials.gov/show/NCT04611425
NCT04503525,Nutritional Assessment of Hospitalized Patients With COVID-19,Observational Model: Other|Time Perspective: Prospective,RC-P00100,"Saint-Vincent Hospital, Lille, Haut-de-France, France",https://ClinicalTrials.gov/show/NCT04503525
NCT04363840,"The LEAD COVID-19 Trial: Low-risk, Early Aspirin and Vitamin D to Reduce COVID-19 Hospitalizations",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,20-063,NA,https://ClinicalTrials.gov/show/NCT04363840
NCT04707703,Isavuconazole for the Prevention of COVID-19-associated Pulmonary Aspergillosis,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention",200639,"University of California Irvine, Orange, California, United States|University of California Davis, Sacramento, California, United States|University of California San Diego, San Diego, California, United States",https://ClinicalTrials.gov/show/NCT04707703
NCT04735744,Evaluation of Allied Healthcare in Patients Recovering From COVID-19,Observational Model: Cohort|Time Perspective: Prospective,ParaCOV,NA,https://ClinicalTrials.gov/show/NCT04735744
NCT04467918,CANnabiDiol for CoviD-19 pATiEnts With Mild to Moderate Symptoms,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",CANDIDATE study,"Serviço de Assistência Médica e Social do Pessoal do Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo, Ribeirão Preto, SP, Brazil|Unidade de Pronto Atendimento/UPA - 13 de Maio/Dr. Luis Atílio Losi Viana (UPA Covid), Ribeirão Preto, São Paulo, Brazil",https://ClinicalTrials.gov/show/NCT04467918
NCT04544878,Pediatric Intensive Care and COVID-19,Observational Model: Cohort|Time Perspective: Prospective,PS-PICRN--20001,"Pediatric Intensive Care and Neonatal Medicine, Bicêtre Hospital, AP-HP PAris Saclay University, Le Kremlin-Bicêtre, France",https://ClinicalTrials.gov/show/NCT04544878
NCT04393233,Drug Management of Rheumatoid Arthritis in Covid-19 Context : Impact on Therapeutic De-escalation,Observational Model: Cohort|Time Perspective: Prospective,RHUMACOVID ( 29BRC20.0110),"CHRU de Brest, Brest, France",https://ClinicalTrials.gov/show/NCT04393233
NCT04407923,Drug Management of Juvenile Idiopathic Arthritis in Covid-19 Context : Impact on Therapeutical Managment,Observational Model: Cohort|Time Perspective: Prospective,RHUMAJICOVID (29BRC20.0148),"CH de Belfort, Belfort, France|CHU de Bordeaux, Bordeaux, France|CHRU de Brest, Brest, France|AP-HP Hôpital Kremlin-Bicêtre, Le Kremlin-Bicêtre, France|CHU de Poitiers, Poitiers, France|CHU de Rennes, Rennes, France|CHU de Strasbourg, Strasbourg, France|CHU de Nancy, Vandœuvre les Nancy, France",https://ClinicalTrials.gov/show/NCT04407923
NCT04302766,Expanded Access Remdesivir (RDV; GS-5734™),NA,S-20-01,"Naval Medical Center San Diego, San Diego, California, United States|Naval Hospital Jacksonville, Jacksonville, Florida, United States|Benning Martin Army Community Hospital, Fort Benning, Georgia, United States|Eisenhower Army Medical Center, Fort Gordon, Georgia, United States|Tripler Army Medical Center, Tripler AMC, Hawaii, United States|Blanchfield Army Community Hospital, Fort Campbell North, Kentucky, United States|Walter Reed National Military Medical Center, Bethesda, Maryland, United States|Naval Medical Center Camp Lejeune, Camp Lejeune, North Carolina, United States|Womack Army Medical Center, Fort Bragg, North Carolina, United States|William Beaumont Army Medical Center, El Paso, Texas, United States|Carl R. Darnall Army Medical Center, Fort Hood, Texas, United States|Brooke Army Medical Center, Fort Sam Houston, Texas, United States|Naval Medical Center Portsmouth, Portsmouth, Virginia, United States|Madigan Army Medical Center, Tacoma, Washington, United States|Craig Joint Theater Hospital, Bagrām, Afghanistan|NATO Role 3 Multinational Medical Unit Kandahar Air Field, Kandahar, Afghanistan|EMF Camp Lemonnier, Djibouti, Djibouti|Landstuhl Regional Medical Center, Landstuhl, APO Ae, Germany|US Naval Hospital Guam, Agaña, Guam|Baghdad Diplomatic Support Center, Baghdad, Iraq|US Naval Hospital Okinawa, Okinawa, Japan|US Military Hospital Kuwait 411th Hospital Center, Kuwait, Kuwait",https://ClinicalTrials.gov/show/NCT04302766
NCT04699916,EEG-based Sedation Protocol for Patients on Mechanical Ventilation Due to SARS-CoV-2 Pneumonia,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment",80320,"Hospital Clinico de la Universidad de Chile, Santiago, RM, Chile",https://ClinicalTrials.gov/show/NCT04699916
NCT04407182,Safety and Efficacy of Viusid and Asbrip in Hospitalized Patients Infected by SARS-Cov-2 With COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Supportive Care",IESS-HTMC-JUTD-2020-0305-M,"Hospital de Especialidades Dr. Teodoro Maldonado Carbo, Guayaquil, Ecuador",https://ClinicalTrials.gov/show/NCT04407182
NCT04499378,Tomographic Findings in COVID-19 and Influenza H1N1,Observational Model: Cohort|Time Perspective: Prospective,F-2020-1008-038,"Hospital General Regional Leon Imss N0. 58, León, Guanajuato, Mexico",https://ClinicalTrials.gov/show/NCT04499378
NCT04408326,Efficacy and Safety of Angiotensin II Use in Coronavirus Disease(COVID)-19 Patients With Acute Respiratory Distress Syndrome,Observational Model: Case-Control|Time Perspective: Retrospective,283005,"Guy's & St Thomas' Hospital, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04408326
NCT04350723,Awake Prone Position in Hypoxemic Patients With Coronavirus Disease 19 (COVI-PRONE): A Randomized Clinical Trial,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2154,"St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada|Hamilton General Hospital, Hamilton, Canada|Juravinski Hospital, Hamilton, Canada|St. Catharine's General -, St. Catharines, Canada|King Fahad Hospital of the University, Khobar, Eastern Province, Saudi Arabia|King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia",https://ClinicalTrials.gov/show/NCT04350723
NCT04492410,COVID-19 Infection Screening in Cancer Patients (NEOSCREENCOVID),Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Screening,2020/23,"Centre Antoine Lacassagne, Nice, France",https://ClinicalTrials.gov/show/NCT04492410
NCT04520191,Home-based Kidney Care in Native Americans of New Mexico (HBKC) - Enhancement: COVID-19 Study,Observational Model: Cohort|Time Perspective: Prospective,16-344-Enhancement,"University of New Mexico, Albuquerque, New Mexico, United States",https://ClinicalTrials.gov/show/NCT04520191
NCT04334928,Randomized Clinical Trial for the Prevention of SARS-CoV-2 Infection (COVID-19) in Healthcare Personnel,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention",PrEP COVID-19,"Hospital Universitario de Ferrol, Ferrol, A Coruña, Spain|Hospital Clínico Universitario de Santiago, Santiago De Compostela, A Coruña, Spain|Hospital General de Elche, Elche, Alicante, Spain|Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain|Hospital Sant Joan de Deu de Esplugues, Esplugues De Llobregat, Barcelona, Spain|Parc Sanitari Sant Joan de Déu de Sant Boi, Sant Boi De Llobregat, Barcelona, Spain|Hospital Moisès Broggi, Sant Joan Despí, Barcelona, Spain|Hospital Infanta Margarita, Cabra, Córdoba, Spain|Hospital Insular de Las Palmas, Las Palmas De Gran Canaria, Gran Canaria, Spain|Hospital Universitario de Canarias, Las Palmas De Gran Canaria, Gran Canaria, Spain|Hospital de Donostia, San Sebastián, Guipuzcoa, Spain|Hospital San Pedro, Logroño, La Rioja, Spain|Hospital Principe de Asturias, Alcalá De Henares, Madrid, Spain|Hospital Fundación de Alcorcón, Alcorcón, Madrid, Spain|Hospital Colllado Villalba, Collado-Villalba, Madrid, Spain|Hospital de Getafe, Getafe, Madrid, Spain|Hospital Severo Ochoa, Leganés, Madrid, Spain|Hospital de Móstoles, Móstoles, Madrid, Spain|Hospital Rey Juan Carlos, Móstoles, Madrid, Spain|Hospital Quirón Pozuelo, Pozuelo De Alarcón, Madrid, Spain|Hospital de Torrejón, Torrejón De Ardoz, Madrid, Spain|Hospital Infanta Elena, Valdemoro, Madrid, Spain|Hospital Virgen del Castillo, Yecla, Murcia, Spain|Hospital Costa del Sol, Marbella, Málaga, Spain|Complejo Hospitalario de Navarra, Pamplona, Navarra, Spain|Hospital Reina Sofía, Tudela, Navarra, Spain|Hospital Arnau de Vilanova, Llíria, Valencia, Spain|Hospital de Araba, Alava, Vitoria, Spain|Hospital General Universitario de Albacete, Albacete, Spain|Centro Médico Teknon, Barcelona, Spain|Hospital Clinic, Barcelona, Spain|Hospital del Mar, Barcelona, Spain|Hospital Dexeus, Barcelona, Spain|Hospital Quirón Barcelona, Barcelona, Spain|Hospital Universitario Sagrat Cor, Barcelona, Spain|Hospital Universitario de Burgos, Burgos, Spain|Hospital Virgen de la Luz, Cuenca, Spain|Hospital Clínico San Cecilio, Granada, Spain|Hospital Universitario de León, León, Spain|Hospital Universitario Ramón y Cajal, Madrid, Spain|Fundación Jiménez Díaz, Madrid, Spain|Hospital Clinico San Carlos, Madrid, Spain|Hospital Infanta Leonor, Madrid, Spain|Hospital La Princesa, Madrid, Spain|Hospital Universitario 12 de Octubre, Madrid, Spain|Hospital Universitario Gregorio Marañon, Madrid, Spain|Hospital Universitario La Paz, Madrid, Spain|Hospital Universitario Puerta de Hierro, Madrid, Spain|Hospital Reina Sofía, Murcia, Spain|Hospital Universitario Virgen de la Arrixaca, Murcia, Spain|Hospital Virgen de la Victoria, Málaga, Spain|Complejo Asistencial de Palencia, Palencia, Spain|Hospital Universitario de Salamanca, Salamanca, Spain|Hospital General de Segovia, Segovia, Spain|Hospital Virgen del Rocio, Sevilla, Spain|Hospital Virgen Macarena, Sevilla, Spain|Hospital Clinico Universitario, Valencia, Spain|Hospital Dr. Peset, Valencia, Spain|Hospital General de Valencia, Valencia, Spain|Hospital La Fe, Valencia, Spain|Hospital de Valladolid, Valladolid, Spain|Hospital Rio Hortega, Valladolid, Spain|Hospital Lozano Blesa, Zaragoza, Spain|Hospital Miguel Servet, Zaragoza, Spain|Hospital Nuestra Señora de Sonsoles, Ávila, Spain",https://ClinicalTrials.gov/show/NCT04334928
NCT04355676,Evaluation of Activity and Safety of Two Regimens of Low Dose Oral Selinexor in Participants With Moderate or Severe COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,XPORT-CoV-1002,NA,https://ClinicalTrials.gov/show/NCT04355676
NCT04935515,C Reactive Protein in Home Quarantined Coronavirus Disease 2019 (COVID -19) Patients.,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,1/MA/URA/21,"ONLINE, Puducherry, India",https://ClinicalTrials.gov/show/NCT04935515
NCT04447781,"Safety, Tolerability and Immunogenicity of INO-4800 Followed by Electroporation in Healthy Volunteers for COVID19","Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",IVI COVID19-001,"Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, Korea, Republic of|Seoul National University Hospital, Seoul, Korea, Republic of",https://ClinicalTrials.gov/show/NCT04447781
NCT04818216,Nicotinamide Riboside in SARS-CoV-2 (COVID-19) Patients for Renal Protection,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",HSC20200914H|3UH3DK114920-04S2,"Icahn School of Medicine at Mount Sinai, New York, New York, United States|The University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States|University Health Systems, San Antonio, Texas, United States|Harborview Medical Center, Seattle, Washington, United States",https://ClinicalTrials.gov/show/NCT04818216
NCT04363333,Obstructive Sleep Apnea & Covid-19 Outcomes,Observational Model: Cohort|Time Perspective: Prospective,2020.140.IRB1.030,"Marmara University Hospital, Istanbul, Basibuyuk, Turkey|Koc University, Istanbul, Turkey|Koc Healthcare Istanbul American Hospital, İstanbul, Turkey",https://ClinicalTrials.gov/show/NCT04363333
NCT04410718,Glycaemia and Cardiac Function in Patients With COVID-19,Observational Model: Cohort|Time Perspective: Prospective,H-20024279,"Herlev and Gentofte Hospital, Hellerup, Please Select, Denmark|Hvidovre Hospital, Hvidovre, Please Select, Denmark",https://ClinicalTrials.gov/show/NCT04410718
NCT04407221,COVID-19 Research in Organ Transplant Recipients,Observational Model: Cohort|Time Perspective: Prospective,COV-19-SU-TX,"The Transplant Institute, Gothenburg, Vastra Gotaland, Sweden",https://ClinicalTrials.gov/show/NCT04407221
NCT04320238,Experimental Trial of rhIFNα Nasal Drops to Prevent 2019-nCOV in Medical Staff,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,Interferon_prophylaxis,"Taihe Hospital, Shiyan, Hubei, China",https://ClinicalTrials.gov/show/NCT04320238
NCT04667936,Evaluation of Sedation in COVID-19 ARDS,Observational Model: Case-Only|Time Perspective: Retrospective,#20-643 -Sed II,"University Hospital Frankfurt, Frankfurt, Hessen, Germany",https://ClinicalTrials.gov/show/NCT04667936
NCT04514016,Cross Sectional CFAR HIV/COVID-19 Study,Observational Model: Cohort|Time Perspective: Cross-Sectional,20200802,"Batchelor's Children's Research Institute, Miami, Florida, United States",https://ClinicalTrials.gov/show/NCT04514016
NCT04373733,Early Intervention in COVID-19: Favipiravir Verses Standard Care,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,CW002|2020-001449-38,"Grupo Hospitalar Conceição, Porto Alegre, Brazil|Fundação Oswaldo Cruz - Instituto Nacional de Infectologia Evandro Chagas (Fiocruz/INI), Rio De Janeiro, Brazil|Instituto Nacional de Ciencias Medicas y Nutricion, Salvador Zubiran, Mexico City, Mexico|Hull University Teaching Hospitals NHS Trust - Castle Hill Hospital, Hull, United Kingdom|Chelsea and Westminster Hospital, London, United Kingdom|West Middlesex University Hospital, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04373733
NCT04388514,Blood Ozonization in Patients With SARS-CoV-2 Respiratory Failure,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Treatment,CIG: Z7C2CA5837,"Dott. Amato De Monte, Udine, Italy",https://ClinicalTrials.gov/show/NCT04388514
NCT04760132,National Cohort Study of Effectiveness and Safety of SARS-CoV-2/COVID-19 Vaccines (ENFORCE),Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,ENFORCE,"Aarhus Universitetshospital, Skejby, Aarhus, Aarhus N, Denmark|Aalborg Universityhospital Syd, Aalborg, Denmark|Hvidovre Hospital, Hvidovre, Denmark|Odense Universityhospital, Odense, Denmark|Sjællandsuniversitetshospital, Roskilde, Denmark",https://ClinicalTrials.gov/show/NCT04760132
NCT04517630,Renal Biomarkers in AKI and COVID-19,Observational Model: Cohort|Time Perspective: Prospective,C26-20,"Centro de Investigacion en Enfermedades Infecciosas, Mexico City, Mexico",https://ClinicalTrials.gov/show/NCT04517630
NCT04283838,Humanistic Care in Healthcare Workers in Coronavirus Disease 2019,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,XJTU2H-WH2,NA,https://ClinicalTrials.gov/show/NCT04283838
NCT04332666,"Angiotensin-(1,7) Treatment in COVID-19: the ATCO Trial","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",P2020/201,NA,https://ClinicalTrials.gov/show/NCT04332666
NCT04373005,Screening of Cancer Patients to Assess Impact of COVID-19,Observational Model: Cohort|Time Perspective: Prospective,U-DEPLOY: RESPONSE|CAPCR 20-5337,"Princess Margaret Cancer Centre, Toronto, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04373005
NCT04830046,Covid-19 Vaccine Responsiveness in MM and Waldenstrom,Observational Model: Cohort|Time Perspective: Prospective,21-108,"Brigham and Women's Hospital, Boston, Massachusetts, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT04830046
NCT04437823,Efficacy of Intravenous Infusions of Stem Cells in the Treatment of COVID-19 Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,JB&RSC-01,"Jinnah Hospital, Lahore, Punjab, Pakistan",https://ClinicalTrials.gov/show/NCT04437823
NCT04431869,In-Utero Vascular Accidents in Neonates From COVID-19 Infected Mothers,Observational Model: Cohort|Time Perspective: Prospective,20-1399,"Children's Hospital Colorado, Aurora, Colorado, United States",https://ClinicalTrials.gov/show/NCT04431869
NCT04847687,Investigation of Hospitalisation Times and Mortality According to Drug Dose in Patients Given Systemic Methylprednisolone With a Pre-diagnosis of Covid-19 Pneumonia; Retrospective Study,Observational Model: Other|Time Perspective: Retrospective,2011-KAEK-25 2021/03-02,"Bursa Yüksek İhtisas EAH, Bursa, Eyalet/Yerleşke, Turkey",https://ClinicalTrials.gov/show/NCT04847687
NCT04674410,Utility of Empiric Antibiotics for Non-intubated Novel Coronavirus Diseases 2019 Patients,Observational Model: Cohort|Time Perspective: Retrospective,BD022383,"National Institutes of Health Clinical Center, Bethesda, Maryland, United States",https://ClinicalTrials.gov/show/NCT04674410
NCT04743388,Study of the Kinetics of Antibodies Against COVID-19 (SARS-CoV-2) and of Cellular Subpopulations of the Immune System,Observational Model: Cohort|Time Perspective: Prospective,900/24-12-2020,"Department of Clinical Therapeutics, General Hospital of Athens ALEXANDRA, Athens, Greece",https://ClinicalTrials.gov/show/NCT04743388
NCT04407260,"Use of Oxygen Hoods in Patients Failing on Conventional High-flow Oxygen Delivery Systems, Effects on Oxygenation, Mechanical Ventilation and Mortality Rates in Hypoxic COVID-19 Patients. Prospective Cohort Study.",Observational Model: Cohort|Time Perspective: Prospective,HoodStudy701,"Phelps Hospital, Sleepy Hollow, New York, United States",https://ClinicalTrials.gov/show/NCT04407260
NCT04330495,"Randomized, Controlled, Double-blind Clinical Trial Comparing the Efficacy and Safety of Chemoprophylaxis With Hydroxychloroquine in Patients Under Biological Treatment and / or JAK Inhibitors in the Prevention of SARS-CoV-2 Infection","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention",EnCOVID-HidroxiCLOROQUINA,NA,https://ClinicalTrials.gov/show/NCT04330495
NCT04357639,Impact of Long-term Protease Inhibitors in Patients Living With HIV on the Incidence of COVID-19 ( COVIP ),Observational Model: Cohort|Time Perspective: Prospective,COVIP,"CHI Créteil, Créteil, France|CHU Henri Mondor, Créteil, France|Centre hospitalier de Melun (GHSIF), Melun, France|Hopital universitaire de Hotel Dieu, Paris, France|Hopital Universitaire de Necker, Paris, France|CHI Villeneuve St Georges, Villeneuve-Saint-Georges, France",https://ClinicalTrials.gov/show/NCT04357639
NCT04601090,Survival Rates and Longterm Outcomes After COVID-19,Observational Model: Cohort|Time Perspective: Prospective,135310,"Oslo University Hospital, Oslo, Norway",https://ClinicalTrials.gov/show/NCT04601090
NCT04378582,Characteristics and Outcomes of Patients With COVID-19 Admitted to the ICU,Observational Model: Case-Only|Time Perspective: Other,31382620.0.0000.0068,"Hospital das Clínicas -HCFMUSP, Sao Paulo, SP, Brazil",https://ClinicalTrials.gov/show/NCT04378582
NCT04889274,Investigation of the Effects of Dietary Nitrate and Sex on COVID-19 Vaccine Induced Vascular Dysfunction in Healthy Men and Women (DiNOVasc-COVID-19),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",21/SC/0154,"The William Harvey Research Institute, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04889274
NCT04643678,Anakinra in the Management of COVID-19 Infection,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,MRC-05-140,"Hamad Medical Corporation, Doha, Qatar",https://ClinicalTrials.gov/show/NCT04643678
NCT04399252,Effect of Lactobacillus on the Microbiome of Household Contacts Exposed to COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Basic Science",Pro00105674,"Duke University, Durham, North Carolina, United States",https://ClinicalTrials.gov/show/NCT04399252
NCT04365881,Loneliness During the NPIs for the COVID-19 Pandemic in Norway: Risk Factors and Associations With Psychopathology,Observational Model: Other|Time Perspective: Cross-Sectional,REK12345,"University of Oslo, Oslo, Norway",https://ClinicalTrials.gov/show/NCT04365881
NCT04611230,"A Study to Assess Infection Rate of Severe Acute Respiratory Syndrome - CoronaVirus 2 (SARS-CoV-2) and It's Affect on Quality of Life in Adult Volunteers in Lake County, Illinois",Observational Model: Cohort|Time Perspective: Prospective,H20-308,"Great Lakes Clinical Trials /ID# 224874, Chicago, Illinois, United States",https://ClinicalTrials.gov/show/NCT04611230
NCT04684550,Use of Hypochlorous Acid as Prophylaxis in Health Personnel at High Risk of Infection by SARS-CoV 2 (COVID19),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention",FM-CIE-0824-20,NA,https://ClinicalTrials.gov/show/NCT04684550
NCT04339881,NOsocomial Dissemination Risk of SARS-Cov2,Observational Model: Other|Time Perspective: Prospective,APHP200417,"Didier Guillemot, Garches, France",https://ClinicalTrials.gov/show/NCT04339881
NCT04747678,Adverse Effects of Ivermectin Used in Egypt During COVID-19,Observational Model: Case-Crossover|Time Perspective: Cross-Sectional,ahmed19782020,"Ahmed Mansour, Shibīn Al Kawm, Menoufia, Egypt",https://ClinicalTrials.gov/show/NCT04747678
NCT04638673,NeuroCovid Rehab and Recovery Related to COVID-19 Diagnosis,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",00101270|U54GM104941-08,"Medical University of South Carolina, Charleston, South Carolina, United States",https://ClinicalTrials.gov/show/NCT04638673
NCT04953065,Coronavirus Disease 2019 (COVID-19) Vaccination in Cancer Patients,Observational Model: Cohort|Time Perspective: Prospective,PSCI-21-100,"Penn State Cancer Institute, Hershey, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04953065
NCT04397588,Extracorporeal Membrane Oxygenation (ECMO) and Coronavirus Disease (COVID) 19,Observational Model: Cohort|Time Perspective: Prospective,35RC20_8979 ECMO-SARS,"Angers University Hospital, Angers, France|Besançon Hospital, Besançon, France|Brest university Hospital, Brest, France|Caen University Hospital, Caen, France|Clermont ferrand University hospital, Clermont-Ferrand, France|APHP Henri Mondor Paris University Hospital, Créteil, France|Dijon University Hospital, Dijon, France|Vendée Hospital, La Roche-sur-Yon, France|Grenoble University Hospital, La Tronche, France|APHP Kremli Bicetre Paris University Hospital, Le Kremlin-Bicêtre, France|Marie Lannelongue Hospital, Le Plessis-Robinson, France|Lens Hospital, Lens, France|Lille University Hospital, Lille, France|Limoges University Hospital, Limoges, France|Clinique de la Sauvegarde, Lyon, France|Lyon University Hospital, Lyon, France|Marseille Européen Hospital, Marseille, France|APHM la Timone- Marseille University Hospital, Marseille, France|Clairval Hospital, Marseille, France|Metz University Hospital, Metz, France|Montpellier University Hospital, Montpellier, France|Emile Muller Hospital, Mulhouse, France|Nancy University Hospital, Nancy, France|Nantes University Hospital, Nantes, France|Ambroise Paré Hospital, Neuilly-sur-Seine, France|Nimes University Hospital, Nimes, France|Institut Mutualiste Montsouris, Paris, France|APHP Hopital Européen Georges Pompidou - Paris University Hospital, Paris, France|APHP necker Paris University Hospital, Paris, France|APHP Bichat - Paris University Hospital, Paris, France|APHP La Pitié Salpêtrière Paris University Hospital, Paris, France|Bordeaux University Hospital, Pessac, France|Poitiers University hospital, Poitiers, France|Reims University hospital, Reims, France|Rennes University hospital, Rennes, France|Rouen University Hospital, Rouen, France|Saint brieuc Hospital, Saint brieuc, France|La Réunion University Hospital, Saint-Denis, France|Saint Nazaire Hospital, Saint-Nazaire, France|Saint Etienne University Hospital, Saint-Étienne, France|Strasbourg University Hospital, Strasbourg, France|Toulouse University Hospital - Rangueil Hospital, Toulouse, France|Tours University Hospital, Tours, France|Bretagne Atlantique Hospital, Vannes, France",https://ClinicalTrials.gov/show/NCT04397588
NCT04750018,Influence of Co-Vid 19 Pandemic on Screening Mammography Single Institution,Observational Model: Cohort|Time Perspective: Retrospective,KSVGH20-CT7-26,"Radiology depart, Kaohsiung, Taiwan",https://ClinicalTrials.gov/show/NCT04750018
NCT04473183,Epidemiologic Assessment of SARS-CoV-2 (COVID-19) Prevalence in Minnesota,Observational Model: Cohort|Time Perspective: Prospective,SURG-2020-28863,"University of Minnesota, Minneapolis, Minnesota, United States",https://ClinicalTrials.gov/show/NCT04473183
NCT04852757,Estimating the Prevalence of Postpartum Anxiety and Depression in the Context of the Coronavirus Disease (COVID-19) Pandemic,Observational Model: Cohort|Time Perspective: Cross-Sectional,PsyCOVIDUM,"Groupe Hospitalier Paris Saint Joseph, Paris, Ile-de-France, France",https://ClinicalTrials.gov/show/NCT04852757
NCT04329533,Effects of Using Mobile App on Perceived Stress During COVID-19 Pandemic,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,2003524869,"Banner University Medicine Women's Institute, Phoenix, Arizona, United States",https://ClinicalTrials.gov/show/NCT04329533
NCT04323787,Viral Infection and Respiratory Illness Universal Study[VIRUS]: COVID-19 Registry,Observational Model: Cohort|Time Perspective: Other,20-002610,"Mayo Clinic in Arizona, Scottsdale, Arizona, United States|Mayo Clinic in Florida, Jacksonville, Florida, United States|Society of Critical Care Medicine (150+ sites), Chicago, Illinois, United States|Rahul Kashyap, Rochester, Minnesota, United States",https://ClinicalTrials.gov/show/NCT04323787
NCT04374786,Effects of Mobile App in House Staff Health and Well-being During COVID-19 Pandemic,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,2003524869 [Sub-study],"Banner University Medical Center Phoenix, Phoenix, Arizona, United States",https://ClinicalTrials.gov/show/NCT04374786
NCT04459702,A Study of Combination Therapies to Treat COVID-19 Infection,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",PRG-043,"ProgenaBiome, Ventura, California, United States",https://ClinicalTrials.gov/show/NCT04459702
NCT04525820,"High Dose Vitamin-D Substitution in Patients With COVID-19: a Randomized Controlled, Multi Center Study","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",2020-01401,"Cantonal Hospital Aarau, Aarau, AG, Switzerland|Cantonal Hospital Baselland Liestal, Liestal, BL, Switzerland|Cantonal Hospital St. Gallen, Saint Gallen, SG, Switzerland",https://ClinicalTrials.gov/show/NCT04525820
NCT04621461,Placebo Controlled Trial to Evaluate Zinc for the Treatment of COVID-19 in the Outpatient Setting,"Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",20-19,"St. Francis Hospital - The Heart Center, Roslyn, New York, United States",https://ClinicalTrials.gov/show/NCT04621461
NCT04352556,COVID19-hematological Malignancies: the Italian Hematology Alliance,Observational Model: Cohort|Time Perspective: Other,HM-COVID19-Italy,"SC Ematologia Ospedale SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy|UOC Ematologia, Ospedali Riuniti, Ancona, Italy|UOC Ematologia e Terapia Cellulare, Ospedale Mazzoni, Ascoli Piceno, Italy|SC Oncologia Medica, CRO, Aviano, Italy|SC Ematologia, Policlinico Bari, Bari, Italy|UOC Ematologia, I.R.C.C.S Istituto Tumori Giovanni Paolo II, Bari, Italy|SSD Ematologia, Ospedale degli Infermi, Biella, Italy|UOC Ematologia, Azienda Ospedaliero-Universitaria Policlinico S.Orsola-Malpighi,, Bologna, Italy|Ematologia e Centro Trapianto Midollo Osseo, Ospedale di Bolzano, Bolzano, Italy|UO Ematologia e CTMO, ASST Spedali Civili, Brescia, Italy|UO Ematologia e CTMO, ASST Spedali Civili, Brescia, Italy|UOC Onco-Ematologia ASST Valle Olona, Busto Arsizio, Italy|SC Ematologia e CTMO AZIENDA OSPEDALIERA ""G. BROTZU"" - OSPEDALE ONCOLOGICO BUSINCO, Cagliari, Italy|UOC Ematologia, AOU Policlinico Vittorio Emanuele, Catania, Italy|Ematologia, Ospedale Valduce, Como, Italy|UOC Ematologia, Azienda Ospedaliera di Cosenza, Cosenza, Italy|UO Ematologia e CTMO, ASST Cremona, Cremona, Italy|SC Ematologia Ospedale S. Croce, Cuneo, Italy|UOC, Ematologia Azienda Ospedaliero Universitaria Arcispedale S. Anna, Ferrara, Italy|S.O.D. Ematologia, Azienda Ospedaliero Universitaria Careggi, Firenze, Italy|UOC Ematologia, Policlinico Ospedali Riuniti, Foggia, Italy|IRST-IRCC di Meldola, Forlì, Italy|UO Ematologia, Ospedale Policlinico S.Martino IRCCS, Genova, Italy|UO Ematologia, Ospedale Policlinico San Martino, Genova, Italy|UOC di Ematologia e Trapianto di Cellule Staminali, P.O. Vito Fazzi, Lecce, Italy|UOC di Ematologia, Ospedale di Legnano, Legnano, Italy|UO Dipartimento di Ematologia, USL 6, Livorno, Italy|UOC Oncologia ASST Lodi, Lodi, Italy|UOC Ematologia Azienda Ospedaliera Universitaria ""G.Martino"", Messina, Italy|UO Ematologia, Ospedale dell'Angelo di Mestre, Mestre, Italy|Ematologia, IEO, Milano, Italy|SC Ematologia, Istituto Nazionale dei Tumori, Milano, Italy|SC Ematologia, Ospedale Niguarda, Milano, Italy|UO Ematologia, IRCCS Ospedale San Raffaele, Milano, Italy|UO Servizio di Ematologia e Medicina Trasfusionale, Ospedale Luigi Sacco, Milano, Italy|UOC Ematologia, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy|UO Ematologia Policlinico di Modena, Modena, Italy|UOC Ematologia, Ospedale S. Gerardo, Monza, Italy|SC Ematologia Istituto Nazionale Tumori - IRCCS ""Fondazione G. Pascale"",, Napoli, Italy|UOC Ematologia e Trapianti di Midollo, AOU Federico II, Napoli, Italy|UOC Ematologia, Ospedale Antonio Cardarelli, Napoli, Italy|UOC Ematologia, Azienda Ospedaliero-Universitaria Maggiore della Carità, Novara, Italy|Ospedale san Luigi Gonzaga, Orbassano, Italy|Ematologia Azienda Ospedaliera di Padova, Padova, Italy|UO Ematologia, Policlinico Paolo Giaccone, Palermo, Italy|UOC Ematologia e CTMO, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy|SC Ematologia, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy|SC Ematologia e Trapianto di Midollo Osseo, Azienda Ospedaliera di Perugia, Perugia, Italy|UO Ematologia e CTMO, Azienda Ospedaliera Ospedali Riuniti, Pesaro, Italy|UOC di Ematologia, Ospedale Civile Spirito Santo, Pescara, Italy|UO Ematologia e CTMO, Presidio Ospedaliero di Piacenza, Piacenza, Italy|UO Ematologia, AOU Pisana- Santa Chiara, Pisa, Italy|UO Ematologia dell'Ospedale Santa Maria delle Croci, Ravenna, Italy|UOC Ematologia, Grande Ospedale Metropolitano Bianchi-Melacrino-Morelli, Reggio Calabria, Italy|SC Ematologia, Arcispedale Santa Maria Nuova, Reggio Emilia, Italy|UO Ematologia, Ospedale Infermi, Rimini, Italy|AOU Azienda Ospedaliera Universitaria Sant'Andrea, Roma, Italy|IFO - Ematologia e Trapianto Cellule -Istituto Nazionale del Cancro di Regina Elena, Roma, Italy|SC Ematologia, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy|UO Ematologia e Trapianti di Cellule Staminali, A.O. S. Camillo-Forlanini, Roma, Italy|UO Ematologia, Policlinico Tor Vergata, Roma, Italy|UOC Ematologia e trapianto di cellule staminali, Policlinico Universitario Campus Bio-Medico, Roma, Italy|UOC Ematologia Policlinico Umberto I, Roma, Italy|UOC Ematologia, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy|UOC Ematologia- Azienda Ospedaliera San Giovanni Addolorata, Roma, Italy|UO Ematologia, Istituto Clinico Humanitas, Rozzano, Italy|UOC Ematologia e centro trapianti cellule staminali emopoietiche, AOU San Giovanni Di Dio e Ruggi D'aragona, Salerno, Italy|Ematologia ASL Imperiese, Sanremo, Italy|Medicina Interna ed Ematologia, Asl 1, Savona, Italy|UOC Ematologia, Policlinico Santa Maria alle Scotte, Siena, Italy|UOC Ematologia e Trapianto Midollo Osseo, Ospedale S. G. Moscati, Taranto, Italy|SCDU Ematologia e terapie cellulari, Ospedale Mauriziano Umberto I, Torino, Italy|UO Ematologia, Ospedale Universitario Molinette San Giovanni Battista, Torino, Italy|UO Ematologia, Ospedale Universitario Molinette San Giovanni Battista, Torino, Italy|UO Ematologia, Ospedale Civili Ca' Foncello, Treviso, Italy|SC Ematologia, Azienda sanitaria universitaria Giuliano Isontina, Trieste, Italy|Clinica Ematologia, Azienda Ospedaliera-Universitaria Santa Maria della Misericordia, Udine, Italy|UOC Ematologia, ASST Sette Laghi, Osp. Di Circolo e Fondazione Macchi, Varese, Italy|UOC Ematologia, Azienda Ospedaliera Integrata di Verona, Verona, Italy|UOC Ematologia, Azienda Ospedaliera Integrata di Verona, Verona, Italy|UOC Ematologia, Ospedale San Bortolo, Vicenza, Italy",https://ClinicalTrials.gov/show/NCT04352556
NCT04375410,Consequences of Intensified Handwash and Hand Disinfection Among Children During the COVID19 Pandemic,Observational Model: Cohort|Time Perspective: Cross-Sectional,SH042020,"Tine Caroc Warner, Hjørring, Nordjylland, Denmark",https://ClinicalTrials.gov/show/NCT04375410
NCT04894682,Safety and Long-term Effects of COVID-19 Vaccines in Patients With Pulmonary Tumor,Observational Model: Cohort|Time Perspective: Prospective,KY-Q-2021-087-01,"Guangdong Provincial People's Hospital, Guangzhou, Guangdong, China",https://ClinicalTrials.gov/show/NCT04894682
NCT04354779,Antibody Seroprevalence and Rate of Asymptomatic Infections With SARS-CoV-2 in Austrian Hospital Personnel.,Observational Model: Cohort|Time Perspective: Cross-Sectional,AUVA SARS-CoV-2 Studie,"Allgemeine Unfallversicherungsanstalt, Vienna, Austria",https://ClinicalTrials.gov/show/NCT04354779
NCT04610515,Innovative Support for Patients With SARS-COV2 Infections (COVID-19) Registry (INSPIRE),Observational Model: Cohort|Time Perspective: Prospective,75D30120C08008,"UCLA, Los Angeles, California, United States|UCSF, San Francisco, California, United States|Yale, New Haven, Connecticut, United States|Rush University Medical Center, Chicago, Illinois, United States|Thomas Jefferson University, Philadelphia, Pennsylvania, United States|University of Texas Southwestern, Dallas, Texas, United States|University of Texas Health Science Center at Houston, Houston, Texas, United States|University of Washington, Seattle, Washington, United States",https://ClinicalTrials.gov/show/NCT04610515
NCT04511962,"Feasibility, of Tele-rehabilitation Following COVID-19",Observational Model: Ecologic or Community|Time Perspective: Prospective,285205,"Castle Hill Hospital, Cottingham, East Yorkshire, United Kingdom",https://ClinicalTrials.gov/show/NCT04511962
NCT04413968,"COVID-19 Infection and Transmission in Exposed, Confined and Community-based Infants",Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,APHP200587|2020-A01540-39,"Hopital Avicenne, Bobigny, France|Hôpital Jean Verdier - Service de Pédiatrie, Bondy, France|Hôpital Jean Verdier, Bondy, France|Hôpital Antoine béclère, Clamart, France|Hôpital Louis Mourier, Colombes, France|CH intercommunal de Créteil, Créteil, France|Hôpital Andé Mignot, Le Chesnay, France|Hôpital Trousseau, Paris, France|Hôpital Robert debré, Paris, France|CHU de Rouen, Rouen, France|Hôpital Annecy Genevois, Épagny, France",https://ClinicalTrials.gov/show/NCT04413968
NCT04605588,A Triple Combination Antiviral Coronavirus Therapy (TriACT) for COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",Pro2020001862,"Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States",https://ClinicalTrials.gov/show/NCT04605588
NCT04342702,A Study on the Prospective Cohort Library of COVID-19 in Southeran,Observational Model: Cohort|Time Perspective: Prospective,SAHoWMU-CR2020-NCP-202,"Wenzhou Medical University, Wenzhou, Zhejiang, China|The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China",https://ClinicalTrials.gov/show/NCT04342702
NCT04627623,Prevalence and Risk Factors of COVID-19 in the Upper Silesian Agglomeration,Observational Model: Case-Crossover|Time Perspective: Cross-Sectional,2020/ABM /COVID19/0044,"Diagnostyka sp zoo, Katowice, Poland",https://ClinicalTrials.gov/show/NCT04627623
NCT04964115,Post Acute Sequelae of COVID-19,Observational Model: Cohort|Time Perspective: Cross-Sectional,210436,"Vanderbilt_University MC, Nashville, Tennessee, United States",https://ClinicalTrials.gov/show/NCT04964115
NCT04494386,Umbilical Cord Lining Stem Cells (ULSC) in Patients With COVID-19 ARDS,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",ULSC-CV-01,"Miami Baptist Hospital, Miami, Florida, United States|Sanford Research, Sioux Falls, South Dakota, United States",https://ClinicalTrials.gov/show/NCT04494386
NCT04537351,The MEseNchymal coviD-19 Trial: MSCs in Adults With Respiratory Failure Due to COVID-19 or Another Underlying Cause,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,CYP-COVID-19-01,"Nepean Hospital, Kingswood, New South Wales, Australia|Westmead Hospital, Westmead, New South Wales, Australia|Footscray Hospital, Footscray, Victoria, Australia|Sunshine Hospital, Saint Albans, Victoria, Australia",https://ClinicalTrials.gov/show/NCT04537351
NCT04532411,COVID-19 Testing Sample Acquisition Throughput and Efficiency,Observational Model: Other|Time Perspective: Other,QI Initiative,"Massachusetts General Hospital, Boston, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT04532411
NCT04419623,A Study of TL-895 With Standard Available Treatment Versus Standard Available Treatment for the Treatment of COVID-19 in Patients With Cancer,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,TL-895-202,"Georgia Cancer Center, Augusta, Georgia, United States|The Ohio State Comprehensive Cancer Center, Columbus, Ohio, United States",https://ClinicalTrials.gov/show/NCT04419623
NCT04904445,COVID-19 Antibody Responses In Cystic Fibrosis,Observational Model: Cohort|Time Perspective: Prospective,NL,NA,https://ClinicalTrials.gov/show/NCT04904445
NCT04818866,International Study of Inflammation in COVID-19,Observational Model: Cohort|Time Perspective: Prospective,HUM00178971-a,"University of Michigan, Ann Arbor, Michigan, United States",https://ClinicalTrials.gov/show/NCT04818866
NCT04535167,"First-In-Human Study To Evaluate Safety, Tolerability, And Pharmacokinetics Following Single Ascending And Multiple Ascending Doses of PF-07304814 In Hospitalized Participants With COVID-19.","Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",C4611001|2020-003905-73,"El Camino Health, Mountain View, California, United States|Palo Alto Medical Foundation, Mountain View, California, United States|Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States|UC Davis Health Investigational Drug Pharmacy, Sacramento, California, United States|UC Davis Medical Center, Sacramento, California, United States|Massachusetts General Hospital Translational and Clinical Research Center, Boston, Massachusetts, United States|Massachusetts General Hospital, Clinical Trials Pharmacy, Boston, Massachusetts, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Regional One Health, Memphis, Tennessee, United States|University Hospital Brugmann, Brussels, Belgium|Santa Casa De Misericórdia de Belo Horizonte, Belo Horizonte, Minas Gerais, Brazil|Hospital Universitario Fundacion Jimenez Diaz, Madrid, Spain|Hospital Universitario Virgen Del Rocio, Sevilla, Spain",https://ClinicalTrials.gov/show/NCT04535167
NCT04389996,COVID-19 Pandemic Impact on Patients With Cancer - a Danish Survey,Observational Model: Cohort|Time Perspective: Cross-Sectional,OP_1132,"Department of Haemotology, Odense University Hospital, Odense, Region Of Southern Denmark, Denmark|Department of Oncology, Odense University Hospital, Odense C, Denmark",https://ClinicalTrials.gov/show/NCT04389996
NCT04713540,Rehabilitation in Intensive Care Unit,Observational Model: Cohort|Time Perspective: Retrospective,intensive care unit,"Bakirkor Dr. Sadi Konuk Research and Training hospital, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04713540
NCT04396210,Patients Perspectives on Discontinuation of Their Fertility Treatment Due to the COVID-19 Pandemic,Observational Model: Other|Time Perspective: Prospective,B6702020000247,"Ghent University Hospital, Ghent, Belgium",https://ClinicalTrials.gov/show/NCT04396210
NCT04695379,Follow-up of a Cohort of Patients With Myasthenic Syndrome and COVID-19 Infection,Observational Model: Cohort|Time Perspective: Prospective,CHUBX 2020/17,"CHU d'Angers, Angers, France|CHU de Bordeaux, Bordeaux, France|Hospices Civils de Lyon, Bron, France|APHP - Hopital Raymond Poincarré, Garches, France|CHRU de Lille, Lille, France|Assistance Publique Hôpitaux de Marseille, Marseille, France|CHU de Nantes, Nantes, France|APHP GH Pitié Salpétrière, Paris, France|CHU de Strasbourg, Strasbourg, France|CHU de Toulouse, Toulouse, France",https://ClinicalTrials.gov/show/NCT04695379
NCT04679493,"Study to Assess Safety, Tolerability and Pharmacokinetics of XC7 (Which is Planned Use in the Treatment of COVID-19) in Healthy Volunteers","Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",COVID-XC7-01,"Federal State Autonomous Educational Institution of Higher Education ""The First Moscow State Medical University named after I.M. Sechenov"" of the Ministry of Health of the Russian Federation, Moscow, Russian Federation",https://ClinicalTrials.gov/show/NCT04679493
NCT04970927,The Effect of Pandemic on Children With Cerebral Palsy,Observational Model: Other|Time Perspective: Other,SASP21,"Sevda Adar, Merkez, Afyon, Turkey",https://ClinicalTrials.gov/show/NCT04970927
NCT04826770,Adaptive Immune Response Against Corona Virus Vaccination,Observational Model: Cohort|Time Perspective: Prospective,BB001/21,"University Medicine Greifswald, Greifswald, MV, Germany",https://ClinicalTrials.gov/show/NCT04826770
NCT04432350,Assessment of Mortality Rates in COVID-19 Infected Populations Treated With Repurposed Medications,Observational Model: Cohort|Time Perspective: Retrospective,COVID-19_TRHCPrescribeWellness,"Tabula Rasa HealthCare Precision Pharmacotherapy Research and Development Institute, Orlando, Florida, United States",https://ClinicalTrials.gov/show/NCT04432350
NCT04414319,Severe Acute Respiratory Syndrome-Coronavirus-2 and Loss of Autonomy in the Elderly,Observational Model: Other|Time Perspective: Prospective,20_RIPH3-02,"University hospital of Rennes, Rennes, France|Va de Lys-Ramsay Gds group Clinic, Tourcoing, France|Hopsital of Valenciennes, Valenciennes, France|University hospital of Guadeloupe, Les Abymes, Guadeloupe|University hospital of Martinique, Fort-de-France, Martinique",https://ClinicalTrials.gov/show/NCT04414319
NCT04860739,Vaccination With COMIRNATY in Subjects With a VAXZEVRIA First Dose,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,5859,"Hospital Universitario de Cruces, Barakaldo, Vizkaia, Spain|Hospital Vall d´Hebron, Barcelona, Spain|Hospital Clinic de Barcelona, Barcelona, Spain|Hospital Clínico San Carlos, Madrid, Spain|La Paz University Hospital, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04860739
NCT04767477,Telerehabilitation and Face-to-face Rehabilitation on COVID-19 Survivors,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,CR and TR,"Universidade Federal de Pernambuco, Recife, PE, Brazil",https://ClinicalTrials.gov/show/NCT04767477
NCT04441814,FOUND - Ancillary Study to Smile Protocol NCT03654105,Observational Model: Cohort|Time Perspective: Retrospective,INT 49/20,"Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy",https://ClinicalTrials.gov/show/NCT04441814
NCT04816942,Clinical Efficacy of Early Administration of Convalescent Plasma Among COVID-19 Cases in Egypt,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,10-2020/13,"Ministry of Health, Cairo, Giza, Egypt",https://ClinicalTrials.gov/show/NCT04816942
NCT04506515,Psychological Impact of COVID-19 Pandemic in Healthcare Workers,Observational Model: Ecologic or Community|Time Perspective: Cross-Sectional,COV2-2020,"CHGUV, Valencia, Spain",https://ClinicalTrials.gov/show/NCT04506515
NCT04334876,Rapid SARS-CoV-2 IgG Antibody Testing in High Risk Healthcare Workers,Observational Model: Ecologic or Community|Time Perspective: Prospective,2003973826,NA,https://ClinicalTrials.gov/show/NCT04334876
NCT04937712,Analysis of SARS-CoV2 Urine Viral Particles and Association With Proximal Tubular Dysfunction,Observational Model: Cohort|Time Perspective: Prospective,2021-A00724-37,NA,https://ClinicalTrials.gov/show/NCT04937712
NCT04374565,Convalescent Plasma for Treatment of COVID-19 Patients With Pneumonia,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,200114,"University of Virginia Medical Center, Charlottesville, Virginia, United States|University of Virginia, Charlottesville, Virginia, United States",https://ClinicalTrials.gov/show/NCT04374565
NCT04718220,"Safety, Testing/Transmission, and Outcomes in Pregnancies With COVID-19",Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,202012075,"Washington University Medical Center, Saint Louis, Missouri, United States",https://ClinicalTrials.gov/show/NCT04718220
NCT04690816,Natural History of Coronavirus Disease (COVID-19) in Systemic Autoimmune Diseases,Observational Model: Case-Control|Time Perspective: Prospective,10000207|000207-AR,"National Institutes of Health Clinical Center, Bethesda, Maryland, United States",https://ClinicalTrials.gov/show/NCT04690816
NCT04748120,Operative vs Non-Operative Management of Acute Appendicitis and Acute Cholecystitis in COVID-19 Positive Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,20-525,"Cleveland Clinic Foundation, Cleveland, Ohio, United States",https://ClinicalTrials.gov/show/NCT04748120
NCT04433546,"Pemziviptadil (PB1046), a Long-acting, Sustained Release Human VIP Analogue, Intended to Provide Clinical Improvement to Hospitalized COVID-19 Patients at High Risk for Rapid Clinical Deterioration and Acute Respiratory Distress Syndrome (ARDS).","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",PB1046-PT-CL-0007,"Baptist Health Research Institute, Jacksonville, Florida, United States|Sarasota Memorial Hospital, Sarasota, Florida, United States|The University of Kansas Medical Center, Kansas City, Kansas, United States|Adventist Healthcare White Oak Medical Center, Silver Spring, Maryland, United States",https://ClinicalTrials.gov/show/NCT04433546
NCT04381936,Randomised Evaluation of COVID-19 Therapy,Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,NDPHRECOVERY|2020-001113-21|ISRCTN50189673,"Eijkman Oxford Clinical Research Unit (EOCRU), Eijkman Institute for Molecular Biology, Jakarta, Indonesia|Clinical Trial Unit, Oxford University Clinical Research Unit-Nepal, Patan Academy of Health Sciences, Kathmandu, Nepal|Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom",https://ClinicalTrials.gov/show/NCT04381936
NCT04372056,The COVID-ICU Healthcare Professional Study,Observational Model: Cohort|Time Perspective: Prospective,136144,"Oslo university hospital, Oslo, Norway",https://ClinicalTrials.gov/show/NCT04372056
NCT04438954,"Investigation of Fatigue, Physical Activity, Sleep Quality and Anxiety Levels",Observational Model: Case-Only|Time Perspective: Prospective,2020,"Ankara Yıldırım Beyazıt University, Faculty of Health Sciences,Department of Physiotherapy and Rehabilitation, Ankara, Turkey",https://ClinicalTrials.gov/show/NCT04438954
NCT04969237,Vitamine D in Post-COVID Patients,Observational Model: Cohort|Time Perspective: Retrospective,1,"Klinikum Emden, Emden, Germany",https://ClinicalTrials.gov/show/NCT04969237
NCT04361461,Use of Hydroxychloroquine Alone or Associated for Inpatients With SARS-CoV2 Virus (COVID-19),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,APS000/2020,"Apsen Farmacêutica S.A., São Paulo, Brazil",https://ClinicalTrials.gov/show/NCT04361461
NCT04478071,Vadadustat for the Prevention and Treatment of Acute Respiratory Distress Syndrome (ARDS) in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",HSC-MS-20-0395,"The University of Texas Health Science Center at Houston, Houston, Texas, United States",https://ClinicalTrials.gov/show/NCT04478071
NCT04337424,Evaluation of Quickly Diagnostic Saliva Tests for SARS-CoV-2,Observational Model: Case-Control|Time Perspective: Prospective,RECHMPL20_0170,"UCH Montpellier, Montpellier, France",https://ClinicalTrials.gov/show/NCT04337424
NCT04408222,Awake Proning in COVID-19 Patients With Hypoxemic Respiratory Failure,Observational Model: Cohort|Time Perspective: Retrospective,AAAT0134,"Columbia University Medical Center, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04408222
NCT04492891,Cyclosporine For The Treatment Of COVID-19(+),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,H-48163,"Baylor College of Medicine, Houston, Texas, United States",https://ClinicalTrials.gov/show/NCT04492891
NCT04374617,Risk of Venous Thromboembolism in Critically Ill Patients With Severe COVID-19,Observational Model: Cohort|Time Perspective: Prospective,PR(AG)213/2020,"Vall d´Hebron Research Institute VHIR, Barcelona, Catalunya, Spain|Hospital Germans Trias i Pujol. Universitat Autònoma de Barcelona, Badalona, Spain|Hospital Universitari Vall d'Hebron. Universitat Autonoma de Barcelona, Barcelona, Spain",https://ClinicalTrials.gov/show/NCT04374617
NCT04353609,"Covid-19 in Patients With Chronic Inflammatory Rheumatism, Auto-immune or Auto-inflammatory Rare and Non-rare Diseases",Observational Model: Cohort|Time Perspective: Retrospective,NI_2020_03,"Hôpital Huriez, Lille, France",https://ClinicalTrials.gov/show/NCT04353609
NCT04367363,Social Media and COVID-19,Observational Model: Cohort|Time Perspective: Prospective,2020-CERC-001B,"Yale-NUS College, Singapore, Singapore",https://ClinicalTrials.gov/show/NCT04367363
NCT04416399,STerOids in COVID-19 Study,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,STOIC study,"Oxford Respiratory Trials Unit, Oxford, Oxfordshire, United Kingdom",https://ClinicalTrials.gov/show/NCT04416399
NCT04306705,Tocilizumab vs CRRT in Management of Cytokine Release Syndrome (CRS) in COVID-19,Observational Model: Cohort|Time Perspective: Retrospective,WHTJCOVID-19,"Tongji Hospital, Wuhan, Hubei, China",https://ClinicalTrials.gov/show/NCT04306705
NCT04632719,The MentalPlus® for Assessment and Rehabilitation of Cognitive Function After Remission of the Symptoms of COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,MentalPlus®,"Livia Stocco Sanches Valentin, São Paulo, SP, Brazil|Livia Stocco Sanches Valentin, Sao Paulo, Brazil",https://ClinicalTrials.gov/show/NCT04632719
NCT04846907,Mental Health of Professionals Working in Pediatric Intensive Care Units During the COVID-19 Pandemic,Observational Model: Cohort|Time Perspective: Cross-Sectional,COVID-EMOTION,"D'Or Institute for Research and Education, Rio De Janeiro, Brazil",https://ClinicalTrials.gov/show/NCT04846907
NCT04368793,Clinical Effects of Internet Assisted Pulmonary Rehabilitation of COVID-2019 Pneumonia Patients After Discharge,Observational Model: Cohort|Time Perspective: Prospective,2020-22-K17,"Wuhan Lung Hospital, Wuhan, Hubei, China|Wuhan Central Hospital, Wuhan, Hubei, China|Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China",https://ClinicalTrials.gov/show/NCT04368793
NCT04312009,Losartan for Patients With COVID-19 Requiring Hospitalization,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",SURG-2020-28675|INV-017069,"University of Florida Health Gainesville, Gainesville, Florida, United States|University of Florida Health Jacksonville, Jacksonville, Florida, United States|Grady Memorial Hospital, Atlanta, Georgia, United States|Henry Ford Hospital, Detroit, Michigan, United States|M Health Fairview Ridges Hospital, Burnsville, Minnesota, United States|M Health Fairview Southdale Hospital, Edina, Minnesota, United States|Hennepin County Medical Center, Minneapolis, Minnesota, United States|M Health Fairview University of Minnesota Medical Center, Minneapolis, Minnesota, United States|University of Minnesota, Minneapolis, Minnesota, United States|North Memorial Health Hospital, Robbinsdale, Minnesota, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|Cooper University Hospital, Camden, New Jersey, United States|University of Cincinnati Medical Center, Cincinnati, Ohio, United States",https://ClinicalTrials.gov/show/NCT04312009
NCT04542083,"Covid-19, Acute Myocardial Infarctions and Strokes in France",Observational Model: Other|Time Perspective: Retrospective,RECHMPL20_0513,"Uh Montpellier, Montpellier, France",https://ClinicalTrials.gov/show/NCT04542083
NCT04894279,Reliability and Validity of the Turkish Version of SMİLE-C,Observational Model: Other|Time Perspective: Cross-Sectional,SMİLE-C,NA,https://ClinicalTrials.gov/show/NCT04894279
NCT04491201,National Survey of the Impact of COVID-19 Pandemics,Observational Model: Cohort|Time Perspective: Cross-Sectional,CMDA-SURVEY2,"Lei Li, Beijing, Beijing, China",https://ClinicalTrials.gov/show/NCT04491201
NCT04395716,A Study of ResCure™ to Treat COVID-19 Infection,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,PRG-048,"ProgenaBiome, Ventura, California, United States",https://ClinicalTrials.gov/show/NCT04395716
NCT04315948,Trial of Treatments for COVID-19 in Hospitalized Adults,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",C20-15,"Medizinische Universität Innsbruck, Innsbruck, Austria|Kepler Universitätsklinikum Linz, Linz, Austria|Landeskrankenhaus Salzburg Universitätsklinikum der Paracelsus Medizinischen Privatuniversität, Salzburg, Austria|Hôpital Erasme - Cliniques universitaires de Bruxelles, Brussels, Belgium|Hôpital Saint Luc, Brussels, Belgium|Hôpital La Citadelle, Liège, Belgium|Centre Hospitalier Universitaire Amiens-Picardie, Amiens, France|Centre Hospitalier Regional Metz-Thionville, Ars-Laquenexy, France|Centre Hospitalier Régional Universitaire de Besançon, Besançon, France|Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France|CHU APHP Ambroise-Paré, Boulogne-Billancourt, France|Centre Hospitalier Andrée Rosemon, Cayenne, France|CHU Clermont-Ferrand, Clermont-Ferrand, France|Hospices Civil, Colmar, France|APHP - hôpital Henri-Mondor, Créteil, France|Centre Hospitalier Universitaire Dijon-Bourgogne, Dijon, France|Centre Hospitalier Universitaire de Martinique, Fort De France, France|AP-HP Hôpital Bicêtre, Kremlin-Bicêtre, France|Centre Hospitalo-Universitaire de Grenoble, La Tronche, France|Centre hospitalier de Versailles, Le Chesnay, France|Centre Hospitalier Régional Universitaire de Lille, Lille, France|Hospices Civils de Lyon, Lyon, France|Centre Hospitalier de Mont de Marsan, Mont-de-Marsan, France|Centre Hospitalier Universitaire de Montpellier, Montpellier, France|Groupe Hospitalier de la Région de Mulhouse Sud Alsace, Mulhouse, France|Centre Hospitalier Régional et Universitaire de Nancy, Nancy, France|Centre Hospitalier Universitaire de Nantes, Nantes, France|Centre Hospitalo-Universitaire de Nice, Nice, France|CHU Nîmes, Nîmes, France|APHP - Hôpital Lariboisière, Paris, France|APHP - Hôpital Saint Louis, Paris, France|APHP - Hôpital Saint Antoine, Paris, France|APHP - Hôpital Universitaire Pitié Salpêtrière, Paris, France|APHP - Hôpital Cochin, Paris, France|Hôpital Paris Saint-Joseph et Marie Lannelongue, Paris, France|APHP - Hôpital Necker, Paris, France|APHP- Hôpital Européen Georges-Pompidou, Paris, France|APHP - Hôpital Bichat Claude Bernard, Paris, France|APHP - Hôpital Tenon, Paris, France|CHU Poitiers, Poitiers, France|CH Cornouaille, Quimper, France|CHU de Reims, Reims, France|Centre Hospitalier Universitaire de Rennes, Rennes, France|Hopital DELAFONTAINE, Saint-Denis, France|Hôpital d'Instruction des Armées BEGIN, Saint-Mandé, France|Centre Hospitalier Universitaire de Saint Etienne, Saint-Étienne, France|Centre Hospitalier Régional Universitaire de Strasbourg, Strasbourg, France|Centre Hospitalier Universitaire de Toulouse, Toulouse, France|Centre Hospitalier Universitaire de Toulouse, Toulouse, France|Centre Hospitalier de Tourcoing, Tourcoing, France|Centre Hospitalier Universitaire de Tours, Tours, France|CH Bretagne Atlantique, Vannes, France|CH Bretagne Atlantique, Vannes, France|Centre Hospitalier Annecy Genevois, Épagny, France|Centre Hospitalier Luxembourg, Luxembourg, Luxembourg|Hôpitaux Robert Schuman, Luxembourg, Luxembourg|Akershus Unniversity Hospital, Oslo, Norway|Lovisenberg Diaconal Hospital, Oslo, Norway|Oslo University Hospital, Oslo, Norway|Hospital de Abrantes (CHMT), Abrantes, Portugal|Hospital de Cascais, Cascais, Portugal|CHULN- Hospital de Santa Maria, Lisboa, Portugal|Centro Hospitalar Universitário de São João, EPE, Porto, Portugal",https://ClinicalTrials.gov/show/NCT04315948
NCT04311177,Losartan for Patients With COVID-19 Not Requiring Hospitalization,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",SURG-2020-28683,"Hennepin County Medical Center, Minneapolis, Minnesota, United States|M Health Fairview University of Minnesota Medical Center, Minneapolis, Minnesota, United States|University of Minnesota, Minneapolis, Minnesota, United States|Mayo Clinic Health System, Rochester, Minnesota, United States",https://ClinicalTrials.gov/show/NCT04311177
NCT04442152,Impact of COVID-19 on Family Dynamics on Bandebereho Study Participants,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention,265A,"Rwanda Men's Resource Centre (Rwamrec), Kigali, Rwanda",https://ClinicalTrials.gov/show/NCT04442152
NCT04335084,"A Study of Hydroxychloroquine, Vitamin C, Vitamin D, and Zinc for the Prevention of COVID-19 Infection","Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention",PRG-042,"ProgenaBiome, Ventura, California, United States",https://ClinicalTrials.gov/show/NCT04335084
NCT04422977,Serological Study of the Exposure of Personnel to Sars-cov-2,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,SEROPHUGAC,NA,https://ClinicalTrials.gov/show/NCT04422977
NCT04405739,The Safety of Molnupiravir (EIDD-2801) and Its Effect on Viral Shedding of SARS-CoV-2 (END-COVID),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",EIDD-2801-2004,"Ronald Reagan UCLA Medical Center, Los Angeles, California, United States|Cook County Hospital, Chicago, Illinois, United States|Advocate Christ Medical Center, Oak Lawn, Illinois, United States|Advocate Lutheran General Hospital, Park Ridge, Illinois, United States|Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States|John Hopkins Hospital, Baltimore, Maryland, United States|Suburban Hospital, Bethesda, Maryland, United States|Howard County General Hospital, Columbia, Maryland, United States|Wake Forest Baptist Health, Winston-Salem, North Carolina, United States|Vanderbilt University, Nashville, Tennessee, United States|Houston Methodist Hospital, Houston, Texas, United States",https://ClinicalTrials.gov/show/NCT04405739
NCT04411511,"COVID-19, Obesity and Lifestyle in Children",Observational Model: Cohort|Time Perspective: Prospective,2020-1330,"Maastricht University Medical Center, Maastricht, Limburg, Netherlands",https://ClinicalTrials.gov/show/NCT04411511
NCT04513561,Evaluation of the Impact of Lock Down and End of Lock Down on the Management of Patients With Inflammatory and Dysimmune Diseases Followed in the Context of IMMINeNT FHU and COVID-19,Observational Model: Cohort|Time Perspective: Prospective,2020_51|2020_A01596_33,"Hop Claude Huriez Chu Lille, Lille, France",https://ClinicalTrials.gov/show/NCT04513561
NCT04949490,A Trial Investigating the Safety and Effects of One or Two Additional Doses of Comirnaty™ or One Dose of BNT162b2s01 in BNT162-01 or BNT162-04 Trial Subjects,Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,BNT162-14|2021-002387-50,NA,https://ClinicalTrials.gov/show/NCT04949490
NCT04672343,Prognostic Impact of the Nutritional Status of Individuals Aged 70 Years and Older With SARS-CoV-2,Observational Model: Cohort|Time Perspective: Retrospective,PUTOT AOIc 2020,"Chu Dijon Bourogne, Dijon, France",https://ClinicalTrials.gov/show/NCT04672343
NCT04916275,"Post-traumatic Stress, Signs of Depression and Burnout Syndrome Among Nursing Home Staff in Occitanie During the COVID-19 Pandemic",Observational Model: Cohort|Time Perspective: Prospective,Local/2020/COVID/JYL IC-04,"CHU de Montpellier, Montpellier, France|CHU de Nîmes, Hôpital Universitaire Carémeau, Nimes, France|CHU de Toulouse, Toulouse, France",https://ClinicalTrials.gov/show/NCT04916275
NCT04313946,Artificial Intelligence Algorithms for Discriminating Between COVID-19 and Influenza Pneumonitis Using Chest X-Rays,Observational Model: Ecologic or Community|Time Perspective: Prospective,110,"U.O. Multidisciplinare di Patologia Mammaria e Ricerca Traslazionale; Dipartimento Universitario Clinico di Scienze Mediche, Chirurgiche e della Salute Università degli Studi di Trieste, Cremona, Italy|University of Medicine and Pharmacy Gr T Popa, Iaşi, Romania|Department of Cardiology at Chelsea and Westminster NHS hospital, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04313946
NCT04459403,Psychiatric Disturbances and COVID-19 Infection,Observational Model: Case-Only|Time Perspective: Cross-Sectional,15-2020/1,"15 Mayo Smart Hospital, Cairo, Egypt|National hepatology and tropical medicine research institute, Cairo, Egypt|Students hospital, Giza, Egypt",https://ClinicalTrials.gov/show/NCT04459403
NCT04978025,"Colloidal Silver, Treatment of COVID-19","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",colloidal silver and COVID-19,"HU Sahloul, sousse, Tunisia, Sousse, Itinéraire Ceinture Cité Sahloul, Tunisia",https://ClinicalTrials.gov/show/NCT04978025
NCT04618835,Physical Activity a Vital Sign? 40 Steps to Safety Test for Patients With COVID-19,Observational Model: Cohort|Time Perspective: Prospective,283998,"Ysbyty Gwynedd, Menai Bridge, Gwynedd, United Kingdom",https://ClinicalTrials.gov/show/NCT04618835
NCT04356833,Nebulised Rt-PA for ARDS Due to COVID-19,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,132151,"Barnet Hospital, London, United Kingdom|The Royal Free Hospital, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04356833
NCT04411784,"PROTECT-ASUC: Covid-19 Pandemic Response Of assessmenT, EndosCopy and Treatment in Acute Severe Ulcerative Colitis",Observational Model: Case-Control|Time Perspective: Retrospective,284030,"Gastroenterology, Hull Royal Infirmary, Hull University Teaaching Hospitals NHS Trust, Hull, United Kingdom",https://ClinicalTrials.gov/show/NCT04411784
NCT04344184,SAFEty Study of Early Infusion of Vitamin C for Treatment of Novel Coronavirus Acute Lung Injury (SAFE EVICT CORONA-ALI),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",HM20018977,"Hunter Holmes McGuire VA Medical Center, Richmond, Virginia, United States|Virginia Commonwealth University, Richmond, Virginia, United States",https://ClinicalTrials.gov/show/NCT04344184
NCT04559113,Methylprednisolone in COVID-19 Patients (Methyl19LGH),Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,LGH005,"Muhammad Irfan Malik, Lahore, Punjab, Pakistan",https://ClinicalTrials.gov/show/NCT04559113
NCT04361474,Trial Evaluating the Efficacy of Local Budesonide Therapy in the Management of Hyposmia in COVID-19 Patients Without Signs of Severity,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,MDL_2020_10,"Amélie YAvchitz, Paris, France",https://ClinicalTrials.gov/show/NCT04361474
NCT04337788,Gerontological Telemonitoring of Older Adults Living in Nursing Homes With COVID-19 Disease,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,87RI20_0013,NA,https://ClinicalTrials.gov/show/NCT04337788
NCT04447404,"DUR-928 in Subjects With SARS-CoV-2 With Acute Lung, Liver or Kidney Injury","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",C928-020,"Site 03, Newark, New Jersey, United States",https://ClinicalTrials.gov/show/NCT04447404
NCT04531774,RECHARGE: A Brief Psychological Intervention to Build Resilience in Healthcare Workers During COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,BASEC-Nr.2020-00796,"Klinik für Konsiliarpsychiatrie und Psychosomatik, Zürich, Switzerland",https://ClinicalTrials.gov/show/NCT04531774
NCT03944447,Outcomes Mandate National Integration With Cannabis as Medicine for Prevention and Treatment of COVID-19,Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,Pro00033337,"OMNI Medical Services, Boca Raton, Florida, United States|OMNI Medical Services, Bradenton, Florida, United States|OMNI Medical Services, Fort Lauderdale, Florida, United States|OMNI Medical Services, Fort Myers, Florida, United States|OMNI Medical Services, Gainesville, Florida, United States|OMNI Medical Services, Merritt Island, Florida, United States|OMNI Medical Services, Miami, Florida, United States|OMNI Medical Services, Ocoee, Florida, United States|OMNI Medical Services, Pensacola, Florida, United States|OMNI Medical Services, Pompano Beach, Florida, United States|OMNI Medical Services, Tampa, Florida, United States|OMNI Medical Services, Wesley Chapel, Florida, United States|OMNI Medical Services, Beechwood, Ohio, United States|OMNI Medical Services, Bowling Green, Ohio, United States|OMNI Medical Services, Sandusky, Ohio, United States|OMNI Medical Services, Toledo, Ohio, United States|OMNI Medical Services, Toledo, Ohio, United States",https://ClinicalTrials.gov/show/NCT03944447
NCT04261426,The Efficacy of Intravenous Immunoglobulin Therapy for Severe 2019-nCoV Infected Pneumonia,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,IVIG-001,NA,https://ClinicalTrials.gov/show/NCT04261426
NCT04377581,"COVID-19 Health Messaging Efficacy and Its Impact on Public Perception, Anxiety, and Behavior",Observational Model: Ecologic or Community|Time Perspective: Cross-Sectional,STUDY00014798,"Penn State College of Medicine, Hershey, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04377581
NCT04726371,Best Practices to Prevent COVID-19 Illness in Staff and People With Serious Mental Illness and Developmental Disabilities in Congregate Living Settings,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,"2020P003803, 2020P003957","Massachusetts General Hospital, Boston, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT04726371
NCT04169542,"Impact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients With Breast Cancer Undergoing Breast Surgery",Observational Model: Cohort|Time Perspective: Prospective,PA18-1077|NCI-2019-07463,"MD Anderson in The Woodlands, Conroe, Texas, United States|M D Anderson Cancer Center, Houston, Texas, United States|MD Anderson League City, League City, Texas, United States|MD Anderson in Sugar Land, Sugar Land, Texas, United States",https://ClinicalTrials.gov/show/NCT04169542
NCT04709120,Analysis of Health Status of Сomorbid Adult COVID-19 Patients Hospitalised in Second Wave of SARS-CoV-2 Infection,Observational Model: Cohort|Time Perspective: Other,ACTIV-2,"Eurasian Association of Therapists, Moscow, Russian Federation",https://ClinicalTrials.gov/show/NCT04709120
NCT04260594,Clinical Study of Arbidol Hydrochloride Tablets in the Treatment of Pneumonia Caused by Novel Coronavirus,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,Abdrcspc202001,"Ruijin Hospital, Medical School of Shanghai Jiaotong University, Shanghai, Shanghai, China",https://ClinicalTrials.gov/show/NCT04260594
NCT04581096,Mapping COVID-19 Spread in a Tertiary Hospital,Observational Model: Cohort|Time Perspective: Prospective,COVID19-MAPA,"CHGUV, Valencia, Spain|CHGUV, Valencia, Spain",https://ClinicalTrials.gov/show/NCT04581096
NCT04934202,Cohort Follow-up of Survivors of Hospitalization for COVID-19 During the 2nd Wave of the Epidemic in France,Observational Model: Cohort|Time Perspective: Prospective,COMEBAC 2,"Bicetre hospital, Le Kremlin-Bicêtre, France",https://ClinicalTrials.gov/show/NCT04934202
NCT04474249,Follow-up of Critical COVID-19 Patients,Observational Model: Cohort|Time Perspective: Prospective,EPM-2020-02697,"Uppsala University Hospital, Uppsala, Sweden",https://ClinicalTrials.gov/show/NCT04474249
NCT04698837,Understanding Potential Airborne Transmission and the Protective Value of Type II Surgical Masks in SARS-CoV-2,Observational Model: Other|Time Perspective: Other,2020-02768,"University Hospital Bern, Bern, Switzerland",https://ClinicalTrials.gov/show/NCT04698837
NCT04698382,"Impact of COVID-19 on the Incidence, Characteristics, Management and Outcome of Sepsis",Observational Model: Cohort|Time Perspective: Retrospective,BD022384,"National Institutes of Health Clinical Center, Bethesda, Maryland, United States",https://ClinicalTrials.gov/show/NCT04698382
NCT04652648,Rapid Development and Implementation of a Remote ECG-monitored Prospective Randomized Clinical Trial During a Pandemic: Hydroxychloroquine Prophylaxis in COVID-19 Household Contacts,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,BM02332,"Bryn Mawr Hospital, Bryn Mawr, Pennsylvania, United States|Paoli Hospital, Paoli, Pennsylvania, United States|Lankenau Medical Center, Wynnewood, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04652648
NCT04910516,Emotional Freedom Technique (EFT) Effect on Nurses,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Health Services Research",B.10.1.TKH.4.34.H.GP.0.01/120,"Marmara University, Istanbul, Kadikoy, Turkey",https://ClinicalTrials.gov/show/NCT04910516
NCT04664101,"REmotely Monitored, Mobile Health-Supported High Intensity Interval Training After COVID-19 Critical Illness (REMM-HIIT-COVID-19)",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,Pro00105798,"Duke University Medical Center, Durham, North Carolina, United States|Vanderbilt University, Nashville, Tennessee, United States",https://ClinicalTrials.gov/show/NCT04664101
NCT04682197,Cereset Research In Healthcare Workers During COVID-19,Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,IRB00066997,NA,https://ClinicalTrials.gov/show/NCT04682197
NCT04255017,"A Prospective/Retrospective,Randomized Controlled Clinical Study of Antiviral Therapy in the 2019-nCoV Pneumonia",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,TJ20200128,"Department and Institute of Infectious Disease, Wuhan, Hubei, China",https://ClinicalTrials.gov/show/NCT04255017
NCT04972591,Follow-up Study of Population Vaccinated With COVID-19 Vaccine,Observational Model: Cohort|Time Perspective: Prospective,TJ20210623,"Department of Infectious Disease, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China",https://ClinicalTrials.gov/show/NCT04972591
NCT04340466,French Multicentre Observational Study on SARS-Cov-2 Infections (COVID-19) ICU Management Study,Observational Model: Cohort|Time Perspective: Prospective,2020-A00797-32,"CHU Nimes, Nîmes, France",https://ClinicalTrials.gov/show/NCT04340466
NCT04745377,Responses to COVID-19 Vaccination in Patients With Cancer,Observational Model: Case-Control|Time Perspective: Prospective,HE_42C/21 ReCOVer study,"Metropolitan Hospital, Athens, Attica, Greece",https://ClinicalTrials.gov/show/NCT04745377
NCT04482686,Trial of Combination Therapy to Treat COVID-19 Infection,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",PRG-049,"ProgenaBiome, Ventura, California, United States",https://ClinicalTrials.gov/show/NCT04482686
NCT04819802,MIcrovascular Dysfunction in CRitically Ill cOVID-19 Patients,Observational Model: Cohort|Time Perspective: Retrospective,APHP210249|2021-A00321-40,"Surgical Intensive Care Unit - Kremlin Bicêtre Hospital, APHP, Le Kremlin Bicêtre, France",https://ClinicalTrials.gov/show/NCT04819802
NCT04496076,COVID-19 Brain Injury,Observational Model: Cohort|Time Perspective: Prospective,STUDY20030201,"University of Pittsburgh, Pittsburgh, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04496076
NCT04323839,COVID-19 PRIORITY (Pregnancy CoRonavIrus Outcomes RegIsTrY),Observational Model: Cohort|Time Perspective: Prospective,20-30410,"University of California, San Francisco, San Francisco, California, United States",https://ClinicalTrials.gov/show/NCT04323839
NCT04547114,Breath Analysis for SARS-CoV-2 in Infected and Healthy Subjects,Observational Model: Case-Control|Time Perspective: Prospective,IMS COVID-19,"Klinikum Bayreuth/ Bayreuth General Hospital, Bayreuth, Germany",https://ClinicalTrials.gov/show/NCT04547114
NCT04410263,Microbiota in COVID-19 Patients for Future Therapeutic and Preventive Approaches,Observational Model: Cohort|Time Perspective: Prospective,2020-00646,"University Hospital Zurich, Zürich, Zurich, Switzerland",https://ClinicalTrials.gov/show/NCT04410263
NCT04261907,Evaluating and Comparing the Safety and Efficiency of ASC09/Ritonavir and Lopinavir/Ritonavir for Novel Coronavirus Infection,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,ASC09F-CTP-ZY-01,NA,https://ClinicalTrials.gov/show/NCT04261907
NCT04711954,HIV/COV in Ukraine-NL,Observational Model: Cohort|Time Perspective: Cross-Sectional,1990 Study,"Erasmus MC, Rotterdam, Netherlands|Lviv Regional AIDS Health Center, Lviv, Ukraine",https://ClinicalTrials.gov/show/NCT04711954
NCT04254874,"A Prospective/Retrospective,Randomized Controlled Clinical Study of Interferon Atomization in the 2019-nCoV Pneumonia",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,TJ20200131,"Department and Institute of Infectious Disease, Wuhan, Hubei, China",https://ClinicalTrials.gov/show/NCT04254874
NCT04689399,Sensitivity and Specificity of SARS-CoV-2 Rapid Antigen Test Compared to RT-PCR Test,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,COVID-19,"Christian von Buchwald, MD, DMSc, Professor, Copenhagen, Denmark",https://ClinicalTrials.gov/show/NCT04689399
NCT04867226,Effectiveness of Colchicine Among Patients With COVID-19 Infection,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,Effectiveness of colchicine,"Hawler medical university ,Rozhawa emergency hospital, Erbil, Iraq",https://ClinicalTrials.gov/show/NCT04867226
NCT04956224,Immunogenicity of VLA2101 Compared to VLA2001.,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",VLA2001-304,"Southern Clinical Trials Waitemata, Auckland, Birkenhead, New Zealand|Lakeland Clinical Trials Waikato, Hamilton, Nawton, New Zealand|Southern Clinical Trials Totara, Auckland, New Lynn, New Zealand|Lakeland Clinical Trials Culloden, Papamoa, Papamoa Beach, New Zealand|Southern Clinical Trials Remuera, Auckland, Remuera, New Zealand|Southern Clinical Trials Tasman, Nelson, Stoke, New Zealand|Southern Clinical Trials Christchurch, Christchurch, New Zealand|Lakeland Clinical Trials Rotorua, Rotorua, New Zealand",https://ClinicalTrials.gov/show/NCT04956224
NCT04546776,COVID-19 Persistence in Stool,Observational Model: Cohort|Time Perspective: Prospective,QIB05/2020,"James Paget University Hospital Foundation Trust, Great Yarmouth, Norfolk, United Kingdom|Quadram Institute Bioscience, Norwich, Norfolk, United Kingdom|Norfolk and Norwich University Hospital Foundation Trust, Norwich, Norfolk, United Kingdom",https://ClinicalTrials.gov/show/NCT04546776
NCT04322565,Colchicine Counteracting Inflammation in COVID-19 Pneumonia,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,ColCOVID-19,"Azienda Ospedaliero Universitaria di Parma, Parma, PR, Italy",https://ClinicalTrials.gov/show/NCT04322565
NCT04519398,Investigating the Involvement of ACE and Angiotensinogen Genes' Polymorphism Along With Other Thrombophilic Genotypes in Severe Forms of COVID-19 With/Without Thrombotic Events,Observational Model: Ecologic or Community|Time Perspective: Prospective,GTP0051,"University of Medicine and Pharmacy Gr T. Popa Iasi, Romania, Iasi, Romania",https://ClinicalTrials.gov/show/NCT04519398
NCT04332016,COVID-19 Biological Samples Collection,Observational Model: Case-Only|Time Perspective: Prospective,CHUBX 2020/11,"Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France",https://ClinicalTrials.gov/show/NCT04332016
NCT04540185,A Phase 3 Randomized Double Blind Efficacy and Safety Study of Oral Polio Vaccine and NA-831 for Covid-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",OPV-NA831,"Coronavirus Research Institute- Testing Site, Los Angeles, California, United States|Coronavirus Research Institute, Orange, California, United States|Coronavirus Research Institute-Testing Site, Palo Alto, California, United States|Coronavirus Research Testing Site, San Francisco, California, United States|Coronavirus Research Institute-Testing Site, Sunnyvale, California, United States|Coronavirus Research Institute, Sunnyvale, California, United States|Coronavirus Research Institute-Testing Site, Naperville, Illinois, United States|Coronavirus Research Institute-Testing Site-, Bronx, New York, United States|NeuroActiva-Clinical Research Unit, Auckland, New Zealand|NeuroActiva Testing Facility of NeuroActiva (New Zealand) Ltd, Auckland, New Zealand",https://ClinicalTrials.gov/show/NCT04540185
NCT04953312,"Calprotectin, a Biomarker of COVID-19 Severity (CALPRO)",Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,APHP210522|2021-A00674-37,"Gustave Roussy Institut, Villejuif, France",https://ClinicalTrials.gov/show/NCT04953312
NCT04665115,Ibrutinib for the Treatment of Patients With B-Cell Malignancies Who Are Infected With Coronavirus Disease 2019 (COVID-19),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,ACCRU-LY-2001|NCI-2020-11785|P30CA015083,"Mayo Clinic in Rochester, Rochester, Minnesota, United States",https://ClinicalTrials.gov/show/NCT04665115
NCT04402060,A Study of APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",APL9-COV-201,"University of California at San Francisco - Fresno, Fresno, California, United States|California Pacific Medical Center, San Francisco, California, United States|Baptist Medical Center Beaches, Jacksonville Beach, Florida, United States|Westchester General Hospital, Miami, Florida, United States|Northwestern University, Feinberg School of Medicine, Chicago, Illinois, United States|Loyola University Medical Center, Maywood, Illinois, United States|Lutheran Health Physicians, Fort Wayne, Indiana, United States|University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States|Norton Women's and Children's Hospital, Louisville, Kentucky, United States|Norton Audobon Hospital, Louisville, Kentucky, United States|Cambridge Medical Trials, Alexandria, Louisiana, United States|Ascension Providence Hospital, Southfield, Michigan, United States|Rutgers University - Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States|University at Buffalo, Buffalo, New York, United States|Columbia University, New York, New York, United States|Texas A&M College of Medicine - Scott and White, Temple, Texas, United States|Hospital Angelina Caron, Campina Grande Do Sul, Paraná, Brazil|Irmandade da Santa Casa de Misericordia de Porto Alegre, Porto Alegre, Rio Grande Do Sul, Brazil|Hospital São Lucas da PUCRS, Porto Alegre, Rio Grande Do Sul, Brazil|Hospital Estadual Mario Covas, Santo André, Sao Paulo, Brazil|CEMEC - Centro Multidisciplinar de Estudos Clinicos LTDA EPP, São Bernardo Do Campo, Sao Paulo, Brazil|Hospital Alemao Oswaldo Cruz, São Paulo, Sao Paulo, Brazil|Hospital Santa Marcelina, São Paulo, Sao Paulo, Brazil|UPECLIN - Unidade de Pesquisa Clínica da Faculdade de Medicina de Botucatu - FMB/UNESP, Botucatu, São Paulo, Brazil",https://ClinicalTrials.gov/show/NCT04402060
NCT04407598,COPD in the Time of COVID-19,Observational Model: Cohort|Time Perspective: Cross-Sectional,778,"NIHR Leicester Biomedical Research Centre (Respiratory), Glenfield Hospital, Leicester, United Kingdom",https://ClinicalTrials.gov/show/NCT04407598
NCT04367870,COVID-19 Detection Test in Oncology,Observational Model: Cohort|Time Perspective: Prospective,UC-TRA-2002|2020-A01002-37,"Centre Hospitalier de Boulogne sur Mer, Boulogne-sur-Mer, France|Centre Jean Perrin, Clermont-Ferrand, France|Hopitaux Civils de Colmar, Colmar, France|Hôpital Universitaire Pitié Salpêtrière, Paris, France|Institut Curie, Paris, France|Centre Eugène Marquis, Rennes, France|Institut Curie, Saint-Cloud, France",https://ClinicalTrials.gov/show/NCT04367870
NCT04528329,Anosmia and / or Ageusia and Early Corticosteroid Use,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,PR0013,"Asalam, Maadi, Cairo, Egypt",https://ClinicalTrials.gov/show/NCT04528329
NCT04791436,Oral and Olfactory Complications of Recovered COVID-19 Patients,Observational Model: Cohort|Time Perspective: Prospective,OORCV,NA,https://ClinicalTrials.gov/show/NCT04791436
NCT04388657,"COVID-19, bLOod Coagulation and Thrombosis",Observational Model: Cohort|Time Perspective: Prospective,2020-A00,"Hôpital Ambroise Paré, Boulogne-Billancourt, IDF, France|Hôpital Privé Jacques Cartier, Massy, IDF, France|Centre Cardiologique du Nord, Saint-Denis, IDF, France",https://ClinicalTrials.gov/show/NCT04388657
NCT04621214,Innovation of Audio-Visual Triage System in Combating the Spread of COVID-19 Infection and Its Efficacy: A Novel Strategy,Observational Model: Case-Only|Time Perspective: Cross-Sectional,IRBEC/BIH/013-2020,"The University of Lahore, Lahore, Punjab, Pakistan",https://ClinicalTrials.gov/show/NCT04621214
NCT04675281,Pathological Findings of Fatal COVID-19,Observational Model: Cohort|Time Perspective: Prospective,MR_HISTOCOVID,"CH Amiens, Amiens, France|Angers University Hospital, Angers, France|CH Angoulême, Angoulême, France|CH Annecy, Annecy, France|Hopital Privé d'Antony, Antony, France|CH Argenteuil, Argenteuil, France|CH Belfort, Belfort, France|CHU Bordeaux, Bordeaux, France|Hopital Sainte Camille, Bry-sur-Marne, France|CH Cahors, Cahors, France|CH Cergy Pontoise, Cergy-Pontoise, France|CH Cholet, Cholet, France|CHU Clermont-Ferrand, Clermont-Ferrand, France|CH Compiègne-Noyon, Compiègne, France|CHD Vendée, La Roche-sur-Yon, France|Hopital Lyon Sud, Lyon, France|Hôpital Lyon Sud, Lyon, France|Marseille Hopital Nord APHM, Marseillette, France|CH Melun, Melun, France|CH Montélimar, Montélimar, France|Nantes University Hospital, Nantes, France|CHU Nice, Nice, France|CHR Orléans, Orléans, France|CH Ambroise Paré APHP, Paris, France|GHEF Marne La Vallée, Paris, France|Hopital Antoine Béclère APHP, Paris, France|Hopital Cochin APHP, Paris, France|Hopital Georges Pompidou APHP, Paris, France|Hopital La Pitié Salpetrière APHP, Paris, France|Hopital Louis Mourier APHP, Paris, France|Hopital Necker APHP, Paris, France|Hopital Saint-Antoine APHP, Paris, France|Hopital Saint-Louis APHP, Paris, France|CH Poissy, Poissy, France|Hopital Privé Claude Galien, Quincy-sous-Sénart, France|CH Reims, Reims, France|CHU Rennes, Rennes, France|CH Saint-Brieuc, Saint-Brieuc, France|CHU Saint-Etienne, Saint-Étienne, France|Hopital Foch, Suresnes, France|CHRU Tours, Tours, France|CH Troyes, Troyes, France|CH Vannes, Vannes, France|CH Versailles, Versailles, France",https://ClinicalTrials.gov/show/NCT04675281
NCT04283396,Study for Novel Coronavirus Pneumonia (NCP),Observational Model: Cohort|Time Perspective: Prospective,NCP01,"Union hospital, Wuhan, Hubei, China",https://ClinicalTrials.gov/show/NCT04283396
NCT04786483,The Effect of Laughter Therapy on Students in the COVID-19 Pandemic,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Health Services Research",21-Jun,"Zonguldak Bülent Ecevit University, Zonguldak, Turkey",https://ClinicalTrials.gov/show/NCT04786483
NCT04410471,Humoral Immunity Against SARS-CoV-2 in Liver Transplanted Patients After COVID-19 in Comparison With Immunocompetent Patients,Observational Model: Case-Control|Time Perspective: Prospective,Sero-Covid19_TH,"Victor Fernandez Alonso, Madrid, Spain|Victor Fernández Alonso, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04410471
NCT04548531,Engaging Patients in Colon Cancer Screening Decisions During COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Health Services Research,2020P001579-2,"Massachusetts General Hospital, Boston, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT04548531
NCT04409535,Effects of the COVID-19 Health Emergency on Biopsychosocial Health,Observational Model: Ecologic or Community|Time Perspective: Other,20-266,"University of New Mexico Department of Pediatrics, Albuquerque, New Mexico, United States",https://ClinicalTrials.gov/show/NCT04409535
NCT04363632,Prospective Analysis of Morbi-mortality of Patients With Cancers in Active Phase of Treatment Suspected or Diagnosed of a SARS-CoV-2 Infection,Observational Model: Cohort|Time Perspective: Other,ET20-069,"Institut Bergonié, Bordeaux, France|Centre François Baclesse, Caen, France|Centre Hospitalier Métropole Savoie, Chambéry, France|Centre Jean Perrin, Clermont-Ferrand, France|Centre Georges François Leclerc, Dijon, France|Centre Oscar Lambret, Lille, France|Centre Leon Berard, Lyon, France|CH Annecy-Genevois, Metz-Tessy, France|Institut de Cancérologie de Montpellier, Montpellier, France|Groupement Hospitalier Porte de Provence, Montélimar, France|Centre Antoine Lacassagne, Nice, France|Centre Hospitalier Lyon-Sud, Pierre-Bénite, France|Institut Jean Godinot, Reims, France|Centre Henri Becquerel, Rouen, France|Institut de Cancérologie de l'Ouest, Saint-Herblain, France|Institut de cancérologie Strasbourg Europe (ICANS), Strasbourg, France|Institut Universitaire du Cancer de Toulouse - IUCT Oncopole, Toulouse, France|CH Valence, Valence, France",https://ClinicalTrials.gov/show/NCT04363632
NCT04960228,Exploring Changes in COVID-19 Vaccination Intentions by Prompting Altruistic Motives Using a Video Intervention,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Prevention,2022-2877,NA,https://ClinicalTrials.gov/show/NCT04960228
NCT04569825,Effect of Nasal Steroid in the Treatment of Anosmia Due to COVID-19 Disease,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",1148,"Raid Muhmid Al-Ani, Ramadi, Anbar, Iraq",https://ClinicalTrials.gov/show/NCT04569825
NCT04316949,Predictors of Respiratory Failure in SARS-Cov-2 Infection,Observational Model: Cohort|Time Perspective: Retrospective,PREDI-CO,"University of Bologna - Department of Medical and Surgical Sciences, Bologna, Italy",https://ClinicalTrials.gov/show/NCT04316949
NCT04593069,The COGCOV Study in ICU Patients,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,COGCOV,"Ziekenhuis Oost-Limburg, Genk, Belgium",https://ClinicalTrials.gov/show/NCT04593069
NCT04360096,Inhaled ZYESAMI™ (Aviptadil Acetate) for the Treatment of Severe COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",RLF-100_002,"St. Jude Medical Center, Fullerton, California, United States|University of California - Irvine, Irvine, California, United States|University of Miami Leonard M. Miller School of Medicine (UMMSM), Miami, Florida, United States|Northwestern Medical Group, Winfield, Illinois, United States|University of Louisville Hospital, Louisville, Kentucky, United States|Doylestown Hospital, Doylestown, Pennsylvania, United States|University of Texas San Antonio Medical Arts and Research Center, San Antonio, Texas, United States",https://ClinicalTrials.gov/show/NCT04360096
NCT04592549,Study of Monoclonal Antibody Cocktail Being Tested for the Prevention of COVID-19,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",ADM03820-001,"PMG Research of Winston-Salem, LLC, Winston-Salem, North Carolina, United States|ICON Early Phase Services, LLC, San Antonio, Texas, United States",https://ClinicalTrials.gov/show/NCT04592549
NCT04422587,Evaluation of the COVID-19 Infection Response in Patients Admitted to the Emergency Department for Dyspnea,Observational Model: Cohort|Time Perspective: Other,RC31/20/0149,"University Hospital of Toulouse, Toulouse, France",https://ClinicalTrials.gov/show/NCT04422587
NCT04659200,Thyroid Function Tests and Status of Thyroid Autoantibodies in Covid-19 Patients,Observational Model: Case-Only|Time Perspective: Retrospective,6122020,"Sabahattin Destek, Fatih, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04659200
NCT04445428,OPV as Potential Protection Against COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Care Provider, Outcomes Assessor)|Primary Purpose: Prevention",77/CNES/INASA/2020,"Bandim Health Project, Bissau, Guinea-Bissau",https://ClinicalTrials.gov/show/NCT04445428
NCT04371978,Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,0303-20-RMC,"Shamir Medical Center, Be'er Ya'aqov, Israel|Rabin Medical Center, Beilinson Campus, Petah tikva, Israel|Rabin Medical Center, Hasharon Campus, Petah tikva, Israel",https://ClinicalTrials.gov/show/NCT04371978
NCT04692779,A Prospective Clinical Study to Explore Response to Prone Positioning in ARDS Patients,Observational Model: Cohort|Time Perspective: Prospective,ProneARDS,"Rush University Medical Center, Chicago, Illinois, United States",https://ClinicalTrials.gov/show/NCT04692779
NCT04954612,Musculoskeletal Problems in School Children During the COVID-19 Pandemic,Observational Model: Other|Time Perspective: Cross-Sectional,2020/205,"Gaziosmanpasa Training and Research Hospital, Istanbul, Gaziosmanpasa, Turkey",https://ClinicalTrials.gov/show/NCT04954612
NCT04645433,Effect of Favipiravir on Mortality in Patients With COVID-19 at a Tertiary Center Intensive Care Unit,Observational Model: Cohort|Time Perspective: Retrospective,2854,"SisliHamidiye Etfal Education and Training Hospital, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04645433
NCT04748471,Immunogenecity and Safety of VaccinemRNA-1273 in Elderly Volunteers (Over 65 y) Compared to Younger Ones (18-45y),Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,APHP201504|2020-005889-34,NA,https://ClinicalTrials.gov/show/NCT04748471
NCT04371328,Emergency Management in a Dedicated Respiratory Unit of Patients With a Possible COVID-19 Infection,Observational Model: Cohort|Time Perspective: Prospective,RC31/20/0094,"University Hospital of Toulouse, Toulouse, France",https://ClinicalTrials.gov/show/NCT04371328
NCT04789603,Effects of Using Mask During the 6-minute Walking Test in Times of COVID-19,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Health Services Research,CBAS-2020-03,"Universitat Internacional de Catalunya, Sant Cugat Del Vallès, Barcelona, Spain|Universitat Internacional de Catalunya, Sant Cugat Del Vallès, Spain",https://ClinicalTrials.gov/show/NCT04789603
NCT04644302,Circulatory Coherence in COVID-19 and Non-COVID-19 Patients With Sepsis,Observational Model: Cohort|Time Perspective: Prospective,FNHK_IGS_8144,"University Hospital Hradec Kralove, Hradec Králové, Třebeš, Czechia",https://ClinicalTrials.gov/show/NCT04644302
NCT04875520,Assessing Testing Strategies for Safe Return to K-12 Schools in an Underserved Population,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,202104013,"Ferguson-Florissant School District, Hazelwood, Missouri, United States|Jennings School District, Jennings, Missouri, United States|Pattonville School District, Saint Ann, Missouri, United States|Normandy Schools Collaborative, Saint Louis, Missouri, United States|The School District of University City, University City, Missouri, United States",https://ClinicalTrials.gov/show/NCT04875520
NCT04782427,COVID-19 Infections and Mortality in Long-term Care Facilities During the First Wave,Observational Model: Cohort|Time Perspective: Retrospective,CentreSuddeMontréal,"CIUSSS Centre-Sud-de-l'Île-de-Montréal, Montreal, Quebec, Canada",https://ClinicalTrials.gov/show/NCT04782427
NCT04413058,Menstrual Cycle Characteristics of Healthcare Professionals,Observational Model: Case-Crossover|Time Perspective: Prospective,HNEAH KAEK 2020/KK/|Ministry of Health,"University of Health Sciences Turkey, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04413058
NCT04561102,Evaluation of the COVIDSeq Test in Nasal Swab and Saliva From a COVID-19 Asymptomatic Population,Observational Model: Case-Only|Time Perspective: Prospective,COVD-B07-002,"Rollins College Alfonds Sports Center, Winter Park, Florida, United States",https://ClinicalTrials.gov/show/NCT04561102
NCT04844268,"Phase 1 Study to Assess Safety, Reactogenicity and Immunogenicity of the HDT-301 Vaccine Against COVID-19",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,CIMATEC01,NA,https://ClinicalTrials.gov/show/NCT04844268
NCT04561089,Evaluation of the COVIDSeq Test in Saliva Specimens From COVID-19 Asymptomatic Illumina Personnel,Observational Model: Case-Only|Time Perspective: Prospective,COVD-B07-001,"Illumina Laboratory Services, Foster City, California, United States|Illumina Hayward, Hayward, California, United States|Illumina Laboratory Services, San Diego, California, United States",https://ClinicalTrials.gov/show/NCT04561089
NCT04594330,Virgin Coconut Oil (VCO) as a Potential Adjuvant Therapy in COVID-19 Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment",002/05/2020,"Central Public Hospital Dr. Sardjito, Yogyakarta, Indonesia|RSUD Wonosari, Yogyakarta, Indonesia|RSUP Sleman, Yogyakarta, Indonesia|Teaching Hospital of Universitas Gadjah Mada (UGM), Yogyakarta, Indonesia",https://ClinicalTrials.gov/show/NCT04594330
NCT04449783,Preoperative Shielding and N/T RT-PCR Swabbing for Elective Cancer Surgery,Observational Model: Cohort|Time Perspective: Prospective,SP0355,"Liverpool University Hospitals NHS Foundation Trust, Liverpool, Merseyside, United Kingdom",https://ClinicalTrials.gov/show/NCT04449783
NCT04366115,Evaluating AVM0703 for Treatment of COVID-19 or Influenza-mediated ARDS,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",AVM0703-101,NA,https://ClinicalTrials.gov/show/NCT04366115
NCT04385238,Health and Wellbeing of Pregnant and Post-Partum Women During the COVID-19 Pandemic,Observational Model: Case-Only|Time Perspective: Cross-Sectional,2,"Pregistry, Los Angeles, California, United States",https://ClinicalTrials.gov/show/NCT04385238
NCT04426266,Psychological Effects of the COVID-19 Pandemic on the Hungarian Adult Population,Observational Model: Cohort|Time Perspective: Cross-Sectional,PSZ-002,"University of Szeged Department of Dermatology and Allergology, Szeged, Hungary",https://ClinicalTrials.gov/show/NCT04426266
NCT04465552,Arrhythmic Manifestations and Management in Hospitalized COVID-19 Patients,Observational Model: Case-Control|Time Perspective: Retrospective,KCHRF-COVID-19-0001,"Kansas City Heart Rhythm Institute, Overland Park, Kansas, United States",https://ClinicalTrials.gov/show/NCT04465552
NCT04407117,Appendicitis During the National Lockdown During the COVID-19 Pandemic,Observational Model: Cohort|Time Perspective: Retrospective,APPCOVID-19,"Nordsjaellands Hospital, Hillerød, Denmark",https://ClinicalTrials.gov/show/NCT04407117
NCT04631497,"Assessment of Stress, Depression and Anxiety in Healthcare Caring for Patients With COVID-19",Observational Model: Cohort|Time Perspective: Prospective,1072.6120.161.2020,"University Hospital in Cracow, Kraków, Poland",https://ClinicalTrials.gov/show/NCT04631497
NCT04378595,Assessing Pediatric Food Insecurity During the COVID-19 Pandemic in Austin,Observational Model: Cohort|Time Perspective: Prospective,2020-004-0019,"Dell Medical School, Austin, Texas, United States|CommUnity Care Clinic - Southeast Health and Wellness Clinic, Austin, Texas, United States|CommUnity Care Clinic - Rundberg, Austin, Texas, United States",https://ClinicalTrials.gov/show/NCT04378595
NCT04912817,PR-VR At-home Program During and After COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Health Services Research,1000075493,NA,https://ClinicalTrials.gov/show/NCT04912817
NCT04686708,COVID-19 Pandemic and General Surgery Emergencies,Observational Model: Cohort|Time Perspective: Retrospective,Gulhane2020-258,"Gulhane Training and Research Hospital, Ankara, Turkey",https://ClinicalTrials.gov/show/NCT04686708
NCT04341935,Effects of DPP4 Inhibition on COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,20200384,"University of Miami, Miami, Florida, United States",https://ClinicalTrials.gov/show/NCT04341935
NCT04343053,Pro-thrombotic Status in Patients With SARS-Cov-2 Infection,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,250320,"Azienda Ospedaliera Universitaria di Ferrara, Ferrara, Italy",https://ClinicalTrials.gov/show/NCT04343053
NCT04370834,Tocilizumab for Patients With Cancer and COVID-19 Disease,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,NCI-2020-02987|TRC-10446,"National Cancer Institute, Rockville, Maryland, United States|University Medical Center of Southern Nevada, Las Vegas, Nevada, United States|Summerlin Hospital Medical Center, Las Vegas, Nevada, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States|Valley Medical Center, Renton, Washington, United States",https://ClinicalTrials.gov/show/NCT04370834
NCT04399967,"COVID-19 Brief Advice and Chat-based Support for Smoking Cessation Via ""Quit to Win"" Contest 2020",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Health Services Research,QTW 2020,"Hong Kong Council on Smoking and Health (COSH), Hong Kong, Hong Kong, China",https://ClinicalTrials.gov/show/NCT04399967
NCT04912791,Obstetric Anaesthesia And Analgesia Month Attributes - in COVID-19,Observational Model: Cohort|Time Perspective: Prospective,MU_IBA2021,"Brno University Hospital, Brno, South Moravian Region, Czechia",https://ClinicalTrials.gov/show/NCT04912791
NCT04522986,An Exploratory Study of ADR-001 in Patients With Severe Pneumonia Caused by SARS-CoV-2 Infection,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,ADR-001-1919,"Osaka University Hospital, Suita, Osaka, Japan",https://ClinicalTrials.gov/show/NCT04522986
NCT04573868,"National Study ""AEC COVID-19""",Observational Model: Case-Only|Time Perspective: Prospective,AEC-COVID,"Salvador Morales-Conde, Sevilla, Spain",https://ClinicalTrials.gov/show/NCT04573868
NCT04605692,Evaluation of Occupational Burnout and Stress Among Dentists in Covid-19 Pandemic,Observational Model: Cohort|Time Perspective: Prospective,KAEK- 590,"Akdeniz Üniversitesi, Antalya, Konyaaltı, Turkey",https://ClinicalTrials.gov/show/NCT04605692
NCT04348929,Birth Experience During COVID-19 Confinement,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Screening,2020-A00881-38,"Centre Hospitalier Régional Universitaire de Nancy, Nancy, France",https://ClinicalTrials.gov/show/NCT04348929
NCT04492384,Analysis of Chronic Non-infectious Diseases Dynamics After COVID-19 Infection in Adult Patients,Observational Model: Cohort|Time Perspective: Other,ACTIV11062020,"Eurasian Association of Therapists, Moscow, Russian Federation",https://ClinicalTrials.gov/show/NCT04492384
NCT04414371,Tools for Wellbeing COVID-19 National Study of Undergraduate Students,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,Pro2020000953,"Rutgers University, New Brunswick, New Jersey, United States",https://ClinicalTrials.gov/show/NCT04414371
NCT04325919,Coronavirus Disease 2019 (COVID-19) Study of Hospitalized Patients in Hong Kong,Observational Model: Case-Control|Time Perspective: Prospective,COVID-19 study 2020.076,"Prince of Wales Hospital, Sha Tin, Hong Kong",https://ClinicalTrials.gov/show/NCT04325919
NCT04959773,Muscle Weakness in COVID-19 Patients,Observational Model: Case-Control|Time Perspective: Retrospective,UPavia-MIOCOVID,"Azienda Ospedaliera, Alessandria, AL, Italy",https://ClinicalTrials.gov/show/NCT04959773
NCT04261270,"A Randomized,Open,Controlled Clinical Study to Evaluate the Efficacy of ASC09F and Ritonavir for 2019-nCoV Pneumonia",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,ASC09F-CTP-TJ-01,"Department and Institute of Infectious Disease, Wuhan, Hubei, China",https://ClinicalTrials.gov/show/NCT04261270
NCT04357938,Risk Stratification With Chest CT to Rule-out Suspected SARS-CoV-2 Infections,Observational Model: Cohort|Time Perspective: Prospective,IDIR-001-2020,"Jena University Hospital, Jena, Thuringia, Germany",https://ClinicalTrials.gov/show/NCT04357938
NCT04878822,Immunogenicity of Covid-19 Vaccination for Patients With Hematological Malignancies,Observational Model: Cohort|Time Perspective: Other,ImmunoHaema-COVID-VAX-21,"UOC Ematologia, ASST Sette Laghi, Osp. Di Circolo e Fondazione Macchi, Varese, Lombardia, Italy",https://ClinicalTrials.gov/show/NCT04878822
NCT04061382,Sero-epidemiological Survey of England in 2019/2020 - COVID-19,Observational Model: Other|Time Perspective: Prospective,ID 263097,"Centre for Clinical Vaccinology & Tropical Medicine (CCVTM), Oxford, Oxfordshire, United Kingdom",https://ClinicalTrials.gov/show/NCT04061382
NCT04721457,The Efficacy of Pre-procedural Mouth Rinses on COVID-19 Saliva Viral Load,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",1384,"Alhamra TETAMMAN clinic (PHC), Jeddah, Saudi Arabia",https://ClinicalTrials.gov/show/NCT04721457
NCT04391140,Prone Positioning and High-flow Nasal Cannula in COVID-19 Induced ARDS,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,PR(AG)198/2020,"Hospital Universitari Vall d'Hebron, Barcelona, Spain",https://ClinicalTrials.gov/show/NCT04391140
NCT04365101,Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19,Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,CYNK-001-COVID-19,"UC Irvine, Irvine, California, United States|UC Davis Medical Center, Sacramento, California, United States|Scripps Health, San Diego, California, United States|Hackensack University Medical Center, Hackensack, New Jersey, United States|Atlantic Health, Morristown, New Jersey, United States|Atlantic Health, Summit, New Jersey, United States|Multicare Health System, Tacoma, Washington, United States",https://ClinicalTrials.gov/show/NCT04365101
NCT04763395,Liver Function Test Abnormalities in COVID-19,Observational Model: Case-Only|Time Perspective: Retrospective,Soh-Med-21-02-27,"Mona Mohammed Abdelrhman, Sohag, Egypt",https://ClinicalTrials.gov/show/NCT04763395
NCT04603105,CCP Cancer UK Companion Study,Observational Model: Cohort|Time Perspective: Prospective,C1147,NA,https://ClinicalTrials.gov/show/NCT04603105
NCT04584658,Dysphagia and Dysphonia Outcomes in SARS CoV-2 (COVID-19) Infection (DYADS Study),Observational Model: Cohort|Time Perspective: Prospective,20/NW/0333,"Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom",https://ClinicalTrials.gov/show/NCT04584658
NCT04861272,Risk Perception Associated With Covid-19 Among Anesthetists,Observational Model: Ecologic or Community|Time Perspective: Cross-Sectional,IRB approval No. E-20-4975,"Salah N. El-Tallawy, Riyadh, Saudi Arabia",https://ClinicalTrials.gov/show/NCT04861272
NCT04733105,Pronostic Value of Type I ANTi-Interferon Antibodies in Patients With COVID-19 Acute Respiratory Failure,Observational Model: Other|Time Perspective: Other,APHP201254,"Assistance Publique Hôpitaux de Paris - CHU HENRI MONDOR, Créteil, France",https://ClinicalTrials.gov/show/NCT04733105
NCT04319900,Clinical Trial of Favipiravir Tablets Combine With Chloroquine Phosphate in the Treatment of Novel Coronavirus Pneumonia,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment",2020-K-24-2,"Beijing Chaoyang hospital, Beijing, Beijing, China",https://ClinicalTrials.gov/show/NCT04319900
NCT04332042,TOFAcitinib in SARS-CoV2 Pneumonia,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,TOFACoV,"Ospedali Riuniti di Ancona, Ancona, Marche, Italy",https://ClinicalTrials.gov/show/NCT04332042
NCT04454606,The New Silicone N99 Half-Piece Respirator,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,053/2563,"Bangkok Metroplitan Administration and Vajira Hospital, Bangkok, Thailand",https://ClinicalTrials.gov/show/NCT04454606
NCT04385576,"Taiwan ""Aerosol Box"" Versus UMMC ""Intubation Box""",Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science,2020410-8498,"University Malaya Medical Centre, Kuala Lumpur, Selangor, Malaysia",https://ClinicalTrials.gov/show/NCT04385576
NCT04558450,Covid-19 Effects on Arterial Stiffness and Vascular Aging (CARTESIAN),Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,APHP200762|20.07.24.57438,"CHU Lille, Lille, France|CHRU Nancy, Nancy, France|Hôpital Européen Georges Pompidou - APHP, Paris, France|CHU Rouen, Rouen, France",https://ClinicalTrials.gov/show/NCT04558450
NCT04438967,Brain Health in the Time of COVID-19,Observational Model: Cohort|Time Perspective: Other,MIRO_001_2020,"Miro Health, San Francisco, California, United States",https://ClinicalTrials.gov/show/NCT04438967
NCT04379063,COVID-19 Pandemic Short Interval National Survey Gauging Psychological Distress,Observational Model: Cohort|Time Perspective: Prospective,NSHA REB#1025690,"Nova Scotia Health Authority, Halifax, Nova Scotia, Canada",https://ClinicalTrials.gov/show/NCT04379063
NCT04701502,Efficacy and Safety of Viusid and Asbrip in Hospitalized Patients With Mild and Moderate COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,COVID_BULG_2020,"MBAL, Sv. Mina, Plovdiv, Bulgaria|MTB Plovdiv, Plovdiv, Bulgaria",https://ClinicalTrials.gov/show/NCT04701502
NCT04547218,Study on Incidence of Elective Surgery Postponed During COVID-19 Pandemic in Geriatric Population,Observational Model: Case-Only|Time Perspective: Cross-Sectional,2020623-8801,"Department of Anesthesiology & Intensive Care, Faculty of Medicine, University of Malaya, Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia",https://ClinicalTrials.gov/show/NCT04547218
NCT04421664,Preemptive Therapy for SARS-Coronavirus-2 (COVID-19 PEP Canada),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",2020-6549,"University of Minnesota, Minneapolis, Minnesota, United States|University of Alberta, Edmonton, Alberta, Canada|University of British Columbia, Vancouver, British Columbia, Canada|University of Manitoba, Winnipeg, Manitoba, Canada|Eastern Health, Saint John's, Newfoundland and Labrador, Canada|McMaster University, Hamilton, Ontario, Canada|Lawson Health Research Institute, London, Ontario, Canada|Research Institute of the McGill University Health Centre, Montréal, Quebec, Canada",https://ClinicalTrials.gov/show/NCT04421664
NCT04337190,Impact of Angiotensin II Receptor Blockers Treatment in Patients With COVID 19 (COVID-ARA2),Observational Model: Cohort|Time Perspective: Prospective,COVID-ARA2,"University Hospital Angers, Angers, France",https://ClinicalTrials.gov/show/NCT04337190
NCT04769349,Effectiveness of Supportive Housing on COVID-19 Related Outcomes for People Experiencing Homelessness,Observational Model: Cohort|Time Perspective: Prospective,UP-20-01081,"Los Angeles Homeless Services Authority (LAHSA), Los Angeles, California, United States",https://ClinicalTrials.gov/show/NCT04769349
NCT04659460,RIC as an Adjunct Therapy for Severe COVID-19 Disease: a Prospective Randomized Pilot Study,"Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",1.4,NA,https://ClinicalTrials.gov/show/NCT04659460
NCT04631172,Covid-19 Anxiety and Phobia Levels of the Parents,Observational Model: Other|Time Perspective: Cross-Sectional,farukcicekci,"Selcuk University, School of Medicine, Konya, Turkey",https://ClinicalTrials.gov/show/NCT04631172
NCT04360863,The Impact of COVID-19 Pandemic on the Smoking Behaviour of Young Smokers and the Youth Quitline Service in Hong Kong,Observational Model: Other|Time Perspective: Cross-Sectional,NCT02758028_1,"The University of Hong Kong, Hong Kong, Hong Kong",https://ClinicalTrials.gov/show/NCT04360863
NCT04466982,Assessment of Olfactory Dysfunction in SARS CoV-2 (COVID-19) Infection,Observational Model: Cohort|Time Perspective: Prospective,REC Ref: 20/SC/0231,"Addenbrookes Hospital, Cambridge, United Kingdom|Charing Cross Hospital, London, United Kingdom|Royal Cornwall Hospital, Truro, United Kingdom",https://ClinicalTrials.gov/show/NCT04466982
NCT04314271,The Observational Study of Cardiac and Pulmonary Ultrasound and Evaluation of Treatment of Severe Patients With Novel Coronavirus Pneumonia,Observational Model: Cohort|Time Perspective: Prospective,202003028,"Xiangya Hospital, Central South University, Changsha, Hunan, China",https://ClinicalTrials.gov/show/NCT04314271
NCT04368637,Acute Cardiovascular Events Triggered by COVID-19-Related Stress,Observational Model: Cohort|Time Perspective: Cross-Sectional,JCCG.JoCORE.4.4040,"Istishari Hospital, Amman, Jordan|Abdelhadi Hospital, Amman, Jordan|Farah Hospital, Amman, Jordan|Jordan Hospital, Amman, Jordan|Specialty Hospital, Amman, Jordan",https://ClinicalTrials.gov/show/NCT04368637
NCT04382547,Treatment of Covid-19 Associated Pneumonia With Allogenic Pooled Olfactory Mucosa-derived Mesenchymal Stem Cells,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,IBCE_MSC2(Covid),"Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus, Minsk, Belarus",https://ClinicalTrials.gov/show/NCT04382547
NCT04345419,Remdesivir Efficacy in Coronavirus Disease,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,COVID 19 treatment,"Tanta university hospital, Assuit University, Ainshams University, Tanta, Egypt",https://ClinicalTrials.gov/show/NCT04345419
NCT04321616,The Efficacy of Different Anti-viral Drugs in COVID 19 Infected Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,118684,"Andreas Barratt-Due, Oslo, Norway",https://ClinicalTrials.gov/show/NCT04321616
NCT04342169,University of Utah COVID-19 Hydrochloroquine Trial,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,IRB_00131893,"University of Utah, Salt Lake City, Utah, United States",https://ClinicalTrials.gov/show/NCT04342169
NCT04392778,Clinical Use of Stem Cells for the Treatment of Covid-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",Bak. Sadi Konuk-Istinye Uni.,"Istinye University, Istanbul, Turkey|SBÜ Dr. Sadi Konuk Eğitim ve Araştırma Hastanesi, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04392778
NCT04588441,The ARCTIC Trial: Aerosolized Inhaled Adenosine Treatment in Patients With Acute Respiratory Distress Syndrome (ARDS) Caused by COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,IRB202002127|OCR39505,NA,https://ClinicalTrials.gov/show/NCT04588441
NCT04683224,"A Study to Evaluate the Safety, Immunogenicity, and Efficacy of UB-612 COVID-19 Vaccine","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",UB-612-301,NA,https://ClinicalTrials.gov/show/NCT04683224
NCT04410432,Immune Response and Risk of Serious Infection to SARS-Cov2,Observational Model: Cohort|Time Perspective: Prospective,GHESQUIERE AOIc 2020,"Chu Dijon Bourogne, Dijon, France",https://ClinicalTrials.gov/show/NCT04410432
NCT04427280,Cancer: Rapid Diagnostics and Immune Assessment for SARS-CoV-2 (COVID-19),Observational Model: Cohort|Time Perspective: Prospective,CCR 5287|20/NE/0139,"The Royal Marden NHS Foundation Trust, Sutton, Surrey, United Kingdom",https://ClinicalTrials.gov/show/NCT04427280
NCT04626089,"Metformin Glycinate in Patients With MS or DM2 , Hospitalized With COVID-19 and SARS Secondary to SARS-CoV-2","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",SIL-30000-II(1),"Hospital Juárez de México, OPD, Mexico City, Mexico",https://ClinicalTrials.gov/show/NCT04626089
NCT04788394,Renal Involvement in Hospitalized Children With COVID-19,Observational Model: Other|Time Perspective: Retrospective,MRC01-21-089,"Hamad General corporation, Doha, Qatar",https://ClinicalTrials.gov/show/NCT04788394
NCT04316728,Clinical Performance of the VivaDiag ™ COVID-19 lgM / IgG Rapid Test in Early Detecting the Infection of COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,VivaDiag-2020,"Unità' Complesse di cure primarie (UCCP), ASP Catanzaro, Catanzaro, Italy",https://ClinicalTrials.gov/show/NCT04316728
NCT04281693,A New Screening Strategy for 2019 Novel Coronavirus Infection,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Screening,307-nCoV,"the Fifth Medical Center of Chinese PLA General Hospital, Beijing, Beijing, China",https://ClinicalTrials.gov/show/NCT04281693
NCT04468217,Evaluation of an Alternative Method of Obtaining Viral RNA for the Detection of SARS-CoV-2 Virus Using PCR,Observational Model: Case-Control|Time Perspective: Prospective,PRO-02,"Laboratorio Neurognos, Santiago, Providencia, Chile",https://ClinicalTrials.gov/show/NCT04468217
NCT04382196,Impact of COVID-19 on Mental Health of Health Care Workers,Observational Model: Cohort|Time Perspective: Prospective,BC-07564,"Ghent University Hospital, Ghent, Belgium",https://ClinicalTrials.gov/show/NCT04382196
NCT04791462,COVID-19 in Osteoarthritis Patients,Observational Model: Case-Only|Time Perspective: Prospective,RECHMPL21_0109,"Uhmontpellier, Montpellier, France",https://ClinicalTrials.gov/show/NCT04791462
NCT04473898,Telerehabilitation After Coronavirus,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Supportive Care,KaratayU2,"KTO Karatay University, Konya, Karatay, Turkey",https://ClinicalTrials.gov/show/NCT04473898
NCT04263402,The Efficacy of Different Hormone Doses in 2019-nCoV Severe Pneumonia,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,TJ20200201,"Department and Institute of Infectious Disease, Wuhan, Hubei, China",https://ClinicalTrials.gov/show/NCT04263402
NCT04327349,Investigating Effect of Convalescent Plasma on COVID-19 Patients Outcome: A Clinical Trial,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,IR.MAZUMS.REC.1399.7330|IRCT20181104041551N1,"Imam Khomeini Hospital, Mazandaran University of Medical Sciences, Sari, Mazandaran, Iran, Islamic Republic of",https://ClinicalTrials.gov/show/NCT04327349
NCT04366752,Thrombo Embolic Events in Critical Care Patients With Covid-19 Serious Acute Pneumopathy,Observational Model: Case-Only|Time Perspective: Prospective,PI2020_843_0036,"CHU Amiens, Amiens, France",https://ClinicalTrials.gov/show/NCT04366752
NCT04438629,Evaluation of Immune Response in COVID-19 Patients,Observational Model: Cohort|Time Perspective: Prospective,IMMUNOVID 2590CESC,"Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy",https://ClinicalTrials.gov/show/NCT04438629
NCT04531735,Respiratory Syncytial Virus Infection May be More Dangerous in Neonate,Observational Model: Case-Control|Time Perspective: Prospective,2020/522,"Behçet Uz Children's Hospital, İzmirli, Izmir, Turkey|İzmir Dr. Behcet Uz Training and Research Hospital, İzmir, Turkey",https://ClinicalTrials.gov/show/NCT04531735
NCT04918914,Critical Care Results of SARS-CoV-2 ARDS by Dapsone and Standard COVID-19 Treatment,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,Badar Kanwar,"Hunt Regional Medical Center, Greenville, Texas, United States",https://ClinicalTrials.gov/show/NCT04918914
NCT04373135,"Understanding Community Considerations, Opinions, Values, Impacts, and Decisions for COVID-19",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,UCLA-20-000683,"University of California, Los Angeles, Los Angeles, California, United States",https://ClinicalTrials.gov/show/NCT04373135
NCT04357730,Fibrinolytic Therapy to Treat ARDS in the Setting of COVID-19 Infection,Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,20-0880,"Scripps Memorial Hospital La Jolla, La Jolla, California, United States|University of Colorado, Denver, Aurora, Colorado, United States|Denver Health Medical Center, Denver, Colorado, United States|National Jewish Health, Denver, Colorado, United States|St. Mary's Medical Center, West Palm Beach, Florida, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Long Island Jewish Medical Center, New York, New York, United States|Methodist Dallas Medical Center, Dallas, Texas, United States|Ben Taub Hospital, Houston, Texas, United States",https://ClinicalTrials.gov/show/NCT04357730
NCT04516668,Effect of Tele-consultation in Addition With Psychiatric Follow-up During COVID-19 in Women Who Have Medical History of Post-partum Depression,Observational Model: Cohort|Time Perspective: Retrospective,APHP200878,NA,https://ClinicalTrials.gov/show/NCT04516668
NCT04358640,Anxiety and Work Resilience Among Tertiary University Hospital Workers During the COVID-19 Outbreak: An Online Survey,Observational Model: Other|Time Perspective: Prospective,LOCAL COVID 2019/JYL-01),"Intensive care unit CHU Nimes, Nîmes, France",https://ClinicalTrials.gov/show/NCT04358640
NCT04453371,Impact of Tissue Plasminogen Activator (tPA) Treatment for an Atypical Acute Respiratory Distress Syndrome (COVID-19),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment",tPA-2020,NA,https://ClinicalTrials.gov/show/NCT04453371
NCT04328129,Household Transmission Investigation Study for COVID-19 in Tropical Regions,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Screening,2020-009,"Centre Hospitalier Andrée Rosemon, Cayenne, French Guiana|Institut Pasteur de la Guyane, Cayenne, French Guiana|Institut Pasteur de Guadeloupe, Les Abymes, Guadeloupe|Institut Pasteur de Nouvelle-Calédonie, Nouméa, New Caledonia",https://ClinicalTrials.gov/show/NCT04328129
NCT04407208,Convalescent Plasma Therapy in Patients With COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,3471041S322342020040800002,"Gatot Soebroto central army presidential hospital, Jakarta Pusat, Indonesia",https://ClinicalTrials.gov/show/NCT04407208
NCT04843878,COVID-19 Testing Pilot Study,Observational Model: Case-Only|Time Perspective: Prospective,844488,"Penn Presbyterian Medical Center, Philadelphia, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04843878
NCT04444700,A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care as a Rapid Response to (SARS-CoV-2) COVID-19 Pandemic,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,CAAE: 33109220.7.0000.0068,"Hospital das Clínicas da FMUSP, São Paulo, SP, Brazil",https://ClinicalTrials.gov/show/NCT04444700
NCT04636021,Restoring Non-Emergent Cardiovascular Care in the Peri- COVID-19 Era,Observational Model: Other|Time Perspective: Prospective,UPMCP # 20-007,"UPMC Pinnacle Harrisburg, Harrisburg, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04636021
NCT04511923,Nebulised Heparin to Reduce COVID-19 Induced Acute Lung Injury,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,NUIG-2020-003,"University Hospital Galway, Galway, Ireland",https://ClinicalTrials.gov/show/NCT04511923
NCT04541680,Nintedanib for the Treatment of SARS-Cov-2 Induced Pulmonary Fibrosis,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",APHP200527,"Pneumologie, Paris, France",https://ClinicalTrials.gov/show/NCT04541680
NCT04884061,Narrow Band Imaging Bronchoscopy During SARS-CoV2 Infection,Observational Model: Case-Control|Time Perspective: Retrospective,PI2021_843_0096,"CHU Amiens, Amiens, France",https://ClinicalTrials.gov/show/NCT04884061
NCT04542330,Using BCG to Protect Senior Citizens During the COVID-19 Pandemic,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Prevention",BCG-DENMARK-SENIOR,"Seniorhuset, Odense, Denmark",https://ClinicalTrials.gov/show/NCT04542330
NCT04382131,Hypertonic Saline Nasal Irrigation and Gargling in Suspected or Confirmed COVID-19 (ELVIS COVID-19),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,AC20042,"NHS Lothian, Edinburgh, United Kingdom",https://ClinicalTrials.gov/show/NCT04382131
NCT04429555,"Efficacy, Safety, Tolerability, and Biomarkers of MN-166 (Ibudilast) in Patients Hospitalized With COVID-19 and at Risk for ARDS","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",MN-166-COVID-19-201,"Denver Health and Hospital Authority, Denver, Colorado, United States|Yale University School of Medicine, New Haven, Connecticut, United States",https://ClinicalTrials.gov/show/NCT04429555
NCT04333368,Cell Therapy Using Umbilical Cord-derived Mesenchymal Stromal Cells in SARS-CoV-2-related ARDS,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",APHP200395|2020-001287-28,"Hôpital Pitié-Salpêtrière - APHP, Paris, France|Hôpital Européen Georges Pompidou - APHP, Paris, France",https://ClinicalTrials.gov/show/NCT04333368
NCT04468958,"Safety, Tolerability, and Pharmacokinetics of SAB-185 in Healthy Participants","Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",SAB-185-101,"Alliance for Multispecialty Research, LLC, Wichita, Kansas, United States|SUNY Upstate Medical University, Syracuse, New York, United States|ICON Early Phase Services, San Antonio, Texas, United States",https://ClinicalTrials.gov/show/NCT04468958
NCT04366817,Psychological Impact of the Lockdown on Patients Giving Birth During the COVID-19 Epidemic Short Title : Isolement and Childbirth: Psychological Impact,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,APHP200471,"Service médecine foetale-Hôpital Trousseau, Paris, France",https://ClinicalTrials.gov/show/NCT04366817
NCT04651387,Efficacy and Safety of Ozonised Oil (HOO) in COVID-19 Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,DEP_052020,NA,https://ClinicalTrials.gov/show/NCT04651387
NCT04339387,COVID-19 Risk Stratification,Observational Model: Cohort|Time Perspective: Other,2020P000944,"Brigham and Women's Hospital, Boston, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT04339387
NCT04379453,Robot Assisted Percutaneous Cardiovascular Intervention as a Strategy to Reduce or Risk of Intra-Procedure Contamination by COVID-19 and Other Respiratory Viruses,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,4094-20,"Hospital Israelita Albert Einstein, São Paulo, Brazil",https://ClinicalTrials.gov/show/NCT04379453
NCT04609332,Endothelial Damage and Angiogenesis Biomarkers During COVID-19,Observational Model: Cohort|Time Perspective: Prospective,OAIC 1164/20,"Hospital Clínico de la Universidad de Chile, Independencia, Santiago, Chile",https://ClinicalTrials.gov/show/NCT04609332
NCT04570488,Predicting Favorable Outcomes in Hospitalized Covid-19 Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Health Services Research",PAU COVID19 RCT,"NYU Langone Health, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04570488
NCT04400838,Investigating a Vaccine Against COVID-19,Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Single (Participant)|Primary Purpose: Prevention,COV002,"University Hospital Southampton NHS Foundation Trust, Southampton, Hampshire, United Kingdom|Castle Hill Hospital, Cottingham, Hull, United Kingdom|St Georges University Hospital NHS Foundation Trust, London, Tooting, United Kingdom|University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom|University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, United Kingdom|North Bristol NHS Trust, Bristol, United Kingdom|NIHR Cambridge Clinical Research Facility, Cambridge, United Kingdom|NHS Lothian, Western General Hospital, Edinburgh, United Kingdom|Glasgow University and NHS Greater Glasgow & Clyde, New Lister Building, Glasgow Royal Infirmary & Queen Elizabeth University Hospital, Glasgow, United Kingdom|Liverpool School of Tropical Medicine (LSTM), Accelerator Research Clinic. Clinical Sciences Accelerator, LIverpool, United Kingdom|London North West University Healthcare Trust (LNWUH), Northwick Park Hospital, London, United Kingdom|University College London Hospitals NHS Foundation Trust, London, United Kingdom|Guy's and St Thomas' NHS Foundation Trust, Department of Infection, St Thomas Hospital, London, United Kingdom|Imperial College Healthcare NHS Trust, London, United Kingdom|The Newcastle upon Tyne Hospitals NHS Foundation Trust, Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom|Public Health Wales, Newport, United Kingdom|University of Nottingham Health Service, Cripps Health Centre, University Park, Nottingham, United Kingdom|CCVTM, University of Oxford, Churchill Hospital, Oxford, United Kingdom|John Radcliffe Hospital, Oxford, United Kingdom|Sheffield Teaching Hospitals, Royal Hallamshire Hospital, Sheffield, United Kingdom",https://ClinicalTrials.gov/show/NCT04400838
NCT04437901,COVIDAR - Arrhythmias in COVID-19,Observational Model: Cohort|Time Perspective: Other,HCB/2020/0333,"Antwerp University Hospital, Antwerpen, Belgium|Istituto Auxologico Italiano, IRCCS, Milan, Italy|Amsterdam UMC, Amsterdam, AZ, Netherlands|Hospital Clinic of Barcelona, Barcelona, Spain|St. Georges University Hospitals, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04437901
NCT04720118,Parkinson's Disease and Experiences Throughout the COVID-19 Pandemic,Observational Model: Other|Time Perspective: Cross-Sectional,1352,"Towson University, Towson, Maryland, United States",https://ClinicalTrials.gov/show/NCT04720118
NCT04811352,Drug Abuse During the COVID-19 Pandemic.,Observational Model: Cohort|Time Perspective: Cross-Sectional,Uso_drogas,"Centro Médico Nacional de Occidente, Guadalajara, Jalisco, Mexico",https://ClinicalTrials.gov/show/NCT04811352
NCT04367077,MultiStem Administration for COVID-19 Induced ARDS (MACoVIA),"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",B04-03,"Athersys Investigational Site 107, Chicago, Illinois, United States|Athersys Investigational Site 103, Akron, Ohio, United States|Athersys Investigational Site 101, Cleveland, Ohio, United States|Athersys Investigational Site 102, Cleveland, Ohio, United States",https://ClinicalTrials.gov/show/NCT04367077
NCT04394377,Full Anticoagulation Versus Prophylaxis in COVID-19: COALIZAO ACTION Trial,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,002/2020,"Centro de Estudos Clínicos do Hospital Cárdio Pulmonar, Salvador, Bahia, Brazil|Instituto de Ensino e Pesquisa do Hospital da Bahia, Salvador, Bahia, Brazil|Santa Casa de Misericórdia da Bahia - Hospital Santa Izabel, Salvador, Bahia, Brazil|Hospital Maternidade São Vicente de Paulo, Barbalha, Ceará, Brazil|Centro de Ensino e Aperfeiçoamento em Pesquisa - CEAP, Serra, Espirito Santo, Brazil|Centro de Pesquisas Cardiológicas de Goiânia do Hospital das Clínicas (UFG), Goiânia, Goiás, Brazil|Hospital Vera Cruz, Belo Horizonte, Minas Gerais, Brazil|Núcleo de Ciências de Saúde - Unidade de Pesquisa - Hospital Felício Rocho, Belo Horizonte, Minas Gerais, Brazil|Centro de Pesquisa Clínica do Hospital de Clínicas da Universidade Federal de Uberlândia, Uberlândia, Minas Gerais, Brazil|Hospital Universitário da Universidade Estadual de Londrina, Londrina, Paraná, Brazil|Hospital Agamenon Magalhães, Recife, Pernambuco, Brazil|Real Hospital Português de Beneficência em Pernambuco, Recife, Pernambuco, Brazil|Hospital Moinhos de Vento, Porto Alegre, Rio Grande Do Sul, Brazil|Hospital Nereu Ramos, Florianópolis, Santa Catarina, Brazil|Instituto Baia Sul de Ensino E Pesquisa Dr. Irineu May Brodbeck / Hospital Baía Sul, Florianópolis, Santa Catarina, Brazil|Hospital Regional Hans Dieter Schmidt, Joinville, Santa Catarina, Brazil|Hospital de Amor de Barretos - (Pio XII), Barretos, São Paulo, Brazil|Unidade de Pesquisa Clínica da Faculdade de Medicina de Botucatu - Unesp, Botucatu, São Paulo, Brazil|Hospital Universitário São Francisco de Assis, Bragança Paulista, São Paulo, Brazil|Hospital Regional do Litoral Norte, Caraguatatuba, São Paulo, Brazil|Hospital Regional de Registro, Registro, São Paulo, Brazil|Praxis Pesquisa Médica, Santo André, São Paulo, Brazil|Centro Integrado de Pesquisa (CIP) - Hospital de Base de Rio Preto, São José Do Rio Preto, São Paulo, Brazil|Hospital Regional de São José dos Campos, São José Dos Campos, São Paulo, Brazil|Santa Casa de Misericórdia de Votuporanga, Votuporanga, São Paulo, Brazil|Hospital Naval Marcílio Dias, Rio de Janeiro, Brazil|BP - A Beneficência Portuguesa de São Paulo, São Paulo, Brazil|Hcor - Hospital do Coração, São Paulo, Brazil|Hospital Israelita Albert Einstein, São Paulo, Brazil|Hospital Moriah, São Paulo, Brazil|Hospital Samaritano Paulista, São Paulo, Brazil|Hospital Santa Paula, São Paulo, Brazil|Hospital São Paulo, São Paulo, Brazil|Instituto Dante Pazzanese de Cardiologia, São Paulo, Brazil|Instituto de Assistência Médica ao Servidor Público Estadual de S. Paulo, São Paulo, Brazil|Instituto do Coração do Hospital das Clínicas da Faculdade de Medicina da USP-InCor-HCFMUSP, São Paulo, Brazil",https://ClinicalTrials.gov/show/NCT04394377
NCT04327570,In-depth Immunological Investigation of COVID-19.,Observational Model: Other|Time Perspective: Prospective,COntAGIouS,"UZ Leuven, Leuven, Belgium",https://ClinicalTrials.gov/show/NCT04327570
NCT04705766,KIDney Injury in Times of COVID-19 (KIDCOV),Observational Model: Cohort|Time Perspective: Prospective,KIDCOV2020|R01DK109720,"University of California, San Francisco, California, United States|Rush University, Chicago, Illinois, United States|University of Michigan, Ann Arbor, Michigan, United States",https://ClinicalTrials.gov/show/NCT04705766
NCT03042143,Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration (REALIST) (COVID-19),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",16154DMcA-AS,"Belfast Health and Social Care Trust, Royal Hospitals, Belfast, Northern Ireland, United Kingdom",https://ClinicalTrials.gov/show/NCT03042143
NCT04415073,A Phase 2 Study to Evaluate Axatilimab for Hospitalized Patients With Respiratory Involvement Secondary to COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment",SNDX-6352-0505,"HonorHealth, Scottsdale, Arizona, United States|Montefiore Medical Center, Bronx, New York, United States",https://ClinicalTrials.gov/show/NCT04415073
NCT04341480,The Safety of Chemotherapy for Patients With Gynecological Malignancy in High-risk Region of COVID-19,Observational Model: Cohort|Time Perspective: Prospective,2020-TJ-COVID-19,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China",https://ClinicalTrials.gov/show/NCT04341480
NCT04885504,Post COVID-19 Biorepository,Observational Model: Cohort|Time Perspective: Cross-Sectional,STUDY#00146337,"University of Kansas Medical Center, Kansas City, Kansas, United States",https://ClinicalTrials.gov/show/NCT04885504
NCT04715932,Study of Hesperidin Therapy on COVID-19 Symptoms (HESPERIDIN),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",MHICC-2020-003,"Montreal Heart Institute, Montréal, Quebec, Canada",https://ClinicalTrials.gov/show/NCT04715932
NCT04872049,Assessment of SARS-CoV-2 Effect on Post-traumatic Stress of Patients Hospitalized in Intensive Care Unit,Observational Model: Cohort|Time Perspective: Cross-Sectional,APHP200450|2020-A03430-39,"GH Pitié Salpêtrière - Charles Foix, Paris, Ile De France, France",https://ClinicalTrials.gov/show/NCT04872049
NCT04944433,Safety and Efficacy of the Coronavirus Disease 2019 Vaccine in Hemodialysis Patients,Observational Model: Cohort|Time Perspective: Prospective,7412,"Universidad de Buenos Aires Facultad de Medicina, Buenos Aires, Caba, Argentina",https://ClinicalTrials.gov/show/NCT04944433
NCT04644172,Improving Thinking in Everyday Life After Covid-19,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,IRB-300002814C,"University of Alabama at Birmingham, Birmingham, Alabama, United States",https://ClinicalTrials.gov/show/NCT04644172
NCT04983823,Persistent Cardiovascular Effects of COVID-19 Viral Infection Trial (PERCEIVE),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Screening,28/21,"Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia",https://ClinicalTrials.gov/show/NCT04983823
NCT04595084,Remotely Delivered Programs Targeting COVID-19 Stress-Related Depression and Substance Use,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,CHA-IRB-1141/05/20|3R33AT010125-03S1,NA,https://ClinicalTrials.gov/show/NCT04595084
NCT04856111,Pirfenidone vs. Nintedanib for Fibrotic Lung Disease After Coronavirus Disease-19 Pneumonia,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,INT/IEC/2021/SPL-462,"Postgraduate Institute of Medical Education and Research, Chandigarh, India",https://ClinicalTrials.gov/show/NCT04856111
NCT04439006,Ibrutinib for the Treatment of COVID-19 in Patients Requiring Hospitalization,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,OSU-20135|NCI-2020-03341|P30CA016058,"Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States",https://ClinicalTrials.gov/show/NCT04439006
NCT04433078,RepurpoSing Old Drugs TO SuppRess a Modern Threat: COVID-19 STORM,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",The STORM Trial,"Temple University Hospital, Philadelphia, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04433078
NCT04426279,Morbimortality of Covid-19 in Patients With Chronic Inflammatory Rheumatism Treated With Immunosuppressants,Observational Model: Cohort|Time Perspective: Retrospective,2020_49|2020-A01650-39,"Lille University Hospital, Lille, France",https://ClinicalTrials.gov/show/NCT04426279
NCT04350710,Description of Respiratory Mechanics in Patients With SARS-CoV-2 Associated ARDS,Observational Model: Cohort|Time Perspective: Prospective,2030/31,"CHU, Angers, France",https://ClinicalTrials.gov/show/NCT04350710
NCT04377165,Innovative Tool to Limit Spread of COVID 19 in Residential Aged Care Facilities,Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,Care Collective Study,NA,https://ClinicalTrials.gov/show/NCT04377165
NCT04646239,Biomarkers of Trained Immunity Following MMR Vaccination,Observational Model: Cohort|Time Perspective: Prospective,202011081,"Washington University School of Medicine, Saint Louis, Missouri, United States",https://ClinicalTrials.gov/show/NCT04646239
NCT04380818,Low Dose Anti-inflammatory Radiotherapy for the Treatment of Pneumonia by COVID-19,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,IPACOVID,"Hospital Sant Joan de Reus, Reus, Tarragona, Spain|Hospital Del Mar, Barcelona, Spain|Hospital Universitario Madrid Sanchinarro, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04380818
NCT04847817,Important Data on COVID-19 Profile in Africa,Observational Model: Case-Control|Time Perspective: Prospective,0011/2020/PR/SG/CNE|CEI-10/2020,"Centre de Recherches Médicales de Lammbaréné, Lambaréné, Moyen- Ogooué, Gabon|Centre de Recherches Médicales de Lambréné, Lambaréne, Gabon",https://ClinicalTrials.gov/show/NCT04847817
NCT04256395,Efficacy of a Self-test and Self-alert Mobile Applet in Detecting Susceptible Infection of COVID-19,Observational Model: Other|Time Perspective: Prospective,RWS-BTCH-002,"Beijing Tsinghua Changgung Hospital, Beijing, Beijing, China",https://ClinicalTrials.gov/show/NCT04256395
NCT04397705,Remote Monitoring of Cancer Patients With Suspected Covid-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,CFTSp186,"The Christie NHS Foundation Trust, Manchester, Greater Manchester, United Kingdom",https://ClinicalTrials.gov/show/NCT04397705
NCT04340349,Low-dose Hydroxychloroquine and Bromhexine: a Novel Regimen for COVID-19 Prophylaxis in Healthcare Professionals,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention",25/20,"National Institute of Rehabilitation, Luis Guillermo Ibarra Ibarra, Mexico City, Cdmx, Mexico",https://ClinicalTrials.gov/show/NCT04340349
NCT04726150,Effect of CoVid-19 (CoronaVirusDisease-19) and Exercise on Myocardial Fibrosis and Ventricular Arrhythmias,Observational Model: Cohort|Time Perspective: Prospective,1499,NA,https://ClinicalTrials.gov/show/NCT04726150
NCT04487977,Survey on COVID-19 Airway Management,Observational Model: Other|Time Perspective: Cross-Sectional,ISAM-COVID,"Consorcio Hospital General Universitario de Valencia, Valencia, Spain",https://ClinicalTrials.gov/show/NCT04487977
NCT04252274,Efficacy and Safety of Darunavir and Cobicistat for Treatment of COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,DC-COVID-19,"Shanghai Public Health Clinical Center, Shanghai, Shanghai, China|Shanghai Public Health Clinical Center, Shanghai, Shanghai, China",https://ClinicalTrials.gov/show/NCT04252274
NCT04376775,Assessment of the Impact of COVID-19 on Transplant Patients and on Patients Awaiting Transplantation,Observational Model: Cohort|Time Perspective: Prospective,CHUBX 2020/19,"Hopital Pellegrin, Bordeaux, France",https://ClinicalTrials.gov/show/NCT04376775
NCT04336761,Prevalence of Covid-19 in Children Admitted to Paediatric Emergency Departments During the Pandemic Period in France,Observational Model: Cohort|Time Perspective: Prospective,2020_21|2020-A00811-38,"CH Louis MOURIER, Colombes, France|Hôpital Jeanne de Flandres, CHU, Lille, France|Hôpital Mère Enfant CHU, Nantes, France|Hôpitaux Pédiatriques de Nice CHU-Lenval, Nice, France|Hôpital des enfants - CHU, Toulouse, France|CHU de Tours, Tours, France",https://ClinicalTrials.gov/show/NCT04336761
NCT04797936,BNO 1030 Extract (Imupret) in the Treatment of Mild Forms of COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,BERI_UA_IMU_2020_000003751,"Ivano-Frankivsk National Medical University, Ivano-Frankivsk, Ukraine",https://ClinicalTrials.gov/show/NCT04797936
NCT04390269,Immunogenetics Predictors With COVID-19,Observational Model: Case-Control|Time Perspective: Cross-Sectional,R.20.05.830.R1,"Mansoura Faculty of Medicine, Mansoura, Dakahlyia, Egypt",https://ClinicalTrials.gov/show/NCT04390269
NCT04344119,Assessment of Chilbains Occuring During Covid-19 Infection,Observational Model: Case-Only|Time Perspective: Prospective,20dermatocovid01,"CHU de Nice, Nice, France",https://ClinicalTrials.gov/show/NCT04344119
NCT04424134,BromhexIne And Spironolactone For CoronаVirUs Infection Requiring HospiTalization,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,MSU160520,"Lomonosov Moscow State University Medical Research and Educational Center, Moscow, Moscow Region, Russian Federation",https://ClinicalTrials.gov/show/NCT04424134
NCT04407572,Evaluation of the Relationship Between Zinc Vitamin D and b12 Levels in the Covid-19 Positive Pregnant Women,Observational Model: Case-Control|Time Perspective: Prospective,zinc-dvit-covid19,"Pinar Yalcin Bahat, Istanbul, İ̇stanbul, Turkey",https://ClinicalTrials.gov/show/NCT04407572
NCT04456556,Combined Endophthalmitis and Orbital Cellulitis in Patients With Novel Coronavirus Disease (COVID-19),Observational Model: Case-Only|Time Perspective: Retrospective,ocular infection in covid19,"Minia university Hospital, Minya, Minia, Egypt",https://ClinicalTrials.gov/show/NCT04456556
NCT04694638,"Use of Combined Prone Positioning and High-Flow Nasal Cannula, and Non-invasive Positive Pressure Ventilation to Prevent Intubation in COVID-19 Infection",Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,20-003191,"Mayo Clinic in Rochester, Rochester, Minnesota, United States",https://ClinicalTrials.gov/show/NCT04694638
NCT04476992,Nitric Oxide Therapy for COVID-19 Patients With Oxygen Requirement,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,22-Jan,"Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russian Federation",https://ClinicalTrials.gov/show/NCT04476992
NCT04408248,AKI Biomarkers in Coronavirus(COVID)-19,Observational Model: Cohort|Time Perspective: Prospective,283675,"Guy's & St Thomas' Hospital, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04408248
NCT04335162,Cardiovascular Complications and COVID-19 (CovCardioVasc-Study),Observational Model: Cohort|Time Perspective: Prospective,20reamedcovid01,"Centre Hospitalier de Cannes, Cannes, France|CHU de Dijon, Dijon, France|Centre Hospitalier de Draguignan, Draguignan, France|Centre Hospitalier de Grasse, Grasse, France|Clinique Ambroise-Paré, Neuilly, France|CHU de Nice, Nice, France|Hôpitaux Universitaires Paris Centre - Hôpital Cochin, Paris, France|CHU de REIMS, Reims, France",https://ClinicalTrials.gov/show/NCT04335162
NCT04324866,Prevalence and Incidence of COVID-19 Infection in Patients With Chronic Plaque Psoriasis on Immunosuppressant Therapy,Observational Model: Cohort|Time Perspective: Prospective,Gisondi 4,NA,https://ClinicalTrials.gov/show/NCT04324866
NCT04357886,Awareness of COVID-19 in Turkey,Observational Model: Cohort|Time Perspective: Prospective,60350273-605.99-,"Istanbul University-Cerrahpasa, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04357886
NCT04432051,The Use of Lung Ultrasonography in COVID-19 Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Other",Gaziosmanpasa,"Gazoosmanpasa Education and Research Hospital, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04432051
NCT04345159,Association Between Long-term Hydroxychloroquine Treatment and Outcome of a History of Symptoms Suggestive of COVID-19 Infection During the Epidemic Period in France in Patients With Autoimmune Disease,Observational Model: Cohort|Time Perspective: Retrospective,GDE_2020_11,"Fondation Adolphe de Rothschild, Paris, France",https://ClinicalTrials.gov/show/NCT04345159
NCT04352634,The Covid-19 HEalth caRe wOrkErS (HEROES) Study,Observational Model: Cohort|Time Perspective: Prospective,HEROES Covid-19,"Columbia University, New York, New York, United States|Universidad del Chubut, Rawson, Chubut, Argentina|National Institute of Health Named After Academician S. Avdalbekyan, Yerevan, Armenia|University of Sydney, Sidney, New South Wales, Australia|Salud Global, Sucre, Chuquisaca, Bolivia|University of Chile, Santiago, Chile|Universidad Nacional de Costa Rica, Heredia, Costa Rica|Society for Emergecy and Disaster Medicine CzMA JEP, Kladno, Bohemia, Czechia|Hochschule Emden/Leer, Emden, Niedersachsen, Germany|Centro de Investigaciones de las Ciencias de la Salud -CICS- Facultad de Ciencias Médicas Universidad de San Carlos de Guatemala -USAC-, Guatemala City, Guatemala|University of Cagliari, Cagliari, CA, Italy|University of Cagliari, Cagliari, Italy|The Institute for Development Research Advocacy and Applied Care (IDRAAC), Beirut, Lebanon|Logotipo del comercio Instituto Jalisciense De Salud Mental (SALME), Guadalajara, Jalisco, Mexico|Maastricht University, Maastricht, Limburg, Netherlands|University of Ibadan, Ibadan, Oyo State, Nigeria|Ponce Health Sciences University, Ponce, Puerto Rico|King Abdullah International medical research center, Riyadh, Central, Saudi Arabia|Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain|Razi Hospital La Manouba, Tunis, La Manouba, Tunisia|Koc University, Istanbul, Sariyer, Turkey|PNFA Salud Colectiva Instituto de Altos Estudios Dr Arnoldo Gabaldon, Maracay, Aragua, Venezuela",https://ClinicalTrials.gov/show/NCT04352634
NCT04393142,Serologic Testing of Household Contacts of Confirmed Cases of COVID-19,Observational Model: Other|Time Perspective: Cross-Sectional,IF20-00004,"Hospital Universitario José E. Gonzalez, Monterrey, Nuevo Leon, Mexico",https://ClinicalTrials.gov/show/NCT04393142
NCT04772586,Sarcopenia and Mechanical Ventilation in Older Patients Admitted Due to COVID-19,Observational Model: Case-Only|Time Perspective: Prospective,SARCO-V_2021/110,"Brugmann university hospital, Brussels, Belgium",https://ClinicalTrials.gov/show/NCT04772586
NCT04371835,COHIVE: Coronavirus (COVID-19) Outcomes in HIV Evaluation in Resource Limited Settings,Observational Model: Cohort|Time Perspective: Prospective,2020-04-COHIVE,"Hospital G de Agudos JM Ramos Mejia, Buenos Aires, Ciudad De Buenos Aires, Argentina|Laboratório de Pesquisa Clinica Em Hiv/Aids - Instituto Nacional de Infectologia - Fiocruz, Rio de Janeiro, Brazil|Central Hospital of Yaoundé, Yaoundé, Cameroon|Cité Verte Hospital, Yaoundé, Cameroon|Hôpital Militaire de Région N°1, Yaoundé, Cameroon|CART CRS, VHS Hospital, Chennai, Tamil Nadu, India|Univerity of Malaya Medical Centre, Kuala Lumpur, Malaysia|Institute of Human Virology, Nigeria (IHVN), Abuja, Nigeria|Desmond Tutu HIV Foundation, Cape Town, South Africa|Perinatal HIV Research Unit (PHRU), Johannesburg, South Africa|Clinical HIV Research Unit (CHRU), Wits Health Consotium (Pty) Ltd, Johannesburg, South Africa|Ezintsha, Parktown, South Africa|HIV-NAT (The HIV Netherlands Australia Thailand Research Collaboration), Thai Red Cross AIDS Research Centre, Bangkok, Thailand|Infectious Diseases Institute, Kampala, Uganda|University of Zimbabwe Clinical Research Centre, Harare, Zimbabwe",https://ClinicalTrials.gov/show/NCT04371835
NCT04305457,Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,NOgas mildCOVID-19,"Providence HealthCare Network, Anchorage, Alaska, United States|Louisiana State University Health Shreveport, Shreveport, Louisiana, United States|Massachusetts General Hospital, Boston, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT04305457
NCT04979208,Impact of Changes in the Use of Care and Reorganization of the Healthcare System Linked to the Covid-19 Outbreak on the Quality of Care Pathways of Patients Suffering From Acute Myocardial Infarction and Stroke in Aquitaine (AVICOVID),Observational Model: Cohort|Time Perspective: Retrospective,CHUBX 2020/39,"CHU Bordeaux, Bordeaux, France",https://ClinicalTrials.gov/show/NCT04979208
NCT04595903,Treatment of SARS-CoV-2 Virus Disease (COVID-19) in Humans With Hemopurifier® Device,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,AEMD-2020-02,"Hoag Hospital - Irvine, Irvine, California, United States|Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States",https://ClinicalTrials.gov/show/NCT04595903
NCT04422470,Registry of Patients With Hematologic Disease and COVID-19 in Russia,Observational Model: Cohort|Time Perspective: Prospective,CHRONOS19,"Regional Clinical Hospital No1, Ekaterinburg, Russian Federation|Republican Clinical Hospital of Tatarstan, Kazan, Russian Federation|City Hospital n.a. V.V. Veresaev, Moscow, Russian Federation|Clinical Hospital n.a. S.P. Botkin, Moscow, Russian Federation|National Research Center for Hematology, Moscow, Russian Federation|Regional Clinical Hospital N.A. Semashko, Nizhny Novgorod, Russian Federation|Regional Hospital, Novosibirsk, Russian Federation|Regional Clinical Hospital, Omsk, Russian Federation|Republican Clinical Hospital No4, Saransk, Russian Federation|Republic Clinical Hospital n.a. N.A. Semashko, Ulan-Ude, Russian Federation|Regional Clinical Hospital, Vladimir, Russian Federation|Regional Clinical Hospital No2, Vladivostok, Russian Federation|Republican Hospital No1, Yakutsk, Russian Federation|Regional Clinical Hospital, Yaroslavl, Russian Federation",https://ClinicalTrials.gov/show/NCT04422470
NCT04927078,Analysis of Vital Signs in Patients With COVID-19,Observational Model: Case-Control|Time Perspective: Retrospective,287454,"Coventry and Warwickshire Partnership NHS, Coventry, United Kingdom",https://ClinicalTrials.gov/show/NCT04927078
NCT04452708,HFNC and NIV for COVID-19 Complicated by Respiratory Failure,Observational Model: Cohort|Time Perspective: Prospective,2020.203,"Prince of Wales Hospital, Hong Kong, Hong Kong",https://ClinicalTrials.gov/show/NCT04452708
NCT04510467,Mental Health Consequences of COVID19 Infection in the French RMD Cohort,Observational Model: Case-Control|Time Perspective: Cross-Sectional,2020_75|2020-A02058-31,NA,https://ClinicalTrials.gov/show/NCT04510467
NCT04815850,Phenotyping Seroconversion Following Vaccination Against COVID-19 in Patients on Haemodialysis Study,Observational Model: Cohort|Time Perspective: Prospective,810,"University Hospital Leicester NHS Trust, Leicester, Leicestershire, United Kingdom",https://ClinicalTrials.gov/show/NCT04815850
NCT04367129,Electrocardiogram Analysis in COVID-19 Patients,Observational Model: Cohort|Time Perspective: Prospective,385/2020/Oss/AOUFe,"Arcispedale S. Anna, Ferrara, Italy",https://ClinicalTrials.gov/show/NCT04367129
NCT04775966,CPAP Observance During the COVID-19 (SARS-CoV-2) Pandemic,Observational Model: Cohort|Time Perspective: Retrospective,RECHMPL21_0067,"Adene Group, Montpellier, France",https://ClinicalTrials.gov/show/NCT04775966
NCT04838106,Outcomes of Patients Who Survived Treatment on an Intensive Care Unit for COVID-19 in England and Wales,Observational Model: Cohort|Time Perspective: Retrospective,PID15456|21/SC/0021|21/CAG/0017,"Critical Care Research Group, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, Oxfordshire, United Kingdom",https://ClinicalTrials.gov/show/NCT04838106
NCT04349228,Assessment of the Efficacy and Safety of (HCQ) as a Prophylaxis for COVID19 for Health Professionals,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention,ECC2020-03,"Eshmoun Clinical Research Centre/ Hôpital Abderrahmane Mami-Ariana, Tunis, Tunisia",https://ClinicalTrials.gov/show/NCT04349228
NCT04872673,The Professional Values and Ethical Sensitivities During the COVID-19 Pandemic,Observational Model: Other|Time Perspective: Prospective,42/2020,"Ankara Yıldırım Beyazıt University, Ankara, Çubuk, Turkey",https://ClinicalTrials.gov/show/NCT04872673
NCT04395859,Collateral Damage From the COVID-19 Pandemic Observed in Patients Treated With Intravitreal Injections (IVT) of Anti-angiogenic Agents,Observational Model: Cohort|Time Perspective: Prospective,MMT_2020_15,"Centre Pôle Vision du val d'Ouest, Ecully, France|Fondation Adolphe de Rothschild, Paris, France|Hôpital Lariboisière, Paris, France|Centre ophtalmologique Maison Rouge, Strasbourg, France",https://ClinicalTrials.gov/show/NCT04395859
NCT04595123,Impact of COVID-19 Pandemic in Perinatal Mental Health (RISEUP-PPD-COVID-19),Observational Model: Cohort|Time Perspective: Prospective,RISEUP-PPD-COVID-19,"Beder College University, Tirana, Albania|Universidade Presbiteriana Mackenzie, São Paulo, Brazil|Sofia University, Sofia, Bulgaria|Universidad de Concepción, Concepción, Chile|European University Cyprus, Nicosia, Cyprus|Groupe Hospitalier du Havre, Le Havre, France|University of Athens, Athens, Greece|Bar-Ilan University, Ramat Gan, Israel|University of Malta, Imsida, Malta|Universidade do Minho, Braga, Portugal|Universidad Loyola Andalucia, Sevilla, Spain|Kırklareli Üniversitesi, Kırklareli, Turkey|King'S College London, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04595123
NCT04520620,Concentration-effect Relationship of Enoxaparin for Thromboembolic Prevention,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,20CH089|2020-001823-15,"Groupement Hospitalier des portes de Province, Montélimar, France|Centre Hospitalier de Roanne, Roanne, France|CHU de Saint-Etienne, Saint-Étienne, France|Clinique Mutualiste, Saint-Étienne, France",https://ClinicalTrials.gov/show/NCT04520620
NCT04401046,COVID-19 and Reorganisation of Cancer Patient Care: Self- Evaluation of Potential Post-traumatic Stress Disorder,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,COVID-TRAUMA-IPC 2020-026,"Institut Paoli-Calmettes, Marseille, France",https://ClinicalTrials.gov/show/NCT04401046
NCT04884321,Complementary And Alternative Medicine During The COVID-19 Pandemic,Observational Model: Other|Time Perspective: Other,HasanKUMYO,"Hasan Kalyoncu Ünivrsitesi, Gaziantep, Lütfen Seç, Turkey",https://ClinicalTrials.gov/show/NCT04884321
NCT03183570,"Detection of Integrin avb6 in IPF, PSC, and COVID19 Using PET/CT",Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,IRB Protocol: 40450,"Stanford University, Stanford, California, United States",https://ClinicalTrials.gov/show/NCT03183570
NCT04558320,COVID-19 and Lactating Mothers,Observational Model: Cohort|Time Perspective: Prospective,STUDY00004889|3U01AI131344-04S1,"University of Rochester Medical Center, Rochester, New York, United States",https://ClinicalTrials.gov/show/NCT04558320
NCT04348695,Study of Ruxolitinib Plus Simvastatin in the Prevention and Treatment of Respiratory Failure of COVID-19.,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,Ruxo-Sim-20|2020-001405-23,"Hospital Universitario Madrid Sanchinarro, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04348695
NCT04762173,Self-Help for Stress Related to COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,STUDY00015766,"The Pennsylvania State University, University Park, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04762173
NCT04970563,"Detection of Asymptomatic SARS-Cov2 Infected Patients by Detection Dogs: ""Proof of Concept"" Study (CoviDetectionDog)-Covid-19",Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,12月21日,"Hôpital Européen Marseille, Marseille, France",https://ClinicalTrials.gov/show/NCT04970563
NCT04751227,Modafinil for Wakefulness in the Critical Care Units,Observational Model: Cohort|Time Perspective: Retrospective,RAC # 2201230,"King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia",https://ClinicalTrials.gov/show/NCT04751227
NCT04669912,COVID-19 Pandemic Lockdown Effect in Adolescents and Young Adults With Type 1 Diabetes: Positive Results of an Unpreceded Challenge for Telemedicine and Patient Self-management,Observational Model: Cohort|Time Perspective: Prospective,IDRCB 2020-A02760-39,"Centre Hospitalier Sud Francilien, Corbeil-Essonnes, France",https://ClinicalTrials.gov/show/NCT04669912
NCT04608097,Understanding Reactions to Emotional Material in the Media During COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Basic Science",2020-03991,"Uppsala University, Uppsala, Sweden",https://ClinicalTrials.gov/show/NCT04608097
NCT04590547,GLS-1027 for the Prevention of Severe Pneumonitis Caused by SARS-CoV-2 Infection (COVID-19),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",GLS27-005,"Baton Rouge General Medical Center, Baton Rouge, Louisiana, United States|University of Puerto Rico, San Juan, Puerto Rico",https://ClinicalTrials.gov/show/NCT04590547
NCT04320277,"Baricitinib in Symptomatic Patients Infected by COVID-19: an Open-label, Pilot Study.",Allocation: Non-Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,HPrato-3,"Fabrizio Cantini, Prato, Tuscany, Italy",https://ClinicalTrials.gov/show/NCT04320277
NCT04904497,Early Occupational Therapy in Mechanical Ventilated Patients With Covid-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",Reh-Covid-19,"University of Chile, Santiago, Metropolitana, Chile",https://ClinicalTrials.gov/show/NCT04904497
NCT04491071,Stress Induced by the COVID-19 Pandemic and Nonconfinement: Study of Anxiety Factors and Potential Effects on Immunity.,Observational Model: Cohort|Time Perspective: Prospective,20CH129|IRBN972020/CHUSTE,"Centre Hospitalier Universitaire de Saint-Etienne, Saint-Étienne, France|Centre de Recherche et d'Innovation Clinique, Glasgow, United Kingdom",https://ClinicalTrials.gov/show/NCT04491071
NCT04485351,Assessing the Impact of the COVID-19 Lockdown on Metabolic Control and Access to Health Care in Patients With Diabetes,Observational Model: Cohort|Time Perspective: Cross-Sectional,2020PI137,"University Regional Hospital of Nancy, Nancy, France",https://ClinicalTrials.gov/show/NCT04485351
NCT04409743,Brief Telehealth CBT-I Intervention in the Context of the COVID-19 Pandemic,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Prevention,IRB-55940,"Stanford University, Palo Alto, California, United States",https://ClinicalTrials.gov/show/NCT04409743
NCT04453839,ZYESAMI (Aviptadil) Intermediate Population Expanded Access Protocol (SAMICARE),NA,RLF-100_EA-1,"Dignity Health-Mercy Gilbert Medical Center, Gilbert, Arizona, United States|Honor Health Shea Medical Center, Scottsdale, Arizona, United States|Kaiser Permanente, Baldwin Park, California, United States|University of California - Irvine, Irvine, California, United States|Lawnwood Regional Medical Center, Fort Pierce, Florida, United States|Lakeland Regional Health, Lakeland, Florida, United States|Miller School of Medicine / University of Miami Medical Center, Miami, Florida, United States|Baptist Hospital of Miami, Miami, Florida, United States|Baycare St. Joseph Hospital, Tampa, Florida, United States|Southeast Georgia Health system, Brunswick, Georgia, United States|Maui Health Systems, Wailuku, Hawaii, United States|St. Anthony Regional Hospital, Carroll, Iowa, United States|University of Louisville, Louisville, Kentucky, United States|St. Tammany Parish Hospital, Covington, Louisiana, United States|Our Ladies of Lourdes Regional Hospital, Lafayette, Louisiana, United States|St. Joseph Heritage Healthcare, Saint Joseph, Missouri, United States|Great Plains Health, North Platte, Nebraska, United States|Self Regional Healthcare, Greenwood, South Carolina, United States|Hendrick Medical Center, Abilene, Texas, United States|Baptist Hospitals of Southeast Texas, Beaumont, Texas, United States|Medical City Denton, Denton, Texas, United States|HR Health Institute for Research & Development, Edinburg, Texas, United States|Houston Methodist Hospital, Houston, Texas, United States|Memorial Hermann Hospital Houston, Houston, Texas, United States|Medical City McKinney, McKinney, Texas, United States",https://ClinicalTrials.gov/show/NCT04453839
NCT04555122,COVID-19 Ad Intervention,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Other",COVID-Ad HS# 2020-5923,"UC Irvine, Irvine, California, United States",https://ClinicalTrials.gov/show/NCT04555122
NCT04649957,Profiling Recovery of Those Discharged Into the Community With COVID-19,Observational Model: Cohort|Time Perspective: Prospective,COVID-19-UoD&RDH20/21,"University of Derby, Derby, United Kingdom",https://ClinicalTrials.gov/show/NCT04649957
NCT04432870,Patients' Preferences About Rescheduling Colonoscopies Delayed Due to COVID-19: Cross Sectional Study,Observational Model: Other|Time Perspective: Cross-Sectional,2020P001579-1,"Massachusetts General Hospital, Boston, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT04432870
NCT04367883,"Influenza Vaccination, ACEI and ARB in the Evolution of SARS-Covid19 Infection",Observational Model: Other|Time Perspective: Other,02-20-161-021,"Hospital de Terrassa, Terrassa, Barcelona, Spain",https://ClinicalTrials.gov/show/NCT04367883
NCT04980534,Evaluation of the Effectiveness of Therapy for Patients With Covid-19 Using Food Supplements Viusid + Asbrip,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,COVID_KAZ_2021,"JSC ""Astana Medical University, Astana, Kazakhstan",https://ClinicalTrials.gov/show/NCT04980534
NCT04680858,Impact of Digital Communication Assist Tools in Endoscopic Team Communication During COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,122020,"Universitätsklinikum Ulm, Ulm, Germany",https://ClinicalTrials.gov/show/NCT04680858
NCT04413071,Cardiac COVID-19 Health Care Workers,Observational Model: Cohort|Time Perspective: Cross-Sectional,CCC_2020,"University Hospital of Salamanca, Salamanca, Spain",https://ClinicalTrials.gov/show/NCT04413071
NCT04710199,Trial to Evaluate the Safety and Efficacy of Maraviroc in Patients Hospitalized for Coronavirus Disease 2019 (COVID-19),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,COVIMAR,"Hospital Universitario Virgen del Rocio, Sevilla, Spain|Hospital Universitario Virgen del Rocío, Sevilla, Spain",https://ClinicalTrials.gov/show/NCT04710199
NCT04723550,COVID-19 Lockdown Related Telemedicine for Type 2 Diabetes,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,NO.2020QN80,"Department of Endocrinology, Xuzhou NO.1 Peoples Hospital, Xuzhou, Jiangsu, China",https://ClinicalTrials.gov/show/NCT04723550
NCT04584541,SarS-Cov-2 Viral Infection (COVID-19) in Patients With Chronic Inflammatory Rheumatism,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science,APHP200598,"Cochin hospital, Paris, France",https://ClinicalTrials.gov/show/NCT04584541
NCT04412356,Timing of Tracheotomy in Covid-19 Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,HBergquist,"Sahlgrenska University Hospital, Gothenburg, Sweden",https://ClinicalTrials.gov/show/NCT04412356
NCT04367740,"ScreenNC, a Study to Determine the Number of Asymptomatic Individuals Who Have Antibodies to the Virus That Causes COVID-19",Observational Model: Case-Only|Time Perspective: Cross-Sectional,20-0937,"Center for Environmental Medicine, Asthma and Lung Biology, Chapel Hill, North Carolina, United States",https://ClinicalTrials.gov/show/NCT04367740
NCT04510441,Artificial Intelligence-assisted Diagnosis and Prognostication in COVID-19 Using Electrocardiograms,Observational Model: Cohort|Time Perspective: Retrospective,20HH5967,"London North West University Healthcare NHS Trust, London, United Kingdom|Chelsea and Westminster Hospital NHS Foundation Trust, London, United Kingdom|Imperial College London (Hammersmith campus), London, United Kingdom|St Mary's Hospital, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04510441
NCT04406181,Psychological Well-being of Patients Awaiting for Cardiac Surgery During the COVID-19 Pandemic,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,COVID-19 Cardiac psy wellbeing,"universitair Ziekenhuis Brussel, Jette, Vlaams Brabant, Belgium",https://ClinicalTrials.gov/show/NCT04406181
NCT04822818,EFFICACY and SAFETY OF BEVACIZUMAB (ZIRABEV®) IN PATIENTS WITH SEVERE HYPOXEMIC COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,APHP200375-BEVA,NA,https://ClinicalTrials.gov/show/NCT04822818
NCT04403438,Familial Mediterranean Fever and Behçet: Analysis Before and After Covid19 Pandemic,Observational Model: Cohort|Time Perspective: Prospective,10840098-604.01.01-E.14697,"IstanbulU, Istanbul, Bakırköy, Turkey",https://ClinicalTrials.gov/show/NCT04403438
NCT04405869,Thromboembolic Events in Severe COVID-19 Patients,Observational Model: Cohort|Time Perspective: Other,7779,"Service d'Anesthésie-Réanimation - Nouvel Hôpital Civil, Strasbourg, France",https://ClinicalTrials.gov/show/NCT04405869
NCT04449081,"Knowledge, Attitude and Practice of Dental Students About COVID-19",Observational Model: Cohort|Time Perspective: Cross-Sectional,MelakaMMC,"Faculty of Dentistry, Melaka-Manipal Medical College, Melaka Tengah, Melaka, Malaysia",https://ClinicalTrials.gov/show/NCT04449081
NCT04342650,Chloroquine Diphosphate in the Prevention of SARS in Covid-19 Infection,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",CAAE: 30504220.5.0000.0005,"Hospital e Pronto Socorro Delphina Rinaldi Abdel Aziz, Manaus, Amazonas, Brazil",https://ClinicalTrials.gov/show/NCT04342650
NCT04507867,Effect of a Nss to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III,Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Single (Investigator)|Primary Purpose: Supportive Care,202036,NA,https://ClinicalTrials.gov/show/NCT04507867
NCT04900233,Effect of Covid-19 Pandemic in Non Covid-19 Patients at the Emergency Surgical Department,Observational Model: Cohort|Time Perspective: Other,5684,"Hospital Italiano de Buenos Aires, Ciudad autónoma de Buenos Aires, Buenos Aires, Argentina",https://ClinicalTrials.gov/show/NCT04900233
NCT04339322,Characteristics and Outcome of Coronavirus Disease 2019 (COVID-19) in Egypt,Observational Model: Cohort|Time Perspective: Prospective,COVID-19 in Egypt,NA,https://ClinicalTrials.gov/show/NCT04339322
NCT04560413,"Depression, Anxiety and SARS-CoV-2 (Covid-19) Phobia in Post-stroke Patients",Observational Model: Other|Time Perspective: Cross-Sectional,FSMEAH-KAEK 2020/41,"Fatih Sultan Mehmet Training and Research Hospital, İstanbul, Turkey",https://ClinicalTrials.gov/show/NCT04560413
NCT04394104,COVID-19 Wellness Survey,Observational Model: Other|Time Perspective: Retrospective,Pro2020001009,"Rutgers, The State University of New Jersey, New Brunswick, New Jersey, United States",https://ClinicalTrials.gov/show/NCT04394104
NCT04398264,Characteristics of COVID-19 Infection Among PREGnant Women,Observational Model: Cohort|Time Perspective: Other,U20-05-4055,"INOVA Health System, Falls Church, Virginia, United States",https://ClinicalTrials.gov/show/NCT04398264
NCT04389463,Patient Outcome of Cardiac Surgery During the COVID-19 Pandemic,Observational Model: Cohort|Time Perspective: Prospective,HEART-19 Study,"University Hospital, Nantes, France",https://ClinicalTrials.gov/show/NCT04389463
NCT04679168,Study on Kidney Disease and EnviromenTal Chemical,Observational Model: Cohort|Time Perspective: Prospective,SKETCH,"Seoul National University Boramae Medical Center, Seoul, Korea, Republic of",https://ClinicalTrials.gov/show/NCT04679168
NCT04637295,"Perceptions, Experiences, and Activity in CancEr Survivors During COVID-19",Observational Model: Cohort|Time Perspective: Cross-Sectional,768-20,"University of Nebraska Medical Center, Omaha, Nebraska, United States",https://ClinicalTrials.gov/show/NCT04637295
NCT04859894,"Physiological Studies in Post-COVID-19 Syndrome, and the Association With DNA Methylation",Observational Model: Case-Only|Time Perspective: Prospective,2021-01620,NA,https://ClinicalTrials.gov/show/NCT04859894
NCT04949061,The Effectiveness of Culturally Adapted Cognitive Behavioral Intervention Among COVID-19 Survivors,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2021.265.IRB1.091,NA,https://ClinicalTrials.gov/show/NCT04949061
NCT04342156,Safety And Efficacy Of Hydroxychloroquine For At Risk Population (SHARP) Against COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,2020/00402,NA,https://ClinicalTrials.gov/show/NCT04342156
NCT04458337,SURgical Outcomes in COvid Patients - the SUROCO Multicenter Cohort Study (COVID-19),Observational Model: Cohort|Time Perspective: Prospective,19.386,"Centre Hospitalier de l'Université de Montréal (CHUM), Montréal, Quebec, Canada",https://ClinicalTrials.gov/show/NCT04458337
NCT04536441,Ultra-brief Online Mindfulness-based Intervention During COVID-19 Movement Control Order,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention",U/SERC/62/2020,"Universiti Tunku Abdul Rahman, Kampar, Perak, Malaysia",https://ClinicalTrials.gov/show/NCT04536441
NCT04558437,"COVID-Impact ""Psychological IMPACT of Covid-19 on AP-HP Staff""",Observational Model: Cohort|Time Perspective: Prospective,APHP200555,"Assistance Publique - Hôpitaux de Paris, Paris, Ile De France, France",https://ClinicalTrials.gov/show/NCT04558437
NCT04501991,Short-term Impact of COVID-19 Lockdown on Metabolic Control of Type 2 Diabetes,Observational Model: Cohort|Time Perspective: Retrospective,AS0007,"University of Pisa, Pisa, Italy",https://ClinicalTrials.gov/show/NCT04501991
NCT04845997,COVID-19 Vaccination in Patients With Rheumatic Diseases,Observational Model: Cohort|Time Perspective: Prospective,2,"Sociedad Argentina de Reumatología, Ciudad Autónoma de Buenos Aires, Caba, Argentina|Sociedad Argentina de Reumatologia, Buenos Aires, Argentina",https://ClinicalTrials.gov/show/NCT04845997
NCT04780152,TDCS in Pediatric and Teenage Patients With Major Depressive Disorder During COVID-19 Pandemic,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",54/20,"Instituto Nacional de Neurología y Neurocirugía, Mexico City, Ciudad De México, Mexico",https://ClinicalTrials.gov/show/NCT04780152
NCT04377425,COVID-19 Prevalence and Cognitive Deficits in Neurological Patients,Observational Model: Cohort|Time Perspective: Prospective,Neuro-Covid-19,"Aalborg University Hospital, Aalborg, DK, Denmark|Aarhus University Hospital, Aarhus, DK, Denmark|Regional Hospital West Jutland, Hostebro, Holstebro, DK, Denmark|Regional Hospital Central Jutland, Viborg, Viborg, DK, Denmark",https://ClinicalTrials.gov/show/NCT04377425
NCT04391816,COVID-19 Pandemic Impact on Alcohol (PIA) - A Natural History Study,Observational Model: Other|Time Perspective: Prospective,200115|20-AA-0115,"NIAAA Section on Human Psychopharmacology, Bethesda, Maryland, United States",https://ClinicalTrials.gov/show/NCT04391816
NCT04356378,Long Term Physical Functional Limitations in Daily Living in SARS-CoV2 Infected Patients Hospitalized in the Acute Phase Then Requiring Rehabilitation,Observational Model: Cohort|Time Perspective: Prospective,PO20055,"Damien JOLLY, Reims, France",https://ClinicalTrials.gov/show/NCT04356378
NCT04325867,Integrated Distance Management Strategy for Patients With Cardiovascular Diseases in the Context of COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,GTP0032,"Medical Sciences Academy, Bucharest, Romania|University of Medicine and Pharmacy Gr T Popa, Iasi, Romania",https://ClinicalTrials.gov/show/NCT04325867
NCT04490772,Characteristics and Outcomes of Gastrointestinal Manifestations of COVID-19,Observational Model: Cohort|Time Perspective: Prospective,COVID gastro intestinal,NA,https://ClinicalTrials.gov/show/NCT04490772
NCT04694014,Emotional Intelligence Skills Health Leaders Need During Covid-19,Observational Model: Cohort|Time Perspective: Prospective,IREC/2020/143 AN0003667W500G,"Alupe University College, Busia, Kenya",https://ClinicalTrials.gov/show/NCT04694014
NCT04958863,Impact of Facemasks on Running During COVID-19 Pandemic,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Other,1718,"Fundación Valle del Lili, Cali, Valle, Colombia",https://ClinicalTrials.gov/show/NCT04958863
NCT04893512,First-In-Human Study Of Orally Administered CoV2-OGEN1 In Healthy Subjects,Allocation: N/A|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,CoV2-OGEN1-101,NA,https://ClinicalTrials.gov/show/NCT04893512
NCT04412330,Optimizing Outcomes With Physical Therapy Treatment for IndividuALs Surviving an ICU Admission for Covid-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,59097,"University of Kentucky, Lexington, Kentucky, United States",https://ClinicalTrials.gov/show/NCT04412330
NCT04284046,CT Scores Predict Mortality in 2019-nCoV Pneumonia,Observational Model: Cohort|Time Perspective: Retrospective,CT2019-nCoV,"Wuhan third hospital, Wuhan, Hubei, China",https://ClinicalTrials.gov/show/NCT04284046
NCT04880135,Supervised Versus Home Based Exercises Neck and Low Back Pain Among Students Due to Quarantine During COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment",REC-FSD-00232,"Riphah International University, Faisalabad, Punjab, Pakistan, Pakistan",https://ClinicalTrials.gov/show/NCT04880135
NCT04878055,Study on Efficacy and Safety of Reparixin in the Treatment of Hospitalized Patients With Severe COVID-19 Pneumonia.,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",REP0220|2020-005919-51,"The George Washington University Medical Faculty Associates, 2150 Pennsylvania Avenue NW, Washington, District of Columbia, United States|Franciscan Alliance, 421 N Emerson Ave,, Greenwood, Indiana, United States|Policlinico S. Orsola Malpighi UO di Pneumologia e Terapia Int. Respiratoria, Bologna, Italy|Ospedale Policlinico San Martino Malattie infettive e tropicali, Genova, Italy|Ospedale regionale San Salvatore U.O.C. Anestesia e Rianimazione, L'Aquila, Italy|IRCCS Istituto Clinico Humanitas U.O. Medicina D'Urgenza, Milano, Italy|ASST Grande Ospedale Metropolitano Niguarda Dipartimento Malattie Infettive, Milano, Italy|IRCCS Ospedale San Raffaele Centro di Ricerca Anestesia e Rianimazione, MIlan, Italy|ASST SANTI PAOLO E CARLO Ospedale San Paolo Struttura Complessa Malattie Infettive, Milan, Italy|ASST-Monza Ospedale San Gerardo Malattie Infettive, Monza, Italy|A.O.U. Federico II Malattie Infettive del Policlinico Federico II, Napoli, Italy|Università della Campania ""Luigi Vanvitelli"" Dipartimento di Malattie Infettive, Napoli, Italy|Policlinico Universitario Campus Bio-Medico UOC Anestesia e Rianimazione, Roma, Italy|Azienda Ospedaliero-Universitaria Policlinico Umberto I, UOC Malattie Infettive, Roma, Italy|Università Cattolica del Sacro Cuore - Policlinico Universitario ""Agostino Gemelli"" - Istituto di Clinica delle Malattie Infettive, Roma, Italy|ASST dei Sette Laghi Ospedale di Circolo e Fondazione Macchi Struttura Complessa Malattie infettive e tropicali, Varese, Italy|A.O.U. Integrata di Verona U.O. Medicina Respiratoria, sezione di Medicina Interna, Verona, Italy",https://ClinicalTrials.gov/show/NCT04878055
NCT04646525,The Relationship Between Covid-19 Infection in Pediatric Patients and Secondary Lymphoid Organs,Observational Model: Case-Only|Time Perspective: Prospective,2020/480,"Selcuk University, Konya, Selcuklu, Turkey",https://ClinicalTrials.gov/show/NCT04646525
NCT04787614,2019 NSECE COVID-19 Follow-up,Observational Model: Ecologic or Community|Time Perspective: Prospective,HHSP233201500048I-CF,"NORC at the University of Chicago, Chicago, Illinois, United States",https://ClinicalTrials.gov/show/NCT04787614
NCT04516824,Experience of Orthopaedic and Spine Center Pakistan During COVID-19,Observational Model: Other|Time Perspective: Retrospective,30,"Ghurki trust hospital, Lahore, Punjab, Pakistan",https://ClinicalTrials.gov/show/NCT04516824
NCT04834375,Randomized Open Investigation Determining Steroid Dose,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,21-0171,"Northwell Health, New Hyde Park, New York, United States",https://ClinicalTrials.gov/show/NCT04834375
NCT04797091,Kidney in Coronavirus Disease 2019 Registry,Observational Model: Case-Control|Time Perspective: Retrospective,Kidney in COVID-19,"University Hospital of Cologne, Cologne, Germany",https://ClinicalTrials.gov/show/NCT04797091
NCT04361877,Cardiovascular Prevention During COVID-19 Pandemic Lockdown in Young Adults (COLA Trial),Observational Model: Cohort|Time Perspective: Prospective,20-268 KB,"University Hospital Munich (LMU Klinikum), Munich, Germany",https://ClinicalTrials.gov/show/NCT04361877
NCT04344197,"Surgery During Covid-19: The Role of Asymptomatic Patients, a Survey",Observational Model: Other|Time Perspective: Cross-Sectional,s-covid survey,"Tor Vergata Hospital, Rome, Italy",https://ClinicalTrials.gov/show/NCT04344197
NCT04844346,Plant Stanol Esters and COVID-19 Vaccination Response,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",METC 21-013,"Maastricht University Medical Center, Maastricht, Limburg, Netherlands",https://ClinicalTrials.gov/show/NCT04844346
NCT04413747,Yoga Pranayama Adjuvant to Treat Burden COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,2020_COVID-19_YOGA,"Ambulatorio Telemedicina Giardino St Lucia, Massa Lombarda, Ravenna, Italy",https://ClinicalTrials.gov/show/NCT04413747
NCT04362319,Burnout and Medical Errors in the Anaesthesiology Fraternity During Covid-19 Pandemic,Observational Model: Cohort|Time Perspective: Cross-Sectional,54753,"Sungai Buloh Hospital, Sungai Buloh, Selangor, Malaysia",https://ClinicalTrials.gov/show/NCT04362319
NCT04558996,Spanish Registry of Pregnant Women With COVID-19,Observational Model: Cohort|Time Perspective: Prospective,55/20|COV20/0021,"Puerta de Hierro University Hospital, Majadahonda, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04558996
NCT04366297,Intravascular Access of COVID-19 Patient Under Personal Protective Equipment,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,IO_PPE_MS_1,"Lazarski Univeristy, Warsaw, Poland",https://ClinicalTrials.gov/show/NCT04366297
NCT04358003,Plasma Adsorption in Patients With Confirmed COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,MH-007/B,"UNM Health Science Center, Albuquerque, New Mexico, United States|Providence Portland Medical Center, Portland, Oregon, United States|UT Southwestern/Clements Hospital, Dallas, Texas, United States|UTMB, Galveston, Texas, United States|Inova Fairfax Medical Campus, Falls Church, Virginia, United States",https://ClinicalTrials.gov/show/NCT04358003
NCT02735707,"Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia",Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,U1111-1189-1653|2015-002340-14|602525|16/631|APP1101719|158584,"University of Pittsburgh Medical Centre, Pittsburgh, Pennsylvania, United States|St Vincent's Hospital Sydney, Sydney, New South Wales, Australia|Royal Prince Alfred Hospital, Sydney, New South Wales, Australia|Royal North Shore Hospital, Sydney, New South Wales, Australia|Nepean Hospital, Sydney, New South Wales, Australia|Wollongong Hospital, Sydney, New South Wales, Australia|Royal Darwin Hospital,, Darwin, Northern Territory, Australia|Sunshine Coast University Hospital, Birtinya, Queensland, Australia|Princess Alexandra Hospital, Brisbane, Queensland, Australia|Logan Hospital, Brisbane, Queensland, Australia|Toowoomba Hospital, Toowoomba, Queensland, Australia|The Queen Elizabeth Hospital, Adelaide, South Australia, Australia|Bendigo Hospital, Bendigo, Victoria, Australia|University Hosptial Geelong, Geelong, Victoria, Australia|The Alfred Hospital, Melbourne, Victoria, Australia|Royal Melbourne Hospital, Melbourne, Victoria, Australia|St Vincent's Hospital Melbourne, Melbourne, Victoria, Australia|Royal Perth Hospital, Perth, Western Australia, Australia|Sir Charles Gairdner Hospital, Perth, Western Australia, Australia|St John of God Hospital Midland, Perth, Western Australia, Australia|Fiona Stanley Hospital, Perth, Western Australia, Australia|St John of God Hospital Murdoch, Perth, Western Australia, Australia|AZ Sint-Jan, Brugge, Belgium|CHU de Charleroi - Hôpital Civil Marie Curie, Charleroi, Belgium|Universitair Ziekenhuis Antwerp, Edegem, Belgium|Universitair Ziekenhuis Gent, Gent, Belgium|St. Joseph's Healthcare Hamilton, Hamilton, Canada|Centre Hospitalier de l'Université de Sherbrooke, Sherbrooke, Canada|St. Michael's Hospital Unity Health Toronto, Toronto, Canada|General County Hospital Požega, Požega, Croatia|University Hospital Centre Zagreb, Zagreb, Croatia|University Hospital for Infectious Diseases, Zagreb, Croatia|Charité - Universitätsmedizin Berlin - Infektiologie und Pneumologie, Berlin, Germany|Charité - Universitätsmedizin Berlin - Nephrologie, Berlin, Germany|Vivantes Klinikum Neukölln, Berlin, Germany|Universitätsklinikum Köln, Cologne, Germany|Universitätsklinikum Frankfurt, Frankfurt, Germany|University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany|Medizinische Hochschule Hannover, Hannover, Germany|Universitätsklinikum Jena, Jena, Germany|Universitätsklinikum Leipzig, Leipzig, Germany|Universitäts Klinikum Tübingen, Tübingen, Germany|Universitätsklinikum Würzburg, Würzburg, Germany|Jósa András County Hospital, Nyíregyháza, Hungary|Csolnoky Ferenc Kórház - Veszprem County Hospital, Veszprém, Hungary|Almási Balogh Pál Kórház, Ózd, Hungary|Beaumont Hospital, Dublin, Ireland|St. Vincent's University Hospital, Dublin, Ireland|University Hospital Galway, Galway, Ireland|Meander Medisch Centrum, Amersfoort, Netherlands|Jeroen Bosch Ziekenhuis, Den Bosch, Netherlands|Martini Hospital Groningen, Groningen, Netherlands|University Medical Center Groningen, Groningen, Netherlands|Leiden University Medical Center, Leiden, Netherlands|Canisius Wilhelmina Ziekenhuis, Nijmegen, Netherlands|Radboud University Medical Center, Nijmegen, Netherlands|University Medical Center Utrecht, Utrecht, Netherlands|North Shore Hospital, Auckland, New Zealand|CVICU, Auckland City Hospital, Auckland, New Zealand|DCCM, Auckland City Hospital, Auckland, New Zealand|Middlemore Hospital, Auckland, New Zealand|Christchurch Hospital, Christchurch, New Zealand|Waikato Hospital, Hamilton, New Zealand|Rotorua Hospital, Rotorua, New Zealand|Tauranga Hospital, Tauranga, New Zealand|Wellington Regional Hospital, Wellington, New Zealand|Whangarei Hospital, Whangarei, New Zealand|Centro Hospitalar do Medio Tejo, Abrantes, Portugal|Hospital Lusíadas Lisbon, Lisboa, Portugal|Clinical Hospital of Infectious and Tropical Diseases ""Dr. Victor Babes"", Bucharest, Romania|Institut Hospital del Mar d'Investigacions Mèdiques, Barcelona, Spain|Hospital Universitario Reina Sofia, Córdoba, Spain|Basingstoke and North Hampshire Hospital, Basingstoke, United Kingdom|Southmead Hospital, Bristol, United Kingdom|University Hospital Coventry, Coventry, United Kingdom|Darlington Memorial Hospital, Darlington, United Kingdom|University Hospital of North Durham, Durham, United Kingdom|Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom|Maidstone Hospital - Maidstone and Tunbridge Wells NHS Trust, Maidstone, United Kingdom|The James Cook University Hospital, Middlesbrough, United Kingdom|Milton Keynes University Hospital, Milton Keynes, United Kingdom|Northampton General Hospital, Northampton, United Kingdom|Queen's Medical Centre - Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom|Poole Hospital NHS Foundation Trust, Poole, United Kingdom|Queen Alexandra Hospital - Portsmouth Hospitals NHS Trust, Portsmouth, United Kingdom|Royal Berkshire Hospital, Reading, United Kingdom|University Hospital of North Tees, Stockton-on-Tees, United Kingdom|Royal Cornwall Hospital, Truro, United Kingdom|Tunbridge Wells Hospital - Maidstone and Tunbridge Wells NHS Trust, Tunbridge Wells, United Kingdom|York Hospital, York, United Kingdom",https://ClinicalTrials.gov/show/NCT02735707
NCT04686409,App-based Symptom Tracking After Corona Vaccination (CoCoV),Observational Model: Case-Only|Time Perspective: Prospective,CoCoV,"Universitätsklinikum Ulm, Ulm, Germany",https://ClinicalTrials.gov/show/NCT04686409
NCT04924673,Impact of the COVID-19 Epidemic on Glycemic Balance and the Level of Stress in Diabetic Patients,Observational Model: Ecologic or Community|Time Perspective: Prospective,35RC20_9780_COVIGLYSTRESS,"Rennes University Hospital, Rennes, Bretagne, France|Centre Hospitalier de l'Agglomération Montargoise, Montargis, Centre-Val De Loire, France|Brest University Hospital, Brest, France|CHU de Dijon, Dijon, France|CHU Grenoble, Grenoble, France|Hospices Civils Lyon, Lyon, France|GHRMSA, Mulhouse, France|CHU Rouen Hôpital Boisguillaume, Rouen, France|CH de Saint Malo, Saint-Malo, France|CHRU de Tours, Tours, France|Bretagne Atlantique Hospital, Vannes, France",https://ClinicalTrials.gov/show/NCT04924673
NCT04603781,CBD Oil for Reducing Emotional Impact of COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",2020-07-0138,"University of Texas at Austin, Laboratory for the Study of Anxiety Disorders, Austin, Texas, United States",https://ClinicalTrials.gov/show/NCT04603781
NCT04339790,Mental Health Impact of COVID-19 Pandemic on NIMH Research Participants and Volunteers,Observational Model: Cohort|Time Perspective: Prospective,999920085|20-M-N085,"National Institute of Mental Health (NIMH), Bethesda, Maryland, United States",https://ClinicalTrials.gov/show/NCT04339790
NCT04821531,Feasibility of a Self-guided Exercise Program Among Hospitalized COVID-19 Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,2020-12575,"Montefiore Medical Center, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04821531
NCT04375501,A Study of Outcomes in Patients With Fractured Neck of Femur During the COVID-19 Pandemic,Observational Model: Cohort|Time Perspective: Prospective,284104,"Barts Health NHS Trust, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04375501
NCT04815018,Shifts in the Respiratory Microbiome and Clinical Outcomes of SARS-CoV-2,Observational Model: Cohort|Time Perspective: Prospective,2020-rmcovid,"Willow Brook Christian Village, Delaware, Ohio, United States|Willow Brook Delaware Run, Delaware, Ohio, United States|Kendall at Granville, Granville, Ohio, United States|Inniswood Village, Westerville, Ohio, United States",https://ClinicalTrials.gov/show/NCT04815018
NCT04449627,Psychological Impact of Admission With Covid-19 During the SARS-CoV-2 Pandemic: Naturalistic Cohort Study With a Digital Intervention,Observational Model: Cohort|Time Perspective: Retrospective,RoyalFreeNHS,NA,https://ClinicalTrials.gov/show/NCT04449627
NCT04338802,Efficacy and Safety of Nintedanib in the Treatment of Pulmonary Fibrosis in Patients With Moderate to Severe COVID -19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,huilanz Zhang,NA,https://ClinicalTrials.gov/show/NCT04338802
NCT04476914,Stress Related Disorders in Family Members of COVID-19 Patients Admitted to the ICU,Observational Model: Cohort|Time Perspective: Prospective,20-1021,"Eastern Colorado Veterans Affairs Health Care System, University Of Colorado, Aurora, Colorado, United States|University of Colorado Hospital, Aurora, Colorado, United States|Tulane Medical Center, New Orleans, Louisiana, United States|Brigham and Women's Medical Center, Boston, Massachusetts, United States|South Shore Medical Center, Weymouth, Massachusetts, United States|Columbia Milstein and Allen Hospitals, New York, New York, United States|Penn State Hershey Milton S Hershey Medical Center, Hershey, Pennsylvania, United States|University of Vermont Medical Center, Burlington, Vermont, United States|University of Washington, Seattle, Washington, United States",https://ClinicalTrials.gov/show/NCT04476914
NCT04394182,Ultra Low Doses of Therapy With Radiation Applicated to COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,20.4.1597-GHM,"Hospital La Milagrosa, GenesisCare, Madrid, Spain|Hospital Vithas Valencia Consuelo, Valencia, Spain",https://ClinicalTrials.gov/show/NCT04394182
NCT04686721,Observational Study for the Evaluation of Tracheal Stenosis in COVID-19 Patients,Observational Model: Case-Control|Time Perspective: Prospective,TS1,"Humanitas Research Hospital, Rozzano, Italy",https://ClinicalTrials.gov/show/NCT04686721
NCT04785781,Effects of Face Masks on Cardiopulmonary Capacity in Healthy Individuals,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Participant)|Primary Purpose: Health Services Research,pamukkaleU:,"Pamukkale University, Denizli, Turkey",https://ClinicalTrials.gov/show/NCT04785781
NCT04497636,Mental Health Impact of the COVID-19 Pandemic Among Migrants in Chile,Observational Model: Cohort|Time Perspective: Prospective,170519004,"Pontificia Universidad Catolica de Chile, Santiago, RM, Chile",https://ClinicalTrials.gov/show/NCT04497636
NCT04389385,COVID-19 Specific T Cell Derived Exosomes (CSTC-Exo),Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,EruCovid2020,"GENKOK, Kayseri, Melikgazi, Turkey",https://ClinicalTrials.gov/show/NCT04389385
NCT04602637,Training Load Management in Three Professional Tennis Players During COVID-19 Lockdown: a Case Series Study,Observational Model: Case-Only|Time Perspective: Retrospective,TLT01,"KINÉ kinesiología deportiva y funcional, Caba, Argentina",https://ClinicalTrials.gov/show/NCT04602637
NCT04422613,Characterization of Persistent Pulmonary Abnormalities Following COVID-19 Pneumonia,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,RC31/20/0181,"University Hospital of Toulouse, Toulouse, France",https://ClinicalTrials.gov/show/NCT04422613
NCT04361396,Assessment of the Presence of the SARS-COV-2 Virus in the Peritoneum of COVID-19 Patients,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,CHRD 0420,"CH Victor Dupouy, Argenteuil, France|CH Intercommunal, Créteil, France|Department of General and Digestive Surgery, Hospital René Dubos, Pontoise, France|Department of Gynecology-Obstetrics, Hospital René Dubos, Pontoise, France|CH Delafontaine, Saint-Denis, France",https://ClinicalTrials.gov/show/NCT04361396
NCT04373382,Peer Champion Support for Hospital Staff During and After the COVID-19 Pandemic,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,20-0084-E,"Sinai Health System, Toronto, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04373382
NCT04954014,Pilot Study of Single Dose Bevacizumab as Treatment for Acute Respiratory Distress Syndrome (ARDS) in COVID-19 Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,BEVACOR,"Hospital Universitario Reina Sofía, Córdoba, Córdona, Spain",https://ClinicalTrials.gov/show/NCT04954014
NCT04900389,The Effect of Nurses' Having COVID-19 on Their Professional Lives,Observational Model: Case-Control|Time Perspective: Prospective,2021-4/49,"Bursa Uludag University Faculty of Health Sciences, Bursa, Turkey",https://ClinicalTrials.gov/show/NCT04900389
NCT04403243,COLchicine Versus Ruxolitinib and Secukinumab In Open Prospective Randomized Trial,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,MSU080520,"Lomonosov Moscow State University Medical Research and Educational Center, Moscow, Moscow Region, Russian Federation",https://ClinicalTrials.gov/show/NCT04403243
NCT04345861,Hydroxychloroquine Plus Azithromycin Versus Hydroxychloroquine for COVID-19 Pneumonia (COVIDOC Trial),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",RECHMPL20_168,"Montpellier University hospital, Montpellier, France",https://ClinicalTrials.gov/show/NCT04345861
NCT04694573,Multicenter CTS Pre-and Post-Transplantation Covid-19 Serum Studies,Observational Model: Case-Control|Time Perspective: Prospective,CTS Covid-19 Serum Studies,"Nierenzentrum Heidelberg, Heidelberg, DE, Germany",https://ClinicalTrials.gov/show/NCT04694573
NCT04367337,Health Behavior Change During COVID-19 Pandemic,Observational Model: Ecologic or Community|Time Perspective: Prospective,3228-1BPSYPSBEH-30,"the University of Melbourne, Melbourne, Australia|University of New Brunswick, Fredericton, Canada|Peking University, Beijing, China|University of Bordeaux, Bordeaux, France|London School of Hygiene and Tropical Medicine (in collaboration with MRC Unit The Gambia at LSHTM), Fajara, Gambia|Freie Universität Berlin, Berlin, Germany|Bar-Ilan University, Ramat Gan, Israel|University of Padova, Padova, Italy|Perdana University, Serdang, Malaysia|SWPS University of Social Sciences and Humanities, Wroclaw, Lower Silezia, Poland|University of Lisbon, Lisbon, Portugal|Babes-Bolyai Unversity, Cluj-Napoca, Romania|Nanyang Technological University, Singapore, Singapore|University of Zurich, Zürich, Switzerland",https://ClinicalTrials.gov/show/NCT04367337
NCT04416373,COVID-19 and Pregnancy Outcomes,Observational Model: Cohort|Time Perspective: Prospective,COVID&PREG,"Nova Medical School - UNL, Lisbon, Portugal",https://ClinicalTrials.gov/show/NCT04416373
NCT04347408,Seroprevalence of SARS-Cov-2 Antibodies in Children,Observational Model: Cohort|Time Perspective: Prospective,282617,"Royal Belfast Hospital for Sick Children, Belfast, United Kingdom|University Hospital of Wales, Cardiff, United Kingdom|Royal Hospital for Children, Glasgow, United Kingdom|Public Health England, London, United Kingdom|Public Health England, Manchester, United Kingdom",https://ClinicalTrials.gov/show/NCT04347408
NCT04453384,Study to Evaluate the Safety and Efficacy of XAV-19 in Patients With COVID-19 Induced Moderate Pneumonia,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",RC20_0230,"CHU Amiens Picardie, Amiens, France|CHU Angers, Angers, France|Hôpital Privé d'Antony, Antony, France|CH Avignon, Avignon, France|CH de la Côte Basque, Bayonne, France|APHP - Hôpital Avicennes, Bobigny, France|CHU Caen, Caen, France|CH Métropole Savoie, Chambéry, France|CH Colmar, Colmar, France|CH Sud Francilien, Corbeil-Essonnes, France|CHD Vendée, La Roche-sur-Yon, France|CH de La Rochelle, La Rochelle, France|CH Le Mans, Le Mans, France|CHRU Lille, Lille, France|CHU Limoges, Limoges, France|Hospices Civils Lyon, Lyon, France|CH de Mont de Marzan, Mont-de-Marsan, France|GHR Mulhouse Sud-Alsace, Mulhouse, France|CHU Nantes, Nantes, France|CHU Nice, Nice, France|CHU Nîmes, Nîmes, France|CHR Orléans La Source, Orléans, France|APHP - Hôpital Tenon, Paris, France|Hôpital Saint Antoine, Paris, France|CH René Dubos, Pontoise, France|CH Cornouaille, Quimper, France|CHU Reims, Reims, France|CHU Saint Etienne, Saint-Priest-en-Jarez, France|CHU Strasbourg, Strasbourg, France|Hôpital FOCH, Suresnes, France|CHRU Nancy, Vandœuvre-lès-Nancy, France|CH Bretagne Atlantique, Vannes, France|CHU Martinique, Fort de France, Martinique|CHU La Réunion, Saint-Pierre, Réunion",https://ClinicalTrials.gov/show/NCT04453384
NCT04327401,COVID-19-associated ARDS Treated With Dexamethasone: Alliance Covid-19 Brasil III,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,CAAE: 30227020.5.1001.0008,"Hospital Ana Nery, Salvador, Bahia, Brazil|Instituto de Cardiologia do Distrito Federal, Brasília, Distrito Federal, Brazil|Fundação Social Rural de Colatina, Colatina, Esoírito Santo, Brazil|Hospital Vera Cruz AS, Belo Horizonte, Minas Gerais, Brazil|Hospital Maternidade E Pronto Socorro Santa Lucia Ltda, Poços De Caldas, Minas Gerais, Brazil|Universidade Estadual de Londrina, Londrina, Paraná, Brazil|Eurolatino Natal Pesquisas Médicas Ltda, Natal, Rio Grande Do Norte, Brazil|Irmandade da Santa Casa de Misericordia de Porto Alegre, Porto Alegre, Rio Grande Do Sul, Brazil|Maestri E Kormann Consultoria Medico-Cientifica, Blumenau, Santa Catarina, Brazil|Sociedade Literaria e Caritativa Santo Agostinho, Criciúma, Santa Catarina, Brazil|Fundação Pio XII, Barretos, São Paulo, Brazil|Santa Casa de Misericordia de Votuporanga, Votuporanga, São Paulo, Brazil|Associacao Beneficente Siria, São Paulo, Brazil|Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da USP - HCFMRP, São Paulo, Brazil|Hospital Israelita Albert Einstein, São Paulo, Brazil|Prevent Senior Private Operadora de Saude Ltda, São Paulo, Brazil|Real e Benemérita Associação Portuguesa de Beneficência/SP, São Paulo, Brazil|Santa Casa de Misericórdia, São Paulo, Brazil|Secretaria de Saúde do Estado de São Paulo, São Paulo, Brazil|Sociedade Beneficente de Senhoras Hospital Sírio-Libanês, São Paulo, Brazil|Universidade Federal de São Paulo, São Paulo, Brazil",https://ClinicalTrials.gov/show/NCT04327401
NCT04817280,COVID-19 in Polish Ice Swimmers.,Observational Model: Case-Control|Time Perspective: Retrospective,KB-03/139/2021,"Department of Public Health at Wroclaw Medical University, Wrocław, Dolny Slask, Poland|Department of Radiotherapy of Multidisciplinary Provincial Hospital, Gorzów Wielkopolski, Lubuskie, Poland|Treasury Medical Company, Zielona Góra, Lubuskie, Poland",https://ClinicalTrials.gov/show/NCT04817280
NCT04510493,Canakinumab in Patients With COVID-19 and Type 2 Diabetes,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",2020-02008; me20Donath2,"University Medical Clinic Aarau, Aarau, Switzerland|University Hospital Basel, Basel, Switzerland|University Hospital Bern, Bern, Switzerland|University Hospital Geneva, Geneva, Switzerland|University Hospital Lausanne, Lausanne, Switzerland|Cantonal Hospital Lucerne, Luzern, Switzerland|Cantonal Hospital St Gallen, St. Gallen, Switzerland|University Hospital Zürich, Zürich, Switzerland",https://ClinicalTrials.gov/show/NCT04510493
NCT04566965,Serology to Covid for Recording Exposures and Evaluating Needs,Observational Model: Case-Control|Time Perspective: Prospective,SCREEN,"Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States",https://ClinicalTrials.gov/show/NCT04566965
NCT04532632,Taste and Smell Impairment in Critically Ill COVID-19 Patients,Observational Model: Other|Time Perspective: Prospective,Feb-34,"Sisli Etfal Research and Training Hospital, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04532632
NCT04448054,"Imaging SARS-CoV-2 Involvement of Leptomeninges, Olfactory and Limbic Areas",Observational Model: Case-Only|Time Perspective: Prospective,2020-A01216-33,"Fondation A De Rothschild, Paris, France",https://ClinicalTrials.gov/show/NCT04448054
NCT04789499,Smell in Covid-19 and Efficacy of Nasal Theophylline,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",202101190,"Washington University School of Medicine in Saint Louis, Saint Louis, Missouri, United States",https://ClinicalTrials.gov/show/NCT04789499
NCT04560231,Remdesivir in COVID-19 Lahore General Hospital,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,LGH003,"Muhammad Irfan Malik, Lahore, Punjab, Pakistan",https://ClinicalTrials.gov/show/NCT04560231
NCT04694742,Ventilatory Efficiency in Critically Ill COVID-19 Patients,Observational Model: Cohort|Time Perspective: Prospective,VentRatio-19,"Arcispedale Sant'Anna, Ferrara, Emilia Romagna, Italy|Ospedale Infermi, Rimini, Emilia Romagna, Italy|ASST Fatebenefratelli Sacco, Milan, Lombardy, Italy|Azienda Ospedaliero Universitaria Ospedali Riuniti, Ancona, Marche, Italy",https://ClinicalTrials.gov/show/NCT04694742
NCT04275414,Bevacizumab in Severe or Critical Patients With COVID-19 Pneumonia,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,QLEmer20200214,"Renmin Hospital of Wuhan University, Wuhan, Hubei, China|Qilu Hospital of Shandong University, Jinan, Shandong, China|Moriggia-Pelascini Gravedona Hospital, Gravedona, Italy",https://ClinicalTrials.gov/show/NCT04275414
NCT04587219,"The Study of ""Gam-COVID-Vac"" Vaccine Against COVID-19 With the Participation of Volunteers of 60 y.o and Older",Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,05-Gam-COVID-Vac-2020,"Federal state budgetary institution ""Central clinical hospital with polyclinic"" Of the office Of the President of the Russian Federation, Moscow, Russian Federation",https://ClinicalTrials.gov/show/NCT04587219
NCT04720404,Mindful Prevention of Psychopathology in Healthcare Workers During the COVID-19 Crisis (COVID-19 MindPreP),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention,MFN-COVID-19 2020-22,"Radboud university medical center, Nijmegen, Netherlands",https://ClinicalTrials.gov/show/NCT04720404
NCT04870411,Immunological Response to COVID-19 Vaccine in Patients With Autoimmune and Inflammatory Diseases Treated With Immunosuppressants and/or Biologics,Observational Model: Case-Control|Time Perspective: Prospective,APHP210167|2021-A00181-40,"Internal medicine Service - Cochin Hospital, Paris, France",https://ClinicalTrials.gov/show/NCT04870411
NCT04383470,Collaborative Outcomes Study on Health and Functioning During Infection Times During COVID-19 Pandemic,Observational Model: Ecologic or Community|Time Perspective: Cross-Sectional,COH-FIT,"Aristotle University of Thessaloniki, Thessaloníki, Greece",https://ClinicalTrials.gov/show/NCT04383470
NCT04619680,The Study Will Evaluate the Use of Nintedanib in Slowing Lung Fibrosis in Patients With Pulmonary Infiltrates Related to COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",GCO 20-2147,"Mount Sinai Beth Israel, New York, New York, United States|Icahn School of Medicine at Mount Sinai, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04619680
NCT04613245,Health-Related Quality of Life of Patients With Asthma During the Pandemic of COVID-19,Observational Model: Case-Only|Time Perspective: Cross-Sectional,Serial 39-2020,"Egypt, Cairo, Egypt",https://ClinicalTrials.gov/show/NCT04613245
NCT04360811,"Assessment of Obstetric, Fetal and Neonatal Risks and Vertical SARS-CoV-2 Transmission During COVID-19 Pandemic",Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,RC31/20/0123,"University Hospital of Toulouse, Toulouse, France",https://ClinicalTrials.gov/show/NCT04360811
NCT04764773,Persistence of Symptoms After Improvement of Acute COVID-19,Observational Model: Case-Control|Time Perspective: Prospective,Soh-Med-21-02-46,"Mona Mohammed Abdelrahman, Sohag, Egypt",https://ClinicalTrials.gov/show/NCT04764773
NCT04491318,COVID-19 Quarantine on Musculoskeletal Status in Hemophilia,Observational Model: Cohort|Time Perspective: Prospective,HemoCov,"European University of Madrid, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04491318
NCT04977479,The Safety of Administering a Second Dose of a COVID-19 mRNA Vaccine in Individuals Who Experienced a Systemic Allergic Reaction to an Initial Dose,"Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Basic Science",10000460|000460-I,"National Institutes of Health Clinical Center, Bethesda, Maryland, United States",https://ClinicalTrials.gov/show/NCT04977479
NCT04877743,Non-Interventional Enhanced Active Surveillance Study of Adults Vaccinated With AZD1222,Observational Model: Cohort|Time Perspective: Prospective,D8111R00003,"Research Site, Amiens, France|Research Site, Argenteuil, France|Research Site, Essen, Germany|Research Site, Hamburg, Germany|Research Site, Logrono, Spain|Research Site, Mataro, Spain|Research Site, Monforte de Lemos, Spain|Research Site, Santiago de Compostela, Spain|Research Site, Goteborg, Sweden|Research Site, Orebro, Sweden|Research Site, Stockholm, Sweden",https://ClinicalTrials.gov/show/NCT04877743
NCT04900402,Activity Level and Quality of Life of Individuals With Physical Disabilities,Observational Model: Case-Crossover|Time Perspective: Prospective,continue_rehabilitation,"Sağlık Bilimleri Üniversitesi, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04900402
NCT04894331,Telemedicine for SNAS Patients in COVID-19 Pandemic,Observational Model: Cohort|Time Perspective: Prospective,ID 3448,"Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy",https://ClinicalTrials.gov/show/NCT04894331
NCT04395144,COVid-19: Awake Proning and High-flow Nasal Cannula in respiratorY DistrEss,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,21-Jan,"Hôtel-Dieu de Gaspé, Gaspé, Quebec, Canada|Hôpital de la Cité-de-la-Santé, Laval, Quebec, Canada|Montreal General Hospital, McGill University Healthcare Center, Montréal, Quebec, Canada|Royal Victoria Hospital, McGill University Healthcare Center, Montréal, Quebec, Canada|Hôpital de Verdun, Montréal, Quebec, Canada",https://ClinicalTrials.gov/show/NCT04395144
NCT04797871,Resistance Training and Clinical Status in Patients With Post Discharge Symptoms After Covid-19,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Investigator)|Primary Purpose: Health Services Research,PI_2020/140,"Robinson Ramírez-Vélez, Ph.D, Pamplona, Spain",https://ClinicalTrials.gov/show/NCT04797871
NCT04893265,Getting Asian Americans INFORMED to Facilitate COVID-19 Testing and Vaccination,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,20-32933|3R01DA036749-05S1,"Chinese Community Health Resource Center, San Francisco, California, United States",https://ClinicalTrials.gov/show/NCT04893265
NCT04376684,Investigating Otilimab in Patients With Severe Pulmonary COVID-19 Related Disease,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",214094,"GSK Investigational Site, Mobile, Alabama, United States|GSK Investigational Site, Little Rock, Arkansas, United States|GSK Investigational Site, Sacramento, California, United States|GSK Investigational Site, Torrance, California, United States|GSK Investigational Site, Gainesville, Florida, United States|GSK Investigational Site, Winfield, Illinois, United States|GSK Investigational Site, Baltimore, Maryland, United States|GSK Investigational Site, Germantown, Maryland, United States|GSK Investigational Site, Silver Spring, Maryland, United States|GSK Investigational Site, Saint Louis Park, Minnesota, United States|GSK Investigational Site, Saint Paul, Minnesota, United States|GSK Investigational Site, Jackson, Mississippi, United States|GSK Investigational Site, Reno, Nevada, United States|GSK Investigational Site, Buffalo, New York, United States|GSK Investigational Site, Charlotte, North Carolina, United States|GSK Investigational Site, Toledo, Ohio, United States|GSK Investigational Site, Doylestown, Pennsylvania, United States|GSK Investigational Site, Philadelphia, Pennsylvania, United States|GSK Investigational Site, Roanoke, Virginia, United States|GSK Investigational Site, Tacoma, Washington, United States|GSK Investigational Site, Milwaukee, Wisconsin, United States|GSK Investigational Site, Munro, Buenos Aires, Argentina|GSK Investigational Site, Cordoba, Córdova, Argentina|GSK Investigational Site, Buenos Aires, Argentina|GSK Investigational Site, Buenos Aires, Argentina|GSK Investigational Site, Cordoba, Argentina|GSK Investigational Site, Cordoba, Argentina|GSK Investigational Site, Brussel, Belgium|GSK Investigational Site, Yvoir, Belgium|GSK Investigational Site, Belo Horizonte, Minas Gerais, Brazil|GSK Investigational Site, Porto Alegre, Rio Grande Do Sul, Brazil|GSK Investigational Site, Campinas, São Paulo, Brazil|GSK Investigational Site, Belo Horizonte, Minas Gerais, Brazil|GSK Investigational Site, São Paulo, Brazil|GSK Investigational Site, São Paulo, Brazil|GSK Investigational Site, São Paulo, Brazil|GSK Investigational Site, São Paulo, Brazil|GSK Investigational Site, Vancouver, British Columbia, Canada|GSK Investigational Site, Ottawa, Ontario, Canada|GSK Investigational Site, Ottawa, Ontario, Canada|GSK Investigational Site, Montréal, Quebec, Canada|GSK Investigational Site, QC, Quebec, Canada|GSK Investigational Site, St-Jerome, Quebec, Canada|GSK Investigational Site, Talca, Región Del Maule, Chile|GSK Investigational Site, Santiago, Chile|GSK Investigational Site, Santiago, Chile|GSK Investigational Site, Bogotá, Colombia|GSK Investigational Site, Amiens Cedex 1, France|GSK Investigational Site, Angers Cedex 9, France|GSK Investigational Site, Argenteuil, France|GSK Investigational Site, La Roche-Sur-Yon, France|GSK Investigational Site, La Tronche, France|GSK Investigational Site, Limoges Cedex, France|GSK Investigational Site, Melun, France|GSK Investigational Site, Paris, France|GSK Investigational Site, Pierre-Bénite, France|GSK Investigational Site, Strasbourg cedex, France|GSK Investigational Site, Strasbourg, France|GSK Investigational Site, Valenciennes Cedex, France|GSK Investigational Site, Hannover, Niedersachsen, Germany|GSK Investigational Site, Aachen, Nordrhein-Westfalen, Germany|GSK Investigational Site, Koeln, Nordrhein-Westfalen, Germany|GSK Investigational Site, Berlin, Germany|GSK Investigational Site, Goettingen, Germany|GSK Investigational Site, Aurangabad, India|GSK Investigational Site, Aurangabad, India|GSK Investigational Site, Hyderabad, India|GSK Investigational Site, Kolkata, India|GSK Investigational Site, Kolkata, India|GSK Investigational Site, Mumbai, India|GSK Investigational Site, Nagpur, India|GSK Investigational Site, New Delhi, India|GSK Investigational Site, Pune, India|GSK Investigational Site, Pune, India|GSK Investigational Site, Napoli, Campania, Italy|GSK Investigational Site, Roma, Lazio, Italy|GSK Investigational Site, Milano, Lombardia, Italy|GSK Investigational Site, Milan, Lombardia, Italy|GSK Investigational Site, Foggia, Puglia, Italy|GSK Investigational Site, Aichi, Japan|GSK Investigational Site, Kanagawa, Japan|GSK Investigational Site, Kanagawa, Japan|GSK Investigational Site, Osaka, Japan|GSK Investigational Site, Saitama, Japan|GSK Investigational Site, Tokyo, Japan|GSK Investigational Site, Tokyo, Japan|GSK Investigational Site, Tokyo, Japan|GSK Investigational Site, Tokyo, Japan|GSK Investigational Site, Mexico City, Ciudad De Mexico, Mexico|GSK Investigational Site, Guadalajara, Jalisco, Mexico|GSK Investigational Site, Monterrey, Nuevo León, Mexico|GSK Investigational Site, Mexico, Mexico|GSK Investigational Site, Breda, Netherlands|GSK Investigational Site, Den Bosch, Netherlands|GSK Investigational Site, Enschede, Netherlands|GSK Investigational Site, Nijmegen, Netherlands|GSK Investigational Site, Rotterdam, Netherlands|GSK Investigational Site, Lima, Peru|GSK Investigational Site, Lima, Peru|GSK Investigational Site, Lima, Peru|GSK Investigational Site, Lima, Peru|GSK Investigational Site, Bydgoszcz, Poland|GSK Investigational Site, Krakow, Poland|GSK Investigational Site, Poznan, Poland|GSK Investigational Site, Warszawa, Poland|GSK Investigational Site, Wroclaw, Poland|GSK Investigational Site, Barnaul, Russian Federation|GSK Investigational Site, Chelyabinsk, Russian Federation|GSK Investigational Site, Ekaterinburg, Russian Federation|GSK Investigational Site, Moscow, Russian Federation|GSK Investigational Site, Nizhniy Novgorod, Russian Federation|GSK Investigational Site, Omsk, Russian Federation|GSK Investigational Site, Perm, Russian Federation|GSK Investigational Site, St. Petersburg, Russian Federation|GSK Investigational Site, Ufa, Russian Federation|GSK Investigational Site, Voronezh, Russian Federation|GSK Investigational Site, Benoni, Gauteng, South Africa|GSK Investigational Site, Johannesburg, Gauteng, South Africa|GSK Investigational Site, Durban, KwaZulu- Natal, South Africa|GSK Investigational Site, Muckleneuk Pretoria, South Africa|GSK Investigational Site, Panorama,, South Africa|GSK Investigational Site, Tygerberg, South Africa|GSK Investigational Site, Worcester, South Africa|GSK Investigational Site, Barcelona, Spain|GSK Investigational Site, L'Hospitalet de Llobregat, Spain|GSK Investigational Site, Logroño, Spain|GSK Investigational Site, Madrid, Spain|GSK Investigational Site, Madrid, Spain|GSK Investigational Site, Madrid, Spain|GSK Investigational Site, Madrid, Spain|GSK Investigational Site, San Sebastián De Los Reyes/Madrid, Spain|GSK Investigational Site, Manchester, Greater Manchester, United Kingdom|GSK Investigational Site, Liverpool, United Kingdom|GSK Investigational Site, Newcastle Upon Tyne, United Kingdom",https://ClinicalTrials.gov/show/NCT04376684
NCT04635618,Psychotherapy Strategies for the Treatment of Professionals and Students From Essential Services With High Levels of Emotional Distress in the Context of COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,20200213_Treatment,"Hospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande Do Sul, Brazil",https://ClinicalTrials.gov/show/NCT04635618
NCT04355234,"Prevalence and Impact of COVID-19 Infection in Pregnant Women, Fetuses and Newborns",Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Screening,APHP 200448,"Tsastaris Vassillis, Paris, France",https://ClinicalTrials.gov/show/NCT04355234
NCT04453579,"Bariatric Surgery During Lockdown, Impact of COVID-19 on Physical and Mental Health",Observational Model: Case-Only|Time Perspective: Prospective,UNRomeB,"Michela Campanelli, Rome, RM, Italy",https://ClinicalTrials.gov/show/NCT04453579
NCT04390555,The Global PCHF-COVICAV Registry,Observational Model: Cohort|Time Perspective: Other,PCHF-COVICAV,"Zurich Heart Center, Unispital Zurich, Zurich, Switzerland",https://ClinicalTrials.gov/show/NCT04390555
NCT04359875,A Phone-call With a Student/General Practitioner Team to Impact Morbidity of Chronic Patients During COVID-19 Containment,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,2020-CD-COVIQuest (COVID-19)|2020-A01061-38,"Dibao-Dina, Tours, France",https://ClinicalTrials.gov/show/NCT04359875
NCT04560257,High Flow Nasal Cannula HFNC In Covid-19 Patients,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,LGH004,"Muhammad Irfan Malik, Lahore, Punjab, Pakistan",https://ClinicalTrials.gov/show/NCT04560257
NCT04452422,Deep Venous Thrombosis in Non-severe COVID-19 Patients Hospitalized for a Neurovascular Pathology,Observational Model: Case-Only|Time Perspective: Other,7908,"Service Unité Neurovasculaire, Strasbourg, France",https://ClinicalTrials.gov/show/NCT04452422
NCT04445506,Short Term Corticosteroids in SARS-CoV2 Patients,Observational Model: Case-Control|Time Perspective: Retrospective,20-027,"The Miriam Hospital, Providence, Rhode Island, United States",https://ClinicalTrials.gov/show/NCT04445506
NCT04540029,Measuring Outcomes of Maternal COVID-19-related Prenatal Exposure,Observational Model: Case-Control|Time Perspective: Prospective,MOM-COPE,"IRCCS Mondino Foundation, Pavia, PV, Italy",https://ClinicalTrials.gov/show/NCT04540029
NCT04583566,"Differential Expression of Cytokines, Transcriptome and miRNA in Coronavirus Disease 2019 (COVID-19) Egyptian's Patients",Observational Model: Case-Control|Time Perspective: Prospective,CTM_COVID-19,"Tanta University Hospital, Tanta, El Gharbia, Egypt|Center of Excellence in Cancer Research, Tanta University Hospital., Tanta, Gharbia, Egypt",https://ClinicalTrials.gov/show/NCT04583566
NCT04797624,Does Coronavirus Disease 2019 (COVID-19) Pandemic Cause a Delay in the Diagnosis of Gastric Cancer Patients?,Observational Model: Other|Time Perspective: Retrospective,1248,"Adana City Training and Research Hospital, Adana, Yuregir, Turkey",https://ClinicalTrials.gov/show/NCT04797624
NCT04487197,"SARS-CoV2 (COVID-19) Seroepidemiological Transplanted Subjects (Kidney, Kidney-pancreas, Pancreas, Langerhans Islets)",Observational Model: Cohort|Time Perspective: Other,COVID-SIERO TRAPIANTI,"IRCCS San Raffaele, Milan, Italy",https://ClinicalTrials.gov/show/NCT04487197
NCT04513847,PsoVac: Educational Needs re Vaccines for Biologic Patients With Psoriasis,Observational Model: Case-Control|Time Perspective: Other,Pso-Vac,"Dermatrials Research, Hamilton, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04513847
NCT04445961,Respiratory Mechanics and Gas Exchange in Patients With COVID-19 and Hypoxemic Acute Respiratory Failure,Observational Model: Case-Only|Time Perspective: Prospective,COVID-VENT,"Sechenov University Clinic #1, Moscow, Russian Federation|Sechenov University Clinic #3, Moscow, Russian Federation|Sechenov University Clinic #4, Moscow, Russian Federation",https://ClinicalTrials.gov/show/NCT04445961
NCT04489628,Tele-health Enabled Clinical Trial for COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",STUDY20200461,"Northwestern University, Chicago, Illinois, United States",https://ClinicalTrials.gov/show/NCT04489628
NCT04920838,Early Treatment of Vulnerable Individuals With Non-Severe SARS-CoV-2 Infection,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,ANRS COV33 COVERAGE-Africa,"Centre Muraz/INSP, Bobo-Dioulasso, Burkina Faso|Centre de traitement des maladies à tendance épidémique de Gbessia, Conakry, Guinea",https://ClinicalTrials.gov/show/NCT04920838
NCT04867265,Mouth-to-mouth Ventilation Efficiency Through Breathable Self-sterilizing Respirator During BLS in COVID-19 Pandemic,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Other,SIMU 1 2021,"Faculty of Medicine, Masaryk University Brno, Brno, Czechia",https://ClinicalTrials.gov/show/NCT04867265
NCT04323592,Methylprednisolone for Patients With COVID-19 Severe Acute Respiratory Syndrome,Observational Model: Cohort|Time Perspective: Prospective,MP-19 023_2020,"Marco Confalonieri, Trieste, TS, Italy",https://ClinicalTrials.gov/show/NCT04323592
NCT04870385,An Islamic Psychospiritual-Acceptance and Commitment-based Prevention Program for At-risk Young Adults in the COVID-19 Pandemic,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,SPI21-052-0052,"International Islamic University Malaysia, Kuala Lumpur, Selangor, Malaysia",https://ClinicalTrials.gov/show/NCT04870385
NCT04500652,Mental Health Status and Related Factors Among Physical Medicine & Rehabilitation Physicians in the Covid-19 Pandemic,Observational Model: Other|Time Perspective: Cross-Sectional,PMRMentalcovid,"Dokuz Eylul University, Izmir, Turkey",https://ClinicalTrials.gov/show/NCT04500652
NCT04870736,Mouth-to-mouth Ventilation Efficiency Through Breathable Self-sterilizing Respirator During BLS in COVID-19 Pandemic (MOVE),Observational Model: Case-Crossover|Time Perspective: Prospective,SIMU 2 2021,"Faculty of Medicine, Masaryk University Brno, Brno, South Moravian Region, Czechia",https://ClinicalTrials.gov/show/NCT04870736
NCT04587414,eHealth Intervention on Physical Activity for Type 2 Diabetics - Frustrated by COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,MySteps ETL 303/2017,"North Karelia Hospital District, Joensuu, Finland",https://ClinicalTrials.gov/show/NCT04587414
NCT04354558,French Single Centre Experience of Critically Ill Patients With Covid 19,Observational Model: Cohort|Time Perspective: Prospective,PI2020_843_0026,"CHU Amiens, Amiens, France",https://ClinicalTrials.gov/show/NCT04354558
NCT04977024,SARS-CoV-2 Vaccine (COH04S1) Versus Emergency Use Authorization SARS-COV-2 Vaccine for the Treatment of COVID-19 in Patients With Blood Cancer,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",21163|NCI-2021-05556|P30CA033572,"City of Hope Medical Center, Duarte, California, United States",https://ClinicalTrials.gov/show/NCT04977024
NCT04377776,"Observational Study Concerning COVID-19 Infection in Transplanted Kidney, Pancreas or Pancreatic Islet Patients",Observational Model: Cohort|Time Perspective: Cross-Sectional,COVID-19 MITRA,"IRCCS San Raffaele, Milano, Italy",https://ClinicalTrials.gov/show/NCT04377776
NCT04371419,COVID-19 Health Messaging to Underserved Communities,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,2003000118,"JPAL North America, Cambridge, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT04371419
NCT04626050,"General Psychological Distress, PTSD, and Co-Morbidities in Healthcare Workers Consequent to COVID-19",Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,20-04021913,"Weill Cornell Medicine, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04626050
NCT04339686,Multicentric Retrospective Observational Study of Thoracic Scanner Performance in COVID Screening.,Observational Model: Cohort|Time Perspective: Retrospective,POWER-COVID_CT,"Chu de Poitiers, Poitiers, France",https://ClinicalTrials.gov/show/NCT04339686
NCT04393792,SINUS WASH Pilot Study in Adults Testing Positive for COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,SPON-AK-0420|2020-001721-31,"Hampshire Hospitals NHS Foundation Trust, Basingstoke, Hampshire, United Kingdom",https://ClinicalTrials.gov/show/NCT04393792
NCT04322487,"Simple, Safe, Same: Lung Ultrasound for COVID-19",Observational Model: Case-Only|Time Perspective: Prospective,0013226/20,"Bresciamed, Brescia, Italy|Pulmonary Medicine Unit, Lodi General Hospital, Lodi, Italy|118 USL Nordovest Toscana, Lucca, Italy|Diagnostic and Interventional Ultrasound Unit, Valle del Serchio General Hospital, Lucca, Italy|Emergency Department, Fondazione IRCCS Policlinico San Matteo, and Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy|Department of woman and child health and public health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy|Pulmonary Medicine Unit, Dept. Medical and Surgical Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy|Department of Information Engineering and Computer Science, Ultrasound Laboratory Trento, University of Trento, Trento, Italy|Emergency Medicine Unit, General Hospital, Voghera, Italy",https://ClinicalTrials.gov/show/NCT04322487
NCT04661540,A Study of Auxora in Patients With Critical COVID-19 Pneumonia,Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,CM4620-205,"Northwestern Memorial Hospital, Chicago, Illinois, United States",https://ClinicalTrials.gov/show/NCT04661540
NCT04471701,Italian Web-based Cross-sectional Survey on COVID-19,Observational Model: Cohort|Time Perspective: Cross-Sectional,EPICOVID19_2020,"Institute of Biomedical Technologies-National Research Council, Segrate, MI, Italy",https://ClinicalTrials.gov/show/NCT04471701
NCT04602481,COVID-19 in People With Primary Ciliary Dyskinesia,Observational Model: Cohort|Time Perspective: Prospective,COVID-PCD,"Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland",https://ClinicalTrials.gov/show/NCT04602481
NCT04345614,A Study of Auxora in Patients With Severe COVID-19 Pneumonia,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",CM4620-204,"Long Beach Memorial, Long Beach, California, United States|University of Southern California / LA County, Los Angeles, California, United States|Sharp Memorial San Diego, San Diego, California, United States|University of Colorado, Aurora, Colorado, United States|National Jewish Health / St. Joseph's Hospital, Denver, Colorado, United States|Northwestern University, Chicago, Illinois, United States|Baton Rouge General, Baton Rouge, Louisiana, United States|Maine Medical Center, Portland, Maine, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States|Detroit Receiving Hospital, Detroit, Michigan, United States|Harper Hospital, Detroit, Michigan, United States|Henry Ford Hospital, Detroit, Michigan, United States|Sinai Grace, Detroit, Michigan, United States|Methodist Hospital, Saint Louis Park, Minnesota, United States|Regions Hospital, Saint Paul, Minnesota, United States|Temple University, Philadelphia, Pennsylvania, United States|Texas Tech University Medical Center, El Paso, Texas, United States|John Peter Smith Hospital, Fort Worth, Texas, United States|Ben Taub (Baylor), Houston, Texas, United States|Houston Methodist Hospital, Houston, Texas, United States|Virginia Commonwealth University, Richmond, Virginia, United States|Aurora Baycare, Green Bay, Wisconsin, United States|Hospital San Cristobal, Ponce, Puerto Rico",https://ClinicalTrials.gov/show/NCT04345614
NCT04500366,GERAS Frailty Rehabilitation at Home During COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Prevention",11408,"McMaster University - Hamilton Health Sciences (St. Peter's Site), Hamilton, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04500366
NCT04796584,Efficacy of COVID-19 Vaccination in Patients With Multiple Sclerosis Treated With Immune Modulating Medication,Observational Model: Cohort|Time Perspective: Prospective,SARSmRNA_MS,"Providence Neurological Specialties West, Portland, Oregon, United States",https://ClinicalTrials.gov/show/NCT04796584
NCT04761874,Telestroke at Comprehensive Stroke Center During the COVID-19 Pandemic,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,TC0002,"M Health Fairview Southdale Hospital, Edina, Minnesota, United States",https://ClinicalTrials.gov/show/NCT04761874
NCT04799808,"Saxon SARS-CoV-2 Infection and Vaccination Study in Dialysis Patients, Solid Organ Recipients and Staff",Observational Model: Cohort|Time Perspective: Prospective,DIA-Vacc-21,"Univercity Hospital Carl Gustav Carus, Dresden, Saxony, Germany",https://ClinicalTrials.gov/show/NCT04799808
NCT04914754,Mechanisms Underlying Long-term Fatigue and Exercise Intolerance Following CoV-2 Infection,Observational Model: Case-Only|Time Perspective: Prospective,137711,"University College London, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04914754
NCT04597775,Chemoprevention Clinical Trial of COVID-19: Hydroxychloroquine Post Exposure Prophylaxis,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,APCC-19,NA,https://ClinicalTrials.gov/show/NCT04597775
NCT04945850,Can COVID-19 Persist in Intraocular Fluid?,Observational Model: Case-Control|Time Perspective: Prospective,100800,"Vanderbilt University Medical Center, Nashville, Tennessee, United States",https://ClinicalTrials.gov/show/NCT04945850
NCT04503057,Exhaled Breath Particles as a Clinical Indicator for Lung Injury and Acute Respiratory Distress Syndrome (ARDS),Observational Model: Case-Control|Time Perspective: Prospective,PEx ARDS,"Region Skåne, Lund, Skåne Län, Sweden",https://ClinicalTrials.gov/show/NCT04503057
NCT04925908,Exclusive Breastfeeding in Infants of Mothers Infected With Novel Coronavirus,Observational Model: Case-Control|Time Perspective: Cross-Sectional,KAEK/2021.05.165,"Kanuni Sultan Suleyman Training and Research Hospital, Istanbul, Kucukcekmece, Turkey",https://ClinicalTrials.gov/show/NCT04925908
NCT04839913,"Seroprevalence of SARS-CoV-2 in Unselected Surgical Patients: an Unicentric, Regional Study",Observational Model: Case-Only|Time Perspective: Retrospective,COVID-SER,"University of Cagliari, Cagliari, Italy",https://ClinicalTrials.gov/show/NCT04839913
NCT04426318,COVID-19 and the Healthy Minds Program for Educators,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Treatment,2020-0533|A171600|EDUC/COUNSELING PSYCH|Protocol Approval 10/15/2020,"University of Wisconsin, Madison, Wisconsin, United States",https://ClinicalTrials.gov/show/NCT04426318
NCT04460027,W-SUDs for COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment",56439,"Stanford University, Palo Alto, California, United States",https://ClinicalTrials.gov/show/NCT04460027
NCT04961489,Impact of Measures Taken to Contain COVID-19 on Hospital Surgical Care Services and Clinical Outcomes,Observational Model: Cohort|Time Perspective: Retrospective,2020/2706,"Singapore General Hospital, Singapore, Singapore|National Cancer Center Singapore, Singapore, Singapore",https://ClinicalTrials.gov/show/NCT04961489
NCT04390126,COVID-19 Related Lockdown Effects On Chronic Diseases,Observational Model: Cohort|Time Perspective: Prospective,BOULIN AOIc 2020,"CHU Dijon Bourgogne, Dijon, France",https://ClinicalTrials.gov/show/NCT04390126
NCT04402970,Dornase Alfa for ARDS in Patients With Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2),Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,2022206,"University of Missouri Hospital and Clinics, Columbia, Missouri, United States",https://ClinicalTrials.gov/show/NCT04402970
NCT04443361,Insomnia After the COVID-19 Pandemic,Observational Model: Other|Time Perspective: Prospective,REK125510 (7),NA,https://ClinicalTrials.gov/show/NCT04443361
NCT04373707,Weight-Adjusted vs Fixed Low Doses of Low Molecular Weight Heparin For Venous Thromboembolism Prevention in COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention,2020-001709-21,"Amiens Academic Hospital, Amiens, France|Besançon Academic Hospital, Besançon, France|Brest Academic Hospital, Brest, France|Civil Hospital, Colmar, France|Dijon Academic Hospital, Dijon, France|Kremlin Bicêtre Academic Hospital, Le Kremlin-Bicêtre, France|Lille Academic Hospital, Lille, France|Groupe Hospitalier Unéos, Metz, France|Metz-Thionville Regional Hospital, Metz, France|Montpellier Academic Hospital, Montpellier, France|Emile Muller Hospital, Mulhouse, France|Nancy Academic Hospital, Nancy, France|George Pompidou European Hospital, Paris, France|Lariboisière Academic Hospital, Paris, France|St Etienne Academic Hospital, Saint-Étienne, France|Strasbourg Academic Hospital, Strasbourg, France|Toulouse Academic Hospital, Toulouse, France",https://ClinicalTrials.gov/show/NCT04373707
NCT04870307,Community-engaged Approaches to Testing in Community and Healthcare Settings for Underserved Populations,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,12582|U54GM104938-08S1,"Oklahoma Clinical and Translational Science Institute, Oklahoma City, Oklahoma, United States",https://ClinicalTrials.gov/show/NCT04870307
NCT04501432,Cardiac Rehabilitation and Ongoing Physical Activity During COVID-19,Observational Model: Cohort|Time Perspective: Other,23_CODIS,"Institute of Sports Medicine, Prevention and Rehabilitation, Salzburg, Austria",https://ClinicalTrials.gov/show/NCT04501432
NCT04615416,Emotion Regulation Training Via Telehealth During the COVID-19 Pandemic,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,20-269,"Teachers College, Columbia University, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04615416
NCT04928911,Expectations About the COVID-19 Vaccines,Observational Model: Cohort|Time Perspective: Prospective,AUvac,NA,https://ClinicalTrials.gov/show/NCT04928911
NCT04635592,Serological Diagnostics of COVID-19 in Health Care Workers,Observational Model: Cohort|Time Perspective: Prospective,KOAIT-1-2020,"University Medical Centre Ljubljana, Ljubljana, Slovenia",https://ClinicalTrials.gov/show/NCT04635592
NCT04351568,Professional and Ethical Challenges of Social Media Usage in Providing Healthcare Services During the Period of 19 Covid Pandemics;,Observational Model: Ecologic or Community|Time Perspective: Cross-Sectional,2020A20,"Assiut, Assiut, Egypt",https://ClinicalTrials.gov/show/NCT04351568
NCT04632082,Telepsychoeducation for the Prevention of Emotional Distress in Professionals and Students From Essential Services in the Context of COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,20200213_Prevention,"Hospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande Do Sul, Brazil",https://ClinicalTrials.gov/show/NCT04632082
NCT04379544,Prognostic Value of Point of Care Cardiac and Lung Ultrasound in COVID-19,Observational Model: Cohort|Time Perspective: Prospective,843008,"University of Pennsylvania Health System, Philadelphia, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04379544
NCT04887233,Efficacy and Safety of Longan Extract Spray (P80 Spray) in Volunteers With Coronavirus Disease 2019 (COVID-19),"Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Supportive Care",214/64,NA,https://ClinicalTrials.gov/show/NCT04887233
NCT04365608,Prehospital Intubation of COVID-19 Patient With Personal Protective Equipment,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,INT_EMS_PPE_1,"Emergency Medical Service, Poznan, Poland|Emergency Medical Service, Warsaw, Poland",https://ClinicalTrials.gov/show/NCT04365608
NCT04659746,MejoraCare-Paraguay: mHealth Solution for Chronic Patients During the COVID-19 Outbreak in Paraguay,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,PINV 20-9,"Hospital Regional de Encarnación, Encarnación, Itapúa, Paraguay",https://ClinicalTrials.gov/show/NCT04659746
NCT04264858,Treatment of Acute Severe 2019-nCoV Pneumonia With Immunoglobulin From Cured Patients,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,WuhanUH-2019 nCoV-Ig,"Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China",https://ClinicalTrials.gov/show/NCT04264858
NCT04706325,COVID-19 RELATED KIDNEY DAMAGE,Observational Model: Case-Control|Time Perspective: Prospective,kocaeli derh,"Akif Şahin, Kocaeli, Turkey",https://ClinicalTrials.gov/show/NCT04706325
NCT04847596,A Multicenter Study to Assess Response to COVID-19 Vaccine in Multiple Sclerosis Participants Treated With Ofatumumab,Observational Model: Cohort|Time Perspective: Prospective,COMB157GUS18,"Novartis Investigative Site, Phoenix, Arizona, United States|Novartis Investigative Site, Owosso, Michigan, United States|Novartis Investigative Site, Plainview, New York, United States",https://ClinicalTrials.gov/show/NCT04847596
NCT04672590,COVID-19 Neurological Disease: A Prospective Study,Observational Model: Case-Control|Time Perspective: Prospective,UoL001596,NA,https://ClinicalTrials.gov/show/NCT04672590
NCT04896983,National Survey of Mental Health After COVID-19 Outbreak,Observational Model: Ecologic or Community|Time Perspective: Cross-Sectional,#7528289|#7528289 COVID-19 CoV2Soul.RS,"Faculty of Medicine, University of Belgrade, Belgrade, Serbia|Faculty of Philosophy, University of Belgrade, Belgrade, Serbia|Faculty of Philosophy, University of Novi Sad, Novi Sad, Serbia",https://ClinicalTrials.gov/show/NCT04896983
NCT04542915,COVID-19-Related Health and Practices Among Dental Hygienists,Observational Model: Ecologic or Community|Time Perspective: Prospective,ADA20-11,"American Dental Association, Chicago, Illinois, United States",https://ClinicalTrials.gov/show/NCT04542915
NCT04529421,Assocation Between In-person Instruction and COVID-19 Risk,Observational Model: Cohort|Time Perspective: Prospective,172155,"Oslo Metropolitan University, Oslo, Norway",https://ClinicalTrials.gov/show/NCT04529421
NCT04847050,"A Trial of the Safety and Immunogenicity of the COVID-19 Vaccine (mRNA-1273) in Participants With Hematologic Malignancies and Various Regimens of Immunosuppression, and in Participants With Solid Tumors on PD1/PDL1 Inhibitor Therapy",Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,10000115|000115-C,"National Institutes of Health Clinical Center, Bethesda, Maryland, United States",https://ClinicalTrials.gov/show/NCT04847050
NCT04321174,COVID-19 Ring-based Prevention Trial With Lopinavir/Ritonavir,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention,CORIPREV-1,"St. Paul's Hospital, Vancouver, British Columbia, Canada|Sunnybrook Hospital, Toronto, Ontario, Canada|St. Michael's Hospital, Toronto, Ontario, Canada|Toronto General Hospital, Toronto, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04321174
NCT04385797,Cognitive Outcomes During COVID-19 confiNemeNt in Elderly and Their Caregivers Using Technologies for DEMentia,Observational Model: Cohort|Time Perspective: Other,CONNECT DEM,"Instituto de Investigacion Biomedica de Malaga-IBIMA, Málaga, Spain",https://ClinicalTrials.gov/show/NCT04385797
NCT04898192,Monitoring of Incidence of Mental Discomfort in Pregnant Women During the Serious COVID-19 Pandemic Conditions,Observational Model: Cohort|Time Perspective: Prospective,EC/045/2021/UNBRuzinov,"2nd Department of Obstetrics and Gynecology, University Hospital Bratislava and Comenius University, Bratislava, Slovak Republic, Bratislava, Slovensko, Slovakia",https://ClinicalTrials.gov/show/NCT04898192
NCT04415359,Evaluation of the Evolution of Pregnancies in the First Trimester Following MAR Management During a COVD-19 Pandemic Period,Observational Model: Case-Only|Time Perspective: Other,7789,"Service Clinico biologique d'Assistance Médicale à La Procréation, Strasbourg, France",https://ClinicalTrials.gov/show/NCT04415359
NCT04712292,Effects of COVID-19 Pandemic on the Diagnosis and Outcomes of Colorectal Cancer (COVID-CRC),Observational Model: Cohort|Time Perspective: Retrospective,854/2020/Oss/AOUBo,"Rho Memorial Hospital, Rho, Milan, Italy|Humanitas Research Center, Rozzano, Milan, Italy|Humanitas Gavazzeni Hospital, Bergamo, Italy|Policlinico San Marco, Bergamo, Italy|Maggiore Hospital, Bologna, Italy|Fondazione Poliambulanza, Brescia, Italy|Spedali Civili, Brescia, Italy|Spedali Civili, Brescia, Italy|Istituto Europeo di Oncologia, Milan, Italy|Sacco Hospital, Milan, Italy|San Raffaele Hospital, Milan, Italy|Istituto Nazionale dei Tumori, Milan, Italy|Policlinic of Milan, Milan, Italy|San Paolo Hospital, Milan, Italy|Istituto Oncologico Veneto, Padova, Italy|Padova University Hospital, Padova, Italy|San Matteo Hospital, Pavia, Italy|Città della salute, Turin, Italy|Mauriziano Hospital, Turin, Italy",https://ClinicalTrials.gov/show/NCT04712292
NCT04369690,"The Psychological, Social, and Economic Impacts of COVID-19",Observational Model: Cohort|Time Perspective: Prospective,2131,"Southlake Regional Health Centre, Newmarket, Ontario, Canada|CHEO Research Institute, Ottawa, Ontario, Canada|The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada|The Centre for Addiction and Mental Health, Ottawa, Ontario, Canada|The University of Ottawa Heart Institute, Ottawa, Ontario, Canada|The Royal's Institute of Mental Health Research, Ottawa, Ontario, Canada|Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada|Hôpital en santé mentale Rivière-des-Prairies (CIUSSS du Nord-de-l'Île-de-Montréal), Montréal, Quebec, Canada|McGill University, Montréal, Quebec, Canada|University of Montréal, Montréal, Quebec, Canada",https://ClinicalTrials.gov/show/NCT04369690
NCT04451993,Physical Activity Level in Patients With OSAS During Covid-19 Pandemic,Observational Model: Case-Control|Time Perspective: Prospective,GO 20/540,"Trabzon Ahi Evren Thoracic and Cardiovascular Surgery Training and Research Hospital, Trabzon, Turkey",https://ClinicalTrials.gov/show/NCT04451993
NCT04318314,COVID-19: Healthcare Worker Bioresource: Immune Protection and Pathogenesis in SARS-CoV-2,Observational Model: Cohort|Time Perspective: Prospective,130852,"Barts Heart Center, London, United Kingdom|Royal Free London NHS Foundation Trust, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04318314
NCT04686565,Covid-19 Pandemic and Cerebral Palsy,Observational Model: Case-Only|Time Perspective: Cross-Sectional,CP-covid,"Diskapi Education and Research Hospital, Ankara, Altındag, Turkey",https://ClinicalTrials.gov/show/NCT04686565
NCT04824638,BNT162b2 Vaccination With Two Doses in COVID-19 Negative Adult Volunteers and With a Single Dose in COVID-19 Positive Adult Volunteers,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,ANRS0002S,"CIC1412, CHRU Brest, Brest, France|Centre de Recherche Clinique, CHU Côte de Nacre, Caen, France|CIC 1405 , CHU Clermont-Ferrand, Clermont-Ferrand, France|CIC1430, Hôpital Henri Mondor, Creteil, France|CIC1413 , Hôtel Dieu - CHU Nantes, Nantes, France|Service des maladies infectieuses, CHU de Caremeau, Nîmes, France|CIC1417, hôpital Cochin, Paris, France|CIC 1427, Hopital Saint-Louis, Paris, France|URCI, Hôpital Lyon Sud, Pierre-Bénite, France|CIC1434, Nouvel Hôpital Civil - Hôpitaux Universitaires de Strasbourg, Strasbourg, France|CIC1415, CHRU Tours Hôpital Bretonneau, Tours, France",https://ClinicalTrials.gov/show/NCT04824638
NCT04873128,Comparative Genetic and Immune Response Analysis of Different COVID-19 Vaccine Candidates Using Multi-OMICS Approach,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,COVID 19-VAC,"University Hospital Tübingen, Tübingen, Germany",https://ClinicalTrials.gov/show/NCT04873128
NCT04570202,Health cAre woRkers exposeD to COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,DR200160-HARD-COVID-19|2020-A01642-37|1-20-046 ID 48680,"Centre Investigation Clinique 1415, Tours, Centre Val De Loire, France|Bretonneau Regional Universitary Hospital, Tours, France",https://ClinicalTrials.gov/show/NCT04570202
NCT04823988,"Emotional, Social, Cognitive and Behavioral Sequalae of the COVID-19 Pandemic",Observational Model: Cohort|Time Perspective: Cross-Sectional,10000376|000376-M,"National Institute of Mental Health (NIMH), Bethesda, Maryland, United States",https://ClinicalTrials.gov/show/NCT04823988
NCT04363593,Serology COVID-19 From the Cornwall Hospital Union,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,29BRC20.0122,"CH de Cornouaille, Quimper, France",https://ClinicalTrials.gov/show/NCT04363593
NCT04475081,Use of a Live Attenuated Vaccine as an Immune-based Preventive Against COVID-19-associated Sepsis,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Prevention,PF-1214,NA,https://ClinicalTrials.gov/show/NCT04475081
NCT04758039,Clinical Characteristics and In-hospital Death of a Chilean COVID-19 Prospective Cohort,Observational Model: Cohort|Time Perspective: Prospective,OAIC N° 1119/20,"Hospital Clinico de la Universidad de Chile, Santiago, Región Metropolitana, Chile",https://ClinicalTrials.gov/show/NCT04758039
NCT04321811,"Behavior, Environment And Treatments for Covid-19",Observational Model: Cohort|Time Perspective: Prospective,XC-PCOR-COVID19,"BEAT19.org, San Francisco, California, United States",https://ClinicalTrials.gov/show/NCT04321811
NCT04935528,Mechanisms of Anti COVID-19 Humoral and Cellular Immune Response After Vaccination in a Sample of Patients and Salaried Staff From a French Anti-cancer Center,Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,2021-002404-12,"Centre Georges Francois Leclerc, Dijon, France",https://ClinicalTrials.gov/show/NCT04935528
NCT04544072,Analysis of the Quality and Quantity of Antibiotic Prescriptions for Bacterial Respiratory Tract Superinfection in Patients Hospitalized in COVID-19 Wards,Observational Model: Cohort|Time Perspective: Prospective,2020-163,"UZ Brussel, Brussel, Belgium",https://ClinicalTrials.gov/show/NCT04544072
NCT04604769,Perceived Stress Among ICU Medical Staff During COVID-19 Crisis,Observational Model: Cohort|Time Perspective: Cross-Sectional,stressICUcovid,"University of Liège, Liège, Province De Liège, Belgium",https://ClinicalTrials.gov/show/NCT04604769
NCT04370210,Sleep Quality During COVID-19 Containment in Children Whether or Not Usually Followed in Child Psychiatry,Observational Model: Cohort|Time Perspective: Prospective,CHRD 0520,"Centre Hospitalier René Dubos, Pontoise, France",https://ClinicalTrials.gov/show/NCT04370210
NCT04486404,"Needs, Perceptions and Acute Stress of Healtcare Workers Caring for COVID-19 Patients in South America",Observational Model: Cohort|Time Perspective: Prospective,08/04/2020,"Institute for Clinical Effectiveness and Health Policy, Buenos Aires, Argentina|Pontificia Universidad Católica de Chile, Santiago, Chile|Universidad de Santander, Bucaramanga, Santander, Colombia|Universidad Católica de Santiago de Guayaquil, Guayaquil, Guayas, Ecuador|Universidad Miguel Hernández de Elche, Elche, Alicante, Spain",https://ClinicalTrials.gov/show/NCT04486404
NCT04324463,Anti-Coronavirus Therapies to Prevent Progression of Coronavirus Disease 2019 (COVID-19) Trial,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,PHRI.ACT.COVID19,"Hospital Adventista de Manaus, Manaus, Amazonas, Brazil|Prodal Saude S/A, Salvador, BA, Brazil|Hospital das Clinicas de Vitoria (Hospital Universitario Cassiano Antonio Moraes), Vitoria, ES, Brazil|Ubermed Serviços em Saúde Eireli - Hospital São Domingos, Uberaba, MG, Brazil|Hospital de Clínicas da Universidade Federal de Uberlândia, Uberlândia, MG, Brazil|Hospital Universitario Julio Muller, Cuiabá, Mount, Brazil|Hospital Universitario da UFPI - Filial EBSERH, Teresina, PI, Brazil|Hospital Universitario Gaffree e Guinle, Rio de Janeiro, RJ, Brazil|Hospital Universitario Prof. Dr. Horacio Carlos Panepucci da Universidade Federal de Sao Carlos (HU-UFSCar), São Carlos, SP, Brazil|Hospital Alemão Oswaldo Cruz, São Paulo, SP, Brazil|Hamilton Health Sciences, Hamilton, Ontario, Canada|London Health Sciences Centre, London, Ontario, Canada|Southlake Regional Health Centre, Newmarket, Ontario, Canada|Halton Healthcare/Oakville Trafalgar Memorial Hospital, Oakville, Ontario, Canada|Niagara Health System-St. Catharine's, St. Catharines, Ontario, Canada|Toronto Western Hospital Family Health Team, Toronto, Ontario, Canada|Windsor Regional Hospital, Windsor, Ontario, Canada|Woodstock Hospital, Woodstock, Ontario, Canada|CIUSSS de L'est-de-l'ile de Montreal, Hopital Maisonneuve-Rosemont, Montreal, Quebec, Canada|Centre Hospitalier de l'Université de Montréal (CHUM), Montréal, Quebec, Canada|Biomelab SAS, Barranquilla, Atlantico, Colombia|Clinica de la Costa LTDA, Barranquilla, Atlantico, Colombia|Instituto de Neumologico del Oriente, Bucaramanga, Santander, Colombia|Unicormed, Guayaquil, Guayas, Ecuador|Hospital de Especialidades Eugenio Espejo, Quito, Pichincha, Ecuador|Hospital Enrique Garces, Quito, Pichincha, Ecuador|Hospital General Pablo Arturo Suarez, Quito, Pichincha, Ecuador|Giza Chest Hospital, Giza, Cairo, Egypt|Abbasia Chest Hospital, Cairo, Egypt|Abbasia Fever Hospital, Cairo, Egypt|National Hepatology and Tropical Medicine Research Institute, Cairo, Egypt|Fayoum University Hospital, Fayoum, Egypt|CIMS Hospital, Ahmedabad, Gujarat, India|City Plus Hospital, Ahmedabad, Gujarat, India|Sanjivani Hospital, Ahmedabad, Gujarat, India|GMERS Medical College & Hospital, Vadodara, Gujarat, India|Post Graduate Institute of Medical Sciences (PGIMS), Rohtak, Haryana, India|Mazumdar Shaw Medical Centre a Unit of Narayana, Bangalore, Karnataka, India|Bharathi Hospital and Research Center, Pune, Maharashtra, India|Sidhu Hospital Pvt.Ltd, Doraha, Punjab, India|Vijaya Medical & Educational Trust, Chennai, Tamil Nadu, India|SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu, India|AIG Hospital, Hyderabad, Telangana, India|KIMS, Hyderabad, Telangana, India|Mahavir Hospital & Research Centre, Hyderabad, Telangana, India|Aga Khan University Hospital, Karachi, Sindh, Pakistan|Jinnah Postgraduate Medical Center, Karachi, Pakistan|Tabba Heart Institute, Karachi, Pakistan|Philippine General Hospital, Manila, Metro Manila, Philippines|State Budgetary Health Care Institution of Sverdlovsk region ""Central city clinical hospital # 6 Ekaterinburg"", Ekaterinburg, Sverdlovsk Region, Russian Federation|Central City Clinical Hospital No. 24, Yekaterinburg, Sverdlovsk Region, Russian Federation|Voronezh State Medical University named after N.N. Burdenko, Voronezh, Voronezh Region, Russian Federation|Altai Regional Hospital for War Veterans, Barnaul, Russian Federation|National Medical Research Center for Therapy and Preventive Medicine, Moscow, Russian Federation|City Clinical Hospital No. 3, Nizhny Novgorod, Russian Federation|Rostov State Medical University, Rostov-on-Don, Russian Federation|King Saud Medical City, Riyadh, Saudi Arabia|Thumbay Hospital Dubai, Al Qusais, Dubai, United Arab Emirates|Hatta Hospital, Hatta, Dubai, United Arab Emirates|Rashid Hospital, Dubai Health Authority, Umm Hurair, Dubai, United Arab Emirates",https://ClinicalTrials.gov/show/NCT04324463
NCT04433286,COVID-19 - Implications on Surgeons' Burnout and Career Satisfaction,Observational Model: Other|Time Perspective: Cross-Sectional,SURG RES COL 1,"Faculty of Medicine Mansoura University, Mansoura, Egypt",https://ClinicalTrials.gov/show/NCT04433286
NCT04416919,Assessment of N-95 Facemask for Use in COVID-19 Pandemic in Case of Shortage of Personal Protective Equipment,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,11887,"Oklahoma City VA Health Care System, Oklahoma City, Oklahoma, United States",https://ClinicalTrials.gov/show/NCT04416919
NCT04852276,Analysis of the Immune Response to COVID-19 Vaccination and Outcomes in Individuals With and Without Immune Deficiencies and Dysregulations,Observational Model: Cohort|Time Perspective: Prospective,10000384|000384-I,"National Institutes of Health Clinical Center, Bethesda, Maryland, United States",https://ClinicalTrials.gov/show/NCT04852276
NCT04370938,Provider Burnout During COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Other,STUDY20040051,"UPMC, Pittsburgh, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04370938
NCT04371848,Impact of the COVID-19 Pandemic on Diet Quality and Food Insecurity: a NutriQuébec Sub-study,Observational Model: Cohort|Time Perspective: Prospective,2018-042Phase IIA6/09-04-2020,"Université Laval, Québec, Canada",https://ClinicalTrials.gov/show/NCT04371848
NCT04374097,Level and Predictors of Trauma-symptoms Among Health Workers and Public Service Providers During the COVID-19 Outbreak,Observational Model: Other|Time Perspective: Cross-Sectional,REK125510(2),"University of Oslo, Oslo, Norway",https://ClinicalTrials.gov/show/NCT04374097
NCT04406571,Reorganization of the Healthcare System During COVID-19 Pandemic: Impact on Management of Patients With Exocrine Pancreatic Cancer,Observational Model: Cohort|Time Perspective: Prospective,PO20042,"Damien JOLLY, Reims, France",https://ClinicalTrials.gov/show/NCT04406571
NCT04418609,Neuro-COVID-19: Neurological Complications of COVID-19,Observational Model: Cohort|Time Perspective: Other,Neuro-COVID-19,"University Hospital Zurich, Zürich, Switzerland",https://ClinicalTrials.gov/show/NCT04418609
NCT04661657,COvid-19 LongitUdinal Multiethnic BioImaging Assessment of CARDiovascular Sequelae Registry,Observational Model: Cohort|Time Perspective: Prospective,AAAT0787,"Columbia University Irving Medical Center, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04661657
NCT04377074,Parental Stress During the COVID-19 Pandemic and Its Association With Depression and Anxiety,Observational Model: Other|Time Perspective: Cross-Sectional,REK125510(3),"University of Oslo, Oslo, Norway",https://ClinicalTrials.gov/show/NCT04377074
NCT04594395,Defining the COVID-19 Immunity Denominator in the Mekong: a Cross-Sectional Seroprevalence Study of SARS-CoV-2 in HealthyVolunteers,Observational Model: Cohort|Time Perspective: Prospective,10000083|000083-I,"Cambodian Center for Communicable Disease (CCDC), Ministry of Health (MOH), Phnom Penh, Cambodia|National Malaria Center (CNM), Ministry of Health (MOH), Phnom Penh, Cambodia",https://ClinicalTrials.gov/show/NCT04594395
NCT04732702,Effects of Contact Restrictions During the COVID-19 Pandemic on Newborns and Their Parents,Observational Model: Cohort|Time Perspective: Prospective,20-1440,"University hospital of Cologne, Department of Neonatology, Cologne, Northrhine-westfalia, Germany",https://ClinicalTrials.gov/show/NCT04732702
NCT04935502,Home Based Exercises With and Without Posture and Ergonomics Among Students During COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,REC-FSD-00254,"Riphah International University, Faisalabad, Punjab, Pakistan",https://ClinicalTrials.gov/show/NCT04935502
NCT04844489,Study of the Humoral Response to SARS-CoV-2 Variants and of the Cellular Response After Vaccination Against COVID-19 in Immunocompromised People,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,APHP210305|2021-A00469-32,"Hospital Pitié-Salpêtrière - AP-HP, Paris, France",https://ClinicalTrials.gov/show/NCT04844489
NCT04887116,Piloting Virtual Reality Environments to Treat PTSD in Healthcare Workers and Patients Consequent to the COVID-19 Pandemic,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,20-04021926,"Weill Cornell Medicine, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04887116
NCT04368975,ARDS Caused by COVID-19,Observational Model: Cohort|Time Perspective: Prospective,COVID-19 ARDS,"Ricard Mellado, Barcelona, Spain",https://ClinicalTrials.gov/show/NCT04368975
NCT04693052,Attitudes Towards Receiving Mental Health Care Using Telehealth During the COVID-19 Pandemic,Observational Model: Other|Time Perspective: Other,STU00213696,"Feinberg School of Medicine, Chicago, Illinois, United States",https://ClinicalTrials.gov/show/NCT04693052
NCT04563065,Active Pregnancy Against COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention,UPM-2020-32/33,"Facultad de Ciencias de la Actividad Física y el Deporte (INEF), Madrid, Spain|Facultad de Ciencias de la Actividad Física y el Deporte - INEF, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04563065
NCT04400019,Prevention of COVID19 Infection in Nursing Homes by Chemoprophylaxis With Hydroxychloroquine (PREVICHARM),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Prevention",COV20/00565,NA,https://ClinicalTrials.gov/show/NCT04400019
NCT04361019,Physical Activity in University Students Around COVID-19 Confinement,Observational Model: Cohort|Time Perspective: Prospective,Covid_PA2020,"Basque Country University (UPV-EHU),, Bilbao, Bizkaia, Spain",https://ClinicalTrials.gov/show/NCT04361019
NCT04715815,COVID-19 and Its Effects on Chronic Pain Patients,Observational Model: Cohort|Time Perspective: Prospective,REC.63-359-8-1,NA,https://ClinicalTrials.gov/show/NCT04715815
NCT04497415,The COVID-19 and Healthcare Workers: An Active Intervention,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Health Services Research,8032,"New York State Psychiatric Institute, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04497415
NCT04878211,A Open-label Study to Assess Response to COVID-19 Vaccine in Multiple Sclerosis Participants Treated With Ofatumumab,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,COMB157GUS16,"Novartis Investigative Site, Sunrise, Florida, United States",https://ClinicalTrials.gov/show/NCT04878211
NCT04733677,User Experience of the OSR M-1,Observational Model: Cohort|Time Perspective: Prospective,IRB00070715,"Wake Forest Baptist Health, Winston-Salem, North Carolina, United States",https://ClinicalTrials.gov/show/NCT04733677
NCT04484207,Addressing COVID-19 Mental Health Problems Among US Veterans,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Health Services Research,8006,"New York State Psychiatric Institute, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04484207
NCT04834089,Clinical Trial for Assessment of Anti-SARS-CoV-2 Serum for Early Treatment of COVID-19 Cases,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",SAS-01-IB,"Hospital do Rim, Sao Paulo, SP, Brazil|Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil",https://ClinicalTrials.gov/show/NCT04834089
NCT04381000,Quarantine and Telerehabilitation in Chronic Pain Patients During COVID-19 Pandemic.,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,3,"Clinical Exercise Physiology and Rehabilitation Laboratory, Lamia, Sterea Ellada, Greece",https://ClinicalTrials.gov/show/NCT04381000
NCT04818736,COVID-19 Vaccine For Indirect Protection,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Prevention",2021-RCT,"McMaster University, Hamilton, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04818736
NCT04736680,Pediatric Virtual Visits as a Strategy for Access to Care During the COVID-19 Pandemic in a Pediatric Hospital,Observational Model: Cohort|Time Perspective: Retrospective,2392,NA,https://ClinicalTrials.gov/show/NCT04736680
NCT04474080,Reducing Burnout Among Frontline Healthcare Workers During COVID-19,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,11136,"St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04474080
NCT04335747,COVID-19 Infection in Vulnerable Patients With Inflammatory Rheumatic Diseases,Observational Model: Cohort|Time Perspective: Prospective,20200401,"Aalborg University Hospital, Aalborg, Denmark",https://ClinicalTrials.gov/show/NCT04335747
NCT04839315,COVID-19 Vaccination in Rheumatic Disease Patients,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,21-000501,"Mayo Clinic in Rochester, Rochester, Minnesota, United States",https://ClinicalTrials.gov/show/NCT04839315
NCT04569266,Effectiveness of an Exercise Re-training Program on Dyspnea in Patients After Acute Respiratory Distress Syndrome Secondary to Severe COVID-19 Pneumonia in Post-ICU,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,RECOVER,"Groupe Hospitalier Paris Saint Joseph, Paris, Ile-de-France, France",https://ClinicalTrials.gov/show/NCT04569266
NCT04340219,"Oncology-patient-reported Anxiety, Mood, and QoL During the COVID-19 Pandemic",Observational Model: Cohort|Time Perspective: Prospective,BC-07505-LGE,"University Hospital Gent, Gent, Belgium",https://ClinicalTrials.gov/show/NCT04340219
NCT04387799,Determinants of COVID-19 Pneumonia (MC-19),Observational Model: Case-Control|Time Perspective: Prospective,20200505,"Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy",https://ClinicalTrials.gov/show/NCT04387799
NCT04498286,COVID-19 and SARS-CoV-2 Antibodies in Multiple Sclerosis Patients,Observational Model: Cohort|Time Perspective: Prospective,NL74243.029.20,"VU medical center, Amsterdam, Netherlands",https://ClinicalTrials.gov/show/NCT04498286
NCT04736524,Immune Response Following COVID-19 Vaccination,Observational Model: Cohort|Time Perspective: Prospective,TCAI_IFVAC,"Texas Cardiac arrhythmia Institute, St. David's Hospital, Austin, Texas, United States",https://ClinicalTrials.gov/show/NCT04736524
NCT04723576,Mental and Physical Well-Being of Frontline Health Care Workers During Coronavirus Disease 2019 (COVID-19),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Health Services Research,COVID-2020C2-10721,"Clinical Directors Network, Inc, New York, New York, United States|Vizient Inc., Irving, Texas, United States",https://ClinicalTrials.gov/show/NCT04723576
NCT04703270,Understanding COVID-19 Infection in Pregnant Women and Their Babies,Observational Model: Case-Control|Time Perspective: Prospective,2020.0276,"St George's, University of London, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04703270
NCT04739462,SMS Maama Project COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,STUDY00010582,"University of Minnesota, Minneapolis, Minnesota, United States|Makerere University, Kampala, Uganda",https://ClinicalTrials.gov/show/NCT04739462
NCT04614844,COVID-19 Responsive Intervention: Systems Improvement Simulations (CRI:SIS),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Other,2000029372|1R01HS028340-01,"Yale New Haven Hospital, New Haven, Connecticut, United States",https://ClinicalTrials.gov/show/NCT04614844
NCT04377412,Risk Factors for Anxiety and Depression Among Pregnant Women During the COVID-19 Pandemic,Observational Model: Ecologic or Community|Time Perspective: Prospective,Maternal axiety and COVID-19,"Wayne State University, Detroit, Michigan, United States|University of Medicine Tirana, Tirana, Albania|Royal Prince Alfred Hospital, Sydney, Australia|Charles University, Prague, Czechia|Université de Paris, Paris, France|Charité - University Medicine Berlin, Berlin, Germany|The Chinese University of Hong Kong, Hong Kong, Hong Kong|Meir Medical Center, Kafr Saba, Israel|University of Brescia, Brescia, Italy|American University of Beirut, Beirut, Lebanon|The Arctic University of Norway, Tromsø, Norway|Nicolaus Copernicus University in Toruń, Collegium Medicum in Bydgoszcz, Bydgoszcz, Poland|Pomeranian Medical University, Szczecin, Poland|Centre of Postgraduate Medical Education, Warsaw, Poland|11. Fundación Para la Investigación y el Desarrollode la Medicina Materno-Fetal y Neonatal ""iMaterna"", Madrid, Spain|Karolinska Institutet, Stockholm, Sweden|Taiji Clinic, Taipei, Taiwan",https://ClinicalTrials.gov/show/NCT04377412
NCT04950673,"Open-label, Post-marketing, Prospective Study to Assess Impact of COVID-19 on Cognitive Function in Patients",Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Screening,COG-COVID19,"Cognivue, Inc., Victor, New York, United States",https://ClinicalTrials.gov/show/NCT04950673
NCT04806074,FOODLIT-PRO: Improving Food Literacy and Food Sustainability Amidst the COVID-19 Pandemic,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Other,SFRH/BD/128528/2017,"ISPA - Instituto Universitário, Lisboa, Portugal",https://ClinicalTrials.gov/show/NCT04806074
NCT04479332,The Change of Critical Patient Managements and Subsequent Influences Under Epidemic of Coronavirus Disease 19 (COVID-19),Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,202005094RIND,NA,https://ClinicalTrials.gov/show/NCT04479332
NCT04881396,Response of Haemodialysis Patients to BNT162b2 mRNA Cov-19 Vaccine,Observational Model: Cohort|Time Perspective: Prospective,69HCL21_0125|2021-A00325-36,"Department of Nephrology, Hopital Edouard Herriot, Lyon, France|Department of Nephrology, Centre Hospitalier Lyon Sud, Pierre Bénite, France",https://ClinicalTrials.gov/show/NCT04881396
NCT04405232,Coagulopathy in COVID19 - A Multi-Centre Observational Study in UK,Observational Model: Cohort|Time Perspective: Prospective,20SM5934,"Imperial College Healthcare NHS Trust, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04405232
NCT04430374,Registry for a Cardiovascular Patient Who COVID-19 Infection in Qatar and Gulf,Observational Model: Cohort|Time Perspective: Other,MRC-05-113,"Hamad Medical Corporation, Doha, Unlisted (UL), Qatar",https://ClinicalTrials.gov/show/NCT04430374
NCT04952376,Equitable Access to COVID-19 Vaccines,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,21-002939,"Mayo Clinic, Scottsdale, Arizona, United States",https://ClinicalTrials.gov/show/NCT04952376
NCT04961502,Humoral and Cellular Responses to Vaccination Against Coronavirus Disease 2019 (COVID-19) in the Very Elderly Living in Geriatric Institutions,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Screening,2021-A00051-40,"Geriatric Department, Charles Foix hospital, Ivry-sur-Seine, IIe-de-France, France",https://ClinicalTrials.gov/show/NCT04961502
NCT04542122,Moral Judgements and Choices of Caregivers in the Time of COVID-19 Pandemic,"Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Other",1474,NA,https://ClinicalTrials.gov/show/NCT04542122
NCT04408027,Mental Health Support for SickKids Children and Families During COVID-19 Using Established eHealth Interventions,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,REB1000070362,"The Hospital for Sick Children (SickKids), Toronto, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04408027
NCT04859023,Comparison of Strategies Based on RT-PCR or Antigenic Test for the Screening of SARS-CoV-2 Infection (COVID-19).,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,21CH037|2021-A00390-41,"CHU Saint-Etienne, Saint-Étienne, France",https://ClinicalTrials.gov/show/NCT04859023
NCT04799977,COVID-19: Post-covid Olfactory Disorders Assessment,Observational Model: Cohort|Time Perspective: Retrospective,21IUFCcovid01,"IUFC, Nice, France",https://ClinicalTrials.gov/show/NCT04799977
NCT04624048,Exercise Influence on COVID-19,Observational Model: Ecologic or Community|Time Perspective: Retrospective,8112020,NA,https://ClinicalTrials.gov/show/NCT04624048
NCT04511949,COVID-19: Epidemiological Study of the Spread of SARS-CoV-2 in the Household of a Person Who Has Had a COVID-19 Disease,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,CREPATS 012,"Christine KATLAMA, Paris, Ile De France, France",https://ClinicalTrials.gov/show/NCT04511949
NCT04568551,"COVID-19-associated Anxiety of Pregnant Women for Anomalies, Stillbirth and Preterm Labor",Observational Model: Cohort|Time Perspective: Prospective,UKGEB001,"University Hospital of Halle, Halle, Saxony Anhalt, Germany",https://ClinicalTrials.gov/show/NCT04568551
NCT04387409,Study to Assess VPM1002 in Reducing Healthcare Professionals' Absenteeism in COVID-19 Pandemic,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",VPM1002-DE-3.06CoV,"Ludwig-Maximilians-Universität München, München, Bayern, Germany|Medizinische Hochschule Hannover, Hannover, Niedersachsen, Germany|SocraTec R&D GmbH, Erfurt, Thüringen, Germany",https://ClinicalTrials.gov/show/NCT04387409
NCT04772859,Evaluation of an Online Lifestyle Intervention in Mexican School Children During COVID-19 Pandemic,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention,Lifestyle intervention,"Rolando Giovanni Diaz Zavala, Hermosillo, Sonora, Mexico",https://ClinicalTrials.gov/show/NCT04772859
NCT04845880,SARS Cov_2 Incidence of Healthy Health Workers,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Screening,KA20/449,"Adana Dr. Turgut Noyan Application and Research Center, Adana, Turkey",https://ClinicalTrials.gov/show/NCT04845880
NCT04673292,Community Collaboration to Combat COVID-19 (C-FORWARD),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Screening,IRB00250298|P30AI094189-09S1,"2212 McElderry Street, Baltimore, Maryland, United States",https://ClinicalTrials.gov/show/NCT04673292
NCT04376515,Harnessing Online Peer Education Online Support Intervention for COVID-19 (HOPE COVID-19),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Supportive Care,UCaliforniaIrvineSYoung No HS#,"UC Irvine, Irvine, California, United States",https://ClinicalTrials.gov/show/NCT04376515
NCT04334629,LIBERATE Trial in COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment",282009,"Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04334629
NCT04383730,Inhaled Sedation in COVID-19-related Acute Respiratory Distress Syndrome (ISCA): an International Research Data Study in the Recent Context of Widespread Disease Resulting From the 2019 (SARS-CoV2) Coronavirus Pandemics (COVID-19),Observational Model: Cohort|Time Perspective: Retrospective,ISCA Study,"Beth Israel Deaconess Medical Center, Inc., Boston, Massachusetts, United States|CHU, Brest, France|CHU, Clermont-Ferrand, France|Centre Hospitalier, Dunkerque, France|Pitié-Salpêtrière Hospital - APHP, Paris, France|CH Privé de la Loire, Saint-Étienne, France|Universitätsklinikum, Bochum, Germany|University Medical Center Schleswig-Holstein, Kiel, Germany|Universitätsklinikum, Oldenburg, Germany|Hospital Clínico Universitario de Valencia, Valencia, Spain|Cantonal Hospital, Münsterlingen, Switzerland|Universitätsspital, Zürich, Switzerland",https://ClinicalTrials.gov/show/NCT04383730
NCT04619368,Post-intensive Care Follow-up of Patients Hospitalized for an Acute Respiratory Distress Syndrome Caused by COVID-19,Observational Model: Cohort|Time Perspective: Prospective,RC31/20/0219,"University Hospital of Toulouse, Toulouse, France",https://ClinicalTrials.gov/show/NCT04619368
NCT04745533,COVID-19 Contact Study by Antigen Detection Test,Observational Model: Cohort|Time Perspective: Prospective,12/2020,NA,https://ClinicalTrials.gov/show/NCT04745533
NCT04527432,COVID-19 Health Professional Impact Study,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,2020COV112,"The Royal Wolverhampton NHS Trust, Wolverhampton, United Kingdom",https://ClinicalTrials.gov/show/NCT04527432
NCT04604080,Post-COVID-19 Epidemic Depression Assessment in Adults in South Punjab Pakistan,Observational Model: Other|Time Perspective: Retrospective,U1111-1260-1614,"The Islamia University of Bahawalpur, Bahāwalpur, Punjab, Pakistan|GC University Faisalabad, Faisalabad, Punjab, Pakistan|University of Veterinary and Animal Sciences, Lahore, Lahore, Punjab, Pakistan|Bahauddin Zakriya University Multan, Multan, Punjab, Pakistan|Quaid-i-Azam University Islamabad, Islamabad, Pakistan",https://ClinicalTrials.gov/show/NCT04604080
NCT04926571,Dexamethasone and COVID-19 Inpatient Mortality,Observational Model: Cohort|Time Perspective: Retrospective,RQ004-1-20210610,"Aetion, Inc., New York, New York, United States",https://ClinicalTrials.gov/show/NCT04926571
NCT04782739,Evaluation of the Impact of the COVID-19 Pandemic on Provision and Uptake of Services for the Prevention of Mother-to-child Transmission of HIV and Syphilis in Zimbabwe,Observational Model: Other|Time Perspective: Other,MRCZ/A/2682,"Kuwadzana Polyclinic, Harare, Zimbabwe|Mabvuku Polyclinic, Harare, Zimbabwe",https://ClinicalTrials.gov/show/NCT04782739
NCT04328467,Pre-exposure Prophylaxis for SARS-Coronavirus-2,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",MED-2020-28720,"Nationwide Enrollment via Internet, please email: covid19@umn.edu, Minneapolis, Minnesota, United States|University of Minnesota, Minneapolis, Minnesota, United States",https://ClinicalTrials.gov/show/NCT04328467
NCT04356885,COVID-19 and Psychotic Symptoms in France,Observational Model: Cohort|Time Perspective: Prospective,RECHMPL20_0225,"UH Montpellier, Montpellier, France",https://ClinicalTrials.gov/show/NCT04356885
NCT04366219,"Impact of Confinement and Preventive Measures in Period of SARS-COV2 Infection on Clinical Features, Diagnostic and Therapeutic Management and Prognosis of Patients With Lung Cancer: an Ambispective Study Extended Over 2 Time Periods.",Observational Model: Other|Time Perspective: Other,CHM-2020/S15/03,NA,https://ClinicalTrials.gov/show/NCT04366219
NCT04368676,Breath Regulation and Yogic Exercise An Online Therapy for Calm and Happiness During the COVID-19 Pandemic,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,115855,"London Health Sciences Centre, London, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04368676
NCT04719182,Practice of Adjunctive Treatments in Intensive Care Unit Patients With COVID-19,Observational Model: Cohort|Time Perspective: Retrospective,PRoAcT-COVID,"Amsterdam UMC location AMC, Amsterdam, Netherlands|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), Amsterdam, Netherlands",https://ClinicalTrials.gov/show/NCT04719182
NCT04694664,COVID-19 Vaccine Confidence Among Pregnant Women and Mothers,Observational Model: Cohort|Time Perspective: Cross-Sectional,3,"Pregistry, Los Angeles, California, United States",https://ClinicalTrials.gov/show/NCT04694664
NCT04858789,The Effectiveness of a CA-CBI on Psychological Distress of University Students During the COVID-19 Pandemic,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,2020.465.IRB3.184,"Koc University, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04858789
NCT04447638,Percutaneous Tracheostomy With COVID-19,Observational Model: Case-Only|Time Perspective: Retrospective,TT17,"Canakkale Onsekiz Mart University, Canakkale, Turkey",https://ClinicalTrials.gov/show/NCT04447638
NCT04380870,Describing Chinese Herbal Medicine Telehealth Care for Symptoms Related to Infectious Diseases Such as COVID-19,Observational Model: Ecologic or Community|Time Perspective: Prospective,2001/4/20,"Seattle Intstitute of East Asian Medicine, Seattle, Washington, United States",https://ClinicalTrials.gov/show/NCT04380870
NCT04444323,3D Telemedicine During COVID-19: Cohort Study,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,GN20HS300,"Canniesburn Regional Plastic Surgery and Burns Unit, Glasgow, Scotland, United Kingdom",https://ClinicalTrials.gov/show/NCT04444323
NCT04556604,Surgical Consent During the COVID-19 Pandemic,Observational Model: Ecologic or Community|Time Perspective: Cross-Sectional,2021.016N,"Medway NHS Foundation Trust, Gillingham, United Kingdom",https://ClinicalTrials.gov/show/NCT04556604
NCT04447495,Self-sampling for the Study of COVID-19,Observational Model: Case-Control|Time Perspective: Prospective,20-001,NA,https://ClinicalTrials.gov/show/NCT04447495
NCT04417374,"Caracteristics of the Patients Hospitalized With Unvonluntary Commitment Procedure, in the Context COVID-19",Observational Model: Cohort|Time Perspective: Prospective,RECHMPL20_0320,"University hospital, Montpellier, France",https://ClinicalTrials.gov/show/NCT04417374
NCT04733846,Corneal Wounds Repair Emergencies During COVID-19 : 10/0 Absorbable Polyglactin Sutures as a Valuable Strategy,Observational Model: Cohort|Time Perspective: Retrospective,IRBN202021,"CHU Saint-Etienne, Saint-Étienne, France",https://ClinicalTrials.gov/show/NCT04733846
NCT04886414,Home-based Care and Hand Hygiene Interventions in Honduras,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,2021P001143,NA,https://ClinicalTrials.gov/show/NCT04886414
NCT04414631,Conestat Alfa in the Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2020-01252; me20Osthoff3,"Práxis Pesquisa Medica, São Paulo, Brazil|Hospital Universitario ""Dr. José Eleiterio González"", Colinia Mitras Centro, Monterey, Nuevo Leon Mexico, Mexico|University Hospital Basel, Division of Internal Medicine, Basel, Switzerland|Kantonsspital St. Gallen, Klinik für Infektiologie/Spitalhygiene, St. Gallen, Switzerland|Stadtspital Triemli, Departement Innere Medizin, Zürich, Switzerland",https://ClinicalTrials.gov/show/NCT04414631
NCT04872686,Virucidal Effect of PVP-I on COVID-19 and as Well as Safety of Its Application on Nasopharynx & Oropharynx,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Prevention",BRiCM LABS BANGASAFE SPRAY,"Bangladesh Reference Institute for Chemical Measurements, Dhaka, Dhanmondi, Bangladesh|Dhaka Medical College Hospital, Dhaka, Bangladesh|Kurmitola General Hospital, Dhaka, Bangladesh|Kuwait-Moitree Hospital, Dhaka, Bangladesh",https://ClinicalTrials.gov/show/NCT04872686
NCT04844632,"COVID19 Vaccination: Clinical, Laboratory and Cellular Monitoring",Observational Model: Cohort|Time Perspective: Prospective,COVID19 vaccination_Sapienza,"AOU Policlinico Umberto I, Roma, Italy",https://ClinicalTrials.gov/show/NCT04844632
NCT04429477,Cerebral Compliance Impairment in COVID-19,Observational Model: Cohort|Time Perspective: Prospective,31750820.1.0000.0068,"Hospital das Clínicas da Faculdade de Medicina da USP., São Paulo, Brazil",https://ClinicalTrials.gov/show/NCT04429477
NCT04356365,The Mental Health Status of the General Population During the COVID-19 Pandemic and Its Association With Adherence to Government-initiated Non-pharmacological Epidemiological Interventions (NPI's),Observational Model: Other|Time Perspective: Cross-Sectional,REK125510,"University of Oslo, Oslo, Norway",https://ClinicalTrials.gov/show/NCT04356365
NCT04347798,IMPACT: IMPact of Antimalarials on Covid-19 Infections in RAPPORT,Observational Model: Case-Control|Time Perspective: Prospective,Pro00100000,"University of Alberta, Edmonton, Alberta, Canada",https://ClinicalTrials.gov/show/NCT04347798
NCT04424836,HFNC Treatment in COVID-19 Pneumonia,Observational Model: Case-Control|Time Perspective: Retrospective,5569,"Sisli Etfal Research and Training Hospital, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04424836
NCT04646616,CRISOL Contigo: a Multi-level Intervention to Reduce the Disproportionate Toll of COVID-19 Among Latino Communities in Philadelphia.,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,3R21MD012352-02S1,"Drexel University Dornsife School of Public Health, Philadelphia, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04646616
NCT04429828,COVID-19 Psychological Wellbeing for Healthcare Students,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,PoWerS_June2020,NA,https://ClinicalTrials.gov/show/NCT04429828
NCT04721444,Optimising Cancer Therapy And Identifying Causes of Pneumonitis USing Artificial Intelligence (COVID-19),Observational Model: Cohort|Time Perspective: Retrospective,5293,"Guys and St. Thomas' NHS Foundation Trust, London, United Kingdom|Imperial College Healthcare NHS Trust, London, United Kingdom|Royal Marsden NHS Foundation Trust, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04721444
NCT04341012,Breath Analysis Based Disease Biomarkers of COVID-19 and Other Diseases,Observational Model: Cohort|Time Perspective: Prospective,19-001971,"Mayo Clinic Florida, Jacksonville, Florida, United States",https://ClinicalTrials.gov/show/NCT04341012
NCT04894448,Immunogenicity of COVID-19 Vaccination in PLWH,Observational Model: Cohort|Time Perspective: Prospective,CTN 328,"The Ottawa Hospital (TOH), Ottawa, Ontario, Canada|University Health Network (UHN), Toronto, Ontario, Canada|Chronic Viral Illness Service (CVIS) McGill University Health Centre (MUHC), Montreal, Quebec, Canada",https://ClinicalTrials.gov/show/NCT04894448
NCT04837651,Humoral and T-Cell Responses to COVID-19 Vaccination in Multiple Sclerosis Patients Treated With Ocrelizumab Treated With Ocrelizumab or Natalizumab,Observational Model: Cohort|Time Perspective: Prospective,VA26843,"Dragonfly Research, LLC, Wellesley, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT04837651
NCT04431284,Impact of COVID-19 Lockdown on Obesity and Eating Behaviors,Observational Model: Other|Time Perspective: Retrospective,69HCL20_0516|2020-A01616-33,"Centre Intégré de l'obésité de Lyon / HCL, Pierre-Bénite, France",https://ClinicalTrials.gov/show/NCT04431284
NCT04464486,Remote COVID-19 Symptom Tracking for Cancer Patients at Home During the Pandemic,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,IRB_00131892,"Huntsman Cancer Institute, Salt Lake City, Utah, United States",https://ClinicalTrials.gov/show/NCT04464486
NCT04727372,Social Acceptability of COVID-19 Vaccines in Pakistan,Observational Model: Other|Time Perspective: Cross-Sectional,Living amongst the fear,"Islamabad City, Islamabad, Capital Territory, Pakistan|Bahawalpur Rural and Urban Areas, Bahawalpur, Punjab, Pakistan|Faisalabad city, Faisalābad, Punjab, Pakistan|Lahore City, Lahore, Punjab, Pakistan",https://ClinicalTrials.gov/show/NCT04727372
NCT04842734,Comparison of the Effect of Online Physical Exercise and Computerized Cognitive Stimulation in Patients With Alzheimer's Disease During the Covid-19 Pandemic,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,25.03.2021/37,"Yeditepe University, İstanbul, Eyalet/Yerleşke, Turkey",https://ClinicalTrials.gov/show/NCT04842734
NCT04752839,Evaluation of the Psychosocial Impact on Health Professionals Exposed During COVID 19 Coronavirus Pandemic,Observational Model: Other|Time Perspective: Prospective,IIBSP-COV-2020-40,"Hospital de la Santa Creu i Sant Pau, Barcelona, Spain",https://ClinicalTrials.gov/show/NCT04752839
NCT04335279,Evaluation of the Scleroderma Patient-centered Intervention Network COVID-19 Home-isolation Activities Together Program,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,2021-2286,"Sir Mortimer B. Davis Jewish General Hospital, Montreal, Quebec, Canada",https://ClinicalTrials.gov/show/NCT04335279
NCT04348227,How COVID-19 Virus Outbreak Affects Antimicrobial Resistance in a Low-middle-income Country's ICU?,Observational Model: Cohort|Time Perspective: Other,KM2020-1,"Department of anesthesia and intensive care, Fattouma Bourguiba Hospital, Monastir, Tunisia",https://ClinicalTrials.gov/show/NCT04348227
NCT04652596,Reducing Food Insecurity During COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention,H-41052|6007145|AD-1603-34662,"Boston Medical Center, Boston, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT04652596
NCT04353583,Renal Outcome in Patients With COVID-19,Observational Model: Cohort|Time Perspective: Prospective,AZ 58/20,"University Hospital Giessen and Marburg, Giessen, Giessen, Hessen, Germany",https://ClinicalTrials.gov/show/NCT04353583
NCT04678778,Virtual Reality Study - COVID-19 Protocol,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,HS17-00354,"Mark and Mary Stevens Neuroimaging and Informatics Institute of the University of Southern California, Los Angeles, California, United States",https://ClinicalTrials.gov/show/NCT04678778
NCT04425616,SafeFit Trial: Virtual Clinics to Deliver Universal Interventions in People With Cancer,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,RHM CRI 0403,"University Hospital Southampton NHS FT, Southampton, United Kingdom",https://ClinicalTrials.gov/show/NCT04425616
NCT04666285,Southampton Women's Survey COVID-19 Study,Observational Model: Cohort|Time Perspective: Prospective,56780,"MRC Lifecourse Epidemiology Unit, Southampton, United Kingdom",https://ClinicalTrials.gov/show/NCT04666285
NCT04379531,LDCT in COVID-19 Pneumonia: a Prospective Moscow Study,Allocation: Non-Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,20-Jan,"Victor Gombolevskiy, Moscow, Russian Federation",https://ClinicalTrials.gov/show/NCT04379531
NCT04444297,3D Telemedicine During COVID-19: Non-clinical Validation,"Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Other",GN20HS287,"Canniesburn Regional Plastic Surgery and Burns Unit, Glasgow, Scotland, United Kingdom",https://ClinicalTrials.gov/show/NCT04444297
NCT04469660,Impact of COVID-19 Pandemic on the Psychological Wellbeing of Healthcare Professionals in India,Observational Model: Cohort|Time Perspective: Prospective,Onco Survey_COVID-19,"Max Super Speciality Hospital Saket, New Delhi, Delhi, India",https://ClinicalTrials.gov/show/NCT04469660
NCT04542343,COVID-19 Risk Reduction Among African American Parishioners,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,COVID19Church,"Charles R. Drew University of Medicine & Science, Los Angeles, California, United States",https://ClinicalTrials.gov/show/NCT04542343
NCT04451902,COVID-19 and Rare Skin Diseases European Observational Study During an Epidemic,Observational Model: Cohort|Time Perspective: Other,COVID19-RareSkin,NA,https://ClinicalTrials.gov/show/NCT04451902
NCT04422522,Fibromyalgia During the COVID-19 Pandemic,Observational Model: Case-Only|Time Perspective: Retrospective,AAGH-01,"Al-Azhar Faculty of medicine, Rheumatology Department, Cairo, Egypt",https://ClinicalTrials.gov/show/NCT04422522
NCT04821921,The Impact of the COVID-19 Pandemic on Diabetes Management,Observational Model: Other|Time Perspective: Prospective,IPA-2021-01,"Department of Primary Medical Care, University Medical Center Hamburg-Eppendorf, Hamburg, Germany",https://ClinicalTrials.gov/show/NCT04821921
NCT04316884,Mechanisms for Organ Dysfunction in Covid-19,Observational Model: Cohort|Time Perspective: Prospective,EPN 2017/043 Covid19,"Uppsala University Hospital, Uppsala, Sweden",https://ClinicalTrials.gov/show/NCT04316884
NCT04628104,CMR Findings in COVID-19 Patients Presenting With Myocardial Infarction,Observational Model: Cohort|Time Perspective: Cross-Sectional,CMR in myocardial infarction,NA,https://ClinicalTrials.gov/show/NCT04628104
NCT04659135,ASCO Survey on COVID-19 in Oncology (ASCO) Registry,Observational Model: Case-Only|Time Perspective: Prospective,Pro00014181,"Anchorage Oncology Center, Anchorage, Alaska, United States|AIS Cancer Center, Bakersfield, California, United States|Long Beach Memorial Medical Center, Fountain Valley, California, United States|Orange Coast Medical Center, Fountain Valley, California, United States|Saddleback Memorial Medical Center, Fountain Valley, California, United States|Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, California, United States|Gene Upshaw Memorial Tahoe Forest Cancer Center, Truckee, California, United States|PIH Health, Whittier, California, United States|Sarah Cannon Research Institute at HealthONE, Denver, Colorado, United States|Hartford HealthCare Cancer Institute, Hartford, Connecticut, United States|Bayhealth Medical Center, Dover, Delaware, United States|Florida Precision Oncology, A Division of 21st Centry Oncology, Fort Myers, Florida, United States|Florida Cancer Specialists & Research Institute, LLC, Sarasota, Florida, United States|Emory University Winship Cancer Institute, Atlanta, Georgia, United States|Augusta University, Augusta, Georgia, United States|Hawaii Cancer Care, Honolulu, Hawaii, United States|NorthShore University HealthSystem, Evanston, Illinois, United States|Joliet Oncology-Hematology Associates, Joliet, Illinois, United States|Edward-Elmhurst Healthcare, Naperville, Illinois, United States|Illinois Cancer Care, Peoria, Illinois, United States|Goshen Center for Cancer Care, Goshen, Indiana, United States|Michiana Hematology Oncology, Mishawaka, Indiana, United States|MidAmerica Oncology Associates, Overland Park, Kansas, United States|University of Kansas Medical Center, Westwood, Kansas, United States|Baptist Health Madisonville, Madisonville, Kentucky, United States|Greater Baltimore Medical Center, Baltimore, Maryland, United States|LifeBridge Health, Baltimore, Maryland, United States|Tufts Medical Center, Boston, Massachusetts, United States|Great Lakes Cancer Management Specialists, Grosse Pointe Woods, Michigan, United States|Lakeland Hospitals, Saint Joseph, Michigan, United States|Mayo Clinic, Rochester, Minnesota, United States|Mosaic Cancer Care, Saint Joseph, Missouri, United States|Nebraska Hematology Oncology, Lincoln, Nebraska, United States|Callahan Cancer Center, North Platte, Nebraska, United States|Nebraska Cancer Specialists, Omaha, Nebraska, United States|University of Nebraska Medical Center, Omaha, Nebraska, United States|Bayonne Medical Center, Bayonne, New Jersey, United States|CarePoint Health - Christ Hospital, Jersey City, New Jersey, United States|Penn Medicine, Princeton Health, Plainsboro, New Jersey, United States|Hematology Oncology Associates of Central New York, East Syracuse, New York, United States|Northwell Health Cancer Institute, Lake Success, New York, United States|University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States|Levine Cancer Institute Atrium Health, Charlotte, North Carolina, United States|East Carolina University, Greenville, North Carolina, United States|Carteret Health Care, Morehead City, North Carolina, United States|CarolinaEast Medical Center, New Bern, North Carolina, United States|Aultman Hospital, Canton, Ohio, United States|Cincinnati Children's Hospital, Cincinnati, Ohio, United States|Oncology Hematology Care, Cincinnati, Ohio, United States|Florida Cancer Specialists, Massillon, Ohio, United States|Columbia Memorial Hospital, Astoria, Oregon, United States|Samaritan Health Services Corvallis, Corvallis, Oregon, United States|Penn Medicine, Lancaster General Health, Lancaster, Pennsylvania, United States|University of Pennsylvania, Philadelphia, Pennsylvania, United States|Thomas Jefferson University, Philadelphia, Pennsylvania, United States|Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States|Monument Health, Rapid City, South Dakota, United States|Baptist Clinical Research Institute, Memphis, Tennessee, United States|Tennessee Oncology, Nashville, Tennessee, United States|BSA Harrington Cancer Center, Amarillo, Texas, United States|Virginia Cancer Specialists, Fairfax, Virginia, United States|Hematology Oncology Associates of Fredericksburg, Fredericksburg, Virginia, United States|Virginia Cancer Institute, Richmond, Virginia, United States",https://ClinicalTrials.gov/show/NCT04659135
NCT04874779,Acute Kidney Injury Risk in COVID-19,Observational Model: Cohort|Time Perspective: Other,COVID-1927,"Faculty of Medicine -Zagazig University, Zagazig, Egypt",https://ClinicalTrials.gov/show/NCT04874779
NCT04337502,Clinical and Radiomic Model of COVID-19,Observational Model: Cohort|Time Perspective: Retrospective,UM_2020_GY_COVID-19,"The central hospital of Wuhan, Wuhan, Hubei, China",https://ClinicalTrials.gov/show/NCT04337502
NCT04337047,Distress in Crisis Situations During COVID-19,Observational Model: Cohort|Time Perspective: Prospective,WefightDistress20,"Wefight, Montpellier, France",https://ClinicalTrials.gov/show/NCT04337047
NCT04682561,STEP: Building Trauma Resilience Among Nurses and Personal Support Workers During COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,STP-01,"St. Michael's Hospital, Toronto, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04682561
NCT04326452,Treating COVID-19 With a Bidirectional Oxygenation Valve,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,COVID19PEEP2020|GO2 PEEP Study,"TMC HealthCare, Tucson, Arizona, United States|Stanford University, Stanford, California, United States|Emory Saint Joseph's Hospital, Atlanta, Georgia, United States",https://ClinicalTrials.gov/show/NCT04326452
NCT04940871,Study to Assess the Efficacy and Safety of Favipiravir-HU,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",HUN-FAVI-02,NA,https://ClinicalTrials.gov/show/NCT04940871
NCT04686578,The Effects of Covid-19 Pandemic on The Patients With Fibromyalgia,Observational Model: Case-Control|Time Perspective: Cross-Sectional,Fibromyalgia-pandemi,"Diskapi Education and Research Hospital, Ankara, Altındag, Turkey",https://ClinicalTrials.gov/show/NCT04686578
NCT04382768,Inhaled Ibuprofen to Treat COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,DNL000004,"Centro de Excelencia en Productos y Procesos Córdoba, Córdoba, Argentina",https://ClinicalTrials.gov/show/NCT04382768
NCT04861402,Non-Invasive Intracranial Pressure in COVID-19 Individuals,Observational Model: Case-Control|Time Perspective: Prospective,31589920.7.1001.5505,"Hospital São Paulo, São Paulo, SP, Brazil",https://ClinicalTrials.gov/show/NCT04861402
NCT04891276,Impact of COVID-19 Infection and Confinement on Diabetic Ulcer Management and Amputation Risk,Observational Model: Cohort|Time Perspective: Retrospective,PETIT SERI 2020,"Chu Dijon Bourogne, Dijon, France",https://ClinicalTrials.gov/show/NCT04891276
NCT04650191,Surfactant Protein Genetic Variants in COVID-19 Infection,Observational Model: Case-Control|Time Perspective: Prospective,15456,"Milton S. Hershey Medical center, Hershey, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04650191
NCT04312243,NO Prevention of COVID-19 for Healthcare Providers,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,NOpreCOVID-19,"Massachusetts General Hospital, Boston, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT04312243
NCT04708457,"The REDEEM Pilot Study: A Feasibility RCT of Early ECMO in Severe Acute Respiratory Infection, Including COVID-19, WHO","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment",ANZIC-RC/AB V3.1,"The Alfred Hospital, Melbourne, Victoria, Australia|Charite Universitatmedizin, Berlin, Germany",https://ClinicalTrials.gov/show/NCT04708457
NCT04964570,Digital Mental Health Care for COVID-19 High-Risk Populations,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Other,8128,NA,https://ClinicalTrials.gov/show/NCT04964570
NCT04734912,Evaluation of Transnasal Endoscopy During COVID-19 Pandemic,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,ETNE v1.0,"University Hospital Mainz, Mainz, Rhenanie-Palatinate, Germany",https://ClinicalTrials.gov/show/NCT04734912
NCT03808922,Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",DAS181-3-01|2018-004318-16,"City of Hope cancer Center, Duarte, California, United States|UCLA, Los Angeles, California, United States|University of California Davis Health System, Sacramento, California, United States|University of California San Diego Medical Center, San Diego, California, United States|Children's Hospital Colorado, Aurora, Colorado, United States|Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States|University of Chicago, Chicago, Illinois, United States|Loyola University Medical Center, Maywood, Illinois, United States|University of Kansas Medical Center, Fairway, Kansas, United States|Louisiana State University, Shreveport, Louisiana, United States|University of Maryland, Baltimore, Maryland, United States|The Johns Hopkins Hospital, Baltimore, Maryland, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Universtiy of Michigan, Ann Arbor, Michigan, United States|Washington University, Saint Louis, Missouri, United States|University of Nebraska Medical Center, Omaha, Nebraska, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|Weill Cornell Medical College, New York, New York, United States|Duke University, Durham, North Carolina, United States|Novant Health, Winston-Salem, North Carolina, United States|The Lindner Center- The Christ Hospital, Cincinnati, Ohio, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|University of Cincinnati, Cincinnati, Ohio, United States|The Cleveland Clinic Foundation, Cleveland, Ohio, United States|St. Elizabeth Youngstown Hospital, Youngstown, Ohio, United States|Oregon Health & Science University, Portland, Oregon, United States|University of Pennsylvania, Philadelphia, Pennsylvania, United States|University of Pittsburgh Medical Center Health System, Pittsburgh, Pennsylvania, United States|Kent Hospital, Warwick, Rhode Island, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|Cook Children's, Fort Worth, Texas, United States|Texas Health, Fort Worth, Texas, United States|Therapeutic Concepts, Houston, Texas, United States|MD Anderson, Houston, Texas, United States|VCU Health System, Richmond, Virginia, United States|Seattle Children's Hospital, Seattle, Washington, United States|Fred Hutchinson Cancer Research Center, Seattle, Washington, United States|Medical College of Wisconsin, Milwaukee, Wisconsin, United States|Froedtert Medical College Pulmonary Clinic, Milwaukee, Wisconsin, United States|Westmead Hospital, Sydney, New South Wales, Australia|The Wesley Hospital, Auchenflower, Queensland, Australia|Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia|Royal Melbourne Hospital, Melbourne, Victoria, Australia|Shanghai Pulmonary Hospital, Yangpu, Shanghai, China|West China Hospital, Chengdu, Sichuan, China|Shulan (Hangzhou) Hospital co., LTD, Hangzhou, Zhejiang, China|The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China|Rigshospitalet, Copenhagen, Denmark|Hôpital Henri Mondor, Créteil, Ile-de-France, France|Prince of Wales Hospital, Sha Tin, New Territories, Hong Kong|Samsung Medical Center, Gangnam-gu, Seoul, Gyeonggi-do, Korea, Republic of|Seoul National University Hospital, Jongno-gu, Seoul, Gyeonggi-do, Korea, Republic of|The Catholic University of Korea, Seoul St. Mary's Hospital, Seocho-gu, Seoul, Gyeonggi-do, Korea, Republic of|Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, Korea, Republic of|Asan Medical Center, Songpa-gu, Seoul, Gyeonggi-do, Korea, Republic of|National Cheng Kung University Hospital, North District, Tainan, Taiwan|National Taiwan University Hospital, Zhongzheng, Taipei City, Taiwan",https://ClinicalTrials.gov/show/NCT03808922
NCT04368377,Enhanced Platelet Inhibition in Critically Ill Patients With COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,18275/2020,"L. Sacco Hospital, Milano, Lombardia, Italy",https://ClinicalTrials.gov/show/NCT04368377
NCT04728594,Emails Promoting COVID-19 Vaccination Among Healthcare Workers,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Prevention",2021-0128,"Geisinger, Danville, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04728594
NCT04935437,Implementing a Rehabilitation Program in Patients Recovering From Covid-19 Infection,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,21-1-2021 22,"Evangelismos Hospital, Athens, Attica, Greece",https://ClinicalTrials.gov/show/NCT04935437
NCT04359849,Sequencing and Tracking of Phylogeny in COVID-19 Study,Observational Model: Cohort|Time Perspective: Retrospective,PHT/2020/34,"Portsmouth Hospitals NHS Trust, Queen Alexandra Hospital, Portsmouth, Hampshire, United Kingdom",https://ClinicalTrials.gov/show/NCT04359849
NCT04730284,Evaluation of a Synbiotic Formula in Patient With COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,COVSyn,"Chinese University of Hong Kong, Hong Kong, Hong Kong",https://ClinicalTrials.gov/show/NCT04730284
NCT04572399,UVA Light Device to Treat COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,883,"Cedars-Sinai Medical Center, Los Angeles, California, United States",https://ClinicalTrials.gov/show/NCT04572399
NCT04668937,Conséquences of the COVID-19 Lockdown Measures on the CHRU Nancy Pediatric Emergency Services,Observational Model: Cohort|Time Perspective: Retrospective,2020PI235,"CHRU Nancy's Pediatric Emergencies, Vandœuvre-lès-Nancy, Lorraine, France",https://ClinicalTrials.gov/show/NCT04668937
NCT04406064,Viral Specific T-cells for Treatment of COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2020-0353,"Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States",https://ClinicalTrials.gov/show/NCT04406064
NCT04961242,Pilot Evaluation of Together for Wellness Website in COVID-19,Observational Model: Ecologic or Community|Time Perspective: Prospective,20-002163,NA,https://ClinicalTrials.gov/show/NCT04961242
NCT04952766,Study Evaluating SARS-CoV-2 (COVID-19) Humoral Response After BNT162b2 Vaccine in Immunocompromised Adults Compared to Healthy Adults,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,CHRO-2021-04,"CHR d'Orleans - Service Maladies Infectieuses, Orléans, France",https://ClinicalTrials.gov/show/NCT04952766
NCT04510025,Capturing MultiORgan Effects of COVID-19,Observational Model: Cohort|Time Perspective: Prospective,282608,"University of Oxford, Oxford, United Kingdom",https://ClinicalTrials.gov/show/NCT04510025
NCT04324684,Prognostic Factors Keeping Track for COVID-19 Pneumonia,Observational Model: Case-Control|Time Perspective: Prospective,20202503,"Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy",https://ClinicalTrials.gov/show/NCT04324684
NCT04830761,Behavior Change in Context to Contain the Spread of COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention",2021-00164,"University of Bern, Bern, Switzerland",https://ClinicalTrials.gov/show/NCT04830761
NCT04408131,Morbi-mortality by COVID-19 Among Homeless People in Marseille: a Cohort Study,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,2020-32|2020-A01398-31,"Assistance Publique Hôpitaux de Marseille, Marseille, Paca, France",https://ClinicalTrials.gov/show/NCT04408131
NCT04803812,Supporting the Wellness of Ontario Physicians During COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Other",39707,"Ontario Medical Association, Toronto, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04803812
NCT04410692,Can the Prediction Market Improve Predictions of COVID-19?,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,SG-COVID,"National University of Singapore, Singapore, Singapore",https://ClinicalTrials.gov/show/NCT04410692
NCT04946565,The Impact of Sinopharm COVID-19 Vaccination on Male Fertility,Observational Model: Case-Only|Time Perspective: Prospective,TBA,"Faculty of Medicine, Cairo University, Cairo, Egypt",https://ClinicalTrials.gov/show/NCT04946565
NCT04510519,Scaling Mental Healthcare in COVID-19 With Voice Biomarkers,Observational Model: Cohort|Time Perspective: Prospective,COV-1,NA,https://ClinicalTrials.gov/show/NCT04510519
NCT04357041,"COVID-19 Survey Study on Dietary Intake, Physical Activity and Overall Well-being",Observational Model: Case-Only|Time Perspective: Other,IRB-2020-91,"Clinical Nutrition Research Center, Chicago, Illinois, United States",https://ClinicalTrials.gov/show/NCT04357041
NCT04876443,Impact of COVID-19 Outbreak on the Alcohol Consumption in Patients With Alcohol-related Liver Disease (ICoLD),Observational Model: Case-Only|Time Perspective: Prospective,284173,"Institute of Liver Studies, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04876443
NCT04730934,Effects of the COVID-19 Pandemic on Fibromyalgia Patients,Observational Model: Cohort|Time Perspective: Prospective,2020/43-01,"Çam and Sakura City Hospital, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04730934
NCT04481529,COVID-19 Serological Status of Hospital Staff Working or Not in the COVID-19 Sector,Observational Model: Case-Only|Time Perspective: Prospective,87RI20_0049/SEROCO,"CH Argenteuil - Service de Réanimation, Argenteuil, France|Ch Belfort, Belfort, France|CHU Dijon - Serve de Réanimation, Dijon, France|CHU de Limoges, Limoges, France",https://ClinicalTrials.gov/show/NCT04481529
NCT04443699,Predictors of Mental Well-being During the COVID-19 Pandemic,Observational Model: Other|Time Perspective: Prospective,REK125510-12,NA,https://ClinicalTrials.gov/show/NCT04443699
NCT04379245,COVID-19 Infection in Patients Infected With HIV and/or on PrEP,Observational Model: Cohort|Time Perspective: Retrospective,CRC_GHN_2020_002,"Croix-Rousse Hospital, Hospices Civils de Lyon, Lyon, France",https://ClinicalTrials.gov/show/NCT04379245
NCT04707820,Antiviral T Lymphocyte Immunity During Acute COVID-19 Infection,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,2020/0100/HP,"Rouen University Hospital, Rouen, France",https://ClinicalTrials.gov/show/NCT04707820
NCT04579588,Understanding Immunity to the Flu Vaccine in COVID-19 Patients,Observational Model: Case-Control|Time Perspective: Prospective,IRB-58356|5U19AI057229-17,"Stanford University, Hospital, and Clinics, Stanford, California, United States",https://ClinicalTrials.gov/show/NCT04579588
NCT04306055,Blood Donor Recruitment During Epidemic of COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,Blood donor recruitment,"Guangzhou Blood Center, Guangzhou, Guangdong, China",https://ClinicalTrials.gov/show/NCT04306055
NCT04425031,Handling Oxygenation Targets in COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention,AAUH-ICU-03|2017-000632-34,"Dept. of Intensive Care, Aalborg University Hospital, Aalborg, Denmark|Dept. of Intensive Care 4131, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark|Dept. of Intensive Care, Herlev Hospital, Herlev, Denmark|Dept. of Intensive Care, Hillerød Hospital, Hillerød, Denmark|Dept. of Intensive Care, Holbæk Hospital, Holbæk, Denmark|Dept. of Intensive Care, Kolding Hospital, Kolding, Denmark|Dept. of Intensive Care, Køge Hospital, Køge, Denmark|Dept. of Intensive Care, Slagelse Hospital, Slagelse, Denmark",https://ClinicalTrials.gov/show/NCT04425031
NCT04519437,"Study Assessing the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Repeated Subcutaneous Doses of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies (REGN10933+REGN10987) in Adult Volunteers as Related to COVID-19","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",R10933-10987-HV-2093,"Regeneron Study Site, Tempe, Arizona, United States|Regeneron Study Site, Rogers, Arkansas, United States|Regeneron Study Site, Sacramento, California, United States|Regeneron Study Site, Miami, Florida, United States|Regeneron Study Site, Lincoln, Nebraska, United States|Regeneron Study Site, Dayton, Ohio, United States|Regeneron Study Site, Austin, Texas, United States",https://ClinicalTrials.gov/show/NCT04519437
NCT04682574,Role of Mega Dose of Vitamin C in Critical COVID-19 Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,IRBEC/BIH/09-2020,"Bahria Town International Hospital, Lahore, Punjab, Pakistan",https://ClinicalTrials.gov/show/NCT04682574
NCT04449276,"A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults",Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention,CV-NCOV-001|2020-001286-36,"Universitair Ziekenhuis Ghent, Ghent, Belgium|Ludwig-Maximilians-Universität München, München, Bavaria, Germany|Medical University Hannover (MHH), Hannover, Germany|University Hospital Tübingen Institut für Tropenmedizin, Tübingen, Germany",https://ClinicalTrials.gov/show/NCT04449276
NCT04522492,Impact of COVID-19 on Mental Health of Patients With Skin Picking,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,31520820.1.0000.5327,"Hospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande Do Sul, Brazil",https://ClinicalTrials.gov/show/NCT04522492
NCT04661423,Use of RDS MultiSense® in Post-ICU Patients in the COVID-19 Era,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,20-004,"Anesthesia Department, Central Hospital, Nancy, France|Anesthesia, Critical Care & Perioperative Medicine, Hautepierre, Strasbourg, France",https://ClinicalTrials.gov/show/NCT04661423
NCT04890483,tDCS in Post-Acute COVID-19 Patients With SARDs,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,MYO-HCFMUSP-09,"Samuel K Shinjo, São Paulo, Brazil",https://ClinicalTrials.gov/show/NCT04890483
NCT04400006,Ozone Therapy in the Prevention of COVID-19 Infection,Observational Model: Case-Only|Time Perspective: Prospective,2761,"Kardelen Gencer Atalay, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04400006
NCT04772404,"Repercussion of the COVID-19 Pandemic on Physical Activity, Psychological State and Sleep",Observational Model: Cohort|Time Perspective: Prospective,DF0094UG,"Department of Physical Therapy, Granada, Spain",https://ClinicalTrials.gov/show/NCT04772404
NCT04365361,The Psychological Impact of the COVID-19 on Students.,Observational Model: Ecologic or Community|Time Perspective: Prospective,UW20-298,"LAI Agnes, Hong Kong, Hong Kong",https://ClinicalTrials.gov/show/NCT04365361
NCT04482595,BIO 300 Oral Suspension in Discharged COVID-19 Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",CL0105-01|272201800011C-P00005-9999-1,"University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States|NYU Langone Health, New York, New York, United States|Houston Methodist Research Institute, Houston, Texas, United States",https://ClinicalTrials.gov/show/NCT04482595
NCT04780581,Glucocorticoid Therapy in Coronavirus Disease COVID-19 Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,MP3-pulses-COVID-19,"Complejo Asistencial Universitario de Burgos, Burgos, Spain|Complejo Asistencial Universitario de León, León, Spain|Complejo Asistencial Universitario de Salamanca, Salamanca, Spain|Hospital Clínico Universitario de Valladolid, Valladolid, Spain|Hospital Universitario Río Hortega, Valladolid, Spain",https://ClinicalTrials.gov/show/NCT04780581
NCT04442386,Parental Burnout During the COVID-19 Pandemic: Risk Factors and Predictors,Observational Model: Other|Time Perspective: Prospective,REK125510-15,NA,https://ClinicalTrials.gov/show/NCT04442386
NCT04357613,IMATINIB IN COVID-19 DISEASE IN AGED PATIENTS.,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,P20/05_IMAGE19,"CHU Bordeaux, Bordeaux, France|CH de Versailles, Le Chesnay, France",https://ClinicalTrials.gov/show/NCT04357613
NCT04816760,Immune Cells Phenotypes During COVID-19,Observational Model: Cohort|Time Perspective: Prospective,2020-A00756-33,"Hopital Europeen Marseille, Marseille, France|Hopital Nord, Marseille, France",https://ClinicalTrials.gov/show/NCT04816760
NCT04414904,Determining the Reproductive Health of Men Post-COVID-19 Infection,Observational Model: Case-Control|Time Perspective: Prospective,20HH5998,"Channa Jayasena, London, Outside U.S./Canada, United Kingdom",https://ClinicalTrials.gov/show/NCT04414904
NCT04370886,Recruit Blood Donors Via SMS During Epidemic of COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,Recruit Blood Donors via SMS,"Guangzhou Blood Center, Guangzhou, Guangdong, China",https://ClinicalTrials.gov/show/NCT04370886
NCT04320732,Risk Factors for Community- and Workplace Transmission of COVID-19,Observational Model: Case-Control|Time Perspective: Prospective,REK-124170,"Oslo University Hospital, Oslo, Norway",https://ClinicalTrials.gov/show/NCT04320732
NCT04420416,Mental Health and Academic Performance in COVID-19,Observational Model: Cohort|Time Perspective: Cross-Sectional,Mental01,"Instituto Mexicano del Seguro Social, Guadalajara, Jalisco, Mexico",https://ClinicalTrials.gov/show/NCT04420416
NCT04369859,Obstetric and Perinatal Outcomes of Women With COVID-19,Observational Model: Cohort|Time Perspective: Prospective,2020-18|ID RCB,"Assistance Publique Hôpitaux de Marseille, Marseille, Paca, France",https://ClinicalTrials.gov/show/NCT04369859
NCT04858568,Immune Responses to COVID-19 Vaccination in Lymphoma Patients,Observational Model: Cohort|Time Perspective: Prospective,RHM CAN1612,"Bedfordshire Hospitals NHS Foundation Trust, Bedford, Bedfordshire, United Kingdom|Portsmouth Hospitals University NHS Trust, Portsmouth, Hampshire, United Kingdom|University Hospital Southampton NHS Foundation Trust, Southampton, Hampshire, United Kingdom|Wye Valley NHS Trust, Hereford, Herefordshire, United Kingdom|University Hospitals of Leicester NHS Trust, Leicester, Leicestershire, United Kingdom|Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, Norfolk, United Kingdom|Nottingham University Hospitals NHS Trust, Nottingham, Nottinghamshire, United Kingdom|Oxford University Hospitals NHS Foundation Trust, Oxford, Oxfordshire, United Kingdom|The Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, Tyne And Wear, United Kingdom",https://ClinicalTrials.gov/show/NCT04858568
NCT04386291,Meditation and Kundalini Yoga for Heightened Anxiety Related to COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,7987,"ProofPilot (Virtual Study: https://proofpilot.com/covid-anxiety/), New York, New York, United States|Columbia University Department of Psychiatry, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04386291
NCT04665193,An Approach to Screening for COVID-19 at Vancouver Airport,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Screening,H20-03225,"Vancouver International Airport, WestJet Domestic Terminal, Level 3, Richmond, British Columbia, Canada",https://ClinicalTrials.gov/show/NCT04665193
NCT04539873,Impact of Colchicine in Hospitalized Colombian Patients With COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,5175,"Fundación Universitaria de Ciencias de La Salud, Bogota, Cundinamarca, Colombia",https://ClinicalTrials.gov/show/NCT04539873
NCT04408287,Improving Activity Engagement Among Persons With SCI During COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,115929,"St. Josephs Parkwood Institute, London, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04408287
NCT04440098,Isolated During COVID-19: Effects of COVID-19's Social Restrictions on Loneliness and Psychosocial Symptomatology,Observational Model: Case-Only|Time Perspective: Cross-Sectional,20200446,"University of Miami, Miami, Florida, United States",https://ClinicalTrials.gov/show/NCT04440098
NCT04718519,Migrant Workers' Responses to the COVID-19 Pandemic,Observational Model: Cohort|Time Perspective: Cross-Sectional,510d2,"Yale NUS, Singapore, Singapore",https://ClinicalTrials.gov/show/NCT04718519
NCT04425863,"Ivermectin, Aspirin, Dexamethasone and Enoxaparin as Treatment of Covid 19",Observational Model: Cohort|Time Perspective: Prospective,IDEA,"Hospital Eurnekian, Buenos Aires, Argentina",https://ClinicalTrials.gov/show/NCT04425863
NCT04375137,Correlation Between Oxidative Stress Status and COVID-19 Severity,Observational Model: Case-Control|Time Perspective: Cross-Sectional,SBMU.12543,"Nooshin Dalili, Tehran, Iran, Islamic Republic of",https://ClinicalTrials.gov/show/NCT04375137
NCT04417673,Living With Sickle Cell Disease in the COVID-19 Pandemic,Observational Model: Cohort|Time Perspective: Prospective,999920125|20-HG-N125,"National Human Genome Research Institute (NHGRI), Bethesda, Maryland, United States",https://ClinicalTrials.gov/show/NCT04417673
NCT04371523,Hydroxychloroquine to Prevent COVID-19 Disease Amongst Healthcare Workers,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",3190,"St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04371523
NCT04416308,COVID 19 : Seroprevalence Study of Anti SRAS-CoV-2 Antibodies in GHT Employees in Haute Bretagne (AntiCoV-HB),Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Diagnostic,35RC20_9716,"CENTRE HOSPITALIER de VITRE_ Saint Jean (La Guerche), La Guerche de Bretagne, La Guerche-de-Bretagne, France|Centre Hospitalier de Fougeres, Fougères, France|Centre Hospitalier Grand Fougeray, Grand-Fougeray, France|Centre Hospitalier de La Roche Aux Fees, Janzé, France|Centre Hospitalier Montfort-Sur-Meu, Montfort sur Meu, France|Centre Hospitalier de Redon Carentoir, Redon, France|Chu Rennes, Rennes, France|Centre Hospitalier St Meen Le Grand, Saint-Méen-le-Grand, France|CENTRE HOSPITALIER VITRE_Simone Veil, Vitré, France",https://ClinicalTrials.gov/show/NCT04416308
NCT04666779,Access to Chiropractic Care During the COVID-19 Pandemic,Observational Model: Cohort|Time Perspective: Prospective,CohortChiroCOVID19,"Real Centro Universitario María Cristina, San Lorenzo De El Escorial, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04666779
NCT04548505,Recovery of Exertion Ability Following COVID-19 Infection in Military Staff,Observational Model: Cohort|Time Perspective: Prospective,2020-COVID19-30|2020-A02140-39,"Institut de Recherche Biomédicale des Armées, Brétigny-sur-Orge, France",https://ClinicalTrials.gov/show/NCT04548505
NCT04791085,Investigation of Stress Levels and Lifestyle of a Sample of Greek General Surgeons in Covid-19,Observational Model: Other|Time Perspective: Cross-Sectional,1183/17.02.21,"Sismanoglio-Amalia Fleming Hospital, Athens, Melissia, Greece",https://ClinicalTrials.gov/show/NCT04791085
NCT04373148,"Understanding Immunity to SARS-CoV-2, the Coronavirus Causing COVID-19",Observational Model: Case-Control|Time Perspective: Prospective,IRB-55689|2U19AI057229|1U54CA260517-01|1R21ES033049-01,"Stanford Health Care - ValleyCare, Pleasanton, California, United States|Stanford University, Hospital, and Clinics, Stanford, California, United States",https://ClinicalTrials.gov/show/NCT04373148
NCT04453540,FilmArray and Management of ICU Patients With Pneumonia in the Covid-19 Context,Observational Model: Case-Only|Time Perspective: Retrospective,2020PI101,NA,https://ClinicalTrials.gov/show/NCT04453540
NCT04472559,Acupressure for COVID-19 Related Quality of Life and Stress,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,20-000773,"UCLA, Los Angeles, California, United States",https://ClinicalTrials.gov/show/NCT04472559
NCT04915820,Iron and COVID-19 Vaccine Response,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science,DIVA II,"Msambweni County Referral Hospital, Msambweni, Kwale, Kenya",https://ClinicalTrials.gov/show/NCT04915820
NCT04853953,Cerebral Bleeding in COVID-19 ARDS Patients on Veno-venous ECMO,Observational Model: Cohort|Time Perspective: Retrospective,SD03,NA,https://ClinicalTrials.gov/show/NCT04853953
NCT04947046,Carotid Stenosis Management During COVID-19 Era - Pilot Study,Observational Model: Cohort|Time Perspective: Prospective,P-2021-1,"Zealand University Hospital, Roskilde, Denmark",https://ClinicalTrials.gov/show/NCT04947046
NCT04501445,Psychological Symptoms and Families of COVID-19 Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,20071101,"Rush University Medical Center, Chicago, Illinois, United States",https://ClinicalTrials.gov/show/NCT04501445
NCT04724642,"COVID-19 Vaccine in Patients After Allogeneic HCT, CAR-T Therapy and With Primary Immune Deficiency",Observational Model: Case-Only|Time Perspective: Prospective,1067-20,"Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel",https://ClinicalTrials.gov/show/NCT04724642
NCT04326387,Evaluation of Novel Diagnostic Tests for COVID-19,Observational Model: Cohort|Time Perspective: Prospective,COVIDx,"Cambridge University Hospitals NHS Foundation Trust, Cambridge, Cambridgeshire, United Kingdom",https://ClinicalTrials.gov/show/NCT04326387
NCT04435106,Compassionate Use of Opaganib in Patients With Coronavirus Disease 2019 (COVID-19),Observational Model: Case-Control|Time Perspective: Retrospective,0123-20- SZMC,"Shaare-Zedek Medical Center, Jerusalem, Israel",https://ClinicalTrials.gov/show/NCT04435106
NCT04444661,Effects of COVID-19 Induced Deconditioning After Long-term High Intensity Resistance Exercise,Observational Model: Cohort|Time Perspective: Retrospective,FrOST-FU,"Institute of Medical Physics, Friedrich Alexander University Erlangen-Nürnberg, Erlangen, Bavaria, Germany",https://ClinicalTrials.gov/show/NCT04444661
NCT04498091,EPIdemiological Approaches to the Cardiovascular Consequences of COVID-19,Observational Model: Cohort|Time Perspective: Prospective,Zeller AOIc 2020,"Chu Dijon Bourgogne, Dijon, France",https://ClinicalTrials.gov/show/NCT04498091
NCT04333654,Hydroxychloroquine in Outpatient Adults With COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",EFC16855|2020-001269-35|U1111-1249-6168,"Investigational Site Number 8400001, Boston, Massachusetts, United States|Investigational Site Number 0561001, Bruxelles, Belgium|Investigational Site Number 0561002, Lodelinsart, Belgium|Investigational Site Number 2501001, Bordeaux Cedex, France|Investigational Site Number 2501002, Paris, France|Investigational Site Number 5281001, Groningen, Netherlands|Investigational Site Number 5281002, Harderwijk, Netherlands",https://ClinicalTrials.gov/show/NCT04333654
NCT04530461,Serologic Profile of SARS CoV2 in COVID-19 Patients With Systemic Diseases,Observational Model: Cohort|Time Perspective: Prospective,UR17DN02-002,"Military Hospital of Tunis, Tunis, Tunisia",https://ClinicalTrials.gov/show/NCT04530461
NCT04766645,ACE2 Gender Differences in Stroke With COVID-19,Observational Model: Cohort|Time Perspective: Prospective,FDG_Acegender_2021,NA,https://ClinicalTrials.gov/show/NCT04766645
NCT04468308,VRQOL in Cataract Patients During the COVID-19 Pandemic,Observational Model: Cohort|Time Perspective: Prospective,VRQOL Cataract COVID-19,"Medical University Innsbruck, Innsbruck, Tyrol, Austria",https://ClinicalTrials.gov/show/NCT04468308
NCT04431297,Virtual Mindfulness Rounds in the Time of COVID-19 Pandemic,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,GCO 20-1022,"Icahn School of Medicine at Mount Sinai, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04431297
NCT04616989,Mental Health in Communities Affected by COVID-19 in Uganda,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,Integration of mental health,"Dickens Akena, Kampala, Uganda",https://ClinicalTrials.gov/show/NCT04616989
NCT04420806,Effects of COVID-19 Lockdown in Exercising Early Postmenopausal Women,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,ER_ACTLIFE_FU,"Institute of Medical Physics, Friedrich-Alexanden University Erlangen-Nürnberg, Erlangen, Germany",https://ClinicalTrials.gov/show/NCT04420806
NCT04429815,Impact of Smoking and Nicotine on the Risk of Being Infected With COVID-19,Observational Model: Cohort|Time Perspective: Prospective,2020-A01681-38,NA,https://ClinicalTrials.gov/show/NCT04429815
NCT04747756,Creating a Virtual Village for People Aging With HIV During COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,60304,"UC Riverside, Riverside, California, United States",https://ClinicalTrials.gov/show/NCT04747756
NCT04970849,Survey Study About Endoscopy During COVID-19 Pandemic for IBD Doctors,Observational Model: Other|Time Perspective: Retrospective,I2020001357,"Second Affiliated Hospital Zhejiang University School of Medicine, Zhengzhou, Hangzhou, China",https://ClinicalTrials.gov/show/NCT04970849
NCT04728906,Heart Patch for Myocardial Infarction COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,120/KEPK-RSB/X/20,NA,https://ClinicalTrials.gov/show/NCT04728906
NCT04728958,Reflective Tasks With Healthcare Workers During COVID-19,Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,170732,NA,https://ClinicalTrials.gov/show/NCT04728958
NCT04748757,Annexin A5 in Patients With Severe COVID-19 Disease,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",REDA-10122,"London Health Sciences Centre, London, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04748757
NCT04424082,External Dead Space in Ventilated COVID-19 Patients,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,Karolinska,"Karolinska University Hospital, Stockholm, Sweden",https://ClinicalTrials.gov/show/NCT04424082
NCT04337489,Remote Monitoring Use In Cases Of Suspected COVID-19 (Coronavirus),Observational Model: Cohort|Time Perspective: Prospective,REMOTE-COVID,NA,https://ClinicalTrials.gov/show/NCT04337489
NCT04635813,The Impact of COVID-19 Pandemic on Thyroid Surgery in Italy: Results From a Nation-wide Multicentric Study,Observational Model: Case-Control|Time Perspective: Retrospective,THYCOVIT,"AOU Cagliari, Cagliari, CA, Italy",https://ClinicalTrials.gov/show/NCT04635813
NCT04296643,Medical Masks vs N95 Respirators for COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention,20006014,"Foothills Medical Centre, Calgary, Alberta, Canada|University of Alberta Hospital, Edmonton, Alberta, Canada|Brantford General Hospital, Brantford, Ontario, Canada|Hamilton Health Sciences, Hamilton, Ontario, Canada|St. Joseph's Healthcare, Hamilton, Ontario, Canada|Ottawa Hospital, Ottawa, Ontario, Canada|Hopital Montfort, Ottawa, Ontario, Canada|Niagara Health Services, St. Catherines, Ontario, Canada|St. Joe's Unity Health, Toronto, Ontario, Canada|St. Mike's Unity Health, Toronto, Ontario, Canada|Montreal University Health Centre, Montréal, Quebec, Canada|The Jewish General Hospital, Montréal, Quebec, Canada|Golden Care LTCF, Tzrifin, Israel",https://ClinicalTrials.gov/show/NCT04296643
NCT04343898,Study of the Treatment and Outcomes in Critically Ill Patients With COVID-19,Observational Model: Cohort|Time Perspective: Other,2007P000003,"Brigham and Women's Hospital, Boston, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT04343898
NCT04319016,Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) in Pregnancy,Observational Model: Cohort|Time Perspective: Other,145/20,"Gabriele Saccone, Napoli, Italy",https://ClinicalTrials.gov/show/NCT04319016
NCT04594291,MRI Changes of Acute Kidney Injury in COVID-19,Observational Model: Cohort|Time Perspective: Prospective,UHDB/2020/077|287571,"University Hospitals of Derby and Burton NHS Foundation Trust, Derby, Derbyshire, United Kingdom",https://ClinicalTrials.gov/show/NCT04594291
NCT04815109,Prospective Electroencephalography Evaluation of Sedation in COVID-19,Observational Model: Cohort|Time Perspective: Prospective,EEG in COVID-19,"University Hospital Frankfurt, Frankfurt, Hessen, Germany",https://ClinicalTrials.gov/show/NCT04815109
NCT04302688,Accurate Classification System for Patients With COVID-19 Pneumonitis,Observational Model: Other|Time Perspective: Retrospective,COVID-19 WU1,"Renmin Hospital of Wuhan University, Wuhan, Hubei, China",https://ClinicalTrials.gov/show/NCT04302688
NCT04488471,Impact of Isolation in Patients With IBD During the COVID-19 Crisis,Observational Model: Cohort|Time Perspective: Prospective,STH21414,"Sheffield Teaching Hospitals NHS FT, Sheffield, United Kingdom",https://ClinicalTrials.gov/show/NCT04488471
NCT04384458,Comparative Study of Hydroxychloroquine and Ivermectin in COVID-19 Prophylaxis,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,HCQ+IVM,"Drug Research and Development Center (NPDM), Federal University of Ceará (UFC), Fortaleza, Ceará, Brazil",https://ClinicalTrials.gov/show/NCT04384458
NCT04686760,Efficacy of Inhaled Nitroglycerin in Moderate to Critically Ill COVID-19 Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,IRBEC/BIH/08-2020,"Bahria Town International Hospital, Lahore, Punjab, Pakistan",https://ClinicalTrials.gov/show/NCT04686760
NCT04448704,Understanding the Mental Health of Migrant Workers During the COVID-19 Outbreak,Observational Model: Cohort|Time Perspective: Cross-Sectional,CCF@EXPO/R001/2020,"EXPO, Singapore, Singapore",https://ClinicalTrials.gov/show/NCT04448704
NCT04442360,The Impact of Information Sources on Mental Health During the COVID-19 Pandemic,Observational Model: Other|Time Perspective: Prospective,REK125510-13,NA,https://ClinicalTrials.gov/show/NCT04442360
NCT04775069,Antibody Response to COVID-19 Vaccines in Liver Disease Patients,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,HHCTC_COVID-19_VACCINE_Ab,"Humanity & Health Medical Group Limited, Hong Kong, Hong Kong",https://ClinicalTrials.gov/show/NCT04775069
NCT04373798,C-reactive Protein Levels Among Individuals With COVID-19,Observational Model: Cohort|Time Perspective: Prospective,APPI2-CV-2020-02,"The Parker Institute, Frederiksberg Hospital, Copenhagen, Denmark",https://ClinicalTrials.gov/show/NCT04373798
NCT04588415,Supporting Family Members With Severe Grief Reaction During the COVID-19 Pandemic,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Supportive Care,20200653-01H,"Ottawa Hospital, Ottawa, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04588415
NCT04406246,Prevention of Coronavirus Disease (COVID-19) Outbreaks With Nitazoxanide,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2020-04-682,"Materno-Perinatal Hospital ""Mónica Pretelini"", Toluca, Mexico",https://ClinicalTrials.gov/show/NCT04406246
NCT04609488,Surfactant Levels in the Lungs of COVID-19 Patients,Observational Model: Case-Only|Time Perspective: Prospective,SJ-859x,NA,https://ClinicalTrials.gov/show/NCT04609488
NCT04442204,Predictors and Mechanisms of Depression and Anxiety During the COVID-19 Pandemic,Observational Model: Other|Time Perspective: Prospective,REK125510-10,NA,https://ClinicalTrials.gov/show/NCT04442204
NCT04819282,Mask Usage and Physical Performance During COVID-19 Pandemic in Geriatrics,Observational Model: Other|Time Perspective: Cross-Sectional,KaratayU4,"KTO Karatay University, Konya, Karatay, Turkey",https://ClinicalTrials.gov/show/NCT04819282
NCT04408378,Change in the Ratio of Mean Platelet Volume (MPV) to Platellet(PLT) in Covid-19 Pneumonia Patients,Observational Model: Case-Control|Time Perspective: Retrospective,69,"Gaziosmanpaşa TREH, Istanbul, Gaziosmanpaşa, Turkey",https://ClinicalTrials.gov/show/NCT04408378
NCT04475484,Online Survey on Psychological Impact of COVID-19 Epidemic on School-age Children,Observational Model: Ecologic or Community|Time Perspective: Cross-Sectional,PSICOcs_2020,"hôpital Femme Mère Enfant, Bron, France",https://ClinicalTrials.gov/show/NCT04475484
NCT04357314,Myocardial Infarction Rates Overview During COVID-19 Pandemic In France: MODIF Study,Observational Model: Cohort|Time Perspective: Retrospective,20-Mar,"Hôpital Universitaire Carémeau, Nîmes, France",https://ClinicalTrials.gov/show/NCT04357314
NCT04964596,Managing Colorectal Cancer Prevention Procedure Wait Lists During the COVID-19 Pandemic,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Diagnostic,2022-10019,"Centre Hospitalier Universitaire de Montréal, Montréal, Quebec, Canada",https://ClinicalTrials.gov/show/NCT04964596
NCT04452799,Hesperidin and Diosmin for Treatment of COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment",1111,NA,https://ClinicalTrials.gov/show/NCT04452799
NCT04346589,Convalescent Antibodies Infusion in Critically Ill COVID 19 Patients,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,DFPP COVID 19,"IRFMN - Clinical Research Center for Rare Diseases, Ranica, BG, Italy|ASST HPG23 - Unit of Nephrology, Bergamo, Italy|ASST Papa Giovanni XXIII - Microbiology and Virology Unit, Bergamo, Italy|Asst Pg23 - S.I.M.T, Bergamo, Italy|ASST-PG23 - Intensive Care Unit, Bergamo, Italy",https://ClinicalTrials.gov/show/NCT04346589
NCT04757285,Copeptin and Psychological Stress of Medic During COVID-19 Pandemic,Observational Model: Cohort|Time Perspective: Prospective,304842,"Alexandria University Faculty of Medicine, Alexandria, Egypt",https://ClinicalTrials.gov/show/NCT04757285
NCT04942392,Digital Dance for People With Parkinson's Disease During the COVID-19 Pandemic,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,136/2019,"Balettakademien, Stockholm, Sweden",https://ClinicalTrials.gov/show/NCT04942392
NCT04394195,sFlt1: a Biomarker of Organ Dysfunction in Critically-ill Patients With COVID-19?,Observational Model: Cohort|Time Perspective: Prospective,PO20043*,"Chu Reims, Reims, France",https://ClinicalTrials.gov/show/NCT04394195
NCT04632368,Targeting the Health Care Provider (HCP) Burnout Crisis During the COVID-19 Pandemic,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,Pro00106191,"Duke University health system, Durham, North Carolina, United States",https://ClinicalTrials.gov/show/NCT04632368
NCT04775056,A Study to Evaluate Vaccines Against COVID-19 in the Real World,Observational Model: Cohort|Time Perspective: Prospective,APASL_COVID-19 Vaccine_Ab,"Humanity & Health Medical Group, Hong Kong, Hong Kong",https://ClinicalTrials.gov/show/NCT04775056
NCT04333849,Telephony Or Videophony for Isolated elDerly in Maine-Et-Loire 49 During COVID-19,Observational Model: Cohort|Time Perspective: Prospective,2020/29,"Angers University Hospital, Angers, France",https://ClinicalTrials.gov/show/NCT04333849
NCT04366947,Intravascular Access in Suspected/Confirmed COVID-19 Patient,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,IO_PPE_1,"Lazarsku University, Warsaw, Masovian, Poland",https://ClinicalTrials.gov/show/NCT04366947
NCT04535297,Consequences of the COVID-19 Lockdown on Health and Well-being of Patients With Parkinson Disease and Post-stroke,Observational Model: Case-Only|Time Perspective: Cross-Sectional,203/20,"Galit Yogev-Seligmann, Haifa, Please Select..., Israel",https://ClinicalTrials.gov/show/NCT04535297
NCT04738721,Physical Activity and Physical Fitness Parameters in COVID-19 Lockdown,Observational Model: Other|Time Perspective: Prospective,E-10840098-772.02-2685,"Istanbul Medipol University, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04738721
NCT04967794,Effectiveness of Teleorientation in Oral Hygiene During the COVID-19 Pandemic,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Participant)|Primary Purpose: Prevention,CAAE 39685920.7.0000.5419,"Marilia G Gomes, Ribeirao Preto, Sao Paulo, Brazil",https://ClinicalTrials.gov/show/NCT04967794
NCT04460677,ASD (Autism Spectrum Disorder) Telehealth for Distress Related to COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,Pro2020001593,"Rutgers University, Piscataway, New Jersey, United States",https://ClinicalTrials.gov/show/NCT04460677
NCT04279899,The Investigation of the Neonates With or With Risk of COVID-19,Observational Model: Case-Only|Time Perspective: Prospective,CHFudanU_NNICU14,"Maternal and Child Health Hospital of Hubei Province, Wuhan, Hubei, China|Children Hospital of Fudan University, Shanghai, Shanghai, China",https://ClinicalTrials.gov/show/NCT04279899
NCT04377100,Impact on Anxiety and Motivation of COVID-19 and Predictors of Individual Responses,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science,999920112|20-M-N112,"National Institute of Mental Health (NIMH), Bethesda, Maryland, United States",https://ClinicalTrials.gov/show/NCT04377100
NCT04611399,MIND-VR: Virtual Reality for COVID-19 Operators' Psychological Support,Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,MIND-VR/Besta,"Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy",https://ClinicalTrials.gov/show/NCT04611399
NCT04459975,Acute Kidney Injury and Renal Outcomes for COVID-19 Patients in Intensive Care Units,Observational Model: Cohort|Time Perspective: Retrospective,CoV-AKI_2020,"Intensive care units attached to the Hospices Civils de Lyon (HCL), Lyon, France",https://ClinicalTrials.gov/show/NCT04459975
NCT04982341,HFNC and Prone Positioning in Awake Patients With Severe COVID-19,Observational Model: Cohort|Time Perspective: Prospective,FattoumaBourguiba_HFNC_Prone,"CHU F.Bourguiba, Monastir, Tunisia",https://ClinicalTrials.gov/show/NCT04982341
NCT04486521,Anti-IL6 and Corticosteroid Monotherapy vs Combination in COVID-19,Observational Model: Other|Time Perspective: Prospective,RAC # 2201053,"King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia",https://ClinicalTrials.gov/show/NCT04486521
NCT04422535,Effects on the Qt Interval of COVID-19 Coronavirus Infection,Observational Model: Cohort|Time Perspective: Retrospective,QT-COVID-19,"Servicio de Anestesia, Hospital General Universitario Gregorio Marañon, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04422535
NCT04838795,Sisonke (Together): OPEN LABEL TRIAL COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,Sisonke (Together): OPEN LABEL,"Nelson Mandela Academic Clinical Research Unit (NeMACRU), Mthatha, Eastern Cape, South Africa|PHOENIX Pharma Pty Ltd, Port Elizabeth, Eastern Cape, South Africa|Josha Research, Bloemfontein, Free State, South Africa|The Aurum Institute: Tembisa Clinical Research Centre, Johannesburg, Gauteng - South, South Africa|Perinatal HIV Research Unit Kliptown, Johannesburg, Gauteng - South, South Africa|CRISMO Research Centre, Dr Bhekithemba, Germiston, Gauteng, South Africa|Perinatal HIV Research Unit (PHRU), SOWETO, Johannesburg, Gauteng, South Africa|Wits RHI: Shandukani Research Centre, Johannesburg, Gauteng, South Africa|Themba Lethu HIV Research Unit (CHRU), Dr, Johannesburg, Gauteng, South Africa|Synexus SA - Stanza Clinical Research Centre, Pretoria, Gauteng, South Africa|Setshaba Research Centre,, Pretoria, Gauteng, South Africa|Synexus Watermeyer Clinical Research Centre,, Pretoria, Gauteng, South Africa|Ndlovu Research Centre, Pretoria, Gauteng, South Africa|Botha's Hill Clinical Research Site, Bothas Hill, KWA ZULU Natal, South Africa|CAPRISA eThekwini Clinical Research Site, Dr, Durban, KWA ZULU Natal, South Africa|Chatsworth Clinical Research Site, Durban, Kwa Zulu Natal, South Africa|CAPRISA Vulindlela Clinical Research Site, Dr, Durban, KWA ZULU Natal, South Africa|Qhakaza Mbokodo Research Clinic, Ladysmith, KWA ZULU Natal, South Africa|Tongaat Clinical Research Site, Dr, Tongaat, Kwa Zulu Natal, South Africa|Mzansi Ethical Research Centre, Middleburg, Mpumalanga, South Africa|The Aurum Institute Klerksdorp Clinical Research Centre, Klerksdorp, North WEST Province, South Africa|FAMCRU (Family Clinical Research Unit),, Cape Town, Western Cape, South Africa|TASK Central, Cape Town, Western Cape, South Africa|TASK Clinical Research Centre, Cape Town, Western Cape, South Africa|Emavundleni Research Centre, Cape Town, Western CAPE, South Africa|Khayelitsha CRS, Dr Amy Ward / Dr Graeme Meintjes, Cape Town, Western CAPE, South Africa|Desmond Tutu Health Foundation CTU J52 Old Main Building Groote SchuurHospital, Cape Town, Western Cape, South Africa|Synexus Helderberg Clinical Research Centre, Dr Vera, Somerset West, Western CAPE, South Africa|South African Vaccine Initiative (SATVI), Dr Angelique Kany Kany, Worcester, Western Cape, South Africa|Desmond Tutu Health Foundation - Masiphumelele Research Office, Cape Town, South Africa|The Aurum Institute: Rustenburg Clinical Research Centre, Dr Lawrence, Rustenburg, South Africa",https://ClinicalTrials.gov/show/NCT04838795
NCT04684615,Mental Health Impact of the COVID-19 Pandemic on Amish and Mennonite Participants in AMBiGen,Observational Model: Cohort|Time Perspective: Prospective,10000038|000038-M,"National Institute of Mental Health (NIMH), Bethesda, Maryland, United States",https://ClinicalTrials.gov/show/NCT04684615
NCT04290871,Nitric Oxide Gas Inhalation for Severe Acute Respiratory Syndrome in COVID-19.,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Treatment",NO-SARS-COVID-19,NA,https://ClinicalTrials.gov/show/NCT04290871
NCT04410458,Recruit Blood Donors Via SMS During Epidemic of COVID-19 （Repeat Trial）,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,Recruit Blood Donors via SMS 2,"Guangzhou Blood Center, Guangzhou, Guangdong, China",https://ClinicalTrials.gov/show/NCT04410458
NCT04365348,The Psychological Impact of COVID-19 Outbreak on COVID-19 Survivors and Their Families,Observational Model: Cohort|Time Perspective: Prospective,UW20-300,"Agnes, Hong Kong, Hong Kong",https://ClinicalTrials.gov/show/NCT04365348
NCT04902118,Burnout Determinants Among Pediatric Psychiatry Workers During COVID-19 Crisis,Observational Model: Cohort|Time Perspective: Retrospective,RECHMPL21_0305,"Uhmontpellier, Montpellier, France",https://ClinicalTrials.gov/show/NCT04902118
NCT04337151,Blood Titanium Analysis of Patients With MAGEC Spine Rods in the COVID-19 Environment,Observational Model: Case-Control|Time Perspective: Retrospective,RNOH MAGEC,"Royal National Orthopaedic Hospital, Stanmore, United Kingdom",https://ClinicalTrials.gov/show/NCT04337151
NCT04459455,"Project H-COVID: Evaluating Hyper-Brief, Online Materials During the COVID-19 Pandemic","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",IRB2020-00204,"Stony Brook University, Stony Brook, New York, United States",https://ClinicalTrials.gov/show/NCT04459455
NCT04794036,Efficacy of an Asynchronous Telerehabilitation Programme in Post-COVID-19 Patient,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,COVID-19_TRHB,"Hospital Real Nuestra Señora de Gracia, Zaragoza, Spain|Hospital Royo Villanova, Zaragoza, Spain",https://ClinicalTrials.gov/show/NCT04794036
NCT04715438,Vaccination Against COVID-19 in Cancer,Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,202000865,"NKI-AvL, Amsterdam, Netherlands|UMCG, Groningen, Netherlands|Erasmus MC, Rotterdam, Netherlands",https://ClinicalTrials.gov/show/NCT04715438
NCT04576299,Health Care Workers' Perception of Patient Safety During COVID-19 Pandemic,Observational Model: Ecologic or Community|Time Perspective: Cross-Sectional,20-Sep,"Pontificia Universidad Católica de Chile, Santiago, Chile|Universidad de Santander, Bucaramanga, Santander, Colombia|Universidad Católica de Santiago de Guayaquil, Guayaquil, Guayas, Ecuador|Miguel Hernández University, Elche, Alicante, Spain",https://ClinicalTrials.gov/show/NCT04576299
NCT04344509,Microbial Etiology of Ventilator-associated Pneumonia in COVID-19 Infected Patients,Observational Model: Case-Control|Time Perspective: Retrospective,PAVM COVID,NA,https://ClinicalTrials.gov/show/NCT04344509
NCT04488549,Delayed Colorectal Cancer Care During Coronavirus Disease (COVID-19) Pandemic (DECOR-19),Observational Model: Other|Time Perspective: Prospective,Treviso,"Treviso Regional Hospital, Treviso, Italy",https://ClinicalTrials.gov/show/NCT04488549
NCT04524754,Prevalence and Outcomes of Olfactory and Gustatory Dysfunctions in Patients With COVID-19,Observational Model: Case-Only|Time Perspective: Retrospective,FMASUP46a/2020,"Ain shams Univesrity, Cairo, Egypt",https://ClinicalTrials.gov/show/NCT04524754
NCT04341493,Hydroxychloroquine vs Nitazoxanide in Patients With COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,2020-03-681,"Materno-Perinatal Hospital ""Mónica Pretelini"", Toluca, Mexico",https://ClinicalTrials.gov/show/NCT04341493
NCT04315480,Tocilizumab for SARS-CoV2 (COVID-19) Severe Pneumonitis,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,TOCICOV-1,"Università Politecnica delle Marche, Ancona, AN, Italy",https://ClinicalTrials.gov/show/NCT04315480
NCT04413435,Clinical Characteristics of Critically Ill Patients With COVID-19,Observational Model: Other|Time Perspective: Retrospective,2020-245,"Konya Trainig and Research Hospital, Konya, Turkey",https://ClinicalTrials.gov/show/NCT04413435
NCT04425499,A Gamified Network for Surgical Education During COVID-19: A Randomized Controlled Trial,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Other,CERSES 20-068-D,NA,https://ClinicalTrials.gov/show/NCT04425499
NCT04431180,Recruit Blood Donors Via SMS During Epidemic of COVID-19 #Second Repeat Trial#,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,Recruit Blood Donors via SMS 3,"Guangzhou Blood Center, Guangzhou, Guangdong, China",https://ClinicalTrials.gov/show/NCT04431180
NCT04855539,Coronavirus: Ventilator Outcomes Using Artificial Intelligence Chest Radiographs & Other Evidence-based Co-variates,Observational Model: Cohort|Time Perspective: Prospective,IRAS 232823,"Princess Royal University Hospital, Orpington, Kent, United Kingdom|Guy's and St Thomas' Hospital, London, United Kingdom|King's College Hospital, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04855539
NCT04497467,Changes in Out-patient Visits in Taiwan During the Time of Global COVID-19 Pandemic,Observational Model: Cohort|Time Perspective: Retrospective,202006225RINA,"National Taiwan University Hospital, Taipei, Taiwan",https://ClinicalTrials.gov/show/NCT04497467
NCT04451239,Topical Steroids and Cyclosporin-A for COVID-19 Keratoconjunctivitis,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,COVID-19 keratoconjunctivitis,"Farawanyia hospital, Kuwait, Farawanyia, Kuwait",https://ClinicalTrials.gov/show/NCT04451239
NCT04661410,Reward Re-Training: A New Treatment to Address Reward Imbalance During the COVID-19 Pandemic,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,2009008088|R01MH122392-01S1,"Drexel University, Stratton Hall, Philadelphia, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04661410
NCT04341142,Assessment of Serological Techniques for Screening Patients Regarding COVID-19-COVID-SER,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,69HCL20_0329,"Hôpital Lyon Sud,Sainte Eugénie bat 4M,5, Chemin du Grand Revoyet, Pierre-Bénite cedex, France",https://ClinicalTrials.gov/show/NCT04341142
NCT04417270,Reliability of the Freestyle Libre CGM in the Inpatient Setting During the COVID-19 Surge,Allocation: Non-Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Other,20-0455,"Lenox Hill Hospital, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04417270
NCT04768153,Prioritising Prevention of COVID-19 in Persons With Cancer in the French West Indies,Observational Model: Cohort|Time Perspective: Prospective,20_RIPH3_04,"CHU Martinique, Fort-de-France, Martinique",https://ClinicalTrials.gov/show/NCT04768153
NCT04328454,Clinical Characteristics and Prognostic Factors of Patients With COVID-19,Observational Model: Cohort|Time Perspective: Retrospective,HBCBH-IEC-2020-101,"Shanghai 10th People's Hospital, Shanghai, Shanghai, China",https://ClinicalTrials.gov/show/NCT04328454
NCT04621058,Efficacy of Vitamin D Treatment in Mortality Reduction Due to COVID-19.,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",VITD,"Joaquín Durán Cantolla, Vitoria-Gasteiz, Alava, Spain",https://ClinicalTrials.gov/show/NCT04621058
NCT04362059,A Clinical Trial of Nebulized Surfactant for the Treatment of Moderate to Severe COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,RHM CRI0399,"University Hospital Southampton NHS Foundation Trust, Southampton, Hampshire, United Kingdom|University College London Hospitals NHS Foundation Trust, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04362059
NCT04826822,Spironolactone and Dexamethasone in Patients Hospitalized With COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,SPII_1789461,"Chita State Regional Clinical Hospital Number 1, Chita, Russian Federation",https://ClinicalTrials.gov/show/NCT04826822
NCT04453514,Feasibility of a Brief Trauma-informed Yoga Intervention for Anxiety During the Coronavirus Disease (COVID-19) Pandemic,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,Tibbitts_TIYoga_COVID,"National University of Natural Medicine, Portland, Oregon, United States",https://ClinicalTrials.gov/show/NCT04453514
NCT04481516,Yoga in NHS Health Care Workers With COVID-19 Related Stress,Observational Model: Cohort|Time Perspective: Prospective,DBH 1058/2020/HRAS,"Doncaster and Bassetlaw Teaching Hospitals NHS Foundation Trust, Doncaster, South Yorkshire, United Kingdom",https://ClinicalTrials.gov/show/NCT04481516
NCT04343664,Mental Health Assessment Among Community Member During the Covid-19 Pandemic in Indonesia,Observational Model: Ecologic or Community|Time Perspective: Cross-Sectional,MH-Covid19,"dr. Cipto Mangunkusumo General Hospital, Jakarta Pusat, DKI Jakarta, Indonesia",https://ClinicalTrials.gov/show/NCT04343664
NCT04401644,COVID-19: Laser Interferometry for Rapid Single Coronavirus Detection,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,RBA20203,"Somerset NHS Foundation Trust, Taunton, Somerset, United Kingdom",https://ClinicalTrials.gov/show/NCT04401644
NCT04479345,"Knowledge, Attitude and Practice of Gastrointestinal Endoscopists Toward PPE in COVID-19 Era",Observational Model: Cohort|Time Perspective: Cross-Sectional,COVID endoscopy,NA,https://ClinicalTrials.gov/show/NCT04479345
NCT04874766,The Effects of Wearing a Face Mask During Exercise in Youth Hockey Players During COVID-19,"Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",2701,"University of Saskatchewan, Saskatoon, Saskatchewan, Canada",https://ClinicalTrials.gov/show/NCT04874766
NCT04418193,Patient Preference Trial for COVID-19 (PPT-COVID),Observational Model: Cohort|Time Perspective: Other,8月20日,"Centre Hospitalier Princesse Grace, Monaco, Monaco",https://ClinicalTrials.gov/show/NCT04418193
NCT04433312,Impact of Cancellation of Non-urgent Surgical Cases on Patients During the COVID-19 Pandemic,Observational Model: Other|Time Perspective: Cross-Sectional,SURG RES COL 2,"Mansoura Faculty of Medicine, Mansoura, Egypt",https://ClinicalTrials.gov/show/NCT04433312
NCT04746092,The Capability of Haemato-oncology Patients to Generate Antibodies Against COVID-19,Observational Model: Case-Control|Time Perspective: Prospective,1068-20,"Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel",https://ClinicalTrials.gov/show/NCT04746092
NCT04973735,A Phase I Study of LY-CovMab Injection in Chinese Healthy Subjects,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",LY-CovMab/CT-CHN-101,"The Second Hospital of Anhui Medical University, Hefei, Anhui, China",https://ClinicalTrials.gov/show/NCT04973735
NCT04693975,Social Distancing During the COVID-19 Pandemic and People Living With Chronic Respiratory Diseases,Observational Model: Other|Time Perspective: Prospective,PIDS-PC,"Laboratory of Reasearch in Respiratory Physiotherapy, State University of Londrina, Londrina, Paraná, Brazil",https://ClinicalTrials.gov/show/NCT04693975
NCT04798625,Vaccine Response to COVID-19 Vaccines in Patients Using Immunosuppressive Medication,Observational Model: Cohort|Time Perspective: Prospective,DIA2021-1,"Akershus University Hospital, Lørenskog, Norway|Diakonhjemmet Hospital, Oslo, Norway",https://ClinicalTrials.gov/show/NCT04798625
NCT04927936,A Trial Among HealthCare Workers (HCW) Vaccinated With Janssen Vaccine: the SWITCH Trial,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Prevention,MEC-2021-0132|2021-000701-24,"AmsterdamUMC, Amsterdam, Netherlands|UMCG, Groningen, Netherlands|LUMC, Leiden, Netherlands|Erasmus MC, Rotterdam, Netherlands",https://ClinicalTrials.gov/show/NCT04927936
NCT04876560,Implementation of a CDSS in Oncology Patients During COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Supportive Care,31052019,"Panos Papandreou, Athens, Greece|Panos Papandreou, Athens, Greece",https://ClinicalTrials.gov/show/NCT04876560
NCT04445870,Oncology Care Pathway's Modifications Impact During COVID-19 Pandemic : the ONCOCARE-COV Study,Observational Model: Other|Time Perspective: Retrospective,2020Ao001*,"Chu Reims, Reims, France",https://ClinicalTrials.gov/show/NCT04445870
NCT04918160,Evaluation of the Sanitary Safety of a Healthcare Professional Conference Held 9-11 June 2021 in Paris,Observational Model: Case-Control|Time Perspective: Prospective,2021-A01185-36,"Centre des Congres, Paris, France",https://ClinicalTrials.gov/show/NCT04918160
NCT04399798,Baricitinib for coRona Virus pnEumonia (COVID-19): a THerapeutic Trial,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2020-001185-11,NA,https://ClinicalTrials.gov/show/NCT04399798
NCT04901065,Xylocaine to Freeze During Unpleasant Nasopharyngeal Swabs,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",2021-3414,"Evelyne D Trottier, Montreal, Quebec, Canada",https://ClinicalTrials.gov/show/NCT04901065
NCT04423289,Telematic Monitoring Through a Mobile Application of Patients With COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,PR(AG)182-2020,"Vall d'Hebron Hospital Universitari, Barcelona, Spain",https://ClinicalTrials.gov/show/NCT04423289
NCT04864925,Measurement of Viral Load Reduction in the Oral Cavity After a Regimental Use of OC Toothpaste Products,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",EXT-SARS2-COV2-OC-RUT-CD,"Rutgers University Hospital, Newark, New Jersey, United States",https://ClinicalTrials.gov/show/NCT04864925
NCT04864132,The Investigation Of Exercise Capacity And Exercise-Induced Fatigue in Young Adults Who Survived From Coronavirus,Observational Model: Case-Control|Time Perspective: Prospective,2015-KAEK-47-21-03,"Biruni University, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04864132
NCT04855162,Use of Lung Ultrasound in Evaluating Physiological Response to Awake Self Proning,Observational Model: Cohort|Time Perspective: Prospective,21040601,"Rush University Medical Center, Chicago, Illinois, United States|Hospital Civil Fray Antonio Alcalde, Guadalajara, Jalisco, Mexico",https://ClinicalTrials.gov/show/NCT04855162
NCT04360850,Use of Telehealth Technology by Mental Health Care Professionals in Times of COVID-19 Pandemic,Observational Model: Ecologic or Community|Time Perspective: Prospective,STUDY00010090,"University of Washington, Seattle, Washington, United States",https://ClinicalTrials.gov/show/NCT04360850
NCT04840082,Optimal Length for Nasal Mid-turbinate and Nasopharyngeal Swabs,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,21015626,"Rigshospitalet, Copenhagen, Copenhagen East, Denmark",https://ClinicalTrials.gov/show/NCT04840082
NCT04837755,CORONA in the Saarland,Observational Model: Case-Only|Time Perspective: Prospective,CORSAAR1,"Saarland University, Homburg, Saarland, Germany",https://ClinicalTrials.gov/show/NCT04837755
NCT04636554,Personalized Phage Treatment in Covid-19 Patients With Bacterial Co-Infections Microbials for Pneumonia or Bacteremia/Septicemia,NA,APT.APS.001,NA,https://ClinicalTrials.gov/show/NCT04636554
NCT04812184,Adhesive Tape Placement on Patients' Masks in the ED Increases Compliance of Proper Face Mask Use,Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,IUMASKstudy,"Eskenazi Hospital, Indianapolis, Indiana, United States",https://ClinicalTrials.gov/show/NCT04812184
NCT04802187,Implementation of SARS-CoV Testing Strategies in Community Health Centers,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,2020P003743,"Massachusetts League of Community Health Centers, Boston, Massachusetts, United States|Massachusetts General Hospital, Boston, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT04802187
NCT04781218,ABC Science Collaborative Registry Study,Observational Model: Other|Time Perspective: Prospective,Pro00107036,NA,https://ClinicalTrials.gov/show/NCT04781218
NCT04776174,Efficacy and Tolerance of Telerobotic vs Standard Ultrasound Exam in Children,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,CHILDMELODY,"CHI Créteil, Créteil, France|CHI Villeneuve-Saint-Georges, Villeneuve-Saint-Georges, France",https://ClinicalTrials.gov/show/NCT04776174
NCT04773756,Evaluation of Sofosbuvir and Daclatasvir Combo in COIVD-19 Patients in Egypt,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,305032,"Amr Aly Abd elmoety, Alexandria, Egypt",https://ClinicalTrials.gov/show/NCT04773756
NCT04542226,Observational Open Study of Polyoxidonium in Hospitalized Patients With COVID-19,Observational Model: Cohort|Time Perspective: Prospective,Covid_v_1.0,"Healthcare Institution ""Grodno Regional Infectious Clinical Hospital"", Grodno, Belarus|State-Funded Healthcare Institution ""Emergency Hospital"" of Ministry of Health of Chuvash Republic, Cheboksary, Chuvashia, Russian Federation|State-Funded Healthcare Institution ""Infectious Disease Hospital No.3"" of Ministry of Health of Krasnodar Krai, Novorossiysk, Krasnodar Krai, Russian Federation|State-Funded Institution of Mari El Republic ""Yoshkar-Ola City Hospital"", Yoshkar-Ola, Mari El Republic, Russian Federation|State-Funded Healthcare Institution of Voronezh Region ""Novaya Usman District Hospital"", Novaya Usman, Voronezh Region, Russian Federation",https://ClinicalTrials.gov/show/NCT04542226
NCT04566276,ChulaCov19 mRNA Vaccine in Healthy Adults,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Other,ChulaVac 001,"Chula Vaccine Research Center (ChulaCRC) Faculty of Medicine Chulalongkorn University, Bangkok, Thailand|Center of Excellence for Vaccine Trial (Vaccine Trial Centre), Faculty of Tropical Medicine Mahidol University, Bangkok, Thailand",https://ClinicalTrials.gov/show/NCT04566276
NCT04363437,COlchicine in Moderate-severe Hospitalized Patients Before ARDS to Treat COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2020/4/12,"Maimonides Medical Center, Brooklyn, New York, United States",https://ClinicalTrials.gov/show/NCT04363437
NCT04573361,Access to Chiropractic Care During the COVID-19 Healthcare Emergency in Spain,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,ChiroCOVID19,"Real Centro Universitario María Cristina, San Lorenzo De El Escorial, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04573361
NCT04681365,Evaluating Bubble-PAPR for Healthcare Workers,Observational Model: Cohort|Time Perspective: Prospective,B00991,"Manchester University NHS Foundation Trust, Manchester, United Kingdom",https://ClinicalTrials.gov/show/NCT04681365
NCT04681261,"Occupational Balance, Fear and Agoraphobia",Observational Model: Cohort|Time Perspective: Cross-Sectional,2020/185,"Özgü İnal, Edirne, Merkez, Turkey",https://ClinicalTrials.gov/show/NCT04681261
NCT04659928,Evaluation of Aerosol in a Dental Clinic,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Prevention",HSC-DB-20-1017,"The University of Texas Health Science Center at Houston, Houston, Texas, United States",https://ClinicalTrials.gov/show/NCT04659928
NCT04644328,The Doctors for Coronavirus Prevention Project Thanksgiving / Christmas Messaging Campaign,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,2003000118A010,"JPAL North America, Cambridge, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT04644328
NCT04727294,"MGUS, SMM, and MM Patient Experience With Coronavirus 19 (COVID-19) Survey",Observational Model: Cohort|Time Perspective: Prospective,MM/COVID-19 part II,"HealthTree.org (Online), Lehi, Utah, United States",https://ClinicalTrials.gov/show/NCT04727294
NCT04401124,Status of Management of Surgery in Beijing During COVID-19,Observational Model: Cohort|Time Perspective: Retrospective,BFH-SurgeryCovid,NA,https://ClinicalTrials.gov/show/NCT04401124
NCT04327804,A Longitudinal Study of COVID-19 Positive Patients Testing Nasal Swabs and Collecting Blood Samples for Research,Observational Model: Case-Only|Time Perspective: Prospective,20-002,"Everett Clinic, Seattle, Washington, United States",https://ClinicalTrials.gov/show/NCT04327804
NCT04597216,Exploration of Feasability of Blood and Saliva Proteomic Analysis Through Harvesting by Silica Matrix (NanoDx-CoV-19),Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,38RC20.289,"olivier EPAULARD, Grenoble, France",https://ClinicalTrials.gov/show/NCT04597216
NCT04345640,The Spectrum and Profile of COVID-19 Infection and Its Impact on Liver.,Observational Model: Cohort|Time Perspective: Prospective,ILBS-COVID-01,"Institute of Liver and Biliary Sciences, New Delhi, Delhi, India",https://ClinicalTrials.gov/show/NCT04345640
NCT04372576,Epidemiology and Outcome of Ventilator-associated Pneumonia Among Critically Ill COVID-19 Patients,Observational Model: Cohort|Time Perspective: Prospective,57/2020.,"Semmelweis University, Budapest, Hungary",https://ClinicalTrials.gov/show/NCT04372576
NCT04372043,Evaluation of the Sleep Hygiene in the Lebanese Population During the COVID-19 Confinement Period.,Observational Model: Cohort|Time Perspective: Prospective,CEHDF1650,"Saint Joseph University, Beirut, Lebanon",https://ClinicalTrials.gov/show/NCT04372043
NCT04533048,A Clinical Study to Evaluate MW33 Injection,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",MW33-2020-CP101,"Shanghai Public Health Clinical Center, Shanghai, Shanghai, China",https://ClinicalTrials.gov/show/NCT04533048
NCT04813692,Mechanical Complications of Acute Myocardial Infarction During COVID-19 Pandemics,Observational Model: Cohort|Time Perspective: Retrospective,IT-VA:85/2021,"Matteucci Matteo, Maastricht, Netherlands",https://ClinicalTrials.gov/show/NCT04813692
NCT04501172,Impact of Spectacles on Compliance to Mask-wearing Directives,Observational Model: Other|Time Perspective: Prospective,ES8/Th5/25-06-2020,"University Hospital of Alexandroupolis, Alexandroupolis, Evros, Greece",https://ClinicalTrials.gov/show/NCT04501172
NCT04497519,Local Tolerability and Pharmacokinetic Evaluation of Cyclops Dry Powder Hydroxychloroquine Inhalation in Healthy Volunteers,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,CARRIED-01,"University Medical Center Groningen, Groningen, Netherlands",https://ClinicalTrials.gov/show/NCT04497519
NCT04490239,Intranasal Heparin Tolerability Study,Allocation: N/A|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,Intranasal Heparin,"The University of Mississippi National Center for Natural Products Research, University, Mississippi, United States",https://ClinicalTrials.gov/show/NCT04490239
NCT04325906,Early PP With HFNC Versus HFNC in COVID-19 Induced Moderate to Severe ARDS,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,COVID-19-HFNC+PP,"Rush University Medical Center, Chicago, Illinois, United States",https://ClinicalTrials.gov/show/NCT04325906
NCT04780113,Evolution of Perceived Stress in General Practice Residents During COVID-19 Sanitary Crisis,Observational Model: Cohort|Time Perspective: Prospective,2020-A03283-36|CHES N°20/01,"CH Eure-Seine, Évreux, France",https://ClinicalTrials.gov/show/NCT04780113
NCT04548934,Effect of Wearing Personal Protective Equipment (PPE) on CPR Quality in Times of the COVID-19-pandemic,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,CPR PPE,"Headquarter of ""Croce Bianca"" EMS organization, Bolzano, Italy",https://ClinicalTrials.gov/show/NCT04548934
NCT04344964,Endoscopy-related Phone Consultation During the COVID-19 Outbreak,Observational Model: Case-Control|Time Perspective: Prospective,38839,"Austin Health, Melbourne, Victoria, Australia",https://ClinicalTrials.gov/show/NCT04344964
NCT04978194,Effects of an Intervention on University Students' Mental Health and Learning During COVID-19,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,UNimes,"Charbonnier, Nîmes, France",https://ClinicalTrials.gov/show/NCT04978194
NCT04731870,Exploring Vaccine Confidence and Uptake of Potential COVID-19 Vaccines,Observational Model: Cohort|Time Perspective: Cross-Sectional,60622,NA,https://ClinicalTrials.gov/show/NCT04731870
NCT04376658,Quality of Life and Long-term Outcomes After Hospitalization for COVID-19,Observational Model: Cohort|Time Perspective: Prospective,Coalition COVID-19: Long-term,"Hospital Moinhos de Vento, Porto Alegre, Rio Grande Do Sul, Brazil",https://ClinicalTrials.gov/show/NCT04376658
NCT04948216,Management and Healthcare Utilization of Patients With Chronic Airway Disease During the COVID-19 Epidemic,Observational Model: Other|Time Perspective: Cross-Sectional,LM2020133,"Peking University Third Hospital, Beijing, Beijing, China",https://ClinicalTrials.gov/show/NCT04948216
NCT04384549,Efficacy of BCG Vaccination in the Prevention of COVID19 Via the Strengthening of Innate Immunity in Health Care Workers,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Prevention,APHP200462|2020-001678-31,"I-REIVAC/CIC 1417 Cochin Hospital, APHP, Paris, France",https://ClinicalTrials.gov/show/NCT04384549
NCT04448769,Epidemiological Study of Seroprevalence Against the SARS-CoV-2 Virus (COVID-19),Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Screening,2020PI128,"Chru Nancy, Vandœuvre-lès-Nancy, France",https://ClinicalTrials.gov/show/NCT04448769
NCT04551339,Zinc Versus Multivitamin Micronutrient Supplementation in the Setting of COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,20-004637,"Mayo Clinic in Scottsdale, Scottsdale, Arizona, United States|Mayo Clinic in Jacksonville, Jacksonville, Florida, United States|Mayo Clinic in Rochester, Rochester, Minnesota, United States",https://ClinicalTrials.gov/show/NCT04551339
NCT04753632,Status of People With Cerebral Palsy and Their Caregivers During COVID-19 Pandemic,Observational Model: Case-Control|Time Perspective: Prospective,DF0095UG,"Department of Physical Therapy, Granada, Spain",https://ClinicalTrials.gov/show/NCT04753632
NCT04887220,Persistent Pain and Its Impact on Quality of Life COVID-19 Patients That Required Critical Care,Observational Model: Cohort|Time Perspective: Prospective,IIBSP-COV-2020-63,"Hospital de la Santa Creu i Sant Pau, Barcelona, Catalunya, Spain",https://ClinicalTrials.gov/show/NCT04887220
NCT04891133,EU SolidAct: An Adaptive Pandemic and Emerging Infection Platform Trial,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",EU SolidAct|2021-000541-41,"Erasme Hospital, Brussels, Belgium|CHU Lille - Hopital Roger Salengro, Lille, France|Technische Universität München, München, Germany|University of Pécs, Pécs, Hungary|Cork University Hospital, Cork, Ireland|Verona University Hospital, Verona, Italy|Centre Hospitalier de Luxembourg, Luxembourg, Luxembourg|Oslo University Hospital, Oslo, Norway|Hospital Universitario Virgen Macarena, Sevilla, Spain|Hacettepe Üniversitesi Tıp Fakültesi, Ankara, Turkey",https://ClinicalTrials.gov/show/NCT04891133
NCT04524598,A CBT-based Mobile Intervention as First Line Treatment for Adolescent Depression During COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,Limbix Spark 02,"Limbix Health, Inc., San Francisco, California, United States",https://ClinicalTrials.gov/show/NCT04524598
NCT04665960,Infection Control for Severe Acute Respiratory Syndrome Coronavirus 2,Observational Model: Cohort|Time Perspective: Prospective,NMCSpecialtyH,"NMC Specialty Hospital, Dubai, United Arab Emirates",https://ClinicalTrials.gov/show/NCT04665960
NCT04667962,Impact of the Change in Hospital Service of Caregivers During COVID-19 Health Crisis on Operational Strain,Observational Model: Cohort|Time Perspective: Prospective,2020-COVID19-33|2020-A02932-37,"Institut de Recherche Biomédicale des Armées, Brétigny-sur-Orge, France|Ecole du Val-de-Grâce, Paris, France",https://ClinicalTrials.gov/show/NCT04667962
NCT04738032,Stories for Change: Digital Storytelling Intervention for Diabetes Self-Management in the COVID-19 Pandemic,Observational Model: Other|Time Perspective: Other,20-006354,"Mountain Park Health Center, Phoenix, Arizona, United States|Hennepin Healthcare, Minneapolis, Minnesota, United States|Mayo Clinic, Rochester, Minnesota, United States",https://ClinicalTrials.gov/show/NCT04738032
NCT04391166,Validity of at Home Visual Acuity Measurements for Telemedicine During Corona Virus (COVID-19) Pandemic,Observational Model: Cohort|Time Perspective: Prospective,200826,"Vanderbilt Eye Institute, Nashville, Tennessee, United States",https://ClinicalTrials.gov/show/NCT04391166
NCT04443764,Status and Predictors of Mental Health Symptoms Among Migrants and Refugees During the COVID-19 Pandemic,Observational Model: Other|Time Perspective: Prospective,REK125510 (8),NA,https://ClinicalTrials.gov/show/NCT04443764
NCT04602832,Enduring Happiness and Continued Self-Enhancement (ENHANCE) for COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,University of British Columbia,"University of British Columbia, Kelowna, British Columbia, Canada",https://ClinicalTrials.gov/show/NCT04602832
NCT04388605,Assessing the Safety of Pregnancy In the CoRonavirus (COVID-19) pandEmic,Observational Model: Cohort|Time Perspective: Prospective,20-30559,"University of California, San Francisco, San Francisco, California, United States",https://ClinicalTrials.gov/show/NCT04388605
NCT04457505,One Year Follow-ups of Patients Admitted to Spanish Intensive Care Units Due to COVID-19,Observational Model: Cohort|Time Perspective: Prospective,CIBERESUCICOVID,"Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain|Hospital Universitario de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain|Hospital de Mataró, Mataró, Barcelona, Spain|Hospital General de Cataluña, Sant Cugat Del Vallès, Barcelona, Spain|Hospital Infanta Margarita de Cabra, Cabra, Córdoba, Spain|Hospital Universitario Lucus Augusti, Lugo, Galicia, Spain|Hospital Son Llatzer, Palma De Mallorca, Mallorca, Spain|Hospital Álvaro Cunqueiro, Vigo, Pontevedra, Spain|Hospital Verge de la Cinta, Tortosa, Tarragona, Spain|Hospital Universitario Sant Joan d'Alacant, Alicante, Spain|Clínica Sagrada Família, Barcelona, Spain|Hospital Sagrat Cor, Barcelona, Spain|Hospital Universitari Vall d'Hebron, Barcelona, Spain|Vall d'Hebron University Hospital, Barcelona, Barcelona, Spain|Hospital Clinic, Barcelona, Spain|Hospital Burgos, Burgos, Spain|Hospital San Pedro de Alcantara, Cáceres, Spain|Hospital de León, León, Spain|Hospital Arnau de Vilanova Lleida, Lleida, Spain|Hospital Infanta Leonor de Madrid, Madrid, Spain|Hospital Universitario La Paz, Madrid, Spain|Complexo Hospitalario Universitario de Ourense, Ourense, Spain|Complejo Asistencial Universitario de Palencia, Palencia, Spain|Hospital Montecelo, Pontevedra, Spain|Hospital Universitario Salamanca, Salamanca, Spain|Hospital Universitari Virgen de Valme, Sevilla, Spain|Hospital Universitari de Tarragona Joan XXIII, Tarragona, Spain|Hospital Clínic Universitari de València, Valencia, Spain|Hospital Universitari i Politècnic La Fe, Valencia, Spain|Hospital Universitario Valladolid, Valladolid, Spain|Hospital Nuestra Señora de Gracia, Zaragoza, Spain",https://ClinicalTrials.gov/show/NCT04457505
NCT04505761,"The Usability, Feasibility, and Tolerability of Virtual Reality for Rehabilitation From COVID-19",Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,COVRehab,"Radboud university medical center, Nijmegen, Gelderland, Netherlands",https://ClinicalTrials.gov/show/NCT04505761
NCT04384965,Accelerated iTBS for Depressed Patients During the COVID-19 Pandemic,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,059/2020,"CAMH, Toronto, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04384965
NCT04769297,"Micro-Dose, Macro-Impact: Leveraging Psychedelics in Frontline Healthcare Workers During the COVID-19 Pandemic",Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,LM-LDK-001,"Limbic Medical, Toluca Lake, California, United States",https://ClinicalTrials.gov/show/NCT04769297
NCT04871854,Evaluating Tocilizumab for Sever COVID-19 Infection in Breast Cancer vs. Non Cancer Pateints,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,REC-H-PHBSU-21010,"ALsafwa specialized hospital, Fayoum, Egypt",https://ClinicalTrials.gov/show/NCT04871854
NCT04410016,Evaluation of Staff COVID-19 Wellbeing Centres in a Healthcare Workplace: COVID-WELL Study,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,COVID-WELL_May20,"Nottingham University Hospitals NHS Trust, Nottingham, Nottinghamshire, United Kingdom",https://ClinicalTrials.gov/show/NCT04410016
NCT04634422,Plasma Exchange (PLEX) and Convalescent Plasma (CCP) in COVID-19 Patients With Multiorgan Failure,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,H-20041716,"Rigshospitalet, Copenhagen, Denmark",https://ClinicalTrials.gov/show/NCT04634422
NCT04865237,SARS-CoV-2 Human Challenge Characterisation Study,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,20IC6437,"hVIVO Services Ltd, QMB Bioenterprise building, London, United Kingdom|Royal Free Foundation Hospital, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04865237
NCT04662437,The Status of Parathyroid Hormone Secretion in Covid-19 Patients,Observational Model: Case-Control|Time Perspective: Retrospective,8122020,"Bezmialem VU, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04662437
NCT04561076,Evaluate Safety and Pharmacokinetics of HLX70 in Healthy Adult Volunteers,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Other",HLX70-001US-255086,NA,https://ClinicalTrials.gov/show/NCT04561076
NCT04821037,Nurse Health Pilot: Feasibility and Acceptability of a Virtual ACT-intervention in Nurses During COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science,NHP,"Faculty of Psychology, University of Basel, Basel, BS, Switzerland",https://ClinicalTrials.gov/show/NCT04821037
NCT04666493,Adapting Anxiety Intervention for Youth With Autism for Rapid Response to COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,240,"Holland Bloorview Kids Rehabilitation Hospital, Toronto, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04666493
NCT04483752,Predicting the Progression to Chronic Fibrosis of Lung Lesions Related to Covid-19 Infection From Chest CT Images,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,2020-A01322-37,"Hôpital Marie Lannelongue, Le Plessis-Robinson, France|Hôpital Saint Joseph, Paris, France|Institut Gustave Roussy (IGR), Villejuif, France",https://ClinicalTrials.gov/show/NCT04483752
NCT04966910,Stay Connected: Testing an Intervention to Combat COVID-19 Related Social Isolation Among Seattle-area Older Adults,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,STUDY00011051|5P50MH115837-03,"University of Washington, Seattle, Washington, United States",https://ClinicalTrials.gov/show/NCT04966910
NCT04967820,Burn-out Among Chinese Anaesthesiologist After COVID-19 Pandemic Peak and Its Protective Factor： a National Survey,Observational Model: Other|Time Perspective: Cross-Sectional,CSAnationalsurveyburnout,NA,https://ClinicalTrials.gov/show/NCT04967820
NCT04558411,"Pilot Study of a Brief, Scaleable Intervention for Coronavirus (COVID-19) Mental Health Sequelae in College Students",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,Pro2020002008,"Rutgers, The State University of New Jersey, Piscataway, New Jersey, United States",https://ClinicalTrials.gov/show/NCT04558411
NCT04622332,A Pilot Study to Assess Safety and Efficacy of SIR1-365 in Patients With Severe COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",SIR365-US-101,"OSF St. Francis Medical Center, Peoria, Illinois, United States",https://ClinicalTrials.gov/show/NCT04622332
NCT04661813,Assess and Adapt to the Impact of COVID-19 on CVD Self-Management and Prevention Care in Adults Living With HIV,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,03-18-16-S1|U01HL142099,"Duke Health, Durham, North Carolina, United States|University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States|MetroHealth Medical Center, Cleveland, Ohio, United States",https://ClinicalTrials.gov/show/NCT04661813
NCT04704544,Effectiveness of Tele-rheumatology for Delivering High Quality Rheumatology Care During the COVID-19 Crisis (EVOLVE),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Care Provider)|Primary Purpose: Treatment,IRB-300006553,"University of Alabama at Birmingham, Birmingham, Alabama, United States",https://ClinicalTrials.gov/show/NCT04704544
NCT04456062,Using Caring Contacts to Reduce Psychiatric Morbidity Following Hospitalization During the COVID-19 Pandemic,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,1804,"Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04456062
NCT04910932,"Effects of Breathing Exercises on Fear of COVID-19, Anxiety, Sleep and Quality of Life During the COVID-19 Pandemic","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment",bakircaymzeren04,"Nuh Naci Yazgan University, Department of Physiotherapy and Rehabilitation, Kayseri, Turkey",https://ClinicalTrials.gov/show/NCT04910932
NCT04325893,Hydroxychloroquine Versus Placebo in COVID-19 Patients at Risk for Severe Disease,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",49RC20_0071,"CH Agen, Agen, France|CHU Amiens, Amiens, France|CHU Angers, Angers, France|CH Auxerre, Auxerre, France|APHP Avicenne, Bobigny, France|CHU Brest, Brest, France|CHU Caen, Caen, France|CH Chalon Sur Saône, Chalon Sur Saône, France|CH Cherbroug, Cherbourg, France|CH Cholet, Cholet, France|CH Colmar, Colmar, France|CH Compiègne, Compiègne, France|APHP Henri Mondor, Créteil, France|CH Intercommunal Créteil, Créteil, France|CHU Dijon, Dijon, France|APHP Joffre Dupuytren, Draveil, France|CHD Vendée, La Roche-sur-Yon, France|CH Laval, Laval, France|CH Le Mans, Le Mans, France|CH Emile Roux, Le Puy-en-Velay, France|APHP Emile ROUX, Limeil-Brevannes, France|CHU Limoges, Limoges, France|CH Lorient, Lorient, France|Hôpital Européen - Marseille, Marseille, France|Hôpital Saint-Joseph, Marseille, France|CH Melun, Melun, France|CHU Nantes, Nantes, France|Hôpital Privé du Confluent, Nantes, France|CH Niort, Niort, France|CHR Orléans, Orléans, France|APHP Saint-Antoine, Paris, France|GH Croix Saint Simon, Paris, France|La Pitié-Salpétrière, Paris, France|CHU Poitiers, Poitiers, France|CH Pointoise, Pontoise, France|CH Quimper, Quimper, France|CH Saint-Brieuc, Saint-Brieuc, France|CH Saint-Nazaire, Saint-Nazaire, France|CHU Saint-Etienne, Saint-Étienne, France|CHU Toulouse, Toulouse, France|CH Tourcoing, Tourcoing, France|CHU Tours, Tours, France|CH Valenciennes, Valenciennes, France|Clinique Tessier Valenciennes, Valenciennes, France|CH Vannes, Vannes, France|CH Versailles, Versailles, France|CH Princesse Grace, Monaco, Monaco",https://ClinicalTrials.gov/show/NCT04325893
NCT04818164,Prone Position Improves End-Expiratory Lung Volumes in COVID-19 Acute Respiratory Distress Syndrome,Observational Model: Cohort|Time Perspective: Retrospective,2020-19-16163,"Istanbul University-Cerrahpaşa, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04818164
NCT04769258,Effectiveness and Safety of COVID-19 Vaccine in Patients With IBD Treated With Immunomodulatory or Biological Drugs (ESCAPE-IBD),Observational Model: Case-Control|Time Perspective: Prospective,IGIBD001,NA,https://ClinicalTrials.gov/show/NCT04769258
NCT04340414,Safety and Effectiveness of Low-flow ECMO Driving by CVVH Machine in Severe NCP,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,Low flow-ECMO by CVVH in NCP,"Yun Long, Beijing, Beijing, China",https://ClinicalTrials.gov/show/NCT04340414
NCT04337008,Renin Angiotensin System - CoronaVirus,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,2020-16|2020-A00795-34,"ASSISTANCE PUBLIQUE HÖPITAUX de MARSEILLE, Marseille, France",https://ClinicalTrials.gov/show/NCT04337008
NCT04427137,Accelerated LFR for Bipolar Patients During the COVID-19 Pandemic,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,071-2020,"CAMH, Toronto, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04427137
NCT04550390,Study of the Analytical Performance of Different Salivary Self-collection Methods for the Detection of COVID-19,Observational Model: Cohort|Time Perspective: Prospective,2020-COVID19-36|2020-A02536-33,"Hôpital d'Instruction des Armées Percy, Clamart, France|Hôpital d'Instruction des Armées Laveran, Marseille, France|Hôpital d'Instruction des Armées Bégin, Saint-Mandé, France|Hôpital d'Instruction des Armées Sainte-Anne, Toulon, France",https://ClinicalTrials.gov/show/NCT04550390
NCT04373213,Evaluation of the Fluid Response of SARS-CoV-2 (COVID-19) Patients in Intensive Care; Pleth Variability Index,Observational Model: Case-Control|Time Perspective: Retrospective,EBYU COVİD PVI,"Erzincan University, Erzincan, Turkey",https://ClinicalTrials.gov/show/NCT04373213
NCT04327388,Sarilumab COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",EFC16844|2020-001162-12|U1111-1249-6021,"Investigational Site Number 0320001, Caba, Argentina|Investigational Site Number 0320003, Caba, Argentina|Investigational Site Number 0320004, Caba, Argentina|Investigational Site Number 0760003, Porto Alegre, Brazil|Investigational Site Number 0760001, Sao Paulo, Brazil|Investigational Site Number 0760002, Sao Paulo, Brazil|Investigational Site Number 0760004, São José Do Rio Preto, Brazil|Investigational Site Number 0760005, São Paulo, Brazil|Investigational Site Number 1240001, Montreal, Canada|Investigational Site Number 1240005, Montreal, Canada|Investigational Site Number 1240004, Toronto, Canada|Investigational Site Number 1240002, Toronto, Canada|Investigational Site Number 1240003, Vancouver, Canada|Investigational Site Number 1520003, Santiago, Chile|Investigational Site Number 1520002, Santiago, Chile|Investigational Site Number 1520004, Santiago, Chile|Investigational Site Number 1520001, Talca, Chile|Investigational Site Number 2500001, Bordeaux Cedex, France|Investigational Site Number 2500007, Clamart, France|Investigational Site Number 2500006, La Roche Sur Yon Cedex 9, France|Investigational Site Number 2500002, Nantes, France|Investigational Site Number 2500005, Paris Cedex 18, France|Investigational Site Number 2500003, Strasbourg, France|Investigational Site Number 2500004, Suresnes, France|Investigational Site Number 2760002, Essen, Germany|Investigational Site Number 2760004, Köln, Germany|Investigational Site Number 2760001, Münster, Germany|Investigational site number 3760003, Ashdod, Israel|Investigational Site Number 3760002, Jerusalem, Israel|Investigational Site Number 3760001, Ramat Gan, Israel|Investigational Site Number 3800005, Milano, Italy|Investigational Site Number 3800001, Milano, Italy|Investigational Site Number 3800002, Milano, Italy|Investigational Site Number 3800003, Modena, Italy|Investigational Site Number 3800004, Parma, Italy|Investigational Site Number 3800006, Rozzano, Italy|Investigational Site Number 3920002, Fuchu-Shi, Japan|Investigational Site Number 3920003, Iruma-Gun, Japan|Investigational Site Number 3920001, Kamakura-Shi, Japan|Investigational Site Number 6430003, Moscow, Russian Federation|Investigational Site Number 6430002, Moscow, Russian Federation|Investigational Site Number 6430001, Moscow, Russian Federation|Investigational Site Number 7240003, Barcelona, Spain|Investigational Site Number 7240004, Barcelona, Spain|Investigational Site Number 7240002, Madrid, Spain|Investigational Site Number 7240005, Madrid, Spain|Investigational Site Number 7240001, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04327388
NCT04619576,Influence of the COVId-19 Pandemic on STRESS of Occupational Health Workers,Observational Model: Cohort|Time Perspective: Cross-Sectional,2020 COVISTRESS Work,"Clermont-Ferrand University Hospital, Clermont-Ferrand, Aura, France",https://ClinicalTrials.gov/show/NCT04619576
NCT04341714,Efficiency and Satisfaction With Telephone Consultation in Neuro-urology: Experience of the COVID-19 Pandemic,Observational Model: Cohort|Time Perspective: Prospective,GREEN GRC01,"Department of Neuro- Urology, Hôpital Tenon, Paris, France",https://ClinicalTrials.gov/show/NCT04341714
NCT04326725,Proflaxis Using Hydroxychloroquine Plus Vitamins-Zinc During COVID-19 Pandemia,Observational Model: Case-Control|Time Perspective: Prospective,2020/2/1,"Istinye University Medical School, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04326725
NCT04321369,Impact of Swab Site and Sample Collector on Testing Sensitivity for COVID-19 Virus in Symptomatic Individuals,Observational Model: Case-Only|Time Perspective: Retrospective,20-001,"Everett Clinic, Seattle, Washington, United States",https://ClinicalTrials.gov/show/NCT04321369
NCT04909879,Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Non-COVID-19 Acute Respiratory Distress Syndrome,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",MSC-ARDS-201,NA,https://ClinicalTrials.gov/show/NCT04909879
NCT04468893,Online Positive Psychology Intervention for Depression and Anxiety Due to COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,VIU-PP,"Universidad Autónoma de Ciudad Juárez, Juarez, Chihuahua, Mexico",https://ClinicalTrials.gov/show/NCT04468893
NCT04369456,Blood Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Kidney Transplant Patients,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,20-PP-09,"Lyon Univerity Hospital, Lyon, France|APHM, Marseille, France|Montpellier University Hospital, Montpellier, France|University Nice Hospital, Nice, France|APHP, Paris, France|Saint Etienne University Hospital, Saint-Étienne, France|Strasbourg Univeristy Hospital, Strasbourg, France",https://ClinicalTrials.gov/show/NCT04369456
NCT04374539,Plasma Exchange in Patients With COVID-19 Disease and Invasive Mechanical Ventilation: a Randomized Controlled Trial,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2020-001722-66,"Hospital Clinic i Provincial de Barcelona, Barcelona, Spain",https://ClinicalTrials.gov/show/NCT04374539
NCT04538469,"Absent Visitors: The Wider Implications of COVID-19 on Non-COVID Cardiothoracic ICU Patients, Relatives and Staff",Observational Model: Cohort|Time Perspective: Retrospective,20/ANAES/02,NA,https://ClinicalTrials.gov/show/NCT04538469
NCT04251871,Treatment and Prevention of Traditional Chinese Medicines (TCMs) on COVID-19 Infection,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2020001D,"The Fifth Medical Center, General Hospital of PLA, Beijing, Beijing, China",https://ClinicalTrials.gov/show/NCT04251871
NCT04458246,Home-based Aerobic Training Among Adolescents With Chronic Diseases During COVID-19 Pandemic,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,31314220.5.0000.0068,"Univsersity of Sao Paulo, Sao Paulo, Brazil",https://ClinicalTrials.gov/show/NCT04458246
NCT04442243,PTSD Symptoms Among Health Workers and Public Service Providers After the COVID-19 Outbreak: A 3 Month Follow up,Observational Model: Other|Time Perspective: Prospective,REK125510 (4),NA,https://ClinicalTrials.gov/show/NCT04442243
NCT04292340,Anti-SARS-CoV-2 Inactivated Convalescent Plasma in the Treatment of COVID-19,Observational Model: Case-Only|Time Perspective: Prospective,Anti-SARS-CoV-2,"Shanghai Public Health Clinical Center, Shanghai, Shanghai, China",https://ClinicalTrials.gov/show/NCT04292340
NCT04346082,Feasibility of Online Based Mindfulness Interventions During COVID-19 Outbreak,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,online-mind,"School of public health and primary care, Hong Kong, Hong Kong",https://ClinicalTrials.gov/show/NCT04346082
NCT04326114,Effectiveness and Safety of Respiratory Training in the Prevention and Severity of COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention,Covid_ISCIII 20/265-E_BS,NA,https://ClinicalTrials.gov/show/NCT04326114
NCT04858542,Evaluating the Impact of Vocal Health Education on Mask-wearing Workers During COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,2020-0889,"Victoria McKenna, Cincinnati, Ohio, United States",https://ClinicalTrials.gov/show/NCT04858542
NCT04904744,"Effect of Varied Outreach Methods on Appointment Scheduling, Appointment Completion, and Receipt of COVID-19 Vaccination","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Health Services Research",2020-0769-1,"Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States",https://ClinicalTrials.gov/show/NCT04904744
NCT04389684,Clinical and Psycho-social Impact of COVID-19 Related Confinement on Patients With Digestive Tumors,Observational Model: Cohort|Time Perspective: Prospective,2020-A01301-38,"MOULIN Valérie, La Rochelle, France|BOURGEOIS Hugues, Le Mans, France|RANDRIAN Violaine, Poitiers, France",https://ClinicalTrials.gov/show/NCT04389684
NCT04677270,Evaluation of Two Versions of a Digital Problem Solving Tool for the General Public Specific for the COVID-19 Pandemic,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,COVIDPROBLEM,"Centrum för Psykiatriforskning, Stockholm, Sweden",https://ClinicalTrials.gov/show/NCT04677270
NCT04388579,Screening Patients for a Strategic Shift to Pulmonary Telerehabilitation Because of COVID-19,Observational Model: Cohort|Time Perspective: Cross-Sectional,046i/17,"Nippon Gases Portugal Unipessoal Lda, Maia, Porto, Portugal|Universidade de Lisboa, Faculdade de Medicina, Instituto de Saúde Ambiental (ISAMB), Lisboa, Portugal|Centro Hospitalar Universitário Lisboa Norte, Hospital Pulido Valente, Unidade de Reabilitação Respiratória, Lisboa, Portugal",https://ClinicalTrials.gov/show/NCT04388579
NCT04798677,Efficacy and Tolerability of ABBC1 in Volunteers Receiving the Influenza or Covid-19 Vaccine,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Other",HMDM/ABBC-1/v4,"Hospital Mare de Déu de la Mercè - Germanes Hospitalàries, Barcelona, Spain",https://ClinicalTrials.gov/show/NCT04798677
NCT04870606,Proxalutamide (GT0918) Treatment for Outpatients With Mild or Moderate COVID-19 Illness,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",GT0918-US-3001,"Zeid Kayali, Rialto, California, United States",https://ClinicalTrials.gov/show/NCT04870606
NCT04441424,Convalescent Plasma Therapy on Critically-ill Novel Coronavirus (COVID-19) Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,CPT-COVID-19,"Akarkh Healt hdirectorate, Baghdad, Iraq",https://ClinicalTrials.gov/show/NCT04441424
NCT04389333,Feasibility of Non-contact Magnetically-controlled Capsule Endoscopy During COVID-19 Pandemic,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,nc-MCE pilotRCT,"Changhai Hospital, Shanghai, Shanghai, China",https://ClinicalTrials.gov/show/NCT04389333
NCT04395430,A Novel School-clinic-community Online Model of Child Obesity Treatment in Singapore During COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,20190049,"KK Women's and Children's Hospital, Singapore, Singapore",https://ClinicalTrials.gov/show/NCT04395430
NCT04406844,Issues and Challenges in Cancer Patients on Active Treatment During the COVID-19 Pandemic,Observational Model: Cohort|Time Perspective: Cross-Sectional,Onco_Covid-19,"Max Superspeciality hospital, A Unit of Balaji Medical and Diagnostic Centre, New Delhi, India",https://ClinicalTrials.gov/show/NCT04406844
NCT04371315,"Risk Factors, Clinical Characteristics and Outcomes of Acute Infection With Coronavirus 2019 (COVID-19) In Children",Observational Model: Other|Time Perspective: Prospective,COVID-19,"St. Jude Children's Research Hospital, Memphis, Tennessee, United States",https://ClinicalTrials.gov/show/NCT04371315
NCT04632602,Awake Prone Position to Reduce Ventilation Inhomogeneity in COVID-19 Acute Respiratory Failure,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Participant)|Primary Purpose: Other,2020-17,"Assistance Publique Höpitaux de Marseille, Marseille, France",https://ClinicalTrials.gov/show/NCT04632602
NCT04860271,Manual Acupuncture Using Acupuncture Needle vs Press Needle for COVID-19 Healthcare Anxiety,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Other",20-12-1513,"Cipto Mangunkusumo Hospital, Jakarta, Jakarta Pusat, Indonesia",https://ClinicalTrials.gov/show/NCT04860271
NCT04977921,Lab Skills Nursing Education Into Effective Clinical Practice During COVID-19: Elsevier Clinical Skill Platform,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,KKU2341751442,"Nursing Faculty, Abha, Saudi Arabia",https://ClinicalTrials.gov/show/NCT04977921
NCT04367636,The Effects of Attention Training on Emotion Regulation and Stress Related Complaints During COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Supportive Care,EC/2019/0841,"Ghent University, Gent, Oost-Vlaanderen, Belgium",https://ClinicalTrials.gov/show/NCT04367636
NCT04380766,Covid-19 Pandemic and Pancreatic Surgery in Italy,Observational Model: Case-Control|Time Perspective: Prospective,FPGemelliIRCCS,"Fondazione Policlinico Universitario Agostino Gemelli IRCCS di Roma, Roma, Lazio, Italy",https://ClinicalTrials.gov/show/NCT04380766
NCT04517006,Prosocial Behavior Can Safeguard Mental Health and Foster Emotional Well-being During the COVID-19 Pandemic,Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,39312,"Online, Amazon's Mechanical Turk, Toronto, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04517006
NCT04954469,B-pVAC-SARS-CoV-2: Study to Prevent COVID-19 Infection in Adults With Bcell/ Antibody Deficiency,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,B-pVAC-SARS-CoV-2,"University Hospital Tuebingen, Tuebingen, Baden-Wuerttemberg, Germany",https://ClinicalTrials.gov/show/NCT04954469
NCT04541472,Influence of the COVId-19 Pandemic on the STRESS of Dental Surgeons (COVISTRESS - Dental Surgery),Observational Model: Cohort|Time Perspective: Cross-Sectional,2020 COVISTRESS Dental Surgery,"University Hospital, Clermont Ferrand, Clermont-Ferrand, France",https://ClinicalTrials.gov/show/NCT04541472
NCT04394013,A Web-Based Gentle Body Stretching to Alleviate Loneliness and Improve Mental Fitness During COVID-19 Isolation Period,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Supportive Care",180320201,"Monash University Malaysia, Subang Jaya, Selangor, Malaysia",https://ClinicalTrials.gov/show/NCT04394013
NCT04978220,Mental and Psychological Problems and Insomnia Disorder of Medical Staff in Hospital With Infected COVID-19 Patients,Observational Model: Cohort|Time Perspective: Prospective,2020-021(BMR),"Peking University Sixth Hospital, Beijing, Beijing, China",https://ClinicalTrials.gov/show/NCT04978220
NCT04751682,Safety and Immunogenicity of an Intranasal SARS-CoV-2 Vaccine (BBV154) for COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",BBIL/BBV154/2020,"AIIMS,Patna, Patna, Bihar, India|Apollo Hospitals,Chennai, Chennai, Tamil Nadu, India|St.Theresa Hospital, Hyderabad, Hyderabad, India|Gillurkar Multispeciality Hospital,Nagpur, Nagpur, India",https://ClinicalTrials.gov/show/NCT04751682
NCT04448782,Characterization of Reverse Triggering and Other Asynchronies in COVID-19 Patients Under Invasive Mechanical Ventilation,Observational Model: Cohort|Time Perspective: Prospective,RT COVID-19,"Candelaria de Haro, Sabadell, Barcelona, Spain",https://ClinicalTrials.gov/show/NCT04448782
NCT04322123,Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-Cov-2 Virus (COVID-19),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,Brazil COVID Coalition I Trial,"Hospital Geral Clériston Andrade, Feira De Santana, BA, Brazil|Hospital Ana Nery - HAN/SESAB, Salvador, BA, Brazil|HHospital SAMUR, Vitória Da Conquista, BA, Brazil|Hospital Geral de Vitória da Conquista, Vitória Da Conquista, BA, Brazil|Hospital de Brasília, Brasilia, DF, Brazil|Instituto de Cardiologia do Distrito Federal, Brasília, DF, Brazil|Hospital Maternidade São José - UNESC - Fundação Social Rural de Colatina, Colatina, ES, Brazil|Hospital Vila da Serra, Nova Lima, MG, Brazil|Santa Casa de Misericórdia de São João Del Rei, São João Del Rei, MG, Brazil|Associação Evangélica Beneficente de Londrina - Hospital Evangélico de Londrina, Londrina, PR, Brazil|Instituto Estadual do Cérebro Paulo Niemeyer, Rio De Janeiro, RJ, Brazil|Hospital Geral de Caxias do Sul, Caxias do Sul, RS, Brazil|Hospital Santa Rita - Irmandade Santa Casa de Porto Alegre, Porto Alegre, RS, Brazil|Hospital São Francisco - Irmandade Santa Casa de Porto Alegre, Porto Alegre, RS, Brazil|Hospital São José, Criciuma, SC, Brazil|Hospital Baía Sul - Baía Sul Medical Center, Florianópolis, SC, Brazil|Hospital Nereu Ramos, Florianópolis, Sc, Brazil|Centro Hospitalar Unimed, Joinville, SC, Brazil|Hospital de Amor - Unidade Barretos (Fundação PIO XII), Barretos, SP, Brazil|Casa de Saúde Santa Marcelina, São Paulo, SP, Brazil|Hospital Albert Einstein, São Paulo, SP, Brazil|Hospital Beneficência Portuguesa - Real e Benemérita Associação Portuguesa de Beneficência, São Paulo, SP, Brazil|Hospital BP Mirante - Real e Benemérita, São Paulo, SP, Brazil|Hospital das Clínicas da FMUSP, São Paulo, SP, Brazil|Hospital do Servidor Público Estadual - HSPE - IAMSPE, São Paulo, SP, Brazil|Hospital São Paulo - UNIFESP, São Paulo, SP, Brazil|Hospital Sírio-Libanês, São Paulo, SP, Brazil|Hospital SEPACO, São Paulo, S, Brazil",https://ClinicalTrials.gov/show/NCT04322123
NCT04358627,Dexmedetomidine to Improve Outcomes of ARDS in Critical Care COVID-19 Patients,Observational Model: Case-Control|Time Perspective: Prospective,SPEC-M|SPEC-M COVID-19,NA,https://ClinicalTrials.gov/show/NCT04358627
NCT04590469,Improving Wellbeing and Health for Care Home Residents During COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,20-21-10,"University of Exeter, Exeter, Devon, UK, United Kingdom",https://ClinicalTrials.gov/show/NCT04590469
NCT04442282,Difficulties in Emotion-regulation and Interpersonal Problems During and After the COVID-19 Pandemic,Observational Model: Other|Time Perspective: Prospective,REK125510 (5),NA,https://ClinicalTrials.gov/show/NCT04442282
NCT04633941,Impact of Social Distancing on Bariatric Versus Non-Surgical Obese Patients During COVID-19 Pandemic,Observational Model: Cohort|Time Perspective: Cross-Sectional,HenryLew,"Singapore General Hospital, Singapore, Singapore",https://ClinicalTrials.gov/show/NCT04633941
NCT04442217,Factors Associated With Adherence to Hygiene-related Behaviors and Viral Mitigation Protocols During the COVID-19 Pandemic,Observational Model: Other|Time Perspective: Prospective,REK125510-11,NA,https://ClinicalTrials.gov/show/NCT04442217
NCT04381819,"Norwegian SARS-CoV-2 Study - Virological, Clinical and Immunological Characterisation of COVID-19",Observational Model: Cohort|Time Perspective: Prospective,20-04072,"Vestre Viken Drammen Hospital, Drammen, Viken, Norway|Haukeland University Hospital, Bergen, Norway|Østfold Hospital Trust, Fredrikstad, Norway|Akershus University Hospital, Lørenskog, Norway|Oslo University Hospital, Oslo, Norway|University Hospital North Norway, Tromsø, Norway|St Olavs Hospital, Trondheim, Norway",https://ClinicalTrials.gov/show/NCT04381819
NCT04932863,BNT162b2 Messenger Ribonucleic Acid (mRNA) Covid-19 Vaccine in Cancer Patients on Active Treatment,Observational Model: Cohort|Time Perspective: Prospective,35UCS2021,"E.O. Ospedali Galliera, Genova, Italy",https://ClinicalTrials.gov/show/NCT04932863
NCT04444336,Information Sources and Their Relationship to Depressive and Anxiety Symptoms During the COVID-19 Pandemic: A Network Study,Observational Model: Other|Time Perspective: Cross-Sectional,REK125510-16,NA,https://ClinicalTrials.gov/show/NCT04444336
NCT04970550,Vaccination Against SARS-Cov2 (COVID-19) in Chronic Inflammatory Rheumatism and Factors Determining Its Decision.,Observational Model: Cohort|Time Perspective: Retrospective,2021-A01013-38,"Hôpital Nord Franche-Comté, Trévenans, France",https://ClinicalTrials.gov/show/NCT04970550
NCT04876872,Modified Pediatric Early Warning Score and Modified PRISA II During COVID-19 Pandemic,Observational Model: Other|Time Perspective: Prospective,KTU-PediEM01,"Karadeniz Technical University Faculty of Medicine Farabi Hospital, Trabzon, Turkey",https://ClinicalTrials.gov/show/NCT04876872
NCT04346953,Video-Based Exercise for Individuals With Social Isolation Due to Coronavirus (COVID-19),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Prevention,2,NA,https://ClinicalTrials.gov/show/NCT04346953
NCT04460196,Healthcare Renunciation During the Confinement Period in Connection With the COVID-19 Epidemic in Adult Emergency Departments,Observational Model: Cohort|Time Perspective: Prospective,49RC20_0155,"CHU Angers, Angers, France|CH Le Mans, Le Mans, France",https://ClinicalTrials.gov/show/NCT04460196
NCT04557358,Impact in the Medical Care Among the Rheumatic Diseases Patients in a Tertiary Hospital in México During the COVID-19 Pandemic,Observational Model: Cohort|Time Perspective: Prospective,IRE-3467,"Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Tlalpan, Mexico",https://ClinicalTrials.gov/show/NCT04557358
NCT04324047,Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients,Observational Model: Cohort|Time Perspective: Prospective,APHP200375|2020-001246-18,"Kremlin Bictre APHP, Le Kremlin-Bicêtre, Ile De France, France|Cochin Aphp, Paris, Ile De France, France|Hegp Aphp, Paris, Ile De France, France",https://ClinicalTrials.gov/show/NCT04324047
NCT04604743,Clinic-based HPV and COVID-19 Vaccine Promoting Intervention for AfAm Adolescents in Alabama,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,MISP #60590,"University of Alabama at Birmingham (UAB), Birmingham, Alabama, United States",https://ClinicalTrials.gov/show/NCT04604743
NCT04880174,SARS-COV-2 Seroprevalence and Seroconversion Among Employees of the Universitair Ziekenhuis Brussel Following mRNA COVID-19 Vaccination,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,COVEMUZ-2,"Universitair ziekenhuis Brussel, Brussels, Belgium",https://ClinicalTrials.gov/show/NCT04880174
NCT04516837,Eltrombopag Plus rhTPO Versus Eltrombopag for ITP During the COVID-19 Pandemic (ELABORATE-19),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,ITP-PKU020,"Peking University Insititute of Hematology, Peking University People's Hospital, Beijing, Beijing, China",https://ClinicalTrials.gov/show/NCT04516837
NCT04392453,Upper Limb Robotic Rehabilitation During COVID-19 Outbreak,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,FDG_Icone,"Fondazione Don Carlo Gnocchi, Rome, Italy",https://ClinicalTrials.gov/show/NCT04392453
NCT04847336,Improving MAternal Newborn carE In the in the WHO European Region During COVID-19 Pandemic,Observational Model: Other|Time Perspective: Cross-Sectional,IRB-BURLO 05/2020,"IRCCS Burlo Garofolo, Trieste, Friuli Venezia Giulia Region, Italy",https://ClinicalTrials.gov/show/NCT04847336
NCT04315870,Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) in Pregnancy: The Italian Registry on Coronavirus in Pregnancy.,Observational Model: Cohort|Time Perspective: Other,5月20日,"University of Naples Federico II, Napoli, Italy",https://ClinicalTrials.gov/show/NCT04315870
NCT04519216,Breastfeeding Education in the Time of COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Other,1613611-2,"University of California - Davis, Sacramento, California, United States",https://ClinicalTrials.gov/show/NCT04519216
NCT04443868,Nitric Oxide Releasing Solution to Treat and Prevent Exacerbation of Mild COVID-19 Infection,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",COVID-IND-02,NA,https://ClinicalTrials.gov/show/NCT04443868
NCT04445324,Effects of Online and Recovery-oriented Peer Support Groups Facilitated by Peer Support Workers in Times of COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Care Provider, Investigator)|Primary Purpose: Supportive Care",2021-2281,"CR-IUSMM, Montreal, Quebec, Canada",https://ClinicalTrials.gov/show/NCT04445324
NCT04410835,Psychological Impact of the Corona Virus (SARS-CoV-2) and COVID-19 Pandemic in Individuals With Psychiatric Disorders,Observational Model: Cohort|Time Perspective: Prospective,32-363 ex 19/20,"Medical University Graz, Department of Psychiatry and Psychotherapeutic Medicine, Graz, Styria, Austria",https://ClinicalTrials.gov/show/NCT04410835
NCT04958902,RESTORE in Patients Who Had COVID-19 and Close Others,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,REB# 21-5394-0,NA,https://ClinicalTrials.gov/show/NCT04958902
NCT04724681,Continuous Wireless Monitoring of Vital Signs and Automated Alerts of Patient Deterioration in Patients Admitted With COVID-19 Infection,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,H-20025357,"Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark",https://ClinicalTrials.gov/show/NCT04724681
NCT04469621,A Phase 1b Trial to Evaluate Safety and Effect of SAR443122 on Immune System in Severe COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",PDY16879|2020-002104-39|U1111-1250-1185,"Investigational Site Number 0320001, Caba, Argentina|Investigational Site Number 0760003, Porto Alegre, Brazil|Investigational Site Number 0760001, São José Do Rio Preto, Brazil|Investigational Site Number 0760002, São Paulo, Brazil|Investigational Site Number 1520001, Santiago, Chile|Investigational Site Number 1520003, Santiago, Chile|Investigational Site Number 1520002, Talca, Chile|Investigational Site Number 4840001, Monterrey, Mexico|Investigational Site Number 6430001, Moscow, Russian Federation|Investigational Site Number 6430002, Moscow, Russian Federation",https://ClinicalTrials.gov/show/NCT04469621
NCT04707833,Evaluation of Serological Techniques for Screening for COVID-19 Infection at the University Hospital of Rouen,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,2020/0126/HP,"Rouen University Hospital, Rouen, France",https://ClinicalTrials.gov/show/NCT04707833
NCT04488796,STAND UP to SARS-CoV-2 (COVID-19): Using Behavioural Economics to Reduce Sedentary Behaviour in At-home Office Workers,Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,116127,"University of Western Ontario, London, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04488796
NCT04365335,Stress Biomarkers Leading to Professional Burnout Among People Involved in a Mobile Intensive Care Unit During the COVID-19 Pandemic,Observational Model: Cohort|Time Perspective: Prospective,2020-COVID19-11|2020-A01058-31,"Elément Militaire de Réanimation (EMR), Mulhouse, France",https://ClinicalTrials.gov/show/NCT04365335
NCT04548544,A Randomized Controlled Feasibility Study of Emotional Well-being of Adolescents Undergoing a Mindfulness Training During COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Basic Science,19-29083 (b),"UCSF, San Francisco, California, United States",https://ClinicalTrials.gov/show/NCT04548544
NCT04321278,Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-CoV2 Virus (Coalition Covid-19 Brasil II),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,30155020.5.1001.0071,"Hospital de Urgência e Emergência de Rio Branco, Rio Branco, AC, Brazil|Hospital e Clínica São Roque, Ipiaú, BA, Brazil|Hospital da Cidade, Salvador, BA, Brazil|Hospital Maternidade São Vicente de Paulo, Barbalha, CE, Brazil|Hospital de Messejana Dr. Carlos Alberto Studart Gomes, Fortaleza, CE, Brazil|Hospital Unimed Cariri, Juazeiro Do Norte, CE, Brazil|Hospital Brasilia, Brasilia, DF, Brazil|Hospital Estadual Jayme dos Santos Neves, Serra, ES, Brazil|Hospital Evangélico de Vila Velha, Vila Velha, ES, Brazil|Secretaria de Estado de Saúde de Goias, Goiânia, GO, Brazil|Santa Casa de Misericórdia de Belo Horizonte Santa Casa de BH, Belo Horizonte, MG, Brazil|Hospital Santa Paula, Passos, MG, Brazil|Santa Casa da Misericordia - UTI (São João Del Rey), São João Del Rei, MG, Brazil|Hospital Maternidade E Pronto Socorro Santa Lucia Ltda, Poços De Caldas, Minas Gerais, Brazil|Universidade Estadual de Londrina, Londrina, Paraná, Brazil|Hospital Adventista de Belém, Belém, Pará, Brazil|Hospital Adventista de Belem, Belem, PA, Brazil|Procape - Pronto S.Cardiologico de Pe.Prof.Luiz Tavares-, Recife, PE, Brazil|Liga Paranaense de Combate ao Câncer, Curitiba, PR, Brazil|Hospital Giselda Trigueiro, Natal, Rio Grande Do Norte, Brazil|Hospital Moinhos de Vento, Porto Alegre, Rio Grande Do Sul, Brazil|Irmandade da Santa Casa de Misericordia de Porto Alegre, Porto Alegre, Rio Grande Do Sul, Brazil|Hospital Naval Marcílio Dias, Rio de Janeiro, RJ, Brazil|Hospital São Lucas, Rio De Janeiro, RJ, Brazil|Hospital Maternidade PROMATER, Natal, RN, Brazil|Associação Dr. Bartholomeu Tacchini, Bento Gonçalves, RS, Brazil|Hospital Geral de Caxias do Sul, Caxias Do Sul, RS, Brazil|Hospital Bruno Born, Lajeado, RS, Brazil|Hospital São Vicente de Paulo, Passo Fundo, RS, Brazil|Maestri E Kormann Consultoria Medico-Cientifica, Blumenau, Santa Catarina, Brazil|Sociedade Literaria e Caritativa Santo Agostinho, Criciúma, Santa Catarina, Brazil|Hospital Nereu Ramos, Florianópolis, SC, Brazil|Hospital Universitário Polydoro Ernani de São Thiago/HU - UFSC, Florianópolis, SC, Brazil|Centro Hospitalar Unimed, Joinville, SC, Brazil|Hospital Dona Helena, Joinville, SC, Brazil|Hospital Municipal Sao Jose, Joinville, SC, Brazil|Hospital Regional Hans Dieter Schmidt, Joinville, SC, Brazil|Faculdade de Medicina de Botucatu, Botucatu, SP, Brazil|nstituto de Pesquisa Clínica de Campinas, Campinas, SP, Brazil|Fundação do ABC (Hospital Estadual Mário Covas), Santo André, SP, Brazil|AC Camargo Cancer Center - Fundação Antonio Prudente, São Paulo, SP, Brazil|Casa de Saude Santa Marcelina, São Paulo, SP, Brazil|Hospital Alemão Oswaldo Cruz, São Paulo, SP, Brazil|Hospital Moriah, São Paulo, SP, Brazil|Hospital Nove de Julho, São Paulo, SP, Brazil|Hospital Santa Paula, São Paulo, SP, Brazil|Hospital São Camilo Pompeia, São Paulo, SP, Brazil|Fundação Pio XII, Barretos, São Paulo, Brazil|Santa Casa de Misericordia de Votuporanga, Votuporanga, São Paulo, Brazil|Hospital Israelita Albert Einstein, São Paulo, Brazil|A Beneficência Portuguesa de São Paulo - BP, São Paulo, Brazil|Associacao Beneficente Siria, São Paulo, Brazil|Hospital Vila Santa Catarina, São Paulo, Brazil|Real e Benemérita Associação Portuguesa de Beneficência/SP - 1, São Paulo, Brazil|Secretaria de Saúde do Estado de São Paulo, São Paulo, Brazil|Serv Social da Industria do papel, papelão e cortiça do estado de SP, São Paulo, Brazil|Sociedade Beneficente de Senhoras Hospital Sírio-Libanês, São Paulo, Brazil|Universidade Federal de São Paulo, São Paulo, Brazil",https://ClinicalTrials.gov/show/NCT04321278
NCT04548492,The Validity of Modern Mobile Applications in Management of COVID-19 Home Isolation Patients: a Survey for Health Care Professionals,Observational Model: Case-Crossover|Time Perspective: Prospective,75 / 2020,NA,https://ClinicalTrials.gov/show/NCT04548492
NCT04530136,Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Treatment,C1 6201,"The Valley Hospital, Ridgewood, New Jersey, United States",https://ClinicalTrials.gov/show/NCT04530136
NCT04741412,"Pediatric SARS-CoV-2 Infections: Course of COVID-19, Immune Responses, Complications and Long-term Consequences",Observational Model: Cohort|Time Perspective: Prospective,212_20 B,"University Hospital Erlangen, Erlangen, Germany",https://ClinicalTrials.gov/show/NCT04741412
NCT04351906,Low-flow Extracorporeal Carbon Dioxide Removal in COVID-19-associated Acute Respiratory Distress Syndrome,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,AZ 63/20,"University Hospital Giessen and Marburg, Giessen, Giessen, Hessen, Germany",https://ClinicalTrials.gov/show/NCT04351906
NCT04581187,An Online-platform to Improve Patient-centered Care During the COVID-19 Pandemic: a GIMEMA Surveillance Program in Hematologic Malignancies,Observational Model: Cohort|Time Perspective: Prospective,GIMEMA-ALLIANCE Platform,"Aou Ospedali Riuniti ""Umberto I - G.M. Lancisi - G. Salesi""- Ancona, Ancona, Italy|Irccs Centro Di Riferimento Oncologico Di Aviano - Sosd Oncoematologia Trapianti Emopoietici E Terapie Cellulari, Aviano, Italy|Aou Consorziale Policlinico - Bari - Uo Ematologia Con Trapianto, Bari, Italy|Irccs Oncologico Istituto Tumori Giovanni Paolo II - UO Ematologia, Bari, Italy|Asl Della Provincia Di Barletta, Andria, Trani, Ospedale ""Mons. Dimiccoli"" - UOC Ematologia, Barletta, Italy|AO Brotzu, Presidio Ospedaliero A. Businco - Cagliari - SC Ematologia E CTMO, Cagliari, Italy|Aou Policlinico Vittorio Emanuele, Presidio Ospedaliero Ferrarotto -Divisione Clinicizzata Di Ematologia, Catania, Italy|Aou Ospedali Riuniti - Foggia- UOC Ematologia, Foggia, Italy|Asl Lecce, Ospedale 'V. Fazzi' - Uo Ematologia, Lecce, Italy|Aou Di Modena- Sc Ematologia- Dipartimento Di Oncologia Ed Ematologia, Modena, Italy|Ao Di Rilievo Nazionale Antonio Cardarelli - UOC Ematologia, Napoli, Italy|S.C.D.U. Ematologia - DIMECS e Dipartimento Oncologico - Aou Maggiore Della Carità Di Novara, Novara, Italy|Ao Ospedali Riuniti Villa Sofia Cervello - Palermo - Uo Ematologia Con Utmo, Palermo, Italy|Aou Policlinico P. Giaccone - Uo Ematologia Dipartimento Biomedico Di Medicina Interna E Specialistica, Palermo, Italy|Asl Pescara, Presidio Ospedaliero 'Spirito Santo' - Uoc Ematologia Clinica, Pescara, Italy|Ausl Reggio Emilia, Presidio Ospedaliero ""Arcispedale Santa Maria Nuova"" - Irccs- Uo Ematologia, Reggio Emilia, Italy|Ao San Camillo Forlanini - Uoc Ematologia E Trapianto Cellule Staminali, Roma, Italy|AOU Policlinico Tor Vergata - UOC Trapianto Cellule Staminali, Roma, Italy|Aou Policlinico Umberto I - Dipartimento Di Medicina Traslazionale - Sezione Ematologia, Roma, Italy|Az. Ospedaliera ""Sant' Andrea""-Università la Sapienza Seconda Facoltà di Medicina e Chirurgia, Roma, Italy|Divisione di Ematologia - Ospedale S. Eugenio, Roma, Italy|Policlinico Universitario Campus Bio Medico - Roma - Uoc Ematologia E Trapianto Di Cellule Staminali, Roma, Italy|Ente Ecclesiastico Casa Sollievo Della Sofferenza - San Giovanni Rotondo - Ematologia, San Giovanni Rotondo, Italy|Aou Di Sassari - Cliniche Universitarie - Stabilimento Cliniche Di San Pietro - Uoc Ematologia, Sassari, Italy|Ospedale Di Sassuolo Spa - Ematologia, Sassuolo, Italy|Asl To 2, Torino Nord Emergenza San Giovanni Bosco - Ssd Ematologia, Torino, Italy|Torino Dipartimento di Oncologia ed Ematologia S.C. Ematologia 2 A.O. Città della Salute e della Scienza di Torino San Giovanni Battista, Torino, Italy",https://ClinicalTrials.gov/show/NCT04581187
NCT04418531,Convalescent Antibodies Infusion in COVID 19 Patients,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,DFPP COVID 19 Early,"ASST - Papa Giovanni XXIII - Unit of Nephrology, Bergamo, BG, Italy|Asst Hpg23 - Eas, Bergamo, BG, Italy|ASST HPG23 - Intensive Care Unit, Bergamo, BG, Italy|ASST HPG23 - Microbioly and Virology Unit, Bergamo, BG, Italy|Sst Hpg23 - S.I.M.T., Bergamo, BG, Italy|IRFMN - Clinical Research Center for Rare Diseases, Ranica, BG, Italy",https://ClinicalTrials.gov/show/NCT04418531
NCT04337918,Nitric Oxide Releasing Solutions to Prevent and Treat Mild/Moderate COVID-19 Infection,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention,COVID-CTP-01,"BC Diabetes, Vancouver, British Columbia, Canada|LMC Manna, Pointe-Claire, Quebec, Canada|Diex Recherche Québec, Québec, Quebec, Canada|Diex Recherche Joliette, Saint-Charles-Borromée, Quebec, Canada|Diex Recherche Sherbrooke, Sherbrooke, Quebec, Canada",https://ClinicalTrials.gov/show/NCT04337918
NCT04594278,COVID-19 Burnout Study,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,20-5678,NA,https://ClinicalTrials.gov/show/NCT04594278
NCT04326036,Use of cSVF Via IV Deployment for Residual Lung Damage After Symptomatic COVID-19 Infection,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,GARM COVID19,"Robert W. Alexander, MD, FICS, LLC, Stevensville, Montana, United States",https://ClinicalTrials.gov/show/NCT04326036
NCT04535778,COMPASS Study: an Online Cognitive-behavioural Therapy (CBT) Program Treating Anxiety and Low Mood in Long-term Conditions During the COVID-19 Pandemic,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,20347,"Health Psychology Section, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04535778
NCT04761692,"Increasing COVID-19, Influenza, and Pneumonia Vaccine Uptake",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,vaccineinc,"Charles R. Drew University of Medicine & Science, Los Angeles, California, United States",https://ClinicalTrials.gov/show/NCT04761692
NCT04391946,Observatory of Patients With Chronic Lymphocytic Leukemia / Lymphocytic Lymphoma or Waldenstrom Disease Infected With COVID-19,Observational Model: Cohort|Time Perspective: Prospective,FILO-COVID19_LLC-MW,"Chu Angers, Angers, France|CHU Jean Minjoz - Hématologie, Besançon, France|Hôpital Avicenne - Centre de Recherche Clinique, Bobigny, France|CHU Estaing - Hématologie Clinique Adulte, Clermont-Ferrand, France|Chu Creteil, Créteil, France|CHU Grenoble - Hématologie, Grenoble, France|Chd Vendee, La Roche-sur-Yon, France|Centre Hospitalier du Mans, Le Mans, France|Hôpital Saint Vicent de Paul, Lille, France|Centre Léon Bérard - Hématologie, Lyon, France|Institut Paoli Calmette, Marseille, France|Hopital E.Muller, Mulhouse, France|CHU DE NANTES - Hematologie clinique, Nantes, France|Hopital Pitie Salpetriere Service Hematologie Clinique - Pavillon de L'Enfant Et Adolescent, Paris, France|Centre Hospitalier Lyon Sud, Pierre-Bénite, France|Hôpital de la Milétrie - Hématologie et Thérapie Cellulaire, Poitiers, France|Hôpital Robert Debré - Hématologie Clinique, Reims, France|Centre Henri Becquerel - Service Hématologie Clinique, Rouen, France|Hôpital Hautepierre - Hématologie, Strasbourg, France|IUCT ONCOPOLE - Hématologie, Toulouse, France|Hôpital Bretonneau - Hématologie et Thérapie Cellulaire, Tours, France|CHU Nancy Brabois, Vandœuvre-lès-Nancy, France",https://ClinicalTrials.gov/show/NCT04391946
NCT04931888,Implementing and Evaluating a Social-Emotional Learning Program for Refugee Children During the COVID-19 Pandemic,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,2000030455,"Yale University, New Haven, Connecticut, United States",https://ClinicalTrials.gov/show/NCT04931888
NCT04638842,Online Multi-component Psychological Intervention for Prevention of Grief Disorder Due to COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,VIU-Grief-COVID,"Universidad Autónoma de Ciudad Juárez, Juárez, Chihuahua, Mexico",https://ClinicalTrials.gov/show/NCT04638842
NCT04824651,Covid-19 Vaccine Cohort in Specific Populations,Observational Model: Cohort|Time Perspective: Prospective,ANRS0001S,NA,https://ClinicalTrials.gov/show/NCT04824651
NCT04460014,Simple Cognitive Task Intervention After Trauma During COVID-19 In Hospital Staff EKUT-P RCT,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention,2020-03085,"Hospital units across Sweden (e.g. FO Akut, Karolinska University Hospital Huddinge), Huddinge, Sweden",https://ClinicalTrials.gov/show/NCT04460014
NCT04523246,Training the Innate Immune System Against SARS-CoV-2 (COVID-19) Using the Shingrix Vaccine in Nursing Home Residents,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Basic Science",OUHSC IRB#12394,"Fran and Earl Ziegler College of Nursing, Oklahoma City, Oklahoma, United States",https://ClinicalTrials.gov/show/NCT04523246
NCT04748172,COVID-19 Vaccine and Ovarian Reserve,Observational Model: Case-Control|Time Perspective: Prospective,8121-21-SMC,"Sheba Medical Center, Ramat-Gan, Israel",https://ClinicalTrials.gov/show/NCT04748172
NCT04371250,Study of Resilience and Loneliness in Youth (18 - 25 Years Old) During the COVID-19 Pandemic Lock-down Measures.,Observational Model: Cohort|Time Perspective: Prospective,SRB2020_158,"Erasme University Hospital, Brussels, Belgium",https://ClinicalTrials.gov/show/NCT04371250
NCT04717089,Extended Post Anaesthetic Care in PACU During COVID-19: Multi-perspective Value-based Analysis,Observational Model: Case-Control|Time Perspective: Retrospective,TMH-ExRR-001,"Operation Theatre, Tuen Mun Hospital, Tuen Mun, Hong Kong",https://ClinicalTrials.gov/show/NCT04717089
NCT04794946,"Safety and Efficacy of a Non-replicating ChAdOx1 Vector Vaccine AZD1222 (COVISHIELD), for Prevention of COVID-19 in Patients With Liver Cirrhosis",Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,ILBS-COVID-05,"Institute of Liver & Biliary Sciences, New Delhi, Delhi, India",https://ClinicalTrials.gov/show/NCT04794946
NCT04535700,Clinical Trial of Pioglitazone Treatment in Patients With Type 2 Diabetes Mellitus and Covid-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,ESCORPIO,"Hospital Ramón y Cajal, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04535700
NCT04953078,"A Study to Evaluate Safety, Tolerability, and Reactogenicity of an RBD-Fc-based Vaccine to Prevent COVID-19",Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,PT-CR-001,NA,https://ClinicalTrials.gov/show/NCT04953078
NCT04818697,"Effect of Social Isolation on Physical Activity Level, and Kinesophobia in Heart Rhythm Disorders During Pandemic",Observational Model: Case-Control|Time Perspective: Prospective,GO 20/633,"Hacettepe University, Ankara, Turkey",https://ClinicalTrials.gov/show/NCT04818697
NCT04678843,Adapting and Adopting Highly Specialized Pediatric Eating Disorder Treatment to Virtual Care: Implementation Research for the COVID-19 Context and Beyond,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,12722,"Southlake Regional Health Centre, Newmarket, Ontario, Canada|St. Joseph's Care Group, Thunder Bay, Ontario, Canada|North York General Hospital, Toronto, Ontario, Canada|CMHA Waterloo Wellington, Waterloo, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04678843
NCT04564040,A Study in Healthy Subjects to Assess Bioavailability (Proportion of a Drug Which Enters the Circulation to Have an Active Effect) of Acalabrutinib Tablet and Protonpump Inhibitor Effect (Members of a Class of Medications That Inhibits in Gastric Acid Production) for Rabeprazole,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,D8223C00005,"Research Site, Berlin, Germany",https://ClinicalTrials.gov/show/NCT04564040
NCT04346693,An Open Randomized Study of Dalargin Effectiveness in Patients With Severe and Critical Manifestations of SARS-COVID-19,Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,DAL-05-04-2020,"Burnasyan Federal Medical Biophysical Center FMBA of Russia, Moscow, Russian Federation",https://ClinicalTrials.gov/show/NCT04346693
NCT04565665,Cord Blood-Derived Mesenchymal Stem Cells for the Treatment of COVID-19 Related Acute Respiratory Distress Syndrome,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2020-0365|NCI-2020-06741,"M D Anderson Cancer Center, Houston, Texas, United States",https://ClinicalTrials.gov/show/NCT04565665
NCT04402827,Different Susceptibility to SARS CoV-2 Infection Among Health Care Workers Highly Exposed to COVID-19.,Observational Model: Case-Control|Time Perspective: Prospective,EC 162/20,"Hospital Ramon y Cajal, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04402827
NCT04322396,Proactive Protection With Azithromycin and hydroxyChloroquine in Hospitalized Patients With COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",KronLungesyg_COVID_19_protokol,"Aalborg Sygehus, Aalborg, Denmark|Bispebjerg Hospital, Copenhagen, Denmark|Herlev-Gentofte Hospital, Copenhagen, Denmark|Hvidovre Hospital, Copenhagen, Denmark|Nordsjællands Hospital, Hillerød, Denmark|Odense Universitetshospital, Odense, Denmark|Roskilde Sygehus, Roskilde, Denmark|Slagelse Sygehus, Slagelse, Denmark",https://ClinicalTrials.gov/show/NCT04322396
NCT04341610,ASC Therapy for Patients With Severe Respiratory COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",EudraCT number: 2020-001330-36,"2014 Department of Cardiology, The Heart Centre, University Hospital Rigshospitalet, Copenhagen, Denmark",https://ClinicalTrials.gov/show/NCT04341610
NCT04673331,"Physical Activity, Exercise Capacity and Coronavirus Phobia of Adult Cystic Fibrosis Patients During COVID-19 Pandemic",Observational Model: Case-Control|Time Perspective: Prospective,GO 20/794,"Hacettepe University, Ankara, Turkey",https://ClinicalTrials.gov/show/NCT04673331
NCT04369599,Trans Thoracic Manipulation of Ventilation/Perfusion: the V/Q System,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,STUDY00000402,"Emory University Hospital, Atlanta, Georgia, United States",https://ClinicalTrials.gov/show/NCT04369599
NCT04400305,"""Increasing Physical Activity in Canadian Adults Affected by COVID-19 Social Distancing Restrictions: A Feasibility Trial of an Online Intervention""",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Other,05-281983,"Behavioural Medicine Lab, University of Victoria, Victoria, British Columbia, Canada|University of Victoria, Victoria, British Columbia, Canada",https://ClinicalTrials.gov/show/NCT04400305
NCT04645368,"Study of Longidaze in the Prevention & Treatment of Pulmonary Fibrosis, Interstitial Lung Diseases Caused by COVID-19",Observational Model: Cohort|Time Perspective: Prospective,DISSOLVE,"Federal State Budgetary Educational Institution of Higher Education ""Astrakhan State Medical University"" of the Ministry of Health of the Russian Federation, Astrakhan, Astrakhan Region, Russian Federation|Municipal autonomous health care institution ""City Clinical Polyclinic No. 8"", Chelyabinsk, Chelyabinsk Region, Russian Federation|State Budgetary Healthcare Institution ""Regional Clinical Hospital No. 3"", Chelyabinsk, Chelyabinsk Region, Russian Federation|Municipal budgetary institution ""Central city clinical hospital number 6 "", Ekaterinburg, Ekaterinburg Region, Russian Federation|Medical center ""Clinic South"", Krasnodar, Krasnodar Region, Russian Federation|Federal State Budgetary Scientific Institution ""Federal Research Center"" Krasnoyarsk Scientific Center of the Siberian Branch of the Russian Academy of Sciences "" Scientific Research Institute of Medical Problems of the North, Krasnoyarsk, Krasnoyarsk Region, Russian Federation|Institute of Clinical Immunology LLC, Krasnoyarsk, Krasnoyarsk Region, Russian Federation|St. Petersburg State Budgetary Healthcare Institution ""City Consultative and Diagnostic Center No. 1"", Saint Petersburg, Leningrad Region, Russian Federation|State Novosibirsk Regional Clinical Hospital, Novosibirsk, Novosibirsk Region, Russian Federation|CJSC ""Medical Center"" Philosophy of Beauty and Health "", Perm, Perm Region, Russian Federation|State budgetary institution of health care Republican clinical hospital named after G.G. Kuvatova, Ufa, Ufa Region, Russian Federation|State health care institution ""Clinical Hospital No. 4"", Volgograd, Volgograd Region, Russian Federation|Federal State Budgetary Educational Institution of Higher Education ""Volgograd State Medical University"" of the Ministry of Health of the Russian Federation Volgograd State Medical University of the Ministry of Health of Russia, Volgograd, Volgograd Region, Russian Federation|FSBI ""Main Military Clinical Hospital named after Academician N.N.Burdenko"" of the Ministry of Defense of the Russian Federation, Moscow, Russian Federation|State Budgetary Institution of Healthcare of the City of Moscow ""City Polyclinic No. 180 of the Department of Healthcare of the City of Moscow"", Moscow, Russian Federation",https://ClinicalTrials.gov/show/NCT04645368
NCT04934085,"COVID-19 Versus Neurological Impairment, Physical Activity, Social Contacts and Education",Observational Model: Case-Control|Time Perspective: Prospective,COVID-19,"University of Rzeszów, Rzeszów, Podkarpackie, Poland",https://ClinicalTrials.gov/show/NCT04934085
NCT04358783,Convalescent Plasma Compared to the Best Available Therapy for the Treatment of SARS-CoV-2 Pneumonia,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",IF20-00002,"Hospital Universitario José E. Gonzalez, Monterrey, Nuevo Leon, Mexico",https://ClinicalTrials.gov/show/NCT04358783
NCT04849546,Staff Physical and Mental Health Assessment in the Aftermath of the First Peak of the Covid-19 Outbreak,Observational Model: Ecologic or Community|Time Perspective: Retrospective,SAMAF - 29BRC21.0125,"Chu Brest, Brest, Bretagne, France",https://ClinicalTrials.gov/show/NCT04849546
NCT04944394,Psychological and Ethical Support for Hospital Professionals During the COVID-19 Pandemic: Suitability and Post-crisis Implications for the Experience of All Professionals,Observational Model: Cohort|Time Perspective: Prospective,QUENOT 2020-3,"Chu Dijon Bourogne, Dijon, France",https://ClinicalTrials.gov/show/NCT04944394
NCT04341519,"Psychological Burden in ICU Survivors of Severe COVID-19 Pneumonia, Their Relatives and Their Healthcare Providers",Observational Model: Cohort|Time Perspective: Prospective,APHP200389,"Saint-Louis Hospital, Paris, Ile De France, France|Cochin, Paris, France|Pitié Salpetrière, Paris, France",https://ClinicalTrials.gov/show/NCT04341519
NCT04603755,Electrical Impedance Tomography: Collapse in Dependent Areas as a Predictor of Response to Prone Position Ventilation in COVID-19 Acute Respiratory Distress Syndrome,Observational Model: Cohort|Time Perspective: Prospective,2020-COVID19-16|2020-A02823-36,"Hôpital de la Timone, Marseille, France|Hôpital d'Instruction des Armées Sainte-Anne, Toulon, France",https://ClinicalTrials.gov/show/NCT04603755
NCT04274322,Identifying Critically-ill Patients With COVID-19 Who Will Benefit Most From Nutrition Support Therapy: Validation of the NUTRIC Nutritional Risk Assessment Tool,Observational Model: Cohort|Time Perspective: Prospective,COV_NUTRIC,"Peking University Third Hospital, Beijing, China",https://ClinicalTrials.gov/show/NCT04274322
NCT04025580,Systems Analyses of the Immune Response to the Seasonal Influenza Vaccine,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science,190126|19-I-0126,"National Institutes of Health Clinical Center, Bethesda, Maryland, United States",https://ClinicalTrials.gov/show/NCT04025580
NCT04412239,To Assess the Efficiency and Satisfaction of Pharmacist Giving Patient-centred Advice on Telephone Consultation in TB Patients: Experience of the COVID-19 Pandemic,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,"NO, F6-2017/NTP-ADMIN","Dhq Bannu Kpk, Bannu, KPK, Pakistan|District Bannu TB Control Center, Bannu, KPK, Pakistan",https://ClinicalTrials.gov/show/NCT04412239
NCT04378257,Efficacy of Therapist Guided e-Therapy Versus Self-Help Therapy on Psychological Distress Among Individuals in Oman During COVID-19 Pandemic,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,12/2020,NA,https://ClinicalTrials.gov/show/NCT04378257
NCT04324073,Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients - Sarilumab Trial - CORIMUNO-19 - SARI,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,APHP200375-2,"Kremlin Bicetre hospital APHP, Le Kremlin-Bicêtre, Ile De France, France|Cochin Aphp, Paris, Ile De France, France|HEGP, Paris, Ile De France, France|NECKER Hospital, Paris, France",https://ClinicalTrials.gov/show/NCT04324073
NCT04480957,Ascending Dose Study of Investigational SARS-CoV-2 Vaccine ARCT-021 in Healthy Adult Subjects,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",ARCT-021-01,"SingHealth Investigational Medicine Unit (IMU), Singapore General Hospital, Singapore, Singapore",https://ClinicalTrials.gov/show/NCT04480957
NCT04952532,"A Novel Cognitive Remediation Intervention Targeting Poor Decision-making and Depression in Veterans at High Risk for Suicide: A Safe, Telehealth Approach During the COVID-19 Pandemic",Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,D3738-P|1I21RX003738-01A1,"James J. Peters VA Medical Center, Bronx, NY, Bronx, New York, United States",https://ClinicalTrials.gov/show/NCT04952532
NCT04588909,Outcomes of Elective Colorectal Cancer Surgery During COVID 19 Pandemic: Implications for Cancer Care Policy,Observational Model: Cohort|Time Perspective: Retrospective,73/2020 (Supl 2),"Sher i Kashmir Institute of Medical Sciences, Srinagar, J&K, India",https://ClinicalTrials.gov/show/NCT04588909
NCT04344041,COvid-19 and Vitamin D Supplementation: a Multicenter Randomized Controlled Trial of High Dose Versus Standard Dose Vitamin D3 in High-risk COVID-19 Patients (CoVitTrial),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2020-001602-34,"CHU Angers, Angers, France|CHU Bordeaux, Bordeaux, France|CH Le Mans, Le Mans, France|CHU Limoges, Limoges, France|CHU Nantes, Nantes, France|CHU Nice, Nice, France|CHU Saint Etienne, Saint Etienne, France|CH Saumur, Saumur, France|CHU Tours, Tours, France",https://ClinicalTrials.gov/show/NCT04344041
NCT04747132,Effectiveness of a Telegeriatric Intervention in Older Adults During the Covid-19 Contingency,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Health Services Research,SALUD-2021-Telegeria,"Universidad Iberoamericana, Ciudad de Mexico, Ciudad De México, Mexico",https://ClinicalTrials.gov/show/NCT04747132
NCT04872712,THE ROLE OF MANUAL ACUPUNCTURE USING PRESS NEEDLES COMPARED WITH FILIFORM NEEDLES IN IMPROVING SYMPTOMS OF INSOMNIA AND MELATONIN HORMONE FOR HEALTHCARE WORKERS TREATING COVID-19 PATIENTS.,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment",21-02-0142,"Cipto Mangunkusumo Hospital, Jakarta Pusat, DKI Jakarta, Indonesia",https://ClinicalTrials.gov/show/NCT04872712
NCT04559074,Personalised Electronic Record Supported Optimisation When Alone for Patients With Hypertension- Pilot Study for Remote Medical Management of Hypertension During the COVID-19 Pandemic,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,283209,"Queen Mary University London, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04559074
NCT04403906,Somerset and South Essex Coronavirus Antigen Testing,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,IRAS283137,"Musgrove Park Hospital, Taunton, Somerset, United Kingdom",https://ClinicalTrials.gov/show/NCT04403906
NCT04596579,SARS-CoV-2 (COVID-19) Immune Surveillance Among a Population Based Sample of Adults in Florida,Observational Model: Ecologic or Community|Time Perspective: Prospective,MCC-20635,"Moffitt Cancer Center, Tampa, Florida, United States",https://ClinicalTrials.gov/show/NCT04596579
NCT04470544,Camostat Mesilate Treating Patients With Hospitalized Patients With COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",CAM20CV,"Mayo Clinic in Arizona, Scottsdale, Arizona, United States|Tucson Medical Center, Tucson, Arizona, United States|Mayo Clinic in Florida, Jacksonville, Florida, United States",https://ClinicalTrials.gov/show/NCT04470544
NCT04890665,"Online Multi-component Psychological Intervention for Anxiety, Depression, and Burnout on Healthcare Workers During the COVID-19 Pandemic",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,VIU-Health_care_workers_COVID,"Universidad Autónoma de Ciudad Juárez, Juarez, Chihuahua, Mexico|Universidad de Guadalajara, Guadalajara, Jalisco, Mexico|Universidad Nacional Autónoma de México, Mexico, Mexico",https://ClinicalTrials.gov/show/NCT04890665
NCT04459533,Sparing in Neuromuscular Blockade in COVID 19 ICU,Observational Model: Case-Control|Time Perspective: Retrospective,2020_TOF-COVID,"Department of Anesthesiology and Intensive Care Medicine, Hôpital de la Croix Rousse, Hospices Civils de Lyon, Lyon, France",https://ClinicalTrials.gov/show/NCT04459533
NCT04453657,"Tele-Wellness Supported App for Family Child Care Home Providers and Families to Promote Health, Family Engagement, and School Readiness Amid COVID-19",Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,IRB00250864,"Johns Hopkins School of Nursing, Baltimore, Maryland, United States",https://ClinicalTrials.gov/show/NCT04453657
NCT04640194,A Study to Test Whether Different Doses of Alteplase Help People With Severe Breathing Problems Because of COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,0135-0347|2020-002913-16,"LKH Klagenfurt am Woerthersee, Klagenfurt, Austria|Wiener Gesundheitsverbund Klinik Favoriten, Vienna, Austria|ULB Hopital Erasme, Bruxelles, Belgium|Centre Hospitalier Universitaire de Liège, Liège, Belgium|Ottignies - HOSP St-Pierre, Ottignies, Belgium|Hospital Samaritano de Campinas HSC, Campinas, Brazil|Hospital Alemao Oswaldo Cruz, São Paulo, Brazil|Hvidovre Hospital, Hvidovre, Denmark|HOP Bicêtre, Le Kremlin Bicêtre cedex, France|HOP Roger Salengro, Lille, France|HOP Marc Jacquet, Melun, France|HOP Européen G. Pompidou, Paris cedex 15, France|HOP Cochin, Paris, France|HOP Pierre Bénite, Pierre Bénite, France|HOP Civil, Strasbourg cedex, France|Universitätsklinikum Essen AöR, Essen, Germany|Medizinische Hochschule Hannover, Hannover, Germany|Universitätsklinikum Heidelberg, Heidelberg, Germany|Universitätsklinikum Leipzig, Leipzig, Germany|Klinikum der Universität München - Campus Großhadern, München, Germany|Fondazione Centro San Raffaele del Monte Tabor, Milano, Italy|Istituto Clinico Humanitas, Rozzano (MI), Italy|Ospedali Riuniti di Ancona, Torrette Di Ancona (AN), Italy|Gelre Ziekenhuizen Apeldoorn, Apeldoorn, Netherlands|Rijnstate Hospital, Arnhem, Netherlands|Canisius-Wilhelmina ziekenhuis, Nijmegen, Netherlands|CHLO, EPE - Hospital Egas Moniz, Lisboa, Portugal|Centro Hospitalar Universitário do Porto, EPE - Hospital de Santo António, Porto, Portugal|ULSAM, EPE - Hospital de Santa Luzia, Viana do Castelo, Portugal|City Clinical Hospital # 40 of the Moscow Health Department, Moscow, Russian Federation|City Clinical Emergency Hospital, Ryazan, Russian Federation|Hospital del Mar, Barcelona, Spain|Hospital Vall d'Hebron, Barcelona, Spain|Hospital Puerta del Mar, Cádiz, Spain",https://ClinicalTrials.gov/show/NCT04640194
NCT04842331,PREvent Viral Exposure aNd Transmission Study: a SARS-CoV-2 PEP Study (PREVENT),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,RESP301-006,"Imperial College Healthcare NHS Trust, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04842331
NCT04868188,Pharmacokinetics of Voriconazole in Adult ECMO Patients,Observational Model: Case-Only|Time Perspective: Prospective,136965 V1.0,NA,https://ClinicalTrials.gov/show/NCT04868188
NCT04632615,Sleep Behaviour in Athletes During Home Confinement Due to the Covid-19 Outbreak,Observational Model: Cohort|Time Perspective: Cross-Sectional,Sleep&Covid19,"IRCCS Istituto Ortopedico Galeazzi, Milan, Italy",https://ClinicalTrials.gov/show/NCT04632615
NCT04534400,Automated Quantification of Radiologic Pulmonary Alteration During Acute Respiratory Failure,Observational Model: Cohort|Time Perspective: Retrospective,7888,"GHR MULHOUSE-SUD ALSACE, Hôpital Emile Muller, Service de Radiologie, Mulhouse, France|HÔPITAUX UNIVERSITAIRES DE STRASBOURG, Hôpital de Hautepierre, Service de Réanimation Médicale, Strasbourg, France",https://ClinicalTrials.gov/show/NCT04534400
NCT04570384,Intravenous L-Citrulline to Delay and Potentially Prevent the Need for Invasive Mechanical Ventilation for Acute Hypoxemic Respiratory Failure in Patients With COVID-19 (SARS-CoV-2) Illness,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",CIT-COVID19-002-01,"University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States",https://ClinicalTrials.gov/show/NCT04570384
NCT04542954,Optimized Management of Covid-19 Positive Kidney Transplant Recipients: Single Center Experience From the Middle East,Observational Model: Cohort|Time Perspective: Other,2020/1481,"OTC, MOH , Kuwait, Kuwait, Kuwait",https://ClinicalTrials.gov/show/NCT04542954
NCT04395508,An Expanded Access Study to Provide at Home Subcutaneous Administration of Pertuzumab and Trastuzumab Fixed-Dose Combination (PH FDC SC) for Patients With HER2-Positive Breast Cancer During the COVID-19 Pandemic,NA,AL42478,"Beverly Hills Cancer Center, Beverly Hills, California, United States|UCSF Helen Diller Family CCC, San Francisco, California, United States|Stanford Univ School of Med; Oncology, Stanford, California, United States|University Of Colorado, Aurora, Colorado, United States|MedStar Washington Hosp Center, Washington, District of Columbia, United States|Mayo Clinic-Jacksonville, Jacksonville, Florida, United States|University of Maryland School of Medicine, Baltimore, Maryland, United States|Dana Farber Cancer Institute, Boston, Massachusetts, United States|Mayo Clinic Hospital-Rochester, St. Marys Campus - PPDS, Minneapolis, Minnesota, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|Levine Cancer Institute, Charlotte, North Carolina, United States|University of Washington Seattle Cancer Care Alliance, Seattle, Washington, United States",https://ClinicalTrials.gov/show/NCT04395508
NCT04427735,Effect of Covid-19 Epidemic on Primary PCI in Patients With STEMI,Observational Model: Case-Crossover|Time Perspective: Cross-Sectional,BFH-COVID-19 and Primary PCI,"Beijing Friendship Hospital, Capital Medical University, Beijing, China",https://ClinicalTrials.gov/show/NCT04427735
NCT04366921,European/Euro-ELSO Survey on Adult and Neonatal/ Pediatric COVID-19 Patients in ECMO,Observational Model: Cohort|Time Perspective: Prospective,METC 2020-1343,"Universitätskliniken Innsbruck, Innsbruck, Austria|Landesklinikum Sankt Polten, St.Pölten, Austria|Medical University of Vienna, Vienna, Austria|Onze Lieve Vrouwziekenhuis Aalst, Aalst, Belgium|University Hospital, Antwerp, Antwerp, Belgium|Centre Hospitalier Universitaire Saint Pierre, Brussels, Belgium|Chirec, Brussels, Belgium|Erasme University Hospital, Brussel, Belgium|Universitair Ziekenhuis Brussel, Brussel, Belgium|Hôpital Civil Marie Curie de Charleroi, Charleroi, Belgium|University Hospital, Ghent, Ghent, Belgium|La Louvière Hopital, La Louvière, Belgium|Universitaire Ziekenhuizen Leuven, Leuven, Belgium|CHU de Liege, Liège, Belgium|Charles University, Czech Republic, Praha, Czechia|General University Hospital, Prague, Praha, Czechia|Copenhagen University Hospital at Herlev, Copenhagen, Denmark|University Hospital, Bordeaux, Bourdeaux, France|Hospices Civils de Lyon, Lyon, France|University Hospital, Montpellier, Montpellier, France|Henri Mondor University Hospital, Paris, France|Paris South University Hospitals, Paris, France|Pitié-Salpêtrière Hospital, Paris, France|Rennes University Hospital, Rennes, France|University Hospital, Aachen, Aachen, Germany|German Heart Center, Berlin, Germany|Universitätsklinikum Düsseldorf, Düsseldorf, Germany|Children's Medical Hospital, University of Essen, Essen, Germany, Essen, Germany|University Hospital, Essen, Essen, Germany|University Heart Center Freiburg - Bad Krozingen, Freiburg, Germany|Hannover Medical School, Hannover, Germany|Klinikum Kassel, Kassel, Germany|Universitätsklinikum Köln, Köln, Germany|Heart Center Leipzig - University Hospital, Leipzig, Germany|Klinikum Nürnberg, Nürnberg, Germany|University Hospital Regensburg, Regensburg, Germany|University Hospital Tuebingen, Tuebingen, Germany|University Hospital, Alexandroupolis, Alexandroupolis, Greece|Heim Pal Children's Hospital, Budapest, Hungary|ECMO Centers Israel, Jerusalem, Israel|San Giorgio Clinic, Alessandria, Italy|Ospedali Riuniti Ancona, Ancona, Italy|Papa Giovanni XXIII Hospital, Bergamo, Italy|St. Orsola Hospital, Bologna, Italy|Azienda Ospedaliera Spedali Civili di Brescia, Brescia, Italy|Ospedale Maurizio Bufalini, Cesena, Italy|Gaslini Children's Hospital, Genua, Italy|G. Pasquinucci Heart Hospital, Massa, Massa, Italy|Policlinico Hospital Milan, Milano, Italy|Niguarda Hospital, Milan, Italy|Ospedale San Donato, Milan, Italy|San Raffaele University Hospital, Italy, Milan, Italy|San Gerardo Hospital, Monza, Italy|IRCCS Policlinico S. Matteo, Pavia, Italy|GVM Care & Research, Puglia, Italy|Bambino Gesù Hospital and Research Institute, Roma, Italy|San Camillo Hospital, Rome, Roma, Italy|A.O.U. Città della Salute e della Scienza - Molinette Hospital, Turin, Italy|Mauriziano Umberto I Hospital, Turin, Italy|Ospedale S. Giovanni Bosco, Turin, Italy|University Hospital, Udine, Italy, Udine, Italy|Ospedale dell'Angelo, Venezia-Mestre, Venice, Italy|Ospedale San Bortolo di Vicenza, Vicenza, Italy|Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania|University of Groningen, Groningen, Netherlands|Leiden University Medical Center, Leiden, Netherlands|Maastricht University Medical Center, Maastricht, Netherlands|Erasmus Medical Center, Rotterdam, Netherlands|UMC Utrecht, Utrecht, Netherlands|Medical University of Warsaw, Warsaw, Poland|Hospital Sao Joao, Porto, Portugal|Chelyabinsk Regional Clinical Hospital, Chelyabinsk, Russian Federation|City Hospital No 41, Ekaterinburg, Russia, Ekaterinburg, Russian Federation|Kemerovo Regional Clinical Cardiological Center named after academician L.S. Barbarash, Kemerovo, Russian Federation|Krasnodar Regional Hospital no 1, Krasnodar, Russian Federation|City Clinical Hospital No. 67, Moscow, Russia, Moscow, Russian Federation|Novosibirsk City Hospital #2, Novosibirsk, Russian Federation|City Hospital No 40, Saint Petersburg, Russia, Saint Petersburg, Russian Federation|Hospital Sant Joan de Deu, Barcelona, Spain|Hospital Vall d'Hebron, Barcelona, Spain|Hospital Universitario Ramon y Cajal, Madrid, Spain|Hospital Miguel Servet, Zaragoza, Spain|Lund University Hospital, Lund, Sweden|Karolinska University Hospital, Stockholm, Sweden|University Hospital, Basel, Switzerland, Basel, Switzerland|University of Bern, Bern, Switzerland|University Hospital, Geneva, Geneva, Switzerland|University of Lausanne Hospitals, Lausanne, Switzerland|Cardiocentro Ticino, Lugano, Switzerland|Klinik Hirslanden, Zurich, Zürich, Switzerland|University of Zurich, Zürich, Switzerland|Royal Brompton & Harefield NHS Foundation Trust, Brompton, United Kingdom|Paediatric Intensive Care Glasgow, Glasgow, United Kingdom|Leicester Children's Hospital, Leicester, United Kingdom|Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom|Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom|Newcastle-upon-Tyne Hospitals NHS Trust, Newcastle Upon Tyne, United Kingdom",https://ClinicalTrials.gov/show/NCT04366921
NCT04343404,Place of ECMO in the Management of Severe Refractory ARDS Associated With Covid-19,Observational Model: Case-Only|Time Perspective: Retrospective,7772,"Service de Chirurgie Thoracique Nouvel Hôpital Civil Hôpitaux Universitaires de Strasbourg, Strasbourg, France",https://ClinicalTrials.gov/show/NCT04343404
NCT04526912,Treatment and Prevention of Acute Lung Injury (ALI) in Patients With COVID-19 Infection,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",VIB7734.P1.S2,"Research Site, Cleveland, Ohio, United States",https://ClinicalTrials.gov/show/NCT04526912
NCT04407663,"Outpatient Clinic in Obesity Care During COVID-19 Outbreak: Physically Far, Virtually Near",Observational Model: Cohort|Time Perspective: Retrospective,Telemedicine,"University of Campania ""Luigi Vanvitelli"", Naples, Italy",https://ClinicalTrials.gov/show/NCT04407663
NCT04352985,Evaluating the Use of Polymyxin B Cartridge Hemoperfusion for Patients With Septic Shock and COVID 19,NA,SDI-PMX-013,"University of Connecticut Health Center, Farmington, Connecticut, United States|George Washington University, Washington, District of Columbia, United States|Stony Brook University Hospital, Stony Brook, New York, United States",https://ClinicalTrials.gov/show/NCT04352985
NCT04381845,Immunity and Infections in the Psychiatric Population,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,APHP200553,NA,https://ClinicalTrials.gov/show/NCT04381845
NCT04405310,Convalescent Plasma of Covid-19 to Treat SARS-COV-2 a Randomized Doble Blind 2 Center Trial,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment",DI/20/201/04/19,"Hospital Nava de Alta Especialidad, Mexico City, Mexico|Hospital General de Mexico Dr Eduardo Liceaga, Mexico City, Mexico",https://ClinicalTrials.gov/show/NCT04405310
NCT04519385,Toclizumam Versus Dexamethasone in Severe Covid-19 Cases,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment",SouthVU,"Qena faculty medicine, Qinā, Egypt",https://ClinicalTrials.gov/show/NCT04519385
NCT04959734,COVID-19 Impact on RSV Emergency Presentations,Observational Model: Cohort|Time Perspective: Prospective,140049,"University Hospitals of Leicester NHS Trust, Leicester, United Kingdom",https://ClinicalTrials.gov/show/NCT04959734
NCT04416009,Extracellular Water in Covid 19 Pneumonia,Observational Model: Cohort|Time Perspective: Prospective,76,"Gaziosmanpaşa TREH, Istanbul, Gaziosmanpaşa, Turkey",https://ClinicalTrials.gov/show/NCT04416009
NCT04435327,Lung Damage Caused by SARS-CoV-2 Pneumonia (COVID-19),Observational Model: Cohort|Time Perspective: Prospective,SequelaeCov,"San Gerardo Hospital, Monza, MB, Italy",https://ClinicalTrials.gov/show/NCT04435327
NCT04865913,Venous Thrombosis Virtual Surveillance in COVID,Observational Model: Cohort|Time Perspective: Prospective,20200677-01T,"Ottawa Hospital Research Institute, Ottawa, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04865913
NCT04969276,Study of a Quadrivalent High-Dose Influenza Vaccine and a Moderna COVID-19 Vaccine Administered Either Concomitantly or Singly in Participants 65 Years of Age and Older Previously Vaccinated With a 2-dose Schedule of Moderna COVID-19 Vaccine,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,QHD00028|U1111-1266-7472,"Investigational Site Number :8400005, Centennial, Colorado, United States",https://ClinicalTrials.gov/show/NCT04969276
NCT04367168,Colchicine Twice Daily During 10 Days as an Option for the Treatment of Symptoms Induced by Inflammation in Patients With Mild and Severe Coronavirus Disease,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",337420-21-1,"Instituto Nacional de Ciencias Medicas y Nutricion, Mexico City, Mexico",https://ClinicalTrials.gov/show/NCT04367168
NCT04400279,The COVID-19 Pandemic and Exercise Study,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Prevention",H20-01497,"University of British Columbia, Vancouver, British Columbia, Canada",https://ClinicalTrials.gov/show/NCT04400279
NCT04353037,PATCH 2&3:Prevention & Treatment of COVID-19 (Severe Acute Respiratory Syndrome Coronavirus 2) With Hydroxychloroquine,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment",2020-0003,"ProHealth New York, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04353037
NCT04904536,Statin TReatment for COVID-19 to Optimise NeuroloGical recovERy,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,X21-0113,"The George Institute for Global Health, Sydney, New South Wales, Australia",https://ClinicalTrials.gov/show/NCT04904536
NCT04836793,COVID-19-Study of Immune Responses Following Vaccination Against SARS-CoV-2,Observational Model: Cohort|Time Perspective: Prospective,2021-A00166-35,"Marie KROEMER, Besançon, France",https://ClinicalTrials.gov/show/NCT04836793
NCT04583319,"Validation of a Rapid, Non-invasive Point-of-care IVD Test for Diagnosis of SARS-COV-2 (COVID-19) Infection",Observational Model: Case-Control|Time Perspective: Prospective,ST0194,"Istanbul University Istanbul Faculty of Medicine (ITF), Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04583319
NCT04397575,The GCO-002 CACOVID-19 Cohort: a French Nationwide Multicenter Study of COVID-19 Infected Cancer Patients,Observational Model: Cohort|Time Perspective: Prospective,GCO002 CACOVID-19,"Ch D'Abbeville, Abbeville, France|CHU - Hôpital Sud, Amiens, France|CHU - Hôtel Dieu, Angers, France|Hôpital Privé, Antony, France|CH Victor Dupouy, Argenteuil, France|CH - Metz Thionville Mercy, Ars-Laquenexy, France|Hôpital Général d'Auch, Auch, France|Ch-Ght Unyon Auxerre, Auxerre, France|CH - Henri Duffaut, Avignon, France|PRIVE - Sainte Catherine, Avignon, France|CH, Bayeux, France|CH - Côte Basque, Bayonne, France|CH, Beauvais, France|CHU - Jean Minjoz, Besançon, France|PRIVE - Franche Comté, Besançon, France|PRIVE - Centre Pierre Curie, Beuvry, France|CH, Blois, France|PRIVE - Tivoli, Bordeaux, France|CH - Duchenne, Boulogne-sur-Mer, France|CHU - Ambroise Paré, Boulogne, France|CH - Fleyriat, Bourg-en-Bresse, France|CHU - Morvan, Brest, France|CHU - Pierre Wertheimer, Bron, France|CH - Germon et Gauthier - Service de Gastroentérologie, Béthune, France|CH, Béziers, France|CHU - Côte de Nacre, Caen, France|PRIVE - François Baclesse, Caen, France|CH, Calais, France|PRIVE - Infirmerie protestante, Caluire-et-Cuire, France|CH, Cannes, France|PRIVE - Médipole de Savoie, Challes-les-Eaux, France|PRIVE - Pôle Santé Léonard de Vinci, Chambray-lès-Tours, France|CH, Charleville-Mézières, France|CH, Chauny, France|CHP du Cotentin, Cherbourg, France|CH, Cholet, France|CH, Châlons-en-Champagne, France|CH - HIA Percy, Clamart, France|CHU - Estaing, Clermont-Ferrand, France|PRIVE - CAC Jean PERRIN, Clermont-Ferrand, France|CHU - Beaujon, Clichy, France|CH - Hôpitaux civils de Colmar, Colmar, France|CHU - Louis MOURIER, Colombes, France|CH - Compiegne, Compiègne, France|PRIVE - Saint Côme, Compiègne, France|CH - Sud Francilien, Corbeil-Essonnes, France|PRIVE - Cédres, Cornebarrieu, France|PRIVE - Clinique de Flandre, Coudekerque-Branche, France|CH - GHPSO Site de Creil, Creil, France|Ch - C.H.I.C., Créteil, France|CHU - Henri Mondor, Créteil, France|PRIVE - Centre Léonard de Vinci, Dechy, France|CHU - Hôpital François Mitterand, Dijon, France|PRIVE - CAC GF Leclerc, Dijon, France|PRIVE - Institut de Cancérologie de Bourgogne GRReCC, Dijon, France|CH - Louis Pasteur, Dole, France|CH, Douai, France|CH - Victor Jousselin, Dreux, France|PRIVE - Clinique Claude Bernard, Ermont, France|CH - Frejus Saint Raphael, Fréjus, France|PRIVE - Forcilles, Férolles-Attilly, France|CH, Grasse, France|CHU - Grenoble Alpes, Grenoble, France|PRIVE - GHM Daniel Hollard, Grenoble, France|CH - Marne La Vallée/Jossigny, Jossigny, France|CH - CHD Vendée, La Roche-sur-Yon, France|CH - Louis Pasteur, Le Coudray, France|PRIVE - L'Estuaire, Le Havre, France|PRIVE - Centre Jean Bernard, Le Mans, France|CH - Docteur Schaffner, Lens, France|CH - Saint Vincent, Lille, France|CHU - Claude Huriez, Lille, France|PRIVE - CAC Oscar Lambret, Lille, France|PRIVE - La Louvière Institut de Cancérologie Lille Métropole, Lille, France|CH - Robert Bisson, Lisieux, France|PRIVE - Teissier, Liévin, France|CH - GH Nord Essone, Longjumeau, France|CH - CHBS Hôpital du Scrorff, Lorient, France|CHU - Edouard Herriot, Lyon, France|CHU - La Croix Rousse, Lyon, France|PRIVE - La Sauvegarde Lyon, Lyon, France|CH - La Conception, Marseille, France|CH - Saint Joseph, Marseille, France|CHU - La Timone, Marseille, France|CH - GHI de l'Est Francilien Site de Meaux, Meaux, France|CH - Layné, Mont-de-Marsan, France|CH - Site du Mittan, Montbéliard, France|CH, Montélimar, France|CH - Emile Muller, Mulhouse, France|CH - Les Chanaux, Mâcon, France|PRIVE - Oncologie Gentilly, Nancy, France|PRIVE - Confluent SAS, Nantes, France|PRIVE - Hartmann, Neuilly-sur-Seine, France|CH - Pierre Beregovoy, Nevers, France|CH, Niort, France|CHU - Caremeau, Nîmes, France|CHR - Centre Hospitalier Régional La Source, Orléans, France|AP - HP - Pitié Salpêtrière, Paris, France|Bichat, Paris, France|CHU - Cochin, Paris, France|CHU - Lariboisière, Paris, France|CHU - Saint Antoine, Paris, France|CHU - Saint Louis, Paris, France|CHU - Tenon, Paris, France|Groupe Hospitalier Diaconesses Croix Saint Simon, Paris, France|Hôpital Européen Georges Pompidou, Paris, France|PRIVE - Saint Joseph, Paris, France|Privé - Montsouris, Paris, France|PRIVE - Centre Oncologie Catalan, Perpignan, France|CHU - Haut Lévêque, Pessac, France|CHU - Lyon Sud, Pierre-Bénite, France|PRIVE - Centre Cario HPCA, Plérin, France|CHU - La Miletrie, Poitiers, France|CH - René Dubos, Pontoise, France|CH, Périgueux, France|PRIVE - Clinique La Croix du Sud, Quint-Fonsegrives, France|CHU - Robert Debré, Reims, France|PRIVE - Polyclinique Courlancy, Reims, France|PRIVEE - Jean Godinot, Reims, France|PRIVEE - Polyclinique Courlancy, Reims, France|CHU - Charles Nicolle, Rouen, France|CAC - Institut Curie R. Huguenin, Saint-Cloud, France|PRIVE - Saint Grégoire, Saint-Grégoire, France|CH - Centre Hospitalier de Saint Malo, Saint-Malo, France|CH - Begin, Saint-Mandé, France|PRIVE - Clinique Mutualiste de l'Estuaire, Saint-Nazaire, France|CHU - Hôpital Nord CHU Saint Etienne, Saint-Priest-en-Jarez, France|PRIVE - Ramsay Sainte Loire, Saint-Étienne, France|PRIVE - Trenel, Sainte-Colombe, France|CHU - Hautepierre, Strasbourg, France|ICAN - Institut de Cancérologie de Strasbourg Europe, Strasbourg, France|PRIVE - Strasbourg Oncologie Libérale, Strasbourg, France|CH - Foch, Suresnes, France|CH - Maison Santé Protestante, Talence, France|CH - Birgorre, Tarbes, France|CH - Leman, Thonon-les-Bains, France|CH - Sainte Musse, Toulon, France|CAC - Oncopole, Toulouse, France|CHU - Rangueil, Toulouse, France|CH - Gustave Dron, Tourcoing, France|CHU - Bretonneau, Tours, France|CH, Valence, France|CH, Valenciennes, France|PRIVE - Dentellières, Valenciennes, France|CHU - Brabois, Vandœuvre-lès-Nancy, France|PRIVE - Robert Schuman, Vantoux, France|CH - Paul Morel, Vesoul, France|CAC - Gustave Roussy, Villejuif, France",https://ClinicalTrials.gov/show/NCT04397575
NCT04336748,HCQ for Primary Prophylaxis Against COVID19 in Health-care Workers,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention",HCQ prophylaxis for COVID19,NA,https://ClinicalTrials.gov/show/NCT04336748
NCT04437342,Postpartum Depression in the Covid-19 Pandemic and the Impact of Anaesthesia,Observational Model: Other|Time Perspective: Prospective,Covid-19 Postpartum depression,"""Elena Venizelou"" General and Maternity Hospital of Athens, Athens, Attica, Greece|Aretaieio University Hospital, Athens, Attica, Greece|Alexandra Genaral Hospital Athens, Athens, Greece|University of Ioannina Health Science, Ioannina, Greece|University of Ioannina, Medical School, Ioannina, Greece|University of Thessaly Medical School, Larisa, Greece",https://ClinicalTrials.gov/show/NCT04437342
NCT04320056,Closed-Loop Oxygen to Verify That Healthcare Workers Interventions Decrease During SARS-CoV-2 Pneumonia (COVID-19),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,21909,"Institut universitaire de cardiologie et de pneumologie de Québec - Université Laval, Quebec, Canada",https://ClinicalTrials.gov/show/NCT04320056
NCT04776005,COVID-19 Vaccine Efficacy in Patients With Malignant Pathologies,Observational Model: Cohort|Time Perspective: Prospective,APHP210640,"Saint-Louis Hospital, AP-HP, Paris, France|Bichat Hospital, AP-HP, Paris, France",https://ClinicalTrials.gov/show/NCT04776005
NCT04793464,COVID-19: Healthy Oregon (Oregon Saludable): Together We Can (Juntos Podemos),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention,10032020.002|P50DA048756-02S2,"University of Oregon, Eugene, Oregon, United States",https://ClinicalTrials.gov/show/NCT04793464
NCT04368208,Impact of Giving Birth During the Covid 19 Pandemia on Postnatal Women's Depression,Observational Model: Cohort|Time Perspective: Prospective,2020-A01065-34,"Bertrand GACHON, Poitiers, France",https://ClinicalTrials.gov/show/NCT04368208
NCT04330261,Clinical Characteristics and Outcomes of Pediatric COVID-19,Observational Model: Cohort|Time Perspective: Prospective,REB18-0107_MOD9,"University of Calgary/Alberta Children's Hospital, Calgary, Alberta, Canada",https://ClinicalTrials.gov/show/NCT04330261
NCT04869202,Covid-19 Infection in Pregnancy,Observational Model: Cohort|Time Perspective: Prospective,Jordan University Hospital,"Jordan University Hospital, Amman, Jordan",https://ClinicalTrials.gov/show/NCT04869202
NCT04433260,COVID19 and Physical and Emotional Wellbeing of HCP,Observational Model: Cohort|Time Perspective: Cross-Sectional,284686,"Ajay K Gupta, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04433260
NCT04368026,SARS-CoV-2 (COVID-19) and Surgery,Observational Model: Other|Time Perspective: Cross-Sectional,1072.6120.103.2020,"2nd Department of General Surgery, Jagiellonian University Medical College, Cracovia, Małopolska, Poland",https://ClinicalTrials.gov/show/NCT04368026
NCT04383717,Levamisole and Isoprinosine in the Treatment of COVID19: A Proposed Therapeutic Trial,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",Levamisole and isoprinosine,NA,https://ClinicalTrials.gov/show/NCT04383717
NCT04435353,Assessment of the Effectiveness of Vibroacoustic Therapy for Respiratory Failure Caused by COVID 19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,AstanaMU,"Mukatova Irina, Astana, Nur-Sultan, Kazakhstan|Center of pulmonology Astana, Astana, Kazakhstan",https://ClinicalTrials.gov/show/NCT04435353
NCT04748185,Immunogenicity and Safety of Commercially Available Vaccines Against SARS-CoV-2 (COVID-19) in Patients With Hematologic Malignancies,Observational Model: Cohort|Time Perspective: Prospective,20-012589,"Mayo Clinic, Rochester, Minnesota, United States",https://ClinicalTrials.gov/show/NCT04748185
NCT04357847,Assessment of Endothelial and Haemostatic Changes During Severe SARS-CoV-2 Infection,Observational Model: Cohort|Time Perspective: Prospective,2020/097/OB,"Rouen University Hospital, Rouen, France",https://ClinicalTrials.gov/show/NCT04357847
NCT04423315,Thrombosis Risk Assessment and Clinical Presentation of Covid-19 Pneumonia,Observational Model: Cohort|Time Perspective: Retrospective,20200504443,"Vital Hospital, Bahcelievler, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04423315
NCT04367350,Prospective Registry of Corona Virus Disease 2019 (Covid-19) Patients With Neuromuscular Involvement,Observational Model: Cohort|Time Perspective: Prospective,246/2020BO2,"University Hospital Tuebingen, Tuebingen, Germany",https://ClinicalTrials.gov/show/NCT04367350
NCT04370197,Covid-19 Epidemic on Acute Stroke Management,Observational Model: Case-Only|Time Perspective: Other,7826,"Service de Neuroradiologie Interventionnelle, Strasbourg, France",https://ClinicalTrials.gov/show/NCT04370197
NCT04517422,Efficacy of L. Plantarum and P. Acidilactici in Adults With SARS-CoV-2 and COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Other",ABB-COVID19,"Hospital General Dr. Manuel Gea Gonzalez, Mexico city, Mexico",https://ClinicalTrials.gov/show/NCT04517422
NCT04338672,The Impact of the Covid-19 Outbreak on Emergency Room Attendances of Surgical Patients,Observational Model: Cohort|Time Perspective: Retrospective,SMC-20-7078-YZ-CTIL,"Sheba Medical Center, Ramat Gan, Israel",https://ClinicalTrials.gov/show/NCT04338672
NCT04539821,Virtual Pain Care Management (COVID-19),Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,C19 20-397,"Rocky Mountain Regional VA Medical Center, Aurora, CO, Aurora, Colorado, United States|VA Connecticut Healthcare System West Haven Campus, West Haven, CT, West Haven, Connecticut, United States",https://ClinicalTrials.gov/show/NCT04539821
NCT04707339,Management of Acute Appendicitis at District General Hospital,Observational Model: Cohort|Time Perspective: Retrospective,3810,"The Princess Alexandra Hospital NHS Trust, Harlow, Essex, United Kingdom",https://ClinicalTrials.gov/show/NCT04707339
NCT04341922,A Online-delivered Cognitive-behavioral Intervention for Dysfunctional Worry Related to the Covid-19 Pandemic,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2020-01719,"Karolinska Institutet, Stockholm, Sweden",https://ClinicalTrials.gov/show/NCT04341922
NCT04643548,WHO Covid 19 - Neurological Abnormalities in SARS-CoV-2 ICU Patients,Observational Model: Cohort|Time Perspective: Prospective,NeuroCovid-RNI 2020 GODET,"CHU, Clermont-Ferrand, France",https://ClinicalTrials.gov/show/NCT04643548
NCT04334434,Telerehabilitation in Individuals Over 65 Years of Age Having Social Isolation Due to Coronavirus (Covid-19),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Prevention,2,"Istanbul university Cerrahpasa, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04334434
NCT04430062,Short-term Outcome of Covid-19 Surgical Patients: Case-series of a High-risk Area Community Hospital,Observational Model: Case-Only|Time Perspective: Retrospective,Covid19nr1,"Ospedale di Lodi - ASST Lodi, Lodi, Lombardia, Italy",https://ClinicalTrials.gov/show/NCT04430062
NCT04583293,Acute kIDnEy Injury in coviD-19,Observational Model: Cohort|Time Perspective: Prospective,UHDB/2020/076,"University Hospitals of Derby and Burton NHS Foundation Trust, Derby, Derbyshire, United Kingdom",https://ClinicalTrials.gov/show/NCT04583293
NCT04382391,Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2020-132-AGH,"AHN Allegheny General Hospital, Pittsburgh, Pennsylvania, United States|AHN West Penn Hospital, Pittsburgh, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04382391
NCT04895982,"Study to Evaluate Safety, Tolerability & Immunogenicity of BNT162b2 in Immunocompromised Participants ≥2 Years",Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,C4591024,NA,https://ClinicalTrials.gov/show/NCT04895982
NCT04621084,Influence of the COVId-19 Pandemic on STRESS and Eating Habits,Observational Model: Cohort|Time Perspective: Cross-Sectional,2020 COVISTRESS NUTRITION,"Clermont-Ferrand University Hospital, clermont-Ferrand, Aura, France",https://ClinicalTrials.gov/show/NCT04621084
NCT04765371,"Comparison Between Prednisolone and Dexamethasone on Mortality in Patients on Oxygen Therapy, With CoViD-19",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,CHRD1520|2020-005883-78,"Department of Emergency, Hospital Victor Dupouy, Argenteuil, France|Department of Pneumology and Infectious Medicine, Hospital Carnelle Portes de l'Oise, Beaumont, France|Department of Infectious and Tropical Diseases, Hospital Simone Veil, Eaubonne, France|Department of Infectious Medicine, Hospital of Gonesse, Gonesse, France|Department of Infectious and Tropical Diseases, Hospital René Dubos,, Pontoise, France|Department of Infectious and respiratory Diseases, Hospital Delafontaine, Saint-Denis, France",https://ClinicalTrials.gov/show/NCT04765371
NCT04402905,"Observational Study in Diagnosed Patients COVID-19, Supported on an Outpatient Basis. (COVID-PSL)",Observational Model: Cohort|Time Perspective: Retrospective,CREPATS 011,"Yasmine Dudoit, Paris, France",https://ClinicalTrials.gov/show/NCT04402905
NCT04410484,PREPARE-IBD: Physician Responses to Disease Flares and Patient Adaptation in Relation to Events in Inflammatory Bowel Disease During COVID-19 Pandemic,Observational Model: Case-Control|Time Perspective: Retrospective,284920,"Gastroenterology, Hull Royal Infirmary, Hull University Teaaching Hospitals NHS Trust, Hull, United Kingdom",https://ClinicalTrials.gov/show/NCT04410484
NCT04431466,A Study to Compare the Efficacy and Safety of Different Doses of Ivermectin for COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,IFORS,"Hospital Univeristário da Universidade Federal de São Carlos (HU-UFSCar), São Carlos, São Paulo, Brazil|Hospital Universitário da Universidade Federal de São Carlos (HU-UFSCar), São Carlos, São Paulo, Brazil",https://ClinicalTrials.gov/show/NCT04431466
NCT04530682,COVID-19 in Rheumatic Inflammatory Diseases Under Immuno-suppressive Drugs,Observational Model: Case-Control|Time Perspective: Prospective,RECHMPL20_0409|UF8074,"Centre hopsitalier universitaire de Montpellier, Montpellier, Occitanie, France",https://ClinicalTrials.gov/show/NCT04530682
NCT04326426,ODYSSEY: A Study to Investigate the Efficacy of Tradipitant in Treating Severe or Critical COVID-19 Infection,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",VLY-686-3501,"Lenox Hill Hospital Northwell Health, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04326426
NCT04685681,The Get Outside Study,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,STUDY00005101,"State University of New York at Buffalo, Buffalo, New York, United States",https://ClinicalTrials.gov/show/NCT04685681
NCT04452318,COVID-19 Study Assessing the Efficacy and Safety of Anti-Spike SARS CoV-2 Monoclonal Antibodies for Prevention of SARS CoV-2 Infection Asymptomatic in Healthy Adults and Adolescents Who Are Household Contacts to an Individual With a Positive SARS-CoV-2 RT-PCR Assay,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",R10933-10987-COV-2069|2020-003654-71,"Regeneron Study Site, Mesa, Arizona, United States|Regeneron Study Site, Tucson, Arizona, United States|Regeneron Study Site, Tucson, Arizona, United States|Regeneron Study Site, La Mesa, California, United States|Regeneron Study Site, La Palma, California, United States|Regeneron Study Site, Long Beach, California, United States|Regeneron Study Site, Los Angeles, California, United States|Regeneron Study Site, Los Angeles, California, United States|Regeneron Study Site, Los Angeles, California, United States|Regeneron Study Site, Montclair, California, United States|Regeneron Study Site, Northridge, California, United States|Regeneron Study Site, Oxnard, California, United States|Regeneron Study Site, Sacramento, California, United States|Regeneron Study Site, Sacramento, California, United States|Regeneron Study Site, San Diego, California, United States|Regeneron Study Site, San Francisco, California, United States|Regeneron Study Site, Stanford, California, United States|Regeneron Study Site, Torrance, California, United States|Regeneron Study Site, Torrance, California, United States|Regeneron Study Site, Aurora, Colorado, United States|Regeneron Study Site, Colorado Springs, Colorado, United States|Regeneron Study Site, Washington, District of Columbia, United States|Regeneron Study Site, Boca Raton, Florida, United States|Regeneron Study Site, Clearwater, Florida, United States|Regeneron Study Site, DeLand, Florida, United States|Regeneron Study Site, Fort Pierce, Florida, United States|Regeneron Study Site, Hialeah, Florida, United States|Regeneron Study Site, Jacksonville, Florida, United States|Regeneron Study Site, Lakeland, Florida, United States|Regeneron Study Site, Loxahatchee Groves, Florida, United States|Regeneron Study Site, Maitland, Florida, United States|Regeneron Study Site, Miami, Florida, United States|Regeneron Study Site, Miami, Florida, United States|Regeneron Study Site, Miami, Florida, United States|Regeneron Study Site, Miami, Florida, United States|Regeneron Study Site, Miami, Florida, United States|Regeneron Study Site, Miami, Florida, United States|Regeneron Study Site, Miami, Florida, United States|Regeneron Study Site, Orlando, Florida, United States|Regeneron Study Site, Sarasota, Florida, United States|Regeneron Study Site, Tampa, Florida, United States|Regeneron Study Site, West Palm Beach, Florida, United States|Regeneron Study Site, Winter Park, Florida, United States|Regeneron Study Site, Atlanta, Georgia, United States|Regeneron Study Site, Atlanta, Georgia, United States|Regeneron Study Site, Columbus, Georgia, United States|Regeneron Study Site, Decatur, Georgia, United States|Regeneron Study Site, Eatonton, Georgia, United States|Regeneron Study Site, Marietta, Georgia, United States|Regeneron Study Site, Sandy Springs, Georgia, United States|Regeneron Study Site, Chicago, Illinois, United States|Regeneron Study Site 2, Chicago, Illinois, United States|Regeneron Study Site 3, Chicago, Illinois, United States|Regeneron Study Site, Chicago, Illinois, United States|Regeneron Study Site 1, Downers Grove, Illinois, United States|Regeneron Study Site 2, Downers Grove, Illinois, United States|Regeneron Study Site, Ames, Iowa, United States|Regeneron Study Site, Lake Charles, Louisiana, United States|Regeneron Study Site, Marrero, Louisiana, United States|Regeneron Study Site, Metairie, Louisiana, United States|Regeneron Study Site, New Orleans, Louisiana, United States|Regeneron Study Site, Baltimore, Maryland, United States|Regeneron Study Site, Boston, Massachusetts, United States|Regeneron Study Site, Boston, Massachusetts, United States|Regeneron Study Site, Boston, Massachusetts, United States|Regeneron Study Site, Boston, Massachusetts, United States|Regeneron Study Site, Boston, Massachusetts, United States|Regeneron Study Site, Detroit, Michigan, United States|Regeneron Study Site, Royal Oak, Michigan, United States|Regeneron Study Site, Minneapolis, Minnesota, United States|Regeneron Study Site, Gulfport, Mississippi, United States|Regeneron Study Site, Jackson, Mississippi, United States|Regeneron Study Site, Hazelwood, Missouri, United States|Regeneron Study Site, Saint Louis, Missouri, United States|Regeneron Study Site, Las Vegas, Nevada, United States|Regeneron Study Site, Las Vegas, Nevada, United States|Regeneron Study Site, Morristown, New Jersey, United States|Regeneron Study Site, Newark, New Jersey, United States|Regeneron Study Site, Summit, New Jersey, United States|Regeneron Study Site, Teaneck, New Jersey, United States|Regeneron Study Site 1, Bronx, New York, United States|Regeneron Study Site 2, Bronx, New York, United States|Regeneron Study Site, Bronx, New York, United States|Regeneron Study Site, Buffalo, New York, United States|Regeneron Study Site, New York, New York, United States|Regeneron Study Site, New York, New York, United States|Regeneron Study Site, New York, New York, United States|Regeneron Study Site, New York, New York, United States|Regeneron Study Site, New York, New York, United States|Regeneron Study Site, New York, New York, United States|Regeneron Study Site, Chapel Hill, North Carolina, United States|Regeneron Study Site, Charlotte, North Carolina, United States|Regeneron Study Site, Fayetteville, North Carolina, United States|Regeneron Study Site, Raleigh, North Carolina, United States|Regeneron Study Site, Wilmington, North Carolina, United States|Regeneron Study Site, Winston-Salem, North Carolina, United States|Regeneron Study Site, Cincinnati, Ohio, United States|Regeneron Study Site, Columbus, Ohio, United States|Regeneron Study Site, Columbus, Ohio, United States|Regeneron Study Site, Dayton, Ohio, United States|Regeneron Study Site, Danville, Pennsylvania, United States|Regeneron Study Site, Philadelphia, Pennsylvania, United States|Regeneron Study Site, Philadelphia, Pennsylvania, United States|Regeneron Study Site, Wilkes-Barre, Pennsylvania, United States|Regeneron Study Site, Providence, Rhode Island, United States|Regeneron Study Site, Charleston, South Carolina, United States|Regeneron Study Site, Charleston, South Carolina, United States|Regeneron Study Site, Clinton, South Carolina, United States|Regeneron Study Site, Gaffney, South Carolina, United States|Regeneron Study Site, Sioux Falls, South Dakota, United States|Regeneron Study Site, Chattanooga, Tennessee, United States|Regeneron Study Site, Knoxville, Tennessee, United States|Regeneron Study Site, Memphis, Tennessee, United States|Regeneron Study Site, Nashville, Tennessee, United States|Regeneron Study Site, Bellaire, Texas, United States|Regeneron Study Site, Corpus Christi, Texas, United States|Regeneron Study Site, Dallas, Texas, United States|Regeneron Study Site, Houston, Texas, United States|Regeneron Study Site, Houston, Texas, United States|Regeneron Study Site, Houston, Texas, United States|Regeneron Study Site, Houston, Texas, United States|Regeneron Study Site, Houston, Texas, United States|Regeneron Study Site, Pearland, Texas, United States|Regeneron Study Site, Red Oak, Texas, United States|Regeneron Study Site, San Antonio, Texas, United States|Regeneron Study Site, Tyler, Texas, United States|Regeneron Study Site, Charlottesville, Virginia, United States|Regeneron Study Site, Richmond, Virginia, United States|Regeneron Study Site, Everett, Washington, United States|Regeneron Study Site, Seattle, Washington, United States|Regeneron Study Site, Yakima, Washington, United States|Regeneron Study Site, Madison, Wisconsin, United States|Regeneron Study Site, Chisinau, Moldova, Republic of|Regeneron Study Site, Bucharest, Romania",https://ClinicalTrials.gov/show/NCT04452318
NCT04374942,Does Hydroxychloroquine Before & During Patient Exposure Protect Healthcare Workers From Coronavirus?,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",HEROs Protocol 1.5|ISRCTN14326006,"University Health Network, Toronto, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04374942
NCT04743947,Vaccination Against COVID-19 in Chronic Kidney Disease,Observational Model: Cohort|Time Perspective: Prospective,2020-1237,"MVZ DaVita Rhein-Ruhr, Düsseldorf, Germany|KfH Kuratorium für Dialyse und Nierentransplantation e.V., Düsseldorf, Germany|University Hospital Düsseldorf, Heinrich Heine University, Düsseldorf, Germany|Nephrocare Mettmann, Mettmann, Germany|Hospital Solingen, Solingen, Germany",https://ClinicalTrials.gov/show/NCT04743947
NCT04282902,A Study to Evaluate the Efficacy and Safety of Pirfenidone With Novel Coronavirus Infection,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,huilanz_76,"Tongji hospital affiliated to huazhong university of science and technology, Wuhan, Hubei, China",https://ClinicalTrials.gov/show/NCT04282902
NCT04918797,COVAXIN in a Pediatric Cohort,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,BBIL/BBV152/2021,"Victoria Government Hospital, Visakhapatnam, Andhra Pradesh, India|All India Institute of Medical Sciences, Patna, Bihar, India|Cheluvambha Hospital, Mysore, Karnataka, India|Meditrina Institute of Medical Sciences, Nagpur, Maharashtra, India|Jawahar Lal Nehru Medical college, Ajmer, Rajasthan, India|Pranam Hospitals Hyderabad, Hyderabad, Telangana, India|Prakhar Hospital, Kanpur, Uttar Pradesh, India",https://ClinicalTrials.gov/show/NCT04918797
NCT04864548,COV-CHIM01: SARS-CoV-2 (COVID-19) Dose Finding Infection Study,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Other,COV-CHIM01,"Oxford Clinical Research Facility (OxCRF), Oxford, Oxon, United Kingdom|Centre for Clinical Vaccinology and Tropical Medicine, Oxford, Oxon, United Kingdom|Oxford University Hospital NHS Trust, Oxford, Oxon, United Kingdom",https://ClinicalTrials.gov/show/NCT04864548
NCT04327180,PREdiction of DIagnosed Covid-19 infecTion in IUC Patients,Observational Model: Cohort|Time Perspective: Prospective,2020_20|2020-A00763-36,"Hôpital Roger Salengro, ICU, CHU Lille, Lille, France",https://ClinicalTrials.gov/show/NCT04327180
NCT04372030,Health Care Use During the Covid19 Crisis,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,US3R,NA,https://ClinicalTrials.gov/show/NCT04372030
NCT04479280,Evaluation of Coagulopathy in Critically Ill COVID-19 Patients.,Observational Model: Case-Control|Time Perspective: Prospective,17300446,"Assiut university, Assiut, Egypt",https://ClinicalTrials.gov/show/NCT04479280
NCT04411563,Epigenetic Tools as Prognostic Predictors in Covid19,Observational Model: Cohort|Time Perspective: Prospective,2020/143,"Bakirkoy Dr. Sadi Konuk Research and Training Hospital, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04411563
NCT04756856,Muscle-targeted Nutritional Therapy for the Recovery From COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,20210006520,"Fondazione IRCCS Policlinico San Matteo, Pavia, Italy",https://ClinicalTrials.gov/show/NCT04756856
NCT04665778,Prediction of the Patient Pathway in Emergency Room in an Exceptional Sanitary Situation,Observational Model: Case-Only|Time Perspective: Prospective,PI2020_843_0055,"CHU Amiens, Amiens, France",https://ClinicalTrials.gov/show/NCT04665778
NCT04613739,Asthma in Families Facing Out-of-pocket Requirements Due to COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,IHS-1602-34331,"Harvard Pilgrim Health Care, Wellesley, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT04613739
NCT04762693,Digital Acoustic Surveillance for Early Detection of Respiratory Disease Outbreaks,Observational Model: Cohort|Time Perspective: Prospective,DASRD,"Universidad de Navarra, Pamplona, Navarra, Spain",https://ClinicalTrials.gov/show/NCT04762693
NCT04792086,Disease Containment Measures Among Older Adults During the Covid-19 Pandemia,Observational Model: Cohort|Time Perspective: Prospective,COVID19-AIT,"Norwegian National Advisory Unit of Ageing and Health, Tønsberg, Norway",https://ClinicalTrials.gov/show/NCT04792086
NCT04944823,"Characterization Immunology, Biochemical and Lung Microbiome, Correlated With the Ventilation Associated Pneumonia (VAP)",Observational Model: Cohort|Time Perspective: Prospective,MED-286-2020,"Clinica Universidad De La Sabana, Chía, Cundinamarca, Colombia",https://ClinicalTrials.gov/show/NCT04944823
NCT04412655,Primary Angioplasty for STEMI During COVID-19 Pandemic (ISACS-STEMI COVID-19) Registry,Observational Model: Cohort|Time Perspective: Retrospective,115/20,"Giuseppe De Luca, Novara, Italy",https://ClinicalTrials.gov/show/NCT04412655
NCT04377737,Incidence of Covid-19 in School Children,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,20-HPNCL-02,"Hôpitaux Pédiatrique de Nice CHU Lenval, Nice, France",https://ClinicalTrials.gov/show/NCT04377737
NCT04519307,Evaluation of Newborns Presenting With Suspected COVID 19,Observational Model: Case-Control|Time Perspective: Prospective,2020/251,"İzmir Dr. Behcet Uz Training and Research Hospital, İzmir, Turkey",https://ClinicalTrials.gov/show/NCT04519307
NCT04916847,Comparative Analysis of Anti-COVID-19 (Severe Acute Respiratory Syndrome) Humoral and Memory T Cell Responses in Children With Various Degrees of Immunosuppression:,Observational Model: Case-Control|Time Perspective: Prospective,APH210217,"Hôpital Robert Debré, Paris, France",https://ClinicalTrials.gov/show/NCT04916847
NCT04276688,"Lopinavir/ Ritonavir, Ribavirin and IFN-beta Combination for nCoV Treatment",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,UW-20-074,"University of Hong Kong, Queen Mary Hospital, Hong Kong, Hong Kong",https://ClinicalTrials.gov/show/NCT04276688
NCT04412551,Lung Ultrasound for Assessment of Patients With Moderate to Severe Covid-19,Observational Model: Cohort|Time Perspective: Prospective,LUS-Covid001,"Falun Hospital, Falun, Sweden",https://ClinicalTrials.gov/show/NCT04412551
NCT04361552,Tocilizumab for the Treatment of Cytokine Release Syndrome in Patients With COVID-19 (SARS-CoV-2 Infection),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,STUDY00000419|NCI-2020-02314|WINSHIP4998-20|P30CA138292,"Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States",https://ClinicalTrials.gov/show/NCT04361552
NCT04961385,Immunogenicity of the ChAdox1 n CoV-19 Vaccine With 12-dose Vial,Observational Model: Case-Only|Time Perspective: Cross-Sectional,111/64,"Thananda Trakarnvanich, Bangkok, Thailand",https://ClinicalTrials.gov/show/NCT04961385
NCT04385186,Inactivated Convalescent Plasma as a Therapeutic Alternative in Patients CoViD-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Treatment,CT01,"Clínica Antioquía, Medellín, Antioquía, Colombia|Clínica Sagrado Corazón, Medellín, Antioquía, Colombia|IPS Universitaria, Medellín, Antioquía, Colombia|Universidad de Antioquía, Medellín, Antioquía, Colombia|National Blood Center Foundation, Hemolife/Fundación Banco Nacional de Sangre Hemolife, Bogotá, Cundinamarca, Colombia|Clínica Rosales, Pereira, Risaralda, Colombia|Clinica Nuestra, Cali, Valle, Colombia|Clínica Corpas, Bogotá, Colombia|E.S.E Hospital San Rafael Facatativa, Facatativa, Colombia|Clínica la Estancia, Popayán, Colombia",https://ClinicalTrials.gov/show/NCT04385186
NCT04668339,A Trial Evaluating the Safety and Effects of an RNA Vaccine ARCT-021 in Healthy Adults,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",ARCT-021-04,"Arcturus Investigational Site 103, Chandler, Arizona, United States|Arcturus Investigational Site 107, Tucson, Arizona, United States|Arcturus Investigational Site 112, San Diego, California, United States|Arcturus Investigational Site 104, Melbourne, Florida, United States|Arcturus Investigational Site 105, Orlando, Florida, United States|Arcturus Investigational Site 106, Pinellas Park, Florida, United States|Arcturus Investigational Site 109, The Villages, Florida, United States|Arcturus Investigational Site 101, Peoria, Illinois, United States|Arcturus Investigational Site 110, Rockville, Maryland, United States|Arcturus Investigational Site 102, Anderson, South Carolina, United States|Arcturus Investigational Site 111, Austin, Texas, United States|Arcturus Investigational Site 108, Dallas, Texas, United States|Arcturus Investigational Site 204, Singapore, Singapore|Arcturus Investigational Site 201, Singapore, Singapore|Arcturus Investigational Site 203, Singapore, Singapore",https://ClinicalTrials.gov/show/NCT04668339
NCT04320862,COVID-19 Pandemic Response Network,Observational Model: Cohort|Time Perspective: Prospective,Pro00105189,"Duke University Medical Center, Durham, North Carolina, United States",https://ClinicalTrials.gov/show/NCT04320862
NCT04515225,COVID-19 Prevalence in HIV-infected Patients,Observational Model: Cohort|Time Perspective: Prospective,7947,NA,https://ClinicalTrials.gov/show/NCT04515225
NCT04412746,Covid-19 and Diabetes in West of Algeria,Observational Model: Cohort|Time Perspective: Prospective,COVIDIAB-13,"Department of Internal Medicine, Acedemic Hospital of Tlemcen, Tlemcen, Algeria",https://ClinicalTrials.gov/show/NCT04412746
NCT04487639,Presence of SARS-CoV-2 in Semen: Impact on Fertility Preservation in Male Oncological Patients ?,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,RNI 2020 BRUGNON|2020-A01409-30,"AP-Hôpitaux de Paris - Hôpital Jean Verdier - Service de Biologie de la reproduction, Bondy, France|AP-Hôpitaux de Paris - Hôpital Antoine Béclére - Service de Biologie de la reproduction et AMP DPI CECOS, Clamart, France|CHU de Clermont-Ferrand - Laboratoire de Virologie, Clermont-Ferrand, France|CHU de Clermont-Ferrand, Clermont-Ferrand, France|CHU de Dijon - Laboratoire de Biologie de la Reproduction-CECOS, Dijon, France|CHU de Grenoble - Laboratoire d'Aide à la Procréation CECOS, Grenoble, France|Hospices Civils de Lyon - Service AMP-CECOS, Lyon, France|Hôpital de la Conception - AP-Hôpitaux de Marseille - Service AMP-CECOS, Marseille, France|CHU de Nancy - Laboratoire de biologie de la reproduction - CECOS, Nancy, France|AP-Hôpitaux de Paris - Hôpital Tenon - Service de Biologie de la reproduction - CECOS, Paris, France|AP-Hôpitaux de Paris - Hôpital Cochin - Service d'Histologie-Embryologie-Biologie de la reproduction, Paris, France|Centre Hospitalier intercommunal (CHI) de Poissy Saint Germain en Laye, Poissy, France|CHU de Reims - Service de Biologie de la Reproduction - CECOS Champagne-Ardenne de Reims, Reims, France|CHU de Rouen Normandie - Service Biologie de la Reproduction-CECOS, Rouen, France|CHU de Strasbourg - Service de Biologie de la reproduction, Strasbourg, France|CHU de Toulouse - CECOS Midi-Pyrénées, Toulouse, France",https://ClinicalTrials.gov/show/NCT04487639
NCT04455360,Early EMDR Following Covid-19 Critical Illness: A Feasibility Trial,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,Protocol version 1.2,"University Hospital Southampton NHS Foundation Trust, Southampton, Hamphsire, United Kingdom",https://ClinicalTrials.gov/show/NCT04455360
NCT04954157,Studies to Determine Whether Oxygen Sensing is Impaired in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infected Patients,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,IRB20-0898,"University of Chicago Medical Center, Chicago, Illinois, United States",https://ClinicalTrials.gov/show/NCT04954157
NCT04359407,Prone Positioning and Regional Ventilation in Mechanically Ventilated COVID-19 Patients,Observational Model: Case-Only|Time Perspective: Prospective,2020-00896,"University Hospitals of Geneva, Geneva, Switzerland",https://ClinicalTrials.gov/show/NCT04359407
NCT04594525,Maternal Telemental Health Interventions in Response to Covid-19*,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention,MRC-05-087,NA,https://ClinicalTrials.gov/show/NCT04594525
NCT04358952,Myocardial Involvement of Severe Acute Respiratory Syndrome-Cov-2 (Covid19) Infected Patients,Observational Model: Other|Time Perspective: Prospective,RC31/20/0117|2020-A00852-37,"UHToulouse, Toulouse, France",https://ClinicalTrials.gov/show/NCT04358952
NCT04344834,Short and Long-term Psychological Impact of Covid-19 on The Egyptians,Observational Model: Ecologic or Community|Time Perspective: Cross-Sectional,Covid-19 mental health,"Faculty of Medicine, Assiut, Egypt",https://ClinicalTrials.gov/show/NCT04344834
NCT04345549,Ayurveda Self-Management for Flu Like Symptoms During the Covid-19 Outbreak,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,AU08,"Aarogyam, Leicester, United Kingdom",https://ClinicalTrials.gov/show/NCT04345549
NCT04290858,Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID19 Infection,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,COVID19 NOgas mild,NA,https://ClinicalTrials.gov/show/NCT04290858
NCT04427176,Evaluation of ARFC Masks Equipped With CF5 Filter in the Care Unit to Allow a Wider Distribution of FFP2 Masks (Covid-19).,Observational Model: Other|Time Perspective: Prospective,20CH073|2020-A00817-32,"CHU Saint-Etienne, Saint-Étienne, France",https://ClinicalTrials.gov/show/NCT04427176
NCT04659252,CORONADO (Circulating tumOur pROtein quaNtification cApillary blooD cOvid-19),Observational Model: Cohort|Time Perspective: Prospective,CCR5361,"The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom",https://ClinicalTrials.gov/show/NCT04659252
NCT04382378,Effects of NMES in Critically Ill Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,FAP042017,"Secretaria de Saúde do Distrito Federal, Brasilia, DF, Brazil",https://ClinicalTrials.gov/show/NCT04382378
NCT04463628,"Impacts of the Covid-19 Epidemic and Associated Lockdown Measures on the Management, Health and Behaviors of Cystic Fibrosis Patients During the 2020 Epidemic",Observational Model: Cohort|Time Perspective: Prospective,MUCONFIN,"Intercommunal hospital of Créteil, Creteil, IDF, France|TROUSSEAU Hospital, Paris, IDF, France|FOCH Hospital, Suresnes, IDF, France",https://ClinicalTrials.gov/show/NCT04463628
NCT04944134,COVID-19 Antibody Levels After Vaccines,Observational Model: Cohort|Time Perspective: Prospective,21-0371,"University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States",https://ClinicalTrials.gov/show/NCT04944134
NCT04918940,Efficacy of COVID-19 Vaccination in Patientstreated With Anti-CD20 for Follicular Lymphoma or Mantle Cell Lymphoma,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,CHB21.03,"Centre Henri Becquerel, Rouen, France",https://ClinicalTrials.gov/show/NCT04918940
NCT04517682,COVID-19 and SARS-CoV-2 Detection in Saliva,Observational Model: Cohort|Time Perspective: Prospective,COV_20_001,"Ambry Genetics, Aliso Viejo, California, United States",https://ClinicalTrials.gov/show/NCT04517682
NCT04726163,Tele-expertise in Patients With Diabetes Hospitalized for Covid-19 Infection,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,8078,"Hopitaux Universitaires de Strasbourg, Strasbourg, France",https://ClinicalTrials.gov/show/NCT04726163
NCT04393818,Mobile Phone Based Intervention to Protect Mental Health in Healthcare Workers at Frontline Against COVID19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Supportive Care",COVID-19/06,"Ignacio Ricci-Cabello, Palma De Mallorca, Balearic Islands, Spain",https://ClinicalTrials.gov/show/NCT04393818
NCT04923386,mRNA Based-Covid-19 Vaccine Effects on Blood Glucose Levels,Observational Model: Case-Only|Time Perspective: Retrospective,Macknofsky 1,NA,https://ClinicalTrials.gov/show/NCT04923386
NCT04324736,"""COVID-19 and Diabetes Outcomes""",Observational Model: Cohort|Time Perspective: Retrospective,RC20_0148,"CHU Nantes, Nantes, France",https://ClinicalTrials.gov/show/NCT04324736
NCT04587245,The Provider Insurance Revenue Study in Healthcare Providers in the United States of America,Observational Model: Cohort|Time Perspective: Retrospective,PIRStudy,"University of California Irvine Beall Applied Innovation, Irvine, California, United States",https://ClinicalTrials.gov/show/NCT04587245
NCT04959708,Online Physical Therapy Management for Physiotherapists to Cope Psychological Distress During Covid-19 Pandemic,"Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment",PHYSFORPHYS,NA,https://ClinicalTrials.gov/show/NCT04959708
NCT04435119,Covid-19 and Vitamin D in Nursing-home,Observational Model: Cohort|Time Perspective: Retrospective,2020/67,"Angers University Hospital, Angers, France",https://ClinicalTrials.gov/show/NCT04435119
NCT04383457,Covid-19 Triage Using Camera-based AI,Observational Model: Cohort|Time Perspective: Prospective,U1111-1251-4114,"Östra Sjukhuset, Gothenburg, Sweden",https://ClinicalTrials.gov/show/NCT04383457
NCT04754698,COVID-19 CoronaVac in Patients With Autoimmune Rheumatic Diseases and HIV/AIDS,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,42566621.0.0000.0068,"University of Sao Paulo General Hospital, São Paulo, SP, Brazil",https://ClinicalTrials.gov/show/NCT04754698
NCT04486417,Feasibility of a Telematics Pre-operative Assessment in a Bariatric Surgery During Covid-19,Observational Model: Other|Time Perspective: Prospective,66.2,"Gianfranco Silecchia, Latina, Italy",https://ClinicalTrials.gov/show/NCT04486417
NCT04416360,Autism Spectrum Disorder or Attention Deficit Hyperactivity Disorder in Covid-19 Outbreak,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,RC31/20/0151,"University hospital of Toulouse, Toulouse, Occitanie, France|Centre Hospitalier de Versailles, Le Chesnay, France|Centre Hospitalier Esquirol, Limoges, France|Hôpital Robert-Debré (AP-HP), Paris, France|Maison de Solenn (Hôpital Cochin AP-HP), Paris, France",https://ClinicalTrials.gov/show/NCT04416360
NCT04869358,Exploring the Immune Response to SARS-CoV-2 COVID-19 Vaccines in Patients With Relapsing Multiple Sclerosis (RMS) Treated With Ofatumumab,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,COMB157GDE01,"Novartis Investigative Site, Bielefeld, Germany|Novartis Investigative Site, Dresden, Germany|Novartis Investigative Site, Erbach, Germany|Novartis Investigative Site, Erlangen, Germany|Novartis Investigative Site, Siegen, Germany|Novartis Investigative Site, Ulm, Germany|Novartis Investigative Site, Unterhaching, Germany",https://ClinicalTrials.gov/show/NCT04869358
NCT04615741,Finding Wellness in the Pandemic,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2020-096,"University of Lethbridge, Lethbridge, Alberta, Canada",https://ClinicalTrials.gov/show/NCT04615741
NCT04375748,Hospital Registry of Acute Myocarditis: Evolution of the Proportion of Positive SARS-COV-2 (COVID19) Cases,Observational Model: Cohort|Time Perspective: Prospective,RC31/20/0139,"Cardiology, Aix-en-Provence, France|Reanimation, Amiens, France|Cardiology, Angers, France|Reanimation, Angers, France|Cardiology, Avignon, France|Cardiology, Bordeaux, France|Pediatric cardiology, Bordeaux, France|Reanimation, Bordeaux, France|Cardiology, Brest, France|Cardiology, Caen, France|Pediatric Cardiology, Caen, France|Cardiology, Clermont-Ferrand, France|Pediatric cardilogy, Clermont-Ferrand, France|Reanimation, Clermont-Ferrand, France|Pediatric cardiology, Dijon, France|Cardiology, Grenoble, France|Pediatric cardiology, Grenoble, France|Reanimation, Grenoble, France|Cardiology, Lille, France|Pediatric cardiology, Lille, France|Pediatric cardiology, Limoges, France|Cardiology, Lyon, France|Pediatric cardiology, Lyon, France|Cardiology, Marseille, France|Pediatric cardiology, Marseille, France|Cardiology, Metz, France|Cardiology, Montpellier, France|Millénaire Clinical - Cardiology, Montpellier, France|Pediatric cardiology, Montpellier, France|Reanimation, Montpellier, France|Cardiology, Nancy, France|Cardiology, Nancy, France|Pediatric cardiology, Nancy, France|Cardiology, Nantes, France|Pediatric cardiology, Nantes, France|Cardiology, Nice, France|Pediatric cardiology, Nice, France|Cardiology, Nîmes, France|Cardiology, Henri Mondor Hospital, Paris, France|Cardiology, Paris, France|Cardiology, Paris, France|Henri Mondor Hospital Reanimation, Paris, France|Marie Lannelongue Hospital - Pediatric Cardiology, Paris, France|Marie Lannelongue Hospital Cardiology, Paris, France|Reanimation, Paris, France|Reanimation, Paris, France|Robert Debré Hospital - Pediatric cardiology, Paris, France|Saint Antoine Hospital - Cardiology, Paris, France|Cardiology, Poitiers, France|Reanimation, Poitiers, France|Pediatric cardiology, Reims, France|Cardiology, Rennes, France|Pediatric reanimation, Rennes, France|Cardiology, Rouen, France|Pediatric cardiology, Rouen, France|Pédiatric cardiology, Strasbourg, France|Reanimation, Strasbourg, France|CHU de TOULOUSE, Toulouse, France|Croix du Sud Clinical, Toulouse, France|Pasteur Clinical - Cardiology, Toulouse, France|Pasteur Clinical - Pediatric cardiology, Toulouse, France|Pediatric Cardiology, Toulouse, France|Cardiolgy, Tours, France|Pediatric Cardiology, Tours, France|Cardiology, Valenciennes, France|Cardiology, Martinique, Martinique|Cardiology, Mamoudzou, Mayotte|Pédiatric cardiology, Réunion, Réunion",https://ClinicalTrials.gov/show/NCT04375748
NCT04371302,Nursing Perspective on Burnout and Medical Errors in the Intensive Care Unit During Covid-19 Pandemic,Observational Model: Cohort|Time Perspective: Cross-Sectional,54843,NA,https://ClinicalTrials.gov/show/NCT04371302
NCT04756609,"Systematic Offer of Nurse-Driven Screening for COVID-19 in Emergency Departments in the Paris Metropolitan Area, DEPIST-COVID",Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Screening,APHP201625|IDRCB: 2020-A03532-37,"URC-EST, Hôpital saint-Antoine, Paris, France",https://ClinicalTrials.gov/show/NCT04756609
NCT04844697,Resilience and Coping in a Rare Skeletal Disease Population to Face Coronavirus (COVID-19) Outbreak Distress: a Longitudinal Study,Observational Model: Cohort|Time Perspective: Prospective,150/2021/Oss/IOR,"IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy",https://ClinicalTrials.gov/show/NCT04844697
NCT04490200,Effectiveness of a Novel Respirator With Chitosan Nanoparticles,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Prevention",VESTA Trial|32862320.0.0000.0030,"HRAN (Hospital Regional da Asa Norte), Brasília, Brazil",https://ClinicalTrials.gov/show/NCT04490200
NCT04354792,Asymptomatic COVID-19 Infection Among Healthcare Workers,Observational Model: Cohort|Time Perspective: Cross-Sectional,N-31-2020,"Cairo University Hospital, Cairo, Egypt",https://ClinicalTrials.gov/show/NCT04354792
NCT04387968,"Epidemiological Study of the Covid-19 Presto Test - The ""COVIDOR"" Study",Observational Model: Ecologic or Community|Time Perspective: Prospective,2020-A01414-35,"Unité de Recherche PARADICT-O - Service de Médecine - Orléans Métropole, Orléans, France|Unité de Recherche PARADICT-O - Service de Médecine - Orléans Métropole, Orléans, France",https://ClinicalTrials.gov/show/NCT04387968
NCT04319172,Multicentric Study of Coronavirus Disease 2019 (COVID-2019) in Solid Organ Transplant Recipients,Observational Model: Cohort|Time Perspective: Prospective,COVIDSOT,"Hospital Universitario Virgen del Rocio, Seville, Spain",https://ClinicalTrials.gov/show/NCT04319172
NCT04288713,Eculizumab (Soliris) in Covid-19 Infected Patients,NA,COVID19,NA,https://ClinicalTrials.gov/show/NCT04288713
NCT04821908,Consequences of COVID 19 Pandemic on Childhood Asthma,Observational Model: Other|Time Perspective: Prospective,2020_85|2020-A03365-34,NA,https://ClinicalTrials.gov/show/NCT04821908
NCT04290780,COVID-19 - Multicenter Study on Nosocomial Transmission of SARS-CoV-2 Virus,Observational Model: Cohort|Time Perspective: Prospective,69HCL20_0214,"Service Hygiène, Epidémiologie et Prévention, Lyon, France|Service Hygiène, Epidémiologie et Prévention, Lyon, France",https://ClinicalTrials.gov/show/NCT04290780
NCT04945356,Telerehabilitation During Pandemic Containment Measures of COVID19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,MP-31-2021-3817,"Université du Québec à Chicoutimi, Chicoutimi, Quebec, Canada|McGill University, Montréal, Quebec, Canada|Centre de recherche sur le vieillissement, Sherbrooke, Quebec, Canada",https://ClinicalTrials.gov/show/NCT04945356
NCT04900467,Compare Immunological Efficacy of a Vaccine Regimen Combining Two Covid19 mRNA Vaccines (Pfizer-BioNTech and Moderna) With That of a Homologous Vaccination of Each Covid19 mRNA Vaccine,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,APHP210605|2021-002174-52,"CIC 1417 Cochin-Pasteur, Paris, France",https://ClinicalTrials.gov/show/NCT04900467
NCT04810949,Vitamine D3 Supplementation in Patients With Serum Values +/- 20ng/ml,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,Vitamina D NOVA,"Hospital Clinica Nova de Monterrey, San Nicolás De Los Garza, Nuevo León, Mexico",https://ClinicalTrials.gov/show/NCT04810949
NCT04427631,Exploring Interventions for Glue Ear During Covid-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,262816,"Peacock Children's centre. Brookfields Hospital, Cambridge, Cambridgeshire, United Kingdom",https://ClinicalTrials.gov/show/NCT04427631
NCT04380701,A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-2019 in Healthy and Immunocompromised Adults,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,BNT162-01|2020-001038-36|U1111-1249-4220,"Contract Research Organization, Berlin, Germany|Universitäts Klinikum, Frankfurt am Main, Germany|Universitäts Klinikum, Heidelberg, Germany|Contract Research Organization, Kiel, Germany|Contract Research Organization, Mannheim, Germany",https://ClinicalTrials.gov/show/NCT04380701
NCT04793997,Microbiome Therapy in Covid-19 Primary Care Support,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",B3002021000018,"Veronique Verhoeven, Antwerp, Belgium",https://ClinicalTrials.gov/show/NCT04793997
NCT04389320,Antimalarial and Covid 19 in Rheumatoid Arthritis,Observational Model: Cohort|Time Perspective: Cross-Sectional,covid 19 in RA,"Manal Hassanien, Assiut, Yes, Egypt",https://ClinicalTrials.gov/show/NCT04389320
NCT04388826,COVID-19 Treatment of Severe Acute Respiratory Syndrome With Veru-111,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",V0211901,"HonorHealth, Scottsdale, Arizona, United States|Methodist Hospital, Saint Louis Park, Minnesota, United States|Regions Hospital, Saint Paul, Minnesota, United States|Inspira Medical Center, Vineland, New Jersey, United States|Memorial Hermann Memorial City Hospital, Houston, Texas, United States",https://ClinicalTrials.gov/show/NCT04388826
NCT04322513,Biomarkers for Identification of COVID-19 Infection,Observational Model: Case-Control|Time Perspective: Prospective,covid-19 biomarkers,"Luca Gallelli, Catanzaro, Italy",https://ClinicalTrials.gov/show/NCT04322513
NCT04637867,COVID-19 - Multicentre Study on Nosocomial Transmission of SARS-CoV-2 Virus: an Ancillary Study (NOSO-COR IMMUNO),Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,69HCL20_0761,"Service épidémiologie, Hopital édouard Herriot, Lyon, Rhone, France|hopital Edouard Herriot, Lyon, France",https://ClinicalTrials.gov/show/NCT04637867
NCT04409951,Pharmacy Education During Covid-19 Outbreak,Observational Model: Case-Crossover|Time Perspective: Cross-Sectional,Educational process & Covid-19,"Damanhour university, Beheira, Damanhour, Egypt",https://ClinicalTrials.gov/show/NCT04409951
NCT04318366,"COVID-19 Patients Characterization, Biobank, Treatment Response and Outcome Predictor",Observational Model: Cohort|Time Perspective: Prospective,COVID-BioB/OSR,"Autoimmunity and Vascular Inflammation Unit, Division of Regenerative Medicine, Stem Cells and Gene Therapy - IRCCS San Raffaele Scientific Institute, Milan, Lombardy, Italy|AIDS Immunopathogenesis Unit - IRCCS San Raffaele Scientific Institute, Milan, Lombardy, Italy|Department of Infection Diseases - IRCCS San Raffaele Scientific Institute -, Milan, Lombardy, Italy|Department of Internal Medicine - IRCCS San Raffaele Scientific Institute, Milan, Lombardy, Italy|Diabetes Research Institute -IRCCS San Raffaele Scientific Istitute, Milan, Lombardy, Italy|Division of Immunology, Transplantation and Infectious Diseases - IRCCS San Raffaele Scientific Institute, Milan, Lombardy, Italy|Division of Research of Regenerative Medicine, Cell and Gene Therapy - IRCCS San Raffaele Scientific Istitute, Milan, Lombardy, Italy|Laboratory of Microbiology and Virology - IRCCS San Raffaele Scientific Institute, Milan, Lombardy, Italy|Nephrology Unit - IRCCS San Raffaele Scientific Institute, Milan, Lombardy, Italy|Strategic Program in Nephrology and Dialysis - IRCCS San Raffaele Scientific Institute, Milan, Lombardy, Italy|Viral pathogens and biosafety Unit - IRCCS San Raffaele Scietific Institute, Milan, Lombardy, Italy|Unit of Immunology, Rheumatology, Allergy and Rare Diseases - IRCCS San Raffaele Scientific Institute, Milan, Lombardy, Italy|Università Vita-Salute San Raffaele, Milano, Mi, Italy",https://ClinicalTrials.gov/show/NCT04318366
NCT04482205,Covid -19 Pandemic: Economic Burden on Patients Operated for Traumatic Close Fractures,Observational Model: Other|Time Perspective: Retrospective,akupde,"Aga Khan University Hospital, Karachi, Sindh, Pakistan",https://ClinicalTrials.gov/show/NCT04482205
NCT04615195,Effect of COVID19-related COntainment in ChildreN,Observational Model: Cohort|Time Perspective: Prospective,RC31/20/0205,"UHToulouse, Toulouse, France",https://ClinicalTrials.gov/show/NCT04615195
NCT04633772,Use of Angiotensin-(1-7) in COVID-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",RBR-35734p,"Hospital Eduardo de Menezes, Belo Horizonte, Minas Gerais, Brazil|Hospital Mater Dei, Belo Horizonte, Minas Gerais, Brazil",https://ClinicalTrials.gov/show/NCT04633772
NCT04374474,Anosmia Rehabilitation in Patients Post Coronavirus Disease (COVID 19),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,Anosmia_CoVID 19,"St. Joseph's Health Care, London, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04374474
NCT04941001,Optimisation of ASthma In Those With Uncontrolled Symptoms (OASIS),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Care Provider)|Primary Purpose: Supportive Care,274450,NA,https://ClinicalTrials.gov/show/NCT04941001
NCT04423692,Knowledge About Covid-19 Infection in Pregnant Women,Observational Model: Other|Time Perspective: Prospective,Knowledge about covid 19,"Aljazeera( Al Gazeera) hospital, Giza, Egypt",https://ClinicalTrials.gov/show/NCT04423692
NCT04448405,Covid-19 Lockdown and Deviant Sexual Fantasies,Observational Model: Cohort|Time Perspective: Prospective,RECHMPL20_0341,"Uhmontpellier, Montpellier, France",https://ClinicalTrials.gov/show/NCT04448405
NCT04345887,Spironolactone in Covid-19 Induced ARDS,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",10042020,"Istanbul University-Cerrahpaşa, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04345887
NCT04320953,Non-contact Endoscopy at Covid-19 Outbreak,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,ncMCE1,"Changhai Hospital, Shanghai, China",https://ClinicalTrials.gov/show/NCT04320953
NCT04409574,COVID 19 Viral Clearance Among the Infected Healthcare Workers In Assiut University Hospitals,Observational Model: Case-Only|Time Perspective: Cross-Sectional,COVID19 among HCWs,NA,https://ClinicalTrials.gov/show/NCT04409574
NCT04378738,Social Media and Covid19 Pandemic,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,AcibademU social media,"Bahar Yuksel, Istanbul, Turkey|Haseki Training and Research Hospital, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04378738
NCT04514705,Characteristics in Post Covid-19 Patients,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,F110820,"Universidade do Estado do Pará, Belém, Pará, Brazil",https://ClinicalTrials.gov/show/NCT04514705
NCT04368312,Psychological Impairment Due to Covid-19,Observational Model: Cohort|Time Perspective: Prospective,TEMP553914-BO,"University Hospital Essen, Essen, NRW, Germany",https://ClinicalTrials.gov/show/NCT04368312
NCT04844658,"Covid-19, Hospitalized, PatIents, Nasafytol",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,CHOPIN,"Delta Hospital, Brussels, Belgium",https://ClinicalTrials.gov/show/NCT04844658
NCT04444674,COVID-19 Vaccine (ChAdOx1 nCoV-19) Trial in South African Adults With and Without HIV-infection,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",ChAdOx1 nCoV-19_ZA_phI/II v4.1,"PHRU Kliptown, Johannesburg, Gauteng, South Africa|Soweto Clinical Trials Centre, Johannesburg, Gauteng, South Africa|Wits RHI Shandukani Research Centre, Johannesburg, Gauteng, South Africa|Setshaba Research Centre (SRC), Soshanguve, Gauteng, South Africa|Chris Hani Baragwanath Academic Hospital - DST/NRF VPD RMPRU, Soweto, Gauteng, South Africa|FAMCRU, Cape Town, Western Cape, South Africa|Groote Schuur hospital, Lung infection and immunity unit, UCT, Cape Town, Western Cape, South Africa",https://ClinicalTrials.gov/show/NCT04444674
NCT04337983,Hemodynamic Characteristics of Patients With SARS-CoV-2,Observational Model: Cohort|Time Perspective: Prospective,2020-A00793-36,"Bicetre Hospital, Paris, Val-de-Marne, France",https://ClinicalTrials.gov/show/NCT04337983
NCT04412343,The Seniors COvid-19 Pandemic and Exercise Study,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention,H20-01515,"University of British Columbia, Vancouver, British Columbia, Canada",https://ClinicalTrials.gov/show/NCT04412343
NCT04702295,ERN ReCONNET Study on COVID-19 Vaccination in Rare and Complex Connective Tissue Disease (VACCINATE),Observational Model: Cohort|Time Perspective: Prospective,UPISA2,NA,https://ClinicalTrials.gov/show/NCT04702295
NCT04854408,Evaluation of the Effect of Coronavac Vaccine (Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2 Vaccine) on Healthcare Workers' Menstrual Patterns,Observational Model: Other|Time Perspective: Prospective,Coronavacendometrium,"Pinar Yalcin Bahat, Istanbul, İ̇stanbul, Turkey",https://ClinicalTrials.gov/show/NCT04854408
NCT04944160,Impact of the Covid-19 on RSV Epidemic,Observational Model: Cohort|Time Perspective: Retrospective,502,"Groupement Hospitalier EST - Hospices Civils de Lyon, Bron, France",https://ClinicalTrials.gov/show/NCT04944160
NCT04553575,CoViD-19 Patient in Reims University Hospital in March to April 2020,Observational Model: Cohort|Time Perspective: Prospective,PO20124*,"Chu Reims, Reims, France",https://ClinicalTrials.gov/show/NCT04553575
NCT04694482,The Impact of the COVID-19 (SARS-CoV-2 Disease) on Psychopathology,Observational Model: Case-Control|Time Perspective: Retrospective,COVID-19-psychiatry,"University of Milan Bicocca - Ospedale San Gerardo, Monza, MB, Italy",https://ClinicalTrials.gov/show/NCT04694482
NCT04750356,"SARS-CoV-2 (COVID-19) Longitudinal Study: Understanding Susceptibility, Transmission and Disease Severity (Legacy Study)",Observational Model: Cohort|Time Perspective: Prospective,UCLH 134617,"The Francis Crick Institute, London, United Kingdom|UCLH, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04750356
NCT04748614,Analysis Before and After COVID 19,Observational Model: Cohort|Time Perspective: Retrospective,Ilke-ICU,NA,https://ClinicalTrials.gov/show/NCT04748614
NCT04307459,Acute Respiratory Failure and COVID-19 in Real Life,Observational Model: Cohort|Time Perspective: Prospective,17263/2020,"Luigi Sacco University Hospital, Milan, Lombardia, Italy",https://ClinicalTrials.gov/show/NCT04307459
NCT04395885,Sexual Function During COVID 19 Pandemic,Observational Model: Other|Time Perspective: Cross-Sectional,SFCOV,"Ahmed Abbas, Assiut, Cairo, Egypt|Assiut Faculty of Medicine, Assiut, Egypt",https://ClinicalTrials.gov/show/NCT04395885
NCT04579562,Regional COVID Epidemiology in England (RECEDE),Observational Model: Case-Control|Time Perspective: Retrospective,UHDB/2020/075,NA,https://ClinicalTrials.gov/show/NCT04579562
NCT04747522,Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) Immune Kidney Transplant Study (COVID-19),Observational Model: Cohort|Time Perspective: Prospective,227626,"Oslo University Hospital, Oslo, Norway",https://ClinicalTrials.gov/show/NCT04747522
NCT04471831,"Physiotherapy as a Complimentary Treatment in Reducing Viral-Load, Complications, Death, Expedite Discharge and Improve Quality of Life, Exercise Endurance and Capacity in Stroke Survivors With CoViD-19: A Clinical-Controlled Study","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",CMUL/HREC/06/20/742,NA,https://ClinicalTrials.gov/show/NCT04471831
NCT04442308,Parental Stress After the Covid-19 Pandemic,Observational Model: Other|Time Perspective: Prospective,REK125510 (6),NA,https://ClinicalTrials.gov/show/NCT04442308
NCT04756271,Safety and Immunogenicity of Inactivated Vaccine Against COVID-19 Infection,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,6738-14-2-21,"Zagazig University Faculty of Medicine, Zagazig, Sharkia, Egypt",https://ClinicalTrials.gov/show/NCT04756271
NCT04385212,Outcomes in Hospitalized Older Patients With COVID-19,Observational Model: Cohort|Time Perspective: Retrospective,2020-00819,"Department of Rehabilitation and Geriatrics, Geneva, Switzerland",https://ClinicalTrials.gov/show/NCT04385212
NCT04429594,Study of the Incidence of SARS-CoV-2 Infection (COVID-19),Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science,20-PP-14,"University Nice Hospital, Nice, France",https://ClinicalTrials.gov/show/NCT04429594
NCT04323800,Convalescent Plasma to Stem Coronavirus (CSSC-001),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",IRB00245634,"University of Alabama at Birmingham, Birmingham, Alabama, United States|Center for American Indian Health - Whiteriver Office, Whiteriver, Arizona, United States|University of California, San Diego, La Jolla, California, United States|University of California, Los Angeles, Los Angeles, California, United States|University of California, Irvine Health, Orange, California, United States|Western Connecticut Health Network, Danbury Hospital, Danbury, Connecticut, United States|Western Connecticut Health Netowrk, Norwalk Hospital, Norwalk, Connecticut, United States|MedStar Georgetown University Hospital, Washington, District of Columbia, United States|University of Miami, Coral Gables, Florida, United States|University of Miami Clinical Translational Research Site, Miami, Florida, United States|NorthShore University HealthSystem, Evanston, Illinois, United States|Anne Arundel Medical Center, Annapolis, Maryland, United States|The Johns Hopkins University, Baltimore, Maryland, United States|University of Massachusetts Worcester, Worcester, Massachusetts, United States|Wayne State University, Detroit, Michigan, United States|University of New Mexico Health Sciences Center, Albuquerque, New Mexico, United States|Center for American Indian Health - Gallup Office, Gallup, New Mexico, United States|Center for American Indian Health - Shiprock Office, Shiprock, New Mexico, United States|Vassar Brothers Medical Center, Poughkeepsie, New York, United States|University of Rochester, Rochester, New York, United States|University of Cincinnati Medical Center, Cincinnati, Ohio, United States|Lifespan/BrownUniversity (Rhode Island Hospital), Providence, Rhode Island, United States|Baylor College of Medicine, Houston, Texas, United States|University of Texas Health Science Center at Houston, Houston, Texas, United States|The University of Utah, Salt Lake City, Utah, United States",https://ClinicalTrials.gov/show/NCT04323800
NCT04407546,Role of Children in Transmission of COVID-19 to Immunocompromised Patients,Observational Model: Cohort|Time Perspective: Prospective,20-000517|NCI-2020-03669,"University of California at Los Angeles, Los Angeles, California, United States",https://ClinicalTrials.gov/show/NCT04407546
NCT04386460,Covid-19 and Prevention of Malnutrition After Confinement by Dentists,Observational Model: Cohort|Time Perspective: Prospective,20odontocovid-02,"University Nice Hospital, Nice, France",https://ClinicalTrials.gov/show/NCT04386460
NCT04404608,Etiology of Lymphopenia in Covid19 Infection,Observational Model: Cohort|Time Perspective: Prospective,201920008.2,NA,https://ClinicalTrials.gov/show/NCT04404608
NCT04871893,Safety and Efficacy Evaluation of CO2 Removal in Combination With Continuous Veno-Venous Hemodialysis/Hemodiafiltration Therapy,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,CRRT-CVVHD/HDF-01-D,"Universitätsklinikum Regensburg Klinik und Poliklinik für Innere Medizin, Regensburg, Bayern, Germany",https://ClinicalTrials.gov/show/NCT04871893
NCT04308187,Influence of the COvid-19 Epidemic on STRESS,Observational Model: Cohort|Time Perspective: Cross-Sectional,2020 COVISTRESS,"University Hospital, Clermont-Ferrand, Clermont-Ferrand, France",https://ClinicalTrials.gov/show/NCT04308187
NCT04492527,Student-delivered Telehealth Program for COVID-19 Education and Health Promotion,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,COACH,"University of British Columbia, Vancouver, British Columbia, Canada",https://ClinicalTrials.gov/show/NCT04492527
NCT04607915,Technology-enabled Collaborative Care for Diabetes Management During COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,104-2020,NA,https://ClinicalTrials.gov/show/NCT04607915
NCT04887948,Safety and Immunogenicity Study of 20vPnC When Coadministered With a Booster Dose of BNT162b2,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",B7471026,"Anaheim Clinical Trials, LLC, Anaheim, California, United States|Diablo Clinical Research, Inc., Walnut Creek, California, United States|Alliance for Multispecialty Research, LLC, Coral Gables, Florida, United States|Indago Research & Health Center, Inc, Hialeah, Florida, United States|Research Centers of America ( Hollywood ), Hollywood, Florida, United States|Acevedo Clinical Research Associates, Miami, Florida, United States|Clinical Neuroscience Solutions, Orlando, Florida, United States|Clinical Research Atlanta, Stockbridge, Georgia, United States|East-West Medical Research Institute, Honolulu, Hawaii, United States|Solaris Clinical Research, Meridian, Idaho, United States|Alliance for Multispecialty Research, LLC, Newton, Kansas, United States|Clinical Research Professionals, Chesterfield, Missouri, United States|Sundance Clinical Research, Saint Louis, Missouri, United States|Meridian Clinical Research, LLC, Omaha, Nebraska, United States|Meridian Clinical Research, LLC, Endwell, New York, United States|PMG Research of Wilmington, LLC, Wilmington, North Carolina, United States|Aventiv Research Inc, Columbus, Ohio, United States|Alliance for Multispecialty Research - Weisgarber Medical Park, Knoxville, Tennessee, United States|Alliance for Multispecialty Research, LLC, Knoxville, Tennessee, United States|Clinical Neuroscience Solutions, Inc. dba CNS Healthcare, Memphis, Tennessee, United States|Benchmark Research, Austin, Texas, United States|Diagnostics Research Group, San Antonio, Texas, United States|DM Clinical Research, Tomball, Texas, United States|Martin Diagnostic Clinic, Tomball, Texas, United States|J. Lewis Research, Inc. / Foothill Family Clinic, Salt Lake City, Utah, United States|J. Lewis Research, Inc. / Foothill Family Clinic South, Salt Lake City, Utah, United States|Wenatchee Valley Hospital, Wenatchee, Washington, United States",https://ClinicalTrials.gov/show/NCT04887948
NCT04322344,Escin in Patients With Covid-19 Infection,"Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Supportive Care",covid-19 add-on therapy,"Luca Gallelli, Catanzaro, Italy",https://ClinicalTrials.gov/show/NCT04322344
NCT04259892,Viral Excretion in Contact Subjects at High/Moderate Risk of Coronavirus 2019-nCoV Infection. COVID-19.,Observational Model: Cohort|Time Perspective: Prospective,C20-06|2020-A00280-39,"Service de maladies infectieuses et tropicales Hôpital Jean Minjoz CHRU Besançon, Besançon, France|Service des Maladies infectieuses et tropicales, Pôle Spécialités médicales, CHU Pellegrin, Bordeaux, France|Service des maladies infectieuses Hôpital Gabriel Montpied CHU de Clermont Ferrand, Clermont-Ferrand, France|Centre d'investigation clinique 1432 Hôpital François Mitterrand CHU Bourgogne, Dijon, France|Centre d'investigation clinique 1406 CHU Grenoble, Grenoble, France|Centre d'Investigation Clinique 1403 -CHU Lille, Lille, France|Centre Investigation Clinique 1433 CHRU de NANCY, Nancy, France|Centre d'investigation clinique Infectiologie Hôtel-Dieu CHU Nantes, Nantes, France|Centre d'Investigation Clinique Hôpital Saint Louis, Paris, France|Centre d'investigation Clinique 1425, Hôpital Bichat Claude Bernard, Paris, France|Centre Investigation Clinique 1417 Hôpital Cochin Bâtiment Lavoisier, Paris, France|Centre d'investigation clinique 1414 Service de Pharmacologie clinique CHU Rennes Hôpital Pontchaillou, Rennes, France|Centre Hospitalier Félix Guyon Ile de la Réunion CHU nord, Saint Denis, France|Centre d'Investigation Clinique Ile de la Réunion CHU sud, Saint-Pierre, France|Département maladie infectieux CHU Saint Etienne, Saint-Étienne, France|Centre Investigation Clinique 1415 CHRU Tours - Hôpital Bretonneau, Tours, France|Service de Maladies infectieuses et tropicales Centre hospitalier, Cayenne, French Guiana",https://ClinicalTrials.gov/show/NCT04259892
NCT04852822,Immune Response to SARS-CoV-2 (COVID-19) Vaccines in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma,Observational Model: Cohort|Time Perspective: Prospective,RG1121418|NCI-2021-02178|10646,"City of Hope, Duarte, California, United States|UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California, United States|University of California San Diego, San Diego, California, United States|MedStar Georgetown University Hospital, Washington, District of Columbia, United States|University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States|Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States|Oregon Health & Sciences University, Portland, Oregon, United States|University of Texas MD Anderson Cancer Center (Department of Neurosurgery), Houston, Texas, United States|Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah, United States|Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States",https://ClinicalTrials.gov/show/NCT04852822
NCT04365166,Study of Clinical and Immune Severity Profiles of Patients Infected With SARS-Cov2 (COVID-19),Observational Model: Case-Only|Time Perspective: Prospective,2020-COVID19-05|2020-A00898-31,"Percy Military Teaching Hospital, Clamart, France|Bégin Military Teaching Hospital, Saint-Mandé, France",https://ClinicalTrials.gov/show/NCT04365166
NCT04299152,Stem Cell Educator Therapy Treat the Viral Inflammation in COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Care Provider)|Primary Purpose: Treatment,2020-TH-001,NA,https://ClinicalTrials.gov/show/NCT04299152
NCT04821570,To Assess Immunogenicity of Coronavirus Disease 2019 (COVID-19) Vaccine in Cancer Patients Receiving Cancer Treatment,Observational Model: Case-Only|Time Perspective: Prospective,IIT-2021-CANINE,"The University of Kansas Cancer Center, Westwood Campus, Kansas City, Kansas, United States",https://ClinicalTrials.gov/show/NCT04821570
NCT04470323,Functional Exhaustion of T Cells in COVID19 Patients,Observational Model: Case-Control|Time Perspective: Prospective,T cells,"Faculty of Medicine, Assiut, Egypt",https://ClinicalTrials.gov/show/NCT04470323
NCT04604145,Self-Collected Saliva Samples Without Viral Transport Media for COVID-19 Testing Via RT-PCR,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,FWH20200198H,"David Grant U.S. Airforce Medical Center, Travis Air Force Base, California, United States",https://ClinicalTrials.gov/show/NCT04604145
NCT04949074,Collection of RNA Extracted From Nasopharyngeal and Saliva Samples From Same Patients With Suspicion of Covid-19,Observational Model: Cohort|Time Perspective: Prospective,2021-A00877-34,"Labosud, Montpellier, France",https://ClinicalTrials.gov/show/NCT04949074
NCT04617262,Pilot Feasibility Study of Remote Problem Management Plus for Adults Affected by COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2020-91-PM+,"The New School, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04617262
NCT04306393,Nitric Oxide Gas Inhalation in Severe Acute Respiratory Syndrome in COVID-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,NO-SARS-COVID-19,"University of Alabama, Birmingham, Alabama, United States|Louisiana State University Health Shreveport, Shreveport, Louisiana, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Danderyd Sjukhus AB, Danderyd, Stockholm, Sweden",https://ClinicalTrials.gov/show/NCT04306393
NCT04476745,The Effect of D3 on Selected Cytokines Involved in Cytokine Storm in the Covid-19 Uninfected Jordanian People,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,2020-PHA-16,"Mahmoud S Abu-Samak, Amman, Jordan",https://ClinicalTrials.gov/show/NCT04476745
NCT04406545,Microvascular Flow and Reactivity in Patients Presenting in the Acute Phase of COVID-19.,Observational Model: Cohort|Time Perspective: Prospective,#CAAE 31237220.1.0000.5272,"National Institute of Cardiology, Rio de Janeiro, Brazil",https://ClinicalTrials.gov/show/NCT04406545
NCT04363229,Psychological Impact of COVID19 Among Doctors in Assiut University Hospitals,Observational Model: Other|Time Perspective: Cross-Sectional,pshycological impact COVID19,NA,https://ClinicalTrials.gov/show/NCT04363229
NCT04815759,Dental Anxiety Among Children Pre and Post COVID 19 Pandemic,Observational Model: Other|Time Perspective: Cross-Sectional,Dental anxiety,"Faculty of Dentistry, Alexandria University, Alexandria, Egypt",https://ClinicalTrials.gov/show/NCT04815759
NCT04416464,Quality of Life and Patient-centered Outcomes After ICU Admission for COVID-19,Observational Model: Cohort|Time Perspective: Prospective,QoL_ICU_COVID,"Centro Hospitalar Universitário do Algarve, Faro, Algarve, Portugal|Hospital de São Francisco Xavier, Lisbon, Portugal|Centro Hospitalar Universitário de São João, Porto, Portugal|Centro Hospitalar Universitário do Porto - Hospital de Santo António, Porto, Portugal",https://ClinicalTrials.gov/show/NCT04416464
NCT04567927,Prevalence and Risk Factors for Venous Thromboembolic Events in Critically Ill Patients With COVID-19,Observational Model: Cohort|Time Perspective: Prospective,2020-01266,"Ospedale Regionale di Bellinzona e Valli, Bellinzona, Ticino, Switzerland",https://ClinicalTrials.gov/show/NCT04567927
NCT04453774,At Home Monitoring for Patients With Covid19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,3185,"Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada|University Health Network, Toronto, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04453774
NCT04914832,Effectiveness of Covid-19 Vaccination in Eswatini Against SARS-CoV-2 Associated Hospitalization and Death,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,Eswatini Implementation & VE,"Vaccination Center, Mbabane, Swaziland",https://ClinicalTrials.gov/show/NCT04914832
NCT04496869,Psychological Impact of COVID19 Among Women Undergoing Infertility Treatment,Observational Model: Cohort|Time Perspective: Retrospective,69HCL20_0577,"Hôpital Femme Mère Enfant, Bron, France",https://ClinicalTrials.gov/show/NCT04496869
NCT04322773,Anti-il6 Treatment of Serious COVID-19 Disease With Threatening Respiratory Failure,Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,APPI2-CV-2020-01,"Bispebjerg-Frederiksberg Hospital, Copenhagen, Denmark|Hillerød Hospital, Hillerød, Denmark",https://ClinicalTrials.gov/show/NCT04322773
NCT04359225,A Comparison of 3D and 2D Telemedicine During Covid 19,"Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Other",GN20HS182,"Canniesburn Regional Plastic Surgery and Burns Unit, Glasgow, Scotland, United Kingdom",https://ClinicalTrials.gov/show/NCT04359225
NCT04728880,Remdesivir in Adults With Covid-19: Mansoura University Hospital Experience,Observational Model: Cohort|Time Perspective: Retrospective,R.20.11.1097,"Mansoura University Hospital, Mansoura, Dakahliya, Egypt",https://ClinicalTrials.gov/show/NCT04728880
NCT04445454,Mesenchymal Stromal Cell Therapy for Severe Covid-19 Infection,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,TJT2012,"CHU de Liège, Liège, Belgium",https://ClinicalTrials.gov/show/NCT04445454
NCT04368832,imPROving prenaTal carE During ConfinemenT,Observational Model: Other|Time Perspective: Prospective,2020-A01023-36,"Maternité Régionale Universitaire de Nancy, Nancy, France",https://ClinicalTrials.gov/show/NCT04368832
NCT04444557,Effect of COvid-19 on Mental Health in Syrian and Turkish Maintenance HemoDialysis Patients: COST-HD Study,Observational Model: Cohort|Time Perspective: Prospective,200620,"Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04444557
NCT04954105,Influence of the COvid-19 Epidemic on STRESS and Heart-Rate Variability in Health-care Workers,Observational Model: Cohort|Time Perspective: Cross-Sectional,2020 COVISTRESS HRV,"CHU clermont-ferrand, Clermont-Ferrand, France",https://ClinicalTrials.gov/show/NCT04954105
NCT04492449,"Evaluation of Systemic and Oral Conditions of Pregnant Women and Their Babies, With Exposure to COVID-19 Infection",Observational Model: Other|Time Perspective: Other,FOBpregnat,NA,https://ClinicalTrials.gov/show/NCT04492449
NCT04811885,The Effects of Covid-19 Pandemic on the Cardiovascular Heath of Children With Autism Spectrum Disorder,Observational Model: Cohort|Time Perspective: Cross-Sectional,Institute Technology Carlow,"Institute of Technology Carlow, Carlow, Lenister, Ireland",https://ClinicalTrials.gov/show/NCT04811885
NCT04623346,Orthopaedic Conservative Treatment in the Time of Covid-19 Pandemic,Observational Model: Cohort|Time Perspective: Retrospective,Treatment in the time of Covid,"SBU Prof. Cemil Tascioglu City Hospital, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04623346
NCT04336410,"Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers",Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,COVID19-001,"Central Kentucky Research Associates, Lexington, Kentucky, United States|Center for Pharmaceutical Research, Kansas City, Missouri, United States|University of Pennsylvania, Philadelphia, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04336410
NCT04836039,Rehabilitation Experiences of Physiotherapists in Covid-19 Outbreak,Observational Model: Cohort|Time Perspective: Retrospective,E-10840098-772.02-2682,"Medipol University, Istanbul, Beykoz, Turkey",https://ClinicalTrials.gov/show/NCT04836039
NCT04398043,SARS-CoV 2 in Personal Protective Equipment,Observational Model: Cohort|Time Perspective: Prospective,rt PCR en EPP,NA,https://ClinicalTrials.gov/show/NCT04398043
NCT04354272,Evaluation of Dental Emergency Treatments During COVID19 Crisis,Observational Model: Cohort|Time Perspective: Prospective,APHP200464,"Service d'odontologie, Hôpital Pitié-Salpêtrière, Paris, France",https://ClinicalTrials.gov/show/NCT04354272
NCT04920851,Cytokine Hemadsorption in Covid 19 Patients With Bacterial Sepsis,Observational Model: Cohort|Time Perspective: Retrospective,BIRUNI 1,"Biruni University, Istanbul, Küçükçekmece, Turkey",https://ClinicalTrials.gov/show/NCT04920851
NCT04948229,Annexin A1 Levels in SARS-CoV-2 Infection,Observational Model: Case-Control|Time Perspective: Prospective,Clinical-5,"Ramazan Sabirli, Kars, Outside Of The US, Turkey",https://ClinicalTrials.gov/show/NCT04948229
NCT04498546,Mask Usage and Exercise During the COVİD-19 Pandemic,Observational Model: Other|Time Perspective: Prospective,KaratayU3,"KTO Karatay University, Konya, Karatay, Turkey",https://ClinicalTrials.gov/show/NCT04498546
NCT04871685,"The ECOVITA Study - Validation of LUS Score in SARS-CoV-2 Disease, i.e COVID-19",Observational Model: Cohort|Time Perspective: Prospective,Vanvitelli,"University of Campania Luigi Vanvitelli, Naples, Campania, Italy",https://ClinicalTrials.gov/show/NCT04871685
NCT04355637,Inhaled Corticosteroid Treatment of COVID19 Patients With Pneumonia,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,TACTIC-COVID|2020-001616-18,"Hospital de Infecciosas ""Francisco Javier Muñiz"", Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina|CEMIC (Centro de Educación Médica e Investigaciones Clínicas ""Norberto Quirno""), Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina|Hospital de Rehabilitación Respiratoria ""María Ferrer"", Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina|Hospital Donación ""Francisco Santojanni"", Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina|Clínica Monte Grande, Monte Grande, Buenos Aires, Argentina|Hospital Centro de Salud Zenón J. Santillán, San Miguel De Tucumán, Tucumán, Argentina|Hospital San Juan de Dios, La plata, Argentina|Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain|Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain|Hospital de Sabadell-Parc Tauli, Sabadell, Barcelona, Spain|Hospital del Mar, Barcelona, Spain|Hospital Universitari Vall d'Hebron, Barcelona, Spain|Hospital Clinic of Barcelona, Barcelona, Spain|Hospital de la Santa Creu i Sant Pau, Barcelona, Spain",https://ClinicalTrials.gov/show/NCT04355637
NCT04420338,"SeroCOVIDial Study: Assessment of COVID-19 Seroconversion in Patients on Chronic Hemodialysis and in Their Caregivers, a Cohort Study",Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,2020-34|2020-A01515-34,"Assistance Publique Hôpitaux de Marseille, Marseille, Paca, France",https://ClinicalTrials.gov/show/NCT04420338
NCT04900376,Evaluation of Covid-19 Vaccination in Elderly Subjects in Retirement Home (EHPAD) and Long-term Care Units (USLD) in Ile-de-France,Observational Model: Cohort|Time Perspective: Prospective,2021-A00007-34,"Geriatric Department, Broca Hospital, Paris, IIe-de-France, France",https://ClinicalTrials.gov/show/NCT04900376
NCT04351542,Ayurveda for Flu Like Illness During Covid-19 Outbreak,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Single (Care Provider)|Primary Purpose: Supportive Care,AU09,"Aarogyam, Leicester, United Kingdom",https://ClinicalTrials.gov/show/NCT04351542
NCT04934020,"Global Impact of the COVID 19 Pandemic on Stroke Care, Cerebral Venous Thrombosis, and Subarachnoid Hemorrhage",Observational Model: Cohort|Time Perspective: Retrospective,NHSR-1,"Grady Memorial Hospital, Emory University, Atlanta, Georgia, United States|Boston Medical Center, Boston, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT04934020
NCT04637893,The Impact of Covid-19 Pandemic on Colorectal Cancer Prevention Due to Delays in Diagnosis: a Global Study,Observational Model: Cohort|Time Perspective: Retrospective,100,NA,https://ClinicalTrials.gov/show/NCT04637893
NCT04433754,The Development of Pancreatic Injury in the Course of Severe Acute Respiratory Syndrome Coronavirus 2 Infection,Observational Model: Case-Control|Time Perspective: Retrospective,UsakU-Cevdet2,"Usak University Training and Research Hospital, Usak, Turkey",https://ClinicalTrials.gov/show/NCT04433754
NCT04385914,Demographics and Outcomes of COVID 19 in Pregnancy at a Community Based Hospital,Observational Model: Cohort|Time Perspective: Prospective,1595116-1,NA,https://ClinicalTrials.gov/show/NCT04385914
NCT04490473,Turkish of the SARS-CoV-2 Anxiety Scale,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,DSAYIK2|Ayfer AÇIKGÖZ|ERTUĞRUL ÇOLAK|DENİZ YİĞİT|ÖZLEM MUMCU,"Eskisehir Osmangazi University, Eskisehir, Turkey",https://ClinicalTrials.gov/show/NCT04490473
NCT04461353,"A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Orally Inhaled Aerosolized Hydroxychloroquine Sulfate in Healthy Adult Volunteers","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",PUL-01,"The Rockefeller University, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04461353
NCT04509986,GlobalSurg-CovidSurg Week,Observational Model: Cohort|Time Perspective: Prospective,GS-CSWeek.20200713,NA,https://ClinicalTrials.gov/show/NCT04509986
NCT04447209,Dietary Diversity of Young Children During CoVID-19 Outbreak: A Longitudinal Study,Observational Model: Cohort|Time Perspective: Prospective,2020410-8500,"University of Malaya Medical Center, Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia",https://ClinicalTrials.gov/show/NCT04447209
NCT04590430,"Study to Assess the Safety, Tolerability, and Pharmacokinetics of HFB30132A Against COVID-19 in Healthy Adults","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",HFB30132A-101,"Medpace Clinical Pharmacology Unit, Cincinnati, Ohio, United States",https://ClinicalTrials.gov/show/NCT04590430
NCT04815135,Effect of Covid-19 Pandemic on Emergency Surgery Practice,Observational Model: Case-Control|Time Perspective: Cross-Sectional,10-2021-5926,"Ibrahim Khrais, Amman, Please Select, Jordan",https://ClinicalTrials.gov/show/NCT04815135
NCT04666025,SARS-CoV-2 Donor-Recipient Immunity Transfer,Observational Model: Cohort|Time Perspective: Prospective,20153|NCI-2020-11156|P30CA033572,"City of Hope Medical Center, Duarte, California, United States",https://ClinicalTrials.gov/show/NCT04666025
NCT04969601,Anti-Covid-19 Vaccine in Children With Acute Leukemia and Their Siblings,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,APHP210639,"Hôpital Armand Trousseau, Paris, France|Hôpital Robert Debré, Paris, France",https://ClinicalTrials.gov/show/NCT04969601
NCT04397666,RT-PCR on Conjunctival Sample for the Detection of SARS-CoV-2 in Patients With Covid-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,P20/09_COVEYES,"Centre Hospitalier de versailles, Le Chesnay, France",https://ClinicalTrials.gov/show/NCT04397666
NCT04508920,A Survey to Assess Effects of Covid-19 on Cardiovascular Patients,Observational Model: Cohort|Time Perspective: Prospective,20-1156,"Centro de Insuficiencia Cardiaca Instituto Nacional de Cardiologia, Mexico City, Mexico",https://ClinicalTrials.gov/show/NCT04508920
NCT04476979,Comparison of Tocilizumab Plus Dexamethasone vs. Dexamethasone for Patients With Covid-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,APHP200375-TOCIDEX|2020-001246-18,"CH Andrée Rosemon, Cayenne, French Guiana",https://ClinicalTrials.gov/show/NCT04476979
NCT04322786,"The Use of Angiotensin Converting Enzyme Inhibitors and Incident Respiratory Infections, Are They Harmful or Protective?",Observational Model: Case-Control|Time Perspective: Prospective,ISAC17_205R,NA,https://ClinicalTrials.gov/show/NCT04322786
NCT04481360,Evaluation of Clinical Characteristics and Outcome of COVID19 Pneumonia in Assiut University Hospital,Observational Model: Cohort|Time Perspective: Prospective,Presentation of COVID19 in AUH,NA,https://ClinicalTrials.gov/show/NCT04481360
NCT04342208,Evaluate the Working Environments of Individuals Working From Home During Covid-19 Outbreak,Observational Model: Case-Only|Time Perspective: Other,GPA1347,NA,https://ClinicalTrials.gov/show/NCT04342208
NCT04425005,Home-based Exercise Training During Covid-19 Pandemic in Post-bariatric,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,21056813.3.0000.0068,"Univsersity of Sao Paulo, Sao Paulo, Brazil",https://ClinicalTrials.gov/show/NCT04425005
NCT04935489,Accelerated Intermittent Theta Burst Stimulation for Depressed Patients During the Covid-19 Pandemic,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,21-008-B,NA,https://ClinicalTrials.gov/show/NCT04935489
NCT04344106,Prone Positioning in Spontaneously Breathing Nonintubated Covid-19 Patient: a Pilot Study,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,20202703-2,"CHI Aix-Pertuis, Aix-en-Provence, France",https://ClinicalTrials.gov/show/NCT04344106
NCT04951362,Role of Ivermectin Nanosuspension as Nasal Spray in Treatment of Persistant Post covid19 Anosmia,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,SVU MED CIT0 23 4 21 1 122,"Zaky Aref, Qina, Egypt",https://ClinicalTrials.gov/show/NCT04951362
NCT04568005,Evaluation of Lymphedema Patients Status During Covid-19 Pandemic,Observational Model: Other|Time Perspective: Cross-Sectional,feyzaakanbegoglu,"Fatih Sultan Mehmet Training and Research Hospital, Istanbul, Ataşehir, Turkey",https://ClinicalTrials.gov/show/NCT04568005
NCT04896840,Tele-rehabilitation in Children With Cerebral Palsy in the Covid-19 Pandemic,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2021/1422,"Inonu University, Malatya, Turkey|Inonu University, Malatya, Turkey",https://ClinicalTrials.gov/show/NCT04896840
NCT04363606,Chronic Fatigue Etiology and Recovery in Covid-19 Patients: the Role of Fatigability,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,20CH085|2020-A00982-37,"CHU de Grenoble, Grenoble, France|Clinique de la Sauvegarde - Lyon, Lyon, France|Hôpital Croix Rousse - HCL, Lyon, France|Centre Hospitalier de Lyon Sud, Pierre-benite, France|Chu Saint-Etienne, Saint Etienne, France|Clinique Mutualiste Saint Etienne, Saint Etienne, France|Hôpital Henry Gabrielle, Saint-Genis-Laval, France|Hôpital privé de la Loire, Saint-Étienne, France",https://ClinicalTrials.gov/show/NCT04363606
NCT04435379,Study to Assess VPM1002 in Reducing Hospital Admissions and/or Severe Respiratory Infectious Diseases in Elderly in COVID-19 Pandemic,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",VPM1002-DE-3.07CoV|2020-001675-33,"Hautarztpraxis Dres. Leitz & Kollegen, Stuttgart, Baden-Württemberg, Germany|MECS Cottbus GmbH, Cottbus, Brandenburg, Germany|Studienzentrum Dr. Keller, Frankfurt, Hessen, Germany|Klinische Forschung Hannover Mitte GmbH, Hannover, Niedersachsen, Germany|Medizinische Hochschule Hannover, Hannover, Niedersachsen, Germany|Medizentrum Essen Borbeck, Essen, Nordrhein-Westfalen, Germany|BAG Dres. med. Quist PartG, Mainz, Rheinland-Pfalz, Germany|SIBAmed GmbH & Co. KG, Leipzig, Sachsen, Germany|SocraTec R&D GmbH, Erfurt, Thüringen, Germany|emovis GmbH, Berlin, Germany|Klinische Forschung Berlin GbR, Berlin, Germany|Klinische Forschung Hamburg GmbH, Hamburg, Germany",https://ClinicalTrials.gov/show/NCT04435379
NCT04740125,SURVEY ABOUT STRESS-COVID IN HEALTH CARE WORKERS IN NORTH AFRICA COUNTRY,Observational Model: Other|Time Perspective: Cross-Sectional,UR17DN05SURVEY,"Military Hospital of Tunis, Tunis, Montfleury, Tunisia",https://ClinicalTrials.gov/show/NCT04740125
NCT04756817,Immunogenicity of the BNT162b2 Covid-19 Vaccine in Elderly People Aged 85 and Older in Greece,Observational Model: Cohort|Time Perspective: Prospective,2/27.1.2021,"G. Gennimatas General Hospital, Thessaloníki, Thessaloniki, Greece",https://ClinicalTrials.gov/show/NCT04756817
NCT04742712,A Feasibility Study Using the CoronaCheck Device to Identify Incident Cases of SARS CoV-2 Covid-19,Observational Model: Cohort|Time Perspective: Prospective,PHT/2020/57,"Portsmouth Hospitals NHS Trust, Portsmouth, Hampshire, United Kingdom",https://ClinicalTrials.gov/show/NCT04742712
NCT04806529,"An Efficacy, Immunogenicity and Safety Study Investigating an Adjuvanted SARS-CoV-2 Influenza Vaccine to Protect Against COVID-19 in Adults Over Aged 18 Years-old and Older","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention",V451_07,NA,https://ClinicalTrials.gov/show/NCT04806529
NCT04379232,Surgical Activity During the Covid-19 Pandemic: Results for 112 Patients in a French Tertiary Care Center,Observational Model: Cohort|Time Perspective: Retrospective,CRC_GHN_2020_001,"Croix-Rousse Hospital, Hospices Civils de Lyon, Lyon, France",https://ClinicalTrials.gov/show/NCT04379232
NCT04466605,Effect of Tele-Yoga Therapy on Patients With Chronic Musculoskeletal Pain During Covid-19 Lockdown,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,AU/NMP/0921,"NMP Medical Research Institute, Jaipur, Rajasthan, India",https://ClinicalTrials.gov/show/NCT04466605
NCT04453475,Feasibility and Benefits of Digital Services During the COVID19 Pandemic,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,Anhand-COVID19,"Jacobs University Bremen gGmbH, Bremen, Germany",https://ClinicalTrials.gov/show/NCT04453475
NCT04955587,A Longitudinal Study on Longstanding Complicated Fatigue,Observational Model: Cohort|Time Perspective: Prospective,EPN2018/1438-31,NA,https://ClinicalTrials.gov/show/NCT04955587
NCT04542395,COVID-2019 Testing and Vaccination Among African American and Latinx Public Housing Residents,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,COVID19testingvacc,"Housing Authority of Clty of Los Angeles, Los Angeles, California, United States",https://ClinicalTrials.gov/show/NCT04542395
NCT04815057,The Effects of Wellness Training Given to Fifth Grade Students During the Covid-19 Epidemic Period,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,Sağlık Bilimleri Univesity,"Second School, Kırşehir, Turkey",https://ClinicalTrials.gov/show/NCT04815057
NCT04380909,ROCO - Self-help for People With Psychological Distress Due to the Covid-19 Situation,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2020-00990,"Universität Bern, Bern, Switzerland",https://ClinicalTrials.gov/show/NCT04380909
NCT04639349,Effect of Home Exercise Activity on Cortisol and Depression in COPD During the Pandemic COVID,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment",P.T.REC/012/002897,"Faculty of Physical Therapy Cairo University, Giza, Dokki, Egypt",https://ClinicalTrials.gov/show/NCT04639349
NCT04369378,Effectiveness of Using a Meditation App in Reducing Anxiety and Improving Well-being During the Covid-19 Pandemic,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,27-126,"LECOM, Erie, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04369378
NCT04305574,Social Media Use During COVID-19,Observational Model: Cohort|Time Perspective: Cross-Sectional,2020-CERC-001,"Yale-NUS College, Singapore, Singapore",https://ClinicalTrials.gov/show/NCT04305574
NCT04913740,Nursing Study of Skin Lesions Related to Health Care Protection in Novel Nursing Study of Skin Lesions Related to Health Care Protection in Novel Coronavirus Epidemic,"Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Diagnostic",2020-841,"Dressing, Hangzhou, Zhejiang, China",https://ClinicalTrials.gov/show/NCT04913740
NCT04757272,Does Hepatitis C Management Protect Egyptian Population Against Severe Corona Virus Disease-2019?,Observational Model: Cohort|Time Perspective: Retrospective,6733-24-2-2021,"Zagazig University Hospitals, Zagazig, Sharkia, Egypt",https://ClinicalTrials.gov/show/NCT04757272
NCT04746066,Observational Study for Patients With Hemoglobinopathies and Rare Inherited Anemia and Covid 19,Observational Model: Other|Time Perspective: Retrospective,EMO AER COVID-19,"Ospedali Galliera - S.S.D. Microcitemia, anemie congenite e dismetabolismo del ferro, Genova, Italy",https://ClinicalTrials.gov/show/NCT04746066
NCT04327479,Characterization of Cardiovascular Diseases and Risk Factors in Patients With Suspected SARS-CoV2/Covid-19 Infection,Observational Model: Cohort|Time Perspective: Prospective,20-9213-BO,"University Hospital Essen, Essen, NRW, Germany",https://ClinicalTrials.gov/show/NCT04327479
NCT04581577,Perceptions of the Clinical and Psychosocial Impact of Covid-19 in Patients With Neuromuscular and Neurological Disorders,Observational Model: Cohort|Time Perspective: Cross-Sectional,286495,"Royal Brompton Hospital, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04581577
NCT04383899,Role of Ibuprofen and Other Medicines on Severity of Coronavirus Disease 2019,Observational Model: Case-Control|Time Perspective: Prospective,CHUBX 2020/13,NA,https://ClinicalTrials.gov/show/NCT04383899
NCT04508868,Treatment of Depressive Symptoms in Older Individuals in Isolation During Covid-19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2020-02079,"Adult Psychiatric Clinic, Västerås, Västmanland, Sweden",https://ClinicalTrials.gov/show/NCT04508868
NCT04410536,Home Detox in Medication Overuse Headache (MOH) During Covid-19 Emergency,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,MOH,"Fondazione IRCCS Istituto Neurologico C. Besta, Neuroalgology Unit, Milano, Italy",https://ClinicalTrials.gov/show/NCT04410536
NCT04796064,Low Versus High-Intensity Aerobic Training in Community-dwelling Older Men With Post-COVID 19 (SARS-CoV-2) Sarcopenia,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",Sarcopenia,"Marwa Eid, Cairo, Egypt",https://ClinicalTrials.gov/show/NCT04796064
NCT04422353,Video Dance Class and Unsupervised Physical Activity During Covid-19 Pandemic in People With Parkinson's Disease,"Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment",PTT-Parkinson/COVID19,"Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande Do Sul, Brazil",https://ClinicalTrials.gov/show/NCT04422353
NCT04385823,Use of High Flow Nasal Cannula Oxygen and Covid-19 Acute Hypoxemic Respiratory Failure,Observational Model: Cohort|Time Perspective: Retrospective,HLM_JDR9,"Hôpital Louis Mourier, Assistance Publique - Hôpitaux de Paris, Colombes, France",https://ClinicalTrials.gov/show/NCT04385823
NCT04679909,Safety and Immunogenicity of AdCOVID in Healthy Adults (COVID-19 Vaccine Study),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention",ALT-501-101,"Optimal Research, Melbourne, Florida, United States|Optimal Research, Peoria, Illinois, United States|Optimal Research, Rockville, Maryland, United States|Optimal Research, Austin, Texas, United States|Clinical Trials of Texas, San Antonio, Texas, United States",https://ClinicalTrials.gov/show/NCT04679909
NCT04556630,Experience of Lock Down Related to the Covid-19 Epidemic and Its Impact on the Project of Parenthood,Observational Model: Cohort|Time Perspective: Prospective,2020_65|2020-A01810-39,NA,https://ClinicalTrials.gov/show/NCT04556630
NCT04419870,"Acute Infection in Mitochondrial Disease: Metabolism, Infection and Immunity During the COVID19 Pandemic",Observational Model: Case-Control|Time Perspective: Prospective,200120|20-HG-0120,"National Institutes of Health Clinical Center, Bethesda, Maryland, United States",https://ClinicalTrials.gov/show/NCT04419870
NCT04877002,Performance Study of SONA Saliva C-19 Rapid Test,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,CT002-SalC19RT,"Humber River Hospital, Toronto, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04877002
NCT04847362,The Effect of Tele-Health Education Provided in the Postpartum Period in the Covid 19 Pandemic,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention,11.04.2021-27076,"Zeynep Kamil Women's and Children's Diseases Training and Research Hospital, İstanbul, Turkey|Saglık Bilimleri Universitesi, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04847362
NCT04384419,"Death Number Perception in Depression, Anxiety, and Schizoypal Personnality in General Population (Covid-19 Pandemic)",Observational Model: Case-Only|Time Perspective: Retrospective,RECHMPL20_0276,"UH Montpellier, Montpellier, France",https://ClinicalTrials.gov/show/NCT04384419
NCT04397471,A Study to Collect Bone Marrow for Process Development and Production of BM-MSC to Treat Severe COVID19 Pneumonitis,Observational Model: Case-Only|Time Perspective: Prospective,COMET20d,"Cambridge University Hospitals NHS Foundation Trust, Cambridge, Cambridgeshire, United Kingdom",https://ClinicalTrials.gov/show/NCT04397471
NCT04690400,Telehealth Stretching Exercise Program for Women With Fibromyalgia During the Covid-19 Pandemic,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,39305720.9.0000.5313,NA,https://ClinicalTrials.gov/show/NCT04690400
NCT04730661,Efficacy of the Sit to Stand Test in the Decision to Hospitalize a Patient Consulting the Emergency Dept for COVID 19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Screening,2020/0339/HP,"Rouen university hospital, Rouen, France",https://ClinicalTrials.gov/show/NCT04730661
NCT04790851,Evaluation of Immunogenicity and Safety of Combined Immunization of COVIV and PPV23 / IIV4,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention,COVIV-PPV23-IIV4-Combine,"Sichuan Center for Disease Control and Prevention, Chengdu, China|Shanghai Municipal Center for Disease Control and Prevention, Shanghai, China|Shanxi Provincial Center for Disease Control and Prevention, Taiyuan, China",https://ClinicalTrials.gov/show/NCT04790851
NCT04465656,Registry of the Evolution of Diagnosed and/or Hospitalized Patients for Pulmonary Embolism During the Covid-19 Pandemic,Observational Model: Cohort|Time Perspective: Retrospective,2020/5/1,"Hôpital Saint Joseph Marseille, Marseille, France",https://ClinicalTrials.gov/show/NCT04465656
NCT04984564,Cardiovascular Fellow-in-training Feedback on Virtual and Simulator-based Learning Experience During Covid-19 Pandemic in A Low to Middle Income Country,Observational Model: Other|Time Perspective: Cross-Sectional,2020-5030-10817,"Pirbhat Shams, Karachi, Outside US And Canada, Pakistan",https://ClinicalTrials.gov/show/NCT04984564
NCT04414618,A Study of Opaganib in Coronavirus Disease 2019 Pneumonia,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",ABC-110,"HonorHealth Research Institute, Scottsdale, Arizona, United States|Miami Cancer Institute, Miami, Florida, United States|Henry Ford Hospital, Detroit, Michigan, United States|Ascension St. John Hospital, Detroit, Michigan, United States|Albany Medical Center, Albany, New York, United States|Oregon Health & Science University, Portland, Oregon, United States|Memorial Herman Southeast Hospital, Houston, Texas, United States|Memorial Hermann, Memorial City Medical Center, Houston, Texas, United States|Ziv Medical Center, Safed, Israel",https://ClinicalTrials.gov/show/NCT04414618
NCT04422418,Impact of Burnout on Cardiovascular and Immune Biomarkers in Healthcare Professionals - Covid-19 Pandemic in Abu Dhabi,Observational Model: Cohort|Time Perspective: Prospective,CPRA-2020-034,"Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates|Mediclinic, Abu Dhabi, United Arab Emirates|Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates|Sheikh Shakhbout Medical City, Abu Dhabi, United Arab Emirates",https://ClinicalTrials.gov/show/NCT04422418
NCT04409197,"Evaluation of Changes in Weight, Sleep, and Other Psycho-behavioural Parameters During Covid-19 Confinement in Subjects Monitored by the RNPC Network",Observational Model: Cohort|Time Perspective: Prospective,38RC20.150,"CHU Grenoble Alpes, Grenoble, France",https://ClinicalTrials.gov/show/NCT04409197
NCT04932369,"The Effect of Emotion Regulation Training on Anxiety, in College Students in Egypt","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",CL-2008,"The British university in Egypt, Cairo, Egypt",https://ClinicalTrials.gov/show/NCT04932369
NCT04347031,A Study of the Effectiveness of an Off Label Mefloquine Use for the Treatment of Patients With COVID19,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,FL-01/20,"Burnasyan Federal Medical Biophysical Center FMBA of Russia, Moscow, Russian Federation",https://ClinicalTrials.gov/show/NCT04347031
NCT04941209,imPulse™ Una Infrasound-to-ultrasound E-stethoscope,Observational Model: Case-Control|Time Perspective: Prospective,L42AI-20210003,"Laboratoire de la foundation Gombes, Pointe Noire, Kouilou, Congo, The Democratic Republic of the|Asian Institute of Public Health, Bhubaneswar, Odisha, India|Institute for Health Research, Epidemiological Surveillance and Training ( IRESSEF), Dakar, Almadies, Senegal",https://ClinicalTrials.gov/show/NCT04941209
NCT04696679,Quality of Life of Very Preterm Children With Dysexecutive Disorders at Elementary School Age During the Confinement-deconfinement Period of Covid-19 Pandemic,Observational Model: Other|Time Perspective: Cross-Sectional,2020-38|2020-A01631-38,"Assistance Publique des Hopitaux de Marseille, Marseille, France",https://ClinicalTrials.gov/show/NCT04696679
NCT04723407,Assessment of the Psychological Impact of the COVID19 (SARS-CoV-2) Pandemic on Patients With Chronic Inflammatory Rheumatism,Observational Model: Cohort|Time Perspective: Retrospective,87RI20_0062 /RICOVID19,"Département de Rhumatologie, Limoges, France",https://ClinicalTrials.gov/show/NCT04723407
NCT04348370,BCG Vaccine for Health Care Workers as Defense Against COVID 19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention",2020-0432F,"Cedars-Sinai Medical Center, Los Angeles, California, United States|Texas A&M Family Care Clinic, Bryan, Texas, United States|Baylor College of Medicine, Houston, Texas, United States|Baylor St. Luke's Medical Center, Houston, Texas, United States|Harris Health System - Ben Taub Hospital, Houston, Texas, United States|MD Anderson Cancer Center, Houston, Texas, United States",https://ClinicalTrials.gov/show/NCT04348370
NCT04384705,HDL Target of CoViD19 ? Analysis on the Caregivers of the Reunion University Hospital,Observational Model: Cohort|Time Perspective: Prospective,2020/CHU/08,"Centre Hospitalier Universitaire Réunion, Saint-Denis, France|Centre Hospitalier Universitaire de la Réunion, Saint-Pierre, France",https://ClinicalTrials.gov/show/NCT04384705
NCT04387253,Study of Late Fetal Loss in Poitou-Charentes. GYNE-COVID,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: Single (Participant)|Primary Purpose: Diagnostic,GYNE-COVID,"CHU de Poitiers, Poitiers, France",https://ClinicalTrials.gov/show/NCT04387253
NCT04362358,Online Cognitive Behavioral Therapy (CBT) for Stress Disorders in Health Workers Involved in the Care of Patients During the Covid-19 Epidemic,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,7799,NA,https://ClinicalTrials.gov/show/NCT04362358
NCT04880668,Impact of Aerosol Box Use on Healthcare Provider Contamination,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,REB20-0893,NA,https://ClinicalTrials.gov/show/NCT04880668
NCT04390152,Safety and Efficacy of Intravenous Wharton's Jelly Derived Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Due to COVID 19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",BIOXSOMCOV001,"BioXcellerator, Medellin, Antioquia-CO, Colombia|Clinical Somer, Rionegro, Antioquia, Colombia",https://ClinicalTrials.gov/show/NCT04390152
NCT04363528,Incidence of Deep Vein Thrombosis at Doppler Echo in Covid-19 Patients With SARS-Cov-2 Pneumopathy Hospitalized in ICU,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,P20/08_COVIDOP-DVT,"Centre Hospitalier de Versailles, Le Chesnay, France",https://ClinicalTrials.gov/show/NCT04363528
NCT04386720,Measurement of Airway Opening Pressure (AOP) in Patients With Acute Respiratory Distress Syndrom and With or Without Covid 19.,Observational Model: Case-Only|Time Perspective: Prospective,CHUBX 2020/15,"HOPITAL HAUT-LEVEQUE - Service Réanimation thoracique, Pessac, France",https://ClinicalTrials.gov/show/NCT04386720
NCT04441476,Ethical and Psychological Support for Health Care Professions in Intensive Care Units in the COVID19 Pandemic Context: Adequacy With Needs and Psychological Impact Crisis and Post-crisis,Observational Model: Cohort|Time Perspective: Prospective,QUENOT SERI 2020,"Chu Dijon Bourgogne, Dijon, France",https://ClinicalTrials.gov/show/NCT04441476
NCT04279795,Detection of 2019 Novel Coronavirus in Multiple Organ System and Its Relationship With Clinical Manifestations,Observational Model: Cohort|Time Perspective: Prospective,PL11,"The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China",https://ClinicalTrials.gov/show/NCT04279795
NCT04279782,Clinical Features of Suspected and Confirmed Patients of 2019 Novel Coronavirus Infection,Observational Model: Cohort|Time Perspective: Prospective,XWX3,"The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China",https://ClinicalTrials.gov/show/NCT04279782
NCT04874363,The Effects of Smoking on Mortality in Patients With Acute Respiratory Syndrome Coronavirus 2 Infection,Observational Model: Case-Control|Time Perspective: Retrospective,2810,"Sisli Hamidiye Etfal Research and Training Hospital, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04874363
NCT04799704,Tear Film SARS-nCoV-2 Detection in Symptomatic and Pauci-symptomatic Patients.,Observational Model: Case-Only|Time Perspective: Prospective,S64002,"UZ Leuven, Leuven, Vlaams Brabant, Belgium",https://ClinicalTrials.gov/show/NCT04799704
NCT04473599,Stay Well at Home: a Text-messaging Study Social Distancing,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Prevention,2020-04-13162,"University of California Berkeley, Berkeley, California, United States",https://ClinicalTrials.gov/show/NCT04473599
NCT04664075,Predicting Severity and Disease Progression in Influenza-like Illness (Including COVID-19),Observational Model: Case-Only|Time Perspective: Cross-Sectional,20SM6170,"Imperial College London, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04664075
NCT04445194,Phase I Clinical Study of Recombinant Novel Coronavirus Vaccine,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention",NCV-Ⅰ-healthy,"The Second Affiliated Hospital of Chongqing Medical University, Chongqing, Chongqing, China",https://ClinicalTrials.gov/show/NCT04445194
NCT04952870,"Perinatal Covid-19 Infection, NO Pathway, and Minipuberty",Observational Model: Case-Control|Time Perspective: Prospective,2020_38|2020-A02122-37|grant agreement No 847941,"Hop Jeanne de Flandre Chu Lille, Lille, France|Uri-National and Kapodistrian University of Athens, Athens, Greece",https://ClinicalTrials.gov/show/NCT04952870
NCT04343729,Methylprednisolone in the Treatment of Patients With Signs of Severe Acute Respiratory Syndrome in Covid-19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",CAEE: 30615920.2.0000.0005,"Hospital e Pronto Socorro Delphina Rinaldi Abdel Aziz, Manaus, Amazonas, Brazil",https://ClinicalTrials.gov/show/NCT04343729
NCT04393077,Emotional Freedom Technique (EFT) Effect on Nurses,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Supportive Care,2020\0192,"Medeniyet University, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04393077
NCT04308668,Post-exposure Prophylaxis / Preemptive Therapy for SARS-Coronavirus-2,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",MED-2020-28673,"Nationwide Enrollment via Internet, please email: covid19@umn.edu, Minneapolis, Minnesota, United States|University of Minnesota, Minneapolis, Minnesota, United States|University of Alberta, Edmonton, Alberta, Canada|University of Manitoba, Winnipeg, Manitoba, Canada|Research Institute of the McGill University Heath Centre, Montréal, Quebec, Canada",https://ClinicalTrials.gov/show/NCT04308668
NCT04853836,Olfactory Disfunction and Co-ultraPEALut,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment",20112020PGFN,"Multicentric, Roma, Italy",https://ClinicalTrials.gov/show/NCT04853836
NCT04882865,Apparatus and Method for Moving Patients,Observational Model: Case-Only|Time Perspective: Prospective,30760,NA,https://ClinicalTrials.gov/show/NCT04882865
NCT04757207,Pandemia And Exercise in Turkey in University Students of Turkey,Observational Model: Cohort|Time Perspective: Cross-Sectional,60116787-020/76132,"Pamukkale University, Denizli, Turkey",https://ClinicalTrials.gov/show/NCT04757207
NCT04644276,Mask Adhesive Institutional Study,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Other,SRCHRCMask Adhesive 2020_11130,"Sleep Disorder Center of Alabama, Birmingham, Alabama, United States",https://ClinicalTrials.gov/show/NCT04644276
NCT04574765,A Research Platform to Screen Healthcare Workers,Observational Model: Cohort|Time Perspective: Prospective,OZUHN-001|20-5289,"University Health Network, Toronto, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04574765
NCT04524962,Study of Descartes-30 in Acute Respiratory Distress Syndrome,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,DC30-1A,"University of Alabama at Birmingham, Birmingham, Alabama, United States|University of California-Irvine, Irvine, California, United States|University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States|University of Maryland Medical Center Medical Center, Baltimore, Maryland, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States",https://ClinicalTrials.gov/show/NCT04524962
NCT04486144,Impact Nerium Oleander on Immune Function,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,52020,"KDunn and Associates, PA, dba Healthquilt, Houston, Texas, United States",https://ClinicalTrials.gov/show/NCT04486144
NCT04492189,Containment Measures and Eating Disorders,Observational Model: Other|Time Perspective: Prospective,RECHMPL20_0220,"Uhmontpellier, Montpellier, France",https://ClinicalTrials.gov/show/NCT04492189
NCT04374643,Descriptive Study of the PSYchological Impact of CONFinement Measures in the General Population,Observational Model: Cohort|Time Perspective: Prospective,RECHMPL20_0197,"University hospital, Montpellier, France",https://ClinicalTrials.gov/show/NCT04374643
NCT04492267,Inflammatory Bowel Disease (IBD) and Covid-19 Infection,Observational Model: Case-Only|Time Perspective: Retrospective,7930,"Service Hépato-Gastroentérologie et Assistance Nutritive Hôpitaux Univesitaires de Strasbourg, Strasbourg, France",https://ClinicalTrials.gov/show/NCT04492267
NCT04907903,"RinasciMENTE, An Internet-Based Self-Help Intervention for People With Psychological Distress Due to COVID-19",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Supportive Care,25-21,NA,https://ClinicalTrials.gov/show/NCT04907903
NCT04788355,Prevention of Complications (SARS-CoV-2): Clinical Study,"Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Prevention",HA and A COVID 19,"Univás, Pouso Alegre, Minas Gerais, Brazil",https://ClinicalTrials.gov/show/NCT04788355
NCT04427969,Early Prone Position on Coronavirus Disease 2019 Pneumonia,Observational Model: Cohort|Time Perspective: Retrospective,pp34,"Sisli Etfal Research and Training Hospital, Istanbul, Marmara, Turkey",https://ClinicalTrials.gov/show/NCT04427969
NCT04341584,CORIMUNO-ANA: Trial Evaluating Efficacy Of Anakinra In Patients With Covid-19 Infection,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,APHP200375-5,"Hôpital Bicêtre, Assistance Publique-Hôpitaux de Paris, Le Kremlin-Bicêtre, France",https://ClinicalTrials.gov/show/NCT04341584
NCT04377607,Haemoglobin Concentration on COVID-19,Observational Model: Other|Time Perspective: Retrospective,145/2020,"Konya Training and Research Hospital, Konya, Turkey",https://ClinicalTrials.gov/show/NCT04377607
NCT04460599,Neurological Features During COVID19,Observational Model: Cohort|Time Perspective: Retrospective,Brain COVID,"Hopital Raymond Poincare, Garches, France",https://ClinicalTrials.gov/show/NCT04460599
NCT04340557,Do Angiotensin Receptor Blockers Mitigate Progression to Acute Respiratory Distress Syndrome With SARS-CoV-2 Infection,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,COVID-ARB|2003902,"Sharp Grossmont Hospital, La Mesa, California, United States|Sharp Chula Vista Medical Center, San Diego, California, United States|Sharp Memorial Hospital, San Diego, California, United States",https://ClinicalTrials.gov/show/NCT04340557
NCT04292327,Clinical Progressive Characteristics and Treatment Effects of 2019-novel Coronavirus,Observational Model: Other|Time Perspective: Retrospective,KY-2020-24.01,"Fujian Provincial Hospital, Fuzhou, Fujian, China",https://ClinicalTrials.gov/show/NCT04292327
NCT04799132,Association Between Body Mass Index and HFNC Therapy Success,Observational Model: Cohort|Time Perspective: Retrospective,BMI AND HFNC,"Clínica del Country., Bogotá, Colombia",https://ClinicalTrials.gov/show/NCT04799132
NCT04430023,Epidemiological and Demographic Data From 150 Patients Diagnosed With Coronavirus Disease 2019 Pneumonia,Observational Model: Other|Time Perspective: Retrospective,DM3334,"Sisli Etfal Research and Training Hospital, Istanbul, Marmara, Turkey",https://ClinicalTrials.gov/show/NCT04430023
NCT04961359,Recombinant New Coronavirus Vaccine (CHO Cells) to Prevent SARS-CoV-2（COVID-19） Phase I Clinical Trial (3~17 Years Old),"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",LKM-2021-NCV01,"Hunan Provincial Center for Disease Control and Prevention, Changsha, Hunan, China",https://ClinicalTrials.gov/show/NCT04961359
NCT04376034,Convalescent Plasma Collection and Treatment in Pediatrics and Adults,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2004965705,"WVU Medicine, Morgantown, West Virginia, United States",https://ClinicalTrials.gov/show/NCT04376034
NCT04269525,Umbilical Cord(UC)-Derived Mesenchymal Stem Cells(MSCs) Treatment for the 2019-novel Coronavirus(nCOV) Pneumonia,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,2020002,"Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China",https://ClinicalTrials.gov/show/NCT04269525
NCT04517097,Study of the Specific Seroprevalence of SARS-CoV-2 in a Sample of Patients and Salaried Staff From a French Anti-cancer Center at the End of the Containment Period of the SARS-CoV-2 Pandemic,Observational Model: Cohort|Time Perspective: Prospective,2020-A00877-32,"Centre Georges-François LECLERC, Dijon, France",https://ClinicalTrials.gov/show/NCT04517097
NCT04559542,"Body Weight Regulation, Disordered Eating Behaviour, and Experiences of Sexual Harassment in Female Martial Art Athletes",Observational Model: Cohort|Time Perspective: Cross-Sectional,20/00378,"Norwegian school of sport sciences, Oslo, Norway",https://ClinicalTrials.gov/show/NCT04559542
NCT03907891,Reducing Hopelessness Through Improved Physical Activity in Adults With Heart Disease: With COVID-19 Considerations,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",2018-1485|R01NR017649|3R01NR017649-04S1,"Spectrum Health, Grand Rapids, Michigan, United States",https://ClinicalTrials.gov/show/NCT03907891
NCT04423042,Tocilizumab in Coronavirus-19 Positive Patients,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,REB20-0713,NA,https://ClinicalTrials.gov/show/NCT04423042
NCT04590209,Clinical and Mechanistic Study of Patients (With COVID-19 or Not) With a Recent Acrosyndrome,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science,APHP200884|N° IDRCB 2020-A0181336,"Department of Dermatology, Tarnier hospital, AP-HP, Paris, France",https://ClinicalTrials.gov/show/NCT04590209
NCT04325672,Convalescent Plasma to Limit Coronavirus Associated Complications,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science,20-002864,NA,https://ClinicalTrials.gov/show/NCT04325672
NCT03188796,The VITDALIZE Study: Effect of High-dose Vitamin D3 on 28-day Mortality in Adult Critically Ill Patients,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",VITDALIZE 1.0,"LKH Hochsteiermark Standort Bruck, Bruck An Der Mur, Austria|LKH Enzenbach, Enzenbach, Austria|LKH Feldbach, Feldbach, Austria|LKH Fürstenfeld, Fürstenfeld, Austria|Medical University of Graz, Graz, Austria|Medical University Innsbruck, Innsbruck, Austria|Klinikum am Wörthersee, Klagenfurt, Austria|LKH Hochsteiermark Standort Leoben, Leoben, Austria|Barmherzige Brüder Konventhospital Linz, Linz, Austria|Barmherzige Schwestern, Linz, Austria|Kepler Universitätsklinikum Linz, Linz, Austria|Krankenhaus Schwarzach, Schwarzach Im Pongau, Austria|Barmherzige Brüder, Vienna, Austria|Medical University of Vienna, Vienna, Austria|LKH Villach, Villach, Austria|Kaiser Franz Josef Spital Wien, Wien, Austria|Erasme Hospital, Brussel, Belgium|CHU de Charleroi, Charleroi, Belgium|CHR Citadelle, Liège, Belgium|CHU Ambroise Pare, Mons, Belgium",https://ClinicalTrials.gov/show/NCT03188796
NCT04821986,Oral Manifestation in Patients With SARS-CoV2 Infection.,Observational Model: Other|Time Perspective: Cross-Sectional,Oral SARS-CoV2,"Faculty of Dentistry, Fayoum, Egypt",https://ClinicalTrials.gov/show/NCT04821986
NCT04956562,Effect of Sinovac on Survival in Intensive Care Unit,Observational Model: Cohort|Time Perspective: Retrospective,1903,"Sisli Hamidiye Etfal Research and Training Hospital, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04956562
NCT04832841,IgG Antibodies After SARS-CoV-2 mRNA Vaccine in Kidney Transplantation (TASMANIA),Observational Model: Cohort|Time Perspective: Prospective,G-21-07,"Institute for Clinical and Experimental Medicine, Prague, Czechia",https://ClinicalTrials.gov/show/NCT04832841
NCT04467112,Non Inferiority Trial for Detection of nCOVID-19 Through Analysis of Exhaled Breath Aerosols,Observational Model: Cohort|Time Perspective: Cross-Sectional,COVID-Breath,"Cambridge University Hospital NHS, Cambridge, United Kingdom",https://ClinicalTrials.gov/show/NCT04467112
NCT01306084,Viral Infections in Healthy and Immunocompromised Hosts,Observational Model: Other|Time Perspective: Prospective,110109|11-I-0109,"National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States",https://ClinicalTrials.gov/show/NCT01306084
NCT04536051,A Study of a Candidate COVID-19 Vaccine (COV003),Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Single (Participant)|Primary Purpose: Prevention,COV003,"Instituto D'Or de Pesquisa e Ensino - I'Dor, Salvador, Bahia, Brazil|Centro de Pesquisas Clinicas de Natal (CPCLIN), Natal, Rio Grande Do Norte, Brazil|Hospital das Clinicas de Porto Alegre, Porto Alegre, Rio Grande Do Sul, Brazil|Universidade Federal de Santa Maria (UFSM), Santa Maria, Rio Grande Do Sul, Brazil|Instituto D'Or de Pesquisa e Ensino - I'Dor, Rio de Janeiro, Brazil|CRIE, Universidade Federal de São Paulo, São Paulo, Brazil",https://ClinicalTrials.gov/show/NCT04536051
NCT04868435,Triggers for Post-Viral Parosmia After Covid and Non-Covid Infections,Observational Model: Cohort|Time Perspective: Prospective,Parosmia Questionnaire,"University of Reading, Reading, United Kingdom",https://ClinicalTrials.gov/show/NCT04868435
NCT04462848,Covid-19 Convalescent Plasma as Prevention and Treatment for Children With Underlying Medical Conditions,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,IRB#20-001263,"University of California, Los Angeles (UCLA), Los Angeles, California, United States",https://ClinicalTrials.gov/show/NCT04462848
NCT04715477,Intensive Care Anxiety in SARS-CoV-2 Patients,Observational Model: Case-Control|Time Perspective: Prospective,derince TRH 2,"İlke Küpeli, İ̇zmi̇t, Kocaeli̇, Turkey",https://ClinicalTrials.gov/show/NCT04715477
NCT04392115,The PREPARE for COVID Trial,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Health Services Research,NA,NA,https://ClinicalTrials.gov/show/NCT04392115
NCT04737486,A First-in-Human Study of AV-001 in Healthy Subjects,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",AV001-PK-001,"Medpace Clinical Pharmacology Unit, Cincinnati, Ohio, United States",https://ClinicalTrials.gov/show/NCT04737486
NCT04322279,Factors Associated With a Positive SARS-CoV-2 Serology in Contact Subjects at High/Moderate Risk of Coronavirus SARS-CoV-2 Infection. COVID19.,Observational Model: Cohort|Time Perspective: Prospective,C20-16|2020-A00609-30,"Service de maladies infectieuses et tropicales Hôpital Jean Minjoz CHRU Besançon, Besançon, France|Service des Maladies infectieuses et tropicales, Pôle Spécialités médicales, CHU Pellegrin, Bordeaux, France|Service des maladies infectieuses Hôpital Gabriel Montpied CHU de Clermont Ferrand, Clermont Ferrand, France|Centre d'investigation clinique 1432 Hôpital François Mitterrand CHU Bourgogne, Dijon, France|Centre d'investigation clinique 1406 CHU Grenoble, Grenoble, France|Centre d'Investigation Clinique 1403 -CHU Lille, Lille, France|Centre d'investigation clinique Infectiologie Hôtel-Dieu CHU Nantes, Nantes, France|Centre d'Investigation Clinique Hôpital Saint Louis, Paris, France|Centre d'investigation Clinique 1425, Hôpital Bichat Claude Bernard, Paris, France|Hôpital Cochin CIC 1417 Bâtiment Lavoisier, Paris, France|Centre d'investigation clinique 1414 Service de Pharmacologie clinique CHU Rennes Hôpital Pontchaillou, Rennes, France|Centre Hospitalier Félix Guyon Ile de la Réunion CHU nord, Saint Denis, France|Département maladie infectieux CHU Saint Etienne, Saint Etienne, France|Centre d'Investigation Clinique Ile de la Réunion CHU sud, Saint-Pierre, France|Centre Investigation Clinique 1415 CHRU Tours - Hôpital Bretonneau, Tours, France|Centre Investigation Clinique 1433 CHRU de NANCY, Vandœuvre-lès-Nancy, France|Service de Maladies infectieuses et tropicales Centre hospitalier, Cayenne, French Guiana",https://ClinicalTrials.gov/show/NCT04322279
NCT04474444,Ambulance Calls for Substance Use and Alcohol in a Pandemic (ASAP),Observational Model: Case-Only|Time Perspective: Retrospective,ASAP01,"University of Lincoln, Lincoln, United Kingdom",https://ClinicalTrials.gov/show/NCT04474444
NCT04728347,Open Label Extension Study to Assess the Safety and Long-Term Immunogenicity of ARCT-021,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,ARCT-021-02,"SingHealth Investigational Medicine Unit (IMU), Singapore General Hospital, Singapore, Singapore",https://ClinicalTrials.gov/show/NCT04728347
NCT04393415,Using PRP and Cord Blood in Treatment of Covid -19,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Supportive Care",covid -19,"Aljazeera( Al Gazeera) hospital, Giza, Egypt",https://ClinicalTrials.gov/show/NCT04393415
NCT04760795,"Stress, Personality, Attachment and Coping During the Covid Crisis.",Observational Model: Case-Only|Time Perspective: Prospective,IRBN922020,"CH Le Vinatier, Bron, France|Chu Saint-Etienne, Saint-Étienne, France",https://ClinicalTrials.gov/show/NCT04760795
NCT04403061,Th1/Th2/Th17/TREG and TLRs Activation/KIR for COVID 19 Prediction of Outcome,Observational Model: Cohort|Time Perspective: Prospective,EC128/20,"Hospital Ramon y Cajal, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04403061
NCT04925999,Distance Learning and Neck Problems During Pandemic Period,Observational Model: Cohort|Time Perspective: Cross-Sectional,P.T.REC/012/003211,"Misr university for science and technology, Cairo, Egypt",https://ClinicalTrials.gov/show/NCT04925999
NCT04727775,Antiviral Drugs on the Treatment of SARS-CoV-2,Observational Model: Cohort|Time Perspective: Retrospective,AMU,"Aidos Konkaev, Nur-Sultan, Kazakhstan|Semey Medical University, Semey, Kazakhstan",https://ClinicalTrials.gov/show/NCT04727775
NCT04757883,Immunological Follow-up After SARS CoV2 Vaccination in Kidney Transplant Recipients,Observational Model: Cohort|Time Perspective: Prospective,8135,NA,https://ClinicalTrials.gov/show/NCT04757883
NCT04453527,The CASCADE Study - Measures of Complement Activation and Inflammation in Patients With Covid-19,Observational Model: Cohort|Time Perspective: Prospective,PHT/2020/37,"Portsmouth Hospitals NHS Trust, Portsmouth, United Kingdom",https://ClinicalTrials.gov/show/NCT04453527
NCT04436276,A Study of Ad26.COV2.S in Adults (COVID-19),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Other",CR108828|2020-001483-28|VAC31518COV1001,"Optimal Research, San Diego, California, United States|Optimal Research, Melbourne, Florida, United States|Optimal Research, Peoria, Illinois, United States|Optimal Research, Rockville, Maryland, United States|Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|AMR New Orleans, Formerly New Orleans Center for Clinical Research - New Orleans, an AMR company, Knoxville, Tennessee, United States|Optimal Research, Austin, Texas, United States|SGS Life Science Services, Antwerpen, Belgium|Center for Vaccinology (CEVAC), Gent, Belgium|UZ Leuven, Leuven, Belgium|Clinical Pharmacology Unit, Merksem, Belgium|Universiteit Antwerpen, Wilrijk, Belgium",https://ClinicalTrials.gov/show/NCT04436276
NCT04537962,Salivary SARS-CoV-2 Load of Covid-19 Patients After Oral Antimicrobial Solutions and Dentifrices,"Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Supportive Care",4172-20,"Hospital israelita Albert Einstein, Sao Paulo, Brazil",https://ClinicalTrials.gov/show/NCT04537962
NCT04264533,Vitamin C Infusion for the Treatment of Severe 2019-nCoV Infected Pneumonia,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Treatment",2020001,"Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China",https://ClinicalTrials.gov/show/NCT04264533
NCT04473300,Assessment of Lung Recruitablity of Acute Respiratory Distress Syndrome With SARS-CoV-2 Pneumonia by Electrical Impedance Tomography,Observational Model: Cohort|Time Perspective: Prospective,ASPEIT,"Osaka University Hospital, Suita, Osaka, Japan",https://ClinicalTrials.gov/show/NCT04473300
NCT04930055,Immune Responses in Oncology Patients to Novel Coronavirus Vaccines (IROC),Observational Model: Cohort|Time Perspective: Prospective,CTO-IUSCCC-0759,"IU Health Joe and Shelly Schwarz Cancer Center, Carmel, Indiana, United States|Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, Indiana, United States",https://ClinicalTrials.gov/show/NCT04930055
NCT04798599,Information and Communication Technologies (ICTS) in Dentistry for SUS,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Supportive Care",TeleDent-COVID19,"University of São Paulo, São Paulo, Brazil",https://ClinicalTrials.gov/show/NCT04798599
NCT04784624,Virtual Lifestyle Program Evaluation During Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2),Observational Model: Cohort|Time Perspective: Prospective,HS24424(H2020:495),NA,https://ClinicalTrials.gov/show/NCT04784624
NCT04828902,Incidence of Postoperative Delirium After Cardiac Surgery in Adults.,Observational Model: Cohort|Time Perspective: Prospective,NKBBN/4421/2020,"Department of Cadiac Anesthesiology, Medical University of Gdańsk, Gdańsk, Pomorskie, Poland",https://ClinicalTrials.gov/show/NCT04828902
NCT04338841,HOME-CoV: Hospitalization or Outpatient ManagEment of Patients With a SARS-CoV-2 Infection,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2020-A00831-38,"Clinique Universitaire Saint-Luc, Bruxelles, Belgium|CHU de Liège, Liege, Belgium|Ch Argenteuil, Argenteuil, France|CH Cholet, Cholet, France|CHU Clermont Ferrand, Clermont Ferrand, France|Ch Colmar, Colmar, France|CH Alpes Lemant, Contamine-sur-Arve, France|CHU Dijon, Dijon, France|CH Le Mans, Le Mans, France|CH Libourne, Libourne, France|CH Limoges, Limoges, France|Ch Longjumeau, Longjumeau, France|Chu Montpellier, Montpellier, France|Centre Hospitalier Universitaire de Nantes, Nantes, France|CH Niort, Niort, France|Hopital Paris Saint Joseph, Paris, France|Hopital Saint Antoine, Paris, France|Hôpital Bichat, Paris, France|Hôpital Lariboisière, Paris, France|CHU de Poitiers, Poitiers, France|CH Reims, Reims, France|Ch Remiremont, Remiremont, France|Chu Rennes, Rennes, France|CHU de Rouen, Rouen, France|CHU de St Etienne, Saint Etienne, France|CH de Saint-Brieuc, Saint-Brieuc, France|Ch Troyes, Troyes, France|CH VICHY, Vichy, France|CH Princesse Grace, Monaco, Monaco",https://ClinicalTrials.gov/show/NCT04338841
NCT04323527,Chloroquine Diphosphate for the Treatment of Severe Acute Respiratory Syndrome Secondary to SARS-CoV2,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",CAAE: 30152620.1.0000.0005,"Hospital e Pronto Socorro Delphina Rinaldi Abdel Aziz, Manaus, Amazonas, Brazil",https://ClinicalTrials.gov/show/NCT04323527
NCT02765191,MR-Evaluation of Renal Function In Septic Patients,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,MERSEP-523-2014-2569,"Uppsala University Hospital, Uppsala, Sweden",https://ClinicalTrials.gov/show/NCT02765191
NCT04768998,Intersectoral Platform (SÜP) of the National Pandemic Cohort Network (NAPKON),Observational Model: Cohort|Time Perspective: Prospective,01KX2021,"RWTH Aachen, Aachen, Germany|University Hospital Augsburg, Augsburg, Germany|Charité Berlin, Berlin, Germany|Klinikum Bielefeld, Bielefeld, Germany|University Hospital Ruhr-University Bochum, Bochum, Germany|University Hospital Bonn, Bonn, Germany|University Hospital Cologne, Cologne, Germany|University Hospital Carl Gustav Carus Dresden, Dresden, Germany|University Hospital Dusseldorf, Dusseldorf, Germany|University Hospital Erlangen, Erlangen, Germany|University Hospital Essen, Essen, Germany|Johann Wolfgang Goethe University, Frankfurt am Main, Germany|University Hospital Freiburg, Freiburg, Germany|University Hospital Greifswald, Greifswald, Germany|University Hospital Göttingen, Göttingen, Germany|University Hospital Halle, Halle/Saale, Germany|University Hospital Hamburg-Eppendorf, Hamburg, Germany|University Hospital MMH Hannover, Hannover, Germany|University Hospital Heidelberg, Heidelberg, Germany|University Hospital UKS Homburg, Homburg, Germany|University Hospital Jena, Jena, Germany|University Hospital UKSH Schleswig-Holstein, Kiel, Germany|University Hospital Leipzig, Leipzig, Germany|University Hospital UKSH Schleswig-Holstein, Lübeck, Germany|University Hospital Mannheim, Mannheim, Germany|University Hospital Giessen/Marburg, Marburg, Germany|University Hospital LMU Munich, Munich, Germany|University Hospital TUM Munich, Munich, Germany|University Hospital Münster, Münster, Germany|Klinikum Oldenburg, Oldenburg, Germany|University Hospital Regensburg, Regensburg, Germany|University Hospital Tübingen, Tübingen, Germany|University Hospital Ulm, Ulm, Germany|University Hospital Würzburg, Würzburg, Germany",https://ClinicalTrials.gov/show/NCT04768998
NCT04907331,Heterologous Vaccination With an Vaxzevria (ChAdOx1-S) Prime and a Comirnaty (BNT162b2) Boost Compared With Homolog Vaccination With Vaxzervria (Prime/Boost) or Comirnaty (Prime/Boost),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Prevention,2021-002171-19,"Medical University of Innsbruck, Innsbruck, Tyrol, Austria",https://ClinicalTrials.gov/show/NCT04907331
NCT04349163,Resilience Evaluation of Caregivers During the SARS-CoV2 Epidemic Period : Prospective Cohort.,Observational Model: Cohort|Time Perspective: Prospective,2020-A00831-39,"CHU, Angers, France",https://ClinicalTrials.gov/show/NCT04349163
NCT04525079,"To Evaluate the Safety, Tolerability and Pharmacokinetics of CT-P59 in Healthy Subjects","Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Screening",CT-P59 1.1|2020-003065-19,"Chungnam National University Hospital, Daejeon, Korea, Republic of",https://ClinicalTrials.gov/show/NCT04525079
NCT04702178,A Clinical Trial of COVAC-2 in Healthy Adults,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",COVAC-001,"Canadian Center for Vaccinology, Dalhousie University, Halifax, Nova Scotia, Canada|Royal University Hospital, Saskatoon, Saskatchewan, Canada",https://ClinicalTrials.gov/show/NCT04702178
NCT04452487,Study of the Consequences of Infection on Compliance of Modalities of Decisions of Limitations and Stops of Treatments (COVID-19-LAT),Observational Model: Case-Control|Time Perspective: Prospective,2020_GUASTELLA_COVID-19-LAT,"CHU de Clermont-Ferrand, Clermont-Ferrand, France|Hospices Civiles de Lyon, Lyon, France|CH de Vichy, Vichy, France",https://ClinicalTrials.gov/show/NCT04452487
NCT04897152,Coronavirus Associated Pneumomediastinum and Pneumothorax,Observational Model: Cohort|Time Perspective: Retrospective,COVI-MIX,"Policlinico S.Orsola-Malpighi, Pneumologia e Terapia Intensiva Respiratoria, Bologna, Italy|Policlinico S.Orsola-Malpighi, U.O Malattie Infettive, Bologna, Italy|Azienda Ospedaliero-Universitaria V.Emanuele Ferrarotto, S.bambino, Malattie Infettive, Catania, Italy|Azienda Ospedaliero-Universitaria V.Emanuele Ferrarotto, S.bambino, U.O.C. di Malattie Infettive, Catania, Italy|Azienda Ospedaliera S.Croce e Carle Cuneo, SC Malattie Infettive e tropicali,, Cuneo, Italy|Ospedale Policlinico San Martino-IRCCS, Clinica di Malattie Infettive e Tropicali, Genova, Italy|Fondazione IRCCS, Ca Granda Ospedale Maggiore Policlinico, UOC, Malattie Infettive, Milano, Italy|Ospedale dei colli, Malattie Infettive ed Urgenze Infettivologiche,, Napoli, Italy|Azienda Ospedaliera di Padova, S.C di Fisiopatologia respiratoria,, Padova, Italy|Unità Operativa Complessa Istituto di Anestesia e Rianimazione dell'Azienda Ospedale-Università di Padova,, Padova, Italy|Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone di Palermo, UOC Anestesia Rianimazione con Terapia Intensiva Polivalente e del Dolore, Palermo, Italy|Azienda Ospedaliero-Universitaria di Parma, Clinica Pneumologica, Parma, Italy|Azienda Ospedaliera Perugia, Malattie Infettive, Perugia, Italy|Azienda USL Toscana Ovest, Ospedale Felice Lotti SOC Medicina Interna, Pontedera, Italy|Azienda Sanitaria Universitaria Friuli Occidentale, S.C Pneumologia, Pordenone, Italy|AOU Città della Salute e Scienza, SC Malattie Infettive, Torino, Italy|Azienda Ospedaliera Ordine Mauriziano S.C. Pneumologia e Unità di Terapia Semi Intensiva Respiratoria, Torino, Italy|Ospedale Cardinal Massaia, SC Malattie Infettive, Torino, Italy|Azienda Sanitaria Universitaria Giuliano Isontina, S.C Pneumologia, Trieste, Italy|Anesthesiology and Intensive Care Clinic - Department of Medicine - ASUIUD, Udine, Italy|Azienda ospedaliero universitaria Friuli Centrale, Anestesia e Rianimazione 1, Udine, Italy|Azienda ospedaliero universitaria Friuli Centrale, Anestesia e Rianimazione 2, Udine, Italy|Azienda ospedaliero universitaria Friuli Centrale, Clinica di Anestesia e Rianimazione, Udine, Italy|Azienda Ospedaliero Universitaria Friuli Centrale, Malattie infettive, Udine, Italy|Azienda Ospedaliero Universitaria Friuli Centrale, Pneumologia, Udine, Italy|Azienda Sanitaria locale di Vercelli, Malattie infettive, Vercelli, Italy|Università di Verona, Clinica delle Malattie Infettive e Tropicali, Verona, Italy",https://ClinicalTrials.gov/show/NCT04897152
NCT04276987,A Pilot Clinical Study on Inhalation of Mesenchymal Stem Cells Exosomes Treating Severe Novel Coronavirus Pneumonia,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,MEXCOVID,"Ruijin Hospital Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, China",https://ClinicalTrials.gov/show/NCT04276987
NCT04792567,Exploring the Immune Response to SARS-CoV-2 modRNA Vaccines in Patients With Secondary Progressive Multiple Sclerosis (AMA-VACC),Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,CBAF312ADE03|2020-005752-38,"Novartis Investigative Site, Mittweida, Sachsen, Germany|Novartis Investigative Site, Bogen, Germany|Novartis Investigative Site, Chemnitz, Germany|Novartis Investigative Site, Dresden, Germany|Novartis Investigative Site, Düsseldorf, Germany|Novartis Investigative Site, Neuburg an der Donau, Germany|Novartis Investigative Site, Pforzheim, Germany|Novartis Investigative Site, Regensburg, Germany|Novartis Investigative Site, Ruelzheim, Germany|Novartis Investigative Site, Ulm, Germany",https://ClinicalTrials.gov/show/NCT04792567
NCT04957199,Physiotherapist Awareness in the Community,Observational Model: Other|Time Perspective: Other,E.38981562-900-62297,"Istanbul University-Cerrahpasa, İ̇stanbul, Turkey",https://ClinicalTrials.gov/show/NCT04957199
NCT04374058,Less Frequency Hemodialysis and COVID-19,Observational Model: Case-Control|Time Perspective: Prospective,coronavirus,"Dialisis Madariaga, General Juan Madariaga, Buenos Aires, Argentina",https://ClinicalTrials.gov/show/NCT04374058
NCT04245631,"Development of a Simple, Fast and Portable Recombinase Aided Amplification Assay for 2019-nCoV",Observational Model: Cohort|Time Perspective: Prospective,DTXY022,"Department of Hepatology Division 2, Beijing Ditan Hospital, Beijing, Beijing, China",https://ClinicalTrials.gov/show/NCT04245631
NCT04480606,Evaluation of the Physical Activity Level of the Elderly in Social Isolation,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention,8,NA,https://ClinicalTrials.gov/show/NCT04480606
NCT04924634,Stress Levels and Mental Well-Being Among Slovak Students During e-Learning,Observational Model: Cohort|Time Perspective: Retrospective,COVID_Slovak,"Faculty of Physical Education and Physiotherapy, Opole University of Technology, Opole, Poland",https://ClinicalTrials.gov/show/NCT04924634
NCT04755972,Mucolytics in Patients on Invasive Mechanical Ventilation Due to Severe Acute Respiratory Syndrome Coronavirus 2,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,2181-147-01/06/M.S.-20-02,"Clinical Hospital Centre Split, Split, Croatia",https://ClinicalTrials.gov/show/NCT04755972
NCT04385004,"Clinical, Biological and Histological Pulmonary and Renal Damage Associated With the SARS-CoV-2 Syndrome in Patients Admitted in ICU",Observational Model: Case-Only|Time Perspective: Other,7815,"Service Reanimation Medicale, Strasbourg, France",https://ClinicalTrials.gov/show/NCT04385004
NCT04849793,The Effect of Acupressure on the Anxiety Level,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Supportive Care,MersinUniversity,"Turkey, Mersin University,, Mersin, Turkey",https://ClinicalTrials.gov/show/NCT04849793
NCT04370067,HUNgarian COronaVirus Disease-19 Epidemiological Research,Observational Model: Ecologic or Community|Time Perspective: Other,H-UNCOVER,"Semmelweis University - Heart and Vascular Center, Budapest, Hungary|University of Debrecen, Debrecen, Hungary|University of Pecs, Pecs, Hungary|University of Szeged, Szeged, Hungary",https://ClinicalTrials.gov/show/NCT04370067
NCT04275388,Xiyanping Injection for the Treatment of New Coronavirus Infected Pneumonia,Observational Model: Cohort|Time Perspective: Retrospective,QF-XYP2001-1,NA,https://ClinicalTrials.gov/show/NCT04275388
NCT04419545,Covid Radiographic Images Data-set for A.I,Observational Model: Case-Control|Time Perspective: Retrospective,CORDA,"Azienda Ospedaliero Universitaria Città della Salute e della Scienza, Torino, Turin, Italy",https://ClinicalTrials.gov/show/NCT04419545
NCT00571389,Isolation and Culture of Immune Cells and Circulating Tumor Cells From Peripheral Blood and Leukapheresis Products,Observational Model: Case-Only|Time Perspective: Prospective,BioCytics 0001|WIRB Protocol # 20070969,"Carolina BioOncology Institute, Huntersville, North Carolina, United States",https://ClinicalTrials.gov/show/NCT00571389
NCT03963622,Careful Ventilation in Acute Respiratory Distress Syndrome (COVID-19),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,1765,"New York University Grossman School of Medicine, New York, New York, United States|St. Michael's Hospital, Toronto, Ontario, Canada|Toronto General Hospital, Toronto, Canada|Toronto Western Hospital, Toronto, Canada|Pontificia Universidad Católica de Chile, Santiago de Chile, Chile|Centre hospitalier universitaire d'Angers, Angers, France|CH Victor Dupouy, Argenteuil, France|CH de Beauvais, Beauvais, France|CHU Bordeaux - Haut Leveque, Bordeaux, France|Hopital de la Cavale Blanche - CHRU Brest, Brest, France|CH de Cholet, Cholet, France|Hopital Intercommunal de Creteil, Creteil, France|CHU Grenoble-Alpes, Grenoble, France|Hopital Roger Salengro - CHU Lille, Lille, France|Groupe Hospitalier de la Region de Mulhouse et Sud Alsace, Mulhouse, France|Hopital de l'Archet 1 - CHU de Nice, Nice, France|Hopital Europeen Georges-Pompidou, Paris, France|CHU de Poitiers - La Miletrie, Poitiers, France|CH Bretagne Atlantique Vannes-Auray, Vannes, France|HIA Robert Picque, Villenave-d'Ornon, France|Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy|L'Hospital de la Santa Creu i Sant Pau, Barcelona, Spain|Vall d'Hebron University Hospital, Barcelona, Spain",https://ClinicalTrials.gov/show/NCT03963622
NCT04846010,"Recovering Damaged Cells for Sequelae Caused by COVID-19, SARS-CoV-2",Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,CHM2282395-2,"All Natural Medicine Clinic, LLC, Rockville, Maryland, United States",https://ClinicalTrials.gov/show/NCT04846010
NCT04822285,Effect Psychological Triaging Intervention on Students' Psychological Distress and Resilience Capacity,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Supportive Care,1522112020,"Faculty of Nursing, Alexandria, Egypt",https://ClinicalTrials.gov/show/NCT04822285
NCT04686747,COVID - 19 and Advanced Gastro-intestinal Cancer Treatment,Observational Model: Cohort|Time Perspective: Retrospective,MH - COVID - AGICT,"Department of General and Emergency Surgery. Misericordia Hospital. Director: Coratti Andrea, MD, Grosseto, Tuscany, Italy",https://ClinicalTrials.gov/show/NCT04686747
NCT04603079,Nurse Leadership for Hospital Infection Control,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,NurseLeadership,NA,https://ClinicalTrials.gov/show/NCT04603079
NCT04442789,Sequelae of Sars-CoV-2 Infections,Observational Model: Cohort|Time Perspective: Prospective,SECOV,"Department of Internal Medicine II, Universities of Giessen and Marburg Lung Center (UGMLC), member of the German Center for Lung Research (DZL), Justus-Liebig-University, Giessen, Germany",https://ClinicalTrials.gov/show/NCT04442789
NCT04316377,Norwegian Coronavirus Disease 2019 Study,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,REC 121446,"Akershus University Hospital, Lørenskog, Norway",https://ClinicalTrials.gov/show/NCT04316377
NCT04556149,"imPulse™ Una Full-spectrum, Over Clothing E-stethoscope",Observational Model: Case-Control|Time Perspective: Prospective,110011,"Johns Hopkins School of Medicine, Baltimore, Maryland, United States",https://ClinicalTrials.gov/show/NCT04556149
NCT03331445,Inhaled Gaseous Nitric Oxide (gNO) Antimicrobial Treatment of Difficult Bacterial and Viral Lung (COVID-19) Infections,Allocation: N/A|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,NTM-CTP-01: H17-02107,"Nitric Solutions-Mobile Unit, Vancouver, British Columbia, Canada",https://ClinicalTrials.gov/show/NCT03331445
NCT04255940,2019-nCoV Outbreak and Cardiovascular Diseases,Observational Model: Case-Only|Time Perspective: Prospective,2019nCoV-CVD,"Affiliated Hospital of Binzhou Medical Universty, Binzhou, Shandong, China|Heze Municipal Hospital, Heze, Shandong, China|Shandong University Qilu Hospital, Jinan, Shandong, China|Jinan Central Hospital, Shandong University, Jinan, Shandong, China|First Hospital Affiliated with Shandong First Medical University, Jinan, Shandong, China|Shandong Provincial Hospital, Shandong University, Jinan, Shandong, China|The Second Hospital of Shandong University, Jinan, Shandong, China|Jining Hospital of Traditional Chinese Medicine, Jining, Shandong, China|Qihe People's Hospital, Qihe, Shandong, China|Affiliated Hospital of Qingdao University Medical College, Qingdao, Shandong, China|Weihai Municipal Hospital, Weihai, Shandong, China|Central Hospital of Zibo, Zibo, Shandong, China",https://ClinicalTrials.gov/show/NCT04255940
NCT04765540,The Effect of Behaviour Change Interventions on Use of Public Handwashing Stations in Bangladesh,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,2020091,"BRAC, Dhaka, Bangladesh|BRAC Khulna, Khulna, Bangladesh|BRAC Mymensingh, Mymensingh, Bangladesh",https://ClinicalTrials.gov/show/NCT04765540
NCT04322682,Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",MHIPS-2020-001|3R01HL146206-02S1,"Mayo Clinic - Arizona, Phoenix, Arizona, United States|Yuma Regional Medical Center Cancer Center, Yuma, Arizona, United States|University of Arkansas for medical Sciences, Little Rock, Arkansas, United States|Centric Health Resources Inc., Bakersfield, California, United States|Westside Medical Associates of Los Angeles, Beverly Hills, California, United States|Rancho Research Institute, Downey, California, United States|University of California, San Francisco - San Francisco General Hospital, San Francisco, California, United States|Mayo Clinic - Jacksonville, Jacksonville, Florida, United States|South Florida Research Organization, Medley, Florida, United States|Miami Center for Advanced Cardiology, Miami Beach, Florida, United States|Mayo Clinic - Rochester, Rochester, Minnesota, United States|North Mississippi Medical Clinics, Inc., Tupelo, Mississippi, United States|New York University School of Medecine, New York, New York, United States|University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States|Prisma Health, Greenville, South Carolina, United States|Baylor Scott & White Research Institute - Pharmacy, Dallas, Texas, United States|University of Texas(UT) Southwestern Medical Center, Dallas, Texas, United States|Spring Clinical Research, Houston, Texas, United States|Heart Institute (inCor), Scholl of Medecine, University of Sao Paulo, São Paulo, Sao Paulo, Brazil|Montreal Heart Institute, Montreal, Quebec, Canada|Tread Research, Tygerberg Hospital, Cape Town, South Africa|Hospital Universitario La Paz, IdiPaz, La Paz, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04322682
NCT04581889,Prevalence of Antibodies Against SARS-CoV-2 Virus That Causes COVID-19 in Tübingen Children,Observational Model: Cohort|Time Perspective: Prospective,Coro-Buddy,"Institute of Tropical Medicine, Tübingen, Deutschland, Germany",https://ClinicalTrials.gov/show/NCT04581889
NCT04786080,Supporting Parents & Kids Through Lockdown Experiences (SPARKLE).,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment",SPARKLE; REC #:HR-20/21-21451,"King's College London, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04786080
NCT04361838,The COVID-19 ICU PRAYER Study,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Supportive Care",Covid Prayer Study,"Research Medical Center, Kansas City, Missouri, United States",https://ClinicalTrials.gov/show/NCT04361838
NCT04817657,Pre-approval Access for Janssen's COVID Vaccine VAC31518 for Treating Physician Use,NA,CR109001|VAC31518COV4006,NA,https://ClinicalTrials.gov/show/NCT04817657
NCT04479540,Assessment of the Risk of Pulmonary Embolism and Coagulation Profile in Patients With COVID-19 Lung Disease,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,2020_0058,"Hôpital Foch, Suresnes, France",https://ClinicalTrials.gov/show/NCT04479540
NCT04698798,Skeletal Muscle Wasting in SARS-CoV-2,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science,SMW-CoV-2,"Jessa Ziekenhuis, Hasselt, Belgium",https://ClinicalTrials.gov/show/NCT04698798
NCT04853199,Quercetin In The Treatment Of SARS-COV 2,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",QUERCOV,"HU Sahloul, sousse, Tunisia, Sousse, Itinéraire Ceinture Cité Sahloul, Tunisia|Riadh Boukef, Sahloul, Sousse, Tunisia",https://ClinicalTrials.gov/show/NCT04853199
NCT04564274,COV2Base-A Rare Disease by COVID Study,Observational Model: Other|Time Perspective: Other,10000091|000091-H,"National Heart, Lung and Blood Institute (NHLBI), Bethesda, Maryland, United States",https://ClinicalTrials.gov/show/NCT04564274
NCT04979871,Analysis of SARS-CoV-2 Antibodies and Virus Neutralisation in a Health Personnel Cohort,Observational Model: Cohort|Time Perspective: Prospective,University of Zurich,"Univeristy Hospital Zurich, Zurich, Switzerland",https://ClinicalTrials.gov/show/NCT04979871
NCT04764422,Assess the Safety and Immunogenicity of NDV-HXP-S Vaccine in Thailand,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention",GPO NDV-HXP-S,"Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand",https://ClinicalTrials.gov/show/NCT04764422
NCT04871932,COVID-2019 Vaccine Immune Response Base on Single Cell Multi-Omics,Observational Model: Cohort|Time Perspective: Prospective,COVID-2019-VIR-SCMO study,"Cardiology, Ren Ji Hospital, Shanghai, China",https://ClinicalTrials.gov/show/NCT04871932
NCT04894253,Immune Response to SARS-CoV-2 Vaccination in Systemic Lupus,Observational Model: Case-Only|Time Perspective: Prospective,8263,"University Hospital of Hautepierre, Strasbourg, Bas-Rhin, France",https://ClinicalTrials.gov/show/NCT04894253
NCT04723706,Response to SARS-CoV-2 Vaccine in Stem Cell Transplant and Cellular Therapy Patients,Observational Model: Cohort|Time Perspective: Prospective,14632,"Henry Ford Health System, Detroit, Michigan, United States",https://ClinicalTrials.gov/show/NCT04723706
NCT04852055,Effect of a COVID-specific Advance Care Planning Intervention,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Supportive Care",2008002779|3U54AG063546-02S1,NA,https://ClinicalTrials.gov/show/NCT04852055
NCT04854941,Efficacy of Probiotics in the Treatment of Hospitalised Patients With Novel Coronavirus Infection,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,PROCOV-19-2020,"I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation",https://ClinicalTrials.gov/show/NCT04854941
NCT04699058,COVID-19 Sero-prevalence Health Care Workers Kinshasa,Observational Model: Ecologic or Community|Time Perspective: Prospective,B3002020000144,"Institut Nationale de recherche Biomédicale, Kinshasa, Congo, The Democratic Republic of the",https://ClinicalTrials.gov/show/NCT04699058
NCT04282135,Detection of Influenza or SARS-CoV-2 Infection by IMS of Nasal Air Sampling,Observational Model: Case-Control|Time Perspective: Prospective,IMS 1,"Klinikum Bayreuth, Bayreuth, Germany",https://ClinicalTrials.gov/show/NCT04282135
NCT04427813,Sexual Health and Problems During the Covid -19 Infection,Observational Model: Other|Time Perspective: Prospective,marital health,"Algazeerah, Giza, Egypt",https://ClinicalTrials.gov/show/NCT04427813
NCT04409275,LUNG FIBROTIC CHANGES ASSOCIATED WITH SARS-CoV-2 INFECTION,Observational Model: Case-Only|Time Perspective: Prospective,INC-CVD-2020-01,"Pulmonary Department. Hospital Clinico., Valencia, Spain",https://ClinicalTrials.gov/show/NCT04409275
NCT04961372,Socio-psychological Status of Healthcare Workers During SARS-CoV2 Pandemic,Observational Model: Ecologic or Community|Time Perspective: Prospective,ErzincanUniversity,"Siran Government Hospital, Gumushane, Siran, Turkey",https://ClinicalTrials.gov/show/NCT04961372
NCT04314817,Adverse Events Related to Treatments Used Against Coronavirus Disease 2019,Observational Model: Case-Only|Time Perspective: Cross-Sectional,CIC1421-20-04,"AP-HP Assistance Publique Hopitaux de Paris, Paris, France",https://ClinicalTrials.gov/show/NCT04314817
NCT04913766,REstoring Mental Health After SARS-CoV-2 Through commUnity-based Psychological Services in New York City,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,R01MH127767,NA,https://ClinicalTrials.gov/show/NCT04913766
NCT04852848,Creating a Sustainable Infrastructure for SARS-CoV-2 Testing at Syringe Exchange Programs,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,11162020.013|3R01DA037628-05S1,NA,https://ClinicalTrials.gov/show/NCT04852848
NCT04363788,Needle Stick Injuries in Emergency Medical Service Practice,Observational Model: Cohort|Time Perspective: Prospective,OH_PPE_1,"Lazarski Univeristy, Warsaw, Poland",https://ClinicalTrials.gov/show/NCT04363788
NCT04868942,Protective Measures Against SARS-CoV-2 Contamination of Young Healthy Volunteers During a Concert of Actual Music,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,ANRS0004s,NA,https://ClinicalTrials.gov/show/NCT04868942
NCT03738774,Addressing Post-Intensive Care Syndrome Among Survivors of COVID (APICS-COVID),Observational Model: Cohort|Time Perspective: Prospective,IRB181120,"Johns Hopkins Hospital, Baltimore, Maryland, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Vanderbilt University, Nashville, Tennessee, United States|Intermountain Medical Center, Murray, Utah, United States|George Wahlen Salt Lake City Veterans Administration Hospital, Salt Lake City, Utah, United States",https://ClinicalTrials.gov/show/NCT03738774
NCT04763681,Couple HOPES (Helping Overcome PTSD and Enhance Satisfaction),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,2019-475|173098|CIHR-IRSC:0525007697|W7714-207266,"York University, Toronto, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04763681
NCT04664296,COVID-19 - SARS-CoV-2 Community Contamination in Children and Adults (Dyn3CEA_Nosocor),Observational Model: Case-Only|Time Perspective: Prospective,69HCL20_1100,"Service de Reanimation Pediatrique, Lyon, Rhone, France",https://ClinicalTrials.gov/show/NCT04664296
NCT04858451,COmmunity Patients at Risk of Viral Infections Including SARS-CoV-2,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,RESP301-005,"Medicines Evaluation Unit, Manchester, United Kingdom|The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, United Kingdom",https://ClinicalTrials.gov/show/NCT04858451
NCT04811781,Epidemiological Features and Clinical Course of SARS-CoV-2 Infection in Cancer Patients: The Rovid Study,Observational Model: Cohort|Time Perspective: Prospective,Rovid,"istituto Oncologico Veneto -UOSD Melanoma, Padova, PD, Italy|Aulss1 Dolomiti, Belluno, Italy|Istituto Oncologico Veneto -UOC Oncologia 1, Padova, Italy",https://ClinicalTrials.gov/show/NCT04811781
NCT04502108,Behavior During and After COVID-19 Crisis,Observational Model: Cohort|Time Perspective: Prospective,BFH Corona,"Bern University of Applied Sciences, Department of Health Professions, Bern, Switzerland",https://ClinicalTrials.gov/show/NCT04502108
NCT04252885,The Efficacy of Lopinavir Plus Ritonavir and Arbidol Against Novel Coronavirus Infection,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,GZ8H-V1.0 20200122,"Guangzhou Eighth People's Hospital, Guangzhou, Guangdong, China",https://ClinicalTrials.gov/show/NCT04252885
NCT04299711,Mental Health and Its Correlates Among Chinese Adolescents Exposed to the Novel Coronavirus Disease 2019,Observational Model: Cohort|Time Perspective: Cross-Sectional,SW888999,NA,https://ClinicalTrials.gov/show/NCT04299711
NCT04260308,A Survey of Psychological Status of Medical Workers and Residents in the Context of 2019 Novel Coronavirus Pneumonia,Observational Model: Case-Only|Time Perspective: Prospective,IRBID:TJ-C 20200107,"Tongji Hospital，Tongji Medical College Affiliated，Huazhong University of Science ＆ Technology, Wuhan, Hubei, China",https://ClinicalTrials.gov/show/NCT04260308
NCT04540939,Neural Mechanisms of Mindfulness-based Cognitive Therapy (MBCT) for Posttraumatic Stress Disorder (PTSD) - COVID Related Substudy,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment",HUM00152509-COVID Substudy|1R61AT009867,"University of Michigan, Ann Arbor, Michigan, United States",https://ClinicalTrials.gov/show/NCT04540939
NCT04385836,Trial of Alpha One Antitrypsin Inhalation in Treating Patient With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,4-0520- 076-K-02-H,"Ministry of Health, Mecca, Saudi Arabia",https://ClinicalTrials.gov/show/NCT04385836
NCT04947488,Evaluation of the Effects of Treatment With Bioarginin C in Adult Subjects Belonging to the Post-Covid Day Hospital,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,Bioarginina C,"Barbara Maglione, Napoli, Italy",https://ClinicalTrials.gov/show/NCT04947488
NCT04924842,COVID-19 - SARS-CoV-2 Community Contamination in Children and Adults - Impact of Variants (Dyn3CEA - Nosocor Phase 2),Observational Model: Case-Only|Time Perspective: Prospective,69HCL21_0564,"Hôpital Femme Mère et enfant, Lyon, Auvergne Rhône Alpes, France",https://ClinicalTrials.gov/show/NCT04924842
NCT04536376,First Responder Resiliency Program During COVID-19,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,20-005017,"Mayo Clinic, Rochester, Minnesota, United States",https://ClinicalTrials.gov/show/NCT04536376
NCT04842747,VERU-111 in the Treatment of SARS-Cov-2 Infection by Assessing Its Effect on the Proportion of Patients Who Die on Study,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",V3011902,"Honor Health, Scottsdale, Arizona, United States|Velocity Clinical Research, Chula Vista, California, United States|Westchester General Hospital, Research Department, Miami, Florida, United States|James A. Haley Veterans Hospital, Tampa, Florida, United States|Inspira Medical Center Mullica Hill, Mullica Hill, New Jersey, United States|Holy Name Medical Center, Institute for Clinical Research, Teaneck, New Jersey, United States|Inspira Medical Center, Vineland, New Jersey, United States|The Stern Cardiovascular Foundation, Inc., Germantown, Tennessee, United States|HD Research (Memorial Hermann - Memorial City Medical Center), Houston, Texas, United States|HD Research (Memorial Hermann Southeast Hospital), Houston, Texas, United States|Clinical Trial Network, Houston, Texas, United States|Hospital De Alta Compleijdad Cuenca Alta Nestor Kirchner, Buenos Aires, Argentina|Hospital del Bicentenario de Esteban Echeverría, Buenos Aires, Argentina|Center Sagrado Corazon, Buenos Aires, Argentina|Sanatorio Güemes, Buenos Aires, Argentina|Hospital De Infecciosas ""Dr. Francisco Javier Muniz"", Buenos Aires, Argentina|Hospital PUC Campinas, Campinas, Sao Paulo, Brazil|Faculdade de Medicina de Botucatu - UNESP, Botucatu, Brazil|Hospital Universitário São Francisco na Providencia de Deus, Bragança Paulista, Brazil|IPECC (Instituto De Pesquisa Clínica de Campinas), Campinas, Brazil|Sociedade Hospital Angelina Caron, Campinas, Brazil|Hospital de Clínicas de Porto Alegre - Infectologia - Centro de Pesquisa Clínica, Porto Alegre, Brazil|Hospital Sao Luca Da PUCRS, Porto Alegre, Brazil|Hospital Universitario Cementino Fraga Filho, Rio De Janeiro, Brazil|IDOR - D'Or Institute for Research and Education, Sao Paulo, Brazil|Incor - Instituto do Coração do Hospital das Clínicas da FMUSP, Sao Paulo, Brazil|Clínica de Alergia Martti Antila S/S LTDA, Sorocaba, Brazil|Fundação Faculdade Regional de Medicina de São José do Rio Preto, São Paulo, Brazil|Fundación Hospital Universidad del Norte (Barranquilla), Atlántico, Colombia|Clinica de la Costa (Barranquilla), Barranquilla, Colombia|Fundacion Santa Fe de Bogota, Bogotá, Colombia|Fundación Cardioinfantil-Instituto de Cardiología, Bogotá, Colombia|Centro Medico Imbanaco de Cali S.A, Cali, Colombia|Corporación para Estudios en Salud - CES, Medellín, Colombia|Sociedad Medica Rionegro- Clínica Somer (Rionegro), Rionegro, Colombia|Hospital General de Culiacán, Culiacán, Mexico|Unidad Médica para la Salud Integral (UMSI), Monterrey, Mexico|Hospital General de Occidente, Zapopan, Mexico",https://ClinicalTrials.gov/show/NCT04842747
NCT04509947,A Study of Ad26.COV2.S in Adults (COVID-19),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention",CR108871|VAC31518COV1002,"Souseikai Hakata Clinic, Fukuoka, Japan|SOUSEIKAI PS Clinic, Fukuoka, Japan|Souseikai Fukuoka Mirai Hospital, Fukuoka, Japan",https://ClinicalTrials.gov/show/NCT04509947
NCT04392219,"COVID-19 First In Human Study to Evaluate Safety, Tolerability, and Pharmacokinetics of EIDD-2801 in Healthy Volunteers","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",EIDD-2801-1001|2020-001407-17,"Covance Leeds Clinical Research Unit, Leeds, United Kingdom",https://ClinicalTrials.gov/show/NCT04392219
NCT04464460,"A Study to Evaluate the Safety, Pharmacokinetics (PK), and Efficacy of TAK-671 for the Treatment of Coronavirus Disease (COVID) 2019 in Adults","Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",TAK-671-1501|U1111-1252-9426,NA,https://ClinicalTrials.gov/show/NCT04464460
NCT04894305,A Study of Ad26.COV2.S in Healthy Adults (COVID-19),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention",CR109013|2021-001374-30|VAC31518COV1003,"PRA Health Sciences, Groningen, Netherlands",https://ClinicalTrials.gov/show/NCT04894305
NCT04666233,Personal Protective Equipment for the Prevention of SARS-Cov-2 During Neonatal Resuscitation,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,SARS-CoV-2-NEO-Res-01,"Central Teaching Hospital of Bolzano/Bozen, Bolzano, Italy|Daniele Trevisanuto, Padova, Italy",https://ClinicalTrials.gov/show/NCT04666233
NCT04852978,"COVID-19 Study to Assess Immunogenicity, Safety, and Tolerability of Moderna mRNA-1273 Vaccine Administered With Casirivimab+Imdevimab in Healthy Adult Volunteers",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,R10933-10987-COV-2118,"Regeneron Research Site, Little Rock, Arkansas, United States|Regeneron Research Site, Rogers, Arkansas, United States|Regeneron Research Site, Miami, Florida, United States|Regeneron Research Site, Orlando, Florida, United States|Regeneron Research Site, Dayton, Ohio, United States",https://ClinicalTrials.gov/show/NCT04852978
NCT04649996,Variation in Acute Appendicitis During COVID-19 Pandemic in Italy,Observational Model: Cohort|Time Perspective: Retrospective,Appendicitis-pandemic,"Policlinico San Pietro, Ponte San Pietro, BG, Italy|Ospedale Manzoni, Lecco, LC, Italy|ASST Monza, Monza, MB, Italy|Ospedale San Raffaele, Milano, Mi, Italy|ASST Lodi, Lodi, Italy|Azienda ospedaliero-universitaria Pisana,Ospedale Cisanello, Pisa, Italy",https://ClinicalTrials.gov/show/NCT04649996
NCT04426071,The Impact of a Societal Lockdown on Those With Spinal Cord and Brain Injuries,Observational Model: Cohort|Time Perspective: Prospective,115999,"Lawson Health Research Institute, London, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04426071
NCT04396600,The Professional Peer Resilience Initiative,Observational Model: Cohort|Time Perspective: Prospective,PSYCH-2020-28762,"University of Minnesota, Minneapolis, Minnesota, United States",https://ClinicalTrials.gov/show/NCT04396600
NCT04765384,A Study of Ad26.COV2.S in Healthy Pregnant Participants (COVID-19),Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,CR108962|2020-005330-14|VAC31518COV2004,"Central Research Associates, Inc., Birmingham, Alabama, United States|SEC Clinical Research, Dothan, Alabama, United States|University of Southern California, Los Angeles, California, United States|Stanford Health Care - Positive Care Clinic, Stanford, California, United States|Holy Cross Hospital - Michael and Dianne Bienes Comprehensive Cancer Center, Fort Lauderdale, Florida, United States|Emory University, Atlanta, Georgia, United States|Spectrum Health System, Grand Rapids, Michigan, United States|Medpharmics, LLC, Gulfport, Mississippi, United States|Meridian Clinical Research, LLC, Grand Island, Nebraska, United States|Meridian Clinical Research, LLC, Norfolk, Nebraska, United States|Excel Clinical Research, Las Vegas, Nevada, United States|Medpharmics, LLC, Albuquerque, New Mexico, United States|Columbia University Medical Center, New York, New York, United States|Monroe Biomedical Research, Monroe, North Carolina, United States|Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|Synexus Clinical Research US, Inc, Columbus, Ohio, United States|University of Pittsburgh Medical Center (UPMC), Pittsburgh, Pennsylvania, United States|Tekton Research Inc., Austin, Texas, United States|Baylor College of Medicine and Texas Childrens Hospital, Houston, Texas, United States|Centex Studies, Inc., Houston, Texas, United States|Maximos OB/GYN, League City, Texas, United States|Women's and Children's Hospital, North Adelaide, Australia|Murdoch Children's Research Institute, Parkville, Australia|Mater Hospital Brisbane, South Brisbane, Australia|Hospital de Clinicas da Universidade Federal De Minas Geraisnas Gerais, Belo Horizonte, Brazil|HMCP - Hospital e Maternidade Celso Pierro - PUC-Campinas, Campinas, Brazil|Centro de Estudos e Pesquisas em Moléstias Infecciosas, Natal, Brazil|Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil|Hospital Geral de Nova Iguacu - HGNI DST/AIDS, Rio De Janeiro, Brazil|Fundacao Faculdade Regional De Medicina De Sao Jose Do Rio Preto, Sao Jose do Rio Preto, Brazil|University of Sao Paulo Brazil NICHD CRS, Sao Paulo, Brazil|CMPC - Consultoria Médica e Pesquisa Clínica, Sorocaba, Brazil|Universidade Municipal de Sao Caetano do Sul, São Caetano do Sul, Brazil|Hospital Das Clinicas Da Faculdade De Medicina Da Universidade De Sao Paulo, São Paulo, Brazil|British Columbia Children's Hospital, Vancouver, British Columbia, Canada|Dalhousie University, Halifax, Nova Scotia, Canada|Alberta Children's Hospital, Calgary, Canada|Helsinki University Hospital, Helsinki, Finland|Kokkolan rokotetutkimusklinikka, Kokkola, Finland|Oulun rokotetutkimusklinikka, Oulu, Finland|Seinäjoen rokotetutkimusklinikka, Seinäjoki, Finland|Tampereen rokotetutkimusklinikka, Tampere, Finland|Turun rokotetutkimusklinikka, Turku, Finland|Shandukani Research Centre, Johannesburg, South Africa|Stanza Clinical Research Centre : Mamelodi, Mamelodi East, South Africa|Setshaba Research Centre, Soshanguve, South Africa|Perinatal HIV Research Unit, Chris Hani Baragwanath Hospital, Soweto, South Africa|Vaccines and Infectious Diseases Analytics Research Unit (VIDA), Formely RMPRU, Soweto, South Africa|Hosp. Univ. 12 de Octubre, Madrid, Spain|Hosp. Univ. La Paz, Madrid, Spain|Hosp. Univ. Pta. de Hierro Majadahonda, Majadahonda, Spain|Hosp. Puerta Del Sur, Mostoles, Spain|Hosp. Quiron Madrid Pozuelo, Pozuelo de Alarcon, Spain|Hosp. Clinico Univ. de Santiago, Santiago de Compostela, Spain|University Hospitals Bristol NHS Trust, Bristol, United Kingdom|Leeds Teaching Hospitals NHS Trust, Leeds,, United Kingdom|Barts Health NHS Trust, Royal London Hospital, London, United Kingdom|University College London Hospitals NHSFT, London, United Kingdom|Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom|Chelsea and Westminster NHS Foundation Trust, London, United Kingdom|University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom",https://ClinicalTrials.gov/show/NCT04765384
NCT04905823,Effect of SARSCoV2 (COVID-19) Vaccination in Type 1 Diabetes (CoVaxT1D),Observational Model: Cohort|Time Perspective: Retrospective,CoVaxT1D,"ASST FBF-Sacco P.O. Sacco, Milan, MI, Italy",https://ClinicalTrials.gov/show/NCT04905823
NCT04413877,Implementation of the Integrated Care of Older People App and ICOPE Monitor in Primary Care (ICOPE),Observational Model: Cohort|Time Perspective: Prospective,GerULiege/SG/DSR/ICOPE,NA,https://ClinicalTrials.gov/show/NCT04413877
NCT04341727,"Hydroxychloroquine,Hydroxychloroquine,Azithromycin in the Treatment of SARS CoV-2 Infection",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,202003188,"Washington University School of Medicine Infectious Disease Clinical Research Unit, Saint Louis, Missouri, United States|Washington University School of Medicine, Saint Louis, Missouri, United States",https://ClinicalTrials.gov/show/NCT04341727
NCT04786301,Severe Acute Respiratory Infection - Preparedness (COVID-19 and Influenza),Observational Model: Cohort|Time Perspective: Prospective,STUDY00011343,"Bellevue Hospital Center, New York, New York, United States|NYU Langone Medical Center, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04786301
NCT04441632,Effect of Positive Attitudes on Behavior and Wellness,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,STUDY00000786,"Cedars-Sinai Medical Center, Los Angeles, California, United States",https://ClinicalTrials.gov/show/NCT04441632
NCT04967755,Jing-Si-Herbal-Tea Accelerates SARS-Cov-2 Load Reduction Among COVID-19 Patients,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,10-X-045,"Taipei Tzu chi hospital,The Buddhist medical fundation., Taipei, Taiwan",https://ClinicalTrials.gov/show/NCT04967755
NCT04394403,Pilot Internet-based Self-Help Program for Managing Corona (COVID-19) Stress,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,coronastress,"Hebrew University of Jerusalem, Jerusalem, Israel",https://ClinicalTrials.gov/show/NCT04394403
NCT04363047,"Immune Cells in Inflammatory Arthritis With Coronaviruses, Including COVID-19",Observational Model: Cohort|Time Perspective: Retrospective,282566,"Universit of Manchester, Manchester, Greater Manchester, United Kingdom",https://ClinicalTrials.gov/show/NCT04363047
NCT04771585,Quantification of Exhaled Particles to Identify Airborne Transmission Risks of COVID-19,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science,20-14 QUELLE,"Fraunhofer ITEM, Hannover, Niedersachsen, Germany",https://ClinicalTrials.gov/show/NCT04771585
NCT04445441,An Observational Study to Assess the Protocol for the COVID-19 Treatment in Burkina Faso,Observational Model: Cohort|Time Perspective: Prospective,IRSS-URCN-CM 001,"Sourou Sanon University Hospital, Bobo-Dioulasso, Burkina Faso|Tingadogo University Hospital, Ouagadougou, Burkina Faso",https://ClinicalTrials.gov/show/NCT04445441
NCT04382560,Coping Strategies and Responsiveness to a Brief Online Intervention During COVID-19 Pandemic,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Other",ESPCOV1,"Sapienza University of Rome, Rome, Italy",https://ClinicalTrials.gov/show/NCT04382560
NCT04408196,QoL and the Emotional-affective Sphere o in Rehabilitation Setting During COVID-19 Quarantine,Observational Model: Cohort|Time Perspective: Prospective,FDG_socialdistancing_COVID-19,"Don Gnocchi Foundation, Rome, Italy",https://ClinicalTrials.gov/show/NCT04408196
NCT04634903,"Testing Scalable, Single-Session Interventions for Adolescent Depression in the Context of COVID-19","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",1505797-3,"Stony Brook University, Stony Brook, New York, United States",https://ClinicalTrials.gov/show/NCT04634903
NCT04495543,Mitigating Suicide Risk With Single Session 'Brief Skills for Safer Living',Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,BSL-01,"St. Michael's Hospital, Toronto, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04495543
NCT04420273,Targeted Melanoma Detection With Skin Self-Examination During COVID-19 Restricted Physician Access,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",STU00212165,"Northwestern University Feinberg School of Medicine Department of Dermatology, Chicago, Illinois, United States",https://ClinicalTrials.gov/show/NCT04420273
NCT04388644,Survey of Satisfaction on Traditional Chinese Medicine Jing-Guan-Fang (JGF) for COVID-19 Prevention,Observational Model: Case-Only|Time Perspective: Retrospective,TCHIRB-10904015-E,"Branch of Chinese Medicine, Taipei City Hospital, Taipei, Taiwan|Branch of Linsen Chinese Medicine and Kunming, Taipei City Hospital, Taipei, Taiwan|Taipei City Hospital, Taipei, Taiwan",https://ClinicalTrials.gov/show/NCT04388644
NCT04524052,"To Evaluate Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of DWRX2003 Against COVID-19","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",DWJ1516101_India,NA,https://ClinicalTrials.gov/show/NCT04524052
NCT04844138,Evaluating Overcoming Anxiety in Pregnancy and Postpartum as an Online Self-Directed Program,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment",P2020:104|53294,"University of Manitoba, Winnipeg, Manitoba, Canada",https://ClinicalTrials.gov/show/NCT04844138
NCT04600713,Physiotherapist-led Exercise Within Cardiac Rehabilitation and Paroxysmal Atrial Fibrillation and COVID-19.,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,273293,NA,https://ClinicalTrials.gov/show/NCT04600713
NCT04758962,A Study of the Safety of and Immune Response to Varying Doses of a Vaccine Against COVID-19 in Healthy Adults,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,214525,"GSK Investigational Site, Rochester, New York, United States",https://ClinicalTrials.gov/show/NCT04758962
NCT04982757,Accelerated TMS for Depression and OCD,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,20-10022827,"Weill Cornell Medicine, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04982757
NCT04980326,A Scalable Psychological Intervention to Reduce Psychological Distress Among Healthcare Workers: a Randomized Trial,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Supportive Care,RESPOND WP4 RCT,"Parc Sanitari Sant Joan de Déu, Sant Boi De Llobregat, Barcelona, Spain|Hospital Universitario La Paz, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04980326
NCT04846790,The Effect of a Combined Nature-based and Virtual Mindfulness Intervention on Perceived Stress in Healthcare Workers,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Supportive Care",CC-000192,"National Institutes of Health, Clinical Center, Bethesda, Maryland, United States",https://ClinicalTrials.gov/show/NCT04846790
NCT04578210,Safety Infusion of NatuRal KillEr celLs or MEmory T Cells as Adoptive Therapy in COVID-19 pnEumonia or Lymphopenia,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",RELEASE,"Hospital Universitario La Paz, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04578210
NCT04791241,A Check-list Including Lung Ultrasound for ED Patients With ARF,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,CHMS20005,"CH Annecy Genevois, Annecy, France|Centre Hospitalier Metropole Savoie, Chambéry, France|CHUGA, Grenoble, France",https://ClinicalTrials.gov/show/NCT04791241
NCT04826809,New Reusable Mask Design With Superior Filtration and Fit,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,20-011897,"Mayo Clinic Health System in Mankato, Mankato, Minnesota, United States",https://ClinicalTrials.gov/show/NCT04826809
NCT04802278,Gestational Immunity for Transfer,Observational Model: Cohort|Time Perspective: Prospective,2021/00095,"National University Hospital, Singapore, Singapore",https://ClinicalTrials.gov/show/NCT04802278
NCT04766333,New Jersey Healthcare Essential Worker Outreach and Education Study - Testing Overlooked Occupations,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,2020002549,"Rutgers University, New Brunswick, New Jersey, United States",https://ClinicalTrials.gov/show/NCT04766333
NCT04394039,Post-Pandemic Perception of Public Space in Singapore,Allocation: N/A|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,NUS-IRB_S-20-12,"Institute for Health Innovation & Technology (iHealthtech), Singapore, Singapore",https://ClinicalTrials.gov/show/NCT04394039
NCT04498416,CoCo-20: a Longitudinal Follow-up Study of the French Paediatric Population During and After the Coronavirus Pandemic COVID-19,Observational Model: Cohort|Time Perspective: Prospective,20-HPNCL-05,"Hôpitaux Pédiatriques de Nice CHU-Lenval, Nice, France",https://ClinicalTrials.gov/show/NCT04498416
NCT04370678,Changes in Preference for Surgery of Patients Signed up for Arthroscopic Procedures,Observational Model: Other|Time Perspective: Cross-Sectional,ArthrocancellationSUH2020,"Zealand University Hospital, Køge, Zealand Region, Denmark",https://ClinicalTrials.gov/show/NCT04370678
NCT04765839,Community-Engaged Bidirectional Pandemic Crisis and Emergency Risk Communication With COVID-19 Vaccine Messages to Minority Populations,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Supportive Care,21-000205,"Mayo Clinic, Rochester, Minnesota, United States",https://ClinicalTrials.gov/show/NCT04765839
NCT04593433,A 3-month Cycle of Virtual Guided Tours to Promote Health in Older Community Members in a Context of COVID-19 Induced Social Isolation: a Pilot Study,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,2021-2604,"Jewish General Hospital, Montréal, Quebec, Canada",https://ClinicalTrials.gov/show/NCT04593433
NCT04447833,Mesenchymal Stromal Cell Therapy For The Treatment Of Acute Respiratory Distress Syndrome,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2020-02238,"Uppsala University Hospital, Uppsala, Sweden",https://ClinicalTrials.gov/show/NCT04447833
NCT04357977,A Human Clinical Study to Collect Calibration and Performance Data for the RBA-2 Device,Observational Model: Ecologic or Community|Time Perspective: Cross-Sectional,KBS005,"Tampa General Hospital, Tampa, Florida, United States|University of South Florida, Tampa, Florida, United States|AdventHealth Tampa, Tampa, Florida, United States",https://ClinicalTrials.gov/show/NCT04357977
NCT04480034,Obesity Surgery During 2020 Italian Pandemic,Observational Model: Cohort|Time Perspective: Prospective,008758/27.05.2020,"University La Sapienza of Rome, Department of Medico-Surgical Sciences and Biotechnologies, Latina, LT, Italy",https://ClinicalTrials.gov/show/NCT04480034
NCT04742049,"The Effects of Telerehabilitation on Muscle Function, Physical Activity and Sleep in Cystic Fibrosis During Pandemic",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,KA-20058,"Hacettepe University, Ankara, Turkey",https://ClinicalTrials.gov/show/NCT04742049
NCT04596657,Vitamin D3 Supplementation to Prevent Respiratory Tract Infections,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,20-455,"Cooper University Hospital, Camden, New Jersey, United States",https://ClinicalTrials.gov/show/NCT04596657
NCT04925258,Supporting Parent and Child Engagement,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,SPACE,"University of Manitoba, Winnipeg, Manitoba, Canada",https://ClinicalTrials.gov/show/NCT04925258
NCT04788433,Registry of Coronavirus Complications - CORRELATION WITH GLYCOMIC PROFILE,Observational Model: Case-Only|Time Perspective: Prospective,ROCCO-197/2020,"Aast Papa Giovanni Xxiii, Bergamo, Italy",https://ClinicalTrials.gov/show/NCT04788433
NCT04715854,Effect on paO2 of Adding an Aerosol Mask Above the Nasal Canulas,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Supportive Care,lmcondorcet,"Epicura, Hornu, Hainaut, Belgium",https://ClinicalTrials.gov/show/NCT04715854
NCT04485741,Strados System at Center of Excellence,Observational Model: Cohort|Time Perspective: Prospective,SL-RS-AEMC01,"Albert Einstein Medical Center, Philadelphia, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04485741
NCT04233268,RASCALS: Rapid Assay for Sick Children With Acute Lung Infection Study,Observational Model: Cohort|Time Perspective: Prospective,277039,"Addenbrooke's Hospital, Cambridge, Cambs, United Kingdom",https://ClinicalTrials.gov/show/NCT04233268
NCT04160975,Persuasion in Medicine: Experimental Evidence on Sender and Signal Effects,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Health Services Research",IRB19-1424,"Harvard University, Cambridge, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT04160975
NCT02788903,A Patient-Centered PaTH to Addressing Diabetes,Observational Model: Cohort|Time Perspective: Other,PCORI|NEN-1509-32304,NA,https://ClinicalTrials.gov/show/NCT02788903
NCT04602286,How Does Mindfulness Meditation Buffer the Negative Effects of Pain and Suffering in the COVID-19 World? (Pain Sample),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",2019000347-S4P,"Health and Behavioural Sciences, Brisbane, Queensland, Australia",https://ClinicalTrials.gov/show/NCT04602286
NCT04490278,CoV-PICS: A Virtual Post-ICU Clinic,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,202007053,"Washington University School of Medicine/Barnes-Jewish Hospital, Saint Louis, Missouri, United States",https://ClinicalTrials.gov/show/NCT04490278
NCT04776941,Expressive Writing for the Management of Stress in Cancer Survivors,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Supportive Care",2020-0538|NCI-2021-00218,"M D Anderson Cancer Center, Houston, Texas, United States",https://ClinicalTrials.gov/show/NCT04776941
NCT04383483,"CoV-ICU Score, Intensive Care Unit, SARS-CoV-2",Observational Model: Case-Only|Time Perspective: Retrospective,BYIEAH-202005,"Bursa Yüksek Ihtisas Training and Research Hospital, Bursa, Yildirim, Turkey",https://ClinicalTrials.gov/show/NCT04383483
NCT04643964,Brief Video Interventions for Depression,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2020B0326,"Department of Psychology, Columbus, Ohio, United States",https://ClinicalTrials.gov/show/NCT04643964
NCT04809272,ePLH Pilot Study: Online Support Parent Groups - ParentChat,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,R72537/RE001,"University of Oxford, Oxford, Oxfordshire, United Kingdom",https://ClinicalTrials.gov/show/NCT04809272
NCT04378803,Mindfulness Training for Seniors,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,20200443,"University of Miami, Coral Gables, Florida, United States",https://ClinicalTrials.gov/show/NCT04378803
NCT04727762,Use of the Mask and Current Pandemic,Observational Model: Cohort|Time Perspective: Other,ID0031,"Gemma Victoria Espí-López, Valencia, Spain",https://ClinicalTrials.gov/show/NCT04727762
NCT04549350,Sleep Quality Among HCWs,Observational Model: Other|Time Perspective: Cross-Sectional,2020/1464,"Zagazig University, Zagazig, Egypt",https://ClinicalTrials.gov/show/NCT04549350
NCT04933474,"Pragmatic Comparative Effectiveness Trial of Evidence-based, On-demand, Digital Behavioral Treatments for Chronic Pain","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Health Services Research",STUDY00001262,"Cedars-Sinai Medical Center, Los Angeles, California, United States",https://ClinicalTrials.gov/show/NCT04933474
NCT04422769,Needs of Persons With Spinal Cord Injury (SCI),Observational Model: Cohort|Time Perspective: Prospective,202005026,"Washington University School of Medicine, Saint Louis, Missouri, United States",https://ClinicalTrials.gov/show/NCT04422769
NCT04618341,A Clinical Study of Online Active Play Program With Adolescents,Observational Model: Other|Time Perspective: Retrospective,RAP/003,"Revival Active, Leicester, Leicestershire, United Kingdom",https://ClinicalTrials.gov/show/NCT04618341
NCT04753645,BRAC Institute of Governance and Development-Hygiene Behavioural Change and Coalition,Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,BIGD2021,"BRAC, Bangladesh, Dhaka, Bangladesh",https://ClinicalTrials.gov/show/NCT04753645
NCT04939714,Caregiving During Crisis,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,STUDY00001424|3P30AG064200-02S1,"Emory University, Atlanta, Georgia, United States",https://ClinicalTrials.gov/show/NCT04939714
NCT04893122,Impact of Pandemic of Presentation to Emergency Department and Admissions,Observational Model: Cohort|Time Perspective: Retrospective,63328,NA,https://ClinicalTrials.gov/show/NCT04893122
NCT04966845,Effect of Face Mask on Exhaled Carbon Monoxide of Smokers,Observational Model: Case-Crossover|Time Perspective: Prospective,ExhaledCO,"Konstantinos Katogiannis, Athens, Attiki, Greece|""Attikon"" University General Hospital, Athens, Attiki, Greece",https://ClinicalTrials.gov/show/NCT04966845
NCT04551274,Music Therapy in Frontline Healthcare Workers,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Supportive Care,H20-02015,"Simon Fraser University, Burnaby, British Columbia, Canada",https://ClinicalTrials.gov/show/NCT04551274
NCT04550351,Recombinant New Coronavirus Vaccine (CHO Cells) to Prevent SARS-CoV-2 Phase I Clinical Trial (≥60 Years Old),"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",LKM-2020-NCV03,"Hunan Provincial Center for Disease Control and Prevention, Xiangtan, Changsha, China",https://ClinicalTrials.gov/show/NCT04550351
NCT04921228,Biofeedback for CHAMPS,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,IRB-FY2021-233,NA,https://ClinicalTrials.gov/show/NCT04921228
NCT04518514,Telemedical Risk Assessment and Preoperative Evaluation (TAPE),Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,19-174,"RWTH Aachen University Hospital, Aachen, Germany",https://ClinicalTrials.gov/show/NCT04518514
NCT04936893,Effects of Mindfulness Practice on Healthcare Workers,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Supportive Care,YaleNUS,"Yle-NUS College, Singapore, Singapore",https://ClinicalTrials.gov/show/NCT04936893
NCT04888832,The Effect of Work Requirements in SNAP in Virginia,Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,IRB19-0859|5R01MD014970-02,NA,https://ClinicalTrials.gov/show/NCT04888832
NCT04962204,Virtual Visitation in Intensive Care Unit Study,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,2105-188-1224,NA,https://ClinicalTrials.gov/show/NCT04962204
NCT04614701,Correlation of Carotid Flow Time and Cardiac Output.,Observational Model: Cohort|Time Perspective: Prospective,HS24296,"St. Boniface General Hospital, Winnipeg, Manitoba, Canada",https://ClinicalTrials.gov/show/NCT04614701
NCT04658979,Pulmonary TELE-REHABilitation Program : Feasibility and Safety Study,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,21983,"Institut universitaire de cardiologie et de pneumologie de Québec, Québec, Quebec, Canada",https://ClinicalTrials.gov/show/NCT04658979
NCT04684836,Comparative Effectiveness of Telemedicine in Primary Care,Observational Model: Cohort|Time Perspective: Retrospective,20-12023014,"University of Florida, Gainesville, New York, United States|Mount Sinai, New York, New York, United States|Weill Cornell Medicine, New York, New York, United States|University of North Carolina, Chapel Hill, North Carolina, United States",https://ClinicalTrials.gov/show/NCT04684836
NCT04557605,Effects of a Face Mask on Oxygenation During Exercise,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,2201,"University of Saskatchewan, Saskatoon, Saskatchewan, Canada",https://ClinicalTrials.gov/show/NCT04557605
NCT04688502,Effects of Wearing a Face Mask During CrossFit Exercise,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention,2431,"University of Saskatchewan, Saskatoon, Saskatchewan, Canada",https://ClinicalTrials.gov/show/NCT04688502
NCT04942990,The Effectiveness of Calistenic Exercise Training in Adolescents,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Supportive Care,KA20/478,"Baskent University, Ankara, Turkey",https://ClinicalTrials.gov/show/NCT04942990
NCT04688840,Smartphone Application: A Possible Solution for Follow up of Patients With Hip Arthroplasty,Observational Model: Other|Time Perspective: Prospective,TantaH,"Ahmed Samy, Tanta, Egypt",https://ClinicalTrials.gov/show/NCT04688840
NCT04262921,French COVID Cohort,Observational Model: Other|Time Perspective: Prospective,C20-05|2020-A00256-33,"CHG Agen, Agen, France|Centre Hospitalier Du Pays D'aix, Aix-en-Provence, France|CHU Amiens, Amiens, France|CHU Angers, Angers, France|CH Annecy Genevois, Annecy, France|Hopital privé d'Antony, Antony, France|Hôpital de Mercy. CHR METZ-THIONVILLE, Ars-Laquenexy, France|Centre Hospitalier Henri Duffaut, Avignon, France|Chu Jean Minjoz, Besançon, France|Hôpital Avicenne AP-HP, Bobigny, France|CHU Pellegrin, Bordeaux, France|CHU Ambroise Paré, Boulogne-Billancourt, France|Ch Fleyriat, Bourg-en-Bresse, France|Chru Hopital Cavale Blanche, Brest, France|CHU Brest, Brest, France|Centre hospitalier de Béziers, Béziers, France|CH Cahors, Cahors, France|Chms Chambery Nh, Chambéry, France|Centre Hospitalier De Cholet, Cholet, France|CHU Gabriel Montpied, Clermont-Ferrand, France|CH Colmar - Hopital Pasteur, Colmar, France|Centre hospitalier Alpes Leman, Contamine-sur-Arve, France|Centre hospitalier Intercommunal de Créteil, Créteil, France|Hôpital Henri Mondor, Créteil, France|Centre Hospitalier Dax, Dax, France|CHU Dijon Bourgogne, Dijon, France|Hopital Raymond Poincare, Garches, France|CHU Grenoble, Grenoble, France|Grand Hopital de l'Est Francilien site Marne-la-Vallée, Jossigny, France|Chd Les Oudairies, La Roche-sur-Yon, France|Hôpital Universitaire Bicêtre, Le Kremlin-Bicêtre, France|Centre Hospitalier Emile Roux, Le Puy-en-Velay, France|Centre Hospitalier Universitaire de Lille, Lille, France|CHRU Lille, Hôpital Salengro, Lille, France|CHU de Lille, Lille, France|Hôpital de la Croix-Rousse, Lyon, France|Hôpital Louis Raffalli, Manosque, France|Assistance publique hopitaux de Marseille, hopital Nord, Marseille, France|Hôpital Conception, Marseille, France|Groupe Hospitalier Sud Ile De France, Melun, France|CH de Mont Marsan, Mont de Marsan, France|CHU Montpellier, Montpellier, France|CHU Nantes, Nantes, France|Hopital Américain de Paris, Neuilly-sur-Seine, France|CHU de Nice, Nice, France|CHU Caremeau, Nîmes, France|APHP Bichat, Paris, France|APHP Tenon, Paris, France|CH Lariboisière, Paris, France|Groupe Hospitalier Diaconesses Croix Saint-Simon, Paris, France|Hopital Cochin-CIC1417, Paris, France|Hopital Européen Georges Pompidou, Paris, France|Hopital Saint Antoine, Paris, France|Hopital Saint Louis, Paris, France|La pitié salpetrière, Paris, France|Centre Hospitalier de Pau, Pau, France|CH de Perpignan, Perpignan, France|CHU de Poitiers, Poitiers, France|Centre Hospitalier de Périgueux, Périgueux, France|Ch Cornouaille, Quimper, France|Chu Reims, Reims, France|Hôpital Pontchaillou, Rennes, France|CHU Rouen Normandie, Rouen, France|Hopital d'instruction des armées Begin 69, Saint-Mandé, France|Centre hospitalier Louis Constant Fleming, Saint-Martin, France|CHU de Saint-Etienne, Saint-Étienne, France|CH de Saintonge, Saintes, France|Centre Hospitalier de Soissons, Soissons, France|N.H.C. - Nouvel Hopital Civil, Strasbourg, France|Hopital Foch, Suresnes, France|CHR Metz-Thionville -Hopital Bel Air, Thionville, France|Hopitaux du Leman, Thonon-les-Bains, France|Centre Hospitalier Universitaire de Rangueil, Toulouse, France|CHU de Toulouse, Toulouse, France|CHU Toulouse IUCT Institut Universitaire de Cancer de Toulouse, Toulouse, France|Hôpital Gustave Dron, Tourcoing, France|Centre Hospitalier Régional Universitaire de Tours, Tours, France|CHRU de Tours, Tours, France|CHU Nancy, Vandœuvre-lès-Nancy, France|Centre Hospitalier Intercommunal, Villeneuve Saint Georges, France|CH Annecy Genevois, Épagny, France",https://ClinicalTrials.gov/show/NCT04262921
NCT04826367,Relaxation Training by Tele-Rehabilitation in Patients With Breast Cancer,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Supportive Care,Tele-Relax,"Florence Nightingale Hospital, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04826367
NCT04335851,Video-Based Exercises and Well-Being During Social Isolation,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,Physical Activity Project,"Biruni University, Istanbul, Turkey|Istanbul University Cerrahpasa, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04335851
NCT04399005,The Efficacy Comparing Daily and After-each-case Room Disinfection.,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Other,DACD-HuY-2005,"First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China",https://ClinicalTrials.gov/show/NCT04399005
NCT04442958,Effectiveness of Convalescent Immune Plasma Therapy,"Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",2020.05.2.14.070,"Istanbul Bagcılar Training and Research Hospital, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04442958
NCT04800939,The Effect of Acupressure on the Sleep Quality and Daytime Sleepiness,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Other,Mersin Uni,"Mersin University, Mersin, Yenişehir, Turkey",https://ClinicalTrials.gov/show/NCT04800939
NCT04763213,New Predictors in Determining the Need for Invasive Treatment in Non-STEMI,Observational Model: Other|Time Perspective: Retrospective,05.08.2020-2020/15/10,"Ekrem Aksu, Kahramanmaraş, Turkey",https://ClinicalTrials.gov/show/NCT04763213
NCT04609371,PanDirect: Self-care Tools and Telephone Coaching for Depression and Anxiety During Pandemics,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Supportive Care,SMHC-20-10,"St Mary's Hospital Research Centre, Montréal, Canada",https://ClinicalTrials.gov/show/NCT04609371
NCT04760418,Trauma and Trauma-Focused Therapy in the University of Kentucky SMART Clinic,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,64485,"University of Kentucky, Lexington, Kentucky, United States",https://ClinicalTrials.gov/show/NCT04760418
NCT04550312,The Impact of Lifestyle Changes on Non-COVID Deaths,Observational Model: Other|Time Perspective: Retrospective,XYFY2020-KL142-01,"Xuzhou Medical University affiliated Hospital, Xuzhou, Jiangsu, China",https://ClinicalTrials.gov/show/NCT04550312
NCT04513496,Telemedicine in HIV Care in Buenos Aires,Observational Model: Cohort|Time Perspective: Prospective,TM HIV BA,NA,https://ClinicalTrials.gov/show/NCT04513496
NCT04346927,Telerehabilitation for Patients Diagnosed With Coronavirus,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,9,"Istinye University, İstanbul, Turkey",https://ClinicalTrials.gov/show/NCT04346927
NCT04409496,Chat-based Support for Preventing Smoking Relapse,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,UW 20-356,"Tung Wah Group of Hospitals Integrated Centre on Smoking Cessation, Hong Kong, Hong Kong",https://ClinicalTrials.gov/show/NCT04409496
NCT04779138,Increasing Vaccine Uptake in Underresourced Public Housing Areas,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,vaccinehousing,NA,https://ClinicalTrials.gov/show/NCT04779138
NCT04857060,Palliative Care Educator,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Health Services Research,H-41482|1R01AG072911-01,"Boston Medical Center, Boston, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT04857060
NCT04884529,Virtual Chair Yoga for Older Adults and Caregivers: Randomized Controlled Trial,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,2021-2761,"Institute of Community and Family Psychiatry, Montreal, Quebec, Canada",https://ClinicalTrials.gov/show/NCT04884529
NCT04885192,Implementation and Evaluation of a Stepped-Care Mental Health Treatment Program for Patients With Chronic Pain,Observational Model: Cohort|Time Perspective: Prospective,20-6290,"University Health Network- Toronto General Hospital, Toronto, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04885192
NCT04927845,StriveWeekly Trial Post-pandemic,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,IRB20-1337,"Harvard University, Cambridge, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT04927845
NCT04368299,Telemedicine for Follow-up of Systemic Lupus Erythematosus,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,TeleSLE,"The Chinese University of Hong Kong, Hong Kong, Hong Kong",https://ClinicalTrials.gov/show/NCT04368299
NCT04468386,Specimen Collection Study Protocol,Observational Model: Case-Only|Time Perspective: Prospective,CV19-Col-004,"Biomerica, Inc., Irvine, California, United States",https://ClinicalTrials.gov/show/NCT04468386
NCT04787536,Perioperative Cognitive Trajectories in Deferred Surgery (CoTELE-SURGE),Observational Model: Cohort|Time Perspective: Prospective,10829,"McMaster University, Hamilton, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04787536
NCT04687488,Aerosol and Droplet Dispersion During Gastrointestinal Motility Investigations,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,S64237,"TARGID, Leuven, Vlaams-Brabant, Belgium",https://ClinicalTrials.gov/show/NCT04687488
NCT04923061,The Effect of Acupressure on the Sleep Quality and Fatigue,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Other,MersinUniversityNursing,"Mersin University, Mersin, Yenişehir, Turkey",https://ClinicalTrials.gov/show/NCT04923061
NCT04644705,Safety and Pharmacokinetics of a Novel Niclosamide Solution in Combination With Camostat,"Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",201767,"Charité Research Organisation GmbH, Berlin, Germany",https://ClinicalTrials.gov/show/NCT04644705
NCT04848831,"Diagnosis of Invasive Pulmonary Aspergillosis, Specific Testing in Bronchial Secretions Versus Bronchoalveolar Fluid",Observational Model: Cohort|Time Perspective: Prospective,DipA2,NA,https://ClinicalTrials.gov/show/NCT04848831
NCT04574219,Virtual Parental Presence on Induction,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,2020-0371,"Cincinnati Childrens Hospital Medical Center, Cincinnati, Ohio, United States|Hospital for Sick Children, Toronto, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04574219
NCT04769999,Computer Assisted Lessening of Intrusive Memories in the Emergency Department,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,R64738/RE001,"South Central Ambulance Service NHS Foundation Trust, Bicester, United Kingdom|Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom|Royal Berkshire NHS Foundation Trust, Reading, United Kingdom",https://ClinicalTrials.gov/show/NCT04769999
NCT04555954,Determining the Physical Activity Level of Healthy Adults During Pandemic,Observational Model: Other|Time Perspective: Prospective,2020/8/318,"Afyonkarahisar Health Science University, Afyonkarahisar, Turkey",https://ClinicalTrials.gov/show/NCT04555954
NCT04545242,Efficacy of DEXamethasone in Patients With Acute Hypoxemic REspiratory Failure Caused by INfEctions,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,ICI20-00062,"Hospital Universitario Mutua Terrassa (ICU), Terrassa, Barcelona, Spain|Hospital General La Mancha Centro (ICU), Alcazar de San Juan, Ciudad Real, Spain|Complejo Hospitalario Universitario de Santiago (Anesthesia), Santiago De Compostela, La Coruña, Spain|Hospital General El Bierzo (ICU), Ponferrada, León, Spain|Hospital Universitario del Henares (ICU), Coslada, Madrid, Spain|Hospital Universitario de Getafe (ICU), Getafe, Madrid, Spain|Hospital Universitario Severo Ochoa (ICU), Leganés, Madrid, Spain|Hospital Universitario Puerta de Hierro (ICU), Majadahonda, Madrid, Spain|Hospital Nuestra Señora del Prado (ICU), Talavera De La Reina, Toledo, Spain|Hospital Universitario de Cruces (Anesthesia), Barakaldo, Vizcaya, Spain|Hospital Universitario de Cruces (ICU), Barakaldo, Vizcaya, Spain|Complejo Hospitalario Universitario de Albacete (ICU), Albacete, Spain|Hospital Clinic de Barcelona (AVI), Barcelona, Spain|Hospital Clinic de Barcelona (Cardiac ICU), Barcelona, Spain|Hospital Clínic (Hepatic ICU), Barcelona, Spain|Hospital Clínic de Barcelona (Anesthesia), Barcelona, Spain|Hospital General de Ciudad Real (ICU), Ciudad Real, Spain|Hospital Virgen de la Luz (ICU), Cuenca, Spain|Hospital Universitario de A Coruña (ICU), La Coruña, Spain|Complejo Asistencial Universitario de León (ICU), León, Spain|Hospital Universitario La Princesa (ICU), Madrid, Spain|Hospital Universitario Ramón y Cajal (Anesthesia), Madrid, Spain|Hospital Clínico Universitario San Carlos (ICU), Madrid, Spain|Hospital Universitario Fundación Jiménez Díaz (ICU), Madrid, Spain|Hospital Universitario Doce de Octubre (ICU), Madrid, Spain|Hospital Universitario La Paz (Anesthesia), Madrid, Spain|Hospital Universitario La Paz (ICU), Madrid, Spain|Hospital Universitario Virgen de Arrixaca (Anesthesia), Murcia, Spain|Hospital Universitario Virgen de Arrixaca (ICU), Murcia, Spain|Hospital Universitario Regional de Malaga Carlos Haya (ICU), Málaga, Spain|Clínica Universidad de Navarra, Pamplona, Spain|Hospital Universitario Montecelo (Anesthesia), Pontevedra, Spain|Hospital Universitario Nuestra Señora de Candelaria (ICU), Santa Cruz De Tenerife, Spain|Hospital General de Segovia (ICU), Segovia, Spain|Hospital Clinico Universitario de Valencia (Anesthesia), Valencia, Spain|Hospital Clinico Universitario de Valencia (ICU), Valencia, Spain|Hospital Clínico Universitario de Valladolid (Anesthesia), Valladolid, Spain|Hospital Universitario Río Hortega (Anesthesia), Valladolid, Spain|Hospital Universitario Río Hortega (ICU), Valladolid, Spain|Hospital Virgen de la Concha (ICU), Zamora, Spain",https://ClinicalTrials.gov/show/NCT04545242
NCT04319211,"Effects of Social Isolation From Coronavirus; on Physical Activity, Quality of Life and Stress",Observational Model: Case-Only|Time Perspective: Cross-Sectional,EAvcil|İpek Yeldan,"Istanbul University Cerrahpasa, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04319211
NCT04703907,Auricular Stimulation for Relief of Stress and Anxiety,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,BB 324/20,"University Medicine of Greifswald, Greifswald, Germany",https://ClinicalTrials.gov/show/NCT04703907
NCT04369274,Repeated Measures Trial of Temporary Automated Manual Ventilation Versus Noninvasive Oxygenation or Conventional Vent,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2020P001051,NA,https://ClinicalTrials.gov/show/NCT04369274
NCT04663594,Online Culture for Mental Health in People Aged 16-24,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Other,9275,"Ashmolean Museum Website, Oxford, Oxfordshire, United Kingdom",https://ClinicalTrials.gov/show/NCT04663594
NCT04751474,"The Effect of Motivational Messages on Optimism, Hopelessness and Life Satisfaction",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science,2021/47-31,"Elif Gezginci, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04751474
NCT04418947,Project Resurgence Communication Trial,"Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Other",843220,"University of Pennsylvania, Philadelphia, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04418947
NCT04981535,Aerosol Particle From EGD in Patients With and Without Head Box,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,RP022,"King Chulalongkorn Memorial Hospital, Bangkok, Thailand",https://ClinicalTrials.gov/show/NCT04981535
NCT03226886,TRACERx Renal CAPTURE Sub-study,Observational Model: Other|Time Perspective: Prospective,CCR 3723,"Edinburgh Western General Hospital, Edinburgh, Scotland, United Kingdom|Guy's & St Thomas Hospital, London, UK, United Kingdom|Barts Health NHS Trust, London, United Kingdom|Royal Free Hospital, London, United Kingdom",https://ClinicalTrials.gov/show/NCT03226886
NCT04877769,Bronchopulmonary PK of AT-527 (R07496998),Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,AT-03A-007,"Atea Study Site, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04877769
NCT04601415,Point of Care Artificial Intelligence Tool for Heart Failure Diagnosis,Observational Model: Cohort|Time Perspective: Prospective,285417,"Patrik Bachtiger, London, Non-US/Non-Canadian, United Kingdom",https://ClinicalTrials.gov/show/NCT04601415
NCT04413006,Self-compassion for Chronic Pain Virtual Group Treatment Program,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,sccpvgtbsas2020,"University of Manitoba, Winnipeg, Manitoba, Canada",https://ClinicalTrials.gov/show/NCT04413006
NCT04962022,Drug-Drug Interaction Study Assessing Effect of Itraconazole on PF-07321332/Ritonavir in Healthy Participants,Allocation: Non-Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science,C4671015|2021-003308-42,"Brussels Clinical Research Unit, Brussels, Bruxelles-capitale, Région DE, Belgium",https://ClinicalTrials.gov/show/NCT04962022
NCT04372693,Unplanned Shifting to Online Distance Learning: Nursing Students' Perception and Achievement,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,FON170133,"Cairo University, Cairo, Egypt",https://ClinicalTrials.gov/show/NCT04372693
NCT04789525,Physical Training and Diet for Childhood Obesity,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,Obesity,"Marwa Eid, Cairo, Egypt",https://ClinicalTrials.gov/show/NCT04789525
NCT04331808,CORIMUNO-19 - Tocilizumab Trial - TOCI (CORIMUNO-TOCI),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,APHP200375-1,"APHP- Hopital Tenon, Paris, France|APHP - Beaujon, Paris, France|APHP - Bichat, Paris, France|APHP - Hopital Necker, Paris, France|APHP - Pitié Salpêtrière, Paris, France|APHP - Saint Louis, Paris, France|CHU Strasbourg, Strasbourg, France|Institut Gustave Roussy, Villejuif, France",https://ClinicalTrials.gov/show/NCT04331808
NCT04930016,Quality of Life and Survival of Patients With Colorectal Cancer 5 Years After Surgery - Follow-up of the RCT DIQOL,Observational Model: Cohort|Time Perspective: Cross-Sectional,DIQOL_Follow-up_2021,"Tumor Center Regensburg, Institute of Quality Management and Health Services Research of the University of Regensburg, Regensburg, Bavaria, Germany",https://ClinicalTrials.gov/show/NCT04930016
NCT04394455,Brief Cognitive Behavioral Therapy Versus Crisis Intervention Therapy Through Telepsychiatry on Psychiatric Symptoms,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Treatment,1.50E+21,"Universidad Nacional Autónoma de Honduras, Tegucigalpa, Francisco Morazán, Honduras",https://ClinicalTrials.gov/show/NCT04394455
NCT04779450,"Effect of Telemonitoring on Functionality, Quality of Life and Risk of Lymphedema in Breast Cancer Survivors","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",Telemonitoring BCS,"Santa Catarina State University, Florianópolis, Santa Catarina, Brazil",https://ClinicalTrials.gov/show/NCT04779450
NCT04353141,International Lung UltraSound Analysis (ILUSA) Study,Observational Model: Cohort|Time Perspective: Prospective,COVID-19: ILUSA (S63988),"University Hospitals Leuven, Leuven, Belgium|University of Brescia, Brescia, Italy|University of Foggia, Foggia, Italy|University of Milan, Milan, Italy|University of Parma, Parma, Italy|Fondazione Policlinico Universitario A. Gemelli, Roma, Italy|Queen Charlotte's & Chelsea Hospital, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04353141
NCT04797208,Remote Glucose Monitoring in Hospital Settings,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,B01121,NA,https://ClinicalTrials.gov/show/NCT04797208
NCT04468789,Evaluation of Six-month HIV Treatment Dispensing in South Africa,Observational Model: Cohort|Time Perspective: Prospective,H-40512|OPP1192640,"Health Economics and Epidemiology Research Office, Johannesburg, Gauteng, South Africa",https://ClinicalTrials.gov/show/NCT04468789
NCT04435028,Ketotifen: as a Cardioprotective Agent in Breast Cancer Patients Receiving Anthracycline-containing Chemotherapy,Observational Model: Other|Time Perspective: Prospective,1890-1-2019,"Horus University, Damietta, Damiete Governonate, Egypt",https://ClinicalTrials.gov/show/NCT04435028
NCT04748536,Safety and PK of Repeated Doses of IRL201104 in Healthy Volunteers,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",C1104-003,"Hammersmith Medicines Research, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04748536
NCT04444713,Do Network Centrality Predict Overall Depression Symptom Reduction With Lifting of Social Distancing Protocols?,Observational Model: Ecologic or Community|Time Perspective: Prospective,802810-2,NA,https://ClinicalTrials.gov/show/NCT04444713
NCT04887350,SSIPP vs. PST vs. WLC,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,11336,NA,https://ClinicalTrials.gov/show/NCT04887350
NCT04780425,"Structured Diabetes Self-Management Education and Care Outcomes in Adults liVIng With Type 2 Diabetes in Accra, Ghana",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Care Provider)|Primary Purpose: Supportive Care,KBTH-IRB 100017512020,"Korle Bu Teaching Hospital, Accra, Ghana|Weija Gbawe Municipal Hospital, Accra, Ghana",https://ClinicalTrials.gov/show/NCT04780425
NCT04148430,A Study of Anakinra to Prevent or Treat Severe Side Effects for Patients Receiving CAR-T Cell Therapy,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,19-168,"Memorial Sloan Kettering Cancer Center, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04148430
NCT04565782,Corona Virus Infection Among Liver Transplant Recipients,Observational Model: Cohort|Time Perspective: Cross-Sectional,17300475,"Assiut University, Assiut, Egypt",https://ClinicalTrials.gov/show/NCT04565782
NCT04443179,Brain Imaging in Babies Study,Observational Model: Case-Control|Time Perspective: Prospective,"IRAS: 108997, REC 12/LO/2017","King's College London, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04443179
NCT04475185,Safety and Effectiveness Assessment of the MakAir Artificial Ventilator,Allocation: N/A|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,RC20_0173,"CHRU Brest, Brest, Finistère, France|CHU Nantes, Nantes, Loire-Atlantique, France",https://ClinicalTrials.gov/show/NCT04475185
NCT04872309,MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology,Observational Model: Cohort|Time Perspective: Prospective,STH20825,"Academic Unit of Radiology, Univeristy of Sheffield, Sheffield, South Yorkshire, United Kingdom",https://ClinicalTrials.gov/show/NCT04872309
NCT04353245,Study of Biomarkers in the Long-term Impact of Coronavirus Infection in the Cardiorespiratory System,Observational Model: Case-Control|Time Perspective: Prospective,UAP107,"Instituto do Coração - Hospital das Clínicas - Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, Brazil",https://ClinicalTrials.gov/show/NCT04353245
NCT04424355,Magnetic Resonance Imaging to Detect Signs of Viral Pneumonia in Patients With Coronavirus Infection.,Observational Model: Cohort|Time Perspective: Cross-Sectional,20-Feb,"Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department, Moscow, Russian Federation",https://ClinicalTrials.gov/show/NCT04424355
NCT04526145,OUR Stress/ Emotion Management for Black/African American Women With Hypertension,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,2020B0182,NA,https://ClinicalTrials.gov/show/NCT04526145
NCT04852809,COvid-19 aNd TechNology - thE Impact on Clinical Trial Patients,Observational Model: Cohort|Time Perspective: Prospective,CFTSp197,"The Christie NHS Foundation Trust, Manchester, Greater Manchester, United Kingdom",https://ClinicalTrials.gov/show/NCT04852809
NCT04666311,Diagnostic Accuracy of CAD4TB and C-reactive Protein Assay as Triage Tests for Pulmonary Tuberculosis,Observational Model: Cohort|Time Perspective: Prospective,P1685-20A,"Butha-Buthe District Hospital, Butha-Buthe, Lesotho|Caluza Clinic, Pietermaritzburg, KwaZulu-Natal, South Africa",https://ClinicalTrials.gov/show/NCT04666311
NCT04333251,Study Testing Convalescent Plasma vs Best Supportive Care,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,020-123,NA,https://ClinicalTrials.gov/show/NCT04333251
NCT04740489,The Impact of Covid-19 on Cardiac Rehabilitation Participants and Staff,Observational Model: Cohort|Time Perspective: Cross-Sectional,5,NA,https://ClinicalTrials.gov/show/NCT04740489
NCT04502433,Poractant Alfa - Curosurf and SARS-COV-19 ARDS (Covid-19),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,CLI-050000-04|2020-002632-75,"UCLH and UCL 250 Euston Road, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04502433
NCT02081326,Repeat BCG Vaccinations for the Treatment of Established Type 1 Diabetes,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",2013P002633,"Immunobiology Labs CNY 149, Charlestown, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT02081326
NCT04547634,Telerehabilitation in Oncology Patients,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,Teleclub_cam,"Antonio Cuesta Vargas, Málaga, Spain",https://ClinicalTrials.gov/show/NCT04547634
NCT04677842,European Pregnancy and Paediatric Infections Cohort Collaboration: Paediatric Protocol,Observational Model: Cohort|Time Perspective: Other,EPPICC,NA,https://ClinicalTrials.gov/show/NCT04677842
NCT04406558,Psychological Impact of the Health Measures Generated by the COVID19 in Adolescents,Observational Model: Cohort|Time Perspective: Prospective,COVADO,"Camille JUNG, Creteil, France",https://ClinicalTrials.gov/show/NCT04406558
NCT04480112,Impact of Covid-19 on Frequent Social Interaction Through Communication Technologies in the Cognitive Status of Socially-isolated Older Adults,Allocation: Non-Randomized|Intervention Model: Crossover Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Other,H-26786,"Boston University Alzheimer Disease Center, Boston, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT04480112
NCT04483271,The Effect of Omega-3 on Selected Cytokines Involved in Cytokine Storm,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,2020-PHA-18,"Mahmoud S Abu-Samak, Amman, Jordan",https://ClinicalTrials.gov/show/NCT04483271
NCT04816019,A Study of Intranasal ChAdOx1 nCOV-19,Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,COV008,"CCVTM, University of Oxford, Churchill Hospital, Oxford, United Kingdom",https://ClinicalTrials.gov/show/NCT04816019
NCT04799561,Teleprehabilitation for Surgical Cancer Patients,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,MUHC-2021-6730,NA,https://ClinicalTrials.gov/show/NCT04799561
NCT04475913,Digital vs Analog Impression in Cases of All-on-4 - Prosthesis,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,5,"OctoberUMSA, Giza, Egypt",https://ClinicalTrials.gov/show/NCT04475913
NCT04744415,Hospitalizations During Pandemia in the Italian Coronary Care Unit Network,Observational Model: Cohort|Time Perspective: Other,K22,"Ospedale Santo Spirito - Sc Cardiologia, Casale Monferrato, AL, Italy|Istituto Scientifico Inrca - Uo Cardiologia/Utic/Telecardiologia, Ancona, AN, Italy|Ospedale Generale Regionale-Po U. Parini - U.O. Cardiologia E Cure Intensive Card., Aosta, AO, Italy|Po Sant'Ottone Frangipane - U.O.C. Cardiologia - Utic, Ariano Irpino, AV, Italy|Aorn San Giuseppe Moscati - U.O. Cardiologia/Utic 'D. Rotiroti', Avellino, AV, Italy|Ospedale Miulli - U.O.C. Cardiologia - Utic, Acquaviva Delle Fonti, BA, Italy|Aou Policlinico - Uoc Cardiologia Ospedaliera, Bari, BA, Italy|Ospedale Di Venere - U.O.C. Di Cardiologia, Bari, BA, Italy|Ospedale San Paolo - Cardiologia-Utic, Bari, BA, Italy|Ospedale Di Bentivoglio - U.O. Di Cardiologia, Bentivoglio, BO, Italy|Ospedale Maggiore - U.O. Di Cardiologia, Bologna, BO, Italy|Asst Spedali Civili - Cardiologia, Brescia, BS, Italy|Ospedale L. Bonomo - Cardiologia - Utic, Andria, BT, Italy|Ospedale Generale Regionale - Divisione Di Cardiologia, Bolzano, BZ, Italy|Arnas G. Brotzu - Cardiologia Con Utic, Cagliari, CA, Italy|A.O.U. Cagliari Policlinico Monserrato - Sc Cardiologia Utic Emodinamica, Monserrato, CA, Italy|Ospedale A. Cardarelli - U.O. Cardiologia E Utic, Campobasso, CB, Italy|Presidio Ospedaliero Moscati - U.O.C. Cardiologia-Utic, Aversa, CE, Italy|Az. Ospedaliera S. Anna E S. Sebastiano - U.O. Cardiologia-Utic, Caserta, CE, Italy|Ospedale Civile Ave Gratia Plena - U.O. Di Cardiologia E Utic, Piedimonte Matese, CE, Italy|Ospedale San Giuseppe E Melorio - U.O.C. Cardiologia Utic, Santa Maria Capua Vetere, CE, Italy|Presidio Ospedaliero San Rocco - U.O.C. Cardiologia - Utic, Sessa Aurunca, CE, Italy|Ospedale San Pio Da Pietrelcina - Cardiologia, Vasto, CH, Italy|Ospedale Regina Montis Regalis - U.O. Cardiologia-Utic, Mondovì, CN, Italy|Ospedale Maggiore Ss. Annunziata - Sc Cardiologia, Savigliano, CN, Italy|Ospedale Moriggia Pelascini - Unita' Operativa Di Cardiologia, Gravedona, CO, Italy|Ospedale S. Anna - U.O.C. Di Cardiologia, San Fermo Della Battaglia, CO, Italy|P.O. Garibaldi Centro - U.O.C. Cardiologia, Catania, CT, Italy|Centro Cuore Morgagni - U.F. Utic Ed Emodinamica, Pedara, CT, Italy|Arcispedale Sant'Anna - U.O. Cardiologia - Utic, Ferrara, FE, Italy|Ospedali Riuniti - S.C. Di Cardiologia Univ.-Utic, Foggia, FG, Italy|Ospedale Casa Sollievo Della Sofferenza - Cardiologia - Utic - Riabil Cardiologica, San Giovanni Rotondo, FG, Italy|Presidio Ospedaliero T. Masselli Mascia - S.C. Cardiologia - Utic - Riabil. Card., San Severo, FG, Italy|Ospedale Santa Maria Annunziata - Cardiologia, Bagno A Ripoli, FI, Italy|Ospedale San Giuseppe - Cardiologia, Empoli, FI, Italy|Aou Careggi - Cardiologia Interventistica, Firenze, FI, Italy|Ospedale San Giovanni Di Dio - Cardiologia, Firenze, FI, Italy|Ospedale Santa Maria Nuova - Hdu Cardiologica/Utic, Firenze, FI, Italy|E.O. Ospedali Galliera - S. C. Cardiologia, Genova, GE, Italy|Presidio Ospedaliero - U.O. Cardiologia, Sanremo, IM, Italy|Ospedale Civile Sacro Cuore Di Gesu' - Uo Cardiologia Utic, Gallipoli, LE, Italy|Ospedale Ignazio Veris Delli Ponti - Uoc Cardiologia-Utic, Scorrano, LE, Italy|Azienda Osp. Cardinale G. Panico - U.O. Cardiologia - Utic, Tricase, LE, Italy|Ospedali Riuniti - U.O.C. Cardiologia E Utic, Livorno, LI, Italy|Nuovo Ospedale Versilia - Sc Cardiologia, Lido Di Camaiore, LU, Italy|Ospedale San Gerardo - U.O. Cardiologia-Utic, Monza, MB, Italy|Aor Papardo - U.O. Cardiologia Con Utic, Messina, ME, Italy|Ospedale Piemonte - Cardiologia E Utic, Messina, ME, Italy|Centro Cardiologico Monzino - Terapia Intensiva Cardiologica (Utic), Milano, MI, Italy|Irccs Policlinico Multimedica - Uo Di Cardiologia, Sesto San Giovanni, MI, Italy|Ospedale Civile Di Baggiovara - U.O. Di Cardiologia, Modena, MO, Italy|Ospedale San Francesco - Cardiologia - Utic, Nuoro, NU, Italy|Fondazione G. Giglio - U.O. Cardiologia E Utic, Cefalù, PA, Italy|Aor Villa Sofia-Cervello P.O. Cervello - U.O. Cardiologia - Cervello, Palermo, PA, Italy|Aor Villa Sofia-Cervello Po Villa Sofia - U.O.C. Cardiologia E Utic - Villa Sofia, Palermo, PA, Italy|Ospedale Civile 'Guglielmo Da Saliceto' - Uo Cardiologia, Piacenza, PC, Italy|Ospedale Civile Dello Spirito Santo - Utic E Cardiologia Interventistica, Pescara, PE, Italy|Presidio Ospedaliero Citta' Di Castello - U.O. Di Cardiologia, Città Di Castello, PG, Italy|Ospedale Gubbio-Gualdo Tadino - U.O. Di Utic E Cardiologia, Gubbio, PG, Italy|Ospedale Generale Provinciale Lotti - U.O. Malattie Cardiovascolari Vde E Avc, Pontedera, PI, Italy|Ospedale Di Pordenone - S.O.C. Cardiologia, Pordenone, PN, Italy|Ospedale Ss. Cosma E Damiano - U. O. Cardiologia - Utic, Pescia, Point, Italy|Ospedale Santo Stefano - U.O. Cardiologia, Prato, PO, Italy|Ospedale Generale Di Zona - U.O. Cardiologia - Utic, Lagonegro, PZ, Italy|Azienda Ospedaliera San Carlo - Ssd Utic, Potenza, PZ, Italy|Ospedale Per Gli Infermi - U.O. Cardiologia - Utic, Faenza, RA, Italy|Ospedale Civile Santa Maria Delle Croci - U.O. Di Cardiologia, Ravenna, RA, Italy|P.O. San Camillo de Lellis - U.O.C. Cardiologia, Rieti, RI, Italy|Ospedale Civile San Paolo - U.O. Cardiologia - Utic, Civitavecchia, RM, Italy|Ospedale S. Maria Goretti - Uoc Malattie Cardiovascolari, Latina, RM, Italy|Aurelia Hospital - U.O.C Cardiologia, Roma, RM, Italy|Clinica Citta' Di Roma - Cardiologia-Utic, Roma, RM, Italy|European Hospital - U.O. Cardiologia Interventistica, Roma, RM, Italy|Ospedale Fatebenefratelli - U.O.C. Cardiologia, Roma, RM, Italy|Ospedale San Camillo - Uoc Cardiologia, Roma, RM, Italy|Ospedale Sandro Pertini - Uoc Cardiologia, Roma, RM, Italy|Ospedale Sant'Andrea Di Roma - U.O.C. Cardiologia, Roma, RM, Italy|Ospedale Santa Maria Della Misericordia - U.O.C. Cardiologia, Rovigo, RO, Italy|Presidio Osped. S. Maria Della Speranza - U.O. Di Cardiologia, Battipaglia, SA, Italy|P.O. Nocera-Pagani - Osp. Umberto I - Uoc Cardiologia - Utic, Nocera Inferiore, SA, Italy|Presidio Ospedaliero Luigi Curto - Uo Cardiologia-Utic, Polla, SA, Italy|Aou S. Giovanni Di Dio-Ruggi D'Aragona - U.O.C. Utic, Salerno, SA, Italy|Ospedale San Luca - U.O. Utic - Cardiologia, Vallo Della Lucania, SA, Italy|Ospedale Dell'Alta Val D'Elsa - Uosd Cardiologia-Utic, Poggibonsi, SI, Italy|Aou Senese Ospedale S. Maria Alle Scotte - U.O.C. Cardiologia Clinico-Chirurg. Utic, Siena, SI, Italy|Ospedale Civile - U.O. Cardiologia, Sondrio, SO, Italy|Ospedale S. Andrea - S.C. Cardiologia, La Spezia, SP, Italy|Ospedale E. Muscatello - U.O. Di Cardiologia - Utic, Augusta, SR, Italy|Ospedale G. Di Maria - Cardiologia Utic, Avola, SR, Italy|P.O. Lentini - U.O. Di Cardiologia Con Utic, Lentini, SR, Italy|Ospedale Nostra Signora Di Bonaria - U.O.C. Cardiologia E Utic, San Gavino Monreale, SU, Italy|Ospedale Santa Maria Del Carmine - Cardiologia, Rovereto, TN, Italy|Ospedale Santa Chiara - Divisione Di Cardiologia, Trento, TN, Italy|Po S. Antonio Abate Di Trapani - U.O.C. Di Cardiologia E Utic, Erice, TP, Italy|Ospedale Santa Maria Dei Battuti - U.O. Di Cardiologia, Conegliano, TV, Italy|Pou Santa Maria Della Misericordia - S.O.C. Cardiologia, Udine, UD, Italy|Presidio Ospedaliero Di Saronno - U.O.C. Di Cardiologia, Saronno, VA, Italy|Ospedale Civile - U.O. Cardiologia, Mirano, VE, Italy|Ospedale Civile - U.O.C. Cardiologia, Arzignano, VI, Italy|Ospedale Civile San Bortolo - U.O.C. Cardiologia, Vicenza, VI, Italy|Ospedale Mater Salutis - U.O.C. Cardiologia, Legnago, VR, Italy|Casa Di Cura Dr. Pederzoli - Servizio Di Cardiologia, Peschiera Del Garda, VR, Italy|Ospedale Ss. Trinita' - S.C. Di Cardiologia, Borgomanero, Italy|Ospedale San Leonardo - U.O. Di Cardiologia-Utic, Castellammare Di Stabia, Italy|Ospedale San Giovanni Di Dio - Uo Cardiologia - Utic, Frattamaggiore, Italy|Ospedale Generale Di Zona - U.O. Cardiologia - Utic, Giugliano In Campania, Italy|Ospedale Anna Rizzoli - Cardiologia-Utic, Lacco Ameno, Italy|Aorn Cardarelli - U.O. Cardiologia Con Utic, Napoli, Italy|Clinica Mediterranea - U.O. Di Cardiologia, Napoli, Italy|Ospedale Dei Pellegrini - Uoc Cardiologia-Utic, Napoli, Italy|Ospedale Del Mare - U.O. Cardiologia Con Utic, Napoli, Italy|Pres. Ospedaliero S. Maria Della Pieta' - U.O. Cardiologia E Utic, Nola, Italy|Aou Maggiore Della Carita' - Cardiologia Ii, Novara, Italy|PO San Filippo neri - ASL Roma1, Roma, Italy",https://ClinicalTrials.gov/show/NCT04744415
NCT04828434,Virtual Individual Cognitive Stimulation Therapy: a Proof of Concept Study,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,17127/002/1,"UCL, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04828434
NCT04695743,Group CST Using Zoom: A Proof of Concept Study,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,17127/002,"University College London, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04695743
NCT04743609,RSV Burden in Outpatient Settings,Observational Model: Cohort|Time Perspective: Prospective,2020-A02876-33,"ACTIV, Créteil, France",https://ClinicalTrials.gov/show/NCT04743609
NCT04946175,National Survey Among Egyptian Pain Practitioners,Observational Model: Other|Time Perspective: Prospective,southvu8,"South Valley University Hospitals, Qinā, Qina, Egypt|South Valley University, Qinā, Egypt",https://ClinicalTrials.gov/show/NCT04946175
NCT04344665,Post Discharge After Surgery Virtual Care With Remote Automated Monitoring Technology (PVC-RAM) Trial,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention,"v5.0, 2020.09.12","University of Alberta Hospital, Edmonton, Alberta, Canada|The Ottawa Hospital, Ottawa, Ontario, Canada|Hamilton General Hospital, Hamilton, Canada|Juravinski Hospital, Hamilton, Canada|St. Joseph's Healthcare Hamilton, Hamilton, Canada|Kingston Health Sciences Centre, Kingston, Canada|London Health Sciences Centre, London, Canada",https://ClinicalTrials.gov/show/NCT04344665
NCT04895475,Antibody Detection of Vaccine-Induced Secretory Effects,Observational Model: Case-Only|Time Perspective: Prospective,ADVISE,"Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States",https://ClinicalTrials.gov/show/NCT04895475
NCT04505098,A Pragmatic Randomized Trial of Icosapent Ethyl for High-Cardiovascular Risk Adults,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention,1597940,"Kaiser Permanente Northern California, Oakland, California, United States",https://ClinicalTrials.gov/show/NCT04505098
NCT04457388,Tele-Yoga Therapy for Chronic Pain,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,AU/018,"Aarogyam UK, Leicester, Leicestershire, United Kingdom",https://ClinicalTrials.gov/show/NCT04457388
NCT04514900,Exploring Optimal Treatment Components for Contactless Online Group-based Behavioral Weight Loss Program,Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,Pro00101006,"University of South Carolina, Columbia, South Carolina, United States",https://ClinicalTrials.gov/show/NCT04514900
NCT04583865,Feasibility and Quality of TeleConsultation in Pediatric Anesthesia,Observational Model: Cohort|Time Perspective: Prospective,RC31/20/0220|2020-A02275-34,"UHToulouse, Toulouse, France",https://ClinicalTrials.gov/show/NCT04583865
NCT04880317,Validation of Quantitative Myocardial Tissue Characterization Through Non-gated CT,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,VALETUDO,"IRCCS Policlinico San Donato, San Donato Milanese, Milano, Italy",https://ClinicalTrials.gov/show/NCT04880317
NCT04781400,"Bidirectional, Upbeat Communication and Differentiated, Distanced Care for Young People",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,448/2020,"Gugulethu Community Health Centre, Cape Town, Western Cape, South Africa",https://ClinicalTrials.gov/show/NCT04781400
NCT04393636,Digital Cardiac Counseling Trial: DCC Trial,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,NL72754.068.20,"Maastricht University Medical Center, Maastricht, Netherlands",https://ClinicalTrials.gov/show/NCT04393636
NCT04389372,"Effectiveness and Acceptability of MINDFULNESS by Smartphone, for Patients With Chronic Migraine and Medication Overuse",Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,Chro-Mig-Smart,"UOC Neurologia 3, Milano, Italy",https://ClinicalTrials.gov/show/NCT04389372
NCT04982887,Tele-Rehabilitation in Parkinson's Disease,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,Tele-Rehabilitation,"Istanbul Rumeli University, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04982887
NCT04604977,Feasibility and Effectiveness of Home-behavioral Program for Adolescents With Migraine,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,Be-Home-Kids,"Fondazione IRCCS Istituto Neurologico C. Besta, Neuroalgology Unit, Milano, Italy",https://ClinicalTrials.gov/show/NCT04604977
NCT04591873,Using Telemedicine to Optimize Teamwork and Infection Control of Critical and Highly-infectious Patients in an Emergency Department,Observational Model: Case-Control|Time Perspective: Prospective,202007114RINA,"National Taiwan University Hospital, Taipei, Taiwan",https://ClinicalTrials.gov/show/NCT04591873
NCT04052607,Progestin Priming Ovarian Stimulation (PPOS) Compared With Antagonist Protocol for Freeze-all Cycles,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment",IbnSina-PPOS,"Banon Fertility Center, Assiut, Egypt|IbnSina IVF Center, IbnSina Hospital, Sohag, Egypt|AlRahma Hospital, Sohag, Egypt",https://ClinicalTrials.gov/show/NCT04052607
NCT04656626,Brief Mindfulness Based Intervention to Improve Psychological Wellbeing,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Other",Mindfullness during a pandemic,"Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia",https://ClinicalTrials.gov/show/NCT04656626
NCT04482387,DigiVis: Self-testing Vision App for Telephone Consultations,Allocation: N/A|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,IRAS196573,"Cambridge University Hospitals NHS Trust, Cambridge, Cambs, United Kingdom",https://ClinicalTrials.gov/show/NCT04482387
NCT04428099,Healthy Lifestyle Promotion as Adjunctive Teletherapy for Treatment-resistant Major Depression,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,RMD01,"Universitat Illes Balears, Palma de Mallorca, Illes Balears, Spain",https://ClinicalTrials.gov/show/NCT04428099
NCT03708718,Prednisolone in Early Diffuse Systemic Sclerosis,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",119220,"Aberdeen Royal Infirmary - NHS Grampian, Aberdeen, Aberdeenshire, United Kingdom|Addenbrooke's Hospital - Cambridge University Hospitals NHS Foundation Trust, Cambridge, Cambridgeshire, United Kingdom|Salford Royal NHS Foundation Trust, Salford, Greater Manchester, United Kingdom|Glasgow Royal Infirmary -, Glasgow, Lanarkshire, United Kingdom|Aintree University Hospitals NHS Foundation Trust, Liverpool, Merseyside, United Kingdom|Queen's Medical Centre - Nottingham University Hospitals NHS Trust, Nottingham, Nottinghamshire, United Kingdom|Royal National Hospital For Rheumatic Diseases - Royal United Hospitals Bath NHS Foundation Trust, Bath, Somerset, United Kingdom|Royal Hallamshire Hospital - Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, South Yorkshire, United Kingdom|Freeman Hospital - The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, Tyne And Wear, United Kingdom|The Dudley Group NHS Foundation Trust, Dudley, West Midlands, United Kingdom|Leeds Institute of Rheumatic and Musculoskeletal Medicine, Leeds, West Yorkshire, United Kingdom|Southmead Hospital Bristol - North Bristol NHS Trust, Bristol, United Kingdom|Ninewells Hospital and Medical School - NHS Tayside, Dundee, United Kingdom|Royal Free London NHS Foundation Trust, London, United Kingdom",https://ClinicalTrials.gov/show/NCT03708718
NCT04662021,Aerobic Training Versus Cognitive Behavioral Therapy in Management of Anxiety,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,12-2020,"Marwa Eid, Cairo, Egypt",https://ClinicalTrials.gov/show/NCT04662021
NCT04441047,Universal Anti-Viral Vaccine for Healthy Elderly Adults,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,MBI-001-ALLOPRIME,"Florida Medical Clinic, LLC, Zephyrhills, Florida, United States",https://ClinicalTrials.gov/show/NCT04441047
NCT04907942,Feasibility and Acceptability of Click's EMA and Text Message Intervention for STRESS Management,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Other",DL-FACE-101,"Click Therapeutics, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04907942
NCT04833088,Exploratory Study About the Implementation of Technology in the Rehabilitation,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,SAIRE FOCUSGR,NA,https://ClinicalTrials.gov/show/NCT04833088
NCT04595695,The Effect of Clear Masks in Improving Patient Relationships,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Health Services Research,20-2229,"University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States",https://ClinicalTrials.gov/show/NCT04595695
NCT04657809,Clinical Assessment of Insulin Fast Dissolving Film in Treatment of Post Infection Anosmia,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment",S85insu23fdf,"Soad, Minya, Egypt",https://ClinicalTrials.gov/show/NCT04657809
NCT04396314,Effectiveness of Basic Body Awareness Therapy in Post-traumatic Stress Disorders: A Randomized Clinical Trial,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,UL-002,NA,https://ClinicalTrials.gov/show/NCT04396314
NCT04833010,Effects of Face Masks During Exercise,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Other,020-353,"Baylor Scott & White Sports Therapy & Research at The Star, Frisco, Texas, United States",https://ClinicalTrials.gov/show/NCT04833010
NCT04829188,Comparative Effectiveness of Readmission Reduction Interventions for Individuals With Sepsis or Pneumonia,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Health Services Research",STUDY20080130,"UPMC Presbyterian, Pittsburgh, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04829188
NCT04629755,A Smartphone Intervention for Relational and Mental Well Being,Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,STUDY00009897,"University of Washington, Seattle, Washington, United States",https://ClinicalTrials.gov/show/NCT04629755
NCT04456933,Intracorporeal Anastomosis in Laparoscopic Left Colectomy. Cohort Comparative Study,Observational Model: Cohort|Time Perspective: Prospective,HEMI-E-INTRACORPOREA-2020,"Hospital Universitario Parc Tauli de Sabadel, Sabadell, Barceelona, Spain",https://ClinicalTrials.gov/show/NCT04456933
NCT04470869,Impact on the OLAF Intervention to Prevent Post Traumatic Disorders During the Confinement.,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,RC31/20/0190,"University Hospital Toulouse, Toulouse, Occitanie, France",https://ClinicalTrials.gov/show/NCT04470869
NCT04768413,Evaluation of a Non-face to Face Multidisciplinary Health Care Model in a Population With Rheumatoid Arthritis,Observational Model: Cohort|Time Perspective: Prospective,5171,"BIOMAP IPS Centro de Atención Integral en Artritis Reumatoide, Bogota, Cundinamarca, Colombia|Colombia Fundación Universitaria de Ciencias de la Salud-FUCS, Bogota, Cundinamarca, Colombia",https://ClinicalTrials.gov/show/NCT04768413
NCT04805125,Immunocompromised Swiss Cohorts Based Trial Platform,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,2021-000593; me20Bucher,"University Hospital Basel, Basel, Switzerland|University Hospital Bern, Bern, Switzerland|University Hospital Lausanne CHUV, Lausanne, Switzerland|University Hospital Zurich, Zurich, Switzerland",https://ClinicalTrials.gov/show/NCT04805125
NCT04640610,Angiotensin-converting Enzyme 2 (ACE2) Expression in Tonsils and Adenoids,Observational Model: Cohort|Time Perspective: Prospective,APHP201032,"Hôpital Mondor, Créteil, France|Hôpital Bicêtre, Le Kremlin-Bicêtre, France|Hôpital Lariboisière, Paris, France|Hôpital Armand Trousseau, Paris, France|Hôpital Pitié Salpêtrière, Paris, France|HEGP, Paris, France|Hôpital Necker-Enfants Malades, Paris, France|Hôpital Bichat, Paris, France|Hôpital Tenon, Paris, France",https://ClinicalTrials.gov/show/NCT04640610
NCT04466085,Clinical Study of Recombinant Novel Coronavirus Vaccine,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention",NCV-Ⅱ-healthy,"Hunan Provincial Center for Disease Control and Prevention, Hunan, Changsha, China",https://ClinicalTrials.gov/show/NCT04466085
NCT04909853,Renal Impairment Study of PF-07321332 Boosted With Ritonavir in Adult Participants With Renal Impairment and in Healthy Participants With Normal Renal Function.,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science,C4671011,NA,https://ClinicalTrials.gov/show/NCT04909853
NCT04712448,Serum Prevalence of Sars-Cov-2 Antibodies in Pre-pandemic Blood Samples (SPARE),Observational Model: Other|Time Perspective: Retrospective,20/33,"IRCCS San Raffaele, Rome, Italy",https://ClinicalTrials.gov/show/NCT04712448
NCT04422262,Analysis of Long Term Risk of Coronavirus Disease-19 Emergency,Observational Model: Cohort|Time Perspective: Retrospective,DEP 1/2020,"IRCCS Neuromed, Pozzilli, Italy",https://ClinicalTrials.gov/show/NCT04422262
NCT04434014,Proper Nutrition And Its Relation To Oral Diseases In Covid -19 Era,Observational Model: Ecologic or Community|Time Perspective: Prospective,12345678,"October university of modern sciences and arts, Giza, Egypt",https://ClinicalTrials.gov/show/NCT04434014
NCT04424953,To Compare Videolaryngoscope Against Direct Laryngoscope for Intubation When Powered Air Purifying Respirator is Worn,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment",2020/2329,"Singapore General Hospital, Singapore, Singapore",https://ClinicalTrials.gov/show/NCT04424953
NCT04530448,Coronavirus Induced Acute Kidney Injury: Prevention Using Urine Alkalinization,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,WVU Protocol #2005006707,"WVU Medicine Heart & Vascular Institute, Morgantown, West Virginia, United States",https://ClinicalTrials.gov/show/NCT04530448
NCT03852537,Steroid Dosing by bioMARker Guided Titration in Critically Ill Patients With Pneumonia,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,18-010925,"Mayo Clinic in Rochester, Rochester, Minnesota, United States",https://ClinicalTrials.gov/show/NCT03852537
NCT04346940,The Effectiveness of Telerehabilitation-Based Exercises in Elderly People,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,7,NA,https://ClinicalTrials.gov/show/NCT04346940
NCT04356144,Thrombomodulin-modified Thrombin Generation Assay (TGA-TM) in Patients With Critical Infections,Observational Model: Cohort|Time Perspective: Prospective,TGA-TM-Critical-2019,"Medical University Vienna, Vienna, Austria",https://ClinicalTrials.gov/show/NCT04356144
NCT04821999,Diode Laser 940 nm in Management of Loss of Taste Sensation,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment",Laser SARS-CoV2,"Faculty of Dentistry, Fayoum, Egypt",https://ClinicalTrials.gov/show/NCT04821999
NCT04393649,First Level Socio-geriatric Evaluation: ESOGER Databank,Observational Model: Cohort|Time Perspective: Prospective,MP-05-2021-2308,"Jewish General Hospital, Montréal, Quebec, Canada",https://ClinicalTrials.gov/show/NCT04393649
NCT04568564,Telerehabilitation in Lung Surgery Patients,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,PostopTele,"Istanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine Thoracic Surgery Clinic, İstanbul, Turkey",https://ClinicalTrials.gov/show/NCT04568564
NCT04443075,Alterations of Gut Microbiome in the Frontline Medical Staff Under the Stress,Observational Model: Cohort|Time Perspective: Prospective,XJTU1AF2020LSK-022,"First Affiliated Hospital of Xian Jiaotong University, Xi'an, Shaanxi, China",https://ClinicalTrials.gov/show/NCT04443075
NCT04884750,Conversational Agent Vaccine Promotion RCT,"Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",IRB#18-07-02,NA,https://ClinicalTrials.gov/show/NCT04884750
NCT04605172,Lockdown Impact on Spontaneous Premature Birth in a Level III NICU,Observational Model: Case-Control|Time Perspective: Retrospective,2020PI168,"Maternite Regionale Universitaire CHRU NANCY, Nancy, Lorraine, France",https://ClinicalTrials.gov/show/NCT04605172
NCT04536935,Mobile Mental Health Apps for Suicide Prevention,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,STUDY00010842,"University of Washington, Seattle, Washington, United States",https://ClinicalTrials.gov/show/NCT04536935
NCT04333875,Morbidity and Mortality Due to Deferral of Aortic Valve Replacement in Patients With Severe Aortic Stenosis,Observational Model: Cohort|Time Perspective: Prospective,2020-00672,"Department of Cardiology, Bern University Hospital, Bern, Switzerland",https://ClinicalTrials.gov/show/NCT04333875
NCT04439825,Impact of Botox Treatment Into the Upper One Third of the Face an Area on Mood and Self -Appearance Satisfaction,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,BTX-PST-COVID,"DeNova Research, Chicago, Illinois, United States",https://ClinicalTrials.gov/show/NCT04439825
NCT04889326,Collection of the Thrombo-VaxCov Cohort,Observational Model: Cohort|Time Perspective: Retrospective,ECH_2021_cb,"CHU lille, Lille, France",https://ClinicalTrials.gov/show/NCT04889326
NCT04663776,Wide Scale Monitoring for Acute Respiratory Infection Using a Mobile-Based Study Platform,Observational Model: Cohort|Time Perspective: Prospective,P00036213,"Boston Children's Hospital, Boston, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT04663776
NCT04467086,Propranolol as an Anxiolytic to Reduce the Use of Sedatives From Critically-ill Adults Receiving Mechanical Ventilation,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,776228483,"Hamilton Health Sciences Centre - Hamilton General Hospital, Hamilton, Ontario, Canada|The Ottawa Hospital, Ottawa, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04467086
NCT04666558,Heal-Me Personalized Online Nutrition and Exercise Routines,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Supportive Care,Pro00103715,"University of Alberta, Edmonton, Alberta, Canada",https://ClinicalTrials.gov/show/NCT04666558
NCT04497922,Virtual White Boards for Patient Satisfaction,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,2020P002382,"Brigham and Women's Hospital, Boston, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT04497922
NCT04363177,Global Mental Health of Urban Mothers,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Prevention,P2SKP3_187728,"Shanghai Women's and Children's Health Center, Shanghai, Shanghai, China|Chinese University Hong Kong, Hong Kong, Hong Kong",https://ClinicalTrials.gov/show/NCT04363177
NCT03256773,High Resolution Micro OCT Imaging,Observational Model: Cohort|Time Perspective: Prospective,F160125001,"University of Alabama at Birmingham, Birmingham, Alabama, United States",https://ClinicalTrials.gov/show/NCT03256773
NCT04974775,Swecrit Biobank - Blood Samples From Critically Ill Patients and Healthy Controls,Observational Model: Cohort|Time Perspective: Other,SWECRIT,"Helsingborg Hospital, Helsingborg, Sweden|Kristianstad Central Hospital, Kristianstad, Sweden|Skane University Hospital, Lund, Sweden|Skane University Hospital, Malmö, Sweden",https://ClinicalTrials.gov/show/NCT04974775
NCT03680274,Lessening Organ Dysfunction With VITamin C,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",MP-31-2019-2945,"Research Center of the CHUS, Sherbrooke, Quebec, Canada",https://ClinicalTrials.gov/show/NCT03680274
NCT04954937,Convalescent Plasma Donor Vaccine Study An Observational Antibody Level Study.,Observational Model: Other|Time Perspective: Prospective,21AS0001,"NHSBT - Birmingham Donation Centre, Birmingham, United Kingdom",https://ClinicalTrials.gov/show/NCT04954937
NCT04606407,Inhaled NO for the Treatment of Viral Pneumonia in Adults,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,BA_VPLF_01,"Shaare Zedek Medical Center, Jerusalem, Israel",https://ClinicalTrials.gov/show/NCT04606407
NCT04569019,Attitudes Towards Influenza Vaccinations Among the Healthcare Workers of Medical University of Warsaw,Observational Model: Case-Crossover|Time Perspective: Cross-Sectional,AKBE/118/2020,"Warsaw Medical Uniwerity, Warsaw, Poland",https://ClinicalTrials.gov/show/NCT04569019
NCT04765215,Investigation of the Effectiveness of CoronaVac Vaccine in Cancer Patients With Active Chemotherapy and Comparison With Healthy People.,Observational Model: Case-Control|Time Perspective: Prospective,CHEMOCOVAC,"Tekirdağ Namık Kemal ÜNiversitesi, Tekirdağ, Turkey",https://ClinicalTrials.gov/show/NCT04765215
NCT04747990,coMpliAnce With evideNce-based cliniCal Guidelines in the managemenT of Acute biliaRy pancreAtitis,Observational Model: Cohort|Time Perspective: Retrospective,Biliary Pancreatitis,"Cagliari University Hospital, Cagliari, Italy|Niguarda Hospital Trauma Center - Acute Care Surgery, Milan, Italy|Hospital Del Mar Barcelona, Barcelona, Spain",https://ClinicalTrials.gov/show/NCT04747990
NCT04480333,"Safety, Tolerability and Pharmacokinetics of Inhaled Nanoparticle Formulation of Remdesivir (GS-5734) and NA-831","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",NEUROSIVIR,"Coronavirus Research Institute, Sunnyvale, California, United States",https://ClinicalTrials.gov/show/NCT04480333
NCT04660422,Advance Care Planning: Communicating With Outpatients for Vital Informed Decision,Observational Model: Cohort|Time Perspective: Other,20-600|UH3AG060626-03S1,"Northwell Health, New Hyde Park, New York, United States",https://ClinicalTrials.gov/show/NCT04660422
NCT04873622,Further Development and Initial Testing of RESTORE in Frontline Workers,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,REB# 20-5546-1,"UHN - Toronto General Hospital, Toronto, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04873622
NCT04816708,A Self-directed Mobile Mindfulness Intervention to Address Distress and Burnout in Frontline Healthcare Workers,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,Pro00107657,"Duke University Medical Center, Durham, North Carolina, United States",https://ClinicalTrials.gov/show/NCT04816708
NCT04748289,Integrated Platform for Multimodal Patient Monitoring and Therapy Support in ICU Patients,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,2020-02177,"University Hospital Zurich, Zurich, Switzerland",https://ClinicalTrials.gov/show/NCT04748289
NCT04346966,The Effectiveness of Video-Based Exercises in Young Adults,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Prevention,1,NA,https://ClinicalTrials.gov/show/NCT04346966
NCT04326309,Audio Data Collection for Identification and Classification of Coughing,Observational Model: Cohort|Time Perspective: Prospective,HM070102,"Virtual Facility, Bronx, New York, United States",https://ClinicalTrials.gov/show/NCT04326309
NCT04983251,"Women s Health Awareness Community Resiliency, Environmental Action and Collaborations for Health (REACH) Equity",Observational Model: Case-Only|Time Perspective: Prospective,10000441|000441-E,"NIEHS Clinical Research Unit (CRU), Research Triangle Park, North Carolina, United States",https://ClinicalTrials.gov/show/NCT04983251
NCT04468581,Characteristics of TraceTogether Users,Observational Model: Cohort|Time Perspective: Retrospective,510d,"Yale NUS, Singapore, Singapore",https://ClinicalTrials.gov/show/NCT04468581
NCT04379986,Remote Blood Pressure Monitoring With the Wearable SENBIOSYS Photoplethysmographic Device,Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Device Feasibility,SENBIOSYS trial,"University and hospital Fribourg, Fribourg, Switzerland",https://ClinicalTrials.gov/show/NCT04379986
NCT04382508,Coronavirus Infection in Primary or Secondary Immunosuppressed Children and Adults.,Observational Model: Cohort|Time Perspective: Prospective,RHM CHI1061,"University Hospital Southampton NHS FT, Southampton, Hampshire, United Kingdom",https://ClinicalTrials.gov/show/NCT04382508
NCT04107402,PLatelets Acetyl-CoA Carboxylase Phosphorylation State in SEPtic Shock,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science,PLACCSEPS|2018/11DEC/469,"Cliniques Universitaires St Luc, Bruxelles, Belgium",https://ClinicalTrials.gov/show/NCT04107402
NCT04862806,"Safety, Efficacy of BNT162b2 mRNA Vaccine in CLL",Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,0214-20-BNZ,"Bnai Zion Medical Center, Haifa, Israel|Hematology Division, Chaim Sheba Medical Center, Tel Aviv, Israel",https://ClinicalTrials.gov/show/NCT04862806
NCT04574050,SELF-BREATHE RCT for Chronic Breathlessness,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,IRAS 285303|20/LO/1108,NA,https://ClinicalTrials.gov/show/NCT04574050
NCT04473274,"GlitazOne Treatment for Coronavirus HypoxiA, a Safety and Tolerability Open Label With Matching Cohort Pilot Study",Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,IRB20-042,"Good Samaritan Hospital Corvallis, Corvallis, Oregon, United States",https://ClinicalTrials.gov/show/NCT04473274
NCT04278404,"Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)",Observational Model: Other|Time Perspective: Prospective,Pro00103838,"Phoenix Children's Hospital, Phoenix, Arizona, United States|Arkansas Children's Hospital Research Institute, Little Rock, Arkansas, United States|University of California, Los Angeles, California, United States|Colorado University Denver, Aurora, Colorado, United States|Alfred I. DuPont Hospital for Children, Wilmington, Delaware, United States|University of Florida Jacksonville Shands Medical Center, Jacksonville, Florida, United States|Kapiolani Womens and Childrens Medical Center, Honolulu, Hawaii, United States|Ann and Robert H. Lurie Childrens Hospital of Chicago, Chicago, Illinois, United States|Riley Hospital for Children at Indiana University, Indianapolis, Indiana, United States|University of Iowa Stead Family Children's Hospital, Iowa City, Iowa, United States|University of Kansas Medical Center, Kansas City, Kansas, United States|Wesley Medical Center, Wichita, Kansas, United States|University of Louisville Norton Childrens Hospital, Louisville, Kentucky, United States|Tulane University Health Science Center, New Orleans, Louisiana, United States|Ochsner Baptist Clinical Trials Unit, New Orleans, Louisiana, United States|Boston Children's Hospital, Boston, Massachusetts, United States|Massachusetts General Hospital, Lexington, Massachusetts, United States|University of Minnesota, Minneapolis, Minnesota, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|Mississippi Center for Advanced Medicine, Madison, Mississippi, United States|Children's Mercy Hospital, Kansas City, Missouri, United States|Childrens Mercy Hospital, Kansas City, Missouri, United States|University of Nebraska Medical Center, Omaha, Nebraska, United States|Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States|University of New Mexico Health Science Center, Albuquerque, New Mexico, United States|Kravis Children's Hospital at Mt. Sinai, New York, New York, United States|University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States|Duke University Health System, Durham, North Carolina, United States|East Carolina University, Greenville, North Carolina, United States|New Hanover Regional Medical Center, Wilmington, North Carolina, United States|Cincinnati Childrens Hospital Medical Center, Cincinnati, Ohio, United States|Board of Regents of the University of Oklahoma, Oklahoma City, Oklahoma, United States|Oregon Health and Science University, Portland, Oregon, United States|Pennsylvania State University--Hershey Children's Hospital, Hershey, Pennsylvania, United States|Rhode Island Hospital, Providence, Rhode Island, United States|Medical University of South Carolina Children's Hospital, Charleston, South Carolina, United States|University of South Carolina, Columbia, South Carolina, United States|Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville, Tennessee, United States|Dell Children's Medical Center of Central Texas, Austin, Texas, United States|University of Texas-Southwestern Medical Center, Dallas, Texas, United States|University of Texas--Memorial Hermann Texas Medical Center, Houston, Texas, United States|Seattle Children's Hospital, Seattle, Washington, United States|University of Wisconsin, Madison, Wisconsin, United States|University of Wisconsin, Madison, Wisconsin, United States|University Wisconsin, Madison, Wisconsin, United States|Medical College of Wisconsin, Milwaukee, Wisconsin, United States|Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada|The Hospital for Sick Children, Toronto, Ontario, Canada|CHU Sainte-Justine, Montréal, Quebec, Canada",https://ClinicalTrials.gov/show/NCT04278404
NCT04770649,Vaccine Observation to Include All Communities for Equitable Science,Observational Model: Cohort|Time Perspective: Prospective,PB-2021-01,"Persephone Biosciences, Inc., San Diego, California, United States",https://ClinicalTrials.gov/show/NCT04770649
NCT04348552,Non-COVID Patient-safety Incidents Reported by Primary Care Professionals in Time of Lockdown: Protocol for a Cross-sectional Descriptive Study,Observational Model: Cohort|Time Perspective: Prospective,RC20_0183,"University Hospital, Nantes, France",https://ClinicalTrials.gov/show/NCT04348552
NCT04346121,Non-COVID Patient-safety Incidents Reported by General Practitioners in Time of Lockdown: Protocol for a Cross-sectional Descriptive Study.cRisis,Observational Model: Cohort|Time Perspective: Prospective,RC20_0182,"University Hospital, Nantes, France",https://ClinicalTrials.gov/show/NCT04346121
NCT04422275,Coronavirus Smell Therapy for Anosmia Recovery,"Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",PA-18-334,"Washington University, Saint Louis, Missouri, United States",https://ClinicalTrials.gov/show/NCT04422275
NCT04731324,"Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of ZYIL1 Following Oral Administration in Healthy Volunteers",Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,ZYIL1 1001|CTRI/2020/12/030045,"Zydus Research Centre, Ahmedabad, Gujarat, India",https://ClinicalTrials.gov/show/NCT04731324
NCT04843774,Vaccine-generated Immunity in Ocrelizumab-treated Patients: Longitudinal Assessments (VIOLA),Observational Model: Case-Only|Time Perspective: Prospective,21-00206,"University of Colorado, Denver (UCD), Denver, Colorado, United States|NYU Langone Health Multiple Sclerosis Comprehensive Care Center (NYULH MSCCC), New York, New York, United States",https://ClinicalTrials.gov/show/NCT04843774
NCT04703400,Analysis of the Impact on Surgical Residency Programs in Times of Pandemic in Argentina,Observational Model: Cohort|Time Perspective: Retrospective,817040,"René M. Palacios Huatuco, Córdoba, Argentina",https://ClinicalTrials.gov/show/NCT04703400
NCT04329897,Acceptance and Commitment Therapy Delivered by Automated Software Messaging,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,201412701-1,"University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States",https://ClinicalTrials.gov/show/NCT04329897
NCT04890652,Digital Interventions to Treat Hazardous Drinking,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science,2000026333|R01AA026844-02S1,"Yale University, New Haven, Connecticut, United States",https://ClinicalTrials.gov/show/NCT04890652
NCT04657471,Hospitalization or Outpatient ManagEment of Patients With SRAS-CoV-2 Infection - Revised HOME-CoV Score Study,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2020-A03067-32,"CHU Angers, Angers, France",https://ClinicalTrials.gov/show/NCT04657471
NCT04926441,Stress Levels and Mental Well-Being Among Students During e-Learning,Observational Model: Cohort|Time Perspective: Retrospective,COVID_International,"Lithuanian Sports University, Kaunas, Lithuania|Jan Dlugosz University in Czestochowa, Częstochowa, Poland|Faculty of Physical Education and Physiotherapy, Opole University of Technology, Opole, Poland|The University School of Physical Education in Wroclaw, Wrocław, Poland|Slovak Medical University in Bratislava, Banská Bystrica, Slovakia|Matej Bel University, Banská Bystrica, Slovakia|Technical University of Košice, Košice, Slovakia|Constantine the Philosopher University in Nitra, Nitra, Slovakia",https://ClinicalTrials.gov/show/NCT04926441
NCT04865081,Clinical Evaluation of an Aerosol Protective Intubation Device on Videolaryngoscopic Intubation Difficulty,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,20212465,"Maisonneuve Rosemont Hospital, Montreal, Quebec, Canada",https://ClinicalTrials.gov/show/NCT04865081
NCT04414826,Preliminary Efficacy of a One-Session Mindfulness Telehealth Intervention for Loneliness,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,2020-04-0088,"Laboratory for the Study of Anxiety Disorders, University of Texas at Austin, Austin, Texas, United States",https://ClinicalTrials.gov/show/NCT04414826
NCT04444986,Bioequivalence Study of Favir 200 mg Film Tablet Kocak Under Fasting Conditions,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Other,NOV2020/01919,"Novagenix Drug R&D Center, Akyurt, Ankara, Turkey|Farmagen Ar-Ge Biyot. Ltd. Sti., Gaziantep, Turkey",https://ClinicalTrials.gov/show/NCT04444986
NCT04363775,Comparison of VieScope vs. Macintosh Laryngoscope for Intubation in Level Cpersonal Protective Equipment Conditions,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,INT_PPE_2020_1,"Lazarski Univeristy, Warsaw, Poland",https://ClinicalTrials.gov/show/NCT04363775
NCT03944603,Longitudinal Innate Immunity and Aging Study,Observational Model: Cohort|Time Perspective: Prospective,18-2607|R01AG058772,"University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States",https://ClinicalTrials.gov/show/NCT03944603
NCT04870775,Effectiveness of a Mindfulness Training Program in Health Care Proffesional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,GESTASTRESS-Covid,"Jose A. Puertas-Gonzalez, Granada, Spain",https://ClinicalTrials.gov/show/NCT04870775
NCT04387708,Care in Patients Hospitalized for Anorexia Nervosa at the Time of the Coronavirus-19 Epidemic (QUALICOVID),Observational Model: Family-Based|Time Perspective: Cross-Sectional,RIPH 2020-01,"Centre Psychothérapique de Nancy, Laxou, France",https://ClinicalTrials.gov/show/NCT04387708
NCT03452774,SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry,Observational Model: Cohort|Time Perspective: Prospective,SYNERGY-AI,"Massive Bio, Inc, New York, New York, United States",https://ClinicalTrials.gov/show/NCT03452774
NCT04885777,Topical Lidocaine Anesthesia for Nasopharyngeal Sampling,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Supportive Care,Ataturk University0000,"Ataturk University, Erzurum, Turkey",https://ClinicalTrials.gov/show/NCT04885777
NCT04939558,Cardiorespiratory Diagnostic Study,Observational Model: Cohort|Time Perspective: Prospective,G001-21,"Modality Partnership, Birmingham, West Midlands, United Kingdom",https://ClinicalTrials.gov/show/NCT04939558
NCT04432038,Healthy Lifestyle or Pro-health Obsession During the Pandemic,Observational Model: Cohort|Time Perspective: Prospective,GdanskUPES,"Gdansk University of Physical Education and Sport, Gdańsk, Poland",https://ClinicalTrials.gov/show/NCT04432038
NCT04424212,ICBT for Mental Health Problems Related to the Coronavirus Pandemic,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,CoronaCope,"Linköping University, Linköping, Östergötland, Sweden",https://ClinicalTrials.gov/show/NCT04424212
NCT04871386,#Stayhealthy - Monitoring and Maintenance of Mental Health Under Conditions of Social Isolation During the Corona Crisis,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,228/2020BO2,"Department of Psychiatry and Psychotherapy, University Hospital Tuebingen, Tuebingen, Baden-Württemberg, Germany",https://ClinicalTrials.gov/show/NCT04871386
NCT04699942,Pilot Study to Evaluate the Revoxa™ System in Hypoxic Patients,Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,6031410,"Kingston Health Sciences Centre, Kingston, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04699942
NCT04523610,Telehealth Intervention Program for Older Adults,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,TIP-OA,"Institute of Community and Family Psychiatry, Montreal, Quebec, Canada",https://ClinicalTrials.gov/show/NCT04523610
NCT04346979,Telerehabilitation-based Yoga and Mindfulness Home Program in Postmenopausal Women Having Social Isolation,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,1,NA,https://ClinicalTrials.gov/show/NCT04346979
NCT04806477,Diagnostic Accuracy Comparison Between Telemedicine and Face-to-face Consultations in Respiratory Infection Patients.,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,3.42E+16,"Hospital Israelita Abert Einstein, São Paulo, SP, Brazil",https://ClinicalTrials.gov/show/NCT04806477
NCT04646421,Responsible Gambling Telephone Intervention to High-risk Gamblers by a State-owned Gambling Operator in Sweden.,Observational Model: Case-Control|Time Perspective: Other,omsorgssamtal,"Lund University, Lund, Sweden",https://ClinicalTrials.gov/show/NCT04646421
NCT04651959,"Bioequivalence Study of Favipiravir 200 mg Film Tablet (Pharma Plant, Turkey) Under Fasting Conditions",Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Other,NOV2020/01941,"Novagenix Drug R&D Center, Akyurt, Ankara, Turkey",https://ClinicalTrials.gov/show/NCT04651959
NCT04406194,"Bioequivalence Study of Favipiravir 200 mg Film Tablet (ATABAY, Turkey) Under Fasting Conditions",Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Other,NOV2020/1917,"Novagenix Drug R&D Center, Akyurt, Ankara, Turkey|Farmagen Ar-Ge Biyot. Ltd. Sti., Sahinbey, Gaziantep, Turkey",https://ClinicalTrials.gov/show/NCT04406194
NCT04400682,"Bioequivalence Study of Favipiravir 200 mg Film Tablet (Novelfarma, Turkey) Under Fasting Conditions",Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Other,NOV2020/1923|FARGE 367,"Novagenix Drug R&D Center, Akyurt, Ankara, Turkey|Farmagen Ar-Ge Biyot. Ltd. Sti., Sahinbey, Gaziantep, Turkey",https://ClinicalTrials.gov/show/NCT04400682
NCT04859699,Reopening Schools Safely and Educating Youth (ROSEY) Research Study,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,STUDY00013064,NA,https://ClinicalTrials.gov/show/NCT04859699
NCT04693689,"Novelty, Conformity and Trust in Vaccines",Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Health Services Research,SG-Trust in Vaccines,"SurveyMonkey, San Mateo, California, United States",https://ClinicalTrials.gov/show/NCT04693689
NCT04683744,Facilitators and Barriers to Cancer Screening: Stakeholder Perspectives on Implementation,Observational Model: Other|Time Perspective: Other,2012926551|CDR-2018C3-14715,"Indiana University, Indianapolis, Indiana, United States",https://ClinicalTrials.gov/show/NCT04683744
NCT04748445,Acute Respiratory Illness Surveillance (AcRIS) With Mobile Application in a Low-Interventional Decentralized Study.,Observational Model: Cohort|Time Perspective: Prospective,X9001293,"Ochsner Medical Center - Jefferson Highway, New Orleans, Louisiana, United States",https://ClinicalTrials.gov/show/NCT04748445
NCT04661189,The Cognitive and spOrt Virtual EPIC Training Study for Cardiovascular Diseases,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Prevention",ICM 2020-2785,"Preventive medicine and physical activity centre (centre EPIC), Montreal Heart Institute, Montréal, Quebec, Canada",https://ClinicalTrials.gov/show/NCT04661189
NCT04502368,Fiberoptic Bronchoscopy and Bronchoalveolar Lavage in Critically Ill Ventilated Patients,Observational Model: Case-Only|Time Perspective: Prospective,SRB2020-289|P2020/375,"Erasme University Hospital - Intensive Care Unit, Brussels, Belgium",https://ClinicalTrials.gov/show/NCT04502368
NCT04339842,Eating Habits of Adults During the Quarantine,Observational Model: Case-Only|Time Perspective: Cross-Sectional,Nutr2020,"Online, Nicosia, Cyprus",https://ClinicalTrials.gov/show/NCT04339842
NCT03262051,Impact of Acute and Chronic Inflammation on Cytochromes P450 Activity Measured With Dried Blood Spot,Observational Model: Cohort|Time Perspective: Prospective,2016-02232,"Geneva University Hospitals, HUG, Genève, Switzerland",https://ClinicalTrials.gov/show/NCT03262051
NCT04476719,"The Bioequivalence Study of Umifenovir 200 mg Capsul (ATABAY, Turkey) Under Fasting Conditions",Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Other,NOV2020/01918,"Novagenix Drug R&D Center, Akyurt, Ankara, Turkey|Farmagen Ar-Ge Biyot. Ltd. Sti., Sahinbey, Gaziantep, Turkey",https://ClinicalTrials.gov/show/NCT04476719
NCT04407000,"Bioequivalence Study of Favipiravir 200 mg Film Tablet (World Medicine, Turkey) Under Fasting Conditions",Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Other,NOV2020/01925,"Novagenix Drug R&D Center, Akyurt, Ankara, Turkey|Farmagen Ar-Ge Biyot. Ltd. Sti., Sahinbey, Gaziantep, Turkey",https://ClinicalTrials.gov/show/NCT04407000
NCT04240886,Open-label Study of APX001 for Treatment of Patients With Invasive Mold Infections Caused by Aspergillus or Rare Molds,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,APX001-202|2019-001386-33,"Clinical Trial Site, Duarte, California, United States|Clinical Trial Site, Sacramento, California, United States|Clinical Trial Site, San Diego, California, United States|Clinical Trial Site, Boston, Massachusetts, United States|Clinical Trial Site, Durham, North Carolina, United States|Clinical Trial Site, Brussels, Belgium|Clinical Trial Site, Brussels, Belgium|Clinical Trial Site, Leuven, Belgium|Clinical Trial Site, Yvoir, Belgium|Clinical Trial Site, Koeln, Germany|Clinical Trial Site, Mainz, Germany|Clinical Trial Site, Haifa, Israel|Clinical Trial Site, Tel Aviv, Israel|Clinical Trial Site, Tel HaShomer, Israel",https://ClinicalTrials.gov/show/NCT04240886
NCT04804943,Pilot Clinical Study of NOA-001 for ARDS (Acute Respiratory Distress Syndrome),Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,NOA001ARDS01,"Showa University Hospital, Tokyo, Japan",https://ClinicalTrials.gov/show/NCT04804943
NCT04891120,Treadmill Stress Test With and Without Mask,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science,2021-4210,"Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Quebec, Canada",https://ClinicalTrials.gov/show/NCT04891120
NCT04666597,Pandemic-adapted Caries Care Multicentre Case Series,Observational Model: Case-Only|Time Perspective: Prospective,IRB00010617,"Indiana University, Indianapolis, Indiana, United States|Tufts University, Boston, Massachusetts, United States|Universidad de Buenos Aires, Buenos Aires, Argentina|Universidad Nacional de Córdoba, Córdoba, Argentina|University of Sao Paulo, São Paulo, Brazil|Universidad El Bosque, Bogotá, Bogotá DC, Colombia|Viva 1A IPS Health Provider, Barranquilla, Colombia|Fundación Universitaria de Colegios de Colombia, Bogotá, Colombia|Corporación Universitaria Rafael Núñez, Cartagena, Colombia|Universidad de Cartagena, Cartagena, Colombia|ACFF Colombian Chapter Manizales Demonstration Territory, Manizales, Colombia|Universidad Cooperativa de Colombia, Medellín, Colombia|Universidad Iberoamericamericana, Santo Domingo, Dominican Republic|Universite Cote d' Azur, Nice, France|Universidad de Guadalajara, Guadalajara, Mexico|ACTA, Amsterdam, Netherlands|Universidad Peruana Cayetano Heredia, Lima, Peru|University of Porto, Porto, Portugal|University of Moscow, Moscow, Russian Federation|University of Sheffield, Sheffield, United Kingdom|Universidad Católica de Uruguay, Buenos aires, Sanmartin, Uruguay",https://ClinicalTrials.gov/show/NCT04666597
NCT04763304,Self-contamination Following Removal of Two Personal Protective Equipment Suits: a Crossover Trial,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention,5646,"Hospital Italiano de Buenos Aires, Ciudad Autonoma de Buenos Aire, Buenos Aires, Argentina",https://ClinicalTrials.gov/show/NCT04763304
NCT04417153,Who Benefits More? Optimising Mindfulness Based Interventions for Improved Psychological Outcomes,Observational Model: Cohort|Time Perspective: Prospective,S-19-176,"National University Singapore, Singapore, Singapore",https://ClinicalTrials.gov/show/NCT04417153
NCT03474965,Study of Dose Confirmation and Safety of Crizanlizumab in Pediatric Sickle Cell Disease Patients,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,CSEG101B2201|2017-001747-12,"University of Alabama 1600 7th ave, Birmingham, Alabama, United States|Phoenix Childrens Hospital CVAL489A2302, Phoenix, Arizona, United States|UC Davis Medical Center, Sacramento, California, United States|Children s National Hospital, Washington, District of Columbia, United States|University of Florida College of Medicine, Gainesville, Florida, United States|Joe DiMaggio Childrens Hospital, Hollywood, Florida, United States|Childrens Healthcare of Atlanta, Atlanta, Georgia, United States|Ann and Robert H Lurie Childrens Hospital of Chicago CTBM100C2407, Chicago, Illinois, United States|University of Chicago Hospital, Chicago, Illinois, United States|Childrens Hospital Boston, Boston, Massachusetts, United States|Childrens Hospital of Michigan, Detroit, Michigan, United States|UMDNJ, New Brunswick, New Jersey, United States|Children's Hospital at Montefiore, Bronx, New York, United States|Duke University Medical Center Oncology, Durham, North Carolina, United States|East Carolina University SC, Greenville, North Carolina, United States|Childrens Hospital of Philadelphia, Philadelphia, Pennsylvania, United States|Medical University of South Carolina Medical Uni of South Carolina, Charleston, South Carolina, United States|St. Jude Children's Research Hosptial, Memphis, Tennessee, United States|Cook Childrens Medical Center Oncology, Fort Worth, Texas, United States|Novartis Investigative Site, Edegem, Antwerpen, Belgium|Novartis Investigative Site, Brussel, Belgium|Novartis Investigative Site, Laeken, Belgium|Novartis Investigative Site, Liege, Belgium|Novartis Investigative Site, Salvador, BA, Brazil|Novartis Investigative Site, Ribeirao Preto, SP, Brazil|Novartis Investigative Site, São Paulo, SP, Brazil|Novartis Investigative Site, Toronto, Ontario, Canada|Novartis Investigative Site, Montreal, Quebec, Canada|Novartis Investigative Site, Medellin, Antioquia, Colombia|Novartis Investigative Site, Cali, Valle Del Cauca, Colombia|Novartis Investigative Site, Monteria, Colombia|Novartis Investigative Site, Paris cedex 15, France|Novartis Investigative Site, Heidelberg, Baden Wuerttemberg, Germany|Novartis Investigative Site, Berlin, Germany|Novartis Investigative Site, Nagpur, Maharashtra, India|Novartis Investigative Site, New Delhi, India|Novartis Investigative Site, Vellore, India|Novartis Investigative Site, Modena, Italy|Novartis Investigative Site, Orbassano, Italy|Novartis Investigative Site, Padova, Italy|Novartis Investigative Site, Beirut, Lebanon|Novartis Investigative Site, Tripoli, Lebanon|Novartis Investigative Site, Muscat, Oman|Novartis Investigative Site, Esplugues de Llobregat, Barcelona, Spain|Novartis Investigative Site, Barcelona, Catalunya, Spain|Novartis Investigative Site, Valencia, Comunidad Valenciana, Spain|Novartis Investigative Site, Palma De Mallorca, Islas Baleares, Spain|Novartis Investigative Site, Madrid, Spain|Novartis Investigative Site, Aarau, Aargau, Switzerland|Novartis Investigative Site, Adana, Turkey|Novartis Investigative Site, Mersin, Turkey|Novartis Investigative Site, London, United Kingdom|Novartis Investigative Site, London, United Kingdom",https://ClinicalTrials.gov/show/NCT03474965
NCT04589923,The VISION-Acute Study,Observational Model: Cohort|Time Perspective: Prospective,PHT/2020/50,"Portsmouth Hospitals NHS Trust, Portsmouth, England, United Kingdom",https://ClinicalTrials.gov/show/NCT04589923
NCT03871491,Azithromycin-Prevention in Labor Use Study (A-PLUS),"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention",CP Azithromycin,"ICDDRB, Dhaka, Bangladesh|Kinshasa School of Public Health, Kinshasa, Congo, The Democratic Republic of the|Institute for Nutrition of Central America and Panama (INCAP), Guatemala City, Guatemala|Jawaharlal Nehru Medical College, Belagavi, India|Lata Medical Research Foundation, Nagpur, India|Moi University School of Medicine, Eldoret, Kenya|The Aga Khan University, Karachi, Pakistan|University Teaching Hospital, Lusaka, Zambia",https://ClinicalTrials.gov/show/NCT03871491
NCT02344290,Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",A5332|11960|1U01HL123339-01|1U01HL123336-01|EU5332,"Alabama CRS, Birmingham, Alabama, United States|University of Arizona CRS, Tucson, Arizona, United States|University of Southern California CRS, Los Angeles, California, United States|UCLA CARE Center CRS, Los Angeles, California, United States|Mills Clinical Research CRS, Los Angeles, California, United States|VA West Los Angeles Medical Center CRS, Los Angeles, California, United States|Los Angeles LGBT Center CRS, Los Angeles, California, United States|Eisenhower Health Center at Rimrock CRS, Palm Springs, California, United States|Stanford AIDS Clinical Trials Unit CRS, Palo Alto, California, United States|UCSD Antiviral Research Center CRS, San Diego, California, United States|Ucsf Hiv/Aids Crs, San Francisco, California, United States|Harbor-UCLA CRS, Torrance, California, United States|University of Colorado Hospital CRS, Aurora, Colorado, United States|Denver Public Health CRS, Denver, Colorado, United States|Yale University CRS, New Haven, Connecticut, United States|VA Connecticut Healthcare System CRS, West Haven, Connecticut, United States|Whitman-Walker Health CRS, Washington, District of Columbia, United States|Georgetown University CRS (GU CRS), Washington, District of Columbia, United States|Capital Medical Associates, PC CRS, Washington, District of Columbia, United States|Infectious Diseases Clinic, Washington DC Veterans Affairs Medical Center CRS, Washington, District of Columbia, United States|Malcom Randall VA Medical Center CRS, Gainesville, Florida, United States|AHF-The Kinder Medical Group CRS, Miami, Florida, United States|The University of Miami AIDS Clinical Research Unit (ACRU) CRS, Miami, Florida, United States|University of Miami Infectious Disease Research Unit at Jackson Memorial Hospital CRS, Miami, Florida, United States|AHF - South Beach CRS, Miami, Florida, United States|Orlando Immunology Center CRS, Orlando, Florida, United States|Community AIDS Network/Comprehensive Care Clinic CRS, Sarasota, Florida, United States|Florida Department of Health - Hillsborough County, Tampa, Florida, United States|AIDS Research and Treatment Center of the Treasure Coast CRS, Vero Beach, Florida, United States|The Ponce de Leon Center CRS, Atlanta, Georgia, United States|Augusta University Research Institute, Inc. CRS, Augusta, Georgia, United States|Northwestern University CRS, Chicago, Illinois, United States|Rush University CRS, Chicago, Illinois, United States|UIC Project WISH CRS, Chicago, Illinois, United States|Indiana University Infectious Diseases Research CRS, Indianapolis, Indiana, United States|Department of Internal Medicine, University of Iowa Hospitals & Clinics CRS, Iowa City, Iowa, United States|Bluegrass Care Clinic/University of Kentucky Research Foundation CRS, Lexington, Kentucky, United States|550 Clinic -University of Louisville CRS, Louisville, Kentucky, United States|Tulane - Louisiana Community AIDS Research Program (T-LaCARP) CRS, New Orleans, Louisiana, United States|Johns Hopkins University CRS, Baltimore, Maryland, United States|Tufts Medical Center CRS, Boston, Massachusetts, United States|Massachusetts General Hospital CRS (MGH CRS), Boston, Massachusetts, United States|Brigham and Women's Hospital Therapeutics Clinical Research Site (BWH TCRS) CRS, Boston, Massachusetts, United States|Boston Medical Center CRS, Boston, Massachusetts, United States|Baystate Infectious Diseases Clinical Research CRS, Springfield, Massachusetts, United States|Henry Ford Hosp. CRS, Detroit, Michigan, United States|St. John Newland Medical Associates CRS, Southfield, Michigan, United States|Abbott Northwestern Hospital CRS, Minneapolis, Minnesota, United States|University of Mississippi Medical Center CRS, Jackson, Mississippi, United States|Washington University Therapeutics (WT) CRS, Saint Louis, Missouri, United States|Specialty Care Center CRS, Omaha, Nebraska, United States|Cooper Univ. Hosp. CRS, Camden, New Jersey, United States|New Jersey Medical School Clinical Research Center CRS, Newark, New Jersey, United States|James J Peters VA Medical Center CRS, Bronx, New York, United States|Mount Sinai Beth Israel CRS, New York, New York, United States|VA New York Harbor Healthcare System (NYHHS), NY Campus CRS, New York, New York, United States|Weill Cornell Chelsea CRS, New York, New York, United States|Mount Sinai Downtown CRS, New York, New York, United States|Mount Sinai West Samuels CRS, New York, New York, United States|Mount Sinai St. Luke's Morningside CRS, New York, New York, United States|Infectious Disease Clinical and Translational Research Center (CTRC) CRS, New York, New York, United States|Columbia P&S CRS, New York, New York, United States|Weill Cornell Uptown CRS, New York, New York, United States|University of Rochester Adult HIV Therapeutic Strategies Network CRS, Rochester, New York, United States|Chapel Hill CRS, Chapel Hill, North Carolina, United States|Duke University Medical Center CRS, Durham, North Carolina, United States|Greensboro CRS, Greensboro, North Carolina, United States|Wake Forest Baptist Medical Center CRS, Winston-Salem, North Carolina, United States|Cincinnati Clinical Research Site, Cincinnati, Ohio, United States|Case Clinical Research Site, Cleveland, Ohio, United States|Ohio State University CRS, Columbus, Ohio, United States|University of Toledo Medical Center CRS, Toledo, Ohio, United States|Oklahoma State University Center for Health Sciences CRS, Tulsa, Oklahoma, United States|Division of Infectious Diseases Clinical Research Center- Drexel University CRS, Philadelphia, Pennsylvania, United States|Penn Therapeutics, CRS, Philadelphia, Pennsylvania, United States|Center of Translational AIDS Research, Lewis Katz School of Medicine at Temple University CRS, Philadelphia, Pennsylvania, United States|Positive Health Clinic CRS, Pittsburgh, Pennsylvania, United States|University of Pittsburgh CRS, Pittsburgh, Pennsylvania, United States|The Miriam Hospital Clinical Research Site (TMH CRS) CRS, Providence, Rhode Island, United States|Medical University of South Carolina: Division of Infectious Diseases CRS, Charleston, South Carolina, United States|Palmetto Health Clinical Trial Department CRS, Columbia, South Carolina, United States|Vanderbilt Therapeutics (VT) CRS, Nashville, Tennessee, United States|Trinity Health and Wellness Center CRS, Dallas, Texas, United States|Dallas VA Medical Center CRS, Dallas, Texas, United States|UT Southwestern HIV/ID Clinical Trials Unit CRS, Dallas, Texas, United States|Houston AIDS Research Team CRS, Houston, Texas, United States|Michael E. DeBakey VAMC REPRIEVE CRS, Houston, Texas, United States|Inova Heart and Vascular Institute CRS, Falls Church, Virginia, United States|Virginia Commonwealth University CRS, Richmond, Virginia, United States|University of Washington AIDS CRS, Seattle, Washington, United States|Medical College of Wisconsin, Inc. CRS, Milwaukee, Wisconsin, United States|Gaborone CRS, Gaborone, South-East District, Botswana|Tropical Medicine Foundation Dr. Heitor Vieira Dourado CRS, Manaus, Amazonas, Brazil|School of Medicine, Federal University of Minas Gerais CRS, Belo Horizonte, Minas Gerais, Brazil|HGNI HIV Family Care Clinic - HHFCC CRS, Nova Iguacu, Rio De Janeiro, Brazil|Hospital Nossa Senhora da Conceicao CRS, Porto Alegre, Rio Grande Do Sul, Brazil|Centro de Referencia e Treinamento DST/AIDS CRS, Sao Paulo, São Paulo, Brazil|Projeto Praça Onze Pesquisa em Saúde CRS, Rio de Janeiro, Brazil|Hospital Federal dos Servidores do Estado CRS, Rio de Janeiro, Brazil|Instituto de Pesquisa Clinica Evandro Chagas (IPEC) CRS, Rio de Janeiro, Brazil|Instituto de Infectologia Emilio Ribas CRS, Sao Paulo, Brazil|Centro de Pesquisas Clínicas IC-HCFMUSP CRS, Sao Paulo, Brazil|Vancouver ID Research & Care Centre Society CRS, Vancouver, British Columbia, Canada|Hamilton Health Sciences - Special Immunology Services Clinic CRS, Hamilton, Ontario, Canada|Maple Leaf Research CRS, Toronto, Ontario, Canada|Toronto General Hospital CRS, Toronto, Ontario, Canada|Chronic Viral Illness Service CRS, Montreal, Quebec, Canada|Centre hospitalier de l'Université Laval CRS, Quebec City, Quebec, Canada|GHESKIO Institute of Infectious Diseases and Reproductive Health (GHESKIO - IMIS) CRS, Port-au-Prince, Haiti|Les Centres GHESKIO Clinical Research Site (GHESKIO-INLR) CRS, Port-au-Prince, Haiti|Byramjee Jeejeebhoy Medical College (BJMC) CRS, Pune, Maharashtra, India|Chennai Antiviral Research and Treatment (CART) CRS, Chennai, Tamil Nadu, India|Barranco CRS, Lima, Peru|San Miguel CRS, Lima, Peru|Puerto Rico AIDS Clinical Trials Unit CRS, San Juan, Puerto Rico|Soweto ACTG CRS, Johannesburg, Gauteng, South Africa|Wits Helen Joseph Hospital CRS (Wits HJH CRS), Johannesburg, Gauteng, South Africa|Durban International Clinical Research Site CRS, Durban, Kwa Zulu Natal, South Africa|University of Cape Town Lung Institute (UCTLI) CRS, Cape Town, Western Cape Province, South Africa|Famcru Crs, Tygerberg, Western Cape Province, South Africa|Hospital General Universitario de Alicante, Alicante, Spain|Hospital Germans Trias i Pujol, Badalona, Spain|Hospital Universitario Valle d'Hebron, Barcelona, Spain|Hospital Clinic de Barcelona, Barcelona, Spain|Hospital Universitario de Bellvitge, Barcelona, Spain|Hospital Universitario de Basurto de Basurto, Bilbao, Spain|Hospital General Universitario De Elche, Elche, Spain|Hospital Gregorio Universitario Maranon, Madrid, Spain|Hospital Universitario Ramon y Cajal, Madrid, Spain|Hospital Universitario Clinico San Carlos, Madrid, Spain|Hospital Universitario 12 de Octubre, Madrid, Spain|Hospital Universitario La Paz, Madrid, Spain|Hospital Universitario Virgen de la Victoria, Málaga, Spain|Thai Red Cross AIDS Research Centre (TRC-ARC) CRS, Bangkok, Thailand|Chiang Mai University HIV Treatment (CMU HIV Treatment) CRS, Chiang Mai, Thailand|Joint Clinical Research Centre (JCRC)/Kampala Clinical Research Site, Kampala, Uganda|Milton Park CRS, Harare, Zimbabwe",https://ClinicalTrials.gov/show/NCT02344290
NCT04386876,"Bioequivalence Study of Lopinavir/Ritonavir 200/50 mg Film Tablet (World Medicine Ilac, Turkey) Under Fasting Conditions",Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Other,NOV2020/01911|FARGE365,"Novagenix Drug R&D Center, Akyurt, Ankara, Turkey|Farmagen Ar-Ge Biyot. Ltd. Sti., Sahinbey, Gaziantep, Turkey",https://ClinicalTrials.gov/show/NCT04386876
NCT04621552,Virtual Simulation for Woven EndoBridge Device Sizing,Observational Model: Case-Control|Time Perspective: Retrospective,RECHMPL20_0601,"Uhmontpellier, Montpellier, France",https://ClinicalTrials.gov/show/NCT04621552
NCT04761510,Mindfulness-SOS: Stress Reduction for Refugees,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,Mindfulness-SOS for Refugees,"Assaf, Tel Aviv, Merkaz, Israel",https://ClinicalTrials.gov/show/NCT04761510
NCT04247620,DiaBetter Together for Young Adults With Type 1 Diabetes,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Supportive Care,H-45360|1R01DK119246,"Baylor College of Medicine, Houston, Texas, United States",https://ClinicalTrials.gov/show/NCT04247620
NCT04772820,Feasibility of Remote Home Support Coaches (SOCIAL Study),Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,2020P004113|3P30AG031679-10S2,"University of Maryland School of Medicine, Baltimore, Maryland, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT04772820
NCT04897646,The TELEAP1 CPAP-telemonitoring Study,Observational Model: Cohort|Time Perspective: Prospective,RECHMPL21_0082,"Uhmontpellier, Montpellier, France",https://ClinicalTrials.gov/show/NCT04897646
NCT04684602,Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,ICSS-2020-032,"Southern California Hospital at Culver City / Southern California Hospital at Hollywood / Multiple US-based Sub-Investigator Sites, Culver City, California, United States",https://ClinicalTrials.gov/show/NCT04684602
NCT04939350,Evaluation of the Vaccination Coverage of Cirrhotic Patients Followed in the General Hospitals in France in 2021,Observational Model: Cohort|Time Perspective: Prospective,IDRCB 2021-A00343-38,"Centre Hospitalier Sud Francilien, Corbeil-essonnes Cedex, France",https://ClinicalTrials.gov/show/NCT04939350
NCT04723602,"Evaluation of Safety, Tolerability and Immune Responses of Ebola-S and Marburg Vaccines in Healthy Adults",Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,Sabin 001,"Oklahoma Blood Institute (OBI), Oklahoma City, Oklahoma, United States",https://ClinicalTrials.gov/show/NCT04723602
